<SEC-DOCUMENT>0001213900-23-032036.txt : 20230424
<SEC-HEADER>0001213900-23-032036.hdr.sgml : 20230424
<ACCEPTANCE-DATETIME>20230424161848
ACCESSION NUMBER:		0001213900-23-032036
CONFORMED SUBMISSION TYPE:	20-F
PUBLIC DOCUMENT COUNT:		110
CONFORMED PERIOD OF REPORT:	20221231
FILED AS OF DATE:		20230424
DATE AS OF CHANGE:		20230424

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Beamr Imaging Ltd.
		CENTRAL INDEX KEY:			0001899005
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-PREPACKAGED SOFTWARE [7372]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			L3
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		20-F
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-41523
		FILM NUMBER:		23840335

	BUSINESS ADDRESS:	
		STREET 1:		10 HAMANOFIM STREET
		CITY:			HERZELIYA
		STATE:			L3
		ZIP:			43305
		BUSINESS PHONE:		972-52-325-8766

	MAIL ADDRESS:	
		STREET 1:		10 HAMANOFIM STREET
		CITY:			HERZELIYA
		STATE:			L3
		ZIP:			43305
</SEC-HEADER>
<DOCUMENT>
<TYPE>20-F
<SEQUENCE>1
<FILENAME>f20f2022_beamrimaging.htm
<DESCRIPTION>ANNUAL REPORT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Mon Apr 24 19:58:58 UTC 2023 -->
<html xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:dtr="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:bmr="http://www.beil.com/20221231" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:compsci="http://compsciresources.com" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:us-types="http://fasb.org/us-types/2022" xmlns:srt="http://fasb.org/srt/2022" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns="http://www.w3.org/1999/xhtml">
<head>
     <title> </title>

<meta content="text/html" http-equiv="Content-Type" />
</head>
<body><div style="font: 10pt Times New Roman, Times, Serif"><div>

</div><p style="text-align: center; margin-top: 0; margin-bottom: 0"></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="text-align: center; margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><b>UNITED STATES</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><b>SECURITIES AND EXCHANGE
COMMISSION</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><b>WASHINGTON, DC 20549</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><b>FORM <ix:nonNumeric contextRef="c0" name="dei:DocumentType">20-F</ix:nonNumeric></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><ix:nonNumeric contextRef="c0" format="ixt:fixed-false" name="dei:DocumentRegistrationStatement">&#9744;</ix:nonNumeric> REGISTRATION
STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">OR</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><ix:nonNumeric contextRef="c0" format="ixt:fixed-true" name="dei:DocumentAnnualReport">&#9746;</ix:nonNumeric> ANNUAL
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">For the fiscal year ended
<ix:nonNumeric contextRef="c0" format="ixt:date-monthname-day-year-en" name="dei:DocumentPeriodEndDate"><ix:nonNumeric contextRef="c0" format="ixt:date-monthname-day-en" name="dei:CurrentFiscalYearEndDate">December 31</ix:nonNumeric>, <ix:nonNumeric contextRef="c0" name="dei:DocumentFiscalYearFocus">2022</ix:nonNumeric></ix:nonNumeric></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">OR</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><ix:nonNumeric contextRef="c0" format="ixt:fixed-false" name="dei:DocumentTransitionReport"><span style="font-family: Times New Roman, Times, Serif">&#9744;</span></ix:nonNumeric>
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">OR</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><ix:nonNumeric contextRef="c0" format="ixt:fixed-false" name="dei:DocumentShellCompanyReport"><span style="font-family: Times New Roman, Times, Serif">&#9744;</span></ix:nonNumeric>
SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">Date of event requiring
this shell company report ____________</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">For the transition period
from ____________ to ____________</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">Commission File No.: &#160;<ix:nonNumeric contextRef="c0" name="dei:EntityFileNumber">001-41523</ix:nonNumeric></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><ix:nonNumeric contextRef="c0" name="dei:EntityRegistrantName"><b>Beamr Imaging Ltd.</b></ix:nonNumeric></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><i>(Exact name of registrant
as specified in its charter)</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><i>Translation of registrant&#8217;s
name into English:</i>&#160;Not applicable</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr> <td style="border-bottom: black 1.5pt solid; vertical-align: bottom; width: 49%; font-size: 10pt; text-align: center"><span style="font-size: 10pt"><b>State of <ix:nonNumeric contextRef="c0" format="ixt-sec:edgarprovcountryen" name="dei:EntityIncorporationStateCountryCode">Israel</ix:nonNumeric></b></span></td> <td style="vertical-align: top; width: 2%; font-size: 10pt">&#160;</td> <td style="border-bottom: black 1.5pt solid; vertical-align: top; width: 49%"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><ix:nonNumeric contextRef="c0" name="dei:EntityAddressAddressLine1"><b>10 HaManofim Street</b></ix:nonNumeric></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><ix:nonNumeric contextRef="c0" name="dei:EntityAddressAddressLine2">Herzeliya</ix:nonNumeric>, <ix:nonNumeric contextRef="c0" name="dei:EntityAddressPostalZipCode">4672561</ix:nonNumeric>, <ix:nonNumeric contextRef="c0" format="ixt-sec:countrynameen" name="dei:EntityAddressCountry"><ix:nonNumeric contextRef="c0" name="dei:EntityAddressCityOrTown">Israel</ix:nonNumeric></ix:nonNumeric></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Tel: +<span style="-sec-ix-hidden: hidden-fact-0"><span style="-sec-ix-hidden: hidden-fact-1">1-888-520-8735</span></span></b></p></td></tr> <tr style="vertical-align: top"> <td style="font-size: 10pt; text-align: center"><span style="font-size: 10pt"><i>(Jurisdiction of incorporation or organization)</i></span></td> <td style="font-size: 10pt">&#160;</td> <td style="font-size: 10pt; text-align: center"><span style="font-size: 10pt"><i>(Address of principal executive offices)</i></span></td></tr> </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p><div>

</div><div><b><ix:nonNumeric contextRef="c0" continuedAt="_ContactPersonnelName-c0_cont_1" name="dei:ContactPersonnelName"><ix:nonNumeric contextRef="c1" continuedAt="_ContactPersonnelName-c1_cont_1" name="dei:ContactPersonnelName"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">Sharon Carmel</p></ix:nonNumeric></ix:nonNumeric></b></div><div>

</div><ix:continuation id="_ContactPersonnelName-c0_cont_1"><ix:continuation id="_ContactPersonnelName-c1_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><b>Chief Executive Officer</b></p></ix:continuation></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><ix:nonNumeric contextRef="c1" name="dei:ContactPersonnelEmailAddress"><b>sharon@beamr.com</b></ix:nonNumeric></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><ix:nonNumeric contextRef="c1" name="dei:EntityAddressAddressLine1"><b>10 HaManofim Street</b></ix:nonNumeric></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><b><ix:nonNumeric contextRef="c1" name="dei:EntityAddressAddressLine2">Herzeliya</ix:nonNumeric>, <ix:nonNumeric contextRef="c1" name="dei:EntityAddressPostalZipCode">4672561</ix:nonNumeric>,
<ix:nonNumeric contextRef="c1" name="dei:EntityAddressCityOrTown"><ix:nonNumeric contextRef="c1" format="ixt-sec:countrynameen" name="dei:EntityAddressCountry">Israel</ix:nonNumeric></ix:nonNumeric></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><i>(Name, Telephone, E-mail
and/or Facsimile number and Address of Company Contact Person)</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">Securities registered
or to be registered pursuant to Section 12(b) of the Act:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; width: 32%; text-align: center"><span style="font-size: 10pt"><b>Title of each class to be registered</b></span></td> <td style="white-space: nowrap; width: 2%; text-align: center">&#160;</td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; width: 32%; text-align: center"><span style="font-size: 10pt"><b>Trading Symbol(s)</b></span></td> <td style="width: 2%; text-align: center">&#160;</td> <td style="border-bottom: black 1.5pt solid; width: 32%; text-align: center"><span style="font-size: 10pt"><b>Name of each exchange on which each<br/>
class is to be registered</b></span></td></tr> <tr style="vertical-align: top; background-color: #CCEEFF"> <td style="text-align: center"><ix:nonNumeric contextRef="c0" name="dei:Security12bTitle"><span style="font-size: 10pt">Ordinary shares, par value NIS 0.05 per share</span></ix:nonNumeric></td> <td style="text-align: center">&#160;</td> <td style="text-align: center"><ix:nonNumeric contextRef="c0" name="dei:TradingSymbol"><span style="font-size: 10pt">BMR</span></ix:nonNumeric></td> <td style="text-align: center">&#160;</td> <td style="text-align: center"><span style="font-size: 10pt"><ix:nonNumeric contextRef="c0" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric> Capital Market</span></td></tr> </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">Securities registered
or to be registered pursuant to Section 12(g) of the Act: None</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">Securities for which there
is a reporting obligation pursuant to Section 15(d) of the Act: None</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"></p><div>

</div><!-- Field: Page; Sequence: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0; margin-bottom: 0">&#160;</p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Number of outstanding shares
of each of the issuer&#8217;s classes of capital or common stock as of December 31, 2022: <ix:nonFraction contextRef="c2" decimals="INF" format="ixt:num-dot-decimal" name="dei:EntityCommonStockSharesOutstanding" scale="0" unitRef="shares">10,932,896</ix:nonFraction> ordinary shares.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Indicate
by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Yes
<span style="font-family: Times New Roman, Times, Serif">&#9744;</span> &#160;<ix:nonNumeric contextRef="c0" name="dei:EntityWellKnownSeasonedIssuer">No</ix:nonNumeric> <span style="font-family: Times New Roman, Times, Serif">&#9746;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">If
this report is an annual or transition report, indicate by check mark if the registrant is not required to file reports pursuant to Section
13 or 15(d) of the Exchange Act of 1934.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Yes
<span style="font-family: Times New Roman, Times, Serif">&#9744;</span> &#160;<ix:nonNumeric contextRef="c0" name="dei:EntityVoluntaryFilers">No</ix:nonNumeric> <span style="font-family: Times New Roman, Times, Serif">&#9746;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Indicate
by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during
the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to
such filing requirements for the past 90 days.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><ix:nonNumeric contextRef="c0" name="dei:EntityCurrentReportingStatus">Yes</ix:nonNumeric>
<span style="font-family: Times New Roman, Times, Serif">&#9746;</span> &#160;No <span style="font-family: Times New Roman, Times, Serif">&#9744;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Indicate
by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule
405 of Regulation S-T during the preceding 12 months.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><ix:nonNumeric contextRef="c0" name="dei:EntityInteractiveDataCurrent">Yes</ix:nonNumeric>
<span style="font-family: Times New Roman, Times, Serif">&#9746;</span> &#160;No <span style="font-family: Times New Roman, Times, Serif">&#9744;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Indicate
by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or an emerging growth
company.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 25%; text-align: justify"><span style="font-size: 10pt">Large accelerated filer &#9744;</span></td> <td style="width: 25%; text-align: justify"><span style="font-size: 10pt">Accelerated filer &#9744;</span></td> <td style="width: 25%; text-align: justify"><ix:nonNumeric contextRef="c0" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory"><span style="font-size: 10pt">Non-accelerated filer</span></ix:nonNumeric></td> <td style="width: 25%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;</span></td></tr> <tr style="vertical-align: top"> <td style="text-align: justify">&#160;</td> <td style="text-align: justify">&#160;</td> <td style="text-align: justify"><span style="font-size: 10pt">Emerging Growth Company</span></td> <td style="text-align: justify"><ix:nonNumeric contextRef="c0" format="ixt:fixed-true" name="dei:EntityEmergingGrowthCompany"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;</span></ix:nonNumeric></td></tr> </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">If
an emerging growth company that prepares its financial statements in accordance with U.S. GAAP, indicate by check mark if the registrant
has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant
to Section 13(a) Exchange Act. <ix:nonNumeric contextRef="c0" format="ixt:fixed-true" name="dei:EntityExTransitionPeriod"><span style="font-family: Times New Roman, Times, Serif">&#9746;</span></ix:nonNumeric></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Indicate
by check mark whether the registrant has filed a report on and attestation to its management&#8217;s assessment of the effectiveness of
its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public
accounting firm that prepared or issued its audit report. <ix:nonNumeric contextRef="c0" format="ixt:fixed-false" name="dei:IcfrAuditorAttestationFlag"><span style="font-family: Times New Roman, Times, Serif">&#9744;</span></ix:nonNumeric></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If securities are registered
pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing
reflect the correction of an error to previously issued financial statements. <span style="font-family: Times New Roman, Times, Serif">&#9744;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 16.2pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Indicate by check mark whether
any of those error corrections are restatements that required a recovery analysis of incentive based compensation received by any of the
registrant&#8217;s executive officers during the relevant recovery period pursuant to &#167;240.10D-1(b). <span style="font-family: Times New Roman, Times, Serif">&#9744;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Indicate
by check mark which basis of accounting the registrant has used to prepare the financial statements included in this filing.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="-sec-ix-hidden: hidden-fact-2">U.S.
GAAP</span> <span style="font-family: Times New Roman, Times, Serif">&#9746;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">International
Financial Reporting Standards as issued by the International Accounting Standards Board&#160;<span style="font-family: Times New Roman, Times, Serif">&#9744;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Other
<span style="font-family: Times New Roman, Times, Serif">&#9744;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">If
&#8220;Other&#8221; has been checked in response to the previous question, indicate by check mark which financial statement item the registrant
has elected to follow.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#9744;</span>
Item 17 &#160;<span style="font-family: Times New Roman, Times, Serif">&#9744;</span> Item 18</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">If
this is an annual report, indicate by check mark whether the registrant is a shell company.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Yes
<span style="font-family: Times New Roman, Times, Serif">&#9744;</span> &#160;No <ix:nonNumeric contextRef="c0" format="ixt:fixed-false" name="dei:EntityShellCompany"><span style="font-family: Times New Roman, Times, Serif">&#9746;</span></ix:nonNumeric></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"></p><div>

</div><!-- Field: Page; Sequence: 2 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0; margin-bottom: 0">&#160;</p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>TABLE OF CONTENTS</b>&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="vertical-align: top; width: 10%; text-align: justify">&#160;</td>
    <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; width: 80%; text-align: justify">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; vertical-align: bottom; width: 10%; text-align: center"><span style="font-size: 10pt"><b>Page</b></span></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td colspan="2" style="vertical-align: top; text-align: justify"><span style="font-size: 10pt"><a href="#a_001">INTRODUCTION</a></span></td>
    <td style="vertical-align: bottom; text-align: center">iii</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td colspan="2" style="text-align: justify"><a href="#a_002"><span style="font-size: 10pt">CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS</span></a></td>
    <td style="text-align: center">iv</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td colspan="2" style="text-align: justify"><span style="font-size: 10pt">EXPLANATORY NOTE</span></td>
    <td style="text-align: center"></td></tr>
  <tr style="background-color: White">
    <td colspan="2" style="vertical-align: top; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><a href="#a_003"><span style="font-size: 10pt">PART I</span></a></td>
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: justify">&#160;</td>
    <td style="text-align: center">1</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; text-align: justify">&#160;</td>
    <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-size: 10pt">ITEM 1.</span></td>
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: justify"><a href="#a_004"><span style="font-size: 10pt">IDENTITY OF DIRECTORS, SENIOR MANAGEMENT AND ADVISERS</span></a></td>
    <td style="text-align: center">1</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: justify"><span style="font-size: 10pt">ITEM 2.</span></td>
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: justify"><a href="#a_005"><span style="font-size: 10pt">OFFER STATISTICS AND EXPECTED TIMETABLE</span></a></td>
    <td style="text-align: center">1</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-size: 10pt">ITEM 3.</span></td>
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: justify"><a href="#a_006"><span style="font-size: 10pt">KEY INFORMATION</span></a></td>
    <td style="text-align: center">1</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: justify"><span style="font-size: 10pt">A.</span></td>
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: justify"><a href="#a_007"><span style="font-size: 10pt">Reserved</span></a></td>
    <td style="text-align: center">1</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-size: 10pt">B.</span></td>
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: justify"><a href="#a_008"><span style="font-size: 10pt">Capitalization and Indebtedness</span></a></td>
    <td style="text-align: center">1</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: justify"><span style="font-size: 10pt">C.</span></td>
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: justify"><a href="#a_009"><span style="font-size: 10pt">Reasons for the Offer and Use of Proceeds</span></a></td>
    <td style="text-align: center">1</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-size: 10pt">D.</span></td>
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: justify"><a href="#a_010"><span style="font-size: 10pt">Risk Factors</span></a></td>
    <td style="text-align: center">1</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: justify"><span style="font-size: 10pt">ITEM 4.</span></td>
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: justify"><a href="#a_011"><span style="font-size: 10pt">INFORMATION ON THE COMPANY</span></a></td>
    <td style="text-align: center">43</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-size: 10pt">A.</span></td>
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: justify"><a href="#a_012"><span style="font-size: 10pt">History and Development of the Company</span></a></td>
    <td style="text-align: center">43</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: justify"><span style="font-size: 10pt">B.</span></td>
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: justify"><a href="#a_013"><span style="font-size: 10pt">Business Overview</span></a></td>
    <td style="text-align: center"><span style="font-size: 10pt">44</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-size: 10pt">C.</span></td>
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: justify"><a href="#a_014"><span style="font-size: 10pt">Organizational Structure</span></a></td>
    <td style="text-align: center">61</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: justify"><span style="font-size: 10pt">D.</span></td>
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: justify"><a href="#a_015"><span style="font-size: 10pt">Property, Plants and Equipment</span></a></td>
    <td style="text-align: center">61</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-size: 10pt">ITEM 4A.</span></td>
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: justify"><a href="#a_016"><span style="font-size: 10pt">UNRESOLVED STAFF COMMENTS</span></a></td>
    <td style="text-align: center">61</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: justify"><span style="font-size: 10pt">ITEM 5.</span></td>
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: justify"><a href="#a_017"><span style="font-size: 10pt">OPERATING AND FINANCIAL REVIEW AND PROSPECTS</span></a></td>
    <td style="text-align: center">61</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-size: 10pt">A.</span></td>
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: justify"><a href="#a_018"><span style="font-size: 10pt">Operating Results</span></a></td>
    <td style="text-align: center">66</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: justify"><span style="font-size: 10pt">B.</span></td>
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: justify"><a href="#a_019"><span style="font-size: 10pt">Liquidity and Capital Resources</span></a></td>
    <td style="text-align: center">69</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-size: 10pt">C.</span></td>
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: justify"><a href="#a_020"><span style="font-size: 10pt">Research and Development, Patents and Licenses</span></a></td>
    <td style="text-align: center">72</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: justify"><span style="font-size: 10pt">D.</span></td>
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: justify"><a href="#a_022"><span style="font-size: 10pt">Trend Information</span></a></td>
    <td style="text-align: center">72</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-size: 10pt">E.</span></td>
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: justify"><a href="#a_023"><span style="font-size: 10pt">Critical Accounting Estimates</span></a></td>
    <td style="text-align: center">73</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: justify"><span style="font-size: 10pt">ITEM 6.</span></td>
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: justify"><a href="#a_024"><span style="font-size: 10pt">DIRECTORS, SENIOR MANAGEMENT AND EMPLOYEES</span></a></td>
    <td style="text-align: center">76</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-size: 10pt">A.</span></td>
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: justify"><a href="#a_025"><span style="font-size: 10pt">Directors and Senior Management</span></a></td>
    <td style="text-align: center">76</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: justify"><span style="font-size: 10pt">B.</span></td>
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: justify"><a href="#a_026"><span style="font-size: 10pt">Compensation</span></a></td>
    <td style="text-align: center">79</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-size: 10pt">C.</span></td>
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: justify"><a href="#a_027"><span style="font-size: 10pt">Board Practices</span></a></td>
    <td style="text-align: center">80</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: justify"><span style="font-size: 10pt">D.</span></td>
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: justify"><a href="#a_028"><span style="font-size: 10pt">Employees</span></a></td>
    <td style="text-align: center">95</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-size: 10pt">E.</span></td>
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: justify"><a href="#a_029"><span style="font-size: 10pt">Share Ownership</span></a></td>
    <td style="text-align: center">95</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: justify"><span style="font-size: 10pt">F.</span></td>
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: justify"><a href="#a_030"><span style="font-size: 10pt">Disclosure of a registrant&#8217;s action to recover erroneously awarded
    compensation</span></a></td>
    <td style="text-align: center">98</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-size: 10pt">ITEM 7.</span></td>
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: justify"><a href="#a_031"><span style="font-size: 10pt">MAJOR SHAREHOLDERS AND RELATED PARTY TRANSACTIONS</span></a></td>
    <td style="text-align: center">98</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: justify"><span style="font-size: 10pt">A.</span></td>
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: justify"><a href="#a_032"><span style="font-size: 10pt">Major Shareholders</span></a></td>
    <td style="text-align: center">98</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-size: 10pt">B.</span></td>
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: justify"><a href="#a_033"><span style="font-size: 10pt">Related Party Transactions</span></a></td>
    <td style="text-align: center">101</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: justify"><span style="font-size: 10pt">C.</span></td>
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: justify"><a href="#a_034"><span style="font-size: 10pt">Interests of Experts and Counsel</span></a></td>
    <td style="text-align: center">102</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-size: 10pt">ITEM 8.</span></td>
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: justify"><a href="#a_035"><span style="font-size: 10pt">FINANCIAL INFORMATION</span></a></td>
    <td style="text-align: center">102</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: justify"><span style="font-size: 10pt">A.</span></td>
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: justify"><a href="#a_036"><span style="font-size: 10pt">Consolidated Statements and Other Financial Information</span></a></td>
    <td style="text-align: center">102</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-size: 10pt">B.</span></td>
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: justify"><a href="#a_037"><span style="font-size: 10pt">Significant Changes</span></a></td>
    <td style="text-align: center">103</td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 3; Options: NewSection; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="width: 10%; text-align: justify"><span style="font-size: 10pt">ITEM 9.</span></td>
    <td style="text-indent: -0.125in; padding-left: 0.125in; width: 80%; text-align: left"><a href="#a_038"><span style="font-size: 10pt">THE OFFER AND LISTING</span></a></td>
    <td style="width: 10%; text-align: center">103</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: justify"><span style="font-size: 10pt">A.</span></td>
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><a href="#a_039"><span style="font-size: 10pt">Offer and Listing Details</span></a></td>
    <td style="text-align: center">103</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-size: 10pt">B.</span></td>
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><a href="#a_040"><span style="font-size: 10pt">Plan of Distribution</span></a></td>
    <td style="text-align: center">103</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: justify"><span style="font-size: 10pt">C.</span></td>
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><a href="#a_041"><span style="font-size: 10pt">Markets</span></a></td>
    <td style="text-align: center">103</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-size: 10pt">D.</span></td>
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><a href="#a_042"><span style="font-size: 10pt">Selling Shareholders</span></a></td>
    <td style="text-align: center">103</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: justify"><span style="font-size: 10pt">E.</span></td>
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><a href="#a_043"><span style="font-size: 10pt">Dilution</span></a></td>
    <td style="text-align: center">103</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-size: 10pt">F.</span></td>
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><a href="#a_044"><span style="font-size: 10pt">Expenses of the Issue</span></a></td>
    <td style="text-align: center">103</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: justify"><span style="font-size: 10pt">ITEM 10.</span></td>
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><a href="#a_045"><span style="font-size: 10pt">ADDITIONAL INFORMATION</span></a></td>
    <td style="text-align: center">103</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-size: 10pt">A.</span></td>
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><a href="#a_046"><span style="font-size: 10pt">Share Capital</span></a></td>
    <td style="text-align: center">103</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: justify"><span style="font-size: 10pt">B.</span></td>
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><a href="#a_047"><span style="font-size: 10pt">Articles of Association</span></a></td>
    <td style="text-align: center">103</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-size: 10pt">C.</span></td>
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><a href="#a_048"><span style="font-size: 10pt">Material Contracts</span></a></td>
    <td style="text-align: center">103</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: justify"><span style="font-size: 10pt">D.</span></td>
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><a href="#a_049"><span style="font-size: 10pt">Exchange Controls</span></a></td>
    <td style="text-align: center">104</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-size: 10pt">E.</span></td>
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><a href="#a_050"><span style="font-size: 10pt">Taxation</span></a></td>
    <td style="text-align: center">104</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: justify"><span style="font-size: 10pt">F.</span></td>
    <td style="padding-left: 0.125in; text-align: left; text-indent: -0.125in"><a href="#a_051"><span style="font-size: 10pt">Dividends and Paying Agents</span></a></td>
    <td style="text-align: center">110</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-size: 10pt">G.</span></td>
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><a href="#a_052"><span style="font-size: 10pt">Statement by Experts</span></a></td>
    <td style="text-align: center">110</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: justify"><span style="font-size: 10pt">H.</span></td>
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><a href="#a_053"><span style="font-size: 10pt">Documents on Display</span></a></td>
    <td style="text-align: center">110</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-size: 10pt">I.</span></td>
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><a href="#a_054"><span style="font-size: 10pt">Subsidiary Information</span></a></td>
    <td style="text-align: center">110</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: justify"><span style="font-size: 10pt">J.</span></td>
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><a href="#a_055"><span style="font-size: 10pt">Annual Report to Security Holders</span></a></td>
    <td style="text-align: center">110</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-size: 10pt">ITEM 11.</span></td>
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><a href="#a_056"><span style="font-size: 10pt">QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</span></a></td>
    <td style="text-align: center">110</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: justify"><span style="font-size: 10pt">ITEM 12.</span></td>
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><a href="#a_057"><span style="font-size: 10pt">DESCRIPTION OF SECURITIES OTHER THAN EQUITY SECURITIES</span></a></td>
    <td style="text-align: center">111</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-size: 10pt">A.</span></td>
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><a href="#a_058"><span style="font-size: 10pt">Debt Securities</span></a></td>
    <td style="text-align: center">111</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: justify"><span style="font-size: 10pt">B.</span></td>
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><a href="#a_059"><span style="font-size: 10pt">Warrants and rights</span></a></td>
    <td style="text-align: center">111</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-size: 10pt">C.</span></td>
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><a href="#a_060"><span style="font-size: 10pt">Other Securities</span></a></td>
    <td style="text-align: center">111</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: justify"><span style="font-size: 10pt">D.</span></td>
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><a href="#a_061"><span style="font-size: 10pt">American Depositary Shares</span></a></td>
    <td style="text-align: center">111</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top">&#160;</td>
    <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">&#160;</td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: justify"><a href="#a_062"><span style="font-size: 10pt">PART II</span></a></td>
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td>
    <td style="text-align: center">112</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify">&#160;</td>
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: justify"><span style="font-size: 10pt">ITEM 13.</span></td>
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><a href="#a_063"><span style="font-size: 10pt">DEFAULTS, DIVIDEND ARREARAGES AND DELINQUENCIES</span></a></td>
    <td style="text-align: center">112</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-size: 10pt">ITEM 14.</span></td>
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><a href="#a_064"><span style="font-size: 10pt">MATERIAL MODIFICATIONS TO THE RIGHTS OF SECURITY HOLDERS AND USE OF
    PROCEEDS</span></a></td>
    <td style="text-align: center">112</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: justify"><span style="font-size: 10pt">ITEM 15.</span></td>
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><a href="#a_065"><span style="font-size: 10pt">CONTROLS AND PROCEDURES</span></a></td>
    <td style="text-align: center">112</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-size: 10pt">ITEM 16.</span></td>
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><a href="#a_066"><span style="font-size: 10pt">[RESERVED]</span></a></td>
    <td style="text-align: center">112</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: justify"><span style="font-size: 10pt">ITEM 16A.</span></td>
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><a href="#a_067"><span style="font-size: 10pt">AUDIT COMMITTEE FINANCIAL EXPERT</span></a></td>
    <td style="text-align: center">112</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-size: 10pt">ITEM 16B.</span></td>
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><a href="#a_068"><span style="font-size: 10pt">CODE OF ETHICS</span></a></td>
    <td style="text-align: center">112</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: justify"><span style="font-size: 10pt">ITEM 16C.</span></td>
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><a href="#a_069"><span style="font-size: 10pt">PRINCIPAL ACCOUNTANT FEES AND SERVICES</span></a></td>
    <td style="text-align: center">113</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-size: 10pt">ITEM 16D.</span></td>
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><a href="#a_070"><span style="font-size: 10pt">EXEMPTIONS FROM THE LISTING STANDARDS FOR AUDIT COMMITTEES</span></a></td>
    <td style="text-align: center">113</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: justify"><span style="font-size: 10pt">ITEM 16E.</span></td>
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><a href="#a_071"><span style="font-size: 10pt">PURCHASES OF EQUITY SECURITIES BY THE ISSUER AND AFFILIATED PURCHASERS</span></a></td>
    <td style="text-align: center">113</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-size: 10pt">ITEM 16F.</span></td>
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><a href="#a_072"><span style="font-size: 10pt">CHANGE IN REGISTRANT&#8217;S CERTIFYING ACCOUNTANT</span></a></td>
    <td style="text-align: center">113</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: justify"><span style="font-size: 10pt">ITEM 16G.</span></td>
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><a href="#a_073"><span style="font-size: 10pt">CORPORATE GOVERNANCE</span></a></td>
    <td style="text-align: center">113</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-size: 10pt">ITEM 16H.</span></td>
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><a href="#a_074"><span style="font-size: 10pt">MINE SAFETY DISCLOSURE</span></a></td>
    <td style="text-align: center">115</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: justify"><span style="font-size: 10pt">ITEM 16I.</span></td>
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><a href="#a_075"><span style="font-size: 10pt">DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS</span></a></td>
    <td style="text-align: center">115</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-align: justify">&#160;</td>
    <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">&#160;</td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; text-align: justify"><a href="#a_076"><span style="font-size: 10pt">PART III</span></a></td>
    <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">&#160;</td>
    <td style="vertical-align: bottom; text-align: center">116</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-align: justify">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: justify"><span style="font-size: 10pt">ITEM 17.</span></td>
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><a href="#a_077"><span style="font-size: 10pt">FINANCIAL STATEMENTS</span></a></td>
    <td style="text-align: center">116</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-size: 10pt">ITEM 18.</span></td>
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><a href="#a_078"><span style="font-size: 10pt">FINANCIAL STATEMENTS</span></a></td>
    <td style="text-align: center">116</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: justify"><span style="font-size: 10pt">ITEM 19.</span></td>
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><a href="#a_079"><span style="font-size: 10pt">EXHIBITS</span></a></td>
    <td style="text-align: center">116</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td colspan="2" style="text-align: justify"><a href="#a_080"><span style="font-size: 10pt">SIGNATURES</span></a></td>
    <td style="text-align: center">117</td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"></p><div>

</div><!-- Field: Page; Sequence: 4; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->ii<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p><div>

</div><div><a id="a_001"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><b>INTRODUCTION</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are an innovator of video
encoding, transcoding and optimization solutions that enable high quality, performance, and unmatched bitrate efficiency for video and
images. With our Emmy&#174;-winning patented technology and award-winning services, we help our customers realize the potential of video
encoding and media optimization to address business-critical challenges. Our customers include tier one over-the-top, or OTT, content
distributors, video streaming platforms, and Hollywood studios who rely on our suite of products and expertise to reduce the cost and
complexity associated with storing, distributing and monetizing video and images across devices.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">At the heart of our patented
optimization technology is the proprietary Beamr Quality Measure, or BQM, that is highly correlated with the human visual system. BQM
is integrated into our Content Adaptive Bitrate, or CABR, system, which maximizes quality and remove visual redundancies resulting in
a smaller file size. The BQM has excellent correlation with subjective results, confirmed in testing under ITU BT.500, an international
standard for rigorous testing of image quality. The perceptual quality preservation of CABR has been repeatedly verified using large scale
crowd-sourcing based testing sessions, as well as by industry leaders and studio &#8220;golden eyes&#8221;.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We currently license three
core video and image compression products that help our customers use video and images to further their businesses in meaningful ways:
(1) a suite of video compression software encoder solutions including the Beamr 4 encoder, Beamr 4X content adaptive encoder, Beamr 5
encoder and the Beamr 5X content adaptive encoder, (2) Beamr JPEGmini photo optimization software solutions for reducing JPEG file sizes,
and (3) Beamr Silicon IP block, a hardware solution for integration into dedicated video encoding ASICs, GPUs, and application processors.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Upon listing of our ordinary
shares in our initial public offering on February 28, 2023, we effected a reverse share spit at a ratio of 1-for-5. All share numbers
in this Annual Report on Form 20-F have been retroactively adjusted and are reflected on a post-reverse share split basis.&#160;</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Unless
the context requires otherwise, the terms &#8220;Beamr,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our,&#8221; &#8220;the Company,&#8221;
and similar designations refer to Beamr Imaging&#160;Ltd. and its wholly-owned subsidiary, Beamr, Inc.. References to &#8220;ordinary
shares&#8221;, &#8220;warrants&#8221; and &#8220;share capital&#8221; refer to our ordinary shares, warrants and share capital, respectively,
of Beamr.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-size: 10pt">References
to &#8220;U.S. dollars&#8221; and &#8220;$&#8221; are to currency of the United States of America, and references to &#8220;NIS&#8221;
are to New Israeli Shekels. References to &#8220;ordinary shares&#8221; are to our ordinary shares, par value NIS 0.05 per share. We report
financial information under generally accepted accounting principles in the United States of America or U.S. GAAP.</span>&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"></p><div>

</div><!-- Field: Page; Sequence: 5; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->iii<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><div><a id="a_002"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><b>CAUTIONARY NOTE REGARDING
FORWARD-LOOKING STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Certain
information included or incorporated by reference in this Annual Report on Form 20-F may be deemed to be &#8220;forward-looking statements&#8221;
within the meaning of the Private Securities Litigation Reform Act of 1995 and other securities laws. Forward-looking statements are often
characterized by the use of forward-looking terminology such as &#8220;may,&#8221; &#8220;will,&#8221; &#8220;expect,&#8221; &#8220;anticipate,&#8221;
&#8220;estimate,&#8221; &#8220;continue,&#8221; &#8220;believe,&#8221; &#8220;should,&#8221; &#8220;intend,&#8221; &#8220;project&#8221;
or other similar words, but are not the only way these statements are identified.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">These
forward-looking statements may include, but are not limited to, statements relating to our objectives, plans and strategies, statements
that contain projections of results of operations or of financial condition, expected capital needs and expenses, statements relating
to the research, development, completion and use of our products, and all statements (other than statements of historical facts) that
address activities, events or developments that we intend, expect, project, believe or anticipate will or may occur in the future.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Forward-looking
statements are not guarantees of future performance and are subject to risks and uncertainties. We have based these forward-looking statements
on assumptions and assessments made by our management in light of their experience and their perception of historical trends, current
conditions, expected future developments and other factors they believe to be appropriate.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Important
factors that could cause actual results, developments and business decisions to differ materially from those anticipated in these forward-looking
statements include, among other things:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">our business, development and operating goals and strategies and plans for the development of existing and new businesses, ability to implement such strategies and plans and expected time;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">our future business development, financial condition and results of operations;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">expected changes in our revenues, costs or expenditures;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">our expectations regarding demand for and market acceptance of our products and services;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">our expectations regarding our relationships with customers, business partners and strategic partners;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">our dependence on and the success of our strategic relationships with third parties and service providers;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">the trends in, expected growth in and market size of the global image and video storage, video streaming, and public cloud video storage industries;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">our estimates of, and future expectations regarding, our market opportunity;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">our ability to maintain and enhance our market position;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">our ability to attract customers, grow our retention rates, expand usage and sell subscription plans;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">our ability to continue to develop new technologies and/or upgrade our existing technologies;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">our ability to ensure that our SaaS solution interoperates with a variety of software and hardware applications that are developed by third parties;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">competitive environment and landscape and potential competitor behavior in our industry and the overall outlook in our industry;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">our ability to maintain the security and availability of our products and solutions and to maintain privacy, data protection and cybersecurity;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 6; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->iv<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">our plans and ability to obtain or protect intellectual property rights, or to obtain, maintain, protect and enforce sufficiently broad intellectual property rights therein, including extensions of patent terms where available and our ability to avoid infringing the intellectual property rights of others;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">the need to hire additional personnel and our ability to attract, train and retain such personnel;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">our estimates regarding expenses, future revenue, capital requirements and needs for additional financing;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">the period over which we estimate our existing cash and cash equivalents will be sufficient to fund our future development and operating expenses and capital expenditure requirements;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">risks related to our international operations and our ability to expand our international business operations;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">risks related to business, political, social, economic and security conditions in Israel and Russia (including the ongoing conflict between Russia and Ukraine);</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">changes in applicable tax law, the stability of effective tax rates and adverse outcomes resulting from examination of our income or other tax returns;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">the effects of currency exchange rate fluctuations on our results of operations;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in; font-size: 10pt">&#160;</td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">risks related to unfavorable economic and market conditions and adverse developments with respect to financial institutions and associated liquidity risk;</span></td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px; font-size: 10pt">&#160;</td>
    <td style="width: 24px; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">any resurgence of the COVID-19 pandemic and its impact on our business and industry;&#160;</span></td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">our ability to generate revenue and profit margin under our collaboration with third parties and anticipated contracts which is subject to certain risks; and</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">those factors referred to in &#8220;Item 3.D. Risk Factors,&#8221; &#8220;Item 4. Information on the Company,&#8221; and &#8220;Item 5. Operating and Financial Review and Prospects&#8221;, as well as in this annual report on Form 20-F generally.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Readers
are urged to carefully review and consider the various disclosures made throughout this Annual Report on Form 20-F which are designed
to advise interested parties of the risks and factors that may affect our business, financial condition, results of operations and prospects.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">You
should not put undue reliance on any forward-looking statements. Any forward-looking statements in this annual report on Form 20-F are
made as of the date hereof and are expressly qualified in their entirety by the cautionary statements included in this Annual Report.
We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future
events or otherwise, except as required by law.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">In
addition, the section of this Annual Report on Form 20-F entitled &#8220;Item 4. Information on the Company&#8221; contains information
obtained from independent industry sources and other sources that we have not independently verified.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"></p><div>

</div><!-- Field: Page; Sequence: 7; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->v<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>INDUSTRY AND MARKET DATA</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Market
data and certain industry data and forecasts used throughout this Annual Report on Form 20-F were obtained from internal company surveys,
market research, consultant surveys commissioned by the Company, publicly available information, reports of governmental agencies and
industry publications and surveys. Industry surveys, publications, consultant surveys commissioned by the Company and forecasts generally
state that the information contained therein has been obtained from sources believed to be reliable. However, this information may prove
to be inaccurate because of the method by which some of the data for the estimates is obtained or because this information cannot always
be verified with complete certainty due to the limits on the availability and reliability of raw data, the voluntary nature of the data
gathering process and other limitations and uncertainties. As a result, the market and industry data and forecasts included or incorporated
by reference in this annual report, and estimates and beliefs based on that data, may not be reliable. We have relied on certain data
from third-party sources, including internal surveys, industry forecasts and market research, which we believe to be reliable based on
our management&#8217;s knowledge of the industry. However, we have not ascertained the underlying economic assumptions relied upon therein.
Forecasts are particularly likely to be inaccurate, especially over long periods of time. In addition, we do not necessarily know what
assumptions regarding general economic growth were used in preparing the forecasts we cite. Statements as to our market position are based
to the best of our knowledge on the most currently available data. While we are not aware of any misstatements regarding the industry
data presented in this annual report, our estimates involve risks and uncertainties and are subject to change based on various factors,
including those discussed under the heading &#8220;Risk Factors&#8221; in this Annual Report.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Statements made in this Annual
Report on Form 20-F concerning the contents of any agreement, contract or other document are summaries of such agreements, contracts or
documents and are not a complete description of all of their terms. If we filed any of these agreements, contracts or documents as exhibits
to this Report or to any previous filing with the Securities and Exchange Commission, or SEC, you may read the document itself for a complete
understanding of its terms.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>PRESENTATION OF FINANCIAL INFORMATION</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our financial statements were
prepared in accordance with generally accepted accounting principles in the United States, or U.S.&#160;GAAP. We present our consolidated
financial statements in U.S. dollars.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our fiscal year ends on December
31 of each year. Our most recent fiscal year ended on December 31, 2022.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Certain figures included in
this Annual Report have been subject to rounding adjustments. Accordingly, figures shown as totals in certain tables may not be an arithmetic
aggregation of the figures that precede them.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><b>EMERGING GROWTH COMPANY
STATUS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">We
are an &#8220;emerging growth company,&#8221; as defined in Section 2(a) of the Securities Act of 1933, as amended, or the Securities
Act, as modified by the&#160;JOBS Act. As such, we are eligible to take advantage of certain exemptions from various reporting requirements
that are applicable to other public companies that are not &#8220;emerging growth companies&#8221; including, but not limited to, not
being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations
regarding executive compensation in our periodic reports and proxy statements and exemptions from the requirements of holding a&#160;non-binding&#160;advisory
vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. If some investors find
our securities less attractive as a result, there may be a less active trading market for our securities and the prices of our securities
may be more volatile.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"></p><div>

</div><!-- Field: Page; Sequence: 8; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->vi<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">In
addition, Section 107 of the JOBS Act also provides that an emerging growth company can take advantage of the extended transition period
provided in Section 13(a) of the Securities Exchange Act of 1934, as amended, or the Exchange Act, for complying with new or revised accounting
standards. We have elected to opt out of this extended transition period and, as a result, we are required to comply with new or revised
accounting standards on the relevant dates on which adoption of such standards is required for non-emerging growth companies. Under federal
securities laws, our decision to opt out of the extended transition period is irrevocable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">We
will remain an emerging growth company until the earliest of: (i) the last day of the first fiscal year in which our annual gross revenues
exceed $&#160;$1.235 billion; (ii) the last day of the fiscal year following the fifth anniversary of the date of our initial public offering
(i.e., December 31, 2028); (iii) the date that we become a &#8220;large accelerated filer&#8221; as defined in Rule&#160;12b-2&#160;under
the&#160;Exchange Act, which would occur if the aggregate worldwide market value of our ordinary shares, including ordinary shares represented
by ADSs, held by non-affiliates is at least $700 million as of the last business day of our most recently completed second fiscal quarter;
or (iv) the date on which we have issued more than $1.0 billion in non-convertible debt securities during any three-year period.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>TRADEMARKS AND TRADE NAMES</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We own or have rights to trademarks,
service marks and trade names that we use in connection with the operation of our business, including our corporate name, logos and website
names. Other trademarks, service marks and trade names appearing in this Annual Report are the property of their respective owners. Solely
for convenience, some of the trademarks, service marks and trade names referred to in this Annual Report are listed without the <sup>&#174;
</sup>and &#8482; symbols, but we will assert, to the fullest extent under applicable law, our rights to our trademarks, service marks
and trade names.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>GLOSSARY OF INDUSTRY TERMS AND CONCEPTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following is a list of
certain industry terms and concepts that are used in this Annual Report:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<i>API</i>&#8221; means
application programming interface, which is a software intermediary that allows two applications to talk to each other.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<i>ASIC</i>&#8221;
means an application-specific integrated circuit which is an integrated circuit chip customized for a particular use, rather than intended
for general-purpose use.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<i>AVC</i>&#8221; means
advanced video coding, also referred to as H.264 or MPEG-4 Part 10, which is a video compression standard based on block-oriented, motion-compensated
integer-discrete cosine transform coding.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<i>BQM</i>&#8221; means
the proprietary Beamr quality measure which is an artificial intelligence trained computer vision processing architecture.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<i>CABR</i>&#8221;
means content adaptive bitrate which refers to our technology combined with our BQM that uses a flexible computer vision engine programmed
with a high level algorithm description to achieve maximal compression of the video input while maintaining the input video resolution,
format, and visual quality.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<i>Codec</i>&#8221;
means a device or computer program which encodes or decodes a data stream, bitstream or signal.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<i>CPU</i>&#8221; means
central processing unit which is the electronic circuitry in a computer that executes instructions.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 9; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->vii<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<i>FPGA</i>&#8221;
means field-programmable gate array which is a hardware circuit that a user can program to carry out one or more logical operations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<i>GPU</i>&#8221; means
graphics processing unit which is a specialized electronic circuit designed to rapidly manipulate and alter memory using parallel computations
to accelerate the creation of images in a frame buffer intended for output to a display device.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<i>HDR</i>&#8221; means
high dynamic range imaging which is the set of techniques used to reproduce a greater range of luminosity than that which is possible
with standard photographic or video graphic techniques.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<i>HEVC</i>&#8221;
means high efficiency video coding, also known as H.265 and MPEG-H Part 2, which is a video compression standard designed as part of the
MPEG-H project as a successor to the widely used AVC standard.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<i>HLG</i>&#8221; means
hybrid log-gamma, an HDR format that uses the HLG transfer function, BT.2020 color primaries and a bit depth of 10-bits.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<i>JPEG</i>&#8221;
means joint photographic experts group which is a commonly used format for lossy compression for digital images, particularly for images
produced by digital photography.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<i>ITU BT. 500</i>&#8221;
is an international standard for testing image quality.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<i>OTT</i>&#8221; means
over-the-top which is a means of providing television and film content over the internet at the request and to suit the requirements of
the individual consumer. Services like Netflix, ViacomCBS and Wowza are video OTT services.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<i>PSNR</i>&#8221;
means peak signal to noise ratio which is a quality measure which represents the ratio between the highest power of an original signal
and the power level of the distortion, on logarithmic scale.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<i>Silicon IP</i>&#8221;
is a reusable unit of logic, cell, or chip layout design and is also the intellectual property of one party. Silicon IP can be used as
building blocks within application-specific integrated circuits (ASIC) chip designs or field programmable gate array (FPGA) logic designs.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<i>SSIM</i>&#8221;
means structural similarity index measure which is a technique to predict the perceived quality of digital images and videos.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<i>UGC</i>&#8221; means
user generated content which refers to any form of content, such as images, videos, text, and audio, that has been created or posted by
users on online platforms.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<i>VBR</i>&#8221; means
variable bit rate which relates to the bitrate used in sound or video encoding.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 10; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->viii<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><div><a id="a_003"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><b>PART I</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><div><a id="a_004"></a></div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><b>ITEM&#160;1. IDENTITY OF DIRECTORS, SENIOR MANAGEMENT AND ADVISERS</b></span></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Not
applicable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><div><a id="a_005"></a></div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><b>ITEM&#160;2. OFFER STATISTICS AND EXPECTED TIMETABLE</b></span></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Not
applicable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><div><a id="a_006"></a></div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><b>ITEM&#160;3. KEY INFORMATION</b></span></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><div><a id="a_007"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><b>A. Reserved.</b></span></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><div><a id="a_008"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><b>B. Capitalization and Indebtedness</b></span></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Not
applicable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p><div>

</div><div><a id="a_009"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><b>C. Reasons for the Offer and Use of Proceeds</b></span></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Not
applicable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><div><a id="a_010"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><b>D. Risk Factors</b></span></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">You should carefully consider
the risks described below, together with all of the other information in this Annual Report on Form 20-F. The risks and uncertainties
described below are those significant risk factors, currently known and specific to us, that we believe are relevant to an investment
in our securities. Additional risks and uncertainties not currently known to us or that we now deem immaterial may also harm us. If any
of these risks materialize, our business, results of operations or financial condition could suffer, and the price of our ordinary shares
could decline substantially.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Summary Risk Factors</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Investing
in our ordinary shares involves a high degree of risk, as fully described below. The principal factors and uncertainties that make investing
in our ordinary shares risky, include, among others:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Risks Related to Our Business and Industry</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">We have a history of losses and may not be able to achieve or maintain profitability.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">We will need to raise additional capital to meet our business requirements in the future, and such capital raising may be costly or difficult to obtain and could dilute our shareholders&#8217; ownership interests.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">To support our business growth we are expanding our product offering to include the Beamr HW-Accelerated Content Adaptive Encoding solution, a new SaaS solution, the development and commercialization of which may not be successful. This change in our products and services also makes it difficult to evaluate our current business and future prospects and may increase the risk that we will not be successful.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 11; Options: NewSection; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">We may not be successful in establishing and maintaining strategic partnerships, which could adversely affect our ability to develop and commercialize our SaaS solution and other future products.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Our future growth depends in part upon the successful deployment of the Beamr HW-Accelerated Content Adaptive Encoding solution in the cloud.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">The failure to effectively develop and expand our marketing and sales capabilities could harm our ability to increase our customer base and achieve broader market acceptance of our offerings.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Our business and operations have experienced growth, and if we do not appropriately manage this growth and any future growth, or if we are unable to improve our systems, processes and controls, our business, financial condition, results of operations and prospects will be adversely affected.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">The markets for our offerings are new and evolving and may develop more slowly or differently than we expect. Our future success depends on the growth and expansion of these markets and our ability to adapt and respond effectively to evolving market conditions.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Our results of operations are likely to fluctuate from quarter to quarter and year to year, which could adversely affect the trading price of our ordinary shares.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">The loss of one or more of our significant customers, or any other reduction in the amount of revenue we derive from any such customer, would adversely affect our business, financial condition, results of operations and growth prospects.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">If we are not able to keep pace with technological and competitive developments and develop or otherwise introduce new products and solutions and enhancements to our existing offerings, our offerings may become less marketable, less competitive or obsolete, and our business, financial condition and results of operations may be adversely affected.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">If we are not able to maintain and expand our relationships with third-party technology partners to integrate our offerings with their products and solutions, our business, financial condition and results of operations may be adversely affected.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">We may not be able to compete successfully against current and future competitors, some of whom have greater financial, technical, and other resources than we do. If we do not compete successfully, our business, financial condition and results of operations could be harmed.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">We depend on our management team and other key employees, and the loss of one or more of these employees or an inability to attract and retain highly skilled employees could adversely affect our business.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Our international operations and expansion expose us to risk.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Currency exchange rate fluctuations affect our results of operations, as reported in our financial statements.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px; font-size: 10pt">&#160;</td>
    <td style="width: 24px; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our business, operating results and growth rates may be adversely affected by current or future unfavorable economic and market conditions and adverse developments with respect to financial institutions and associated liquidity risk.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A resurgence of the COVID-19 pandemic could adversely affect our business, financial condition and results of operations.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 12; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Risks Related to Information Technology,
Intellectual Property and Data Security and Privacy</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">A real or perceived bug, defect, security vulnerability, error, or other performance failure involving our products and services could cause us to lose revenue, damage our reputation, and expose us to liability.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">If we or our third-party service providers experience a security breach, data loss or other compromise, including if unauthorized parties obtain access to our customers&#8217; data, our reputation may be harmed, demand for our products and services may be reduced, and we may incur significant liabilities.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Insufficient investment in, or interruptions or performance problems associated with, our technology and infrastructure, including in connection with our Beamr HW-Accelerated Content Adaptive Encoding solution which is to be deployed on a public cloud infrastructure, and our reliance on technologies from third parties, may adversely affect our business operations and financial results.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Failure to protect our proprietary technology, or to obtain, maintain, protect and enforce sufficiently broad intellectual property rights therein, could substantially harm our business, financial condition and results of operations.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">We could incur substantial costs and otherwise suffer harm as a result of any claim of infringement, misappropriation or other violation of another party&#8217;s intellectual property or proprietary rights.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">We could incur substantial costs and otherwise suffer harm as a result of patent royalty claims, in particular patents related to the implementation of image and video standards.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">We rely on software and services licensed from other parties. The loss of software or services from third parties could increase our costs and limit the features available in our products and services.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Risks Related to Other Legal, Regulatory
and Tax Matters</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Changes in laws and regulations related to the internet or video standards, changes in the internet infrastructure itself, or increases in the cost of internet connectivity and network access may diminish the demand for our offerings and could harm our business.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Changes in U.S. and foreign tax laws could have a material adverse effect on our business, cash flow, results of operations or financial conditions.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Our corporate structure and intercompany arrangements are subject to the tax laws of various jurisdictions, and we could be obligated to pay additional taxes, which would adversely affect our results of operations.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Risks Related to Our Operations in Israel
and Russia</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Political, economic and military conditions in Israel could materially and adversely affect our business.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Russia&#8217;s invasion of Ukraine and sanctions brought against Russia could disrupt our software development operations in Russia.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Political, military conditions or other risks in Russia could adversely affect our business.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Risks Related to Ownership of our Ordinary
Shares</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">The market price for our ordinary shares may be volatile or may decline regardless of our operating performance.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in; text-align: justify"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Our principal shareholders will continue to have significant influence over us.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 13; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in; text-align: justify"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Your ownership and voting power may be diluted by the issuance of additional shares of our ordinary shares in connection with financings, acquisitions, investments, our equity incentive plans or otherwise.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.5in; text-align: justify">&#160;</td>
    <td style="width: 0.25in; text-align: justify"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Our management team has limited experience managing a public company, and the requirements of being a public company may strain our resources, divert management&#8217;s attention, and affect our ability to attract and retain qualified board members.</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">We incur significant increased costs as a result of operating as a public company, and our management will be required to devote substantial time to new compliance initiatives.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.5in; text-align: justify">&#160;</td>
    <td style="width: 0.25in; text-align: justify"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">We have identified a material weakness in our internal control over financial reporting, and we may not be able to successfully implement remedial measures.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt"><b>Risks Related to Our Business
and Industry</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We have a history of losses and may not
be able to achieve or maintain profitability.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have incurred losses in
each year since our incorporation in 2009, including net losses of $1.2 million and $0.9 million in the years ended December 31, 2022
and 2021. As a result, we had an accumulated deficit of $30.9 million and $29.7 million as of December 31, 2022 and 2021, respectively.
We intend to continue to expend substantial financial and other resources on, among other things:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">extending our product leadership by investing in our video storage optimization products and services, and other recently introduced offerings, as well as by developing new products, expanding our platform into additional industries and enhancing our offerings with additional core capabilities and technologies;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">sales and marketing expenses by hiring customer success personnel and investment in online marketing to attract new customers;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">augmenting our current offerings by increasing the breadth of our technology partnerships and exploring potential transactions that may enhance our capabilities or increase the scope of our technology footprint; and</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">general administration, including legal, accounting, and other expenses related to our transition to being a new public company.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">These efforts may prove more
expensive than we currently anticipate, and we may not succeed in increasing our revenue sufficiently, or at all, to offset these higher
expenses. In addition, to the extent we are successful in increasing our customer base, we may also incur increased losses because of
unforeseen costs. If our revenue does not increase to offset our operating expenses, we will not achieve profitability in future periods
and our net losses may increase. Revenue growth may slow or revenue may decline for a number of possible reasons, many of which are beyond
our control, including inability to penetrate new markets, slowing demand for our products and services, increasing competition, or any
of the other factors discussed in this Risk Factors section. Any failure to increase our revenue as we grow our business could prevent
us from achieving profitability at all or on a consistent basis, which would cause our business, financial condition and results of operations
to suffer and the market price of our ordinary shares to decline.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 14; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We will need to raise additional capital
to meet our business requirements in the future, and such capital raising may be costly or difficult to obtain and could dilute our shareholders&#8217;
ownership interests.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In order for us to pursue
our business objectives, we will need to raise additional capital, which additional capital may not be available on reasonable terms or
at all. Any additional capital raised through the sale of equity or equity-backed securities may dilute our shareholders&#8217; ownership
percentages and could also result in a decrease in the market value of our equity securities. The terms of any securities issued by us
in future capital transactions may be more favorable to new investors, and may include preferences, superior voting rights and the issuance
of warrants or other derivative securities, which may have a further dilutive effect on the holders of any of our securities then outstanding.
In addition, we may incur substantial costs in pursuing future capital financing, including investment banking fees, legal fees, accounting
fees, securities law compliance fees, printing and distribution expenses and other costs. We may also be required to recognize non-cash
expenses in connection with certain securities we issue, such as convertible notes and warrants, which may adversely impact our financial
condition.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Our indebtedness could adversely affect
our ability to raise additional capital to fund operations, limit our ability to react to changes in the economy or our industry and prevent
us from meeting our financial obligations.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On July 7, 2022, we entered
into a funding agreement with IBI Spikes, Ltd., or IBI, providing for a loan in the amount of NIS 3.1 million (approximately $900,000)
and the issuance of 65,562 warrants to purchase ordinary shares. See &#8220;Item 5.B&#8212;Operating and Financial Review and Prospects&#8212;Liquidity
and Resources&#8212;IBI Spikes Loan&#8221;.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On February 27, 2023, we announced
the pricing of our initial public offering of 1,950,000 ordinary shares at a public offering price of $4.00 per share, for aggregate gross
proceeds of $7.8 million prior to deducting underwriting discounts and other offering expenses.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If we cannot generate sufficient
cash flow from operations to service our debt, we may need to further refinance our debt, dispose of assets or issue equity to obtain
necessary funds. We do not know whether we will be able to do any of this on a timely basis, on terms satisfactory to us, or at all. Our
indebtedness could have important consequences, including:&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">our ability to obtain additional debt or equity financing for working capital, capital expenditures, debt service requirements, acquisitions and general corporate or other purposes may be limited;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">a portion of our cash flows from operations will be dedicated to the payment of principal and interest on the indebtedness and will not be available for other purposes, including operations, capital expenditures and future business opportunities;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">our ability to adjust to changing market conditions may be limited and may place us at a competitive disadvantage compared to less-leveraged competitors; and</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">we may be vulnerable during a downturn in general economic conditions or in our business, or may be unable to carry on capital spending that is important to our growth.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>To support our business growth we are expanding
our product offering to include the Beamr HW-Accelerated Content Adaptive Encoding solution, a new SaaS solution, the development and
commercialization of which may not be successful. This change in our products and services also makes it difficult to evaluate our current
business and future prospects and may increase the risk that we will not be successful.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our current product line is
mainly geared to the high end, high quality media customers and we count among our customers Netflix, ViacomCBS, Snapfish, Wowza and other
leading media companies using video and photo solutions.&#160; This product line involves high cost and complexity of deploying our existing
software solutions and the long sales lead times.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In order to grow our business,
in 2019, we resolved to build a lower cost offering which requires hardware acceleration and started to integrate with hardware encoders.
In the first quarter of 2020, we introduced our first proof of concept results with Intel&#8217;s GPU. Then, we made a strategic decision
to focus our resources on the development and commercialization of our next-generation product, the Beamr HW-Accelerated Content Adaptive
Encoding solution, a SaaS solution that is designed, based on our own internal testing, to provide up to 10x cost-effective video optimization
than existing solutions to an industry agnostic target market. This change in strategy and these efforts may prove more expensive than
we currently anticipate, or may require longer development and deployment times, and we may not succeed in fully developing and implementing
our SaaS solution sufficiently, or at all.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 15; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We may not be successful in establishing
and maintaining strategic partnerships, which could adversely affect our ability to develop and commercialize our SaaS solution and other
future products.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">To successfully develop and
commercialize our Beamr HW-Accelerated Content Adaptive Encoding solution and other product offerings, we will need substantial financial
resources as well as expertise and physical resources and systems. We may elect to develop some or all of these physical resources and
systems and expertise ourselves, or we may seek to collaborate with another company or companies that can provide some or all of such
physical resources and systems as well as financial resources and expertise. For example, we are collaborating with NVIDIA, a leading
developer of GPUs, in the development of our next generation product, the Beamr HW-Accelerated Content Adaptive Encoding solution, and
we are collaborating with Allegro DVT in the development the world&#8217;s first content-adaptive silicon IP encoder.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We face significant competition
in seeking appropriate partners for our products, and the negotiation process is time-consuming and complex. In order for us to successfully
develop and commercialize our products with a strategic partner, potential partners must view our products as economically valuable in
markets they determine to be attractive in light of the terms that we are seeking and other available products for licensing by other
companies. Even if we are successful in our efforts to establish strategic partnerships, the terms that we agree upon may not be favorable
to us, and we may not be able to maintain such strategic partnerships if, for example, development of a product is delayed or sales of
a product are disappointing. Any delay in entering into strategic partnership agreements related to our products could delay the development
and commercialization of our products and reduce their competitiveness even if they reach the market. If we fail to establish and maintain
strategic partnerships related to our products, we will bear all of the risk and costs related to the development and commercialization
of our products, and we will need to seek additional financing, hire additional employees and otherwise develop expertise which we do
not have and for which we have not budgeted.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The risks in a strategic partnership include the
following:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 20.5pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">the strategic partner may not apply the expected financial resources, efforts, or required expertise in developing the physical resources and systems necessary to successfully develop and commercialize a product;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">the strategic partner may not invest in the development of a sales and marketing force and the related infrastructure at levels that ensure that sales of the products reach their full potential;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">we may be required to undertake the expenditure of substantial operational, financial, and management resources;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 38.5pt; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">we may be required to issue equity securities that would dilute our existing shareholders&#8217; percentage ownership;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">we may be required to assume substantial actual or contingent liabilities;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">strategic partners could decide to withdraw a development program or a collaboration, or move forward with a competing product developed either independently or in collaboration with others, including our competitors;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">disputes may arise between us and a strategic partner that delay the development or commercialization or adversely affect the sales or profitability of the product; or</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">the strategic partner may independently develop, or develop with third parties, products that could compete with our products.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 38.5pt; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 38.5pt; text-align: justify; text-indent: -0.25in"></p><div>

</div><!-- Field: Page; Sequence: 16; Options: NewSection; Value: 6 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 38.5pt; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, a strategic partner
for one or more of our products may have the right to terminate the collaboration at its discretion. For example, our collaboration with
NVIDIA is based on a mutual development program of our Beamr HW-Accelerated Content Adaptive Encoding solution that is in advanced stages
and that has been approved at senior levels at NVIDIA however our collaboration has not been reduced to a written agreement and we have
not signed any agreement with NVIDIA, which exposes us to the risk of termination of our collaboration at any time for any or no reason.
Any early termination of our collaboration in a manner adverse to us could have a material adverse effect on our liquidity, financial
condition and results of operations. Any termination may require us to seek a new strategic partner or partners, which we may not be able
to do on a timely basis, if at all, or require us to delay or scale back our development and commercialization efforts. The occurrence
of any of these events could adversely affect the development and commercialization of our products or product candidates and materially
harm our business and share price by delaying the development of our products, and the sale of any products, by slowing the growth of
such sales, by reducing the profitability of the product and/or by adversely affecting the reputation of the product.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Further, a strategic partner
may breach an agreement with us, and we may not be able to adequately protect our rights under these agreements. Furthermore, a strategic
partner will likely negotiate for certain rights to control decisions regarding the development and commercialization of our products
and may not conduct those activities in the same manner as we would do so.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Our future growth depends in part upon the
successful deployment of the Beamr HW-Accelerated Content Adaptive Encoding solution in the cloud. </i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our current business is based
on software licensing and is not capital intensive, usually paid for by our customers upfront on an annual basis. We are planning to expand
our product offering with the Beamr HW-Accelerated Content Adaptive Encoding solution, a SaaS solution which is to be deployed on cloud
platforms (e.g., AWS, Azure, and GCP) and will be volume-based solutions. Future payments that we will make to cloud platforms and payments
we will receive from customers are hard to predict and will be based on different terms and conditions. We may also be at risk if there
will be gaps between account receivables and account payables. In addition, attracting new customers to our SaaS offering may involve
evaluation processes that prospects may not be willing to cover before experiencing satisfying results with our products and services,
while we will continue to accrue cloud platform service costs.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We expect our SaaS operation
will be based on spreads in which we first pay for computing platforms (e.g. GPU instances), and then we sell storage/bandwidth savings
(e.g., AWS S3, CloudFront). Any future margins may be at risk if computing platform costs increase and storage/bandwidth costs decrease.
In addition, our ability to grow and maintain customer base and revenue also depends on achieving significant storage/bitrate savings,
translating into superior total cost of ownership and return on investment for our customers. While we believe that the Beamr HW-Accelerated
Content Adaptive Encoding solution will result in significant savings for our customers, there is a risk that our savings for the customers
might not be significant.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, the Beamr HW-Accelerated
Content Adaptive Encoding solution is based on hardware acceleration of our core technology. While we successfully tested our technology
and our technology and software libraries have matured, the new implementation of the Beamr HW-Accelerated Content Adaptive Encoding has
only been tested in limited proof of concept testing, and there is a technical risk when we transition to ultra-high volume production
and utilizing platforms that were not tested.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">There is a risk that we may
not win customers that moved their long-tail assets to cold, or off-line storage services (e.g., Amazon S3 Glacier) for reduced storage
costs. In addition, improvements in general encoding solutions that are based on &#8220;content-adaptive&#8221; or &#8220;content-aware&#8221;
technologies may reduce the savings which our products and services can provide. Moreover, if the public cloud data services that utilize
NVIDIA GPUs (e.g., Amazon, GCP, Azure) do not adopt, or take significant time to adopt, the Nvidia driver and firmware with our new capabilities,
that could adversely affect our market penetration and future revenue growth.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We believe any future revenue
growth will depend on a number of factors, including, among other things, our ability to:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">continually enhance and improve our products and services, including the features, integrations and capabilities we offer, and develop or otherwise introduce new products and solutions;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">attract new customers and maintain our relationships with, and increase revenue from, our existing customers;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 17; Value: 6 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">provide excellent customer and end user experiences;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">maintain the security and reliability of our products and services;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">introduce and grow adoption of our offerings in new markets outside the United States;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">hire, integrate, train and retain skilled personnel;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">adequately expand our sales and marketing force and distribution channels;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">obtain, maintain, protect and enforce intellectual property protection for our platform and technologies;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">expand into new technologies, industries and use cases;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">expand and maintain our partner ecosystem;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">comply with existing and new applicable laws and regulations, including those related to data privacy and security;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">price our offerings effectively and determine appropriate contract terms;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">determine the most appropriate investments for our limited resources;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">successfully compete against established companies and new market entrants; and</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">increase awareness of our brand on a global basis.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If we are unable to accomplish
any of these objectives, any revenue growth will be impaired. Many factors may contribute to declines in growth rate, including increased
competition, slowing demand for our offerings, a failure by us to continue capitalizing on growth opportunities, the maturation of our
business, and global economic downturns, among others. If our growth rate declines as a result of this or any of the other factors described
above, investors&#8217; perceptions of our business and the market price of our ordinary shares could be adversely affected.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our ability to forecast our
future results of operations is subject to a number of uncertainties, including our ability to effectively plan for and model future growth.
We have encountered in the past, and may encounter in the future, risks and uncertainties frequently experienced by growing companies
in rapidly changing industries that may prevent us from achieving the objectives outlined herein. If we fail to achieve the necessary
level of efficiency in our organization as it grows, or if we are not able to accurately forecast future growth, our business would be
adversely affected. Moreover, if the assumptions that we use to plan our business are incorrect or change in reaction to changes in our
market, or if we are unable to maintain consistent revenue or revenue growth, the market price of our ordinary shares could be volatile,
and it may be difficult to achieve and maintain profitability.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>The failure to effectively develop and expand
our marketing and sales capabilities could harm our ability to increase our customer base and achieve broader market acceptance of our
offerings.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our ability to increase our
customer base and achieve broader market acceptance of our products and services and in particular the Beamr HW-Accelerated Content Adaptive
Encoding solution will depend to a significant extent on our ability to expand our sales and marketing operations. As part of our growth
strategy, we plan to dedicate significant resources to our marketing programs. All of these efforts will require us to invest significant
financial and other resources. Our business will be harmed if our efforts do not generate a correspondingly significant increase in revenue.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 18; Value: 6 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Our business and operations have experienced
growth, and if we do not appropriately manage this growth and any future growth, or if we are unable to improve our systems, processes
and controls, our business, financial condition, results of operations and prospects will be adversely affected.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We plan to make continued
investments in the growth and expansion of our business and customer base including in particular substantial investment of resources
in the development and commercialization of our next-generation product, the Beamr HW-Accelerated Content Adaptive Encoding solution.
The growth and expansion of our business places a continuous and significant strain on our management, operational, financial and other
resources. In addition, as customers adopt our offerings for an increasing number of use cases, we have had to support more complex commercial
relationships. In order to manage our growth effectively, we must continue to improve and expand our information technology and financial
infrastructure, our security and compliance requirements, our operating and administrative systems, our customer service and support capabilities,
our relationships with various partners and other third parties, and our ability to manage headcount and processes in an efficient manner.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We may not be able to sustain
the pace of improvements to our products and services, or the development and introduction of new offerings, successfully, or implement
systems, processes, and controls in an efficient or timely manner or in a manner that does not negatively affect our results of operations.
Our failure to improve our systems, processes, and controls, or their failure to operate in the intended manner, may result in our inability
to manage the growth of our business and to forecast our revenue, expenses, and earnings accurately, or to prevent losses.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As we continue to expand our
business and operate as a public company, we may find it difficult to maintain our corporate culture while managing our employee growth.
Any failure to manage our anticipated growth and related organizational changes in a manner that preserves our culture could negatively
impact future growth and achievement of our business objectives. Additionally, our productivity and the quality of our offerings may be
adversely affected if we do not integrate and train our new employees quickly and effectively. Failure to manage our growth to date and
any future growth effectively could result in increased costs, negatively affect customer satisfaction and adversely affect our business,
financial condition, results of operations and growth prospects.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>The markets for our offerings are new and
evolving and may develop more slowly or differently than we expect. Our future success depends on the growth and expansion of these markets
and our ability to adapt and respond effectively to evolving market conditions.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The markets in which we operate,
in particular the video storage market, are relatively new and rapidly evolving. Accordingly, it is difficult to predict customer adoption,
renewals and demand, the entry of new competitive products, the success of existing competitive products, and the future growth rate,
expansion, longevity, and size of the markets for our products and services. The expansion of these new and evolving markets depends on
a number of factors, including the cost, performance, and perceived value associated with the technologies that we and others in our industry
develop. If we or other companies in our industry experience security incidents, loss of customer data, or disruptions in delivery or
service, the market for these applications as a whole, including the demand for our offerings, may be negatively affected. If video products
and solutions such as ours do not continue to achieve market acceptance, or there is a reduction in demand caused by decreased customer
acceptance, technological challenges, weakening economic conditions, privacy, data protection and data security concerns, governmental
regulation, competing technologies and products, or decreases in information technology spending or otherwise, the market for our offerings
might not continue to develop or might develop more slowly than we expect, which could adversely affect our business, financial condition,
results of operations and growth prospects.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 19; Value: 6 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Our results of operations are likely to
fluctuate from quarter to quarter and year to year, which could adversely affect the trading price of our ordinary shares.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our results of operations,
including our revenue, cost of revenue, gross margin, operating expenses, cash flow, and deferred revenue, have fluctuated from quarter
to quarter and year to year in the past and may continue to vary significantly in the future so that period-to-period comparisons of our
results of operations may not be meaningful. Accordingly, our financial results in any one quarter should not be relied upon as indicative
of future performance. Our quarterly financial results may fluctuate as a result of a variety of factors, many of which are outside of
our control, may be difficult to predict, and may not fully reflect the underlying performance of our business. Factors that may cause
fluctuations in our quarterly financial results include:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">our ability to attract new customers and increase revenue from our existing customers&#894;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">the loss of existing customers&#894;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">customer satisfaction with our products, solutions, platform capabilities and customer support&#894;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">mergers and acquisitions or other factors resulting in the consolidation of our customer base&#894;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">mix of our revenue&#894;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">our ability to gain new partners and retain existing partners&#894;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">fluctuations in share-based compensation expense&#894;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">decisions by potential customers to purchase competing offerings or develop in-house technologies and solutions as alternatives to our offerings&#894;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">changes in the spending patterns of our customers;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">the amount and timing of operating expenses related to the maintenance and expansion of our business and operations, including investments in research and development, sales and marketing, and general and administrative resources&#894;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">network outages&#894;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">developments or disputes concerning our intellectual property or proprietary rights, our products and services, or third-party intellectual property or proprietary rights;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">negative publicity about our company, our offerings or our partners, including as a result of actual or perceived breaches of, or failures relating to, privacy, data protection or data security&#894;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">the timing of expenses related to the development or acquisition of technologies or businesses and potential future charges for impairment of goodwill from acquired companies&#894;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">general economic, industry, and market conditions&#894;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify">the impact any resurgence of the COVID-19 pandemic, or any other pandemic,
epidemic, outbreak of infectious disease or other global health crises on our business, the businesses of our customers and partners and
general economic conditions&#894;</td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 20; Value: 6 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">the impact of political uncertainty or unrest&#894;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">changes in our pricing policies or those of our competitors&#894;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">fluctuations in the growth rate of the markets that our offerings address&#894;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">seasonality in the underlying businesses of our customers, including budgeting cycles, purchasing practices and usage patterns&#894;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">the business strengths or weakness of our customers&#894;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">our ability to collect timely on invoices or receivables&#894;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">the cost and potential outcomes of future litigation or other disputes&#894;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">future accounting pronouncements or changes in our accounting policies&#894;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">our overall effective tax rate, including impacts caused by any reorganization in our corporate tax structure and any new legislation or regulatory developments&#894;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">our ability to successfully expand our business in the United States and internationally&#894;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">fluctuations in foreign currency exchange rates&#894; and</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">the timing and success of new products and solutions introduced by us or our competitors, or any other change in the competitive dynamics of our industry, including consolidation among competitors, customers or partners.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In particular, our cost of
revenue is generally higher in periods during which we acquire new customers.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The impact of one or more
of the foregoing or other factors may cause our results of operations to vary significantly. Such fluctuations make forecasting more difficult
and could cause us to fail to meet the expectations of investors and securities analysts, which could cause the trading price of our ordinary
shares to fall substantially, resulting in the loss of all or part of your investment, and subject us to costly lawsuits, including securities
class action suits.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>The loss of one or more of our significant
customers, or any other reduction in the amount of revenue we derive from any such customer, would adversely affect our business, financial
condition, results of operations and growth prospects.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our future success is dependent
on our ability to establish and maintain successful relationships with a diverse set of customers. We currently derive a significant portion
of our revenue from a limited number of our customers. For the years ended December 31, 2022 and December 31, 2021, our top ten customers
in the aggregate accounted for approximately 61% and 62% of our revenues, respectively.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Until we can derive revenue,
if any, from the Beamr HW-Accelerated Content Adaptive Encoding solution, we expect to continue to derive a significant portion of our
revenue from a limited number of customers in the future and, in some cases, the portion of our revenue attributable to individual customers
may increase. The loss of one or more significant customers or a reduction in the amount of revenue we derive from any such customer could
significantly and adversely affect our business, financial condition and results of operations. Customers may choose not to renew their
contracts or may otherwise reduce the breadth of the offerings which they purchase for any number of reasons. We are also subject to the
risk that any such customer will experience financial difficulties that prevent them from making payments to us on a timely basis or at
all.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 21; Value: 6 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>If we are not able to keep pace with technological
and competitive developments and develop or otherwise introduce new products and solutions and enhancements to our existing offerings,
our offerings may become less marketable, less competitive or obsolete, and our business, financial condition and results of operations
may be adversely affected.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The markets in which we compete
are characterized by rapid technological change, frequent introductions of new products, services, features and capabilities, and evolving
industry standards and regulatory requirements. Our ability to grow our customer base and increase our revenue will depend in significant
part on our ability to develop or otherwise introduce new products and solutions; develop or otherwise introduce new features, integrations,
capabilities and other enhancements to our existing offerings on a timely basis; and interoperate across an increasing range of devices,
operating systems and third-party applications. The success of any new products or solutions, or enhancements to our existing offerings,
will depend on a number of factors including, but not limited to, the timeliness and effectiveness of our research and product development
activities and go-to-market strategy, our ability to anticipate customer needs and achieve market acceptance, our ability to manage the
risks associated with new product releases, the effective management of development and other spending in connection with the product
development process, and the availability of other newly developed products and technologies by our competitors.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, in connection
with our product development efforts, we may introduce significant changes to our existing products or solutions, or develop or otherwise
introduce new and unproven products or solutions, including technologies with which we have little or no prior development or operating
experience. These new products, solutions and updates may not perform as expected, may fail to engage our customer base or other end users
of our products, or may otherwise create a lag in adoption of such new products. New products may initially suffer from performance and
quality issues that may negatively impact our ability to market and sell such products to new and existing customers. We have in the past
experienced bugs, errors, or other defects or deficiencies in new products and product updates and delays in releasing new products, deployment
options, and product enhancements and may have similar experiences in the future. As a result, some of our customers may either defer
purchasing our offerings until the next upgrade is released or switch to a competitor if we are not able to keep up with technological
developments. To keep pace with technological and competitive developments we have in the past invested, and may in the future invest,
in the acquisition of complementary businesses, technologies, services, products, and other assets that expand our offerings. We may make
these investments without being certain that they will result in products or enhancements that will be accepted by existing or prospective
customers or that will achieve market acceptance. The short- and long-term impact of any major change to our offerings, or the introduction
of new products or solutions, is particularly difficult to predict. If new or enhanced offerings fail to engage our customer base or other
end users of our products, or do not perform as expected, we may fail to generate sufficient revenue, operating margin, or other value
to justify our investments in such products, any of which may adversely affect our reputation and negatively affect our business in the
short-term, long-term, or both. If we are unable to successfully enhance our existing offerings to meet evolving customer requirements,
increase adoption and use cases of our offerings, develop or otherwise introduce new products and solutions and quickly resolve security
vulnerabilities or other errors or defects, or if our efforts in any of these areas are more expensive than we expect, our business, financial
condition and results of operations would be adversely affected.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>If we are not able to maintain and expand
our relationships with third-party technology partners to integrate our offerings with their products and solutions, our business, financial
condition and results of operations may be adversely affected.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our success depends in part
on our ability to integrate our products and services with a variety of network, hardware and software platforms, and we need to continuously
modify and enhance our offerings to adapt to changes in hardware, software, networking, browser and database technologies. Third-party
products and services are constantly evolving, and we may not be able to modify our offerings to ensure their compatibility with those
of other third parties following development changes. Any losses or shifts in the market position of the providers of these third-party
products and services could require us to identify and develop integrations with new third-party technologies. Such changes could consume
substantial resources and may not be effective. Any expansion into new geographies may also require us to integrate our offerings with
new third-party technologies, products and services and invest in developing new relationships with these providers. If we are unable
to respond to changes in a cost-effective manner, our offerings may become less marketable, less competitive, or obsolete, and our business,
financial condition and results of operations may be negatively impacted.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 22; Value: 6 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, a significant
percentage of our customers may choose to integrate our products and services with certain capabilities of third-party hardware and software
providers using APIs. The functionality and popularity of our products and services may depend, in part, on their ability to integrate
with a wide variety of third-party applications and software. Third-party providers of applications may change the features of their applications
and software, restrict our access to their applications and software or alter the terms governing use of their applications and access
to those applications and software in an adverse manner. Such changes could functionally limit or eliminate our ability to use these third-party
applications and software in conjunction with our offerings, which could negatively impact customer demand, our competitive position and
adversely affect our business.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We may not be able to compete successfully
against current and future competitors, some of whom have greater financial, technical, and other resources than we do. If we do not compete
successfully, our business, financial condition and results of operations could be harmed.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">While there are several companies
offering video compression solutions such as MainConcept, Ateme, Ittiam, Visionular and open source (x264/x265), we believe there is currently
no direct competitor with our content-adaptive video compression solutions. There are companies that offer software solutions for video
optimization such as Harmonic and Elemental, and other companies offering storage optimization (but not involving video technologies)
such as EMC and Seagate. In addition, for our quality measure, some of our current competitors include SSIMWave (SSIMPlus), Apple (AVQT),
Google (YouVQ) and open source (VMAF). We operate in a highly specialized area that is evolving very quickly with rapid developments.
In the future, competitors could develop products or solutions that compete with our video compression solutions. For example, the public
cloud platforms such as AWS, Azure, and GCP could in the future develop their own video optimization hardware accelerated solutions.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">We believe the following
competitive attributes are necessary for our solutions to successfully compete in the video compression market:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in; background-color: white">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">the performance and reliability of our solutions;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">cost of deployment and return on investment in terms of cost savings;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">sophistication, novel and innovative intellectual property and technology, and functionality of our offerings;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">cross-platform operability;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">security;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">ease of implementation and use of service;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">high quality customer support; and</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">price.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We believe that we compare
favorably on the basis of the factors listed above. However, many of our competitors have substantially greater financial, technical,
and marketing resources; relationships with large vendor partners; larger global presence; larger customer bases; longer operating histories;
greater brand recognition; and more established relationships in the industry than we do. Furthermore, new entrants not currently considered
to be competitors may enter the market through <i>acquisitions, partnerships, or strategic relationships</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 23; Value: 6 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Additionally, we compete with
home-grown, start-up, and open source technologies across the categories described above. With the introduction of new technologies and
the entrance of new market participants, competition has intensified, and we expect it to continue to intensify in the future. Established
companies are also developing their own video encoding and optimization platforms, products and solutions within their own core product
lines, and may continue to do so in the future. Established companies may also acquire or establish product integration, distribution
or other cooperative relationships with our current competitors. New competitors or alliances among competitors may emerge from time to
time and rapidly acquire significant market share due to various factors such as their greater brand name recognition, larger existing
user or customer base, consumer preferences for their offerings, a larger or more effective sales organization and greater financial,
technical, marketing and other resources and experience. Furthermore, with the recent increase in large merger and acquisition transactions
in the technology industry, particularly transactions involving cloud-based technologies, there is a greater likelihood that we will compete
with other larger technology companies in the future. Companies resulting from these potential consolidations may create more compelling
product offerings and be able to offer more attractive pricing options, making it more difficult for us to compete effectively.&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Many of our competitors have,
and some of our potential competitors may have, greater financial, technical, and other resources, longer operating histories, greater
brand recognition, larger sales forces and marketing budgets, broader distribution networks, more diverse product and services offerings,
larger and more mature intellectual property portfolios, more established relationships in the industry and with customers, lower cost
structures and greater customer experience resources. These competitors may be able to respond more quickly and effectively than we can
to new or changing opportunities, technologies, standards and customer requirements. They may be able to leverage these resources to gain
business in a manner that discourages customers from purchasing our offerings, including through selling at zero or negative margins,
product bundling, forced product migrations, auto-installation of applications, or closed technology platforms. Potential customers may
also prefer to purchase from companies with which they have an existing relationship rather than a new supplier, regardless of product
performance or features. Furthermore, we expect that our industry will continue to attract new companies, including smaller emerging companies,
which could introduce new offerings. We may also expand into new markets and encounter additional competitors in such markets. These competitive
pressures in the markets in which we operate, or our failure to compete effectively, may result in price reductions, fewer customers,
reduced revenue, gross profit and gross margins, increased net losses and loss of market share. Any failure to effectively address these
factors could significantly and adversely affect our business, financial condition and results of operations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>If we are unable to increase sales of our
products and services to new customers, expand the offerings to which our existing customers subscribe, or expand the value of our existing
sales, our future revenue and results of operations will be adversely affected.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our success depends on our
ability to sell our products and services to new customers and to expand within our existing customer base by selling products and services
for additional offerings to our existing customers and expanding the value of existing customers&#8217; subscriptions, and to do so in
a cost-effective manner. Our ability to sell new products and services and expand the value of existing sales depends on a number of factors,
including the prices of our offerings and their functionality, the prices of products offered by our competitors, and the budgets of our
customers. We also plan to offer an initial trial period for certain of our offerings. To the extent prospective customers utilize this
trial period without becoming, or lead others not to become, paying customers, our expenses may increase as a result of associated hosting
costs, and our ability to grow our business may be adversely affected. There is no guarantee that such events will translate into new
customers.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, a significant
aspect of our sales and marketing focus is to expand deployments within existing customers. The rate at which our customers purchase additional
offerings and expand the value of their existing offerings depends on a number of factors, including, among other things, customers&#8217;
level of satisfaction with our offerings and customer support, the nature and size of the deployments, the desire to address additional
use cases, and the availability of, and customers&#8217; awareness of and perceived need for, additional features, integrations, capabilities
or other enhancements, as well as general economic conditions. If our customers do not recognize the potential of our offerings, our business
would be materially and adversely affected.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 24; Value: 6 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>If our existing customers do not renew their
order of products or subscription to services, or if they renew on terms that are less economically beneficial to us, it could have an
adverse effect on our business, financial condition and results of operations.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We expect to derive a significant
portion of our revenue from renewals of subscriptions. Customers have no contractual obligation to renew their subscriptions after the
completion of their subscription term. Subscriptions for most of our offerings are offered on either an annual or multi-year basis. Our
subscriptions may also generally include committed usage amounts. As a result, we cannot provide assurance that customers will renew their
subscriptions for a similar contract period or with the same or greater product depth, number of users, functionality or other terms that
are equally or more economically beneficial to us, if they renew at all.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our customers&#8217; renewals
may decline or fluctuate as a result of a number of factors, including their satisfaction with our products and our customer support,
the frequency and severity of product outages, our product uptime or latency, the pricing of our offering in relation to competing offerings,
additional new features, integrations, capabilities or other enhancements that we offer, updates to our products as a result of updates
by technology partners, and customers or users no longer having a need for our offerings . Renewal rates may also be impacted by general
economic conditions or other factors that reduce customers&#8217; spending levels. If our customers do not renew their subscriptions or
renew on terms less economically favorable to us, our revenue may decline or grow less quickly than anticipated, which would adversely
affect our business, financial condition and results of operations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>If we fail to meet contractual commitments
under our customer agreements, we could be subject to contractual penalties, litigation and other liabilities, and could experience an
increase in contract terminations or decrease in contract renewals in future periods, which would lower our revenue, increase our costs
and otherwise adversely affect our business, financial condition and results of operations.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our customer agreements may
contain service-level commitments. If we are unable to meet the stated service-level commitments, including failure to meet the uptime
and response time requirements under our customer agreements, we may be contractually obligated to provide these customers with service
credits, or customers could elect to terminate and receive refunds for prepaid amounts related to unused subscriptions, either of which
could significantly affect our revenue in the periods in which the failure occurs and the credits are applied or refunds paid out. In
addition, customer terminations or any reduction in renewals resulting from service-level failures could significantly affect both our
current and future revenue. We cannot guarantee that we will not experience a material decrease in customer renewals in future periods
as additional customers cycle through their subscription terms.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Furthermore, any service-level
failures or failure to meet committed delivery schedules and milestones could also create negative publicity and damage our reputation,
which may discourage prospective customers from adopting our offerings. In addition, if we modify the terms of our contractual commitments
in future customer agreements in a manner customers perceive to be unfavorable, demand for our offerings could be reduced. The occurrence
of these or any of the events discussed above could have a significant adverse effect on our business, financial condition, results of
operations and cash flow, as well as our ability to grow our business.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We rely on third parties, including third
parties outside the United States, for some of our software development, quality assurance, operations, and customer support.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We currently depend on various
third parties for some of our software development efforts, quality assurance, operations, and customer support services. Specifically,
through our subsidiary Beamr Imaging RU we undertake some of our software development and design, quality assurance, and operations activities
using employees and consultants located in Russia. Our dependence on third-parties creates a number of risks, in particular, the risk
that we may not maintain development quality, control, or effective management with respect to these business operations. In addition,
the Russian invasion of Ukraine, poor relations between the United States and Russia, and sanctions by the United States and the European
Union, or the EU, against Russia could have an adverse impact on our third-party software development in Russia. See also &#8220;Risk
Factors&#8212;Risks Related to Our Operations in Russia.&#8221; We anticipate that we will continue to depend on these and other third-party
relationships in order to grow our business for the foreseeable future. If we are unsuccessful in maintaining existing and, if needed,
establishing new relationships with third parties, our ability to efficiently operate existing services or develop new services and provide
adequate customer support could be impaired, and, as a result, our competitive position or our results of operations could suffer.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 25; Value: 6 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We depend on our management team and other
key employees, and the loss of one or more of these employees or an inability to attract and retain highly skilled employees could adversely
affect our business.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our future success depends,
in part, on our ability to continue to attract and retain highly skilled personnel. The loss of the services of any of our key personnel,
the inability to attract or retain qualified personnel, or delays in hiring required personnel, particularly in engineering and sales,
may seriously and adversely affect our business, financial condition and results of operations. Although we have entered into employment
or consulting agreements with our personnel, their employment is generally for no specific duration. We are also substantially dependent
on the continued service of our existing IT personnel because of the complexity of our products.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our future performance also
depends on the continued services and continuing contributions of our senior management team, which includes Sharon Carmel, our founder
and Chief Executive Officer, to execute on our business plan and to identify and pursue new opportunities and product innovations. The
loss of services of our senior management team, particularly our Chief Executive Officer, could significantly delay or prevent the achievement
of our development and strategic objectives, which could adversely affect our business, financial condition and results of operations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Additionally, the industry
in which we operate is generally characterized by significant competition for skilled personnel, as well as high employee attrition. There
is currently a high demand for experienced software industry personnel, particularly for engineering, research and development, sales
and support positions, and we may not be successful in attracting, integrating and retaining qualified personnel to fulfill our current
and future needs. This intense competition has resulted in increasing wages, especially in Israel, where our headquarters is located and
most of our research and development positions are located, and in California, where our sales offices are located, which may make it
more difficult for us to attract and retain qualified personnel, as many of the companies against which we compete for personnel have
greater financial resources than we do. These competitors may also actively seek to hire our existing personnel away from us, even if
such employee has entered into a non-compete agreement. We may be unable to enforce these agreements under the laws of the jurisdictions
in which our employees work. For example, Israeli labor courts have required employers seeking to enforce non-compete undertakings of
a former employee to demonstrate that the competitive activities of the former employee will harm one of a limited number of material
interests of the employer that have been recognized by the courts, such as the protection of a company&#8217;s confidential information
or other intellectual property, taking into account, among other things, the employee&#8217;s tenure, position, and the degree to which
the non-compete undertaking limits the employee&#8217;s freedom of occupation. We may not be able to make such a demonstration. Also,
to the extent we hire personnel from competitors, we may be subject to allegations that they have been improperly solicited or that they
have divulged their former employers&#8217; proprietary or other confidential information or incorporated such information into our products,
which could include claims that such former employers therefore own or otherwise have rights to their inventions or other work product
developed while employed by us.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, in making employment
decisions, particularly in the internet and high-technology industries, job candidates often consider the value of the equity they are
to receive in connection with their employment. Employees may be more likely to leave us if the shares they own or the shares underlying
their equity incentive awards have significantly appreciated or significantly reduced in value. Many of our employees may receive significant
proceeds from sales of our equity in the public markets, which may reduce their motivation to continue to work for us and could lead to
employee attrition. If we fail to attract new personnel, or fail to retain and motivate our current personnel, our business, financial
condition, results of operations and growth prospects could be adversely affected.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>If we are not able to maintain and enhance
awareness of our brand, especially among companies who store large amounts of video files, our business, financial condition and results
of operations may be adversely affected.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We believe that developing
and maintaining widespread awareness of our brand, especially with companies who store large amounts of video files, is critical to achieving
widespread acceptance of our products and services and attracting new users and customers. Brand promotion activities may not generate
user or customer awareness or increase revenue, and even if they do, any increase in revenue may not offset the expenses we incur in building
our brand. If we fail to successfully promote and maintain our brand, we may fail to attract and retain users and customers necessary
to realize a sufficient return on our brand-building efforts, and may fail to achieve the widespread brand awareness that is critical
for broad customer adoption of our offerings.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 26; Value: 6 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Our corporate culture has contributed to
our success, and if we cannot maintain this culture as we grow, we could lose the innovation, creativity, and entrepreneurial spirit we
have worked to foster, which could adversely affect our business.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We believe that our corporate
culture, which is based on openness, flexibility, and collaboration, has been and will continue to be a key contributor to our success.
We expect to hire aggressively as we expand. If we do not continue to maintain our corporate culture as we grow, we may be unable to foster
the innovation, creativity, and entrepreneurial spirit we believe we need to support our growth. The growth and expansion of our business
and our transition from a private company to a public company may result in changes to our corporate culture, which could adversely affect
our business, including our ability to recruit and retain qualified personnel.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Our failure to offer high quality customer
support would have an adverse effect on our business, reputation and results of operations.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our customers depend on our
customer success managers to resolve issues and realize the full benefits relating to our products and services. If we do not succeed
in helping our customers quickly resolve post-deployment issues or provide effective ongoing support and education, our ability to renew
contracts with, or establish contracts for additional offerings to, existing customers, or expand the value of existing customers&#8217;
contracts, would be adversely affected and our reputation with potential customers could be damaged. In addition, most of our existing
customers are large enterprises with complex information technology environments and, as a result, require significant levels of support.
If we fail to meet the requirements of these customers, it may be more difficult to grow sales or maintain our relationships with them.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Additionally, while growing
our need for customer success managers is a key component of our growth strategy, it can take several months to recruit, hire and train
qualified engineering-level customer support employees, and we may not be able to hire such resources fast enough to keep up with demand
during the relevant time in the future. To the extent that we are unsuccessful in hiring, training and retaining adequate support resources,
our ability to provide adequate and timely support to our customers, and our customers&#8217; satisfaction with our products and services,
will be adversely affected. Any failure by us to provide and maintain high-quality customer support services would have an adverse effect
on our business, reputation and results of operations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>The sales prices of our offerings may change,
which may reduce our revenue and gross profit and adversely affect our financial results.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The sales prices for our offerings
may be subject to change for a variety of reasons, including competitive pricing pressures, discounts, anticipation of the introduction
of new products, promotional programs, general economic conditions, or our marketing, user acquisition and technology costs and, as a
result, we anticipate that we will need to change our pricing model from time to time. In the past, we have sometimes adjusted our prices
for individual customers in certain situations, and expect to continue to do so in the future. Moreover, demand for our offerings is price-sensitive.
Competition continues to increase in the market segments in which we operate, and we expect competition to further increase in the future,
thereby leading to increased pricing pressures. Larger competitors with more diverse offerings may reduce the price of offerings that
compete with ours or may bundle them with other offerings and provide for free. Similarly, certain competitors may use marketing strategies
that enable them to acquire customers more rapidly or at a lower cost than us, or both, and we may be unable to attract new customers
or grow and retain our customer base based on our historical pricing. Additionally, currency fluctuations in certain countries and regions
may negatively impact actual prices that customers and resellers are willing to pay in those countries and regions. As we develop and
introduce new offerings, as well as features, integrations, capabilities and other enhancements, we may need to, or choose to, revise
our pricing. There can be no assurance that we will not be forced to engage in price-cutting initiatives or to increase our marketing
and other expenses to attract customers in response to competitive or other pressures. Any decrease in the sales prices for our products,
without a corresponding decrease in costs, increase in volume or increase in revenue from our other offerings, would adversely affect
our revenue and gross profit. We cannot assure you that we will be able to maintain our prices and gross profits at levels that will allow
us to achieve and maintain profitability.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 27; Value: 6 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Our international operations and expansion
expose us to risk.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our products and services
address the needs of customers and end users around the world, and we see continued international expansion as a significant opportunity.
For the years ended December 31, 2022 and 2021, we generated approximately 25% and 21% of our revenue, respectively, from customers outside
the United States. Our customers, end users, employees and partners are located in a number of different jurisdictions worldwide, and
we expect our operations will become increasingly global as our business continues to grow. Our current international operations involve,
and future initiatives will also involve, a variety of risks, including:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">unexpected changes in practices, tariffs, export quotas, custom duties, trade disputes, tax laws and treaties, particularly due to economic tensions and trade negotiations or other trade restrictions;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">different labor regulations, especially in the EU, where labor laws are generally more advantageous to employees as compared to the United States, including deemed hourly wage and overtime regulations in these locations&#894;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">exposure to many evolving stringent and potentially inconsistent laws and regulations relating to privacy, data protection, and information security, particularly in the EU&#894;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">changes in a specific country&#8217;s or region&#8217;s political or economic conditions&#894;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify">risks resulting from any resurgence of the COVID-19 pandemic, or any
other pandemic, epidemic or outbreak of infectious disease, including uncertainty regarding what measures the U.S. or foreign governments
will take in response&#894;</td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">risks resulting from changes in currency exchange rates&#894;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">challenges inherent to efficiently managing an increased number of employees over large geographic distances, including the need to implement appropriate systems, policies, benefits and compliance programs&#894;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">difficulties in maintaining our corporate culture with a dispersed workforce;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">risks relating to the implementation of exchange controls, including restrictions promulgated by the United States Department of the Treasury&#8217;s Office of Foreign Assets Control, or OFAC, and other similar trade protection regulations and measures in the United States or in other jurisdictions&#894;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">reduced ability to timely collect amounts owed to us by our customers in countries where our recourse may be more limited&#894;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">slower than anticipated availability and adoption of cloud infrastructures by international businesses, which would increase our on-premise deployments&#894;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">limitations on our ability to reinvest earnings from operations derived from one country to fund the capital needs of our operations in other countries&#894;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">limited or unfavorable&#8212;including greater difficulty in enforcing&#8212;intellectual property protection&#894; and</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">exposure to liabilities under anti-corruption and anti-money laundering laws, including the U.S. Foreign Corrupt Practices Act of 1977, as amended, and similar applicable laws and regulations in other jurisdictions.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If we are unable to address
these difficulties and challenges or other problems encountered in connection with our international operations and expansion, we might
incur unanticipated liabilities or we might otherwise suffer harm to our business generally.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 28; Value: 6 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Currency exchange rate fluctuations and
inflation affect our results of operations, as reported in our financial statements.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We report our financial results
in U.S. dollars. We collect our revenue primarily in U.S. dollars and NIS. A portion of the cost of revenue, research and development,
selling and marketing and general and administrative expenses of our Israeli and Russian operations are incurred in NIS or in Russian
Ruble, or RUB. As a result, we are exposed to exchange rate risks that may materially and adversely affect our financial results. If the
NIS or RUB appreciates against the U.S. dollar, or if the value of the NIS or RUB decline against the U.S. dollar, at a time when the
rate of inflation in the cost of Israeli and Russian goods and services exceed the rate of decline in the relative value of the NIS and
RUB, then the U.S. dollar-denominated cost of our operations in Israel and Russia would increase and our results of operations could be
materially and adversely affected.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Inflation in Israel compounds
the adverse impact of a devaluation of the NIS against the U.S. dollar by further increasing the amount of our Israeli expenses. Israeli
inflation may also (in the future) outweigh the positive effect of any appreciation of the U.S. dollar relative to the NIS, if, and to
the extent that, it outpaces such appreciation or precedes such appreciation. The Israeli rate of inflation did not have a material adverse
effect on our financial condition during 2021 or 2022. Given our general lack of currency hedging arrangements to protect us from fluctuations
in the exchange rates of the NIS or the RUB in relation to the U.S. dollar (and/or from inflation of such non-U.S. currencies), we may
be exposed to material adverse effects from such movements. We cannot predict any future trends in the rate of inflation in Israel or
in Russia or the rate of devaluation (if any) of the U.S. dollar against the NIS or the RUB.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In particular, due to the
recent Russian invasion of Ukraine, there has been significant currency rate fluctuations between the U.S. dollar and RUB. We cannot predict
any future exchange-rate fluctuations and future trends in the rate of inflation in Israel and Russia and our ability to hedge our exposure
to currency exchange rate fluctuations may be limited.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, we use products
and services and offer our products and services through cloud services, which may publish different prices in different locations. These
differences in prices and locations may impact our costs and margins, and value we bring to our customers.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b><i>Our business, operating
results and growth rates may be adversely affected by current or future unfavorable economic and market conditions and adverse developments
with respect to financial institutions and associated liquidity risk.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Our
business depends on the economic health of the global economies. If the conditions in the global economies remain uncertain or continue
to be volatile, or if they deteriorate, including as a result of the impact of military conflict, such as the war between Russia and Ukraine,
terrorism or other geopolitical events, our business, operating results and financial condition may be materially adversely affected.
Economic weakness, inflation and increases in interest rates, limited availability of credit, liquidity shortages and constrained capital
spending have at times in the past resulted, and may in the future result, in challenging and delayed sales cycles, slower adoption of
new technologies and increased price competition, and could negatively affect our ability to forecast future periods, which could result
in an inability to satisfy demand for our products and a loss of market share.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">In
addition, increases in inflation raise our costs for commodities, labor, materials and services and other costs required to grow and operate
our business, and failure to secure these on reasonable terms may adversely impact our financial condition. Additionally, increases in
inflation, along with the uncertainties surrounding COVID-19, geopolitical developments and global supply chain disruptions, have caused,
and may in the future cause, global economic uncertainty and uncertainty about the interest rate environment, which may make it more difficult,
costly or dilutive for us to secure additional financing. A failure to adequately respond to these risks could have a material adverse
impact on our financial condition, results of operations or cash flows.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"></p><div>

</div><!-- Field: Page; Sequence: 29; Value: 6 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">More
recently, the closures of SVB and Signature Bank and their placement into receivership with the FDIC created bank-specific and broader
financial institution liquidity risk and concerns. Although the Department of the Treasury, the Federal Reserve and the FDIC jointly
released a statement that depositors at SVB and Signature Bank would have access to their funds, even those in excess of the standard
FDIC insurance limits, under a systemic risk exception, future adverse developments with respect to specific financial institutions or
the broader financial services industry may lead to market-wide liquidity shortages, impair the ability of companies to access near-term
working capital needs, and create additional market and economic uncertainty. There can be no assurance that future credit and financial
market instability and a deterioration in confidence in economic conditions will not occur. Our general business strategy may be adversely
affected by any such economic downturn, liquidity shortages, volatile business environment or continued unpredictable and unstable market
conditions. If the current equity and credit markets deteriorate, or if adverse developments are experienced by financial institutions,
it may cause short-term liquidity risk and also make any necessary debt or equity financing more difficult, more costly, more onerous
with respect to financial and operating covenants and more dilutive. Failure to secure any necessary financing in a timely manner and
on favorable terms could have a material adverse effect on our growth strategy, financial performance and stock price and could require
us to alter our operating plans. In addition, there is a risk that one or more of our service providers, financial institutions, manufacturers,
suppliers and other partners may be adversely affected by the foregoing risks, which could directly affect our ability to attain our
operating goals on schedule and on budget.</p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b><i>Increasing scrutiny
of, and evolving expectations for, sustainability and environmental, social, and governance, or ESG, initiatives could increase our costs
or otherwise adversely impact our business.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Public
companies are facing increasing scrutiny related to&#160;ESG&#160;practices and disclosures from certain investors, capital providers,
shareholder advocacy groups, other market participants and other stakeholder groups. With this increased focus, public reporting regarding&#160;ESG&#160;practices
is becoming more broadly expected. Such increased scrutiny may result in increased costs, enhanced compliance or disclosure obligations,
or other adverse impacts on our business, financial condition or results of operations. If our&#160;ESG&#160;practices and reporting do
not meet investor or other stakeholder expectations, which continue to evolve, we may be subject to investor or regulator engagement regarding
such matters. In addition, new sustainability rules and regulations have been adopted and may continue to be introduced in various states
and other jurisdictions. For example, the SEC has published proposed rules that would require companies to provide significantly expanded
climate-related disclosures in their periodic reporting, which may require us to incur significant additional costs to comply and impose
increased oversight obligations on our management and board of directors. Our failure to comply with any applicable rules or regulations
could lead to penalties and adversely impact our reputation, access to capital and employee retention. Such&#160;ESG&#160;matters may
also impact our third-party contract manufacturers and other third parties on which we rely, which may augment or cause additional impacts
on our business, financial condition, or results of operations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Any resurgence of the COVID-19 pandemic
could adversely affect our business, financial condition and results of operations.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In December 2019, an
outbreak of a novel coronavirus disease, or COVID-19, was first identified and began to spread across the globe and, in March 2020,
the World Health Organization declared it a pandemic. This contagious disease spread across the globe and impacted economic activity
and financial markets worldwide, including countries in which our end users and customers are located, as well as the United States
and Israel where we have business operations. As a result of the COVID-19 pandemic, government authorities around the world ordered
schools and businesses to close, imposed restrictions on non-essential activities and required people to remain at home while
imposing significant restrictions on traveling and social gatherings.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">While COVID-19 has not had
a material adverse impact on our operations through the date of this Annual Report, our ability to attract, serve, retain or upsell customers
is inherently uncertain and depends on the duration, severity and potential resurgence of the pandemic and its impact on end users, customers
and the macroeconomic environment as a whole. Prior to the COVID-19 pandemic, our employees traveled frequently to establish and maintain
relationships with one another, as well as our customers, partners, and investors. Although we continue to monitor the situation, any
renewed limitations on travel and doing business in person may negatively affect our customer success efforts, sales and marketing efforts,
challenge our ability to enter into customer contracts in a timely manner, slow down our recruiting efforts, or create operational or
other challenges, any of which could adversely affect our business, financial condition and results of operations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"></p><div>

</div><!-- Field: Page; Sequence: 30; Value: 6 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Furthermore, COVID-19 has
disrupted and may continue to disrupt the operations of our customers and technology partners for an indefinite period of time, including
as a result of travel restrictions and/or business shutdowns, all of which could negatively impact our business, financial condition and
results of operations. More generally, the COVID-19 pandemic has adversely affected economies and financial markets globally, leading
to an economic downturn, which could decrease technology spending and adversely affect demand for our offerings and harm our business,
financial condition and results of operations. Existing and potential customers may choose to reduce or delay technology investments in
response to the COVID-19 pandemic, or attempt to renegotiate contracts and obtain concessions, which may materially and negatively impact
our operating results, financial condition and prospects. For example, as a result of COVID-19, we have experienced and expect to continue
to experience an increase in the average length of sales cycles to onboard new customers, delays in new projects, and requests by some
customers for extension of payment obligations, all of which could materially and adversely impact our business, financial condition and
results of operations in future periods. The COVID-19 pandemic has also resulted in, and may continue to result in, significant disruption
of global financial markets, reducing our ability to access capital, which could in the future negatively affect our liquidity. It is
also possible that continued widespread remote work arrangements may have a negative impact on our operations, the execution of our business
plans, the productivity and availability of key personnel and other employees necessary to conduct our business, and on third-party service
providers who perform critical services for us, or otherwise cause operational failures due to changes in our normal business practices
necessitated by the pandemic and related governmental actions. If a natural disaster, power outage, connectivity issue, or other event
occurred that impacted our employees&#8217; ability to work remotely, it may be difficult or, in certain cases, impossible, for us to
continue our business for a substantial period of time. The increase in remote working may also result in privacy, data protection, data
security, and fraud risks, and our understanding of applicable legal and regulatory requirements, as well as the latest guidance from
regulatory authorities in connection with the COVID-19 pandemic, may be subject to legal or regulatory challenge, particularly as regulatory
guidance evolves in response to future developments.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: justify; margin: 0pt 0">It is not possible at this time to estimate the long-term impact that
COVID-19 could have on our business, financial condition and results of operations as the impact will depend on future developments, which
are highly uncertain and cannot be predicted, including, but not limited to, the duration and spread of the pandemic, its severity, the
actions to contain the virus or treat its impact, and how quickly and to what extent normal economic and operating conditions can resume.
Even after the COVID-19 pandemic has subsided, we may experience materially adverse impacts to our business as a result of its global
economic impact, including any recession that has occurred or may occur in the future.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Risks Related to Information Technology, Intellectual
Property and Data Security and Privacy</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>A real or perceived bug, defect, security
vulnerability, error, or other performance failure involving our products and services could cause us to lose revenue, damage our reputation,
and expose us to liability.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our products and services
are inherently complex and, despite extensive testing and quality control, have in the past and may in the future contain bugs, defects,
security vulnerabilities, errors, or other performance failures, especially when first introduced, or otherwise not perform as intended.
Any such bug, defect, security vulnerability, error, or other performance failure could cause damage to our reputation, loss of customers
or revenue, order cancellations, service terminations, and lack of market acceptance of our offerings. As the use of our offerings among
new and existing customers expands, particularly to more sensitive, secure, or mission critical uses, we may be subject to increased scrutiny,
potential reputational risk, or potential liability should our offerings fail to perform as contemplated in such deployments. We have
in the past and may in the future need to issue corrective releases of our software to fix these defects, errors or performance failures,
which could require us to allocate significant research and development and customer support resources to address these problems. Despite
our efforts, such corrections may take longer to develop and release than we or our customers anticipate and expect.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Any limitation of liability
provision contained in an agreement with a customer, user, third-party vendor, service provider, or partner may not be enforceable, adequate
or effective as a result of existing or future applicable law or judicial decisions, and may not function to limit our liability arising
from regulatory enforcement or other specific circumstances. The sale and support of our offerings entail the risk of liability claims,
which could be substantial in light of the use of our offerings in enterprise-wide environments. In addition, our insurance against any
such liability may not be adequate to cover a potential claim, and may be subject to exclusions, or subject us to the risk that the insurer
will deny coverage as to any future claim or exclude from our coverage such claims in policy renewals, increase our fees or deductibles
or impose co-insurance requirements. Any such bugs, defects, security vulnerabilities, errors, or other performance failures in our products
and services, including as a result of denial of claims by our insurer or the successful assertion of claims by others against us that
exceed available insurance coverage, or the occurrence of changes in our insurance policies, including increases or the imposition of
large deductible or co-insurance requirements, could have a material adverse effect on our business, including our financial condition,
results of operations and reputation.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 31; Value: 6 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>If we or our third-party service providers
experience a security breach, data loss or other compromise, including if unauthorized parties obtain access to our customers&#8217; data,
our reputation may be harmed, demand for our products and services may be reduced, and we may incur significant liabilities.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our business products and
services involve the collection, storage, processing, transmission and other use of data, including certain confidential, sensitive, and
personal information. Any security breach, data loss, or other compromise, including those resulting from a cybersecurity attack, phishing
attack, or any unauthorized access, unauthorized usage, virus or similar breach or disruption could result in the loss or destruction
of or unauthorized access to, or use, alteration, disclosure, or acquisition of, data, damage to our reputation, litigation, regulatory
investigations, or other liabilities. These attacks may come from individual hackers, criminal groups, and state-sponsored organizations.
If our security measures are breached as a result of third-party action, employee error or negligence, a defect or bug in our offerings
or those of our third-party service providers, malfeasance or otherwise and, as a result, someone obtains unauthorized access to any data,
including our confidential, sensitive, or personal information or the confidential, sensitive, or personal information of our customers,
or other persons, or any of these types of information is lost, destroyed, or used, altered, disclosed, or acquired without authorization,
our reputation may be damaged, our business may suffer, and we could incur significant liability, including under applicable data privacy
and security laws and regulations. Even the perception of inadequate security may damage our reputation and negatively impact our ability
to win new customers and retain and receive timely payments from existing customers. Further, we could be required to expend significant
capital and other resources to protect against and address any data security incident or breach, which may not be covered or fully covered
by our insurance and which may involve payments for investigations, forensic analyses, regulatory compliance, breach notification, legal
advice, public relations advice, system repair or replacement, or other services. In addition, we do not maintain cybersecurity insurance
and therefore have no insurance coverage in the event of any breach or disruption of our or our customers&#8217; or service providers&#8217;
systems, including any unauthorized access or loss of any personal data that we may collect, store or otherwise process. To the extent
that any disruption or security breach were to result in a loss of, or damage to, our data or systems, or inappropriate disclosure of
confidential or proprietary information, we could incur liability, our competitive position could be harmed and our business, operations,
and financial results could be adversely affected.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, part of the process
of our solution is replacing our customer&#8217;s native image and video files with optimized, compressed files. This process and replacement
of files can result in data loss. Additionally, we do not directly control content that our customers store or use in our products. If
our customers use our products for the transmission or storage of personal, confidential, sensitive, or other information about individuals
and our security measures are or are believed to have been breached as a result of third-party action, employee error, malfeasance or
otherwise, our reputation could be damaged, our business may suffer, and we could incur significant liability.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We engage third-party vendors
and service providers to store and otherwise process some of our and our customers&#8217; data, including personal, confidential, sensitive,
and other information about individuals. Our vendors and service providers may also be the targets of cyberattacks, malicious software,
phishing schemes, and fraud. Our ability to monitor our vendors and service providers&#8217; data security is limited, and, in any event,
third parties may be able to circumvent those security measures, resulting in the unauthorized access to, misuse, acquisition, disclosure,
loss, alteration, or destruction of our and our customers&#8217; data, including confidential, sensitive, and other information about
individuals.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Techniques used to sabotage
or obtain unauthorized access to systems or networks are constantly evolving and, in some instances, are not identified until after they
have been launched against a target. We and our service providers may be unable to anticipate these techniques, react in a timely manner,
or implement adequate preventative and mitigating measures. If we are unable to efficiently and effectively maintain and upgrade our system
safeguards, we may incur unexpected costs and certain of our systems may become more vulnerable to unauthorized access or disruption.
Any of the foregoing could have a material adverse effect on our business, including our financial condition, results of operations and
reputation.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 32; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Insufficient investment in, or interruptions
or performance problems associated with, our technology and infrastructure, including in connection with our Beamr HW-Accelerated Content
Adaptive Encoding solution is to be deployed on a public cloud infrastructure, and our reliance on technologies from third parties, may
adversely affect our business operations and financial results.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Customers of our offerings
will need to be able to access our platform at any time, without interruption or degradation of performance. Our Beamr HW-Accelerated
Content Adaptive Encoding solution is to be deployed on a public cloud infrastructure with the goal of providing improved stability, reliability,
scalability and elasticity for our offerings. We may discover deficiencies in our design, implementation or maintenance of our Beamr HW-Accelerated
Content Adaptive Encoding solution that could adversely affect our business, financial condition and results of operations. Furthermore,
we cannot yet know the ultimate impact of this or any similar future event on our customer relationships.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, third-party cloud
providers run their own platforms that we access, and we are, therefore, vulnerable to their service interruptions and any changes in
their product offerings. Any limitation on the capacity of our third-party hosting services could impede our ability to onboard new customers
or expand the usage of our existing customers, which could adversely affect our business, financial condition and results of operations.
In addition, any incident affecting our third-party hosting services&#8217; infrastructure that may be caused by cyber-attacks, computer
viruses, malware, systems failures or other technical malfunctions, natural disasters, fire, flood, severe storm, earthquake, power loss,
telecommunications failures, terrorist or other attacks, protests or riots, and other similar events beyond our control could negatively
affect our cloud-based offerings. It is also possible that our customers and regulators would seek to hold us accountable for any breach
of security affecting a third-party cloud provider&#8217;s infrastructure and we may incur significant liability in investigating such
an incident and responding to any claims, investigations, or proceedings made or initiated by those customers, regulators, and other third
parties. We may not be able to recover a material portion of such liabilities from any of our third-party cloud providers. It may also
become increasingly difficult to maintain and improve our performance and cost, especially during peak usage times, as our processing
cost might be higher during peak hours. Moreover, our insurance may not be adequate to cover such liability and may be subject to exclusions.
Any of the above circumstances or events may adversely affect our business, financial condition and results of operations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In the event that our service
agreements with our third-party hosting services are terminated, or there is a lapse of service, elimination of services or features that
we utilize, interruption of internet service provider connectivity or damage to our providers&#8217; facilities, we could experience interruptions
in access to our platform as well as significant delays and additional expense in arranging or creating new facilities and services and/or
re-architecting our cloud-based offerings for deployment on a different cloud infrastructure service provider, which could adversely affect
our business, financial condition and results of operations. Upon the termination or expiration of such service agreements, we cannot
guarantee that adequate third-party hosting services will be available to us on commercially acceptable terms or within adequate timelines
from the same or different hosting services providers or at all.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We may also rely on cloud
technologies from third parties in order to operate critical functions of our business, including financial management services, relationship
management services, and lead generation management services. If these services become unavailable due to extended outages or interruptions
or because they are no longer available on commercially reasonable terms or prices, our expenses could increase, our ability to manage
our finances could be interrupted, our processes for managing sales of our products and supporting our customers could be impaired, and
our ability to generate and manage sales leads could be weakened until equivalent services are identified, obtained, and implemented.
Even if such services are available, we may not be able to identify, obtain and implement such services in time to avoid disruption to
our business, and such services may only be available on a more costly basis or otherwise less favorable terms. Any of the foregoing could
have a material adverse effect on our business, including our financial condition, results of operations and reputation.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Failure to protect our proprietary technology,
or to obtain, maintain, protect and enforce sufficiently broad intellectual property rights therein, could substantially harm our business,
financial condition and results of operations.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our success depends to a significant
degree on our ability to protect our proprietary technology, methodologies, know-how, and brand. We rely on a combination of trademarks,
copyrights, patents, trade secret laws, contractual restrictions, and other intellectual property laws and confidentiality procedures
to establish and protect our proprietary rights. However, our competitors or other third parties could reverse engineering our code and
use it to create software and service offerings that compete with ours. While software can, in some cases, be protected under copyright
law, in order to bring a copyright infringement lawsuit in the United States, the copyright must first be registered. We have chosen not
to register any copyrights and rely on trade secret protection in addition to unregistered copyrights to protect our proprietary software.
Accordingly, the remedies and damages available to us for unauthorized use of our software may be limited.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 33; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Further, the steps we take
to protect our intellectual property and proprietary rights may be inadequate. We may not be able to register our intellectual property
rights in all jurisdictions where we conduct or anticipate conducting business, and may experience conflicts with third parties who contest
our applications to register our intellectual property. Even if registered or issued, we cannot guarantee that our trademarks, patents,
copyrights or other intellectual property or proprietary rights will be of sufficient scope or strength to provide us with any meaningful
protection or commercial advantage. We will not be able to protect our intellectual property and proprietary rights if we are unable to
enforce our rights or if we do not detect infringement, misappropriation, dilution or other unauthorized use or violation thereof. If
we fail to defend and protect our intellectual property rights adequately, our competitors and other third parties may gain access to
our proprietary technology, information and know-how, reverse-engineer our software, and infringe upon or dilute the value of our brand,
and our business may be harmed. In addition, obtaining, maintaining, defending, and enforcing our intellectual property rights might entail
significant expense. Any patents, trademarks, copyrights, or other intellectual property rights that we have or may obtain may be challenged
by others or invalidated through administrative process or litigation. Even if we continue to seek patent protection in the future, we
may be unable to obtain further patent protection for our technology. In addition, any patents issued in the future may not provide us
with competitive advantages, may be designed around by our competitors, or may be successfully challenged by third parties. Furthermore,
legal standards relating to the validity, enforceability, and scope of protection of intellectual property rights are uncertain.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We may be unable to prevent
third parties from acquiring domain names or trademarks that are similar to, infringe upon, dilute or diminish the value of our trademarks
and other proprietary rights. Additionally, our trademarks may be opposed, otherwise challenged or declared invalid, unenforceable or
generic, or determined to be infringing on or dilutive of other marks. We may not be able to protect our rights in these trademarks, which
we need in order to build name recognition with customers. If third parties succeed in registering or developing common law rights in
such trademarks and we are not successful in challenging such third-party rights, or if our trademark rights are successfully challenged,
we may not be able to use our trademarks to commercialize our products in certain relevant jurisdictions.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Despite our precautions, it
may be possible for unauthorized third parties to copy our products and use information that we regard as proprietary to create offerings
that compete with ours. Effective patent, trademark, copyright, and trade secret protection may not be available to us in every country
in which our products are available. The laws of some countries may not be as protective of intellectual property rights as those in the
United States, and mechanisms for enforcement of intellectual property rights may be inadequate. As we continue to expand our international
activities, our exposure to unauthorized copying and use of our products and proprietary information will likely increase. Accordingly,
despite our efforts, we may be unable to prevent third parties from infringing upon, diluting, misappropriating or otherwise violating
our intellectual property rights.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have devoted substantial
resources to the development of our technology, business operations and business plans. We attempt to protect our intellectual property
and proprietary information, including trade secrets, by implementing administrative, technical and physical practices, including source
code access controls, to secure our proprietary information. We also seek to enter into confidentiality, non-compete, proprietary, and
inventions assignment agreements with our employees, consultants and contractors, and enter into confidentiality agreements with other
parties, such as licensees and customers. However, such agreements may not be self-executing, and there can be no guarantee that all applicable
parties have executed such agreements. No assurance can be given that these practices or agreements will be effective in controlling access
to and distribution of our proprietary information, or in providing adequate remedies in the event of unauthorized access or distribution,
especially in certain states and countries, including Israel and Russia, that are less willing to enforce such agreements or otherwise
provide protection for trade secrets. Further, these agreements may not prevent our competitors from independently developing technologies
that are substantially equivalent or superior to our products, and in such cases we would not be able to assert trade secret rights against
such parties. We also employ individuals who were previously employed at other companies in our field, and our efforts to ensure that
such individuals do not use the proprietary information or know-how of others in their work for us may not prevent others from claiming
that we or our employees or independent contractors have used or disclosed intellectual property, including trade secrets or other proprietary
information, of a former employer or other third parties. Litigation may be necessary to defend against any such claims. If we are unsuccessful
in defending against any such claims, we may be liable for damages or prevented from using certain intellectual property, which in turn
could materially adversely affect our business, financial condition or results of operations; even if we are successful in defending against
such claims, litigation could result in substantial costs and distract management and other employees.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 34; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In order to protect our intellectual
property and proprietary rights and to monitor for and take action against any infringement, misappropriation or other violations thereof,
we may be required to spend significant resources. Litigation may be necessary to enforce and protect our trade secrets and other intellectual
property and proprietary rights, which could be costly, time-consuming, and distracting to management, and could result in the impairment
or loss of portions of our intellectual property. Further, our efforts to enforce our intellectual property and proprietary rights may
be met with defenses, counterclaims, and countersuits attacking the ownership, scope, validity and enforceability of such rights. Our
inability to protect our proprietary technology or our brand against unauthorized copying or use, as well as any costly litigation or
diversion of our management&#8217;s attention and resources, could delay further sales or the implementation of our offerings or impair
their functionality, delay introductions of new offerings, result in our substituting inferior or more costly technologies into our offerings,
or injure our reputation. Any of the foregoing could materially and adversely affect our business, financial condition, results of operations
and growth prospects.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We could incur substantial costs and otherwise
suffer harm as a result of any claim of infringement, misappropriation or other violation of another party&#8217;s intellectual property
or proprietary rights.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In recent years, there has
been significant litigation involving patents and other intellectual property and proprietary rights in the software industry. Our competitors
and others may now and in the future have significantly larger and more mature patent portfolios than we have. Even a large patent portfolio
may not serve as a deterrent to litigation by certain third parties, some of whose sole or primary business is to assert patent claims
and some of whom have sent letters to and/or filed suit alleging infringement against us or some of our customers. We could incur substantial
costs in prosecuting or defending any intellectual property litigation. If we sue to enforce our rights or are sued by a third party claiming
that our offerings infringe, misappropriate or violate their rights, the litigation could be expensive and could divert management attention
and resources away from our core business operations. In addition, there could be public announcements of the results of hearings, motions
or other interim proceedings or developments, and if securities analysts or investors perceive these results to be negative, it could
have a material adverse effect on the price of our ordinary shares.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Any intellectual property
litigation to which we might become a party, or for which we are required to provide indemnification, may require us to do one or more
of the following:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">cease selling or using offerings that incorporate or are otherwise covered by the intellectual property rights that we allegedly infringe, misappropriate or otherwise violate&#894;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">make substantial payments for legal fees, settlement payments or other costs or damages, including potentially treble damages if we are found liable for willful infringement&#894;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">obtain a license to sell or use the relevant technology, which may not be available on reasonable terms or at all, may be non-exclusive and thereby allow our competitors and other parties access to the same technology, and may require the payment of substantial licensing, royalty or other fees&#894; or</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">redesign the allegedly infringing offerings to avoid infringement, misappropriation or other violation, which could be costly, time-consuming or impossible.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&#160;&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If we are required to make
substantial payments or undertake or suffer any of the other actions and consequences noted above as a result of any intellectual property
infringement, misappropriation or violation claims against us or any obligation to indemnify our customers for such claims, such payments,
actions and consequences could materially and adversely affect our business, financial condition, results of operations and growth prospects.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 35; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We could incur substantial costs and otherwise
suffer harm as a result of patent royalty claims, in particular patents related to the implementation of image and video standards</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our products and services
decode and encode media files which are compressed using compression methods that are standardized by international standard bodies such
as ISO and ITU. These standard compression methods include, for example, JPEG and HEIC for images, and H.264, HEVC, EVC and VVC for video.
Some of the algorithms included in these image and video compression standards are covered by patents which are licensed by patent pools,
such as MPEG-LA, Access Advance and Velos Media, and by independent patent holders. Depending on the use case and application of these
image and video standards in our products and services, we may be required to pay patent royalties to such patent pools and independent
patent holders, which might affect our margins and our profitability. Historically, almost all of our products and services have not required
such patent royalty payment however as we expand our SaaS offering, we expect to pay such patent royalties in the future. In addition,
in order to avoid paying patent royalties, some of our customers may opt to use open source compression standards such as VP9 or AV1,
which in turn would require us to support such standards in our products and services, causing additional product development costs due
to this fragmentation.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Indemnity provisions in various agreements
potentially expose us to substantial liability for intellectual property infringement, misappropriation, violation, and other losses.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our agreements with customers
and other third parties may include indemnification provisions under which we agree to indemnify them for losses suffered or incurred
as a result of claims of intellectual property infringement, misappropriation or violation, damages caused by us to property or persons,
or other liabilities relating to or arising from our software, services or other contractual obligations. Large indemnity payments could
adversely affect our business, financial condition and results of operations. Although we normally seek to contractually limit our liability
with respect to such indemnity obligations, we do not and may not in the future have a cap on our liability in certain agreements, which
could result in substantial liability. Substantial indemnity payments under such agreements could harm our business, financial condition
and results of operations. Any dispute with a customer or other third party with respect to such obligations could have adverse effects
on our relationship with that customer, other existing customers and new customers, and other parties, and could harm our reputation,
business, financial condition and results of operations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We rely on software and services licensed
from other parties. The loss of software or services from third parties could increase our costs and limit the features available in our
products and services.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Components of our offerings
include various types of software and services licensed from unaffiliated parties. If any of the software or services we license from
others or functional equivalents thereof were either no longer available to us or no longer offered on commercially reasonable terms,
we would be required to either redesign the offerings that include such software or services to function with software or services available
from other parties or develop these components ourselves, which we may not be able to do without incurring increased costs, experiencing
delays in our product launches and the release of new offerings, or at all. Furthermore, we might be forced to temporarily limit the features
available in our current or future products and solutions. If we fail to maintain or renegotiate any of these software or service licenses,
we could face significant delays and diversion of resources in attempting to license and integrate functional equivalents. We and our
customers may also be subject to suits by parties claiming infringement, misappropriation or other violation of third-party intellectual
property or proprietary rights due to the reliance by our solutions on such third-party software and services, such third-party software
and services may contain bugs or other errors that cause our own offerings to malfunction, and our agreements with such third parties
may not contain any, or adequate, warranties, indemnities or other protective provisions on our behalf. Any of the foregoing could materially
and adversely affect our business, financial condition and results of operations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 36; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Risks Related to Other Legal, Regulatory and
Tax Matters</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Changes in laws and regulations related
to the internet, changes in the internet infrastructure itself, or increases in the cost of internet connectivity and network access may
diminish the demand for our offerings and could harm our business.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The future success of our
business depends upon the continued use of the internet as a primary medium for commerce, communication, and business applications. Federal,
state, or foreign governmental bodies or agencies have in the past adopted, and may in the future adopt, laws or regulations affecting
the use of the internet as a commercial medium. The adoption of any laws or regulations that could reduce the growth, popularity, or use
of the internet, including laws or practices limiting internet neutrality, could decrease the demand for our offerings, increase our cost
of doing business, and adversely affect our results of operations. Changes in these laws or regulations could require us to modify our
offerings, or certain aspects of our offerings, in order to comply with these changes. In addition, government agencies or private organizations
have imposed and may impose additional taxes, fees, or other charges for accessing the internet or commerce conducted via the internet.
These laws or charges could limit the growth of internet-related commerce or communications generally or result in reductions in the demand
for internet-based products such as ours. In addition, the use of the internet as a business tool could be harmed due to delays in the
development or adoption of new standards and protocols to handle increased demands of internet activity, security, reliability, cost,
ease-of-use, accessibility, and quality of service. Further, our platform depends on the quality of our customers&#8217; and end users&#8217;
access to the internet.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On June 11, 2018, the repeal
of the &#8220;net neutrality&#8221; rules of the Federal Communications Commission, or the FCC, took effect and returned to a &#8220;light-touch&#8221;
regulatory framework. The prior rules were designed to ensure that all online content is treated the same by internet service providers
and other companies that provide broadband services. Additionally, on September 30, 2018, California enacted the California Internet Consumer
Protection and Net Neutrality Act of 2018, making California the fourth state to enact a state-level net neutrality law since the FCC
repealed its nationwide regulations, mandating that all broadband services in California must be provided in accordance with state net
neutrality requirements. The U.S. Department of Justice has sued to block the law going into effect, and California has agreed to delay
enforcement until the resolution of the FCC&#8217;s repeal of the federal rules. A number of other states are considering legislation
or executive actions that would regulate the conduct of broadband providers. We cannot predict whether the FCC order or state initiatives
will be modified, overturned, or vacated by legal action of the court, federal legislation or the FCC. With the repeal of net neutrality
rules in effect, we could incur greater operating expenses, which could harm our results of operations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As the internet continues
to experience growth in the number of users, frequency of use, and amount of data transmitted, the internet infrastructure that we and
our customers and end users rely on may be unable to support the demands placed upon it. The failure of the internet infrastructure that
we or our customers and end users rely on, even for a short period of time, could adversely affect our business, financial condition and
results of operations. In addition, the performance of the internet and its acceptance as a business tool has been harmed by &#8220;viruses,&#8221;
&#8220;worms&#8221; and similar malicious programs and the internet has experienced a variety of outages and other delays as a result
of damage to portions of its infrastructure. If the use of the internet is adversely affected by these issues, demand for our offerings
could decline.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Internet access is frequently
provided by companies that have significant market power and the ability to take actions that degrade, disrupt, or increase the cost of
user access to our offerings. As demand for online media increases, there can be no assurance that internet and network service providers
will continue to price their network access services on reasonable terms. The distribution of online media requires delivery of digital
content files and providers of network access and distribution may change their business models and increase their prices significantly,
which could slow the widespread adoption of such services. We could incur greater operating expenses and our customer acquisition and
retention could be negatively impacted if network operators:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">implement usage-based pricing;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">discount pricing for competitive products;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">otherwise materially change their pricing rates or schemes;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">charge us to deliver our traffic at certain levels or at all;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 37; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">throttle traffic based on its source or type;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">implement bandwidth caps or other usage restrictions; or</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">otherwise try to monetize or control access to their networks.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In order for our services
to be successful, there must be a reasonable price model in place to allow for the continuous distribution of digital media files. We
have limited or no control over the extent to which any of these circumstances may occur, and if network access or distribution prices
rise, our business, financial condition and results of operations would likely be adversely affected.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Failure to comply with anti-bribery, anti-corruption,
anti-money laundering laws, and similar laws, could subject us to penalties and other adverse consequences.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are subject to the U.S.
Foreign Corrupt Practices Act of 1977, as amended, or the FCPA, the U.S. domestic bribery statute contained in 18 U.S.C. &#167; 201, the
U.S. Travel Act, the USA PATRIOT Act, Chapter 9 (sub-chapter 5) of the Israeli Criminal Law, 5737-1977, the Israeli Prohibition on Money
Laundering Law, 5760-2000 and other anti-bribery and anti-money laundering laws in countries outside of the United States in which we
conduct our activities, such as Russia. Anti-corruption and anti-bribery laws have been enforced aggressively in recent years and are
interpreted broadly to generally prohibit companies, their employees, and their third-party intermediaries from authorizing, offering,
or providing, directly or indirectly, improper payments or benefits to recipients in the public or private sector.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We sometimes leverage third
parties to sell our offerings and conduct our business abroad. We and our third-party intermediaries may have direct or indirect interactions
with officials and employees of government agencies or state-owned or affiliated entities and may be held liable for the corrupt or other
illegal activities of these third-party business partners and intermediaries, our employees, representatives, contractors, partners, and
agents, even if we do not explicitly authorize such activities. We cannot assure you that our employees and agents will not take actions
in violation of applicable law, for which we may be ultimately held responsible. As we increase our international sales and business operations,
our risks under these laws are likely to increase.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Any actual or alleged violation
of the FCPA or other applicable anti-bribery, anti-corruption or anti-money laundering laws could result in whistleblower complaints,
sanctions, settlements, prosecution, enforcement actions, fines, damages, adverse media coverage, investigations, loss of export privileges,
severe criminal or civil sanctions, or suspension or debarment from U.S. government contracts, any of which would adversely affect our
reputation, as well as our business, financial condition, results of operations and growth prospects. Responding to any investigation
or action would likely result in a materially significant diversion of management&#8217;s attention and resources and significant defense
costs and other professional fees. In addition, the U.S. government may seek to hold us liable for successor liability for FCPA violations
committed by companies in which we invest or that we acquire.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Changes in financial accounting standards
or practices may cause adverse, unexpected financial reporting fluctuations and affect our results of operations.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The accounting rules and regulations
that we must comply with are complex and subject to interpretation by the Financial Accounting Standards Board, or the FASB, the SEC and
various bodies formed to promulgate and interpret appropriate accounting principles. Recent actions and public comments from the FASB
and the SEC have focused on the integrity of financial reporting and internal controls. In addition, many companies&#8217; accounting
policies are being subject to heightened scrutiny by regulators and the public. Further, the accounting rules and regulations are continually
changing in ways that could materially impact our financial statements.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We cannot predict the impact
of future changes to accounting principles or our accounting policies on our financial statements going forward, which could have a significant
effect on our reported financial results and could affect the reporting of transactions completed before the announcement of the change.
In addition, if we were to change our critical accounting estimates, including those related to the recognition of subscription revenue
and other revenue sources, our operating results could be significantly affected.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 38; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Changes in U.S. and foreign tax laws could
have a material adverse effect on our business, cash flow, results of operations or financial conditions.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are subject to taxation
in several countries, including the United States and Israel; changes in tax laws or challenges to our tax positions could adversely affect
our business, results of operations, and financial condition. As such, we are subject to tax laws, regulations, and policies of the U.S.
federal, state, and local governments and of comparable taxing authorities in foreign jurisdictions. Changes in tax laws, including the
U.S. federal tax legislation enacted in 2017, commonly referred to as the Tax Cuts and Jobs Act of 2017, as well as other factors, could
cause us to experience fluctuations in our tax obligations and effective tax rates in the future and otherwise adversely affect our tax
positions and/or our tax liabilities. There can be no assurance that our effective tax rates, tax payments, tax credits, or incentives
will not be adversely affected by changes in tax laws in various jurisdictions.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Biden administration has
proposed a number of changes to the U.S. tax system. The proposals include changes that would increase U.S. corporate tax rates, impose
a corporate minimum book tax, and double the tax rate on and make other tax changes to &#8220;global intangible low-taxed income&#8221;
earned by foreign subsidiaries. Many aspects of the proposals are unclear or undeveloped. We are unable to predict which, if any, U.S.
tax reform proposals will be enacted into law, and what effects any enacted legislation might have on our liability for U.S. tax.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Unanticipated changes in effective tax rates
or adverse outcomes resulting from examination of our income or other tax returns could expose us to greater than anticipated tax liabilities.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The tax laws applicable to
our business, including the laws of the United States, Israel, Russia, and other jurisdictions, are subject to interpretation, and certain
jurisdictions may aggressively interpret their laws in an effort to raise additional tax revenue. The taxing authorities of the jurisdictions
in which we operate may challenge our methodologies for valuing developed technology or intercompany arrangements or our revenue recognition
policies, which could increase our worldwide effective tax rate and adversely affect our financial position and results of operations.
It is possible that tax authorities may disagree with certain positions we have taken, and any adverse outcome of such a review or audit
could have a negative effect on our business, financial condition and results of operations. Further, the determination of our worldwide
provision for income taxes and other tax liabilities requires significant judgment by management, and there are transactions where the
ultimate tax determination is uncertain. Although we believe that our estimates are reasonable, the ultimate tax outcome may differ from
the amounts recorded in our consolidated financial statements and may materially affect our financial results in the period or periods
for which such determination is made.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Our corporate structure and intercompany
arrangements are subject to the tax laws of various jurisdictions, and we could be obligated to pay additional taxes, which would adversely
affect our results of operations.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Based on our current corporate
structure, we are subject to taxation in several jurisdictions around the world with increasingly complex tax laws, the application of
which can be uncertain. The amount of taxes we pay in these jurisdictions could increase substantially as a result of changes in the applicable
tax principles, including increased tax rates, new tax laws or revised interpretations of existing tax laws and precedents. The authorities
in these jurisdictions could review our tax returns or require us to file tax returns in jurisdictions in which we are not currently filing,
and could impose additional tax, interest, and penalties. These authorities could also claim that various withholding requirements apply
to us or our subsidiaries, assert that benefits of tax treaties are not available to us or our subsidiaries, or challenge our methodologies
for valuing developed technology or intercompany arrangements, including our transfer pricing. The relevant taxing authorities may determine
that the manner in which we operate our business does not achieve the intended tax consequences. If such a disagreement were to occur,
and our position was not sustained, we could be required to pay additional taxes, interest, and penalties. Such authorities could claim
that various withholding requirements apply to us or our subsidiaries or assert that benefits of tax treaties are not available to us
or our subsidiaries. Any increase in the amount of taxes we pay or that are imposed on us could increase our worldwide effective tax rate
and adversely affect our business, financial condition and results of operations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 39; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We could be required to collect additional
sales, use, value added, digital services or other similar taxes or be subject to other liabilities that may increase the costs our customers
would have to pay for our offerings and adversely affect our results of operations.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We could be required to collect
sales, value added and other similar taxes in a number of jurisdictions. One or more U.S. states or countries may seek to impose incremental
or new sales, use, value added, digital services, or other tax collection obligations on us. Further, an increasing number of U.S. states
have considered or adopted laws that attempt to impose tax collection obligations on out-of-state companies. Additionally, the Supreme
Court of the United States has ruled that online sellers can be required to collect sales and use tax despite not having a physical presence
in the state of the customer. As a result, U.S. states and local governments may adopt, or begin to enforce, laws requiring us to calculate,
collect, and remit taxes on sales in their jurisdictions, even if we have no physical presence in that jurisdiction. A successful assertion
by one or more U.S. states requiring us to collect taxes where we presently do not do so, or to collect more taxes in a jurisdiction in
which we currently do collect some taxes, could result in substantial liabilities, including taxes on past sales, as well as interest
and penalties. Furthermore, certain jurisdictions, such as the United Kingdom and France, have recently introduced a digital services
tax, which is generally a tax on gross revenue generated from users or customers located in those jurisdictions, and other jurisdictions
have enacted or are considering enacting similar laws. A successful assertion that we should have been or should currently be collecting
additional sales, use, value added, digital services or other similar taxes in a particular jurisdiction could, among other things, result
in substantial tax payments, create significant administrative burdens for us, discourage potential customers from subscribing to our
platform due to the incremental cost of any such sales or other related taxes, or otherwise adversely affect our business.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Risks Related to Our Operations in Israel</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Political, economic and military conditions
in Israel could materially and adversely affect our business.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have offices in Herzeliya,
near Tel Aviv, Israel where our primary operations, research and development, and certain other finance activities are based. In addition,
a number of our officers and directors, as well as our founder, are residents of Israel. As of April 15, 2023, we had six full-time and
part-time employees in Israel. Accordingly, political, economic and military conditions in Israel and the surrounding region may directly
affect our business and operations. Since the establishment of the State of Israel in 1948, a number of armed conflicts have taken place
between Israel and its neighboring countries, as well as terrorist acts committed within Israel by hostile elements. In recent years,
Israel has been engaged in sporadic armed conflicts with Hamas, an Islamist terrorist group that controls the Gaza Strip, with Hezbollah,
an Islamist terrorist group that controls large portions of southern Lebanon, and with Iranian-backed military forces in Syria. In addition,
Iran has threatened to attack Israel and may be developing nuclear weapons. Some of these hostilities were accompanied by missiles being
fired against civilian targets in various parts of Israel, including areas in which our employees, and some of our consultants are located,
and negatively affected business conditions in Israel. Any hostilities, armed conflicts, terrorist activities involving Israel or the
interruption or curtailment of trade between Israel and its trading partners, or any political instability in the region could adversely
affect business conditions and our results of operations and could make it more difficult for us to raise capital. Parties with whom we
do business have sometimes declined to travel to Israel during periods of heightened unrest or tension, forcing us to make alternative
arrangements when necessary in order to meet our business partners face to face. In addition, the political and security situation in
Israel may result in parties with whom we have agreements involving performance in Israel claiming that they are not obligated to perform
their commitments under those agreements pursuant to force majeure provisions in such agreements.&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b>&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Continued hostilities between
Israel and its neighbors and any future armed conflict, terrorist activity or political instability in the region could adversely affect
our operations in Israel and adversely affect the market price of our ordinary shares. An escalation of tensions or violence might result
in a significant downturn in the economic or financial condition of Israel, which could have a material adverse effect on our operations
in Israel and our business.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our commercial insurance does
not cover losses that may occur as a result of events associated with war and terrorism. Although the Israeli government currently covers
the reinstatement value of direct damages that are caused by terrorist attacks or acts of war, we cannot assure you that this government
coverage will be maintained or that it will sufficiently cover our potential damages. Any losses or damages incurred by us could have
a material adverse effect on our business. Any armed conflicts or political instability in the region would likely negatively affect business
conditions and could adversely affect our results of operations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Further, in the past, the
State of Israel and Israeli companies have been subjected to economic boycotts. Several countries still restrict business with the State
of Israel and with Israeli companies. These restrictive laws and policies may have an adverse impact on our operating results, financial
condition or the expansion of our business. A campaign of boycotts, divestment and sanctions has been undertaken against Israel, which
could also adversely impact our business.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 40; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Israel&#8217;s most recent
general elections were held on April 9, 2019, September 17, 2019, March 2, 2020, March 23, 2021 and November 1, 2022. In addition, proposed
judicial reform has sparked widespread protests across Israel. Uncertainty surrounding future elections and the outcome of the judicial
reform in Israel may continue and the political situation in Israel may further deteriorate. Actual or perceived political instability
in Israel or any negative changes in the political environment, may individually or in the aggregate adversely affect the Israeli economy
and, in turn, our business, financial condition, results of operations and growth prospects.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Our operations could be disrupted as a result
of the obligation of certain of our personnel residing in Israel to perform military service.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Many of our officers and employees
reside in Israel and may be required to perform annual military reserve duty. Currently, all male adult citizens and permanent residents
of Israel under the age of 40 (or older, depending on their position with the Israeli Defense Forces reserves), unless exempt, are obligated
to perform military reserve duty annually and are subject to being called to active duty at any time under emergency circumstances. Our
operations could be disrupted by the absence for a significant period of one or more of our key officers and employees due to military
service. Any such disruption could have a material adverse effect on our business, results of operations and financial condition.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We may not be able to enforce covenants
not-to-compete under current Israeli law.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have non-competition agreements
with most of our employees, many of which are governed by Israeli law. These agreements generally prohibit our employees from competing
with us or working for our competitors for a specified period following termination of their employment. However, Israeli courts are reluctant
to enforce non-compete undertakings of former employees and tend, if at all, to enforce those provisions for relatively brief periods
of time in restricted geographical areas and only when the employee has unique value specific to that employer&#8217;s business and not
just regarding the professional development of the employee. Any such inability to enforce non-compete covenants may cause us to lose
any competitive advantage resulting from advantages provided to us by such confidential information.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;<b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We may become subject to claims for remuneration
or royalties for assigned service invention rights by our employees and consultants, which could result in litigation and would adversely
affect our business.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">A significant portion of our
intellectual property has been developed by our employees and consultants in the course of their engagement with us. Under the Israeli
Patent Law, 5727-1967, or the Patent Law, inventions conceived by an employee during the scope of his or her employment relationship with
a company are regarded as &#8220;service inventions,&#8221; which belong to the employer, absent a specific agreement stating otherwise.
The Patent Law also provides that absent an agreement providing otherwise, the Israeli Compensation and Royalties Committee, or the Committee,
a body constituted under the Patent Law, shall determine whether the employee is entitled to remuneration for his or her inventions. Case
law clarifies that the right to receive consideration for &#8220;service inventions&#8221; can be waived by the employee and that such
waiver does not necessarily have to be explicit. The Committee will examine, on a case-by-case basis, the general contractual framework
between the parties, using interpretation rules of the general Israeli contract laws. Further, the Committee has not yet determined one
specific formula for calculating this remuneration, but rather uses the criteria specified in the Patent Law. Although we generally seek
to enter into assignment-of-invention agreements with our employees and consultants pursuant to which such individuals assign to us all
rights to any inventions created in the scope of their employment or engagement with us, we cannot guarantee that all such agreements
are self-executing or have been entered into by all applicable individuals. Even when such agreements include provisions regarding the
assignment and waiver of rights to additional compensation in respect of inventions created within the course of their employment or consulting
relationship with us, including in respect of service inventions, we cannot guarantee that such provisions will be upheld by Israeli courts,
as a result of uncertainty under Israeli law with respect to the efficacy of such provisions. We may face claims demanding remuneration
in consideration for assigned inventions, which could require us to pay additional remuneration or royalties to our current and former
employees and consultants, or be forced to litigate such claims, which could negatively affect our business.<b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 41; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>It may be difficult for investors in the
United States to enforce any judgments obtained against us or some of our directors or officers.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The majority of our assets
are located outside the U.S. In addition, our officers are nationals and/or residents of countries other than the U.S., and all or a substantial
portion of such persons&#8217; assets are located outside the U.S. As a result, it may be difficult for investors to enforce within the
United States any judgments obtained against us or any of our non-U.S. officers, including judgments predicated upon the civil liability
provisions of the securities laws of the U.S. or any state thereof. Additionally, it may be difficult to assert U.S. securities law claims
in actions originally instituted outside of the U.S. Israeli courts may refuse to hear a U.S. securities law claim because Israeli courts
may not be the most appropriate forums in which to bring such a claim. Even if an Israeli court agrees to hear a claim, it may determine
that the Israeli law, and not U.S. law, is applicable to the claim. Further, if U.S. law is found to be applicable, certain content of
applicable U.S. law must be proved as a fact, which can be a time-consuming and costly process, and certain matters of procedure would
still be governed by the Israeli law. Consequently, you may be effectively prevented from pursuing remedies under U.S. federal and state
securities laws against us or any of our non-U.S. directors or officers.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Our amended and restated articles of association
provide that, unless we consent to an alternative forum, the federal district courts of the United States shall be the exclusive forum
for resolution of any complaint asserting a cause of action arising under the Securities Act, and under the Courts Law 5744-1984 [consolidated
version] (&#8220;Courts Law&#8221;) the competent courts of Tel Aviv, Israel, shall be the exclusive forum for resolution of substantially
all disputes between the Company and its shareholders under the Companies Law and the Israeli Securities Law, which could limit our shareholders&#8217;
ability to choose the judicial forum for disputes with us, our directors, shareholders, or other employees.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 22 of the Securities
Act creates concurrent jurisdiction for U.S. federal and state courts over all such Securities Act actions. Accordingly, both U.S. state
and federal courts have jurisdiction to entertain such claims. To prevent having to litigate claims in multiple jurisdictions and the
threat of inconsistent or contrary rulings by different courts, among other considerations, our amended and restated articles of association
provide that, unless we consent in writing to the selection of an alternative forum, the federal district courts of the United States
shall be the exclusive forum for the resolution of any complaint asserting a cause of action arising under the Securities Act. This exclusive
forum provision will not apply to suits brought to enforce any liability or duty created by the Exchange Act, and our shareholders cannot
and will not be deemed to have waived our compliance with the U.S. federal securities laws and the rules and regulations thereunder as
a result of our exclusive forum provision.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Under the Courts Law, the
competent courts of Tel Aviv, Israel, is the exclusive forum for the resolution of (i) any derivative action or proceeding brought on
behalf of the Company, (ii) any action asserting a claim of breach of fiduciary duty owed by any director, officer or other employee of
the Company to the Company or the Company&#8217;s shareholders, or (iii) any action asserting a claim arising pursuant to any provision
of the Companies Law or the Israeli Securities Law, 1968, or the Israeli Securities Law. Such exclusive forum provision is intended to
apply to claims arising under Israeli law and does not apply to claims for which the federal courts would have exclusive jurisdiction,
whether by law or pursuant to our amended and restated articles of association, as described above.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Any person or entity purchasing
or otherwise acquiring any interest in any of our securities shall be deemed to have notice of and consented to the foregoing provisions
of our amended and restated articles of association. However, the enforceability of similar forum provisions (including exclusive federal
forum provisions for actions, suits, or proceedings asserting a cause of action arising under the Securities Act) in other companies&#8217;
organizational documents has been challenged in legal proceedings, and there is uncertainty as to whether courts would enforce the exclusive
forum provisions in our amended and restated articles of association. If a court were to find the exclusive forum provisions contained
in our amended and restated articles of association to be inapplicable or unenforceable in an action, we may incur additional costs associated
with resolving such action in other jurisdictions, which could materially adversely affect our business, financial condition, and results
of operations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Although we believe these
exclusive forum provisions benefit us by providing increased consistency in the application of U.S. federal securities laws or the Companies
Law, as applicable, in the types of lawsuits to which they apply, such exclusive forum provisions may limit a shareholder&#8217;s ability
to bring a claim in the judicial forum of their choosing for disputes with us or any of our directors, shareholders, officers, or other
employees, which may discourage lawsuits with respect to such claims against us and our current and former directors, shareholders, officers,
or other employees.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 42; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Risks Related to Our Operations in Russia</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Russia&#8217;s invasion of Ukraine and sanctions
brought against Russia could disrupt our software development operations in Russia.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="background-color: white">In
addition to our U.S. and Israel operations, we have operations in Russia through our wholly owned subsidiary, Beamr Imaging RU, and may
expand international operations and development in the future. Specifically, we undertake some of our software development and design,
quality assurance, and support in Russia using personnel located there. While a majority of our developers are located in Russia, our
research and development leadership is located in Israel. </span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="background-color: white">On
February 24, 2022, Russia invaded Ukraine. The outbreak of hostilities between the two countries could result in more widespread conflict
and could have a severe adverse effect on the region.</span> Following Russia&#8217;s actions, various countries, including the U.S.,
Canada, the United Kingdom, Germany and France, as well as the European Union, issued broad-ranging economic sanctions against Russia.
Such sanctions included, among other things, a prohibition on doing business with certain Russian companies, officials and citizens; a
commitment by certain countries and the European Union to remove selected Russian banks from the Society for Worldwide Interbank Financial
Telecommunications (SWIFT) electronic banking network that connects banks globally; and restrictive measures to prevent the Russian Central
Bank from undermining the impact of the sanctions. In response to sanctions, the Russian Central Bank raised its interest rates and banned
sales of local securities by foreigners. Russia may take additional counter measures or retaliatory actions in the future. The continuation
of these hostilities may result in additional economic and other sanctions against Russia. The potential impact of the conflict and any
resulting bans, sanctions and boycotts on companies doing business in Russia is currently uncertain due to the fluid nature of the conflict
as it is unfolding and has the potential to result in broadened military actions. The duration of ongoing hostilities and such sanctions
and related events cannot be predicted. Uncertainty as to future relations between Russia and the U.S. and other countries in the west,
or between Russia and other eastern European countries, may have a negative impact on our operations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="background-color: white">We
do not operate in any sectors of the Russian economy that have been targeted by U.S. or EU sanctions and have no reason to believe that
we would be targeted by any sanctions in the future. Nonetheless such sanctions and potential responses to such sanctions, including those
that may limit or restrict transfer funds into Russia, may in the future significantly affect our ability to pay our personnel based in
Russia. In response, </span>we have begun to partially implement a business continuity plan in order to address risks related to the conflict
on our personnel, operations and product development that includes alternative payment solutions for personnel in Russia and relocation
of certain personnel to territories outside Russia and Belarus on short notice. As of April 15, 2023, some of the Russian employees and contractors of our wholly owned subsidiary in St. Petersburg, Russia have relocated
to other countries and we are continuing to monitor the situation with respect to our business continuity plan.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our operations and presence
in Russia is limited. We have no manufacturing operations in Russia and we do not sell any products in Russia and as a consequence we
have not derived any revenues from there. To date, none of our investors expressed concern with respect to our operations in Russia and
none of our customers terminated or downsized their engagement with us as a result of such operations. Our employees in Russia have not
to date experienced any change in their daily ability to perform their tasks. We do not expect Russia or another government to nationalize
our assets or operations in Russia. In particular, our primary asset is software that are stored outside of Russia and our products and
services are all delivered outside of Russia. In addition, we believe that if we needed to, we would be able to recruit personnel outside
Russia without any material interruption to our operations. As a result, we believe that if nationalization were to occur, any impact
on our financial statements would be immaterial. Nevertheless, we cannot predict the progress or outcome of the situation in Ukraine,
as the conflict and governmental reactions are rapidly developing and beyond our control.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Political, military conditions or other
risks in Russia could adversely affect our business.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Russia is a federative state
consisting of 85 constituent entities, or &#8220;subjects.&#8221; The Russian Constitution reserves some governmental powers for the Russian
Government, some for the subjects and some for areas of joint competence. In addition, eight &#8220;federal districts&#8221; (&#8220;federal&#8217;nye
okruga&#8221;), which are overseen by a plenipotentiary representative of the President, supplement the country&#8217;s federal system.
The delineation of authority among and within the subjects is, in many instances, unclear and contested, particularly with respect to
the division of tax revenues and authority over regulatory matters. For these reasons, the Russian political system is vulnerable to tension
and conflict between federal, subject and local authorities. This tension creates uncertainties in the operating environment in Russia,
which may prevent us from carrying out our strategy effectively. The risks associated with these events or potential events could materially
and adversely affect the investment environment and overall consumer and entrepreneurial confidence in Russia, and our business, prospects,
financial condition, hiring ability, and results of operations could be materially and adversely affected.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 43; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Furthermore, high levels of
corruption reportedly exist in Russia, including the bribing of officials for the purpose of initiating investigations by government agencies.
Corruption and other illegal activities could disrupt our ability to conduct our business effectively, and claims that the we are involved
in such corruption or illegal activities could generate negative publicity, of which could harm our development, financial condition,
results of operations or prospects.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Economic and other risks in Russia could adversely affect our
business.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Operating a business in an
emerging market such as Russia can involve a greater degree of risk than operating a business in more developed markets.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Over the last two decades,
the Russian economy has experienced or continues to experience at various times:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in; text-align: justify"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">significant volatility in its GDP;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">the impact of international sanctions;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">high levels of inflation;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">increases in, or high, interest rates;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">price volatility in oil and other natural resources;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">instability in the local currency market;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">budget deficits;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">the continued operation of loss-making enterprises due to the lack of effective bankruptcy proceedings;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">capital flight; and</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">significant increases in poverty rates, unemployment and underemployment.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Russian economy has been
subject to abrupt downturns in the past, including as a result of the invasion of Ukraine, global financial crisis, and, as an emerging
market, remains particularly vulnerable to further external shocks and any future fluctuations in the global markets. Any further deterioration
in the general economic conditions in Russia (whether or not as a result of the events mentioned above) could have a material adverse
effect on the Russian economy and may result in hiring and operational difficulties, as well as potential flight of human capital, which
could have a material adverse effect on our business, product development and results of operations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Legal risks in Russia could materially adversely
affect our operations and Russian tax legislation is subject to frequent change.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Among the risks of the Russian
legal system are: inconsistencies among laws, presidential decrees, and government and ministerial orders and resolutions; conflicting
local, regional and federal laws and regulations; the untested nature of the independence of the judiciary and its sensitivity to economic
or political influences; substantial gaps in the regulatory structure due to the delay or absence of implementing legislation; a high
degree of discretion on the part of governmental authorities; reported corruption within governmental entities and other governmental
authorities; the relative inexperience of judges and courts in interpreting laws applicable to complex transactions; and the unpredictability
of enforcement of foreign judgments and foreign arbitral awards. Many Russian laws and regulations are construed in a way that provides
for significant administrative discretion in application and enforcement. Unlawful, selective or arbitrary actions of the Russian Government
have reportedly included the denial or withdrawal of licenses, sudden and unexpected tax audits, criminal prosecutions, and civil claims.
Any of the above events may have a material adverse effect on our product development and results of operations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 44; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Despite certain improvements
in the taxation system made by the Russian Government over the past decade, Russian tax legislation is still subject to frequent change,
varying interpretations, and inconsistent and selective enforcement. There are currently no clear rules for distinguishing between lawful
tax optimization and tax evasion. In addition, Russian tax laws do not contain detailed rules on the taxation in Russia of foreign companies.
As such, taxpayers often have to resort to court proceedings to defend their position against the Russian tax authorities. However, in
the absence of consistent court practice or binding precedents, there is inconsistency amongst court decisions. Further, the possibility
exists that the Russian Federation would impose arbitrary or onerous taxes and penalties in the future, which could have a material adverse
effect on our product development and results of operations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;<b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Risks Related to Ownership of our Ordinary
Shares</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>The market price for our ordinary shares
may be volatile or may decline regardless of our operating performance.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The market price of our ordinary
shares may be highly volatile and may fluctuate or decline substantially as a result of a variety of factors, many of which are beyond
our control, including:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">actual or anticipated changes or fluctuations in our results of operations&#894;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">the guidance we may provide to analysts and investors from time to time, and any changes in, or our failure to perform in line with, such guidance&#894;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">announcements by us or our competitors of new offerings or new or terminated contracts, commercial relationships or capital commitments&#894;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">industry or financial analyst or investor reaction to our press releases, other public announcements, and filings with the SEC&#894;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">rumors and market speculation involving us or other companies in our industry&#894;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">future sales or expected future sales of our ordinary shares&#894;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">investor perceptions of us and the industries in which we operate&#894;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">price and volume fluctuations in the overall stock market from time to time&#894;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">changes in operating performance and stock market valuations of other technology companies generally, or those in our industry in particular&#894;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">failure of industry or financial analysts to maintain coverage of us, the issuance of new or updated reports or recommendations by any analysts who follow our company, or our failure to meet the expectations of investors&#894;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">actual or anticipated developments in our business or our competitors&#8217; businesses or the competitive landscape generally&#894;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">litigation involving us, other companies in our industry or both, or investigations by regulators into our operations or those of our competitors&#894;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">developments or disputes concerning our intellectual property or proprietary rights or our solutions, or third-party intellectual or proprietary rights&#894;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 45; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">announced or completed acquisitions of businesses or technologies, or other strategic transactions by us or our competitors&#894;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">actual or perceived breaches of, or failures relating to, privacy, data protection or data security&#894;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">new laws or regulations or new interpretations of existing laws or regulations applicable to our business&#894;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">actual or anticipated changes in our management or our board of directors&#894;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">general economic conditions and slow or negative growth of our target markets&#894; and</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">other events or factors, including those resulting from war, incidents of terrorism or responses to these events.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Furthermore, the stock market
has experienced extreme volatility that in some cases has been unrelated or disproportionate to the operating performance of particular
companies. These and other factors may cause the market price and demand for our ordinary shares to fluctuate substantially, which may
limit or prevent investors from readily selling their shares and may otherwise negatively affect the liquidity of our ordinary shares.
In addition, in the past, when the market price of a stock has been volatile, holders of that stock have sometimes instituted securities
class action litigation against the company that issued the stock. If any of our shareholders were to bring a lawsuit against us, we could
incur substantial costs defending the lawsuit. Such a lawsuit could also divert the time and attention of our management from our business.&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b><i>An active trading
market for our ordinary shares may not be sustained.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">An&#160;active&#160;public&#160;trading&#160;market
for our ordinary shares may not be sustained. The lack of an active market may impair your ability to sell your ordinary shares at the
time you wish to sell them or at a price that you consider reasonable. The lack of an active market may also reduce the fair value of
your ordinary shares. An inactive market may also impair our ability to raise capital to continue to fund operations by selling ordinary
shares and may impair our ability to acquire other companies or technologies by using our ordinary shares as consideration.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Our principal shareholders have significant
influence over us.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our principal shareholders
each holding more than 5% of our outstanding ordinary shares collectively beneficially own approximately 71% of our outstanding ordinary
shares. See &#8220;Item 7.A. Major Shareholders&#8221;. These shareholders or their affiliates will be able to exert significant influence
over us and, if acting together, will be able to control matters requiring shareholder approval, including the election of directors and
approval of significant corporate transactions, including a merger, consolidation or sale of all or substantially all of our assets and
the issuance or redemption of equity interests in certain circumstances. The interests of these shareholders may not always coincide with,
and in some cases may conflict with, our interests and the interests of our other shareholders. For instance, these shareholders could
attempt to delay or prevent a change in control of our company, even if such change in control would benefit our other shareholders, which
could deprive our shareholders of an opportunity to receive a premium for their ordinary shares. This concentration of ownership may also
affect the prevailing market price of our ordinary shares due to investors&#8217; perceptions that conflicts of interest may exist or
arise. As a result, this concentration of ownership may not be in your best interests.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;&#160;&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Future sales of substantial amounts of our
ordinary shares in the public markets, or the perception that such sales might occur, could reduce the price that our ordinary shares
might otherwise attain.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 35.45pt">Future sales of a substantial
number of shares of our ordinary shares in the public market, particularly sales by our directors, executive officers and significant
shareholders, or the perception that these sales could occur, could adversely affect the market price of our ordinary shares and may make
it more difficult for you to sell your ordinary shares at a time and price that you deem appropriate.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 46; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, we intend to
register the offer and sale of all ordinary shares that we may issue from time to time under our equity compensation plans. Once we register
these shares, they will be freely tradable in the public market, subject to the volume limitations under Rule 144 of the Securities Act
in the case of our affiliates and the lock-up agreements or market stand-off provisions agreed with the representative of the underwriters
in connection with our initial public offering on February 28, 2023.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Your ownership and voting power may be diluted
by the issuance of additional shares of our ordinary shares in connection with financings, acquisitions, investments, our equity incentive
plans or otherwise.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have 222,000,000
ordinary shares authorized. Subject to compliance with applicable rules and regulations, we may issue ordinary shares or securities
convertible into ordinary shares from time to time for the consideration and on the terms and conditions established by our board of
directors in its sole discretion, whether in connection with a financing, acquisition, investment, our equity incentive plans or
otherwise. As of April 15, 2023, 12,882,896 ordinary shares were outstanding and we had 1,604,241 ordinary shares issuable upon the
exercise of outstanding options at a weighted average exercise price of $1.87 per share, of which 1,142,602 were vested as of such
date, warrants to purchase 644,666 ordinary shares and an additional 322,279 ordinary shares reserved for future issuance under our
2015 Plan. See &#8220;Item 6.C&#8212;Director, Senior Management and Employees&#8212;Compensation.&#8221; Any additional ordinary
shares that we issue, including under our 2015 Plan or other equity incentive plans that we may adopt in the future, or in
connection with the exercise of our warrants, would dilute the percentage ownership and voting power held by investors. In the
future, we may also issue additional securities if we need to raise capital, including, but not limited to, in connection with
acquisitions, which could constitute a material portion of our then-outstanding ordinary shares. Any such issuance could
substantially dilute the ownership and voting power of our existing shareholders and cause the market price of our ordinary shares
to decline.&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Our management team has limited experience
managing a public company, and the requirements of being a public company may strain our resources, divert management&#8217;s attention,
and affect our ability to attract and retain qualified board members.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As a public company listed
in the United States, we incur significant additional legal, accounting, and other expenses. In addition, changing laws, regulations,
and standards relating to corporate governance and public disclosure, including regulations implemented by the SEC and The Nasdaq Stock
Market LLC, or Nasdaq, may increase legal and financial compliance costs, and make some activities more time consuming. These laws, regulations
and standards are subject to varying interpretations, and as a result, their application in practice may evolve over time as new guidance
is provided by regulatory and governing bodies.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Most members of our management
team have no prior experience managing a publicly traded company, interacting with public company investors, and complying with the increasingly
complex laws pertaining to public companies. Our management team may not successfully or efficiently manage our transition of becoming
a public company that is subject to significant regulatory oversight and reporting obligations under the federal securities laws and the
continuous scrutiny of securities analysts and investors. Furthermore, we are committed to maintaining high standards of corporate governance
and public disclosure, and our efforts to establish the corporate infrastructure required of a public company and to comply with evolving
laws, regulations and standards are likely to divert management&#8217;s time and attention away from revenue-generating activities to
compliance activities, which may prevent us from implementing our business strategy and growing our business. Moreover, we may not be
successful in implementing these requirements. If we do not effectively and efficiently manage our transition into a public company and
continue to develop and implement the right processes and tools to manage our changing enterprise and maintain our culture, our ability
to compete successfully and achieve our business objectives could be impaired, which could negatively impact our business, financial condition
and results of operations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Additionally, as a public
company, we may from time to time be subject to proposals by shareholders urging us to take certain corporate actions. If activist shareholder
activity ensues, we may be required to incur additional costs to retain the services of professional advisors, management time and attention
will be diverted from our core business operations, and perceived uncertainties as to our future direction, strategy or leadership may
cause us to lose potential business opportunities and impair our brand and reputation, any of which could materially and adversely affect
our business, financial condition and results of operations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 47; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition to increasing
our legal and financial compliance costs, the additional rules and regulations described above might also make it more difficult for us
to obtain certain types of insurance, including director and officer liability insurance, and we might be forced to accept reduced policy
limits and coverage or incur substantially higher costs to obtain the same or similar coverage. As a result, it may be more difficult
for us to attract and retain qualified persons to serve on our board of directors, on committees of our board of directors or as members
of our senior management team.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We are an &#8220;emerging growth company&#8221;
and we cannot be certain if the reduced disclosure requirements applicable to emerging growth companies will make our ordinary shares
less attractive to investors.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are an &#8220;emerging
growth company&#8221; within the meaning of the Securities Act, as modified by the JOBS Act, and we may take advantage of certain exemptions
from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but
not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced
disclosure obligations regarding executive compensation in our periodic reports and proxy statements, and exemptions from the requirements
of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously
approved. As a result, our shareholders may not have access to certain information they may deem important. We cannot predict whether
investors will find our securities less attractive because we intend to rely on these exemptions. If some investors find our securities
less attractive as a result of our reliance on these exemptions, the trading prices of our securities may be lower than they otherwise
would be, there may be a less active trading market for our securities and the trading prices of our securities may be more volatile.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Further, Section 102(b)(1) of the JOBS Act exempts
emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that
is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered
under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company
can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but
any such an election to opt out is irrevocable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We have elected to opt out of this extended transition
period and, as a result, we are required to comply with new or revised accounting standards on the relevant dates on which adoption of
such standards is required for non-emerging growth companies. Under federal securities laws, our decision to opt out of the extended transition
period is irrevocable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We may take advantage of these
provisions until December 31, 2028 or such earlier time that we are no longer an emerging growth company. We would cease to be an emerging
growth company upon the earlier to occur of: (1) the last day of the fiscal year in which we have total annual gross revenue of $1.235
billion or more; (2) the date on which we have issued more than $1.0 billion in nonconvertible debt during the previous three years; or
(3) the date on which we are deemed to be a large accelerated filer under the rules of the SEC. We may choose to take advantage of some
but not all of these reduced burdens, and therefore the information that we provide holders of our ordinary shares may be different than
the information you might receive from other public companies in which you hold equity.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">When we are no longer deemed
to be an emerging growth company, we will not be entitled to the exemptions provided in the JOBS Act discussed above. We cannot predict
if investors will find our ordinary shares less attractive as a result of our reliance on exemptions under the JOBS Act. If some investors
find our ordinary shares less attractive as a result, there may be a less active trading market for our ordinary shares and our share
price may be more volatile. &#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 48; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We do not anticipate paying dividends on
our ordinary shares in the foreseeable future. As a result, your ability to achieve a return on your investment will depend on appreciation
in the price of our ordinary shares.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have never declared or
paid any cash dividends on our ordinary shares and do not anticipate paying any cash dividends on our ordinary shares in the foreseeable
future. We anticipate that we will retain all of our available funds and any future earnings for use in the operation and expansion of
our business and the repayment of outstanding debt. Any future determination as to the payment of cash dividends will be at the discretion
of our board of directors and will depend on, among other things, our business prospects, financial condition, results of operations,
current and anticipated cash needs and availability, industry trends and other factors that our board of directors may consider to be
relevant. Our ability to pay cash dividends on our ordinary shares in the future may also be limited by the terms of any preferred securities
we may issue or financial and other covenants in any instruments or agreements governing any additional indebtedness we may incur in the
future. Consequently, investors who purchase ordinary shares may be unable to realize a return on their investment except by selling sell
such shares after price appreciation, which may never occur. Our inability or decision not to pay dividends, particularly when others
in our industry have elected to do so, could also adversely affect the market price of our ordinary shares.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>There can be no assurance that we will not
be classified as a passive foreign investment company, which could result in adverse U.S. federal income tax consequences to U.S. Holders
of our ordinary shares.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We would be classified as
a passive foreign investment company, or PFIC, for any taxable year if, after the application of certain look-through rules, either: (i)
75% or more of our gross income for such year is &#8220;passive income&#8221; (as defined in the relevant provisions of the Internal Revenue
Code of 1986, as amended, or the Code), or (ii) 50% or more of the value of our assets (generally determined on the basis of a quarterly
average) during such year is attributable to assets that produce or are held for the production of passive income. For these purposes,
cash and other assets readily convertible into cash or that do or could generate passive income are categorized as passive assets, and
the value of goodwill and other unbooked intangible assets is generally taken into account. Passive income generally includes, among other
things, rents, dividends, interest, royalties, gains from the disposition of passive assets and gains from commodities and securities
transactions. For purposes of this test, we will be treated as owning a proportionate share of the assets and earning a proportionate
share of the income of any other corporation of which we own, directly or indirectly, at least 25% (by value) of the stock. Based on our
market capitalization and the composition of our income, assets and operations, we do not expect to be a PFIC for United States federal
income tax purposes for the current taxable year or in the foreseeable future. However, this is a factual determination that must be made
annually after the close of each taxable year. Moreover, the value of our assets for purposes of the PFIC determination may be determined
by reference to the public price of our ordinary shares, which could fluctuate significantly. In addition, it is possible that the Internal
Revenue Service may take a contrary position with respect to our determination in any particular year, and therefore, there can be no
assurance that we will not be classified as a PFIC in the current taxable year or in the future. Certain adverse U.S. federal income tax
consequences could apply to a U.S. Holder (as defined in &#8220;U.S. Federal Income Tax Considerations&#8221;) if we are treated as a
PFIC for any taxable year during which such U.S. Holder holds our ordinary shares. U.S. Holders should consult their tax advisors about
the potential application of the PFIC rules to their investment in our ordinary shares. For further discussion, see &#8220;Item 10.E&#8212;Additional
Information&#8212;Taxation&#8212;U.S. Federal Income Tax Considerations&#8212;Passive Foreign Investment Companies.&#8221;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>If a United States person is treated as
owning at least 10% of our ordinary shares, such holder may be subject to adverse U.S. federal income tax consequences.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If a United States person
is treated as owning (directly, indirectly, or constructively) at least 10% of the value or voting power of our ordinary shares, such
person may be treated as a &#8220;United States shareholder&#8221; with respect to each controlled foreign corporation, or CFC, in our
group (if any). Because our group includes a U.S. subsidiary, certain of our non-U.S. subsidiaries will be treated as CFCs (regardless
of whether or not we are treated as a CFC). A United States shareholder of a CFC may be required to report annually and include in its
U.S. taxable income its pro rata share of &#8220;Subpart F income,&#8221; &#8220;global intangible low-taxed income,&#8221; and investments
in U.S. property by CFCs, regardless of whether we make any distributions. An individual that is a United States shareholder with respect
to a CFC generally would not be allowed certain tax deductions or foreign tax credits that would be allowed to a United States shareholder
that is a U.S. corporation. Failure to comply with these reporting obligations may subject a United States shareholder to significant
monetary penalties and may prevent the statute of limitations with respect to such shareholder&#8217;s U.S. federal income tax return
for the year for which reporting was due from starting. We cannot provide any assurances that we will assist investors in determining
whether we are or any of our non-U.S. subsidiaries is treated as CFC or whether any investor is treated as a United States shareholder
with respect to any such CFC or furnish to any United States shareholders information that may be necessary to comply with the aforementioned
reporting and tax paying obligations. The United States Internal Revenue Service has provided limited guidance on situations in which
investors may rely on publicly available information to comply with their reporting and tax paying obligations with respect to foreign-controlled
CFCs. A United States investor should consult its advisors regarding the potential application of these rules to an investment in our
ordinary shares.&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"></p><div>

</div><!-- Field: Page; Sequence: 49; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We incur significant increased costs as
a result of operating as a public company, and our management is required to devote substantial time to new compliance initiatives.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As a public company whose
ordinary shares are listed in the United States, we incur significant legal, accounting and other expenses that we did not incur as a
private company. We are subject to the reporting requirements of the Exchange Act, the other rules and regulations of the SEC, and the
rules and regulations of Nasdaq and provisions of the Companies Law that apply to public companies such as us. The expenses that are required
in order to be a public company are material and compliance with the various reporting and other requirements applicable to public companies
require considerable time and attention of management. For example, the Sarbanes-Oxley Act and the rules of the SEC and national securities
exchanges have imposed various requirements on public companies, including requiring establishment and maintenance of effective disclosure
and financial controls. Our management and other personnel devote a substantial amount of time to these compliance initiatives. These
rules and regulations will continue to increase our legal and financial compliance costs and will make some activities more time-consuming
and costly. For example, we expect these rules and regulations to make it more difficult and more expensive for us to obtain director
and officer liability insurance, and we may be required to accept reduced policy limits on coverage or incur substantial costs to maintain
the same or similar coverage. The impact of these events could also make it more difficult for us to attract and retain qualified personnel
to serve on our board of directors, our board committees, or as executive officers.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Sarbanes-Oxley Act requires,
among other things, that we maintain effective internal control over financial reporting and disclosure controls and procedures. In particular,
we must perform system and process evaluation and testing of our internal control over financial reporting to allow management to report
on the effectiveness of our internal control over financial reporting, as required by Section 404 of the Sarbanes-Oxley Act, beginning
as early as our second annual report on Form 20-F for the fiscal year ended December 31, 2023. In addition, we will be required to have
our independent registered public accounting firm attest to the effectiveness of our internal control over financial reporting beginning
with our annual report on Form 20-F following the date on which we are no longer an emerging growth company. Our compliance with Section
404 of the Sarbanes-Oxley Act will require that we incur substantial accounting expense and expend significant management efforts. We
currently do not have an internal audit group, and we will need to hire additional accounting and financial staff with appropriate public
company experience and technical accounting knowledge. If we are not able to comply with the requirements of Section 404 in a timely manner,
or if we or our independent registered public accounting firm identify deficiencies in our internal control over financial reporting that
are deemed to be material weaknesses, the market price of our shares could decline and we could be subject to sanctions or investigations
by Nasdaq, the SEC or other regulatory authorities, which would require additional financial and management resources.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our ability to successfully
implement our business plan and comply with Section 404 requires us to be able to prepare timely and accurate financial statements. We
expect that we will need to continue to improve existing, and implement new operational and financial systems, procedures and controls
to manage our business effectively. Any delay in the implementation of, or disruption in the transition to, new or enhanced systems, procedures
or controls, may cause our operations to suffer and we may be unable to conclude that our internal control over financial reporting is
effective and to obtain an unqualified report on internal controls from our auditors as required under Section 404 of the Sarbanes-Oxley
Act. This, in turn, could have an adverse impact on trading prices for our ordinary shares and could adversely affect our ability to access
the capital markets.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><b><i>We have identified a material weakness
in our internal control over financial reporting, and we may not be able to successfully implement remedial measures.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">We
have identified control deficiencies in our financial reporting process that constitute a material weakness related to lack of sufficient
internal accounting personnel, segregation of duties, lack of sufficient internal controls (including IT general controls, entity level
controls and transaction level controls).</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"></p><div>

</div><!-- Field: Page; Sequence: 50; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">We
expect to take a number of measures to address the material weaknesses that have been identified. See &#8220;Item 5.E&#8212;Operating
and Financial Review and Prospects&#8212;Critical Account Estimates&#8212;Internal Control Over Financial Reporting.&#8221; However, we
cannot assure you that these measures may fully address the material weaknesses in our internal control over financial reporting or that
we may conclude that they have been fully remediated.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">We
expect to complete our remediation plan within the next 12 months. However, we have not tested the effectiveness of our internal control
over financial reporting and cannot assure you that we will be able to successfully remediate this material weakness and, even if we do,
we cannot assure you that we will not suffer from other material weaknesses in the future. Except for additional personnel costs, the
cost of systems and the costs of our third-party service providers, we do not expect to incur any material costs related to our remediation
plan.&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Further,
there can be no assurance that we will not suffer from other material weaknesses or significant deficiencies in the future. If we fail
to remediate these material weaknesses or fail to otherwise maintain effective internal controls over financial reporting in the future,
such failure could result in a material misstatement of our annual or quarterly financial statements that would not be prevented or detected
on a timely basis and which could cause investors and other users to lose confidence in our financial statements, limit our ability to
raise capital and have a negative effect on the trading price of our ordinary shares. Additionally, failure to remediate the material
weakness or otherwise maintain effective internal controls over financial reporting may also negatively impact our operating results and
financial condition, impair our ability to timely file our periodic and other reports with the SEC, subject us to additional litigation
and regulatory actions and cause us to incur substantial additional costs in future periods relating to the implementation of remedial
measures.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Our disclosure controls and procedures may
not prevent or detect all errors or acts of fraud.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are subject to the periodic
reporting requirements of the Exchange Act. We designed our disclosure controls and procedures to provide reasonable assurance that information
we must disclose in reports we file or submit under the Exchange Act is accumulated and communicated to management, and recorded, processed,
summarized and reported within the time periods specified in the rules and forms of the SEC. We believe that any disclosure controls and
procedures, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the
control system are met.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">These inherent limitations
include the realities that judgments in decision making can be faulty, and that breakdowns can occur because of simple error or mistake.
Additionally, controls can be circumvented by the individual acts of some persons, by collusion of two or more people or by an unauthorized
override of the controls. Accordingly, because of the inherent limitations in our control system, misstatements due to error or fraud
may occur and not be detected.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>If our estimates or judgments relating to
our critical accounting policies are based on assumptions that change or prove to be incorrect, our results of operations could fall below
the expectations of securities analysts and investors, resulting in a decline in the trading price of our ordinary shares.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The preparation of financial
statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in our consolidated
financial statements and accompanying notes. We base our estimates on historical experience and on various other assumptions that we believe
to be reasonable under the circumstances. See &#8220;Item 5 &#8211;Operating and Financial Review and Prospects&#8221;, the results of
which form the basis for making judgments about the carrying values of assets, liabilities, equity, revenue, and expenses that are not
readily apparent from other sources. Our results of operations may be adversely affected if our assumptions change or if actual circumstances
differ from those in our assumptions, which could cause our results of operations to fall below our publicly announced guidance or the
expectations of securities analysts and investors, resulting in a decline in the market price of our ordinary shares.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 51; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Unfavorable conditions in our industry or
the global economy or reductions in information technology spending could limit our ability to grow our business and negatively affect
our results of operations.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our results of operations may vary based on the impact of changes in
our industry and the global economy on us and our customers. Current or future economic uncertainties or downturns could adversely affect
our business, financial condition and results of operations. Negative conditions in the general economy both in the United States and
abroad, including conditions resulting from changes in gross domestic product growth, financial, and credit market fluctuations, political
turmoil, natural catastrophes, any resurgence of the COVID-19 pandemic, any other pandemic, epidemic or outbreak of infectious disease,
warfare, protests and riots, and terrorist attacks on the United States, Europe, the Asia Pacific region, or elsewhere, could cause a
decrease in business investments by our customers and potential customers, including spending on information technology, and negatively
affect the growth of our business. To the extent our offerings are perceived by customers and potential customers as discretionary, our
revenue may be disproportionately affected by delays or reductions in general information technology spending. Also, customers may choose
to develop in-house software as an alternative to using our offerings. Moreover, competitors may respond to market conditions by lowering
prices. We cannot predict the timing, strength or duration of any economic slowdown, instability or recovery, generally or within any
particular industry. If the economic conditions of the general economy or markets in which we operate do not improve, or worsen from present
levels, our business, financial condition and results of operations could be adversely affected.&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>The estimates of market opportunity and
forecasts of market growth included in this Annual Report may prove to be inaccurate, and even if the markets in which we compete achieve
the forecasted growth, our business could fail to grow at similar rates, or at all.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The estimates of market opportunity
and forecasts of market growth included in this Annual Report may prove to be inaccurate. Market opportunity estimates and growth forecasts
are subject to significant uncertainty and are based on assumptions and estimates that may not prove to be accurate, including as a result
of any of the risks described in this Annual Report.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, the variables
that go into the calculation of our market opportunity are subject to change over time, and there is no guarantee that any particular
number or percentage of addressable users or companies covered by our market opportunity estimates will purchase our offerings or generate
any particular level of revenue for us. In addition, our ability to expand in any of our target markets depends on a number of factors,
including the cost, performance, and perceived value associated with our platform and those of our competitors. Even if the markets in
which we compete meet the size estimates and growth forecasted in this Annual Report, our business could fail to grow at similar rates,
or at all. Our growth is subject to many factors, including our success in implementing our business strategy, which is subject to many
risks and uncertainties. Accordingly, the forecasts of market growth included in this Annual Report should not be taken as indicative
of our future growth.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>If industry or financial analysts do not
publish research or reports about our business, or if they issue inaccurate or unfavorable research regarding our ordinary shares, the
market price and trading volume of our ordinary shares could decline.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The trading market for our
ordinary shares is influenced by the research and reports that industry or financial analysts publish about us and our business. We do
not control these analysts or the content and opinions included in their reports. As a new public company, we may be slow to attract research
coverage and the analysts who publish information about our ordinary shares will have had relatively little experience with our company,
which could affect their ability to accurately forecast our results and make it more likely that we fail to meet their estimates. In the
event we obtain industry or financial analyst coverage, if any of the analysts who cover us issues an inaccurate or unfavorable opinion
regarding our company, the market price of our ordinary shares would likely decline. In addition, the share prices of many companies in
the technology industry have declined significantly after those companies have failed to meet, or significantly exceed, the financial
guidance they have publicly announced or the expectations of analysts and investors. If our financial results fail to meet, or significantly
exceed, our announced guidance or the expectations of analysts or investors, analysts could downgrade our ordinary shares or publish unfavorable
research about us. If one or more of these analysts cease coverage of our company or fail to publish reports on us regularly, our visibility
in the financial markets could decrease, which in turn could cause the market price or trading volume of our ordinary shares to decline.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 52; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><div><a id="a_011"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>ITEM&#160;4.</b>&#160;<b>INFORMATION ON THE
COMPANY</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><b>&#160;</b></p><div>

</div><div><a id="a_012"></a></div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><b>A. History and Development of the Company</b></span></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are a leading innovator
of video encoding, transcoding and optimization solutions that enable high quality, performance, and unmatched bitrate efficiency for
video and images. With our Emmy&#174;-winning patented technology and award-winning services, we help our customers realize the potential
of video encoding and media optimization to address business-critical challenges. Our customers include tier one OTT, content distributors,
video streaming platforms, and Hollywood studios who rely on our suite of products and expertise to reduce the cost and complexity associated
with storing, distributing and monetizing video and images across devices.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">At the heart of our patented
optimization technology is the proprietary Beamr quality measure, or BQM, that is highly correlated with the human visual system. BQM
is integrated into our content adaptive bitrate, or CABR, system which together maximizes quality and removes visual redundancies resulting
in a smaller file size. The BQM has excellent correlation with subjective results, confirmed in testing under ITU BT.500, an international
standard for rigorous testing of image quality. The perceptual quality preservation of CABR has been repeatedly verified using large scale
crowd-sourcing based testing sessions, as well as by industry leaders and studio &#8220;golden eyes&#8221;.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We currently license three
core video and image compression products that help our customers use video and images to further their businesses in meaningful ways:
(1) a suite of video compression software encoder solutions including the Beamr 4 H.264 encoder, Beamr 4X H.264 content adaptive encoder,
Beamr 5 HEVC encoder and the Beamr 5X HEVC content adaptive encoder, (2) Beamr JPEGmini photo optimization software solutions for reducing
JPEG file sizes, and (3) Beamr Silicon IP block, a hardware solution for integration into dedicated video encoding ASICs, GPUs, and application
processors.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our current product line is
mainly geared to the high end, high quality media customers and we count among our enterprise customers Netflix, Snapfish, ViacomCBS,
Wowza, Microsoft, VMware, Genesys, Deluxe, Vimeo, Encoding.com, Citrix, Walmart, Photobox, Antix, Dalet, and other leading media companies
using video and photo solutions. Due to the high cost and complexity of deploying our existing software solutions and the long sales lead
times, we have a made a strategic decision to focus our resources on the development and commercialization of our next-generation product,
the Beamr HW-Accelerated Content Adaptive Encoding solution, a SaaS solution that is designed, based on our own internal testing, to be
up to 10x more cost efficient than our existing software-based solutions, resulting in reduced media storage, processing and delivery
costs.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our legal and commercial name
is Beamr Imaging Ltd. We were incorporated in Israel on October 1, 2009 under the name I.C.V.T Ltd. On January 11, 2015, we changed our
name to Beamr Imaging Ltd.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have two wholly owned subsidiaries:
Beamr, Inc. and&#160;Beamr Imaging RU LLC. Beamr, Inc. is our wholly owned subsidiary incorporated in 2012 in the State of Delaware. Beamr,
Inc. is engaged in reselling our software and products in the U.S. and Canada. Beamr Imaging RU LLC is our wholly owned subsidiary, a
limited Russian partnership formed in 2016. Beamr Imaging RU LLC is engaged in research and development for us.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, we previously
had a wholly owned subsidiary, Beamr UK Ltd, which was incorporated in 2017 in England. Beamr UK Ltd was engaged in reselling our software
and products in the U.K. Beamr UK Ltd was dissolved in May 2020.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On February 27, 2023, our
ordinary shares were approved for trading on the Nasdaq Capital Market under our ticker symbol &#8220;BMR&#8221; and began trading at
the open of market on February 28, 2023. Upon listing of our ordinary shares in our initial public offering on February 28, 2023, we effected
a reverse share spit at a ratio of 1-for-5.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our principal office is located
at 10 HaManofim Street, Herzeliya, 4672561, Israel, and our telephone number is +1-888-520-8735. Our primary internet address is https://beamr.com/.
None of the information on our website is incorporated by reference herein. Our wholly-owned subsidiary, Beamr, Inc., serves as our agent
for service of process in the United States for certain limited matters, and its address is 16185 Los Gatos Blvd, Ste 205, Mailbox 12,
Los Gatos, CA 95032.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 53; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We use our website (https://beamr.com/)
as a channel of distribution of Company information. The information we post on our website may be deemed material. Accordingly, investors
should monitor our website, in addition to following our press releases, SEC filings and public conference calls and webcasts. The contents
of our website are not, however, a part of this Annual Report.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are an emerging growth company, as defined in Section 2(a) of the
Securities Act, as implemented under the JOBS Act. As such, we are eligible to, and intend to, take advantage of certain exemptions from
reporting requirements that generally apply to public companies, including the auditor attestation requirements with respect to internal
control over financial reporting under Section 404 of the Sarbanes-Oxley Act, compliance with new standards adopted by the Public Company
Accounting Oversight Board which may require mandatory audit firm rotation or auditor discussion and analysis, exemption from say on pay,
say on frequency, and say on golden parachute voting requirements, and reduced disclosure obligations regarding executive compensation
in our periodic reports and proxy statements. We will be an emerging growth company until the earliest of: (i) the last day of the fiscal
year during which we had total annual gross revenues of $ $1.235 billion or more, (ii) the last day of the fiscal year following the fifth
anniversary of the date of the first sale of the ordinary shares pursuant to an effective registration statement (i.e., December 31, 2028),
(iii) the date on which we have, during the previous three-year period, issued more than $1 billion in non-convertible debt, or (iv) the
date on which we are deemed a &#8220;large accelerated filer&#8221; as defined in Regulation S-K under the Securities Act, which means
the market value of our ordinary shares that is held by non-affiliates exceeds $700 million as of the prior June 30th.&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We report under the Exchange
Act as a non-U.S. company with foreign private issuer status. Even after we no longer qualify as an emerging growth company, as long as
we continue to qualify as a foreign private issuer under the Exchange Act, we will be exempt from certain provisions of the Exchange Act
that are applicable to U.S. domestic public companies, including:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">the sections of the Exchange Act regulating the solicitation of proxies, consents or authorizations with respect to a security registered under the Exchange Act;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">the sections of the Exchange Act requiring insiders to file public reports of their share ownership and trading activities and liability for insiders who profit from trades made in a short period of time; and</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">the rules under the Exchange Act requiring the filing with the SEC of quarterly reports on Form&#160;10-Q containing unaudited financial statements and other specified information, and current reports on Form&#160;8-K upon the occurrence of specified significant events.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are required to file an
annual report on Form 20-F within four months of the end of each fiscal year. In addition, we intend to publish our results on a quarterly
basis through press releases, distributed pursuant to the rules and regulations of the Nasdaq. Press releases relating to financial results
and material events will also be furnished to the SEC on Form 6-K. However, the information we are required to file with or furnish to
the SEC will be less extensive and less timely compared to that required to be filed with the SEC by U.S. domestic issuers. As a result,
you may not be afforded the same protections or information, which would be made available to you, were you investing in a U.S. domestic
issuer.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We may take advantage of these
exemptions until such time as we are no longer a foreign private issuer. We would cease to be a foreign private issuer at such time as
more than 50% of our outstanding voting securities are held by U.S. residents and any of the following three circumstances applies: (i)
the majority of our executive officers or directors are U.S. citizens or residents; (ii) more than 50% of our assets are located in the
United States; or (iii) our business is administered principally in the United States.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Both foreign private issuers
and emerging growth companies are also exempt from certain more stringent executive compensation disclosure rules. Thus, even if we no
longer qualify as an emerging growth company, but remain a foreign private issuer, we will continue to be exempt from the more stringent
compensation disclosures required of companies that are neither an emerging growth company nor a foreign private issuer.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><div><a id="a_013"></a></div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><b>B. Business Overview</b></span></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Overview</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are a leading innovator
of video encoding, transcoding and optimization solutions that enable high quality, performance, and unmatched bitrate efficiency for
video and images. With our Emmy&#174;-winning patented technology and award-winning services, we help our customers realize the potential
of video encoding and media optimization to address business-critical challenges. Our customers include tier one OTT, content distributors,
video streaming platforms, and Hollywood studios who rely on our suite of products and expertise to reduce the cost and complexity associated
with storing, distributing and monetizing video and images across devices.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 54; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">At the heart of our patented
optimization technology is the proprietary Beamr quality measure, or BQM, that is highly correlated with the human visual system. BQM
is integrated into our content adaptive bitrate, or CABR, system which together maximizes quality and removes visual redundancies resulting
in a smaller file size. The BQM has excellent correlation with subjective results, confirmed in testing under ITU BT.500, an international
standard for rigorous testing of image quality. The perceptual quality preservation of CABR has been repeatedly verified using large scale
crowd-sourcing based testing sessions, as well as by industry leaders and studio &#8220;golden eyes&#8221;.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We currently license three
core video and image compression products that help our customers use video and images to further their businesses in meaningful ways:
(1) a suite of video compression software encoder solutions including the Beamr 4 H.264 encoder, Beamr 4X H.264 content adaptive encoder,
Beamr 5 HEVC encoder and the Beamr 5X HEVC content adaptive encoder, (2) Beamr JPEGmini photo optimization software solutions for reducing
JPEG file sizes, and (3) Beamr Silicon IP block, a hardware solution for integration into dedicated video encoding ASICs, GPUs, and application
processors.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our current product line is
mainly geared to the high end, high quality media customers and we count among our enterprise customers Netflix, Snapfish, ViacomCBS,
Wowza, Microsoft, VMware, Genesys, Deluxe, Vimeo, Encoding.com, Citrix, Walmart, Photobox, Antix, Dalet, and other leading media companies
using video and photo solutions. Due to the high cost and complexity of deploying our existing software solutions and the long sales lead
times, we have a made a strategic decision to focus our resources on the development and commercialization of our next-generation product,
the Beamr HW-Accelerated Content Adaptive Encoding solution, a SaaS solution that is designed, based on our own internal testing, to be
up to 10x more cost efficient than our existing software-based solutions, resulting in reduced media storage, processing and delivery
costs.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are currently collaborating
with NVIDIA, a multinational technology company and a leading developer of GPUs, with an annual revenue of $26.9 billion for the fiscal
year 2022, to develop the Beamr HW-Accelerated Content Adaptive Encoding solution, the world&#8217;s first GPU accelerated encoding solution
powered with our CABR, which will allow fast and easy end-user deployment combined with superior video compression rates. Upon completion,
our CABR software will execute directly on NVIDIA GPU cores and interact with the NVIDIA video accelerator encoder known as NVENC. NVIDIA
NVENC is a high-quality, high-performance hardware video encoder that is built into most NVIDIA GPUs. NVENC offloads video encoding to
hardware, and provides extreme performance for applications such as live video encoding, cloud gaming and cloud storage. NVIDIA GPUs with
NVENC are available on all major cloud platforms.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As planned, the first version
of the integrated video optimization engine was released at the end of the first quarter of 2023. Following this, we plan to build out
the cloud based SaaS platform and test it with beta customers in the third quarter of 2023. Following that, we plan to commercially launch
the first release of our cloud based Beamr HW-Accelerated Content Adaptive Encoding solution in the first quarter of 2024 and expect that
following release, end-users of the solution will enjoy significant end-user storage and networking cost savings. Using the Beamr HW-Accelerated
Content Adaptive Encoding solution will potentially reduce their return on investment for storage optimization to approximately four months,
compared to approximately two years with our existing software encoder solutions.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 55; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><img alt="" src="image_001.jpg"/>&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Our Business Strengths</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We believe that the following
business strengths differentiate us from our competitors and are key to our success:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt"><b><i>We are a recognized video compression market leader</i></b>. In January 2021 we were recognized with an Emmy&#174; Award for the &#8220;Development of Open Perceptual Metrics for Video Encoding Optimization&#8221; and in November 2021 we won the Seagate Lyve Innovator of the Year competition. We have over 50 patents, and count among our customers leading content distributors including Netflix, ViacomCBS and Wowza Media Systems.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 56; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt"><b><i>Strong value proposition</i></b>. We believe our existing video compression encoding solutions are among the fastest software video encoders on the market and provide a lower total cost-of-ownership to our customers by reducing media storage, processing and delivery costs. Upon release of our next generation SaaS solution, the Beamr HW-Accelerated Content Adaptive Encoding, we believe that its performance will be up to 10x more cost efficient than our existing software-based solutions, resulting in even greater reduced, based on our own internal testing, media storage, processing and delivery costs.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt"><b><i>Partnering with leading technology giants to enable the adoption of our video compression solutions</i></b>. We offer industry proven video optimization solutions and are collaborating in product development with industry giants such as NVIDIA and Allegro DVT that provide incremental improvements to existing products without having to reinvent the wheel.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt"><b><i>Core technology is powered by proprietary content-adaptive quality measure. </i></b>Our CABR technology, built over our proprietary BQM, achieves maximal compression of the video input while maintaining the input video resolution, format, and visual quality. The CABR powers our existing video compression encoders as well as our next generation Beamr HW-Accelerated Content Adaptive Encoding in development. The BQM has excellent correlation with subjective results, confirmed in testing under ITU BT.500, an international standard for rigorous testing of image quality. The perceptual quality preservation of CABR has been repeatedly verified using large scale crowd-sourcing based testing sessions, as well as by industry&#160;leaders and tier one Hollywood studios &#8220;golden eyes&#8221;.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt"><b><i>Our management team has experience building and scaling software companies</i></b>. Our visionary and experienced management team with best-in-class research and development, or R&amp;D, capabilities and in-depth industry backgrounds and experiences has been leading us since our inception. Members of our senior leadership team have held senior product, business and technology roles at companies such as Scitex, Kodak, Comverse, IBM and Intel. Sharon Carmel, our founder and Chief Executive Officer is a serial entrepreneur with a proven track record in the software space having co-founded Emblaze (LON: BLZ) which developed the Internet&#8217;s first vector-based graphics player, preceding Macromedia Flash, and BeInSync, which developed P2P synchronization and online backup technologies, and was acquired in 2008 by Phoenix Technologies (NASDAQ: PTEC).</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt"><b><i>Ongoing customer-driven development</i></b>. Through our account managers, support teams, product development teams and regular outreach from senior leadership, we solicit and capture feedback from our customer base for incorporation into ongoing enhancements to our solutions. We regularly provide our customers with enhancements to our products.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 57; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><img alt="" src="image_002.jpg"/>&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Our Market Opportunity</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">According to Fortune Business
Insights, the global cloud video storage market is projected to grow from $7.3 billion in 2021 to $13.5 billion in 2025 and to $20.9 billion
by 2028, at a compound annual growth rate, or CAGR, of 16% during the forecast period.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The fact that the video data
is often required to be stored and accessed forever cannot be ignored for long periods. This brings about the problem of lifetime costs
associated with the efficient storing and managing of data. While the upfront cost might appear manageable but over a period, the rise
in data volumes might require organizations to result in the need to pay more in the future to keep the data in the cloud. In today&#8217;s
environment, with deployment of media and entertainment, user generated content, enterprise video, agricultural technology, or AgTech,
and industrial solutions, autonomous vehicles, surveillance and smart cities, we believe that the usage of video and its storage on public
cloud platforms is expected to increase exponentially and we believe existing solutions are not suitable for large volume storage optimization.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 58; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><img alt="" src="image_003.jpg"/>&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Our Growth Strategies</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We intend to pursue the following growth strategies:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt"><b><i>Complete development and gain broad market acceptance for our SaaS solution</i></b>. We are collaborating with NVIDIA in the development of our next generation product, the Beamr HW-Accelerated Content Adaptive Encoding. Upon release, we believe it will provide a simple, easily deployable, fast, scalable, low cost and best-in-class video optimization solution resulting in reduced media storage, processing and delivery costs. We plan to make our next generation SaaS solution available through public cloud services such as AWS, Azure and GCP allowing us to potentially access and acquire large numbers of new customers with relatively low sales investment. According to Canalys estimates, these three cloud service providers accounted for 61% of the total cloud spend in the third quarter of 2021.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 59; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt"><b><i>Expand business growth through collaborations and partnerships
    with industry-leading solution providers in new verticals. </i></b>We are currently collaborating with NVIDIA and plan to expand
    our collaborations to develop further market-leading products. We believe that our hardware-accelerated CABR powered video optimization
    solutions have broad application to a wide array of verticals including UGC, public safety, smart cities, education, enterprise,
    autonomous vehicles, government and media and entertainment.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt"><b><i>Continue to innovate and develop new products and features.</i></b>&#160;We continue to invest in research and development to enhance our product offerings and release new products and features. We maintain close relationships with our customer base who provide us with frequent and real-time feedback, which we leverage to rapidly update and further improve our products.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt; background-color: white"><b><i>Selectively Pursue Acquisitions and Strategic Investments.</i></b>&#160;While we have not identified any specific targets, we plan to selectively pursue acquisitions and strategic investments in businesses and technologies that strengthen our products, enhance our capabilities and/or expand our market presence in our core vertical markets.</span> <span style="font-size: 10pt">In 2016, we acquired Vanguard Video, a leading developer of software encoders.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Our CABR System</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">At the heart of our patented
optimization technology is the proprietary BQM, a novel, efficient and reliable quality evaluation algorithm which is highly correlated
with the human vision system. The CABR technology, with the BQM at its core, allows encoders to make smarter, quality driven, encoding
decisions. CABR is a closed-loop content-adaptive rate control mechanism enabling video encoders to lower the bitrate of their encode,
while simultaneously preserving the perceptual quality of the higher bitrate encode. An integrated CABR encoding solution consists of
a video encoder and the CABR rate control engine. The CABR engine comprises the CABR control module responsible for managing the optimization
process and a module which evaluates video quality. The video encoder first encodes a frame using a configuration based on its regular
rate control mechanism, resulting in an initial encode. Then, Beamr&#8217;s CABR rate control instructs the encoder to encode the same
frame again with various values of encoding parameters, creating candidate encodes. Using the BQM, each candidate encode is compared with
the initial encode, and then the best candidate is selected and placed in the output stream. The best candidate is the one that has the
lowest bitrate but still has the same perceptual quality as the initial encode. Due to very efficient control algorithms, only approximately
1.5-2 iterations are required on average to find the best candidate. Combined with the real-time oriented design of BQM, and the possibility
to reuse encoding decisions&#160;from the initial encode, the impact on overall performance is quite manageable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following is a depiction
of the CABR system showing how the BQM interacts with a video encoder.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><img alt="" src="image_004.jpg"/>&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 60; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In testing, BQM demonstrated
higher correlation with subjective results than other quality measures such as PSNR and SSIM. In user testing, under ITU BT.500, an international
standard for testing image quality, the correlation of our BQM with subjective (human) results was, in our opinion, very high.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Beamr&#8217;s CABR technology
was integrated as a new rate control mechanism into our software H.264 and HEVC encoders. With regular VBR encoding, the user of the encoder
sets a target bitrate, and the resulting bitrate of the encoded video will be that target bitrate. With CABR encoding, the user also sets
a target bitrate, but the resulting bitrate of the encoded video will be lower than that target. The video will be encoded to the lowest
possible bitrate that is still perceptually identical to a VBR encode at that target bitrate. CABR with BQM can also be used to optimize
an input video stream, by removing redundancies and creating an equivalent, lower bitrate, perceptually identical output video stream.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As seen in the two graphs
below, for VBR encoding the actual average bitrate of the encoded clip is very similar to the requested target bitrate. For CABR encoding,
the actual bitrate of the encoded clips is lower than the requested target bitrate. The difference between the requested target bitrate
(dotted line) and the actual encoded CABR bitrate (blue line) is the bitrate savings. As seen in the graphs, the bitrate savings increase
as the target bitrate increases, since for higher target bitrates there is more redundancy present in the encoded stream, redundancy which
CABR removes.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><img alt="" src="image_005.jpg"/>&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><img alt="" src="image_006.jpg"/>&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Ultimately, Beamr&#8217;s
CABR system enables the bitrate of video files to be reduced by up to 50% over the current state of the art standard compliant block based
encoders, without compromising image quality, bitstream standard compliance or changing the artistic intent. We believe that a source
video and a Beamr-optimized video viewed side-by-side will look exactly the same to the human eye.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 61; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><img alt="" src="image_007.jpg"/>&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Beamr has integrated the CABR
engine into its AVC software encoder, Beamr 4, and into its HEVC software encoder, Beamr 5. Similarly, the CABR engine can be integrated
with any software or hardware video encoder, supporting any block-based video standard such as AVC (the most popular video standard supported
on almost all end user devices), HEVC (the leading 4K video standard available on almost all 4K televisions), and AV1 (the emerging royalty-free
standard led by Google, Apple, Microsoft, Intel and many others which is used on Netflix, Youtube and Vimeo).&#160;In addition, CABR with
BQM can be used to optimize an input video stream, by removing redundancies and creating an equivalent, lower bitrate, perceptually identical
output video stream.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Our Product Offerings</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Our Next-Generation SaaS Product: Beamr HW-Accelerated Content
Adaptive Encoding</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are currently collaborating
with NVIDIA, a leading developer of GPUs, to develop the world&#8217;s first GPU accelerated encoding solution that would allow fast and
easy end-user deployment combined with superior video compression rates powered with our CABR rate control and BQM quality measure.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our BQM quality measure software
will execute directly on NVIDIA GPU cores and interact with the NVIDIA video accelerator encoder known as NVENC. NVIDIA NVENC is a high-quality,
high-performance hardware video encoder that is built into most NVIDIA GPUs. NVENC offloads video encoding to hardware, and provides extreme
performance for applications such as live video encoding, cloud gaming and cloud storage. NVIDIA GPUs with NVENC are available on all
major cloud platforms.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our current product line of
CABR software encoders run on the CPU. In proof of concept tests with both Intel and NVIDIA, we have demonstrated that when our CABR is
offloaded from the CPU to the GPU, the cost/performance ratio is up to 10x better than on the CPU.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">To accommodate Beamr&#8217;s
content-adaptive GPU accelerated encoding solution, NVIDIA is currently modifying the API of the NVENC. On March 27, 2023, we announced
that our content adaptive technology officially support NVIDIA GPU acceleration, which was a major milestone for us. We are also in advanced
stages of porting the CABR to run on the GPU, and once completed, we will be able to use the NVENC as the video encoder for CABR, offloading
CABR-based video encoding from the CPU to the GPU enabling low-cost, high resolution, real time CABR encoding.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Upon release, we believe the
Beamr HW-Accelerated Content Adaptive Encoding solution will provide a simple, easily deployable, fast, scalable, low cost and best-in-class
video optimization solution resulting in reduced media storage, processing and delivery costs. We initially plan to offer our Beamr HW-Accelerated
Content Adaptive Encoding solution as a SaaS offering through public cloud data services that utilize NVIDIA GPUs (e.g., AWS, Microsoft
Azure, GCP) allowing us to potentially access and acquire large numbers of new customers with relatively low sales investment.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 62; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We initiated the collaboration
with NVIDIA on developing the Beamr HW-Accelerated Content Adaptive Encoding solution in January 2021. Our collaboration with NVIDIA is
based on a mutual development program that is in advanced stages and that has been approved at senior levels at NVIDIA. While our collaboration
has not been reduced to a written agreement, we believe that NVIDIA has a commercial incentive to complete the development and deploy
the software update that enables the CABR powered NVENC because of the superior video compression rates of the NVENC when combined with
our CABR solution. Since commencing the collaboration, we have successfully completed the following steps: (i) demonstrated proof of concept;
(ii) jointly defined the required frame-level APIs that enable our CABR system to determine the optimal tradeoff between bitrate and quality;
(iii) NVIDIA has approved the plan of record; (iv) NVIDIA completed delivery of the first version of the APIs; (v) we verified implementation
of the APIs that result in significant reduction of the bitrate of video streams; (vi) in December 2022, we received a pre-final implementation
from NVIDIA showing major progress, an indication that the work is close to completion and (vii) on March 23, 2023, the first General
Availability (GA) of the API was public release by NVIDIA.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As planned, the first version
of the integrated video optimization engine was released at the end of the first quarter of 2023. Following this, we plan to build out
the cloud based SaaS platform and test it with beta customers in the third quarter of 2023. Following that, we plan to commercially launch
the first release of our cloud based Beamr HW-Accelerated Content Adaptive Encoding solution in the first quarter of 2024 and expect that
following release, end-users of the solution will enjoy significant end-user storage and networking cost savings. Using the Beamr HW-Accelerated
Content Adaptive Encoding solution will potentially reduce their return on investment for storage optimization to approximately four months,
compared to approximately two years with our existing software encoder solutions.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Below is a depiction of how
we expect the end-user dashboard of the Beamr HW-Accelerated Content Adaptive Encoding to look.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><img alt="" src="image_008.jpg"/>&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 63; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->53<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Following integration into
the NVIDIA GPU, we believe the Beamr HW-Accelerated Content Adaptive Encoding solution will provide the following key benefits including:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt"><b><i>Attractive return on investment</i>. </b>The Beamr HW-Accelerated Content Adaptive Encoding solution will be available at an accessible price point in which we estimate it will reduce the return on investment for storage optimization to approximately four months, compared to approximately two years with our existing software solutions.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt"><b><i>Fast set-up</i></b>. The Beamr HW-Accelerated Content Adaptive Encoding solution will be deployable in a self-service (one-click) installation process within minutes without any specialized hardware or need to download third-party software, allowing new users to quickly derive value without any specialized training or heavy implementation or customization.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt"><b><i>Easy to use</i></b><i>. </i>The Beamr HW-Accelerated Content Adaptive Encoding solution will have an intuitive interface that can be easily navigated by even first-time users. Our solution removes the need for video-specific expertise and high-touch user support and troubleshooting.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt"><b><i>Cloud agnostic and scalable</i></b>. Our Beamr HW-Accelerated Content Adaptive Encoding solution is highly scalable and designed to be deployable across all environments employing NVIDIA GPUs, including public cloud, private cloud, on-premise and multi-cloud hybrid environments.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt"><b><i>Security</i></b>. By using public cloud platforms best security practices, we address our customers security concerns.</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt"><b><i>Reducing carbon footprint.</i></b> Smaller video files means less disk space occupied and smaller files transferred over the network from one place to another. This in turn results in lower energy consumption, which we believe is going to be an accelerator for our service adoption.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Using our content adaptive bit rate
solution, we estimate end users will be able to save up to 50% of their video storage costs and an average of 30% in their cost of video
public cloud storage, which, based on 2020 amounts, according to Fortune Business Insights, currently stands at $9 billion.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Video Compression Software Encoder Solutions</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt"><b><i>Beamr 4 AVC Encoder</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Beamr4 is our fully standard
compliant AVC (H.264) video encoder. This encoding standard is still the primary format used in video applications across the market.
While the decoder and bitstream are fully defined by the standard, video coding standards do not define the encoder, and this is completely&#160;up
to the implementation ingenuity. At Beamr we have spent many years perfecting our encoder, resulting in an efficient, high performance,
high quality AVC encoder, which enables using less computation&#160;to achieve the same compression efficiency&#160;as competing implementations.
(Compression efficiency is defined by how much you can compress the video to obtain a target quality, or vice-versa, what quality&#160;can
be obtained at a specified bitrate, The higher the compression efficiency, the less bits are needed for a certain quality level). Beamr4
has an extensive API enabling deep control of the encoder configuration to maximize the benefit for each and every application or use
case, and our support team is available to help&#160;users find the best setup for their specific needs.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 64; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->54<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt"><b><i>Beamr 5 HEVC Encoder</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Beamr5 is our fully standard
compliant HEVC (H.265) video encoder. This encoding standard is the primary format used today for high resolution (4K, 8K) and premium
quality encoding of 10 and 12 bit and High-Dynamic-Range content. Once again, only the decoder and bitstream are defined by the standard,
and encoders&#160;can differ quite significantly in how well they&#160;perform the encoding and utilize the advanced tools available in
HEVC to obtain maximum compression efficiency without incurring prohibitive performance costs. An important factor in supporting live
encoding is to be able to reach very good parallelization of the encoding tasks. This is not easy in video encoding which is very serial,
and unevenly distributed by nature. At Beamr we have developed a unique architecture for the encoder, which enables very efficient deep
parallelization making the best concurrent use of all available cores, enabling the world&#8217;s first live 8K HEVC encoder. In addition,
Beamr5 is one of the few HEVC codecs that has wide support for HDR and can be used in conjunction with Dolby Vision, HDR10 and HLG - various
HDR formats used around the globe. Beamr5 also has an extensive API enabling deep control of the encoder configuration to maximize the
benefit for each and every application or use case, and our support team is always available to help&#160;users find the best setup for
their specific needs.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt"><b><i>Beamr 4X AVC Content
Adaptive Encoder</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Beamr4x is achieved&#160;by
adding our Content&#160;Adaptive Bit-Rate rate control, to Beamr4. Video encoders generally operate either in a bit-rate driven mode,
such as VBR (Variable Bit-Rate), or in a quality driven mode. The new mode introduced in Beamr4x, enables encode that is bit-rate driven,
but where any bits that are redundant for the perceptual quality of the video are swiftly removed. This is done by first compressing the
video frame according to the bit-rate considerations. Then, for each frame, more aggressive compression is applied, reducing the frame
size in bits to the maximal extent that is possible&#160;without&#160;compromising perceptual quality of this video&#160;frame. This is
done using our novel, award winning&#160;quality measure, which can reliably report the perceptual&#160;quality of the reduced size frame,
relative to the initial encode, and make sure we get to the best compression point. While this may sound like a difficult problem to solve
for each frame, using our sophisticated search algorithm, we actually guess the correct compression point on the first try more often
than not, and on average require less than two attempts per frame. The resulting bitstream has the same perceptual quality as the VBR
encode to target bitrate would have, while offering significant bitrate savings for many use cases.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt"><b><i>Beamr 5X HEVC Content Adaptive Encoder</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Similarly, Beamr 5x combines
Beamr 5 with CABR, enabling HEVC encoding with significant bitrate savings.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>JPEGMini Photo Optimization Solutions</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">JPEGmini is a patented photo
recompression technology, which significantly reduces the size of photographs without affecting their perceptual quality. JPEGmini is
fully compliant with the JPEG standard, resulting in files that are fully compatible with any browser, photo software or device that support
the standard JPEG format.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 65; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->55<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">JPEGmini is capable of reducing
the file size of standard JPEG photos by up to 50%, while the resulting photos are visually identical to the original photos. The JPEGmini
algorithm imitates the perceptual qualities of the human visual system, ensuring that each photo is compressed to the maximum extent possible
by removing redundancies, without creating any visual artifacts in the process. This enables fully automatic, maximal compression of photos
with no human intervention required. JPEGmini has also been successfully tested with artificial intelligence/machine learning image sets
in which a reduction of storage cost of up to 50% was obtained, without compromising classification and detection accuracy.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Silicon IP</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our CABR technology, which
has been integrated with Beamr software codecs to create Beamr4x and Beamr5x, has also been implemented as a silicon IP design, which
can be integrated with any HW video encoder, such as our collaboration with Allegro DVT, a leading provider of video processing silicon
IPs, to create the world&#8217;s first content-adaptive silicon IP encoder. This enhances the encoder by providing the additional, bitrate
saving, encoding mode.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><b>Sales and Marketing</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of April 15, 2023, we have
two-full time and part-time sales and marketing employees and consultants, whose focus is to work together to accelerate the adoption
of our existing products, to drive awareness and increase brand recognition of our products and technologies, to improve new customer
acquisitions and to increase revenue from our existing customers.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="background-color: white">For
our next-generation </span>Beamr HW-Accelerated Content Adaptive Encoding solution<span style="background-color: white">, we plan to launch
our solution on the largest cloud platform, AWS, and after initial deployment on AWS to integrate our solution both with Azure and GCP.
Since NVIDIA GPUs are widely adopted by cloud platforms, we believe that by making the Beamr HW-Accelerated Content Adaptive Encoding
solution on cloud platforms will </span>allow us to potentially access and acquire large numbers of new customers with relatively low
sales investment through a self service, online sales process, with low touch pay as you go subscription service to our SaaS solution.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, since the Beamr
HW-Accelerated Content Adaptive Encoding solution is designed to be deployable across all environments, including public cloud, private
cloud, on-premise and multi-cloud hybrid environments, we intend to focus our direct sales efforts on particular vertical markets that
store large amounts of video including internet of things (IoT), smart cities, surveillance, autonomous cars, AgTech, and medical imaging.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="background-color: white">We
primarily market and license directly our existing products to media customers through outbound sales networking and customer and partner
referrals. Our direct customers include category leaders such as Netflix, </span>Snapfish, <span style="background-color: white">ViacomCBS,
Wowza and Encoding.com. Our sales cycles for our existing products typically require a significant investment of time and a substantial
expenditure of resources before we can realize revenue from the sale of our solutions, if any. Our typical sales cycle consists of a multi-month
sales and development process involving our customers&#8217; system designers and management and our sales personnel and software engineers.
If successful, this process culminates in a customer&#8217;s decision to use our solutions in its system, which we refer to as an account
win. </span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 66; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->56<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We focus our marketing efforts
on the strength of our product and technology innovation, the value we provide and our domain expertise. We target the video engineering
and information technology (IT) operations community through our marketing activities, using diverse tactics to connect with prospective
customers, such as content marketing, events, social media, and public relations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27.8pt; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">We
intend to continue to invest in our sales and marketing capabilities to capitalize on our market opportunity.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">We
enter into written contracts with our customers pursuant to which we license the rights to use our software and provide maintenance and
technical support. Our contracts are generally for one to three-year terms, with automatic renewal terms of one year terms. Some of our
contracts are on a perpetual basis. We bill most of our customers annually in advance for the fees associated with the software licenses
and related support. Some of our customers are billed on a quarterly basis.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Research and Development</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our research and development
team is responsible for the design, development, testing and delivery of new technologies, features and integrations of our solutions,
as well as the continued improvement and iteration of our existing products. It is also responsible for operating and scaling our solutions
including the underlying infrastructure. Our research and development investments seek to drive core technology innovation and bring new
products to market.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Members of our research and
development team specialize in many functional areas including algorithms, machine learning, and electrical engineering as well as computer
science. As we shift our focus to a SaaS based cloud service offering, we intend to make significant investments in a cloud-optimized
delivery model while continuing to invest in our software offerings, both for standalone consumption and for deployment in hybrid environments.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our main research and development
facility is located in central Israel, which we believe is a strategic advantage for us, allowing us to leverage a talented pool of engineers
and product experts.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of April 15, 2023, we had
20 full-time and part-time employees dedicated to research and development. We have made substantial investments in product and technology
development since our inception. Research and development expense totaled $2 million and $2 million in the years ended December 31, 2022
and 2021, respectively. We expect our research and development expense to increase significantly for the foreseeable future as we enhance
our existing product, develop new products for our current markets and introduce new products in new markets.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Acquisition</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">In
2016, we acquired Vanguard Video, a provider of HEVC and H.264 codec technologies, which enabled us to integrate our CABR technology with
Vanguard Videos video encoders, which today are available as Beamr 4x and Beamr 5x.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Competition</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">While there are several companies
offering video compression solutions such as MainConcept, Ateme, Ittiam, Visionular and open source (x264/x265), we believe there is currently
no direct competitor with our content-adaptive video compression solutions. There are companies which offer software solutions for video
optimization such as Harmonic and Elemental, and other companies offering storage optimization (but not involving video technologies)
such as EMC and Seagate. In addition, for our quality measure, some of our current competitors include SSIMWave (SSIMPlus), Apple (AVQT),
Google (YouVQ) and open source (VMAF). We operate in a highly specialized area that is evolving very quickly with rapid developments.
In the future, competitors could develop products or solutions that compete with our video compression solutions. For example, the public
cloud platforms such as AWS, Azure and GCP could in the future develop their own video optimization hardware accelerated solutions.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 67; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->57<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">We believe the following
competitive attributes are necessary for our solutions to successfully compete in the video compression market:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td><span style="font-size: 10pt">the performance and reliability of our solutions;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-size: 10pt">&#9679;</span></td>
    <td><span style="font-size: 10pt">cost of deployment and return on investment in terms of cost savings;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-size: 10pt">&#9679;</span></td>
    <td><span style="font-size: 10pt">sophistication, novel and innovative intellectual property and technology, and functionality of our offerings;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-size: 10pt">&#9679;</span></td>
    <td><span style="font-size: 10pt">cross-platform operability;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-size: 10pt">&#9679;</span></td>
    <td><span style="font-size: 10pt">security;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-size: 10pt">&#9679;</span></td>
    <td><span style="font-size: 10pt">ease of implementation and use of service;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-size: 10pt">&#9679;</span></td>
    <td><span style="font-size: 10pt">high quality customer support; and</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-size: 10pt">&#9679;</span></td>
    <td><span style="font-size: 10pt">price.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We believe that we compare
favorably on the basis of the factors listed above. However, many of our competitors have substantially greater financial, technical,
and marketing resources; relationships with large vendor partners; larger global presence; larger customer bases; longer operating histories;
greater brand recognition; and more established relationships in the industry than we do. Furthermore, new entrants not currently considered
to be competitors may enter the market through acquisitions, partnerships, or strategic relationships. See &#8220;Item 3.D Risk Factors&#8212;Risks
Related to Our Business and Industry&#8212;We may not be able to compete successfully against current and future competitors, some of
whom have greater financial, technical, and other resources than we do. If we do not compete successfully, our business, financial condition
and results of operations could be harmed.&#8221;&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Intellectual Property</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Intellectual property is an
important aspect of our business and we seek protection for our intellectual property rights as appropriate. To establish and protect
our proprietary rights, we rely on a combination of patent, copyright, trade secret and trademark laws, know-how and continuing innovation,
and contractual restrictions such as confidentiality agreements, licenses, and intellectual property assignment agreements. We strive
to protect the proprietary technologies that we believe are important to our business, including seeking and maintaining patent protection
intended to cover our system.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of April 15, 2023, our
exclusively owned patent portfolio includes 53 issued patents (one of which is jointly owned), of which 33 are U.S. patents and 20 are
foreign patents, and two U.S. patent applications are pending. The claims of these owned patents and patent applications are directed
toward various aspects of our family of products, method of their manufacturing and research programs.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We pursue the registration
of our domain names that we consider material to the marketing of our products, including the <i>beamr.com</i> domain name</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We generally seek to enter
into confidentiality agreements and proprietary rights agreements with our employees and consultants and to control access to, and distribution
of, our proprietary information. However, we cannot guarantee that all applicable parties have executed such agreements. Such agreements
can also be breached, and we may not have adequate remedies for such breach.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Intellectual property laws,
procedures, and restrictions provide only limited protection, and any of our intellectual property rights may be challenged, invalidated,
circumvented, infringed, misappropriated or otherwise violated. Furthermore, the laws of certain countries do not protect intellectual
property and proprietary rights to the same extent as the laws of the United States, and we therefore may be unable to protect our proprietary
technology in certain jurisdictions. Moreover, our platform and many of our products and services incorporate software components licensed
to the general public under open-source software licenses. We obtain some components from software developed and released by contributors
to independent open-source components of our platform. Open-source licenses grant licensees broad permissions to use, copy, modify and
redistribute certain components of our platform. As a result, open-source development and licensing practices can limit the value of our
proprietary software assets.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 68; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->58<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Despite our efforts to protect
our proprietary rights, unauthorized parties may attempt to copy or obtain and use our technology to develop products and services with
the same functionality as our platform. Policing unauthorized use of our technology is difficult. Our competitors could also independently
develop technologies like ours, and our intellectual property rights may not be broad enough for us to prevent competitors from selling
products and services incorporating those technologies. For more information regarding the risks relating to intellectual property, see
&#8220;Item 3.D Risk Factors&#8212;Risks Related to Information Technology, Intellectual Property and Data Security and Privacy.&#8221;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><img alt="" src="image_009.jpg"/>&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 69; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->59<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><b>Regulatory Environment</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">We
are subject to a number of U.S. federal and state and foreign laws and regulations that involve matters central to our business. These
laws and regulations involve privacy, data protection, intellectual property, competition, consumer protection and other subjects. Many
of the laws and regulations to which we are subject are still evolving and being tested in courts and could be interpreted in ways that
could harm our business. In addition, the application and interpretation of these laws and regulations are often uncertain, particularly
in the new and rapidly evolving industry in which we operate. Because global laws and regulations have continued to develop and evolve
rapidly, it is possible that we may not be, or may not have been, compliant with each such applicable law or regulation.&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Employees </b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 0.5in"><span style="font-size: 10pt">As of April 15, 2023,
we had six employees in Israel, 17 employees who are employed by our wholly owned subsidiary in St. Petersburg, Russia and two employees
who are employed by our wholly owned subsidiary in California, United States. We are not bound by any collective bargaining agreements.
We consider the relationship with our employees to be good. We also use outside consultants and contractors with special expertise and
skills for limited engagements, including manufacturing and quality assurance. During the fourth quarter of 2022, we implemented a cost
reduction plan, including layoffs of certain employees, reducing certain employees from full-time status to part-time status and salary
and bonus reductions of our management and employees.</span>&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Environmental, Health, and Safety Matters</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our research, development,
and manufacturing processes involve the controlled use of certain hazardous materials. Therefore, we are subject to extensive environmental,
health, and safety laws and regulations in a number of jurisdictions in Israel, governing, among other things: the use, storage, registration,
handling, emission, and disposal of chemicals, waste materials, and sewage; chemicals, air, water, and ground contamination; air emissions;
and the cleanup of contaminated sites, including any contamination that results from spills due to our failure to properly dispose of
chemicals, waste materials, and sewage. Our operations at our Rehovot manufacturing facility use chemicals and produce waste materials
and sewage. Our activities require permits from various governmental authorities including local municipal authorities, the Ministry of
Environmental Protection, and the Ministry of Health. The Ministry of Environmental Protection, the Ministry of Health, local authorities,
and the municipal water and sewage company conduct periodic inspections in order to review and ensure our compliance with various regulations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">These laws, regulations, and
permits could potentially require the expenditure by us of significant amounts for compliance or remediation. We believe that our environmental,
health, and safety procedures for handling and disposing of these materials comply with the standards prescribed by the controlling laws
and regulations. If we fail to comply with such laws, regulations, or permits, we may be subject to fines and other civil, administrative,
or criminal sanctions, including the revocation of permits and licenses necessary to continue our business activities. In addition, we
may be required to pay damages or civil judgments with respect to third-party claims, including those relating to personal injury (including
exposure to hazardous substances we use, store, handle, transport, manufacture, or dispose of), property damage, or contribution claims.
These risks are managed to minimize or eliminate associated business impacts. Some environmental, health, and safety laws allow for strict
joint and several liability for remediation costs, regardless of comparative fault. We may be identified as a responsible party under
such laws. Such developments could have a material adverse effect on our business, financial condition, and results of operations as these
kinds of liabilities could exceed our resources. We could be subject to a regulatory shutdown of a facility that could prevent the distribution
and sale of products manufactured in such facility for a significant period of time, and we could suffer a casualty loss that could require
a shutdown of the facility in order to repair it, any of which could have a material, adverse effect on our business. Although we continuously
strive to maintain full compliance with respect to all applicable global environmental, health, and safety laws and regulations, we could
incur substantial costs to fully comply with future laws and regulations, and our operations, business, or assets may be negatively affected.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, compliance with
laws and regulations relating to environmental, health, and safety matters is an ongoing process and is often subject to change. In the
event of any changes or new laws or regulations, we could be subject to new compliance measures or to penalties for activities which were
previously permitted. For instance, Israeli regulations were promulgated in 2012 relating to the discharge of industrial sewage into the
sewer system. These regulations establish new and potentially significant fines for discharging forbidden or irregular sewage into the
sewage system. We have compliance procedures in place for employee health and safety programs, driven by a centrally led organizational
structure that ensures proper implementation, which is essential to our overall business objectives.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 70; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->60<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We invest resources in creating
a green production environment and in the treatment and disposal of waste using environmentally friendly processes. We have received all
the necessary permits from the Ministry of Environmental Protection regarding our operations in Yessod Hama&#8217;ala and we have obtained
a business license for our new facilities in Rehovot. We consult with environmental consultants for direction on environmental issues.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Legal Proceedings</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are not currently party
to any pending material legal proceedings. From time to time, we may become a party to litigation incident to the ordinary course of our
business. Regardless of the outcome, litigation can have an adverse impact on us because of defense and settlement costs, diversion of
management resources and other factors.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><div><a id="a_014"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>C. Organizational Structure</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have two wholly owned subsidiaries:
Beamr, Inc. and&#160;Beamr Imaging RU LLC. Beamr, Inc. is our wholly owned subsidiary incorporated in 2012 in the State of Delaware. Beamr,
Inc. is engaged in reselling our software and products in the U.S. and Canada. Beamr Imaging RU LLC is our wholly owned subsidiary, a
limited Russian partnership formed in 2016. Beamr Imaging RU LLC is engaged in research and development for us.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, we previously
had a wholly owned subsidiary, Beamr UK Ltd, which was incorporated in 2017 in England. Beamr UK Ltd was engaged in reselling our software
and products in the U.K. Beamr UK Ltd was dissolved in May 2020.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><div><a id="a_015"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>D. Property, Plant and Equipment</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our principle executive offices
are located in Herzliya, Israel and consist of approximately 300 square feet of office space. Our wholly owned Russian subsidiary operates
from a leased office located in St Petersburg, Russia. Our employees in our wholly owned US subsidiary operate primarily from their home
offices.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We lease all of our facilities
and do not own any real property. We intend to procure additional space in the future as we continue to add employees and expand geographically.
We believe our facilities are adequate and suitable for our current needs and that, should it be needed, suitable additional or alternative
space will be available to accommodate our operations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><div><a id="a_016"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>ITEM&#160;4A. UNRESOLVED STAFF COMMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Not applicable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><div><a id="a_017"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>ITEM&#160;5. OPERATING AND FINANCIAL REVIEW
AND PROSPECTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">You should read the following
discussion and analysis of our financial condition and results of operations together with the section titled &#8220;Item 3.A.&#8212;Selected
Financial Data&#8221; and our consolidated financial statements and related notes included elsewhere in this Annual Report on Form 20-F.
This discussion and other parts of this Annual Report on Form 20-F contain forward-looking statements based upon current expectations
that involve risks and uncertainties. This discussion and other parts of this Annual Report on Form 20-F contain forward-looking statements
that involve risk and uncertainties, such as statements of our plans, objectives, expectations, and intentions. Our actual results could
differ materially from those discussed in these forward looking statements. Factors that could cause or contribute to such differences
include, but are not limited to, those discussed in the section titled &#8220;Item 3.D.&#8212;Risk Factors&#8221; and elsewhere in this
Annual Report in Form 20-F.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 71; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->61<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Overview</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are a leading innovator
of video encoding, transcoding and optimization solutions that enable high quality, performance, and unmatched bitrate efficiency for
video and images. With our Emmy&#174;-winning patented technology and award-winning services, we help our customers realize the potential
of video encoding and media optimization to address business-critical challenges. Our customers include tier one OTT, content distributors,
video streaming platforms, and Hollywood studios who rely on our suite of products and expertise to reduce the cost and complexity associated
with storing, distributing and monetizing video and images across devices.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">At the heart of our patented
optimization technology is the proprietary BQM, that is highly correlated with the human visual system. BQM is integrated into our CABR,
system, which maximizes quality and remove visual redundancies resulting in a smaller file size. The BQM has excellent correlation with
subjective results, confirmed in testing under ITU BT.500, an international standard for rigorous testing of image quality. The perceptual
quality preservation of CABR has been repeatedly verified using large scale crowd-sourcing based testing sessions, as well as by industry
leaders and studio &#8220;golden eyes&#8221;.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We currently license three
core video and image compression products that help our customers use video and images to further their businesses in meaningful ways:
(1) a suite of video compression software encoder solutions including the Beamr 4 encoder, Beamr 4X content adaptive encoder, Beamr 5
encoder and the Beamr 5X content adaptive encoder, (2) Beamr JPEGmini photo optimization software solutions for reducing JPEG file sizes,
and (3) Beamr Silicon IP block, a hardware solution for integration into dedicated video encoding ASICs, GPUs, and application processors.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our current product line is
mainly geared to the high end, high quality media customers and we count among our enterprise customers Netflix, ViacomCBS, Snapfish,
Wowza, Microsoft, VMware, Genesys, Deluxe, Vimeo, Encoding.com, Citrix, Walmart, Photobox, Antix, Dalet, and other leading media companies
using video and photo solutions.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We currently derive a significant
portion of our revenue from a limited number of our customers. For the years ended December 31, 2022 and December 31, 2021, our top ten
customers in the aggregate accounted for approximately 61% and 62% of our revenues.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Due to the high cost and complexity
of deploying our existing software solutions and the long sales lead times, we have a made a strategic decision to focus our resources
on the development and commercialization of our next-generation product, the Beamr HW-Accelerated Content Adaptive Encoding solution,
a SaaS solution that is designed, based on our own internal testing, to be up to 10x more cost efficient than our existing software-based
solutions, resulting in reduced media storage, processing and delivery costs.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are currently collaborating
with NVIDIA, a multinational technology company and a leading developer of GPUs, with an annual revenue of $26.9 billion for the fiscal
year 2022, to develop the world&#8217;s first GPU accelerated encoding solution that would allow fast and easy end-user deployment combined
with superior video compression rates powered with our CABR rate control and BQM quality measure. Our BQM quality measure software will
execute directly on NVIDIA GPU cores and interact with the NVIDIA video accelerator encoder known as NVENC. NVIDIA NVENC is a high-quality,
high-performance hardware video encoder that is built into most NVIDIA GPUs. NVENC offloads video encoding to hardware, and provides extreme
performance for applications such as live video encoding, cloud gaming and cloud storage. NVIDIA GPUs with NVENC are available on all
major cloud platforms. We are in the advanced stages of development and expect to beta release the Beamr HW-Accelerated Content Adaptive
Encoding solution during the third quarter of 2023 and expect that following release, end-users of the solution will enjoy significant
end-user storage and networking cost savings, potentially reducing their return on investment for storage optimization to approximately
four months, compared to approximately two years with our existing software encoder solutions.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 72; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->62<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Impact of COVID-19</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">For additional information,
see &#8220;Item 3.D Risk Factors&#8212;Risks Related to Our Business and Industry&#8211;Any resurgence of the COVID-19 pandemic could
adversely affect our business, financial condition and results of operations.&#8221;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Impact of Invasion of Ukraine</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="background-color: white">In
addition to our U.S. and Israel operations, we have operations in Russia through our wholly owned subsidiary, Beamr Imaging RU. Specifically,
we undertake some of our software development and design, quality assurance, and support in Russia using personnel located there. While
a majority of our developers are located in Russia, our research and development leadership is all located in Israel. </span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="background-color: white">On
February 24, 2022, Russia invaded Ukraine. The outbreak of hostilities between the two countries could result in more widespread conflict
and could have a severe adverse effect on the region.</span> Following Russia&#8217;s actions, various countries, including the U.S.,
Canada, the United Kingdom, Germany and France, as well as the European Union, issued broad-ranging economic sanctions against Russia.
Such sanctions included, among other things, a prohibition on doing business with certain Russian companies, officials and citizens; a
commitment by certain countries and the European Union to remove selected Russian banks from the Society for Worldwide Interbank Financial
Telecommunications (SWIFT) electronic banking network that connects banks globally; and restrictive measures to prevent the Russian Central
Bank from undermining the impact of the sanctions. In response to sanctions, the Russian Central Bank raised its interest rates and banned
sales of local securities by foreigners. Russia may take additional counter measures or retaliatory actions in the future. The continuation
of these hostilities may result in additional economic and other sanctions against Russia. The potential impact of the conflict and any
resulting bans, sanctions and boycotts on companies doing business in Russia is currently uncertain due to the fluid nature of the conflict
as it is unfolding and has the potential to result in broadened military actions. The duration of ongoing hostilities and such sanctions
and related events cannot be predicted. Uncertainty as to future relations between Russia and the U.S. and other countries in the west,
or between Russia and other eastern European countries, may have a negative impact on our operations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="background-color: white">We
do not operate in any sectors of the Russian economy that have been targeted by U.S. or EU sanctions and have no reason to believe that
we would be targeted by any sanctions in the future. Nonetheless, such sanctions and potential responses to such sanctions, including
those that may limit or restrict transfer funds into Russia, may in the future significantly affect our ability to pay our personnel based
in Russia.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our operations and presence
in Russia is limited. We have no manufacturing operations in Russia and we do not sell any products in Russia and as a consequence we
have not derived any revenues from there. To date, none of our investors expressed concern with respect to our operations in Russia and
none of our customers terminated or downsized their engagement with us as a result of such operations. Our employees in Russia have not
to date experienced any change in their daily ability to perform their tasks. We do not expect Russia or another government to nationalize
our assets or operations in Russia. In particular, our primary assets are software that are stored outside of Russia and our products
and services are all delivered outside of Russia. In addition, we believe that if we needed to, we would be able to recruit personnel
outside Russia without any material interruption to our operations. As a result, we believe that if nationalization were to occur, any
impact on our financial statements would be immaterial.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 73; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->63<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="background-color: white">Since
the start of the conflict, we have been constantly evaluating our activities in Russia. Our board is responsible for overseeing risks
related to Russia&#8217;s invasion of Ukraine, including risks related to cybersecurity, sanctions, employees based in Russia and risks
associated with ongoing or halted operations or investments in affected regions and is actively monitoring key risks. In response to Russia&#8217;s
invasion of Ukraine, in March 2022, our management presented to our board a business continuity plan. We have begun to partially implement
the business continuity plan in order to address risks related to the conflict on our personnel, operations and product development that
includes alternative payment solutions for personnel in Russia and relocation of certain personnel to territories outside Russia and Belarus
on short notice</span>. As of April 15, 2023, some of the Russian employees and contractors of our wholly owned subsidiary in St. Petersburg,
Russia have relocated to other countries and we are continuing to monitor the situation with respect to our business continuity plan.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">For additional information,
see &#8220;Item 3.D&#8212;Risk Factors&#8212;Risks Related to Our Operations in Russia&#8212;Russia&#8217;s invasion of Ukraine and sanctions
brought against Russia could disrupt our software development operations in Russia.&#8221;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Components of Our Results of Operations</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt"><b><i>Revenue</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt"><i>Software Licensing</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our revenues are mainly comprised
of revenue from licensing the rights to use our software for a limited term (mainly for a period of one to three years) or on a perpetual
basis for enterprises that incorporate our perpetual license in their own products delivered to end users and for our products&#160;sold
to thousands of private consumers, as applicable to each contract, and from and provision of related maintenance and technical support
services (i.e. Post-Contract Customer Support, or PCS).</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Revenue from the sale of software
license (either timely-based or perpetual) is recognized at a point in time in which the license is delivered to the customer. The software
license is considered a distinct performance obligation, as the customer can benefit from the software on its own. Revenue from PCS services
are also derived from annual maintenance providing for unspecified upgrades on a when-and-if-available basis. The right for an unspecified
upgrade for the version acquired by the customer and enhancements on a when-and-if-available basis that do not specify the features, functionality
and release date of future product enhancements for the customer to know what will be made available and the general timeframe in which
it will be delivered. We consider the PCS performance obligation as a distinct performance obligation that is satisfied over time and
recognized on a straight-line basis over the contractual period (mainly over a period of one year either for timely-based license or for
perpetual license).</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As we bundle software licenses
(either timely-based or perpetual) together with PCS, the transaction price is allocated to the separate performance obligations on a
relative standalone selling price basis.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Since we do not sell PCS on
a stand-alone basis and due to the fact that these services are usually involved with limited customer support, mainly based on several
hours of technical support per contract (as management believes the technology and products covered under the software license component
are mature and fully functional), the standalone selling prices of the PCS are determined based on the expected cost plus a margin based
on estimation of direct fulfillment cost (an hourly service) and a reasonable margin. Such estimate is also corroborated with the price
that the customer would have to pay to a third-party service provider for a similar support service.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The stand-alone selling price
of the software licenses (either timely-based or perpetual) is estimated by management based on adjusted market assessment approach which
represents management estimation of the price that a customer in the market will be willing to pay for such license on a stand-alone basis
(i.e. without any PCS).</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Due to the fact that these
services are usually involved with limited customer support, mainly based on several hours of technical support per contract, the transaction
price allocated to the PCS is considered insignificant. Consequently, most of the transaction price is allocated to the software licenses
as management believes the technology and products covered under the software license component are mature and fully functional.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 74; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->64<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt"><i>Advertising</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Commencing 2022, revenue in
small volume is also derived from the traffic operations in the Google AdSense program, a web advertising platform, that we make available
on our websites.&#160;Google pays us on a cost-per-click basis. We recognize as revenue the fees paid to it by Google based on the volume
of clicks through to Google AdSense advertisements.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt"><b><i>Cost of Revenue</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Cost of software licensing
and related maintenance and technical support services revenues primarily consist of costs related to salaries, of our support team and
additional overhead allocation costs such as rent, utilities and supplies to all departments based on relative headcount.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt"><b><i>Gross Margins</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Gross margins have been, and
will continue to be, affected by a variety of factors, including the average sales price of our products and services, volume growth,
the mix of revenues, software licenses, maintenance and technical support and professional services, onboarding of new media and telecom
customers, and changes in cloud infrastructure and personnel costs.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt"><b><i>Operating Expenses</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt"><i>Research and Development</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our research and development
expenses consist primarily of costs incurred for personnel-related expenses for our technical staff, including salaries and other direct
personnel-related costs. Additional expenses include consulting, amortization of acquired technology intangible asset and professional
fees for third-party development resources. We expect our research and development expenses to increase in absolute dollars for the foreseeable
future as we continue to dedicate substantial resources to develop, improve and expand the functionality of our solutions. Subsequent
costs incurred for the development of future upgrades and enhancements, which are expected to result in additional functionality, may
qualify for capitalization under internal-use software and therefore may cause research and development expenses to fluctuate.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt"><i>Selling and Marketing Expenses</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our selling and marketing
expenses consist primarily of personnel related costs for our sales and marketing functions, including salaries and other direct personnel-related
costs. Additional expenses include marketing program costs, amortization of acquired customer relationships and trade names, intangible
assets, and payment processer commissions. We expect our selling and marketing expenses will increase on an absolute dollar basis for
the foreseeable future as we continue to increase investments to support our growth. We also anticipate that selling and marketing expenses
will increase as a percentage of revenue in the near and medium-term.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt"><i>General and Administrative
Expenses</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our general and administrative
expenses consist primarily of personnel-related costs for our executive, finance, human resources, professional fees, information technology
and legal functions, including salaries and other direct personnel-related costs. We expect general and administrative expense to increase
on an absolute dollar basis for the foreseeable future as we continue to increase investments to support our growth and as a result of
our becoming a public company.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We allocate overhead expenses
related to the services agreement and the office agreement expenses under which we receive recurring consulting and related services from
our founder Sharon Carmel as Chief Executive Officer and an entity controlled by him, Sharon Carmel Management, Ltd. The allocation was
done based on the management estimation to reflect the contribution to the related activity.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 75; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->65<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt"><i>Other Income</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In 2021, other income consisted
primarily of loans forgiveness as it were utilized for qualifying expenses under the Coronavirus Aid, Relief, and Economic Security Act.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt"><i>Financing Income (Expenses),
Net</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Financing income (expenses),
net consists of amortization of discounts and interest expense on our indebtedness, modification of terms relating to our loan with Silicon
Valley Bank, or SVB, and changes in the fair value of warrants and convertible advanced investments. Financial expenses, net also includes
foreign exchange gains and losses.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt"><i>Taxes on Income</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are subject to taxes in
jurisdictions or countries in which we conduct business. Our effective tax rate is affected by tax rates in jurisdictions and the relative
amounts of income we earn in those jurisdictions, changes in the valuation of our deferred tax assets and liabilities, applicability of
any valuation allowances, and changes in tax laws in jurisdictions in which we operate. Due to cumulative losses, we maintain a valuation
allowance against our deferred tax assets. We consider all available evidence, both positive and negative, in assessing the extent to
which a valuation allowance should be applied against our deferred tax assets. Realization of our deferred tax assets depends upon future
earnings, the timing and amount of which are uncertain. Our effective tax rate is affected by tax rates in foreign jurisdictions and the
relative amounts of income we earn in those jurisdictions, as well as non-deductible expenses, such as share-based compensation, and changes
in our valuation allowance.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><div><a id="a_018"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>A. Operating Results</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The table below provides our
results of operations for the years ended December 31, 2022, 2021, and 2020.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;Year
Ended&#160;December 31,</b></p>

</td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-style: italic">(U.S. dollars in thousands)</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%">Revenues</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">2,863</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">3,300</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">3,176</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt">Cost of revenues</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(98</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(90</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(94</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Gross profit</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">2,765</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">3,210</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">3,082</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Operating expenses:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Research and development</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(2,063</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(2,032</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(2,727</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Sales and marketing</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(905</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(959</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(1,371</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">General and administrative</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(828</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(773</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(671</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Other income</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">129</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">20</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Operating loss</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(1,031</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(425</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(1,667</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Financing expenses, net</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(165</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(475</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(697</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Tax on income</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(52</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(52</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(95</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 4pt">Net loss</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(1,248</td><td style="padding-bottom: 4pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(952</td><td style="padding-bottom: 4pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(2,459</td><td style="padding-bottom: 4pt; text-align: left">)</td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt"><i>Revenues, Cost of Revenues and Gross Profit</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following table presents
our revenue, cost of revenues and gross profit for the periods indicated:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year Ended&#160;December 31,</td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-style: italic">(U.S. dollars in thousands)</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%">Revenues</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">2,863</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">3,300</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">3,176</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt">Cost of revenues</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(98</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(90</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(94</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 4pt">Gross profit</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">2,765</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">3,210</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">3,082</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 76; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->66<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Revenues decreased by $0.4
million, or 13%, to $2.9 million for the year ended December 31, 2022, from $3.3 million for the year ended December 31, 2021. The decrease
was primarily due to a shifting of a license renewal that occurred in December 2021 for a 15-month extension until March 2023, which resulted
in recognizing the related revenues in a higher amount in 2021 and a shifting of the next scheduled license renewal to March 2023 when
there is expected to be additional revenue recognition.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">

</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Revenues increased by $0.1
million, or 4%, to $3.3 million for the year ended December 31, 2021, from $3.2 million for the year ended December 31, 2020. The increase
was primarily due to higher volume of transactions in which license renewal transactions have occurred in 2021 which resulted in recognizing
the related revenues in higher amount in such reported year compared to 2020.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt"><b><i>Operating Expenses</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt"><i>Research and Development
Expenses</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;Year
Ended&#160;December 31,</b></p>

</td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-style: italic">(U.S. dollars in thousands)</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">Salary and related expenses</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(1,722</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(1,645</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(1,963</td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Professional fees</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(123</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(99</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(161</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Depreciation and amortization</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(4</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(107</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(415</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Travel and overhead expenses</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(214</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(181</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(188</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 4pt">Total research and development expenses</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(2,063</td><td style="padding-bottom: 4pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(2,032</td><td style="padding-bottom: 4pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(2,727</td><td style="padding-bottom: 4pt; text-align: left">)</td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Research and development expenses
did not change materially for the year ended December 31, 2022, compared to 2021. There was a slight increase in salaries, professional
fees and overhead expenses offset by a decrease in depreciation and amortization expenses.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Research and development expenses
decreased by $0.7 million, or 25% to $2 million for the year ended December 31, 2021, from $2.7 million in 2020. The decrease was primarily
due to (i) a reduction in salary and expenses related to a change in priority of deployment of our resources, (ii) a decrease in depreciation
and amortization of intangible assets, and (iii) our focus of our R&amp;D on our new SaaS solution, the Beamr HW-Accelerated Content Adaptive
Encoding solution.</p><div>

</div><p style="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt"><i>Selling and Marketing Expenses</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>&#160;</i></p><div>

</div><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="text-align: center; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Year
Ended December 31,</b></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-style: italic; border-bottom: Black 1.5pt solid">(U.S. dollars in thousands)</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">Salary and related expenses</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(564</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(560</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(777</td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Professional fees and platform commissions</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(236</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(241</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(207</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Depreciation and amortization</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(22</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(81</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(255</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Marketing conferences and trade shows</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(3</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(1</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(17</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Travel and overhead expenses</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(80</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(76</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(115</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 4pt">Total selling and marketing expenses</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(905</td><td style="padding-bottom: 4pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(959</td><td style="padding-bottom: 4pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(1,371</td><td style="padding-bottom: 4pt; text-align: left">)</td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Selling and marketing expenses
decreased by $0.05 million, or 6%, to $0.9 million for the year ended December 31, 2022, from $0.95 million in 2021. The decrease was
primarily due to a decrease in depreciation and amortization of intangible assets.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Selling and marketing expenses
decreased by $0.4 million, or 30%, to $1 million for the year ended December 31, 2021, from $1.4 million in 2020. The decrease was primarily
due to (i) a reduction in salary and expenses related to a change in priority of deployment of our resources, (ii) a decrease in depreciation
and amortization of intangible assets, and (iii) our focus of our R&amp;D on our new SaaS solution, the Beamr HW-Accelerated Content Adaptive
Encoding solution.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 77; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->67<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt"><i>General and Administrative</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>&#160;</i></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Year
Ended&#160;December 31,</b></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-style: italic">(U.S. dollars in thousands)</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">Salary and related expenses</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(346</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(297</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(352</td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Professional fees and consulting</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(504</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(509</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(360</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Overhead allocated</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">153</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">140</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">220</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Travel, office and other expenses</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(131</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(107</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(179</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 4pt">Total general and administrative expenses</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(828</td><td style="padding-bottom: 4pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(773</td><td style="padding-bottom: 4pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(671</td><td style="padding-bottom: 4pt; text-align: left">)</td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">General and administrative
expenses increased by $0.05 million, or 7%, to $0.83 million for the year ended December 31, 2022, from $0.78 million in 2021. The increase
was primarily due to salaries and related expenses.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">General and administrative
expenses increased by $0.1 million, or 15%, to $0.8 million for the year ended December 31, 2021, from $0.7 million in 2020. The increase
was primarily due to IPO related service providers.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt"><i>Other Income</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>&#160;</i></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year Ended <br/> December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-style: italic">(U.S. dollars in thousands)</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; padding-bottom: 4pt">Other income</td><td style="width: 1%; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;-</td><td style="width: 1%; padding-bottom: 4pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right">129</td><td style="width: 1%; padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Other income of $0.01 million
for the year ended December 31, 2021, was a onetime occurrence of other income due to forgiveness of loans under paycheck protection program.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt"><i>Financing Expenses, Net</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>&#160;</i></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Year
Ended&#160;December 31,</b></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; text-align: left; font-style: italic">(U.S. dollars in thousands)</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">2022</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">Change in fair value of convertible advanced investment</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(71</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(288</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(436</td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Amortization of discount and accrued interest on straight loan</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(103</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(59</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(120</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Modification of terms relating to straight loan</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(90</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Discount relating to liability to related party</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(40</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Exchange rate differences and other finance expenses</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(49</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(38</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(141</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 4pt">Total financing expenses, net</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(165</td><td style="padding-bottom: 4pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(475</td><td style="padding-bottom: 4pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(697</td><td style="padding-bottom: 4pt; text-align: left">)</td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Financing expenses decreased
by $0.3 million, or 65%, to $0.17 million for the year ended December 31, 2022, from $0.47 million in 2021. The decrease was primarily
due to a decrease in the change of fair value of convertible advanced investment, a decrease in exchange rate differences and a decrease
in modification of terms relating to straight loan offset by an increase in amortization of discount and accrued interest and discount
expense relating to liability to related party.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Financing expenses decreased
by $0.2 million, or 32%, to $0.5 million for the year ended December 31, 2021, from $0.7 million in 2020. The decrease was primarily due
to a decrease in the change of fair value of convertible advanced investment, a decrease in exchange rate differences, a decrease in amortization
of discount and accrued interest on our loan from SVB and offset by one-time expenses incurred as result of modification of terms relating
to straight loan.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 78; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->68<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt"><i>Taxes on Income</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>&#160;</i></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Year
Ended&#160;December 31,</b></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-style: italic">(U.S. dollars in thousands)</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left; padding-bottom: 4pt">Taxes on income</td><td style="width: 1%; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right">(52</td><td style="width: 1%; padding-bottom: 4pt; text-align: left">)</td><td style="width: 1%; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right">(52</td><td style="width: 1%; padding-bottom: 4pt; text-align: left">)</td><td style="width: 1%; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right">(95</td><td style="width: 1%; padding-bottom: 4pt; text-align: left">)</td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Taxes on income expenses did
not change for the year ended December 31, 2022, compared to 2021.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Taxes on income decreased
by $0.04 million, or 45%, to $0.05 million for the year ended December 31, 2021, from $0.1 million in 2020. The decrease was primarily
due to tax provision adjustments related to amortization of intangible assets.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Recent Accounting Pronouncements</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Certain recently issued accounting
pronouncements are discussed in Note 2, Significant Accounting Policies, to the consolidated financial statements included in &#8220;Item
18. Financial Statements&#8221; of this Annual Report.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>JOBS Act</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Under the JOBS Act, an &#8220;emerging
growth company&#8221; can take advantage of an extended transition period for complying with new or revised accounting standards. This
provision allows an &#8220;emerging growth company&#8221; to delay the adoption of new or revised accounting standards that have different
transition dates for public and private companies until those standards would otherwise apply to private companies. Although we meet the
definition of an &#8220;emerging growth company&#8221; and we have elected not to use this extended transition period for complying with
new or revised accounting standards.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><div><a id="a_019"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>B.</b>&#160;<b>Liquidity and Capital Resources</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have financed our operations
through cash generated from operations, the proceeds from private offerings, proceeds from receiving convertible advanced investments
from our current shareholders and others and proceeds from our initial public offering on the Nasdaq. During the fourth quarter of 2022,
we implemented a cost reduction plan, including layoffs of certain employees, reducing certain employees from full-time status to part-time
status and salary and bonus reductions of our management and employees. This plan is expected to reduce our annual costs in 2023 by approximately
$0.6 million, and, with the recruitment of our new Chief Product Officer, will also allow us to focus on building our future SaaS, and
building a short term roadmap to maximize revenues from our existing products.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We believe that our existing
capital resources and cash flows from operations together with funds received from the initial public offering will be adequate to satisfy
our expected liquidity requirements through the next twelve months. Without derogating from the foregoing estimate regarding our existing
capital resources and cash flows from operations, we may decide to raise additional funds in 2023. We believe that, if required, we will
be able to raise additional capital or reduce discretionary spending to provide the required liquidity beyond the next twelve months.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our future capital requirements
will depend on many factors, including our revenue growth, the timing and extent of investments to support such growth, the expansion
of sales and marketing activities, increases in general and administrative costs and many other factors as described under &#8220;Risk
Factors.&#8221;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">To the extent additional funds
are necessary to meet our long-term liquidity needs as we continue to execute our business strategy, we anticipate that they will be obtained
through the incurrence of additional indebtedness, additional equity financings or a combination of these potential sources of funds;
however, such financing may not be available on favorable terms, or at all. In particular, the widespread COVID-19 pandemic has resulted
in, and may result in, significant disruption of global financial markets, reducing our ability to access capital. If we are unable to
raise additional funds when desired, our business, financial condition and results of operations could be adversely affected.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 79; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->69<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt"><b><i>SVB Loans</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On February 19, 2017, we and
Beamr, Inc., our wholly owned subsidiary, entered into a Loan Agreement, or the 2017 Loan Agreement, with SVB under which we had a right
to borrow from SVB up to $3 million bearing interest at a floating per annum rate equal to the Wall Street Journal Prime Rate plus 3.5%
(upon occurrence of an &#8216;default event&#8217; as defined in the Loan Agreement, the principal amount shall bear interest at a rate
per annum which is 5% above the rate that is otherwise applicable thereto) which shall be payable monthly. In June 2018, we subsequently
drew down a cash amount in the aggregate principal amount of $3 million, or the 2017 Loan, payable in 36 equal installments on a monthly
basis commencing the following month after draw down. On July 26, 2022, we terminated the 2017 Loan Agreement. The Loan is sometimes referred
to herein as a &#8220;straight loan&#8221;<b><i>.&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In connection with the execution
of the 2017 Loan Agreement, we issued to SVB a 15-year warrant to purchase (i) 41,040 Series C Convertible Preferred Shares at an exercise
price of $5.12 per share or (ii) 41,040 shares to be issued in the &#8216;next round&#8217; at an exercise price equal to the lowest price
per share at which we will sell and issue shares of the next round shares.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On April 15, 2020, we signed
a deferral agreement in connection with the 2017 Loan Agreement with SVB according to which it was agreed that the original monthly repayment
date for the principal due from May 2020 to October 2020 shall be extended by a period of six months commencing November 2020.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, on April 29,
2021, or the Deferral Effective Date, we signed a second deferral agreement in connection with the 2017 Loan Agreement with SVB according
to which it was agreed that the original monthly repayment date for the principal due from May 2021 to October 2021 shall be extended
by a period of six months commencing November 2021. In consideration, we agreed to (i) pay to SVB a total deferral facility fee equal
to $50, which fee shall be fully earned at the Deferral Effective Date, and payable in 10 monthly equal installments over the period commencing
April 29, 2021 through January 29, 2022; (ii) reimburse SVB for all reasonable legal fees and expenses incurred in connection with the
deferral agreement and (iii) issue to SVB a 15-year warrant to purchase 9,764 shares exercisable at an exercise price of $5.12 per share
(subject to standard adjustments) into either Series C Preferred Shares or a class of securities sold and issued by us in the next equity
financing round. Furthermore, if SVB exercises the warrant and the warrant value (as determined in the warrant) is lower than $50,000,
then immediately following such exercise, we are required to pay the holder an amount equal to the difference between the $50,000 and
the warrant value.&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On February 17, 2022, we entered
into a second Loan and Securities Agreement, or the 2022 Loan Agreement providing a credit line against our accounts receivables. According
to the 2022 Loan Agreement, commencing as of August 1, 2022 through December 31, 2022, SVB may, in its sole discretion in each instance,
pursuant to our request, finance specific eligible account receivables of ours, as determined in the 2022 Loan Agreement, in a total amount
equal to the face amount of the eligible account receivable multiplied by a rate of 80%, subject to reduction by SVB in its discretion,
or the Advance, provided that the aggregate amount of all outstanding Advances shall not exceed the lesser of (i) an aggregate principal
amount equal to $350,000, or the Revolving Line, or (ii) 80% of all eligible account receivables minus the sum of all outstanding principal
amounts of any Advances, subject to reduction by SVB in its discretion. The outstanding principal amount of any Advance shall accrue interest
at a floating rate per annum equal to the greater of (i) 8.25% and (ii) a floating per annum rate equal to the Wall Street Journal Prime
Rate plus 5% (upon occurrence of a &#8216;default event&#8217; as defined in the 2022 Loan Agreement, the aggregate loan principal amount
shall bear interest at a rate per annum which is 5% above the rate that is otherwise applicable thereto). Interest on the principal amount
of each Advance will be payable in monthly arrears (i) on each the last day of each month and (ii) on December 31, 2022, or the Revolving
Line Maturity Date. The security interest granted in the 2022 Loan Agreement shall at all times continue to be a first priority perfected
security. On July 26, 2022, we terminated the 2022 Loan Agreement and the security interest on all our assets was removed.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 80; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->70<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Upon making of the initial
Advance, we agreed to issue to SVB a warrant to purchase (i) 4,784 Series C Convertible Preferred Shares, or (ii) ordinary shares in the
event that we have listed its securities for trading on Nasdaq, or (iii) upon SVB&#8217;s written irrevocable election in its sole discretion,
the same class and series, or other designation, of convertible preferred share or other senior equity security sold and issued by us
in the next equity financing over a 15-years period commencing the issuance date of such warrant, at an exercise price of $5.12 per share,
provided that if the class is the next equity financing securities, then the exercise price shall be the lowest price per share for which
next equity financing securities are sold or issued by us. Upon termination of the 2022 Loan Agreement, we have no commitment to issue
to SVB the aforesaid warrant.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of March 13, 2023, we held
approximately $10,000 at SVB and do not have any additional deposits or securities in accounts at SVB.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt"><b><i>Convertible Advance
Investment</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On August 25, 2021 and August 6, 2019, we entered into separate advance
investment agreements with several current shareholders under which we raised an amount of $560,000 and $3,097,000, respectively, which
was not interest bearing but was eligible for conversion into our ordinary shares based on a variable conversion price depending on the
occurrence of certain liquidation events. Upon completion of our initial public offering, the advance investment amounts were converted
into an aggregate of 1,142,856 ordinary shares based on a conversion price of $3.20 per ordinary share.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt"><b><i>IBI Spikes Loan</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On July 7, 2022, we entered
into a funding agreement with IBI providing for a loan, or the IBI Loan, in the amount of NIS 3.1 million (approximately $900,000), or
the IBI Loan Agreement. The loan is repayable on a monthly basis based on a formula set forth in the IBI Loan Agreement until the earlier
repayment of NIS 4,172,760 (approximately $1.2 million), or the Repayment Amount, or January 5, 2026. We may repay the IBI Loan early
based on formula set forth in the IBI Loan Agreement. The IBI Loan Agreement provides for certain customary covenants and accelerates
in the event of default.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In consideration for the grant of the IBI Loan, we are required to
pay to IBI a non-refundable one-time fee of 1.5% of the IBI Loan amount and we issued a warrant to purchase 65,562 ordinary shares at
an exercise price of $3.20 per share. The warrant has a term of the earlier of 10 years or certain liquidation events and a variable exercise
price depending on the occurrence of certain liquidation events. The warrant can be exercised on cashless exercise based on the discretion
of IBI.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt"><b><i>Completion of our Initial
Public Offering </i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On February 27, 2023, we announced
the pricing of our initial public offering of 1,950,000 ordinary shares at a public offering price of $4.00 per ordinary share, for aggregate
gross proceeds of $7,800,000 prior to deducting underwriting discounts and other offering expenses.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our ordinary shares began
trading on the Nasdaq Capital Market under the ticker symbol &#8220;BMR&#8221; on February 28, 2023.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt"><b><i>Cash Flows</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following table summarizes
our cash flows for the periods presented:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Year
Ended&#160;December&#160;31,</b></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-style: italic">(U.S. dollars in thousands)</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">Net cash provided by (used in) operating activities</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(645</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">569</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(1,020</td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Net cash provided by (used in) investing activities</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(2</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(4</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Net cash used in financing activities</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">312</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(141</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(418</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Change in cash, cash equivalents</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(335</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">424</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(1,437</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Cash, cash equivalents at beginning of period</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1,028</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">604</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">2,041</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Cash, cash equivalents at end of period</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">692</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1,028</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">604</td><td style="text-align: left">&#160;</td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 81; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->71<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt"><i>Net cash used in operating
activities</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">For the year ended December
31, 2022, net cash used by operating activities was mainly due to&#160;a net loss of $1.2 million, offset by $0.2 million of share-based
compensation and change in other working capital items as shown in the consolidated statements of cash flows of the annual financial statements.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">For the year ended December
31, 2021, net cash provided by operating activities was mainly due to&#160;a net loss of $1 million and $0.1 million of forgiveness of
loan under a paycheck protection program note, which was offset by $0.2 million of depreciation and amortization, $0.2 million of share-based
compensation, $0.01 million of amortization of discount relating to our loan from SVB, $0.3 million of change in the fair value of convertible
advanced investments, $0.1 million of modification of terms of our loan from SVB, $0.7 million change in trade receivables and $0.2 million
change in other working capital items as shown in the condensed consolidated statements of cash flows of the interim financial statements.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">For the year ended December
31, 2020, net cash used in operating activities was mainly due to&#160;a net loss of $2.4 million, which was offset by $0.6 million of
depreciation and amortization, $0.1 million of share-based compensation, $0.02 million of amortization of discount relating to our loan
from SVB, $0.4 million of change in the fair value of convertible advanced investments and $0.1 million of change in other working capital
items as shown in the consolidated statement of cash flows of the annual financial statements.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt"><i>Investing Activities</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">For the years ended December
31, 2022, 2021 and 2020, the change in net cash used in investing activities was immaterial.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt"><i>Financing Activities</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Net cash provided by financing activities of $0.3 million for the year
ended December 31, 2022 was related to $0.9 million of proceeds received from a loan granted from a commercial bank (IBI) and $0.1 million
of proceeds from loan received from related party, offset by deferred offering costs of $0.1 million and repayment of principal relating
to a straight loan received from a commercial bank (SVB) of $0.6 million.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Net cash used in financing
activities of $0.1 million for the year ended December 31, 2021 was related to repayment of a straight loan and facility fees of $0.5
million and deferred offering costs of $0.2 million and offset by proceeds received from a paycheck protection program note of $0.05 million
and proceeds received from issuance of convertible advanced investments of $0.6 million.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Net cash used in financing
activities of $0.4 million for the year ended December 31, 2020 was related to repayment of our loan from SVB of $0.5 million and offset
by proceeds received from a paycheck protection program note of $0.07 million and proceeds received from exercise of share options into
shares of $0.01 million.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><div><a id="a_020"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.3pt"><b>C.&#160;Research and Development, Patents and
Licenses</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">See above, under
Item 5 &#8211; &#8220;Research and Development Expenses.&#8221;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><div><a id="a_022"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.3pt"><b>D.</b>&#160;<b>Trend Information</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Other than as disclosed in
&#8220;<i>Item 5. Operating and Financial Review and Prospectus&#8212;Components of Our Results of Operations</i>&#8221; and elsewhere
in this Annual Report, we are not aware of any trends, uncertainties, demands, commitments or events for the period from January 1, 2022
to December 31, 2022 that are reasonably likely to have a material effect on our total revenues, income, profitability, liquidity or capital
resources, or that caused the disclosed financial information to be not necessarily indicative of future operating results or financial
condition.&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 82; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->72<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><div><a id="a_023"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.3pt"><b>E.</b>&#160;<b>Critical Accounting Estimates</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt"><b><i>Use of Estimates</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The preparation of financial
statements in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions that affect the amounts reported
in the consolidated financial statements and accompanying notes. Our management believes that the estimates, judgment and assumptions
used are reasonable based upon information available at the time they are made. These estimates, judgments and assumptions can affect
the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the consolidated financial
statements, and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from those estimates.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We believe that the accounting
policies described below require management&#8217;s most difficult, subjective or complex judgments. Judgments or uncertainties affecting
the application of these policies may result in materially different amounts being reported under different conditions or using different
assumptions. Accordingly, we believe these are the most critical to aid in fully understanding and evaluating our financial condition
and results of operations. See Note 2 to the audited consolidated financial statements for additional information regarding these and
our other significant accounting policies.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt"><b><i>Share-based compensation</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt"><i>Service-based awards</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We account for share-based
compensation in accordance with ASC 718, &#8220;Compensation - Stock Compensation&#8221;, or ASC 718, which requires companies to estimate
the fair value of equity-based payment awards on the date of grant using an option-pricing model. The value of the portion of the award
is recognized as an expense over the requisite service periods by applying the straight-line method in our consolidated statements of
comprehensive loss.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We selected the Black-Scholes
option-pricing model as the most appropriate fair value method for our option awards. The Black-Scholes option-pricing model requires
the input of highly subjective assumptions, including the fair value of the underlying ordinary shares, the expected volatility of the
price of our ordinary shares, the expected term of the option, risk-free interest rates and the expected dividend yield of our ordinary
shares. These estimates involve inherent uncertainties and the application of management&#8217;s judgment. These assumptions are estimated
as follows:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt"><i>Key Assumptions</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Fair Value of our ordinary shares.&#160;&#160; The fair value of the underlying ordinary shares is determined based on the price of our ordinary shares on the Nasdaq.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Expected Volatility.&#160;&#160;The expected price volatility for our ordinary shares was estimated by taking the average historical price volatility for our ordinary shares on the Nasdaq.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Expected Term. The expected term represents the period that our share-based awards are expected to be outstanding and is determined based on the simplified method until sufficient historical exercise data will support using expected life assumptions.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Risk-Free Rate.&#160;&#160;The risk-free interest rate is based on the yields of U.S. Treasury securities with maturities similar to the expected term of the options for each option group.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Dividend Yield.&#160;&#160;We have never declared or paid any cash dividends and do not presently plan to pay cash dividends in the foreseeable future. Consequently, we used an expected dividend yield of zero.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&#160;&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"></p><div>

</div><!-- Field: Page; Sequence: 83; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->73<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt"><b><i>Ordinary shares valuation</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The fair value of ordinary
shares was determined by our board of directors, with input from management, and taking into account the most recent valuation from an
independent third-party valuation specialist. These valuations were determined in accordance with the guidelines outlined in the American
Institute of Certified Public Accountants Accounting and Valuation Guide: Valuation of Privately-Held-Company Equity Securities Issued
as Compensation. The assumptions we used in the valuation models were based on future expectations combined with management judgment.
Numerous objective and subjective factors were considered in the determination of the fair value of our ordinary shares as of the date
of each option grant, including the following factors:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">contemporaneous valuations performed at periodic intervals by an independent third-party specialist;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">the likelihood and timing of achieving a liquidity event, such as an initial public offering or sale;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">the liquidation preferences, rights, and privileges of our preferred shares relative to our ordinary shares;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">the nature and history of our business;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">the general economic conditions and our industry outlook;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">our overall financial condition;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">our earning capacity;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">our dividend history;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">the existence of goodwill or other intangible value within our business;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">the prior sales of interests in the business and the size of the interest being valued;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">the market price of equity interest in companies engaged in the same or a similar line of business; and</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">adjustments necessary to recognize a lack of marketability of the ordinary shares.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In valuing our ordinary shares,
absent an arm&#8217;s-length current/recent round of financing, the fair value of our business, or equity value, was determined using
both the income approach and market approach.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The income approach estimates
value based on the expectation of future cash flows that we will generate. These future cash flows are discounted to their present values
using a discount rate based on the capital rates of return for comparable publicly traded companies and are adjusted to reflect the risks
inherent in our cash flows relative to those inherent in the companies utilized in the discount rate calculation.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The market approach estimates
value based on a comparison of us to comparable public companies in a similar line of business. From the comparable companies, representative
market value multiples are determined and then applied to our financial results to estimate our value.&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The resulting equity value
was then allocated to each share class using an OPM. Under the OPM, preferred and ordinary shares are treated as a series of call options,
with the preferred shares having an exercise price based on the liquidation preference of the respective preferred share. The OPM operates
through a series of Black-Scholes-Merton option pricing models, with the exercise prices of the options representing the upper and lower
bounds of the proceed ranges that a security holder would receive upon a liquidity event. The strike prices occur at break points where
the allocation of firm value changes among the various security holders. The ordinary shares are presumed to have value only if funds
available for distribution to shareholders exceed the value of the respective liquidation preferences at the time of a liquidity event.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 84; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->74<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">For each valuation date, after
the ordinary shares value was determined, a discount for lack of marketability, or DLOM, was applied to arrive at the fair value of the
ordinary shares on a non-marketable basis. A DLOM is applied in order to reflect the lack of a recognized market for a closely held interest
and the fact that a non-controlling equity interest may not be readily transferable. A market participant purchasing this share would
recognize this illiquidity associated with the shares, which would reduce the overall fair value. The discount for lack of marketability
was determined using a put option as a proxy for measuring discounts for lack of marketability of securities.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We also considered any secondary
transactions involving our capital shares. In our evaluation of those transactions, we considered the facts and circumstances of each
transaction to determine the extent to which they represented a fair value exchange. Factors considered include:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">transaction volume;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">proximity in time to other transactions as well as the valuation date;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">frequency of similar transactions;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">whether the transactions occurred between willing and unrelated parties; and</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">whether the transactions involved parties with sufficient access to our financial; information from which to make an informed decision on price.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Application of these approaches
involves the use of estimates, judgments, and assumptions that are highly complex and subjective, such as those regarding our expected
future revenue, expenses, future cash flows, discount rates, market multiples, the selection of comparable companies, and the probability
of possible future events. Changes in any or all of these estimates and assumptions or the relationships between those assumptions impact
our valuations as of each valuation date and may have a material impact on the valuation of our ordinary shares.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Internal Control Over
Financial Reporting</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Prior to our initial public offering, we were a private company with
limited accounting and financial reporting personnel and other resources to address our internal controls and procedures. In connection
with the audit of our consolidated financial statements as of December&#160;31, 2022, we identified control deficiencies in our financial
reporting process that constitute a material weakness for the three years then ended. The material weakness related to lack of sufficient
internal accounting personnel, segregation of duties, and lack of sufficient internal controls (including IT general controls, entity
level controls and transaction level controls).</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">As
defined in the standards established by the Public Company Accounting Oversight Board of the United States, a &#8220;material weakness&#8221;
is a deficiency, or a combination of deficiencies, in internal control over financial reporting such that there is a reasonable possibility
that a material misstatement of the company&#8217;s annual or interim financial statements will not be prevented or detected on a timely
basis.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">We
expect to take a number of measures to address the internal control deficiencies that have been identified including expanding our existing
accounting and financial reporting personnel, establishing effective monitoring and oversight controls and engaging an external consulting
firm to assist us with assessment of Sarbanes-Oxley compliance requirements and improvement of overall internal controls. However, we
cannot assure you that these measures may fully address the material weaknesses in our internal control over financial reporting or that
we may conclude that they have been fully remediated.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">We
expect to complete our remediation plan within the next 12 months. However, we have not tested the effectiveness of our internal control
over financial reporting and cannot assure you that we will be able to successfully remediate this material weakness and, even if we do,
we cannot assure you that we will not suffer from other material weaknesses in the future. Except for additional personnel costs, the
cost of systems and the costs of our third-party service providers, we do not expect to incur any material costs related to our remediation
plan.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"></p><div>

</div><!-- Field: Page; Sequence: 85; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->75<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The
process of designing and implementing an effective financial reporting system is a continuous effort that requires us to anticipate and
react to changes in our business and the economic and regulatory environments and to expend significant resources to maintain a financial
reporting system that is adequate to satisfy our reporting obligation. See &#8220;Item 3.D&#8212;Risk Factors&#8212;Risks Related to Ownership
of our Ordinary Shares&#8212; We have identified a material weakness in our internal control over financial reporting, and we may not
be able to successfully implement remedial measures.&#8221;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">As
a company with less than US $1.235&#160;billion in revenue for our last fiscal year, we are an &#8220;emerging growth company&#8221; pursuant
to the JOBS Act. An emerging growth company may take advantage of specified reduced reporting and other requirements that are otherwise
applicable generally to public companies. These provisions include exemption from the auditor attestation requirement under Section&#160;404
of the Sarbanes-Oxley Act of 2002, in the assessment of the emerging growth company&#8217;s internal control over financial reporting.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><div><a id="a_024"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>ITEM&#160;6. DIRECTORS, SENIOR MANAGEMENT AND EMPLOYEES</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><div><a id="a_025"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.3pt"><b>A.</b>&#160;<b>Directors and Senior Management</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following table sets forth
certain information relating to our directors and senior management as of April 15, 2023. Unless otherwise stated, the address for our
directors and senior management is at the Company&#8217;s registered address c/o 10 HaManofim Street, Herzeliya, 4672561, Israel.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid; width: 32%"><span style="font-size: 10pt"><b>Name</b></span></td>
    <td style="width: 1%; text-align: center">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 8%; text-align: center"><span style="font-size: 10pt"><b>Age</b></span></td>
    <td style="width: 1%; text-align: center">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 58%; text-align: center"><span style="font-size: 10pt"><b>Position</b></span></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top"><span style="font-size: 10pt">Sharon Carmel </span></td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-size: 10pt">52 </span></td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: bottom"><span style="font-size: 10pt">Chief Executive Officer and Chairman </span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top"><span style="font-size: 10pt">Danny Sandler </span></td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-size: 10pt">37 </span></td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: bottom"><span style="font-size: 10pt">Chief Financial Officer </span></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top"><span style="font-size: 10pt">Tamar Shoham </span></td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-size: 10pt">48 </span></td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: bottom"><span style="font-size: 10pt">Chief Technology Officer </span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top"><span style="font-size: 10pt">Dan Julius </span></td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-size: 10pt">46 </span></td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: bottom"><span style="font-size: 10pt">V.P. of Research and Development </span></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top"><span style="font-size: 10pt">Dani Megrelishvili </span></td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-size: 10pt">47 </span></td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: bottom"><span style="font-size: 10pt">Chief Product Officer </span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top"><span style="font-size: 10pt">Eliezer Lubitch </span></td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-size: 10pt">61 </span></td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: bottom"><span style="font-size: 10pt">President, Beamr, Inc. </span></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top"><span style="font-size: 10pt">Tal Barnoach (1) </span></td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-size: 10pt">59 </span></td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: bottom"><span style="font-size: 10pt">Director </span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top"><span style="font-size: 10pt">Lluis Pedragosa (1) </span></td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-size: 10pt">44 </span></td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: bottom"><span style="font-size: 10pt">Director </span></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top"><span style="font-size: 10pt">Yair Shoham (1)(2) </span></td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-size: 10pt">69 </span></td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: bottom"><span style="font-size: 10pt">Director </span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top"><span style="font-size: 10pt">Osnat Michaeli (1)(2) </span></td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-size: 10pt">54 </span></td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: bottom"><span style="font-size: 10pt">Director </span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 24px"><span style="font-size: 10pt">(1)</span></td>
    <td><span style="font-size: 10pt">Independent director (as defined under Nasdaq Stock Market Listing Rules).</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-size: 10pt">(2)</span></td>
    <td><span style="font-size: 10pt">External director (as defined under the Companies Law)</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><b>Sharon Carmel, Chief Executive Officer,
Director</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Sharon Carmel, </i>52,
serves as our Chief Executive Officer and as the Chairman of the board of directors since he founded our company in October 2009. Prior
to founding Beamr, Mr. Carmel is a serial entrepreneur with a proven track record in the software space. Prior to founding Beamr, in August
2002, Mr. Carmel co-founded, BeInSync, which developed P2P synchronization and online backup technologies. Prior to that, in January 1994,
Mr. Carmel co-founded Emblaze (LON: BLZ), a software company, which developed the Internet&#8217;s first vector-based graphics player.
Mr. Carmel received his training in computer science and software development during his mandatory military service in the IDF.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Danny Sandler, Chief Financial Officer</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Danny Sandler</i>, 37,
serves as our Chief Financial Officer since December 2021. Mr. Sandler joined us in May 2020, and prior to his current role, served as
our Director of Finance. Prior to joining us, between December 2014 and May 2020, Mr. Sandler served in various roles and, most recently
as Assurance Manager, in the Hi-Tech and Life Science Practice at EY, a global accounting and consulting firm. Prior to that, between
November 2011 and November 2014, Mr. Sandler was a finance associate at Seeking Alpha, a crowd-sourced content service for financial markets.
Mr. Sandler holds a Bachelor&#8217;s degree in Economics and Accounting from Bar-Ilan University.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 86; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->76<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Tamar Shoham, Chief Technology Officer</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Tamar Shoham</i>, 48, serves
as our Chief Technology Officer since November 2021. Mrs. Shoham is a leading imaging and video scientist, with over 20 years&#8217; experience
in algorithm development and industry-oriented research, primarily in the field of video quality and compression. Mrs. Shoham joined us
in August 2009, and prior to her current role, served as our Vice President of Technology where she led our algorithm and intellectual
property development. Prior to joining us, between 2006 and 2009, Mrs. Shoham was a research fellow at the NEGEV consortium, Signal and
Image Processing Lab at the Technion Institute of Technology. Prior to that, between 1997 and 2005, Mrs. Shoham served as a digital signal
processing algorithm developer at Comverse Ltd. Mrs. Shoham holds a Master&#8217;s degree in Electrical Engineering from the Technion
Institute of Technology and a Bachelor&#8217;s degree in Electrical Engineering from Tel Aviv University.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Dan Julius, V.P. of Research and Development</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Dan Julius</i>, 45, serves
as our Vice President of Research and Development. Mr. Julius brings more than two decades of experience in management and software development.
Mr. Julius joined us in March 2011, and prior to his current role served as a team lead for our system overseeing design, development,
and quality control. Prior to joining us, between February 2008 and May 2011, Mr. Julius was the co-founder and served as Chief Technology
Officer at Joliper Ltd. Prior to that, between February 2007 and February 2008, Mr. Julius served as a software developer and a team leader
at BeInSync Ltd., a software platform enabling users to backup, synchronize, share and access their files, documents and other data online.
Prior to that, between November 2001 and August 2004, Mr. Julius served as a CAD engineer at Intel. Between February 1999 and August 2001,
Mr. Julius served as a software developer and a team leader at TeleVend Inc. Mr. Julius holds a Master&#8217;s degree in Computer Science
from the University of British Columbia and a Bachelor&#8217;s degree in Computer Science from Tel Aviv University.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;<b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Dani Megrelishvili, Chief Product Officer</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Dani Megrelishvili</i>,
47, serves as our Chief Product Officer since December 2022. Mr. Megrelishvili&#8217;s previous roles with us were between November 2014
and November 2017, serving as Head of Product (JPEGmini business unit), and between February 2012 and November 2014, serving as Head of
User experience. Prior to rejoining us, between January 2022 and November 2022, Mr. Megrelishvili served as product manager at Lexense
Technologies Ltd., a legal-tech startup offering tools for handling and managing legal disputes. Prior to that, between June 2020 and
December 2021, Mr. Megrelishvili served as product manager at Wix.Com Ltd (NASDQ: WIX), a cloud-based web development services company.
Prior to that, between August 2018 and June 2020, Mr. Megrelishvili served as a consultant to several technology companies, including
ZOOZ Mobile Ltd., a payment processing platform (acquired by PayU in 2018) and Augmented Intelligence Inc., a startup that builds an AI
Assistant for a variety of use-cases.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Eliezer Lubitch, President, Beamr, Inc.</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Eliezer Lubitch</i>, 61,
serves as the President of our subsidiary, Beamr, Inc. since 2011. Mr. Lubitch heads our U.S. operations, including sales, business development,
new markets, and strategic partnerships. Prior to joining us, between 2008 and 2011, Mr. Lubitch served as Vice President of Business
Development and Brand Licensing at Eastman Kodak Company. Prior to that, between 2004 and 2007, Mr. Lubitch served as Vice President of
Business Development at Kodak Versamark Inc., a wholly owned subsidiary of Kodak. Between 1990 and 2003, Mr. Lubitch served in various
roles at Scitex Corporation, Ltd. (NASDAQ: SCIX), including Vice President of Business Development, Director of Business Development,
Product Line R&amp;D Manager, and software engineer. Mr. Lubitch was a seed investor in Tivella, Inc., a pioneering company of IPTV (acquired
by Cisco in 2007). Mr. Lubitch holds a Master&#8217;s degree in Business Administration from the Technion Institute of Technology, a Master&#8217;s
degree in Computer Science from Tel Aviv University, and a Bachelor&#8217;s degree in Mathematics and Computer Science from Hebrew University.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 87; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->77<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Tal Barnoach, Director</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Tal Barnoach</i>, 58, serves
as a board member in our company since January 2014. Mr. Barnoach is a general partner at Disruptive VC, a venture capital fund since
July 2014 Disruptive Opportunity Fund since 2018 and Disruptive AI since 2020. Besides his role as a general partner in Disruptive and
serving as a board member of Beamr, Mr. Barnoach serves as a board member in several other technological companies like Idomoo, Anodot,
Tailor Brands, Bit, Lumen, Deep, Replix, Qwilt, Minta and more. Over the last 20 years, Mr. Barnoach has founded and led companies such
as S.E.A. Multimedia (which went public in 1996), Orca Interactive (acquired by France Telecom in 2008), BeInsync (acquired by Phoenix
Technologies in 2008) and Dotomi (acquired by ValueClick in 2011). Mr. Barnoach holds a B.A. degree in economics from Tel Aviv University.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Lluis Pedragosa, Director</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Liuis Pedragosa, </i>43<i>,
</i>serves as a board member in our company since August 2016, and was appointed by our shareholder, Marker LLC. Since May 2018, Mr. Pedragosa
is a managing partner and the Chief Financial Officer of Team8, a cybersecurity and fintech company creation platform and a venture capital
fund. Prior to that, between December 2012 and April 2018, Mr. Pedragosa was a partner and founding team member at Marker LLC, a venture
capital firm with over $400 million under management. Besides his role in Team8 and serving as a board member of Beamr, Mr. Pedragosa
serves as a board member in Screenz, and as a board observer in Overwolf Ltd. Mr. Pedragosa holds a Master&#8217;s degree in Business
Administration from The Wharton School of the University of Pennsylvania, a Master&#8217;s degree in International Studies from the University
of Pennsylvania, and a Bachelor&#8217;s of science in Business Administration from ESADE Business School.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Yair Shoham, Director</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Yair Shoham</i>, 68, serves
as a board member in our company since March 2023. Mr. Shoham brings more than two decades of global experience in venture capital and
is a serial entrepreneur with a track record in the software and hardware spaces. Prior to joining us, between 2018 and December 2021,
Mr. Shoham served as Managing Director and Israel Country Manager at Intel Capital, the venture arm of Intel Corporation. Prior to this
role, between July 2012 and 2018, he served as Investment Director at Intel Capital. Prior to that, between 1999 and 2012, Mr. Shoham
served as General Partner at Genesis Partners, a leading early stage Israel-based venture capital firm. During his career, Mr. Shoham
has founded and led several companies such as VDOnet Corp. (acquired by Citrix Systems, Inc.), Butterfly VLSI Ltd. (acquired by Texas
Instruments Incorporated), and RFWaves Ltd. (acquired by Vishay Intertechnology Inc.). Between 1995 and 2006, Mr. Shoham served as an
independent board member at M-Systems Ltd., until the company was acquired by SanDisk Corporation. Mr. Shoham holds a Juris Doctor degree
from Loyola University School of Law and a Bachelor&#8217;s degree in psychology from the University of Haifa.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Osnat Michaeli, Director</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Osnat Michaeli</i>, 53,
serves as a board member in our company since March 2023. Ms. Michaeli brings more than two decades of global experience in finance and
operations. Prior to joining us, between May 2019 and August 2021, Ms. Michaeli served as Chief Financial Officer at Twine Solutions Ltd,
a leading digital thread-dyeing technology company. Between March 2017 and May 2019, Ms. Michaeli served as Chief Financial Officer at
Cardo Systems Ltd., a leading company for Bluetooth&#174; and Dynamic Mesh Communication, and entertainment systems for motorcycle riders.
Prior to that, between March 2011 and August 2015, Ms. Michaeli served as Chief Financial Officer at Kornit Digital Ltd., an international
manufacturing company, which produces high-speed industrial inkjet printers, pigmented ink, and chemical products, where she held a key
role in leading the company to its Initial Public Offering in, 2015 (NASDAQ: KRNT). Ms. Michaeli holds a Bachelor&#8217;s degree in economics
and a Master&#8217;s degree in Business Administration, both from Tel Aviv University.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 88; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->78<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><div><a id="a_026"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.3pt"><b>B. Compensation</b>&#160;&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The aggregate compensation we paid to our executive officers and directors
for the year ended December 31, 2022, was approximately $1,025,749. This amount includes approximately $79,701 paid, set aside or accrued
to provide pension, severance, retirement or similar benefits or expenses and $96,897 share based compensation expenses, but does not
include business travel, professional and business association dues and expenses reimbursed to office holders, and other benefits commonly
reimbursed or paid by companies in our industry. As of December 31, 2022, options to purchase 826,234 ordinary shares granted to our officers
and directors were outstanding under our share option plan at a weighted average exercise price of $1.65 per share.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In accordance with the Companies
Law, the table below reflects the compensation granted to our five most highly compensated officers during or with respect to the year
ended December 31, 2022. For purposes of the table and the summary below, &#8220;compensation&#8221; includes base salary, bonuses, equity-based
compensation, retirement or termination payments, benefits and perquisites such as car, phone and social benefits and any undertaking
to provide such compensation.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; text-align: left; font-weight: bold">Name and Principal Position</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Salary<sup>
    (1)</sup></b></span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Bonus</b>&#160;<b><sup>(2)</sup></b></span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Equity-Based
Compensation&#160;<sup>(3)</sup></b></span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Other Compensation</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Total</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="18" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">(USD in thousands)</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: left">Sharon Carmel, CEO</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">161</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">-</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">--</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">161</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Danny Sandler, CFO</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">159</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">18</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">--</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">177</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Eliezer Lubitch, US President</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">241</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">26</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">--</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">267</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Tamar Shoham, CTO</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">164</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">19</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">--</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">183</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Dan Julius, VP R&amp;D</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">189</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">21</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">--</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">210</td><td style="text-align: left">&#160;</td></tr>
  </table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 24px"><span style="font-size: 10pt">(1)</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Salary includes the officer&#8217;s gross salary plus payment by us of social benefits on behalf of the officer. Such benefits may include payments, contributions and/or allocations for savings funds (e.g., Managers&#8217; Life Insurance Policy), pension, severance, risk insurance (e.g., life, or work disability insurance), payments for social security and tax gross-up payments, vacation, medical insurance and benefits, convalescence or recreation pay and other benefits and perquisites consistent with our policies.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 24px"><span style="font-size: 10pt">(2)</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Represents annual bonuses granted to the officer based on formulas set forth in the respective resolutions of our Compensation Committee and Board of Directors with respect to 2022.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 24px"><span style="font-size: 10pt">(3)</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Represents the equity-based compensation expenses recorded in our financial statements for the year ended December&#160;31, 2022, based on the securities&#8217; fair value on the grant date, calculated in accordance with applicable accounting guidance for equity-based compensation. For a discussion of the assumptions used in reaching this valuation, see Note&#160;12 to our financial statements included in this Annual Report.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">For
so long as we are a foreign private issuer, we will not be required to comply with the proxy rules applicable to U.S. domestic companies
regarding disclosure of the compensation of certain executive officers on an individual basis. Pursuant to the Companies Law, we are required
to disclose the annual compensation of our five most highly compensated officers on an individual basis. This disclosure will not be as
extensive as that required of a U.S. domestic issuer. We intend to commence providing such disclosure, at the latest, in the annual proxy
statement for our first annual meeting of shareholders, which will be filed under cover of a report on Form 6-K.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b><i>Employment Agreements
with Executive Officers</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have entered into written
employment or consulting agreements with each of our executive officers. All of these agreements contain customary provisions regarding
noncompetition, confidentiality of information and assignment of inventions. However, the enforceability of the noncompetition provisions
may be limited under applicable law. In addition, we intend to enter into indemnification agreements, subject to the listing of our securities
on the Nasdaq Capital Market, with each executive officer, director, and director nominee pursuant to which we will indemnify each of
them up to a certain amount and to the extent that these liabilities are not covered by directors and officers insurance.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">For
a description of the terms of our options and option plans, see &#8220;Item 6.E Directors, Senior Management and Employees&#8212;Share
Ownership&#8212;Share Option Plans<span style="font-variant: small-caps">&#8221;&#160;</span>below.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b><i>Directors&#8217;
Service Contracts</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Other than with respect to
our directors that are also executive officers, we do not have written agreements with any director providing for benefits upon the termination
of his employment with our company.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Non-Executive Board Engagement Terms</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">During
the term of office as a director, each non-executive director shall be entitled to receive an annual remuneration payment of $20,000 per
full year (payable in four (4) equal payments, one for each calendar quarter ending on March 31, June 30, September 30 and December 31
of each year), or a pro rata thereof. In addition, each non-executive director shall also be entitled to receive a payment of $750.00
for each face-to-face or zoom meeting of the board of directors or a committee thereof, and a payment of $500.00 for each written resolution
of the board of birectors or a committee thereof.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="margin: 0"></p><div>

</div><!-- Field: Page; Sequence: 89; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->79<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="margin: 0">&#160;</p><div>

</div><div><a id="a_027"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.3pt"><b>C. Board Practices</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Introduction</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our board of directors consists
of five&#160;members. We believe that Tal Barnoach, Lluis Pedragosa, Yair Shoham and Osnat Michaeli are &#8220;independent&#8221; for
purposes of the Nasdaq Stock Market rules. Our amended and restated articles of association provide that the number of board of directors&#8217;
members shall be set by the general meeting of the shareholders provided that it will consist of not less than five and not more than
ten. Pursuant to the Companies Law, the management of our business is vested in our board of directors. Our board of directors may exercise
all powers and may take all actions that are not specifically granted to our shareholders or to management. Our executive officers are
responsible for our day-to-day management and have individual responsibilities established by our board of directors. Our Chief Executive
Officer is appointed by, and serves at the discretion of, our board of directors, subject to the service agreement that we have entered
into with him. All other executive officers are appointed by our Chief Executive Officer. Their terms of employment are subject to the
approval of the board of directors, and are subject to the terms of any applicable employment agreements that we may enter into with them.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Each director, except external
directors that may be required to be appointed under the Companies Law under certain circumstances, will hold office pursuant to the Companies
Law, until the next annual general meeting of our shareholders following his or her appointment, or until he or she resigns or unless
he or she is removed by a majority vote of our shareholders at a general meeting of our shareholders or upon the occurrence of certain
events, in accordance with the Companies Law and our amended and restated articles of association.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, if a director&#8217;s
office becomes vacant, the remaining serving directors may continue to act in any manner, provided that their number is of the minimal
number specified in our amended and restated articles of association. If the number of serving directors is lower than such minimum number,
then our board of directors may only act in an emergency or to fill the office of director which has become vacant up to a number equal
to the minimum number provided for pursuant to our amended and restated articles of association, or in order to call a general meeting
of our shareholders for the purpose of electing directors to fill any of our vacancies . External directors may be elected for up to two
additional three-year terms after their initial three-year term under the circumstances described below, with certain exceptions as described
in &#8220;External Directors&#8221; below. External directors may be removed from office only under the limited circumstances set forth
in the Companies Law.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Under the Companies Law, any
shareholder holding at least one percent of our outstanding voting power may nominate a director. However, any such shareholder may make
such a nomination only if a written notice of such shareholder&#8217;s intent to make such nomination has been given to our board of directors.
Any such notice must include certain information, including the consent of the proposed director nominee to serve as our director if elected,
and a declaration that the nominee signed declaring that he or she possesses the requisite skills and has the availability to carry out
his or her duties. Additionally, the nominee must provide details of such skills, and demonstrate an absence of any limitation under the
Companies Law that may prevent his or her election, and affirm that all of the required election-information is provided to us, pursuant
to the Companies Law.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Under the Companies Law, our
board of directors must determine the minimum number of directors who are required to have accounting and financial expertise. In determining
the number of directors required to have such expertise, our board of directors must consider, among other things, the type and size of
the company and the scope and complexity of its operations. Our board of directors has determined that the minimum number of directors
of our company who are required to have accounting and financial expertise is two.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The board of directors must
elect one director to serve as the chairman of the board of directors to preside at the meetings of the board of directors, and may also
remove that director as chairman. Pursuant to the Companies Law, neither the chief executive officer nor any of his or her relatives is
permitted to serve as the chairman of the board of directors, and a company may not vest the chairman or any of his or her relatives with
the chief executive officer&#8217;s authorities. In addition, a person who reports, directly or indirectly, to the chief executive officer
may not serve as the chairman of the board of directors; the chairman may not be vested with authorities of a person who reports, directly
or indirectly, to the chief executive officer; and the chairman may not serve in any other position in the company or a controlled company,
but he or she may serve as a director or chairman of a controlled company. However, the Companies Law permits a company&#8217;s shareholders
to determine, for a period not exceeding three years from each such determination, that the chairman or his or her relative may serve
as chief executive officer or be vested with the chief executive officer&#8217;s authorities, and that the chief executive officer or
his or her relative may serve as chairman or be vested with the chairman&#8217;s authorities. Such determination of a company&#8217;s
shareholders requires either: (1) the approval of at least a majority of the shares of those shareholders present and voting on the matter
(other than controlling shareholders and those having a personal interest in the determination) (shares held by abstaining shareholders
shall not be considered); or (2) that the total number of shares opposing such determination does not exceed 2% of the total voting power
in the company.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 90; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->80<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The board of directors may,
subject to the provisions of the Companies Law, delegate any or all of its powers to committees of the board, and it may, from time to
time, revoke such delegation or alter the composition of any such committees, subject to certain limitations. Unless otherwise expressly
provided by the board of directors, the committees shall not be empowered to further delegate such powers. The composition and duties
of our audit committee, financial statement examination committee and compensation committee that will be established upon the listing
of our ordinary shares on the Nasdaq Capital Market, are described below.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The board of directors oversees
how management monitors compliance with our risk management policies and procedures, and reviews the adequacy of the risk management framework
in relation to the risks faced by us. The board of directors is assisted in its oversight role by an internal auditor. The internal auditor
undertakes both regular and ad hoc reviews of risk management controls and procedures, the results of which will be reported to our audit
committee.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><b>DIVERSITY OF THE BOARD
OF DIRECTORS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><b>Board Diversity Matrix
(As of April 15, 2023)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><b>&#160;</b></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Country of Principal Executive Offices</td><td>&#160;</td>
    <td style="text-align: center">Israel</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Foreign Private Issuer</td><td>&#160;</td>
    <td style="text-align: center">Yes</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Disclosure Prohibited under Home Country Law</td><td>&#160;</td>
    <td style="text-align: center">No</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 88%; text-align: left">Total Number of Directors</td><td style="width: 1%">&#160;</td>
    <td style="width: 11%; text-align: center">5</td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; border-bottom: Black 1.5pt solid">Part I: Gender Identity</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Female</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Male</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Non-<br/> Binary</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Did Not<br/> Disclose</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Gender</b></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%">Directors</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">0</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">3</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">0</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">2</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Part II: Demographic Background</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8195;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Underrepresented Individual in Home Country Jurisdiction</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>LGBTQ+</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Did Not Disclose Demographic Background</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  </table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>External Directors</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Under
the Companies Law, companies incorporated under the laws of the State of Israel that are publicly traded, including Israeli companies
with shares listed on the Nasdaq, are required to appoint at least two external directors who meet the qualification requirements set
forth in the Companies Law. The definitions of an external director under the Companies Law and independent director under Nasdaq Stock
Market rules are similar such that it would generally be expected that our two external directors will also comply with the independence
requirement under Nasdaq Stock Market rules.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">A
person may not be appointed as an external director if the person is a relative of a controlling shareholder or if on the date of the
person&#8217;s appointment or within the preceding two years the person or his or her relatives, partners, employers or anyone to whom
that person is subordinate, whether directly or indirectly, or entities under the person&#8217;s control have or had any affiliation with
any of the following, or an affiliated entity: (1)&#160;us; (2)&#160;any person or entity controlling us on the date of such appointment;
(3)&#160;any relative of a controlling shareholder; or (4)&#160;any entity controlled, on the date of such appointment or within the preceding
two years, by us or by a controlling shareholder. If there is no controlling shareholder or any shareholder holding 25% or more of voting
rights in the company, a person may not be appointed as an external director if the person has any affiliation to the chairman of the
board of directors, the chief executive officer (referred to in the Companies Law as a general manager), any shareholder holding 5% or
more of the company&#8217;s shares or voting rights or the senior financial officer as of the date of the person&#8217;s appointment.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><b><i>&#160;</i></b>&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"></p><div>

</div><!-- Field: Page; Sequence: 91; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->81<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The
term &#8220;controlling shareholder&#8221; means a shareholder with the ability to direct the activities of the company, other than by
virtue of being an office holder. A shareholder is presumed to have &#8220;control&#8221; of the company and thus to be a controlling
shareholder of the company if the shareholder holds 50% or more of the &#8220;means of control&#8221; of the company. &#8220;Means of
control&#8221; is defined as (1)&#160;the right to vote at a general meeting of a company or a corresponding body of another corporation;
or (2)&#160;the right to appoint directors of the corporation or its general manager. For the purpose of approving related-party transactions,
the term also includes any shareholder that holds 25% or more of the voting rights of the company if the company has no shareholder that
owns more than 50% of its voting rights. For the purpose of determining the holding percentage stated above, two or more shareholders
who have a personal interest in a transaction that is brought for the company&#8217;s approval are deemed as joint holders.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The
term affiliation includes:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">an employment relationship;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">a business or professional relationship maintained on a regular basis;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">control; and</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">service as an office holder, excluding service as a director in a private company prior to the first offering of its shares to the public if such director was appointed as a director of the private company in order to serve as an external director following the initial public offering.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The
term &#8220;relative&#8221; is defined as a spouse, sibling, parent, grandparent, descendant, spouse&#8217;s descendant, sibling and parent
and the spouse of each of the foregoing.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The
term &#8220;office holder&#8221; is defined as a general manager, chief business manager, deputy general manager, vice general manager,
director or manager directly subordinate to the general manager or any other person assuming the responsibilities of any of the foregoing
positions, without regard to such person&#8217;s title.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">A
person may not serve as an external director if that person or that person&#8217;s relative, partner, employer, a person to whom such
person is subordinate (directly or indirectly) or any entity under the person&#8217;s control has a business or professional relationship
with any entity that has an affiliation with any affiliated entity, even if such relationship is intermittent (excluding insignificant
relationships). Additionally, any person who has received compensation intermittently (excluding insignificant relationships) other than
compensation permitted under the Companies Law may not continue to serve as an external director.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">No
person can serve as an external director if the person&#8217;s position or other affairs create, or may create, a conflict of interest
with the person&#8217;s responsibilities as a director or may otherwise interfere with the person&#8217;s ability to serve as a director
or if such a person is an employee of the Israeli Securities Authority or of an Israeli stock exchange. If at the time an external director
is appointed all current members of the board of directors, who are not controlling shareholders or relatives of controlling shareholders,
are of the same gender, then the external director to be appointed must be of the other gender. In addition, a person who is a director
of a company may not be elected as an external director of another company.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">According
to regulations promulgated under the Companies law, at least one of the external directors is required to have &#8220;financial and accounting
expertise,&#8221; unless another member of the audit committee, who is an independent director under the Nasdaq Stock Market rules, has
&#8220;financial and accounting expertise,&#8221; and the other external director or directors are required to have &#8220;professional
expertise.&#8221; An external director may not be appointed to an additional term unless: (1)&#160;such director has &#8220;accounting
and financial expertise;&#8221; or (2)&#160;he or she has &#8220;professional expertise,&#8221; and on the date of appointment for another
term there is another external director who has &#8220;accounting and financial expertise&#8221; and the number of &#8220;accounting and
financial experts&#8221; on the board of directors is at least equal to the minimum number determined appropriate by the board of directors.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt"></p><div>

</div><!-- Field: Page; Sequence: 92; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->82<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The
regulations promulgated under the Companies Law define an external director with requisite professional qualifications as a director who
satisfies one of the following requirements: (1)&#160;the director holds an academic degree in either economics, business administration,
accounting, law or public administration, (2)&#160;the director either holds an academic degree in any other field or has completed another
form of higher education in the company&#8217;s primary field of business or in an area which is relevant to his or her office as an external
director in the company, or (3)&#160;the director has at least five years of experience serving in any one of the following, or at least
five years of cumulative experience serving in two or more of the following capacities: (a)&#160;a senior business management position
in a company with a substantial scope of business, (b)&#160;a senior position in the company&#8217;s primary field of business or (c)&#160;a
senior position in public administration.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Until
the lapse of a two-year period from the date that an external director of a company ceases to act in such capacity, the company in which
such external director served, and its controlling shareholder or any entity under control of such controlling shareholder may not, directly
or indirectly, grant such former external director, or his or her spouse or child, any benefit, including by way of (i)&#160;the appointment
of such former director or his or her spouse or his child as an officer in the company or in an entity controlled by the company&#8217;s
controlling shareholder, (ii)&#160;the employment of such former director, and (iii)&#160;the engagement, directly or indirectly, of such
former director as a provider of professional services for compensation, directly or indirectly, including via an entity under his or
her control. With respect to a relative who is not a spouse or a child, such limitations only apply for one year from the date such external
director ceased to be engaged in such capacity.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The
provisions of the Companies Law set forth special approval requirements for the election of external directors. External directors must
be elected by a majority vote of the shares present and voting at a shareholders meeting, provided that either:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">such majority includes at least a majority of the shares held by shareholders who are non-controlling shareholders and do not have a personal interest in the election of the external director (other than a personal interest not deriving from a relationship with a controlling shareholder) that are voted at the meeting, excluding abstentions, to which we refer as a disinterested majority; or</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">the total number of shares voted by non-controlling shareholders and by shareholders who do not have a personal interest in the election of the external director, against the election of the external director, does not exceed 2% of the aggregate voting rights in the company.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The
initial term of an external director is three years. Thereafter, an external director may be reelected by shareholders to serve in that
capacity for up to two additional three-year terms, provided that:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">his or her service for each such additional term is recommended by one or more shareholders holding at least 1% of the company&#8217;s voting rights and is approved at a shareholders meeting by a disinterested majority, where the total number of shares held by non-controlling, disinterested shareholders voting for such reelection exceeds 2% of the aggregate voting rights in the company. In such event, the external director so reappointed may not be a Related or Competing Shareholder, as defined below, or a relative of such shareholder, at the time of the appointment, and is not and has not had any affiliation with a Related or Competing Shareholder, at such time or during the two years preceding such person&#8217;s reappointment to serve an additional term as external director. The term &#8220;Related or Competing Shareholder&#8221; means a shareholder proposing the reappointment or a shareholder holding 5% or more of the outstanding shares or voting rights of the company, provided, that at the time of the reappointment, such shareholder, the controlling shareholder of such shareholder, or a company controlled by such shareholder, have a business relationship with the company or are competitors of the company;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">the external director proposed his or her own nomination, and such nomination was approved in accordance with the requirements described above;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">his or her service for each such additional term is recommended by the board of directors and is approved at a shareholders meeting by the same majority required for the initial election of an external director (as described above).</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt"></p><div>

</div><!-- Field: Page; Sequence: 93; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->83<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The
term of office for external directors for Israeli companies traded on certain foreign stock exchanges, including the Nasdaq Marketplace
Rules, may be extended indefinitely in increments of additional three-year terms, in each case provided that the audit committee and the
board of directors of the company confirm that, in light of the external director&#8217;s expertise and special contribution to the work
of the board of directors and its committees, the reelection for such additional period(s) is beneficial to the company, and provided
that the external director is reelected subject to the same shareholder vote requirements as if elected for the first time (as described
above).</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">External
directors may be removed from office by a special general meeting of shareholders called by the board of directors, which approves such
dismissal by the same shareholder vote percentage required for their election, after receiving the board of directors arguments for such
removal, or by a court, in each case, only under limited circumstances, including ceasing to meet the statutory qualifications for appointment,
or violating their duty of loyalty to the company. If an external directorship becomes vacant and there are fewer than two external directors
on the board of directors at the time, then the board of directors is required under the Companies Law to call a shareholders meeting
as soon as practicable to appoint a replacement external director.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Each
committee of the board of directors that is authorized to exercise the powers of the board of directors must include at least one external
director, except that the audit committee and the compensation committee must include all external directors then serving on the board
of directors.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">External
directors may be compensated only in accordance with regulations adopted under the Companies Law.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">&#160;<b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Alternate Directors</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Our
amended and restated articles of association provide, as allowed by the Companies Law, that any director may, subject to the conditions
set thereto, appoint a person as an alternate to act in his place, to remove the alternate and appoint another in his place and to appoint
an alternate in place of an alternate whose office is vacated for any reason whatsoever. Under the Companies Law, a person who is not
qualified to be appointed as a director, a person who is already serving as a director or a person who is already serving as an alternate
director for another director, may not be appointed as an alternate director. Nevertheless, a director who is already serving as a director
may be appointed as an alternate director for a member of a committee of the board of directors so long as he or she is not already serving
as a member of such committee, and if the alternate director is to replace an external director, he or she is required to be an external
director and to have either &#8220;financial and accounting expertise&#8221; or &#8220;professional expertise,&#8221; depending on the
qualifications of the external director he or she is replacing. A person who does not have the requisite &#8220;financial and accounting
experience&#8221; or the &#8220;professional expertise,&#8221; depending on the qualifications of the external director he or she is replacing,
may not be appointed as an alternate director for an external director. A person who is not qualified to be appointed as an independent
director, pursuant to the Companies Law, may not be appointed as an alternate director of an independent director qualified as such under
the Companies Law. Unless the appointing director limits the time or scope of the appointment, the appointment is effective for all purposes
until the appointing director ceases to be a director or terminates the appointment.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Committees of the Board of Directors</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our board of directors has
established two standing committees, the audit committee and the compensation committee.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Audit Committee</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Under the Companies Law, we
are required to appoint an audit committee subject to the listing of our ordinary shares on the Nasdaq Capital Market. The audit committee
must be comprised of at least three directors, including all of the external directors, if applicable, (one of whom must serve as chair
of the committee). The audit committee may not include the chairman of the board; a controlling shareholder of the company or a relative
of a controlling shareholder; a director employed by or providing services on a regular basis to the company, to a controlling shareholder
or to an entity controlled by a controlling shareholder; or a director who derives most of his or her income from a controlling shareholder.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 94; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->84<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our audit committee is comprised
of Lluis Pedragosa, Yair Shoham and Osnat Michaeli.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Under the Companies Law, our
audit committee is responsible for:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px; text-align: justify">&#160;</td>
    <td style="width: 24px; text-align: justify"><span style="font-size: 10pt">(i)</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">determining whether there are deficiencies in the business management practices of our company, and making recommendations to the board of directors to improve such practices;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt">(ii)</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">determining whether to approve certain related party transactions (including transactions in which an office holder has a personal interest and whether such transaction is extraordinary or material under Companies Law) and establishing the approval process for certain transactions with a controlling shareholder or in which a controlling shareholder has a personal interest (see &#8220;Item 6.C Directors, Senior Management and Employees&#8212;Board Practices&#8212;Approval of Related Party Transactions under Israeli Law&#8221;);</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt">(iii)</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">determining the approval process for transactions that are &#8220;non-negligible&#8221; (i.e., transactions with a controlling shareholder that are classified by the audit committee as non-negligible, even though they are not deemed extraordinary transactions), as well as determining which types of transactions would require the approval of the audit committee, optionally based on criteria which may be determined annually in advance by the audit committee;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt">(iv)</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">examining our internal controls and internal auditor&#8217;s performance, including whether the internal auditor has sufficient resources and tools to dispose of its responsibilities;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px; text-align: justify">&#160;</td>
    <td style="width: 24px; text-align: justify"><span style="font-size: 10pt">(v)</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">examining the scope of our auditor&#8217;s work and compensation and submitting a recommendation with respect thereto to our board of directors or shareholders, depending on which of them is considering the appointment of our auditor;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt">(vi)</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">establishing procedures for the handling of employees&#8217; complaints as to deficiencies in the management of our business and the protection to be provided to such employees; and</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt">(vii)</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">where the board of directors approves the working plan of the internal auditor, examining such working plan before its submission to the board of directors and proposing amendments thereto.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the Companies
Law, our audit committee may not conduct any discussions or approve any actions requiring its approval (see &#8220;Item 6.C Directors,
Senior Management and Employees&#8212;Board Practices&#8212;Approval of Related Party Transactions under Israeli Law&#8221;), unless at
the time of the approval a majority of the committee&#8217;s members are present.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our board of directors intends
to adopt an audit committee charter to be effective upon the listing of our ordinary shares on the Nasdaq Capital Market setting forth,
among others, the responsibilities of the audit committee consistent with the rules of the SEC and Nasdaq Listing Rules (in addition to
the requirements for such committee under the Companies Law), including, among others, the following:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px; text-align: justify">&#160;</td>
    <td style="width: 24px; text-align: justify"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">oversight of our independent registered public accounting firm and recommending the engagement, compensation or termination of engagement of our independent registered public accounting firm to the board of directors in accordance with Israeli law;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">recommending the engagement or termination of the person filling the office of our internal auditor, reviewing the services provided by our internal auditor and reviewing effectiveness of our system of internal control over financial reporting;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">recommending the terms of audit and non-audit services provided by the independent registered public accounting firm for pre-approval by our board of directors; and</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">reviewing and monitoring, if applicable, legal matters with significant impact, finding of regulatory authorities&#8217; findings, receive reports regarding irregularities and legal compliance, acting according to &#8220;whistleblower policy&#8221; and recommend to our board of directors if so required.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 95; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->85<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Nasdaq Stock Market Requirements for Audit
Committee</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Under the Nasdaq Stock Market
rules, we are required to maintain an audit committee consisting of at least three members, all of whom are independent and are financially
literate and one of whom has accounting or related financial management expertise.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As noted above, the members
of our audit committee include&#160;Lluis Pedragosa, Yair Shoham and Osnat Michaeli. Osnat Michaeli&#160; serves as the chairman of our
audit committee. All members of our audit committee will meet the requirements for financial literacy under the Nasdaq Stock Market rules.
Our board of directors has determined that each member of our audit committee will be an audit committee financial expert as defined by
the SEC rules and has the requisite financial experience as defined by the Nasdaq Stock Market rules.&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Under the Companies Law, our
audit committee will also carry out the duties of a financial statement examination committee. As such, the audit committee will be responsible
for: (i) estimations and assessments made in connection with the preparation of financial statements; (ii) internal controls related to
the financial statements; (iii) completeness and propriety of the disclosure in the financial statements; (iv) the accounting policies
adopted and the accounting treatments implemented in material matters of the company; and (v) value evaluations, including the assumptions
and assessments on which evaluations are based and the supporting data in the financial statements.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Compensation Committee</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Under the Companies Law, the
board of directors of any public company must establish a compensation committee. The compensation committee must be comprised of at least
three directors, including all of the external directors (if any). The compensation committee is subject to the same Companies Law restrictions
as the audit committee as to: (a) who may not be a member of the committee; and (b)&#160;who may not be present during committee deliberations
as described above.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our compensation committee,
acting pursuant to a written charter, is comprised of Tal Barnoach, Yair Shoham and Osnat Michaeli. Our compensation committee complies
with the provisions of the Companies Law, the regulations promulgated thereunder on all aspects referring to its independence, authorities
and practice. Our compensation committee follows home country practice as opposed to complying with the compensation committee membership
and charter requirements prescribed under the Nasdaq Stock Market rules.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our compensation committee
will review and recommend to our board of directors: with respect to our executive officers&#8217; and directors&#8217;: (1) annual base
compensation (2) annual incentive bonus, including the specific goals and amounts; (3) equity compensation; (4) employment agreements,
severance arrangements, and change in control agreements and provisions; (5) retirement grants and/or retirement bonuses; and (6) any
other benefits, compensation, compensation policies or arrangements.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The duties of the compensation
committee include the recommendation to the company&#8217;s board of directors of a policy regarding the terms of engagement of office
holders, to which we refer as a compensation policy. Such policy must be adopted by the company&#8217;s board of directors, after considering
the recommendations of the compensation committee. The compensation policy is then brought for approval by our shareholders, which requires
a special majority (see &#8220;Item 6.C Directors, Senior Management and Employees&#8212;Board Practices&#8212;Approval of Related Party
Transactions under Israeli Law&#8221;). Under the Companies Law, the board of directors may adopt the compensation policy if it is not
approved by the shareholders, provided that after the shareholders oppose the approval of such policy, the compensation committee and
the board of directors revisit the matter and determine that adopting the compensation policy would be in the best interests of the company.
Under the Companies Law, we are required to adopt an office holder compensation policy by November 27, 2023, which is 9 months from the
date of our initial public offering.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 96; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->86<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The compensation policy must
serve as the basis for decisions concerning the financial terms of employment or engagement of executive officers and directors, including
exculpation, insurance, indemnification or any monetary payment or obligation of payment in respect of employment or engagement. The compensation
policy must relate to certain factors, including advancement of the company&#8217;s objectives, the company&#8217;s business and its long-term
strategy, and creation of appropriate incentives for executives. It must also consider, among other things, the company&#8217;s risk management,
size and the nature of its operations. The compensation policy must furthermore consider the following additional factors:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px; text-align: justify">&#160;</td>
    <td style="width: 24px; text-align: justify"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">the education, skills, expertise and accomplishments of the relevant director or executive;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">the director&#8217;s or executive&#8217;s roles and responsibilities and prior compensation agreements with him or her;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">the relationship between the cost of the terms of service of an office holder and the average median compensation of the other employees of the company (including those employed through manpower companies), including the impact of disparities in salary upon work relationships in the company;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">the possibility of reducing variable compensation at the discretion of the board of directors; and the possibility of setting a limit on the exercise value of non-cash variable compensation; and</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">as to severance compensation, the period of service of the director or executive, the terms of his or her compensation during such service period, the company&#8217;s performance during that period of service, the person&#8217;s contribution towards the company&#8217;s achievement of its goals and the maximization of its profits, and the circumstances under which the person is leaving the company.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The compensation policy must
also include the following principles:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px; text-align: justify">&#160;</td>
    <td style="width: 24px; text-align: justify"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">with the exception of office holders who report directly to the chief executive officer, the link between variable compensation and long-term performance and measurable criteria;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">the relationship between variable and fixed compensation, and the ceiling for the value of variable compensation at the time of its grant;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">the conditions under which a director or executive would be required to repay compensation paid to him or her if it was later shown that the data upon which such compensation was based was inaccurate and was required to be restated in the company&#8217;s financial statements;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">the minimum holding or vesting period for variable, equity-based compensation; and</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">maximum limits for severance compensation.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The compensation policy must
also consider appropriate incentives from a long-term perspective.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The compensation committee
will be responsible for: (1) recommending the compensation policy to a company&#8217;s board of directors for its approval (and subsequent
approval by the shareholders); and (2) duties related to the compensation policy and to the compensation of a company&#8217;s office holders,
including:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px; text-align: justify">&#160;</td>
    <td style="width: 24px; text-align: justify"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">recommending whether a compensation policy should continue in effect, if the then-current policy has a term of greater than three years (approval of either a new compensation policy or the continuation of an existing compensation policy must in any case occur every three years);</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">recommending to the board of directors periodic updates to the compensation policy;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">assessing implementation of the compensation policy;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">determining whether the terms of compensation of certain office holders of the company need not be brought to approval of the shareholders; and</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">determining whether to approve the terms of compensation of office holders that require the committee&#8217;s approval.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 97; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->87<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our compensation policy will
be designed to promote our long-term goals, work plan and policy, retain, motivate and incentivize our directors and executive officers,
while considering the risks that our activities involve, our size, the nature and scope of our activities and the contribution of an officer
to the achievement of our goals and maximization of profits, and align the interests of our directors and executive officers with our
long-term performance. To that end, a portion of an executive officer compensation package is targeted to reflect our short and long-term
goals, as well as the executive officer&#8217;s individual performance. On the other hand, our compensation policy will include measures
designed to reduce the executive officer&#8217;s incentives to take excessive risks that may harm us in the long-term, such as limits
on the value of cash bonuses and equity-based compensation, limitations on the ratio between the variable and the total compensation of
an executive officer and minimum vesting periods for equity-based compensation.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our compensation policy will
also address our executive officer&#8217;s individual characteristics (such as his or her respective position, education, scope of responsibilities
and contribution to the attainment of our goals) as the basis for compensation variation among our executive officers, and considers the
internal ratios between compensation of our executive officers and directors and other employees. For example, the compensation that may
be granted to an executive officer may include: base salary, annual bonuses, equity-based compensation, benefits and retirement and termination
of service arrangements. All cash bonuses are limited to a maximum amount linked to the executive officer&#8217;s base salary. In addition,
our compensation policy will provide for maximum permitted ratios between the total variable (cash bonuses and equity-based compensation)
and non-variable (base salary) compensation components, in accordance with an officer&#8217;s respective position with the company.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">An annual cash bonus may be
awarded to executive officers upon the attainment of pre-set periodic objectives and individual targets. The annual cash bonus that may
be granted to executive officers other than our chairman or Chief Executive Officer may be based entirely on a discretionary evaluation.
Our Chief Executive Officer will be entitled to recommend performance objectives to such executive officers, and such performance objectives
will be approved by our compensation committee (and, if required by law, by our board of directors).</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The performance measurable
objectives of our chairman and Chief Executive Officer will be determined annually by our compensation committee and board of directors.
A less significant portion of the chairman&#8217;s and/or the Chief Executive Officer&#8217;s annual cash bonus may be based on a discretionary
evaluation of the chairman&#8217;s or the Chief Executive Officer&#8217;s respective overall performance by the compensation committee
and the board of directors based on quantitative and qualitative criteria.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The equity-based compensation
under our compensation policy for our executive officers (including members of our board of directors) will be designed in a manner consistent
with the underlying objectives in determining the base salary and the annual cash bonus, with its main objectives being to enhance the
alignment between the executive officers&#8217; interests with our long-term interests and those of our shareholders and to strengthen
the retention and the motivation of executive officers in the long term. Our compensation policy will provide for executive officer compensation
in the form of share options or other equity-based awards, such as restricted shares and phantom, options, in accordance with our equity
incentive plan then in place. Share options granted to executive officers shall be subject to vesting periods in order to promote long-term
retention of the awarded executive officers. The equity-based compensation shall be granted from time to time and be individually determined
and awarded according to the performance, educational background, prior business experience, qualifications, role and the personal responsibilities
of the executive officer.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, our compensation
policy will contain compensation recovery provisions which allows us under certain conditions to recover bonuses paid in excess, will
enable our Chief Executive Officer to approve an immaterial change in the terms of employment of an executive officer (provided that the
changes of the terms of employment are in accordance our compensation policy) and will allow us to exculpate, indemnify and insure our
executive officers and directors subject to certain limitations set forth thereto.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our compensation policy will
also provide for compensation to the members of our board of directors either: (i) in accordance with the amounts provided in the Companies
Regulations (Rules Regarding the Compensation and Expenses of an External Director) of 2000, as amended by the Companies Regulations (Relief
for Public Companies Traded in Stock Exchange Outside of Israel) of 2000, as such regulations may be amended from time to time; or (ii)
in accordance with the amounts determined in our compensation policy.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 98; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->88<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Internal Auditor</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Under the Companies Law, the
board of directors of an Israeli public company must appoint an internal auditor nominated by the audit committee. We intend to appoint
our internal auditor by May 28, 2023, which is 90 days following our initial public offering. The role of the internal auditor is to examine,
among other things, whether a company&#8217;s actions comply with the law and proper business procedure. The chairman of the Board, or
whoever the Board of the Company determines from time to time is required to oversee the activities, and to assess the performance of
the internal auditor as well as to review the internal auditor&#8217;s work plan. An internal auditor may not be an interested party or
office holder, or a relative of any interested party or office holder, and may not be a member of the company&#8217;s independent accounting
firm or its representative. The Companies Law defines an interested party as a holder of 5% or more of the outstanding shares or voting
rights of a company, any person or entity that has the right to appoint at least one director or the general manager of the company or
any person who serves as a director or as the general manager of a company. Our internal auditor is not our employee, but partner of a
firm which specializes in internal auditing.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Remuneration of Directors</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Under the Companies Law, remuneration
of directors is subject to the approval of the compensation committee, thereafter by the board of directors and thereafter, unless exempted
under the regulations promulgated under the Companies Law, by the general meeting of the shareholders. In case the remuneration of the
directors is in accordance with regulations applicable to remuneration of the external directors then such remuneration shall be exempt
from the approval of the general meeting. Where the director is also a controlling shareholder, the requirements for approval of transactions
with controlling shareholders apply.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Fiduciary Duties of Office Holders</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Companies Law imposes
a duty of care and a duty of loyalty on all office holders of a company.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The duty of care requires
an office holder to act with the level of care with which a reasonable office holder in the same position would have acted under the same
circumstances. The duty of care of an office holder includes a duty to use reasonable means to obtain:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px; text-align: justify">&#160;</td>
    <td style="width: 24px; text-align: justify"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">information on the advisability of a given action brought for his approval or performed by him by virtue of his position; and</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">all other important information pertaining to these actions.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The duty of loyalty of an
office holder requires an office holder to act in good faith and for the benefit of the company, and includes a duty to:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px; text-align: justify">&#160;</td>
    <td style="width: 24px; text-align: justify"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">refrain from any conflict of interest between the performance of his duties in the company and his performance of his other duties or personal affairs;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">refrain from any action that is competitive with the company&#8217;s business;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">refrain from exploiting any business opportunity of the company to receive a personal gain for himself or others; and</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">disclose to the company any information or documents relating to the company&#8217;s affairs which the office holder has received due to his position as an office holder.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 99; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->89<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Insurance</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Under the Companies Law, a
company may obtain insurance for any of its office holders against the following liabilities incurred due to acts he or she performed
as an office holder, if and to the extent provided for in the company&#8217;s articles of association:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px; text-align: justify">&#160;</td>
    <td style="width: 24px; text-align: justify"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">breach of his or her duty of care to the company or to another person;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px; text-align: justify">&#160;</td>
    <td style="width: 24px; text-align: justify"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">a breach of his or her duty of loyalty to the company, provided that the office holder acted in good faith and had reasonable cause to assume that his or her act would not prejudice the company&#8217;s interests; and</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">a financial liability imposed upon him or her in favor of another person.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We purchase increased insurance
coverage for a company of our size.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Indemnification</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Companies Law and the
Israeli Securities Law, 5728-1968, or the Securities Law, provide that a company may indemnify an office holder against the following
liabilities and expenses incurred for acts performed by him or her as an office holder, either pursuant to an undertaking made in advance
of an event or following an event, provided its articles of association include a provision authorizing such indemnification:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px; text-align: justify">&#160;</td>
    <td style="width: 24px; text-align: justify"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">a financial liability imposed on him or her in favor of another person by any judgment concerning an act performed in his or her capacity as an office holder, including a settlement or arbitrator&#8217;s award approved by a court;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">reasonable litigation expenses, including attorneys&#8217; fees, expended by the office holder (a) as a result of an investigation or proceeding instituted against him or her by an authority authorized to conduct such investigation or proceeding, provided that (1) no indictment (as defined in the Companies Law) was filed against such office holder as a result of such investigation or proceeding; and (2) no financial liability as a substitute for the criminal proceeding (as defined in the Companies Law) was imposed upon him or her as a result of such investigation or proceeding, or, if such financial liability was imposed, it was imposed with respect to an offense that does not require proof of criminal intent; or (b) in connection with a monetary sanction;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">reasonable litigation expenses, including attorneys&#8217; fees, expended by the office holder or imposed on him or her by a court: (1) in proceedings that the company institutes, or that another person institutes on the company&#8217;s behalf, against him or her; (2) in a criminal proceeding of which he or she was acquitted; or (3) as a result of a conviction for a crime that does not require proof of criminal intent; and</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">expenses incurred by an office holder in connection with an Administrative Procedure under the Securities Law, including reasonable litigation expenses and reasonable attorneys&#8217; fees. An &#8220;Administrative Procedure&#8221; is defined as a procedure pursuant to chapters H3 (Monetary Sanction by the Israeli Securities Authority), H4 (Administrative Enforcement Procedures of the Administrative Enforcement Committee) or I1 (Arrangement to prevent Procedures or Interruption of procedures subject to conditions) to the Securities Law.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 100; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->90<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Companies Law also permits
a company to undertake in advance to indemnify an office holder, provided that if such indemnification relates to financial liability
imposed on him or her, as described above, then the undertaking should be limited and shall detail the following foreseen events and amount
or criterion:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px; text-align: justify">&#160;</td>
    <td style="width: 24px; text-align: justify"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">to events that in the opinion of the board of directors can be foreseen based on the company&#8217;s activities at the time that the undertaking to indemnify is made; and</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">in amount or criterion determined by the board of directors, at the time of the giving of such undertaking to indemnify, to be reasonable under the circumstances.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We intend to enter, into indemnification
agreements with all of our directors and with all members of our senior management subject to the listing of our securities on the Nasdaq
Capital Market. Each such indemnification agreement will provide the office holder with indemnification permitted under applicable law
and up to a certain amount, and to the extent that these liabilities are not covered by directors and officers insurance.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Exculpation</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Under the Companies Law, an
Israeli company may not exculpate an office holder from liability for a breach of his or her duty of loyalty, but may exculpate in advance
an office holder from his or her liability to the company, in whole or in part, for damages caused to the company as a result of a breach
of his or her duty of care (other than in relation to distributions), but only if a provision authorizing such exculpation is included
in its articles of association. Our amended and restated articles of association provide that we may exculpate, in whole or in part, any
office holder from liability to us for damages caused to the company as a result of a breach of his or her duty of care, other than a
breach of the duty of care in a distribution. Subject to the aforesaid limitations, under the indemnification agreements we intend to
enter, we will exculpate and release our office holders from any and all liability to us related to any breach by them of their duty of
care to us to the fullest extent permitted by law.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;<i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Limitations</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Companies Law provides
that we may not exculpate or indemnify an office holder nor enter into an insurance contract that would provide coverage for any liability
incurred as a result of any of the following: (1) a breach by the office holder of his or her duty of loyalty unless (in the case of indemnity
or insurance only, but not exculpation) the office holder acted in good faith and had a reasonable basis to believe that the act would
not prejudice us; (2) a breach by the office holder of his or her duty of care if the breach was carried out intentionally or recklessly
(as opposed to merely negligently); (3) any act or omission committed with the intent to derive an illegal personal benefit; or (4) any
fine, monetary sanction, penalty or forfeit levied against the office holder.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Under the Companies Law, exculpation,
indemnification and insurance of office holders in a public company must be approved by the compensation committee and the board of directors
and, with respect to certain office holders or under certain circumstances, also by the shareholders.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our amended and restated articles
of association permit us to exculpate (subject to the aforesaid limitation), indemnify and insure our office holders to the fullest extent
permitted or to be permitted by the Companies Law.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The foregoing descriptions
summarize the material aspects and practices of our board of directors. For additional details, we also refer you to the full text of
the Companies Law, as well as of our amended and restated articles of association, which are exhibits to this Annual Report.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">There are no service contracts
between us or our Subsidiary, on the one hand, and our directors in their capacity as directors, on the other hand, providing for benefits
upon termination of service.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 101; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->91<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Approval of Related Party Transactions under
Israeli Law</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>General</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Under
the Companies Law, we may approve an action by an office holder from which the office holder would otherwise have to refrain, as described
above, if:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px; text-align: justify">&#160;</td>
    <td style="width: 24px; text-align: justify"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">the office holder acts in good faith and the act or its approval does not cause harm to the company; and</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">the office holder disclosed the nature of his or her interest in the transaction (including any significant fact or document) to the company at a reasonable time before the company&#8217;s approval of such matter.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Disclosure of Personal Interests of an Office
Holder</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The
Companies Law requires that an office holder disclose to the company, promptly, and, in any event, not later than the board meeting at
which the transaction is first discussed, any direct or indirect personal interest that he or she may have and all related material information
known to him or her relating to any existing or proposed transaction by the company. If the transaction is an extraordinary transaction,
the office holder must also disclose any personal interest held by:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px; text-align: justify">&#160;</td>
    <td style="width: 24px; text-align: justify"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">the office holder&#8217;s relatives; or</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">any corporation in which the office holder or his or her relatives holds 5% or more of the shares or voting rights, serves as a director or general manager or has the right to appoint at least one director or the general manager.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">An
office holder is not, however, obliged to disclose a personal interest if it derives solely from the personal interest of his or her relative
in a transaction that is not considered an extraordinary transaction. Under the Companies Law, an extraordinary transaction is a transaction:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px; text-align: justify">&#160;</td>
    <td style="width: 24px; text-align: justify"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">not in the ordinary course of business;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">not on market terms; or</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">that is likely to have a material effect on the company&#8217;s profitability, assets or liabilities.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The
Companies Law does not specify to whom within us nor the manner in which required disclosures are to be made. We require our office holders
to make such disclosures to our board of directors.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Under
the Companies Law, once an office holder complies with the above disclosure requirement, the board of directors may approve a transaction
between the company and an office holder, or a third party in which an office holder has a personal interest, unless the articles of association
provide otherwise and provided that the transaction is in the company&#8217;s interest. If the transaction is an extraordinary transaction
in which an office holder has a personal interest, first the audit committee and then the board of directors, in that order, must approve
the transaction. Under specific circumstances, shareholder approval may also be required. Generally, a person who has a personal interest
in a matter which is considered at a meeting of the board of directors or the audit committee may not be present at such a meeting unless
the chairman of the audit committee or board of directors (as applicable) determines that he or she should be present in order to present
the transaction that is subject to approval. A director who has a personal interest in a transaction, which is considered at a meeting
of the board of directors or the audit committee, may not be present at this meeting or vote on this matter, unless a majority of members
of the board of directors or the audit committee, as the case may be, has a personal interest. If a majority of the board of directors
has a personal interest, then shareholder approval is generally also required.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"></p><div>

</div><!-- Field: Page; Sequence: 102; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->92<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Disclosure of Personal Interests of a Controlling
Shareholder</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Under
the Companies Law, the disclosure requirements that apply to an office holder also apply to a controlling shareholder of a public company.
Extraordinary transactions with a controlling shareholder or in which a controlling shareholder has a personal interest, including a private
placement in which a controlling shareholder has a personal interest, as well as transactions for the provision of services whether directly
or indirectly by a controlling shareholder or his or her relative, or a company such controlling shareholder controls, and transactions
concerning the terms of engagement and compensation of a controlling shareholder or a controlling shareholder&#8217;s relative, whether
as an office holder or an employee, require the approval of the audit committee or the compensation committee, as the case may be, the
board of directors and a majority of the shares voted by the shareholders of the company participating and voting on the matter in a shareholders&#8217;
meeting. In addition, the shareholder approval must fulfill one of the following requirements:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px; text-align: justify">&#160;</td>
    <td style="width: 24px; text-align: justify"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">at least a majority of the shares held by shareholders who have no personal interest in the transaction and are voting at the meeting must be voted in favor of approving the transaction, excluding abstentions; or</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">the shares voted by shareholders who have no personal interest in the transaction who vote against the transaction represent no more than 2% of the voting rights in the company.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">In
addition, any extraordinary transaction with a controlling shareholder or in which a controlling shareholder has a personal interest with
a term of more than three years requires the abovementioned approval every three years; however, such transactions not involving the receipt
of services or compensation can be approved for a longer term, provided that the audit committee determines that such longer term is reasonable
under the circumstances.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The
Companies Law requires that every shareholder that participates, in person, by proxy or by voting instrument, in a vote regarding a transaction
with a controlling shareholder, must indicate in advance or in the ballot whether or not that shareholder has a personal interest in the
vote in question. Failure to so indicate will result in the invalidation of that shareholder&#8217;s vote.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The
term &#8220;controlling shareholder&#8221; is defined in the Companies Law as a shareholder with the ability to direct the activities
of the company, other than by virtue of being an office holder. A shareholder is presumed to be a controlling shareholder if the shareholder
holds 50% or more of the voting rights in a company or has the right to appoint 50% or more of the directors of the company or its general
manager. In the context of a transaction involving a shareholder of the company, a controlling shareholder also includes a shareholder
who holds 25% or more of the voting rights in the company if no other shareholder holds more than 50% of the voting rights in the company.
For this purpose, the holdings of all shareholders who have a personal interest in the same transaction will be aggregated.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Approval of the Compensation of Directors and
Executive Officers</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The compensation of, or an
undertaking to indemnify, insure or exculpate, an office holder who is not a director requires the approval of the company&#8217;s compensation
committee, followed by the approval of the company&#8217;s board of directors, and, if such compensation arrangement or an undertaking
to indemnify, insure or exculpate is inconsistent with the company&#8217;s stated compensation policy, or if the said office holder is
the chief executive officer of the company (subject to a number of specific exceptions), then such arrangement is subject to the approval
of our shareholders, subject to a special majority requirement.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Directors</i>. Under the
Companies Law, the compensation of our directors requires the approval of our compensation committee, the subsequent approval of the board
of directors and, unless exempted under the regulations promulgated under the Companies Law, the approval of the general meeting of our
shareholders. If the compensation of our directors is inconsistent with our stated compensation policy, then, provided that those provisions
that must be included in the compensation policy according to the Companies Law have been considered by the compensation committee and
board of directors, shareholder approval by a special majority will be required.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Executive officers other
than the chief executive officer.</i>&#160;The Companies Law requires the approval of the compensation of a public company&#8217;s executive
officers (other than the chief executive officer) in the following order: (i) the compensation committee, (ii) the company&#8217;s board
of directors, and (iii) only if such compensation arrangement is inconsistent with the company&#8217;s stated compensation policy, the
company&#8217;s shareholders by a special majority. However, if the shareholders of the company do not approve a compensation arrangement
with an executive officer that is inconsistent with the company&#8217;s stated compensation policy, the compensation committee and board
of directors may override the shareholders&#8217; decision if each of the compensation committee and the board of directors provide detailed
reasons for their decision.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 103; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->93<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Chief executive officer.</i>&#160;Under
the Companies Law, the compensation of a public company&#8217;s chief executive officer is required to be approved by: (i) the company&#8217;s
compensation committee; (ii) the company&#8217;s board of directors, and (iii) the company&#8217;s shareholders by a special majority.
However, if the shareholders of the company do not approve the compensation arrangement with the chief executive officer, the compensation
committee and board of directors may override the shareholders&#8217; decision if each of the compensation committee and the board of
directors provides detailed reasons for their decision. In addition, the compensation committee may exempt the engagement terms of a candidate
to serve as the chief executive officer from shareholders&#8217; approval, if the compensation committee determines that the compensation
arrangement is consistent with the company&#8217;s stated compensation policy, that the chief executive officer did not have a prior business
relationship with the company or a controlling shareholder of the company, and that subjecting the approval to a shareholder vote would
impede the company&#8217;s ability to attain the candidate to serve as the company&#8217;s chief executive officer (and provide detailed
reasons for the latter).</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The approval of each of the
compensation committee and the board of directors, with regard to the office holders and directors above, must be in accordance with the
company&#8217;s stated compensation policy; however, under special circumstances, the compensation committee and the board of directors
may approve compensation terms of a chief executive officer that are inconsistent with the company&#8217;s compensation policy provided
that they have considered those provisions that must be included in the compensation policy according to the Companies Law and that shareholder
approval was obtained by a special majority requirement.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Duties of Shareholders</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Under
the Companies Law, a shareholder has a duty to refrain from abusing his power in the company and to act in good faith and in an acceptable
manner in exercising his rights and performing his obligations toward the company and other shareholders, including, among other things,
in voting at general meetings of shareholders (and at shareholder class meetings) on the following matters:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>&#160;</i></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px; text-align: justify">&#160;</td>
    <td style="width: 24px; text-align: justify"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">amendment of the articles of association;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">increase in the company&#8217;s authorized share capital;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">merger; and</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">the approval of related party transactions and acts of office holders that require shareholder approval.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">A
shareholder also has a general duty to refrain from oppressing other shareholders. The remedies generally available upon a breach of contract
will also apply to a breach of the above mentioned duties, and in the event of oppression of other shareholders, additional remedies are
available to the injured shareholder.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">In
addition, any controlling shareholder, any shareholder that knows that its vote can determine the outcome of a shareholder vote and any
shareholder that, under a company&#8217;s articles of association, has the power to appoint or prevent the appointment of an office holder,
or has another power with respect to a company, is under a duty to act with fairness towards the company. The Companies Law does not describe
the substance of this duty except to state that the remedies generally available upon a breach of contract will also apply in the event
of a breach of the duty to act with fairness, taking the shareholder&#8217;s position in the company into account.&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Employment and Consulting Agreements with Executive
Officers</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have entered into written
employment or consulting agreements with each of our executive officers. These agreements provide for notice periods of varying duration
for termination of the agreement by us or by the relevant executive officer, during which time the executive officer will continue to
receive salary and benefits. These agreements also contain customary provisions regarding non-competition, non-solicitation, confidentiality
of information and assignment of inventions. However, the enforceability of the non-competition provisions may be limited under applicable
law.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 104; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->94<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><div><a id="a_028"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.3pt"><b>D.</b>&#160;<b>Employees.</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">See &#8220;Item 4.B. Business
Overview&#8212;Employees.&#8221;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><div><a id="a_029"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.3pt"><b>E.</b>&#160;<b>Share Ownership.</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">See
&#8220;Item 7.A. Major Shareholders&#8221; below.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Share Option Plans</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>2010 Option Plan</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In December 22, 2010, our
board of directors adopted our 2010 Option Plan, or the 2010 Plan. We are no longer granting options under the 2010 Plan and currently
grant options under the 2015 Plan (as defined below). There are currently 142,760 ordinary shares resulting from the exercise of certain
options granted under the 2010 Plan which are held in trust in favor of the employees who exercised such options. We maintain the 2010
Plan in order to allow our employees to enjoy certain tax benefits under Israeli tax law. Of the 543,120 outstanding options as of April
15, 2023 under the 2010 Plan, all options were fully vested.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Administration</i>. Our
board of directors, a duly authorized committee of our board of directors, or the administrator, administer the 2010 Plan. Under the 2010
Plan, the administrator has the authority, subject to applicable law, to interpret the terms of the 2010 Plan and any option agreements
or options granted thereunder, designate recipients of options, determine and amend the terms of options, including, but not limited to,
the number and class of ordinary shares underlying each option, the time of grant of an option, the exercise price of an option (with
the consent of the grantee in the event of an increase of the exercise price), the time and vesting schedule applicable to an option,
accelerate or amend the vesting schedule applicable to an option (with the consent of the grantee in the event of an extension to the
vesting schedule) and take all other actions and make all other determinations necessary or advisable for the administration of the 2010
Plan.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The administrator also has
the authority to approve the conversion, substitution, cancellation or suspension under and in accordance with the 2010 Plan of any or
all options or ordinary shares. The administrator also has the authority to amend and rescind rules and regulations relating to the 2010
Plan or terminate the 2010 Plan at any time before the date of expiration of its ten-year term.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Grant</i>. All options
granted pursuant to the 2010 Plan are evidenced by an option agreement. The option agreement sets forth the terms and conditions of the
options, including the number of shares subject to such options, vesting schedule, the exercise price, if applicable, the tax route and
other terms and conditions not inconsistent with the 2010 Plan as the administrator may determine</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Exercise</i>. An option
under the 2010 Plan may be exercised by providing us with a written notice of exercise, specifying the number of shares with respect to
which the option is being exercised and full payment of the exercise price for such shares, if applicable, in such form and method as
may be determined by the administrator and permitted by applicable law. An option may not be exercised for a fraction of a share.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>&#160;&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Termination of Employment</i>.
Options under the 2010 Plan shall expire in accordance with the period determined in the applicable option agreement or following the
termination of the grantee&#8217;s employment or engagement with us, as set forth below. In the event of the death of a grantee while
employed by or performing service for us or a subsidiary, or in the event of termination of a grantee&#8217;s employment or services for
reasons of disability, the grantee, or in the case of death, such grantee&#8217;s legal successor, may exercise options that have vested
prior to termination within the earlier of the twelve-month period following the date of death or termination, or the options&#8217; expiration
date.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In the case of termination
of the grantee&#8217;s employee, other than for cause, any option that is vested prior to the date of termination may be exercised within
such period of time ending on the earlier of 90 days following the termination date, or the option&#8217;s expiration date.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 105; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->95<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Transferability</i>. Unless
otherwise determined by the board of directors, options under the 2010 Plan may not, other than by will or laws of descent, be transferred
by the grantee nor may of the rights arising under the options be subject to a mortgage, attachment or other willful encumbrance.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Transactions</i>. In the
event of a merger, consolidation or sale of all, or substantially all, of our assets or shares, any and all outstanding, unexercised options
granted under the 2010 Plan, whether vested or unvested shall be cancelled for no consideration, unless determined otherwise by our board
of directors in its sole and absolute discretion to cause or effect any actions such as (i) the assumption or exchange of the options
for options or shares of a successor company; (ii) the exchange of options for monetary compensation; or (iii) the determination that
all unvested options and unexercised vested options shall expire on the date of such transactions.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>2015 Share Incentive Plan</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The 2015 Share Incentive Plan,
or the 2015 Plan, was adopted by our board of directors on January 1, 2015. The 2015 Plan provides for the grant of equity-based incentive
awards to our employees, directors, office holders, service providers and consultants in order to incentivize them to increase their efforts
on behalf of the company and to promote the success of our business.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Authorized Shares</i>.
As of April 15, 2023, there are 322,279 ordinary shares reserved and available for issuance under the 2015 Plan.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Shares underlying an award
granted under the 2015 Plan or an award granted under the 2010 Plan that has expired, or was cancelled, terminated, forfeited, or repurchased
or settled in cash in lieu of issuance of shares, for any reason, without having been exercised, and if permitted by us, shares tendered
to pay the exercise price or withholding tax obligations, are available for issuance under the 2015 Plan in accordance with applicable
law.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Administration</i>. Our
board of directors, a duly authorized committee of our board of directors or the administrator administer the 2015 Plan. Under the 2015
Plan, the administrator has the authority, subject to applicable law, to interpret the terms of the 2015 Plan and any award agreements
or awards granted thereunder, designate recipients of awards, determine and amend the terms of awards, including, but not limited to,
the number and class of ordinary shares underlying each option award, the time of grant of an option award, the exercise price of an option
award (with the consent of the grantee in the event of an increase of the exercise price), the fair market value of an ordinary share,
the time and vesting schedule applicable to an award or the method of payment for an award, accelerate or amend the vesting schedule applicable
to an award, prescribe the forms of agreement for use under the 2015 Plan and take all other actions and make all other determinations
necessary for the administration of the 2015 Plan.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The administrator also has
the authority to approve the conversion, substitution, cancellation or suspension under and in accordance with the 2015 Plan of any or
all option awards or ordinary shares. The administrator also has the authority to modify option awards to eligible individuals who are
foreign nationals or are individuals who are employed outside Israel to recognize differences in local law, tax policy or custom in order
to effectuate the purposes of the 2015 Plan but without amending the 2015 Plan. The administrator also has the authority to amend and
rescind rules and regulations relating to the 2015 Plan or terminate the 2015 Plan at any time before the date of expiration of its ten-year
term.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Eligibility</i>. The 2015
Plan provides for granting awards under various tax regimes, including, without limitation, in compliance with Section 102 of the Israeli
Income Tax Ordinance (New Version), 5721-1961, or the Ordinance, and Section 3(i) of the Ordinance and for awards granted to our U.S.
employees or service providers, including those who are deemed to be U.S. residents for tax purposes, in compliance with Section 422 of
the Code, and Section 409A of the Code, or Incentive Stock Options.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 102 of the Ordinance
allows employees, directors and officers who are not controlling shareholders and are considered Israeli residents to receive favorable
tax treatment for compensation in the form of shares, options or certain other types of equity awards. Our non-employee service providers
and controlling shareholders may only be granted options under section 3(i) of the Ordinance, which does not provide for similar tax benefits.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 106; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->96<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Grant</i>. All awards granted
pursuant to the 2015 Plan are evidenced by an award agreement, in a form approved, from time to time, by the administrator in its sole
discretion. The award agreement sets forth the terms and conditions of the award, including the type of award, number of shares subject
to such award, vesting schedule and conditions (including performance goals or measures) and the exercise price, if applicable, and other
terms and conditions not inconsistent with the 2015 Plan as the administrator may determine. Certain awards under the 2015 Plan may constitute
or provide for a deferral of compensation, subject to Section 409A of the Code, which may impose additional requirements on the terms
and conditions of such awards.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Unless otherwise determined
by the administrator and stated in the award agreement, and subject to the conditions of the 2015 Plan, awards for new employees vest
and become exercisable under the following schedule: 25% of the shares covered by the award, on the first anniversary of the vesting commencement
date determined by the administrator (and in the absence of such determination, the date on which such award was granted), and 6.25% of
the shares covered by the award at the end of each subsequent three-month period thereafter over the course of the following three years;
provided that the grantee remains continuously as an employee or provides services to us throughout such vesting dates.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Each award granted under the
2015 Plan will expire ten years from the date of the grant thereof, unless such shorter term of expiration is otherwise designated by
the administrator. In the case of an Incentive Stock Option granted to a 10% shareholder, within the meaning of Section 422(b)(6) of the
Code, the exercise period shall not exceed five years from the effective date of grant of such Incentive Stock Option.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Awards. </i>The 2015 Plan
provides for the grant of share options (including Incentive Stock Options and Nonqualified Stock Options), restricted shares, RSUs and
other share-based awards. Options granted under the 2015 Plan to our employees who are U.S. residents may qualify as Incentive Stock Options
within the meaning of Section 422 of the Code, or may be non-qualified stock options. The exercise price of a stock option may not be
less than 100% of the fair market value of the underlying share on the date of grant unless the administrator specifically indicates that
the share option will have a lower exercise price and it complies with Section 409A of the Code, and in the case of Incentive Stock Options
granted to 10% shareholders, not less than 110%.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Exercise</i>. An award
under the 2015 Plan may be exercised by providing us with a written notice of exercise, specifying the number of shares with respect to
which the award is being exercised and full payment of the exercise price for such shares, if applicable, in such form and method as may
be determined by the administrator and permitted by applicable law. An award may not be exercised for a fraction of a share. With regard
to tax withholding, exercise price and purchase price obligations arising in connection with awards under the 2015 Plan, the administrator
may, in its discretion, (1) accept cash, (2) provide for net withholding of shares in a cashless exercise mechanism or (3) direct a securities
broker to sell shares and deliver all or a part of the proceeds to the company or the trustee, or to pledge shares to a securities broker
or lender, as security for a loan, and to deliver all or part of the loan proceeds to the company or the trustee.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Transferability</i>. Other
than by will, the laws of descent and distribution or as otherwise provided under the 2015 Plan or determined by the administrator, neither
the options nor any right in connection with such options are assignable or transferable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Termination of Employment</i>.
Unless otherwise determined by the administrator and subject to the conditions of the 2015 Plan, an award may only be exercised for as
long as the grantee is an employee or provides services to us. In the event of termination of a grantee&#8217;s employment or service
with us or any of our affiliates, other than for cause, all vested and exercisable awards held by such grantee as of the date of termination
may be exercised within three months after such date of termination, unless otherwise determined by the administrator and subject to the
conditions of the 2015 Plan and in no event later than the expiration of the term of such awards. After such three-month period or expiration
of the term of such awards, all such unexercised awards will terminate and the shares covered by such awards shall again be available
for issuance under the 2015 Plan.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 107; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->97<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In the event of termination
of a grantee&#8217;s employment or service with us or any of our affiliates due to such grantee&#8217;s death or permanent disability
all vested and exercisable awards held by such grantee as of the date of termination may be exercised by the grantee or the grantee&#8217;s
legal guardian, estate, or by a person who acquired the right to exercise the award by bequest or inheritance, as applicable, within one
year after such date of termination, unless otherwise provided by the administrator and in the event of termination due to such grantee&#8217;s
retirement, within three months of such termination. Any awards which are unvested as of the date of such termination or which are vested
but not then exercised within the one-year period following such date, will terminate and the shares covered by such awards shall again
be available for issuance under the 2015 Plan.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Notwithstanding any of the
foregoing, if a grantee&#8217;s employment or services with us or any of our affiliates is terminated for &#8220;cause&#8221; (as defined
in the 2015 Plan), all outstanding awards held by such grantee (whether vested or unvested) will terminate on the date of such termination
and the shares covered by such awards shall again be available for issuance under the 2015 Plan.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Transactions</i>. In the
event of a share split, reverse share split, share dividend, recapitalization, combination or reclassification of our shares, merger,
consolidation, amalgamation, a reorganization or other similar occurrences, the administrator in its sole discretion shall make an appropriate
adjustment in the number of shares related to each outstanding award and to the number of shares reserved for issuance under the 2015
Plan, to the class and kind of shares subject to the 2015 Plan, as well as the exercise price per share of each outstanding award, as
applicable, the terms and conditions concerning vesting and exercisability and the term and duration of outstanding awards, or any other
terms that the administrator adjusts in its discretion; provided that any fractional shares resulting from such adjustment shall be rounded
to the nearest whole share unless otherwise determined by the administrator. Notwithstanding any of the foregoing, unless determined by
the administrator, no adjustment shall be made by reason of the distribution of subscription rights or rights offering to outstanding
shares or other issuance of shares by us.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In the event of a merger or
consolidation of the company, or a sale of all, or substantially all, of the our shares or assets or other transaction having a similar
effect on us, or liquidation or dissolution, or such other transaction or circumstances that our board of directors determines to be a
relevant transaction, then without the consent of the grantee, the administrator may but is not required to (i) cause any outstanding
award to be assumed or substituted by such successor corporation, (ii) regardless of whether or not the successor corporation assumes
or substitutes the award (a) provide the grantee with the option to exercise the award as to all or part of the shares, and may provide
for an acceleration of vesting of unvested awards, or (b) cancel the award and pay in cash, shares of the company, the acquirer or other
corporation which is a party to such transaction or other property as determined by the administrator as fair in the circumstances, (iii)
determine that any payments made in respect of awards shall be made or delayed to the same extent that payment of consideration to the
holders of the shares in connection with the merger/sale is made or delayed, or (iv) suspend the grantee&#8217;s rights to exercise any
vested portion of an award for a period of time prior to the signing or consummation of a merger/sale transaction.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Notwithstanding the foregoing,
the administrator may upon such event amend, modify or terminate the terms of any award as it shall deem, in good faith, appropriate.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p><div>

</div><div><a id="a_030"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.3pt"><b>F.</b>&#160;<b>Disclosure of a registrant&#8217;s
action to recover erroneously awarded compensation.</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Not applicable.&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;&#160;</p><div>

</div><div><a id="a_031"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>ITEM&#160;7. MAJOR SHAREHOLDERS AND RELATED PARTY TRANSACTIONS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><div><a id="a_032"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.3pt"><b>A.</b>&#160;<b>Major Shareholders</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following table sets forth
information with respect to the beneficial ownership of our ordinary shares as of April 15, 2023 by:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 48px; text-align: justify">&#160;</td>
    <td style="width: 24px; text-align: justify"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">each of our directors and senior management;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 48px; text-align: justify">&#160;</td>
    <td style="width: 24px; text-align: justify"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">all of our directors and senior management as a group; and</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 48px; text-align: justify">&#160;</td>
    <td style="width: 24px; text-align: justify"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">each person (or group of affiliated persons) known by us to be the beneficial owner of 5% or more of the outstanding ordinary shares.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 108; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->98<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The beneficial ownership of
our ordinary shares is determined in accordance with the rules of the SEC and generally includes any shares over which a person exercises
sole or shared voting or investment power, or the right to receive the economic benefit of ownership. For purposes of the table below,
we deem ordinary shares issuable pursuant to options that are currently exercisable or exercisable within 60&#160;days from April 15,
2023 to be outstanding and to be beneficially owned by the person holding the options for the purposes of computing the percentage ownership
of that person, but we do not treat them as outstanding for the purpose of computing the percentage ownership of any other person. Percentage
of shares beneficially owned is based on ordinary shares issued and outstanding as of April 15, 2023.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of April 15, 2023 and based
on their reported registered office, thirteen of our shareholders were U.S. persons, holding in aggregate approximately 39% of our outstanding
ordinary shares. We have also set forth below information known to us regarding any significant change in the percentage ownership of
our ordinary shares by any major shareholders during the past three years. Except where otherwise indicated, we believe, based on information
furnished to us by such owners, that the beneficial owners of the ordinary shares listed below have sole investment and voting power with
respect to such shares.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">All of our shareholders, including
the shareholders listed below, have the same voting rights attached to their ordinary shares, and neither our principal shareholders nor
our directors and executive officers have different or special voting rights with respect to their ordinary shares. A description of any
material relationship that our principal shareholders have had with us or any of our predecessors or affiliates within the past three
years is included under &#8220;Item 7.A Major Shareholders and Related Party Transactions&#8212;Certain Relationships and Related Party
Transactions.&#8221;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Unless otherwise noted below,
the address of each shareholder, director and executive officer is c/o&#160;Beamr Imaging&#160;Ltd., 10 HaManofim Street Herzeliya, 43305,
Israel.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Number of<br/> Shares</td><td style="font-weight: bold">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold">Name of beneficial owner</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">beneficially<br/> owned</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Percentage</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">5% or Greater Shareholder</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; text-indent: -9pt; padding-left: 9pt">Marker II LP (1)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">2,272,150</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">17.6</td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -9pt; padding-left: 9pt">Innovation Endeavors II, L.P. (2)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,042,445</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8.1</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -9pt; padding-left: 9pt">Disruptive Technologies III L.P. (3)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,056,290</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8.2</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -9pt; padding-left: 9pt">Verizon Ventures LLC (4)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,073,731</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8.3</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; text-indent: -9pt; padding-left: 9pt">Directors and Executive Officers</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -9pt; padding-left: 9pt">Sharon Carmel (5)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,693,190</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">28.67</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -9pt; padding-left: 9pt">Danny Sandler (6)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">27,750</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-size: 10pt">*</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -9pt; padding-left: 9pt">Tamar Shoham (7)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">92,050</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-size: 10pt">*</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -9pt; padding-left: 9pt">Dan Julius (8)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">114,335</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-size: 10pt">*</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -9pt; padding-left: 9pt">Dani Megrelishvili (9)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">42,658</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-size: 10pt">*</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -9pt; padding-left: 9pt">Eliezer Lubitch (10)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">286,390</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2.22</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -9pt; padding-left: 9pt">Tal Barnoach (11)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">241,105</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1.87</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -9pt; padding-left: 9pt">Lluis Pedragosa (12)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,584</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-size: 10pt">*</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -9pt; padding-left: 9pt">Yair Shoham (12)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,584</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-size: 10pt">*</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -9pt; padding-left: 9pt">Osnat Michaeli (12)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,584</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-size: 10pt">*</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -9pt; padding-left: 9pt">All directors, director nominees and executive officers as a group (10 persons)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,502,230</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">32.76</td><td style="text-align: left">%</td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 24px"><span style="font-size: 10pt">*</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Indicates beneficial ownership of less than 1% of the total ordinary shares outstanding.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">(1)</span></td><td style="text-align: justify"><span style="font-size: 10pt">Consists of (i) 2,272,150 ordinary
shares. Richard Scanlon is the sole director of the managers and the general partner of the Marker II LP. Ohad Finkelstein and Yuval
Shachar are independent members of the investment committee of the Marker II LP. Voting and investment power over the shares held by
the Marker II LP resides with the general partner and the members of any such investment committee. The address of the foregoing entity
and individuals is c/o Marker LLC, 10 East 53rd Street, New York, NY 10022.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 109; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->99<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-size: 10pt">(2) </span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Consists of 1,042,445 ordinary shares. Dror Berman is a managing partner at Innovation Endeavors, and as such may be deemed to have voting and investment control over the shares held by Innovation Endeavors II, L.P. The address of the principal office of Innovation Endeavors II, L.P. is 1845 El Camino Real, Palo Alto, CA 94306.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-size: 10pt">(3) </span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Consists of (i) 1,007,570 ordinary shares held by Disruptive Technologies III L.P., and (ii) 48,720 ordinary shares held by Disruptive Technologies L.P. Disruptive Technology Ltd is the general partner of Disruptive Technologies L.P &amp; Disruptive Technologies III L.P, Tal Barnoach and Adam Rothstein holds the GP and therefore they are deemed to have voting and dispositive power concerning the shares. The address of the principal office of Technologies L.P &amp; Disruptive Technologies III L.P is PO Box 309, Ugland House, Grand Cayman, KY1-1104, Cayman Islands.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-size: 10pt">(4) </span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Consists of 1,073,731 ordinary shares. Verizon Ventures LLC is an indirect, wholly-owned subsidiary of Verizon Communications, Inc. The address of the principal office of Verizon Ventures LLC is 1095 Avenues of the Americas, New York, NY 10036.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-size: 10pt">(5) </span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Consists of 3,693,190 ordinary shares.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-size: 10pt">(6)</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Consists of&#160;27,750 options to purchase ordinary shares that are currently exercisable or will be exercisable within 60 days from April 15, 2023. Does not include 44,250 options to purchase ordinary shares that are not exercisable within 60 days of April 15, 2023.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-size: 10pt">(7)</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Consists of 92,050 options to purchase ordinary shares that are currently exercisable or will be exercisable within 60 days from April 15, 2023. Does not include 18,750 options to purchase ordinary shares that are not exercisable within 60 days of April 15, 2023.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-size: 10pt">(8) </span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Consists of&#160;114,335 options to purchase ordinary shares that are currently exercisable or will be exercisable within 60 days from April 15, 2023. Does not include 20,625 options to purchase ordinary shares that are not exercisable within 60 days of April 15, 2023.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-size: 10pt">(9) </span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Consists of&#160;12,000 ordinary shares, and (ii) 30,658 options to purchase ordinary shares that are currently exercisable or will be exercisable within 60 days from April 15, 2023. Does not include 216,616 options to purchase ordinary shares that are not exercisable within 60 days of April 15, 2023.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-size: 10pt">(10)</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Consists of (i) 97,440 ordinary shares, and (ii) 188,950 options to purchase ordinary shares that are currently exercisable or will be exercisable within 60 days from April 15, 2023. Does not include 26,250 options to purchase ordinary shares that are not exercisable within 60 days of April 15, 2023.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-size: 10pt">(11) </span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Consists of (i) 63,121 ordinary shares, (iii) 128,400 ordinary shares held in favor of certain beneficiaries, and (iv) options to purchase 49,584 ordinary shares that are currently exercisable or will be exercisable within 60 days from April 15, 2023. The ordinary shares do not include shares held by Disruptive Technologies III L.P. or Disruptive Technologies L.P. Does not include 17,416 options to purchase ordinary shares that are not exercisable within 60 days of April 15, 2023.</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-size: 10pt">(12) </span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Consists of&#160;1,584 options to purchase ordinary shares that are currently exercisable or will be exercisable within 60 days from April 15, 2023. Does not include 17,416 options to purchase ordinary shares that are not exercisable within 60 days of April 15, 2023</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">To our knowledge, other than
as disclosed in the table above, our other filings with the SEC and this Annual Report, there has been no significant change in the percentage
ownership held by any major shareholder since January 1, 2020.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 110; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->100<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><div><a id="a_033"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.3pt"><b>B.</b>&#160;<b>Related Party Transactions</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following is a description
of the material terms of those transactions with related parties to which we, or our subsidiaries, are party since January 1, 2022.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Advance Investment Agreements</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On August 6, 2019, we entered
into Advanced Investment Agreements, or the 2019 AIA, with several of our current shareholders, providing for bridge loan financing in
the aggregate amount of $3,097,000. The 2019 AIAs provide for the conversion of the investment amount into our ordinary shares under certain
circumstances including in particular in the case of an initial public offering such that immediately prior to the closing our initial
public the investment amount automatically converted into such number of our ordinary shares equal to the initial public offering price
multiplied by 0.8.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On August 26, 2021, we entered
into Advanced Investment Agreements, or the 2021 AIA, with several of our current shareholders, providing for bridge loan financing in
the aggregate amount of $560,000. The 2021 AIAs provide for the conversion of the investment amount into our ordinary shares under certain
circumstances including in particular in the case of an initial public offering such that immediately prior to the closing of our initial
public offering the investment amount automatically convert into such number of our ordinary shares equal to the initial public offering
price multiplied by 0.8.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Related party participants
in the 2019 AIAs and 2021 AIAs, collectively, the AIAs, that were converted into ordinary shares in our initial public offering included
the following:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: justify">Participant</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Aggregate<br/> Investment<br/> Amount</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Number of Ordinary Shares from Conversion of AIA in our Initial Public Offering*</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: justify">Sharon Carmel</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,100,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">343,750</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Disruptive Technologies LP</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">100,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">31,250</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Marker II LP</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1,100,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">343,750</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Verizon Ventures LLC</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">947,619</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">296,131</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Innovation Endeavors II LP</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">250,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">78,125</td><td style="text-align: left">&#160;</td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left">*</td><td style="text-align: justify">Number of ordinary shares issued upon the automatic conversion
of advance investment agreements on February 27, 2023 in our initial public offering based on a conversion price equal to 80% of the
initial public offering price of $&#8204;4.00.</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Sharon Carmel Management</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On November 1, 2009, we entered
into a services agreement with Sharon Carmel Management Ltd., or SCM, a company owned by our Chief Executive Officer and Chairman, Sharon
Carmel, according to which we receive consulting services for a current monthly gross amount of NIS 45,000 from Mr. Carmel as our full
time Chief Executive Officer. Since January 1, 2020, we have not been paying SCM for the consulting services and as further discussed
below, we have accrued expenses of an aggregate of $460,000 as of December 31, 2022.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, on February 16,
2022, we entered into an addendum to the services agreement with SCM under which it was agreed that (i) the term of the services agreement
with SCM was extended until December 31, 2025 and (ii) the current liability towards SCM as was accrued for services rendered under the
services agreement over a period commencing January 1, 2020 through February 16, 2022 in total amount of $359,000, or the Current Liability,
will be paid in 18 equal installments (without an interest) starting on March 1, 2022, or the Commencement Date. However, in the event
that we shall not have available sufficient funds in any such payment date from and after the Commencement Date to repay the installments
of the Current Liability and/or the on-going fee owed to SCM or in the event that we determine that according to the following 12-months
period budget that we shall not have available sufficient funds to pay such installments and/or the on-going fee, then SCM hereby agrees
to postpone such payments owed to it until we will have such sufficient funds. Any unpaid on-going fee payments will be added to the Current
Liability.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 111; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->101<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Agreements and Arrangements With, and Compensation
of Executive Officers</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Certain of our executive officers
have employment agreements that contain customary provisions and representations, including confidentiality, non-competition, non-solicitation
and inventions assignment undertakings by the executive officers. Under current applicable Israeli employment laws, we may not be able
to enforce (either in whole or in part) covenants not to compete and therefore may be unable to prevent our competitors from benefiting
from the expertise of some of our former employees. See &#8220;Item 6.B Directors, Senior Management and Employees&#8212;Compensation.&#8221;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Options</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Since
our inception we have granted options to purchase our ordinary shares to our officers and to our directors. Such option agreements may
contain acceleration provisions upon certain merger, acquisition, or change of control transactions. We describe our option plans under
&#8220;Management&#8212;Share Option Plans.&#8221; If the relationship between us and an executive officer or a director is terminated,
except for cause (as defined in the various Option Plan agreements), options that are vested will generally remain exercisable for three
(3) months following the date of such termination if we initiate such termination or two weeks following the date of such termination,
if an executive officer or a director initiates such termination.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 10pt; text-align: justify; text-indent: -10pt"><b>Indemnification
Agreements</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 10pt; text-align: justify; text-indent: -10pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our amended and restated articles
of association permits us to exculpate, indemnify and insure each of our directors and office holders to the fullest extent permitted
by the Israeli Companies Law. Upon the closing of our initial public offering, we entered into indemnification agreements with each of
our directors, director nominees and executive officers, undertaking to indemnify them to the fullest extent permitted by Israeli law,
including with respect to liabilities resulting from a public offering of our shares, to the extent that these liabilities are not covered
by insurance. We have also obtained directors and officers insurance for each of our executive officers and directors. For further information,
see &#8220;Item 6.C Directors, Senior Management and Employees&#8212;Board Practices&#8212;Exculpation,&#8221; Item 6.C Directors, Senior
Management and Employees&#8212;Board Practices&#8212;Insurance,&#8221; and &#8220;Item 6.C Directors, Senior Management and Employees&#8212;Board
Practices&#8212;Indemnification.&#8221;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><div><a id="a_034"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.3pt"><b>C.</b>&#160;<b>Interests of Experts and Counsel</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Not applicable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><div><a id="a_035"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>ITEM&#160;8. FINANCIAL INFORMATION.</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><div><a id="a_036"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.3pt"><b>A.</b>&#160;<b>Consolidated Statements and Other
Financial Information.</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">See &#8220;Item 18. Financial
Statements.&#8221;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Legal Proceedings</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt">See
&#8220;Item 4.B. Business Overview&#8212;Legal Proceedings.&#8221;</span>&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Dividends</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 15pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have never declared or
paid any cash dividends to our shareholders of our ordinary shares, and we do not anticipate or intend to pay cash dividends in the foreseeable
future. Payment of cash dividends, if any, in the future will be at the discretion of our board of directors in compliance with applicable
legal requirements and will depend on a number of factors, including future earnings, our financial condition, operating results, contractual
restrictions, capital requirements, business prospects, our strategic goals and plans to expand our business, applicable law and other
factors that our board of directors may deem relevant.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Companies Law imposes
further restrictions on our ability to declare and pay dividends</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Payment of dividends may be
subject to Israeli withholding taxes. See &#8220;Item 10.E&#8212;Additional Information&#8212;Taxation&#8221; for additional information.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"></p><div>

</div><!-- Field: Page; Sequence: 112; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->102<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p><div>

</div><div><a id="a_037"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.3pt"><b>B.</b>&#160;<b>Significant Changes</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Other than as otherwise described
in this Annual Report on Form 20-F and as set forth below, no significant change has occurred in our operations since the date of our
consolidated financial statements included in this Annual Report on Form 20-F.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p><div>

</div><div><a id="a_038"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>ITEM&#160;9. THE OFFER AND LISTING</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><div><a id="a_039"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.3pt"><b>A.</b>&#160;<b>Offer and Listing Details</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On February 27, 2023, our
ordinary shares were approved for trading on the Nasdaq Capital Market under our ticker symbol &#8220;BMR&#8221; and began trading at
the open of market on February 28, 2023. Upon listing of our ordinary shares in our initial public offering on February 28, 2023, we effected
a reverse share spit at a ratio of 1-for-5.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><div><a id="a_040"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.3pt"><b>B.</b>&#160;<b>Plan of Distribution</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Not applicable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><div><a id="a_041"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.3pt"><b>C.</b>&#160;<b>Markets</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our ordinary shares are listed
on the Nasdaq Capital Market.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><div><a id="a_042"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.3pt"><b>D.</b>&#160;<b>Selling Shareholders</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Not applicable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><div><a id="a_043"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.3pt"><b>E.</b>&#160;<b>Dilution</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Not applicable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><div><a id="a_044"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.3pt"><b>F.</b>&#160;<b>Expenses of the Issue</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Not applicable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;<b>&#160;</b></p><div>

</div><div><a id="a_045"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>ITEM&#160;10. ADDITIONAL INFORMATION</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><div><a id="a_046"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.3pt"><b>A.</b>&#160;<b>Share Capital</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Not applicable.&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><div><a id="a_047"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.3pt"><b>B.</b>&#160;<b>Memorandum and Articles of Association</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">A copy of our Amended and
Restated Articles of Association is attached as Exhibit 1.1 to this Annual Report. Other than as disclosed below, the information called
for by this Item is set forth in Exhibit 2.1 to this Annual Report and is incorporated by reference into this Annual Report.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><div><a id="a_048"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.3pt"><b>C.</b>&#160;<b>Material Contracts</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Except
as set forth below, we have not entered into any material contract within the two years prior to the date of this Annual Report on Form
20-F, other than contracts entered into in the ordinary course of business, or as otherwise described herein in &#8220;Item&#160;4.A.
History and Development of the Company&#8221;, &#8220;Item&#160;4.B. Business Overview&#8221;, &#8220;Item&#160;7A. Major Shareholders&#8221;
or &#8220;Item 7B. Related Party Transactions&#8221; above.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"></p><div>

</div><!-- Field: Page; Sequence: 113; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->103<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><div><a id="a_049"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.3pt"><b>D.</b>&#160;<b>Exchange Controls</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">There are currently no Israeli
currency control restrictions on remittances of dividends on our ordinary shares, proceeds from the sale of the shares or interest or
other payments to non-residents of Israel, except for shareholders who are subjects of countries that are, or have been, in a state of
war with Israel.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><div><a id="a_050"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.3pt"><b>E.</b>&#160;<b>Taxation.</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>The following description
is not intended to constitute a complete analysis of all tax consequences relating to the acquisition, ownership and disposition of our
ordinary shares. You should consult your own tax advisor concerning the tax consequences of your particular situation, as well as any
tax consequences that may arise under the laws of any state, local, foreign, or other taxing jurisdiction.</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Israeli Tax Considerations and Government Programs</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="background-color: white">The
following is a description of the material Israeli income tax consequences of the ownership of our ordinary shares. The following also
contains a description of material relevant provisions of the current Israeli income tax structure applicable to companies in Israel,
with reference to its effect on us. To the extent that the discussion is based on new tax legislation which has not been subject to judicial
or administrative interpretation, there can be no assurance that the tax authorities will accept the views expressed in the discussion
in question. The discussion is not intended, and should not be taken, as legal or professional tax advice and is not exhaustive of all
possible tax considerations.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="background-color: white">The
following description is not intended to constitute a complete analysis of all tax consequences relating to the ownership or disposition
of our ordinary shares. Shareholders should consult their own tax advisors concerning the tax consequences of their particular situation,
as well as any tax consequences that may arise under the laws of any state, local, foreign or other taxing jurisdiction.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>General Corporate Tax Structure in Israel</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="background-color: white">Israeli
companies are generally subject to corporate tax. As of January 1, 2018, the corporate tax rate is 23%. However, the effective tax rate
payable by a company that derives income from a Preferred Enterprise (as discussed below) may be considerably less. Capital gains derived
by an Israeli resident company are generally subject to the prevailing corporate tax rate.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="background-color: white">Under
Israeli tax legislation, a corporation will be considered as an &#8220;Israeli resident company&#8221; if it meets one of the following:
(i) it was incorporated in Israel; or (ii) the control and management of its business are exercised in Israel.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Tax Benefits for Research and Development</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="background-color: white">Israeli
tax ordinance allows, under certain conditions, a tax deduction for expenditures, including capital expenditures, for the year in which
they are incurred. Expenditures are deemed related to scientific research and development projects, and the tax deduction shall usually
take place as long as one of the following applies:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px; text-align: justify">&#160;</td>
    <td style="width: 24px; text-align: justify"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">The expenditures are <span style="background-color: white">in the fields of industry, agriculture, transportation or energy</span>, and <span style="background-color: white">the research is carried out by a factory owner who is in the field of the said industries or at his order for the development or promotion of his factory;</span></span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px; text-align: justify">&#160;</td>
    <td style="width: 24px; text-align: justify"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">the expenses are of the <span style="background-color: white">expenditures </span>operator who does not have a <span style="background-color: white">factory </span>in the said <span style="background-color: white">industries</span>, or the expenses constitute as a participation in research funding carried out by another person in exchange for a right to the profits of the results of the <span style="background-color: white">expenditures </span>(that are reasonable in relation to his participation in research expenses.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 114; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->104<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="background-color: white">The
amount of such deductible expenses is reduced by the sum of any funds received through government grants for the finance of such scientific
research and development projects. No deduction under these research and development deduction rules is allowed if such deduction is related
to an expense invested in an asset depreciable under the general depreciation rules of the income Tax Ordinance, 1961. Expenditures not
so approved are deductible in equal amounts over three years.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="background-color: white">From
time to time we may apply the Office of the Chief Scientist for approval to allow a tax deduction for all research and development expenses
during the year incurred. There can be no assurance that such application will be accepted.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Law for the Encouragement of Capital Investments,
5719-1959</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="background-color: white">The
Law for the Encouragement of Capital Investments, 5719-1959, generally referred to as the Investment Law, provides certain incentives
for capital investments in production facilities (or other eligible assets).</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Tax Benefits</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="background-color: white">The
Investment Law grants tax benefits for income generated by a &#8220;Preferred Company&#8221; through its &#8220;Preferred Enterprise&#8221;
(as such terms are defined in the Investment Law) The definition of a Preferred Company includes a company incorporated in Israel that
is not fully owned by a governmental entity, and that has, among other things, Preferred Enterprise status and is controlled and managed
from Israel. A Preferred Company is entitled to a reduced corporate tax rate of 16% with respect to its income derived by its Preferred
Enterprise, unless the Preferred Enterprise is located in a specified development zone, in which case the rate will be 9%.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="background-color: white">Dividends
paid out of income attributed to a Preferred Enterprise are generally subject to withholding tax at source at the rate of 20%.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Taxation of our Shareholders</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="background-color: white">Capital
Gains Taxes Applicable to Non-Israeli Resident Shareholders. However, non-Israeli corporations will not be entitled to the foregoing exemption
if Israeli residents: (i) have a controlling interest of 25% or more in such non-Israeli corporation or (ii) are the beneficiaries of,
or are entitled to, 25% or more of the revenues or profits of such non-Israeli corporation, whether directly or indirectly.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="background-color: white">Additionally,
a sale of securities by a non-Israeli resident may be exempt from Israeli capital gains tax under the provisions of an applicable tax
treaty. For example, under Convention Between the Government of the United States of America and the Government of the State of Israel
with respect to Taxes on Income, as amended, or the United States-Israel Tax Treaty, the sale, exchange or other disposition of shares
by a shareholder who is a United States resident (for purposes of the treaty) holding the shares as a capital asset and is entitled to
claim the benefits afforded to such a resident by the U.S.-Israel Tax Treaty, or a Treaty U.S. Resident, is generally exempt from Israeli
capital gains tax unless: (i) the capital gain arising from such sale, exchange or disposition is attributed to real estate located in
Israel; (ii) the capital gain arising from such sale, exchange or disposition is attributed to royalties; (iii) the capital gain arising
from the such sale, exchange or disposition is attributed to a permanent establishment in Israel, under certain terms; (iv) such Treaty
U.S. Resident holds, directly or indirectly, shares representing 10% or more of the voting capital during any part of the 12-month period
preceding the disposition, subject to certain conditions; or (v) such Treaty U.S. Resident is an individual and was present in Israel
for 183 days or more during the relevant taxable year.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="background-color: white">In
some instances where our shareholders may be liable for Israeli tax on the sale of their ordinary shares, the payment of the consideration
may be subject to the withholding of Israeli tax at source. Shareholders may be required to demonstrate that they are exempt from tax
on their capital gains in order to avoid withholding at source at the time of sale.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 115; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->105<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="background-color: white">Taxation
of Non-Israeli Shareholders on Receipt of Dividends. Non-Israeli residents are generally subject to Israeli income tax on the receipt
of dividends paid on our ordinary shares at the rate of 25%, With respect to a person who is a &#8220;substantial shareholder&#8221; at
the time of receiving the dividend or on any time during the preceding twelve months, the applicable tax rate is 30%. A &#8220;substantial
shareholder&#8221; is generally a person who alone or together with another person, holds, directly or indirectly, at least 10% of any
of the &#8220;means of control&#8221; of the corporation. &#8220;Means of control&#8221; generally include the right to vote, receive
profits, nominate a director or an executive officer, receive assets upon liquidation, or order someone who holds any of the aforesaid
rights how to act, regardless of the source of such right. However, a distribution of dividends to non-Israeli residents is subject to
withholding tax at source at a rate of 20% if the dividend is distributed from income attributed to a Preferred Enterprise, unless a reduced
tax rate is provided under an applicable tax treaty. For example, under the United States-Israel Tax Treaty, the maximum rate of tax withheld
at source in Israel on dividends paid to a holder of our ordinary shares who is a Treaty U.S. Resident is 25%. However, generally, the
maximum rate of withholding tax on dividends, not generated by a Preferred Enterprise, that are paid to a United States corporation holding
10% or more of the outstanding voting capital throughout the tax year in which the dividend is distributed as well as during the previous
tax year, is 12.5%, provided that not more than 25% of the gross income for such preceding year consists of certain types of dividends
and interest. Notwithstanding the foregoing, dividends distributed from income attributed to an Preferred Enterprise are not entitled
to such reduction under the tax treaty but are subject to a withholding tax rate of 15% for a shareholder that is a U.S. corporation,
provided that the condition related to our gross income for the previous year (as set forth in the previous sentence) is met. If the dividend
is attributable partly to income derived from a Preferred Enterprise, and partly to other sources of income, the withholding rate will
be a blended rate reflecting the relative portions of the two types of income. We cannot assure you that we will designate the profits
that we may distribute in a way that will reduce shareholders&#8217; tax liability.<b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="background-color: white"><b>U.S. Federal Income Tax Considerations</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">THE FOLLOWING SUMMARY IS INCLUDED
HEREIN FOR GENERAL INFORMATION AND IS NOT INTENDED TO BE, AND SHOULD NOT BE CONSIDERED TO BE, LEGAL OR TAX ADVICE. EACH U.S. HOLDER SHOULD
CONSULT WITH HIS OR HER OWN TAX ADVISOR AS TO THE PARTICULAR U.S. FEDERAL INCOME TAX CONSEQUENCES OF THE PURCHASE, OWNERSHIP AND SALE
OF ORDINARY SHARES, INCLUDING THE EFFECTS OF APPLICABLE STATE, LOCAL, FOREIGN OR OTHER TAX LAWS AND POSSIBLE CHANGES IN THE TAX LAWS.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Subject to the limitations
described in the next two paragraphs, the following discussion summarizes the material U.S. federal income tax consequences to a &#8220;U.S.
Holder&#8221; arising from the purchase, ownership and sale of the ordinary shares. For this purpose, a &#8220;U.S. Holder&#8221; is a
holder of ordinary shares that is: (1) an individual citizen or resident of the United States, including an alien individual who is a
lawful permanent resident of the United States or meets the substantial presence residency test under U.S. federal income tax laws; (2)
a corporation (or entity treated as a corporation for U.S. federal income tax purposes) or a partnership (other than a partnership that
is not treated as a U.S. person under any applicable U.S. Treasury regulations) created or organized under the laws of the United States
or the District of Columbia or any political subdivision thereof; (3) an estate, the income of which is includable in gross income for
U.S. federal income tax purposes regardless of its source; (4) a trust if a court within the United States is able to exercise primary
supervision over the administration of the trust and one or more U.S. persons have authority to control all substantial decisions of the
trust; or (5) a trust that has a valid election in effect to be treated as a U.S. person to the extent provided in U.S. Treasury regulations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This summary is for general
information purposes only and does not purport to be a comprehensive description of all of the U.S. federal income tax considerations
that may be relevant to a decision to purchase our ordinary shares. This summary generally considers only U.S. Holders that will own our
ordinary shares as capital assets. Except to the limited extent discussed below, this summary does not consider the U.S. federal tax consequences
to a person that is not a U.S. Holder, nor does it describe the rules applicable to determine a taxpayer&#8217;s status as a U.S. Holder.
This summary is based on the provisions of the Code and final, temporary and proposed U.S. Treasury regulations promulgated thereunder,
administrative and judicial interpretations thereof, and the United States-Israel Income Tax Treaty, all as in effect as of the date hereof
and all of which are subject to change, possibly on a retroactive basis, and all of which are open to differing interpretations. We will
not seek a ruling from the Internal Revenue Service, or the IRS, with regard to the U.S. federal income tax treatment of an investment
in our ordinary shares by U.S. Holders and, therefore, can provide no assurances that the IRS will agree with the conclusions set forth
below.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 116; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->106<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This discussion does not address
all of the aspects of U.S. federal income taxation that may be relevant to a particular U.S. holder based on such holder&#8217;s particular
circumstances and in particular does not discuss any estate, gift, generation-skipping transfer, state, local, excise or foreign tax considerations.
In addition, this discussion does not address the U.S. federal income tax treatment of a U.S. Holder who is: (1) a bank, life insurance
company, regulated investment company, or other financial institution or &#8220;financial services entity;&#8221; (2) a broker or dealer
in securities or foreign currency; (3) a person who acquired our ordinary shares in connection with employment or other performance of
services; (4) a U.S. Holder that is subject to the U.S. alternative minimum tax; (5) a U.S. Holder that holds our ordinary shares as a
hedge or as part of a hedging, straddle, conversion or constructive sale transaction or other risk-reduction transaction for U.S. federal
income tax purposes; (6) a tax-exempt entity; (7) real estate investment trusts or grantor trusts; (8) a U.S. Holder that expatriates
out of the United States or a former long-term resident of the United States; or (9) a person having a functional currency other than
the U.S. dollar. This discussion does not address the U.S. federal income tax treatment of a U.S. Holder that owns, directly or constructively,
at any time, ordinary shares representing 10% or more of the shares of our company. Additionally, the U.S. federal income tax treatment
of partnerships (or other pass-through entities) or persons who hold ordinary shares through a partnership or other pass-through entity
are not addressed.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Each prospective investor
is advised to consult his or her own tax adviser for the specific tax consequences to that investor of purchasing, holding or disposing
of our ordinary shares, including the effects of applicable state, local, foreign or other tax laws and possible changes in the tax laws.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="background-color: white"><b><i>Taxation
of Dividends Paid on Ordinary Shares</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We do not intend to pay dividends
in the foreseeable future. In the event that we do pay dividends, and subject to the discussion under the heading &#8220;Passive Foreign
Investment Companies&#8221; below and the discussion of &#8220;qualified dividend income&#8221; below, a U.S. Holder, other than certain
U.S. Holders that are U.S. corporations, will be required to include in gross income as ordinary income the amount of any distribution
paid on the ordinary shares (including the amount of any Israeli tax withheld on the date of the distribution), to the extent that such
distribution does not exceed our current and accumulated earnings and profits, as determined for U.S. federal income tax purposes. The
amount of a distribution that exceeds our earnings and profits will be treated first as a non-taxable return of capital, reducing the
U.S. Holder&#8217;s tax basis for the ordinary shares to the extent thereof, and then capital gain. We do not expect to maintain calculations
of our earnings and profits under U.S. federal income tax principles and, therefore, U.S. Holders should expect that the entire amount
of any distribution generally will be reported as dividend income.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In general, preferential tax
rates for &#8220;qualified dividend income&#8221; and long-term capital gains are applicable for U.S. Holders that are individuals, estates
or trusts. For this purpose, &#8220;qualified dividend income&#8221; means, inter alia, dividends received from a &#8220;qualified foreign
corporation.&#8221; A &#8220;qualified foreign corporation&#8221; is a corporation that is entitled to the benefits of a comprehensive
tax treaty with the United States that includes an exchange of information program. The IRS has stated that the United States-Israel Tax
Treaty satisfies this requirement and we believe we are eligible for the benefits of that treaty.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, our dividends
will be qualified dividend income if our ordinary shares are readily tradable on the Nasdaq Capital Market or another established securities
market in the United States. Dividends will not qualify for the preferential rate if we are treated, in the year the dividend is paid
or in the prior year, as a passive foreign investment company, or PFIC, as described below under &#8220;Passive Foreign Investment Companies.&#8221;
A U.S. Holder will not be entitled to the preferential rate: (1) if the U.S. Holder has not held our ordinary shares for at least 61 days
of the 121 day period beginning on the date which is 60 days before the ex-dividend date, or (2) to the extent the U.S. Holder is under
an obligation to make related payments with respect to positions in substantially similar or related property. Any days during which the
U.S. Holder has diminished its risk of loss on our ordinary shares are not counted towards meeting the 61-day holding period. Finally,
U.S. Holders who elect to treat the dividend income as &#8220;investment income&#8221; pursuant to Section 163(d)(4) of the Code will
not be eligible for the preferential rate of taxation.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 117; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->107<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The amount of a distribution
with respect to our ordinary shares will be measured by the amount of the fair market value of any property distributed, and for U.S.
federal income tax purposes, the amount of any Israeli taxes withheld therefrom. Cash distributions paid by us in NIS will be included
in the income of U.S. Holders at a U.S. dollar amount based upon the spot rate of exchange in effect on the date the dividend is includible
in the income of the U.S. Holder, and U.S. Holders will have a tax basis in such NIS for U.S. federal income tax purposes equal to such
U.S. dollar value. If the U.S. Holder subsequently converts the NIS into U.S. dollars or otherwise disposes of them, any subsequent gain
or loss in respect of such NIS arising from exchange rate fluctuations will be U.S. source ordinary exchange gain or loss.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Dividends paid with respect
to our ordinary shares will be treated as foreign source income, which may be relevant in calculating the holder&#8217;s foreign tax credit
limitation. The limitation on foreign taxes eligible for credit is calculated separately with respect to specific classes of income. For
this purpose, dividends that we distribute generally should constitute &#8220;passive category income,&#8221; or, in the case of certain
U.S. Holders, &#8220;general category income.&#8221; A foreign tax credit for foreign taxes imposed on distributions may be denied if
holders do not satisfy certain minimum holding period requirements. The rules relating to the determination of the foreign tax credit
are complex, and U.S. Holders should consult their tax advisor to determine whether and to what extent such holder will be entitled to
this credit.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="background-color: white"><b><i>Taxation
of the Sale, Exchange or other Disposition of </i></b></span><b><i>Ordinary Shares</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Except as provided under the
PFIC rules described below under &#8220;Passive Foreign Investment Companies,&#8221; upon the sale, exchange or other disposition of our
ordinary shares, a U.S. Holder will recognize capital gain or loss in an amount equal to the difference between such U.S. Holder&#8217;s
tax basis for the ordinary shares, determined in U.S. dollars, and the U.S. dollar value of the amount realized on the disposition (or
its U.S. dollar equivalent determined by reference to the spot rate of exchange on the date of disposition, if the amount realized is
denominated in a foreign currency). The gain or loss realized on the sale, exchange or other disposition of ordinary shares will be long-term
capital gain or loss if the U.S. Holder has a holding period of more than one year at the time of the disposition. Individuals who recognize
long-term capital gains may be taxed on such gains at reduced rates of tax. The deduction of capital losses is subject to various limitations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="background-color: white"><b><i>Passive
Foreign Investment Companies</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Special U.S. federal income
tax laws apply to U.S. taxpayers who own shares of a corporation that is a PFIC. We will be treated as a PFIC for U.S. federal income
tax purposes for any taxable year that either:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px; text-align: justify">&#160;</td>
    <td style="width: 24px; text-align: justify"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">75% or more of our gross income (including our pro rata share of gross income for any company, in which we are considered to own 25% or more of the shares by value), in a taxable year is passive; or</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">At least 50% of our assets generally determined on the basis of a quarterly average and based upon fair market value (including our pro rata share of the assets of any company in which we are considered to own 25% or more of the shares by value) are held for the production of, or produce, passive income.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">For this purpose, passive
income generally consists of rents, dividends, interest, royalties, gains from the disposition of passive assets and gains from commodities
and securities transactions. Cash is treated as generating passive income.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We believe that we will not
be a PFIC for the current taxable year, although we have not determined whether we will be a PFIC in the foreseeable future. The tests
for determining PFIC status are applied annually, and it is difficult to make accurate projections of future income and assets which are
relevant to this determination. In addition, our PFIC status may depend in part on the market value of our ordinary shares. Accordingly,
there can be no assurance that we currently are not or will not become a PFIC.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If we currently are or become
a PFIC, each U.S. Holder who has not elected to mark the shares to market (as discussed below), would, upon receipt of certain &#8220;excess
distributions&#8221; by us and upon disposition of our ordinary shares at a gain:&#160;(1) have such excess distribution or gain allocated
ratably over the U.S. Holder&#8217;s holding period for the ordinary shares, as the case may be; (2) the amount allocated to the current
taxable year and any period prior to the first day of the first taxable year in which we were a PFIC would be taxed as ordinary income;
and (3) the amount allocated to each of the other taxable years would be subject to tax at the highest rate of tax in effect for the applicable
class of taxpayer for that year, and an interest charge for the deemed deferral benefit would be imposed with respect to the resulting
tax attributable to each such other taxable year. Distributions received by a U.S. Holder in a taxable year that are greater than 125%
of the average annual distributions received during the shorter of the three preceding taxable years or the U.S. Holder&#8217;s holding
period for the ordinary shares will be treated as excess distributions. In addition, when shares of a PFIC are acquired by reason of death
from a decedent that was a U.S. Holder, the tax basis of such shares would not receive a step-up to fair market value as of the date of
the decedent&#8217;s death, but instead would be equal to the decedent&#8217;s basis if lower, unless all gain were recognized by the
decedent. Indirect investments in a PFIC may also be subject to these special U.S. federal income tax rules.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="background-color: white">&#160;&#160;&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"></p><div>

</div><!-- Field: Page; Sequence: 118; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->108<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="background-color: white">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The PFIC rules described above
would not apply to a U.S. Holder who makes a qualified electing fund, or QEF, election for all taxable years that such U.S. Holder has
held the ordinary shares while we are a PFIC, provided that we comply with specified reporting requirements. Instead, each U.S. Holder
who has made such a QEF election is required for each taxable year that we are a PFIC to include in income such U.S. Holder&#8217;s pro
rata share of our ordinary earnings as ordinary income and such U.S. Holder&#8217;s pro rata share of our net capital gains as long-term
capital gain, regardless of whether we make any distributions of such earnings or gain. In general, a QEF election is effective only if
we make available certain required information. The QEF election is made on a shareholder-by-shareholder basis and generally may be revoked
only with the consent of the IRS. We do not intend to notify U.S. Holders if we believe we will be treated as a PFIC for any tax year.
In addition, we do not intend to furnish U.S. Holders annually with information needed in order to complete IRS Form 8621 and to make
and maintain a valid QEF election for any year in which we or any of our subsidiaries are a PFIC. Therefore, the QEF election will not
be available with respect to our ordinary shares.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, the PFIC rules
described above would not apply if we were a PFIC and a U.S. Holder made a mark-to-market election. A U.S. Holder of our ordinary shares
which are regularly traded on a qualifying exchange, including the Nasdaq Capital Market, can elect to mark the ordinary shares to market
annually, recognizing as ordinary income or loss each year an amount equal to the difference as of the close of the taxable year between
the fair market value of the ordinary shares and the U.S. Holder&#8217;s adjusted tax basis in the ordinary shares. Losses are allowed
only to the extent of net mark-to-market gain previously included income by the U.S. Holder under the election for prior taxable years.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">U.S. Holders who hold our
ordinary shares during a period when we are a PFIC will be subject to the foregoing rules, even if we cease to be a PFIC. U.S. Holders
are strongly urged to consult their tax advisors about the PFIC rules.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="background-color: white"><b>Tax
on Net Investment Income</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">U.S. Holders who are individuals,
estates or trusts will generally be required to pay a 3.8% Medicare tax on their net investment income (including dividends on and gains
from the sale or other disposition of our ordinary shares), or in the case of estates and trusts on their net investment income that is
not distributed to beneficiaries of the estate or trust. In each case, the 3.8% Medicare tax applies only to the extent the U.S. Holder&#8217;s
total adjusted income exceeds applicable thresholds.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="background-color: white"><b><i>Information
Reporting and Withholding</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">A U.S. Holder may be subject
to backup withholding at a rate of 24% with respect to cash dividends and proceeds from a disposition of ordinary shares. In general,
backup withholding will apply only if a U.S. Holder fails to comply with specified identification procedures. Backup withholding will
not apply with respect to payments made to designated exempt recipients, such as corporations and tax-exempt organizations. Backup withholding
is not an additional tax and may be claimed as a credit against the U.S. federal income tax liability of a U.S. Holder, provided that
the required information is timely furnished to the IRS.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Certain U.S. Holders with
interests in &#8220;specified foreign financial assets&#8221; (including, among other assets, our ordinary shares, unless such ordinary
shares are held on such U.S. Holder&#8217;s behalf through a financial institution) may be required to file an information report with
the IRS if the aggregate value of all such assets exceeds $50,000 on the last day of the taxable year or $75,000 at any time during the
taxable year (or such higher dollar amount as may be prescribed by applicable IRS guidance); and may be required to file a Report of Foreign
Bank and Financial Accounts, or FBAR, if the aggregate value of the foreign financial accounts exceeds $10,000 at any time during the
calendar year. You should consult your own tax advisor as to the possible obligation to file such information report.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 119; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->109<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b>THE DISCUSSION ABOVE IS
A GENERAL SUMMARY AND IS NOT INTENDED TO CONSTITUTE A COMPLETE ANALYSIS OF ALL TAX CONSEQUENCES RELATING TO THE PURCHASE, OWNERSHIP AND
DISPOSITION OF OUR ORDINARY SHARES. IT DOES NOT COVER ALL TAX MATTERS THAT MAY BE OF IMPORTANCE TO A PROSPECTIVE INVESTOR. EACH PROSPECTIVE
INVESTOR IS URGED TO CONSULT ITS OWN TAX ADVISOR ABOUT THE TAX CONSEQUENCES TO IT RELATING TO THE PURCHASE, OWNERSHIP, AND DISPOSITION
OF ORDINARY SHARES IN LIGHT OF THE INVESTOR&#8217;S OWN CIRCUMSTANCES.</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><div><a id="a_051"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><b>F. Dividends and Paying Agents</b></span></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Not applicable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><div><a id="a_052"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><b>G. Statement by Experts</b></span></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Not applicable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><div><a id="a_053"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><b>H. Documents on Display</b></span></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are subject to certain
information reporting requirements of the Exchange Act, applicable to foreign private issuers and under those requirements will file reports
with the SEC.&#160;The SEC maintains an internet site at http://www.sec.gov that contains reports, proxy and information statements and
other information regarding issuers that file electronically with the SEC. Our filings with the SEC will also be available to the public
through the SEC&#8217;s website at www.sec.gov.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As a foreign private issuer,
we are exempt from the rules under the Exchange Act related to the furnishing and content of proxy statements, and our officers, directors
and principal shareholders will be exempt from the reporting and short-swing profit recovery provisions contained in Section 16 of the
Exchange Act. In addition, we are not required under the Exchange Act to file annual, quarterly and current reports and financial statements
with the SEC as frequently or as promptly as U.S. domestic companies whose securities are registered under the Exchange Act. However,
we will file with the SEC, within 120 days after the end of each fiscal year, or such applicable time as required by the SEC, an annual
report on Form 20-F containing financial statements audited by an independent registered public accounting firm, and may submit to the
SEC, on a Form 6-K, unaudited quarterly financial information.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;&#160;</p><div>

</div><div><a id="a_054"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><b>I. Subsidiary Information.</b></span></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Not applicable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><div><a id="a_055"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><b>J. Annual Report to Security Holders.</b></span></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Not applicable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><div><a id="a_056"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><b>ITEM&#160;11. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</b></span></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are exposed to market risk
from changes in exchange rates, interest rates and inflation. All of these market risks arise in the ordinary course of business, as we
do not engage in speculative trading activities. The following analysis provides additional information regarding these risks.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 120; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->110<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt"><b><i>Foreign Currency and
Exchange Risk</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our functional currency and
all of our subsidiaries all of which are primarily a direct and integral component of our operation is the U.S. dollars, as the U.S. dollars
is the primary currency of the economic environment in which us and our subsidiaries have operated (which is the currency of the environment
in which an entity primarily generates cash) and expects to continue to operate in the foreseeable future. Our sales are mainly denominated
in U.S. dollars. A significant portion of our operating costs are in Israel and in Russia, consisting principally of salaries and related
personnel expenses, and facility expenses, which are denominated in NIS and RUB. This foreign currency exposure gives rise to market risk
associated with exchange rate movements of the U.S. dollar against the NIS and RUB. Furthermore, we anticipate that a significant portion
of our expenses will continue to be denominated in NIS and RUB. We do not hedge against currency risk. A hypothetical 10% change in foreign
currency exchange rates applicable to our business would have had an impact on our results for the year ended December 31, 2022 of $0.1
million due to NIS, and $0.1 million due to RUB.&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt"><b><i>Impact of Inflation</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">While it is difficult to accurately
measure the impact of inflation due to the imprecise nature of the estimates required, we do not believe inflation has had a material
effect on our historical results of operations and financial condition. However, if our costs were to become subject to significant inflationary
pressures, we may not be able to fully offset higher costs through price increases or other corrective measures, and our inability or
failure to do so could adversely affect our business, financial condition and results of operations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p><div>

</div><div><a id="a_057"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><b>ITEM&#160;12.
DESCRIPTION OF SECURITIES OTHER THAN EQUITY SECURITIES</b></span></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><div><a id="a_058"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><b>A. Debt Securities.</b></span></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Not applicable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><div><a id="a_059"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><b>B. Warrants and rights.</b></span></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Not applicable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><div><a id="a_060"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><b>C. Other Securities.</b></span></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Not applicable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><div><a id="a_061"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><b>D. American Depositary Shares</b></span></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Not applicable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 121; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->111<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><div><a id="a_062"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><b>PART&#160;II</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><div><a id="a_063"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><b>ITEM&#160;13.
DEFAULTS, DIVIDEND ARREARAGES AND DELINQUENCIES</b></span></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">None.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><div><a id="a_064"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><b>ITEM&#160;14. MATERIAL MODIFICATIONS TO THE RIGHTS OF SECURITY HOLDERS AND USE OF PROCEEDS</b></span></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">There are no material modifications
to the rights of security holders.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><div><a id="a_065"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><b>ITEM&#160;15. CONTROLS AND PROCEDURES</b></span></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><b>(a) Disclosure Controls and Procedures</b></span></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our management, with the participation
of our Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of our disclosure controls and procedures
(as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) as of December 31, 2022, or the Evaluation Date. Based
on such evaluation, those officers have concluded that, as of the Evaluation Date, our disclosure controls and procedures were not effective
due to a material weakness in our internal control over financial reporting related to lack of sufficient internal accounting personnel,
segregation of duties, lack of sufficient internal controls (including IT general controls, entity level controls and transaction level
controls). See &#8220;Item 5.E&#8212;Operating and Financial Review and Prospects&#8212;Critical Account Estimates&#8212;Internal Control
Over Financial Reporting&#8221; for additional information.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><b>(b) Management&#8217;s Annual Report on Internal Control over Financial Reporting</b></span></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Annual Report does not
include a report of management&#8217;s assessment regarding internal control over financial reporting due to a transition period established
by rules of the SEC for newly public companies. See &#8220;Item 5.E&#8212;Operating and Financial Review and Prospects&#8212;Critical
Account Estimates&#8212;Internal Control Over Financial Reporting&#8221; for additional information.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><b>(c) Attestation Report of the Registered Public Accounting Firm</b></span></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Annual Report does not
include a report of management&#8217;s assessment regarding internal control over financial reporting due to a transition period established
by rules of the SEC for newly public companies.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><b>(d) Changes in Internal Control over Financial Reporting</b></span></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">During the year ended December
31, 2022, there were no changes in our internal control over financial reporting that have materially affected, or are reasonably likely
to materially affect, our internal control over financial reporting.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><div><a id="a_066"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><b>ITEM 16. [RESERVED]</b></span></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><div><a id="a_067"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><b>ITEM&#160;16A.
AUDIT COMMITTEE FINANCIAL EXPERT</b></span></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our board of directors has
determined that three members of our audit committee, include Lluis Pedragosa, Yair Shoham and Osnat Michaeli. Osnat Michaeli, are an
audit committee financial expert, as defined under the rules under the Exchange Act, and is independent in accordance with applicable
Exchange Act rules and the Nasdaq Listing Rules.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><div><a id="a_068"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><b>ITEM&#160;16B. CODE OF ETHICS</b></span></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our board of directors has
adopted a Code of Ethics applicable to all of our directors and employees, including our Chief Executive Officer, Chief Financial Officer,
controller or principal accounting officer, or other persons performing similar functions, which is a &#8220;code of ethics&#8221; as
defined in Item 16B of Form 20-F promulgated by the SEC. The full text of the Code of Ethics is posted on our website at&#160;<i>https://beamr.com/</i>.
Information contained on, or that can be accessed through, our website does not constitute a part of this a part of this Annual Report
on Form 20-F and is not incorporated by reference herein. If we make any amendment to the Code of Ethics or grant any waivers, including
any implicit waiver, from a provision of the Code of Ethics, we will disclose the nature of such amendment or waiver on our website to
the extent required by the rules and regulations of the SEC. We have not granted any waivers under our Code of Business Conduct and Ethics.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 122; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->112<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><div><a id="a_069"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><b>ITEM&#160;16C. PRINCIPAL ACCOUNTANT FEES AND SERVICES</b></span></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following table provides
information regarding fees paid by us to Fahn Kanne &amp; Co. Grant Thornton Israel, an independent registered public accounting firm,
for all services, including audit services, for the years ended December 31, 2022 and 2021:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>(USD)</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; text-indent: -0.15in; padding-left: 0.15in"><span style="font-size: 10pt">Audit fees&#160;<sup>(1)</sup></span></td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">60,134</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">35,096</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt; text-indent: -0.15in; padding-left: 0.15in"><span style="font-size: 10pt">Tax fees<sup>(2)</sup></span></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">643</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 4pt; text-indent: -0.15in; padding-left: 0.15in">All other fees</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">0</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">0</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.15in; padding-left: 0.15in">Total</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">60,777</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">35,096</td><td style="text-align: left">&#160;</td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 24px"><span style="font-size: 10pt">(1)</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">The audit fees for the years ended December 31, 2022 and 2021 includes professional services rendered in connection with the audit of our annual consolidated financial statements and the review of our consolidated interim financial statements, our statutory tax audits and assistance with review of documents filed with the SEC.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 24px"><span style="font-size: 10pt">(2)</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Tax fees include professional services rendered in substance related to receive a certificate from the Israeli tax authority for an exemption or a reduction of withholding tax at the source regarding transfer of funds.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Pre-Approval of Auditors&#8217; Compensation</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our audit committee has a
pre-approval policy for the engagement of our independent registered public accounting firm to perform certain audit and non-audit services.
Pursuant to this policy, which is designed to assure that such engagements do not impair the independence of our auditors, the audit committee
pre-approves annually a catalog of specific audit and non-audit services in the categories of audit services, audit-related services and
tax services that may be performed by our independent registered public accounting firm. If a type of service, that is to be provided
by our auditors, has not received such general pre-approval, it will require specific pre-approval by our audit committee. The policy
prohibits retention of the independent registered public accounting firm to perform the prohibited non-audit functions defined in applicable
SEC rules.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><div><a id="a_070"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><b>ITEM&#160;16D.
EXEMPTIONS FROM THE LISTING STANDARDS FOR AUDIT COMMITTEES</b></span></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Not applicable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><div><a id="a_071"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><b>ITEM&#160;16E. PURCHASES OF EQUITY SECURITIES BY THE ISSUER AND AFFILIATED PURCHASERS</b></span></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Not applicable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><div><a id="a_072"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><b>ITEM&#160;16F. CHANGE IN REGISTRANT&#8217;S CERTIFYING ACCOUNTANT</b></span></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Not applicable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><div><a id="a_073"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><b>ITEM&#160;16G.
CORPORATE GOVERNANCE</b></span></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Under the Companies Law, companies
incorporated under the laws of the State of Israel, whose shares are publicly traded, including companies whose shares are listed on the
Nasdaq Capital Market are considered public companies under Israeli law and are required to comply with various corporate governance requirements
under Israeli law relating to such matters as external directors, the audit committee, compensation committee, compensation policy, company&#8217;s
auditors, and an internal auditor. These requirements are in addition to the corporate governance requirements imposed by the Nasdaq Listing
Rules, and other applicable provisions of U.S. securities laws to which we are subject as a foreign private issuer due to the listing
of our ordinary shares on the Nasdaq Capital Market. However, pursuant to regulations promulgated under the Companies Law, companies with
shares traded on certain U.S. stock exchanges, including the Nasdaq Capital Market, may, subject to certain conditions, &#8220;opt out&#8221;
from the requirement of the Companies Law to appoint external directors and related Companies Law rules concerning the composition of
the audit committee and compensation committee of the board of directors (other than the gender diversification rule under the Companies
Law which requires the appointment of a director from the other gender if, at the time a director is appointed, all members of the board
of directors are of the same gender). In accordance with these regulations, we have elected to &#8220;opt out&#8221; from such requirements
of the Companies Law. Under these regulations, the exemptions from such Companies Law&#8217;s requirements will continue to be available
to us so long as we comply with the following: (i) we do not have a &#8220;controlling shareholder&#8221; (as such term is defined under
the Companies Law), (ii) our shares are traded on certain U.S. stock exchanges, including the Nasdaq Capital Market, and (iii) we comply
with the director independence requirements and the requirements regarding the composition of the audit committee and the compensation
committee under U.S. laws (including applicable Nasdaq rules) applicable to U.S. domestic issuers.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 123; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->113<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In accordance with Israeli
law and practice and subject to the exemption set forth in Rule&#160;5615 of the Nasdaq Stock Market rules, we have elected to follow
the provisions of the Companies Law, rather than the Nasdaq Stock Market rules, with respect to the following requirements:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px; text-align: justify; font-size: 10pt">&#160;</td>
    <td style="width: 24px; text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Quorum</i>. While the Nasdaq Stock Market rules require that the quorum for purposes of any meeting of the holders of a listed company&#8217;s ordinary voting stock, as specified in the company&#8217;s bylaws, be no less than 33 1/3% of the company&#8217;s outstanding ordinary voting stock, under Israeli law, a company is entitled to determine in its articles of association the number of shareholders and percentage of holdings required for a quorum at a shareholders meeting. Our amended and restated articles of association provide that a quorum of two or more shareholders holding at least 25% of the voting rights in person or by proxy is required for commencement of business at a general meeting. However, the quorum set forth in our amended and restated articles of association with respect to an adjourned meeting consists of any number of shareholders present in person or by proxy.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px; text-align: justify">&#160;</td>
    <td style="width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Compensation of officers.</i>&#160;Israeli law and our amended and restated articles of association do not require that the independent members of our board of directors (or a compensation committee composed solely of independent members of our board of directors) determine an executive officer&#8217;s compensation, as is generally required under the Nasdaq Stock Market rules with respect to the chief executive officer and all other executive officers. Instead, compensation of executive officers is determined and approved by our board of directors, and in certain circumstances by our shareholders, either in consistency with our office holder compensation policy or, in special circumstances in deviation therefrom, taking into account certain considerations stated in the Companies Law. See &#8220;Item 6.C Directors, Senior Management and Employees&#8212;&#8212;Board Practices&#8212;Approval of Related Party Transactions under Israeli Law&#8221; for additional information.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px; text-align: justify">&#160;</td>
    <td style="width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Shareholder approval.</i>&#160;We will seek shareholder approval for all corporate actions requiring such approval under the requirements of the Companies Law, rather than seeking approval for corporation actions in accordance with Nasdaq Listing Rule&#160;5635. In particular, under this Nasdaq Stock Market rule, shareholder approval is generally required for: (i)&#160;an acquisition of shares/assets of another company that involves the issuance of 20% or more of the acquirer&#8217;s shares or voting rights or if a director, officer or 5% shareholder has greater than a 5% interest in the target company or the consideration to be received; (ii)&#160;the issuance of shares leading to a change of control; (iii)&#160;adoption/amendment of equity compensation arrangements (although under the provisions of the Companies Law there is no requirement for shareholder approval for the adoption/amendment of the equity compensation plan); and (iv)&#160;issuances of 20% or more of the shares or voting rights (including securities convertible into, or exercisable for, equity) of a listed company via a private placement (and/or via sales by directors/officers/5% shareholders) if such equity is issued (or sold) at below the greater of the book or market value of shares. By contrast, under the Companies Law, shareholder approval is required for, among other things: (i)&#160;transactions with directors concerning the terms of their service or indemnification, exemption and insurance for their service (or for any other position that they may hold at a company), for which approvals of the compensation committee, board of directors and shareholders are all required, (ii)&#160;extraordinary transactions with controlling shareholders of publicly held companies, which require the special approval, and (iii)&#160;terms of employment or other engagement of the controlling shareholder of us or such controlling shareholder&#8217;s relative, which require special approval. In addition, under the Companies Law, a merger requires approval of the shareholders of each of the merging companies.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 124; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->114<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px; text-align: justify">&#160;</td>
    <td style="width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679; </span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Nomination of Directors. </i>We will not have to comply with the requirements that we have a nominating committee composed entirely of independent directors with a written charter addressing the committee&#8217;s purpose and responsibilities. </span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679; </span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Director Independence. </i>Israeli law does not require that a majority of the directors serving on our board of directors be &#8220;independent,&#8221; as defined under Nasdaq Stock Market Rule 5605(a)(2), and rather requires we have at least two external directors who meet the requirements of the Companies Law, as described below under &#8220;Management&#8212;Board Practices&#8212;External Directors.&#8221; The definition of independent director under Nasdaq Stock Market rules and external director under the Companies Law overlap to a significant degree such that we would generally expect the directors serving as external directors to satisfy the requirements to be independent under Nasdaq Stock Market rules. However, it is possible for a director to qualify as an &#8220;external director&#8217;&#8217; under the Companies Law without qualifying as an &#8220;independent director&#8217;&#8217; under the Nasdaq Stock Market rules, or vice-versa. Notwithstanding Israeli law, we believe that a majority of our directors will be &#8220;independent&#8221; under the Nasdaq Stock Market rules. We are required, however, to ensure that all members of our Audit Committee are &#8220;independent&#8221; under the applicable Nasdaq and SEC criteria for independence (as we cannot exempt ourselves from compliance with that SEC independence requirement, despite our status as a foreign private issuer), and we must also ensure that a majority of the members of our Audit Committee are &#8220;independent directors&#8221; as defined in the Companies Law. Furthermore, Israeli law does not require, nor do our independent directors conduct, regularly scheduled meetings at which only they are present, which the Nasdaq Stock Market rules otherwise require </span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Approval of Related Party Transactions</i>. All related party transactions are approved in accordance with the requirements and procedures for approval of interested party acts and transaction as set forth in the Companies Law, which requires the approval of the audit committee, or the compensation committee, as the case may be, the board of directors and shareholders, as may be applicable, for specified transactions, rather than approval by the audit committee or other independent body of our board of directors as required under the Nasdaq Stock Market rules. See &#8220;Item 6.C Directors, Senior Management and Employees&#8212;Board Practices&#8212;Approval of Related Party Transactions under Israeli Law&#8221; for additional information.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;&#160;&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px; text-align: justify">&#160;</td>
    <td style="width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Annual Shareholders Meeting.&#160;</i>&#160;As opposed to the Nasdaq Stock Market Rule 5620(a), which mandates that a listed company hold its annual shareholders meeting within one year of the company&#8217;s fiscal year-end, we are required, under the Companies Law, to hold an annual shareholders meeting each calendar year and within 15 months of the last annual shareholders meeting.</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Distribution of periodic reports to shareholders; proxy solicitation.</i>&#160;As opposed to the Nasdaq Stock Market rules, which require listed issuers to make such reports available to shareholders in one of a number of specific manners, Israeli law does not require us to distribute periodic reports directly to shareholders, and the generally accepted business practice in Israel is not to distribute such reports to shareholders but to make such reports available through a public website. In addition to making such reports available on a public website, we currently make our audited consolidated financial statements available to our shareholders at our offices and will only mail such reports to shareholders upon request. As a foreign private issuer, we are generally exempt from the SEC&#8217;s proxy solicitation rules.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Except
as stated above, we intend to comply with the rules generally applicable to U.S. domestic companies listed on the Nasdaq Capital Market,
subject to certain exemptions the JOBS Act provides to emerging growth companies. We may in the future decide to use other foreign private
issuer exemptions with respect to some or all of the other Nasdaq Listing Rules. Following our home country governance practices, as opposed
to the requirements that would otherwise apply to a company listed on the Nasdaq Capital Market, may provide less protection than is accorded
to investors under the Nasdaq Listing Rules applicable to domestic issuers.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><div><a id="a_074"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><b>ITEM&#160;16H.
MINE SAFETY DISCLOSURE</b></span></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Not applicable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><div><a id="a_075"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>ITEM&#160;16I. DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT
INSPECTIONS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Not applicable.<span style="clear: both; display: block;"><br/></span>
&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 125; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->115<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-size: 6pt">&#160;</span></p><div>

</div><div><a id="a_076"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><b>PART&#160;III</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-size: 6pt">&#160;</span></p><div>

</div><div><a id="a_077"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><b>ITEM&#160;17.
FINANCIAL STATEMENTS</b></span></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-size: 6pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have elected to provide
financial statements and related information pursuant to Item&#160;18.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-size: 6pt">&#160;</span></p><div>

</div><div><a id="a_078"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><b>ITEM&#160;18.
FINANCIAL STATEMENTS</b></span></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-size: 6pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The consolidated financial
statements and the related notes required by this Item are included in this Annual Report on Form 20-F beginning on page&#160;F-1.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-size: 6pt">&#160;</span></p><div>

</div><div><a id="a_079"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><b>ITEM&#160;19. EXHIBITS.</b></span></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-size: 6pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="vertical-align: top; width: 10%; border-bottom: black 1.5pt solid"><span style="font-size: 10pt"><b>Exhibit&#160;No.</b></span></td>
    <td style="width: 1%">&#160;</td>
    <td style="vertical-align: bottom; width: 89%; border-bottom: black 1.5pt solid"><span style="font-size: 10pt"><b>Description</b></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-size: 10pt">1.1</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1899005/000121390023018552/ea174872ex99-1_beamrimag.htm">Amended and Restated Articles of Association of the Registrant (filed as Exhibit 99.1 to our Report on Form 6-K as filed with the Securities and Exchange Commission on March 8, 2023, and incorporated herein by reference)</a></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-size: 10pt">2.1*</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="f20f2022ex2-1_beamrimaging.htm"><span style="font-size: 10pt">Description of Securities Registered under Section 12</span></a></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-size: 10pt">4.1</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1899005/000121390022048262/ea163870ex4-1_beamrimag.htm">Specimen share certificate of the Registrant (filed as Exhibit 4.1 to our Registration Statement on Form F-1 as filed with the Securities and Exchange Commission on August 15, 2022, and incorporated herein by reference)</a></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-size: 10pt">10.1</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1899005/000121390022008695/ea155804ex10-1_beamrimag.htm">Form of Indemnification Agreement (filed as Exhibit 10.1 to our Registration Statement on Form F-1 as filed with the Securities and Exchange Commission on February 22, 2022, and incorporated herein by reference)</a></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-size: 10pt">10.2+</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1899005/000121390022008695/ea155804ex10-2_beamrimag.htm">2010 Option Plan (filed as Exhibit 10.2 to our Registration Statement on Form F-1 as filed with the Securities and Exchange Commission on February 22, 2022, and incorporated herein by reference)</a></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-size: 10pt">10.3+</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1899005/000121390022008695/ea155804ex10-3_beamrimag.htm">2015 Share Incentive Plan (filed as Exhibit 10.3 to our Registration Statement on Form F-1 as filed with the Securities and Exchange Commission on February 22, 2022, and incorporated herein by reference)</a></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-size: 10pt">10.4</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1899005/000121390022038918/ea162604ex10-4_beamrimag.htm">Form of Compensation Policy for Directors and Officers (filed as Exhibit 10.4 to our Registration Statement on Form F-1 as filed with the Securities and Exchange Commission on July 12,2022, and incorporated herein by reference)</a></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-size: 10pt">10.5</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1899005/000121390022008695/ea155804ex10-5_beamrimag.htm">Loan and Security Agreement dated as of February 19, 2017 between Silicon Valley Bank, Beamr Imaging Ltd. and Beamr, Inc. (filed as Exhibit 10.5 to our Registration Statement on Form F-1 as filed with the Securities and Exchange Commission on February 22, 2022, and incorporated herein by reference)</a></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-size: 10pt">10.6</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1899005/000121390022008695/ea155804ex10-6_beamrimag.htm">Warrant to Purchase Shares issued February 19, 2017 to Silicon Valley Bank (filed as Exhibit 10.6 to our Registration Statement on Form F-1 as filed with the Securities and Exchange Commission on February 22, 2022, and incorporated herein by reference).</a></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-size: 10pt">10.7</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1899005/000121390022008695/ea155804ex10-7_beamrimag.htm">Form of Advance Investment Agreement dated August 6, 2019 (filed as Exhibit 10.7 to our Registration Statement on Form F-1 as filed with the Securities and Exchange Commission on February 22, 2022, and incorporated herein by reference).</a></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-size: 10pt">10.8</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1899005/000121390022008695/ea155804ex10-8_beamrimag.htm">Deferral Agreement dated April 15, 2020 between Silicon Valley Bank and Beamr Imaging Ltd and Beamr, Inc. (filed as Exhibit 10.8 to our Registration Statement on Form F-1 as filed with the Securities and Exchange Commission on February 22, 2022, and incorporated herein by reference).</a></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-size: 10pt">10.9</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1899005/000121390022008695/ea155804ex10-9_beamrimag.htm">Deferral Agreement dated April 29, 2021 between Silicon Valley Bank, Beamr Imaging Ltd. and Beamr, Inc. (filed as Exhibit 10.9 to our Registration Statement on Form F-1 as filed with the Securities and Exchange Commission on February 22, 2022, and incorporated herein by reference).</a></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-size: 10pt">10.10</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1899005/000121390022008695/ea155804ex10-10_beamrimag.htm">Warrant to Purchase Stock issued April 29, 2021 to Silicon Valley Bank (filed as Exhibit 10.10 to our Registration Statement on Form F-1 as filed with the Securities and Exchange Commission on February 22, 2022, and incorporated herein by reference).</a></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-size: 10pt">10.11</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1899005/000121390022008695/ea155804ex10-11_beamrimag.htm">Form of Advance Investment Agreement dated August 26, 2021 (filed as Exhibit 10.11 to our Registration Statement on Form F-1 as filed with the Securities and Exchange Commission on February 22, 2022, and incorporated herein by reference).</a></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-size: 10pt">10.12&#x5e;</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1899005/000121390022038918/ea162604ex10-13_beamrimag.htm">Funding Agreement dated as of July 5, 2022 between IBI Spikes Ltd. and Beamr Imaging Ltd. &#160;(filed as Exhibit 10.13 to our Registration Statement on Form F-1 as filed with the Securities and Exchange Commission on July 12, 2022, and incorporated herein by reference)</a></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-size: 10pt">10.13</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1899005/000121390022038918/ea162604ex10-14_beamrimag.htm">Warrant to Purchase Shares of Beamr Imaging Ltd. dated as of July 5, 2022 issued to IBI Spikes Ltd. (filed as Exhibit 10.14 to our Registration Statement on Form F-1 as filed with the Securities and Exchange Commission on July 12, 2022, and incorporated herein by reference)</a></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td>10.14</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1899005/000121390022048262/ea163870ex1-1_beamrimag.htm">Form of Underwriting Agreement (filed as Exhibit 1.1 to our Registration
Statement on Form F-1 as filed with the Securities and Exchange Commission on August 15, 2022, and incorporated herein by reference)</a></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td>10.15</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1899005/000121390022048262/ea163870ex4-2_beamrimag.htm">Form of Representative&#8217;s Warrant (filed as Exhibit 4.2 to our
Registration Statement on Form F-1 as filed with the Securities and Exchange Commission on August 15, 2022, and incorporated herein by
reference)</a></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td>12.1*</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: justify"><a href="f20f2022ex12-1_beamrimaging.htm">Certification of the Chief Executive Officer pursuant to rule 13a-14(a)
of the Securities Exchange Act of 1934</a></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td>12.2*</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: justify"><a href="f20f2022ex12-2_beamrimaging.htm">Certification of the Chief Financial Officer pursuant to rule 13a-14(a)
of the Securities Exchange Act of 1934</a></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td>13.1*</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: justify"><a href="f20f2022ex13-1_beamrimaging.htm">Certification of the Chief Executive Officer pursuant to 18 U.S.C.
1350</a></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td>13.2*</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: justify"><a href="f20f2022ex13-2_beamrimaging.htm">Certification of the Chief Executive Officer pursuant to 18 U.S.C.
1350</a></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-size: 10pt">21.1</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1899005/000121390022008695/ea155804ex21-1_beamrimag.htm">List of Subsidiaries of the Registrant (filed as Exhibit 21.1 to our Registration Statement on Form F-1 as filed with the Securities and Exchange Commission on February 22, 2022, and incorporated herein by reference).</a></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-size: 10pt">101.INS</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt">Inline XBRL Instance Document</span></td></tr>

<tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-size: 10pt">101.SCH</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt">Inline XBRL Taxonomy Extension Schema Document</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-size: 10pt">101.CAL</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt">Inline XBRL Taxonomy Extension Calculation Linkbase Document</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-size: 10pt">101.DEF</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt">Inline XBRL Taxonomy Extension Definition Linkbase Document</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-size: 10pt">101.LAB</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt">Inline XBRL Taxonomy Extension Label Linkbase Document</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-size: 10pt">101.PRE</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt">Inline XBRL Taxonomy Extension Presentation Linkbase Document</span></td></tr>

  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-size: 10pt">104</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt">Cover Page Interactive Data File (embedded within the Inline XBRL document)</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-size: 6pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 24px"><span style="font-size: 10pt">*</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Filed herewith.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><span style="font-size: 6pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">+</span></td><td style="text-align: justify"><span style="font-size: 10pt">Indicates a management contract
or any compensatory plan, contract or arrangement.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 6pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">&#x5e;</span></td><td style="text-align: justify"><span style="font-size: 10pt">Certain schedules and exhibits
have been omitted pursuant to Item 601(a)(5) of Regulation S-K. The Company agrees to furnish supplementally a copy of any omitted schedule
or exhibit to the SEC upon request.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"></p><div>

</div><!-- Field: Page; Sequence: 126; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->116<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&#160;</p><div>

</div><div><a id="a_080"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SIGNATURES</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The
registrant hereby certifies that it meets all of the requirements for filing on Form&#160;20-F and that it has duly caused and authorized
the undersigned to sign this Annual Report on Form 20-F filed on its behalf.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td colspan="2"><span style="font-size: 10pt"><b>BEAMR IMAGING LTD.</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="width: 60%; text-align: justify">&#160;</td>
    <td style="width: 4%; text-align: justify">&#160;</td>
    <td style="width: 36%; text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-size: 10pt">Date: April 24</span>, 2023</td>
    <td style="text-align: justify"><span style="font-size: 10pt">By:</span></td>
    <td style="border-bottom: black 1.5pt solid; white-space: nowrap; text-align: justify"><span style="font-size: 10pt">/s/ Sharon Carmel</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="white-space: nowrap; text-align: justify"><span style="font-size: 10pt">Sharon Carmel</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt">Chief Executive Officer</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 127; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->117<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">BEAMR IMAGING LTD.</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">CONSOLIDATED FINANCIAL STATEMENTS</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>AS OF DECEMBER 31, 2022</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p><div>


</div><!-- Field: Page; Sequence: 128; Options: NewSection; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">BEAMR IMAGING LTD.</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CONSOLIDATED FINANCIAL STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>AS OF DECEMBER 31, 2022</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>INDEX TO CONSOLIDATED FINANCIAL STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse"> <tr style="background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-indent: -0.125in; vertical-align: top; width: 85%; text-align: left"><a href="#fin_001">Report of Independent Registered Public Accounting Firm (PCAOB ID: <ix:nonNumeric contextRef="c0" name="dei:AuditorFirmId">1375</ix:nonNumeric>)</a></td> <td style="vertical-align: bottom; width: 15%; text-align: center">F-3</td></tr> <tr style="background-color: White"> <td style="padding-left: 0.125in; text-indent: -0.125in; vertical-align: top; text-align: left"><a href="#fin_002">Consolidated Balance Sheets as of December 31, 2022 and 2021</a></td> <td style="vertical-align: bottom; text-align: center">F-4</td></tr> <tr style="background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-indent: -0.125in; vertical-align: top; text-align: left"><a href="#fin_003">Consolidated Statements of Operations and Comprehensive Loss for the three years ended December 31, 2022</a></td> <td style="vertical-align: bottom; text-align: center">F-5</td></tr> <tr style="background-color: White"> <td style="padding-left: 0.125in; text-indent: -0.125in; vertical-align: top; text-align: left"><a href="#fin_004">Consolidated Statements of Changes in Shareholders&#8217; Equity (Deficit) for the three years ended December 31, 2022</a></td> <td style="vertical-align: bottom; text-align: center">F-6</td></tr> <tr style="background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-indent: -0.125in; vertical-align: top; text-align: left"><a href="#fin_005">Consolidated Statements of Cash Flows for the three years ended December 31, 2022</a></td> <td style="vertical-align: bottom; text-align: center">F-7</td></tr> <tr style="background-color: White"> <td style="padding-left: 0.125in; text-indent: -0.125in; vertical-align: top; text-align: left"><a href="#fin_006">Notes to Consolidated Financial Statements</a></td> <td style="vertical-align: bottom; text-align: center">F-8 - F-34</td></tr> </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><img alt="" src="image_010.jpg"/>&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>


</div><!-- Field: Page; Sequence: 129; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><img alt="" src="image_011.jpg"/>&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><div><a id="fin_001"></a></div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 76%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Board
    of Directors and Shareholders</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Beamr Imaging Ltd. &#160;</p></td>
    <td style="width: 24%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Fahn Kanne &amp; Co.</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Head Office</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">32 Hamasger Street</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Tel-Aviv 6721118, ISRAEL</i></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>PO Box 36172, 6136101</i></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">T +972 3 7106666</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">F +972 3 7106660<br/>
 www.gtfk.co.il</p></td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Opinion on the financial statements </b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have audited the accompanying consolidated
balance sheets of Beamr Imaging Ltd. and its subsidiaries (the &#8220;Company&#8221;) as of December 31, 2022 and 2021, the related consolidated
statements of operations and comprehensive loss, changes in shareholders&#8217; equity (deficit), and cash flows for each of the three
years in the period ended December 31, 2022, and the related notes (collectively referred to as the &#8220;financial statements&#8221;).
In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December
31, 2022 and 2021, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2022,
in conformity with accounting principles generally accepted in the United States of America.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Basis for opinion </b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">These financial statements are the responsibility
of the Company&#8217;s management. Our responsibility is to express an opinion on the Company&#8217;s financial statements based on our
audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (&#8220;PCAOB&#8221;)
and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable
rules and regulations of the U.S. Securities and Exchange Commission and the PCAOB.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We conducted our audits in accordance with the
standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial
statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged
to perform, an audit of its internal control over financial reporting. As part of our audits, we are required to obtain an understanding
of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company&#8217;s
internal control over financial reporting. Accordingly, we express no such opinion.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our audits included performing procedures to assess
the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond
to those risks. Such procedures included examining, on a test basis, evidence supporting the amounts and disclosures in the financial
statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as
evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">/s/ <ix:nonNumeric contextRef="c0" name="dei:AuditorName">Fahn Kanne &amp; Co. Grant Thornton Israel</ix:nonNumeric></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>FAHN KANNE &amp; CO. GRANT THORNTON ISRAEL</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have served as the Company&#8217;s auditor
since 2021.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><ix:nonNumeric contextRef="c0" name="dei:AuditorLocation">Tel Aviv, Israel</ix:nonNumeric></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">April 24, 2023</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Certified Public Accountants</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b>Fahn Kanne
&amp; Co. is the Israeli member firm of Grant Thornton International Ltd</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>


</div><!-- Field: Page; Sequence: 130; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><div><a id="fin_002"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>BEAMR IMAGING LTD.</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>CONSOLIDATED BALANCE SHEETS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(U.S. dollars in thousands except share and per
share amounts)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="text-align: center; border-bottom: Black 1.5pt solid"><div style="padding: 0cm 0cm 1pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>As
of<br/>
December 31,</b></p> </div></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Note</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: justify">ASSETS</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: justify">Current assets:</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: justify; text-indent: -5.65pt; padding-left: 5.65pt">Cash and cash equivalents</td><td style="width: 1%">&#160;</td>
    <td style="width: 11%; text-align: center; padding-left: 2.85pt">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" unitRef="usd">693</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" unitRef="usd">1,028</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; text-indent: -5.65pt; padding-left: 5.65pt">Trade receivables</td><td>&#160;</td>
    <td style="text-align: center; padding-left: 2.85pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ReceivablesNetCurrent" scale="3" unitRef="usd">581</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ReceivablesNetCurrent" scale="3" unitRef="usd">891</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 1.5pt; text-indent: -5.65pt; padding-left: 5.65pt">Other current assets</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt; padding-left: 2.85pt">3</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherAssetsCurrent" scale="3" unitRef="usd">64</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherAssetsCurrent" scale="3" unitRef="usd">66</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt; text-align: justify; text-indent: -5.65pt; padding-left: 17pt">Total current assets</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: center; padding-left: 2.85pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AssetsCurrent" scale="3" unitRef="usd">1,338</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AssetsCurrent" scale="3" unitRef="usd">1,985</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; text-indent: -5.65pt; padding-left: 5.65pt">&#160;</td><td>&#160;</td>
    <td style="text-align: center; padding-left: 2.85pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: justify; text-indent: -5.65pt; padding-left: 5.65pt">Non-current assets:</td><td>&#160;</td>
    <td style="text-align: center; padding-left: 2.85pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; text-indent: -5.65pt; padding-left: 5.65pt">Deferred offering costs</td><td>&#160;</td>
    <td style="text-align: center; padding-left: 2.85pt">2F</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredCosts" scale="3" unitRef="usd">313</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredCosts" scale="3" unitRef="usd">215</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; text-indent: -5.65pt; padding-left: 5.65pt">Property and equipment, net</td><td>&#160;</td>
    <td style="text-align: center; padding-left: 2.85pt">4</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" unitRef="usd">15</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" unitRef="usd">21</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; text-indent: -5.65pt; padding-left: 5.65pt">Intangible assets, net</td><td>&#160;</td>
    <td style="text-align: center; padding-left: 2.85pt">5</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="3" unitRef="usd">67</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="3" unitRef="usd">87</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt; text-align: justify; text-indent: -5.65pt; padding-left: 5.65pt">Goodwill</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: center; padding-left: 2.85pt">2G, 5</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Goodwill" scale="3" unitRef="usd">4,379</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Goodwill" scale="3" unitRef="usd">4,379</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 1.5pt; text-indent: -5.65pt; padding-left: 17pt">Total non-current assets</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt; padding-left: 2.85pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AssetsNoncurrent" scale="3" unitRef="usd">4,774</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AssetsNoncurrent" scale="3" unitRef="usd">4,702</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; text-indent: -5.65pt; padding-left: 5.65pt">&#160;</td><td>&#160;</td>
    <td style="text-align: center; padding-left: 2.85pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: justify; padding-bottom: 4pt; text-indent: -5.65pt; padding-left: 5.65pt">Total assets</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 4pt; padding-left: 2.85pt">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Assets" scale="3" unitRef="usd">6,112</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Assets" scale="3" unitRef="usd">6,687</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; text-indent: -5.65pt; padding-left: 5.65pt">&#160;</td><td>&#160;</td>
    <td style="text-align: center; padding-left: 2.85pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: justify; text-indent: -5.65pt; padding-left: 5.65pt">LIABILITIES AND SHAREHOLDERS&#8217; EQUITY (DEFICIT)</td><td>&#160;</td>
    <td style="text-align: center; padding-left: 2.85pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: justify; text-indent: -5.65pt; padding-left: 5.65pt">Current liabilities:</td><td>&#160;</td>
    <td style="text-align: center; padding-left: 2.85pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; text-indent: -5.65pt; padding-left: 5.65pt">Current maturities of loans, net</td><td>&#160;</td>
    <td style="text-align: center; padding-left: 2.85pt">6</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShortTermBorrowings" scale="3" unitRef="usd">330</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShortTermBorrowings" scale="3" unitRef="usd">508</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; text-indent: -5.65pt; padding-left: 5.65pt">Account payables</td><td>&#160;</td>
    <td style="text-align: center; padding-left: 2.85pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccountsPayableCurrent" scale="3" unitRef="usd">33</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccountsPayableCurrent" scale="3" unitRef="usd">27</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; text-indent: -5.65pt; padding-left: 5.65pt">Deferred revenues</td><td>&#160;</td>
    <td style="text-align: center; padding-left: 2.85pt">2N</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredRevenueCurrent" scale="3" unitRef="usd">31</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredRevenueCurrent" scale="3" unitRef="usd">33</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; text-indent: -5.65pt; padding-left: 5.65pt">Liability from related party, net</td><td>&#160;</td>
    <td style="text-align: center; padding-left: 2.85pt">14</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DueToRelatedPartiesCurrent" scale="3" unitRef="usd">126</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DueToRelatedPartiesCurrent" scale="3" unitRef="usd">345</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 1.5pt; text-indent: -5.65pt; padding-left: 5.65pt">Other current liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt; padding-left: 2.85pt">7</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherLiabilitiesCurrent" scale="3" unitRef="usd">425</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherLiabilitiesCurrent" scale="3" unitRef="usd">500</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt; text-align: justify; text-indent: -5.65pt; padding-left: 17pt">Total current liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: center; padding-left: 2.85pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesCurrent" scale="3" unitRef="usd">945</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesCurrent" scale="3" unitRef="usd">1,413</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; text-indent: -5.65pt; padding-left: 5.65pt">&#160;</td><td>&#160;</td>
    <td style="text-align: center; padding-left: 2.85pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: justify; text-indent: -5.65pt; padding-left: 5.65pt">Non-current liabilities:</td><td>&#160;</td>
    <td style="text-align: center; padding-left: 2.85pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; text-indent: -5.65pt; padding-left: 5.65pt">Loans, net of current maturities</td><td>&#160;</td>
    <td style="text-align: center; padding-left: 2.85pt">6</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LongTermDebtNoncurrent" scale="3" unitRef="usd">387</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-3">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; text-indent: -5.65pt; padding-left: 5.65pt">Liability from related party, net</td><td>&#160;</td>
    <td style="text-align: center; padding-left: 2.85pt">14</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DueToRelatedPartiesNoncurrent" scale="3" unitRef="usd">262</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-4">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; text-indent: -5.65pt; padding-left: 5.65pt">Derivative warrants liability</td><td>&#160;</td>
    <td style="text-align: center; padding-left: 2.85pt">8</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DerivativeLiabilitiesNoncurrent" scale="3" unitRef="usd">138</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DerivativeLiabilitiesNoncurrent" scale="3" unitRef="usd">50</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1.5pt; text-indent: -5.65pt; padding-left: 5.65pt">Convertible advanced investments</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt; padding-left: 2.85pt">9</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="bmr:ConvertibleAdvancedInvestments" scale="3" unitRef="usd">4,840</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="bmr:ConvertibleAdvancedInvestments" scale="3" unitRef="usd">4,770</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; text-align: justify; text-indent: -5.65pt; padding-left: 17pt">Total non-current liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: center; padding-left: 2.85pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesNoncurrent" scale="3" unitRef="usd">5,627</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesNoncurrent" scale="3" unitRef="usd">4,820</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; text-indent: -5.65pt; padding-left: 5.65pt">&#160;</td><td>&#160;</td>
    <td style="text-align: center; padding-left: 2.85pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: justify; text-indent: -5.65pt; padding-left: 5.65pt">Commitments and contingent liabilities</td><td>&#160;</td>
    <td style="text-align: center; padding-left: 2.85pt">10</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-5">&#160;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-6">&#160;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: justify; text-indent: -5.65pt; padding-left: 5.65pt">&#160;</td><td>&#160;</td>
    <td style="text-align: center; padding-left: 2.85pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: justify; text-indent: -5.65pt; padding-left: 5.65pt">Shareholders&#8217; equity (deficit):</td><td>&#160;</td>
    <td style="text-align: center; padding-left: 2.85pt">11</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -14.2pt; padding-left: 14.2pt">Ordinary Shares of NIS 0.05 par value each:</td><td>&#160;</td>
    <td style="text-align: center; padding-left: 2.85pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left"><div style="-sec-ix-hidden: hidden-fact-8; -sec-ix-hidden: hidden-fact-7">Authorized: <ix:nonFraction contextRef="c4" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" unitRef="shares">14,307,116</ix:nonFraction> and <ix:nonFraction contextRef="c5" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" unitRef="shares">14,316,880</ix:nonFraction> shares at December 31, 2022 and 2021, respectively; Issued and outstanding: <ix:nonFraction contextRef="c4" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesIssued" scale="0" unitRef="shares"><ix:nonFraction contextRef="c5" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesIssued" scale="0" unitRef="shares"><ix:nonFraction contextRef="c4" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" unitRef="shares"><ix:nonFraction contextRef="c5" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" unitRef="shares">2,578,760</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> shares at December 31, 2022 and 2021</div></td><td>&#160;</td>
    <td style="text-align: center; padding-left: 2.85pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CommonStockValue" scale="3" unitRef="usd">51</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CommonStockValue" scale="3" unitRef="usd">51</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -14.2pt; padding-left: 14.2pt">Convertible Ordinary 1 and 2 Shares of NIS 0.05 par value each:</td><td>&#160;</td>
    <td style="text-align: center; padding-left: 2.85pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left"><div style="-sec-ix-hidden: hidden-fact-10; -sec-ix-hidden: hidden-fact-9">Authorized: <ix:nonFraction contextRef="c6" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" unitRef="shares"><ix:nonFraction contextRef="c6" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesIssued" scale="0" unitRef="shares"><ix:nonFraction contextRef="c6" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" unitRef="shares">1,496,880</ix:nonFraction></ix:nonFraction></ix:nonFraction> shares at December 31, 2022 and 2021; Issued and outstanding: <ix:nonFraction contextRef="c7" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" unitRef="shares"><ix:nonFraction contextRef="c7" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesIssued" scale="0" unitRef="shares"><ix:nonFraction contextRef="c7" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" unitRef="shares">1,496,880</ix:nonFraction></ix:nonFraction></ix:nonFraction> shares at December 31, 2022 and 2021</div></td><td>&#160;</td>
    <td style="text-align: center; padding-left: 2.85pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="bmr:CommonStockValue1" scale="3" unitRef="usd">5</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="bmr:CommonStockValue1" scale="3" unitRef="usd">5</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; text-indent: -5.65pt; padding-left: 5.65pt">Convertible Preferred Shares of NIS 0.05 par value each:</td><td>&#160;</td>
    <td style="text-align: center; padding-left: 2.85pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left"><div style="-sec-ix-hidden: hidden-fact-12; -sec-ix-hidden: hidden-fact-11">Authorized: <ix:nonFraction contextRef="c2" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockSharesAuthorized" scale="0" unitRef="shares">6,196,004</ix:nonFraction> and <ix:nonFraction contextRef="c3" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockSharesAuthorized" scale="0" unitRef="shares">6,186,240</ix:nonFraction> shares at December 31, 2022 and 2021, respectively; Issued and outstanding: <ix:nonFraction contextRef="c2" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockSharesIssued" scale="0" unitRef="shares"><ix:nonFraction contextRef="c3" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockSharesIssued" scale="0" unitRef="shares"><ix:nonFraction contextRef="c2" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockSharesOutstanding" scale="0" unitRef="shares"><ix:nonFraction contextRef="c3" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockSharesOutstanding" scale="0" unitRef="shares">5,714,400</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> shares at December 31, 2022 and 2021</div></td><td>&#160;</td>
    <td style="text-align: center; padding-left: 2.85pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockValue" scale="3" unitRef="usd">78</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockValue" scale="3" unitRef="usd">78</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; text-indent: -5.65pt; padding-left: 5.65pt">Additional paid-in capital</td><td>&#160;</td>
    <td style="text-align: center; padding-left: 2.85pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdditionalPaidInCapital" scale="3" unitRef="usd">30,375</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdditionalPaidInCapital" scale="3" unitRef="usd">30,041</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 1.5pt; text-indent: -5.65pt; padding-left: 5.65pt">Accumulated deficit</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt; padding-left: 2.85pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="3" sign="-" unitRef="usd">30,969</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="3" sign="-" unitRef="usd">29,721</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1.5pt; text-indent: -5.65pt; padding-left: 5.65pt">Total shareholders&#8217; equity (deficit)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt; padding-left: 2.85pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" sign="-" unitRef="usd">460</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd">454</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; text-indent: -5.65pt; padding-left: 5.65pt">&#160;</td><td>&#160;</td>
    <td style="text-align: center; padding-left: 2.85pt">&#160;</td><td style="font-size: 1pt">&#160;</td>
    <td style="font-size: 1pt; text-align: left">&#160;</td><td style="font-size: 1pt; text-align: right">&#160;</td><td style="font-size: 1pt; text-align: left">&#160;</td><td style="font-size: 1pt">&#160;</td>
    <td style="font-size: 1pt; text-align: left">&#160;</td><td style="font-size: 1pt; text-align: right">&#160;</td><td style="font-size: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: justify; padding-bottom: 4pt; text-indent: -5.65pt; padding-left: 5.65pt">Total liabilities and shareholders&#8217; equity (deficit)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 4pt; padding-left: 2.85pt">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="3" unitRef="usd">6,112</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="3" unitRef="usd">6,687</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>The accompanying notes are an integral part of these consolidated financial statements.</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><div>


</div><!-- Field: Page; Sequence: 131; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b>&#160;</b></p><div>

</div><div><a id="fin_003"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>BEAMR IMAGING LTD.&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE
LOSS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(U.S. dollars in thousands except share and per
share amounts)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year ended December 31,</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Note</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="6" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: justify; text-indent: -5.65pt; padding-left: 5.65pt">Revenues</td><td style="width: 1%">&#160;</td>
    <td style="width: 11%; text-align: center; padding-left: 5.4pt">16</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="3" unitRef="usd">2,863</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="3" unitRef="usd">3,300</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c9" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="3" unitRef="usd">3,176</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1.5pt; text-indent: -5.65pt; padding-left: 5.65pt">Cost of revenues</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt; padding-left: 5.4pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CostOfRevenue" scale="3" unitRef="usd">98</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CostOfRevenue" scale="3" unitRef="usd">90</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c9" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CostOfRevenue" scale="3" unitRef="usd">94</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; text-indent: -5.65pt; padding-left: 5.65pt">Gross profit</td><td>&#160;</td>
    <td style="text-align: center; padding-left: 5.4pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GrossProfit" scale="3" unitRef="usd">2,765</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GrossProfit" scale="3" unitRef="usd">3,210</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c9" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GrossProfit" scale="3" unitRef="usd">3,082</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; text-indent: -5.65pt; padding-left: 5.65pt">&#160;</td><td>&#160;</td>
    <td style="text-align: center; padding-left: 5.4pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; text-indent: -5.65pt; padding-left: 5.65pt">Research and development expenses</td><td>&#160;</td>
    <td style="text-align: center; padding-left: 5.4pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" unitRef="usd">2,063</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" unitRef="usd">2,032</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c9" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" unitRef="usd">2,727</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; text-indent: -5.65pt; padding-left: 5.65pt">Sales and marketing expenses</td><td>&#160;</td>
    <td style="text-align: center; padding-left: 5.4pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SellingAndMarketingExpense" scale="3" unitRef="usd">905</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SellingAndMarketingExpense" scale="3" unitRef="usd">959</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c9" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SellingAndMarketingExpense" scale="3" unitRef="usd">1,371</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; text-indent: -5.65pt; padding-left: 5.65pt">General and administrative expenses</td><td>&#160;</td>
    <td style="text-align: center; padding-left: 5.4pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="3" unitRef="usd">828</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="3" unitRef="usd">773</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c9" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="3" unitRef="usd">671</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1.5pt; text-indent: -5.65pt; padding-left: 5.65pt">Other income</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt; padding-left: 5.4pt">6B</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherOperatingIncomeExpenseNet" scale="3" unitRef="usd">129</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c9" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherOperatingIncomeExpenseNet" scale="3" unitRef="usd">20</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; text-indent: -5.65pt; padding-left: 5.65pt">&#160;</td><td>&#160;</td>
    <td style="text-align: center; padding-left: 5.4pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: justify; text-indent: -5.65pt; padding-left: 5.65pt">Operating loss</td><td>&#160;</td>
    <td style="text-align: center; padding-left: 5.4pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="3" sign="-" unitRef="usd">1,031</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="3" sign="-" unitRef="usd">425</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c9" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="3" sign="-" unitRef="usd">1,667</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; text-indent: -5.65pt; padding-left: 5.65pt">&#160;</td><td>&#160;</td>
    <td style="text-align: center; padding-left: 5.4pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1.5pt; text-indent: -5.65pt; padding-left: 5.65pt">Financing expenses, net</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt; padding-left: 5.4pt">13</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FinancingInterestExpense" scale="3" unitRef="usd">165</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FinancingInterestExpense" scale="3" unitRef="usd">475</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c9" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FinancingInterestExpense" scale="3" unitRef="usd">697</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; text-indent: -5.65pt; padding-left: 5.65pt">&#160;</td><td>&#160;</td>
    <td style="text-align: center; padding-left: 5.4pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: justify; text-indent: -5.65pt; padding-left: 5.65pt">Loss before taxes on income</td><td>&#160;</td>
    <td style="text-align: center; padding-left: 5.4pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" sign="-" unitRef="usd">1,196</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" sign="-" unitRef="usd">900</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c9" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" sign="-" unitRef="usd">2,364</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; text-indent: -5.65pt; padding-left: 5.65pt">&#160;</td><td>&#160;</td>
    <td style="text-align: center; padding-left: 5.4pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1.5pt; text-indent: -5.65pt; padding-left: 5.65pt">Taxes on income</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt; padding-left: 5.4pt">15</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" unitRef="usd">52</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" unitRef="usd">52</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c9" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" unitRef="usd">95</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; text-indent: -5.65pt; padding-left: 5.65pt">&#160;</td><td>&#160;</td>
    <td style="text-align: center; padding-left: 5.4pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: justify; padding-bottom: 4pt; text-indent: -5.65pt; padding-left: 5.65pt">Net loss and comprehensive loss for the year</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 4pt; padding-left: 5.4pt">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" sign="-" unitRef="usd">1,248</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" sign="-" unitRef="usd">952</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c9" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" sign="-" unitRef="usd">2,459</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; text-indent: -5.65pt; padding-left: 5.65pt">&#160;</td><td>&#160;</td>
    <td style="text-align: center; padding-left: 5.4pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 4pt; text-indent: -5.65pt; padding-left: 5.65pt"><div style="-sec-ix-hidden: hidden-fact-15; -sec-ix-hidden: hidden-fact-14; -sec-ix-hidden: hidden-fact-13">Basic and diluted net loss per share</div></td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 4pt; padding-left: 5.4pt">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareBasic" scale="0" sign="-" unitRef="usdPershares">0.48</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c8" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareBasic" scale="0" sign="-" unitRef="usdPershares">0.37</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c9" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareBasic" scale="0" sign="-" unitRef="usdPershares">0.96</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; text-indent: -5.65pt; padding-left: 5.65pt">&#160;</td><td>&#160;</td>
    <td style="text-align: center; padding-left: 5.4pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 4pt; text-indent: -11.35pt; padding-left: 11.35pt"><div style="-sec-ix-hidden: hidden-fact-18; -sec-ix-hidden: hidden-fact-17; -sec-ix-hidden: hidden-fact-16">Weighted average number of Ordinary Shares used in computing basic and diluted net loss per share</div></td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 4pt; padding-left: 5.4pt">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" unitRef="shares">2,578,760</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c8" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" unitRef="shares">2,578,760</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c9" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" unitRef="shares">2,574,814</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><b>The accompanying notes are an integral part of these consolidated financial statements.</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>


</div><!-- Field: Page; Sequence: 132; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><div><a id="fin_004"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>BEAMR IMAGING LTD.</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS&#8217;
EQUITY (DEFICIT)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(U.S. dollars in thousands except share and per
share amounts)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Ordinary shares</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Convertible<br/> Ordinary 1 and 2 shares</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Convertible<br/> Preferred shares</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">Additional<br/> paid-in</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">Accumulated</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold; text-align: center">Total<br/> shareholders&#8217;<br/>
Equity</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Number</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amount</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Number</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amount</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Number</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amount</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">capital</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">deficit</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">(deficit)</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; width: 32.5%; text-align: left">Balance as of January 1, 2020</td><td style="width: 0.5%">&#160;</td>
    <td style="width: 0.5%; text-align: left">&#160;</td><td style="width: 6%; text-align: right"><ix:nonFraction contextRef="c10" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="0" unitRef="shares">2,568,960</ix:nonFraction></td><td style="width: 0.5%; text-align: left">&#160;</td><td style="width: 0.5%">&#160;</td>
    <td style="width: 0.5%; text-align: left">&#160;</td><td style="width: 6%; text-align: right"><ix:nonFraction contextRef="c10" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd">51</ix:nonFraction></td><td style="width: 0.5%; text-align: left">&#160;</td><td style="width: 0.5%">&#160;</td>
    <td style="width: 0.5%; text-align: left">&#160;</td><td style="width: 6%; text-align: right"><ix:nonFraction contextRef="c11" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="0" unitRef="shares">1,496,880</ix:nonFraction></td><td style="width: 0.5%; text-align: left">&#160;</td><td style="width: 0.5%">&#160;</td>
    <td style="width: 0.5%; text-align: left">&#160;</td><td style="width: 6%; text-align: right"><ix:nonFraction contextRef="c11" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd">5</ix:nonFraction></td><td style="width: 0.5%; text-align: left">&#160;</td><td style="width: 0.5%">&#160;</td>
    <td style="width: 0.5%; text-align: left">&#160;</td><td style="width: 6%; text-align: right"><ix:nonFraction contextRef="c12" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="0" unitRef="shares">5,714,400</ix:nonFraction></td><td style="width: 0.5%; text-align: left">&#160;</td><td style="width: 0.5%">&#160;</td>
    <td style="width: 0.5%; text-align: left">&#160;</td><td style="width: 6%; text-align: right"><ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd">78</ix:nonFraction></td><td style="width: 0.5%; text-align: left">&#160;</td><td style="width: 0.5%">&#160;</td>
    <td style="width: 0.5%; text-align: left">&#160;</td><td style="width: 6%; text-align: right"><ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd">29,753</ix:nonFraction></td><td style="width: 0.5%; text-align: left">&#160;</td><td style="width: 0.5%">&#160;</td>
    <td style="width: 0.5%; text-align: left">&#160;</td><td style="width: 6%; text-align: right">(<ix:nonFraction contextRef="c14" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" sign="-" unitRef="usd">26,310</ix:nonFraction></td><td style="width: 0.5%; text-align: left">)</td><td style="width: 0.5%">&#160;</td>
    <td style="width: 0.5%; text-align: left">&#160;</td><td style="width: 6%; text-align: right"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd">3,577</ix:nonFraction></td><td style="width: 0.5%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Exercise of share options into Ordinary Shares (Note
    12)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c16" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" scale="0" unitRef="shares">9,800</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-19; font-size: 10pt">*</span></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-20">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-21">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c19" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" unitRef="usd">11</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-22">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c9" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" unitRef="usd">11</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Share-based compensation (Note 12)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-23">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-24">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-25">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-26">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-27">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c19" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" unitRef="usd">120</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-28">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c9" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" unitRef="usd">120</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Net loss for the year</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-29">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-30">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-31">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-32">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c20" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" sign="-" unitRef="usd">2,459</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c9" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" sign="-" unitRef="usd">2,459</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Balance as of December 31, 2020</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c21" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="0" unitRef="shares">2,578,760</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c21" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd">51</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c22" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="0" unitRef="shares">1,496,880</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c22" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd">5</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c23" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="0" unitRef="shares">5,714,400</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c23" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd">78</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c24" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd">29,884</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(<ix:nonFraction contextRef="c25" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" sign="-" unitRef="usd">28,769</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c26" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd">1,249</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Share-based compensation (Note 12)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-33">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-34">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-35">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c30" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" unitRef="usd">157</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-36">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" unitRef="usd">157</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Net loss for the year</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-37">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-38">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-39">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-40">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c31" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" sign="-" unitRef="usd">952</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" sign="-" unitRef="usd">952</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Balance as of December 31, 2021</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="0" unitRef="shares">2,578,760</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd">51</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="0" unitRef="shares">1,496,880</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd">5</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c32" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="0" unitRef="shares">5,714,400</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c32" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd">78</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c33" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd">30,041</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(<ix:nonFraction contextRef="c34" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" sign="-" unitRef="usd">29,721</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd">454</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Contribution to equity due to free interest loan from
    controlling shareholder (Note&#160;14)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-41">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-42">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-43">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c38" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueOther" scale="3" unitRef="usd">112</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueOther" scale="3" unitRef="usd">112</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Share-based compensation (Note 12)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-44">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-45">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-46">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c38" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" unitRef="usd">222</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-47">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" unitRef="usd">222</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Net loss for the year</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-48">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-49">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-50">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-51">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c39" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" sign="-" unitRef="usd">1,248</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" sign="-" unitRef="usd">1,248</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 4pt">Balance as of December 31, 2022</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="0" unitRef="shares">2,578,760</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd">51</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="0" unitRef="shares">1,496,880</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd">5</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c40" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="0" unitRef="shares">5,714,400</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c40" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd">78</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c41" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd">30,375</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c42" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" sign="-" unitRef="usd">30,969</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" sign="-" unitRef="usd">460</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">)</td></tr>
  </table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left">*)</td><td style="text-align: justify"><ix:footnote id="ix_0_footnote" xml:lang="en-US">Representing an amount less than $1.</ix:footnote></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: left; text-indent: -21.3pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>The accompanying notes
are an integral part of these consolidated financial statements.</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p><div>


</div><!-- Field: Page; Sequence: 133; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><div><a id="fin_005"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>BEAMR IMAGING LTD.</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>CONSOLIDATED STATEMENTS OF CASH FLOWS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(U.S. dollars in
thousands except share and per share amounts)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Year ended December 31</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left">Cash flows from operating activities:</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; width: 64%; text-align: left; padding-left: 0.25in">Net loss</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" sign="-" unitRef="usd">1,248</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(<ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" sign="-" unitRef="usd">952</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(<ix:nonFraction contextRef="c9" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" sign="-" unitRef="usd">2,459</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.25in">Adjustments required to reconcile net loss to net cash used in operating activities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.375in">Depreciation and amortization</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" unitRef="usd">28</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" unitRef="usd">193</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c9" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" unitRef="usd">679</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.375in">Share-based compensation (Note 12)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="3" unitRef="usd">222</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="3" unitRef="usd">157</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c9" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="3" unitRef="usd">120</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.375in">Amortization of discount relating to straight loan received from commercial bank (Note 6)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AmortizationOfDebtDiscountPremium" scale="3" unitRef="usd">14</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AmortizationOfDebtDiscountPremium" scale="3" unitRef="usd">14</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c9" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AmortizationOfDebtDiscountPremium" scale="3" unitRef="usd">29</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.375in">Exchange rate differences on straight loan received from commercial bank (Note 6)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="3" unitRef="usd">12</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.375in">Amortization of discount relating to liability to related party (see Note 14)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AmortizationOfFinancingCosts" scale="3" unitRef="usd">40</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.375in">Change in the fair value of convertible advanced investments (Note 9)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FairValueOptionChangesInFairValueGainLoss1" scale="3" sign="-" unitRef="usd">70</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FairValueOptionChangesInFairValueGainLoss1" scale="3" sign="-" unitRef="usd">288</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c9" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FairValueOptionChangesInFairValueGainLoss1" scale="3" sign="-" unitRef="usd">436</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.375in">Capital gain from selling of property and equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-52">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c9" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" scale="3" unitRef="usd">5</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.375in">Capital loss from disposal of property and equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GainLossOnDispositionOfAssets" scale="3" sign="-" unitRef="usd">6</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.375in">Modification of terms of straight loan (Note 6A)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="bmr:ModificationOfTermsOfStraightLoan" scale="3" sign="-" unitRef="usd">90</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.375in">Forgiveness of loan under paycheck protection program notes (Note 6B)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GainsLossesOnRestructuringOfDebt" scale="3" unitRef="usd">129</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.375in">Decrease (increase) in trade receivables</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInOtherReceivables" scale="3" sign="-" unitRef="usd">310</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInOtherReceivables" scale="3" sign="-" unitRef="usd">704</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c9" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInOtherReceivables" scale="3" unitRef="usd">113</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.375in">Decrease (increase) in other current assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInOtherCurrentAssets" scale="3" sign="-" unitRef="usd">2</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInOtherCurrentAssets" scale="3" unitRef="usd">26</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c9" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInOtherCurrentAssets" scale="3" sign="-" unitRef="usd">366</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.375in">Increase (decrease) in account payables</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="3" unitRef="usd">6</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="3" unitRef="usd">16</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c9" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="3" sign="-" unitRef="usd">14</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.375in">Increase (decrease) in deferred revenues</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInDeferredRevenue" scale="3" sign="-" unitRef="usd">2</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInDeferredRevenue" scale="3" sign="-" unitRef="usd">32</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c9" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInDeferredRevenue" scale="3" unitRef="usd">31</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.375in">Increase in liability from related party</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInDueFromRelatedParties" scale="3" sign="-" unitRef="usd">177</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c9" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInDueFromRelatedParties" scale="3" sign="-" unitRef="usd">168</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt; padding-left: 0.375in">Increase (decrease) in other current liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInOtherCurrentLiabilities" scale="3" sign="-" unitRef="usd">75</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInOtherCurrentLiabilities" scale="3" unitRef="usd">63</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c9" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInOtherCurrentLiabilities" scale="3" sign="-" unitRef="usd">258</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt; padding-left: 0.25in">Net cash provided by (used in) operating activities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="3" sign="-" unitRef="usd">645</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="3" unitRef="usd">569</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c9" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="3" sign="-" unitRef="usd">1,020</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left">Cash flows from investing activities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.25in">Purchase of property and equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" unitRef="usd">2</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" unitRef="usd">4</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c9" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" unitRef="usd">7</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt; padding-left: 0.25in">Selling of property and equipment</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-53">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c9" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" scale="3" unitRef="usd">8</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt; padding-left: 0.25in">Net cash provided by (used in) investing activities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" sign="-" unitRef="usd">2</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" sign="-" unitRef="usd">4</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c9" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" unitRef="usd">1</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left">Cash flows from financing activities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.25in">Deferred offering costs (Note 2F)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsOfFinancingCosts" scale="3" unitRef="usd">98</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsOfFinancingCosts" scale="3" unitRef="usd">215</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.25in">Proceeds received from issuance of convertible advanced investments (Note 9)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="3" unitRef="usd">560</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.25in">Proceeds received from paycheck protection program note (Note 6B)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromNotesPayable" scale="3" unitRef="usd">54</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c9" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromNotesPayable" scale="3" unitRef="usd">75</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.25in">Repayment of principal relating to straight loan received from commercial bank (Note 6)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RepaymentsOfRelatedPartyDebt" scale="3" unitRef="usd">582</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RepaymentsOfRelatedPartyDebt" scale="3" unitRef="usd">500</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c9" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RepaymentsOfRelatedPartyDebt" scale="3" unitRef="usd">504</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.25in">Repayment of Facility Fee relating to straight loan received from commercial bank (Note 6)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RepaymentsOfFederalHomeLoanBankBorrowings" scale="3" unitRef="usd">10</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RepaymentsOfFederalHomeLoanBankBorrowings" scale="3" unitRef="usd">40</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.25in">Proceeds from issuance of unit consist of straight loan and warrant granted to commercial bank, net (Note 6C)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" scale="3" unitRef="usd">887</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.25in">Proceeds from loan received from related party</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromRelatedPartyDebt" scale="3" unitRef="usd">115</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt; padding-left: 0.25in">Proceeds received from exercise of share options into Ordinary Shares (Note 12)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-54">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c9" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromStockOptionsExercised" scale="3" unitRef="usd">11</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt; padding-left: 0.25in">Net cash provided by (used in) financing activities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" unitRef="usd">312</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" sign="-" unitRef="usd">141</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c9" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" sign="-" unitRef="usd">418</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left">Change in cash, cash equivalents</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="3" sign="-" unitRef="usd">335</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="3" unitRef="usd">424</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c9" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="3" sign="-" unitRef="usd">1,437</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt">Cash, cash equivalents at beginning of year</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" unitRef="usd">1,028</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c26" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" unitRef="usd">604</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" unitRef="usd">2,041</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 4pt">Cash, cash equivalents at end of year</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" unitRef="usd">693</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" unitRef="usd">1,028</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c26" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" unitRef="usd">604</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left">Non-cash financing activities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 4pt">Contribution to equity due to free interest loan from controlling shareholder (Note 14)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssued1" scale="3" unitRef="usd">112</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">-</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">-</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><b>Supplemental disclosure of
cash flow information:</b></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>

<tr style="vertical-align: bottom; background-color: White">
    <td style="width: 64%; text-align: left; padding-bottom: 4pt">Interest paid</td><td style="width: 1%; padding-bottom: 4pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 4pt double; text-align: left">$</td><td style="width: 9%; border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InterestPaidNet" scale="3" unitRef="usd">77</ix:nonFraction></td><td style="width: 1%; padding-bottom: 4pt; text-align: left">)</td><td style="width: 1%; padding-bottom: 4pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 4pt double; text-align: left">$</td><td style="width: 9%; border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InterestPaidNet" scale="3" unitRef="usd">90</ix:nonFraction></td><td style="width: 1%; padding-bottom: 4pt; text-align: left">)</td><td style="width: 1%; padding-bottom: 4pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 4pt double; text-align: left">$</td><td style="width: 9%; border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c9" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InterestPaidNet" scale="3" unitRef="usd">91</ix:nonFraction></td><td style="width: 1%; padding-bottom: 4pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 4pt">Taxes paid</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxesPaid" scale="3" unitRef="usd">54</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxesPaid" scale="3" unitRef="usd">49</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c9" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxesPaid" scale="3" unitRef="usd">99</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">)</td></tr>
  </table><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b>The accompanying notes are an integral part of these consolidated financial statements.</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 134; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><div><a id="fin_006"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>BEAMR IMAGING LTD.&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS </b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(U.S. dollars in
thousands except share and per share amounts)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2cm; text-align: justify; text-indent: -2cm"><span style="font-weight: normal">&#160;</span></p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_1" escape="true" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2cm; text-align: justify; text-indent: -2cm">NOTE 1 - GENERAL</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: left; text-indent: -1cm"><b>&#160;</b></p></ix:nonNumeric><div>

</div><div>

</div><ix:continuation continuedAt="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_2" id="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_1"><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0%"></td><td style="width: 0.5in"><b>A.</b></td><td style="text-align: left"><b>Operations</b></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_3" id="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Beamr Imaging Ltd. (the &#8220;Company&#8221;
or &#8220;Beamr&#8221;) was incorporated on October 1, 2009 under the laws of the State of Israel and it engages in the development of
optimization technologies for video and photo compression.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: left; text-indent: -1cm"><b>&#160;</b></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_4" id="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_3"><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0%"></td><td style="width: 0.5in"><b>B.</b></td><td style="text-align: left"><b>Foreign operations</b></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.5pt; text-align: justify; text-indent: -22.5pt"><b>&#160;</b></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_5" id="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_4"><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in"><b>1.</b></td><td style="text-align: justify"><b>Beamr Inc.</b></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.5pt; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_6" id="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_5"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">In 2012, the Company incorporated a
wholly-owned U.S. subsidiary, Beamr Inc. (&#8220;Beamr Inc.&#8221;), for the purpose of reselling the Company&#8217;s software and products
in the U.S. and Canadian markets.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.5pt; text-align: justify; text-indent: -22.5pt"><b>&#160;</b></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_7" id="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_6"><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in"><b>2.</b></td><td style="text-align: justify"><b>Beamr Imaging RU LLC </b></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.5pt; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_8" id="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_7"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">In 2016, the Company incorporated a
wholly-owned Russian limited partnership, Beamr Imaging RU LLC, (&#8220;Beamr Imaging RU&#8221;) for the purpose of conducting research
and development services to the Company.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_9" id="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_8"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company and its subsidiaries, Beamr
Inc. and Beamr Imaging RU, are collectively referred to as the &#8220;Group&#8221;.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: left; text-indent: -1cm"><b>&#160;</b></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_10" id="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_9"><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0%"></td><td style="width: 0.5in"><b>C.</b></td><td style="text-align: left"><b>Liquidity and capital resources </b></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_11" id="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_10"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company has devoted substantially
all of its efforts to research and development, the commercialization of its software and products and raising capital for such purposes.
The development and commercialization of the Company&#8217;s software and products are expected to require substantial further expenditures.
To date, the Company has not yet generated sufficient revenues from operations to support its activities, and therefore it is dependent
upon external sources for financing its operations. In 2022, the Company had net losses of $<ix:nonFraction contextRef="c43" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" unitRef="usd">1,248</ix:nonFraction>. As of December 31, 2022, the Company
had an accumulated deficit of $<ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="3" sign="-" unitRef="usd">30,969</ix:nonFraction>. The Company plans to finance its operations through the sales of equity (including the Company&#8217;s
Initial Public Offering (IPO) of its ordinary shares, par value NIS <ix:nonFraction contextRef="c4" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:VariableInterestDifferenceBetweenCarryingAmountAndMaximumExposure" scale="0" unitRef="ils">0.05</ix:nonFraction> per share, of the Company (the &#8220;Ordinary Shares&#8221;)
that closed in March 2023) and to the extent available, refinancing of liabilities on a long-term basis and through revenues from sales
of its software, products and related services. In addition, the Company has recently commenced collaborating with a strategic partner
in development of the Company&#8217;s next generation product, the Beamr HW-Accelerated Content Adaptive Encoding, which is expected to allow
the Company to potentially access new customers and new markets with relatively low sales investment.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_12" id="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_11"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">During the year ended December 31, 2020,
the Company raised net amounts of $<ix:nonFraction contextRef="c9" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromNotesPayable" scale="3" unitRef="usd">75</ix:nonFraction> and $<ix:nonFraction contextRef="c9" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromStockOptionsExercised" scale="3" unitRef="usd">11</ix:nonFraction> through the paycheck protection program and exercise of share options into Ordinary Shares,
respectively (see also Note 6B and Note 12, respectively). During the year ended December 31, 2021, the Company raised net amounts of
$<ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromNotesPayable" scale="3" unitRef="usd">54</ix:nonFraction> and $<ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="3" unitRef="usd">560</ix:nonFraction> through the paycheck protection program and issuance of convertible advanced investment, respectively (see also Note 6B and
Note 9, respectively). During the year ended December 31, 2022, the Company raised net amounts of $<ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CapitalUnitsNetAmount" scale="3" unitRef="usd">887</ix:nonFraction> through a Funding Agreement with
IBI Spikes Ltd (see also Note 6C).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_13" id="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_12"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Management has considered the significance
of such conditions in relation to the Company&#8217;s ability to meet its current obligations and to achieve its business targets and determined
that these conditions are not raising substantial doubt about the Company&#8217;s ability to continue as a going concern taking into consideration,
among others (i) an agreement from February 2022 with the Company&#8217;s founder and significant shareholder (the &#8220;Founder&#8221;) under
which the Company&#8217;s outstanding current liability towards an entity controlled by the Founder (the &#8220;Service Provider&#8221;), as
noted in Note 14, will be paid in 18 equal installments pending availability of sufficient liquidity funds and (ii) the execution of a
definitive agreement (the &#8220;Definitive Agreement&#8221;) with another commercial bank for receiving straight loan and issuance of
warrants, as noted in Note 6C. As of December 31, 2022, it was agreed to extend the term of liability to the Service Provider (including
with respect to amount relating to services provided to the Company by the Service Provider throughout fiscal year ended December 31,
2022).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_14" id="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_13"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">On February 27, 2023, the Company announced
the pricing of its initial public offering of <ix:nonFraction contextRef="c44" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" scale="0" unitRef="usd">1,950,000</ix:nonFraction> Ordinary Shares at a public offering price of $<ix:nonFraction contextRef="c45" decimals="2" format="ixt:num-dot-decimal" name="bmr:PublicOfferingPrice" scale="0" unitRef="usdPershares">4.00</ix:nonFraction> per share, for aggregate gross
proceeds of $<ix:nonFraction contextRef="c46" decimals="-3" format="ixt:num-dot-decimal" name="bmr:AggregateGrossProceeds" scale="3" unitRef="usd">7,800</ix:nonFraction> prior to deducting underwriting discounts and other offering expenses. For additional information, see also Note 17.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: left; text-indent: -1cm"><b>&#160;</b></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_15" id="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_14"><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0%"></td><td style="width: 0.5in"><b>D.</b></td><td style="text-align: left"><b>The impact of COVID-19</b></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_16" id="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_15"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">During the year ended December 31, 2022,
there were no material adverse impacts on the consolidated financial statements. The duration, scope and effects of the ongoing COVID-19
pandemic, government and other third-party responses to it, the related macroeconomic effects, and the extent of its impact on the Company&#8217;s
operational and financial performance will depend on future developments. As events continue to evolve and additional information becomes
available, the Company&#8217;s estimates and assumptions may change in future periods.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 135; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>BEAMR IMAGING LTD.&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Cont.)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(U.S. dollars in
thousands except share and per share amounts)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2cm; text-align: justify; text-indent: -2cm"><span style="font-weight: normal">&#160;</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2cm; text-align: justify; text-indent: -2cm">NOTE 1 - GENERAL
(Cont.)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: left; text-indent: -1cm"><b>&#160;</b></p><div>

</div><ix:continuation continuedAt="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_17" id="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_16"><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0%"></td><td style="width: 0.5in"><b>E.</b></td><td style="text-align: left"><b>The impact of the Russian Invasion of Ukraine</b></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation id="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_17"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">On February 24, 2022, Russia invaded Ukraine.
The Company has an operation in Russia through its wholly-owned subsidiary, Beamr Imaging RU. The Company undertakes some of its software
development and design, quality assurance and support in Russia using personnel located there. While most of the Company&#8217;s developers
are located in Russia, its research and development leadership are all located in Israel. The Company has no manufacturing operations
in Russia, and the Company does not sell any products in Russia. The Company constantly evaluates its activities in Russia and currently
believes there was no significant impact on its activities.</p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify">&#160;</p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_1" escape="true" name="us-gaap:SignificantAccountingPoliciesTextBlock"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2cm; text-align: justify; text-indent: -2cm">NOTE 2 - SIGNIFICANT
ACCOUNTING POLICIES</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:nonNumeric><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_2" id="_SignificantAccountingPoliciesTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The financial statements have been prepared in
accordance with accounting principles generally accepted in the United States of America (&#8220;US GAAP&#8221;).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: left; text-indent: -1cm"><b>&#160;</b></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_3" id="_SignificantAccountingPoliciesTextBlock-c0_cont_2"><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0%"></td><td style="width: 0.5in"><b>A.</b></td><td style="text-align: left"><ix:nonNumeric contextRef="c0" continuedAt="_UseOfEstimates-c0_cont_1" escape="true" name="us-gaap:UseOfEstimates"><b>Use of estimates in the preparation of financial statements </b></ix:nonNumeric></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_4" id="_SignificantAccountingPoliciesTextBlock-c0_cont_3"><ix:continuation id="_UseOfEstimates-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The preparation of the financial statements
in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities
and the disclosure of contingent assets and liabilities at the dates of the financial statements, and the reported amounts of revenue
and expenses during the reported periods. Actual results could differ from those estimates. As applicable to these financial statements,
the most significant estimates and assumptions include (i) revenues recognition; (ii) identification of and measurement of financial instruments
in funding transactions; (iii) recoverability of the Company&#8217;s goodwill upon subsequent periods (iv) measurement of fair value of
equity awards and (v) evaluation of going concern.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: left; text-indent: -1cm"><b>&#160;</b></p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_5" id="_SignificantAccountingPoliciesTextBlock-c0_cont_4"><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0%"></td><td style="width: 0.5in"><b>B.</b></td><td style="text-align: left"><ix:nonNumeric contextRef="c0" continuedAt="_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"><b>Functional currency</b></ix:nonNumeric></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_6" id="_SignificantAccountingPoliciesTextBlock-c0_cont_5"><ix:continuation continuedAt="_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock-c0_cont_2" id="_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The functional currency of the Company
and all of its subsidiaries all of which are primarily a direct and integral component of the Company&#8217;s operation is the US dollar (&#8220;$&#8221;
or &#8220;dollar&#8221;), as the dollar is the primary currency of the economic environment in which the Company and its subsidiaries
have operated (which is the currency of the environment in which an entity primarily generates cash) and expects to continue to operate
in the foreseeable future.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_7" id="_SignificantAccountingPoliciesTextBlock-c0_cont_6"><ix:continuation id="_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In accordance with ASC 830, &#8220;Foreign
Currency Matters&#8221;, balances denominated in or linked to foreign currency are stated on the basis of the exchange rates prevailing
at the applicable balance sheet date. For foreign currency transactions included in the consolidated Statement of Operations and Comprehensive
Loss, the exchange rates applicable on the relevant transaction dates are used. Gains or losses arising from changes in the exchange rates
used in the translation of such transactions are presented within financing income or expenses.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: left; text-indent: -1cm"><b>&#160;</b></p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_8" id="_SignificantAccountingPoliciesTextBlock-c0_cont_7"><ix:nonNumeric contextRef="c0" continuedAt="_ConsolidationPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:ConsolidationPolicyTextBlock"><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0%"></td><td style="width: 0.5in"><b>C.</b></td><td style="text-align: left"><b>Principles of Consolidation</b></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify">&#160;</p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_9" id="_SignificantAccountingPoliciesTextBlock-c0_cont_8"><ix:continuation id="_ConsolidationPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The consolidated financial statements
include the accounts of the Group. Intercompany transactions and balances have been eliminated upon consolidation.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: left; text-indent: -1cm"><b>&#160;</b></p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_10" id="_SignificantAccountingPoliciesTextBlock-c0_cont_9"><ix:nonNumeric contextRef="c0" continuedAt="_CashAndCashEquivalentsPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock"><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0%"></td><td style="width: 0.5in"><b>D.</b></td><td style="text-align: left"><b>Cash and cash equivalents</b></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify">&#160;</p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_11" id="_SignificantAccountingPoliciesTextBlock-c0_cont_10"><ix:continuation id="_CashAndCashEquivalentsPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Cash equivalents are short-term highly
liquid investments which include short term bank deposits (up to three months from date of deposit), that are not restricted as to withdrawals
or use and that are readily convertible to cash with maturities of three months or less as of the date acquired.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: left; text-indent: -1cm"><b>&#160;</b></p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_12" id="_SignificantAccountingPoliciesTextBlock-c0_cont_11"><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0%"></td><td style="width: 0.5in"><b>E.</b></td><td style="text-align: left"><ix:nonNumeric contextRef="c0" continuedAt="_ResearchAndDevelopmentExpensePolicy-c0_cont_1" escape="true" name="us-gaap:ResearchAndDevelopmentExpensePolicy"><b>Research and development expenses </b></ix:nonNumeric></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_13" id="_SignificantAccountingPoliciesTextBlock-c0_cont_12"><ix:continuation continuedAt="_ResearchAndDevelopmentExpensePolicy-c0_cont_2" id="_ResearchAndDevelopmentExpensePolicy-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Research and development expenses are
charged to operations, as incurred.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_14" id="_SignificantAccountingPoliciesTextBlock-c0_cont_13"><ix:continuation id="_ResearchAndDevelopmentExpensePolicy-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">ASC 985-20, &#8220;Software - Costs of
Computer Software to be Sold, Leased or Otherwise Marketed&#8221;, requires capitalization of certain software development costs subsequent
to the establishment of technological feasibility. In accordance with ASC 985-20, capitalization ceases when the related product is available
for general release to customers. Costs of maintenance and customer support are charged to expenses, as incurred. Based on the Company&#8217;s
product development process, technological feasibility is established upon completion of a working model. Costs incurred by the Company
between completion of the working models and the point at which the products are ready for general release have been insignificant. Therefore,
all research and development costs have been expensed.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>


</div><!-- Field: Page; Sequence: 136; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>BEAMR IMAGING LTD.&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Cont.)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(U.S. dollars in
thousands except share and per share amounts)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2cm; text-align: justify; text-indent: -2cm"><span style="font-weight: normal">&#160;</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2cm; text-align: justify; text-indent: -2cm">NOTE 2 - SIGNIFICANT
ACCOUNTING POLICIES (Cont.)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: left; text-indent: -1cm"><b>&#160;</b></p><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_15" id="_SignificantAccountingPoliciesTextBlock-c0_cont_14"><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0%"></td><td style="width: 0.5in"><b>F.</b></td><td style="text-align: left"><ix:nonNumeric contextRef="c0" continuedAt="_DeferredChargesPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:DeferredChargesPolicyTextBlock"><b>Deferred offering costs </b></ix:nonNumeric></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_16" id="_SignificantAccountingPoliciesTextBlock-c0_cont_15"><ix:continuation id="_DeferredChargesPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Prior to the effective
date of an offering of equity securities, specific incremental costs directly (i.e. accounting, consulting, legal and printing fees) attributable
to a proposed or actual offering of securities are deferred and charged against the gross proceeds of the offering, unless the offering
of equity securities has been delayed but is currently in process, under which such specific incremental and direct costs are charged
immediately to operations. As of December 31, 2022, the Company deferred specific incremental costs directly attributable to offering
of securities through its IPO that closed in March 2023 in total amount of $<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" scale="3" unitRef="usd">313</ix:nonFraction>, which was classified as non-current asset in the Company&#8217;s
Consolidated Balance Sheet.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: left; text-indent: -1cm"><b>&#160;</b></p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_17" id="_SignificantAccountingPoliciesTextBlock-c0_cont_16"><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0%"></td><td style="width: 0.5in"><b>G.</b></td><td style="text-align: left"><ix:nonNumeric contextRef="c0" continuedAt="_GoodwillAndIntangibleAssetsPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock"><b>Goodwill and Intangible Assets</b></ix:nonNumeric></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_18" id="_SignificantAccountingPoliciesTextBlock-c0_cont_17"><ix:continuation continuedAt="_GoodwillAndIntangibleAssetsPolicyTextBlock-c0_cont_2" id="_GoodwillAndIntangibleAssetsPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Goodwill is the amount
by which the purchase price of acquired net assets in a business combination exceeded the fair values of the net identifiable assets on
the date of acquisition.&#160;Goodwill is not amortized but evaluated for impairment annually or more frequently if events or changes
in circumstances indicate that the asset might be impaired. The provisions of ASC 350 &#8220;Intangibles-Goodwill and Other&#8221; (&#8220;ASC
350&#8221;) require that the impairment test be performed on goodwill at the level of the reporting unit. As required by ASC 350, the
Company chooses either to perform a qualitative assessment whether a goodwill impairment test is necessary or proceeds directly to the
goodwill impairment test. Such determination is made for each reporting unit on a stand-alone basis. The qualitative assessment includes
various factors such as macroeconomic conditions, industry and market considerations, cost factors, overall financial performance, earnings
multiples, gross margin and cash flows from operating activities and other relevant factors. When the Company chooses to perform a qualitative
assessment and determines that it is more likely than not (more than 50 percent likelihood) that the fair value of the reporting unit
is less than its carrying value, then the Company proceeds to the goodwill impairment test. If the Company determines otherwise, no further
evaluation is necessary.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_19" id="_SignificantAccountingPoliciesTextBlock-c0_cont_18"><ix:continuation continuedAt="_GoodwillAndIntangibleAssetsPolicyTextBlock-c0_cont_3" id="_GoodwillAndIntangibleAssetsPolicyTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">When the Company decides
or is required to perform the quantitative goodwill impairment test, the Company compares the fair value of the reporting unit to its
carrying value and an impairment charge is recognized for the amount by which the carrying amount exceeds the reporting unit&#8217;s fair
value, if any.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_20" id="_SignificantAccountingPoliciesTextBlock-c0_cont_19"><ix:continuation continuedAt="_GoodwillAndIntangibleAssetsPolicyTextBlock-c0_cont_4" id="_GoodwillAndIntangibleAssetsPolicyTextBlock-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company determined
that its operations represent a single reporting unit. The Company determines the fair value of its reporting unit by using the income
approach, which utilizes a discounted cash flow model, as it believes that this approach best approximates the reporting unit&#8217;s
fair value. Judgments and assumptions related to revenue, operating income, future short-term and long-term growth rates, weighted average
cost of capital, interest, capital expenditures, cash flows, and market conditions are inherent in developing the discounted cash flow
model. The Company considers historical rates and current market conditions when determining the discount and growth rates to use in its
analyses. If these estimates or their related assumptions change in the future, the Company may be required to record impairment charges
for its goodwill. As of December 31, 2022 and 2021, the Company has performed the annual impairment test and has determined that impairment
loss is not required to be recognized.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_21" id="_SignificantAccountingPoliciesTextBlock-c0_cont_20"><ix:continuation continuedAt="_GoodwillAndIntangibleAssetsPolicyTextBlock-c0_cont_5" id="_GoodwillAndIntangibleAssetsPolicyTextBlock-c0_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Finite lived intangible
assets acquired in business combinations, which include technology, customer relationships and trade names, are initially recorded at
fair value.&#160;They are amortized on a straight-line basis over their estimated useful lives.&#160;The intangible asset lives have been
determined based upon the anticipated period over which the Company will derive future cash flows from the intangible assets.&#160;The
Company has considered the effects of legal, regulatory, contractual, competitive, and other economic factors in determining these useful
lives.&#160;Recoverability of these assets is assessed when triggering events have occurred that may give rise to an impairment loss and
is determined by a comparison of the carrying amount of the asset to the future undiscounted net cash flows expected to be generated by
the asset.&#160;When it is determined that the carrying value of the asset is not recoverable, the asset is written down to its estimated
fair value.&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_22" id="_SignificantAccountingPoliciesTextBlock-c0_cont_21"><ix:continuation continuedAt="_GoodwillAndIntangibleAssetsPolicyTextBlock-c0_cont_6" id="_GoodwillAndIntangibleAssetsPolicyTextBlock-c0_cont_5"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">As a result of continued
losses, the management performed an impairment test with respect to its intangible assets by maintaining an external valuation which utilized
discounted cash flow model. Accordingly,&#160;certain assumptions and judgments were made to determine the discount rate as well as future
cash flows of the Company.&#160;During the years ended December 31, 2022, 2021 and 2020, no impairment losses were identified through
the impairment test.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27.35pt">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_23" id="_SignificantAccountingPoliciesTextBlock-c0_cont_22"><ix:continuation continuedAt="_GoodwillAndIntangibleAssetsPolicyTextBlock-c0_cont_7" id="_GoodwillAndIntangibleAssetsPolicyTextBlock-c0_cont_6"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The lives used in computing straight-line amortization
for financial reporting purposes are as follows:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_24" id="_SignificantAccountingPoliciesTextBlock-c0_cont_23"><ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"><ix:continuation id="_GoodwillAndIntangibleAssetsPolicyTextBlock-c0_cont_7"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: left; border-bottom: Black 1.5pt solid">Rate of depreciation</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">%</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%; text-align: left">Technology</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c48" decimals="2" format="ixt:num-dot-decimal" name="bmr:PropertyPlantAndEquipmentDepreciationPercentage" scale="-2" unitRef="pure">20</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Customer relationships</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c49" decimals="2" format="ixt:num-dot-decimal" name="bmr:PropertyPlantAndEquipmentDepreciationPercentage" scale="-2" unitRef="pure">20</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Trade names</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c50" decimals="2" format="ixt:num-dot-decimal" name="bmr:PropertyPlantAndEquipmentDepreciationPercentage" scale="-2" unitRef="pure">10</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p></ix:continuation></ix:nonNumeric></ix:continuation><div>


</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 137; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>BEAMR IMAGING LTD.&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Cont.)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(U.S. dollars in
thousands except share and per share amounts)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white"><b>&#160;</b></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2cm; text-align: justify; text-indent: -2cm">NOTE 2 - SIGNIFICANT
ACCOUNTING POLICIES (Cont.)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: left; text-indent: -1cm"><b>&#160;</b></p><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_25" id="_SignificantAccountingPoliciesTextBlock-c0_cont_24"><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0%"></td><td style="width: 0.5in"><b>H.</b></td><td style="text-align: left"><ix:nonNumeric contextRef="c0" continuedAt="_PropertyPlantAndEquipmentPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock"><b>Property and equipment</b></ix:nonNumeric></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_26" id="_SignificantAccountingPoliciesTextBlock-c0_cont_25"><ix:continuation continuedAt="_PropertyPlantAndEquipmentPolicyTextBlock-c0_cont_2" id="_PropertyPlantAndEquipmentPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Property and equipment
are stated at cost, net of accumulated depreciation. Depreciation is calculated using the straight-line method over the estimated useful
lives of the assets. When an asset is retired or otherwise disposed of, the related cost and accumulated depreciation are removed from
the respective accounts and the net difference less any amount realized from disposition is reflected in the consolidated Statements of
Operations and Comprehensive Loss.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_27" id="_SignificantAccountingPoliciesTextBlock-c0_cont_26"><ix:continuation continuedAt="_PropertyPlantAndEquipmentPolicyTextBlock-c0_cont_3" id="_PropertyPlantAndEquipmentPolicyTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company&#8217;s long-lived
assets are reviewed for impairment in accordance with ASC 360, &#8220;Property, Plant and Equipment&#8221;, whenever events or changes
in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is
measured by a comparison of the carrying amount of an asset to the future undiscounted cash flows expected to be generated by the asset.
If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of
the asset exceeds its fair value. To date, the Company has not incurred any impairment losses.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27.35pt">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_28" id="_SignificantAccountingPoliciesTextBlock-c0_cont_27"><ix:continuation continuedAt="_PropertyPlantAndEquipmentPolicyTextBlock-c0_cont_4" id="_PropertyPlantAndEquipmentPolicyTextBlock-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The lives used in computing straight-line depreciation
for financial reporting purposes are as follows:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_29" id="_SignificantAccountingPoliciesTextBlock-c0_cont_28"><ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:PropertyPlantAndEquipmentAndIntangibleAssetsTextBlock"><ix:continuation id="_PropertyPlantAndEquipmentPolicyTextBlock-c0_cont_4"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: left; border-bottom: Black 1.5pt solid">Rate of depreciation</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">%</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%; text-align: left">Computers and peripheral equipment</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c51" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentSalvageValuePercentage" scale="-2" unitRef="pure">33</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Office furniture and equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-size: 10pt"><ix:nonFraction contextRef="c52" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentSalvageValuePercentage" scale="-2" unitRef="pure">7</ix:nonFraction>-<ix:nonFraction contextRef="c53" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentSalvageValuePercentage" scale="-2" unitRef="pure">15</ix:nonFraction></span></td><td style="text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; background-color: white">&#160;</p></ix:continuation></ix:nonNumeric></ix:continuation><div>


</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_30" id="_SignificantAccountingPoliciesTextBlock-c0_cont_29"><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0%"></td><td style="width: 0.5in"><b>I.</b></td><td style="text-align: left"><ix:nonNumeric contextRef="c0" continuedAt="_LesseeLeasesPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:LesseeLeasesPolicyTextBlock"><b>Leases</b></ix:nonNumeric></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_31" id="_SignificantAccountingPoliciesTextBlock-c0_cont_30"><ix:continuation continuedAt="_LesseeLeasesPolicyTextBlock-c0_cont_2" id="_LesseeLeasesPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company entered
into several non-cancelable lease agreements for offices for use in its operations, which are classified as operating leases (see below).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_32" id="_SignificantAccountingPoliciesTextBlock-c0_cont_31"><ix:continuation continuedAt="_LesseeLeasesPolicyTextBlock-c0_cont_3" id="_LesseeLeasesPolicyTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company applies
ASC Topic 842, Leases (&#8220;ASC 842&#8221;).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_33" id="_SignificantAccountingPoliciesTextBlock-c0_cont_32"><ix:continuation continuedAt="_LesseeLeasesPolicyTextBlock-c0_cont_4" id="_LesseeLeasesPolicyTextBlock-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Accordingly, the Company
determines if an arrangement is a lease at inception. The Company&#8217;s assessment is based on: (i) whether the contract involves the
use of an identified asset, (ii) whether the Company obtains the right to substantially all of the economic benefits from the use of the
asset throughout the period of use, and (iii) whether the Company has the right to direct the use of the asset.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_34" id="_SignificantAccountingPoliciesTextBlock-c0_cont_33"><ix:continuation continuedAt="_LesseeLeasesPolicyTextBlock-c0_cont_5" id="_LesseeLeasesPolicyTextBlock-c0_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Leases are classified
as either finance leases or operating leases. A lease is classified as a finance lease if any one of the following criteria are met: (i)
the lease transfers ownership of the asset by the end of the lease term, (ii) the lease contains an option to purchase the asset that
is reasonably certain to be exercised, (iii) the lease term is for a major part of the remaining useful life of the asset, (iv) the present
value of the lease payments equals or exceeds substantially all of the fair value of the asset, or (v) the underlying asset is of such
a specialized nature that it is expected to have no alternative use to the lessor at the end of lease term. A lease is classified as an
operating lease if it does not meet any one of these criteria. Since all the Company&#8217;s lease contracts for premises do not meet
any of the criteria above, the Company concluded that all its lease contracts should be classified as operating leases.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_35" id="_SignificantAccountingPoliciesTextBlock-c0_cont_34"><ix:continuation continuedAt="_LesseeLeasesPolicyTextBlock-c0_cont_6" id="_LesseeLeasesPolicyTextBlock-c0_cont_5"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Right of Use (&#8220;ROU&#8221;)
assets and liabilities are recognized on the commencement date based on the present value of remaining lease payments over the lease term.
For this purpose, the Company considers only payments that are fixed and determinable at the time of commencement. As most of the Company&#8217;s
leases do not provide an implicit rate, the Company uses its incremental borrowing rate (&#8220;IBR&#8221;) based on the information available
on the commencement date in determining the present value of lease payments. The Company&#8217;s IBR is estimated to approximate the interest
rate for collateralized borrowing with similar terms and payments and in economic environments where the leased asset is located. The
ROU asset also includes any lease payments made prior to commencement and is recorded net of any lease incentives received. Moreover,
the ROU asset may also include initial direct costs, which are incremental costs of a lease that would not have been incurred if the lease
had not been obtained. The Company uses the long-lived assets impairment guidance in ASC 360-10, &#8220;Property, Plant, and Equipment
- Overall&#8221;, to determine whether a ROU asset is impaired, and if so, the amount of the impairment loss to recognize. Certain leases
include options to extend or terminate the lease. An option to extend the lease is considered in connection with determining the ROU asset
and lease liability when it is reasonably certain that the Company will exercise that option. An option to terminate is considered unless
it is reasonably certain that the Company will not exercise the option.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_36" id="_SignificantAccountingPoliciesTextBlock-c0_cont_35"><ix:continuation id="_LesseeLeasesPolicyTextBlock-c0_cont_6"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company also elected
the short-term lease recognition exemption for all leases that qualify (leases with a term shorter than 12 months). For those leases,
ROU assets or lease liabilities are not recognized and rent&#160;expense is recognized on a straight-line basis over the lease term. See
also Note 10A for further discussion.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: center; background-color: white">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>


</div><!-- Field: Page; Sequence: 138; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: center; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><b>BEAMR IMAGING LTD.&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><b>NOTES TO CONSOLIDATED
FINANCIAL STATEMENTS (Cont.)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(U.S. dollars in
thousands except share and per share amounts)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white"><b>&#160;</b></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2cm; text-align: justify; text-indent: -2cm">NOTE 2 - SIGNIFICANT
ACCOUNTING POLICIES (Cont.)</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2cm; text-align: justify; text-indent: -2cm">&#160;</p><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_37" id="_SignificantAccountingPoliciesTextBlock-c0_cont_36"><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0%"></td><td style="width: 0.5in"><b>J.</b></td><td style="text-align: left"><ix:nonNumeric contextRef="c0" continuedAt="_IncomeTaxPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:IncomeTaxPolicyTextBlock"><b>Deferred income taxes</b></ix:nonNumeric></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_38" id="_SignificantAccountingPoliciesTextBlock-c0_cont_37"><ix:continuation continuedAt="_IncomeTaxPolicyTextBlock-c0_cont_2" id="_IncomeTaxPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company accounts
for income taxes in accordance with ASC Topic 740, &#8220;Income Taxes&#8221;. Accordingly, deferred income taxes are determined utilizing
the asset and liability method based on the estimated future tax effects of differences between the financial accounting and the tax bases
of assets and liabilities under the applicable tax law. Deferred tax balances are computed using the enacted tax rates expected to be
in effect when these differences reverse. Valuation allowance in respect of deferred tax assets is provided for, if necessary, to reduce
deferred tax assets is amounts more likely than not to be realized.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; background-color: white">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_39" id="_SignificantAccountingPoliciesTextBlock-c0_cont_38"><ix:continuation id="_IncomeTaxPolicyTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company accounts
for uncertain tax positions in accordance with ASC Topic 740-10, which prescribes detailed guidance for the financial statement recognition,
measurement and disclosure of uncertain tax positions recognized in an enterprise&#8217;s financial statements. According to ASC Topic
740-10, tax positions must meet a more-likely-than-not recognition threshold. The Company&#8217;s accounting policy is to classify interest
and penalties relating to uncertain tax positions under income taxes, however the Company did not recognize such items in its consolidated
financial statements during the years ended December 31, 2022, 2021 and 2020 and did not recognize any liability with respect to an unrecognized
tax position in its balance sheets.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; background-color: white">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_40" id="_SignificantAccountingPoliciesTextBlock-c0_cont_39"><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0%"></td><td style="width: 0.5in"><b>K.</b></td><td style="text-align: left"><ix:nonNumeric contextRef="c0" continuedAt="_PostemploymentBenefitPlansPolicy-c0_cont_1" escape="true" name="us-gaap:PostemploymentBenefitPlansPolicy"><b>Employees benefit plans </b></ix:nonNumeric></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_41" id="_SignificantAccountingPoliciesTextBlock-c0_cont_40"><ix:continuation id="_PostemploymentBenefitPlansPolicy-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company&#8217;s
liability for severance pay to its Israeli employees is pursuant to Section 14 of the Israeli Severance Compensation Act, 1963 (&#8220;Section
14&#8221;), pursuant to which all the Company&#8217;s employees are included under Section 14, and are entitled only to monthly deposits,
at a rate of <ix:nonFraction contextRef="c0" decimals="4" format="ixt:num-dot-decimal" name="bmr:EmployeeCompensationPercentage" scale="-2" unitRef="pure">8.33</ix:nonFraction>% of their monthly salary, made in the employee&#8217;s name with insurance companies. Under Israeli employment law,
payments in accordance with Section 14 release the Company from any future severance payments in respect of those employees. The fund
is made available to the employee at the time the employer-employee relationship is terminated, regardless of cause of termination. The
severance pay liabilities and deposits under Section 14 are not reflected in the balance sheets as the severance pay risks have been irrevocably
transferred to the severance funds. All deposits required through December 31, 2022 have been made.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: left; text-indent: -1cm"><b>&#160;</b></p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_42" id="_SignificantAccountingPoliciesTextBlock-c0_cont_41"><ix:nonNumeric contextRef="c0" continuedAt="_CommitmentsAndContingenciesPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:CommitmentsAndContingenciesPolicyTextBlock"><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0%"></td><td style="width: 0.5in"><b>L.</b></td><td style="text-align: left"><b>Contingencies</b></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm">&#160;</p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_43" id="_SignificantAccountingPoliciesTextBlock-c0_cont_42"><ix:continuation id="_CommitmentsAndContingenciesPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company and its
subsidiaries may be involved in certain legal proceedings and certain business relationships that arise from time to time in the ordinary
course of their business and in connection with certain agreements with third parties. Except for income tax contingencies, the Company
applies the provisions of ASC Topic 450, Contingencies. Thus, the Company records accruals for contingencies to the extent that the management
concludes that the occurrence is probable and that the related liabilities are estimable. Legal expenses associated with contingencies
are expensed as incurred.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: left; text-indent: -1cm"><b>&#160;</b></p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_44" id="_SignificantAccountingPoliciesTextBlock-c0_cont_43"><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0%"></td><td style="width: 0.5in"><b>M.</b></td><td style="text-align: left"><ix:nonNumeric contextRef="c0" continuedAt="bmr_ConcentrationOfCreditRiskPolicyTextBlock-c0_cont_1" escape="true" name="bmr:ConcentrationOfCreditRiskPolicyTextBlock"><b>Concentrations of credit risk and allowance for doubtful accounts</b></ix:nonNumeric></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_45" id="_SignificantAccountingPoliciesTextBlock-c0_cont_44"><ix:continuation continuedAt="bmr_ConcentrationOfCreditRiskPolicyTextBlock-c0_cont_2" id="bmr_ConcentrationOfCreditRiskPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Financial instruments
that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents and trade receivables
as well as certain other current assets that do not amount to a significant amount. Cash and cash equivalents, which are primarily held
in US Dollars and New Israeli Shekels (NIS), are deposited with major banks in Israel, U.S. and Russian Federation. Management believes
that such financial institutions are financially sound and, accordingly, minimal credit risk exists with respect to these financial instruments.
The Company does not have any significant off-balance-sheet concentration of credit risk, such as foreign exchange contracts, option contracts
or other foreign hedging arrangements. Most of the Company&#8217;s sales are mainly derived from sales to a diverse set of customers located
primarily in the United States. Management periodically evaluates the collectability of the trade receivables to determine the amounts
that are doubtful of collection and determine a proper allowance for doubtful accounts, as described below. Accordingly, management believes
that the Company&#8217;s trade receivables do not represent a substantial concentration of credit risk.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_46" id="_SignificantAccountingPoliciesTextBlock-c0_cont_45"><ix:continuation id="bmr_ConcentrationOfCreditRiskPolicyTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company extends credit to customers
in the normal course of business and does not require collateral or any other security to support amounts due. Management performs ongoing
credit evaluations of its customers. The allowance for doubtful accounts is determined with respect to amounts the Group has determined
to be doubtful of collection. In determining the allowance for doubtful accounts, the Company considers, among other things, its past
experience with customers, the length of time that the balance is past due, the customer&#8217;s current ability to pay and available information
about the credit risk on such customers.&#160;Provisions for the allowance for doubtful accounts are recorded under general and administrative
expenses in the consolidated Statements of Operations and Comprehensive Loss. During the years ended December 31, 2022, 2021 and 2020,
the Company has not recorded allowance in respect of accounts receivable.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: center; background-color: white"><b>&#160;</b></p></ix:continuation></ix:continuation><div>

</div><div>


</div><!-- Field: Page; Sequence: 139; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: center; background-color: white"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><b>BEAMR IMAGING LTD.&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><b>NOTES TO CONSOLIDATED
FINANCIAL STATEMENTS (Cont.)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(U.S. dollars in
thousands except share and per share amounts)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white"><b>&#160;</b></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2cm; text-align: justify; text-indent: -2cm">NOTE 2 - SIGNIFICANT
ACCOUNTING POLICIES (Cont.)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: left; text-indent: -1cm"><b>&#160;</b></p><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_47" id="_SignificantAccountingPoliciesTextBlock-c0_cont_46"><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0%"></td><td style="width: 0.5in"><b>N.</b></td><td style="text-align: left"><ix:nonNumeric contextRef="c0" continuedAt="_RevenueRecognitionPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:RevenueRecognitionPolicyTextBlock"><b>Revenue recognition</b></ix:nonNumeric></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_48" id="_SignificantAccountingPoliciesTextBlock-c0_cont_47"><ix:continuation continuedAt="_RevenueRecognitionPolicyTextBlock-c0_cont_2" id="_RevenueRecognitionPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company recognizes revenues in accordance
with ASC 606, &#8220;Revenue from Contracts with Customers&#8221; (&#8220;ASC 606&#8221;) under which the Company determines revenue recognition
through the following five steps:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.5pt; text-align: justify; text-indent: -22.5pt">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_49" id="_SignificantAccountingPoliciesTextBlock-c0_cont_48"><ix:continuation continuedAt="_RevenueRecognitionPolicyTextBlock-c0_cont_3" id="_RevenueRecognitionPolicyTextBlock-c0_cont_2"><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in"><span>&#9726;</span></td><td style="text-align: justify">Identification of the contract, or contracts, with a customer;</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.5pt; text-align: justify; text-indent: -22.5pt">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_50" id="_SignificantAccountingPoliciesTextBlock-c0_cont_49"><ix:continuation continuedAt="_RevenueRecognitionPolicyTextBlock-c0_cont_4" id="_RevenueRecognitionPolicyTextBlock-c0_cont_3"><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in"><span>&#9726;</span></td><td style="text-align: justify">Identification of the performance obligations in the contract;</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.5pt; text-align: justify; text-indent: -22.5pt">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_51" id="_SignificantAccountingPoliciesTextBlock-c0_cont_50"><ix:continuation continuedAt="_RevenueRecognitionPolicyTextBlock-c0_cont_5" id="_RevenueRecognitionPolicyTextBlock-c0_cont_4"><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in"><span>&#9726;</span></td><td style="text-align: justify">Determination of the transaction price;</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.5pt; text-align: justify; text-indent: -22.5pt">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_52" id="_SignificantAccountingPoliciesTextBlock-c0_cont_51"><ix:continuation continuedAt="_RevenueRecognitionPolicyTextBlock-c0_cont_6" id="_RevenueRecognitionPolicyTextBlock-c0_cont_5"><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in"><span>&#9726;</span></td><td style="text-align: justify">Allocation of the transaction price to the performance obligations in the contract; and</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.5pt; text-align: justify; text-indent: -22.5pt">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_53" id="_SignificantAccountingPoliciesTextBlock-c0_cont_52"><ix:continuation continuedAt="_RevenueRecognitionPolicyTextBlock-c0_cont_7" id="_RevenueRecognitionPolicyTextBlock-c0_cont_6"><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in"><span>&#9726;</span></td><td style="text-align: justify">Recognition of revenue when, or as, the Company satisfies a performance obligation.</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_54" id="_SignificantAccountingPoliciesTextBlock-c0_cont_53"><ix:continuation continuedAt="_RevenueRecognitionPolicyTextBlock-c0_cont_8" id="_RevenueRecognitionPolicyTextBlock-c0_cont_7"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company enters into contracts that
mostly include software and software related services (i.e. Post-Contract Customer Support (&#8220;PCS&#8221;)), which are generally capable
as being distinct from each other and accounted for as separate performance obligations.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_55" id="_SignificantAccountingPoliciesTextBlock-c0_cont_54"><ix:continuation continuedAt="_RevenueRecognitionPolicyTextBlock-c0_cont_9" id="_RevenueRecognitionPolicyTextBlock-c0_cont_8"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company derives its revenues from
licensing the rights to use its software for a limited term (mainly for a period of one to three years) or on a perpetual basis for enterprises
that incorporate the Company&#8217;s perpetual license in their own products delivered to end users and for the Company&#8217;s products&#160;sold
to thousands private consumers, as applicable to each contract, and from, provision of related maintenance and technical support. The
Company sells its products through direct sales force and indirectly through distributors and consumer platforms.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_56" id="_SignificantAccountingPoliciesTextBlock-c0_cont_55"><ix:continuation continuedAt="_RevenueRecognitionPolicyTextBlock-c0_cont_10" id="_RevenueRecognitionPolicyTextBlock-c0_cont_9"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Revenues are recognized when control of
the promised goods or services are transferred to the customers, in an amount that reflects the consideration that the company expects
to receive in exchange for those goods or services. However, when the consideration for the license is based on sales of the related customer,
the company applies the provisions of ASC 606 with respect to sales-based or usage-based royalties promised in exchange for a license
of intellectual property and recognizes revenues only when the underlying sales occur, as long as this approach does not result in the
acceleration of revenue ahead of the company&#8217;s performance.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_57" id="_SignificantAccountingPoliciesTextBlock-c0_cont_56"><ix:continuation continuedAt="_RevenueRecognitionPolicyTextBlock-c0_cont_11" id="_RevenueRecognitionPolicyTextBlock-c0_cont_10"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Under ASC 606, an entity recognizes revenue
when or as it satisfies a performance obligation by transferring software license (either timely-based or perpetual) or software related
services to the customer, either at a point in time or over time. The Company recognizes its revenues from software sales at a point in
time upon delivery of its software license. The software license is considered a distinct performance obligation, as the customer can
benefit from the software on its own. The Company&#8217;s revenues from PCS are derived from annual maintenance providing for unspecified
upgrades on a when-and-if-available basis. The right for an unspecified upgrade for the version acquired by the customer and enhancements
on a when-and-if-available basis that do not specify the features, functionality and release date of future product enhancements for the
customer to know what will be made available and the general timeframe in which it will be delivered. The Company considers the PCS performance
obligation as a distinct performance obligation that is satisfied over time and recognized on a straight-line basis over the contractual
period (mainly over a period of one year either for timely-based license or for perpetual license).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_58" id="_SignificantAccountingPoliciesTextBlock-c0_cont_57"><ix:continuation continuedAt="_RevenueRecognitionPolicyTextBlock-c0_cont_12" id="_RevenueRecognitionPolicyTextBlock-c0_cont_11"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">As the Company bundles software licenses
(either time-based or perpetual) together with PCS, the transaction price is allocated to the separate performance obligations on a relative
standalone selling price basis.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_59" id="_SignificantAccountingPoliciesTextBlock-c0_cont_58"><ix:continuation continuedAt="_RevenueRecognitionPolicyTextBlock-c0_cont_13" id="_RevenueRecognitionPolicyTextBlock-c0_cont_12"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Since the Company does not sell PCS on
a stand-alone basis and due to the fact that these services are usually involved with limited customer support, mainly based on several
hours of technical support per contract (as management believes the technology and products covered under the software license component
are mature and fully functional), the standalone selling prices of the PCS are determined based on the expected cost plus a margin (&#8220;cost-plus
approach&#8221;) based on estimation of direct fulfillment cost (an hourly service) and a reasonable margin. Such estimate is also corroborated
with the price that the company would have to pay to a third-party service provider for a similar support service.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_60" id="_SignificantAccountingPoliciesTextBlock-c0_cont_59"><ix:continuation continuedAt="_RevenueRecognitionPolicyTextBlock-c0_cont_14" id="_RevenueRecognitionPolicyTextBlock-c0_cont_13"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The stand-alone selling price of the software
licenses (either timely-based or perpetual) is estimated by management based on adjusted market assessment approach which represents management
estimation of the price that a customer in the market will be willing to pay for such license on a stand-alone basis (i.e. without any
PCS).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_61" id="_SignificantAccountingPoliciesTextBlock-c0_cont_60"><ix:continuation continuedAt="_RevenueRecognitionPolicyTextBlock-c0_cont_15" id="_RevenueRecognitionPolicyTextBlock-c0_cont_14"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Due to the fact that the PCS services
are usually involved with limited customer support, mainly based on several hours of technical support per contract, the transaction price
allocated to the PCS is considered insignificant. Consequently, most of the transaction price is allocated to the software licenses as
management believes the technology and products covered under the software license component are mature and fully functional.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 140; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>BEAMR IMAGING LTD.&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Cont.)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(U.S. dollars in
thousands except share and per share amounts)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: left">&#160;</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2cm; text-align: justify; text-indent: -2cm">NOTE 2 - SIGNIFICANT
ACCOUNTING POLICIES (Cont.)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: left; text-indent: -1cm"><b>&#160;</b></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0%"></td><td style="width: 0.5in"><b>N.</b></td><td style="text-align: left"><b>Revenue recognition (Cont.)</b></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify">&#160;</p><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_62" id="_SignificantAccountingPoliciesTextBlock-c0_cont_61"><ix:continuation continuedAt="_RevenueRecognitionPolicyTextBlock-c0_cont_16" id="_RevenueRecognitionPolicyTextBlock-c0_cont_15"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">During the reported periods, costs to
obtain contracts were in an insignificant amount.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_63" id="_SignificantAccountingPoliciesTextBlock-c0_cont_62"><ix:continuation continuedAt="_RevenueRecognitionPolicyTextBlock-c0_cont_17" id="_RevenueRecognitionPolicyTextBlock-c0_cont_16"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company does not grant a right of
return to its customers. When product delivered to the customer is subject to evaluation, the Company defers revenue until evaluation
is completed subject to formal selling agreement with the customer, at which time revenue is recognized provided that all other revenue
recognition criteria are met.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_64" id="_SignificantAccountingPoliciesTextBlock-c0_cont_63"><ix:continuation continuedAt="_RevenueRecognitionPolicyTextBlock-c0_cont_18" id="_RevenueRecognitionPolicyTextBlock-c0_cont_17"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Commencing 2022, revenue is also derived
from the traffic operations in the Google AdSense program, a web advertising platform, that the Company makes available on its websites.&#160;Google
pays the Company on a cost-per-click basis. The Company recognizes as revenue the fees paid to it by Google based on the volume of clicks
through to Google AdSense advertisements.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_65" id="_SignificantAccountingPoliciesTextBlock-c0_cont_64"><ix:continuation continuedAt="_RevenueRecognitionPolicyTextBlock-c0_cont_19" id="_RevenueRecognitionPolicyTextBlock-c0_cont_18"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company receives payments from customers
based upon contractual payment schedules. Trade receivables are recorded when right to consideration becomes unconditional, and an invoice
is issued to the customer. Unbilled receivables include amounts related to the Company&#8217;s contractual right to consideration for
completed performance obligations not yet invoiced. As of December 31, 2022 and 2021, unbilled receivables balance amounted to $<ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherReceivables" scale="3" unitRef="usd">35</ix:nonFraction>&#160;and
$<ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherReceivables" scale="3" unitRef="usd">29</ix:nonFraction>, respectively, and are included within trade receivables balance in the Company&#8217;s Consolidated Balance Sheets.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_66" id="_SignificantAccountingPoliciesTextBlock-c0_cont_65"><ix:continuation continuedAt="_RevenueRecognitionPolicyTextBlock-c0_cont_20" id="_RevenueRecognitionPolicyTextBlock-c0_cont_19"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">As of December 31, 2022 and 2021, the
Company had $<ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredRevenue" scale="3" unitRef="usd">31</ix:nonFraction>&#160;and $<ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredRevenue" scale="3" unitRef="usd">33</ix:nonFraction>, respectively, of remaining performance obligations not yet satisfied or partly satisfied related to revenues
(mostly PCS). Such amounts are presented as deferred revenues which are expected to be recognized as revenues during the next twelve months.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_67" id="_SignificantAccountingPoliciesTextBlock-c0_cont_66"><ix:continuation id="_RevenueRecognitionPolicyTextBlock-c0_cont_20"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">See also Note 16 for further discussion
related to disaggregation of revenues.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: left; text-indent: -1cm"><b>&#160;</b></p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_68" id="_SignificantAccountingPoliciesTextBlock-c0_cont_67"><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0%"></td><td style="width: 0.5in"><b>O.</b></td><td style="text-align: left"><ix:nonNumeric contextRef="c0" continuedAt="_FairValueMeasurementPolicyPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:FairValueMeasurementPolicyPolicyTextBlock"><b>Fair Value Measurements</b></ix:nonNumeric></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_69" id="_SignificantAccountingPoliciesTextBlock-c0_cont_68"><ix:continuation continuedAt="_FairValueMeasurementPolicyPolicyTextBlock-c0_cont_2" id="_FairValueMeasurementPolicyPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company measures
and discloses fair value in accordance with the ASC 820, &#8220;Fair Value Measurements and Disclosures&#8221; which defines fair value,
establishes a framework and gives guidance regarding the methods used for measuring fair value, and expands disclosures about fair value
measurements. Fair value is an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability
in an orderly transaction between market participants at the measurement date. As such, fair value is a market-based measurement that
should be determined based on assumptions that market participants would use in pricing an asset or liability. As a basis for considering
such assumptions there exists a three-tier fair-value hierarchy, which prioritizes the inputs used in measuring fair value as follows:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_70" id="_SignificantAccountingPoliciesTextBlock-c0_cont_69"><ix:continuation continuedAt="_FairValueMeasurementPolicyPolicyTextBlock-c0_cont_3" id="_FairValueMeasurementPolicyPolicyTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Level 1 - unadjusted
quoted prices are available in active markets for identical assets or liabilities that the Company has the ability to access as of the
measurement date.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_71" id="_SignificantAccountingPoliciesTextBlock-c0_cont_70"><ix:continuation continuedAt="_FairValueMeasurementPolicyPolicyTextBlock-c0_cont_4" id="_FairValueMeasurementPolicyPolicyTextBlock-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Level 2 - pricing inputs
are other than quoted prices in active markets that are directly observable for the asset or liability or indirectly observable through
corroboration with observable market data.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_72" id="_SignificantAccountingPoliciesTextBlock-c0_cont_71"><ix:continuation continuedAt="_FairValueMeasurementPolicyPolicyTextBlock-c0_cont_5" id="_FairValueMeasurementPolicyPolicyTextBlock-c0_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Level 3 - pricing inputs
are unobservable for the non-financial asset or liability and only used when there is little, if any, market activity for the non-financial
asset or liability at the measurement date. The inputs into the determination of fair value require significant management judgment or
estimation. Level 3 inputs are considered as the lowest priority within the fair value hierarchy. The valuation of certain financial instruments
classified under fair value through profit or loss category and the fair value of reporting units for purposes of goodwill impairment
analysis, fall under this category.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_73" id="_SignificantAccountingPoliciesTextBlock-c0_cont_72"><ix:continuation continuedAt="_FairValueMeasurementPolicyPolicyTextBlock-c0_cont_6" id="_FairValueMeasurementPolicyPolicyTextBlock-c0_cont_5"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">This hierarchy requires
the Company to use observable market data, when available, and to minimize the use of unobservable inputs when determining fair value.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_74" id="_SignificantAccountingPoliciesTextBlock-c0_cont_73"><ix:continuation id="_FairValueMeasurementPolicyPolicyTextBlock-c0_cont_6"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The fair value of cash
and cash equivalents is based on its demand value, which is equal to its carrying value. Additionally, the carrying value of all other
short-term monetary assets and liabilities are estimated to be equal to their fair value due to the short-term nature of these instruments.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: left; text-indent: -1cm"><b>&#160;</b></p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_75" id="_SignificantAccountingPoliciesTextBlock-c0_cont_74"><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0%"></td><td style="width: 0.5in"><b>P.</b></td><td style="text-align: left"><ix:nonNumeric contextRef="c0" continuedAt="bmr_ConvertibleOrdinary1And2SharesAndPreferredSharesPolicyTextBlock-c0_cont_1" escape="true" name="bmr:ConvertibleOrdinary1And2SharesAndPreferredSharesPolicyTextBlock"><b>Convertible Ordinary 1 and 2 Shares and Preferred Shares</b></ix:nonNumeric></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_76" id="_SignificantAccountingPoliciesTextBlock-c0_cont_75"><ix:continuation id="bmr_ConvertibleOrdinary1And2SharesAndPreferredSharesPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Convertible Ordinary 1 and 2 Shares
and Convertible Preferred Shares are not subject to redemption feature upon any events that are considered not solely within the control
of the Company. In addition, upon occurrence of liquidation event, as defined in the Company&#8217;s Articles of Association, all holders of
the Ordinary Shares, Convertible Ordinary 1 and 2 Shares and Convertible Preferred Shares will be entitled to receive the same form of
consideration. Thus, the Company classifies its Convertible Ordinary 1 and 2 Shares and Convertible Preferred Shares as part of permanent
equity.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>


</div><!-- Field: Page; Sequence: 141; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>BEAMR IMAGING LTD.&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Cont.)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(U.S. dollars in
thousands except share and per share amounts)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white"><b>&#160;</b></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2cm; text-align: justify; text-indent: -2cm">NOTE 2 - SIGNIFICANT
ACCOUNTING POLICIES (Cont.)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: left; text-indent: -1cm"><b>&#160;</b></p><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_77" id="_SignificantAccountingPoliciesTextBlock-c0_cont_76"><ix:nonNumeric contextRef="c0" continuedAt="bmr_AllocationOfProceedsAndRelatedIssuanceCostsPolicyTextBlock-c0_cont_1" escape="true" name="bmr:AllocationOfProceedsAndRelatedIssuanceCostsPolicyTextBlock"><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0%"></td><td style="width: 0.5in"><b>Q.</b></td><td style="text-align: left"><b>Allocation of proceeds and related issuance costs</b></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify">&#160;</p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_78" id="_SignificantAccountingPoliciesTextBlock-c0_cont_77"><ix:continuation continuedAt="bmr_AllocationOfProceedsAndRelatedIssuanceCostsPolicyTextBlock-c0_cont_2" id="bmr_AllocationOfProceedsAndRelatedIssuanceCostsPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">When multiple instruments are issued in
a single transaction (package issuance), the total net proceeds from the transaction are allocated among the individual freestanding instruments
identified. The allocation occurs after identifying all the freestanding instruments and the subsequent measurement basis for those instruments.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_79" id="_SignificantAccountingPoliciesTextBlock-c0_cont_78"><ix:continuation continuedAt="bmr_AllocationOfProceedsAndRelatedIssuanceCostsPolicyTextBlock-c0_cont_3" id="bmr_AllocationOfProceedsAndRelatedIssuanceCostsPolicyTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Financial instruments that are required
to be subsequently measured at fair value (such as derivative warrants liability) are measured at fair value and the remaining consideration
is allocated to other financial instruments that are not required to be subsequently measured at fair value (i.e. straight loan), based
on the relative fair value basis for such instruments.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_80" id="_SignificantAccountingPoliciesTextBlock-c0_cont_79"><ix:continuation continuedAt="bmr_AllocationOfProceedsAndRelatedIssuanceCostsPolicyTextBlock-c0_cont_4" id="bmr_AllocationOfProceedsAndRelatedIssuanceCostsPolicyTextBlock-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The allocation of issuance costs to freestanding
instruments was based on an approach that is consistent with the allocation of the proceeds, as described above.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_81" id="_SignificantAccountingPoliciesTextBlock-c0_cont_80"><ix:continuation continuedAt="bmr_AllocationOfProceedsAndRelatedIssuanceCostsPolicyTextBlock-c0_cont_5" id="bmr_AllocationOfProceedsAndRelatedIssuanceCostsPolicyTextBlock-c0_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Issuance costs allocated to the derivative
warrant liability were immediately expensed.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_82" id="_SignificantAccountingPoliciesTextBlock-c0_cont_81"><ix:continuation id="bmr_AllocationOfProceedsAndRelatedIssuanceCostsPolicyTextBlock-c0_cont_5"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Issuance costs allocated to straight loan
are recorded as a discount of the straight loan and accreted over the contractual term of straight loan up to face value of such loans
using the effective interest method.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: left; text-indent: -1cm"><b>&#160;</b></p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_83" id="_SignificantAccountingPoliciesTextBlock-c0_cont_82"><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0%"></td><td style="width: 0.5in"><b>R.</b></td><td style="text-align: left"><ix:nonNumeric contextRef="c0" continuedAt="bmr_WarrantsPolicyTextBlock-c0_cont_1" escape="true" name="bmr:WarrantsPolicyTextBlock"><b>Warrants</b></ix:nonNumeric></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_84" id="_SignificantAccountingPoliciesTextBlock-c0_cont_83"><ix:continuation continuedAt="bmr_WarrantsPolicyTextBlock-c0_cont_2" id="bmr_WarrantsPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Certain warrants that
were issued to a commercial bank as part of entering into a straight loan and to seller through transaction in which certain identified
intangible assets have been purchased are classified as a component of permanent equity since they are freestanding financial instruments
that are legally detachable and separately exercisable, do not embody an obligation for the Company to repurchase its own shares, and
permit the holders to receive a fixed number of Ordinary Shares upon exercise for a fixed exercise price and thus, are considered as indexed
to the Company&#8217;s own shares. In addition, the warrants must require physical settlement and may not provide any guarantee of value or
return. As such warrants were issued together with financial instruments that are not subsequently measured at fair value the warrants
were measured based on allocation of the proceeds received by the Company in accordance with the relative fair value basis. When applicable,
direct issuance expenses that were allocated to such warrants were deducted from additional paid-in capital.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_85" id="_SignificantAccountingPoliciesTextBlock-c0_cont_84"><ix:continuation id="bmr_WarrantsPolicyTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Commencing January 1,
2018 and following the early adoption of ASU 2017-11, &#8220;Earnings Per Share&#8221; (ASU 2017-11), the Company disregards the down
round feature when assessing whether an instrument is indexed to its own shares, for purposes of determining liability or equity classification.
Based on its evaluation, management has determined that certain warrants with down-round protection are eligible for equity classification.
In accordance with the provisions of ASU 2017-11, upon the occurrence of an event that triggers down round protection (i.e., when the
exercise price of the warrants is adjusted downward because of the down round feature), the effect is accounted for as a deemed dividend
and as a reduction of income available to common shareholders for purposes of basic earnings per share (EPS) calculation. However, during
the reported periods there were no events that trigger a down round protection.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: left; text-indent: -1cm"><b>&#160;</b></p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_86" id="_SignificantAccountingPoliciesTextBlock-c0_cont_85"><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0%"></td><td style="width: 0.5in"><b>S.</b></td><td style="text-align: left"><ix:nonNumeric contextRef="c0" continuedAt="_DerivativesPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:DerivativesPolicyTextBlock"><b>Derivative Warrants Liability</b></ix:nonNumeric></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_87" id="_SignificantAccountingPoliciesTextBlock-c0_cont_86"><ix:continuation continuedAt="_DerivativesPolicyTextBlock-c0_cont_2" id="_DerivativesPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Certain warrants that
were granted by the Company for commercial bank through funding transaction entitle the bank to exercise the warrants for a variable number
of shares and/or for a variable exercise price and thus the fixed-for-fixed criteria is not met. Accordingly, the warrants were classified
as a non-current liability according to the provisions of ASC 815-40, &#8220;Derivatives and Hedging - Contracts in Entity&#8217;s Own
Equity&#8221; (&#8220;ASC 815-40&#8221;). The Company accounted for these warrants as a financial derivative liability measured upon initial
recognition and on subsequent periods at fair value by using the Hybrid Method by combining the OPM and an IPO scenario.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_88" id="_SignificantAccountingPoliciesTextBlock-c0_cont_87"><ix:continuation id="_DerivativesPolicyTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The fair value of the
aforesaid warrants derivative liability is estimated using the Black-Scholes Model which requires inputs such as the expected term of
the warrants, share price volatility and risk-free interest rate. These assumptions are reviewed on a regular basis and changes in the
estimated fair value of the outstanding warrants are recognized each reporting period as part of the &#8220;Financing (income) expenses,
net&#8221; line in the consolidated statements of operations and comprehensive loss, until such warrants are exercised or expired. When
applicable, direct issuance expenses that were allocated to the above warrants were expensed as incurred.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p></ix:continuation></ix:continuation><div>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 142; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>BEAMR IMAGING LTD.&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Cont.)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(U.S. dollars in
thousands except share and per share amounts)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white"><b>&#160;</b></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2cm; text-align: justify; text-indent: -2cm">NOTE 2
- SIGNIFICANT ACCOUNTING POLICIES (Cont.)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: left; text-indent: -1cm"><b>&#160;</b></p><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_89" id="_SignificantAccountingPoliciesTextBlock-c0_cont_88"><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0%"></td><td style="width: 0.5in"><b>T.</b></td><td style="text-align: left"><ix:nonNumeric contextRef="c0" continuedAt="bmr_ModificationsOrExchangeOfLoansPolicyTextBlock-c0_cont_1" escape="true" name="bmr:ModificationsOrExchangeOfLoansPolicyTextBlock"><b>Modifications or exchanges of loans</b></ix:nonNumeric></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_90" id="_SignificantAccountingPoliciesTextBlock-c0_cont_89"><ix:continuation continuedAt="bmr_ModificationsOrExchangeOfLoansPolicyTextBlock-c0_cont_2" id="bmr_ModificationsOrExchangeOfLoansPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Modifications to, or
exchanges of, financial instruments such as loans or convertible loans, are accounted for as a modification or an extinguishment, following
to provisions of ASC 470-50, &#8220;Debt &#8211; Modification and Extinguishments&#8221; (ASC 470-50<span style="font-family: Times New Roman, Times, Serif">)</span>.
Such an assessment done by management either qualitatively or quantitatively based on the facts and circumstances of each transaction<span style="font-family: Times New Roman, Times, Serif">.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_91" id="_SignificantAccountingPoliciesTextBlock-c0_cont_90"><ix:continuation continuedAt="bmr_ModificationsOrExchangeOfLoansPolicyTextBlock-c0_cont_3" id="bmr_ModificationsOrExchangeOfLoansPolicyTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Under ASC 470-50, modifications
or exchanges are generally considered extinguishments with gains or losses recognized in current earnings if the terms of the new debt
and original instrument are substantially different. The instruments are considered &#8220;substantially different&#8221; when the present
value of the cash flows under the terms of the new debt instrument is at least <ix:nonFraction contextRef="c2" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" unitRef="pure">10</ix:nonFraction>% different from the present value of the remaining cash
flows under the terms of the original instrument<span style="font-family: Times New Roman, Times, Serif">.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_92" id="_SignificantAccountingPoliciesTextBlock-c0_cont_91"><ix:continuation continuedAt="bmr_ModificationsOrExchangeOfLoansPolicyTextBlock-c0_cont_4" id="bmr_ModificationsOrExchangeOfLoansPolicyTextBlock-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">If the terms of a debt
instrument are changed or modified and the present value of the cash flows under the terms of the new debt instrument is less than <ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentRedemptionPricePercentage" scale="-2" unitRef="pure">10</ix:nonFraction>%,
the debt instruments are not considered to be substantially different, except in the following two circumstances: (i)<span style="font-family: Times New Roman, Times, Serif">&#160;&#160;</span>the
transaction significantly affects the terms of an embedded conversion option, such that the change in the fair value of the embedded conversion
option (calculated as the difference between the fair value of the embedded conversion option immediately before and after the modification
or exchange) is at least <ix:nonFraction contextRef="c2" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" unitRef="pure">10</ix:nonFraction>% of the carrying amount of the original debt instrument immediately before the modification or exchange or
(ii)<span style="font-family: Times New Roman, Times, Serif">&#160;&#160;</span>the transaction adds a substantive conversion option or
eliminates a conversion option that was substantive at the date of the modification or exchange<span style="font-family: Times New Roman, Times, Serif">.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_93" id="_SignificantAccountingPoliciesTextBlock-c0_cont_92"><ix:continuation continuedAt="bmr_ModificationsOrExchangeOfLoansPolicyTextBlock-c0_cont_5" id="bmr_ModificationsOrExchangeOfLoansPolicyTextBlock-c0_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">If the original and
new debt instruments are considered as &#8220;substantially different&#8221;, the original debt is derecognized and the new debt is initially
recorded at fair value, with the difference recognized as an extinguishment gain or loss under financial expense or income as applicable<span style="font-family: Times New Roman, Times, Serif">.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_94" id="_SignificantAccountingPoliciesTextBlock-c0_cont_93"><ix:continuation continuedAt="bmr_ModificationsOrExchangeOfLoansPolicyTextBlock-c0_cont_6" id="bmr_ModificationsOrExchangeOfLoansPolicyTextBlock-c0_cont_5"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">If a convertible debt
instrument with a beneficial conversion option that was separately accounted for in equity, is extinguished prior to its conversion or
stated maturity date, a portion of the reacquisition price is allocated to the repurchase of the beneficial conversion option. The amount
of the reacquisition price allocated to the beneficial conversion option is measured using the intrinsic value of that conversion option
at the extinguishment date. The residual amount, if any, is allocated to the convertible debt instrument<span style="font-family: Times New Roman, Times, Serif">.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_95" id="_SignificantAccountingPoliciesTextBlock-c0_cont_94"><ix:continuation id="bmr_ModificationsOrExchangeOfLoansPolicyTextBlock-c0_cont_6"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The gain or loss on
the extinguishment of the convertible debt instrument is determined based on the difference between the carrying amount and the fair value
of the allocated reacquisition price.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: left; text-indent: -1cm"><b>&#160;</b></p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_96" id="_SignificantAccountingPoliciesTextBlock-c0_cont_95"><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0%"></td><td style="width: 0.5in"><b>U.</b></td><td style="text-align: left"><ix:nonNumeric contextRef="c0" continuedAt="_EarningsPerSharePolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:EarningsPerSharePolicyTextBlock"><b>Basic and diluted net loss per Ordinary Share </b></ix:nonNumeric></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_97" id="_SignificantAccountingPoliciesTextBlock-c0_cont_96"><ix:continuation continuedAt="_EarningsPerSharePolicyTextBlock-c0_cont_2" id="_EarningsPerSharePolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company applies
the two-class method as required by ASC&#160;260-10, &#8220;Earnings Per Share&#8221; (&#8220;ASC&#160;260-10&#8221;) which requires the
income or loss per share for each class of shares (ordinary and all other shares with preferences over Ordinary Shares) to be calculated
assuming <ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="bmr:PercentageOfDividend" scale="-2" unitRef="pure">100</ix:nonFraction>% of the Company&#8217;s earnings are distributed as dividends to each class of shares based on their contractual rights. No dividends
were declared or paid during the reported periods. According to the provisions of ASC&#160;260-10, the Company&#8217;s Convertible Preferred
Shares and Convertible Ordinary 1 and 2 Shares do not have contractual obligation to share losses of the Company and therefore are not
included in the computation in period of net loss per share.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_98" id="_SignificantAccountingPoliciesTextBlock-c0_cont_97"><ix:continuation continuedAt="_EarningsPerSharePolicyTextBlock-c0_cont_3" id="_EarningsPerSharePolicyTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Basic net loss per Ordinary
Share is computed by dividing the net loss for the period applicable to ordinary shareholders, by the weighted average number of Ordinary
Shares outstanding during the period. Diluted loss per share gives effect to all potentially dilutive common shares outstanding during
the year using the treasury stock method with respect to shares with preferences over Ordinary Shares (Convertible Ordinary 1 and 2 shares
and Convertible Preferred Shares), share options and certain warrants and using the if-converted method with respect to convertible advance
investments and certain warrants accounted for as derivative liability. In computing diluted loss per share, the average share price for
the period is used in determining the number of shares assumed to be purchased from the exercise of share options or warrants.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_99" id="_SignificantAccountingPoliciesTextBlock-c0_cont_98"><ix:continuation id="_EarningsPerSharePolicyTextBlock-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">During the years ended
December 31, 2022, 2021 and 2020, the total weighted average number of Ordinary Shares related to outstanding shares with preferences
over Ordinary Shares (Convertible Ordinary 1 and 2 shares and Convertible Preferred Shares), share options, warrants and convertible advance
investments excluded from the calculation of the diluted loss per share was <ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ExcessStockSharesOutstanding" scale="0" unitRef="shares">9,067,438</ix:nonFraction>, <ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ExcessStockSharesOutstanding" scale="0" unitRef="shares">8,957,327</ix:nonFraction> and <ix:nonFraction contextRef="c26" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ExcessStockSharesOutstanding" scale="0" unitRef="shares">8,842,202</ix:nonFraction>, respectively.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>


</div><!-- Field: Page; Sequence: 143; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>BEAMR IMAGING LTD.&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Cont.)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(U.S. dollars in
thousands except share and per share amounts)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white"><b>&#160;</b></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2cm; text-align: justify; text-indent: -2cm">NOTE 2 - SIGNIFICANT
ACCOUNTING POLICIES (Cont.)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: left; text-indent: -1cm"><b>&#160;</b></p><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_100" id="_SignificantAccountingPoliciesTextBlock-c0_cont_99"><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0%"></td><td style="width: 0.5in"><b>V.</b></td><td style="text-align: left"><ix:nonNumeric contextRef="c0" continuedAt="bmr_ConvertibleAdvanceInvestmentsPolicyTextBlock-c0_cont_1" escape="true" name="bmr:ConvertibleAdvanceInvestmentsPolicyTextBlock"><b>Convertible Advance Investments</b></ix:nonNumeric></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_101" id="_SignificantAccountingPoliciesTextBlock-c0_cont_100"><ix:continuation continuedAt="bmr_ConvertibleAdvanceInvestmentsPolicyTextBlock-c0_cont_2" id="bmr_ConvertibleAdvanceInvestmentsPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Upon initial recognition, the Company
has considered the provisions of ASC 480-10 &#8220;Distinguishing Liabilities from Equity&#8221; with respect to certain obligations to
issue a variable number of shares and has determined that the convertible advance investments represent a financial liability since most
of its settlement alternatives embody either a conditional or an unconditional obligation to issue a variable number of the Company&#8217;s
shares with monetary value based predominantly on a fixed monetary amount known at inception (the original issue price of the convertible
advance investments together with a fixed &#160;return to the investors).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_102" id="_SignificantAccountingPoliciesTextBlock-c0_cont_101"><ix:continuation continuedAt="bmr_ConvertibleAdvanceInvestmentsPolicyTextBlock-c0_cont_3" id="bmr_ConvertibleAdvanceInvestmentsPolicyTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Upon initial recognition, the Company
has considered the provisions of ASC 815-15,&#160;&#8220;Derivatives and Hedging - Embedded Derivatives&#8221;, and determined that the
embedded conversion feature of the convertible advance investments cannot be considered as clearly and closely related to the host debt
instrument. However, it was determined that the embedded conversion feature should not be separated from the host instrument because the
embedded conversion option, if freestanding, did not meet a derivative definition based on the provisions of ASC 815-10, &#8220;Derivatives
and Hedging&#8221;&#160;since its terms did not require or permit net settlement. Thus, it was determined that the conversion feature
does not meet the characteristic of being readily convertible to cash. However, the Company has determined that the redemption feature
upon certain events is not solely within the Company&#8217;s control under which the Company will be required to repay an amount equal to <ix:nonFraction contextRef="c47" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" unitRef="pure">200</ix:nonFraction>%
of the original investment was determined to represent a contingent interest feature that requires bifurcation from a host debt contract
because the contingent interest feature meets a derivative definition and the economic characteristics of the embedded feature are not
clearly and closely related to those of host debt instrument as such feature is not directly credit risk related.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_103" id="_SignificantAccountingPoliciesTextBlock-c0_cont_102"><ix:continuation continuedAt="bmr_ConvertibleAdvanceInvestmentsPolicyTextBlock-c0_cont_4" id="bmr_ConvertibleAdvanceInvestmentsPolicyTextBlock-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Furthermore, the Company applied ASC 470-20,
&#8220;Debt - Debt with Conversion and Other Options&#8221; (&#8220;ASC 470-20&#8221;) which clarifies the accounting for instruments with
Beneficial Conversion Features (BCF) or contingently adjustable conversion ratios and has applied the BCFs guidance to determine whether
the conversion feature is beneficial to investors. However, as the convertible advance investments were not convertible upon inception
(such instrument would have become convertible if the Company would have completed qualified financing by August 5, 2020), it was determined
that no BCF was required to be recognized upon initial recognition of the instrument.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_104" id="_SignificantAccountingPoliciesTextBlock-c0_cont_103"><ix:continuation id="bmr_ConvertibleAdvanceInvestmentsPolicyTextBlock-c0_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Based on the characteristics of the convertible
advance investments, the Company elected to measure this liability in its entirety, at its fair value in accordance with ASC 825-10, &#8220;Financial
Instruments&#8221; due to the existence of certain redemption option and the potential requirement to recognize contingent BCF. Accordingly,
upon initial recognition and in subsequent periods, the Company measures the liability related to the convertible advance investments
based on its fair value taking into consideration, among others all relevant settlement possibilities and their respective likelihood.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: left; text-indent: -1cm"><b>&#160;</b></p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_105" id="_SignificantAccountingPoliciesTextBlock-c0_cont_104"><ix:nonNumeric contextRef="c0" continuedAt="bmr_CapitalContributionFromAControllingShareholderPolicyTextBlock-c0_cont_1" escape="true" name="bmr:CapitalContributionFromAControllingShareholderPolicyTextBlock"><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0%"></td><td style="width: 0.5in"><b>W.</b></td><td style="text-align: left"><b>Capital contribution from a controlling shareholder</b></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify">&#160;</p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_106" id="_SignificantAccountingPoliciesTextBlock-c0_cont_105"><ix:continuation id="bmr_CapitalContributionFromAControllingShareholderPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The fair value of the benefit received
in respect of loan received from the controlling shareholder is calculated on the basis of the difference between the interest rate that
the Company would have required to pay for similar loan from commercial bank and the interest rate that the Company is actually charged
under the agreement with the controlling shareholders. Such benefit is accounted for as capital contribution received from the controlling
shareholder as additional paid-in capital and it is recorded as discount on the loan received against at the initial measurement date.
Subsequently, such discount is expensed over the economic life of the loan based on the effective interest rate method.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>


</div><!-- Field: Page; Sequence: 144; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="margin: 0">&#160;</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">BEAMR IMAGING LTD.</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Cont.)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(U.S. dollars in
thousands except share and per share amounts)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white"><b>&#160;</b></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: -56.7pt">NOTE 2 -
SIGNIFICANT ACCOUNTING POLICIES (Cont.)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: left; text-indent: -28.35pt"><b>&#160;</b></p><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_107" id="_SignificantAccountingPoliciesTextBlock-c0_cont_106"><ix:nonNumeric contextRef="c0" continuedAt="_ShareBasedCompensationOptionAndIncentivePlansPolicy-c0_cont_1" escape="true" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy"><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0%"></td><td style="width: 0.5in"><b>X.</b></td><td style="text-align: left"><b>Share-based compensation</b></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: 0in">&#160;</p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_108" id="_SignificantAccountingPoliciesTextBlock-c0_cont_107"><ix:continuation continuedAt="_ShareBasedCompensationOptionAndIncentivePlansPolicy-c0_cont_2" id="_ShareBasedCompensationOptionAndIncentivePlansPolicy-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0in">The Company measures
and recognizes compensation expense for all equity-based payments to employees based on their estimated fair values in accordance with
ASC 718, &#8220;Compensation-Stock Compensation&#8221;. Share-based payments are recognized in the Statement of Operations and Comprehensive
Loss as an operating expense based on fair value of the award at the grant date by using Black-Scholes option-pricing model. The inputs
for the valuation analysis of the share options include several assumptions of which the most significant are the fair market value of
the underlying Ordinary Share, the expected share price volatility and the expected option term. Expected volatility was calculated based
upon historical volatility of peer companies in the same industry on daily basis since the Company&#8217;s marketability is considered low.
The expected option term represents the period that the Company&#8217;s share options are expected to be outstanding and is determined
based on the simplified method until sufficient historical exercise data will support using expected life assumptions. The risk-free interest
rate is based on the yield from U.S. treasury bonds with an equivalent term. The expected dividend yield assumption is based on the Company&#8217;s
historical experience and expectation of no future dividend payouts. The Company has historically not paid cash dividends and has no foreseeable
plans to pay cash dividends in the future. The Company expensed compensation costs net of estimated forfeitures over the requisite service
period by applying the straight-line method.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: 0in">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_109" id="_SignificantAccountingPoliciesTextBlock-c0_cont_108"><ix:continuation continuedAt="_ShareBasedCompensationOptionAndIncentivePlansPolicy-c0_cont_3" id="_ShareBasedCompensationOptionAndIncentivePlansPolicy-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0in">The fair value of
Ordinary Shares underlying the share options was determined by the Company&#8217;s management with the assistance of an independent valuation
firm. Because there has been no public market for the Ordinary Shares, the Company&#8217;s management has determined fair value of the Ordinary
Shares at the time of grant by considering several objective and subjective factors including data from other comparable companies, sales
of Convertible Preferred Shares to unrelated third parties, operating and financial performance, the lack of liquidity of share capital
and general and industry specific economic outlook, amongst other factors. The fair value of the underlying Ordinary Shares shall be determined
by management until such time as the ordinary shares are listed on an established stock exchange, national market system or other quotation
system. For all reported periods through December&#160;31, 2020, the valuations were performed using the Option Pricing Method (&#8220;OPM&#8221;).
Commencing June&#160;30, 2021, the valuations were performed using Hybrid Method by combining the OPM and an IPO scenario.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: 0in">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_110" id="_SignificantAccountingPoliciesTextBlock-c0_cont_109"><ix:continuation continuedAt="_ShareBasedCompensationOptionAndIncentivePlansPolicy-c0_cont_4" id="_ShareBasedCompensationOptionAndIncentivePlansPolicy-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0in">Commencing January
1, 2019, following the adoption of ASU 2018-07 which aligns the measurement and classification guidance for share-based payments to nonemployees
with the guidance for share-based payments to employees (with certain exceptions), share-based payments to non-employees are accounted
in accordance with ASC 718.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: 0in">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation id="_SignificantAccountingPoliciesTextBlock-c0_cont_110"><ix:continuation id="_ShareBasedCompensationOptionAndIncentivePlansPolicy-c0_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0in">When applicable,
a modification to the terms and/or conditions of an award (i.e. a change of award&#8217;s fair value, vesting conditions or classification
as an equity or a liability instrument) is accounted for as an exchange of the original award for a new award resulting in total compensation
cost equal to the grant-date fair value of the original award, plus the incremental value of the modification to the award. The calculation
of the incremental value is based on the excess of the fair value of the modified award following the modification over the fair value
of the original award measured immediately before its terms were modified.</p></ix:continuation></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b>&#160;</b></p><ix:nonNumeric contextRef="c0" continuedAt="_OtherCurrentAssetsTextBlock-c0_cont_1" escape="true" name="us-gaap:OtherCurrentAssetsTextBlock"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63.8pt; text-align: left; text-indent: -63.8pt"><b>NOTE 3 - OTHER
CURRENT ASSETS</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63.8pt; text-align: left; text-indent: -63.8pt"><b>&#160;</b></p></ix:nonNumeric><div>

</div><div>

</div><ix:continuation id="_OtherCurrentAssetsTextBlock-c0_cont_1"><ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: justify">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of<br/>
 December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; text-indent: -14.15pt; padding-left: 14.15pt">Prepaid expenses</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PrepaidExpenseCurrentAndNoncurrent" scale="3" unitRef="usd">32</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PrepaidExpenseCurrentAndNoncurrent" scale="3" unitRef="usd">33</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -14.15pt; padding-left: 14.15pt">Government authorities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="bmr:GovernmentAuthoritiesAssets" scale="3" unitRef="usd">15</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="bmr:GovernmentAuthoritiesAssets" scale="3" unitRef="usd">22</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -14.15pt; padding-left: 14.15pt">Others</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherPrepaidExpenseCurrent" scale="3" unitRef="usd">17</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherPrepaidExpenseCurrent" scale="3" unitRef="usd">11</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 4pt; text-indent: -14.15pt; padding-left: 14.15pt">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherAssetsCurrent" scale="3" unitRef="usd">64</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherAssetsCurrent" scale="3" unitRef="usd">66</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric></ix:continuation><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p><div>

</div><!-- Field: Page; Sequence: 145; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">BEAMR IMAGING LTD.</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Cont.)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(U.S. dollars in
thousands except share and per share amounts)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_PropertyPlantAndEquipmentDisclosureTextBlock-c0_cont_1" escape="true" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><b>NOTE 4 - PROPERTY AND EQUIPMENT,
NET</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><b>&#160;</b></p></ix:nonNumeric><div>

</div><div>

</div><ix:continuation continuedAt="_PropertyPlantAndEquipmentDisclosureTextBlock-c0_cont_2" id="_PropertyPlantAndEquipmentDisclosureTextBlock-c0_cont_1"><ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:PropertyPlantAndEquipmentTextBlock"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: justify">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">As of<br/>
 December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: justify">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">Computers and peripheral equipment</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c54" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" unitRef="usd">95</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c55" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" unitRef="usd">93</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt; text-align: left">Office furniture and equipment</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c56" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" unitRef="usd">42</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c57" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" unitRef="usd">42</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" unitRef="usd">137</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" unitRef="usd">135</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt; text-align: left">Less - accumulated depreciation</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="3" unitRef="usd">122</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="3" unitRef="usd">114</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; text-align: left">Total property and equipment, net</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" unitRef="usd">15</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" unitRef="usd">21</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.65pt; text-align: left; text-indent: -5.65pt">&#160;</p></ix:nonNumeric></ix:continuation><div>


</div><div>

</div><ix:continuation id="_PropertyPlantAndEquipmentDisclosureTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">During the years ended December
31, 2022, 2021 and 2020, total depreciation expenses were $<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DepreciationExpenseOnReclassifiedAssets" scale="3" unitRef="usd">8</ix:nonFraction>, $<ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DepreciationExpenseOnReclassifiedAssets" scale="3" unitRef="usd">16</ix:nonFraction> and $<ix:nonFraction contextRef="c9" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DepreciationExpenseOnReclassifiedAssets" scale="3" unitRef="usd">32</ix:nonFraction>, respectively.</p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_GoodwillAndIntangibleAssetsDisclosureTextBlock-c0_cont_1" escape="true" name="us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><b>NOTE 5 - INTANGIBLE ASSETS,
NET AND GOODWILL</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><b>&#160;</b></p></ix:nonNumeric><div>

</div><div>

</div><ix:continuation continuedAt="_GoodwillAndIntangibleAssetsDisclosureTextBlock-c0_cont_2" id="_GoodwillAndIntangibleAssetsDisclosureTextBlock-c0_cont_1"><ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:ScheduleOfImpairedIntangibleAssetsTextBlock"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="text-align: center; border-bottom: Black 1.5pt solid"><b>As of<br/>
 December 31,</b></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">Carrying amount:</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: left">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; width: 76%; text-align: left">Technology</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c58" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AssetsUnderManagementCarryingAmount" scale="3" unitRef="usd">2,007</ix:nonFraction></td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c59" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AssetsUnderManagementCarryingAmount" scale="3" unitRef="usd">2,007</ix:nonFraction></td>
    <td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-align: left">Customer relationships</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><ix:nonFraction contextRef="c60" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AssetsUnderManagementCarryingAmount" scale="3" unitRef="usd">1,127</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><ix:nonFraction contextRef="c61" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AssetsUnderManagementCarryingAmount" scale="3" unitRef="usd">1,127</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Trade names</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c62" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AssetsUnderManagementCarryingAmount" scale="3" unitRef="usd">201</ix:nonFraction></td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c63" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AssetsUnderManagementCarryingAmount" scale="3" unitRef="usd">201</ix:nonFraction></td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 4pt">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AssetsUnderManagementCarryingAmount" scale="3" unitRef="usd">3,335</ix:nonFraction></td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AssetsUnderManagementCarryingAmount" scale="3" unitRef="usd">3,335</ix:nonFraction></td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Accumulated amortization:</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-align: left">Technology</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction contextRef="c58" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccumulatedAmortizationDeferredFinanceCosts" scale="3" unitRef="usd">2,007</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction contextRef="c59" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccumulatedAmortizationDeferredFinanceCosts" scale="3" unitRef="usd">2,007</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-align: left">Customer relationships</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><ix:nonFraction contextRef="c60" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccumulatedAmortizationDeferredFinanceCosts" scale="3" unitRef="usd">1,127</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><ix:nonFraction contextRef="c61" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccumulatedAmortizationDeferredFinanceCosts" scale="3" unitRef="usd">1,127</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Trade names</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c62" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccumulatedAmortizationDeferredFinanceCosts" scale="3" unitRef="usd">134</ix:nonFraction></td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c63" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccumulatedAmortizationDeferredFinanceCosts" scale="3" unitRef="usd">114</ix:nonFraction></td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccumulatedAmortizationDeferredFinanceCosts" scale="3" unitRef="usd">3,268</ix:nonFraction></td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccumulatedAmortizationDeferredFinanceCosts" scale="3" unitRef="usd">3,248</ix:nonFraction></td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 4pt">Intangible assets, net</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherIntangibleAssetsNet" scale="3" unitRef="usd">67</ix:nonFraction></td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherIntangibleAssetsNet" scale="3" unitRef="usd">87</ix:nonFraction></td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.65pt; text-align: left; text-indent: -5.65pt">&#160;</p></ix:nonNumeric></ix:continuation><div>


</div><div>

</div><ix:continuation continuedAt="_GoodwillAndIntangibleAssetsDisclosureTextBlock-c0_cont_3" id="_GoodwillAndIntangibleAssetsDisclosureTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">During the years ended December
31, 2022, 2021 and 2020, total amortization expenses were $<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="3" unitRef="usd">20</ix:nonFraction>, $<ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="3" unitRef="usd">177</ix:nonFraction> and $<ix:nonFraction contextRef="c9" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="3" unitRef="usd">647</ix:nonFraction>, respectively.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_GoodwillAndIntangibleAssetsDisclosureTextBlock-c0_cont_4" id="_GoodwillAndIntangibleAssetsDisclosureTextBlock-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">As of December 31, 2022, the
estimated future amortization expense of intangible assets is as follows:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_GoodwillAndIntangibleAssetsDisclosureTextBlock-c0_cont_5" id="_GoodwillAndIntangibleAssetsDisclosureTextBlock-c0_cont_4"><ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%; text-align: left">2023</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths" scale="3" unitRef="usd">20</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">2024-2026</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo" scale="3" unitRef="usd">47</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 4pt; padding-left: 2.85pt">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" unitRef="usd">67</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation id="_GoodwillAndIntangibleAssetsDisclosureTextBlock-c0_cont_5"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">As of December 31, 2022 and 2021, the Company performed an annual impairment analysis with respect to goodwill and due to continued losses,
an impairment analysis was performed also with respect to the remaining balance of intangible assets. The analysis was based on valuation
performed by management using the assistance of third-party appraiser by using the income approach. The significant assumptions used for
the assessment were a discount rate of <ix:nonFraction contextRef="c2" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:LesseeOperatingLeaseDiscountRate" scale="-2" unitRef="pure">25.3</ix:nonFraction>% and <ix:nonFraction contextRef="c3" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:LesseeOperatingLeaseDiscountRate" scale="-2" unitRef="pure">25.5</ix:nonFraction>% as of December 31, 2022 and 2021, respectively, and long-term growth rate of <ix:nonFraction contextRef="c2" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:LongDurationContractsAssumptionsByProductAndGuaranteeDiscountRate" scale="-2" unitRef="pure"><ix:nonFraction contextRef="c3" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:LongDurationContractsAssumptionsByProductAndGuaranteeDiscountRate" scale="-2" unitRef="pure">3</ix:nonFraction></ix:nonFraction>%
as of December 31, 2022 and 2021.&#160;The measurement was classified at level 3 in the fair value hierarchy whereby it was determined
that impairment is not required to be recognized with respect to goodwill or intangible assets as of December 31, 2022 and 2021.</p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 146; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">BEAMR IMAGING LTD.</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Cont.)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(U.S. dollars in
thousands except share and per share amounts)</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: -56.7pt">&#160;</p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_DebtDisclosureTextBlock-c0_cont_1" escape="true" name="us-gaap:DebtDisclosureTextBlock"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.65pt; text-align: left; text-indent: -5.65pt"><b>NOTE 6 - LOANS,
NET</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.65pt; text-align: left; text-indent: -5.65pt"><b>&#160;</b></p></ix:nonNumeric><div>

</div><div>

</div><ix:continuation continuedAt="_DebtDisclosureTextBlock-c0_cont_2" id="_DebtDisclosureTextBlock-c0_cont_1"><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"><b>A.</b></td><td style="text-align: justify"><b>Loan and Security Agreements with Silicon Valley Bank</b></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.3pt; text-align: justify; text-indent: -0.25in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DebtDisclosureTextBlock-c0_cont_3" id="_DebtDisclosureTextBlock-c0_cont_2"><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in">1.</td><td style="text-align: justify">On February 19, 2017, the Company and Beamr Inc. entered into a Loan and Security Agreement (the &#8220;2017
Loan Agreement&#8221;) with Silicon Valley Bank (the &#8220;SVB&#8221;), under which the Company had a right to borrow from SVB up to
$<ix:nonFraction contextRef="c64" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFaceAmount" scale="3" unitRef="usd">3,000</ix:nonFraction> bearing interest at a floating per annum rate equal to the Wall Street Journal Prime Rate plus <ix:nonFraction contextRef="c64" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:ShortTermDebtPercentageBearingVariableInterestRate" scale="-2" unitRef="pure">3.5</ix:nonFraction>% (upon occurrence of &#8217;default
event&#8217; as defined in the 2017 Loan Agreement, the Aggregate Loan Principal Amount shall bear interest at a rate per annum which is <ix:nonFraction contextRef="c64" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:LoansReceivableBasisSpreadOnVariableRate" scale="-2" unitRef="pure">5</ix:nonFraction>%
above the rate that is otherwise applicable thereto) which shall be payable monthly.</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: 0in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DebtDisclosureTextBlock-c0_cont_4" id="_DebtDisclosureTextBlock-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: 0in">In June 2018, the
Company drew down a cash amount in the aggregate principal amount of $<ix:nonFraction contextRef="c65" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFaceAmount" scale="3" unitRef="usd">3,000</ix:nonFraction> (the &#8220;Loan&#8221;) payable in 36 equal installments
on a monthly basis commencing the following month after drawing down. The Loan is sometimes referred to herein as a &#8220;straight loan&#8221;.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: 0in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DebtDisclosureTextBlock-c0_cont_5" id="_DebtDisclosureTextBlock-c0_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: 0in">In connection with
the execution of the 2017 Loan Agreement, the Company issued to SVB a warrant to purchase over a period of 15-years from the issuance
date of the warrant (i) <ix:nonFraction contextRef="c66" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ClassOfWarrantOrRightOutstanding" scale="0" unitRef="shares">41,040</ix:nonFraction> Series C Convertible Preferred Shares at an exercise price of $<ix:nonFraction contextRef="c66" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" unitRef="usdPershares">5.12</ix:nonFraction> per share or (ii) <ix:nonFraction contextRef="c67" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" scale="0" unitRef="shares">41,040</ix:nonFraction> shares to
be issued in the &#8216;next round&#8217; (as defined in the Agreement) at an exercise price equal to the lowest price per share at which the Company
will sell and issue shares of the Next Round Shares (the &#8220;2017 Warrant&#8221;).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: 0in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DebtDisclosureTextBlock-c0_cont_6" id="_DebtDisclosureTextBlock-c0_cont_5"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: 0in">Upon initial recognition,
the management by assistance of third-party appraiser allocated the net cash proceeds received based on the relative fair value of the
Loan and the detachable 2017 Warrant in total amount of $<ix:nonFraction contextRef="c68" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WarrantsAndRightsOutstanding" scale="3" unitRef="usd">2,875</ix:nonFraction> and $<ix:nonFraction contextRef="c69" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WarrantsAndRightsOutstanding" scale="3" unitRef="usd">125</ix:nonFraction>, respectively. The amount allocated to the 2017 Warrant was classified
as a component of permanent equity (as their terms permit the holder to receive a fixed number of Ordinary Shares upon exercise for a
fixed exercise price) and the same amount was presented as a discount of the loan component.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: 0in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DebtDisclosureTextBlock-c0_cont_7" id="_DebtDisclosureTextBlock-c0_cont_6"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: 0in">In subsequent periods,
the Loan is accounted for using the effective interest method over the Loan term, until its stated maturity. Consequently, the Company
recorded expenses amounting to $<ix:nonFraction contextRef="c70" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AmortizationOfDebtDiscountPremium" scale="3" unitRef="usd">12</ix:nonFraction> and $<ix:nonFraction contextRef="c71" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AmortizationOfDebtDiscountPremium" scale="3" unitRef="usd">59</ix:nonFraction> related to amortization of discount and interest expenses of the Loan under finance expenses
line in the consolidated Statement of Operations and Comprehensive Loss for the years ended December 31, 2022 and 2021, respectively.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: 0in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DebtDisclosureTextBlock-c0_cont_8" id="_DebtDisclosureTextBlock-c0_cont_7"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: 0in">To secure its obligations
under the 2017 Loan Agreement, the Company provided a fixed and floating collateral on all its assets (including its intellectual property).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: 0in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DebtDisclosureTextBlock-c0_cont_9" id="_DebtDisclosureTextBlock-c0_cont_8"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: 0in">On April 15, 2020,
the Company entered into deferral agreement with SVB in connection with the 2017 Loan Agreement under which the original monthly repayment
date for the remaining principal due from May 2020 to October 2020 was extended by a period of six months commencing November 2020. However,
management has determined that such modification of terms does not represent extinguishment of the original Loan, as the Loan before and
after the modification was not considered as &#8220;substantially different&#8221; in accordance with the provisions of ASC 470-50.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: 0in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DebtDisclosureTextBlock-c0_cont_10" id="_DebtDisclosureTextBlock-c0_cont_9"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: 0in">On April 29, 2021
(the &#8220;Deferral Effective Date&#8221;), the Company entered into a second deferral agreement in connection with the straight loan
made under the 2017 Loan Agreement with SVB, under which it was agreed that the original monthly repayment dates for the remaining balance
of the principal due from May 2021 to October 2021 (amounting to $<ix:nonFraction contextRef="c72" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" scale="3" unitRef="usd">667</ix:nonFraction> as of that date) shall be extended by a period of six months commencing
November 2021. In consideration, the Company was required to (i) pay SVB a deferral facility fee equal to $<ix:nonFraction contextRef="c73" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LineOfCreditFacilityCommitmentFeeAmount" scale="3" unitRef="usd">50</ix:nonFraction> which shall be fully earned
at the Deferral Effective Date, and payable in 10 monthly equal installments over the period commencing April 29, 2021 through January
29, 2022 (the &#8220;Facility Fee&#8221;); (ii) reimburse SVB for all reasonable legal fees and expenses incurred in connection with the
Deferral Agreement and (iii) issue SVB warrants to purchase <ix:nonFraction contextRef="c74" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1" scale="0" unitRef="shares">9,764</ix:nonFraction> shares (the &#8220;2021 Warrant&#8221;) at an exercise price of $<ix:nonFraction contextRef="c75" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" unitRef="usdPershares">5.12</ix:nonFraction>
per share (subject to standard adjustments) over a period of 15-years at SVB&#8217;s discretion into either to Series C Convertible Preferred
Shares or class of securities sold and issued by the Company in the next equity financing round (as determined in accordance with the
warrant agreement for the 2021 Warrant (the &#8220;Warrant Agreement&#8221;)) . If SVB exercises the 2021 Warrant and the Warrant Value
(as defined in and determined in the Warrant Agreement) will be lower than an amount of $<ix:nonFraction contextRef="c76" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FairValueAdjustmentOfWarrants" scale="3" unitRef="usd">50</ix:nonFraction> (the &#8220;Minimum Value&#8221;), then immediately
following such exercise, the Company shall pay SVB an amount in cash equal to the difference between the Minimum Value and Warrant Value.
The 2021 Warrant was issued on April 29, 2021.</p><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p></ix:continuation><div>

</div><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 147; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">BEAMR IMAGING LTD.</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Cont.)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(U.S. dollars in
thousands except share and per share amounts)</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: -56.7pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.65pt; text-align: left; text-indent: -5.65pt"><b>NOTE 6 - LOANS,
NET (Cont.)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.65pt; text-align: left; text-indent: -5.65pt"><b>&#160;</b></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0%"></td><td style="width: 0.5in"><b>A.</b></td><td style="text-align: justify"><b>Loan and Security Agreements with Silicon Valley Bank (Cont.)</b></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.3pt">&#160;</p><div>

</div><ix:continuation continuedAt="_DebtDisclosureTextBlock-c0_cont_11" id="_DebtDisclosureTextBlock-c0_cont_10"><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">1.</td><td style="text-align: justify">(Cont.)</td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.3pt; text-align: justify; text-indent: 0in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DebtDisclosureTextBlock-c0_cont_12" id="_DebtDisclosureTextBlock-c0_cont_11"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: 0in">Upon the modification
of the terms under the 2017 Loan Agreement, the Company has considered the provisions of ASC 470-50 &#8220;Debt - Modification or Extinguishment&#8221;
(&#8220;ASC 470-50&#8221;), and based on such assessment, management has determined by using the assistance of a third-party appraiser
that the fair value of the modified loan (including the Facility Fee) plus the fair value of the 2021 Warrant granted are considered as
substantially different than the fair value of the original straight loan prior to the modification date. As per the provisions of ASC
470-50, it was determined that the modification represents an extinguishment of the original straight loan. Accordingly, the Company derecognized
the remaining balance of the original straight loan in the total amount of $<ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LineOfCreditFacilityFairValueOfAmountOutstanding" scale="3" unitRef="usd">672</ix:nonFraction> and recorded an amount of $<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LineOfCreditFacilityCollateralFeesAmount" scale="3" unitRef="usd">712</ix:nonFraction> which represented the fair
value of the modified loan (including the Facility Fee) and the fair value of the issued 2021 Warrant in a total amount of $<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FairValueAdjustmentOfWarrants" scale="3" unitRef="usd">50</ix:nonFraction> as non-current
financial liability as their terms permit the holders to receive a variable number of Ordinary Shares upon exercise and as such, the 2021
Warrant is subject to a minimum fair value mechanism. Changes in the estimated fair value of the 2021 Warrant are recognized each reporting
period under Financing Expenses, net in the consolidated Statement of Operations and Comprehensive Loss, until the 2021 Warrant is exercised
or expired, as earlier. See also Note 8.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.3pt; text-align: justify; text-indent: 0in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DebtDisclosureTextBlock-c0_cont_13" id="_DebtDisclosureTextBlock-c0_cont_12"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: 0in">In June 2022, the
Loan was fully repaid.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.3pt; text-align: justify; text-indent: -0.25in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DebtDisclosureTextBlock-c0_cont_14" id="_DebtDisclosureTextBlock-c0_cont_13"><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in">2.</td><td style="text-align: justify">On February 17, 2022, the Company entered into a Loan and Securities Agreement (the &#8220;2022 Loan Agreement&#8221;)
with SVB, according to which commencing as of August 1, 2022 through December 31, 2022, SVB may, in its sole discretion in each instance,
pursuant to the Company&#8217;s request, finance specific eligible accounts receivables of the Company, as determined in the 2022 Loan
Agreement, in a total amount equal to the face amount of the eligible account multiplied by a rate of <ix:nonFraction contextRef="c77" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:InvestmentInterestRate" scale="-2" unitRef="pure">80</ix:nonFraction>%, subject to reduction by SVB
in its discretion (the &#8220;Advance&#8221;), provided that the aggregate amount of all outstanding Advances shall not exceed the lesser
of (i) an aggregate principal amount equal to $<ix:nonFraction contextRef="c78" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFaceAmount" scale="3" unitRef="usd">350</ix:nonFraction>, the (&#8220;Revolving Line&#8221;), or (ii) <ix:nonFraction contextRef="c78" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:DerivativeFixedInterestRate" scale="-2" unitRef="pure">80</ix:nonFraction>% of all eligible accounts minus the
sum of all outstanding principal amounts of any Advances, subject to reduction by SVB in its discretion. The outstanding principal amount
of any Advance shall accrue interest at a floating rate per annum equal to the greater of (i) <ix:nonFraction contextRef="c79" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:DerivativeFixedInterestRate" scale="-2" unitRef="pure">8.25</ix:nonFraction>% and (ii) a floating per annum rate
equal to the Wall Street Journal Prime Rate plus <ix:nonFraction contextRef="c80" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:DerivativeFixedInterestRate" scale="-2" unitRef="pure">5</ix:nonFraction>% (upon occurrence of a &#8216;default event&#8217; as defined in the 2022 Loan Agreement, the aggregate
loan principal amount shall bear interest at a rate per annum which is <ix:nonFraction contextRef="c78" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:InvestmentInterestRate" scale="-2" unitRef="pure">5</ix:nonFraction>% above the rate that is otherwise applicable thereto). Interest
on the principal amount of each Advance will be payable in monthly arrears (i) on each the last day of each month and (ii) on December
31, 2022 (the &#8220;Revolving Line Maturity Date&#8221;). The security interest granted in the 2022 Loan Agreement shall at all times
continue to be a first priority preferred security interest in the collateral and a first priority fixed and floating charges.</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.3pt; text-align: justify; text-indent: 0in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DebtDisclosureTextBlock-c0_cont_15" id="_DebtDisclosureTextBlock-c0_cont_14"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: 0in">Upon making of the
initial Advance, the Company agreed to issue to SVB a warrant to purchase (i) <ix:nonFraction contextRef="c81" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockSharesIssued" scale="0" unitRef="shares">4,785</ix:nonFraction> Series C Convertible Preferred Shares, or (ii) Ordinary
Shares in the event that the Company has listed its securities for trading on Nasdaq, or (iii) upon SVB&#8217;s written irrevocable election
in its sole discretion, the same class and series, or other designation, of convertible preferred share or other senior equity security
sold and issued by the Company in the next equity financing over a 15-years period commencing the issuance date of such warrant, at an
exercise price of $<ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:WarrantExercisePriceIncrease" scale="0" unitRef="usdPershares">5.12</ix:nonFraction> per share, provided that if the class is the next equity financing securities, then the exercise price shall be
the lowest price per share for which next equity financing securities are sold or issued by the Company.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.3pt; text-align: justify; text-indent: 0in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DebtDisclosureTextBlock-c0_cont_16" id="_DebtDisclosureTextBlock-c0_cont_15"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: 0in">On July 26, 2022,
the 2022 Loan Agreement was terminated, and all related collateral was released.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify; text-indent: -21.3pt"><b>&#160;</b></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DebtDisclosureTextBlock-c0_cont_17" id="_DebtDisclosureTextBlock-c0_cont_16"><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0%"></td><td style="width: 0.5in"><b>B.</b></td><td style="text-align: justify"><b>Paycheck Protection Program Notes</b></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify; text-indent: 0in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DebtDisclosureTextBlock-c0_cont_18" id="_DebtDisclosureTextBlock-c0_cont_17"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0in">On May 7, 2020 and
March 25, 2021, Beamr Inc. entered into separate Paycheck Protection Program Notes (the &#8220;PPP Notes&#8221;) with SVB under which
Beamr Inc. borrowed amounts of $<ix:nonFraction contextRef="c82" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:EquityMethodInvestmentAggregateCost" scale="3" unitRef="usd">75</ix:nonFraction> and $<ix:nonFraction contextRef="c83" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:EquityMethodInvestmentAggregateCost" scale="3" unitRef="usd">54</ix:nonFraction>, respectively, (in aggregate the &#8220;PPP Amount&#8221;). The PPP Amount bears interest of
<ix:nonFraction contextRef="c3" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:AccountsPayableInterestBearingInterestRate" scale="-2" unitRef="pure">1.0</ix:nonFraction>% per annum. Beamr Inc. was required make a monthly payment of principal and interest on the applicable PPP Amount, each monthly payment
to be in equal amounts such that the applicable PPP Amount was fully amortized by the maturity date which was determined as 24 months
from the date of the first PPP Note or 60 months from the date of the second PPP Note. At any time, Beamr Inc. was entitled to fully prepay
the PPP Amount without payment of penalty or premium.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify; text-indent: 0in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DebtDisclosureTextBlock-c0_cont_19" id="_DebtDisclosureTextBlock-c0_cont_18"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0in">The Company used
the PPP Amount for qualifying expenses which may be forgiven if it is utilized for qualifying expenses as described in the CARES Act.
In 2021, the PPP Amount was fully forgiven due to qualification for used expenses under the CARES Act and consequently the Company recorded
an amount of $<ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherIncome" scale="3" unitRef="usd">129</ix:nonFraction> under other income in the consolidated Statement of Operations and Comprehensive Loss for the year ended December 31,
2021.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: 0in">&#160;</p></ix:continuation><div>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: 0in"></p><div>

</div><!-- Field: Page; Sequence: 148; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">BEAMR IMAGING LTD.</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Cont.)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(U.S. dollars in
thousands except share and per share amounts)</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: -56.7pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.65pt; text-align: left; text-indent: -5.65pt"><b>NOTE 6 - LOANS,
NET (Cont.)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.65pt; text-align: left; text-indent: -5.65pt"><b>&#160;</b></p><div>

</div><ix:continuation continuedAt="_DebtDisclosureTextBlock-c0_cont_20" id="_DebtDisclosureTextBlock-c0_cont_19"><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0%"></td><td style="width: 0.5in"><b>C.</b></td><td style="text-align: justify"><b>Funding Agreement with IBI Spikes Ltd.</b></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify; text-indent: 0in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DebtDisclosureTextBlock-c0_cont_21" id="_DebtDisclosureTextBlock-c0_cont_20"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0in">On July 7, 2022 (the
&#8220;Effective Date&#8221;), the Company entered into the Definitive Agreement with IBI Spikes Ltd. (the &#8220;IBI&#8221;), according
to which the Company received an amount of NIS <ix:nonFraction contextRef="c84" decimals="-5" format="ixt:num-dot-decimal" name="bmr:AgreementAmountReceived" scale="6" unitRef="ils">3.1</ix:nonFraction> million (approximately $<ix:nonFraction contextRef="c84" decimals="-3" format="ixt:num-dot-decimal" name="bmr:AgreementAmountReceived" scale="3" unitRef="usd">900</ix:nonFraction>) (the &#8220;IBI Loan&#8221;). The Company granted IBI
a right to receive consecutive monthly repayments equal to Net Cash Receipts multiplied by the Royalty Rate, as both defined in the Definitive
Agreement, until such time as IBI receives an amount equal to NIS <ix:nonFraction contextRef="c84" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromRoyaltiesReceived" scale="3" unitRef="ils">4,172,760</ix:nonFraction> (approximately $<ix:nonFraction contextRef="c84" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromRoyaltiesReceived" scale="6" unitRef="usd">1.2</ix:nonFraction> million) (the &#8220;Repayment Amount&#8221;)
with any amount on account of the Repayment Amount which remains outstanding on the 42nd month anniversary of the later of (i) the Closing
Date, and (ii) the last payment provided by IBI (the &#8220;Final Repayment Date&#8221;) to be paid to IBI at such time. Notwithstanding
the above, Company&#8217;s minimum annual payment during any Annual Calculation Period will not be less than the lower of (i) $<ix:nonFraction contextRef="c85" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentAnnualPrincipalPayment" scale="3" unitRef="usd">330</ix:nonFraction> and
(ii) the outstanding Repayment Amount in recent year.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify; text-indent: 0in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DebtDisclosureTextBlock-c0_cont_22" id="_DebtDisclosureTextBlock-c0_cont_21"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0in">The Company may repay
the Repayment Amount at any time prior to the Final Repayment Date. If early repayment (such amount, the &#8220;Payment Amount&#8221;)
occurs prior to 12-month anniversary date of the Effective Date, then, a <ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="bmr:PercentageOfOutstandingRepaymentAndPaymentAmount" scale="-2" unitRef="pure">50</ix:nonFraction>% discount will be applied on the outstanding difference between
the Repayment Amount and the Payment Amount (the &#8220;Rev-Share Amount&#8221;) component of the outstanding Repayment Amount; or if
early repayment occurs after 12-month anniversary date of the Closing Date but before 18-month anniversary date of the Closing Date, then,
a <ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="bmr:PercentageOfDiscountOutstanding" scale="-2" unitRef="pure">35</ix:nonFraction>% discount will be applied on the outstanding Rev-Share Amount of the outstanding Repayment Amount (the &#8220;Early Repayment Amount&#8221;).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify; text-indent: 0in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DebtDisclosureTextBlock-c0_cont_23" id="_DebtDisclosureTextBlock-c0_cont_22"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0in">In case the Company
and/or its subsidiaries consummates a change of control, merger transaction, IPO (excluding an IPO on the Nasdaq Capital Market (the &#8220;Nasdaq&#8221;))
or sale of all or substantially all of assets (the &#8220;Exit Event&#8221;), the Company shall fully pay IBI the Repayment Amount or
the Early Repayment Amount, as the case may be.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify; text-indent: 0in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DebtDisclosureTextBlock-c0_cont_24" id="_DebtDisclosureTextBlock-c0_cont_23"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0in">The Company incurred
non-refundable one-time fee of $<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InterestAndFeeIncomeOtherLoans" scale="3" unitRef="usd">13</ix:nonFraction>, reflecting <ix:nonFraction contextRef="c86" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed" scale="-2" unitRef="pure">1.5</ix:nonFraction>% of the Payment Amount plus VAT.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify; text-indent: 0in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DebtDisclosureTextBlock-c0_cont_25" id="_DebtDisclosureTextBlock-c0_cont_24"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0in">Upon making of the
Payment Amount, the Company issued warrant to IBI to purchase <ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ClassOfWarrantOrRightOutstanding" scale="0" unitRef="shares">65,563</ix:nonFraction> of (i) the most senior class of shares outstanding or (ii) Ordinary
Shares in case of an exercise following to completion of an IPO transaction (the &#8220;Warrant Share&#8221;). The exercise price for
each of the Warrant Share, shall be as follows:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify; text-indent: 0in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DebtDisclosureTextBlock-c0_cont_26" id="_DebtDisclosureTextBlock-c0_cont_25"><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in">1.</td><td style="text-align: justify">If financing round in consideration for an aggregate investment of at least $<ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:EquityMethodInvestmentAggregateCost" scale="0" unitRef="usd">10,000</ix:nonFraction> (including the Investment
Amount and any additional amount provided to the Company under any additional AIA) (the &#8220;Qualified Financing&#8221;) occurs within
12 months following the Effective Date consummates, the exercise price for each Warrant Share, will be the price per share in such Qualified
Financing, less a <ix:nonFraction contextRef="c87" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:LesseeFinanceLeaseDiscountRate" scale="-2" unitRef="pure">20</ix:nonFraction>% discount and the shares type upon conversion of the Warrant Share shall have the same rights and preferences as
attached to the shares issued to the investors in such Qualified Financing. If transactions consummated in such closings are not on the
same terms and conditions and/or involve the issuance of more than one type of Company&#8217;s securities, then, the shares type upon conversion
of the Warrant Share shall have the most favorable terms of such closing.</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt; text-align: justify; text-indent: -21.25pt">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DebtDisclosureTextBlock-c0_cont_27" id="_DebtDisclosureTextBlock-c0_cont_26"><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in">2.</td><td style="text-align: justify">If a Non-Qualified Financing occurs, IBI shall have the right but not the obligation to elect, by delivery
of written notice to the Company no later than 30 days from the receipt of a written notice from the Company setting forth the terms and
conditions of such Non-Qualified Financing, to determine that the exercise price for each Warrant Share, will be the price per share in
such Non-Qualified Financing, less a <ix:nonFraction contextRef="c2" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:LesseeFinanceLeaseDiscountRate" scale="-2" unitRef="pure">20</ix:nonFraction>% discount and the shares type upon conversion of the Warrant Share shall have the same rights
and preferences as attached to the shares issued to the investors in such Non-Qualified Financing. If transactions consummated in such
closings are not on the same terms and conditions and/or involve the issuance of more than one type of Company&#8217;s securities, then, the
shares type upon conversion of the Warrant Share shall have the most favorable terms of such closing.</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt; text-align: justify; text-indent: -21.25pt">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DebtDisclosureTextBlock-c0_cont_28" id="_DebtDisclosureTextBlock-c0_cont_27"><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in">3.</td><td style="text-align: justify">In the event the Company has not consummated (a Qualified Financing or an Realization Event (as defined
in the Definitive Agreement) within period of 12 months of the Effective Date of the Definitive Agreement, IBI shall have the right but
not the obligation to elect, by delivery of written notice to the Company no later than 30-days from the receipt of a written notice from
the Company, to determine that the exercise price for each Warrant Share will be based on Company value of $<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueStockDividend" scale="3" unitRef="usd">62,500</ix:nonFraction> divided by the then
fully diluted number of Company shares and the shares type upon conversion of the Warrant Share shall have the same rights of the Company&#8217;s
most senior class of shares then outstanding.</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt; text-align: justify; text-indent: -21.25pt">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DebtDisclosureTextBlock-c0_cont_29" id="_DebtDisclosureTextBlock-c0_cont_28"><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in">4.</td><td style="text-align: justify">In the event of Realization Event, the exercise price for each Warrant Share will be the price per share
in such Financing, less a <ix:nonFraction contextRef="c88" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:LesseeFinanceLeaseDiscountRate" scale="-2" unitRef="pure">20</ix:nonFraction>% discount, and the shares type upon conversion of the Warrant Share shall have the Company&#8217;s Most Senior
Shares, or Ordinary Shares in case the Realization Event is an IPO.</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify; text-indent: 0in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DebtDisclosureTextBlock-c0_cont_30" id="_DebtDisclosureTextBlock-c0_cont_29"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0in">Each Warrant Share
is exercisable until the earlier of (a) M&amp;A, (b) IPO, or (c) a <ix:nonNumeric contextRef="c2" format="ixt-sec:duryear" name="us-gaap:LoansHeldForSaleTerm">10</ix:nonNumeric>-years period from the issuance date and shall be in customary form
approved by IBI and shall contain standard and customary provisions.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify; text-indent: 0in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DebtDisclosureTextBlock-c0_cont_31" id="_DebtDisclosureTextBlock-c0_cont_30"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0in">As the exercise price
of the Warrant Share will be determined based on the occurrence of one of the aforesaid trigger events, the Warrant Share was accounted
for as a derivative financial liability. (See note 8).</p><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p></ix:continuation><div>

</div><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 149; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">BEAMR IMAGING LTD.</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Cont.)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(U.S. dollars in
thousands except share and per share amounts)</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 46.35pt; text-align: justify; text-indent: 0in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.65pt; text-align: left; text-indent: -5.65pt"><b>NOTE 6 - LOANS,
NET (Cont.)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.65pt; text-align: left; text-indent: -5.65pt"><b>&#160;</b></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0%"></td><td style="width: 0.5in"><b>C.</b></td><td style="text-align: justify"><b>Funding Agreement with IBI Spikes Ltd. (Cont.)</b></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify; text-indent: 0in">&#160;</p><div>

</div><ix:continuation continuedAt="_DebtDisclosureTextBlock-c0_cont_32" id="_DebtDisclosureTextBlock-c0_cont_31"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0in">Pursuant to the above,
at the Effective Date, management by assistance of third-party appraiser allocated the IBI Loan to identified components as follows:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify; text-indent: 0in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DebtDisclosureTextBlock-c0_cont_33" id="_DebtDisclosureTextBlock-c0_cont_32"><ix:nonNumeric contextRef="c0" escape="true" name="bmr:ScheduleOfTheMemberEffectiveDateManagementByAssistanceOfThirdpartyTableTextBlock"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>As of Closing Date</b></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%; text-align: left">Derivative warrant liability (see Note 8)</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right">&#160;&#160;&#160;&#160;&#160;<ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="bmr:DerivativeWarrantLiabilityseeNote8" scale="3" unitRef="usd">78</ix:nonFraction></td>
    <td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Straight loan</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StraightLineRent" scale="3" unitRef="usd">822</ix:nonFraction></td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Total gross consideration</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="bmr:TotalGrossConsideration" scale="3" unitRef="usd">900</ix:nonFraction></td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify; text-indent: 0in">&#160;</p></ix:nonNumeric></ix:continuation><div>


</div><div>

</div><ix:continuation continuedAt="_DebtDisclosureTextBlock-c0_cont_34" id="_DebtDisclosureTextBlock-c0_cont_33"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0in">Total incremental and direct debt costs of $<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost" scale="3" unitRef="usd">1</ix:nonFraction> and $<ix:nonFraction contextRef="c0" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:PaymentsOfLoanCosts" scale="6" unitRef="usd">12</ix:nonFraction> were allocated to Warrant Share and straight loan, respectively, based on their
relative value at the Effective Date. The portion of issuance costs allocated to Warrant Share was recognized immediately as finance expenses
in the consolidated statements of operations and comprehensive loss and the portion of issuance costs allocated to straight loan was deducted
from the principal amount.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify; text-indent: -21.3pt"><b>&#160;</b></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DebtDisclosureTextBlock-c0_cont_35" id="_DebtDisclosureTextBlock-c0_cont_34"><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0%"></td><td style="width: 0.5in"><b>D.</b></td><td style="text-align: justify">The following tabular presentation reflects the reconciliation of the carrying amount of the Company&#8217;s
loans during the years ended December 31, 2022, 2021:</td></tr></table><p style="margin-top: 0; margin-bottom: 0">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DebtDisclosureTextBlock-c0_cont_36" id="_DebtDisclosureTextBlock-c0_cont_35"><ix:nonNumeric contextRef="c0" escape="true" name="bmr:ScheduleOfPresentationReflectsTheReconciliationOfTheCarryingAmountTableTextBlock"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="text-align: center; border-bottom: Black 1.5pt solid"><b>Year ended  December 31,</b></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2020</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left; text-indent: -14.15pt; padding-left: 14.15pt">Opening balance</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="bmr:ReconciliationOfTheCarryingAmount" scale="3" unitRef="usd">508</ix:nonFraction></td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="bmr:ReconciliationOfTheCarryingAmount" scale="3" unitRef="usd">1,069</ix:nonFraction></td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c9" decimals="-3" format="ixt:num-dot-decimal" name="bmr:ReconciliationOfTheCarryingAmount" scale="3" unitRef="usd">1,469</ix:nonFraction></td>
    <td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -14.15pt; padding-left: 14.15pt">Consideration received from PPP Note</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-55">-</div></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="bmr:ConsiderationReceivedFromPPPNote" scale="3" unitRef="usd">54</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><ix:nonFraction contextRef="c9" decimals="-3" format="ixt:num-dot-decimal" name="bmr:ConsiderationReceivedFromPPPNote" scale="3" unitRef="usd">75</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -14.15pt; padding-left: 14.15pt">Net consideration received from IBI Loan</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="bmr:NetConsiderationReceivedFromIBILoan" scale="3" unitRef="usd">887</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-56">-</div></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-57">-</div></td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -14.15pt; padding-left: 14.15pt">Recognition of fair value of derivative warrant liability</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">(<ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DerivativeLiabilityFairValueOfCollateral" scale="3" unitRef="usd">88</ix:nonFraction></td>
    <td style="text-align: left">)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-58">-</div></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-59">-</div></td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -14.15pt; padding-left: 14.15pt">PPP Note forgiveness (see also Note 6B)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-60">-</div></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">(<ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentDecreaseForgiveness" scale="3" unitRef="usd">129</ix:nonFraction></td>
    <td style="text-align: left">)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-61">-</div></td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -14.15pt; padding-left: 14.15pt">Amortization of discounts relating to straight loan (see also Note 13)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments" scale="3" unitRef="usd">14</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments" scale="3" unitRef="usd">14</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><ix:nonFraction contextRef="c9" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments" scale="3" unitRef="usd">29</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -14.15pt; padding-left: 14.15pt">Accrued interest expenses relating to straight loan (see also Note 13)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccountsPayableAndAccruedLiabilitiesFairValueDisclosure" scale="3" unitRef="usd">77</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccountsPayableAndAccruedLiabilitiesFairValueDisclosure" scale="3" unitRef="usd">45</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><ix:nonFraction contextRef="c26" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccountsPayableAndAccruedLiabilitiesFairValueDisclosure" scale="3" unitRef="usd">91</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -14.15pt; padding-left: 14.15pt">Repayment of accrued interest relating to straight loan</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RepaymentsOfDebt" scale="3" unitRef="usd">77</ix:nonFraction></td>
    <td style="text-align: left">)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">(<ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RepaymentsOfDebt" scale="3" unitRef="usd">45</ix:nonFraction></td>
    <td style="text-align: left">)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">(<ix:nonFraction contextRef="c9" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RepaymentsOfDebt" scale="3" unitRef="usd">91</ix:nonFraction></td>
    <td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -14.15pt; padding-left: 14.15pt">Repayment of Facility Fee relating to straight loan</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LoanProcessingFee" scale="3" unitRef="usd">10</ix:nonFraction></td>
    <td style="text-align: left">)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">(<ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LoanProcessingFee" scale="3" unitRef="usd">40</ix:nonFraction></td>
    <td style="text-align: left">)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-62">-</div></td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -14.15pt; padding-left: 14.15pt">Repayment of principal relating to straight loans</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RepaymentsOfOtherLongTermDebt" scale="3" unitRef="usd">582</ix:nonFraction></td>
    <td style="text-align: left">)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">(<ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RepaymentsOfOtherLongTermDebt" scale="3" unitRef="usd">500</ix:nonFraction></td>
    <td style="text-align: left">)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">(<ix:nonFraction contextRef="c9" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RepaymentsOfOtherLongTermDebt" scale="3" unitRef="usd">504</ix:nonFraction></td>
    <td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -14.15pt; padding-left: 14.15pt">Derecognition due to extinguishment of original straight loan</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-63">-</div></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">(<ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ExtinguishmentOfDebtAmount" scale="3" unitRef="usd">672</ix:nonFraction></td>
    <td style="text-align: left">)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-64">-</div></td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -14.15pt; padding-left: 14.15pt">Recognition subsequent to substantial modification of terms</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-65">-</div></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="bmr:RecognitionSubsequentToSubstantialModificationOfTerms" scale="3" unitRef="usd">712</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-66">-</div></td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -14.15pt; padding-left: 14.15pt">Exchange rate differences</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" scale="3" unitRef="usd">12</ix:nonFraction></td>
    <td style="padding-bottom: 1.5pt; text-align: left">)</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-67">-</div></td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-68">-</div></td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 4pt; text-indent: -14.15pt; padding-left: 14.15pt">Closing balance</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="bmr:ReconciliationOfCarryingAmount" scale="3" unitRef="usd">717</ix:nonFraction></td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="bmr:ReconciliationOfCarryingAmount" scale="3" unitRef="usd">508</ix:nonFraction></td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c9" decimals="-3" format="ixt:num-dot-decimal" name="bmr:ReconciliationOfCarryingAmount" scale="3" unitRef="usd">1,069</ix:nonFraction></td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify; text-indent: 0in">&#160;</p></ix:nonNumeric></ix:continuation><div>


</div><div>

</div><ix:continuation continuedAt="_DebtDisclosureTextBlock-c0_cont_37" id="_DebtDisclosureTextBlock-c0_cont_36"><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0%"></td><td style="width: 0.5in"><b>E.</b></td><td style="text-align: justify">Maturity dates of outstanding loans:</td></tr></table><p style="margin-top: 0; margin-bottom: 0">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DebtDisclosureTextBlock-c0_cont_38" id="_DebtDisclosureTextBlock-c0_cont_37"><ix:nonNumeric contextRef="c0" continuedAt="bmr_ScheduleOfMaturityDatesOfOutstandingLoanTableTextBlock-c0_cont_1" escape="true" name="bmr:ScheduleOfMaturityDatesOfOutstandingLoanTableTextBlock"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="text-align: center; border-bottom: Black 1.5pt solid"><b>As of <br/>
December 31,</b></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; text-indent: -14.15pt; padding-left: 14.15pt">First year (current maturities) (*)</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" id="ix_0_fact" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" scale="3" unitRef="usd">164</ix:nonFraction></td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" id="ix_1_fact" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" scale="3" unitRef="usd">508</ix:nonFraction></td>
    <td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -14.15pt; padding-left: 14.15pt">Second year</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" scale="3" unitRef="usd">288</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-69">-</div></td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -14.15pt; padding-left: 14.15pt">Third year</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" scale="3" unitRef="usd">265</ix:nonFraction></td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-70">-</div></td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 4pt; text-indent: -14.15pt; padding-left: 14.15pt">Closing balance</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LongTermDebt" scale="3" unitRef="usd">717</ix:nonFraction></td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LongTermDebt" scale="3" unitRef="usd">508</ix:nonFraction></td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p></ix:nonNumeric></ix:continuation><div>


</div><div>

</div><ix:continuation id="_DebtDisclosureTextBlock-c0_cont_38"><ix:continuation id="bmr_ScheduleOfMaturityDatesOfOutstandingLoanTableTextBlock-c0_cont_1"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left">(*)</td><td style="text-align: justify"><ix:footnote id="ix_1_footnote" xml:lang="en-US">As described in Note 6C above, the Company is required to repay
each year a minimum amount of $<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RepaymentsOfSecuredDebt" scale="3" unitRef="usd">330</ix:nonFraction> with respect to Repayment Amount (principal and interest).</ix:footnote></td>
</tr></table></ix:continuation></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.65pt; text-align: left; text-indent: -5.65pt"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.65pt; text-align: left; text-indent: -5.65pt"></p><div>

</div><!-- Field: Page; Sequence: 150; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.65pt; text-align: left; text-indent: -5.65pt"><b>&#160;</b></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">BEAMR IMAGING LTD.</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Cont.)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(U.S. dollars in
thousands except share and per share amounts)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-weight: normal">&#160;</span></p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock-c0_cont_1" escape="true" name="us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63.8pt; text-align: left; text-indent: -63.8pt"><b>NOTE 7 - OTHER
CURRENT LIABILITIES</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63.8pt; text-align: left; text-indent: -63.8pt"><b>&#160;</b></p></ix:nonNumeric><div>

</div><div>

</div><ix:continuation continuedAt="_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock-c0_cont_2" id="_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock-c0_cont_1"><ix:nonNumeric contextRef="c0" continuedAt="_OtherCurrentLiabilitiesTableTextBlock-c0_cont_1" escape="true" name="us-gaap:OtherCurrentLiabilitiesTableTextBlock"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: justify">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"><b>As of <br/>
December 31,</b></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; text-indent: -14.15pt; padding-left: 14.15pt">Employees and payroll accruals</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="3" unitRef="usd">298</ix:nonFraction></td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="3" unitRef="usd">341</ix:nonFraction></td>
    <td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -14.15pt; padding-left: 14.15pt">Accrued expenses (*)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" id="ix_2_fact" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" scale="3" unitRef="usd">85</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" id="ix_3_fact" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" scale="3" unitRef="usd">126</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -14.15pt; padding-left: 14.15pt">Government authorities</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="bmr:GovernmentAuthorities" scale="3" unitRef="usd">42</ix:nonFraction></td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="bmr:GovernmentAuthorities" scale="3" unitRef="usd">33</ix:nonFraction></td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 4pt; text-indent: -14.15pt; padding-left: 14.15pt">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherLiabilitiesCurrent" scale="3" unitRef="usd">425</ix:nonFraction></td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherLiabilitiesCurrent" scale="3" unitRef="usd">500</ix:nonFraction></td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p></ix:nonNumeric></ix:continuation><div>


</div><div>

</div><ix:continuation id="_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock-c0_cont_2"><ix:continuation id="_OtherCurrentLiabilitiesTableTextBlock-c0_cont_1"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left">(*)</td><td style="text-align: justify"><ix:footnote id="ix_2_footnote" xml:lang="en-US">Including accrued interest relating to straight loan amounted
to $<ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DepositLiabilitiesAccruedInterest" scale="3" unitRef="usd">11</ix:nonFraction> as of December 31, 2022. See also Note 13.</ix:footnote></td>
</tr></table></ix:continuation></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify; text-indent: -21.3pt">&#160;</p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock-c0_cont_1" escape="true" name="us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.65pt; text-align: left; text-indent: -5.65pt"><b>NOTE 8 - DERIVATIVE
WARRANTS LIABILITIES</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.65pt; text-align: left; text-indent: -5.65pt"><b>&#160;</b></p></ix:nonNumeric><div>

</div><div>

</div><ix:continuation continuedAt="_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock-c0_cont_2" id="_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">The following tabular presentation
reflects the reconciliation of the fair value of derivative warrants liabilities during the years ended December 31, 2022, 2021 and 2020:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock-c0_cont_3" id="_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock-c0_cont_2"><ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -0.125in; text-align: justify">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Year ended  December 31,</b></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: justify">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; width: 76%; text-align: left">Opening balance</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DerivativeFairValueOfDerivativeNet" scale="3" unitRef="usd">50</ix:nonFraction></td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-71">-</div></td>
    <td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Recognition of fair value of 2021 Warrant issued upon substantial modification of terms (see Note 6A1)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-72">&#160;&#160;&#160;&#160;&#160;&#160;-</div></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet" scale="3" unitRef="usd">50</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Recognition of fair value of Warrant Share issued at Effective Date (see Note 6C)</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentOfWarrantsGrantedForServices" scale="3" unitRef="usd">88</ix:nonFraction></td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-73">-</div></td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Closing balance</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DerivativeFairValueOfDerivativeNet" scale="3" unitRef="usd">138</ix:nonFraction></td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DerivativeFairValueOfDerivativeNet" scale="3" unitRef="usd">50</ix:nonFraction></td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p></ix:nonNumeric></ix:continuation><div>


</div><div>

</div><ix:continuation continuedAt="_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock-c0_cont_4" id="_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">The fair values of the 2021
Warrant and the Warrant Share were determined by the Company&#8217;s management with the assistance of an independent valuation firm by using
the Hybrid Method by combining the OPM and an IPO scenario. Because there has been no public market for the Ordinary Shares, the Company&#8217;s
management has determined fair value of the Ordinary Shares at the time of grant by considering several objective and subjective factors
including data from other comparable companies, the lack of liquidity of share capital and general and industry specific economic outlook,
amongst other factors. The fair value of the underlying Ordinary Shares shall be determined by management until such time as the Ordinary
Shares are listed on an established stock exchange, national market system or other quotation system.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation id="_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock-c0_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">Through December 31, 2022, the
estimated fair values of derivative liability for the 2021 Warrant and Warrant Share have not changed significantly and the 2021 Warrant
and Warrant Share have not been exercised.</p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"></p><div>

</div><!-- Field: Page; Sequence: 151; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">BEAMR IMAGING LTD.</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Cont.)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(U.S. dollars in
thousands except share and per share amounts)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.65pt; text-align: left; text-indent: -5.65pt"><b>&#160;</b></p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_InvestmentHoldingsTextBlock-c0_cont_1" escape="true" name="us-gaap:InvestmentHoldingsTextBlock"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.65pt; text-align: left; text-indent: -5.65pt"><b>NOTE 9 - CONVERTIBLE
ADVANCE INVESTMENT</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.65pt; text-align: left; text-indent: -5.65pt"><b>&#160;</b></p></ix:nonNumeric><div>

</div><div>

</div><ix:continuation continuedAt="_InvestmentHoldingsTextBlock-c0_cont_2" id="_InvestmentHoldingsTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">On August 25, 2021 and August
6, 2019, the Company entered into separate Advance Investment Agreements (the &#8220;AIA&#8221;) with several current shareholders (the
&#8220;2021 AIA Investors&#8221;, &#8220;2019 AIA Investors&#8221; and together the &#8220;AIA Investors&#8221;) under which the Company
raised an amount of $<ix:nonFraction contextRef="c89" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFaceAmount" scale="3" unitRef="usd">560</ix:nonFraction> and $<ix:nonFraction contextRef="c90" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFaceAmount" scale="3" unitRef="usd">3,097</ix:nonFraction>, respectively, (together the &#8220;AIA Investment Amounts&#8221;) which is not interest bearing but
is eligible for conversion into shares of the Company, based on the following terms:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify; text-indent: -21.3pt">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_InvestmentHoldingsTextBlock-c0_cont_3" id="_InvestmentHoldingsTextBlock-c0_cont_2"><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0%"></td><td style="width: 0.25in">1.</td><td style="text-align: justify">In the event of a consummation by the Company of a transaction or series of related transactions in which
the Company issues preferred shares for an aggregate investment of at least $<ix:nonFraction contextRef="c91" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:EquityMethodInvestmentAggregateCost" scale="3" unitRef="usd">10,000</ix:nonFraction> (including the AIA Investment Amounts and any additional
amount provided to the Company under any additional AIA Agreement(s)) (the &#8220;AIA Qualifying Financing&#8221;), the AIA Investment
Amounts shall automatically be converted immediately prior to the consummation of such Qualified Financing into such number of preferred
shares (or a sub-class thereof) issued in such Qualified Financing (the &#8220;Next Round Shares&#8221;), as is obtained by dividing the
AIA Investment Amounts by a price per share which shall reflect a <ix:nonFraction contextRef="c92" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentRedemptionPricePercentage" scale="-2" unitRef="pure">20</ix:nonFraction>% discount off the lowest price per share paid in the AIA Qualified
Financing.</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify; text-indent: -21.3pt">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_InvestmentHoldingsTextBlock-c0_cont_4" id="_InvestmentHoldingsTextBlock-c0_cont_3"><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0%"></td><td style="width: 0.25in">2.</td><td style="text-align: justify">In the event of a consummation by the Company of a transaction or series of related transactions in which
the Company issues preferred shares in consideration for an aggregate investment of less than $<ix:nonFraction contextRef="c93" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:EquityMethodInvestmentAggregateCost" scale="3" unitRef="usd">10,000</ix:nonFraction> (including the AIA Investment Amounts
and any additional amount provided to the Company under any additional AIA Agreement(s)), or which for any other reason would not be deemed
as a AIA Qualified Financing (the &#8220;AIA Non-Qualified Financing&#8221;), then each time when the Company consummates such Non-Qualified
Financing, the AIA Investors shall have the right (but not the obligation) to elect to be converted immediately prior to the consummation
of such Non-Qualified Financing the AIA Investment Amounts into the shares and/or securities issued and sold at the closing of such Non-Qualified
Financing in accordance with <ix:nonFraction contextRef="c94" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentRedemptionPricePercentage" scale="-2" unitRef="pure">20</ix:nonFraction>% discount off the price per share paid in the Non-Qualified Financing.</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify; text-indent: -21.3pt">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_InvestmentHoldingsTextBlock-c0_cont_5" id="_InvestmentHoldingsTextBlock-c0_cont_4"><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0%"></td><td style="width: 0.25in">3.</td><td style="text-align: justify">In the event that the Company has not consummated a AIA Qualified Financing or an Exit Event (as defined
below) and the AIA Investment Amounts or any portion thereof has not been converted in accordance with the terms of the AIA Agreements
by August 26, 2022, then, the 2021 AIA Investors shall have the right (but not the obligation) to elect, by delivery of written notice
to the Company no later than 30 days from the receipt of a written notice from the Company, to convert their AIA Investment Amount into
such number of shares of the Company of the most senior class then outstanding (the &#8220;Most Senior Shares&#8221;), equal to the quotient
received by dividing their AIA Investment Amount by a price per share reflecting a pre-money valuation of the Company (determined on a
fully diluted basis as of the date of the conversion) of $<ix:nonFraction contextRef="c94" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtConversionConvertedInstrumentAmount1" scale="3" unitRef="usd">62,500</ix:nonFraction> (&#8220;AIA Target Valuation&#8221;).</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify; text-indent: -21.3pt">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_InvestmentHoldingsTextBlock-c0_cont_6" id="_InvestmentHoldingsTextBlock-c0_cont_5"><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0%"></td><td style="width: 0.25in">4.</td><td style="text-align: justify">In the event of the consummation of an Acquisition or an Asset Transfer (as defined in the Company&#8217;s Articles
of Association), each, an &#8220;Exit Event&#8221;, then immediately prior to the closing of such Acquisition or Asset Transfer, the AIA
Investors shall either elect, at its discretion, to (i) convert the AIA Investment Amounts into such number of Most Senior Shares, as
is obtained by dividing the AIA Investment Amounts by the quotient obtained by dividing (A) the AIA Target Valuation by (B) the issued
and outstanding share capital of the Company, on a fully diluted basis, as of immediately prior to the closing of the Acquisition or Asset
Transfer, as applicable, excluding any shares to be issued under the AIA Agreement); or (ii) receive, prior and in preference to payment
in respect of other Company securities, a redemption payment equal to <ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed" scale="-2" unitRef="pure">200</ix:nonFraction>% of the AIA Investment Amounts.</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify; text-indent: -21.3pt">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_InvestmentHoldingsTextBlock-c0_cont_7" id="_InvestmentHoldingsTextBlock-c0_cont_6"><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0%"></td><td style="width: 0.25in">5.</td><td style="text-align: justify">In connection with the effectiveness of the Company&#8217;s initial public offering of its Ordinary Shares
on the Nasdaq (see Note 17), the AIA Investment Amounts automatically converted into Ordinary Shares at a conversion price equal to <ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:DebtConversionConvertedInstrumentRate" scale="-2" unitRef="pure">80</ix:nonFraction>%
of the initial public offering price of $<ix:nonFraction contextRef="c43" decimals="-1" format="ixt:num-dot-decimal" name="bmr:PublicOfferingPrice" scale="3" unitRef="usdPershares">4.00</ix:nonFraction>.</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_InvestmentHoldingsTextBlock-c0_cont_8" id="_InvestmentHoldingsTextBlock-c0_cont_7"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">In addition to the mechanism
for the repayment of the investment through shares, subject to the scenarios set out above, the AIA Agreements provide that upon the occurrence
of certain bankruptcy related events, the Company will be required to pay the AIA Investors in cash the amount of their original investment.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_InvestmentHoldingsTextBlock-c0_cont_9" id="_InvestmentHoldingsTextBlock-c0_cont_8"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">Moreover, upon entry into the
AIA, the Company entered into a subordination agreement under which the AIA Investors agreed that all of the Company&#8217;s indebtedness
and obligations to the AIA Investors pursuant to the AIA is subordinated to all of the Company&#8217;s indebtedness and obligations to
SVB under the Loan Agreement. See also Note 6A.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_InvestmentHoldingsTextBlock-c0_cont_10" id="_InvestmentHoldingsTextBlock-c0_cont_9"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">As described in Note 2V, based
on the characteristics of the convertible advance investments (and its embedded derivatives), the Company elected to measure this liability
in its entirety, at its fair value (the &#8220;Fair Value Option&#8221;) in accordance with ASC 825-10, &#8220;Financial Instruments&#8221;
due to the existence of a certain redemption option and the potential requirement to recognize contingent BCF. Measurement of the fair
value of the convertible advance investments was classified as level 3 of the fair value hierarchy, using the scenario method.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p></ix:continuation><div>

</div><div>




</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"></p><div>

</div><!-- Field: Page; Sequence: 152; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">BEAMR IMAGING LTD.</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Cont.)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(U.S. dollars in
thousands except share and per share amounts)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.65pt; text-align: left; text-indent: -5.65pt"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.65pt; text-align: left; text-indent: -5.65pt"><b>NOTE 9 - CONVERTIBLE
ADVANCE INVESTMENT (Cont.)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.65pt; text-align: left; text-indent: -5.65pt">&#160;</p><div>

</div><ix:continuation continuedAt="_InvestmentHoldingsTextBlock-c0_cont_11" id="_InvestmentHoldingsTextBlock-c0_cont_10"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">The following tabular presentation
reflects the reconciliation of the carrying amount of the convertible advance investment during the years ended December 31, 2022, 2021
and 2020:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation id="_InvestmentHoldingsTextBlock-c0_cont_11"><ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:InvestmentHoldingsScheduleOfInvestmentsTableTextBlock"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="text-align: center; border-bottom: Black 1.5pt solid"><b>Year ended December 31,</b></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2020</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left; text-indent: -14.15pt; padding-left: 14.15pt">Opening balance</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ConvertibleDebtFairValueDisclosures" scale="3" unitRef="usd">4,770</ix:nonFraction></td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c26" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ConvertibleDebtFairValueDisclosures" scale="3" unitRef="usd">3,922</ix:nonFraction></td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ConvertibleDebtFairValueDisclosures" scale="3" unitRef="usd">3,486</ix:nonFraction></td>
    <td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -14.15pt; padding-left: 14.15pt">Net consideration received</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-74">-</div></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1" scale="3" unitRef="usd">560</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-75">-</div></td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -14.15pt; padding-left: 14.15pt">Change in the fair value of convertible advance investments (see also Note 13)</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="bmr:ChangeInTheFairValueOfConvertibleAdvanceInvestments" scale="3" unitRef="usd">70</ix:nonFraction></td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="bmr:ChangeInTheFairValueOfConvertibleAdvanceInvestments" scale="3" unitRef="usd">288</ix:nonFraction></td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c9" decimals="-3" format="ixt:num-dot-decimal" name="bmr:ChangeInTheFairValueOfConvertibleAdvanceInvestments" scale="3" unitRef="usd">436</ix:nonFraction></td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 4pt; text-indent: -14.15pt; padding-left: 14.15pt">Closing balance</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ConvertibleDebtFairValueDisclosures" scale="3" unitRef="usd">4,840</ix:nonFraction></td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ConvertibleDebtFairValueDisclosures" scale="3" unitRef="usd">4,770</ix:nonFraction></td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c26" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ConvertibleDebtFairValueDisclosures" scale="3" unitRef="usd">3,922</ix:nonFraction></td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric></ix:continuation><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 14.2pt; text-align: justify; text-indent: -14.2pt">&#160;</p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_1" escape="true" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63.8pt; text-align: left; text-indent: -63.8pt"><b>NOTE 10 - COMMITMENTS
AND CONTINGENT LIABILITIES</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63.8pt; text-align: left; text-indent: -63.8pt"><b>&#160;</b></p></ix:nonNumeric><div>

</div><div>

</div><ix:continuation continuedAt="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_2" id="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_1"><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0%"></td><td style="width: 0.5in">A.</td><td style="text-align: justify">Lease commitments</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.3pt; text-align: justify; text-indent: -0.25in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_3" id="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_2"><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in">1.</td><td style="text-align: justify">On July 29, 2020, the Company entered into a lease agreement for premises with an unrelated party over
a period commencing August 24, 2020 through February 28, 2021, for a monthly rental fee amounted of NIS <ix:nonFraction contextRef="c95" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsForRent" scale="3" unitRef="ils">18</ix:nonFraction> (approximately $<ix:nonFraction contextRef="c95" decimals="-2" format="ixt:num-dot-decimal" name="us-gaap:PaymentsForRent" scale="3" unitRef="usd">5.6</ix:nonFraction>).</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.3pt; text-align: justify; text-indent: 0in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_4" id="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: 0in">In January 2021,
the Company renewed its lease agreement with an unrelated party for the period commencing March 1, 2021 through August 31, 2021 for a
monthly fee of NIS <ix:nonFraction contextRef="c96" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsForFees" scale="3" unitRef="ils">17</ix:nonFraction> thousand (approximately $<ix:nonFraction contextRef="c96" decimals="-2" format="ixt:num-dot-decimal" name="us-gaap:PaymentsForFees" scale="3" unitRef="usd">5.3</ix:nonFraction>). In August 2021, the Company renewed its lease agreement with an unrelated party for
a further period commencing September 1, 2021 through February 28, 2022 for a monthly fee of NIS <ix:nonFraction contextRef="c97" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsForFees" scale="3" unitRef="ils">21</ix:nonFraction> thousand (approximately $<ix:nonFraction contextRef="c97" decimals="-2" format="ixt:num-dot-decimal" name="us-gaap:PaymentsForFees" scale="3" unitRef="usd">6.5</ix:nonFraction>).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.3pt; text-align: justify; text-indent: 0in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_5" id="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: 0in">In February 2022,
the Company renewed its lease agreement with an unrelated party for a period commencing March 1, 2022 through August 31, 2022 for a monthly
fee of NIS <ix:nonFraction contextRef="c98" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsForFees" scale="3" unitRef="ils">23</ix:nonFraction> thousand (approximately $<ix:nonFraction contextRef="c98" decimals="-2" format="ixt:num-dot-decimal" name="us-gaap:PaymentsForFees" scale="3" unitRef="usd">7.4</ix:nonFraction>). In August 2022, the Company renewed its lease agreement with an unrelated party for the period
commencing September 1, 2022 through August 31, 2023 for a monthly fee of NIS <ix:nonFraction contextRef="c99" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsForFees" scale="3" unitRef="ils">25</ix:nonFraction> thousand (approximately $<ix:nonFraction contextRef="c99" decimals="-2" format="ixt:num-dot-decimal" name="us-gaap:PaymentsForFees" scale="3" unitRef="usd">7.1</ix:nonFraction>).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.3pt; text-align: justify; text-indent: -0.25in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_6" id="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_5"><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in">2.</td><td style="text-align: justify">On November 1, 2020, Beamr Imaging RU entered into a lease agreement for premises with an unrelated party
over a period until September 30, 2021, for a monthly a rental fee of Russian Ruble 200 (approximately $3).</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.3pt; text-align: justify; text-indent: 0in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_7" id="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_6"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: 0in">On October 1, 2021,
Beamr Imaging RU entered into a lease agreement for premises with an unrelated party over a period until August 30, 2022, for a monthly
a rental fee of Russian Ruble 213 (approximately $<ix:nonFraction contextRef="c100" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsForFees" scale="3" unitRef="usd">3</ix:nonFraction>). In September 2022, Beamr Imaging RU renewed its lease agreement for the period commencing
September 1, 2022 through July 31, 2023 for a monthly fee of Russian Ruble 213 (approximately $<ix:nonFraction contextRef="c101" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsForFees" scale="3" unitRef="usd">3</ix:nonFraction>).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify; text-indent: 0in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_8" id="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_7"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0in">As of December 31,
2022, the future minimum commitment under binding short-term operating lease agreements is as follows:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify; text-indent: 0in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_9" id="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_8"><ix:nonNumeric contextRef="c0" escape="true" name="bmr:scheduleOfFutureMinimumCommitmentUnderBindingLeaseAgreeementsTableTextBlock"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Lease of<br/>
 premises</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%; text-align: left; padding-bottom: 1.5pt">2023</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;<ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="bmr:LesseeOperatingLeasesLiabilityPaymentsDueNextTwelveMonths" scale="3" unitRef="usd">77</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 4pt; padding-left: 2.85pt">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="bmr:LesseeOperatingLeasesLiabilityPaymentsDue" scale="3" unitRef="usd">77</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify; text-indent: 0in">&#160;</p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_10" id="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_9"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0in">The payments above are associated with short-term operating leases of premises with a lease term of twelve months or less. As the Company
elected the short-term recognition exemption (see also Note 2I), such leases are out of scope of ASC 842 &#8220;Leases&#8221;. Consequently,
these payments are recognized on a straight-line basis as an operating expense in the Consolidated Statements of Operations and Comprehensive
Loss.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify; text-indent: 0in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_11" id="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_10"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0in">During the years
ended December 31, 2022, 2021 and 2020, the total lease expenses were $<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LeaseCost" scale="3" unitRef="usd">119</ix:nonFraction>, $<ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LeaseCost" scale="3" unitRef="usd">115</ix:nonFraction> and $<ix:nonFraction contextRef="c9" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LeaseCost" scale="3" unitRef="usd">167</ix:nonFraction>, respectively.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify; text-indent: -21.3pt">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_12" id="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_11"><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0%"></td><td style="width: 0.5in">B.</td><td style="text-align: justify">Grant of share options upon completion of an IPO transaction</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify; text-indent: 0in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation id="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_12"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0in">On March 14, 2022,
the Company&#8217;s shareholders approved, among other matters, that upon completion of the IPO transaction, each of the member of the Company&#8217;s
Board of Directors (except the Founder which serves inter alia as the Board chairman) will be entitled to <ix:nonFraction contextRef="c102" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" scale="0" unitRef="shares">19,000</ix:nonFraction> share options to purchase
the same number of Ordinary Shares at an exercise price that will be equal to the listing price per share over a vesting schedule on a
monthly basis over 36-months period commencing the listing date. However, as the grant is contingent upon a performance condition (successful
IPO) which is out of the Company&#8217;s control, the related expenses will be recognized when the IPO will occur. Accordingly, compensation
cost relating to such obligation has not been recorded in 2022.</p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: center">&#160;</p><div>




</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 153; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">BEAMR IMAGING LTD.</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Cont.)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(U.S. dollars in
thousands except share and per share amounts)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><b>&#160;</b></p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_1" escape="true" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><b>NOTE 11 - SHAREHOLDERS&#8217; EQUITY
(DEFICIT)</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in">&#160;</p></ix:nonNumeric><div>

</div><div>

</div><ix:continuation continuedAt="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_2" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Composition of shareholders&#8217; equity (deficit):</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_3" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_2"><ix:nonNumeric contextRef="c0" continuedAt="_ScheduleOfStockholdersEquityTableTextBlock-c0_cont_1" escape="true" name="us-gaap:ScheduleOfStockholdersEquityTableTextBlock"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">As of <br/> December 31, 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">As of <br/> December 31, 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Authorized</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Issued and<br/> outstanding</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Authorized</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Issued and<br/> outstanding</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="14" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number of shares</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">Shares of NIS&#160;0.05 par value:</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left">Series Ordinary Shares (A)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c103" decimals="INF" format="ixt:num-dot-decimal" id="ix_4_fact" name="us-gaap:ExcessStockSharesAuthorized" scale="0" unitRef="shares">14,307,116</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c103" decimals="0" format="ixt:num-dot-decimal" id="ix_5_fact" name="bmr:ExcessSharesIssuedAndOutstandingShares" scale="0" unitRef="shares">2,578,760</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c104" decimals="INF" format="ixt:num-dot-decimal" id="ix_6_fact" name="us-gaap:ExcessStockSharesAuthorized" scale="0" unitRef="shares">14,316,880</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c104" decimals="0" format="ixt:num-dot-decimal" id="ix_7_fact" name="bmr:ExcessSharesIssuedAndOutstandingShares" scale="0" unitRef="shares">2,578,760</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Series Convertible Ordinary 1 Shares (B)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c105" decimals="INF" format="ixt:num-dot-decimal" id="ix_8_fact" name="us-gaap:ExcessStockSharesAuthorized" scale="0" unitRef="shares">607,680</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c105" decimals="0" format="ixt:num-dot-decimal" id="ix_9_fact" name="bmr:ExcessSharesIssuedAndOutstandingShares" scale="0" unitRef="shares">607,680</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c106" decimals="INF" format="ixt:num-dot-decimal" id="ix_10_fact" name="us-gaap:ExcessStockSharesAuthorized" scale="0" unitRef="shares">607,680</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c106" decimals="0" format="ixt:num-dot-decimal" id="ix_11_fact" name="bmr:ExcessSharesIssuedAndOutstandingShares" scale="0" unitRef="shares">607,680</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Series Convertible Ordinary 2 Shares (B)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c107" decimals="INF" format="ixt:num-dot-decimal" id="ix_12_fact" name="us-gaap:ExcessStockSharesAuthorized" scale="0" unitRef="shares">889,200</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c107" decimals="0" format="ixt:num-dot-decimal" id="ix_13_fact" name="bmr:ExcessSharesIssuedAndOutstandingShares" scale="0" unitRef="shares">889,200</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c108" decimals="INF" format="ixt:num-dot-decimal" id="ix_14_fact" name="us-gaap:ExcessStockSharesAuthorized" scale="0" unitRef="shares">889,200</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c108" decimals="0" format="ixt:num-dot-decimal" id="ix_15_fact" name="bmr:ExcessSharesIssuedAndOutstandingShares" scale="0" unitRef="shares">889,200</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Series Convertible B Preferred Shares (B)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c109" decimals="INF" format="ixt:num-dot-decimal" id="ix_16_fact" name="us-gaap:ExcessStockSharesAuthorized" scale="0" unitRef="shares">2,047,200</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c109" decimals="0" format="ixt:num-dot-decimal" id="ix_17_fact" name="bmr:ExcessSharesIssuedAndOutstandingShares" scale="0" unitRef="shares">2,047,200</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c110" decimals="INF" format="ixt:num-dot-decimal" id="ix_18_fact" name="us-gaap:ExcessStockSharesAuthorized" scale="0" unitRef="shares">2,047,200</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c110" decimals="0" format="ixt:num-dot-decimal" id="ix_19_fact" name="bmr:ExcessSharesIssuedAndOutstandingShares" scale="0" unitRef="shares">2,047,200</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Series Convertible B1 Preferred Shares B)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c111" decimals="INF" format="ixt:num-dot-decimal" id="ix_20_fact" name="us-gaap:ExcessStockSharesAuthorized" scale="0" unitRef="shares">738,240</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c111" decimals="0" format="ixt:num-dot-decimal" id="ix_21_fact" name="bmr:ExcessSharesIssuedAndOutstandingShares" scale="0" unitRef="shares">738,240</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c112" decimals="INF" format="ixt:num-dot-decimal" id="ix_22_fact" name="us-gaap:ExcessStockSharesAuthorized" scale="0" unitRef="shares">738,240</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c112" decimals="0" format="ixt:num-dot-decimal" id="ix_23_fact" name="bmr:ExcessSharesIssuedAndOutstandingShares" scale="0" unitRef="shares">738,240</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Series Convertible C Preferred Shares (B)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c113" decimals="INF" format="ixt:num-dot-decimal" id="ix_24_fact" name="us-gaap:ExcessStockSharesAuthorized" scale="0" unitRef="shares">3,410,564</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c113" decimals="0" format="ixt:num-dot-decimal" id="ix_25_fact" name="bmr:ExcessSharesIssuedAndOutstandingShares" scale="0" unitRef="shares">2,928,960</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c114" decimals="INF" format="ixt:num-dot-decimal" id="ix_26_fact" name="us-gaap:ExcessStockSharesAuthorized" scale="0" unitRef="shares">3,400,800</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c114" decimals="0" format="ixt:num-dot-decimal" id="ix_27_fact" name="bmr:ExcessSharesIssuedAndOutstandingShares" scale="0" unitRef="shares">2,928,960</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 4pt">Total</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c2" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ExcessStockSharesAuthorized" scale="0" unitRef="shares">22,000,000</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="bmr:ExcessSharesIssuedAndOutstandingShares" scale="0" unitRef="shares">9,790,040</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c3" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ExcessStockSharesAuthorized" scale="0" unitRef="shares">22,000,000</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="bmr:ExcessSharesIssuedAndOutstandingShares" scale="0" unitRef="shares">9,790,040</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.3pt; text-align: justify"><b>&#160;</b></p></ix:nonNumeric></ix:continuation><div>



</div><div>

</div><ix:continuation continuedAt="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_4" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_3"><ix:continuation continuedAt="_ScheduleOfStockholdersEquityTableTextBlock-c0_cont_2" id="_ScheduleOfStockholdersEquityTableTextBlock-c0_cont_1"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left">A.</td><td style="text-align: justify"><ix:footnote id="ix_3_footnote" xml:lang="en-US">The Ordinary Shares confer upon the holders thereof all rights
accruing to a shareholder of the Company, as provided in the Company&#8217;s Articles of Association (the &#8220;Articles&#8221;), including,
without limitation, the right to receive notices of, and to attend, all general meetings, the right to vote thereat with each Ordinary
Share held entitling the holder thereof to one vote at all general meetings (and written actions in lieu of meetings), the right to participate
and share on a per share basis, in any distribution and in distribution of surplus assets and funds of the Company in the event of a
liquidation event, and certain other rights as may be expressly provided for herein or under the Companies Law. All Ordinary Shares rank
pari passu amongst themselves for all intents and purposes, including, without limitation, in relation to the amounts of capital paid
or credited as paid on their nominal value. The voting, dividend and liquidation rights of the holders of Ordinary Shares are subject
to and qualified by the rights, powers and preferences of the holders of the Convertible Preferred Shares and the Convertible Ordinary
1 and 2 Shares as set below.</ix:footnote></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify; text-indent: -21.3pt">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_5" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_4"><ix:continuation continuedAt="_ScheduleOfStockholdersEquityTableTextBlock-c0_cont_3" id="_ScheduleOfStockholdersEquityTableTextBlock-c0_cont_2"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left">B.</td><td style="text-align: justify">The Convertible Ordinary 1 Shares, Convertible Ordinary 2 Shares,
Convertible B Preferred Shares, Convertible B1 Preferred Shares and the Convertible C Preferred Shares (referring together herein as
&#8220;Convertible Preferred Shares&#8221;) shall confer upon the holders thereof all rights conferred upon the holders of Ordinary Shares
in the Company. In addition, the holders of Convertible Preferred Shares shall have rights, preferences and privileges, as follows:</td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_6" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_5"><ix:continuation continuedAt="_ScheduleOfStockholdersEquityTableTextBlock-c0_cont_4" id="_ScheduleOfStockholdersEquityTableTextBlock-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify">Liquidation preference&#160;- Based
on preference of distribution, in the event of any liquidation, dissolution or winding up of the Company, whether voluntary or involuntary,
change in control or distribution, the Company&#8217;s assets or surplus funds legally available for distribution shall be distributed to the
holders of Convertible Preferred Shares pursuant to which each Convertible Preferred Share will be entitled to receive <ix:nonFraction contextRef="c2" decimals="1" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockConvertibleConversionPrice" scale="0" unitRef="usdPershares">1.2</ix:nonFraction> of the applicable
original issue price paid by each Convertible Preferred shareholder plus all accrued but unpaid dividends and less the aggregate of all
amounts previously paid in preference. The aggregate liquidation preference of all shares with preferences over Ordinary Shares as of
December&#160;31, 2022 and 2021 amounted to $<ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockAmountOfPreferredDividendsInArrears" scale="3" unitRef="usd"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockAmountOfPreferredDividendsInArrears" scale="3" unitRef="usd">33,785</ix:nonFraction></ix:nonFraction>. None of the foregoing dollar amounts include dividends, as the Board of Directors
has not declared any dividends since inception.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_7" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_6"><ix:continuation continuedAt="_ScheduleOfStockholdersEquityTableTextBlock-c0_cont_5" id="_ScheduleOfStockholdersEquityTableTextBlock-c0_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify">The Convertible Preferred Shares have
been classified as part of the permanent equity of the Company since upon occurrence of liquidation event all holder of the Ordinary Shares
and the Convertible Preferred Shares will be entitled to receive the same form of consideration.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_8" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_7"><ix:continuation continuedAt="_ScheduleOfStockholdersEquityTableTextBlock-c0_cont_6" id="_ScheduleOfStockholdersEquityTableTextBlock-c0_cont_5"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify">Voting&#160;- Each shareholder shall
have one vote for each Ordinary Share held by such shareholder of record or such Ordinary Shares as would be held by each holder of Convertible
Preferred Share if all Convertible Preferred Shares were converted to Ordinary Shares at the then effective conversion rate, on every
resolution.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_9" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_8"><ix:continuation continuedAt="_ScheduleOfStockholdersEquityTableTextBlock-c0_cont_7" id="_ScheduleOfStockholdersEquityTableTextBlock-c0_cont_6"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify">Conversion&#160;- Each holder of a
Convertible Preferred Share shall be entitled to convert, at any time and from time to time, and without payment of additional consideration,
into such number of fully paid and non-assessable shares of Ordinary Share in ratio as determined in the Articles, which initially shall
be one to one. The conversion price initially shall be the applicable Original Issue Price subject to adjustments as describe in the Articles.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_10" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_9"><ix:continuation continuedAt="_ScheduleOfStockholdersEquityTableTextBlock-c0_cont_8" id="_ScheduleOfStockholdersEquityTableTextBlock-c0_cont_7"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify">All outstanding Convertible Preferred
Shares shall automatically be converted into Ordinary Shares at the then-effective conversion rate applicable upon the earlier of (i)
closing of sale of Ordinary Shares in an initial firm-commitment underwritten public offering, with net proceeds to the Company of $<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromDebtNetOfIssuanceCosts" scale="3" unitRef="usd">50,000</ix:nonFraction>
and at an offering price per share equal to at least 5 times the Preferred C Original Issue Price (Qualified IPO) or (ii) affirmative
vote or written consent of majority shareholders of the then outstanding Convertible Preferred Shares, with respect to each series.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p></ix:continuation></ix:continuation><div>

</div><div>




</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 154; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">BEAMR IMAGING LTD.</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Cont.)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(U.S. dollars in
thousands except share and per share amounts)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><b>NOTE 11 - SHAREHOLDERS&#8217; EQUITY
(DEFICIT) (Cont.)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><b>&#160;</b></p><div>

</div><ix:continuation continuedAt="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_11" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_10"><ix:continuation continuedAt="_ScheduleOfStockholdersEquityTableTextBlock-c0_cont_9" id="_ScheduleOfStockholdersEquityTableTextBlock-c0_cont_8"><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0%"></td><td style="width: 0.5in">C.</td><td style="text-align: justify">On March 14, 2022, the Company&#8217;s shareholders approved, among other matters, the following matters as
were originally approved by the Company&#8217;s Board of Directors on March&#160;1, 2022&#160;-</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify; text-indent: -21.3pt">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_12" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_11"><ix:continuation continuedAt="_ScheduleOfStockholdersEquityTableTextBlock-c0_cont_10" id="_ScheduleOfStockholdersEquityTableTextBlock-c0_cont_9"><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in">1.</td><td style="text-align: justify">In connection with listing of the Company&#8217;s Ordinary Shares on
Nasdaq, increase the Company&#8217;s authorized shares from <ix:nonFraction contextRef="c69" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ExcessStockSharesAuthorized" scale="0" unitRef="shares">22,000,000</ix:nonFraction> to <ix:nonFraction contextRef="c68" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ExcessStockSharesAuthorized" scale="0" unitRef="shares">222,000,000</ix:nonFraction>.</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt; text-align: justify; text-indent: -21.25pt">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_13" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_12"><ix:continuation continuedAt="_ScheduleOfStockholdersEquityTableTextBlock-c0_cont_11" id="_ScheduleOfStockholdersEquityTableTextBlock-c0_cont_10"><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in">2.</td><td style="text-align: justify">Approve and ratify (i) <ix:nonNumeric contextRef="c0" name="bmr:VoluntaryConversionDescription">subject to the listing of the Company&#8217;s Ordinary Shares on Nasdaq, the voluntary
conversion of all the Ordinary 1, Ordinary 2, Preferred B, Preferred B-1 and Preferred B shares of the Company into Ordinary Shares (collectively,
the &#8220;Voluntary Conversion&#8221;), (ii) subject to the listing of the Company&#8217;s Ordinary Shares on Nasdaq, a reverse share
split of all outstanding Ordinary Shares of the Company at a ratio of 5:1 so that each 5 ordinary shares nominal value NIS 0.01 each shall
be consolidated into 1 Ordinary Share each, and (the &#8220;Reverse Share Split&#8221;) (iii) subject to the listing of the Company&#8217;s
Ordinary Shares on Nasdaq, the recapitalization and redistribution of the entire share capital of the Company (the &#8220;Recapitalization&#8221;),
so that following such Voluntary Conversion and Recapitalization, the share capital of the Company shall consist of NIS 11,100,000 divided
into 222,000,000 Ordinary Shares each of which 9,790,040 are issued and outstanding (post the aforesaid Reverse Share Split).</ix:nonNumeric></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt; text-align: justify; text-indent: -21.25pt">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_13"><ix:continuation id="_ScheduleOfStockholdersEquityTableTextBlock-c0_cont_11"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify">For accounting purposes, following
the completion of the IPO transaction as noted in Note 17 below, all shares, options and warrants to purchase Ordinary Shares and loss
per share amounts have been adjusted to give retroactive effect to the Reverse Share Split for all periods presented in these consolidated
financial statements. Any fractional shares resulting from the Reverse Share Split were rounded up to the nearest whole share.</p></ix:continuation></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt; text-align: justify">&#160;</p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock-c0_cont_1" escape="true" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><b>NOTE 12 - SHARE OPTIONS</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><b>&#160;</b></p></ix:nonNumeric><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock-c0_cont_2" id="_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Share option plan:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock-c0_cont_3" id="_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On January 11, 2015, the Company&#8217;s Board
of Directors approved and adopted the 2015 Share Incentive Plan (the &#8220;Plan&#8221;), pursuant to which the Company&#8217;s Board
of Directors may award share options to purchase the Company&#8217;s Ordinary Shares as well as restricted shares, RSUs and other share-based
awards to designated participants. Subject to the terms and conditions of the Plan, the Company&#8217;s Board of Directors has full authority
in its discretion, from time to time and at any time, to determine (i) the designate participants; (ii) the terms and provisions of the
respective award agreements, including, but not limited to, the number of share options to be granted to each optionee, the number of
shares to be covered by each share option, provisions concerning the time and the extent to which the share options may be exercised and
the nature and duration of restrictions as to the transferability or restrictions constituting substantial risk of forfeiture and to cancel
or suspend awards, as necessary; (iii) determine the fair market value of the shares covered by each award; (iv) make an election as to
the type of approved 102 Option under Israeli tax law; (v) designate the type of share options; (vi) take any measures, and to take actions,
as deemed necessary or advisable for the administration and implementation of the Plan; (vii) interpret the provisions of the Plan and
to amend from time to time the terms of the Plan.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock-c0_cont_4" id="_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Plan permits the grant of up to <ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="bmr:OrdinarySharesSubjectToAdjustments" scale="0" unitRef="shares">2,069,280</ix:nonFraction>
share Ordinary Shares subject to adjustments set in the Plan. As of December 31, 2022, considering the effect of previously exercised
share options, there were <ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="bmr:OrdinarySharesAvailableForFutureIssuance" scale="0" unitRef="shares">355,530</ix:nonFraction> Ordinary Shares available for future issuance under the Plan.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock-c0_cont_5" id="_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock-c0_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table presents the Company&#8217;s
share option activity for employees and members of the Board of Directors of the Company under the Plan for the years ended December 31,
2022, 2021 and 2020:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock-c0_cont_6" id="_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock-c0_cont_5"><ix:nonNumeric contextRef="c0" continuedAt="_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock-c0_cont_1" escape="true" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: left"><b>&#160;</b></td>
    <td style="font-weight: bold; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><b>Number of<br/>
    Share<br/>
    Options</b></td>
    <td style="padding-bottom: 1.5pt; font-weight: bold"><b>&#160;</b></td>
    <td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><b>Weighted<br/>
    Average<br/>
    Exercise<br/>
    Price <br/>
$</b></td>
    <td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td style="font-weight: bold; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><b>Weighted<br/> average<br/>
    remaining<br/> contractual<br/> life (years)</b></td>
    <td style="padding-bottom: 1.5pt; font-weight: bold"><b>&#160;</b></td>
    <td style="font-weight: bold; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><b>Intrinsic<br/> value<br/>
 $</b></td>
    <td style="padding-bottom: 1.5pt; font-weight: bold"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left">Outstanding as of December 31, 2019</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c15" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" unitRef="shares">1,291,810</ix:nonFraction></td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c15" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" unitRef="usdPershares">1.65</ix:nonFraction></td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: center">&#160;</td>
    <td style="width: 9%; text-align: right"><ix:nonNumeric contextRef="c9" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2">5.94</ix:nonNumeric></td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" scale="3" unitRef="usd">194</ix:nonFraction></td>
    <td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Granted</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><ix:nonFraction contextRef="c9" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="0" unitRef="shares">353,960</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><ix:nonFraction contextRef="c9" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" unitRef="usdPershares">1.80</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: right"><ix:nonNumeric contextRef="c9" format="ixt-sec:duryear" name="bmr:WeightedAverageRemainingContractualLifeGranted">9.35</ix:nonNumeric></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Exercised</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">(<ix:nonFraction contextRef="c9" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" unitRef="shares">9,800</ix:nonFraction></td>
    <td style="text-align: left">)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><ix:nonFraction contextRef="c9" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" unitRef="usdPershares">1.15</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-76">-</div></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Forfeited or expired</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c9" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" scale="0" unitRef="shares">381,970</ix:nonFraction></td>
    <td style="padding-bottom: 1.5pt; text-align: left">)</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c9" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" scale="0" unitRef="usdPershares">1.75</ix:nonFraction></td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-77">-</div></td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 4pt">Outstanding as of December 31, 2020</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c26" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" unitRef="shares">1,254,000</ix:nonFraction></td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c26" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" unitRef="usdPershares">1.70</ix:nonFraction></td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: center">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: right"><ix:nonNumeric contextRef="c9" format="ixt-sec:duryear" name="bmr:WeightedAverageRemainingContractualLifeOutstanding">6.12</ix:nonNumeric></td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c26" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" scale="3" unitRef="usd">125</ix:nonFraction></td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 4pt">Exercisable as of December&#160;31, 2020</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c26" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" scale="0" unitRef="shares">839,665</ix:nonFraction></td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c26" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" scale="0" unitRef="usdPershares">1.50</ix:nonFraction></td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: center">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: right"><ix:nonNumeric contextRef="c9" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2">4.73</ix:nonNumeric></td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c26" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" scale="3" unitRef="usd">252</ix:nonFraction></td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:nonNumeric></ix:continuation><div>


</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 155; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">BEAMR IMAGING LTD.</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Cont.)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(U.S. dollars in
thousands except share and per share amounts)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><b>NOTE 12 - SHARE OPTIONS (Cont.)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><b>&#160;</b></p><div>

</div><ix:continuation continuedAt="_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock-c0_cont_7" id="_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock-c0_cont_6"><ix:continuation continuedAt="_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock-c0_cont_2" id="_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock-c0_cont_1"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: left"><b>&#160;</b></td>
    <td style="font-weight: bold; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><b>Number of<br/>
    Share<br/>
    Options</b></td>
    <td style="padding-bottom: 1.5pt; font-weight: bold"><b>&#160;</b></td>
    <td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><b>Weighted<br/>
    Average<br/>
    Exercise<br/>
    Price<br/>
    $</b></td>
    <td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td style="font-weight: bold; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><b>Weighted<br/> average<br/>
    remaining<br/> contractual<br/> life (years)</b></td>
    <td style="padding-bottom: 1.5pt; font-weight: bold"><b>&#160;</b></td>
    <td style="font-weight: bold; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><b>Intrinsic<br/> value<br/>
 $</b></td>
    <td style="padding-bottom: 1.5pt; font-weight: bold"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left">Outstanding as of December 31, 2020</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c26" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" unitRef="shares">1,254,000</ix:nonFraction></td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c26" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" unitRef="usdPershares">1.70</ix:nonFraction></td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: center">&#160;</td>
    <td style="width: 9%; text-align: right"><ix:nonNumeric contextRef="c8" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2">6.12</ix:nonNumeric></td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c26" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" scale="3" unitRef="usd">125</ix:nonFraction></td>
    <td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Granted</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><ix:nonFraction contextRef="c8" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="0" unitRef="shares">214,688</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><ix:nonFraction contextRef="c8" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" unitRef="usdPershares">2.05</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: right"><ix:nonNumeric contextRef="c8" format="ixt-sec:duryear" name="bmr:WeightedAverageRemainingContractualLifeGranted">9.64</ix:nonNumeric></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Forfeited or expired</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c8" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" scale="0" unitRef="shares">101,520</ix:nonFraction></td>
    <td style="padding-bottom: 1.5pt; text-align: left">)</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c8" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" scale="0" unitRef="usdPershares">1.80</ix:nonFraction></td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-78">-</div></td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Outstanding as of December 31, 2021</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c3" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" unitRef="shares">1,367,168</ix:nonFraction></td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c3" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" unitRef="usdPershares">1.75</ix:nonFraction></td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: center">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: right"><ix:nonNumeric contextRef="c8" format="ixt-sec:duryear" name="bmr:WeightedAverageRemainingContractualLifeOutstanding">5.72</ix:nonNumeric></td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" scale="3" unitRef="usd">4,860</ix:nonFraction></td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Exercisable as of December&#160;31, 2021</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c3" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" scale="0" unitRef="shares">927,988</ix:nonFraction></td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c3" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" scale="0" unitRef="usdPershares">1.60</ix:nonFraction></td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: center">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: right"><ix:nonNumeric contextRef="c8" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2">4.25</ix:nonNumeric></td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" scale="3" unitRef="usd">3,429</ix:nonFraction></td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><b>&#160;</b></p></ix:continuation></ix:continuation><div>


</div><div>

</div><ix:continuation continuedAt="_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock-c0_cont_8" id="_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock-c0_cont_7"><ix:continuation id="_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock-c0_cont_2"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: left"><b>&#160;</b></td>
    <td style="font-weight: bold; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><b>Number of<br/>
    Share<br/>
    Options</b></td>
    <td style="padding-bottom: 1.5pt; font-weight: bold"><b>&#160;</b></td>
    <td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><b>Weighted<br/>
    Average<br/>
    Exercise<br/>
    Price<br/>
    $</b></td>
    <td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td style="font-weight: bold; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><b>Weighted<br/> average<br/>
    remaining<br/> contractual<br/> life (years)</b></td>
    <td style="padding-bottom: 1.5pt; font-weight: bold"><b>&#160;</b></td>
    <td style="font-weight: bold; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><b>Intrinsic<br/> value<br/>
    $</b></td>
    <td style="padding-bottom: 1.5pt; font-weight: bold"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left">Outstanding as of December 31, 2021</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c3" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" unitRef="shares">1,367,168</ix:nonFraction></td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c3" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" unitRef="usdPershares">1.75</ix:nonFraction></td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: center">&#160;</td>
    <td style="width: 9%; text-align: right"><ix:nonNumeric contextRef="c0" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2">5.72</ix:nonNumeric></td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" scale="3" unitRef="usd">4,860</ix:nonFraction></td>
    <td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Granted</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="0" unitRef="shares">286,875</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" unitRef="usdPershares">1.83</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Forfeited or expired</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" scale="0" unitRef="shares">83,052</ix:nonFraction></td>
    <td style="padding-bottom: 1.5pt; text-align: left">)</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" scale="0" unitRef="usdPershares">1.45</ix:nonFraction></td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">-</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Outstanding as of December 31, 2022</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c2" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" unitRef="shares">1,570,991</ix:nonFraction></td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c2" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" unitRef="usdPershares">1.78</ix:nonFraction></td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: center">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: right"><ix:nonNumeric contextRef="c0" format="ixt-sec:duryear" name="bmr:WeightedAverageRemainingContractualLifeOutstanding">4.97</ix:nonNumeric></td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" scale="3" unitRef="usd">2,435</ix:nonFraction></td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Exercisable as of December&#160;31, 2022</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c2" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" scale="0" unitRef="shares">1,048,297</ix:nonFraction></td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c2" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" scale="0" unitRef="usdPershares">1.70</ix:nonFraction></td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: center">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: right"><ix:nonNumeric contextRef="c0" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2">3.2</ix:nonNumeric></td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" scale="3" unitRef="usd">1,677</ix:nonFraction></td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:continuation></ix:continuation><div>


</div><div>

</div><ix:continuation continuedAt="_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock-c0_cont_9" id="_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock-c0_cont_8"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The aggregate intrinsic value in the table above represents the total intrinsic value (the difference between the deemed fair value of
the Company&#8217;s Ordinary Shares on the last day of each of the applicable reported period and the exercise price, multiplied by the number
of in-the-money share options) that would have been received by the share option holders had all share options holders exercised their
share options on December&#160;31 of each of the reported period. This amount is impacted by the changes in the fair market value of the
Company&#8217;s Ordinary Share.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock-c0_cont_10" id="_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock-c0_cont_9"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The outstanding and exercisable share options
as of December&#160;31, 2022 have been separated into ranges of exercise prices, as follows:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock-c0_cont_11" id="_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock-c0_cont_10"><ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; text-align: justify"><b>Exercise price</b></td>
    <td style="font-weight: bold; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><b>Share options<br/> outstanding<br/>
    as of<br/> December&#160;31,<br/> 2022</b></td>
    <td style="padding-bottom: 1.5pt; font-weight: bold"><b>&#160;</b></td>
    <td style="font-weight: bold; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><b>Weighted<br/> average<br/>
remaining<br/> contractual<br/> term (years)</b></td>
    <td style="padding-bottom: 1.5pt; font-weight: bold"><b>&#160;</b></td>
    <td style="font-weight: bold; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><b>Share options<br/> exercisable<br/>
    as of<br/> December&#160;31,<br/> 2022</b></td>
    <td style="padding-bottom: 1.5pt; font-weight: bold"><b>&#160;</b></td>
    <td style="font-weight: bold; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><b>Weighted<br/> average<br/>
    remaining<br/> contractual<br/> term (years)</b></td>
    <td style="padding-bottom: 1.5pt; font-weight: bold"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left"><b>$</b></td>
    <td><b>&#160;</b></td>
    <td colspan="2" style="text-align: right"><b>&#160;</b></td>
    <td><b>&#160;</b></td>
    <td><b>&#160;</b></td>
    <td colspan="2" style="text-align: center"><b>$</b></td>
    <td><b>&#160;</b></td>
    <td><b>&#160;</b></td>
    <td colspan="2" style="text-align: right"><b>&#160;</b></td>
    <td><b>&#160;</b></td>
    <td><b>&#160;</b></td>
    <td colspan="2" style="text-align: center"><b>$</b></td>
    <td><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left"><ix:nonFraction contextRef="c115" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" scale="0" unitRef="usdPershares">0.00</ix:nonFraction></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c116" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" scale="0" unitRef="shares">152,640</ix:nonFraction></td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: center">&#160;</td>
    <td style="width: 9%; text-align: right"><ix:nonNumeric contextRef="c117" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1">2.42</ix:nonNumeric></td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c118" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" scale="3" unitRef="shares">152,640</ix:nonFraction></td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: center">&#160;</td>
    <td style="width: 9%; text-align: right"><ix:nonNumeric contextRef="c119" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1">1.03</ix:nonNumeric></td>
    <td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><ix:nonFraction contextRef="c120" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" scale="0" unitRef="usdPershares">1.14</ix:nonFraction></td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><ix:nonFraction contextRef="c121" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" scale="0" unitRef="shares">228,480</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: right"><ix:nonNumeric contextRef="c122" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1">1.39</ix:nonNumeric></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><ix:nonFraction contextRef="c123" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" scale="3" unitRef="shares">228,480</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: right"><ix:nonNumeric contextRef="c124" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1">1.39</ix:nonNumeric></td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><ix:nonFraction contextRef="c125" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" scale="0" unitRef="usdPershares">1.67</ix:nonFraction></td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><ix:nonFraction contextRef="c126" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" scale="0" unitRef="shares">43,200</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: right"><ix:nonNumeric contextRef="c127" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1">2.21</ix:nonNumeric></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><ix:nonFraction contextRef="c128" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" scale="3" unitRef="shares">43,200</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: right"><ix:nonNumeric contextRef="c129" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1">2.21</ix:nonNumeric></td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><ix:nonFraction contextRef="c130" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" scale="0" unitRef="usdPershares">1.83</ix:nonFraction></td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><ix:nonFraction contextRef="c131" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" scale="0" unitRef="shares">982,870</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: right"><ix:nonNumeric contextRef="c132" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1">6.75</ix:nonNumeric></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><ix:nonFraction contextRef="c133" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" scale="3" unitRef="shares">489,239</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: right"><ix:nonNumeric contextRef="c134" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1">4.70</ix:nonNumeric></td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><ix:nonFraction contextRef="c135" decimals="1" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" scale="0" unitRef="usdPershares">3.2</ix:nonFraction></td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><ix:nonFraction contextRef="c136" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" scale="0" unitRef="shares">35,001</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: right"><ix:nonNumeric contextRef="c137" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1">6.45</ix:nonNumeric></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><ix:nonFraction contextRef="c138" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" scale="3" unitRef="shares">10,938</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: right"><ix:nonNumeric contextRef="c139" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1">6.45</ix:nonNumeric></td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><ix:nonFraction contextRef="c140" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" scale="0" unitRef="usdPershares">3.79</ix:nonFraction></td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><ix:nonFraction contextRef="c141" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" scale="0" unitRef="shares">60,000</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: right"><ix:nonNumeric contextRef="c142" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1">1.59</ix:nonNumeric></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><ix:nonFraction contextRef="c143" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" scale="3" unitRef="shares">60,000</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: right"><ix:nonNumeric contextRef="c144" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1">1.59</ix:nonNumeric></td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><ix:nonFraction contextRef="c145" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" scale="0" unitRef="usdPershares">4.17</ix:nonFraction></td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><ix:nonFraction contextRef="c146" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" scale="0" unitRef="shares">28,800</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: right"><ix:nonNumeric contextRef="c147" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1">3.03</ix:nonNumeric></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><ix:nonFraction contextRef="c148" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" scale="3" unitRef="shares">28,800</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: right"><ix:nonNumeric contextRef="c149" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1">3.03</ix:nonNumeric></td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt"><ix:nonFraction contextRef="c150" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" scale="0" unitRef="usdPershares">5.12</ix:nonFraction></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c151" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" scale="0" unitRef="shares">40,000</ix:nonFraction></td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: right"><ix:nonNumeric contextRef="c152" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1">6.54</ix:nonNumeric></td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c153" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" scale="3" unitRef="shares">35,000</ix:nonFraction></td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: right"><ix:nonNumeric contextRef="c154" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1">6.54</ix:nonNumeric></td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 4pt">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c155" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" scale="0" unitRef="shares">1,570,991</ix:nonFraction></td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="padding-bottom: 4pt; text-align: center">&#160;</td>
    <td style="padding-bottom: 4pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c156" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" scale="3" unitRef="shares">1,048,297</ix:nonFraction></td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="padding-bottom: 4pt; text-align: center">&#160;</td>
    <td style="padding-bottom: 4pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:nonNumeric></ix:continuation><div>


</div><div>

</div><ix:continuation continuedAt="_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock-c0_cont_12" id="_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock-c0_cont_11"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The weighted average grant date fair value of share options granted during the years ended December&#160;31, 2022, 2021 and 2020 was $<ix:nonFraction contextRef="c2" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" unitRef="usdPershares">0.51</ix:nonFraction>,
$<ix:nonFraction contextRef="c3" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" unitRef="usdPershares">0.44</ix:nonFraction> and $<ix:nonFraction contextRef="c26" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" unitRef="usdPershares">0.20</ix:nonFraction> per share option, respectively.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock-c0_cont_13" id="_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock-c0_cont_12"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During the years ended December 31, 2022 and 2021,
share options have not been exercised into Ordinary Shares. During the year ended December 31, 2020, certain employees exercised <ix:nonFraction contextRef="c9" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" unitRef="shares">9,800</ix:nonFraction>
share options into the same number of Ordinary Shares for total consideration of $<ix:nonFraction contextRef="c26" decimals="-3" format="ixt:num-dot-decimal" name="bmr:TotalConsideration" scale="3" unitRef="usd">11</ix:nonFraction>.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 156; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">BEAMR IMAGING LTD.</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Cont.)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(U.S. dollars in
thousands except share and per share amounts)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><b>NOTE 12 &#8211; SHARE OPTIONS
(Cont.)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in">&#160;</p><div>

</div><ix:continuation continuedAt="_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock-c0_cont_14" id="_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock-c0_cont_13"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table presents the assumptions used
to estimate the fair values of the share options granted in the reported periods presented:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock-c0_cont_15" id="_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock-c0_cont_14"><ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="text-align: center; border-bottom: Black 1.5pt solid"><b>Year ended December 31</b></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2020</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">Volatility (%)</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c0" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" unitRef="pure">61.49</ix:nonFraction></td>
    <td style="width: 1%; text-align: left">%</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c8" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" unitRef="pure">64.75</ix:nonFraction></td>
    <td style="width: 1%; text-align: left">%</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="white-space: nowrap; width: 9%; text-align: right"><span style="font-size: 10pt"><ix:nonFraction contextRef="c157" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" unitRef="pure">61.89</ix:nonFraction>%-<ix:nonFraction contextRef="c158" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" unitRef="pure">61.91</ix:nonFraction></span></td>
    <td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Risk-free interest rate (%)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="white-space: nowrap; text-align: right"><span style="font-size: 10pt"><ix:nonFraction contextRef="c159" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" unitRef="pure">3.64</ix:nonFraction>%-<ix:nonFraction contextRef="c70" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" unitRef="pure">3.85</ix:nonFraction></span></td>
    <td style="text-align: left">%</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><ix:nonFraction contextRef="c8" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" unitRef="pure">0.09</ix:nonFraction></td>
    <td style="text-align: left">%</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="white-space: nowrap; text-align: right"><span style="font-size: 10pt"><ix:nonFraction contextRef="c157" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" unitRef="pure">0.03</ix:nonFraction>%-<ix:nonFraction contextRef="c158" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" unitRef="pure">0.04</ix:nonFraction></span></td>
    <td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Dividend yield (%)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-79">-</span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-80">-</span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">-</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Expected life (years)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><ix:nonNumeric contextRef="c0" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">6.25</ix:nonNumeric></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><ix:nonNumeric contextRef="c8" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">6.25</ix:nonNumeric></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><ix:nonNumeric contextRef="c9" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">6.25</ix:nonNumeric></td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Exercise price ($)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" scale="0" unitRef="usdPershares">1.83</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt"><ix:nonFraction contextRef="c160" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" scale="0" unitRef="usdPershares">1.80</ix:nonFraction>-<ix:nonFraction contextRef="c161" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" scale="0" unitRef="usdPershares">3.20</ix:nonFraction></span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><ix:nonFraction contextRef="c26" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" scale="0" unitRef="usdPershares">1.80</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Share price ($)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:SharePrice" scale="0" unitRef="usdPershares">3.30</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><ix:nonFraction contextRef="c3" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:SharePrice" scale="0" unitRef="usdPershares">3.20</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><ix:nonFraction contextRef="c26" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:SharePrice" scale="0" unitRef="usdPershares">1.80</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:nonNumeric></ix:continuation><div>


</div><div>

</div><ix:continuation continuedAt="_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock-c0_cont_16" id="_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock-c0_cont_15"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of December 31, 2022, there was $<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" scale="3" unitRef="usd">1,029</ix:nonFraction> of unrecognized
compensation expense related to unvested share options. The Company recognizes compensation expense on a straight-line basis over the
requisite service periods, which results in a weighted average period of approximately <ix:nonNumeric contextRef="c0" format="ixt-sec:duryear" name="us-gaap:NetAmountAtRiskByProductAndGuaranteeWeightedAveragePeriodRemaining1">1.72</ix:nonNumeric> years over which the unrecognized compensation
expense is expected to be recognized.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock-c0_cont_17" id="_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock-c0_cont_16"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The total compensation cost related to all of
the Company&#8217;s equity-based awards recognized during the years ended December&#160;31, 2022, 2021 and 2020 was comprised as follows:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation id="_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock-c0_cont_17"><ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="text-align: center; border-bottom: Black 1.5pt solid"><b>Year ended December 31</b></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2020</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">Research and development</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherResearchAndDevelopmentExpense" scale="3" unitRef="usd">144</ix:nonFraction></td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherResearchAndDevelopmentExpense" scale="3" unitRef="usd">94</ix:nonFraction></td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c9" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherResearchAndDevelopmentExpense" scale="3" unitRef="usd">60</ix:nonFraction></td>
    <td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Sales and marketing</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherSellingAndMarketingExpense" scale="3" unitRef="usd">49</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherSellingAndMarketingExpense" scale="3" unitRef="usd">45</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><ix:nonFraction contextRef="c9" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherSellingAndMarketingExpense" scale="3" unitRef="usd">48</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">General and administrative</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherGeneralAndAdministrativeExpense" scale="3" unitRef="usd">29</ix:nonFraction></td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherGeneralAndAdministrativeExpense" scale="3" unitRef="usd">18</ix:nonFraction></td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c9" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherGeneralAndAdministrativeExpense" scale="3" unitRef="usd">12</ix:nonFraction></td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" scale="3" unitRef="usd">222</ix:nonFraction></td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" scale="3" unitRef="usd">157</ix:nonFraction></td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c9" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" scale="3" unitRef="usd">120</ix:nonFraction></td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric></ix:continuation><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="bmr_FinancingExpenses-c0_cont_1" escape="true" name="bmr:FinancingExpenses"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63.8pt; text-align: left; text-indent: -63.8pt"><b>NOTE 13 - FINANCING
EXPENSES, NET</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63.8pt; text-align: left; text-indent: -63.8pt"><b>&#160;</b></p></ix:nonNumeric><div>

</div><div>

</div><ix:continuation id="bmr_FinancingExpenses-c0_cont_1"><ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:ConvertibleDebtTableTextBlock"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="text-align: center; border-bottom: Black 1.5pt solid"><b>Year ended  December 31</b></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2020</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; width: 64%; text-align: left">Change in fair value of convertible advance investment (see Note 9)</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="bmr:ChangeInTheFairValueOfConvertibleAdvanceInvestments" scale="3" unitRef="usd">70</ix:nonFraction></td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="bmr:ChangeInTheFairValueOfConvertibleAdvanceInvestments" scale="3" unitRef="usd">288</ix:nonFraction></td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c9" decimals="-3" format="ixt:num-dot-decimal" name="bmr:ChangeInTheFairValueOfConvertibleAdvanceInvestments" scale="3" unitRef="usd">436</ix:nonFraction></td>
    <td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Amortization of discount and accrued interest relating to straight loan received from commercial Bank (see Note 6 and Note 7)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PresentValueOfFutureInsuranceProfitsAmortizationExpenseAccruedInterest" scale="3" unitRef="usd">102</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PresentValueOfFutureInsuranceProfitsAmortizationExpenseAccruedInterest" scale="3" unitRef="usd">59</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><ix:nonFraction contextRef="c9" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PresentValueOfFutureInsuranceProfitsAmortizationExpenseAccruedInterest" scale="3" unitRef="usd">120</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Modification of terms relating to straight loan (see Note 6A1)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-81">-</div></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="bmr:ModificationOfTermsRelatingToStraightLoan" scale="3" unitRef="usd">90</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-82">-</div></td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Amortization of discount relating to liability to related party (see Note 14)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" scale="3" unitRef="usd">40</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-83">-</div></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-84">-</div></td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Exchange rate differences and others</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="bmr:ExchangeRateDifferencesAndOthers" scale="3" sign="-" unitRef="usd">47</ix:nonFraction></td>
    <td style="padding-bottom: 1.5pt; text-align: left">)</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="bmr:ExchangeRateDifferencesAndOthers" scale="3" unitRef="usd">38</ix:nonFraction></td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c9" decimals="-3" format="ixt:num-dot-decimal" name="bmr:ExchangeRateDifferencesAndOthers" scale="3" unitRef="usd">141</ix:nonFraction></td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherNonoperatingExpense" scale="3" unitRef="usd">165</ix:nonFraction></td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherNonoperatingExpense" scale="3" unitRef="usd">475</ix:nonFraction></td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c9" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherNonoperatingExpense" scale="3" unitRef="usd">697</ix:nonFraction></td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric></ix:continuation><div>





</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 157; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">BEAMR IMAGING LTD.</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Cont.)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(U.S. dollars in
thousands except share and per share amounts)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 99.8pt; text-align: left; text-indent: 8.2pt"><b>&#160;</b></p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_RelatedPartyTransactionsDisclosureTextBlock-c0_cont_1" escape="true" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63.8pt; text-align: left; text-indent: -63.8pt"><b>NOTE 14 - RELATED
PARTIES TRANSACTIONS</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63.8pt; text-align: left; text-indent: -63.8pt"><b>&#160;</b></p></ix:nonNumeric><div>

</div><div>

</div><ix:continuation continuedAt="_RelatedPartyTransactionsDisclosureTextBlock-c0_cont_2" id="_RelatedPartyTransactionsDisclosureTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The liability to related party derives from a
service agreement with the Company&#8217;s Founder under which the Company receives consulting services on recurring basis from the Founder
as Chief Executive Officer indirectly through an entity controlled by the Founder (the &#8220;Service Provider&#8221;) for total current
monthly gross amount of NIS <ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RelatedPartyTransactionDueFromToRelatedPartyCurrent" scale="3" unitRef="ils">45</ix:nonFraction> thousand. On March 14, 2022, the Company&#8217;s shareholders approved, among other matters, to renew the service
agreement with the Founder for a period ending December 31, 2025.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_RelatedPartyTransactionsDisclosureTextBlock-c0_cont_3" id="_RelatedPartyTransactionsDisclosureTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On February 16, 2022, the Company entered into
an addendum to the aforesaid service agreement with the Service Provider under which it was agreed that (i) the term of the service agreement
with the Service Provider was extended to December 31, 2025 and (ii) the then current liability towards the Service Provider as was accrued
for services rendered under the service agreement over a period commencing January 1, 2020 through the date hereof in total nominal amount
of $<ix:nonFraction contextRef="c162" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DueToOtherRelatedPartiesClassifiedCurrent" scale="3" unitRef="usd">357</ix:nonFraction> (the &#8220;Current Liability&#8221;) will be paid in 18 equal installments (without an interest) starting on March 1, 2022 (the
&#8220;Commencement Date&#8221;). However, in the event that the Company shall not have available sufficient funds in any such payment
date from and after the Commencement Date to repay the installments of the Current Liability and/or the on-going fee owed to the Service
Provider or in the event that the Company determines that according to the following 12-months period budget that it shall not have available
sufficient funds to pay such installments and/or the on-going fee, then the Service Provider hereby agrees to postpone such payments owed
to it until the Company will have such sufficient funds. Any unpaid on-going fee payments will be added to the Current Liability.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_RelatedPartyTransactionsDisclosureTextBlock-c0_cont_4" id="_RelatedPartyTransactionsDisclosureTextBlock-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Since the liability towards the Founder was considered
as free interest loan which did not represent the applicable rate of risk for the Company, the aforesaid addendum was accounted for as
a capital contribution from a controlling shareholder. Thus, the liability towards the Founder was measured at fair value based on future
cash payments discounted using an interest rate of <ix:nonFraction contextRef="c2" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:InvestmentInterestRate" scale="-2" unitRef="pure">15.45</ix:nonFraction>% which represented the applicable rate of risk for the Company, as determined
by management using the assistance of third-party appraiser. As a result, the Company recorded a discount on the balance of liability
towards the Founder in total amount of $<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalOther" scale="3" unitRef="usd">112</ix:nonFraction> against additional paid-in capital (including in respect to amounts due for services period
through fiscal year for 2022). The Company will record a discount expense over the economic life of the loan based on the effective interest
rate method. As of December 31, 2022, management has updated the repayments schedule of the obligation based on its current projection
of the availability of funds. Accordingly, the obligation is expected to be repaid over the following 24-months period.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_RelatedPartyTransactionsDisclosureTextBlock-c0_cont_5" id="_RelatedPartyTransactionsDisclosureTextBlock-c0_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following tabular presentation reflects the
reconciliation of the carrying amount of the Company&#8217;s Liability to related party, net during the years ended December 31, 2022,
2021 and 2020:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_RelatedPartyTransactionsDisclosureTextBlock-c0_cont_6" id="_RelatedPartyTransactionsDisclosureTextBlock-c0_cont_5"><ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:ScheduleOfRegulatoryLiabilitiesTextBlock"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="text-align: center; border-bottom: Black 1.5pt solid"><b>Year ended  December 31,</b></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2020</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left; text-indent: -14.15pt; padding-left: 14.15pt">Opening balance</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InvestmentRelatedLiabilities" scale="3" unitRef="usd">345</ix:nonFraction></td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c26" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InvestmentRelatedLiabilities" scale="3" unitRef="usd">168</ix:nonFraction></td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-85">-</div></td>
    <td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -14.15pt; padding-left: 14.15pt">Accrued liability in respect to additional services rendered</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherAccruedLiabilitiesCurrentAndNoncurrent" scale="3" unitRef="usd">115</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherAccruedLiabilitiesCurrentAndNoncurrent" scale="3" unitRef="usd">177</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><ix:nonFraction contextRef="c26" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherAccruedLiabilitiesCurrentAndNoncurrent" scale="3" unitRef="usd">168</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -14.15pt; padding-left: 14.15pt">Recognition of capital contribution from a controlling shareholder</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PartnersCapitalAccountContributions" scale="3" unitRef="usd">112</ix:nonFraction></td>
    <td style="text-align: left">)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-86">-</div></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-87">-</div></td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -14.15pt; padding-left: 14.15pt">Amortization of discount relating to liability to related party</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InvestmentIncomeAmortizationOfDiscount" scale="3" unitRef="usd">40</ix:nonFraction></td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-88">-</div></td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-89">-</div></td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 4pt; text-indent: -14.15pt; padding-left: 14.15pt">Closing balance</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InvestmentRelatedLiabilities" scale="3" unitRef="usd">388</ix:nonFraction></td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InvestmentRelatedLiabilities" scale="3" unitRef="usd">345</ix:nonFraction></td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c26" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InvestmentRelatedLiabilities" scale="3" unitRef="usd">168</ix:nonFraction></td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:nonNumeric></ix:continuation><div>


</div><div>

</div><ix:continuation continuedAt="_RelatedPartyTransactionsDisclosureTextBlock-c0_cont_7" id="_RelatedPartyTransactionsDisclosureTextBlock-c0_cont_6"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Maturity dates:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_RelatedPartyTransactionsDisclosureTextBlock-c0_cont_8" id="_RelatedPartyTransactionsDisclosureTextBlock-c0_cont_7"><ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="text-align: center; border-bottom: Black 1.5pt solid"><b>As of<br/>
 December 31,</b></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; text-indent: -14.15pt; padding-left: 14.15pt">First year (current maturities)</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LongTermDebtCurrent" scale="3" unitRef="usd">126</ix:nonFraction></td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LongTermDebtCurrent" scale="3" unitRef="usd">345</ix:nonFraction></td>
    <td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -14.15pt; padding-left: 14.15pt">Second year</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherCommitmentDueInSecondYear" scale="3" unitRef="usd">262</ix:nonFraction></td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-90">-</div></td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 4pt; text-indent: -14.15pt; padding-left: 14.15pt">Closing balance</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherLongTermDebtCurrent" scale="3" unitRef="usd">388</ix:nonFraction></td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherLongTermDebtCurrent" scale="3" unitRef="usd">345</ix:nonFraction></td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:nonNumeric></ix:continuation><div>


</div><div>

</div><ix:continuation continuedAt="_RelatedPartyTransactionsDisclosureTextBlock-c0_cont_9" id="_RelatedPartyTransactionsDisclosureTextBlock-c0_cont_8"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company allocated the expenses related to
the above service agreement and addendum as follows:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_RelatedPartyTransactionsDisclosureTextBlock-c0_cont_10" id="_RelatedPartyTransactionsDisclosureTextBlock-c0_cont_9"><ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="text-align: center; border-bottom: Black 1.5pt solid"><b>Year ended  December 31</b></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2020</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left; text-indent: -8.6pt; padding-left: 8.6pt">Research and development</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ResearchAndDevelopmentInProcess" scale="3" unitRef="usd">42</ix:nonFraction></td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ResearchAndDevelopmentInProcess" scale="3" unitRef="usd">44</ix:nonFraction></td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c9" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ResearchAndDevelopmentInProcess" scale="3" unitRef="usd">82</ix:nonFraction></td>
    <td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -8.6pt; padding-left: 8.6pt">Sales and marketing</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:MarketingAndAdvertisingExpense" scale="3" unitRef="usd">42</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:MarketingAndAdvertisingExpense" scale="3" unitRef="usd">44</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><ix:nonFraction contextRef="c9" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:MarketingAndAdvertisingExpense" scale="3" unitRef="usd">58</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -8.6pt; padding-left: 8.6pt">General and administrative</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherSellingGeneralAndAdministrativeExpense" scale="3" unitRef="usd">83</ix:nonFraction></td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherSellingGeneralAndAdministrativeExpense" scale="3" unitRef="usd">89</ix:nonFraction></td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c9" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherSellingGeneralAndAdministrativeExpense" scale="3" unitRef="usd">108</ix:nonFraction></td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInDueToOtherRelatedParties" scale="3" unitRef="usd">167</ix:nonFraction></td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInDueToOtherRelatedParties" scale="3" unitRef="usd">177</ix:nonFraction></td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c9" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInDueToOtherRelatedParties" scale="3" unitRef="usd">248</ix:nonFraction></td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:nonNumeric></ix:continuation><div>


</div><div>

</div><ix:continuation id="_RelatedPartyTransactionsDisclosureTextBlock-c0_cont_10"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The allocation was done based on the management estimation to reflect the contribution to the related activity.</p></ix:continuation><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 158; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">BEAMR IMAGING LTD.</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Cont.)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(U.S. dollars in
thousands except share and per share amounts)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><b>&#160;</b></p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_IncomeTaxDisclosureTextBlock-c0_cont_1" escape="true" name="us-gaap:IncomeTaxDisclosureTextBlock"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><b>NOTE 15 - TAXES ON INCOME</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><b>&#160;</b></p></ix:nonNumeric><div>

</div><div>

</div><ix:continuation continuedAt="_IncomeTaxDisclosureTextBlock-c0_cont_2" id="_IncomeTaxDisclosureTextBlock-c0_cont_1"><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0%"></td><td style="width: 0.5in"><b>A.</b></td><td style="text-align: justify">Israeli taxation:</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_IncomeTaxDisclosureTextBlock-c0_cont_3" id="_IncomeTaxDisclosureTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify">Taxable income of the Company is subject
to the Israeli corporate tax at the rate of <ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings" scale="-2" unitRef="pure">23</ix:nonFraction>%.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_IncomeTaxDisclosureTextBlock-c0_cont_4" id="_IncomeTaxDisclosureTextBlock-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify">As of December 31, 2022, the Company
has net operating losses and capital losses carryforward for Israeli income tax purposes of approximately $<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherNonoperatingGainsLosses" scale="3" unitRef="usd">27,169</ix:nonFraction> and $<ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" scale="3" unitRef="usd">409</ix:nonFraction> respectively,
which can be offset against future taxable income for an indefinite period of time.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_IncomeTaxDisclosureTextBlock-c0_cont_5" id="_IncomeTaxDisclosureTextBlock-c0_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify">The Company has final (considered
final) tax assessments through the 2017 tax year.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: -28.35pt"><b>&#160;</b></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_IncomeTaxDisclosureTextBlock-c0_cont_6" id="_IncomeTaxDisclosureTextBlock-c0_cont_5"><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0%"></td><td style="width: 0.5in"><b>B.</b></td><td style="text-align: justify">Foreign entities:</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 46.35pt; text-align: justify; text-indent: -0.25in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_IncomeTaxDisclosureTextBlock-c0_cont_7" id="_IncomeTaxDisclosureTextBlock-c0_cont_6"><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in">1.</td><td style="text-align: justify">Beamr Inc. is taxed under United States federal and state tax rules. Income tax is calculated based on
a U.S. federal tax rate of <ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" unitRef="pure">21</ix:nonFraction>%.</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 46.35pt; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_IncomeTaxDisclosureTextBlock-c0_cont_8" id="_IncomeTaxDisclosureTextBlock-c0_cont_7"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify">Beamr Inc. have not received final
tax assessments for the tax years ended December 31, 2019 through 2022.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 46.35pt; text-align: justify; text-indent: -0.25in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_IncomeTaxDisclosureTextBlock-c0_cont_9" id="_IncomeTaxDisclosureTextBlock-c0_cont_8"><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in">2.</td><td style="text-align: justify">Beamr Imaging RU is taxed under the Russian tax code at the rate of 0% (Clause 1.15 of Article 284 of
the Tax Code of the Russian Federation, with changes provided by Federal Law No. 321-FZ of 14.07.2022).</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 46.35pt; text-align: justify; text-indent: -0.25in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_IncomeTaxDisclosureTextBlock-c0_cont_10" id="_IncomeTaxDisclosureTextBlock-c0_cont_9"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify">Beamr Imaging RU have not received
final tax assessments for the tax years ended December 31, 2020 through 2022.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 46.35pt; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_IncomeTaxDisclosureTextBlock-c0_cont_11" id="_IncomeTaxDisclosureTextBlock-c0_cont_10"><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0%"></td><td style="width: 0.5in"><b>C.</b></td><td style="text-align: justify">Taxes on income are comprised from taxes incurred as result of (i) withholding tax deducted at source
in accordance with U.S. - Israel tax treaty related to selling of software and (ii) implementation of the intercompany agreement between
the Company and&#160;Beamr Inc. for conducting reseller services and implementation of the intercompany agreement between the Company
and Beamr Imaging RU for conducting research and development services on behalf of the Company (see also Note 1B).</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: -28.35pt"><b>&#160;</b></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_IncomeTaxDisclosureTextBlock-c0_cont_12" id="_IncomeTaxDisclosureTextBlock-c0_cont_11"><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0%"></td><td style="width: 0.5in"><b>D.</b></td><td style="text-align: justify">Loss (income) before taxes on income consists of the following:</td></tr></table><p style="margin-top: 0; margin-bottom: 0">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_IncomeTaxDisclosureTextBlock-c0_cont_13" id="_IncomeTaxDisclosureTextBlock-c0_cont_12"><ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="text-align: center; border-bottom: Black 1.5pt solid"><b>Year ended  December 31</b></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2020</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">Domestic</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" scale="3" unitRef="usd">1,293</ix:nonFraction></td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" scale="3" unitRef="usd">1,104</ix:nonFraction></td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c9" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" scale="3" unitRef="usd">2,529</ix:nonFraction></td>
    <td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Foreign operations (Beamr Inc and Imaging RU)</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" scale="3" sign="-" unitRef="usd">97</ix:nonFraction></td>
    <td style="padding-bottom: 1.5pt; text-align: left">)</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" scale="3" sign="-" unitRef="usd">204</ix:nonFraction></td>
    <td style="padding-bottom: 1.5pt; text-align: left">)</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c9" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" scale="3" sign="-" unitRef="usd">165</ix:nonFraction></td>
    <td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" scale="3" unitRef="usd">1,196</ix:nonFraction></td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" scale="3" unitRef="usd">900</ix:nonFraction></td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c9" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" scale="3" unitRef="usd">2,364</ix:nonFraction></td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify">&#160;</p></ix:nonNumeric></ix:continuation><div>


</div><div>

</div><ix:continuation continuedAt="_IncomeTaxDisclosureTextBlock-c0_cont_14" id="_IncomeTaxDisclosureTextBlock-c0_cont_13"><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0%"></td><td style="width: 0.5in"><b>E.</b></td><td style="text-align: justify">Deferred income taxes reflect the net tax effects of net operating loss and temporary differences between
the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Significant
components of the Company&#8217;s deferred tax assets are as follows:</td></tr></table><p style="margin-top: 0; margin-bottom: 0">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_IncomeTaxDisclosureTextBlock-c0_cont_15" id="_IncomeTaxDisclosureTextBlock-c0_cont_14"><ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="text-align: center; border-bottom: Black 1.5pt solid"><b>As of <br/>
December 31</b></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">Composition of deferred tax assets:</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">Net operating loss and capital losses carry-forward</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsCapitalLossCarryforwards" scale="3" unitRef="usd">6,343</ix:nonFraction></td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsCapitalLossCarryforwards" scale="3" unitRef="usd">6,254</ix:nonFraction></td>
    <td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Research and development credits</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment" scale="3" unitRef="usd">438</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment" scale="3" unitRef="usd">588</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Vacation accrual</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" scale="3" unitRef="usd">48</ix:nonFraction></td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" scale="3" unitRef="usd">62</ix:nonFraction></td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Net deferred tax asset before deferred tax liabilities and valuation allowance</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsGross" scale="3" unitRef="usd">6,829</ix:nonFraction></td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsGross" scale="3" unitRef="usd">6,904</ix:nonFraction></td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Valuation allowance</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="3" unitRef="usd">6,829</ix:nonFraction></td>
    <td style="padding-bottom: 1.5pt; text-align: left">)</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="3" unitRef="usd">6,904</ix:nonFraction></td>
    <td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Net deferred tax assets</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-91">-</div></td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-92">-</div></td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify">&#160;</p></ix:nonNumeric></ix:continuation><div>


</div><div>

</div><ix:continuation continuedAt="_IncomeTaxDisclosureTextBlock-c0_cont_16" id="_IncomeTaxDisclosureTextBlock-c0_cont_15"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify">In assessing the realization of deferred
tax assets, management considers whether it is more likely than not that all or some portion of the deferred tax assets will not be realized.
The ultimate realization of the deferred tax assets is dependent upon the generation of future taxable income during the periods in which
temporary differences are deductible and net operating losses are utilized. Based on consideration of these factors, the Company recorded
a full valuation allowance as of December 31, 2022 and 2021.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: -28.35pt"><b>&#160;</b></p></ix:continuation><div>

</div><div>

</div><ix:continuation id="_IncomeTaxDisclosureTextBlock-c0_cont_16"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 28.35pt"><b>F.</b></td><td style="text-align: justify">During the years ended December 31, 2022, 2021 and 2020, the main reconciling item between the statutory
tax rate of the Company (as noted in Note 15A) and the effective tax rate at the rate of <ix:nonFraction contextRef="c0" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="-2" unitRef="pure">4.4</ix:nonFraction>%, <ix:nonFraction contextRef="c8" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="-2" unitRef="pure">5.8</ix:nonFraction>% and <ix:nonFraction contextRef="c9" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="-2" unitRef="pure">4.0</ix:nonFraction>%, respectively, is the recognition
of valuation allowance in respect of deferred taxes relating to accumulated net operating losses carried forward and other permanent and
temporary differences due to the uncertainty of the realization of such deferred taxes and withholding taxes that were deducted by the
Company&#8217;s customers.</td></tr></table></ix:continuation><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 159; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">BEAMR IMAGING LTD.</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Cont.)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(U.S. dollars in
thousands except share and per share amounts)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63.8pt; text-align: left; text-indent: -63.8pt"><b>&#160;</b></p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_SegmentReportingDisclosureTextBlock-c0_cont_1" escape="true" name="us-gaap:SegmentReportingDisclosureTextBlock"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><b>NOTE 16 - SEGMENT GEOGRAPHICAL
INFORMATION AND MAJOR CUSTOMERS</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in">&#160;</p></ix:nonNumeric><div>

</div><div>

</div><ix:continuation continuedAt="_SegmentReportingDisclosureTextBlock-c0_cont_2" id="_SegmentReportingDisclosureTextBlock-c0_cont_1"><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0%"></td><td style="width: 0.5in"><b>A.</b></td><td style="text-align: justify"><b>General information</b></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: -28.35pt"><b>&#160;</b></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SegmentReportingDisclosureTextBlock-c0_cont_3" id="_SegmentReportingDisclosureTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify">Since inception date, the operation
of the Company is conducted through <ix:nonFraction contextRef="c0" decimals="0" format="ixt-sec:numwordsen" name="us-gaap:NumberOfOperatingSegments" scale="0" unitRef="Segment">one</ix:nonFraction> operating segment, the optimization technology for video and photo compression, which represents
a single reporting unit. This activity also represents the reportable segment of the Group.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SegmentReportingDisclosureTextBlock-c0_cont_4" id="_SegmentReportingDisclosureTextBlock-c0_cont_3"><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0%"></td><td style="width: 0.5in"><b>B.</b></td><td style="text-align: justify"><b>Revenues by geographic region are as follows:</b></td></tr></table><p style="margin-top: 0; margin-bottom: 0">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SegmentReportingDisclosureTextBlock-c0_cont_5" id="_SegmentReportingDisclosureTextBlock-c0_cont_4"><ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="text-align: center; border-bottom: Black 1.5pt solid"><b>Year ended December 31</b></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2020</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">United States</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c163" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="3" unitRef="usd">2,134</ix:nonFraction></td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c164" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="3" unitRef="usd">2,597</ix:nonFraction></td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c165" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="3" unitRef="usd">2,558</ix:nonFraction></td>
    <td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Israel</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><ix:nonFraction contextRef="c166" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="3" unitRef="usd">22</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><ix:nonFraction contextRef="c167" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="3" unitRef="usd">101</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><ix:nonFraction contextRef="c168" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="3" unitRef="usd">61</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Rest of the world</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c169" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="3" unitRef="usd">707</ix:nonFraction></td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c170" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="3" unitRef="usd">602</ix:nonFraction></td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c171" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="3" unitRef="usd">557</ix:nonFraction></td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="3" unitRef="usd">2,863</ix:nonFraction></td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="3" unitRef="usd">3,300</ix:nonFraction></td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c9" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="3" unitRef="usd">3,176</ix:nonFraction></td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify">&#160;</p></ix:nonNumeric></ix:continuation><div>


</div><div>

</div><ix:continuation continuedAt="_SegmentReportingDisclosureTextBlock-c0_cont_6" id="_SegmentReportingDisclosureTextBlock-c0_cont_5"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify">Revenues were attributed to countries
based on customer location.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SegmentReportingDisclosureTextBlock-c0_cont_7" id="_SegmentReportingDisclosureTextBlock-c0_cont_6"><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0%"></td><td style="width: 0.5in"><b>C.</b></td><td style="text-align: justify"><b>Long-lived assets, net, by geographic areas:</b></td></tr></table><p style="margin-top: 0; margin-bottom: 0">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SegmentReportingDisclosureTextBlock-c0_cont_8" id="_SegmentReportingDisclosureTextBlock-c0_cont_7"><ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:LongLivedAssetsByGeographicAreasTableTextBlock"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: justify">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"><b>As of<br/>
 December 31,</b></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; text-indent: -14.15pt; padding-left: 14.15pt">Israel</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c172" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NoncurrentAssets" scale="3" unitRef="usd">12</ix:nonFraction></td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c173" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NoncurrentAssets" scale="3" unitRef="usd">13</ix:nonFraction></td>
    <td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -14.15pt; padding-left: 14.15pt">United States</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><ix:nonFraction contextRef="c174" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NoncurrentAssets" scale="3" unitRef="usd">1</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><ix:nonFraction contextRef="c175" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NoncurrentAssets" scale="3" unitRef="usd">4</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -14.15pt; padding-left: 14.15pt">Russia</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c176" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NoncurrentAssets" scale="3" unitRef="usd">2</ix:nonFraction></td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c177" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NoncurrentAssets" scale="3" unitRef="usd">4</ix:nonFraction></td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 4pt; text-indent: -14.15pt; padding-left: 14.15pt">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NoncurrentAssets" scale="3" unitRef="usd">15</ix:nonFraction></td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NoncurrentAssets" scale="3" unitRef="usd">21</ix:nonFraction></td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify">&#160;</p></ix:nonNumeric></ix:continuation><div>


</div><div>

</div><ix:continuation continuedAt="_SegmentReportingDisclosureTextBlock-c0_cont_9" id="_SegmentReportingDisclosureTextBlock-c0_cont_8"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify">Such balance is comprised of property
and equipment that are attributed to the geographic area in which they are located or originated, as applicable.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify"><b>&#160;</b></p></ix:continuation><div>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 160; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p><p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">BEAMR IMAGING LTD.</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Cont.)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(U.S. dollars in
thousands except share and per share amounts)</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"><b>NOTE 16 - SEGMENT GEOGRAPHICAL
INFORMATION AND MAJOR CUSTOMERS (Cont.)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt">&#160;</span></p><div>

</div><ix:continuation continuedAt="_SegmentReportingDisclosureTextBlock-c0_cont_10" id="_SegmentReportingDisclosureTextBlock-c0_cont_9"><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0%"></td><td style="width: 0.5in"><b>D.</b></td><td style="text-align: justify"><b>Major customers</b></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: -28.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SegmentReportingDisclosureTextBlock-c0_cont_11" id="_SegmentReportingDisclosureTextBlock-c0_cont_10"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify">During the years ended December 31,
2022, 2021 and 2020, the Company had one customer which accounted for <ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense" scale="-2" unitRef="pure">26</ix:nonFraction>%, <ix:nonFraction contextRef="c8" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense" scale="-2" unitRef="pure">23</ix:nonFraction>% and <ix:nonFraction contextRef="c9" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense" scale="-2" unitRef="pure">23</ix:nonFraction>% of the Company&#8217;s total revenues, respectively.
In addition, as of December 31, 2022 and 2021, the Company had one customer which accounted for <ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="bmr:TradeReceivablesIncomeTaxRate" scale="-2" unitRef="pure">28</ix:nonFraction>% and <ix:nonFraction contextRef="c8" decimals="2" format="ixt:num-dot-decimal" name="bmr:TradeReceivablesIncomeTaxRate" scale="-2" unitRef="pure">44</ix:nonFraction>% of the Company&#8217;s total trade
receivables, respectively.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SegmentReportingDisclosureTextBlock-c0_cont_12" id="_SegmentReportingDisclosureTextBlock-c0_cont_11"><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0%"></td><td style="width: 0.5in"><b>E.</b></td><td style="text-align: justify"><b>Major product lines and services and timing of revenue recognition</b></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: -28.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SegmentReportingDisclosureTextBlock-c0_cont_13" id="_SegmentReportingDisclosureTextBlock-c0_cont_12"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify">In the following table, revenue is
disaggregated by primary major product lines and services, and timing of revenue recognition for the years ended December 31, 2022, 2021
and 2020:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SegmentReportingDisclosureTextBlock-c0_cont_14" id="_SegmentReportingDisclosureTextBlock-c0_cont_13"><ix:nonNumeric contextRef="c0" continuedAt="_DisaggregationOfRevenueTableTextBlock-c0_cont_1" escape="true" name="us-gaap:DisaggregationOfRevenueTableTextBlock"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><b>Year ended  December 31,</b></td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2020</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">Software license:</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: justify">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; width: 64%; text-align: left">Perpetual based software license - transferred at a point of time</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c178" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsForSoftware" scale="3" unitRef="usd">1,068</ix:nonFraction></td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c179" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsForSoftware" scale="3" unitRef="usd">1,156</ix:nonFraction></td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c180" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsForSoftware" scale="3" unitRef="usd">1,043</ix:nonFraction></td>
    <td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Term-based software license - transferred at a point of time</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c181" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsForSoftware" scale="3" unitRef="usd">1,630</ix:nonFraction></td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c182" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsForSoftware" scale="3" unitRef="usd">2,032</ix:nonFraction></td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c183" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsForSoftware" scale="3" unitRef="usd">1,976</ix:nonFraction></td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Total software license (*)</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" id="ix_28_fact" name="us-gaap:PaymentsForSoftware" scale="3" unitRef="usd">2,740</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" id="ix_29_fact" name="us-gaap:PaymentsForSoftware" scale="3" unitRef="usd">3,188</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction contextRef="c9" decimals="-3" format="ixt:num-dot-decimal" id="ix_30_fact" name="us-gaap:PaymentsForSoftware" scale="3" unitRef="usd">3,019</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">PCS services transferred over a period of time</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="bmr:PCSServicesTransferredOverAPeriod" scale="3" unitRef="usd">123</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="bmr:PCSServicesTransferredOverAPeriod" scale="3" unitRef="usd">112</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><ix:nonFraction contextRef="c9" decimals="-3" format="ixt:num-dot-decimal" name="bmr:PCSServicesTransferredOverAPeriod" scale="3" unitRef="usd">157</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Advertising at a point of time upon clicks</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="bmr:AdvertisingAtAPointOfTimeUponClicks" scale="3" unitRef="usd">42</ix:nonFraction></td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-93">-</div></td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-94">-</div></td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 4pt">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="bmr:RecognitionofRevenue" scale="3" unitRef="usd">2,863</ix:nonFraction></td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="bmr:RecognitionofRevenue" scale="3" unitRef="usd">3,300</ix:nonFraction></td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c9" decimals="-3" format="ixt:num-dot-decimal" name="bmr:RecognitionofRevenue" scale="3" unitRef="usd">3,176</ix:nonFraction></td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.65pt; text-align: justify; text-indent: -21.3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt">&#160;</span></p></ix:nonNumeric></ix:continuation><div>


</div><div>

</div><ix:continuation id="_SegmentReportingDisclosureTextBlock-c0_cont_14"><ix:continuation id="_DisaggregationOfRevenueTableTextBlock-c0_cont_1"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left">(*)</td><td style="text-align: justify"><ix:footnote id="ix_5_footnote" xml:lang="en-US">Revenue recognized from sales-based software license was $<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredRevenueRevenueRecognized1" scale="3" unitRef="usd">48</ix:nonFraction>,
$<ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredRevenueRevenueRecognized1" scale="3" unitRef="usd">45</ix:nonFraction> and $<ix:nonFraction contextRef="c9" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredRevenueRevenueRecognized1" scale="3" unitRef="usd">99</ix:nonFraction> during the years ended December 31, 2022, 2021 and 2020, respectively (see also Note 2N).</ix:footnote></td>
</tr></table></ix:continuation></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.65pt; text-align: justify; text-indent: -21.3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt">&#160;</span></p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_SubsequentEventsTextBlock-c0_cont_1" escape="true" name="us-gaap:SubsequentEventsTextBlock"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><b>NOTE 17 - SUBSEQUENT EVENTS</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt">&#160;</span></p></ix:nonNumeric><div>

</div><div>

</div><ix:continuation continuedAt="_SubsequentEventsTextBlock-c0_cont_2" id="_SubsequentEventsTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">The Company evaluated subsequent
events and transactions that occurred after the balance sheet date up to the date that the consolidated financial statements were available
to be issued (April 17, 2023). Based upon this review, the Company did not identify any other subsequent events that would have required
adjustment or disclosure in the financial statements except as disclosed below.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SubsequentEventsTextBlock-c0_cont_3" id="_SubsequentEventsTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><b>Completion of an Initial
Public Offering Transaction</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SubsequentEventsTextBlock-c0_cont_4" id="_SubsequentEventsTextBlock-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">On February 27, 2023, the Company
announced the pricing of its initial public offering of <ix:nonFraction contextRef="c184" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" scale="0" unitRef="shares">1,950,000</ix:nonFraction> Ordinary Shares at a public offering price of $<ix:nonFraction contextRef="c185" decimals="2" format="ixt:num-dot-decimal" name="bmr:PublicOfferingPrice" scale="0" unitRef="usdPershares">4.00</ix:nonFraction> per share, for aggregate
gross proceeds of $<ix:nonFraction contextRef="c186" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="3" unitRef="usdPershares">7,800</ix:nonFraction> prior to deducting underwriting discounts and other offering expenses. <ix:nonNumeric contextRef="c0" name="us-gaap:DebtInstrumentInterestRateTerms">In addition, the Company granted the underwriters
(i) 97,500 warrants which shall be exercisable into Ordinary Shares of the Company at an exercise price of $5.00 per Ordinary Share over
a period of 5-years commencing August 26, 2023 and (ii) a 45-day option to purchase up to an additional 292,500 ordinary shares at the
public offering price less discounts, to cover over-allotments.</ix:nonNumeric> The over-allotment option was not exercised and has expired as of the
date of filing of these consolidated financial statements.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SubsequentEventsTextBlock-c0_cont_5" id="_SubsequentEventsTextBlock-c0_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">The Ordinary Shares began trading
on the Nasdaq Capital Market under the ticker symbol &#8220;BMR&#8221; on February 28, 2023. The Company&#8217;s IPO closed on March 2,
2023.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SubsequentEventsTextBlock-c0_cont_6" id="_SubsequentEventsTextBlock-c0_cont_5"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">For accounting purposes, following
the completion of the above IPO transaction, all shares, options and warrants to purchase Ordinary Shares and loss per share amounts have
been adjusted to give retroactive effect to the Reverse Share Split for all periods presented in these consolidated financial statements.
Any fractional shares resulting from the Reverse Share Split were rounded up to the nearest whole share.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SubsequentEventsTextBlock-c0_cont_7" id="_SubsequentEventsTextBlock-c0_cont_6"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">In addition, the holders of&#160;all
other shares with preferences over Ordinary Shares (i.e. Convertible Preferred Shares and Convertible Ordinary <ix:nonFraction contextRef="c187" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockConvertibleSharesIssuable" scale="0" unitRef="shares">1</ix:nonFraction> and <ix:nonFraction contextRef="c188" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockConvertibleSharesIssuable" scale="0" unitRef="shares">2</ix:nonFraction> Shares) effected
a conversion of all such shares to <ix:nonFraction contextRef="c189" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ConversionOfStockSharesIssued1" scale="0" unitRef="shares">7,211,280</ix:nonFraction> Ordinary Shares, effective as of the pricing of the IPO on February 27, 2023.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation id="_SubsequentEventsTextBlock-c0_cont_7"><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">Further, in connection with the above IPO, on March 14, 2022, the Company's
shareholders approved to increase the Company's authorized shares from <ix:nonFraction contextRef="c190" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquitySharesAuthorized" scale="0" unitRef="shares">22,000,000</ix:nonFraction> to <ix:nonFraction contextRef="c191" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquitySharesAuthorized" scale="0" unitRef="shares">222,000,000</ix:nonFraction>. These consolidated financial statements
exclude the aforesaid increase of authorized shares, as if such change to the Company&#8217;s capital structure had not yet occurred.</p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt">&#160;</span></p><div>

</div><p style="text-align: center; margin-top: 0; margin-bottom: 0">F-34</p><div>

</div><p style="margin: 0"></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="font-size: 1pt; border-top: Black 1.5pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="margin: 0">&#160;</p><div>













































































































































</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><div style="display: none"><ix:header>
<ix:hidden>
<ix:nonNumeric contextRef="c1" id="hidden-fact-0" name="dei:LocalPhoneNumber">520-8735</ix:nonNumeric>
<ix:nonNumeric contextRef="c1" id="hidden-fact-1" name="dei:CityAreaCode">1-888</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" id="hidden-fact-2" name="dei:DocumentAccountingStandard">U.S. GAAP</ix:nonNumeric>
<ix:nonFraction contextRef="c3" id="hidden-fact-3" name="us-gaap:LongTermDebtNoncurrent" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c3" id="hidden-fact-4" name="us-gaap:DueToRelatedPartiesNoncurrent" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c2" id="hidden-fact-5" name="us-gaap:CommitmentsAndContingencies" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c3" id="hidden-fact-6" name="us-gaap:CommitmentsAndContingencies" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" decimals="2" id="hidden-fact-7" name="us-gaap:CommonStockParOrStatedValuePerShare" unitRef="ilsPershares">0.05</ix:nonFraction>
<ix:nonFraction contextRef="c5" decimals="2" id="hidden-fact-8" name="us-gaap:CommonStockParOrStatedValuePerShare" unitRef="ilsPershares">0.05</ix:nonFraction>
<ix:nonFraction contextRef="c6" decimals="2" id="hidden-fact-9" name="us-gaap:CommonStockParOrStatedValuePerShare" unitRef="ilsPershares">0.05</ix:nonFraction>
<ix:nonFraction contextRef="c7" decimals="2" id="hidden-fact-10" name="us-gaap:CommonStockParOrStatedValuePerShare" unitRef="ilsPershares">0.05</ix:nonFraction>
<ix:nonFraction contextRef="c2" decimals="2" id="hidden-fact-11" name="us-gaap:PreferredStockParOrStatedValuePerShare" unitRef="ilsPershares">0.05</ix:nonFraction>
<ix:nonFraction contextRef="c3" decimals="2" id="hidden-fact-12" name="us-gaap:PreferredStockParOrStatedValuePerShare" unitRef="ilsPershares">0.05</ix:nonFraction>
<ix:nonFraction contextRef="c8" decimals="2" id="hidden-fact-13" name="us-gaap:EarningsPerShareDiluted" sign="-" unitRef="usdPershares">0.37</ix:nonFraction>
<ix:nonFraction contextRef="c0" decimals="2" id="hidden-fact-14" name="us-gaap:EarningsPerShareDiluted" sign="-" unitRef="usdPershares">0.48</ix:nonFraction>
<ix:nonFraction contextRef="c9" decimals="2" id="hidden-fact-15" name="us-gaap:EarningsPerShareDiluted" sign="-" unitRef="usdPershares">0.96</ix:nonFraction>
<ix:nonFraction contextRef="c9" decimals="INF" id="hidden-fact-16" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" unitRef="shares">2574814</ix:nonFraction>
<ix:nonFraction contextRef="c0" decimals="INF" id="hidden-fact-17" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" unitRef="shares">2578760</ix:nonFraction>
<ix:nonFraction contextRef="c8" decimals="INF" id="hidden-fact-18" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" unitRef="shares">2578760</ix:nonFraction>
<ix:nonFraction contextRef="c16" id="hidden-fact-19" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c17" id="hidden-fact-20" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c18" id="hidden-fact-21" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c20" id="hidden-fact-22" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c16" id="hidden-fact-23" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c17" id="hidden-fact-24" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c17" id="hidden-fact-25" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c18" id="hidden-fact-26" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c18" id="hidden-fact-27" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c20" id="hidden-fact-28" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c16" id="hidden-fact-29" name="us-gaap:NetIncomeLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c17" id="hidden-fact-30" name="us-gaap:NetIncomeLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c18" id="hidden-fact-31" name="us-gaap:NetIncomeLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c19" id="hidden-fact-32" name="us-gaap:NetIncomeLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c27" id="hidden-fact-33" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c28" id="hidden-fact-34" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c29" id="hidden-fact-35" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c31" id="hidden-fact-36" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c27" id="hidden-fact-37" name="us-gaap:NetIncomeLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c28" id="hidden-fact-38" name="us-gaap:NetIncomeLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c29" id="hidden-fact-39" name="us-gaap:NetIncomeLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c30" id="hidden-fact-40" name="us-gaap:NetIncomeLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c35" id="hidden-fact-41" name="us-gaap:StockIssuedDuringPeriodValueOther" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c36" id="hidden-fact-42" name="us-gaap:StockIssuedDuringPeriodValueOther" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c37" id="hidden-fact-43" name="us-gaap:StockIssuedDuringPeriodValueOther" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c35" id="hidden-fact-44" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c36" id="hidden-fact-45" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c37" id="hidden-fact-46" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c39" id="hidden-fact-47" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c35" id="hidden-fact-48" name="us-gaap:NetIncomeLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c36" id="hidden-fact-49" name="us-gaap:NetIncomeLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c37" id="hidden-fact-50" name="us-gaap:NetIncomeLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c38" id="hidden-fact-51" name="us-gaap:NetIncomeLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-52" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-53" name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-54" name="us-gaap:ProceedsFromStockOptionsExercised" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-55" name="bmr:ConsiderationReceivedFromPPPNote" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c8" id="hidden-fact-56" name="bmr:NetConsiderationReceivedFromIBILoan" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c9" id="hidden-fact-57" name="bmr:NetConsiderationReceivedFromIBILoan" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c3" id="hidden-fact-58" name="us-gaap:DerivativeLiabilityFairValueOfCollateral" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c26" id="hidden-fact-59" name="us-gaap:DerivativeLiabilityFairValueOfCollateral" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-60" name="us-gaap:DebtInstrumentDecreaseForgiveness" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c9" id="hidden-fact-61" name="us-gaap:DebtInstrumentDecreaseForgiveness" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c9" id="hidden-fact-62" name="us-gaap:LoanProcessingFee" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-63" name="us-gaap:ExtinguishmentOfDebtAmount" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c9" id="hidden-fact-64" name="us-gaap:ExtinguishmentOfDebtAmount" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-65" name="bmr:RecognitionSubsequentToSubstantialModificationOfTerms" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c9" id="hidden-fact-66" name="bmr:RecognitionSubsequentToSubstantialModificationOfTerms" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c8" id="hidden-fact-67" name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c9" id="hidden-fact-68" name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c3" id="hidden-fact-69" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c3" id="hidden-fact-70" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c26" id="hidden-fact-71" name="us-gaap:DerivativeFairValueOfDerivativeNet" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-72" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c8" id="hidden-fact-73" name="us-gaap:AdjustmentOfWarrantsGrantedForServices" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-74" name="us-gaap:NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c9" id="hidden-fact-75" name="us-gaap:NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:footnote id="ix_4_footnote" xml:lang="en-US">The Convertible Ordinary 1 Shares, Convertible Ordinary 2 Shares, Convertible B Preferred Shares, Convertible B1 Preferred Shares and the Convertible C Preferred Shares (referring together herein as &#8220;Convertible Preferred Shares&#8221;) shall confer upon the holders thereof all rights conferred upon the holders of Ordinary Shares in the Company. In addition, the holders of Convertible Preferred Shares shall have rights, preferences and privileges, as follows:

Liquidation preference - Based on preference of distribution, in the event of any liquidation, dissolution or winding up of the Company, whether voluntary or involuntary, change in control or distribution, the Company&#8217;s assets or surplus funds legally available for distribution shall be distributed to the holders of Convertible Preferred Shares pursuant to which each Convertible Preferred Share will be entitled to receive 1.2 of the applicable original issue price paid by each Convertible Preferred shareholder plus all accrued but unpaid dividends and less the aggregate of all amounts previously paid in preference. The aggregate liquidation preference of all shares with preferences over Ordinary Shares as of December 31, 2022 and 2021 amounted to $33,785. None of the foregoing dollar amounts include dividends, as the Board of Directors has not declared any dividends since inception.

The Convertible Preferred Shares have been classified as part of the permanent equity of the Company since upon occurrence of liquidation event all holder of the Ordinary Shares and the Convertible Preferred Shares will be entitled to receive the same form of consideration.

Voting - Each shareholder shall have one vote for each Ordinary Share held by such shareholder of record or such Ordinary Shares as would be held by each holder of Convertible Preferred Share if all Convertible Preferred Shares were converted to Ordinary Shares at the then effective conversion rate, on every resolution.

Conversion - Each holder of a Convertible Preferred Share shall be entitled to convert, at any time and from time to time, and without payment of additional consideration, into such number of fully paid and non-assessable shares of Ordinary Share in ratio as determined in the Articles, which initially shall be one to one. The conversion price initially shall be the applicable Original Issue Price subject to adjustments as describe in the Articles.

All outstanding Convertible Preferred Shares shall automatically be converted into Ordinary Shares at the then-effective conversion rate applicable upon the earlier of (i) closing of sale of Ordinary Shares in an initial firm-commitment underwritten public offering, with net proceeds to the Company of $50,000 and at an offering price per share equal to at least 5 times the Preferred C Original Issue Price (Qualified IPO) or (ii) affirmative vote or written consent of majority shareholders of the then outstanding Convertible Preferred Shares, with respect to each series.</ix:footnote><!--Text not found in footnote sections assigned to Schedule of composition of shareholders' equity-->
<ix:nonNumeric contextRef="c9" id="hidden-fact-76" name="bmr:WeightedAverageRemainingContractualLifeExercised" xsi:nil="true"></ix:nonNumeric>
<ix:nonNumeric contextRef="c9" id="hidden-fact-77" name="bmr:WeightedAverageRemainingContractualLifeForfeitedOrExpired" xsi:nil="true"></ix:nonNumeric>
<ix:nonNumeric contextRef="c8" id="hidden-fact-78" name="bmr:WeightedAverageRemainingContractualLifeForfeitedOrExpired" xsi:nil="true"></ix:nonNumeric>
<ix:nonFraction contextRef="c0" id="hidden-fact-79" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" unitRef="pure" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c8" id="hidden-fact-80" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" unitRef="pure" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-81" name="bmr:ModificationOfTermsRelatingToStraightLoan" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c9" id="hidden-fact-82" name="bmr:ModificationOfTermsRelatingToStraightLoan" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c8" id="hidden-fact-83" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c9" id="hidden-fact-84" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c15" id="hidden-fact-85" name="us-gaap:InvestmentRelatedLiabilities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c8" id="hidden-fact-86" name="us-gaap:PartnersCapitalAccountContributions" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c9" id="hidden-fact-87" name="us-gaap:PartnersCapitalAccountContributions" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c8" id="hidden-fact-88" name="us-gaap:InvestmentIncomeAmortizationOfDiscount" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c9" id="hidden-fact-89" name="us-gaap:InvestmentIncomeAmortizationOfDiscount" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c3" id="hidden-fact-90" name="us-gaap:OtherCommitmentDueInSecondYear" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c2" id="hidden-fact-91" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c3" id="hidden-fact-92" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c8" id="hidden-fact-93" name="bmr:AdvertisingAtAPointOfTimeUponClicks" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c9" id="hidden-fact-94" name="bmr:AdvertisingAtAPointOfTimeUponClicks" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonNumeric contextRef="c0" name="dei:AmendmentFlag">false</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="dei:DocumentFiscalPeriodFocus">FY</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="dei:EntityCentralIndexKey">0001899005</ix:nonNumeric>
</ix:hidden>
<ix:references><link:schemaRef xlink:href="bmr-20221231.xsd" xlink:type="simple"></link:schemaRef></ix:references>
<ix:resources><ix:relationship fromRefs="hidden-fact-19" toRefs="ix_0_footnote"></ix:relationship>
<ix:relationship fromRefs="ix_0_fact ix_1_fact" toRefs="ix_1_footnote"></ix:relationship>
<ix:relationship fromRefs="ix_2_fact ix_3_fact" toRefs="ix_2_footnote"></ix:relationship>
<ix:relationship fromRefs="ix_4_fact ix_5_fact ix_6_fact ix_7_fact" toRefs="ix_3_footnote"></ix:relationship>
<ix:relationship fromRefs="ix_8_fact ix_9_fact ix_10_fact ix_11_fact ix_12_fact ix_13_fact ix_14_fact ix_15_fact ix_16_fact ix_17_fact ix_18_fact ix_19_fact ix_20_fact ix_21_fact ix_22_fact ix_23_fact ix_24_fact ix_25_fact ix_26_fact ix_27_fact" toRefs="ix_4_footnote"></ix:relationship>
<ix:relationship fromRefs="ix_28_fact ix_29_fact ix_30_fact" toRefs="ix_5_footnote"></ix:relationship>
<xbrli:context id="c0">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c1">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="dei:EntityAddressesAddressTypeAxis">dei:BusinessContactMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c2">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c3">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c4">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c5">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c6">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">bmr:ConvertibleOrdinary1And2SharesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c7">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">bmr:ConvertibleOrdinary1And2SharesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c8">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c9">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-01-01</xbrli:startDate>
    <xbrli:endDate>2020-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c10">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2019-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c11">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">bmr:ConvertibleOrdinary1And2SharesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2019-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c12">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">bmr:ConvertiblePreferredSharesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2019-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c13">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2019-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c14">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2019-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c15">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2019-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c16">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-01-01</xbrli:startDate>
    <xbrli:endDate>2020-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c17">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">bmr:ConvertibleOrdinary1And2SharesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-01-01</xbrli:startDate>
    <xbrli:endDate>2020-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c18">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">bmr:ConvertiblePreferredSharesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-01-01</xbrli:startDate>
    <xbrli:endDate>2020-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c19">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-01-01</xbrli:startDate>
    <xbrli:endDate>2020-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c20">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-01-01</xbrli:startDate>
    <xbrli:endDate>2020-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c21">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c22">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">bmr:ConvertibleOrdinary1And2SharesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c23">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">bmr:ConvertiblePreferredSharesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c24">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c25">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c26">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c27">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c28">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">bmr:ConvertibleOrdinary1And2SharesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c29">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">bmr:ConvertiblePreferredSharesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c30">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c31">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c32">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">bmr:ConvertiblePreferredSharesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c33">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c34">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c35">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c36">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">bmr:ConvertibleOrdinary1And2SharesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c37">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">bmr:ConvertiblePreferredSharesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c38">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c39">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c40">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">bmr:ConvertiblePreferredSharesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c41">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c42">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c43">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c44">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-02-27</xbrli:startDate>
    <xbrli:endDate>2023-02-27</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c45">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-02-27</xbrli:startDate>
    <xbrli:endDate>2023-02-27</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c46">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-02-27</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c47">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">bmr:ConvertibleAdvanceInvestmentsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c48">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:TechnologyEquipmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c49">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c50">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c51">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">bmr:CompareAndPeripheralEquipmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c52">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">bmr:OfficeFurnitureAndEquipmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c53">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">bmr:OfficeFurnitureAndEquipmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c54">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c55">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c56">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c57">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c58">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">bmr:TechnologyMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c59">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">bmr:TechnologyMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c60">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c61">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c62">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c63">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c64">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">bmr:LoansAndSecurityAgreementMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2017-02-19</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c65">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">bmr:LoansAndSecurityAgreementMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2018-06-01</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c66">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c67">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">bmr:LoansAndSecurityAgreementMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c68">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c69">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c70">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c71">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c72">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">bmr:LoansAndSecurityAgreementMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-04-29</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c73">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">bmr:LoansAndSecurityAgreementMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-04-29</xbrli:startDate>
    <xbrli:endDate>2021-04-29</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c74">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-04-29</xbrli:startDate>
    <xbrli:endDate>2021-04-29</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c75">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-04-29</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c76">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-04-29</xbrli:startDate>
    <xbrli:endDate>2021-04-29</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c77">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">bmr:TwoZeroTwoTwoLoanAgreementMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-02-17</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c78">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-02-17</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c79">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">bmr:FloatingRateMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-02-17</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c80">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:PrimeRateMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-02-17</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c81">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c82">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-05-07</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c83">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-03-25</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c84">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-07-01</xbrli:startDate>
    <xbrli:endDate>2022-07-07</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c85">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-07-07</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c86">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">bmr:IBISpikesLtdMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c87">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c88">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c89">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">bmr:AdvanceInvestmentAgreementsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-08-25</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c90">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">bmr:AdvanceInvestmentAgreementsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2019-08-06</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c91">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">bmr:AdvanceInvestmentAgreementsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c92">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">bmr:AdvanceInvestmentAgreementsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c93">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">bmr:AdvanceInvestmentAgreementsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c94">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">bmr:AdvanceInvestmentAgreementsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c95">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
  </xbrli:entity>
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt/tSeJz73kx1cLt0ZFF2SK/vxBCY0vdSrZb6DUpe9prgZNYqdZsfXqxEEXb49NXhOeJEcoYxL52lqzrxV1ixmGk3x5z3C+boGMFyF1bCAC6SzXA8EeoS+J4OsCx1oPIoujQb0ZEh03dOL9+qx7qvcGHsJ6a9scdOGp0N/fSOils3JiDVUH+POJSLwkIXq+NgTrCVG8rYfDvkQSvrvKPWWMVcBANNTBXl2zY1PyEERRwwQ==] CSR-->
  <xbrli:period>
    <xbrli:startDate>2020-08-24</xbrli:startDate>
    <xbrli:endDate>2021-02-28</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c96">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-03-01</xbrli:startDate>
    <xbrli:endDate>2021-08-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c97">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-09-01</xbrli:startDate>
    <xbrli:endDate>2022-02-28</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c98">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-03-01</xbrli:startDate>
    <xbrli:endDate>2022-08-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c99">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-09-01</xbrli:startDate>
    <xbrli:endDate>2023-08-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c100">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-08-01</xbrli:startDate>
    <xbrli:endDate>2022-08-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c101">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-09-01</xbrli:startDate>
    <xbrli:endDate>2023-07-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c102">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c103">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bmr:SeriesOrdinarySharesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c104">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bmr:SeriesOrdinarySharesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c105">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bmr:SeriesConvertibleOrdinary1SharesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c106">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bmr:SeriesConvertibleOrdinary1SharesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c107">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bmr:SeriesConvertibleOrdinary2SharesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c108">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bmr:SeriesConvertibleOrdinary2SharesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c109">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bmr:SeriesConvertibleBPreferredSharesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c110">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bmr:SeriesConvertibleBPreferredSharesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c111">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bmr:SeriesConvertibleB1PreferredSharesBMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c112">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bmr:SeriesConvertibleB1PreferredSharesBMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c113">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bmr:SeriesConvertibleCPreferredSharesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c114">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bmr:SeriesConvertibleCPreferredSharesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c115">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">bmr:ExercisePrice0000Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c116">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">bmr:ShareOptionsOutstandingMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">bmr:ExercisePrice0000Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c117">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">bmr:ShareOptionsOutstandingMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">bmr:ExercisePrice0000Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c118">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">bmr:ShareOptionsExercisableMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">bmr:ExercisePrice0000Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c119">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">bmr:ShareOptionsExercisableMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">bmr:ExercisePrice0000Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c120">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">bmr:ExercisePrice0227Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c121">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">bmr:ShareOptionsOutstandingMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">bmr:ExercisePrice0227Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c122">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">bmr:ShareOptionsOutstandingMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">bmr:ExercisePrice0227Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c123">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">bmr:ShareOptionsExercisableMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">bmr:ExercisePrice0227Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c124">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">bmr:ShareOptionsExercisableMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">bmr:ExercisePrice0227Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c125">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">bmr:ExercisePrice0333Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c126">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">bmr:ShareOptionsOutstandingMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">bmr:ExercisePrice0333Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c127">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">bmr:ShareOptionsOutstandingMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">bmr:ExercisePrice0333Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c128">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">bmr:ShareOptionsExercisableMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">bmr:ExercisePrice0333Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c129">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">bmr:ShareOptionsExercisableMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">bmr:ExercisePrice0333Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c130">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">bmr:ExercisePrice0365Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c131">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">bmr:ShareOptionsOutstandingMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">bmr:ExercisePrice0365Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c132">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">bmr:ShareOptionsOutstandingMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">bmr:ExercisePrice0365Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c133">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">bmr:ShareOptionsExercisableMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">bmr:ExercisePrice0365Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c134">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">bmr:ShareOptionsExercisableMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">bmr:ExercisePrice0365Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c135">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">bmr:ExercisePrice0640Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c136">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">bmr:ShareOptionsOutstandingMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">bmr:ExercisePrice0640Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c137">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">bmr:ShareOptionsOutstandingMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">bmr:ExercisePrice0640Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c138">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">bmr:ShareOptionsExercisableMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">bmr:ExercisePrice0640Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c139">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">bmr:ShareOptionsExercisableMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">bmr:ExercisePrice0640Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c140">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">bmr:ExercisePrice0757Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c141">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">bmr:ShareOptionsOutstandingMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">bmr:ExercisePrice0757Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c142">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">bmr:ShareOptionsOutstandingMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">bmr:ExercisePrice0757Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c143">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">bmr:ShareOptionsExercisableMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">bmr:ExercisePrice0757Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c144">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">bmr:ShareOptionsExercisableMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">bmr:ExercisePrice0757Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c145">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">bmr:ExercisePrice0833Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c146">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">bmr:ShareOptionsOutstandingMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">bmr:ExercisePrice0833Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c147">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">bmr:ShareOptionsOutstandingMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">bmr:ExercisePrice0833Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c148">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">bmr:ShareOptionsExercisableMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">bmr:ExercisePrice0833Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c149">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">bmr:ShareOptionsExercisableMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">bmr:ExercisePrice0833Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c150">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">bmr:ExercisePrice1024Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c151">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">bmr:ShareOptionsOutstandingMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">bmr:ExercisePrice1024Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c152">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">bmr:ShareOptionsOutstandingMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">bmr:ExercisePrice1024Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c153">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">bmr:ShareOptionsExercisableMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">bmr:ExercisePrice1024Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c154">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">bmr:ShareOptionsExercisableMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">bmr:ExercisePrice1024Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c155">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">bmr:ShareOptionsOutstandingMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c156">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">bmr:ShareOptionsExercisableMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c157">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-01-01</xbrli:startDate>
    <xbrli:endDate>2020-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c158">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-01-01</xbrli:startDate>
    <xbrli:endDate>2020-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c159">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c160">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c161">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c162">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-01-01</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c163">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c164">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c165">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-01-01</xbrli:startDate>
    <xbrli:endDate>2020-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c166">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c167">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c168">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-01-01</xbrli:startDate>
    <xbrli:endDate>2020-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c169">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bmr:RestOfTheWorldMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c170">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bmr:RestOfTheWorldMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c171">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bmr:RestOfTheWorldMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-01-01</xbrli:startDate>
    <xbrli:endDate>2020-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c172">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c173">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c174">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c175">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c176">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:RU</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c177">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:RU</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c178">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">bmr:PerpetualBasedSoftwareLicenseMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c179">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">bmr:PerpetualBasedSoftwareLicenseMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c180">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">bmr:PerpetualBasedSoftwareLicenseMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-01-01</xbrli:startDate>
    <xbrli:endDate>2020-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c181">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">bmr:TermbasedSoftwareLicenseMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c182">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">bmr:TermbasedSoftwareLicenseMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c183">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">bmr:TermbasedSoftwareLicenseMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-01-01</xbrli:startDate>
    <xbrli:endDate>2020-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c184">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="bmr:LoanAgreementsAxis">bmr:TwoThousandTwentyTwoLoanAgreementMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-02-27</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c185">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-02-27</xbrli:startDate>
    <xbrli:endDate>2023-02-27</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c186">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-02-27</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c187">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-02-27</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c188">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-02-27</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c189">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-02-27</xbrli:startDate>
    <xbrli:endDate>2023-02-27</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c190">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-03-14</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c191">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001899005</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-03-14</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:unit id="shares">
  <xbrli:measure>xbrli:shares</xbrli:measure>
</xbrli:unit><xbrli:unit id="usd">
  <xbrli:measure>iso4217:USD</xbrli:measure>
</xbrli:unit><xbrli:unit id="ilsPershares">
  <xbrli:divide>
    <xbrli:unitNumerator>
      <xbrli:measure>iso4217:ILS</xbrli:measure>
    </xbrli:unitNumerator>
    <xbrli:unitDenominator>
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unitDenominator>
  </xbrli:divide>
</xbrli:unit><xbrli:unit id="usdPershares">
  <xbrli:divide>
    <xbrli:unitNumerator>
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unitNumerator>
    <xbrli:unitDenominator>
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unitDenominator>
  </xbrli:divide>
</xbrli:unit><xbrli:unit id="ils">
  <xbrli:measure>iso4217:ILS</xbrli:measure>
</xbrli:unit><xbrli:unit id="pure">
  <xbrli:measure>xbrli:pure</xbrli:measure>
</xbrli:unit><xbrli:unit id="Segment">
  <xbrli:measure>bmr:Segment</xbrli:measure>
</xbrli:unit></ix:resources></ix:header>

</div></div></body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-2.1
<SEQUENCE>2
<FILENAME>f20f2022ex2-1_beamrimaging.htm
<DESCRIPTION>DESCRIPTION OF SECURITIES REGISTERED UNDER SECTION 12
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 2.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>DESCRIPTION OF SECURITIES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>REGISTERED UNDER SECTION 12 OF THE EXCHANGE
ACT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>General</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 10pt; text-align: justify; text-indent: -10pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our authorized share capital
consists of 222,000,000&nbsp;ordinary shares, par value NIS 0.05 per ordinary share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">All of our outstanding ordinary
shares are validly issued, fully paid and non-assessable. Our ordinary shares are not redeemable and do not have any preemptive rights.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">All ordinary shares have identical
voting and other rights in all respects.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white"><B>The Powers
of the Directors</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="background-color: white">Our
Board of Directors shall direct our policy and shall supervise the performance of our Chief Executive Officer and his actions. Our Board
of Directors may exercise all powers that are not required under the Companies Law or under our amended and restated articles of association
to be exercised or taken by&nbsp;our shareholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white"><B>Rights
Attached to Shares</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="background-color: white">Our
ordinary shares shall confer upon the holders thereof:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">equal right to attend and to
vote at all of our general meetings, whether regular or special, with each ordinary share entitling the holder thereof, which attend
the meeting and participate at the voting, either in person or by a proxy or by a written ballot, to one vote;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">equal right to participate in
distribution of dividends, if any, whether payable in cash or in bonus shares, in distribution of assets or in any other distribution,
on a per share pro rata basis; and</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">equal right to participate,
upon our dissolution, in the distribution of our assets legally available for distribution, on a per share pro rata basis.</FONT></TD>
</TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white"><B>Election
of Directors</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Pursuant
to our amended and restated articles of association, our directors will be elected at an annual general meeting and/or a special meeting
of our shareholders and serve on the board of directors until the next annual general meeting (except for external directors) or until
they resign or until they cease to act as board members pursuant to the provisions of our amended and restated articles of association
or any applicable law, upon the earlier. Pursuant to our amended and restated articles of association, other than the external directors,
for whom special election requirements apply under the Companies Law, the vote that will be required to appoint a director is a simple
majority vote of holders of our voting shares, participating and voting at the relevant meeting. In addition, as detailed hereinabove
(See &ndash; &ldquo;Board Practices&rdquo;), our Board of Directors is allowed to appoint directors to fill vacancies and/or as an addition
to the Board of Directors (subject to the maximum number of directors) to serve according to the duration of office of the director whom
he replaces<FONT STYLE="background-color: white">. External directors will be elected for an initial term of three years, may be elected
for two additional terms of three years each under certain circumstances, and may be removed from office pursuant to the terms of the
Companies Law. See &ldquo;Management&mdash;Board Practices&mdash;External Directors.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white"><B>Annual
and Special Meetings</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="background-color: white">Under
the Israeli law, we are required to hold an annual general meeting of our shareholders once every calendar year, at such time and place
which shall be determined by our Board of Directors, that must be no later than 15 months after the date of the previous annual general
meeting. All meetings other than the annual general meeting of shareholders are referred to as special general meetings. Our Board of
Directors may call special meetings whenever it sees fit, upon request of two directors or one-quarter of the directors in office; and
upon the request of&nbsp;</FONT>any shareholder or shareholders holding at least five percent (5%) or a higher percent of our voting rights<FONT STYLE="background-color: white">.&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="background-color: white">Subject
to the provisions of the Companies Law and the regulations promulgated thereunder, shareholders entitled to participate and vote at general
meetings are the shareholders of record on a date to be decided by the board of directors, which may be between four and twenty one days
prior to the date of the meeting. Resolutions regarding the following matters must be passed at a general meeting of our shareholders:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">amendments to our amended and
restated articles of association;</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">the exercise of our Board of
Director&rsquo;s powers by a general meeting if our Board of Directors is unable to exercise its powers and the exercise of any of its
powers is required for our proper management;</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">appointment or termination of
our auditor, his conditions of employment and termination of his employment;</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">appointment of directors, including
external directors;</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">approval of acts and transactions
requiring general meeting approval pursuant to the provisions of the Companies Law (mainly certain related party transactions) and any
other applicable law;</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">increases or reductions of our
authorized share capital; and</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">a merger (as such term is defined
in the Companies Law).</FONT></TD>
</TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white"><B>Notices</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="background-color: white">Our
amended and restated articles of association</FONT> and&nbsp;<FONT STYLE="background-color: white">the Companies Law require that a notice
of any annual or special shareholders meeting be provided at least 14 days prior to the meeting, and if the agenda of the meeting includes
(1) the appointment or removal of directors; (2) the approval of acts and / or transactions with office holders or interested or related
parties, approval of the company&rsquo;s general manager or its relative to serve as the chairman of the board of directors and to exercise
its powers or the approval of the chairman of the board of directors or its relative to serve as the company&rsquo;s general manager;
(3) an approval of a merger; or; (4) any other matter in respect of which there is a provision in the articles of association or thereunder
to the effect that decisions of the general meeting may also be passed by means of a voting paper, notice must be provided at least 35
days prior to the meeting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white"><B>Quorum</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="background-color: white">As
permitted under the Companies Law, the quorum required for our general meetings will consist of at least two shareholders present in person,
by proxy, written ballot or voting by means of electronic voting system, who hold or represent between them at least 25% of the total
outstanding voting rights. If within half an hour of the time set forth for the general meeting a quorum is not present, the general meeting
shall stand adjourned the same day of the following week, at the same hour and in the same place, or to such other date, time and place
as prescribed in the notice to the shareholders and in such adjourned meeting, if no quorum is present at the adjourned meeting within
half an hour of the time arranged, any number of shareholders participating in the meeting, shall constitute a quorum.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="background-color: white">If
a special general meeting was summoned following the request of a shareholder, the adjourned meeting shall only take place only if there
were present at least the number of shareholders required to convene a meeting as provided in section 63 of the Companies Law.&nbsp;</FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I></I></B></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white"><B>Adoption
of Resolutions</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="background-color: white">Our
amended and restated articles of association provide that all resolutions of our shareholders will require a simple majority vote, unless
otherwise required under the Companies Law or our amended and restated articles of association. A shareholder may vote in a general meeting
in person, by proxy, by a written ballot.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white"><B>Changing
Rights Attached to Shares</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="background-color: white">Unless
otherwise provided by the terms of the shares and subject to any applicable law, any modification of rights attached to any class of shares
must be adopted by the holders of a majority of the shares of that class present a general meeting of the affected class or by a written
consent of all the shareholders of the affected class.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="background-color: white">The
enlargement of an existing class of shares or the issuance of additional shares thereof, shall not be deemed to modify the rights attached
to the previously issued shares of such class or of any other class, unless otherwise provided by the terms of the shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white"><B>Limitations
on the Right to Own Securities in Our Company</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="background-color: white">There
are no limitations on the right to own our securities. &nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white"><B>Provisions
Restricting Change in Control of Our Company</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="background-color: white">There
are no specific provisions of our amended and restated articles of association that would have an effect of delaying, deferring or preventing
a change in control of our company or that would operate only with respect to a merger, acquisition or corporate restructuring involving
us (or our Subsidiary). However, as described below, certain provisions of the Companies Law may have such effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="background-color: white">The
Companies Law includes provisions that allow a merger transaction and requires that each company that is a party to the merger have the
transaction approved by its board of directors and, unless certain requirements described under the Companies Law are met, a vote of the
majority of shareholders, and, in the case of the target company, also a majority vote of each class of its shares.&nbsp;&nbsp;For purposes
of the shareholder vote of each party (unless a court rules otherwise&nbsp;</FONT>on the application of the shareholders holding at least
twenty five percent of all the voting rights in the company)<FONT STYLE="background-color: white">, the merger will not be deemed approved
if shares representing a majority of the voting power present at the shareholders meeting and which are not held by the other party to
the merger&nbsp;</FONT>the person so holding or anyone acting on behalf of either of these, including relatives or corporations under
their control&nbsp;<FONT STYLE="background-color: white">or by any person or group of persons acting in concert who holds 25% or more
of the voting power or the right to appoint 25% or more of the directors of the other party vote against the merger.&nbsp;If, however,
the merger involves a merger with a company&rsquo;s own controlling shareholder or if the controlling shareholder has a personal interest
in the merger, then the merger is instead subject to the same Special Majority approval that governs all extraordinary transactions with
controlling shareholders.&nbsp;Upon the request of a creditor of either party to the proposed merger, the court may delay or prevent the
merger if it concludes that there exists a reasonable concern that as a result of the merger the surviving company will be unable to satisfy
the obligations of any of the parties to the merger, and may further give instructions to secure the rights of creditors.&nbsp;If the
transaction would have been approved by the shareholders of a merging company but for the separate approval of each class or the exclusion
of the votes of certain shareholders as provided above, a court may still approve the merger upon the petition of holders of at least
25% of the voting rights of a company. For such petition to be granted, the court must find that the merger is fair and reasonable, taking
into account the value of the parties to the merger and the consideration offered to the shareholders.&nbsp;In addition, a merger may
not be completed unless&nbsp;</FONT>the Registrar of Companies has received all the required approvals for merger from each of the merging
companies and&nbsp;<FONT STYLE="background-color: white">at least (1) 50 days have passed from the time that the requisite proposals for
approval of the merger were filed with the Israeli Registrar of Companies by each merging company and (2) 30 days have passed since the
merger was approved by the shareholders of each merging company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="background-color: white">The
Companies Law also provides that, subject to certain exceptions, an acquisition of shares in an Israeli public company must be made by
means of a &ldquo;special&rdquo; tender offer if as a result of the acquisition (1) the purchaser would become a controlling shareholder
if there is no controlling shareholder in the company or (2) the purchaser would become a holder of 45% or more of the voting rights in
the company, unless there is already a holder of more than 45% of the voting rights in the company. These requirements do not apply if,
in general, the acquisition (1) was made in a private placement that received shareholders&rsquo; approval, subject to certain conditions,
(2) was from a controlling shareholder in the company which resulted in the acquirer becoming a controlling shareholder in the company,
or (3) was from a holder of more than 45% of the voting rights in the company which resulted in the acquirer becoming a holder of more
than 45% of the voting rights in the company. A &ldquo;special&rdquo; tender offer must be extended to all shareholders. In general, a
&ldquo;special&rdquo; tender offer may be consummated only if (1) at least 5% of the voting power attached to the company&rsquo;s outstanding
shares will be acquired by the offeror and (2) the offer is accepted by a majority of the offerees who notified the company of their position
in connection with such offer (excluding the offeror, controlling shareholders, holders of a control block, any person having a personal
interest in the acceptance of the tender offer or anyone on the behalf of the abovementioned, including their relatives or corporations
under their control. If a special tender offer is accepted, then the purchaser or any person or entity controlling it or any entity under
common control with the purchaser or such controlling person may not make a subsequent tender offer for the purchase of shares of the
target company and may not enter into a merger with the target company for a period of one year from the date of the offer, unless the
purchaser or such person or entity undertook to effect such an offer or merger in the initial special tender offer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="background-color: white">If,
as a result of an acquisition of shares, the acquirer will hold more than 90% of an Israeli company&rsquo;s outstanding shares or of certain
class of shares, the acquisition must be made by means of a tender offer for all of the outstanding shares, or for all of the outstanding
shares of such class, as applicable, or the Takeover Bid. In general, if less than 5% of the outstanding shares, or of applicable class,
are not tendered in the Takeover Bid and more than half of the offerees who have no personal interest in the offer tendered their shares,
all the shares that the acquirer offered to purchase will be transferred to him by operation of law, and the records of ownership of the
shares shall be amended accordingly. However, a Takeover Bid will also be accepted if the shareholders who do not accept the offer hold
less than 2% of the issued and outstanding share capital of the company or of the applicable class of shares. Any shareholders that was
an offeree in such Takeover Bid, whether such shareholder accepted the Takeover Bid or not, may request, by petition to an Israeli court,
for a period of six months following the acceptance of the Takeover Bid, (i) a ruling stating that the consideration for the shares was
less than their fair value, and (ii) that the fair value should be paid as determined by the court. However, the acquirer is entitled
to stipulate, under certain conditions, that tendering shareholders will forfeit such appraisal rights.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="background-color: white">Lastly,
Israeli tax ordinance treats some acquisitions, such as stock-for-stock exchanges between Israeli companies, less favorably than U.S.
tax laws. For example, Israeli tax ordinance may, under certain circumstances, subject a shareholder who exchanges his ordinary shares
for shares in another corporation to taxation prior to the sale of the shares received in such stock-for-stock swap.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-12.1
<SEQUENCE>3
<FILENAME>f20f2022ex12-1_beamrimaging.htm
<DESCRIPTION>CERTIFICATION
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 12.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CERTIFICATION PURSUANT TO EXCHANGE ACT RULE
13a-14(a) or 15d-14(a)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I, Sharon Carmel, certify that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
have reviewed this annual report on Form 20&ndash;F of Beamr Imaging Ltd.;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make
the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered
by this report;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects
the financial condition, results of operations and cash flows of the company as of, and for, the periods presented in this report;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
company&rsquo;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as
defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) [language omitted in accordance with Exchange Act Rule 13a-14(a)] for the company
and have:</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Designed
such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure
that material information relating to the company, including its consolidated subsidiaries, is made known to us by others within those
entities, particularly during the period in which this report is being prepared;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[paragraph
omitted in accordance with Exchange Act Rule 13a-14(a)];</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Evaluated
the effectiveness of the company&rsquo;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness
of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Disclosed
in this report any change in the company&rsquo;s internal control over financial reporting that occurred during the period covered by
the annual report that has materially affected, or is reasonably likely to materially affect, the company&rsquo;s internal control over
financial reporting.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
company&rsquo;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial
reporting, to the company&rsquo;s auditors and the audit committee of the company&rsquo;s board of directors:</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably
likely to adversely affect the company&rsquo;s ability to record, process, summarize and report financial information; and</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
fraud, whether or not material, that involves management or other employees who have a significant role in the company&rsquo;s internal
control over financial reporting.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%; padding-top: 1.3pt; padding-right: 1.3pt; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date: April 24, 2023</FONT></TD>
    <TD STYLE="width: 40%; border-bottom: black 1.5pt solid; padding-top: 1.3pt; padding-right: 1.3pt; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Sharon Carmel</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 1.3pt; padding-right: 1.3pt; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="padding-top: 1.3pt; padding-right: 1.3pt; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sharon Carmel</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 1.3pt; padding-right: 1.3pt; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="padding-top: 1.3pt; padding-right: 1.3pt; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-12.2
<SEQUENCE>4
<FILENAME>f20f2022ex12-2_beamrimaging.htm
<DESCRIPTION>CERTIFICATION
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 12.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CERTIFICATION PURSUANT TO EXCHANGE ACT RULE
13a-14(a) or 15d-14(a)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I, Danny Sandler, certify that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
have reviewed this annual report on Form 20&ndash;F of Beamr Imaging Ltd.;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make
the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered
by this report;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects
the financial condition, results of operations and cash flows of the company as of, and for, the periods presented in this report;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
company&rsquo;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as
defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) [language omitted in accordance with Exchange Act Rule 13a-14(a)] for the company
and have:</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Designed
such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure
that material information relating to the Company, including its consolidated subsidiaries, is made known to us by others within those
entities, particularly during the period in which this report is being prepared;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[paragraph
omitted in accordance with Exchange Act Rule 13a-14(a)];</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Evaluated
the effectiveness of the Company&rsquo;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness
of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Disclosed
in this report any change in the Company&rsquo;s internal control over financial reporting that occurred during the period covered by
the annual report that has materially affected, or is reasonably likely to materially affect, the Company&rsquo;s internal control over
financial reporting; and</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&rsquo;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial
reporting, to the Company&rsquo;s auditors and the audit committee of the Company&rsquo;s board of directors (or persons performing the
equivalent function):</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably
likely to adversely affect the Company&rsquo;s ability to record, process, summarize and report financial information; and</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
fraud, whether or not material, that involves management or other employees who have a significant role in the Company&rsquo;s internal
control over financial reporting.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%; padding-top: 1.3pt; padding-right: 1.3pt; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date: April 24, 2023</FONT></TD>
    <TD STYLE="width: 40%; border-bottom: black 1.5pt solid; padding-top: 1.3pt; padding-right: 1.3pt; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Danny Sandler</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 1.3pt; padding-right: 1.3pt; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="padding-top: 1.3pt; padding-right: 1.3pt; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Danny Sandler</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 1.3pt; padding-right: 1.3pt; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="padding-top: 1.3pt; padding-right: 1.3pt; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Financial Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-13.1
<SEQUENCE>5
<FILENAME>f20f2022ex13-1_beamrimaging.htm
<DESCRIPTION>CERTIFICATION
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 13.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CERTIFICATION PURSUANT TO</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>18 U.S.C. Section 1350</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.25in">In connection with the filing
of the Annual Report on Form 20-F for the period ended December 31, 2022 (the &ldquo;Report&rdquo;) by Beamr Imaging Ltd. (the &ldquo;Company&rdquo;),
the undersigned, as the Chief Executive Officer of the Company, hereby certifies pursuant to 18 U.S.C. Section 1350, that, to my knowledge:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
Report fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934; and</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the
Company.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%; padding-top: 1.3pt; padding-right: 1.3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date: April 24, 2023</FONT></TD>
    <TD STYLE="width: 40%; border-bottom: black 1.5pt solid; padding-top: 1.3pt; padding-right: 1.3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Sharon Carmel</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 1.3pt; padding-right: 1.3pt">&nbsp;</TD>
    <TD STYLE="padding-top: 1.3pt; padding-right: 1.3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sharon Carmel</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 1.3pt; padding-right: 1.3pt">&nbsp;</TD>
    <TD STYLE="padding-top: 1.3pt; padding-right: 1.3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-13.2
<SEQUENCE>6
<FILENAME>f20f2022ex13-2_beamrimaging.htm
<DESCRIPTION>CERTIFICATION
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 13.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CERTIFICATION PURSUANT TO</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>18 U.S.C. Section 1350</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In connection with the filing
of the Annual Report on Form 20-F for the period ended December 31, 2022 (the &ldquo;Report&rdquo;) by Beamr Imaging Ltd. (the &ldquo;Company&rdquo;),
the undersigned, as the Chief Financial Officer of the Company, hereby certifies pursuant to 18 U.S.C. Section 1350, that, to my knowledge:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
Report fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934; and</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the
Company.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%; padding-top: 1.3pt; padding-right: 1.3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date: April 24, 2023</FONT></TD>
    <TD STYLE="width: 40%; border-bottom: black 1.5pt solid; padding-top: 1.3pt; padding-right: 1.3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Danny Sandler</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 1.3pt; padding-right: 1.3pt">&nbsp;</TD>
    <TD STYLE="padding-top: 1.3pt; padding-right: 1.3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Danny Sandler</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 1.3pt; padding-right: 1.3pt">&nbsp;</TD>
    <TD STYLE="padding-top: 1.3pt; padding-right: 1.3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Financial Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>7
<FILENAME>bmr-20221231.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Mon Apr 24 19:58:56 UTC 2023 -->
<xs:schema elementFormDefault="qualified" xmlns:bmr="http://www.beil.com/20221231" xmlns:srt-types="http://fasb.org/srt-types/2022" targetNamespace="http://www.beil.com/20221231" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:us-types="http://fasb.org/us-types/2022" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:dtr="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xlink:type="simple" xlink:href="bmr-20221231_lab.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="bmr-20221231_pre.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="bmr-20221231_def.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="bmr-20221231_cal.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef"/>
      <link:roleType roleURI="http://www.beil.com/role/ConsolidatedBalanceSheet" id="bmr_r_ConsolidatedBalanceSheet">
        <link:definition>001 - Statement - Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.beil.com/role/ConsolidatedBalanceSheet_Parentheticals" id="bmr_r_ConsolidatedBalanceSheet_Parentheticals">
        <link:definition>002 - Statement - Consolidated Balance Sheets (Parentheticals)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.beil.com/role/ConsolidatedIncomeStatement" id="bmr_r_ConsolidatedIncomeStatement">
        <link:definition>003 - Statement - Consolidated Statements of Operations and Comprehensive Loss</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.beil.com/role/ConsolidatedIncomeStatement_Parentheticals" id="bmr_r_ConsolidatedIncomeStatement_Parentheticals">
        <link:definition>004 - Statement - Consolidated Statements of Operations and Comprehensive Loss (Parentheticals)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.beil.com/role/ShareholdersEquityType2or3" id="bmr_r_ShareholdersEquityType2or3">
        <link:definition>005 - Statement - onsolidated Statements of Changes in Shareholders&#8217; Equity (Deficit)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.beil.com/role/ConsolidatedCashFlow" id="bmr_r_ConsolidatedCashFlow">
        <link:definition>006 - Statement - Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.beil.com/role/General" id="bmr_r_General">
        <link:definition>007 - Disclosure - General</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.beil.com/role/SignificantAccountingPolicies" id="bmr_r_SignificantAccountingPolicies">
        <link:definition>008 - Disclosure - Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.beil.com/role/OtherCurrentAssets" id="bmr_r_OtherCurrentAssets">
        <link:definition>009 - Disclosure - Other Current Assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.beil.com/role/PropertyandEquipmentNet" id="bmr_r_PropertyandEquipmentNet">
        <link:definition>010 - Disclosure - Property and Equipment, Net</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.beil.com/role/IntangibleAssetsNetandGoodwill" id="bmr_r_IntangibleAssetsNetandGoodwill">
        <link:definition>011 - Disclosure - Intangible Assets, Net and Goodwill</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.beil.com/role/LoansNet" id="bmr_r_LoansNet">
        <link:definition>012 - Disclosure - Loans, Net</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.beil.com/role/OtherCurrentLiabilities" id="bmr_r_OtherCurrentLiabilities">
        <link:definition>013 - Disclosure - Other Current Liabilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.beil.com/role/DerivativeWarrantsLiabilities" id="bmr_r_DerivativeWarrantsLiabilities">
        <link:definition>014 - Disclosure - Derivative Warrants Liabilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.beil.com/role/ConvertibleAdvanceInvestment" id="bmr_r_ConvertibleAdvanceInvestment">
        <link:definition>015 - Disclosure - Convertible Advance Investment</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.beil.com/role/CommitmentsandContingentLiabilities" id="bmr_r_CommitmentsandContingentLiabilities">
        <link:definition>016 - Disclosure - Commitments and Contingent Liabilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.beil.com/role/ShareholdersEquityDeficit" id="bmr_r_ShareholdersEquityDeficit">
        <link:definition>017 - Disclosure - Shareholders&#8217; Equity (Deficit)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.beil.com/role/ShareOptions" id="bmr_r_ShareOptions">
        <link:definition>018 - Disclosure - Share Options</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.beil.com/role/FinancingExpensesNet" id="bmr_r_FinancingExpensesNet">
        <link:definition>019 - Disclosure - Financing Expenses, Net</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.beil.com/role/RelatedPartiesTransactions" id="bmr_r_RelatedPartiesTransactions">
        <link:definition>020 - Disclosure - Related Parties Transactions</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.beil.com/role/TaxesonIncome" id="bmr_r_TaxesonIncome">
        <link:definition>021 - Disclosure - Taxes on Income</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.beil.com/role/SegmentGeographicalInformationAndMajorCustomers" id="bmr_r_SegmentGeographicalInformationAndMajorCustomers">
        <link:definition>022 - Disclosure - Segment Geographical Information And Major Customers</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.beil.com/role/SubsequentEvents" id="bmr_r_SubsequentEvents">
        <link:definition>023 - Disclosure - Subsequent Events</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.beil.com/role/AccountingPoliciesByPolicy" id="bmr_r_AccountingPoliciesByPolicy">
        <link:definition>024 - Disclosure - Accounting Policies, by Policy (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.beil.com/role/SignificantAccountingPoliciesTables" id="bmr_r_SignificantAccountingPoliciesTables">
        <link:definition>025 - Disclosure - Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.beil.com/role/OtherCurrentAssetsTables" id="bmr_r_OtherCurrentAssetsTables">
        <link:definition>026 - Disclosure - Other Current Assets (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.beil.com/role/PropertyandEquipmentNetTables" id="bmr_r_PropertyandEquipmentNetTables">
        <link:definition>027 - Disclosure - Property and Equipment, Net (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.beil.com/role/IntangibleAssetsNetandGoodwillTables" id="bmr_r_IntangibleAssetsNetandGoodwillTables">
        <link:definition>028 - Disclosure - Intangible Assets, Net and Goodwill (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.beil.com/role/LoansNetTables" id="bmr_r_LoansNetTables">
        <link:definition>029 - Disclosure - Loans, Net (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.beil.com/role/OtherCurrentLiabilitiesTables" id="bmr_r_OtherCurrentLiabilitiesTables">
        <link:definition>030 - Disclosure - Other Current Liabilities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.beil.com/role/DerivativeWarrantsLiabilitiesTables" id="bmr_r_DerivativeWarrantsLiabilitiesTables">
        <link:definition>031 - Disclosure - Derivative Warrants Liabilities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.beil.com/role/ConvertibleAdvanceInvestmentTables" id="bmr_r_ConvertibleAdvanceInvestmentTables">
        <link:definition>032 - Disclosure - Convertible Advance Investment (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.beil.com/role/CommitmentsandContingentLiabilitiesTables" id="bmr_r_CommitmentsandContingentLiabilitiesTables">
        <link:definition>033 - Disclosure - Commitments and Contingent Liabilities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.beil.com/role/ShareholdersEquityDeficitTables" id="bmr_r_ShareholdersEquityDeficitTables">
        <link:definition>034 - Disclosure - Shareholders&#8217; Equity (Deficit) (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.beil.com/role/ShareOptionsTables" id="bmr_r_ShareOptionsTables">
        <link:definition>035 - Disclosure - Share Options (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.beil.com/role/FinancingExpensesNetTables" id="bmr_r_FinancingExpensesNetTables">
        <link:definition>036 - Disclosure - Financing Expenses, Net (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.beil.com/role/RelatedPartiesTransactionsTables" id="bmr_r_RelatedPartiesTransactionsTables">
        <link:definition>037 - Disclosure - Related Parties Transactions (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.beil.com/role/TaxesonIncomeTables" id="bmr_r_TaxesonIncomeTables">
        <link:definition>038 - Disclosure - Taxes on Income (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.beil.com/role/SegmentGeographicalInformationAndMajorCustomersTables" id="bmr_r_SegmentGeographicalInformationAndMajorCustomersTables">
        <link:definition>039 - Disclosure - Segment Geographical Information And Major Customers (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.beil.com/role/GeneralDetails" id="bmr_r_GeneralDetails">
        <link:definition>040 - Disclosure - General (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.beil.com/role/SignificantAccountingPoliciesDetails" id="bmr_r_SignificantAccountingPoliciesDetails">
        <link:definition>041 - Disclosure - Significant Accounting Policies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.beil.com/role/ScheduleofcomputingstraightlineamortizationTable" id="bmr_r_ScheduleofcomputingstraightlineamortizationTable">
        <link:definition>042 - Disclosure - Significant Accounting Policies (Details) - Schedule of computing straight-line amortization</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.beil.com/role/ScheduleofcomputingstraightlinedepreciationTable" id="bmr_r_ScheduleofcomputingstraightlinedepreciationTable">
        <link:definition>043 - Disclosure - Significant Accounting Policies (Details) - Schedule of computing straight-line depreciation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.beil.com/role/ScheduleofothercurrentassetsTable" id="bmr_r_ScheduleofothercurrentassetsTable">
        <link:definition>044 - Disclosure - Other Current Assets (Details) - Schedule of other current assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.beil.com/role/PropertyandEquipmentNetDetails" id="bmr_r_PropertyandEquipmentNetDetails">
        <link:definition>045 - Disclosure - Property and Equipment, Net (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.beil.com/role/ScheduleofpropertyandequipmentnetTable" id="bmr_r_ScheduleofpropertyandequipmentnetTable">
        <link:definition>046 - Disclosure - Property and Equipment, Net (Details) - Schedule of property and equipment net</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.beil.com/role/IntangibleAssetsNetandGoodwillDetails" id="bmr_r_IntangibleAssetsNetandGoodwillDetails">
        <link:definition>047 - Disclosure - Intangible Assets, Net and Goodwill (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.beil.com/role/ScheduleofintangibleassetsnetandgoodwilTable" id="bmr_r_ScheduleofintangibleassetsnetandgoodwilTable">
        <link:definition>048 - Disclosure - Intangible Assets, Net and Goodwill (Details) - Schedule of intangible assets, net and goodwil</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.beil.com/role/ScheduleoftheestimatedfutureamortizationexpenseofintangibleassetsTable" id="bmr_r_ScheduleoftheestimatedfutureamortizationexpenseofintangibleassetsTable">
        <link:definition>049 - Disclosure - Intangible Assets, Net and Goodwill (Details) - Schedule of the estimated future amortization expense of intangible assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.beil.com/role/LoansNetDetails" id="bmr_r_LoansNetDetails">
        <link:definition>050 - Disclosure - Loans, Net (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.beil.com/role/ScheduleoftheEffectiveDatemanagementbyassistanceofthirdpartyTable" id="bmr_r_ScheduleoftheEffectiveDatemanagementbyassistanceofthirdpartyTable">
        <link:definition>051 - Disclosure - Loans, Net (Details) - Schedule of the Effective Date, management by assistance of third-party</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.beil.com/role/ScheduleofthereconciliationofthecarryingamountTable" id="bmr_r_ScheduleofthereconciliationofthecarryingamountTable">
        <link:definition>052 - Disclosure - Loans, Net (Details) - Schedule of the reconciliation of the carrying amount</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.beil.com/role/ScheduleofmaturitydatesofoutstandingloansTable" id="bmr_r_ScheduleofmaturitydatesofoutstandingloansTable">
        <link:definition>053 - Disclosure - Loans, Net (Details) - Schedule of maturity dates of outstanding loans</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.beil.com/role/OtherCurrentLiabilitiesDetails" id="bmr_r_OtherCurrentLiabilitiesDetails">
        <link:definition>054 - Disclosure - Other Current Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.beil.com/role/ScheduleofothercurrentliabiltiesTable" id="bmr_r_ScheduleofothercurrentliabiltiesTable">
        <link:definition>055 - Disclosure - Other Current Liabilities (Details) - Schedule of other current liabilties</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.beil.com/role/ScheduleofreconciliationofthefairvalueofderivativewarrantsliabilitiesTable" id="bmr_r_ScheduleofreconciliationofthefairvalueofderivativewarrantsliabilitiesTable">
        <link:definition>056 - Disclosure - Derivative Warrants Liabilities (Details) - Schedule of reconciliation of the fair value of derivative warrants liabilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt/tSeJz73kx1cLt0ZFF2SK/vxBCY0vdSrZb6DUpe9prgZNYqdZsfXqxEEXb49NXhOeJEcoYxL52lqzrxV1ixmGk3x5z3C+boGMFyF1bCAC6SzXA8EeoS+J4OsCx1oPIoujQb0ZEh03dOL9+qx7qvcGHsJ6a9scdOGp0N/fSOils3JiDVUH+POJSLwkIXq+NgTrCVG8rYfDvkQSvrvKPWWMVp35N/5C4wzZOJuox/WmcMw==] CSR-->
      <link:roleType roleURI="http://www.beil.com/role/ConvertibleAdvanceInvestmentDetails" id="bmr_r_ConvertibleAdvanceInvestmentDetails">
        <link:definition>057 - Disclosure - Convertible Advance Investment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.beil.com/role/ScheduleofreconciliationofthecarryingamountoftheconvertibleadvanceinvestmentTable" id="bmr_r_ScheduleofreconciliationofthecarryingamountoftheconvertibleadvanceinvestmentTable">
        <link:definition>058 - Disclosure - Convertible Advance Investment (Details) - Schedule of reconciliation of the carrying amount of the convertible advance investment</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.beil.com/role/CommitmentsandContingentLiabilitiesDetails" id="bmr_r_CommitmentsandContingentLiabilitiesDetails">
        <link:definition>059 - Disclosure - Commitments and Contingent Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.beil.com/role/ScheduleoffutureminimumcommitmentunderbindingleaseagreeementsTable" id="bmr_r_ScheduleoffutureminimumcommitmentunderbindingleaseagreeementsTable">
        <link:definition>060 - Disclosure - Commitments and Contingent Liabilities (Details) - Schedule of future minimum commitment under binding lease agreeements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.beil.com/role/ShareholdersEquityDeficitDetails" id="bmr_r_ShareholdersEquityDeficitDetails">
        <link:definition>061 - Disclosure - Shareholders&#8217; Equity (Deficit) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.beil.com/role/ScheduleofcompositionofshareholdersequityTable" id="bmr_r_ScheduleofcompositionofshareholdersequityTable">
        <link:definition>062 - Disclosure - Shareholders&#8217; Equity (Deficit) (Details) - Schedule of composition of shareholders' equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.beil.com/role/ShareOptionsDetails" id="bmr_r_ShareOptionsDetails">
        <link:definition>063 - Disclosure - Share Options (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.beil.com/role/ScheduleofcompanysshareoptionactivityforemployeesandmembersoftheboardofdirectorsTable" id="bmr_r_ScheduleofcompanysshareoptionactivityforemployeesandmembersoftheboardofdirectorsTable">
        <link:definition>064 - Disclosure - Share Options (Details) - Schedule of company&#8217;s share option activity for employees and members of the board of directors</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.beil.com/role/ScheduleofoutstandingandexercisableshareoptionsseparatedrangesofexercisepricesTable" id="bmr_r_ScheduleofoutstandingandexercisableshareoptionsseparatedrangesofexercisepricesTable">
        <link:definition>065 - Disclosure - Share Options (Details) - Schedule of outstanding and exercisable share options separated ranges of exercise prices</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.beil.com/role/ScheduleofassumptionsusedtoestimatethefairvaluesoftheshareoptionsgrantedTable" id="bmr_r_ScheduleofassumptionsusedtoestimatethefairvaluesoftheshareoptionsgrantedTable">
        <link:definition>066 - Disclosure - Share Options (Details) - Schedule of assumptions used to estimate the fair values of the share options granted</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.beil.com/role/ScheduleofcompanysequitybasedawardsrecognizedTable" id="bmr_r_ScheduleofcompanysequitybasedawardsrecognizedTable">
        <link:definition>067 - Disclosure - Share Options (Details) - Schedule of company&#8217;s equity-based awards recognized</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.beil.com/role/ScheduleoffinancingexpensesTable" id="bmr_r_ScheduleoffinancingexpensesTable">
        <link:definition>068 - Disclosure - Financing Expenses, Net (Details) - Schedule of financing expenses</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.beil.com/role/RelatedPartiesTransactionsDetails" id="bmr_r_RelatedPartiesTransactionsDetails">
        <link:definition>069 - Disclosure - Related Parties Transactions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.beil.com/role/ScheduleofthereconciliationofthecarryingamountoftheCompanyTable" id="bmr_r_ScheduleofthereconciliationofthecarryingamountoftheCompanyTable">
        <link:definition>070 - Disclosure - Related Parties Transactions (Details) - Schedule of the reconciliation of the carrying amount of the Company</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.beil.com/role/ScheduleofmaturitydatesTable" id="bmr_r_ScheduleofmaturitydatesTable">
        <link:definition>071 - Disclosure - Related Parties Transactions (Details) - Schedule of maturity dates</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.beil.com/role/ScheduleofexpensesrelatedtoserviceagreementandtheofficeservicesagreementTable" id="bmr_r_ScheduleofexpensesrelatedtoserviceagreementandtheofficeservicesagreementTable">
        <link:definition>072 - Disclosure - Related Parties Transactions (Details) - Schedule of expenses related to service agreement and the office services agreement</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.beil.com/role/TaxesonIncomeDetails" id="bmr_r_TaxesonIncomeDetails">
        <link:definition>073 - Disclosure - Taxes on Income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.beil.com/role/ScheduleoflossincomebeforetaxesonincomeTable" id="bmr_r_ScheduleoflossincomebeforetaxesonincomeTable">
        <link:definition>074 - Disclosure - Taxes on Income (Details) - Schedule of loss (income) before taxes on income</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.beil.com/role/ScheduleofdeferredincometaxesreflectthenettaxeffectsofnetoperatinglossTable" id="bmr_r_ScheduleofdeferredincometaxesreflectthenettaxeffectsofnetoperatinglossTable">
        <link:definition>075 - Disclosure - Taxes on Income (Details) - Schedule of deferred income taxes reflect the net tax effects of net operating loss</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.beil.com/role/SegmentGeographicalInformationAndMajorCustomersDetails" id="bmr_r_SegmentGeographicalInformationAndMajorCustomersDetails">
        <link:definition>076 - Disclosure - Segment Geographical Information And Major Customers (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.beil.com/role/ScheduleofrevenuesbygeographicregionTable" id="bmr_r_ScheduleofrevenuesbygeographicregionTable">
        <link:definition>077 - Disclosure - Segment Geographical Information And Major Customers (Details) - Schedule of revenues by geographic region</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.beil.com/role/ScheduleofLonglivedassetsnetbygeographicareasTable" id="bmr_r_ScheduleofLonglivedassetsnetbygeographicareasTable">
        <link:definition>078 - Disclosure - Segment Geographical Information And Major Customers (Details) - Schedule of Long-lived assets net by geographic areas</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.beil.com/role/ScheduleofrevenuedisaggregatedbyprimarymajorproductlinesandservicesTable" id="bmr_r_ScheduleofrevenuedisaggregatedbyprimarymajorproductlinesandservicesTable">
        <link:definition>079 - Disclosure - Segment Geographical Information And Major Customers (Details) - Schedule of revenue disaggregated by primary major product lines and services</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.beil.com/role/SubsequentEventsDetails" id="bmr_r_SubsequentEventsDetails">
        <link:definition>080 - Disclosure - Subsequent Events (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.beil.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
        <link:definition>000 - Document - Document And Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-types/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://fasb.org/srt-types/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/sic/2022" schemaLocation="https://xbrl.sec.gov/sic/2022/sic-2022.xsd"/>
  <xs:element name="ScheduleOfComputingStraightLineAmortizationAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_ScheduleOfComputingStraightLineAmortizationAbstract"/>
  <xs:element name="ScheduleOfComputingStraightLineDepreciationAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_ScheduleOfComputingStraightLineDepreciationAbstract"/>
  <xs:element name="ScheduleOfOtherCurrentAssetsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_ScheduleOfOtherCurrentAssetsAbstract"/>
  <xs:element name="ScheduleOfPropertyAndEquipmentNetAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_ScheduleOfPropertyAndEquipmentNetAbstract"/>
  <xs:element name="ScheduleOfIntangibleAssetsNetAndGoodwilAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_ScheduleOfIntangibleAssetsNetAndGoodwilAbstract"/>
  <xs:element name="ScheduleOfTheEstimatedFutureAmortizationExpenseOfIntangibleAssetsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_ScheduleOfTheEstimatedFutureAmortizationExpenseOfIntangibleAssetsAbstract"/>
  <xs:element name="ScheduleOfTheEffectiveDateManagementByAssistanceOfThirdPartyAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_ScheduleOfTheEffectiveDateManagementByAssistanceOfThirdPartyAbstract"/>
  <xs:element name="ScheduleOfTheReconciliationOfTheCarryingAmountAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_ScheduleOfTheReconciliationOfTheCarryingAmountAbstract"/>
  <xs:element name="ScheduleOfMaturityDatesOfOutstandingLoansAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_ScheduleOfMaturityDatesOfOutstandingLoansAbstract"/>
  <xs:element name="ScheduleOfOtherCurrentLiabiltiesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_ScheduleOfOtherCurrentLiabiltiesAbstract"/>
  <xs:element name="ScheduleOfReconciliationOfTheFairValueOfDerivativeWarrantsLiabilitiesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_ScheduleOfReconciliationOfTheFairValueOfDerivativeWarrantsLiabilitiesAbstract"/>
  <xs:element name="InvestmentHoldingsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_InvestmentHoldingsAbstract"/>
  <xs:element name="ScheduleOfReconciliationOfTheCarryingAmountOfTheConvertibleAdvanceInvestmentAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_ScheduleOfReconciliationOfTheCarryingAmountOfTheConvertibleAdvanceInvestmentAbstract"/>
  <xs:element name="ScheduleOfFutureMinimumCommitmentUnderBindingLeaseAgreeementsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_ScheduleOfFutureMinimumCommitmentUnderBindingLeaseAgreeementsAbstract"/>
  <xs:element name="ScheduleOfCompositionOfShareholdersEquityAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_ScheduleOfCompositionOfShareholdersEquityAbstract"/>
  <xs:element name="ScheduleOfCompanySShareOptionActivityForEmployeesAndMembersOfTheBoardOfDirectorsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_ScheduleOfCompanySShareOptionActivityForEmployeesAndMembersOfTheBoardOfDirectorsAbstract"/>
  <xs:element name="ScheduleOfOutstandingAndExercisableShareOptionsSeparatedRangesOfExercisePricesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_ScheduleOfOutstandingAndExercisableShareOptionsSeparatedRangesOfExercisePricesAbstract"/>
  <xs:element name="ScheduleOfAssumptionsUsedToEstimateTheFairValuesOfTheShareOptionsGrantedAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_ScheduleOfAssumptionsUsedToEstimateTheFairValuesOfTheShareOptionsGrantedAbstract"/>
  <xs:element name="ScheduleOfCompanySEquityBasedAwardsRecognizedAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_ScheduleOfCompanySEquityBasedAwardsRecognizedAbstract"/>
  <xs:element name="FinancingExpensesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_FinancingExpensesAbstract"/>
  <xs:element name="ScheduleOfFinancingExpensesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_ScheduleOfFinancingExpensesAbstract"/>
  <xs:element name="ScheduleOfTheReconciliationOfTheCarryingAmountOfTheCompanyAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_ScheduleOfTheReconciliationOfTheCarryingAmountOfTheCompanyAbstract"/>
  <xs:element name="ScheduleOfMaturityDatesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_ScheduleOfMaturityDatesAbstract"/>
  <xs:element name="ScheduleOfExpensesRelatedToServiceAgreementAndTheOfficeServicesAgreementAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_ScheduleOfExpensesRelatedToServiceAgreementAndTheOfficeServicesAgreementAbstract"/>
  <xs:element name="ScheduleOfLossIncomeBeforeTaxesOnIncomeAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_ScheduleOfLossIncomeBeforeTaxesOnIncomeAbstract"/>
  <xs:element name="ScheduleOfDeferredIncomeTaxesReflectTheNetTaxEffectsOfNetOperatingLossAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_ScheduleOfDeferredIncomeTaxesReflectTheNetTaxEffectsOfNetOperatingLossAbstract"/>
  <xs:element name="ScheduleOfRevenuesByGeographicRegionAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_ScheduleOfRevenuesByGeographicRegionAbstract"/>
  <xs:element name="ScheduleOfLongLivedAssetsNetByGeographicAreasAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_ScheduleOfLongLivedAssetsNetByGeographicAreasAbstract"/>
  <xs:element name="ScheduleOfRevenueDisaggregatedByPrimaryMajorProductLinesAndServicesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_ScheduleOfRevenueDisaggregatedByPrimaryMajorProductLinesAndServicesAbstract"/>
  <xs:element name="UnlabeledAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_UnlabeledAbstract"/>
  <xs:element name="NonCurrentAssetsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_NonCurrentAssetsAbstract"/>
  <xs:element name="UnlabeledAbstract0" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_UnlabeledAbstract0"/>
  <xs:element name="UnlabeledAbstract1" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_UnlabeledAbstract1"/>
  <xs:element name="LiabilitiesAndShareholdersEquityDeficitAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_LiabilitiesAndShareholdersEquityDeficitAbstract"/>
  <xs:element name="UnlabeledAbstract2" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_UnlabeledAbstract2"/>
  <xs:element name="NonCurrentLiabilitiesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_NonCurrentLiabilitiesAbstract"/>
  <xs:element name="UnlabeledAbstract3" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_UnlabeledAbstract3"/>
  <xs:element name="UnlabeledAbstract4" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_UnlabeledAbstract4"/>
  <xs:element name="ShareholdersEquityDeficitAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_ShareholdersEquityDeficitAbstract"/>
  <xs:element name="OrdinarySharesOfNis005ParValueEachAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_OrdinarySharesOfNis005ParValueEachAbstract"/>
  <xs:element name="ConvertibleOrdinary1And2SharesOfNis005ParValueEachAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_ConvertibleOrdinary1And2SharesOfNis005ParValueEachAbstract"/>
  <xs:element name="ConvertiblePreferredSharesOfNis005ParValueEachAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_ConvertiblePreferredSharesOfNis005ParValueEachAbstract"/>
  <xs:element name="UnlabeledAbstract5" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_UnlabeledAbstract5"/>
  <xs:element name="UnlabeledAbstract6" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_UnlabeledAbstract6"/>
  <xs:element name="UnlabeledAbstract7" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_UnlabeledAbstract7"/>
  <xs:element name="UnlabeledAbstract8" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_UnlabeledAbstract8"/>
  <xs:element name="UnlabeledAbstract9" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_UnlabeledAbstract9"/>
  <xs:element name="UnlabeledAbstract10" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_UnlabeledAbstract10"/>
  <xs:element name="UnlabeledAbstract11" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_UnlabeledAbstract11"/>
  <xs:element name="UnlabeledAbstract12" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_UnlabeledAbstract12"/>
  <xs:element name="UnlabeledAbstract13" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_UnlabeledAbstract13"/>
  <xs:element name="UnlabeledAbstract14" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_UnlabeledAbstract14"/>
  <xs:element name="UnlabeledAbstract15" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_UnlabeledAbstract15"/>
  <xs:element name="UnlabeledAbstract16" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_UnlabeledAbstract16"/>
  <xs:element name="UnlabeledAbstract17" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_UnlabeledAbstract17"/>
  <xs:element name="UnlabeledAbstract18" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_UnlabeledAbstract18"/>
  <xs:element name="UnlabeledAbstract19" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_UnlabeledAbstract19"/>
  <xs:element name="CashFlowsFromOperatingActivitiesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_CashFlowsFromOperatingActivitiesAbstract"/>
  <xs:element name="AdjustmentsRequiredToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_AdjustmentsRequiredToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract"/>
  <xs:element name="UnlabeledAbstract20" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_UnlabeledAbstract20"/>
  <xs:element name="CashFlowsFromInvestingActivitiesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_CashFlowsFromInvestingActivitiesAbstract"/>
  <xs:element name="UnlabeledAbstract21" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_UnlabeledAbstract21"/>
  <xs:element name="CashFlowsFromFinancingActivitiesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_CashFlowsFromFinancingActivitiesAbstract"/>
  <xs:element name="UnlabeledAbstract22" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_UnlabeledAbstract22"/>
  <xs:element name="NonCashFinancingActivitiesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_NonCashFinancingActivitiesAbstract"/>
  <xs:element name="UnlabeledAbstract23" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_UnlabeledAbstract23"/>
  <xs:element name="SupplementalDisclosureOfCashFlowInformationAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_SupplementalDisclosureOfCashFlowInformationAbstract"/>
  <xs:element name="CarryingAmountAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_CarryingAmountAbstract"/>
  <xs:element name="UnlabeledAbstract24" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_UnlabeledAbstract24"/>
  <xs:element name="AccumulatedAmortizationAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_AccumulatedAmortizationAbstract"/>
  <xs:element name="UnlabeledAbstract25" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_UnlabeledAbstract25"/>
  <xs:element name="UnlabeledAbstract26" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_UnlabeledAbstract26"/>
  <xs:element name="UnlabeledAbstract27" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_UnlabeledAbstract27"/>
  <xs:element name="NumberOfSharesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_NumberOfSharesAbstract"/>
  <xs:element name="SharesOfNis005ParValueAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_SharesOfNis005ParValueAbstract"/>
  <xs:element name="UnlabeledAbstract28" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_UnlabeledAbstract28"/>
  <xs:element name="UnlabeledAbstract29" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_UnlabeledAbstract29"/>
  <xs:element name="SoftwareLicenseAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_SoftwareLicenseAbstract"/>
  <xs:element name="ConvertibleAdvancedInvestments" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="bmr_ConvertibleAdvancedInvestments"/>
  <xs:element name="CommonStockValue1" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="bmr_CommonStockValue1"/>
  <xs:element name="ModificationOfTermsOfStraightLoan" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="bmr_ModificationOfTermsOfStraightLoan"/>
  <xs:element name="FinancingExpenses" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_FinancingExpenses"/>
  <xs:element name="ConcentrationOfCreditRiskPolicyTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_ConcentrationOfCreditRiskPolicyTextBlock"/>
  <xs:element name="ConvertibleOrdinary1And2SharesAndPreferredSharesPolicyTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_ConvertibleOrdinary1And2SharesAndPreferredSharesPolicyTextBlock"/>
  <xs:element name="AllocationOfProceedsAndRelatedIssuanceCostsPolicyTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_AllocationOfProceedsAndRelatedIssuanceCostsPolicyTextBlock"/>
  <xs:element name="WarrantsPolicyTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_WarrantsPolicyTextBlock"/>
  <xs:element name="ModificationsOrExchangeOfLoansPolicyTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_ModificationsOrExchangeOfLoansPolicyTextBlock"/>
  <xs:element name="ConvertibleAdvanceInvestmentsPolicyTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_ConvertibleAdvanceInvestmentsPolicyTextBlock"/>
  <xs:element name="CapitalContributionFromAControllingShareholderPolicyTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_CapitalContributionFromAControllingShareholderPolicyTextBlock"/>
  <xs:element name="ScheduleOfTheMemberEffectiveDateManagementByAssistanceOfThirdpartyTableTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_ScheduleOfTheMemberEffectiveDateManagementByAssistanceOfThirdpartyTableTextBlock"/>
  <xs:element name="ScheduleOfPresentationReflectsTheReconciliationOfTheCarryingAmountTableTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_ScheduleOfPresentationReflectsTheReconciliationOfTheCarryingAmountTableTextBlock"/>
  <xs:element name="ScheduleOfMaturityDatesOfOutstandingLoanTableTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_ScheduleOfMaturityDatesOfOutstandingLoanTableTextBlock"/>
  <xs:element name="scheduleOfFutureMinimumCommitmentUnderBindingLeaseAgreeementsTableTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_scheduleOfFutureMinimumCommitmentUnderBindingLeaseAgreeementsTableTextBlock"/>
  <xs:element name="PropertyPlantAndEquipmentDepreciationPercentage" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_PropertyPlantAndEquipmentDepreciationPercentage"/>
  <xs:element name="SignificantAccountingPoliciesDetailsScheduleofcomputingstraightlinedepreciationTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="bmr_SignificantAccountingPoliciesDetailsScheduleofcomputingstraightlinedepreciationTable"/>
  <xs:element name="SignificantAccountingPoliciesDetailsScheduleofcomputingstraightlinedepreciationLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_SignificantAccountingPoliciesDetailsScheduleofcomputingstraightlinedepreciationLineItems"/>
  <xs:element name="GovernmentAuthoritiesAssets" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="bmr_GovernmentAuthoritiesAssets"/>
  <xs:element name="IntangibleAssetsNetandGoodwillDetailsScheduleofintangibleassetsnetandgoodwilTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="bmr_IntangibleAssetsNetandGoodwillDetailsScheduleofintangibleassetsnetandgoodwilTable"/>
  <xs:element name="IntangibleAssetsNetandGoodwillDetailsScheduleofintangibleassetsnetandgoodwilLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_IntangibleAssetsNetandGoodwillDetailsScheduleofintangibleassetsnetandgoodwilLineItems"/>
  <xs:element name="DerivativeWarrantLiabilityseeNote8" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="bmr_DerivativeWarrantLiabilityseeNote8"/>
  <xs:element name="TotalGrossConsideration" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="bmr_TotalGrossConsideration"/>
  <xs:element name="ReconciliationOfTheCarryingAmount" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="bmr_ReconciliationOfTheCarryingAmount"/>
  <xs:element name="ConsiderationReceivedFromPPPNote" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="bmr_ConsiderationReceivedFromPPPNote"/>
  <xs:element name="NetConsiderationReceivedFromIBILoan" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="bmr_NetConsiderationReceivedFromIBILoan"/>
  <xs:element name="RecognitionSubsequentToSubstantialModificationOfTerms" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="bmr_RecognitionSubsequentToSubstantialModificationOfTerms"/>
  <xs:element name="ReconciliationOfCarryingAmount" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="bmr_ReconciliationOfCarryingAmount"/>
  <xs:element name="GovernmentAuthorities" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="bmr_GovernmentAuthorities"/>
  <xs:element name="ChangeInTheFairValueOfConvertibleAdvanceInvestments" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="bmr_ChangeInTheFairValueOfConvertibleAdvanceInvestments"/>
  <xs:element name="LesseeOperatingLeasesLiabilityPaymentsDueNextTwelveMonths" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="bmr_LesseeOperatingLeasesLiabilityPaymentsDueNextTwelveMonths"/>
  <xs:element name="LesseeOperatingLeasesLiabilityPaymentsDue" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="bmr_LesseeOperatingLeasesLiabilityPaymentsDue"/>
  <xs:element name="ShareholdersEquityDeficitDetailsScheduleofcompositionofshareholdersequityTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="bmr_ShareholdersEquityDeficitDetailsScheduleofcompositionofshareholdersequityTable"/>
  <xs:element name="ShareholdersEquityDeficitDetailsScheduleofcompositionofshareholdersequityLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_ShareholdersEquityDeficitDetailsScheduleofcompositionofshareholdersequityLineItems"/>
  <xs:element name="ExcessSharesIssuedAndOutstandingShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="bmr_ExcessSharesIssuedAndOutstandingShares"/>
  <xs:element name="WeightedAverageRemainingContractualLifeGranted" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_WeightedAverageRemainingContractualLifeGranted"/>
  <xs:element name="WeightedAverageRemainingContractualLifeExercised" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_WeightedAverageRemainingContractualLifeExercised"/>
  <xs:element name="WeightedAverageRemainingContractualLifeForfeitedOrExpired" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_WeightedAverageRemainingContractualLifeForfeitedOrExpired"/>
  <xs:element name="WeightedAverageRemainingContractualLifeOutstanding" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_WeightedAverageRemainingContractualLifeOutstanding"/>
  <xs:element name="ShareOptionsDetailsScheduleofassumptionsusedtoestimatethefairvaluesoftheshareoptionsgrantedTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="bmr_ShareOptionsDetailsScheduleofassumptionsusedtoestimatethefairvaluesoftheshareoptionsgrantedTable"/>
  <xs:element name="ShareOptionsDetailsScheduleofassumptionsusedtoestimatethefairvaluesoftheshareoptionsgrantedLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_ShareOptionsDetailsScheduleofassumptionsusedtoestimatethefairvaluesoftheshareoptionsgrantedLineItems"/>
  <xs:element name="ModificationOfTermsRelatingToStraightLoan" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="bmr_ModificationOfTermsRelatingToStraightLoan"/>
  <xs:element name="ExchangeRateDifferencesAndOthers" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="bmr_ExchangeRateDifferencesAndOthers"/>
  <xs:element name="SegmentGeographicalInformationAndMajorCustomersDetailsScheduleofrevenuesbygeographicregionTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="bmr_SegmentGeographicalInformationAndMajorCustomersDetailsScheduleofrevenuesbygeographicregionTable"/>
  <xs:element name="SegmentGeographicalInformationAndMajorCustomersDetailsScheduleofrevenuesbygeographicregionLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_SegmentGeographicalInformationAndMajorCustomersDetailsScheduleofrevenuesbygeographicregionLineItems"/>
  <xs:element name="SegmentGeographicalInformationAndMajorCustomersDetailsScheduleofLonglivedassetsnetbygeographicareasTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="bmr_SegmentGeographicalInformationAndMajorCustomersDetailsScheduleofLonglivedassetsnetbygeographicareasTable"/>
  <xs:element name="SegmentGeographicalInformationAndMajorCustomersDetailsScheduleofLonglivedassetsnetbygeographicareasLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_SegmentGeographicalInformationAndMajorCustomersDetailsScheduleofLonglivedassetsnetbygeographicareasLineItems"/>
  <xs:element name="PCSServicesTransferredOverAPeriod" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="bmr_PCSServicesTransferredOverAPeriod"/>
  <xs:element name="AdvertisingAtAPointOfTimeUponClicks" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="bmr_AdvertisingAtAPointOfTimeUponClicks"/>
  <xs:element name="RecognitionofRevenue" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="bmr_RecognitionofRevenue"/>
  <xs:element name="GeneralDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="bmr_GeneralDetailsTable"/>
  <xs:element name="GeneralDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_GeneralDetailsLineItems"/>
  <xs:element name="PublicOfferingPrice" type="dtr:perShareItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_PublicOfferingPrice"/>
  <xs:element name="AggregateGrossProceeds" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="bmr_AggregateGrossProceeds"/>
  <xs:element name="SignificantAccountingPoliciesDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="bmr_SignificantAccountingPoliciesDetailsTable"/>
  <xs:element name="SignificantAccountingPoliciesDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_SignificantAccountingPoliciesDetailsLineItems"/>
  <xs:element name="EmployeeCompensationPercentage" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_EmployeeCompensationPercentage"/>
  <xs:element name="PercentageOfDividend" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_PercentageOfDividend"/>
  <xs:element name="LoansNetDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="bmr_LoansNetDetailsTable"/>
  <xs:element name="LoansNetDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_LoansNetDetailsLineItems"/>
  <xs:element name="AgreementAmountReceived" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="bmr_AgreementAmountReceived"/>
  <xs:element name="PercentageOfOutstandingRepaymentAndPaymentAmount" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_PercentageOfOutstandingRepaymentAndPaymentAmount"/>
  <xs:element name="PercentageOfDiscountOutstanding" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_PercentageOfDiscountOutstanding"/>
  <xs:element name="ConvertibleAdvanceInvestmentDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="bmr_ConvertibleAdvanceInvestmentDetailsTable"/>
  <xs:element name="ConvertibleAdvanceInvestmentDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_ConvertibleAdvanceInvestmentDetailsLineItems"/>
  <xs:element name="CommitmentsandContingentLiabilitiesDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="bmr_CommitmentsandContingentLiabilitiesDetailsTable"/>
  <xs:element name="CommitmentsandContingentLiabilitiesDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_CommitmentsandContingentLiabilitiesDetailsLineItems"/>
  <xs:element name="ShareholdersEquityDeficitDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="bmr_ShareholdersEquityDeficitDetailsTable"/>
  <xs:element name="ShareholdersEquityDeficitDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_ShareholdersEquityDeficitDetailsLineItems"/>
  <xs:element name="VoluntaryConversionDescription" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_VoluntaryConversionDescription"/>
  <xs:element name="OrdinarySharesSubjectToAdjustments" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="bmr_OrdinarySharesSubjectToAdjustments"/>
  <xs:element name="OrdinarySharesAvailableForFutureIssuance" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="bmr_OrdinarySharesAvailableForFutureIssuance"/>
  <xs:element name="TotalConsideration" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="bmr_TotalConsideration"/>
  <xs:element name="TradeReceivablesIncomeTaxRate" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_TradeReceivablesIncomeTaxRate"/>
  <xs:element name="LoanAgreementsDomain" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_LoanAgreementsDomain"/>
  <xs:element name="SubsequentEventsDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="bmr_SubsequentEventsDetailsTable"/>
  <xs:element name="SubsequentEventsDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_SubsequentEventsDetailsLineItems"/>
  <xs:element name="LoanAgreementsAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:dimensionItem" id="bmr_LoanAgreementsAxis"/>
  <xs:element name="AdvanceInvestmentAgreementsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_AdvanceInvestmentAgreementsMember"/>
  <xs:element name="CompareAndPeripheralEquipmentMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_CompareAndPeripheralEquipmentMember"/>
  <xs:element name="ConvertibleAdvanceInvestmentsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_ConvertibleAdvanceInvestmentsMember"/>
  <xs:element name="ConvertibleOrdinary1And2SharesMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_ConvertibleOrdinary1And2SharesMember"/>
  <xs:element name="ConvertiblePreferredSharesMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_ConvertiblePreferredSharesMember"/>
  <xs:element name="ExercisePrice0000Member" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_ExercisePrice0000Member"/>
  <xs:element name="ExercisePrice0227Member" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_ExercisePrice0227Member"/>
  <xs:element name="ExercisePrice0333Member" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_ExercisePrice0333Member"/>
  <xs:element name="ExercisePrice0365Member" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_ExercisePrice0365Member"/>
  <xs:element name="ExercisePrice0640Member" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_ExercisePrice0640Member"/>
  <xs:element name="ExercisePrice0757Member" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_ExercisePrice0757Member"/>
  <xs:element name="ExercisePrice0833Member" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_ExercisePrice0833Member"/>
  <xs:element name="ExercisePrice1024Member" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_ExercisePrice1024Member"/>
  <xs:element name="FloatingRateMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_FloatingRateMember"/>
  <xs:element name="IBISpikesLtdMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_IBISpikesLtdMember"/>
  <xs:element name="LoansAndSecurityAgreementMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_LoansAndSecurityAgreementMember"/>
  <xs:element name="OfficeFurnitureAndEquipmentMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_OfficeFurnitureAndEquipmentMember"/>
  <xs:element name="PerpetualBasedSoftwareLicenseMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_PerpetualBasedSoftwareLicenseMember"/>
  <xs:element name="RestOfTheWorldMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_RestOfTheWorldMember"/>
  <xs:element name="SeriesConvertibleB1PreferredSharesBMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_SeriesConvertibleB1PreferredSharesBMember"/>
  <xs:element name="SeriesConvertibleBPreferredSharesMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_SeriesConvertibleBPreferredSharesMember"/>
  <xs:element name="SeriesConvertibleCPreferredSharesMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_SeriesConvertibleCPreferredSharesMember"/>
  <xs:element name="SeriesConvertibleOrdinary1SharesMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_SeriesConvertibleOrdinary1SharesMember"/>
  <xs:element name="SeriesConvertibleOrdinary2SharesMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_SeriesConvertibleOrdinary2SharesMember"/>
  <xs:element name="SeriesOrdinarySharesMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_SeriesOrdinarySharesMember"/>
  <xs:element name="ShareOptionsExercisableMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_ShareOptionsExercisableMember"/>
  <xs:element name="ShareOptionsOutstandingMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_ShareOptionsOutstandingMember"/>
  <xs:element name="TechnologyMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_TechnologyMember"/>
  <xs:element name="TermbasedSoftwareLicenseMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_TermbasedSoftwareLicenseMember"/>
  <xs:element name="TwoThousandTwentyTwoLoanAgreementMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_TwoThousandTwentyTwoLoanAgreementMember"/>
  <xs:element name="TwoZeroTwoTwoLoanAgreementMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_TwoZeroTwoTwoLoanAgreementMember"/>
  <xs:element name="GeneralAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_GeneralAbstract"/>
  <xs:element name="DocumentAndEntityInformationAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmr_DocumentAndEntityInformationAbstract"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>8
<FILENAME>bmr-20221231_cal.xml
<DESCRIPTION>XBRL CALCULATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Mon Apr 24 19:58:56 UTC 2023 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_ConsolidatedBalanceSheet" roleURI="http://www.beil.com/role/ConsolidatedBalanceSheet"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_ConsolidatedIncomeStatement" roleURI="http://www.beil.com/role/ConsolidatedIncomeStatement"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_ConsolidatedCashFlow" roleURI="http://www.beil.com/role/ConsolidatedCashFlow"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_ScheduleofothercurrentassetsTable" roleURI="http://www.beil.com/role/ScheduleofothercurrentassetsTable"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_ScheduleoftheestimatedfutureamortizationexpenseofintangibleassetsTable" roleURI="http://www.beil.com/role/ScheduleoftheestimatedfutureamortizationexpenseofintangibleassetsTable"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_ScheduleofothercurrentliabiltiesTable" roleURI="http://www.beil.com/role/ScheduleofothercurrentliabiltiesTable"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_ScheduleofexpensesrelatedtoserviceagreementandtheofficeservicesagreementTable" roleURI="http://www.beil.com/role/ScheduleofexpensesrelatedtoserviceagreementandtheofficeservicesagreementTable"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_ScheduleoflossincomebeforetaxesonincomeTable" roleURI="http://www.beil.com/role/ScheduleoflossincomebeforetaxesonincomeTable"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_ScheduleofdeferredincometaxesreflectthenettaxeffectsofnetoperatinglossTable" roleURI="http://www.beil.com/role/ScheduleofdeferredincometaxesreflectthenettaxeffectsofnetoperatinglossTable"/>
  <calculationLink xlink:type="extended" xlink:role="http://www.beil.com/role/ConsolidatedBalanceSheet">
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ReceivablesNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesNetCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_ReceivablesNetCurrent" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_OtherAssetsCurrent" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsNoncurrent"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCosts"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsNoncurrent" xlink:to="us-gaap_DeferredCosts" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsNoncurrent" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsNoncurrent" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsNoncurrent" xlink:to="us-gaap_Goodwill" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_AssetsCurrent" order="1" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_AssetsNoncurrent" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermBorrowings" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermBorrowings"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_ShortTermBorrowings" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableCurrent" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredRevenueCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredRevenueCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_DeferredRevenueCurrent" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DueToRelatedPartiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueToRelatedPartiesCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_DueToRelatedPartiesCurrent" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_OtherLiabilitiesCurrent" order="5" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesNoncurrent"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LongTermDebtNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesNoncurrent" xlink:to="us-gaap_LongTermDebtNoncurrent" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DueToRelatedPartiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueToRelatedPartiesNoncurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesNoncurrent" xlink:to="us-gaap_DueToRelatedPartiesNoncurrent" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DerivativeLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilitiesNoncurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesNoncurrent" xlink:to="us-gaap_DerivativeLiabilitiesNoncurrent" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="bmr_ConvertibleAdvancedInvestments" xlink:href="bmr-20221231.xsd#bmr_ConvertibleAdvancedInvestments"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesNoncurrent" xlink:to="bmr_ConvertibleAdvancedInvestments" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_CommitmentsAndContingencies" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_CommonStockValue" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="bmr_CommonStockValue1" xlink:href="bmr-20221231.xsd#bmr_CommonStockValue1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="bmr_CommonStockValue1" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_PreferredStockValue" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_AdditionalPaidInCapital" order="5" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="6" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesCurrent" order="1" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesNoncurrent" order="2" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_StockholdersEquity" order="3" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.beil.com/role/ConsolidatedIncomeStatement">
    <loc xlink:type="locator" xlink:label="us-gaap_GrossProfit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_Revenues" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CostOfRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfRevenue"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_CostOfRevenue" order="2" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_GrossProfit" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherOperatingIncomeExpenseNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOperatingIncomeExpenseNet"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OtherOperatingIncomeExpenseNet" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="3" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SellingAndMarketingExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingAndMarketingExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_SellingAndMarketingExpense" order="4" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_GeneralAndAdministrativeExpense" order="5" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_OperatingIncomeLoss" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FinancingInterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingInterestExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_FinancingInterestExpense" order="2" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_OperatingIncomeLoss" order="1" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_FinancingInterestExpense" order="2" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="3" weight="-1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.beil.com/role/ConsolidatedCashFlow">
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetIncomeLoss" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_DepreciationDepletionAndAmortization" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_ShareBasedCompensation" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AmortizationOfDebtDiscountPremium" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfDebtDiscountPremium"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_AmortizationOfDebtDiscountPremium" order="4" weight="1"/>
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt/tSeJz73kx1cLt0ZFF2SK/vxBCY0vdSrZb6DUpe9prgZNYqdZsfXqxEEXb49NXhOeJEcoYxL52lqzrxV1ixmGk3x5z3C+boGMFyF1bCAC6SzXA8EeoS+J4OsCx1oPIoujQb0ZEh03dOL9+qx7qvcGHsJ6a9scdOGp0N/fSOils3JiDVUH+POJSLwkIXq+NgTrCVG8rYfDvkQSvrvKPWWMVrvvskGlslRGwiQuNeW1McA==] CSR-->
    <loc xlink:type="locator" xlink:label="us-gaap_AmortizationOfFinancingCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_AmortizationOfFinancingCosts" order="5" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable" order="6" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInDeferredRevenue" order="7" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherCurrentLiabilities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" order="8" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt" order="9" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueOptionChangesInFairValueGainLoss1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOptionChangesInFairValueGainLoss1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_FairValueOptionChangesInFairValueGainLoss1" order="10" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_GainLossOnSaleOfPropertyPlantEquipment" order="11" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GainLossOnDispositionOfAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnDispositionOfAssets"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_GainLossOnDispositionOfAssets" order="12" weight="-1"/>
    <loc xlink:type="locator" xlink:label="bmr_ModificationOfTermsOfStraightLoan" xlink:href="bmr-20221231.xsd#bmr_ModificationOfTermsOfStraightLoan"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="bmr_ModificationOfTermsOfStraightLoan" order="13" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GainsLossesOnRestructuringOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnRestructuringOfDebt"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_GainsLossesOnRestructuringOfDebt" order="14" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOtherReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherReceivables"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInOtherReceivables" order="15" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherCurrentAssets"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInOtherCurrentAssets" order="16" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInDueFromRelatedParties" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDueFromRelatedParties"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInDueFromRelatedParties" order="17" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="2" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromNotesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromNotesPayable"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromNotesPayable" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromIssuanceOfPrivatePlacement" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromRelatedPartyDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRelatedPartyDebt"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromRelatedPartyDebt" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromStockOptionsExercised" order="5" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsOfFinancingCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfFinancingCosts"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_PaymentsOfFinancingCosts" order="6" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RepaymentsOfRelatedPartyDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfRelatedPartyDebt"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_RepaymentsOfRelatedPartyDebt" order="7" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RepaymentsOfFederalHomeLoanBankBorrowings" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfFederalHomeLoanBankBorrowings"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_RepaymentsOfFederalHomeLoanBankBorrowings" order="8" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="1" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="2" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="3" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.beil.com/role/ScheduleofothercurrentassetsTable">
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseCurrentAndNoncurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseCurrentAndNoncurrent" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="bmr_GovernmentAuthoritiesAssets" xlink:href="bmr-20221231.xsd#bmr_GovernmentAuthoritiesAssets"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OtherAssetsCurrent" xlink:to="bmr_GovernmentAuthoritiesAssets" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherPrepaidExpenseCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherPrepaidExpenseCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OtherAssetsCurrent" xlink:to="us-gaap_OtherPrepaidExpenseCurrent" order="3" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.beil.com/role/ScheduleoftheestimatedfutureamortizationexpenseofintangibleassetsTable">
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo" order="2" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.beil.com/role/ScheduleofothercurrentliabiltiesTable">
    <loc xlink:type="locator" xlink:label="us-gaap_OtherLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OtherLiabilitiesCurrent" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OtherLiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="bmr_GovernmentAuthorities" xlink:href="bmr-20221231.xsd#bmr_GovernmentAuthorities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OtherLiabilitiesCurrent" xlink:to="bmr_GovernmentAuthorities" order="3" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.beil.com/role/ScheduleofexpensesrelatedtoserviceagreementandtheofficeservicesagreementTable">
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInDueToOtherRelatedParties" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDueToOtherRelatedParties"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentInProcess" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentInProcess"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncreaseDecreaseInDueToOtherRelatedParties" xlink:to="us-gaap_ResearchAndDevelopmentInProcess" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MarketingAndAdvertisingExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketingAndAdvertisingExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncreaseDecreaseInDueToOtherRelatedParties" xlink:to="us-gaap_MarketingAndAdvertisingExpense" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherSellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherSellingGeneralAndAdministrativeExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncreaseDecreaseInDueToOtherRelatedParties" xlink:to="us-gaap_OtherSellingGeneralAndAdministrativeExpense" order="3" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.beil.com/role/ScheduleoflossincomebeforetaxesonincomeTable">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" order="2" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.beil.com/role/ScheduleofdeferredincometaxesreflectthenettaxeffectsofnetoperatinglossTable">
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsCapitalLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsCapitalLossCarryforwards"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsCapitalLossCarryforwards" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="us-gaap_DeferredTaxAssetsGross" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance" order="2" weight="-1"/>
  </calculationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>9
<FILENAME>bmr-20221231_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Mon Apr 24 19:58:56 UTC 2023 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:xbrldt="http://xbrl.org/2005/xbrldt">
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_ConsolidatedBalanceSheet" roleURI="http://www.beil.com/role/ConsolidatedBalanceSheet"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_ConsolidatedBalanceSheet_Parentheticals" roleURI="http://www.beil.com/role/ConsolidatedBalanceSheet_Parentheticals"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_ConsolidatedIncomeStatement" roleURI="http://www.beil.com/role/ConsolidatedIncomeStatement"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_ConsolidatedIncomeStatement_Parentheticals" roleURI="http://www.beil.com/role/ConsolidatedIncomeStatement_Parentheticals"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_ShareholdersEquityType2or3" roleURI="http://www.beil.com/role/ShareholdersEquityType2or3"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_ConsolidatedCashFlow" roleURI="http://www.beil.com/role/ConsolidatedCashFlow"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_General" roleURI="http://www.beil.com/role/General"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_SignificantAccountingPolicies" roleURI="http://www.beil.com/role/SignificantAccountingPolicies"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_OtherCurrentAssets" roleURI="http://www.beil.com/role/OtherCurrentAssets"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_PropertyandEquipmentNet" roleURI="http://www.beil.com/role/PropertyandEquipmentNet"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_IntangibleAssetsNetandGoodwill" roleURI="http://www.beil.com/role/IntangibleAssetsNetandGoodwill"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_LoansNet" roleURI="http://www.beil.com/role/LoansNet"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_OtherCurrentLiabilities" roleURI="http://www.beil.com/role/OtherCurrentLiabilities"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_DerivativeWarrantsLiabilities" roleURI="http://www.beil.com/role/DerivativeWarrantsLiabilities"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_ConvertibleAdvanceInvestment" roleURI="http://www.beil.com/role/ConvertibleAdvanceInvestment"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_CommitmentsandContingentLiabilities" roleURI="http://www.beil.com/role/CommitmentsandContingentLiabilities"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_ShareholdersEquityDeficit" roleURI="http://www.beil.com/role/ShareholdersEquityDeficit"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_ShareOptions" roleURI="http://www.beil.com/role/ShareOptions"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_FinancingExpensesNet" roleURI="http://www.beil.com/role/FinancingExpensesNet"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_RelatedPartiesTransactions" roleURI="http://www.beil.com/role/RelatedPartiesTransactions"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_TaxesonIncome" roleURI="http://www.beil.com/role/TaxesonIncome"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_SegmentGeographicalInformationAndMajorCustomers" roleURI="http://www.beil.com/role/SegmentGeographicalInformationAndMajorCustomers"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_SubsequentEvents" roleURI="http://www.beil.com/role/SubsequentEvents"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_AccountingPoliciesByPolicy" roleURI="http://www.beil.com/role/AccountingPoliciesByPolicy"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_SignificantAccountingPoliciesTables" roleURI="http://www.beil.com/role/SignificantAccountingPoliciesTables"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_OtherCurrentAssetsTables" roleURI="http://www.beil.com/role/OtherCurrentAssetsTables"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_PropertyandEquipmentNetTables" roleURI="http://www.beil.com/role/PropertyandEquipmentNetTables"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_IntangibleAssetsNetandGoodwillTables" roleURI="http://www.beil.com/role/IntangibleAssetsNetandGoodwillTables"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_LoansNetTables" roleURI="http://www.beil.com/role/LoansNetTables"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_OtherCurrentLiabilitiesTables" roleURI="http://www.beil.com/role/OtherCurrentLiabilitiesTables"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_DerivativeWarrantsLiabilitiesTables" roleURI="http://www.beil.com/role/DerivativeWarrantsLiabilitiesTables"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_ConvertibleAdvanceInvestmentTables" roleURI="http://www.beil.com/role/ConvertibleAdvanceInvestmentTables"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_CommitmentsandContingentLiabilitiesTables" roleURI="http://www.beil.com/role/CommitmentsandContingentLiabilitiesTables"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_ShareholdersEquityDeficitTables" roleURI="http://www.beil.com/role/ShareholdersEquityDeficitTables"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_ShareOptionsTables" roleURI="http://www.beil.com/role/ShareOptionsTables"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_FinancingExpensesNetTables" roleURI="http://www.beil.com/role/FinancingExpensesNetTables"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_RelatedPartiesTransactionsTables" roleURI="http://www.beil.com/role/RelatedPartiesTransactionsTables"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_TaxesonIncomeTables" roleURI="http://www.beil.com/role/TaxesonIncomeTables"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_SegmentGeographicalInformationAndMajorCustomersTables" roleURI="http://www.beil.com/role/SegmentGeographicalInformationAndMajorCustomersTables"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_ScheduleofcomputingstraightlineamortizationTable" roleURI="http://www.beil.com/role/ScheduleofcomputingstraightlineamortizationTable"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_ScheduleofcomputingstraightlinedepreciationTable" roleURI="http://www.beil.com/role/ScheduleofcomputingstraightlinedepreciationTable"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_ScheduleofothercurrentassetsTable" roleURI="http://www.beil.com/role/ScheduleofothercurrentassetsTable"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_ScheduleofpropertyandequipmentnetTable" roleURI="http://www.beil.com/role/ScheduleofpropertyandequipmentnetTable"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_ScheduleofintangibleassetsnetandgoodwilTable" roleURI="http://www.beil.com/role/ScheduleofintangibleassetsnetandgoodwilTable"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_ScheduleoftheestimatedfutureamortizationexpenseofintangibleassetsTable" roleURI="http://www.beil.com/role/ScheduleoftheestimatedfutureamortizationexpenseofintangibleassetsTable"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_ScheduleoftheEffectiveDatemanagementbyassistanceofthirdpartyTable" roleURI="http://www.beil.com/role/ScheduleoftheEffectiveDatemanagementbyassistanceofthirdpartyTable"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_ScheduleofthereconciliationofthecarryingamountTable" roleURI="http://www.beil.com/role/ScheduleofthereconciliationofthecarryingamountTable"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_ScheduleofmaturitydatesofoutstandingloansTable" roleURI="http://www.beil.com/role/ScheduleofmaturitydatesofoutstandingloansTable"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_ScheduleofothercurrentliabiltiesTable" roleURI="http://www.beil.com/role/ScheduleofothercurrentliabiltiesTable"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_ScheduleofreconciliationofthefairvalueofderivativewarrantsliabilitiesTable" roleURI="http://www.beil.com/role/ScheduleofreconciliationofthefairvalueofderivativewarrantsliabilitiesTable"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_ScheduleofreconciliationofthecarryingamountoftheconvertibleadvanceinvestmentTable" roleURI="http://www.beil.com/role/ScheduleofreconciliationofthecarryingamountoftheconvertibleadvanceinvestmentTable"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_ScheduleoffutureminimumcommitmentunderbindingleaseagreeementsTable" roleURI="http://www.beil.com/role/ScheduleoffutureminimumcommitmentunderbindingleaseagreeementsTable"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_ScheduleofcompositionofshareholdersequityTable" roleURI="http://www.beil.com/role/ScheduleofcompositionofshareholdersequityTable"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_ScheduleofcompanysshareoptionactivityforemployeesandmembersoftheboardofdirectorsTable" roleURI="http://www.beil.com/role/ScheduleofcompanysshareoptionactivityforemployeesandmembersoftheboardofdirectorsTable"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_ScheduleofoutstandingandexercisableshareoptionsseparatedrangesofexercisepricesTable" roleURI="http://www.beil.com/role/ScheduleofoutstandingandexercisableshareoptionsseparatedrangesofexercisepricesTable"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_ScheduleofassumptionsusedtoestimatethefairvaluesoftheshareoptionsgrantedTable" roleURI="http://www.beil.com/role/ScheduleofassumptionsusedtoestimatethefairvaluesoftheshareoptionsgrantedTable"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_ScheduleofcompanysequitybasedawardsrecognizedTable" roleURI="http://www.beil.com/role/ScheduleofcompanysequitybasedawardsrecognizedTable"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_ScheduleoffinancingexpensesTable" roleURI="http://www.beil.com/role/ScheduleoffinancingexpensesTable"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_ScheduleofthereconciliationofthecarryingamountoftheCompanyTable" roleURI="http://www.beil.com/role/ScheduleofthereconciliationofthecarryingamountoftheCompanyTable"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_ScheduleofmaturitydatesTable" roleURI="http://www.beil.com/role/ScheduleofmaturitydatesTable"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_ScheduleofexpensesrelatedtoserviceagreementandtheofficeservicesagreementTable" roleURI="http://www.beil.com/role/ScheduleofexpensesrelatedtoserviceagreementandtheofficeservicesagreementTable"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_ScheduleoflossincomebeforetaxesonincomeTable" roleURI="http://www.beil.com/role/ScheduleoflossincomebeforetaxesonincomeTable"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_ScheduleofdeferredincometaxesreflectthenettaxeffectsofnetoperatinglossTable" roleURI="http://www.beil.com/role/ScheduleofdeferredincometaxesreflectthenettaxeffectsofnetoperatinglossTable"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_ScheduleofrevenuesbygeographicregionTable" roleURI="http://www.beil.com/role/ScheduleofrevenuesbygeographicregionTable"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_ScheduleofLonglivedassetsnetbygeographicareasTable" roleURI="http://www.beil.com/role/ScheduleofLonglivedassetsnetbygeographicareasTable"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_ScheduleofrevenuedisaggregatedbyprimarymajorproductlinesandservicesTable" roleURI="http://www.beil.com/role/ScheduleofrevenuedisaggregatedbyprimarymajorproductlinesandservicesTable"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_GeneralDetails" roleURI="http://www.beil.com/role/GeneralDetails"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_SignificantAccountingPoliciesDetails" roleURI="http://www.beil.com/role/SignificantAccountingPoliciesDetails"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_PropertyandEquipmentNetDetails" roleURI="http://www.beil.com/role/PropertyandEquipmentNetDetails"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_IntangibleAssetsNetandGoodwillDetails" roleURI="http://www.beil.com/role/IntangibleAssetsNetandGoodwillDetails"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_LoansNetDetails" roleURI="http://www.beil.com/role/LoansNetDetails"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_OtherCurrentLiabilitiesDetails" roleURI="http://www.beil.com/role/OtherCurrentLiabilitiesDetails"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_ConvertibleAdvanceInvestmentDetails" roleURI="http://www.beil.com/role/ConvertibleAdvanceInvestmentDetails"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_CommitmentsandContingentLiabilitiesDetails" roleURI="http://www.beil.com/role/CommitmentsandContingentLiabilitiesDetails"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_ShareholdersEquityDeficitDetails" roleURI="http://www.beil.com/role/ShareholdersEquityDeficitDetails"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_ShareOptionsDetails" roleURI="http://www.beil.com/role/ShareOptionsDetails"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_RelatedPartiesTransactionsDetails" roleURI="http://www.beil.com/role/RelatedPartiesTransactionsDetails"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_TaxesonIncomeDetails" roleURI="http://www.beil.com/role/TaxesonIncomeDetails"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_SegmentGeographicalInformationAndMajorCustomersDetails" roleURI="http://www.beil.com/role/SegmentGeographicalInformationAndMajorCustomersDetails"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_SubsequentEventsDetails" roleURI="http://www.beil.com/role/SubsequentEventsDetails"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#DocumentAndEntityInformation" roleURI="http://www.beil.com/role/DocumentAndEntityInformation"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all"/>
  <definitionLink xlink:type="extended" xlink:role="http://www.beil.com/role/ConsolidatedBalanceSheet">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_AssetsCurrentAbstract" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ReceivablesNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesNetCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_ReceivablesNetCurrent" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_OtherAssetsCurrent" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherAssetsCurrent" xlink:to="us-gaap_AssetsCurrent" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmr_NonCurrentAssetsAbstract" xlink:href="bmr-20221231.xsd#bmr_NonCurrentAssetsAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="bmr_NonCurrentAssetsAbstract" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCosts"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_NonCurrentAssetsAbstract" xlink:to="us-gaap_DeferredCosts" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_NonCurrentAssetsAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_NonCurrentAssetsAbstract" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_NonCurrentAssetsAbstract" xlink:to="us-gaap_Goodwill" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsNoncurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_Goodwill" xlink:to="us-gaap_AssetsNoncurrent" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_Assets" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermBorrowings" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermBorrowings"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_ShortTermBorrowings" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableCurrent" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredRevenueCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredRevenueCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_DeferredRevenueCurrent" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DueToRelatedPartiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueToRelatedPartiesCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_DueToRelatedPartiesCurrent" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_OtherLiabilitiesCurrent" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherLiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmr_NonCurrentLiabilitiesAbstract" xlink:href="bmr-20221231.xsd#bmr_NonCurrentLiabilitiesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="bmr_NonCurrentLiabilitiesAbstract" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LongTermDebtNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_NonCurrentLiabilitiesAbstract" xlink:to="us-gaap_LongTermDebtNoncurrent" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DueToRelatedPartiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueToRelatedPartiesNoncurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_NonCurrentLiabilitiesAbstract" xlink:to="us-gaap_DueToRelatedPartiesNoncurrent" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DerivativeLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilitiesNoncurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_NonCurrentLiabilitiesAbstract" xlink:to="us-gaap_DerivativeLiabilitiesNoncurrent" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmr_ConvertibleAdvancedInvestments" xlink:href="bmr-20221231.xsd#bmr_ConvertibleAdvancedInvestments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_NonCurrentLiabilitiesAbstract" xlink:to="bmr_ConvertibleAdvancedInvestments" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesNoncurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_ConvertibleAdvancedInvestments" xlink:to="us-gaap_LiabilitiesNoncurrent" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommitmentsAndContingencies" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmr_ShareholdersEquityDeficitAbstract" xlink:href="bmr-20221231.xsd#bmr_ShareholdersEquityDeficitAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="bmr_ShareholdersEquityDeficitAbstract" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_ShareholdersEquityDeficitAbstract" xlink:to="us-gaap_CommonStockValue" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmr_CommonStockValue1" xlink:href="bmr-20221231.xsd#bmr_CommonStockValue1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_ShareholdersEquityDeficitAbstract" xlink:to="bmr_CommonStockValue1" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_ShareholdersEquityDeficitAbstract" xlink:to="us-gaap_PreferredStockValue" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_ShareholdersEquityDeficitAbstract" xlink:to="us-gaap_AdditionalPaidInCapital" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_ShareholdersEquityDeficitAbstract" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_ShareholdersEquityDeficitAbstract" xlink:to="us-gaap_StockholdersEquity" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity" order="7" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.beil.com/role/ConsolidatedBalanceSheet_Parentheticals">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmr_ConvertibleOrdinary1And2SharesMember" xlink:href="bmr-20221231.xsd#bmr_ConvertibleOrdinary1And2SharesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="bmr_ConvertibleOrdinary1And2SharesMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesIssued" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesAuthorized" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesIssued" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesOutstanding" order="8" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.beil.com/role/ConsolidatedIncomeStatement">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_Revenues" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CostOfRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfRevenue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_CostOfRevenue" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GrossProfit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_GrossProfit" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SellingAndMarketingExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingAndMarketingExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_SellingAndMarketingExpense" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_GeneralAndAdministrativeExpense" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherOperatingIncomeExpenseNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOperatingIncomeExpenseNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_OtherOperatingIncomeExpenseNet" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_OperatingIncomeLoss" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FinancingInterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingInterestExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_FinancingInterestExpense" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_EarningsPerShareBasic" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" order="13" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.beil.com/role/ConsolidatedIncomeStatement_Parentheticals">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_EarningsPerShareDiluted" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.beil.com/role/ShareholdersEquityType2or3">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmr_ConvertibleOrdinary1And2SharesMember" xlink:href="bmr-20221231.xsd#bmr_ConvertibleOrdinary1And2SharesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="bmr_ConvertibleOrdinary1And2SharesMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmr_ConvertiblePreferredSharesMember" xlink:href="bmr-20221231.xsd#bmr_ConvertiblePreferredSharesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="bmr_ConvertiblePreferredSharesMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AdditionalPaidInCapitalMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_RetainedEarningsMember" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesOutstanding" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueOther"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueOther" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" order="8" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.beil.com/role/ConsolidatedCashFlow">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <loc xlink:type="locator" xlink:label="bmr_CashFlowsFromOperatingActivitiesAbstract" xlink:href="bmr-20221231.xsd#bmr_CashFlowsFromOperatingActivitiesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="bmr_CashFlowsFromOperatingActivitiesAbstract" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_CashFlowsFromOperatingActivitiesAbstract" xlink:to="us-gaap_NetIncomeLoss" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmr_AdjustmentsRequiredToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract" xlink:href="bmr-20221231.xsd#bmr_AdjustmentsRequiredToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_CashFlowsFromOperatingActivitiesAbstract" xlink:to="bmr_AdjustmentsRequiredToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_AdjustmentsRequiredToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_DepreciationDepletionAndAmortization" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_AdjustmentsRequiredToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ShareBasedCompensation" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AmortizationOfDebtDiscountPremium" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfDebtDiscountPremium"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_AdjustmentsRequiredToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AmortizationOfDebtDiscountPremium" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_AdjustmentsRequiredToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AmortizationOfFinancingCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_AdjustmentsRequiredToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AmortizationOfFinancingCosts" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueOptionChangesInFairValueGainLoss1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOptionChangesInFairValueGainLoss1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_AdjustmentsRequiredToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_FairValueOptionChangesInFairValueGainLoss1" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_AdjustmentsRequiredToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_GainLossOnSaleOfPropertyPlantEquipment" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GainLossOnDispositionOfAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnDispositionOfAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_AdjustmentsRequiredToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_GainLossOnDispositionOfAssets" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmr_ModificationOfTermsOfStraightLoan" xlink:href="bmr-20221231.xsd#bmr_ModificationOfTermsOfStraightLoan"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_AdjustmentsRequiredToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract" xlink:to="bmr_ModificationOfTermsOfStraightLoan" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GainsLossesOnRestructuringOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnRestructuringOfDebt"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_AdjustmentsRequiredToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_GainsLossesOnRestructuringOfDebt" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOtherReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherReceivables"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_AdjustmentsRequiredToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInOtherReceivables" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherCurrentAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_AdjustmentsRequiredToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInOtherCurrentAssets" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_AdjustmentsRequiredToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_AdjustmentsRequiredToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInDeferredRevenue" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInDueFromRelatedParties" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDueFromRelatedParties"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_AdjustmentsRequiredToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInDueFromRelatedParties" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherCurrentLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_AdjustmentsRequiredToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_CashFlowsFromOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmr_CashFlowsFromInvestingActivitiesAbstract" xlink:href="bmr-20221231.xsd#bmr_CashFlowsFromInvestingActivitiesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="bmr_CashFlowsFromInvestingActivitiesAbstract" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_CashFlowsFromInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_CashFlowsFromInvestingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_CashFlowsFromInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmr_CashFlowsFromFinancingActivitiesAbstract" xlink:href="bmr-20221231.xsd#bmr_CashFlowsFromFinancingActivitiesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="bmr_CashFlowsFromFinancingActivitiesAbstract" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsOfFinancingCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfFinancingCosts"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_CashFlowsFromFinancingActivitiesAbstract" xlink:to="us-gaap_PaymentsOfFinancingCosts" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_CashFlowsFromFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromNotesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromNotesPayable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_CashFlowsFromFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromNotesPayable" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RepaymentsOfRelatedPartyDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfRelatedPartyDebt"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_CashFlowsFromFinancingActivitiesAbstract" xlink:to="us-gaap_RepaymentsOfRelatedPartyDebt" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RepaymentsOfFederalHomeLoanBankBorrowings" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfFederalHomeLoanBankBorrowings"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_CashFlowsFromFinancingActivitiesAbstract" xlink:to="us-gaap_RepaymentsOfFederalHomeLoanBankBorrowings" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_CashFlowsFromFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOfPrivatePlacement" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromRelatedPartyDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRelatedPartyDebt"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_CashFlowsFromFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromRelatedPartyDebt" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_CashFlowsFromFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromStockOptionsExercised" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_CashFlowsFromFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmr_NonCashFinancingActivitiesAbstract" xlink:href="bmr-20221231.xsd#bmr_NonCashFinancingActivitiesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="bmr_NonCashFinancingActivitiesAbstract" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssued1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssued1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_NonCashFinancingActivitiesAbstract" xlink:to="us-gaap_StockIssued1" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmr_SupplementalDisclosureOfCashFlowInformationAbstract" xlink:href="bmr-20221231.xsd#bmr_SupplementalDisclosureOfCashFlowInformationAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="bmr_SupplementalDisclosureOfCashFlowInformationAbstract" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_SupplementalDisclosureOfCashFlowInformationAbstract" xlink:to="us-gaap_InterestPaidNet" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxesPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaid"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_SupplementalDisclosureOfCashFlowInformationAbstract" xlink:to="us-gaap_IncomeTaxesPaid" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.beil.com/role/General">
    <loc xlink:type="locator" xlink:label="bmr_GeneralAbstract" xlink:href="bmr-20221231.xsd#bmr_GeneralAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_GeneralAbstract" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.beil.com/role/SignificantAccountingPolicies">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.beil.com/role/OtherCurrentAssets">
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureTextBlockSupplementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureTextBlockSupplementAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherCurrentAssetsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCurrentAssetsTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisclosureTextBlockSupplementAbstract" xlink:to="us-gaap_OtherCurrentAssetsTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.beil.com/role/PropertyandEquipmentNet">
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.beil.com/role/IntangibleAssetsNetandGoodwill">
    <loc xlink:type="locator" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.beil.com/role/LoansNet">
    <loc xlink:type="locator" xlink:label="us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.beil.com/role/OtherCurrentLiabilities">
    <loc xlink:type="locator" xlink:label="us-gaap_OtherLiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesCurrentAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherLiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.beil.com/role/DerivativeWarrantsLiabilities">
    <loc xlink:type="locator" xlink:label="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.beil.com/role/ConvertibleAdvanceInvestment">
    <loc xlink:type="locator" xlink:label="bmr_InvestmentHoldingsAbstract" xlink:href="bmr-20221231.xsd#bmr_InvestmentHoldingsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentHoldingsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentHoldingsTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_InvestmentHoldingsAbstract" xlink:to="us-gaap_InvestmentHoldingsTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.beil.com/role/CommitmentsandContingentLiabilities">
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.beil.com/role/ShareholdersEquityDeficit">
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.beil.com/role/ShareOptions">
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.beil.com/role/FinancingExpensesNet">
    <loc xlink:type="locator" xlink:label="bmr_FinancingExpensesAbstract" xlink:href="bmr-20221231.xsd#bmr_FinancingExpensesAbstract"/>
    <loc xlink:type="locator" xlink:label="bmr_FinancingExpenses" xlink:href="bmr-20221231.xsd#bmr_FinancingExpenses"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_FinancingExpensesAbstract" xlink:to="bmr_FinancingExpenses" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.beil.com/role/RelatedPartiesTransactions">
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.beil.com/role/TaxesonIncome">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.beil.com/role/SegmentGeographicalInformationAndMajorCustomers">
    <loc xlink:type="locator" xlink:label="us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_SegmentReportingDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.beil.com/role/SubsequentEvents">
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.beil.com/role/AccountingPoliciesByPolicy">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_UseOfEstimates" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConsolidationPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ConsolidationPolicyTextBlock" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredChargesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredChargesPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_DeferredChargesPolicyTextBlock" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_LesseeLeasesPolicyTextBlock" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_IncomeTaxPolicyTextBlock" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PostemploymentBenefitPlansPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PostemploymentBenefitPlansPolicy"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_PostemploymentBenefitPlansPolicy" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesPolicyTextBlock" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmr_ConcentrationOfCreditRiskPolicyTextBlock" xlink:href="bmr-20221231.xsd#bmr_ConcentrationOfCreditRiskPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="bmr_ConcentrationOfCreditRiskPolicyTextBlock" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmr_ConvertibleOrdinary1And2SharesAndPreferredSharesPolicyTextBlock" xlink:href="bmr-20221231.xsd#bmr_ConvertibleOrdinary1And2SharesAndPreferredSharesPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="bmr_ConvertibleOrdinary1And2SharesAndPreferredSharesPolicyTextBlock" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmr_AllocationOfProceedsAndRelatedIssuanceCostsPolicyTextBlock" xlink:href="bmr-20221231.xsd#bmr_AllocationOfProceedsAndRelatedIssuanceCostsPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="bmr_AllocationOfProceedsAndRelatedIssuanceCostsPolicyTextBlock" order="16" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmr_WarrantsPolicyTextBlock" xlink:href="bmr-20221231.xsd#bmr_WarrantsPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="bmr_WarrantsPolicyTextBlock" order="17" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DerivativesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_DerivativesPolicyTextBlock" order="18" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmr_ModificationsOrExchangeOfLoansPolicyTextBlock" xlink:href="bmr-20221231.xsd#bmr_ModificationsOrExchangeOfLoansPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="bmr_ModificationsOrExchangeOfLoansPolicyTextBlock" order="19" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock" order="20" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmr_ConvertibleAdvanceInvestmentsPolicyTextBlock" xlink:href="bmr-20221231.xsd#bmr_ConvertibleAdvanceInvestmentsPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="bmr_ConvertibleAdvanceInvestmentsPolicyTextBlock" order="21" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmr_CapitalContributionFromAControllingShareholderPolicyTextBlock" xlink:href="bmr-20221231.xsd#bmr_CapitalContributionFromAControllingShareholderPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="bmr_CapitalContributionFromAControllingShareholderPolicyTextBlock" order="22" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" order="23" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.beil.com/role/SignificantAccountingPoliciesTables">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentAndIntangibleAssetsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAndIntangibleAssetsTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentAndIntangibleAssetsTextBlock" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.beil.com/role/OtherCurrentAssetsTables">
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureTextBlockSupplementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureTextBlockSupplementAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisclosureTextBlockSupplementAbstract" xlink:to="us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.beil.com/role/PropertyandEquipmentNetTables">
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.beil.com/role/IntangibleAssetsNetandGoodwillTables">
    <loc xlink:type="locator" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfImpairedIntangibleAssetsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfImpairedIntangibleAssetsTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_ScheduleOfImpairedIntangibleAssetsTextBlock" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.beil.com/role/LoansNetTables">
    <loc xlink:type="locator" xlink:label="us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="bmr_ScheduleOfTheMemberEffectiveDateManagementByAssistanceOfThirdpartyTableTextBlock" xlink:href="bmr-20221231.xsd#bmr_ScheduleOfTheMemberEffectiveDateManagementByAssistanceOfThirdpartyTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="bmr_ScheduleOfTheMemberEffectiveDateManagementByAssistanceOfThirdpartyTableTextBlock" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmr_ScheduleOfPresentationReflectsTheReconciliationOfTheCarryingAmountTableTextBlock" xlink:href="bmr-20221231.xsd#bmr_ScheduleOfPresentationReflectsTheReconciliationOfTheCarryingAmountTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="bmr_ScheduleOfPresentationReflectsTheReconciliationOfTheCarryingAmountTableTextBlock" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmr_ScheduleOfMaturityDatesOfOutstandingLoanTableTextBlock" xlink:href="bmr-20221231.xsd#bmr_ScheduleOfMaturityDatesOfOutstandingLoanTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="bmr_ScheduleOfMaturityDatesOfOutstandingLoanTableTextBlock" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.beil.com/role/OtherCurrentLiabilitiesTables">
    <loc xlink:type="locator" xlink:label="us-gaap_OtherLiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesCurrentAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCurrentLiabilitiesTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherLiabilitiesCurrentAbstract" xlink:to="us-gaap_OtherCurrentLiabilitiesTableTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.beil.com/role/DerivativeWarrantsLiabilitiesTables">
    <loc xlink:type="locator" xlink:label="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.beil.com/role/ConvertibleAdvanceInvestmentTables">
    <loc xlink:type="locator" xlink:label="bmr_InvestmentHoldingsAbstract" xlink:href="bmr-20221231.xsd#bmr_InvestmentHoldingsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_InvestmentHoldingsAbstract" xlink:to="us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.beil.com/role/CommitmentsandContingentLiabilitiesTables">
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="bmr_scheduleOfFutureMinimumCommitmentUnderBindingLeaseAgreeementsTableTextBlock" xlink:href="bmr-20221231.xsd#bmr_scheduleOfFutureMinimumCommitmentUnderBindingLeaseAgreeementsTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="bmr_scheduleOfFutureMinimumCommitmentUnderBindingLeaseAgreeementsTableTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.beil.com/role/ShareholdersEquityDeficitTables">
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfStockholdersEquityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockholdersEquityTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_ScheduleOfStockholdersEquityTableTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.beil.com/role/ShareOptionsTables">
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.beil.com/role/FinancingExpensesNetTables">
    <loc xlink:type="locator" xlink:label="bmr_FinancingExpensesAbstract" xlink:href="bmr-20221231.xsd#bmr_FinancingExpensesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertibleDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_FinancingExpensesAbstract" xlink:to="us-gaap_ConvertibleDebtTableTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.beil.com/role/RelatedPartiesTransactionsTables">
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfRegulatoryLiabilitiesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRegulatoryLiabilitiesTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_ScheduleOfRegulatoryLiabilitiesTextBlock" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.beil.com/role/TaxesonIncomeTables">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.beil.com/role/SegmentGeographicalInformationAndMajorCustomersTables">
    <loc xlink:type="locator" xlink:label="us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_DisaggregationOfRevenueTableTextBlock" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.beil.com/role/ScheduleofcomputingstraightlineamortizationTable">
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TechnologyEquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TechnologyEquipmentMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_TechnologyEquipmentMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CustomerRelationshipsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_CustomerRelationshipsMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TradeNamesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_TradeNamesMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmr_PropertyPlantAndEquipmentDepreciationPercentage" xlink:href="bmr-20221231.xsd#bmr_PropertyPlantAndEquipmentDepreciationPercentage"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="bmr_PropertyPlantAndEquipmentDepreciationPercentage" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.beil.com/role/ScheduleofcomputingstraightlinedepreciationTable">
    <loc xlink:type="locator" xlink:label="bmr_SignificantAccountingPoliciesDetailsScheduleofcomputingstraightlinedepreciationLineItems" xlink:href="bmr-20221231.xsd#bmr_SignificantAccountingPoliciesDetailsScheduleofcomputingstraightlinedepreciationLineItems"/>
    <loc xlink:type="locator" xlink:label="bmr_SignificantAccountingPoliciesDetailsScheduleofcomputingstraightlinedepreciationTable" xlink:href="bmr-20221231.xsd#bmr_SignificantAccountingPoliciesDetailsScheduleofcomputingstraightlinedepreciationTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="bmr_SignificantAccountingPoliciesDetailsScheduleofcomputingstraightlinedepreciationLineItems" xlink:to="bmr_SignificantAccountingPoliciesDetailsScheduleofcomputingstraightlinedepreciationTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="bmr_SignificantAccountingPoliciesDetailsScheduleofcomputingstraightlinedepreciationTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="bmr_SignificantAccountingPoliciesDetailsScheduleofcomputingstraightlinedepreciationTable" xlink:to="srt_RangeAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember_0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmr_CompareAndPeripheralEquipmentMember" xlink:href="bmr-20221231.xsd#bmr_CompareAndPeripheralEquipmentMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="bmr_CompareAndPeripheralEquipmentMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmr_OfficeFurnitureAndEquipmentMember" xlink:href="bmr-20221231.xsd#bmr_OfficeFurnitureAndEquipmentMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="bmr_OfficeFurnitureAndEquipmentMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentSalvageValuePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentSalvageValuePercentage"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_SignificantAccountingPoliciesDetailsScheduleofcomputingstraightlinedepreciationLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentSalvageValuePercentage" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.beil.com/role/ScheduleofothercurrentassetsTable">
    <loc xlink:type="locator" xlink:label="bmr_ScheduleOfOtherCurrentAssetsAbstract" xlink:href="bmr-20221231.xsd#bmr_ScheduleOfOtherCurrentAssetsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseCurrentAndNoncurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_ScheduleOfOtherCurrentAssetsAbstract" xlink:to="us-gaap_PrepaidExpenseCurrentAndNoncurrent" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmr_GovernmentAuthoritiesAssets" xlink:href="bmr-20221231.xsd#bmr_GovernmentAuthoritiesAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_ScheduleOfOtherCurrentAssetsAbstract" xlink:to="bmr_GovernmentAuthoritiesAssets" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherPrepaidExpenseCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherPrepaidExpenseCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_ScheduleOfOtherCurrentAssetsAbstract" xlink:to="us-gaap_OtherPrepaidExpenseCurrent" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_ScheduleOfOtherCurrentAssetsAbstract" xlink:to="us-gaap_OtherAssetsCurrent" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.beil.com/role/ScheduleofpropertyandequipmentnetTable">
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ComputerEquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComputerEquipmentMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_ComputerEquipmentMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OfficeEquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OfficeEquipmentMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_OfficeEquipmentMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentGross" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.beil.com/role/ScheduleofintangibleassetsnetandgoodwilTable">
    <loc xlink:type="locator" xlink:label="bmr_IntangibleAssetsNetandGoodwillDetailsScheduleofintangibleassetsnetandgoodwilLineItems" xlink:href="bmr-20221231.xsd#bmr_IntangibleAssetsNetandGoodwillDetailsScheduleofintangibleassetsnetandgoodwilLineItems"/>
    <loc xlink:type="locator" xlink:label="bmr_IntangibleAssetsNetandGoodwillDetailsScheduleofintangibleassetsnetandgoodwilTable" xlink:href="bmr-20221231.xsd#bmr_IntangibleAssetsNetandGoodwillDetailsScheduleofintangibleassetsnetandgoodwilTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="bmr_IntangibleAssetsNetandGoodwillDetailsScheduleofintangibleassetsnetandgoodwilLineItems" xlink:to="bmr_IntangibleAssetsNetandGoodwillDetailsScheduleofintangibleassetsnetandgoodwilTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="bmr_IntangibleAssetsNetandGoodwillDetailsScheduleofintangibleassetsnetandgoodwilTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmr_TechnologyMember" xlink:href="bmr-20221231.xsd#bmr_TechnologyMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="bmr_TechnologyMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CustomerRelationshipsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_CustomerRelationshipsMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TradeNamesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_TradeNamesMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmr_CarryingAmountAbstract" xlink:href="bmr-20221231.xsd#bmr_CarryingAmountAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_IntangibleAssetsNetandGoodwillDetailsScheduleofintangibleassetsnetandgoodwilLineItems" xlink:to="bmr_CarryingAmountAbstract" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsUnderManagementCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsUnderManagementCarryingAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_CarryingAmountAbstract" xlink:to="us-gaap_AssetsUnderManagementCarryingAmount" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmr_AccumulatedAmortizationAbstract" xlink:href="bmr-20221231.xsd#bmr_AccumulatedAmortizationAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_IntangibleAssetsNetandGoodwillDetailsScheduleofintangibleassetsnetandgoodwilLineItems" xlink:to="bmr_AccumulatedAmortizationAbstract" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccumulatedAmortizationDeferredFinanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedAmortizationDeferredFinanceCosts"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_AccumulatedAmortizationAbstract" xlink:to="us-gaap_AccumulatedAmortizationDeferredFinanceCosts" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIntangibleAssetsNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_IntangibleAssetsNetandGoodwillDetailsScheduleofintangibleassetsnetandgoodwilLineItems" xlink:to="us-gaap_OtherIntangibleAssetsNet" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.beil.com/role/ScheduleoftheestimatedfutureamortizationexpenseofintangibleassetsTable">
    <loc xlink:type="locator" xlink:label="bmr_ScheduleOfTheEstimatedFutureAmortizationExpenseOfIntangibleAssetsAbstract" xlink:href="bmr-20221231.xsd#bmr_ScheduleOfTheEstimatedFutureAmortizationExpenseOfIntangibleAssetsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_ScheduleOfTheEstimatedFutureAmortizationExpenseOfIntangibleAssetsAbstract" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_ScheduleOfTheEstimatedFutureAmortizationExpenseOfIntangibleAssetsAbstract" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_ScheduleOfTheEstimatedFutureAmortizationExpenseOfIntangibleAssetsAbstract" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.beil.com/role/ScheduleoftheEffectiveDatemanagementbyassistanceofthirdpartyTable">
    <loc xlink:type="locator" xlink:label="bmr_ScheduleOfTheEffectiveDateManagementByAssistanceOfThirdPartyAbstract" xlink:href="bmr-20221231.xsd#bmr_ScheduleOfTheEffectiveDateManagementByAssistanceOfThirdPartyAbstract"/>
    <loc xlink:type="locator" xlink:label="bmr_DerivativeWarrantLiabilityseeNote8" xlink:href="bmr-20221231.xsd#bmr_DerivativeWarrantLiabilityseeNote8"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_ScheduleOfTheEffectiveDateManagementByAssistanceOfThirdPartyAbstract" xlink:to="bmr_DerivativeWarrantLiabilityseeNote8" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StraightLineRent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StraightLineRent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_ScheduleOfTheEffectiveDateManagementByAssistanceOfThirdPartyAbstract" xlink:to="us-gaap_StraightLineRent" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmr_TotalGrossConsideration" xlink:href="bmr-20221231.xsd#bmr_TotalGrossConsideration"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_ScheduleOfTheEffectiveDateManagementByAssistanceOfThirdPartyAbstract" xlink:to="bmr_TotalGrossConsideration" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.beil.com/role/ScheduleofthereconciliationofthecarryingamountTable">
    <loc xlink:type="locator" xlink:label="bmr_ScheduleOfTheReconciliationOfTheCarryingAmountAbstract" xlink:href="bmr-20221231.xsd#bmr_ScheduleOfTheReconciliationOfTheCarryingAmountAbstract"/>
    <loc xlink:type="locator" xlink:label="bmr_ReconciliationOfTheCarryingAmount" xlink:href="bmr-20221231.xsd#bmr_ReconciliationOfTheCarryingAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_ScheduleOfTheReconciliationOfTheCarryingAmountAbstract" xlink:to="bmr_ReconciliationOfTheCarryingAmount" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmr_ConsiderationReceivedFromPPPNote" xlink:href="bmr-20221231.xsd#bmr_ConsiderationReceivedFromPPPNote"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_ScheduleOfTheReconciliationOfTheCarryingAmountAbstract" xlink:to="bmr_ConsiderationReceivedFromPPPNote" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmr_NetConsiderationReceivedFromIBILoan" xlink:href="bmr-20221231.xsd#bmr_NetConsiderationReceivedFromIBILoan"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_ScheduleOfTheReconciliationOfTheCarryingAmountAbstract" xlink:to="bmr_NetConsiderationReceivedFromIBILoan" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DerivativeLiabilityFairValueOfCollateral" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilityFairValueOfCollateral"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_ScheduleOfTheReconciliationOfTheCarryingAmountAbstract" xlink:to="us-gaap_DerivativeLiabilityFairValueOfCollateral" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentDecreaseForgiveness" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentDecreaseForgiveness"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_ScheduleOfTheReconciliationOfTheCarryingAmountAbstract" xlink:to="us-gaap_DebtInstrumentDecreaseForgiveness" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_ScheduleOfTheReconciliationOfTheCarryingAmountAbstract" xlink:to="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesFairValueDisclosure"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_ScheduleOfTheReconciliationOfTheCarryingAmountAbstract" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesFairValueDisclosure" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RepaymentsOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfDebt"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_ScheduleOfTheReconciliationOfTheCarryingAmountAbstract" xlink:to="us-gaap_RepaymentsOfDebt" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LoanProcessingFee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoanProcessingFee"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_ScheduleOfTheReconciliationOfTheCarryingAmountAbstract" xlink:to="us-gaap_LoanProcessingFee" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RepaymentsOfOtherLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfOtherLongTermDebt"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_ScheduleOfTheReconciliationOfTheCarryingAmountAbstract" xlink:to="us-gaap_RepaymentsOfOtherLongTermDebt" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ExtinguishmentOfDebtAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExtinguishmentOfDebtAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_ScheduleOfTheReconciliationOfTheCarryingAmountAbstract" xlink:to="us-gaap_ExtinguishmentOfDebtAmount" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmr_RecognitionSubsequentToSubstantialModificationOfTerms" xlink:href="bmr-20221231.xsd#bmr_RecognitionSubsequentToSubstantialModificationOfTerms"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_ScheduleOfTheReconciliationOfTheCarryingAmountAbstract" xlink:to="bmr_RecognitionSubsequentToSubstantialModificationOfTerms" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_ScheduleOfTheReconciliationOfTheCarryingAmountAbstract" xlink:to="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmr_ReconciliationOfCarryingAmount" xlink:href="bmr-20221231.xsd#bmr_ReconciliationOfCarryingAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_ScheduleOfTheReconciliationOfTheCarryingAmountAbstract" xlink:to="bmr_ReconciliationOfCarryingAmount" order="13" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.beil.com/role/ScheduleofmaturitydatesofoutstandingloansTable">
    <loc xlink:type="locator" xlink:label="bmr_ScheduleOfMaturityDatesOfOutstandingLoansAbstract" xlink:href="bmr-20221231.xsd#bmr_ScheduleOfMaturityDatesOfOutstandingLoansAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_ScheduleOfMaturityDatesOfOutstandingLoansAbstract" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_ScheduleOfMaturityDatesOfOutstandingLoansAbstract" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_ScheduleOfMaturityDatesOfOutstandingLoansAbstract" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_ScheduleOfMaturityDatesOfOutstandingLoansAbstract" xlink:to="us-gaap_LongTermDebt" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.beil.com/role/ScheduleofothercurrentliabiltiesTable">
    <loc xlink:type="locator" xlink:label="bmr_ScheduleOfOtherCurrentLiabiltiesAbstract" xlink:href="bmr-20221231.xsd#bmr_ScheduleOfOtherCurrentLiabiltiesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_ScheduleOfOtherCurrentLiabiltiesAbstract" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_ScheduleOfOtherCurrentLiabiltiesAbstract" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmr_GovernmentAuthorities" xlink:href="bmr-20221231.xsd#bmr_GovernmentAuthorities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_ScheduleOfOtherCurrentLiabiltiesAbstract" xlink:to="bmr_GovernmentAuthorities" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_ScheduleOfOtherCurrentLiabiltiesAbstract" xlink:to="us-gaap_OtherLiabilitiesCurrent" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.beil.com/role/ScheduleofreconciliationofthefairvalueofderivativewarrantsliabilitiesTable">
    <loc xlink:type="locator" xlink:label="bmr_ScheduleOfReconciliationOfTheFairValueOfDerivativeWarrantsLiabilitiesAbstract" xlink:href="bmr-20221231.xsd#bmr_ScheduleOfReconciliationOfTheFairValueOfDerivativeWarrantsLiabilitiesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DerivativeFairValueOfDerivativeNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_ScheduleOfReconciliationOfTheFairValueOfDerivativeWarrantsLiabilitiesAbstract" xlink:to="us-gaap_DerivativeFairValueOfDerivativeNet" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_ScheduleOfReconciliationOfTheFairValueOfDerivativeWarrantsLiabilitiesAbstract" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentOfWarrantsGrantedForServices" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentOfWarrantsGrantedForServices"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_ScheduleOfReconciliationOfTheFairValueOfDerivativeWarrantsLiabilitiesAbstract" xlink:to="us-gaap_AdjustmentOfWarrantsGrantedForServices" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.beil.com/role/ScheduleofreconciliationofthecarryingamountoftheconvertibleadvanceinvestmentTable">
    <loc xlink:type="locator" xlink:label="bmr_ScheduleOfReconciliationOfTheCarryingAmountOfTheConvertibleAdvanceInvestmentAbstract" xlink:href="bmr-20221231.xsd#bmr_ScheduleOfReconciliationOfTheCarryingAmountOfTheConvertibleAdvanceInvestmentAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertibleDebtFairValueDisclosures" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtFairValueDisclosures"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_ScheduleOfReconciliationOfTheCarryingAmountOfTheConvertibleAdvanceInvestmentAbstract" xlink:to="us-gaap_ConvertibleDebtFairValueDisclosures" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_ScheduleOfReconciliationOfTheCarryingAmountOfTheConvertibleAdvanceInvestmentAbstract" xlink:to="us-gaap_NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmr_ChangeInTheFairValueOfConvertibleAdvanceInvestments" xlink:href="bmr-20221231.xsd#bmr_ChangeInTheFairValueOfConvertibleAdvanceInvestments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_ScheduleOfReconciliationOfTheCarryingAmountOfTheConvertibleAdvanceInvestmentAbstract" xlink:to="bmr_ChangeInTheFairValueOfConvertibleAdvanceInvestments" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.beil.com/role/ScheduleoffutureminimumcommitmentunderbindingleaseagreeementsTable">
    <loc xlink:type="locator" xlink:label="bmr_ScheduleOfFutureMinimumCommitmentUnderBindingLeaseAgreeementsAbstract" xlink:href="bmr-20221231.xsd#bmr_ScheduleOfFutureMinimumCommitmentUnderBindingLeaseAgreeementsAbstract"/>
    <loc xlink:type="locator" xlink:label="bmr_LesseeOperatingLeasesLiabilityPaymentsDueNextTwelveMonths" xlink:href="bmr-20221231.xsd#bmr_LesseeOperatingLeasesLiabilityPaymentsDueNextTwelveMonths"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_ScheduleOfFutureMinimumCommitmentUnderBindingLeaseAgreeementsAbstract" xlink:to="bmr_LesseeOperatingLeasesLiabilityPaymentsDueNextTwelveMonths" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmr_LesseeOperatingLeasesLiabilityPaymentsDue" xlink:href="bmr-20221231.xsd#bmr_LesseeOperatingLeasesLiabilityPaymentsDue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_ScheduleOfFutureMinimumCommitmentUnderBindingLeaseAgreeementsAbstract" xlink:to="bmr_LesseeOperatingLeasesLiabilityPaymentsDue" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.beil.com/role/ScheduleofcompositionofshareholdersequityTable">
    <loc xlink:type="locator" xlink:label="bmr_ShareholdersEquityDeficitDetailsScheduleofcompositionofshareholdersequityLineItems" xlink:href="bmr-20221231.xsd#bmr_ShareholdersEquityDeficitDetailsScheduleofcompositionofshareholdersequityLineItems"/>
    <loc xlink:type="locator" xlink:label="bmr_ShareholdersEquityDeficitDetailsScheduleofcompositionofshareholdersequityTable" xlink:href="bmr-20221231.xsd#bmr_ShareholdersEquityDeficitDetailsScheduleofcompositionofshareholdersequityTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="bmr_ShareholdersEquityDeficitDetailsScheduleofcompositionofshareholdersequityLineItems" xlink:to="bmr_ShareholdersEquityDeficitDetailsScheduleofcompositionofshareholdersequityTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="bmr_ShareholdersEquityDeficitDetailsScheduleofcompositionofshareholdersequityTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmr_SeriesOrdinarySharesMember" xlink:href="bmr-20221231.xsd#bmr_SeriesOrdinarySharesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="bmr_SeriesOrdinarySharesMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmr_SeriesConvertibleOrdinary1SharesMember" xlink:href="bmr-20221231.xsd#bmr_SeriesConvertibleOrdinary1SharesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="bmr_SeriesConvertibleOrdinary1SharesMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmr_SeriesConvertibleOrdinary2SharesMember" xlink:href="bmr-20221231.xsd#bmr_SeriesConvertibleOrdinary2SharesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="bmr_SeriesConvertibleOrdinary2SharesMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmr_SeriesConvertibleBPreferredSharesMember" xlink:href="bmr-20221231.xsd#bmr_SeriesConvertibleBPreferredSharesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="bmr_SeriesConvertibleBPreferredSharesMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmr_SeriesConvertibleB1PreferredSharesBMember" xlink:href="bmr-20221231.xsd#bmr_SeriesConvertibleB1PreferredSharesBMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="bmr_SeriesConvertibleB1PreferredSharesBMember" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmr_SeriesConvertibleCPreferredSharesMember" xlink:href="bmr-20221231.xsd#bmr_SeriesConvertibleCPreferredSharesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="bmr_SeriesConvertibleCPreferredSharesMember" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmr_NumberOfSharesAbstract" xlink:href="bmr-20221231.xsd#bmr_NumberOfSharesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_ShareholdersEquityDeficitDetailsScheduleofcompositionofshareholdersequityLineItems" xlink:to="bmr_NumberOfSharesAbstract" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ExcessStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExcessStockSharesAuthorized"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_NumberOfSharesAbstract" xlink:to="us-gaap_ExcessStockSharesAuthorized" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmr_ExcessSharesIssuedAndOutstandingShares" xlink:href="bmr-20221231.xsd#bmr_ExcessSharesIssuedAndOutstandingShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_NumberOfSharesAbstract" xlink:to="bmr_ExcessSharesIssuedAndOutstandingShares" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.beil.com/role/ScheduleofcompanysshareoptionactivityforemployeesandmembersoftheboardofdirectorsTable">
    <loc xlink:type="locator" xlink:label="bmr_ScheduleOfCompanySShareOptionActivityForEmployeesAndMembersOfTheBoardOfDirectorsAbstract" xlink:href="bmr-20221231.xsd#bmr_ScheduleOfCompanySShareOptionActivityForEmployeesAndMembersOfTheBoardOfDirectorsAbstract"/>
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt/tSeJz73kx1cLt0ZFF2SK/vxBCY0vdSrZb6DUpe9prgZNYqdZsfXqxEEXb49NXhOeJEcoYxL52lqzrxV1ixmGk3x5z3C+boGMFyF1bCAC6SzXA8EeoS+J4OsCx1oPIoujQb0ZEh03dOL9+qx7qvcGHsJ6a9scdOGp0N/fSOils3JiDVUH+POJSLwkIXq+NgTrCVG8rYfDvkQSvrvKPWWMVVU9+bmCyNY/IFZmUYME5kA==] CSR-->
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_ScheduleOfCompanySShareOptionActivityForEmployeesAndMembersOfTheBoardOfDirectorsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_ScheduleOfCompanySShareOptionActivityForEmployeesAndMembersOfTheBoardOfDirectorsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_ScheduleOfCompanySShareOptionActivityForEmployeesAndMembersOfTheBoardOfDirectorsAbstract" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_ScheduleOfCompanySShareOptionActivityForEmployeesAndMembersOfTheBoardOfDirectorsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_ScheduleOfCompanySShareOptionActivityForEmployeesAndMembersOfTheBoardOfDirectorsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_ScheduleOfCompanySShareOptionActivityForEmployeesAndMembersOfTheBoardOfDirectorsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmr_WeightedAverageRemainingContractualLifeGranted" xlink:href="bmr-20221231.xsd#bmr_WeightedAverageRemainingContractualLifeGranted"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_ScheduleOfCompanySShareOptionActivityForEmployeesAndMembersOfTheBoardOfDirectorsAbstract" xlink:to="bmr_WeightedAverageRemainingContractualLifeGranted" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_ScheduleOfCompanySShareOptionActivityForEmployeesAndMembersOfTheBoardOfDirectorsAbstract" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_ScheduleOfCompanySShareOptionActivityForEmployeesAndMembersOfTheBoardOfDirectorsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmr_WeightedAverageRemainingContractualLifeExercised" xlink:href="bmr-20221231.xsd#bmr_WeightedAverageRemainingContractualLifeExercised"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_ScheduleOfCompanySShareOptionActivityForEmployeesAndMembersOfTheBoardOfDirectorsAbstract" xlink:to="bmr_WeightedAverageRemainingContractualLifeExercised" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_ScheduleOfCompanySShareOptionActivityForEmployeesAndMembersOfTheBoardOfDirectorsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_ScheduleOfCompanySShareOptionActivityForEmployeesAndMembersOfTheBoardOfDirectorsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmr_WeightedAverageRemainingContractualLifeForfeitedOrExpired" xlink:href="bmr-20221231.xsd#bmr_WeightedAverageRemainingContractualLifeForfeitedOrExpired"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_ScheduleOfCompanySShareOptionActivityForEmployeesAndMembersOfTheBoardOfDirectorsAbstract" xlink:to="bmr_WeightedAverageRemainingContractualLifeForfeitedOrExpired" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmr_WeightedAverageRemainingContractualLifeOutstanding" xlink:href="bmr-20221231.xsd#bmr_WeightedAverageRemainingContractualLifeOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_ScheduleOfCompanySShareOptionActivityForEmployeesAndMembersOfTheBoardOfDirectorsAbstract" xlink:to="bmr_WeightedAverageRemainingContractualLifeOutstanding" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_ScheduleOfCompanySShareOptionActivityForEmployeesAndMembersOfTheBoardOfDirectorsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_ScheduleOfCompanySShareOptionActivityForEmployeesAndMembersOfTheBoardOfDirectorsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_ScheduleOfCompanySShareOptionActivityForEmployeesAndMembersOfTheBoardOfDirectorsAbstract" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" order="16" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_ScheduleOfCompanySShareOptionActivityForEmployeesAndMembersOfTheBoardOfDirectorsAbstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" order="17" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.beil.com/role/ScheduleofoutstandingandexercisableshareoptionsseparatedrangesofexercisepricesTable">
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="us-gaap_AwardTypeAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmr_ExercisePrice0000Member" xlink:href="bmr-20221231.xsd#bmr_ExercisePrice0000Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="bmr_ExercisePrice0000Member" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmr_ExercisePrice0227Member" xlink:href="bmr-20221231.xsd#bmr_ExercisePrice0227Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="bmr_ExercisePrice0227Member" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmr_ExercisePrice0333Member" xlink:href="bmr-20221231.xsd#bmr_ExercisePrice0333Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="bmr_ExercisePrice0333Member" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmr_ExercisePrice0365Member" xlink:href="bmr-20221231.xsd#bmr_ExercisePrice0365Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="bmr_ExercisePrice0365Member" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmr_ExercisePrice0640Member" xlink:href="bmr-20221231.xsd#bmr_ExercisePrice0640Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="bmr_ExercisePrice0640Member" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmr_ExercisePrice0757Member" xlink:href="bmr-20221231.xsd#bmr_ExercisePrice0757Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="bmr_ExercisePrice0757Member" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmr_ExercisePrice0833Member" xlink:href="bmr-20221231.xsd#bmr_ExercisePrice0833Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="bmr_ExercisePrice0833Member" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmr_ExercisePrice1024Member" xlink:href="bmr-20221231.xsd#bmr_ExercisePrice1024Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="bmr_ExercisePrice1024Member" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmr_ShareOptionsOutstandingMember" xlink:href="bmr-20221231.xsd#bmr_ShareOptionsOutstandingMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="bmr_ShareOptionsOutstandingMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmr_ShareOptionsExercisableMember" xlink:href="bmr-20221231.xsd#bmr_ShareOptionsExercisableMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="bmr_ShareOptionsExercisableMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" order="4" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.beil.com/role/ScheduleofassumptionsusedtoestimatethefairvaluesoftheshareoptionsgrantedTable">
    <loc xlink:type="locator" xlink:label="bmr_ShareOptionsDetailsScheduleofassumptionsusedtoestimatethefairvaluesoftheshareoptionsgrantedLineItems" xlink:href="bmr-20221231.xsd#bmr_ShareOptionsDetailsScheduleofassumptionsusedtoestimatethefairvaluesoftheshareoptionsgrantedLineItems"/>
    <loc xlink:type="locator" xlink:label="bmr_ShareOptionsDetailsScheduleofassumptionsusedtoestimatethefairvaluesoftheshareoptionsgrantedTable" xlink:href="bmr-20221231.xsd#bmr_ShareOptionsDetailsScheduleofassumptionsusedtoestimatethefairvaluesoftheshareoptionsgrantedTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="bmr_ShareOptionsDetailsScheduleofassumptionsusedtoestimatethefairvaluesoftheshareoptionsgrantedLineItems" xlink:to="bmr_ShareOptionsDetailsScheduleofassumptionsusedtoestimatethefairvaluesoftheshareoptionsgrantedTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="bmr_ShareOptionsDetailsScheduleofassumptionsusedtoestimatethefairvaluesoftheshareoptionsgrantedTable" xlink:to="srt_RangeAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember_0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_ShareOptionsDetailsScheduleofassumptionsusedtoestimatethefairvaluesoftheshareoptionsgrantedLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_ShareOptionsDetailsScheduleofassumptionsusedtoestimatethefairvaluesoftheshareoptionsgrantedLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_ShareOptionsDetailsScheduleofassumptionsusedtoestimatethefairvaluesoftheshareoptionsgrantedLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_ShareOptionsDetailsScheduleofassumptionsusedtoestimatethefairvaluesoftheshareoptionsgrantedLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_ShareOptionsDetailsScheduleofassumptionsusedtoestimatethefairvaluesoftheshareoptionsgrantedLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_ShareOptionsDetailsScheduleofassumptionsusedtoestimatethefairvaluesoftheshareoptionsgrantedLineItems" xlink:to="us-gaap_SharePrice" order="6" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.beil.com/role/ScheduleofcompanysequitybasedawardsrecognizedTable">
    <loc xlink:type="locator" xlink:label="bmr_ScheduleOfCompanySEquityBasedAwardsRecognizedAbstract" xlink:href="bmr-20221231.xsd#bmr_ScheduleOfCompanySEquityBasedAwardsRecognizedAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherResearchAndDevelopmentExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_ScheduleOfCompanySEquityBasedAwardsRecognizedAbstract" xlink:to="us-gaap_OtherResearchAndDevelopmentExpense" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherSellingAndMarketingExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherSellingAndMarketingExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_ScheduleOfCompanySEquityBasedAwardsRecognizedAbstract" xlink:to="us-gaap_OtherSellingAndMarketingExpense" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherGeneralAndAdministrativeExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_ScheduleOfCompanySEquityBasedAwardsRecognizedAbstract" xlink:to="us-gaap_OtherGeneralAndAdministrativeExpense" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_ScheduleOfCompanySEquityBasedAwardsRecognizedAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.beil.com/role/ScheduleoffinancingexpensesTable">
    <loc xlink:type="locator" xlink:label="bmr_ScheduleOfFinancingExpensesAbstract" xlink:href="bmr-20221231.xsd#bmr_ScheduleOfFinancingExpensesAbstract"/>
    <loc xlink:type="locator" xlink:label="bmr_ChangeInTheFairValueOfConvertibleAdvanceInvestments" xlink:href="bmr-20221231.xsd#bmr_ChangeInTheFairValueOfConvertibleAdvanceInvestments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_ScheduleOfFinancingExpensesAbstract" xlink:to="bmr_ChangeInTheFairValueOfConvertibleAdvanceInvestments" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PresentValueOfFutureInsuranceProfitsAmortizationExpenseAccruedInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PresentValueOfFutureInsuranceProfitsAmortizationExpenseAccruedInterest"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_ScheduleOfFinancingExpensesAbstract" xlink:to="us-gaap_PresentValueOfFutureInsuranceProfitsAmortizationExpenseAccruedInterest" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmr_ModificationOfTermsRelatingToStraightLoan" xlink:href="bmr-20221231.xsd#bmr_ModificationOfTermsRelatingToStraightLoan"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_ScheduleOfFinancingExpensesAbstract" xlink:to="bmr_ModificationOfTermsRelatingToStraightLoan" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_ScheduleOfFinancingExpensesAbstract" xlink:to="us-gaap_AmortizationOfFinancingCostsAndDiscounts" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmr_ExchangeRateDifferencesAndOthers" xlink:href="bmr-20221231.xsd#bmr_ExchangeRateDifferencesAndOthers"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_ScheduleOfFinancingExpensesAbstract" xlink:to="bmr_ExchangeRateDifferencesAndOthers" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherNonoperatingExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_ScheduleOfFinancingExpensesAbstract" xlink:to="us-gaap_OtherNonoperatingExpense" order="5" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.beil.com/role/ScheduleofthereconciliationofthecarryingamountoftheCompanyTable">
    <loc xlink:type="locator" xlink:label="bmr_ScheduleOfTheReconciliationOfTheCarryingAmountOfTheCompanyAbstract" xlink:href="bmr-20221231.xsd#bmr_ScheduleOfTheReconciliationOfTheCarryingAmountOfTheCompanyAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentRelatedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentRelatedLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_ScheduleOfTheReconciliationOfTheCarryingAmountOfTheCompanyAbstract" xlink:to="us-gaap_InvestmentRelatedLiabilities" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrentAndNoncurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_ScheduleOfTheReconciliationOfTheCarryingAmountOfTheCompanyAbstract" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrentAndNoncurrent" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PartnersCapitalAccountContributions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PartnersCapitalAccountContributions"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_ScheduleOfTheReconciliationOfTheCarryingAmountOfTheCompanyAbstract" xlink:to="us-gaap_PartnersCapitalAccountContributions" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentIncomeAmortizationOfDiscount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeAmortizationOfDiscount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_ScheduleOfTheReconciliationOfTheCarryingAmountOfTheCompanyAbstract" xlink:to="us-gaap_InvestmentIncomeAmortizationOfDiscount" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.beil.com/role/ScheduleofmaturitydatesTable">
    <loc xlink:type="locator" xlink:label="bmr_ScheduleOfMaturityDatesAbstract" xlink:href="bmr-20221231.xsd#bmr_ScheduleOfMaturityDatesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LongTermDebtCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_ScheduleOfMaturityDatesAbstract" xlink:to="us-gaap_LongTermDebtCurrent" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherCommitmentDueInSecondYear" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentDueInSecondYear"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_ScheduleOfMaturityDatesAbstract" xlink:to="us-gaap_OtherCommitmentDueInSecondYear" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherLongTermDebtCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLongTermDebtCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_ScheduleOfMaturityDatesAbstract" xlink:to="us-gaap_OtherLongTermDebtCurrent" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.beil.com/role/ScheduleofexpensesrelatedtoserviceagreementandtheofficeservicesagreementTable">
    <loc xlink:type="locator" xlink:label="bmr_ScheduleOfExpensesRelatedToServiceAgreementAndTheOfficeServicesAgreementAbstract" xlink:href="bmr-20221231.xsd#bmr_ScheduleOfExpensesRelatedToServiceAgreementAndTheOfficeServicesAgreementAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentInProcess" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentInProcess"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_ScheduleOfExpensesRelatedToServiceAgreementAndTheOfficeServicesAgreementAbstract" xlink:to="us-gaap_ResearchAndDevelopmentInProcess" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MarketingAndAdvertisingExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketingAndAdvertisingExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_ScheduleOfExpensesRelatedToServiceAgreementAndTheOfficeServicesAgreementAbstract" xlink:to="us-gaap_MarketingAndAdvertisingExpense" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherSellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherSellingGeneralAndAdministrativeExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_ScheduleOfExpensesRelatedToServiceAgreementAndTheOfficeServicesAgreementAbstract" xlink:to="us-gaap_OtherSellingGeneralAndAdministrativeExpense" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInDueToOtherRelatedParties" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDueToOtherRelatedParties"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_ScheduleOfExpensesRelatedToServiceAgreementAndTheOfficeServicesAgreementAbstract" xlink:to="us-gaap_IncreaseDecreaseInDueToOtherRelatedParties" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.beil.com/role/ScheduleoflossincomebeforetaxesonincomeTable">
    <loc xlink:type="locator" xlink:label="bmr_ScheduleOfLossIncomeBeforeTaxesOnIncomeAbstract" xlink:href="bmr-20221231.xsd#bmr_ScheduleOfLossIncomeBeforeTaxesOnIncomeAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_ScheduleOfLossIncomeBeforeTaxesOnIncomeAbstract" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_ScheduleOfLossIncomeBeforeTaxesOnIncomeAbstract" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_ScheduleOfLossIncomeBeforeTaxesOnIncomeAbstract" xlink:to="us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.beil.com/role/ScheduleofdeferredincometaxesreflectthenettaxeffectsofnetoperatinglossTable">
    <loc xlink:type="locator" xlink:label="bmr_ScheduleOfDeferredIncomeTaxesReflectTheNetTaxEffectsOfNetOperatingLossAbstract" xlink:href="bmr-20221231.xsd#bmr_ScheduleOfDeferredIncomeTaxesReflectTheNetTaxEffectsOfNetOperatingLossAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsCapitalLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsCapitalLossCarryforwards"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_ScheduleOfDeferredIncomeTaxesReflectTheNetTaxEffectsOfNetOperatingLossAbstract" xlink:to="us-gaap_DeferredTaxAssetsCapitalLossCarryforwards" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_ScheduleOfDeferredIncomeTaxesReflectTheNetTaxEffectsOfNetOperatingLossAbstract" xlink:to="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_ScheduleOfDeferredIncomeTaxesReflectTheNetTaxEffectsOfNetOperatingLossAbstract" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_ScheduleOfDeferredIncomeTaxesReflectTheNetTaxEffectsOfNetOperatingLossAbstract" xlink:to="us-gaap_DeferredTaxAssetsGross" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_ScheduleOfDeferredIncomeTaxesReflectTheNetTaxEffectsOfNetOperatingLossAbstract" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_ScheduleOfDeferredIncomeTaxesReflectTheNetTaxEffectsOfNetOperatingLossAbstract" xlink:to="us-gaap_DeferredTaxAssetsLiabilitiesNet" order="5" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.beil.com/role/ScheduleofrevenuesbygeographicregionTable">
    <loc xlink:type="locator" xlink:label="bmr_SegmentGeographicalInformationAndMajorCustomersDetailsScheduleofrevenuesbygeographicregionLineItems" xlink:href="bmr-20221231.xsd#bmr_SegmentGeographicalInformationAndMajorCustomersDetailsScheduleofrevenuesbygeographicregionLineItems"/>
    <loc xlink:type="locator" xlink:label="bmr_SegmentGeographicalInformationAndMajorCustomersDetailsScheduleofrevenuesbygeographicregionTable" xlink:href="bmr-20221231.xsd#bmr_SegmentGeographicalInformationAndMajorCustomersDetailsScheduleofrevenuesbygeographicregionTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="bmr_SegmentGeographicalInformationAndMajorCustomersDetailsScheduleofrevenuesbygeographicregionLineItems" xlink:to="bmr_SegmentGeographicalInformationAndMajorCustomersDetailsScheduleofrevenuesbygeographicregionTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="bmr_SegmentGeographicalInformationAndMajorCustomersDetailsScheduleofrevenuesbygeographicregionTable" xlink:to="srt_StatementGeographicalAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_SegmentGeographicalDomain_0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="country_US" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_SegmentGeographicalDomain" xlink:to="country_US" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="country_IL" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_IL"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_SegmentGeographicalDomain" xlink:to="country_IL" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmr_RestOfTheWorldMember" xlink:href="bmr-20221231.xsd#bmr_RestOfTheWorldMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_SegmentGeographicalDomain" xlink:to="bmr_RestOfTheWorldMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_SegmentGeographicalInformationAndMajorCustomersDetailsScheduleofrevenuesbygeographicregionLineItems" xlink:to="us-gaap_Revenues" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.beil.com/role/ScheduleofLonglivedassetsnetbygeographicareasTable">
    <loc xlink:type="locator" xlink:label="bmr_SegmentGeographicalInformationAndMajorCustomersDetailsScheduleofLonglivedassetsnetbygeographicareasLineItems" xlink:href="bmr-20221231.xsd#bmr_SegmentGeographicalInformationAndMajorCustomersDetailsScheduleofLonglivedassetsnetbygeographicareasLineItems"/>
    <loc xlink:type="locator" xlink:label="bmr_SegmentGeographicalInformationAndMajorCustomersDetailsScheduleofLonglivedassetsnetbygeographicareasTable" xlink:href="bmr-20221231.xsd#bmr_SegmentGeographicalInformationAndMajorCustomersDetailsScheduleofLonglivedassetsnetbygeographicareasTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="bmr_SegmentGeographicalInformationAndMajorCustomersDetailsScheduleofLonglivedassetsnetbygeographicareasLineItems" xlink:to="bmr_SegmentGeographicalInformationAndMajorCustomersDetailsScheduleofLonglivedassetsnetbygeographicareasTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="bmr_SegmentGeographicalInformationAndMajorCustomersDetailsScheduleofLonglivedassetsnetbygeographicareasTable" xlink:to="srt_StatementGeographicalAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_SegmentGeographicalDomain_0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="country_IL" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_IL"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_SegmentGeographicalDomain" xlink:to="country_IL" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="country_US" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_SegmentGeographicalDomain" xlink:to="country_US" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="country_RU" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_RU"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_SegmentGeographicalDomain" xlink:to="country_RU" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NoncurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncurrentAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_SegmentGeographicalInformationAndMajorCustomersDetailsScheduleofLonglivedassetsnetbygeographicareasLineItems" xlink:to="us-gaap_NoncurrentAssets" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.beil.com/role/ScheduleofrevenuedisaggregatedbyprimarymajorproductlinesandservicesTable">
    <loc xlink:type="locator" xlink:label="us-gaap_DisaggregationOfRevenueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DisaggregationOfRevenueTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="us-gaap_DisaggregationOfRevenueTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DisaggregationOfRevenueTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmr_PerpetualBasedSoftwareLicenseMember" xlink:href="bmr-20221231.xsd#bmr_PerpetualBasedSoftwareLicenseMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="bmr_PerpetualBasedSoftwareLicenseMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmr_TermbasedSoftwareLicenseMember" xlink:href="bmr-20221231.xsd#bmr_TermbasedSoftwareLicenseMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="bmr_TermbasedSoftwareLicenseMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmr_SoftwareLicenseAbstract" xlink:href="bmr-20221231.xsd#bmr_SoftwareLicenseAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="bmr_SoftwareLicenseAbstract" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsForSoftware" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForSoftware"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_SoftwareLicenseAbstract" xlink:to="us-gaap_PaymentsForSoftware" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmr_PCSServicesTransferredOverAPeriod" xlink:href="bmr-20221231.xsd#bmr_PCSServicesTransferredOverAPeriod"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="bmr_PCSServicesTransferredOverAPeriod" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmr_AdvertisingAtAPointOfTimeUponClicks" xlink:href="bmr-20221231.xsd#bmr_AdvertisingAtAPointOfTimeUponClicks"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="bmr_AdvertisingAtAPointOfTimeUponClicks" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmr_RecognitionofRevenue" xlink:href="bmr-20221231.xsd#bmr_RecognitionofRevenue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="bmr_RecognitionofRevenue" order="4" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.beil.com/role/GeneralDetails">
    <loc xlink:type="locator" xlink:label="bmr_GeneralDetailsLineItems" xlink:href="bmr-20221231.xsd#bmr_GeneralDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="bmr_GeneralDetailsTable" xlink:href="bmr-20221231.xsd#bmr_GeneralDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="bmr_GeneralDetailsLineItems" xlink:to="bmr_GeneralDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="bmr_GeneralDetailsTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="bmr_GeneralDetailsTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IPOMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IPOMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_IPOMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_GeneralDetailsLineItems" xlink:to="us-gaap_NetIncomeLoss" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_GeneralDetailsLineItems" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_VariableInterestDifferenceBetweenCarryingAmountAndMaximumExposure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestDifferenceBetweenCarryingAmountAndMaximumExposure"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_GeneralDetailsLineItems" xlink:to="us-gaap_VariableInterestDifferenceBetweenCarryingAmountAndMaximumExposure" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromNotesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromNotesPayable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_GeneralDetailsLineItems" xlink:to="us-gaap_ProceedsFromNotesPayable" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_GeneralDetailsLineItems" xlink:to="us-gaap_ProceedsFromStockOptionsExercised" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_GeneralDetailsLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CapitalUnitsNetAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalUnitsNetAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_GeneralDetailsLineItems" xlink:to="us-gaap_CapitalUnitsNetAmount" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_GeneralDetailsLineItems" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmr_PublicOfferingPrice" xlink:href="bmr-20221231.xsd#bmr_PublicOfferingPrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_GeneralDetailsLineItems" xlink:to="bmr_PublicOfferingPrice" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmr_AggregateGrossProceeds" xlink:href="bmr-20221231.xsd#bmr_AggregateGrossProceeds"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_GeneralDetailsLineItems" xlink:to="bmr_AggregateGrossProceeds" order="10" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.beil.com/role/SignificantAccountingPoliciesDetails">
    <loc xlink:type="locator" xlink:label="bmr_SignificantAccountingPoliciesDetailsLineItems" xlink:href="bmr-20221231.xsd#bmr_SignificantAccountingPoliciesDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="bmr_SignificantAccountingPoliciesDetailsTable" xlink:href="bmr-20221231.xsd#bmr_SignificantAccountingPoliciesDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="bmr_SignificantAccountingPoliciesDetailsLineItems" xlink:to="bmr_SignificantAccountingPoliciesDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="bmr_SignificantAccountingPoliciesDetailsTable" xlink:to="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_EquityMethodInvesteeNameDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="srt_EquityMethodInvesteeNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_EquityMethodInvesteeNameDomain_0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="srt_EquityMethodInvesteeNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmr_ConvertibleAdvanceInvestmentsMember" xlink:href="bmr-20221231.xsd#bmr_ConvertibleAdvanceInvestmentsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_EquityMethodInvesteeNameDomain" xlink:to="bmr_ConvertibleAdvanceInvestmentsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_SignificantAccountingPoliciesDetailsLineItems" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmr_EmployeeCompensationPercentage" xlink:href="bmr-20221231.xsd#bmr_EmployeeCompensationPercentage"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_SignificantAccountingPoliciesDetailsLineItems" xlink:to="bmr_EmployeeCompensationPercentage" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherReceivables"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_SignificantAccountingPoliciesDetailsLineItems" xlink:to="us-gaap_OtherReceivables" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredRevenue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_SignificantAccountingPoliciesDetailsLineItems" xlink:to="us-gaap_DeferredRevenue" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_SignificantAccountingPoliciesDetailsLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_SignificantAccountingPoliciesDetailsLineItems" xlink:to="us-gaap_DebtInstrumentRedemptionPricePercentage" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_SignificantAccountingPoliciesDetailsLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateEffectivePercentage" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmr_PercentageOfDividend" xlink:href="bmr-20221231.xsd#bmr_PercentageOfDividend"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_SignificantAccountingPoliciesDetailsLineItems" xlink:to="bmr_PercentageOfDividend" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ExcessStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExcessStockSharesOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_SignificantAccountingPoliciesDetailsLineItems" xlink:to="us-gaap_ExcessStockSharesOutstanding" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_SignificantAccountingPoliciesDetailsLineItems" xlink:to="us-gaap_EquityMethodInvestmentOwnershipPercentage" order="10" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.beil.com/role/PropertyandEquipmentNetDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DepreciationExpenseOnReclassifiedAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationExpenseOnReclassifiedAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_DepreciationExpenseOnReclassifiedAssets" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.beil.com/role/IntangibleAssetsNetandGoodwillDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_AmortizationOfIntangibleAssets" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseDiscountRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseDiscountRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_LesseeOperatingLeaseDiscountRate" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LongDurationContractsAssumptionsByProductAndGuaranteeDiscountRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongDurationContractsAssumptionsByProductAndGuaranteeDiscountRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_LongDurationContractsAssumptionsByProductAndGuaranteeDiscountRate" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.beil.com/role/LoansNetDetails">
    <loc xlink:type="locator" xlink:label="bmr_LoansNetDetailsLineItems" xlink:href="bmr-20221231.xsd#bmr_LoansNetDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="bmr_LoansNetDetailsTable" xlink:href="bmr-20221231.xsd#bmr_LoansNetDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="bmr_LoansNetDetailsLineItems" xlink:to="bmr_LoansNetDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="bmr_LoansNetDetailsTable" xlink:to="us-gaap_ShortTermDebtTypeAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ShortTermDebtTypeAxis" xlink:to="us-gaap_ShortTermDebtTypeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermDebtTypeDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ShortTermDebtTypeAxis" xlink:to="us-gaap_ShortTermDebtTypeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="bmr_LoansNetDetailsTable" xlink:to="us-gaap_AwardTypeAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="bmr_LoansNetDetailsTable" xlink:to="us-gaap_RelatedPartyTransactionAxis" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="bmr_LoansNetDetailsTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="bmr_LoansNetDetailsTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_VariableRateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="bmr_LoansNetDetailsTable" xlink:to="us-gaap_VariableRateAxis" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_VariableRateDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_VariableRateAxis" xlink:to="us-gaap_VariableRateDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_VariableRateDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_VariableRateAxis" xlink:to="us-gaap_VariableRateDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="bmr_LoansNetDetailsTable" xlink:to="srt_RangeAxis" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember_0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="bmr_LoansNetDetailsTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmr_FloatingRateMember" xlink:href="bmr-20221231.xsd#bmr_FloatingRateMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_VariableRateDomain" xlink:to="bmr_FloatingRateMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrimeRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrimeRateMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_VariableRateDomain" xlink:to="us-gaap_PrimeRateMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_WarrantMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IPOMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IPOMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_IPOMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmr_LoansAndSecurityAgreementMember" xlink:href="bmr-20221231.xsd#bmr_LoansAndSecurityAgreementMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShortTermDebtTypeDomain" xlink:to="bmr_LoansAndSecurityAgreementMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertiblePreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertiblePreferredStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShortTermDebtTypeDomain" xlink:to="us-gaap_ConvertiblePreferredStockMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesCPreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesCPreferredStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesCPreferredStockMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmr_TwoZeroTwoTwoLoanAgreementMember" xlink:href="bmr-20221231.xsd#bmr_TwoZeroTwoTwoLoanAgreementMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="bmr_TwoZeroTwoTwoLoanAgreementMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmr_IBISpikesLtdMember" xlink:href="bmr-20221231.xsd#bmr_IBISpikesLtdMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="bmr_IBISpikesLtdMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_LoansNetDetailsLineItems" xlink:to="us-gaap_DebtInstrumentFaceAmount" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermDebtPercentageBearingVariableInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtPercentageBearingVariableInterestRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_LoansNetDetailsLineItems" xlink:to="us-gaap_ShortTermDebtPercentageBearingVariableInterestRate" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LoansReceivableBasisSpreadOnVariableRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansReceivableBasisSpreadOnVariableRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_LoansNetDetailsLineItems" xlink:to="us-gaap_LoansReceivableBasisSpreadOnVariableRate" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_LoansNetDetailsLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_LoansNetDetailsLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_LoansNetDetailsLineItems" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantsAndRightsOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_LoansNetDetailsLineItems" xlink:to="us-gaap_WarrantsAndRightsOutstanding" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AmortizationOfDebtDiscountPremium" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfDebtDiscountPremium"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_LoansNetDetailsLineItems" xlink:to="us-gaap_AmortizationOfDebtDiscountPremium" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentOwnedBalancePrincipalAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentOwnedBalancePrincipalAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_LoansNetDetailsLineItems" xlink:to="us-gaap_InvestmentOwnedBalancePrincipalAmount" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LineOfCreditFacilityCommitmentFeeAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityCommitmentFeeAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_LoansNetDetailsLineItems" xlink:to="us-gaap_LineOfCreditFacilityCommitmentFeeAmount" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_LoansNetDetailsLineItems" xlink:to="us-gaap_DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueAdjustmentOfWarrants" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAdjustmentOfWarrants"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_LoansNetDetailsLineItems" xlink:to="us-gaap_FairValueAdjustmentOfWarrants" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_LoansNetDetailsLineItems" xlink:to="us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LineOfCreditFacilityCollateralFeesAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityCollateralFeesAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_LoansNetDetailsLineItems" xlink:to="us-gaap_LineOfCreditFacilityCollateralFeesAmount" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentInterestRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_LoansNetDetailsLineItems" xlink:to="us-gaap_InvestmentInterestRate" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DerivativeFixedInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFixedInterestRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_LoansNetDetailsLineItems" xlink:to="us-gaap_DerivativeFixedInterestRate" order="16" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_LoansNetDetailsLineItems" xlink:to="us-gaap_PreferredStockSharesIssued" order="17" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantExercisePriceIncrease" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantExercisePriceIncrease"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_LoansNetDetailsLineItems" xlink:to="us-gaap_WarrantExercisePriceIncrease" order="18" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityMethodInvestmentAggregateCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentAggregateCost"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_LoansNetDetailsLineItems" xlink:to="us-gaap_EquityMethodInvestmentAggregateCost" order="19" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableInterestBearingInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableInterestBearingInterestRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_LoansNetDetailsLineItems" xlink:to="us-gaap_AccountsPayableInterestBearingInterestRate" order="20" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIncome"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_LoansNetDetailsLineItems" xlink:to="us-gaap_OtherIncome" order="21" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmr_AgreementAmountReceived" xlink:href="bmr-20221231.xsd#bmr_AgreementAmountReceived"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_LoansNetDetailsLineItems" xlink:to="bmr_AgreementAmountReceived" order="22" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromRoyaltiesReceived" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRoyaltiesReceived"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_LoansNetDetailsLineItems" xlink:to="us-gaap_ProceedsFromRoyaltiesReceived" order="23" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentAnnualPrincipalPayment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAnnualPrincipalPayment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_LoansNetDetailsLineItems" xlink:to="us-gaap_DebtInstrumentAnnualPrincipalPayment" order="24" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmr_PercentageOfOutstandingRepaymentAndPaymentAmount" xlink:href="bmr-20221231.xsd#bmr_PercentageOfOutstandingRepaymentAndPaymentAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_LoansNetDetailsLineItems" xlink:to="bmr_PercentageOfOutstandingRepaymentAndPaymentAmount" order="25" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmr_PercentageOfDiscountOutstanding" xlink:href="bmr-20221231.xsd#bmr_PercentageOfDiscountOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_LoansNetDetailsLineItems" xlink:to="bmr_PercentageOfDiscountOutstanding" order="26" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestAndFeeIncomeOtherLoans" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestAndFeeIncomeOtherLoans"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_LoansNetDetailsLineItems" xlink:to="us-gaap_InterestAndFeeIncomeOtherLoans" order="27" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_LoansNetDetailsLineItems" xlink:to="us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed" order="28" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeFinanceLeaseDiscountRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeFinanceLeaseDiscountRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_LoansNetDetailsLineItems" xlink:to="us-gaap_LesseeFinanceLeaseDiscountRate" order="29" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockDividend" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockDividend"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_LoansNetDetailsLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockDividend" order="30" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LoansHeldForSaleTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansHeldForSaleTerm"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_LoansNetDetailsLineItems" xlink:to="us-gaap_LoansHeldForSaleTerm" order="31" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_LoansNetDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost" order="32" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsOfLoanCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfLoanCosts"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_LoansNetDetailsLineItems" xlink:to="us-gaap_PaymentsOfLoanCosts" order="33" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RepaymentsOfSecuredDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfSecuredDebt"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_LoansNetDetailsLineItems" xlink:to="us-gaap_RepaymentsOfSecuredDebt" order="34" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.beil.com/role/OtherCurrentLiabilitiesDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_OtherLiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesCurrentAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DepositLiabilitiesAccruedInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepositLiabilitiesAccruedInterest"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherLiabilitiesCurrentAbstract" xlink:to="us-gaap_DepositLiabilitiesAccruedInterest" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.beil.com/role/ConvertibleAdvanceInvestmentDetails">
    <loc xlink:type="locator" xlink:label="bmr_ConvertibleAdvanceInvestmentDetailsLineItems" xlink:href="bmr-20221231.xsd#bmr_ConvertibleAdvanceInvestmentDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="bmr_ConvertibleAdvanceInvestmentDetailsTable" xlink:href="bmr-20221231.xsd#bmr_ConvertibleAdvanceInvestmentDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="bmr_ConvertibleAdvanceInvestmentDetailsLineItems" xlink:to="bmr_ConvertibleAdvanceInvestmentDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="bmr_ConvertibleAdvanceInvestmentDetailsTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="bmr_ConvertibleAdvanceInvestmentDetailsTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="bmr_ConvertibleAdvanceInvestmentDetailsTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="bmr_ConvertibleAdvanceInvestmentDetailsTable" xlink:to="srt_RangeAxis" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember_0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IPOMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IPOMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_IPOMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmr_AdvanceInvestmentAgreementsMember" xlink:href="bmr-20221231.xsd#bmr_AdvanceInvestmentAgreementsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="bmr_AdvanceInvestmentAgreementsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertiblePreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertiblePreferredStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_ConvertiblePreferredStockMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_ConvertibleAdvanceInvestmentDetailsLineItems" xlink:to="us-gaap_DebtInstrumentFaceAmount" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityMethodInvestmentAggregateCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentAggregateCost"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_ConvertibleAdvanceInvestmentDetailsLineItems" xlink:to="us-gaap_EquityMethodInvestmentAggregateCost" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_ConvertibleAdvanceInvestmentDetailsLineItems" xlink:to="us-gaap_DebtInstrumentRedemptionPricePercentage" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_ConvertibleAdvanceInvestmentDetailsLineItems" xlink:to="us-gaap_DebtConversionConvertedInstrumentAmount1" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_ConvertibleAdvanceInvestmentDetailsLineItems" xlink:to="us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtConversionConvertedInstrumentRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtConversionConvertedInstrumentRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_ConvertibleAdvanceInvestmentDetailsLineItems" xlink:to="us-gaap_DebtConversionConvertedInstrumentRate" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmr_PublicOfferingPrice" xlink:href="bmr-20221231.xsd#bmr_PublicOfferingPrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_ConvertibleAdvanceInvestmentDetailsLineItems" xlink:to="bmr_PublicOfferingPrice" order="7" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.beil.com/role/CommitmentsandContingentLiabilitiesDetails">
    <loc xlink:type="locator" xlink:label="bmr_CommitmentsandContingentLiabilitiesDetailsLineItems" xlink:href="bmr-20221231.xsd#bmr_CommitmentsandContingentLiabilitiesDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="bmr_CommitmentsandContingentLiabilitiesDetailsTable" xlink:href="bmr-20221231.xsd#bmr_CommitmentsandContingentLiabilitiesDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="bmr_CommitmentsandContingentLiabilitiesDetailsLineItems" xlink:to="bmr_CommitmentsandContingentLiabilitiesDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_TitleOfIndividualAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="bmr_CommitmentsandContingentLiabilitiesDetailsTable" xlink:to="srt_TitleOfIndividualAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain_0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_StatementScenarioAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="bmr_CommitmentsandContingentLiabilitiesDetailsTable" xlink:to="srt_StatementScenarioAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioUnspecifiedDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioUnspecifiedDomain_0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioForecastMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioForecastMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ScenarioUnspecifiedDomain" xlink:to="srt_ScenarioForecastMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_BoardOfDirectorsChairmanMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_BoardOfDirectorsChairmanMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="srt_BoardOfDirectorsChairmanMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsForRent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_CommitmentsandContingentLiabilitiesDetailsLineItems" xlink:to="us-gaap_PaymentsForRent" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsForFees" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForFees"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_CommitmentsandContingentLiabilitiesDetailsLineItems" xlink:to="us-gaap_PaymentsForFees" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCost"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_CommitmentsandContingentLiabilitiesDetailsLineItems" xlink:to="us-gaap_LeaseCost" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_CommitmentsandContingentLiabilitiesDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" order="4" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.beil.com/role/ShareholdersEquityDeficitDetails">
    <loc xlink:type="locator" xlink:label="bmr_ShareholdersEquityDeficitDetailsLineItems" xlink:href="bmr-20221231.xsd#bmr_ShareholdersEquityDeficitDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="bmr_ShareholdersEquityDeficitDetailsTable" xlink:href="bmr-20221231.xsd#bmr_ShareholdersEquityDeficitDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="bmr_ShareholdersEquityDeficitDetailsLineItems" xlink:to="bmr_ShareholdersEquityDeficitDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="bmr_ShareholdersEquityDeficitDetailsTable" xlink:to="srt_RangeAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember_0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockConvertibleConversionPrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockConvertibleConversionPrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_ShareholdersEquityDeficitDetailsLineItems" xlink:to="us-gaap_PreferredStockConvertibleConversionPrice" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockAmountOfPreferredDividendsInArrears" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockAmountOfPreferredDividendsInArrears"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_ShareholdersEquityDeficitDetailsLineItems" xlink:to="us-gaap_PreferredStockAmountOfPreferredDividendsInArrears" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDebtNetOfIssuanceCosts"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_ShareholdersEquityDeficitDetailsLineItems" xlink:to="us-gaap_ProceedsFromDebtNetOfIssuanceCosts" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ExcessStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExcessStockSharesAuthorized"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_ShareholdersEquityDeficitDetailsLineItems" xlink:to="us-gaap_ExcessStockSharesAuthorized" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmr_VoluntaryConversionDescription" xlink:href="bmr-20221231.xsd#bmr_VoluntaryConversionDescription"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_ShareholdersEquityDeficitDetailsLineItems" xlink:to="bmr_VoluntaryConversionDescription" order="5" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.beil.com/role/ShareOptionsDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <loc xlink:type="locator" xlink:label="bmr_OrdinarySharesSubjectToAdjustments" xlink:href="bmr-20221231.xsd#bmr_OrdinarySharesSubjectToAdjustments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="bmr_OrdinarySharesSubjectToAdjustments" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmr_OrdinarySharesAvailableForFutureIssuance" xlink:href="bmr-20221231.xsd#bmr_OrdinarySharesAvailableForFutureIssuance"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="bmr_OrdinarySharesAvailableForFutureIssuance" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmr_TotalConsideration" xlink:href="bmr-20221231.xsd#bmr_TotalConsideration"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="bmr_TotalConsideration" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetAmountAtRiskByProductAndGuaranteeWeightedAveragePeriodRemaining1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetAmountAtRiskByProductAndGuaranteeWeightedAveragePeriodRemaining1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_NetAmountAtRiskByProductAndGuaranteeWeightedAveragePeriodRemaining1" order="6" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.beil.com/role/RelatedPartiesTransactionsDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionDueFromToRelatedPartyCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDueFromToRelatedPartyCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_RelatedPartyTransactionDueFromToRelatedPartyCurrent" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DueToOtherRelatedPartiesClassifiedCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueToOtherRelatedPartiesClassifiedCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_DueToOtherRelatedPartiesClassifiedCurrent" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentInterestRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_InvestmentInterestRate" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalOther"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.beil.com/role/TaxesonIncomeDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherNonoperatingGainsLosses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingGainsLosses"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_OtherNonoperatingGainsLosses" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" order="4" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.beil.com/role/SegmentGeographicalInformationAndMajorCustomersDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NumberOfOperatingSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfOperatingSegments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_NumberOfOperatingSegments" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmr_TradeReceivablesIncomeTaxRate" xlink:href="bmr-20221231.xsd#bmr_TradeReceivablesIncomeTaxRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="bmr_TradeReceivablesIncomeTaxRate" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredRevenueRevenueRecognized1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredRevenueRevenueRecognized1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_DeferredRevenueRevenueRecognized1" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.beil.com/role/SubsequentEventsDetails">
    <loc xlink:type="locator" xlink:label="bmr_SubsequentEventsDetailsLineItems" xlink:href="bmr-20221231.xsd#bmr_SubsequentEventsDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="bmr_SubsequentEventsDetailsTable" xlink:href="bmr-20221231.xsd#bmr_SubsequentEventsDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="bmr_SubsequentEventsDetailsLineItems" xlink:to="bmr_SubsequentEventsDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_StatementScenarioAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="bmr_SubsequentEventsDetailsTable" xlink:to="srt_StatementScenarioAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioUnspecifiedDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioUnspecifiedDomain_0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="bmr_SubsequentEventsDetailsTable" xlink:to="us-gaap_SubsequentEventTypeAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="bmr_SubsequentEventsDetailsTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="bmr_SubsequentEventsDetailsTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmr_LoanAgreementsAxis" xlink:href="bmr-20221231.xsd#bmr_LoanAgreementsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="bmr_SubsequentEventsDetailsTable" xlink:to="bmr_LoanAgreementsAxis" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmr_LoanAgreementsDomain" xlink:href="bmr-20221231.xsd#bmr_LoanAgreementsDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="bmr_LoanAgreementsAxis" xlink:to="bmr_LoanAgreementsDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmr_LoanAgreementsDomain_0" xlink:href="bmr-20221231.xsd#bmr_LoanAgreementsDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="bmr_LoanAgreementsAxis" xlink:to="bmr_LoanAgreementsDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="bmr_SubsequentEventsDetailsTable" xlink:to="srt_RangeAxis" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember_0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="bmr_SubsequentEventsDetailsTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioForecastMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioForecastMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ScenarioUnspecifiedDomain" xlink:to="srt_ScenarioForecastMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IPOMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IPOMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_IPOMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesCPreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesCPreferredStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesCPreferredStockMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmr_TwoThousandTwentyTwoLoanAgreementMember" xlink:href="bmr-20221231.xsd#bmr_TwoThousandTwentyTwoLoanAgreementMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_LoanAgreementsDomain" xlink:to="bmr_TwoThousandTwentyTwoLoanAgreementMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_SubsequentEventsDetailsLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmr_PublicOfferingPrice" xlink:href="bmr-20221231.xsd#bmr_PublicOfferingPrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_SubsequentEventsDetailsLineItems" xlink:to="bmr_PublicOfferingPrice" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_SubsequentEventsDetailsLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentInterestRateTerms" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateTerms"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_SubsequentEventsDetailsLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateTerms" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockConvertibleSharesIssuable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockConvertibleSharesIssuable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_SubsequentEventsDetailsLineItems" xlink:to="us-gaap_PreferredStockConvertibleSharesIssuable" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConversionOfStockSharesIssued1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConversionOfStockSharesIssued1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_SubsequentEventsDetailsLineItems" xlink:to="us-gaap_ConversionOfStockSharesIssued1" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TemporaryEquitySharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesAuthorized"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmr_SubsequentEventsDetailsLineItems" xlink:to="us-gaap_TemporaryEquitySharesAuthorized" order="7" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.beil.com/role/DocumentAndEntityInformation">
    <loc xlink:type="locator" xlink:label="dei_DocumentInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentInformationLineItems"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentInformationTable" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentInformationTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentInformationTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressesAddressTypeAxis" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressesAddressTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="dei_DocumentInformationTable" xlink:to="dei_EntityAddressesAddressTypeAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_AddressTypeDomain" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AddressTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_EntityAddressesAddressTypeAxis" xlink:to="dei_AddressTypeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_AddressTypeDomain_0" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AddressTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dei_EntityAddressesAddressTypeAxis" xlink:to="dei_AddressTypeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_BusinessContactMember" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_BusinessContactMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_AddressTypeDomain" xlink:to="dei_BusinessContactMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_TradingSymbol" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CurrentFiscalYearEndDate" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCommonStockSharesOutstanding" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCurrentReportingStatus" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityVoluntaryFilers" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityVoluntaryFilers" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFilerCategory" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityWellKnownSeasonedIssuer" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityWellKnownSeasonedIssuer" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFiscalYearFocus" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFiscalPeriodFocus" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityShellCompany" order="16" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityExTransitionPeriod" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityExTransitionPeriod" order="17" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_IcfrAuditorAttestationFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_IcfrAuditorAttestationFlag"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_IcfrAuditorAttestationFlag" order="18" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentRegistrationStatement" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentRegistrationStatement"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentRegistrationStatement" order="19" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentAnnualReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentAnnualReport" order="20" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentTransitionReport" order="21" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentShellCompanyReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyReport"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentShellCompanyReport" order="22" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFileNumber" order="23" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" order="24" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" order="25" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine2" order="26" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" order="27" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" order="28" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressCountry" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCountry" order="29" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_LocalPhoneNumber" order="30" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CityAreaCode" order="31" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_ContactPersonnelName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_ContactPersonnelName"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_ContactPersonnelName" order="32" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_ContactPersonnelEmailAddress" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_ContactPersonnelEmailAddress"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_ContactPersonnelEmailAddress" order="33" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_Security12bTitle" order="34" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SecurityExchangeName" order="35" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityInteractiveDataCurrent" order="36" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentAccountingStandard" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAccountingStandard"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentAccountingStandard" order="37" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_AuditorFirmId" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorFirmId"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AuditorFirmId" order="38" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_AuditorName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorName"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AuditorName" order="39" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_AuditorLocation" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorLocation"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AuditorLocation" order="40" xbrldt:closed="true"/>
  </definitionLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>10
<FILENAME>bmr-20221231_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Mon Apr 24 19:58:56 UTC 2023 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel"/>
  <labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <loc xlink:type="locator" xlink:label="dei_EntityAddressesAddressTypeAxis" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressesAddressTypeAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressesAddressTypeAxis_lbl" xml:lang="en-US">Entity Addresses, Address Type [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressesAddressTypeAxis" xlink:to="dei_EntityAddressesAddressTypeAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsCurrent_lbl" xml:lang="en-US">Total current assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsNoncurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsNoncurrent_lbl" xml:lang="en-US">Total non-current assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsNoncurrent" xlink:to="us-gaap_AssetsNoncurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Assets_lbl" xml:lang="en-US">Total assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xml:lang="en-US">Total current liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesNoncurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesNoncurrent_lbl" xml:lang="en-US">Total non-current liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesNoncurrent" xlink:to="us-gaap_LiabilitiesNoncurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xml:lang="en-US">Equity Components [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_StockholdersEquity_lbl" xml:lang="en-US">Total shareholders&#8217; equity (deficit)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_StockholdersEquity_lbl0" xml:lang="en-US">Balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_StockholdersEquity_lbl1" xml:lang="en-US">Balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xml:lang="en-US">Total liabilities and shareholders&#8217; equity (deficit)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GrossProfit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_GrossProfit_lbl" xml:lang="en-US">Gross profit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_GrossProfit_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xml:lang="en-US">Operating loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xml:lang="en-US">Loss before taxes on income</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax_lbl" xml:lang="en-US">Net loss and comprehensive loss for the year</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_SharesOutstanding_lbl" xml:lang="en-US">Balance (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_SharesOutstanding_lbl0" xml:lang="en-US">Balance (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xml:lang="en-US">Net cash provided by (used in) operating activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xml:lang="en-US">Net cash provided by (used in) investing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xml:lang="en-US">Net cash provided by (used in) financing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xml:lang="en-US">Change in cash, cash equivalents</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xml:lang="en-US">Cash, cash equivalents at beginning of year</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl0" xml:lang="en-US">Cash, cash equivalents at end of year</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl0"/>
    <loc xlink:type="locator" xlink:label="bmr_GeneralAbstract" xlink:href="bmr-20221231.xsd#bmr_GeneralAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_GeneralAbstract_lbl" xml:lang="en-US">General [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_GeneralAbstract" xlink:to="bmr_GeneralAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_RangeAxis_lbl" xml:lang="en-US">Statistical Measurement [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeAxis" xlink:to="srt_RangeAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureTextBlockSupplementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureTextBlockSupplementAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisclosureTextBlockSupplementAbstract_lbl" xml:lang="en-US">Other Current Assets [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureTextBlockSupplementAbstract" xlink:to="us-gaap_DisclosureTextBlockSupplementAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_ScheduleOfOtherCurrentAssetsAbstract" xlink:href="bmr-20221231.xsd#bmr_ScheduleOfOtherCurrentAssetsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_ScheduleOfOtherCurrentAssetsAbstract_lbl" xml:lang="en-US">Schedule of Other Current Assets [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_ScheduleOfOtherCurrentAssetsAbstract" xlink:to="bmr_ScheduleOfOtherCurrentAssetsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OtherAssetsCurrent_lbl" xml:lang="en-US">Total other current assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsCurrent" xlink:to="us-gaap_OtherAssetsCurrent_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherAssetsCurrent_lbl0" xml:lang="en-US">Other current assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsCurrent" xlink:to="us-gaap_OtherAssetsCurrent_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract_lbl" xml:lang="en-US">Property and Equipment, Net [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl" xml:lang="en-US">Intangible Assets, Net and Goodwill [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_ScheduleOfTheEstimatedFutureAmortizationExpenseOfIntangibleAssetsAbstract" xlink:href="bmr-20221231.xsd#bmr_ScheduleOfTheEstimatedFutureAmortizationExpenseOfIntangibleAssetsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_ScheduleOfTheEstimatedFutureAmortizationExpenseOfIntangibleAssetsAbstract_lbl" xml:lang="en-US">Schedule of the Estimated Future Amortization Expense of Intangible Assets [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_ScheduleOfTheEstimatedFutureAmortizationExpenseOfIntangibleAssetsAbstract" xlink:to="bmr_ScheduleOfTheEstimatedFutureAmortizationExpenseOfIntangibleAssetsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet_lbl" xml:lang="en-US">Total</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtDisclosureAbstract_lbl" xml:lang="en-US">Loans, Net [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtDisclosureAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_ScheduleOfTheEffectiveDateManagementByAssistanceOfThirdPartyAbstract" xlink:href="bmr-20221231.xsd#bmr_ScheduleOfTheEffectiveDateManagementByAssistanceOfThirdPartyAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_ScheduleOfTheEffectiveDateManagementByAssistanceOfThirdPartyAbstract_lbl" xml:lang="en-US">Schedule of the Effective Date Management by Assistance of Third Party [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_ScheduleOfTheEffectiveDateManagementByAssistanceOfThirdPartyAbstract" xlink:to="bmr_ScheduleOfTheEffectiveDateManagementByAssistanceOfThirdPartyAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_ScheduleOfTheReconciliationOfTheCarryingAmountAbstract" xlink:href="bmr-20221231.xsd#bmr_ScheduleOfTheReconciliationOfTheCarryingAmountAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_ScheduleOfTheReconciliationOfTheCarryingAmountAbstract_lbl" xml:lang="en-US">Schedule of the Reconciliation of the Carrying Amount [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_ScheduleOfTheReconciliationOfTheCarryingAmountAbstract" xlink:to="bmr_ScheduleOfTheReconciliationOfTheCarryingAmountAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_ScheduleOfMaturityDatesOfOutstandingLoansAbstract" xlink:href="bmr-20221231.xsd#bmr_ScheduleOfMaturityDatesOfOutstandingLoansAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_ScheduleOfMaturityDatesOfOutstandingLoansAbstract_lbl" xml:lang="en-US">Schedule of Maturity Dates of Outstanding Loans [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_ScheduleOfMaturityDatesOfOutstandingLoansAbstract" xlink:to="bmr_ScheduleOfMaturityDatesOfOutstandingLoansAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherLiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesCurrentAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherLiabilitiesCurrentAbstract_lbl" xml:lang="en-US">Other Current Liabilities [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesCurrentAbstract" xlink:to="us-gaap_OtherLiabilitiesCurrentAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OtherLiabilitiesCurrent_lbl" xml:lang="en-US">Total other current liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesCurrent" xlink:to="us-gaap_OtherLiabilitiesCurrent_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherLiabilitiesCurrent_lbl0" xml:lang="en-US">Other current liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesCurrent" xlink:to="us-gaap_OtherLiabilitiesCurrent_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_lbl" xml:lang="en-US">Derivative Warrants Liabilities [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DerivativeFairValueOfDerivativeNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeNet"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_DerivativeFairValueOfDerivativeNet_lbl" xml:lang="en-US">Opening balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeFairValueOfDerivativeNet" xlink:to="us-gaap_DerivativeFairValueOfDerivativeNet_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_DerivativeFairValueOfDerivativeNet_lbl0" xml:lang="en-US">Closing balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeFairValueOfDerivativeNet" xlink:to="us-gaap_DerivativeFairValueOfDerivativeNet_lbl0"/>
    <loc xlink:type="locator" xlink:label="bmr_InvestmentHoldingsAbstract" xlink:href="bmr-20221231.xsd#bmr_InvestmentHoldingsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_InvestmentHoldingsAbstract_lbl" xml:lang="en-US">Convertible Advance Investment [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_InvestmentHoldingsAbstract" xlink:to="bmr_InvestmentHoldingsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_ScheduleOfReconciliationOfTheCarryingAmountOfTheConvertibleAdvanceInvestmentAbstract" xlink:href="bmr-20221231.xsd#bmr_ScheduleOfReconciliationOfTheCarryingAmountOfTheConvertibleAdvanceInvestmentAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_ScheduleOfReconciliationOfTheCarryingAmountOfTheConvertibleAdvanceInvestmentAbstract_lbl" xml:lang="en-US">Schedule Of Reconciliation Of The Carrying Amount Of The Convertible Advance Investment [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_ScheduleOfReconciliationOfTheCarryingAmountOfTheConvertibleAdvanceInvestmentAbstract" xlink:to="bmr_ScheduleOfReconciliationOfTheCarryingAmountOfTheConvertibleAdvanceInvestmentAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertibleDebtFairValueDisclosures" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtFairValueDisclosures"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ConvertibleDebtFairValueDisclosures_lbl" xml:lang="en-US">Opening balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleDebtFairValueDisclosures" xlink:to="us-gaap_ConvertibleDebtFairValueDisclosures_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ConvertibleDebtFairValueDisclosures_lbl0" xml:lang="en-US">Closing balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleDebtFairValueDisclosures" xlink:to="us-gaap_ConvertibleDebtFairValueDisclosures_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xml:lang="en-US">Commitments and Contingent Liabilities [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityNoteAbstract_lbl" xml:lang="en-US">Shareholders&#8217; Equity (Deficit) [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_StockholdersEquityNoteAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xml:lang="en-US">Class of Stock [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl" xml:lang="en-US">Share Options [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xml:lang="en-US">Number of Share Options, Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl0" xml:lang="en-US">Number of Share Options, Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted Average Exercise Price, Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl0" xml:lang="en-US">Weighted Average Exercise Price, Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xml:lang="en-US">Intrinsic value, Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl0" xml:lang="en-US">Intrinsic value, Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_lbl" xml:lang="en-US">Exercise Price Range [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AwardTypeAxis_lbl" xml:lang="en-US">Award Type [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_AwardTypeAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_FinancingExpensesAbstract" xlink:href="bmr-20221231.xsd#bmr_FinancingExpensesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_FinancingExpensesAbstract_lbl" xml:lang="en-US">Financing Expenses [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_FinancingExpensesAbstract" xlink:to="bmr_FinancingExpensesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_ScheduleOfFinancingExpensesAbstract" xlink:href="bmr-20221231.xsd#bmr_ScheduleOfFinancingExpensesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_ScheduleOfFinancingExpensesAbstract_lbl" xml:lang="en-US">Schedule Of Financing Expenses [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_ScheduleOfFinancingExpensesAbstract" xlink:to="bmr_ScheduleOfFinancingExpensesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentRelatedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentRelatedLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_InvestmentRelatedLiabilities_lbl" xml:lang="en-US">Opening balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentRelatedLiabilities" xlink:to="us-gaap_InvestmentRelatedLiabilities_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_InvestmentRelatedLiabilities_lbl0" xml:lang="en-US">Closing balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentRelatedLiabilities" xlink:to="us-gaap_InvestmentRelatedLiabilities_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInDueToOtherRelatedParties" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDueToOtherRelatedParties"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IncreaseDecreaseInDueToOtherRelatedParties_lbl" xml:lang="en-US">Total</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInDueToOtherRelatedParties" xlink:to="us-gaap_IncreaseDecreaseInDueToOtherRelatedParties_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureAbstract_lbl" xml:lang="en-US">Taxes on Income [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_lbl" xml:lang="en-US">Total</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_DeferredTaxAssetsGross_lbl" xml:lang="en-US">Net deferred tax asset before deferred tax liabilities and valuation allowance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsGross_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl" xml:lang="en-US">Net deferred tax assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SegmentReportingAbstract_lbl" xml:lang="en-US">Segment Geographical Information And Major Customers [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_SegmentReportingAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_StatementGeographicalAxis_lbl" xml:lang="en-US">Geographical [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_StatementGeographicalAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentRegistrationStatement" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentRegistrationStatement"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentAnnualReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentShellCompanyReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyReport"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressCountry" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_ContactPersonnelName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_ContactPersonnelName"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_ContactPersonnelName_lbl" xml:lang="en-US">Contact Personnel Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_ContactPersonnelName" xlink:to="dei_ContactPersonnelName_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_ContactPersonnelEmailAddress" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_ContactPersonnelEmailAddress"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_ContactPersonnelEmailAddress_lbl" xml:lang="en-US">Contact Personnel Email Address</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_ContactPersonnelEmailAddress" xlink:to="dei_ContactPersonnelEmailAddress_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityWellKnownSeasonedIssuer" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityVoluntaryFilers" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityExTransitionPeriod" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Entity Ex Transition Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_IcfrAuditorAttestationFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_IcfrAuditorAttestationFlag"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_IcfrAuditorAttestationFlag_lbl" xml:lang="en-US">ICFR Auditor Attestation Flag</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_IcfrAuditorAttestationFlag" xlink:to="dei_IcfrAuditorAttestationFlag_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentAccountingStandard" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAccountingStandard"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_AuditorFirmId" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorFirmId"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_AuditorFirmId_lbl" xml:lang="en-US">Auditor Firm ID</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorFirmId" xlink:to="dei_AuditorFirmId_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_AuditorName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorName"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_AuditorName_lbl" xml:lang="en-US">Auditor Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorName" xlink:to="dei_AuditorName_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_AuditorLocation" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorLocation"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_AuditorLocation_lbl" xml:lang="en-US">Auditor Location</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorLocation" xlink:to="dei_AuditorLocation_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AssetsAbstract_lbl" xml:lang="en-US">ASSETS</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xml:lang="en-US">Current assets:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xml:lang="en-US">Cash and cash equivalents</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ReceivablesNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesNetCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ReceivablesNetCurrent_lbl" xml:lang="en-US">Trade receivables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ReceivablesNetCurrent" xlink:to="us-gaap_ReceivablesNetCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_UnlabeledAbstract" xlink:href="bmr-20221231.xsd#bmr_UnlabeledAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmr_UnlabeledAbstract_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_UnlabeledAbstract" xlink:to="bmr_UnlabeledAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_NonCurrentAssetsAbstract" xlink:href="bmr-20221231.xsd#bmr_NonCurrentAssetsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmr_NonCurrentAssetsAbstract_lbl" xml:lang="en-US">Non-current assets:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_NonCurrentAssetsAbstract" xlink:to="bmr_NonCurrentAssetsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCosts"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredCosts_lbl" xml:lang="en-US">Deferred offering costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredCosts" xlink:to="us-gaap_DeferredCosts_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xml:lang="en-US">Property and equipment, net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl0" xml:lang="en-US">Total property and equipment, net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl" xml:lang="en-US">Intangible assets, net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_Goodwill_lbl" xml:lang="en-US">Goodwill</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Goodwill" xlink:to="us-gaap_Goodwill_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_UnlabeledAbstract0" xlink:href="bmr-20221231.xsd#bmr_UnlabeledAbstract0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmr_UnlabeledAbstract0_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_UnlabeledAbstract0" xlink:to="bmr_UnlabeledAbstract0_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_UnlabeledAbstract1" xlink:href="bmr-20221231.xsd#bmr_UnlabeledAbstract1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmr_UnlabeledAbstract1_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_UnlabeledAbstract1" xlink:to="bmr_UnlabeledAbstract1_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_LiabilitiesAndShareholdersEquityDeficitAbstract" xlink:href="bmr-20221231.xsd#bmr_LiabilitiesAndShareholdersEquityDeficitAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmr_LiabilitiesAndShareholdersEquityDeficitAbstract_lbl" xml:lang="en-US">LIABILITIES AND SHAREHOLDERS&#8217; EQUITY (DEFICIT)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_LiabilitiesAndShareholdersEquityDeficitAbstract" xlink:to="bmr_LiabilitiesAndShareholdersEquityDeficitAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xml:lang="en-US">Current liabilities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermBorrowings" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermBorrowings"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShortTermBorrowings_lbl" xml:lang="en-US">Current maturities of loans, net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermBorrowings" xlink:to="us-gaap_ShortTermBorrowings_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xml:lang="en-US">Account payables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrent" xlink:to="us-gaap_AccountsPayableCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredRevenueCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredRevenueCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredRevenueCurrent_lbl" xml:lang="en-US">Deferred revenues</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRevenueCurrent" xlink:to="us-gaap_DeferredRevenueCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DueToRelatedPartiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueToRelatedPartiesCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DueToRelatedPartiesCurrent_lbl" xml:lang="en-US">Liability from related party, net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DueToRelatedPartiesCurrent" xlink:to="us-gaap_DueToRelatedPartiesCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_UnlabeledAbstract2" xlink:href="bmr-20221231.xsd#bmr_UnlabeledAbstract2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmr_UnlabeledAbstract2_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_UnlabeledAbstract2" xlink:to="bmr_UnlabeledAbstract2_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_NonCurrentLiabilitiesAbstract" xlink:href="bmr-20221231.xsd#bmr_NonCurrentLiabilitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmr_NonCurrentLiabilitiesAbstract_lbl" xml:lang="en-US">Non-current liabilities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_NonCurrentLiabilitiesAbstract" xlink:to="bmr_NonCurrentLiabilitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LongTermDebtNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LongTermDebtNoncurrent_lbl" xml:lang="en-US">Loans, net of current maturities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtNoncurrent" xlink:to="us-gaap_LongTermDebtNoncurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DueToRelatedPartiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueToRelatedPartiesNoncurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DueToRelatedPartiesNoncurrent_lbl" xml:lang="en-US">Liability from related party, net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DueToRelatedPartiesNoncurrent" xlink:to="us-gaap_DueToRelatedPartiesNoncurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DerivativeLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilitiesNoncurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DerivativeLiabilitiesNoncurrent_lbl" xml:lang="en-US">Derivative warrants liability</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeLiabilitiesNoncurrent" xlink:to="us-gaap_DerivativeLiabilitiesNoncurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_ConvertibleAdvancedInvestments" xlink:href="bmr-20221231.xsd#bmr_ConvertibleAdvancedInvestments"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmr_ConvertibleAdvancedInvestments_lbl" xml:lang="en-US">Convertible advanced investments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_ConvertibleAdvancedInvestments" xlink:to="bmr_ConvertibleAdvancedInvestments_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_UnlabeledAbstract3" xlink:href="bmr-20221231.xsd#bmr_UnlabeledAbstract3"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmr_UnlabeledAbstract3_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_UnlabeledAbstract3" xlink:to="bmr_UnlabeledAbstract3_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xml:lang="en-US">Commitments and contingent liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingencies" xlink:to="us-gaap_CommitmentsAndContingencies_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_UnlabeledAbstract4" xlink:href="bmr-20221231.xsd#bmr_UnlabeledAbstract4"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmr_UnlabeledAbstract4_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_UnlabeledAbstract4" xlink:to="bmr_UnlabeledAbstract4_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_ShareholdersEquityDeficitAbstract" xlink:href="bmr-20221231.xsd#bmr_ShareholdersEquityDeficitAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmr_ShareholdersEquityDeficitAbstract_lbl" xml:lang="en-US">Shareholders&#8217; equity (deficit):</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_ShareholdersEquityDeficitAbstract" xlink:to="bmr_ShareholdersEquityDeficitAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_OrdinarySharesOfNis005ParValueEachAbstract" xlink:href="bmr-20221231.xsd#bmr_OrdinarySharesOfNis005ParValueEachAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmr_OrdinarySharesOfNis005ParValueEachAbstract_lbl" xml:lang="en-US">Ordinary Shares of NIS 0.05 par value each:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_OrdinarySharesOfNis005ParValueEachAbstract" xlink:to="bmr_OrdinarySharesOfNis005ParValueEachAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockValue_lbl" xml:lang="en-US">Ordinary Shares of NIS 0.05 par value each: Authorized: 14,307,116 and 14,316,880 shares at December 31, 2022 and 2021, respectively; Issued and outstanding: 2,578,760 shares at December 31, 2022 and 2021</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Ordinary shares, par value (in New Shekels per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xml:lang="en-US">Ordinary shares, authorized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xml:lang="en-US">Ordinary shares, issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xml:lang="en-US">Ordinary shares, outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_ConvertibleOrdinary1And2SharesOfNis005ParValueEachAbstract" xlink:href="bmr-20221231.xsd#bmr_ConvertibleOrdinary1And2SharesOfNis005ParValueEachAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmr_ConvertibleOrdinary1And2SharesOfNis005ParValueEachAbstract_lbl" xml:lang="en-US">Convertible Ordinary 1 and 2 Shares of NIS 0.05 par value each:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_ConvertibleOrdinary1And2SharesOfNis005ParValueEachAbstract" xlink:to="bmr_ConvertibleOrdinary1And2SharesOfNis005ParValueEachAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_CommonStockValue1" xlink:href="bmr-20221231.xsd#bmr_CommonStockValue1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmr_CommonStockValue1_lbl" xml:lang="en-US">Convertible Ordinary 1 and 2 Shares of NIS 0.05 par value each: Authorized: 1,496,880 shares at December 31, 2022 and 2021; Issued and outstanding: 1,496,880 shares at December 31, 2022 and 2021</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_CommonStockValue1" xlink:to="bmr_CommonStockValue1_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_ConvertiblePreferredSharesOfNis005ParValueEachAbstract" xlink:href="bmr-20221231.xsd#bmr_ConvertiblePreferredSharesOfNis005ParValueEachAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmr_ConvertiblePreferredSharesOfNis005ParValueEachAbstract_lbl" xml:lang="en-US">Convertible Preferred Shares of NIS 0.05 par value each:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_ConvertiblePreferredSharesOfNis005ParValueEachAbstract" xlink:to="bmr_ConvertiblePreferredSharesOfNis005ParValueEachAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PreferredStockValue_lbl" xml:lang="en-US">Convertible Preferred Shares of NIS 0.05 par value each: Authorized: 6,196,004 and 6,186,240 shares at December 31, 2022 and 2021, respectively; Issued and outstanding: 5,714,400 shares at December 31, 2022 and 2021</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockValue" xlink:to="us-gaap_PreferredStockValue_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Convertible preferred shares, par value (in New Shekels per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xml:lang="en-US">Convertible preferred shares, authorized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xml:lang="en-US">Convertible preferred shares, issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PreferredStockSharesIssued_lbl0" xml:lang="en-US">Preferred Stock, Shares Issued (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xml:lang="en-US">Convertible preferred shares, outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AdditionalPaidInCapital_lbl" xml:lang="en-US">Additional paid-in capital</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapital" xlink:to="us-gaap_AdditionalPaidInCapital_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xml:lang="en-US">Accumulated deficit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl0" xml:lang="en-US">Accumulative deficit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl0"/>
    <loc xlink:type="locator" xlink:label="bmr_UnlabeledAbstract5" xlink:href="bmr-20221231.xsd#bmr_UnlabeledAbstract5"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmr_UnlabeledAbstract5_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_UnlabeledAbstract5" xlink:to="bmr_UnlabeledAbstract5_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_Revenues_lbl" xml:lang="en-US">Revenues</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_Revenues_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_UnlabeledAbstract6" xlink:href="bmr-20221231.xsd#bmr_UnlabeledAbstract6"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmr_UnlabeledAbstract6_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_UnlabeledAbstract6" xlink:to="bmr_UnlabeledAbstract6_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherOperatingIncomeExpenseNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOperatingIncomeExpenseNet"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherOperatingIncomeExpenseNet_lbl" xml:lang="en-US">Other income</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherOperatingIncomeExpenseNet" xlink:to="us-gaap_OtherOperatingIncomeExpenseNet_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_UnlabeledAbstract7" xlink:href="bmr-20221231.xsd#bmr_UnlabeledAbstract7"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmr_UnlabeledAbstract7_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_UnlabeledAbstract7" xlink:to="bmr_UnlabeledAbstract7_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_UnlabeledAbstract8" xlink:href="bmr-20221231.xsd#bmr_UnlabeledAbstract8"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmr_UnlabeledAbstract8_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_UnlabeledAbstract8" xlink:to="bmr_UnlabeledAbstract8_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_UnlabeledAbstract9" xlink:href="bmr-20221231.xsd#bmr_UnlabeledAbstract9"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmr_UnlabeledAbstract9_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_UnlabeledAbstract9" xlink:to="bmr_UnlabeledAbstract9_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_UnlabeledAbstract10" xlink:href="bmr-20221231.xsd#bmr_UnlabeledAbstract10"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmr_UnlabeledAbstract10_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_UnlabeledAbstract10" xlink:to="bmr_UnlabeledAbstract10_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_UnlabeledAbstract11" xlink:href="bmr-20221231.xsd#bmr_UnlabeledAbstract11"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmr_UnlabeledAbstract11_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_UnlabeledAbstract11" xlink:to="bmr_UnlabeledAbstract11_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_UnlabeledAbstract12" xlink:href="bmr-20221231.xsd#bmr_UnlabeledAbstract12"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmr_UnlabeledAbstract12_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_UnlabeledAbstract12" xlink:to="bmr_UnlabeledAbstract12_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xml:lang="en-US">Basic and diluted net loss per share (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xml:lang="en-US">Basic and diluted net loss per share (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_UnlabeledAbstract13" xlink:href="bmr-20221231.xsd#bmr_UnlabeledAbstract13"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmr_UnlabeledAbstract13_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_UnlabeledAbstract13" xlink:to="bmr_UnlabeledAbstract13_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xml:lang="en-US">Weighted average number of Ordinary Shares used in computing basic and diluted net loss per share (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xml:lang="en-US">Weighted average number of Ordinary Shares used in computing diluted net loss per share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_UnlabeledAbstract14" xlink:href="bmr-20221231.xsd#bmr_UnlabeledAbstract14"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmr_UnlabeledAbstract14_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_UnlabeledAbstract14" xlink:to="bmr_UnlabeledAbstract14_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" xml:lang="en-US">Exercise of share options into Ordinary Shares (Note 12)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl" xml:lang="en-US">Exercise of share options into Ordinary Shares (Note 12) (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_lbl" xml:lang="en-US">Share-based compensation (Note 12)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_lbl" xml:lang="en-US">Share-based compensation (Note 12) (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:to="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US">Net loss for the year</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_NetIncomeLoss_lbl0" xml:lang="en-US">Net loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl0"/>
    <loc xlink:type="locator" xlink:label="bmr_UnlabeledAbstract15" xlink:href="bmr-20221231.xsd#bmr_UnlabeledAbstract15"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmr_UnlabeledAbstract15_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_UnlabeledAbstract15" xlink:to="bmr_UnlabeledAbstract15_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_UnlabeledAbstract16" xlink:href="bmr-20221231.xsd#bmr_UnlabeledAbstract16"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmr_UnlabeledAbstract16_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_UnlabeledAbstract16" xlink:to="bmr_UnlabeledAbstract16_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_UnlabeledAbstract17" xlink:href="bmr-20221231.xsd#bmr_UnlabeledAbstract17"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmr_UnlabeledAbstract17_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_UnlabeledAbstract17" xlink:to="bmr_UnlabeledAbstract17_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_UnlabeledAbstract18" xlink:href="bmr-20221231.xsd#bmr_UnlabeledAbstract18"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmr_UnlabeledAbstract18_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_UnlabeledAbstract18" xlink:to="bmr_UnlabeledAbstract18_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueOther"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueOther_lbl" xml:lang="en-US">Contribution to equity due to free interest loan from controlling shareholder (Note 14)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueOther" xlink:to="us-gaap_StockIssuedDuringPeriodValueOther_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_UnlabeledAbstract19" xlink:href="bmr-20221231.xsd#bmr_UnlabeledAbstract19"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmr_UnlabeledAbstract19_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_UnlabeledAbstract19" xlink:to="bmr_UnlabeledAbstract19_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_CashFlowsFromOperatingActivitiesAbstract" xlink:href="bmr-20221231.xsd#bmr_CashFlowsFromOperatingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmr_CashFlowsFromOperatingActivitiesAbstract_lbl" xml:lang="en-US">Cash flows from operating activities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_CashFlowsFromOperatingActivitiesAbstract" xlink:to="bmr_CashFlowsFromOperatingActivitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_AdjustmentsRequiredToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract" xlink:href="bmr-20221231.xsd#bmr_AdjustmentsRequiredToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmr_AdjustmentsRequiredToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Adjustments required to reconcile net loss to net cash used in operating activities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_AdjustmentsRequiredToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract" xlink:to="bmr_AdjustmentsRequiredToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DepreciationDepletionAndAmortization_lbl" xml:lang="en-US">Depreciation and amortization</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationDepletionAndAmortization" xlink:to="us-gaap_DepreciationDepletionAndAmortization_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensation_lbl" xml:lang="en-US">Share-based compensation (Note 12)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AmortizationOfDebtDiscountPremium" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfDebtDiscountPremium"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AmortizationOfDebtDiscountPremium_lbl" xml:lang="en-US">Amortization of discount relating to straight loan received from commercial bank (Note 6)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfDebtDiscountPremium" xlink:to="us-gaap_AmortizationOfDebtDiscountPremium_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AmortizationOfDebtDiscountPremium_lbl0" xml:lang="en-US">Amortization of discount and interest expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfDebtDiscountPremium" xlink:to="us-gaap_AmortizationOfDebtDiscountPremium_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AmortizationOfFinancingCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AmortizationOfFinancingCosts_lbl" xml:lang="en-US">Amortization of discount relating to liability to related party (see Note 14)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfFinancingCosts" xlink:to="us-gaap_AmortizationOfFinancingCosts_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" xml:lang="en-US">Increase (decrease) in account payables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncreaseDecreaseInDeferredRevenue_lbl" xml:lang="en-US">Increase (decrease) in deferred revenues</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:to="us-gaap_IncreaseDecreaseInDeferredRevenue_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherCurrentLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_lbl" xml:lang="en-US">Increase (decrease) in other current liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:to="us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_UnlabeledAbstract20" xlink:href="bmr-20221231.xsd#bmr_UnlabeledAbstract20"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmr_UnlabeledAbstract20_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_UnlabeledAbstract20" xlink:to="bmr_UnlabeledAbstract20_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_CashFlowsFromInvestingActivitiesAbstract" xlink:href="bmr-20221231.xsd#bmr_CashFlowsFromInvestingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmr_CashFlowsFromInvestingActivitiesAbstract_lbl" xml:lang="en-US">Cash flows from investing activities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_CashFlowsFromInvestingActivitiesAbstract" xlink:to="bmr_CashFlowsFromInvestingActivitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_lbl" xml:lang="en-US">Selling of property and equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:to="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_UnlabeledAbstract21" xlink:href="bmr-20221231.xsd#bmr_UnlabeledAbstract21"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmr_UnlabeledAbstract21_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_UnlabeledAbstract21" xlink:to="bmr_UnlabeledAbstract21_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_CashFlowsFromFinancingActivitiesAbstract" xlink:href="bmr-20221231.xsd#bmr_CashFlowsFromFinancingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmr_CashFlowsFromFinancingActivitiesAbstract_lbl" xml:lang="en-US">Cash flows from financing activities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_CashFlowsFromFinancingActivitiesAbstract" xlink:to="bmr_CashFlowsFromFinancingActivitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xml:lang="en-US">Proceeds received from issuance of convertible advanced investments (Note 9)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl0" xml:lang="en-US">Issuance of convertible debt</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromNotesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromNotesPayable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromNotesPayable_lbl" xml:lang="en-US">Proceeds received from paycheck protection program note (Note 6B)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromNotesPayable" xlink:to="us-gaap_ProceedsFromNotesPayable_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ProceedsFromNotesPayable_lbl0" xml:lang="en-US">Net amounts raised</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromNotesPayable" xlink:to="us-gaap_ProceedsFromNotesPayable_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromIssuanceOfPrivatePlacement_lbl" xml:lang="en-US">Proceeds from issuance of unit consist of straight loan and warrant granted to commercial bank, net (Note 6C)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:to="us-gaap_ProceedsFromIssuanceOfPrivatePlacement_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromRelatedPartyDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRelatedPartyDebt"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromRelatedPartyDebt_lbl" xml:lang="en-US">Proceeds from loan received from related party</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromRelatedPartyDebt" xlink:to="us-gaap_ProceedsFromRelatedPartyDebt_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromStockOptionsExercised_lbl" xml:lang="en-US">Proceeds received from exercise of share options into Ordinary Shares (Note 12)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromStockOptionsExercised" xlink:to="us-gaap_ProceedsFromStockOptionsExercised_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ProceedsFromStockOptionsExercised_lbl0" xml:lang="en-US">Exercise of share option value through paycheck protection</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromStockOptionsExercised" xlink:to="us-gaap_ProceedsFromStockOptionsExercised_lbl0"/>
    <loc xlink:type="locator" xlink:label="bmr_UnlabeledAbstract22" xlink:href="bmr-20221231.xsd#bmr_UnlabeledAbstract22"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmr_UnlabeledAbstract22_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_UnlabeledAbstract22" xlink:to="bmr_UnlabeledAbstract22_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_NonCashFinancingActivitiesAbstract" xlink:href="bmr-20221231.xsd#bmr_NonCashFinancingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmr_NonCashFinancingActivitiesAbstract_lbl" xml:lang="en-US">Non-cash financing activities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_NonCashFinancingActivitiesAbstract" xlink:to="bmr_NonCashFinancingActivitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssued1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssued1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssued1_lbl" xml:lang="en-US">Contribution to equity due to free interest loan from controlling shareholder (Note 14)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssued1" xlink:to="us-gaap_StockIssued1_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_UnlabeledAbstract23" xlink:href="bmr-20221231.xsd#bmr_UnlabeledAbstract23"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmr_UnlabeledAbstract23_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_UnlabeledAbstract23" xlink:to="bmr_UnlabeledAbstract23_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_SupplementalDisclosureOfCashFlowInformationAbstract" xlink:href="bmr-20221231.xsd#bmr_SupplementalDisclosureOfCashFlowInformationAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmr_SupplementalDisclosureOfCashFlowInformationAbstract_lbl" xml:lang="en-US">Supplemental disclosure of cash flow information:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_SupplementalDisclosureOfCashFlowInformationAbstract" xlink:to="bmr_SupplementalDisclosureOfCashFlowInformationAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CostOfRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfRevenue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_CostOfRevenue_lbl" xml:lang="en-US">Cost of revenues</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfRevenue" xlink:to="us-gaap_CostOfRevenue_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xml:lang="en-US">Research and development expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="us-gaap_ResearchAndDevelopmentExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SellingAndMarketingExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingAndMarketingExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_SellingAndMarketingExpense_lbl" xml:lang="en-US">Sales and marketing expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingAndMarketingExpense" xlink:to="us-gaap_SellingAndMarketingExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xml:lang="en-US">General and administrative expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpense" xlink:to="us-gaap_GeneralAndAdministrativeExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FinancingInterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingInterestExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_FinancingInterestExpense_lbl" xml:lang="en-US">Financing expenses, net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinancingInterestExpense" xlink:to="us-gaap_FinancingInterestExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Taxes on income</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt_lbl" xml:lang="en-US">Exchange rate differences on straight loan received from commercial bank (Note 6)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueOptionChangesInFairValueGainLoss1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOptionChangesInFairValueGainLoss1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_FairValueOptionChangesInFairValueGainLoss1_lbl" xml:lang="en-US">Change in the fair value of convertible advanced investments (Note 9)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueOptionChangesInFairValueGainLoss1" xlink:to="us-gaap_FairValueOptionChangesInFairValueGainLoss1_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_GainLossOnSaleOfPropertyPlantEquipment_lbl" xml:lang="en-US">Capital gain from selling of property and equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:to="us-gaap_GainLossOnSaleOfPropertyPlantEquipment_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GainLossOnDispositionOfAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnDispositionOfAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_GainLossOnDispositionOfAssets_lbl" xml:lang="en-US">Capital loss from disposal of property and equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnDispositionOfAssets" xlink:to="us-gaap_GainLossOnDispositionOfAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_ModificationOfTermsOfStraightLoan" xlink:href="bmr-20221231.xsd#bmr_ModificationOfTermsOfStraightLoan"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="bmr_ModificationOfTermsOfStraightLoan_lbl" xml:lang="en-US">Modification of terms of straight loan (Note 6A)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_ModificationOfTermsOfStraightLoan" xlink:to="bmr_ModificationOfTermsOfStraightLoan_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GainsLossesOnRestructuringOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnRestructuringOfDebt"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_GainsLossesOnRestructuringOfDebt_lbl" xml:lang="en-US">Forgiveness of loan under paycheck protection program notes (Note 6B)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainsLossesOnRestructuringOfDebt" xlink:to="us-gaap_GainsLossesOnRestructuringOfDebt_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOtherReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherReceivables"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInOtherReceivables_lbl" xml:lang="en-US">Decrease (increase) in trade receivables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherReceivables" xlink:to="us-gaap_IncreaseDecreaseInOtherReceivables_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherCurrentAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInOtherCurrentAssets_lbl" xml:lang="en-US">Decrease (increase) in other current assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:to="us-gaap_IncreaseDecreaseInOtherCurrentAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInDueFromRelatedParties" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDueFromRelatedParties"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInDueFromRelatedParties_lbl" xml:lang="en-US">Increase in liability from related party</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInDueFromRelatedParties" xlink:to="us-gaap_IncreaseDecreaseInDueFromRelatedParties_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xml:lang="en-US">Purchase of property and equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsOfFinancingCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfFinancingCosts"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsOfFinancingCosts_lbl" xml:lang="en-US">Deferred offering costs (Note 2F)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfFinancingCosts" xlink:to="us-gaap_PaymentsOfFinancingCosts_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RepaymentsOfRelatedPartyDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfRelatedPartyDebt"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_RepaymentsOfRelatedPartyDebt_lbl" xml:lang="en-US">Repayment of principal relating to straight loan received from commercial bank (Note 6)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfRelatedPartyDebt" xlink:to="us-gaap_RepaymentsOfRelatedPartyDebt_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RepaymentsOfFederalHomeLoanBankBorrowings" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfFederalHomeLoanBankBorrowings"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_RepaymentsOfFederalHomeLoanBankBorrowings_lbl" xml:lang="en-US">Repayment of Facility Fee relating to straight loan received from commercial bank (Note 6)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfFederalHomeLoanBankBorrowings" xlink:to="us-gaap_RepaymentsOfFederalHomeLoanBankBorrowings_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_InterestPaidNet_lbl" xml:lang="en-US">Interest paid</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPaidNet" xlink:to="us-gaap_InterestPaidNet_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxesPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaid"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncomeTaxesPaid_lbl" xml:lang="en-US">Taxes paid</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxesPaid" xlink:to="us-gaap_IncomeTaxesPaid_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_BusinessContactMember" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_BusinessContactMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_BusinessContactMember_lbl" xml:lang="en-US">Business Contact</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_BusinessContactMember" xlink:to="dei_BusinessContactMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockMember_lbl" xml:lang="en-US">Ordinary shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommonStockMember_lbl0" xml:lang="en-US">Ordinary shares [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:label="us-gaap_CommonStockMember_lbl1" xml:lang="en-US">Ordinary Shares [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockMember_lbl2" xml:lang="en-US">Common Stock [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl2"/>
    <loc xlink:type="locator" xlink:label="bmr_ConvertibleOrdinary1And2SharesMember" xlink:href="bmr-20221231.xsd#bmr_ConvertibleOrdinary1And2SharesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmr_ConvertibleOrdinary1And2SharesMember_lbl" xml:lang="en-US">Convertible Ordinary 1 and 2 shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_ConvertibleOrdinary1And2SharesMember" xlink:to="bmr_ConvertibleOrdinary1And2SharesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_ConvertiblePreferredSharesMember" xlink:href="bmr-20221231.xsd#bmr_ConvertiblePreferredSharesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmr_ConvertiblePreferredSharesMember_lbl" xml:lang="en-US">Convertible Preferred shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_ConvertiblePreferredSharesMember" xlink:to="bmr_ConvertiblePreferredSharesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xml:lang="en-US">Additional paid-in capital</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RetainedEarningsMember_lbl" xml:lang="en-US">Accumulated deficit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl" xml:lang="en-US">GENERAL</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xml:lang="en-US">SIGNIFICANT ACCOUNTING POLICIES</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_lbl" xml:lang="en-US">Schedule of computing straight-line amortization</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:to="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_PropertyPlantAndEquipmentDepreciationPercentage" xlink:href="bmr-20221231.xsd#bmr_PropertyPlantAndEquipmentDepreciationPercentage"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmr_PropertyPlantAndEquipmentDepreciationPercentage_lbl" xml:lang="en-US">Property, plant and equipment, depreciation percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_PropertyPlantAndEquipmentDepreciationPercentage" xlink:to="bmr_PropertyPlantAndEquipmentDepreciationPercentage_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentAndIntangibleAssetsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAndIntangibleAssetsTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentAndIntangibleAssetsTextBlock_lbl" xml:lang="en-US">Schedule of computing straight-line depreciation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentAndIntangibleAssetsTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentAndIntangibleAssetsTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentSalvageValuePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentSalvageValuePercentage"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentSalvageValuePercentage_lbl" xml:lang="en-US">Property, plant and equipment, depreciation percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentSalvageValuePercentage" xlink:to="us-gaap_PropertyPlantAndEquipmentSalvageValuePercentage_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherCurrentAssetsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCurrentAssetsTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherCurrentAssetsTextBlock_lbl" xml:lang="en-US">OTHER CURRENT ASSETS</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherCurrentAssetsTextBlock" xlink:to="us-gaap_OtherCurrentAssetsTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock_lbl" xml:lang="en-US">Schedule of other current assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:to="us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseCurrentAndNoncurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PrepaidExpenseCurrentAndNoncurrent_lbl" xml:lang="en-US">Prepaid expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseCurrentAndNoncurrent" xlink:to="us-gaap_PrepaidExpenseCurrentAndNoncurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_GovernmentAuthoritiesAssets" xlink:href="bmr-20221231.xsd#bmr_GovernmentAuthoritiesAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmr_GovernmentAuthoritiesAssets_lbl" xml:lang="en-US">Government authorities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_GovernmentAuthoritiesAssets" xlink:to="bmr_GovernmentAuthoritiesAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherPrepaidExpenseCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherPrepaidExpenseCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherPrepaidExpenseCurrent_lbl" xml:lang="en-US">Others</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherPrepaidExpenseCurrent" xlink:to="us-gaap_OtherPrepaidExpenseCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" xml:lang="en-US">PROPERTY AND EQUIPMENT, NET</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xml:lang="en-US">Schedule of property and equipment net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xml:lang="en-US">Property and equipment, gross</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentGross" xlink:to="us-gaap_PropertyPlantAndEquipmentGross_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_lbl" xml:lang="en-US">INTANGIBLE ASSETS, NET AND GOODWILL</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfImpairedIntangibleAssetsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfImpairedIntangibleAssetsTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfImpairedIntangibleAssetsTextBlock_lbl" xml:lang="en-US">Schedule of intangible assets, net and goodwil</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfImpairedIntangibleAssetsTextBlock" xlink:to="us-gaap_ScheduleOfImpairedIntangibleAssetsTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_CarryingAmountAbstract" xlink:href="bmr-20221231.xsd#bmr_CarryingAmountAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmr_CarryingAmountAbstract_lbl" xml:lang="en-US">Carrying amount:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_CarryingAmountAbstract" xlink:to="bmr_CarryingAmountAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsUnderManagementCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsUnderManagementCarryingAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AssetsUnderManagementCarryingAmount_lbl" xml:lang="en-US">Carrying amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsUnderManagementCarryingAmount" xlink:to="us-gaap_AssetsUnderManagementCarryingAmount_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_UnlabeledAbstract24" xlink:href="bmr-20221231.xsd#bmr_UnlabeledAbstract24"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmr_UnlabeledAbstract24_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_UnlabeledAbstract24" xlink:to="bmr_UnlabeledAbstract24_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_AccumulatedAmortizationAbstract" xlink:href="bmr-20221231.xsd#bmr_AccumulatedAmortizationAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmr_AccumulatedAmortizationAbstract_lbl" xml:lang="en-US">Accumulated amortization:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_AccumulatedAmortizationAbstract" xlink:to="bmr_AccumulatedAmortizationAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccumulatedAmortizationDeferredFinanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedAmortizationDeferredFinanceCosts"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AccumulatedAmortizationDeferredFinanceCosts_lbl" xml:lang="en-US">Accumulated amortization</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedAmortizationDeferredFinanceCosts" xlink:to="us-gaap_AccumulatedAmortizationDeferredFinanceCosts_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_UnlabeledAbstract25" xlink:href="bmr-20221231.xsd#bmr_UnlabeledAbstract25"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmr_UnlabeledAbstract25_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_UnlabeledAbstract25" xlink:to="bmr_UnlabeledAbstract25_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_UnlabeledAbstract26" xlink:href="bmr-20221231.xsd#bmr_UnlabeledAbstract26"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmr_UnlabeledAbstract26_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_UnlabeledAbstract26" xlink:to="bmr_UnlabeledAbstract26_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIntangibleAssetsNet"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherIntangibleAssetsNet_lbl" xml:lang="en-US">Intangible assets, net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherIntangibleAssetsNet" xlink:to="us-gaap_OtherIntangibleAssetsNet_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl" xml:lang="en-US">Schedule of the estimated future amortization expense of intangible assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths_lbl" xml:lang="en-US">2023</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo_lbl" xml:lang="en-US">2024-2026</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_UnlabeledAbstract27" xlink:href="bmr-20221231.xsd#bmr_UnlabeledAbstract27"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmr_UnlabeledAbstract27_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_UnlabeledAbstract27" xlink:to="bmr_UnlabeledAbstract27_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtDisclosureTextBlock_lbl" xml:lang="en-US">LOANS, NET</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureTextBlock" xlink:to="us-gaap_DebtDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_ScheduleOfTheMemberEffectiveDateManagementByAssistanceOfThirdpartyTableTextBlock" xlink:href="bmr-20221231.xsd#bmr_ScheduleOfTheMemberEffectiveDateManagementByAssistanceOfThirdpartyTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmr_ScheduleOfTheMemberEffectiveDateManagementByAssistanceOfThirdpartyTableTextBlock_lbl" xml:lang="en-US">Schedule of the Effective Date, management by assistance of third-party</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_ScheduleOfTheMemberEffectiveDateManagementByAssistanceOfThirdpartyTableTextBlock" xlink:to="bmr_ScheduleOfTheMemberEffectiveDateManagementByAssistanceOfThirdpartyTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_DerivativeWarrantLiabilityseeNote8" xlink:href="bmr-20221231.xsd#bmr_DerivativeWarrantLiabilityseeNote8"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmr_DerivativeWarrantLiabilityseeNote8_lbl" xml:lang="en-US">Derivative warrant liability (see Note 8)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_DerivativeWarrantLiabilityseeNote8" xlink:to="bmr_DerivativeWarrantLiabilityseeNote8_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StraightLineRent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StraightLineRent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StraightLineRent_lbl" xml:lang="en-US">Straight loan</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StraightLineRent" xlink:to="us-gaap_StraightLineRent_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_TotalGrossConsideration" xlink:href="bmr-20221231.xsd#bmr_TotalGrossConsideration"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmr_TotalGrossConsideration_lbl" xml:lang="en-US">Total gross consideration</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_TotalGrossConsideration" xlink:to="bmr_TotalGrossConsideration_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_ScheduleOfPresentationReflectsTheReconciliationOfTheCarryingAmountTableTextBlock" xlink:href="bmr-20221231.xsd#bmr_ScheduleOfPresentationReflectsTheReconciliationOfTheCarryingAmountTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmr_ScheduleOfPresentationReflectsTheReconciliationOfTheCarryingAmountTableTextBlock_lbl" xml:lang="en-US">Schedule of the reconciliation of the carrying amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_ScheduleOfPresentationReflectsTheReconciliationOfTheCarryingAmountTableTextBlock" xlink:to="bmr_ScheduleOfPresentationReflectsTheReconciliationOfTheCarryingAmountTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_ReconciliationOfTheCarryingAmount" xlink:href="bmr-20221231.xsd#bmr_ReconciliationOfTheCarryingAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmr_ReconciliationOfTheCarryingAmount_lbl" xml:lang="en-US">Opening balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_ReconciliationOfTheCarryingAmount" xlink:to="bmr_ReconciliationOfTheCarryingAmount_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_ConsiderationReceivedFromPPPNote" xlink:href="bmr-20221231.xsd#bmr_ConsiderationReceivedFromPPPNote"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmr_ConsiderationReceivedFromPPPNote_lbl" xml:lang="en-US">Consideration received from PPP Note</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_ConsiderationReceivedFromPPPNote" xlink:to="bmr_ConsiderationReceivedFromPPPNote_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_NetConsiderationReceivedFromIBILoan" xlink:href="bmr-20221231.xsd#bmr_NetConsiderationReceivedFromIBILoan"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmr_NetConsiderationReceivedFromIBILoan_lbl" xml:lang="en-US">Net consideration received from IBI Loan</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_NetConsiderationReceivedFromIBILoan" xlink:to="bmr_NetConsiderationReceivedFromIBILoan_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_lbl" xml:lang="en-US">Amortization of discounts relating to straight loan (see also Note 13)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:to="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesFairValueDisclosure"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesFairValueDisclosure_lbl" xml:lang="en-US">Accrued interest expenses relating to straight loan (see also Note 13)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesFairValueDisclosure" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesFairValueDisclosure_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_RecognitionSubsequentToSubstantialModificationOfTerms" xlink:href="bmr-20221231.xsd#bmr_RecognitionSubsequentToSubstantialModificationOfTerms"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmr_RecognitionSubsequentToSubstantialModificationOfTerms_lbl" xml:lang="en-US">Recognition subsequent to substantial modification of terms</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_RecognitionSubsequentToSubstantialModificationOfTerms" xlink:to="bmr_RecognitionSubsequentToSubstantialModificationOfTerms_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_ReconciliationOfCarryingAmount" xlink:href="bmr-20221231.xsd#bmr_ReconciliationOfCarryingAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmr_ReconciliationOfCarryingAmount_lbl" xml:lang="en-US">Closing balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_ReconciliationOfCarryingAmount" xlink:to="bmr_ReconciliationOfCarryingAmount_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_ScheduleOfMaturityDatesOfOutstandingLoanTableTextBlock" xlink:href="bmr-20221231.xsd#bmr_ScheduleOfMaturityDatesOfOutstandingLoanTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmr_ScheduleOfMaturityDatesOfOutstandingLoanTableTextBlock_lbl" xml:lang="en-US">Schedule of maturity dates of outstanding loans</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_ScheduleOfMaturityDatesOfOutstandingLoanTableTextBlock" xlink:to="bmr_ScheduleOfMaturityDatesOfOutstandingLoanTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_lbl" xml:lang="en-US">First year (current maturities)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_lbl" xml:lang="en-US">Second year</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_lbl" xml:lang="en-US">Third year</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LongTermDebt_lbl" xml:lang="en-US">Closing balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebt" xlink:to="us-gaap_LongTermDebt_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_lbl" xml:lang="en-US">OTHER CURRENT LIABILITIES</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:to="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCurrentLiabilitiesTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherCurrentLiabilitiesTableTextBlock_lbl" xml:lang="en-US">Schedule of other current liabilties</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:to="us-gaap_OtherCurrentLiabilitiesTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" xml:lang="en-US">Employees and payroll accruals</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_lbl" xml:lang="en-US">Accrued expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_GovernmentAuthorities" xlink:href="bmr-20221231.xsd#bmr_GovernmentAuthorities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmr_GovernmentAuthorities_lbl" xml:lang="en-US">Government authorities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_GovernmentAuthorities" xlink:to="bmr_GovernmentAuthorities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_lbl" xml:lang="en-US">DERIVATIVE WARRANTS LIABILITIES</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:to="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_lbl" xml:lang="en-US">Schedule of reconciliation of the fair value of derivative warrants liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" xlink:to="us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet_lbl" xml:lang="en-US">Recognition of fair value of 2021 Warrant issued upon substantial modification of terms (see Note 6A1)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentOfWarrantsGrantedForServices" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentOfWarrantsGrantedForServices"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AdjustmentOfWarrantsGrantedForServices_lbl" xml:lang="en-US">Recognition of fair value of Warrant Share issued at Effective Date (see Note 6C)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentOfWarrantsGrantedForServices" xlink:to="us-gaap_AdjustmentOfWarrantsGrantedForServices_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentHoldingsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentHoldingsTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InvestmentHoldingsTextBlock_lbl" xml:lang="en-US">CONVERTIBLE ADVANCE INVESTMENT</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentHoldingsTextBlock" xlink:to="us-gaap_InvestmentHoldingsTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock_lbl" xml:lang="en-US">Schedule of reconciliation of the carrying amount of the convertible advance investment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock" xlink:to="us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1_lbl" xml:lang="en-US">Net consideration received</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1" xlink:to="us-gaap_NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_ChangeInTheFairValueOfConvertibleAdvanceInvestments" xlink:href="bmr-20221231.xsd#bmr_ChangeInTheFairValueOfConvertibleAdvanceInvestments"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmr_ChangeInTheFairValueOfConvertibleAdvanceInvestments_lbl" xml:lang="en-US">Change in the fair value of convertible advance investments (see also Note 13)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_ChangeInTheFairValueOfConvertibleAdvanceInvestments" xlink:to="bmr_ChangeInTheFairValueOfConvertibleAdvanceInvestments_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="bmr_ChangeInTheFairValueOfConvertibleAdvanceInvestments_lbl0" xml:lang="en-US">Change in fair value of convertible advance investment (see Note 9)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_ChangeInTheFairValueOfConvertibleAdvanceInvestments" xlink:to="bmr_ChangeInTheFairValueOfConvertibleAdvanceInvestments_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xml:lang="en-US">COMMITMENTS AND CONTINGENT LIABILITIES</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_scheduleOfFutureMinimumCommitmentUnderBindingLeaseAgreeementsTableTextBlock" xlink:href="bmr-20221231.xsd#bmr_scheduleOfFutureMinimumCommitmentUnderBindingLeaseAgreeementsTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmr_scheduleOfFutureMinimumCommitmentUnderBindingLeaseAgreeementsTableTextBlock_lbl" xml:lang="en-US">Schedule of future minimum commitment under binding lease agreeements</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_scheduleOfFutureMinimumCommitmentUnderBindingLeaseAgreeementsTableTextBlock" xlink:to="bmr_scheduleOfFutureMinimumCommitmentUnderBindingLeaseAgreeementsTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_LesseeOperatingLeasesLiabilityPaymentsDueNextTwelveMonths" xlink:href="bmr-20221231.xsd#bmr_LesseeOperatingLeasesLiabilityPaymentsDueNextTwelveMonths"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmr_LesseeOperatingLeasesLiabilityPaymentsDueNextTwelveMonths_lbl" xml:lang="en-US">2023</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_LesseeOperatingLeasesLiabilityPaymentsDueNextTwelveMonths" xlink:to="bmr_LesseeOperatingLeasesLiabilityPaymentsDueNextTwelveMonths_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_LesseeOperatingLeasesLiabilityPaymentsDue" xlink:href="bmr-20221231.xsd#bmr_LesseeOperatingLeasesLiabilityPaymentsDue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmr_LesseeOperatingLeasesLiabilityPaymentsDue_lbl" xml:lang="en-US">Total</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_LesseeOperatingLeasesLiabilityPaymentsDue" xlink:to="bmr_LesseeOperatingLeasesLiabilityPaymentsDue_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xml:lang="en-US">SHAREHOLDERS&#8217; EQUITY (DEFICIT)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfStockholdersEquityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockholdersEquityTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfStockholdersEquityTableTextBlock_lbl" xml:lang="en-US">Schedule of composition of shareholders&apos; equity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfStockholdersEquityTableTextBlock" xlink:to="us-gaap_ScheduleOfStockholdersEquityTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_NumberOfSharesAbstract" xlink:href="bmr-20221231.xsd#bmr_NumberOfSharesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmr_NumberOfSharesAbstract_lbl" xml:lang="en-US">Number of shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_NumberOfSharesAbstract" xlink:to="bmr_NumberOfSharesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_SharesOfNis005ParValueAbstract" xlink:href="bmr-20221231.xsd#bmr_SharesOfNis005ParValueAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmr_SharesOfNis005ParValueAbstract_lbl" xml:lang="en-US">Shares of NIS 0.05 par value:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_SharesOfNis005ParValueAbstract" xlink:to="bmr_SharesOfNis005ParValueAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ExcessStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExcessStockSharesAuthorized"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ExcessStockSharesAuthorized_lbl" xml:lang="en-US">Authorized shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ExcessStockSharesAuthorized" xlink:to="us-gaap_ExcessStockSharesAuthorized_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ExcessStockSharesAuthorized_lbl0" xml:lang="en-US">Shares authorized (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ExcessStockSharesAuthorized" xlink:to="us-gaap_ExcessStockSharesAuthorized_lbl0"/>
    <loc xlink:type="locator" xlink:label="bmr_ExcessSharesIssuedAndOutstandingShares" xlink:href="bmr-20221231.xsd#bmr_ExcessSharesIssuedAndOutstandingShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmr_ExcessSharesIssuedAndOutstandingShares_lbl" xml:lang="en-US">Issued and outstanding shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_ExcessSharesIssuedAndOutstandingShares" xlink:to="bmr_ExcessSharesIssuedAndOutstandingShares_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xml:lang="en-US">SHARE OPTIONS</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xml:lang="en-US">Schedule of company&#8217;s share option activity for employees and members of the board of directors</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_lbl" xml:lang="en-US">Weighted average remaining contractual life, Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xml:lang="en-US">Number of Share Options, Granted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted Average Exercise Price, Granted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_WeightedAverageRemainingContractualLifeGranted" xlink:href="bmr-20221231.xsd#bmr_WeightedAverageRemainingContractualLifeGranted"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmr_WeightedAverageRemainingContractualLifeGranted_lbl" xml:lang="en-US">Weighted average remaining contractual life, Granted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_WeightedAverageRemainingContractualLifeGranted" xlink:to="bmr_WeightedAverageRemainingContractualLifeGranted_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted Average Exercise Price, Exercised</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_WeightedAverageRemainingContractualLifeExercised" xlink:href="bmr-20221231.xsd#bmr_WeightedAverageRemainingContractualLifeExercised"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmr_WeightedAverageRemainingContractualLifeExercised_lbl" xml:lang="en-US">Weighted average remaining contractual life, Exercised</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_WeightedAverageRemainingContractualLifeExercised" xlink:to="bmr_WeightedAverageRemainingContractualLifeExercised_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted Average Exercise Price, Forfeited or expired</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_WeightedAverageRemainingContractualLifeForfeitedOrExpired" xlink:href="bmr-20221231.xsd#bmr_WeightedAverageRemainingContractualLifeForfeitedOrExpired"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmr_WeightedAverageRemainingContractualLifeForfeitedOrExpired_lbl" xml:lang="en-US">Weighted average remaining contractual life, Forfeited or expired</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_WeightedAverageRemainingContractualLifeForfeitedOrExpired" xlink:to="bmr_WeightedAverageRemainingContractualLifeForfeitedOrExpired_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_WeightedAverageRemainingContractualLifeOutstanding" xlink:href="bmr-20221231.xsd#bmr_WeightedAverageRemainingContractualLifeOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmr_WeightedAverageRemainingContractualLifeOutstanding_lbl" xml:lang="en-US">Weighted average remaining contractual life, Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_WeightedAverageRemainingContractualLifeOutstanding" xlink:to="bmr_WeightedAverageRemainingContractualLifeOutstanding_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xml:lang="en-US">Number of Share Options, Exercisable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl0" xml:lang="en-US">Options to purchase (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted Average Exercise Price, Exercisable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_lbl" xml:lang="en-US">Weighted average remaining contractual life, Exercisable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl" xml:lang="en-US">Intrinsic value, Exercisable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_lbl" xml:lang="en-US">Schedule of outstanding and exercisable share options separated ranges of exercise prices</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_UnlabeledAbstract28" xlink:href="bmr-20221231.xsd#bmr_UnlabeledAbstract28"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmr_UnlabeledAbstract28_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_UnlabeledAbstract28" xlink:to="bmr_UnlabeledAbstract28_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_lbl" xml:lang="en-US">Exercise price (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_lbl" xml:lang="en-US">Share options outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_lbl" xml:lang="en-US">Weighted average remaining contractual term (years)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_lbl" xml:lang="en-US">Share options exercisable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock_lbl" xml:lang="en-US">Schedule of assumptions used to estimate the fair values of the share options granted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" xml:lang="en-US">Volatility (%)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xml:lang="en-US">Risk-free interest rate (%)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xml:lang="en-US">Dividend yield (%)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xml:lang="en-US">Expected life (years)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_lbl" xml:lang="en-US">Exercise price ($) (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SharePrice_lbl" xml:lang="en-US">Share price ($) (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharePrice" xlink:to="us-gaap_SharePrice_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_lbl" xml:lang="en-US">Schedule of company&#8217;s equity-based awards recognized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:to="us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherResearchAndDevelopmentExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherResearchAndDevelopmentExpense_lbl" xml:lang="en-US">Research and development</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherResearchAndDevelopmentExpense" xlink:to="us-gaap_OtherResearchAndDevelopmentExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherSellingAndMarketingExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherSellingAndMarketingExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherSellingAndMarketingExpense_lbl" xml:lang="en-US">Sales and marketing</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherSellingAndMarketingExpense" xlink:to="us-gaap_OtherSellingAndMarketingExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherGeneralAndAdministrativeExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherGeneralAndAdministrativeExpense_lbl" xml:lang="en-US">General and administrative</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherGeneralAndAdministrativeExpense" xlink:to="us-gaap_OtherGeneralAndAdministrativeExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_lbl" xml:lang="en-US">Total compensation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_FinancingExpenses" xlink:href="bmr-20221231.xsd#bmr_FinancingExpenses"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmr_FinancingExpenses_lbl" xml:lang="en-US">FINANCING EXPENSES, NET</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_FinancingExpenses" xlink:to="bmr_FinancingExpenses_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertibleDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ConvertibleDebtTableTextBlock_lbl" xml:lang="en-US">Schedule of financing expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleDebtTableTextBlock" xlink:to="us-gaap_ConvertibleDebtTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PresentValueOfFutureInsuranceProfitsAmortizationExpenseAccruedInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PresentValueOfFutureInsuranceProfitsAmortizationExpenseAccruedInterest"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PresentValueOfFutureInsuranceProfitsAmortizationExpenseAccruedInterest_lbl" xml:lang="en-US">Amortization of discount and accrued interest relating to straight loan received from commercial Bank (see Note 6 and Note 7)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PresentValueOfFutureInsuranceProfitsAmortizationExpenseAccruedInterest" xlink:to="us-gaap_PresentValueOfFutureInsuranceProfitsAmortizationExpenseAccruedInterest_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_ModificationOfTermsRelatingToStraightLoan" xlink:href="bmr-20221231.xsd#bmr_ModificationOfTermsRelatingToStraightLoan"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmr_ModificationOfTermsRelatingToStraightLoan_lbl" xml:lang="en-US">Modification of terms relating to straight loan (see Note 6A1)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_ModificationOfTermsRelatingToStraightLoan" xlink:to="bmr_ModificationOfTermsRelatingToStraightLoan_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AmortizationOfFinancingCostsAndDiscounts_lbl" xml:lang="en-US">Amortization of discount relating to liability to related party (see Note 14)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:to="us-gaap_AmortizationOfFinancingCostsAndDiscounts_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_ExchangeRateDifferencesAndOthers" xlink:href="bmr-20221231.xsd#bmr_ExchangeRateDifferencesAndOthers"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmr_ExchangeRateDifferencesAndOthers_lbl" xml:lang="en-US">Exchange rate differences and others</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_ExchangeRateDifferencesAndOthers" xlink:to="bmr_ExchangeRateDifferencesAndOthers_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherNonoperatingExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherNonoperatingExpense_lbl" xml:lang="en-US">Total</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingExpense" xlink:to="us-gaap_OtherNonoperatingExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xml:lang="en-US">RELATED PARTIES TRANSACTIONS</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfRegulatoryLiabilitiesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRegulatoryLiabilitiesTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfRegulatoryLiabilitiesTextBlock_lbl" xml:lang="en-US">Schedule of the reconciliation of the carrying amount of the Company</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRegulatoryLiabilitiesTextBlock" xlink:to="us-gaap_ScheduleOfRegulatoryLiabilitiesTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrentAndNoncurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrentAndNoncurrent_lbl" xml:lang="en-US">Accrued liability in respect to additional services rendered</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAccruedLiabilitiesCurrentAndNoncurrent" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrentAndNoncurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentIncomeAmortizationOfDiscount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeAmortizationOfDiscount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InvestmentIncomeAmortizationOfDiscount_lbl" xml:lang="en-US">Amortization of discount relating to liability to related party</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentIncomeAmortizationOfDiscount" xlink:to="us-gaap_InvestmentIncomeAmortizationOfDiscount_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_lbl" xml:lang="en-US">Schedule of maturity dates</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:to="us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LongTermDebtCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LongTermDebtCurrent_lbl" xml:lang="en-US">First year (current maturities)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtCurrent" xlink:to="us-gaap_LongTermDebtCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherCommitmentDueInSecondYear" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentDueInSecondYear"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherCommitmentDueInSecondYear_lbl" xml:lang="en-US">Second year</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherCommitmentDueInSecondYear" xlink:to="us-gaap_OtherCommitmentDueInSecondYear_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherLongTermDebtCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLongTermDebtCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherLongTermDebtCurrent_lbl" xml:lang="en-US">Closing balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLongTermDebtCurrent" xlink:to="us-gaap_OtherLongTermDebtCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_lbl" xml:lang="en-US">Schedule of expenses related to service agreement and the office services agreement</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentInProcess" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentInProcess"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ResearchAndDevelopmentInProcess_lbl" xml:lang="en-US">Research and development</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentInProcess" xlink:to="us-gaap_ResearchAndDevelopmentInProcess_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MarketingAndAdvertisingExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketingAndAdvertisingExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_MarketingAndAdvertisingExpense_lbl" xml:lang="en-US">Sales and marketing</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketingAndAdvertisingExpense" xlink:to="us-gaap_MarketingAndAdvertisingExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherSellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherSellingGeneralAndAdministrativeExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherSellingGeneralAndAdministrativeExpense_lbl" xml:lang="en-US">General and administrative</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherSellingGeneralAndAdministrativeExpense" xlink:to="us-gaap_OtherSellingGeneralAndAdministrativeExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xml:lang="en-US">TAXES ON INCOME</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl" xml:lang="en-US">Schedule of loss (income) before taxes on income</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_lbl" xml:lang="en-US">Domestic</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_lbl" xml:lang="en-US">Foreign operations (Beamr Inc and Imaging RU)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xml:lang="en-US">Schedule of deferred income taxes reflect the net tax effects of net operating loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsCapitalLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsCapitalLossCarryforwards"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredTaxAssetsCapitalLossCarryforwards_lbl" xml:lang="en-US">Net operating loss and capital losses carry-forward</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsCapitalLossCarryforwards" xlink:to="us-gaap_DeferredTaxAssetsCapitalLossCarryforwards_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_lbl" xml:lang="en-US">Research and development credits</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:to="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_lbl" xml:lang="en-US">Vacation accrual</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_UnlabeledAbstract29" xlink:href="bmr-20221231.xsd#bmr_UnlabeledAbstract29"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmr_UnlabeledAbstract29_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_UnlabeledAbstract29" xlink:to="bmr_UnlabeledAbstract29_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock_lbl" xml:lang="en-US">SEGMENT GEOGRAPHICAL INFORMATION AND MAJOR CUSTOMERS</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="us-gaap_SegmentReportingDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock_lbl" xml:lang="en-US">Schedule of revenues by geographic region</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock" xlink:to="us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock_lbl" xml:lang="en-US">Schedule of Long-lived assets net by geographic areas</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock" xlink:to="us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NoncurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncurrentAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NoncurrentAssets_lbl" xml:lang="en-US">Long-lived assets, net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncurrentAssets" xlink:to="us-gaap_NoncurrentAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DisaggregationOfRevenueTableTextBlock_lbl" xml:lang="en-US">Schedule of revenue disaggregated by primary major product lines and services</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="us-gaap_DisaggregationOfRevenueTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_SoftwareLicenseAbstract" xlink:href="bmr-20221231.xsd#bmr_SoftwareLicenseAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmr_SoftwareLicenseAbstract_lbl" xml:lang="en-US">Software license:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_SoftwareLicenseAbstract" xlink:to="bmr_SoftwareLicenseAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsForSoftware" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForSoftware"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PaymentsForSoftware_lbl" xml:lang="en-US">Software license - transferred at a point of time</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForSoftware" xlink:to="us-gaap_PaymentsForSoftware_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_PCSServicesTransferredOverAPeriod" xlink:href="bmr-20221231.xsd#bmr_PCSServicesTransferredOverAPeriod"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmr_PCSServicesTransferredOverAPeriod_lbl" xml:lang="en-US">PCS services transferred over a period of time</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_PCSServicesTransferredOverAPeriod" xlink:to="bmr_PCSServicesTransferredOverAPeriod_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_AdvertisingAtAPointOfTimeUponClicks" xlink:href="bmr-20221231.xsd#bmr_AdvertisingAtAPointOfTimeUponClicks"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmr_AdvertisingAtAPointOfTimeUponClicks_lbl" xml:lang="en-US">Advertising at a point of time upon clicks</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_AdvertisingAtAPointOfTimeUponClicks" xlink:to="bmr_AdvertisingAtAPointOfTimeUponClicks_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_RecognitionofRevenue" xlink:href="bmr-20221231.xsd#bmr_RecognitionofRevenue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmr_RecognitionofRevenue_lbl" xml:lang="en-US">Total</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_RecognitionofRevenue" xlink:to="bmr_RecognitionofRevenue_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xml:lang="en-US">SUBSEQUENT EVENTS</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xml:lang="en-US">Less - accumulated depreciation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DerivativeLiabilityFairValueOfCollateral" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilityFairValueOfCollateral"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DerivativeLiabilityFairValueOfCollateral_lbl" xml:lang="en-US">Recognition of fair value of derivative warrant liability</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeLiabilityFairValueOfCollateral" xlink:to="us-gaap_DerivativeLiabilityFairValueOfCollateral_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentDecreaseForgiveness" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentDecreaseForgiveness"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DebtInstrumentDecreaseForgiveness_lbl" xml:lang="en-US">PPP Note forgiveness (see also Note 6B)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentDecreaseForgiveness" xlink:to="us-gaap_DebtInstrumentDecreaseForgiveness_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RepaymentsOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfDebt"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_RepaymentsOfDebt_lbl" xml:lang="en-US">Repayment of accrued interest relating to straight loan</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfDebt" xlink:to="us-gaap_RepaymentsOfDebt_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LoanProcessingFee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoanProcessingFee"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_LoanProcessingFee_lbl" xml:lang="en-US">Repayment of Facility Fee relating to straight loan</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LoanProcessingFee" xlink:to="us-gaap_LoanProcessingFee_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RepaymentsOfOtherLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfOtherLongTermDebt"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_RepaymentsOfOtherLongTermDebt_lbl" xml:lang="en-US">Repayment of principal relating to straight loans</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfOtherLongTermDebt" xlink:to="us-gaap_RepaymentsOfOtherLongTermDebt_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ExtinguishmentOfDebtAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExtinguishmentOfDebtAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ExtinguishmentOfDebtAmount_lbl" xml:lang="en-US">Derecognition due to extinguishment of original straight loan</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ExtinguishmentOfDebtAmount" xlink:to="us-gaap_ExtinguishmentOfDebtAmount_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_lbl" xml:lang="en-US">Exchange rate differences</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:to="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xml:lang="en-US">Number of Share Options, Exercised</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl0" xml:lang="en-US">Exercised share options</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_lbl" xml:lang="en-US">Number of Share Options, Forfeited or expired</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PartnersCapitalAccountContributions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PartnersCapitalAccountContributions"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PartnersCapitalAccountContributions_lbl" xml:lang="en-US">Recognition of capital contribution from a controlling shareholder</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PartnersCapitalAccountContributions" xlink:to="us-gaap_PartnersCapitalAccountContributions_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xml:lang="en-US">Valuation allowance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TechnologyEquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TechnologyEquipmentMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_TechnologyEquipmentMember_lbl" xml:lang="en-US">Technology {Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TechnologyEquipmentMember" xlink:to="us-gaap_TechnologyEquipmentMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CustomerRelationshipsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CustomerRelationshipsMember_lbl" xml:lang="en-US">Customer Relationships [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CustomerRelationshipsMember" xlink:to="us-gaap_CustomerRelationshipsMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CustomerRelationshipsMember_lbl0" xml:lang="en-US">Customer relationships [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CustomerRelationshipsMember" xlink:to="us-gaap_CustomerRelationshipsMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TradeNamesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_TradeNamesMember_lbl" xml:lang="en-US">Trade Names [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TradeNamesMember" xlink:to="us-gaap_TradeNamesMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_TradeNamesMember_lbl0" xml:lang="en-US">Trade names [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TradeNamesMember" xlink:to="us-gaap_TradeNamesMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="bmr_CompareAndPeripheralEquipmentMember" xlink:href="bmr-20221231.xsd#bmr_CompareAndPeripheralEquipmentMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmr_CompareAndPeripheralEquipmentMember_lbl" xml:lang="en-US">Compare and Peripheral equipment [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_CompareAndPeripheralEquipmentMember" xlink:to="bmr_CompareAndPeripheralEquipmentMember_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_OfficeFurnitureAndEquipmentMember" xlink:href="bmr-20221231.xsd#bmr_OfficeFurnitureAndEquipmentMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmr_OfficeFurnitureAndEquipmentMember_lbl" xml:lang="en-US">Office furniture and equipment [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_OfficeFurnitureAndEquipmentMember" xlink:to="bmr_OfficeFurnitureAndEquipmentMember_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="srt_MinimumMember_lbl" xml:lang="en-US">Minimum [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MinimumMember" xlink:to="srt_MinimumMember_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="srt_MaximumMember_lbl" xml:lang="en-US">Maximum [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MaximumMember" xlink:to="srt_MaximumMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ComputerEquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComputerEquipmentMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ComputerEquipmentMember_lbl" xml:lang="en-US">Computers and peripheral equipment [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComputerEquipmentMember" xlink:to="us-gaap_ComputerEquipmentMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OfficeEquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OfficeEquipmentMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OfficeEquipmentMember_lbl" xml:lang="en-US">Office furniture and equipment [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OfficeEquipmentMember" xlink:to="us-gaap_OfficeEquipmentMember_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_TechnologyMember" xlink:href="bmr-20221231.xsd#bmr_TechnologyMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmr_TechnologyMember_lbl" xml:lang="en-US">Technology [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_TechnologyMember" xlink:to="bmr_TechnologyMember_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_SeriesOrdinarySharesMember" xlink:href="bmr-20221231.xsd#bmr_SeriesOrdinarySharesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmr_SeriesOrdinarySharesMember_lbl" xml:lang="en-US">Series Ordinary Shares [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_SeriesOrdinarySharesMember" xlink:to="bmr_SeriesOrdinarySharesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_SeriesConvertibleOrdinary1SharesMember" xlink:href="bmr-20221231.xsd#bmr_SeriesConvertibleOrdinary1SharesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmr_SeriesConvertibleOrdinary1SharesMember_lbl" xml:lang="en-US">Series Convertible Ordinary 1 Shares [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_SeriesConvertibleOrdinary1SharesMember" xlink:to="bmr_SeriesConvertibleOrdinary1SharesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_SeriesConvertibleOrdinary2SharesMember" xlink:href="bmr-20221231.xsd#bmr_SeriesConvertibleOrdinary2SharesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmr_SeriesConvertibleOrdinary2SharesMember_lbl" xml:lang="en-US">Series Convertible Ordinary 2 Shares [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_SeriesConvertibleOrdinary2SharesMember" xlink:to="bmr_SeriesConvertibleOrdinary2SharesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_SeriesConvertibleBPreferredSharesMember" xlink:href="bmr-20221231.xsd#bmr_SeriesConvertibleBPreferredSharesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmr_SeriesConvertibleBPreferredSharesMember_lbl" xml:lang="en-US">Series Convertible B Preferred Shares [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_SeriesConvertibleBPreferredSharesMember" xlink:to="bmr_SeriesConvertibleBPreferredSharesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_SeriesConvertibleB1PreferredSharesBMember" xlink:href="bmr-20221231.xsd#bmr_SeriesConvertibleB1PreferredSharesBMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmr_SeriesConvertibleB1PreferredSharesBMember_lbl" xml:lang="en-US">Series Convertible B1 Preferred Shares [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_SeriesConvertibleB1PreferredSharesBMember" xlink:to="bmr_SeriesConvertibleB1PreferredSharesBMember_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_SeriesConvertibleCPreferredSharesMember" xlink:href="bmr-20221231.xsd#bmr_SeriesConvertibleCPreferredSharesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmr_SeriesConvertibleCPreferredSharesMember_lbl" xml:lang="en-US">Series Convertible C Preferred Shares [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_SeriesConvertibleCPreferredSharesMember" xlink:to="bmr_SeriesConvertibleCPreferredSharesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_ExercisePrice0000Member" xlink:href="bmr-20221231.xsd#bmr_ExercisePrice0000Member"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmr_ExercisePrice0000Member_lbl" xml:lang="en-US">0.000 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_ExercisePrice0000Member" xlink:to="bmr_ExercisePrice0000Member_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_ExercisePrice0227Member" xlink:href="bmr-20221231.xsd#bmr_ExercisePrice0227Member"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmr_ExercisePrice0227Member_lbl" xml:lang="en-US">1.14 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_ExercisePrice0227Member" xlink:to="bmr_ExercisePrice0227Member_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_ExercisePrice0333Member" xlink:href="bmr-20221231.xsd#bmr_ExercisePrice0333Member"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmr_ExercisePrice0333Member_lbl" xml:lang="en-US">1.67	[Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_ExercisePrice0333Member" xlink:to="bmr_ExercisePrice0333Member_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_ExercisePrice0365Member" xlink:href="bmr-20221231.xsd#bmr_ExercisePrice0365Member"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmr_ExercisePrice0365Member_lbl" xml:lang="en-US">1.83	[Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_ExercisePrice0365Member" xlink:to="bmr_ExercisePrice0365Member_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_ExercisePrice0640Member" xlink:href="bmr-20221231.xsd#bmr_ExercisePrice0640Member"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmr_ExercisePrice0640Member_lbl" xml:lang="en-US">3.2 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_ExercisePrice0640Member" xlink:to="bmr_ExercisePrice0640Member_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_ExercisePrice0757Member" xlink:href="bmr-20221231.xsd#bmr_ExercisePrice0757Member"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmr_ExercisePrice0757Member_lbl" xml:lang="en-US">3.79 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_ExercisePrice0757Member" xlink:to="bmr_ExercisePrice0757Member_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_ExercisePrice0833Member" xlink:href="bmr-20221231.xsd#bmr_ExercisePrice0833Member"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmr_ExercisePrice0833Member_lbl" xml:lang="en-US">4.17 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_ExercisePrice0833Member" xlink:to="bmr_ExercisePrice0833Member_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_ExercisePrice1024Member" xlink:href="bmr-20221231.xsd#bmr_ExercisePrice1024Member"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmr_ExercisePrice1024Member_lbl" xml:lang="en-US">5.12 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_ExercisePrice1024Member" xlink:to="bmr_ExercisePrice1024Member_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_ShareOptionsOutstandingMember" xlink:href="bmr-20221231.xsd#bmr_ShareOptionsOutstandingMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmr_ShareOptionsOutstandingMember_lbl" xml:lang="en-US">Share options outstanding [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_ShareOptionsOutstandingMember" xlink:to="bmr_ShareOptionsOutstandingMember_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_ShareOptionsExercisableMember" xlink:href="bmr-20221231.xsd#bmr_ShareOptionsExercisableMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmr_ShareOptionsExercisableMember_lbl" xml:lang="en-US">Share options exercisable [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_ShareOptionsExercisableMember" xlink:to="bmr_ShareOptionsExercisableMember_lbl"/>
    <loc xlink:type="locator" xlink:label="country_US" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="country_US_lbl" xml:lang="en-US">United States [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_US" xlink:to="country_US_lbl"/>
    <loc xlink:type="locator" xlink:label="country_IL" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_IL"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="country_IL_lbl" xml:lang="en-US">Israel [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_IL" xlink:to="country_IL_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_RestOfTheWorldMember" xlink:href="bmr-20221231.xsd#bmr_RestOfTheWorldMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmr_RestOfTheWorldMember_lbl" xml:lang="en-US">Rest of the world [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_RestOfTheWorldMember" xlink:to="bmr_RestOfTheWorldMember_lbl"/>
    <loc xlink:type="locator" xlink:label="country_RU" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_RU"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="country_RU_lbl" xml:lang="en-US">Russia [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_RU" xlink:to="country_RU_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_PerpetualBasedSoftwareLicenseMember" xlink:href="bmr-20221231.xsd#bmr_PerpetualBasedSoftwareLicenseMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmr_PerpetualBasedSoftwareLicenseMember_lbl" xml:lang="en-US">Perpetual based software license [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_PerpetualBasedSoftwareLicenseMember" xlink:to="bmr_PerpetualBasedSoftwareLicenseMember_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_TermbasedSoftwareLicenseMember" xlink:href="bmr-20221231.xsd#bmr_TermbasedSoftwareLicenseMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmr_TermbasedSoftwareLicenseMember_lbl" xml:lang="en-US">Term-based software license [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_TermbasedSoftwareLicenseMember" xlink:to="bmr_TermbasedSoftwareLicenseMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsidiarySaleOfStockAxis_lbl" xml:lang="en-US">Sale of Stock [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SubsidiarySaleOfStockAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_lbl" xml:lang="en-US">Investment, Name [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShortTermDebtTypeAxis_lbl" xml:lang="en-US">Short-Term Debt, Type [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermDebtTypeAxis" xlink:to="us-gaap_ShortTermDebtTypeAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_VariableRateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_VariableRateAxis_lbl" xml:lang="en-US">Variable Rate [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VariableRateAxis" xlink:to="us-gaap_VariableRateAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionAxis_lbl" xml:lang="en-US">Related Party Transaction [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xml:lang="en-US">Related Party [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_StatementScenarioAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_StatementScenarioAxis_lbl" xml:lang="en-US">Scenario [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_StatementScenarioAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_TitleOfIndividualAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_TitleOfIndividualAxis_lbl" xml:lang="en-US">Title of Individual [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_LoanAgreementsAxis" xlink:href="bmr-20221231.xsd#bmr_LoanAgreementsAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmr_LoanAgreementsAxis_lbl" xml:lang="en-US">Loan Agreement [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_LoanAgreementsAxis" xlink:to="bmr_LoanAgreementsAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventTypeAxis_lbl" xml:lang="en-US">Subsequent Event Type [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xml:lang="en-US">Accounting Policies [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_VariableInterestDifferenceBetweenCarryingAmountAndMaximumExposure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestDifferenceBetweenCarryingAmountAndMaximumExposure"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_VariableInterestDifferenceBetweenCarryingAmountAndMaximumExposure_lbl" xml:lang="en-US">Ordinary shares per value (in New Shekels)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VariableInterestDifferenceBetweenCarryingAmountAndMaximumExposure" xlink:to="us-gaap_VariableInterestDifferenceBetweenCarryingAmountAndMaximumExposure_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CapitalUnitsNetAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalUnitsNetAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CapitalUnitsNetAmount_lbl" xml:lang="en-US">Net amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CapitalUnitsNetAmount" xlink:to="us-gaap_CapitalUnitsNetAmount_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering_lbl" xml:lang="en-US">Public offering price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering_lbl0" xml:lang="en-US">Initial public offering total amount (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering_lbl0"/>
    <loc xlink:type="locator" xlink:label="bmr_PublicOfferingPrice" xlink:href="bmr-20221231.xsd#bmr_PublicOfferingPrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmr_PublicOfferingPrice_lbl" xml:lang="en-US">Public offering price (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_PublicOfferingPrice" xlink:to="bmr_PublicOfferingPrice_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="bmr_PublicOfferingPrice_lbl0" xml:lang="en-US">Offering price (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_PublicOfferingPrice" xlink:to="bmr_PublicOfferingPrice_lbl0"/>
    <loc xlink:type="locator" xlink:label="bmr_AggregateGrossProceeds" xlink:href="bmr-20221231.xsd#bmr_AggregateGrossProceeds"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmr_AggregateGrossProceeds_lbl" xml:lang="en-US">Aggregate gross proceeds</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_AggregateGrossProceeds" xlink:to="bmr_AggregateGrossProceeds_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_EmployeeCompensationPercentage" xlink:href="bmr-20221231.xsd#bmr_EmployeeCompensationPercentage"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmr_EmployeeCompensationPercentage_lbl" xml:lang="en-US">Employee compensation percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_EmployeeCompensationPercentage" xlink:to="bmr_EmployeeCompensationPercentage_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherReceivables"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherReceivables_lbl" xml:lang="en-US">Receivable amount (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherReceivables" xlink:to="us-gaap_OtherReceivables_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredRevenue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredRevenue_lbl" xml:lang="en-US">Deferred revenue (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRevenue" xlink:to="us-gaap_DeferredRevenue_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl" xml:lang="en-US">Debt instrument percent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtInstrumentRedemptionPricePercentage_lbl" xml:lang="en-US">New debt instrument percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:to="us-gaap_DebtInstrumentRedemptionPricePercentage_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DebtInstrumentRedemptionPricePercentage_lbl0" xml:lang="en-US">Discount percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:to="us-gaap_DebtInstrumentRedemptionPricePercentage_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtInstrumentInterestRateEffectivePercentage_lbl" xml:lang="en-US">Carrying amount percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:to="us-gaap_DebtInstrumentInterestRateEffectivePercentage_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_PercentageOfDividend" xlink:href="bmr-20221231.xsd#bmr_PercentageOfDividend"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmr_PercentageOfDividend_lbl" xml:lang="en-US">Percentage of dividend</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_PercentageOfDividend" xlink:to="bmr_PercentageOfDividend_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ExcessStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExcessStockSharesOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ExcessStockSharesOutstanding_lbl" xml:lang="en-US">Weighted average number of ordinary shares related to outstanding (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ExcessStockSharesOutstanding" xlink:to="us-gaap_ExcessStockSharesOutstanding_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl" xml:lang="en-US">Investment percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:to="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DepreciationExpenseOnReclassifiedAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationExpenseOnReclassifiedAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DepreciationExpenseOnReclassifiedAssets_lbl" xml:lang="en-US">Total depreciation expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationExpenseOnReclassifiedAssets" xlink:to="us-gaap_DepreciationExpenseOnReclassifiedAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AmortizationOfIntangibleAssets_lbl" xml:lang="en-US">Total amortization expenses (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfIntangibleAssets" xlink:to="us-gaap_AmortizationOfIntangibleAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseDiscountRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseDiscountRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LesseeOperatingLeaseDiscountRate_lbl" xml:lang="en-US">Discount rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseDiscountRate" xlink:to="us-gaap_LesseeOperatingLeaseDiscountRate_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LongDurationContractsAssumptionsByProductAndGuaranteeDiscountRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongDurationContractsAssumptionsByProductAndGuaranteeDiscountRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LongDurationContractsAssumptionsByProductAndGuaranteeDiscountRate_lbl" xml:lang="en-US">Long-term growth rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongDurationContractsAssumptionsByProductAndGuaranteeDiscountRate" xlink:to="us-gaap_LongDurationContractsAssumptionsByProductAndGuaranteeDiscountRate_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtInstrumentFaceAmount_lbl" xml:lang="en-US">Aggregate principal amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentFaceAmount" xlink:to="us-gaap_DebtInstrumentFaceAmount_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DebtInstrumentFaceAmount_lbl0" xml:lang="en-US">Amount raised</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentFaceAmount" xlink:to="us-gaap_DebtInstrumentFaceAmount_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermDebtPercentageBearingVariableInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtPercentageBearingVariableInterestRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShortTermDebtPercentageBearingVariableInterestRate_lbl" xml:lang="en-US">Bearing interest rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermDebtPercentageBearingVariableInterestRate" xlink:to="us-gaap_ShortTermDebtPercentageBearingVariableInterestRate_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LoansReceivableBasisSpreadOnVariableRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansReceivableBasisSpreadOnVariableRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LoansReceivableBasisSpreadOnVariableRate_lbl" xml:lang="en-US">Interest rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LoansReceivableBasisSpreadOnVariableRate" xlink:to="us-gaap_LoansReceivableBasisSpreadOnVariableRate_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_lbl" xml:lang="en-US">Issuance of warrants (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xml:lang="en-US">Exercise price of per share (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl0" xml:lang="en-US">Aggregate gross proceeds (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl" xml:lang="en-US">Shares issued (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantsAndRightsOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_WarrantsAndRightsOutstanding_lbl" xml:lang="en-US">Warrant total amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsOutstanding" xlink:to="us-gaap_WarrantsAndRightsOutstanding_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentOwnedBalancePrincipalAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentOwnedBalancePrincipalAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InvestmentOwnedBalancePrincipalAmount_lbl" xml:lang="en-US">Remaining balance principal due</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentOwnedBalancePrincipalAmount" xlink:to="us-gaap_InvestmentOwnedBalancePrincipalAmount_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LineOfCreditFacilityCommitmentFeeAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityCommitmentFeeAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LineOfCreditFacilityCommitmentFeeAmount_lbl" xml:lang="en-US">Line of Credit Facility, Commitment Fee Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityCommitmentFeeAmount" xlink:to="us-gaap_LineOfCreditFacilityCommitmentFeeAmount_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1_lbl" xml:lang="en-US">Warrants purchase (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1" xlink:to="us-gaap_DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueAdjustmentOfWarrants" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAdjustmentOfWarrants"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueAdjustmentOfWarrants_lbl" xml:lang="en-US">Warrant value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAdjustmentOfWarrants" xlink:to="us-gaap_FairValueAdjustmentOfWarrants_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding_lbl" xml:lang="en-US">Line of Credit Facility, Fair Value of Amount Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding" xlink:to="us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LineOfCreditFacilityCollateralFeesAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityCollateralFeesAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LineOfCreditFacilityCollateralFeesAmount_lbl" xml:lang="en-US">Represent value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityCollateralFeesAmount" xlink:to="us-gaap_LineOfCreditFacilityCollateralFeesAmount_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentInterestRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InvestmentInterestRate_lbl" xml:lang="en-US">Interest rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentInterestRate" xlink:to="us-gaap_InvestmentInterestRate_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DerivativeFixedInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFixedInterestRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DerivativeFixedInterestRate_lbl" xml:lang="en-US">Principal amounts interest rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeFixedInterestRate" xlink:to="us-gaap_DerivativeFixedInterestRate_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantExercisePriceIncrease" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantExercisePriceIncrease"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_WarrantExercisePriceIncrease_lbl" xml:lang="en-US">Exercise price (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantExercisePriceIncrease" xlink:to="us-gaap_WarrantExercisePriceIncrease_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityMethodInvestmentAggregateCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentAggregateCost"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EquityMethodInvestmentAggregateCost_lbl" xml:lang="en-US">Aggregate cost</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestmentAggregateCost" xlink:to="us-gaap_EquityMethodInvestmentAggregateCost_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_EquityMethodInvestmentAggregateCost_lbl0" xml:lang="en-US">Aggregate investment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestmentAggregateCost" xlink:to="us-gaap_EquityMethodInvestmentAggregateCost_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableInterestBearingInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableInterestBearingInterestRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AccountsPayableInterestBearingInterestRate_lbl" xml:lang="en-US">PPP Amount bears interest rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableInterestBearingInterestRate" xlink:to="us-gaap_AccountsPayableInterestBearingInterestRate_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIncome"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherIncome_lbl" xml:lang="en-US">Other income</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherIncome" xlink:to="us-gaap_OtherIncome_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_AgreementAmountReceived" xlink:href="bmr-20221231.xsd#bmr_AgreementAmountReceived"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmr_AgreementAmountReceived_lbl" xml:lang="en-US">Agreement amount received</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_AgreementAmountReceived" xlink:to="bmr_AgreementAmountReceived_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromRoyaltiesReceived" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRoyaltiesReceived"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromRoyaltiesReceived_lbl" xml:lang="en-US">Royalty amount received</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromRoyaltiesReceived" xlink:to="us-gaap_ProceedsFromRoyaltiesReceived_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentAnnualPrincipalPayment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAnnualPrincipalPayment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtInstrumentAnnualPrincipalPayment_lbl" xml:lang="en-US">Minimum annual payment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentAnnualPrincipalPayment" xlink:to="us-gaap_DebtInstrumentAnnualPrincipalPayment_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_PercentageOfOutstandingRepaymentAndPaymentAmount" xlink:href="bmr-20221231.xsd#bmr_PercentageOfOutstandingRepaymentAndPaymentAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmr_PercentageOfOutstandingRepaymentAndPaymentAmount_lbl" xml:lang="en-US">Percentage of outstanding repayment and payment amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_PercentageOfOutstandingRepaymentAndPaymentAmount" xlink:to="bmr_PercentageOfOutstandingRepaymentAndPaymentAmount_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_PercentageOfDiscountOutstanding" xlink:href="bmr-20221231.xsd#bmr_PercentageOfDiscountOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmr_PercentageOfDiscountOutstanding_lbl" xml:lang="en-US">Percentage of discount outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_PercentageOfDiscountOutstanding" xlink:to="bmr_PercentageOfDiscountOutstanding_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestAndFeeIncomeOtherLoans" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestAndFeeIncomeOtherLoans"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InterestAndFeeIncomeOtherLoans_lbl" xml:lang="en-US">Non-refundable one-time fee</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestAndFeeIncomeOtherLoans" xlink:to="us-gaap_InterestAndFeeIncomeOtherLoans_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed_lbl" xml:lang="en-US">Percentage of payment amount plus VAT</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed" xlink:to="us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed_lbl0" xml:lang="en-US">Redemption payment percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed" xlink:to="us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeFinanceLeaseDiscountRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeFinanceLeaseDiscountRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LesseeFinanceLeaseDiscountRate_lbl" xml:lang="en-US">Financing, less rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeFinanceLeaseDiscountRate" xlink:to="us-gaap_LesseeFinanceLeaseDiscountRate_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockDividend" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockDividend"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockDividend_lbl" xml:lang="en-US">Value of divided</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueStockDividend" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockDividend_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LoansHeldForSaleTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansHeldForSaleTerm"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LoansHeldForSaleTerm_lbl" xml:lang="en-US">Issuance term</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LoansHeldForSaleTerm" xlink:to="us-gaap_LoansHeldForSaleTerm_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost_lbl" xml:lang="en-US">Total incremental</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsOfLoanCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfLoanCosts"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PaymentsOfLoanCosts_lbl" xml:lang="en-US">Payments of Loan Costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfLoanCosts" xlink:to="us-gaap_PaymentsOfLoanCosts_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RepaymentsOfSecuredDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfSecuredDebt"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RepaymentsOfSecuredDebt_lbl" xml:lang="en-US">Repayment amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfSecuredDebt" xlink:to="us-gaap_RepaymentsOfSecuredDebt_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DepositLiabilitiesAccruedInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepositLiabilitiesAccruedInterest"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DepositLiabilitiesAccruedInterest_lbl" xml:lang="en-US">Accrued interest</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepositLiabilitiesAccruedInterest" xlink:to="us-gaap_DepositLiabilitiesAccruedInterest_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtConversionConvertedInstrumentAmount1_lbl" xml:lang="en-US">Conversion amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:to="us-gaap_DebtConversionConvertedInstrumentAmount1_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtConversionConvertedInstrumentRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtConversionConvertedInstrumentRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtConversionConvertedInstrumentRate_lbl" xml:lang="en-US">Conversion price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtConversionConvertedInstrumentRate" xlink:to="us-gaap_DebtConversionConvertedInstrumentRate_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsForRent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PaymentsForRent_lbl" xml:lang="en-US">Rental fee</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForRent" xlink:to="us-gaap_PaymentsForRent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsForFees" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForFees"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PaymentsForFees_lbl" xml:lang="en-US">Monthly fee</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForFees" xlink:to="us-gaap_PaymentsForFees_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCost"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LeaseCost_lbl" xml:lang="en-US">Lease expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseCost" xlink:to="us-gaap_LeaseCost_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockConvertibleConversionPrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockConvertibleConversionPrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PreferredStockConvertibleConversionPrice_lbl" xml:lang="en-US">Original issue price per share (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockConvertibleConversionPrice" xlink:to="us-gaap_PreferredStockConvertibleConversionPrice_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockAmountOfPreferredDividendsInArrears" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockAmountOfPreferredDividendsInArrears"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PreferredStockAmountOfPreferredDividendsInArrears_lbl" xml:lang="en-US">Aggregate liquidation preference of shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockAmountOfPreferredDividendsInArrears" xlink:to="us-gaap_PreferredStockAmountOfPreferredDividendsInArrears_lbl"/>
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt/tSeJz73kx1cLt0ZFF2SK/vxBCY0vdSrZb6DUpe9prgZNYqdZsfXqxEEXb49NXhOeJEcoYxL52lqzrxV1ixmGk3x5z3C+boGMFyF1bCAC6SzXA8EeoS+J4OsCx1oPIoujQb0ZEh03dOL9+qx7qvcGHsJ6a9scdOGp0N/fSOils3JiDVUH+POJSLwkIXq+NgTrCVG8rYfDvkQSvrvKPWWMVWSdvTqL+F4TZDa6ea44zqQ==] CSR-->
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDebtNetOfIssuanceCosts"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromDebtNetOfIssuanceCosts_lbl" xml:lang="en-US">Net proceeds</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:to="us-gaap_ProceedsFromDebtNetOfIssuanceCosts_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_VoluntaryConversionDescription" xlink:href="bmr-20221231.xsd#bmr_VoluntaryConversionDescription"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmr_VoluntaryConversionDescription_lbl" xml:lang="en-US">Voluntary conversion description</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_VoluntaryConversionDescription" xlink:to="bmr_VoluntaryConversionDescription_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_OrdinarySharesSubjectToAdjustments" xlink:href="bmr-20221231.xsd#bmr_OrdinarySharesSubjectToAdjustments"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmr_OrdinarySharesSubjectToAdjustments_lbl" xml:lang="en-US">Ordinary shares subject to adjustments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_OrdinarySharesSubjectToAdjustments" xlink:to="bmr_OrdinarySharesSubjectToAdjustments_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_OrdinarySharesAvailableForFutureIssuance" xlink:href="bmr-20221231.xsd#bmr_OrdinarySharesAvailableForFutureIssuance"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmr_OrdinarySharesAvailableForFutureIssuance_lbl" xml:lang="en-US">Ordinary shares available for future issuance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_OrdinarySharesAvailableForFutureIssuance" xlink:to="bmr_OrdinarySharesAvailableForFutureIssuance_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US">Weighted average grant date fair value of share options granted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_TotalConsideration" xlink:href="bmr-20221231.xsd#bmr_TotalConsideration"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmr_TotalConsideration_lbl" xml:lang="en-US">Total consideration</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_TotalConsideration" xlink:to="bmr_TotalConsideration_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_lbl" xml:lang="en-US">Unrecognized compensation expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:to="us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetAmountAtRiskByProductAndGuaranteeWeightedAveragePeriodRemaining1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetAmountAtRiskByProductAndGuaranteeWeightedAveragePeriodRemaining1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NetAmountAtRiskByProductAndGuaranteeWeightedAveragePeriodRemaining1_lbl" xml:lang="en-US">Weighted average period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetAmountAtRiskByProductAndGuaranteeWeightedAveragePeriodRemaining1" xlink:to="us-gaap_NetAmountAtRiskByProductAndGuaranteeWeightedAveragePeriodRemaining1_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionDueFromToRelatedPartyCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDueFromToRelatedPartyCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RelatedPartyTransactionDueFromToRelatedPartyCurrent_lbl" xml:lang="en-US">Gross amount (in New Shekels)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionDueFromToRelatedPartyCurrent" xlink:to="us-gaap_RelatedPartyTransactionDueFromToRelatedPartyCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DueToOtherRelatedPartiesClassifiedCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueToOtherRelatedPartiesClassifiedCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DueToOtherRelatedPartiesClassifiedCurrent_lbl" xml:lang="en-US">Current liability</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DueToOtherRelatedPartiesClassifiedCurrent" xlink:to="us-gaap_DueToOtherRelatedPartiesClassifiedCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalOther"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_lbl" xml:lang="en-US">Additional paid-in capital</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings_lbl" xml:lang="en-US">Corporate tax rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherNonoperatingGainsLosses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingGainsLosses"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherNonoperatingGainsLosses_lbl" xml:lang="en-US">Net operating losses (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingGainsLosses" xlink:to="us-gaap_OtherNonoperatingGainsLosses_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_lbl" xml:lang="en-US">Capital losses carryforward (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" xml:lang="en-US">Federal tax rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xml:lang="en-US">Effective tax rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NumberOfOperatingSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfOperatingSegments"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NumberOfOperatingSegments_lbl" xml:lang="en-US">Number of operating segments (in Segment)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NumberOfOperatingSegments" xlink:to="us-gaap_NumberOfOperatingSegments_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense_lbl" xml:lang="en-US">Total revenue rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_TradeReceivablesIncomeTaxRate" xlink:href="bmr-20221231.xsd#bmr_TradeReceivablesIncomeTaxRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmr_TradeReceivablesIncomeTaxRate_lbl" xml:lang="en-US">Trade receivables interest rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_TradeReceivablesIncomeTaxRate" xlink:to="bmr_TradeReceivablesIncomeTaxRate_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredRevenueRevenueRecognized1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredRevenueRevenueRecognized1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredRevenueRevenueRecognized1_lbl" xml:lang="en-US">Revenue recognized (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRevenueRevenueRecognized1" xlink:to="us-gaap_DeferredRevenueRevenueRecognized1_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_lbl" xml:lang="en-US">Initial public offering</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentInterestRateTerms" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateTerms"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtInstrumentInterestRateTerms_lbl" xml:lang="en-US">Second loan and securities agreement, description</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateTerms" xlink:to="us-gaap_DebtInstrumentInterestRateTerms_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockConvertibleSharesIssuable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockConvertibleSharesIssuable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PreferredStockConvertibleSharesIssuable_lbl" xml:lang="en-US">Convertible preferred shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockConvertibleSharesIssuable" xlink:to="us-gaap_PreferredStockConvertibleSharesIssuable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConversionOfStockSharesIssued1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConversionOfStockSharesIssued1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ConversionOfStockSharesIssued1_lbl" xml:lang="en-US">Conversion shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConversionOfStockSharesIssued1" xlink:to="us-gaap_ConversionOfStockSharesIssued1_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TemporaryEquitySharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesAuthorized"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_TemporaryEquitySharesAuthorized_lbl" xml:lang="en-US">Authorized shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquitySharesAuthorized" xlink:to="us-gaap_TemporaryEquitySharesAuthorized_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_UseOfEstimates_lbl" xml:lang="en-US">Use of estimates in the preparation of financial statements</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_lbl" xml:lang="en-US">Functional currency</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConsolidationPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ConsolidationPolicyTextBlock_lbl" xml:lang="en-US">Principles of Consolidation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConsolidationPolicyTextBlock" xlink:to="us-gaap_ConsolidationPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xml:lang="en-US">Cash and cash equivalents</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl" xml:lang="en-US">Research and development expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredChargesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredChargesPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredChargesPolicyTextBlock_lbl" xml:lang="en-US">Deferred offering costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredChargesPolicyTextBlock" xlink:to="us-gaap_DeferredChargesPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_lbl" xml:lang="en-US">Goodwill and Intangible Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:to="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xml:lang="en-US">Property and equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock_lbl" xml:lang="en-US">Leases</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="us-gaap_LesseeLeasesPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xml:lang="en-US">Deferred income taxes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PostemploymentBenefitPlansPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PostemploymentBenefitPlansPolicy"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PostemploymentBenefitPlansPolicy_lbl" xml:lang="en-US">Employees benefit plans</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PostemploymentBenefitPlansPolicy" xlink:to="us-gaap_PostemploymentBenefitPlansPolicy_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommitmentsAndContingenciesPolicyTextBlock_lbl" xml:lang="en-US">Contingencies</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_ConcentrationOfCreditRiskPolicyTextBlock" xlink:href="bmr-20221231.xsd#bmr_ConcentrationOfCreditRiskPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmr_ConcentrationOfCreditRiskPolicyTextBlock_lbl" xml:lang="en-US">Concentrations of credit risk and allowance for doubtful accounts</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_ConcentrationOfCreditRiskPolicyTextBlock" xlink:to="bmr_ConcentrationOfCreditRiskPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock_lbl" xml:lang="en-US">Revenue recognition</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueMeasurementPolicyPolicyTextBlock_lbl" xml:lang="en-US">Fair Value Measurements</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:to="us-gaap_FairValueMeasurementPolicyPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_ConvertibleOrdinary1And2SharesAndPreferredSharesPolicyTextBlock" xlink:href="bmr-20221231.xsd#bmr_ConvertibleOrdinary1And2SharesAndPreferredSharesPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmr_ConvertibleOrdinary1And2SharesAndPreferredSharesPolicyTextBlock_lbl" xml:lang="en-US">Convertible Ordinary 1 and 2 Shares and Preferred Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_ConvertibleOrdinary1And2SharesAndPreferredSharesPolicyTextBlock" xlink:to="bmr_ConvertibleOrdinary1And2SharesAndPreferredSharesPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_AllocationOfProceedsAndRelatedIssuanceCostsPolicyTextBlock" xlink:href="bmr-20221231.xsd#bmr_AllocationOfProceedsAndRelatedIssuanceCostsPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmr_AllocationOfProceedsAndRelatedIssuanceCostsPolicyTextBlock_lbl" xml:lang="en-US">Allocation of proceeds and related issuance costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_AllocationOfProceedsAndRelatedIssuanceCostsPolicyTextBlock" xlink:to="bmr_AllocationOfProceedsAndRelatedIssuanceCostsPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_WarrantsPolicyTextBlock" xlink:href="bmr-20221231.xsd#bmr_WarrantsPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmr_WarrantsPolicyTextBlock_lbl" xml:lang="en-US">Warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_WarrantsPolicyTextBlock" xlink:to="bmr_WarrantsPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DerivativesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DerivativesPolicyTextBlock_lbl" xml:lang="en-US">Derivative Warrants Liability</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativesPolicyTextBlock" xlink:to="us-gaap_DerivativesPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_ModificationsOrExchangeOfLoansPolicyTextBlock" xlink:href="bmr-20221231.xsd#bmr_ModificationsOrExchangeOfLoansPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmr_ModificationsOrExchangeOfLoansPolicyTextBlock_lbl" xml:lang="en-US">Modifications or exchanges of loans</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_ModificationsOrExchangeOfLoansPolicyTextBlock" xlink:to="bmr_ModificationsOrExchangeOfLoansPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xml:lang="en-US">Basic and diluted net loss per ordinary share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_ConvertibleAdvanceInvestmentsPolicyTextBlock" xlink:href="bmr-20221231.xsd#bmr_ConvertibleAdvanceInvestmentsPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmr_ConvertibleAdvanceInvestmentsPolicyTextBlock_lbl" xml:lang="en-US">Convertible Advance Investments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_ConvertibleAdvanceInvestmentsPolicyTextBlock" xlink:to="bmr_ConvertibleAdvanceInvestmentsPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_CapitalContributionFromAControllingShareholderPolicyTextBlock" xlink:href="bmr-20221231.xsd#bmr_CapitalContributionFromAControllingShareholderPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmr_CapitalContributionFromAControllingShareholderPolicyTextBlock_lbl" xml:lang="en-US">Capital contribution from a controlling shareholder</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_CapitalContributionFromAControllingShareholderPolicyTextBlock" xlink:to="bmr_CapitalContributionFromAControllingShareholderPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl" xml:lang="en-US">Share-based compensation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IPOMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IPOMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IPOMember_lbl" xml:lang="en-US">IPO [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IPOMember" xlink:to="us-gaap_IPOMember_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_ConvertibleAdvanceInvestmentsMember" xlink:href="bmr-20221231.xsd#bmr_ConvertibleAdvanceInvestmentsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmr_ConvertibleAdvanceInvestmentsMember_lbl" xml:lang="en-US">Convertible Advance Investments [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_ConvertibleAdvanceInvestmentsMember" xlink:to="bmr_ConvertibleAdvanceInvestmentsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_LoansAndSecurityAgreementMember" xlink:href="bmr-20221231.xsd#bmr_LoansAndSecurityAgreementMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmr_LoansAndSecurityAgreementMember_lbl" xml:lang="en-US">Loans and Security Agreement [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_LoansAndSecurityAgreementMember" xlink:to="bmr_LoansAndSecurityAgreementMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertiblePreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertiblePreferredStockMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ConvertiblePreferredStockMember_lbl" xml:lang="en-US">Convertible Preferred Shares [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertiblePreferredStockMember" xlink:to="us-gaap_ConvertiblePreferredStockMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ConvertiblePreferredStockMember_lbl0" xml:lang="en-US">Convertible Preferred Stock [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertiblePreferredStockMember" xlink:to="us-gaap_ConvertiblePreferredStockMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="bmr_TwoZeroTwoTwoLoanAgreementMember" xlink:href="bmr-20221231.xsd#bmr_TwoZeroTwoTwoLoanAgreementMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmr_TwoZeroTwoTwoLoanAgreementMember_lbl" xml:lang="en-US">2022 Loan Agreement [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_TwoZeroTwoTwoLoanAgreementMember" xlink:to="bmr_TwoZeroTwoTwoLoanAgreementMember_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_FloatingRateMember" xlink:href="bmr-20221231.xsd#bmr_FloatingRateMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmr_FloatingRateMember_lbl" xml:lang="en-US">Floating rate [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_FloatingRateMember" xlink:to="bmr_FloatingRateMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrimeRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrimeRateMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PrimeRateMember_lbl" xml:lang="en-US">Prime Rate [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrimeRateMember" xlink:to="us-gaap_PrimeRateMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesCPreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesCPreferredStockMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SeriesCPreferredStockMember_lbl" xml:lang="en-US">Series C Preferred Stock [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesCPreferredStockMember" xlink:to="us-gaap_SeriesCPreferredStockMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SeriesCPreferredStockMember_lbl0" xml:lang="en-US">Series C Convertible Preferred Shares [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesCPreferredStockMember" xlink:to="us-gaap_SeriesCPreferredStockMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="bmr_IBISpikesLtdMember" xlink:href="bmr-20221231.xsd#bmr_IBISpikesLtdMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmr_IBISpikesLtdMember_lbl" xml:lang="en-US">IBI Spikes Ltd [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_IBISpikesLtdMember" xlink:to="bmr_IBISpikesLtdMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_WarrantMember_lbl" xml:lang="en-US">Warrant [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantMember" xlink:to="us-gaap_WarrantMember_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_AdvanceInvestmentAgreementsMember" xlink:href="bmr-20221231.xsd#bmr_AdvanceInvestmentAgreementsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmr_AdvanceInvestmentAgreementsMember_lbl" xml:lang="en-US">Advance Investment Agreements [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_AdvanceInvestmentAgreementsMember" xlink:to="bmr_AdvanceInvestmentAgreementsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioForecastMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioForecastMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="srt_ScenarioForecastMember_lbl" xml:lang="en-US">Forecast [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScenarioForecastMember" xlink:to="srt_ScenarioForecastMember_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_BoardOfDirectorsChairmanMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_BoardOfDirectorsChairmanMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="srt_BoardOfDirectorsChairmanMember_lbl" xml:lang="en-US">Board of Directors [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_BoardOfDirectorsChairmanMember" xlink:to="srt_BoardOfDirectorsChairmanMember_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_TwoThousandTwentyTwoLoanAgreementMember" xlink:href="bmr-20221231.xsd#bmr_TwoThousandTwentyTwoLoanAgreementMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmr_TwoThousandTwentyTwoLoanAgreementMember_lbl" xml:lang="en-US">2022 Loan Agreement [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_TwoThousandTwentyTwoLoanAgreementMember" xlink:to="bmr_TwoThousandTwentyTwoLoanAgreementMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SubsequentEventMember_lbl" xml:lang="en-US">Subsequent Event [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventMember" xlink:to="us-gaap_SubsequentEventMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityComponentDomain_lbl" xml:lang="en-US">Equity Component [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_EquityComponentDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_lbl" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsLineItems_lbl" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_RangeMember_lbl" xml:lang="en-US">Statistical Measurement [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeMember" xlink:to="srt_RangeMember_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_SignificantAccountingPoliciesDetailsScheduleofcomputingstraightlinedepreciationTable" xlink:href="bmr-20221231.xsd#bmr_SignificantAccountingPoliciesDetailsScheduleofcomputingstraightlinedepreciationTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_SignificantAccountingPoliciesDetailsScheduleofcomputingstraightlinedepreciationTable_lbl" xml:lang="en-US">Significant Accounting Policies (Details) - Schedule of computing straight-line depreciation [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_SignificantAccountingPoliciesDetailsScheduleofcomputingstraightlinedepreciationTable" xlink:to="bmr_SignificantAccountingPoliciesDetailsScheduleofcomputingstraightlinedepreciationTable_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_SignificantAccountingPoliciesDetailsScheduleofcomputingstraightlinedepreciationLineItems" xlink:href="bmr-20221231.xsd#bmr_SignificantAccountingPoliciesDetailsScheduleofcomputingstraightlinedepreciationLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_SignificantAccountingPoliciesDetailsScheduleofcomputingstraightlinedepreciationLineItems_lbl" xml:lang="en-US">Significant Accounting Policies (Details) - Schedule of computing straight-line depreciation [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_SignificantAccountingPoliciesDetailsScheduleofcomputingstraightlinedepreciationLineItems" xlink:to="bmr_SignificantAccountingPoliciesDetailsScheduleofcomputingstraightlinedepreciationLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xml:lang="en-US">Property, Plant and Equipment [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xml:lang="en-US">Property, Plant and Equipment [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_lbl" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_IntangibleAssetsNetandGoodwillDetailsScheduleofintangibleassetsnetandgoodwilTable" xlink:href="bmr-20221231.xsd#bmr_IntangibleAssetsNetandGoodwillDetailsScheduleofintangibleassetsnetandgoodwilTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_IntangibleAssetsNetandGoodwillDetailsScheduleofintangibleassetsnetandgoodwilTable_lbl" xml:lang="en-US">Intangible Assets, Net and Goodwill (Details) - Schedule of intangible assets, net and goodwil [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_IntangibleAssetsNetandGoodwillDetailsScheduleofintangibleassetsnetandgoodwilTable" xlink:to="bmr_IntangibleAssetsNetandGoodwillDetailsScheduleofintangibleassetsnetandgoodwilTable_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_IntangibleAssetsNetandGoodwillDetailsScheduleofintangibleassetsnetandgoodwilLineItems" xlink:href="bmr-20221231.xsd#bmr_IntangibleAssetsNetandGoodwillDetailsScheduleofintangibleassetsnetandgoodwilLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_IntangibleAssetsNetandGoodwillDetailsScheduleofintangibleassetsnetandgoodwilLineItems_lbl" xml:lang="en-US">Intangible Assets, Net and Goodwill (Details) - Schedule of intangible assets, net and goodwil [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_IntangibleAssetsNetandGoodwillDetailsScheduleofintangibleassetsnetandgoodwilLineItems" xlink:to="bmr_IntangibleAssetsNetandGoodwillDetailsScheduleofintangibleassetsnetandgoodwilLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfStockDomain_lbl" xml:lang="en-US">Class of Stock [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_ClassOfStockDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_ShareholdersEquityDeficitDetailsScheduleofcompositionofshareholdersequityTable" xlink:href="bmr-20221231.xsd#bmr_ShareholdersEquityDeficitDetailsScheduleofcompositionofshareholdersequityTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_ShareholdersEquityDeficitDetailsScheduleofcompositionofshareholdersequityTable_lbl" xml:lang="en-US">Shareholders&#8217; Equity (Deficit) (Details) - Schedule of composition of shareholders&apos; equity [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_ShareholdersEquityDeficitDetailsScheduleofcompositionofshareholdersequityTable" xlink:to="bmr_ShareholdersEquityDeficitDetailsScheduleofcompositionofshareholdersequityTable_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_ShareholdersEquityDeficitDetailsScheduleofcompositionofshareholdersequityLineItems" xlink:href="bmr-20221231.xsd#bmr_ShareholdersEquityDeficitDetailsScheduleofcompositionofshareholdersequityLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_ShareholdersEquityDeficitDetailsScheduleofcompositionofshareholdersequityLineItems_lbl" xml:lang="en-US">Shareholders&#8217; Equity (Deficit) (Details) - Schedule of composition of shareholders&apos; equity [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_ShareholdersEquityDeficitDetailsScheduleofcompositionofshareholdersequityLineItems" xlink:to="bmr_ShareholdersEquityDeficitDetailsScheduleofcompositionofshareholdersequityLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl" xml:lang="en-US">Award Type [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_lbl" xml:lang="en-US">Exercise Price Range [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_lbl" xml:lang="en-US">Share-Based Payment Arrangement, Option, Exercise Price Range [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_lbl" xml:lang="en-US">Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_ShareOptionsDetailsScheduleofassumptionsusedtoestimatethefairvaluesoftheshareoptionsgrantedTable" xlink:href="bmr-20221231.xsd#bmr_ShareOptionsDetailsScheduleofassumptionsusedtoestimatethefairvaluesoftheshareoptionsgrantedTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_ShareOptionsDetailsScheduleofassumptionsusedtoestimatethefairvaluesoftheshareoptionsgrantedTable_lbl" xml:lang="en-US">Share Options (Details) - Schedule of assumptions used to estimate the fair values of the share options granted [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_ShareOptionsDetailsScheduleofassumptionsusedtoestimatethefairvaluesoftheshareoptionsgrantedTable" xlink:to="bmr_ShareOptionsDetailsScheduleofassumptionsusedtoestimatethefairvaluesoftheshareoptionsgrantedTable_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_ShareOptionsDetailsScheduleofassumptionsusedtoestimatethefairvaluesoftheshareoptionsgrantedLineItems" xlink:href="bmr-20221231.xsd#bmr_ShareOptionsDetailsScheduleofassumptionsusedtoestimatethefairvaluesoftheshareoptionsgrantedLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_ShareOptionsDetailsScheduleofassumptionsusedtoestimatethefairvaluesoftheshareoptionsgrantedLineItems_lbl" xml:lang="en-US">Share Options (Details) - Schedule of assumptions used to estimate the fair values of the share options granted [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_ShareOptionsDetailsScheduleofassumptionsusedtoestimatethefairvaluesoftheshareoptionsgrantedLineItems" xlink:to="bmr_ShareOptionsDetailsScheduleofassumptionsusedtoestimatethefairvaluesoftheshareoptionsgrantedLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_SegmentGeographicalDomain_lbl" xml:lang="en-US">Geographical [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_SegmentGeographicalDomain" xlink:to="srt_SegmentGeographicalDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_SegmentGeographicalInformationAndMajorCustomersDetailsScheduleofrevenuesbygeographicregionTable" xlink:href="bmr-20221231.xsd#bmr_SegmentGeographicalInformationAndMajorCustomersDetailsScheduleofrevenuesbygeographicregionTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_SegmentGeographicalInformationAndMajorCustomersDetailsScheduleofrevenuesbygeographicregionTable_lbl" xml:lang="en-US">Segment Geographical Information And Major Customers (Details) - Schedule of revenues by geographic region [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_SegmentGeographicalInformationAndMajorCustomersDetailsScheduleofrevenuesbygeographicregionTable" xlink:to="bmr_SegmentGeographicalInformationAndMajorCustomersDetailsScheduleofrevenuesbygeographicregionTable_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_SegmentGeographicalInformationAndMajorCustomersDetailsScheduleofrevenuesbygeographicregionLineItems" xlink:href="bmr-20221231.xsd#bmr_SegmentGeographicalInformationAndMajorCustomersDetailsScheduleofrevenuesbygeographicregionLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_SegmentGeographicalInformationAndMajorCustomersDetailsScheduleofrevenuesbygeographicregionLineItems_lbl" xml:lang="en-US">Segment Geographical Information And Major Customers (Details) - Schedule of revenues by geographic region [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_SegmentGeographicalInformationAndMajorCustomersDetailsScheduleofrevenuesbygeographicregionLineItems" xlink:to="bmr_SegmentGeographicalInformationAndMajorCustomersDetailsScheduleofrevenuesbygeographicregionLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_SegmentGeographicalInformationAndMajorCustomersDetailsScheduleofLonglivedassetsnetbygeographicareasTable" xlink:href="bmr-20221231.xsd#bmr_SegmentGeographicalInformationAndMajorCustomersDetailsScheduleofLonglivedassetsnetbygeographicareasTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_SegmentGeographicalInformationAndMajorCustomersDetailsScheduleofLonglivedassetsnetbygeographicareasTable_lbl" xml:lang="en-US">Segment Geographical Information And Major Customers (Details) - Schedule of Long-lived assets net by geographic areas [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_SegmentGeographicalInformationAndMajorCustomersDetailsScheduleofLonglivedassetsnetbygeographicareasTable" xlink:to="bmr_SegmentGeographicalInformationAndMajorCustomersDetailsScheduleofLonglivedassetsnetbygeographicareasTable_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_SegmentGeographicalInformationAndMajorCustomersDetailsScheduleofLonglivedassetsnetbygeographicareasLineItems" xlink:href="bmr-20221231.xsd#bmr_SegmentGeographicalInformationAndMajorCustomersDetailsScheduleofLonglivedassetsnetbygeographicareasLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_SegmentGeographicalInformationAndMajorCustomersDetailsScheduleofLonglivedassetsnetbygeographicareasLineItems_lbl" xml:lang="en-US">Segment Geographical Information And Major Customers (Details) - Schedule of Long-lived assets net by geographic areas [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_SegmentGeographicalInformationAndMajorCustomersDetailsScheduleofLonglivedassetsnetbygeographicareasLineItems" xlink:to="bmr_SegmentGeographicalInformationAndMajorCustomersDetailsScheduleofLonglivedassetsnetbygeographicareasLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DisaggregationOfRevenueTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisaggregationOfRevenueTable_lbl" xml:lang="en-US">Disaggregation of Revenue [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisaggregationOfRevenueTable" xlink:to="us-gaap_DisaggregationOfRevenueTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DisaggregationOfRevenueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisaggregationOfRevenueLineItems_lbl" xml:lang="en-US">Disaggregation of Revenue [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="us-gaap_DisaggregationOfRevenueLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_lbl" xml:lang="en-US">Sale of Stock [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_GeneralDetailsTable" xlink:href="bmr-20221231.xsd#bmr_GeneralDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_GeneralDetailsTable_lbl" xml:lang="en-US">General (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_GeneralDetailsTable" xlink:to="bmr_GeneralDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_GeneralDetailsLineItems" xlink:href="bmr-20221231.xsd#bmr_GeneralDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_GeneralDetailsLineItems_lbl" xml:lang="en-US">General (Details) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_GeneralDetailsLineItems" xlink:to="bmr_GeneralDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_EquityMethodInvesteeNameDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_EquityMethodInvesteeNameDomain_lbl" xml:lang="en-US">Investment, Name [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_EquityMethodInvesteeNameDomain" xlink:to="srt_EquityMethodInvesteeNameDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_SignificantAccountingPoliciesDetailsTable" xlink:href="bmr-20221231.xsd#bmr_SignificantAccountingPoliciesDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_SignificantAccountingPoliciesDetailsTable_lbl" xml:lang="en-US">Significant Accounting Policies (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_SignificantAccountingPoliciesDetailsTable" xlink:to="bmr_SignificantAccountingPoliciesDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_SignificantAccountingPoliciesDetailsLineItems" xlink:href="bmr-20221231.xsd#bmr_SignificantAccountingPoliciesDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_SignificantAccountingPoliciesDetailsLineItems_lbl" xml:lang="en-US">Significant Accounting Policies (Details) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_SignificantAccountingPoliciesDetailsLineItems" xlink:to="bmr_SignificantAccountingPoliciesDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShortTermDebtTypeDomain_lbl" xml:lang="en-US">Short-Term Debt, Type [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermDebtTypeDomain" xlink:to="us-gaap_ShortTermDebtTypeDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionDomain_lbl" xml:lang="en-US">Related Party Transaction [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="us-gaap_RelatedPartyTransactionDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_VariableRateDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_VariableRateDomain_lbl" xml:lang="en-US">Variable Rate [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VariableRateDomain" xlink:to="us-gaap_VariableRateDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_LoansNetDetailsTable" xlink:href="bmr-20221231.xsd#bmr_LoansNetDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_LoansNetDetailsTable_lbl" xml:lang="en-US">Loans, Net (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_LoansNetDetailsTable" xlink:to="bmr_LoansNetDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_LoansNetDetailsLineItems" xlink:href="bmr-20221231.xsd#bmr_LoansNetDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_LoansNetDetailsLineItems_lbl" xml:lang="en-US">Loans, Net (Details) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_LoansNetDetailsLineItems" xlink:to="bmr_LoansNetDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyDomain_lbl" xml:lang="en-US">Related Party [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="us-gaap_RelatedPartyDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_ConvertibleAdvanceInvestmentDetailsTable" xlink:href="bmr-20221231.xsd#bmr_ConvertibleAdvanceInvestmentDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_ConvertibleAdvanceInvestmentDetailsTable_lbl" xml:lang="en-US">Convertible Advance Investment (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_ConvertibleAdvanceInvestmentDetailsTable" xlink:to="bmr_ConvertibleAdvanceInvestmentDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_ConvertibleAdvanceInvestmentDetailsLineItems" xlink:href="bmr-20221231.xsd#bmr_ConvertibleAdvanceInvestmentDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_ConvertibleAdvanceInvestmentDetailsLineItems_lbl" xml:lang="en-US">Convertible Advance Investment (Details) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_ConvertibleAdvanceInvestmentDetailsLineItems" xlink:to="bmr_ConvertibleAdvanceInvestmentDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain_lbl" xml:lang="en-US">Title of Individual [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioUnspecifiedDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ScenarioUnspecifiedDomain_lbl" xml:lang="en-US">Scenario [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScenarioUnspecifiedDomain" xlink:to="srt_ScenarioUnspecifiedDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_CommitmentsandContingentLiabilitiesDetailsTable" xlink:href="bmr-20221231.xsd#bmr_CommitmentsandContingentLiabilitiesDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_CommitmentsandContingentLiabilitiesDetailsTable_lbl" xml:lang="en-US">Commitments and Contingent Liabilities (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_CommitmentsandContingentLiabilitiesDetailsTable" xlink:to="bmr_CommitmentsandContingentLiabilitiesDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_CommitmentsandContingentLiabilitiesDetailsLineItems" xlink:href="bmr-20221231.xsd#bmr_CommitmentsandContingentLiabilitiesDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_CommitmentsandContingentLiabilitiesDetailsLineItems_lbl" xml:lang="en-US">Commitments and Contingent Liabilities (Details) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_CommitmentsandContingentLiabilitiesDetailsLineItems" xlink:to="bmr_CommitmentsandContingentLiabilitiesDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_ShareholdersEquityDeficitDetailsTable" xlink:href="bmr-20221231.xsd#bmr_ShareholdersEquityDeficitDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_ShareholdersEquityDeficitDetailsTable_lbl" xml:lang="en-US">Shareholders&#8217; Equity (Deficit) (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_ShareholdersEquityDeficitDetailsTable" xlink:to="bmr_ShareholdersEquityDeficitDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_ShareholdersEquityDeficitDetailsLineItems" xlink:href="bmr-20221231.xsd#bmr_ShareholdersEquityDeficitDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_ShareholdersEquityDeficitDetailsLineItems_lbl" xml:lang="en-US">Shareholders&#8217; Equity (Deficit) (Details) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_ShareholdersEquityDeficitDetailsLineItems" xlink:to="bmr_ShareholdersEquityDeficitDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventTypeDomain_lbl" xml:lang="en-US">Subsequent Event Type [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventTypeDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_LoanAgreementsDomain" xlink:href="bmr-20221231.xsd#bmr_LoanAgreementsDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_LoanAgreementsDomain_lbl" xml:lang="en-US">LoanAgreements [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_LoanAgreementsDomain" xlink:to="bmr_LoanAgreementsDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_SubsequentEventsDetailsTable" xlink:href="bmr-20221231.xsd#bmr_SubsequentEventsDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_SubsequentEventsDetailsTable_lbl" xml:lang="en-US">Subsequent Events (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_SubsequentEventsDetailsTable" xlink:to="bmr_SubsequentEventsDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_SubsequentEventsDetailsLineItems" xlink:href="bmr-20221231.xsd#bmr_SubsequentEventsDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_SubsequentEventsDetailsLineItems_lbl" xml:lang="en-US">Subsequent Events (Details) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_SubsequentEventsDetailsLineItems" xlink:to="bmr_SubsequentEventsDetailsLineItems_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="bmr_AdvertisingAtAPointOfTimeUponClicks_lbl0" xml:lang="en-US">Advertising at a point of time upon clicks.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_AdvertisingAtAPointOfTimeUponClicks" xlink:to="bmr_AdvertisingAtAPointOfTimeUponClicks_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="bmr_AggregateGrossProceeds_lbl0" xml:lang="en-US">Amount of aggregate gross proceeds.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_AggregateGrossProceeds" xlink:to="bmr_AggregateGrossProceeds_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="bmr_AgreementAmountReceived_lbl0" xml:lang="en-US">The amount of agreement amount received.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_AgreementAmountReceived" xlink:to="bmr_AgreementAmountReceived_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="bmr_ChangeInTheFairValueOfConvertibleAdvanceInvestments_lbl1" xml:lang="en-US">Change in the fair value of convertible advance investments.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_ChangeInTheFairValueOfConvertibleAdvanceInvestments" xlink:to="bmr_ChangeInTheFairValueOfConvertibleAdvanceInvestments_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="bmr_CommonStockValue1_lbl0" xml:lang="en-US">Common Stock Value.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_CommonStockValue1" xlink:to="bmr_CommonStockValue1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="bmr_ConcentrationOfCreditRiskPolicyTextBlock_lbl0" xml:lang="en-US">Disclosure of concentration of credit risks.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_ConcentrationOfCreditRiskPolicyTextBlock" xlink:to="bmr_ConcentrationOfCreditRiskPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="bmr_ConsiderationReceivedFromPPPNote_lbl0" xml:lang="en-US">The amount of consideration received from PPP Note.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_ConsiderationReceivedFromPPPNote" xlink:to="bmr_ConsiderationReceivedFromPPPNote_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="bmr_ConvertibleAdvanceInvestmentsPolicyTextBlock_lbl0" xml:lang="en-US">Disclosure of accounting policy of convertible advance investments.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_ConvertibleAdvanceInvestmentsPolicyTextBlock" xlink:to="bmr_ConvertibleAdvanceInvestmentsPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="bmr_ConvertibleAdvancedInvestments_lbl0" xml:lang="en-US">Convertible advanced investments.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_ConvertibleAdvancedInvestments" xlink:to="bmr_ConvertibleAdvancedInvestments_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="bmr_ConvertibleOrdinary1And2SharesAndPreferredSharesPolicyTextBlock_lbl0" xml:lang="en-US">Disclosure of accounting policy of convertible ordinary 1 and 2 shares and preferred shares.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_ConvertibleOrdinary1And2SharesAndPreferredSharesPolicyTextBlock" xlink:to="bmr_ConvertibleOrdinary1And2SharesAndPreferredSharesPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="bmr_DerivativeWarrantLiabilityseeNote8_lbl0" xml:lang="en-US">Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_DerivativeWarrantLiabilityseeNote8" xlink:to="bmr_DerivativeWarrantLiabilityseeNote8_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="bmr_EmployeeCompensationPercentage_lbl0" xml:lang="en-US">Employee compensation percentage.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_EmployeeCompensationPercentage" xlink:to="bmr_EmployeeCompensationPercentage_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="bmr_ExcessSharesIssuedAndOutstandingShares_lbl0" xml:lang="en-US">Issued and outstanding shares.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_ExcessSharesIssuedAndOutstandingShares" xlink:to="bmr_ExcessSharesIssuedAndOutstandingShares_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="bmr_ExchangeRateDifferencesAndOthers_lbl0" xml:lang="en-US">The amount of exchange rate differences and others.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_ExchangeRateDifferencesAndOthers" xlink:to="bmr_ExchangeRateDifferencesAndOthers_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="bmr_FinancingExpenses_lbl0" xml:lang="en-US">Financing expenses text block.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_FinancingExpenses" xlink:to="bmr_FinancingExpenses_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="bmr_GovernmentAuthorities_lbl0" xml:lang="en-US">Amount of government authorities.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_GovernmentAuthorities" xlink:to="bmr_GovernmentAuthorities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="bmr_GovernmentAuthoritiesAssets_lbl0" xml:lang="en-US">Government authorities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_GovernmentAuthoritiesAssets" xlink:to="bmr_GovernmentAuthoritiesAssets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="bmr_LesseeOperatingLeasesLiabilityPaymentsDue_lbl0" xml:lang="en-US">Amount of lessee&apos;s undiscounted obligation for lease payment for operating lease.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_LesseeOperatingLeasesLiabilityPaymentsDue" xlink:to="bmr_LesseeOperatingLeasesLiabilityPaymentsDue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="bmr_LesseeOperatingLeasesLiabilityPaymentsDueNextTwelveMonths_lbl0" xml:lang="en-US">Amount of lessee&apos;s undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_LesseeOperatingLeasesLiabilityPaymentsDueNextTwelveMonths" xlink:to="bmr_LesseeOperatingLeasesLiabilityPaymentsDueNextTwelveMonths_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="bmr_ModificationOfTermsOfStraightLoan_lbl0" xml:lang="en-US">Amount of modification of terms of straight loan.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_ModificationOfTermsOfStraightLoan" xlink:to="bmr_ModificationOfTermsOfStraightLoan_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="bmr_ModificationsOrExchangeOfLoansPolicyTextBlock_lbl0" xml:lang="en-US">Disclosure of accounting policy modifications or exchange of loans.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_ModificationsOrExchangeOfLoansPolicyTextBlock" xlink:to="bmr_ModificationsOrExchangeOfLoansPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="bmr_NetConsiderationReceivedFromIBILoan_lbl0" xml:lang="en-US">The amount of net consideration received from IBI Loan.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_NetConsiderationReceivedFromIBILoan" xlink:to="bmr_NetConsiderationReceivedFromIBILoan_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="bmr_PercentageOfDiscountOutstanding_lbl0" xml:lang="en-US">Percentage of discount outstanding.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_PercentageOfDiscountOutstanding" xlink:to="bmr_PercentageOfDiscountOutstanding_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="bmr_PercentageOfDividend_lbl0" xml:lang="en-US">Percentage of dividend.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_PercentageOfDividend" xlink:to="bmr_PercentageOfDividend_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="bmr_PercentageOfOutstandingRepaymentAndPaymentAmount_lbl0" xml:lang="en-US">Percentage of outstanding repayment and payment amount.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_PercentageOfOutstandingRepaymentAndPaymentAmount" xlink:to="bmr_PercentageOfOutstandingRepaymentAndPaymentAmount_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="bmr_PropertyPlantAndEquipmentDepreciationPercentage_lbl0" xml:lang="en-US">The annual rate of depreciation (related to property, plant and equipment, but not including land) that has been recognized during the period.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_PropertyPlantAndEquipmentDepreciationPercentage" xlink:to="bmr_PropertyPlantAndEquipmentDepreciationPercentage_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="bmr_PublicOfferingPrice_lbl1" xml:lang="en-US">Public offering price.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_PublicOfferingPrice" xlink:to="bmr_PublicOfferingPrice_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="bmr_RecognitionSubsequentToSubstantialModificationOfTerms_lbl0" xml:lang="en-US">The amount of recognition subsequent to substantial modification of terms.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_RecognitionSubsequentToSubstantialModificationOfTerms" xlink:to="bmr_RecognitionSubsequentToSubstantialModificationOfTerms_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="bmr_RecognitionofRevenue_lbl0" xml:lang="en-US">Recognition of revenue amount.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_RecognitionofRevenue" xlink:to="bmr_RecognitionofRevenue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="bmr_ReconciliationOfCarryingAmount_lbl0" xml:lang="en-US">The amount of reconciliation of the carrying amount of closing balance.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_ReconciliationOfCarryingAmount" xlink:to="bmr_ReconciliationOfCarryingAmount_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="bmr_ReconciliationOfTheCarryingAmount_lbl0" xml:lang="en-US">The amount of reconciliation of the carrying amount at the opening balance.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_ReconciliationOfTheCarryingAmount" xlink:to="bmr_ReconciliationOfTheCarryingAmount_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="bmr_ScheduleOfTheMemberEffectiveDateManagementByAssistanceOfThirdpartyTableTextBlock_lbl0" xml:lang="en-US">Tabular disclosure of effective date, management by assistance of third-party.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_ScheduleOfTheMemberEffectiveDateManagementByAssistanceOfThirdpartyTableTextBlock" xlink:to="bmr_ScheduleOfTheMemberEffectiveDateManagementByAssistanceOfThirdpartyTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="bmr_VoluntaryConversionDescription_lbl0" xml:lang="en-US">Voluntary conversion description.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_VoluntaryConversionDescription" xlink:to="bmr_VoluntaryConversionDescription_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="bmr_WarrantsPolicyTextBlock_lbl0" xml:lang="en-US">Disclosure of accounting policy of warrants.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_WarrantsPolicyTextBlock" xlink:to="bmr_WarrantsPolicyTextBlock_lbl0"/>
    <loc xlink:type="locator" xlink:label="dei_AddressTypeDomain" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AddressTypeDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AddressTypeDomain_lbl" xml:lang="en-US">Address Type [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AddressTypeDomain" xlink:to="dei_AddressTypeDomain_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_LesseeOperatingLeasesLiabilityPaymentsDue_lbl1" xml:lang="en-US">Lessee Operating Leases Liability Payments Due</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_LesseeOperatingLeasesLiabilityPaymentsDue" xlink:to="bmr_LesseeOperatingLeasesLiabilityPaymentsDue_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SeriesCPreferredStockMember_lbl1" xml:lang="en-US">Series C Preferred Stock [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesCPreferredStockMember" xlink:to="us-gaap_SeriesCPreferredStockMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LoansReceivableBasisSpreadOnVariableRate_lbl0" xml:lang="en-US">Loans Receivable, Basis Spread on Variable Rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LoansReceivableBasisSpreadOnVariableRate" xlink:to="us-gaap_LoansReceivableBasisSpreadOnVariableRate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentRedemptionPricePercentage_lbl1" xml:lang="en-US">Debt Instrument, Redemption Price, Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:to="us-gaap_DebtInstrumentRedemptionPricePercentage_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ScenarioForecastMember_lbl0" xml:lang="en-US">Forecast [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScenarioForecastMember" xlink:to="srt_ScenarioForecastMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl0" xml:lang="en-US">Entity File Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl0" xml:lang="en-US">Deferred Tax Assets, Net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl0" xml:lang="en-US">Entity Well-known Seasoned Issuer</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsAbstract_lbl0" xml:lang="en-US">Assets [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditorName_lbl0" xml:lang="en-US">Auditor Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorName" xlink:to="dei_AuditorName_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl0" xml:lang="en-US">Document Accounting Standard</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_lbl0" xml:lang="en-US">Adjustments to Additional Paid in Capital, Other</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherNonoperatingGainsLosses_lbl0" xml:lang="en-US">Other Nonoperating Gains (Losses)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingGainsLosses" xlink:to="us-gaap_OtherNonoperatingGainsLosses_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentHoldingsTextBlock_lbl0" xml:lang="en-US">Investment Holdings [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentHoldingsTextBlock" xlink:to="us-gaap_InvestmentHoldingsTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromRoyaltiesReceived_lbl0" xml:lang="en-US">Proceeds from Royalties Received</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromRoyaltiesReceived" xlink:to="us-gaap_ProceedsFromRoyaltiesReceived_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_lbl0" xml:lang="en-US">Investments Classified by Contractual Maturity Date [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:to="us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet_lbl0" xml:lang="en-US">Finite-Lived Intangible Assets, Net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_DerivativeWarrantLiabilityseeNote8_lbl1" xml:lang="en-US">Derivative Warrant Liabilitysee Note8</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_DerivativeWarrantLiabilityseeNote8" xlink:to="bmr_DerivativeWarrantLiabilityseeNote8_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_WeightedAverageRemainingContractualLifeGranted_lbl0" xml:lang="en-US">Weighted Average Remaining Contractual Life Granted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_WeightedAverageRemainingContractualLifeGranted" xlink:to="bmr_WeightedAverageRemainingContractualLifeGranted_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl0" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockConvertibleSharesIssuable_lbl0" xml:lang="en-US">Preferred Stock, Convertible, Shares Issuable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockConvertibleSharesIssuable" xlink:to="us-gaap_PreferredStockConvertibleSharesIssuable_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInDueToOtherRelatedParties_lbl0" xml:lang="en-US">Increase (Decrease) in Due to Other Related Parties</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInDueToOtherRelatedParties" xlink:to="us-gaap_IncreaseDecreaseInDueToOtherRelatedParties_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_TwoZeroTwoTwoLoanAgreementMember_lbl0" xml:lang="en-US">Two Zero Two Two Loan Agreement Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_TwoZeroTwoTwoLoanAgreementMember" xlink:to="bmr_TwoZeroTwoTwoLoanAgreementMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_lbl0" xml:lang="en-US">Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:to="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_TermbasedSoftwareLicenseMember_lbl0" xml:lang="en-US">Termbased Software License Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_TermbasedSoftwareLicenseMember" xlink:to="bmr_TermbasedSoftwareLicenseMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtConversionConvertedInstrumentAmount1_lbl0" xml:lang="en-US">Debt Conversion, Converted Instrument, Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:to="us-gaap_DebtConversionConvertedInstrumentAmount1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantsAndRightsOutstanding_lbl0" xml:lang="en-US">Warrants and Rights Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsOutstanding" xlink:to="us-gaap_WarrantsAndRightsOutstanding_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestPaidNet_lbl0" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPaidNet" xlink:to="us-gaap_InterestPaidNet_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentAndIntangibleAssetsTextBlock_lbl0" xml:lang="en-US">Property, Plant, and Equipment and Intangible Assets [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentAndIntangibleAssetsTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentAndIntangibleAssetsTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt_lbl0" xml:lang="en-US">Gain (Loss) on Extinguishment of Debt</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock_lbl0" xml:lang="en-US">Investment Holdings, Schedule of Investments [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock" xlink:to="us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl0" xml:lang="en-US">Stockholders&apos; Equity Note Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_NonCurrentLiabilitiesAbstract_lbl0" xml:lang="en-US">Non Current Liabilities Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_NonCurrentLiabilitiesAbstract" xlink:to="bmr_NonCurrentLiabilitiesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShortTermDebtPercentageBearingVariableInterestRate_lbl0" xml:lang="en-US">Short-Term Debt, Percentage Bearing Variable Interest Rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermDebtPercentageBearingVariableInterestRate" xlink:to="us-gaap_ShortTermDebtPercentageBearingVariableInterestRate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_SeriesConvertibleOrdinary2SharesMember_lbl0" xml:lang="en-US">Series Convertible Ordinary2 Shares Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_SeriesConvertibleOrdinary2SharesMember" xlink:to="bmr_SeriesConvertibleOrdinary2SharesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_SeriesConvertibleOrdinary1SharesMember_lbl0" xml:lang="en-US">Series Convertible Ordinary1 Shares Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_SeriesConvertibleOrdinary1SharesMember" xlink:to="bmr_SeriesConvertibleOrdinary1SharesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_IBISpikesLtdMember_lbl0" xml:lang="en-US">IBISpikes Ltd Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_IBISpikesLtdMember" xlink:to="bmr_IBISpikesLtdMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl0" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl0" xml:lang="en-US">Preferred Stock, Shares Authorized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl0" xml:lang="en-US">Local Phone Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="country_US_lbl0" xml:lang="en-US">UNITED STATES</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_US" xlink:to="country_US_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsGross_lbl0" xml:lang="en-US">Deferred Tax Assets, Gross</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsGross_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DueToRelatedPartiesNoncurrent_lbl0" xml:lang="en-US">Due to Related Parties, Noncurrent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DueToRelatedPartiesNoncurrent" xlink:to="us-gaap_DueToRelatedPartiesNoncurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_lbl0" xml:lang="en-US">Increase (Decrease) in Accounts Payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_ExchangeRateDifferencesAndOthers_lbl1" xml:lang="en-US">Exchange Rate Differences And Others</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_ExchangeRateDifferencesAndOthers" xlink:to="bmr_ExchangeRateDifferencesAndOthers_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl0" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl0"/>
    <loc xlink:type="locator" xlink:label="bmr_ScheduleOfCompanySEquityBasedAwardsRecognizedAbstract" xlink:href="bmr-20221231.xsd#bmr_ScheduleOfCompanySEquityBasedAwardsRecognizedAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_ScheduleOfCompanySEquityBasedAwardsRecognizedAbstract_lbl" xml:lang="en-US">Schedule Of Company SEquity Based Awards Recognized Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_ScheduleOfCompanySEquityBasedAwardsRecognizedAbstract" xlink:to="bmr_ScheduleOfCompanySEquityBasedAwardsRecognizedAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl0" xml:lang="en-US">Document Registration Statement</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl0" xml:lang="en-US">Entity Common Stock, Shares Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost_lbl0" xml:lang="en-US">Share-Based Payment Arrangement, Plan Modification, Incremental Cost</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareDiluted_lbl0" xml:lang="en-US">Earnings Per Share, Diluted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CustomerRelationshipsMember_lbl1" xml:lang="en-US">Customer Relationships [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CustomerRelationshipsMember" xlink:to="us-gaap_CustomerRelationshipsMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_lbl0" xml:lang="en-US">Goodwill and Intangible Assets, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:to="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_ConvertibleAdvancedInvestments_lbl1" xml:lang="en-US">Convertible Advanced Investments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_ConvertibleAdvancedInvestments" xlink:to="bmr_ConvertibleAdvancedInvestments_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfImpairedIntangibleAssetsTextBlock_lbl0" xml:lang="en-US">Schedule of Impaired Intangible Assets [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfImpairedIntangibleAssetsTextBlock" xlink:to="us-gaap_ScheduleOfImpairedIntangibleAssetsTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsMember_lbl0" xml:lang="en-US">Retained Earnings [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConvertibleDebtFairValueDisclosures_lbl1" xml:lang="en-US">Convertible Debt, Fair Value Disclosures</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleDebtFairValueDisclosures" xlink:to="us-gaap_ConvertibleDebtFairValueDisclosures_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesIssued_lbl1" xml:lang="en-US">Preferred Stock, Shares Issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_ExercisePrice0333Member_lbl0" xml:lang="en-US">Exercise Price0333 Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_ExercisePrice0333Member" xlink:to="bmr_ExercisePrice0333Member_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_lbl0" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_BoardOfDirectorsChairmanMember_lbl0" xml:lang="en-US">Board of Directors Chairman [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_BoardOfDirectorsChairmanMember" xlink:to="srt_BoardOfDirectorsChairmanMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_UnlabeledAbstract18_lbl0" xml:lang="en-US">Unlabeled Abstract18</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_UnlabeledAbstract18" xlink:to="bmr_UnlabeledAbstract18_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RepaymentsOfDebt_lbl0" xml:lang="en-US">Repayments of Debt</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfDebt" xlink:to="us-gaap_RepaymentsOfDebt_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_UnlabeledAbstract19_lbl0" xml:lang="en-US">Unlabeled Abstract19</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_UnlabeledAbstract19" xlink:to="bmr_UnlabeledAbstract19_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_UnlabeledAbstract16_lbl0" xml:lang="en-US">Unlabeled Abstract16</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_UnlabeledAbstract16" xlink:to="bmr_UnlabeledAbstract16_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_UnlabeledAbstract17_lbl0" xml:lang="en-US">Unlabeled Abstract17</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_UnlabeledAbstract17" xlink:to="bmr_UnlabeledAbstract17_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NoncurrentAssets_lbl0" xml:lang="en-US">Long-Lived Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncurrentAssets" xlink:to="us-gaap_NoncurrentAssets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="country_RU_lbl0" xml:lang="en-US">RUSSIAN FEDERATION</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_RU" xlink:to="country_RU_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_ExercisePrice0365Member_lbl0" xml:lang="en-US">Exercise Price0365 Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_ExercisePrice0365Member" xlink:to="bmr_ExercisePrice0365Member_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PartnersCapitalAccountContributions_lbl0" xml:lang="en-US">Partners&apos; Capital Account, Contributions</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PartnersCapitalAccountContributions" xlink:to="us-gaap_PartnersCapitalAccountContributions_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MaximumMember_lbl0" xml:lang="en-US">Maximum [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MaximumMember" xlink:to="srt_MaximumMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl0" xml:lang="en-US">Significant Accounting Policies [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_UnlabeledAbstract21_lbl0" xml:lang="en-US">Unlabeled Abstract21</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_UnlabeledAbstract21" xlink:to="bmr_UnlabeledAbstract21_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_UnlabeledAbstract22_lbl0" xml:lang="en-US">Unlabeled Abstract22</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_UnlabeledAbstract22" xlink:to="bmr_UnlabeledAbstract22_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesPolicyTextBlock_lbl0" xml:lang="en-US">Commitments and Contingencies, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_UnlabeledAbstract20_lbl0" xml:lang="en-US">Unlabeled Abstract20</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_UnlabeledAbstract20" xlink:to="bmr_UnlabeledAbstract20_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl0" xml:lang="en-US">Entity Incorporation, State or Country Code</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl0" xml:lang="en-US">Security Exchange Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl0" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_UnlabeledAbstract25_lbl0" xml:lang="en-US">Unlabeled Abstract25</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_UnlabeledAbstract25" xlink:to="bmr_UnlabeledAbstract25_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_UnlabeledAbstract26_lbl0" xml:lang="en-US">Unlabeled Abstract26</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_UnlabeledAbstract26" xlink:to="bmr_UnlabeledAbstract26_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl0" xml:lang="en-US">Entity Address, Address Line Two</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_UnlabeledAbstract23_lbl0" xml:lang="en-US">Unlabeled Abstract23</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_UnlabeledAbstract23" xlink:to="bmr_UnlabeledAbstract23_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl0" xml:lang="en-US">Entity Address, Address Line One</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_UnlabeledAbstract24_lbl0" xml:lang="en-US">Unlabeled Abstract24</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_UnlabeledAbstract24" xlink:to="bmr_UnlabeledAbstract24_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_lbl0" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:to="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_UnlabeledAbstract29_lbl0" xml:lang="en-US">Unlabeled Abstract29</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_UnlabeledAbstract29" xlink:to="bmr_UnlabeledAbstract29_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MinimumMember_lbl0" xml:lang="en-US">Minimum [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MinimumMember" xlink:to="srt_MinimumMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_UnlabeledAbstract27_lbl0" xml:lang="en-US">Unlabeled Abstract27</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_UnlabeledAbstract27" xlink:to="bmr_UnlabeledAbstract27_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl0" xml:lang="en-US">Common Stock, Shares, Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_UnlabeledAbstract28_lbl0" xml:lang="en-US">Unlabeled Abstract28</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_UnlabeledAbstract28" xlink:to="bmr_UnlabeledAbstract28_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ExcessStockSharesOutstanding_lbl0" xml:lang="en-US">Excess Stock, Shares Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ExcessStockSharesOutstanding" xlink:to="us-gaap_ExcessStockSharesOutstanding_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_lbl0" xml:lang="en-US">Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherOperatingIncomeExpenseNet_lbl0" xml:lang="en-US">Other Operating Income (Expense), Net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherOperatingIncomeExpenseNet" xlink:to="us-gaap_OtherOperatingIncomeExpenseNet_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl0" xml:lang="en-US">Title of 12(b) Security</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl0" xml:lang="en-US">Additional Paid-in Capital [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ComputerEquipmentMember_lbl0" xml:lang="en-US">Computer Equipment [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComputerEquipmentMember" xlink:to="us-gaap_ComputerEquipmentMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_VariableInterestDifferenceBetweenCarryingAmountAndMaximumExposure_lbl0" xml:lang="en-US">Variable Interest Entity, Nonconsolidated, Comparison of Carrying Amount of Assets and Liabilities to Maximum Loss Exposure</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VariableInterestDifferenceBetweenCarryingAmountAndMaximumExposure" xlink:to="us-gaap_VariableInterestDifferenceBetweenCarryingAmountAndMaximumExposure_lbl0"/>
    <loc xlink:type="locator" xlink:label="bmr_ScheduleOfLossIncomeBeforeTaxesOnIncomeAbstract" xlink:href="bmr-20221231.xsd#bmr_ScheduleOfLossIncomeBeforeTaxesOnIncomeAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_ScheduleOfLossIncomeBeforeTaxesOnIncomeAbstract_lbl" xml:lang="en-US">Schedule Of Loss Income Before Taxes On Income Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_ScheduleOfLossIncomeBeforeTaxesOnIncomeAbstract" xlink:to="bmr_ScheduleOfLossIncomeBeforeTaxesOnIncomeAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl0" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherLongTermDebtCurrent_lbl0" xml:lang="en-US">Other Long-Term Debt, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLongTermDebtCurrent" xlink:to="us-gaap_OtherLongTermDebtCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LineOfCreditFacilityCollateralFeesAmount_lbl0" xml:lang="en-US">Line of Credit Facility, Collateral Fees, Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityCollateralFeesAmount" xlink:to="us-gaap_LineOfCreditFacilityCollateralFeesAmount_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl1" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl1" xml:lang="en-US">Property, Plant and Equipment, Net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_ContactPersonnelName_lbl0" xml:lang="en-US">Contact Personnel Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_ContactPersonnelName" xlink:to="dei_ContactPersonnelName_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl0" xml:lang="en-US">Preferred Stock, Shares Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_ConvertibleOrdinary1And2SharesOfNis005ParValueEachAbstract_lbl0" xml:lang="en-US">Convertible Ordinary1 And2 Shares Of Nis005 Par Value Each Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_ConvertibleOrdinary1And2SharesOfNis005ParValueEachAbstract" xlink:to="bmr_ConvertibleOrdinary1And2SharesOfNis005ParValueEachAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsForSoftware_lbl0" xml:lang="en-US">Payments for Software</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForSoftware" xlink:to="us-gaap_PaymentsForSoftware_lbl0"/>
    <loc xlink:type="locator" xlink:label="bmr_ScheduleOfComputingStraightLineAmortizationAbstract" xlink:href="bmr-20221231.xsd#bmr_ScheduleOfComputingStraightLineAmortizationAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_ScheduleOfComputingStraightLineAmortizationAbstract_lbl" xml:lang="en-US">Schedule Of Computing Straight Line Amortization Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_ScheduleOfComputingStraightLineAmortizationAbstract" xlink:to="bmr_ScheduleOfComputingStraightLineAmortizationAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet_lbl0" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Transfers, Net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl0" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ExcessStockSharesAuthorized_lbl1" xml:lang="en-US">Excess Stock, Shares Authorized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ExcessStockSharesAuthorized" xlink:to="us-gaap_ExcessStockSharesAuthorized_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Goodwill_lbl0" xml:lang="en-US">Goodwill</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Goodwill" xlink:to="us-gaap_Goodwill_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtDisclosureTextBlock_lbl0" xml:lang="en-US">Debt Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureTextBlock" xlink:to="us-gaap_DebtDisclosureTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_ShareOptionsOutstandingMember_lbl0" xml:lang="en-US">Share Options Outstanding Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_ShareOptionsOutstandingMember" xlink:to="bmr_ShareOptionsOutstandingMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_SeriesConvertibleBPreferredSharesMember_lbl0" xml:lang="en-US">Series Convertible BPreferred Shares Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_SeriesConvertibleBPreferredSharesMember" xlink:to="bmr_SeriesConvertibleBPreferredSharesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl0" xml:lang="en-US">Document Shell Company Report</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl1" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeaseCost_lbl0" xml:lang="en-US">Lease, Cost</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseCost" xlink:to="us-gaap_LeaseCost_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherIncome_lbl0" xml:lang="en-US">Other Income</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherIncome" xlink:to="us-gaap_OtherIncome_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_lbl0" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Domestic</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_UnlabeledAbstract10_lbl0" xml:lang="en-US">Unlabeled Abstract10</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_UnlabeledAbstract10" xlink:to="bmr_UnlabeledAbstract10_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_UnlabeledAbstract11_lbl0" xml:lang="en-US">Unlabeled Abstract11</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_UnlabeledAbstract11" xlink:to="bmr_UnlabeledAbstract11_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_UnlabeledAbstract14_lbl0" xml:lang="en-US">Unlabeled Abstract14</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_UnlabeledAbstract14" xlink:to="bmr_UnlabeledAbstract14_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_UnlabeledAbstract15_lbl0" xml:lang="en-US">Unlabeled Abstract15</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_UnlabeledAbstract15" xlink:to="bmr_UnlabeledAbstract15_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_UnlabeledAbstract12_lbl0" xml:lang="en-US">Unlabeled Abstract12</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_UnlabeledAbstract12" xlink:to="bmr_UnlabeledAbstract12_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_UnlabeledAbstract13_lbl0" xml:lang="en-US">Unlabeled Abstract13</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_UnlabeledAbstract13" xlink:to="bmr_UnlabeledAbstract13_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1_lbl0" xml:lang="en-US">Debt Conversion, Converted Instrument, Warrants or Options Issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1" xlink:to="us-gaap_DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestAndFeeIncomeOtherLoans_lbl0" xml:lang="en-US">Interest and Fee Income, Other Loans</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestAndFeeIncomeOtherLoans" xlink:to="us-gaap_InterestAndFeeIncomeOtherLoans_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_ReconciliationOfCarryingAmount_lbl1" xml:lang="en-US">Reconciliation Of Carrying Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_ReconciliationOfCarryingAmount" xlink:to="bmr_ReconciliationOfCarryingAmount_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1_lbl0" xml:lang="en-US">Noncash or Part Noncash Divestiture, Amount of Consideration Received</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1" xlink:to="us-gaap_NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_SupplementalDisclosureOfCashFlowInformationAbstract_lbl0" xml:lang="en-US">Supplemental Disclosure Of Cash Flow Information Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_SupplementalDisclosureOfCashFlowInformationAbstract" xlink:to="bmr_SupplementalDisclosureOfCashFlowInformationAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_lbl0" xml:lang="en-US">Class of Warrant or Right, Number of Securities Called by Each Warrant or Right</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_ModificationOfTermsOfStraightLoan_lbl1" xml:lang="en-US">Modification Of Terms Of Straight Loan</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_ModificationOfTermsOfStraightLoan" xlink:to="bmr_ModificationOfTermsOfStraightLoan_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax_lbl0" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TemporaryEquitySharesAuthorized_lbl0" xml:lang="en-US">Temporary Equity, Shares Authorized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquitySharesAuthorized" xlink:to="us-gaap_TemporaryEquitySharesAuthorized_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantExercisePriceIncrease_lbl0" xml:lang="en-US">Warrant, Exercise Price, Increase</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantExercisePriceIncrease" xlink:to="us-gaap_WarrantExercisePriceIncrease_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebt_lbl0" xml:lang="en-US">Long-Term Debt</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebt" xlink:to="us-gaap_LongTermDebt_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_UnlabeledAbstract2_lbl0" xml:lang="en-US">Unlabeled Abstract2</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_UnlabeledAbstract2" xlink:to="bmr_UnlabeledAbstract2_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_lbl0" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:to="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_UnlabeledAbstract1_lbl0" xml:lang="en-US">Unlabeled Abstract1</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_UnlabeledAbstract1" xlink:to="bmr_UnlabeledAbstract1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_UnlabeledAbstract4_lbl0" xml:lang="en-US">Unlabeled Abstract4</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_UnlabeledAbstract4" xlink:to="bmr_UnlabeledAbstract4_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_UnlabeledAbstract3_lbl0" xml:lang="en-US">Unlabeled Abstract3</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_UnlabeledAbstract3" xlink:to="bmr_UnlabeledAbstract3_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_lbl0" xml:lang="en-US">Long-Term Debt, Maturity, Year Three</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GainLossOnSaleOfPropertyPlantEquipment_lbl0" xml:lang="en-US">Gain (Loss) on Disposition of Property Plant Equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:to="us-gaap_GainLossOnSaleOfPropertyPlantEquipment_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_UnlabeledAbstract0_lbl0" xml:lang="en-US">Unlabeled Abstract0</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_UnlabeledAbstract0" xlink:to="bmr_UnlabeledAbstract0_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_UnlabeledAbstract9_lbl0" xml:lang="en-US">Unlabeled Abstract9</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_UnlabeledAbstract9" xlink:to="bmr_UnlabeledAbstract9_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromRelatedPartyDebt_lbl0" xml:lang="en-US">Proceeds from Related Party Debt</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromRelatedPartyDebt" xlink:to="us-gaap_ProceedsFromRelatedPartyDebt_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OfficeEquipmentMember_lbl0" xml:lang="en-US">Office Equipment [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OfficeEquipmentMember" xlink:to="us-gaap_OfficeEquipmentMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_UnlabeledAbstract6_lbl0" xml:lang="en-US">Unlabeled Abstract6</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_UnlabeledAbstract6" xlink:to="bmr_UnlabeledAbstract6_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_UnlabeledAbstract5_lbl0" xml:lang="en-US">Unlabeled Abstract5</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_UnlabeledAbstract5" xlink:to="bmr_UnlabeledAbstract5_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_UnlabeledAbstract8_lbl0" xml:lang="en-US">Unlabeled Abstract8</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_UnlabeledAbstract8" xlink:to="bmr_UnlabeledAbstract8_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_UnlabeledAbstract7_lbl0" xml:lang="en-US">Unlabeled Abstract7</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_UnlabeledAbstract7" xlink:to="bmr_UnlabeledAbstract7_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock_lbl0" xml:lang="en-US">Schedule of Other Current Assets [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:to="us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_SeriesConvertibleB1PreferredSharesBMember_lbl0" xml:lang="en-US">Series Convertible B1 Preferred Shares BMember</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_SeriesConvertibleB1PreferredSharesBMember" xlink:to="bmr_SeriesConvertibleB1PreferredSharesBMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_PercentageOfOutstandingRepaymentAndPaymentAmount_lbl1" xml:lang="en-US">Percentage Of Outstanding Repayment And Payment Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_PercentageOfOutstandingRepaymentAndPaymentAmount" xlink:to="bmr_PercentageOfOutstandingRepaymentAndPaymentAmount_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_OrdinarySharesOfNis005ParValueEachAbstract_lbl0" xml:lang="en-US">Ordinary Shares Of Nis005 Par Value Each Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_OrdinarySharesOfNis005ParValueEachAbstract" xlink:to="bmr_OrdinarySharesOfNis005ParValueEachAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_lbl0" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards, State and Local</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl0" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_BusinessContactMember_lbl0" xml:lang="en-US">Business Contact [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_BusinessContactMember" xlink:to="dei_BusinessContactMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_lbl0" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseDiscountRate_lbl0" xml:lang="en-US">Lessee, Operating Lease, Discount Rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseDiscountRate" xlink:to="us-gaap_LesseeOperatingLeaseDiscountRate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl0" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_lbl0" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAdjustmentOfWarrants_lbl0" xml:lang="en-US">Fair Value Adjustment of Warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAdjustmentOfWarrants" xlink:to="us-gaap_FairValueAdjustmentOfWarrants_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl0" xml:lang="en-US">Current Fiscal Year End Date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_LoansAndSecurityAgreementMember_lbl0" xml:lang="en-US">Loans And Security Agreement Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_LoansAndSecurityAgreementMember" xlink:to="bmr_LoansAndSecurityAgreementMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_UnlabeledAbstract_lbl0" xml:lang="en-US">Unlabeled Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_UnlabeledAbstract" xlink:to="bmr_UnlabeledAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_NetConsiderationReceivedFromIBILoan_lbl1" xml:lang="en-US">Net Consideration Received From IBILoan</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_NetConsiderationReceivedFromIBILoan" xlink:to="bmr_NetConsiderationReceivedFromIBILoan_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl0" xml:lang="en-US">Common Stock, Shares Authorized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockConvertibleConversionPrice_lbl0" xml:lang="en-US">Preferred Stock, Convertible, Conversion Price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockConvertibleConversionPrice" xlink:to="us-gaap_PreferredStockConvertibleConversionPrice_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LoanProcessingFee_lbl0" xml:lang="en-US">Loan Processing Fee</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LoanProcessingFee" xlink:to="us-gaap_LoanProcessingFee_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsAbstract_lbl" xml:lang="en-US">Related Party Transactions [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_RelatedPartyTransactionsAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo_lbl0" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Rolling Year Two</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionDueFromToRelatedPartyCurrent_lbl0" xml:lang="en-US">Related Party Transaction, Due from (to) Related Party, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionDueFromToRelatedPartyCurrent" xlink:to="us-gaap_RelatedPartyTransactionDueFromToRelatedPartyCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Exercise Price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableInterestBearingInterestRate_lbl0" xml:lang="en-US">Accounts Payable, Interest-Bearing, Interest Rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableInterestBearingInterestRate" xlink:to="us-gaap_AccountsPayableInterestBearingInterestRate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_lbl0" xml:lang="en-US">Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_lbl0"/>
    <loc xlink:type="locator" xlink:label="bmr_ScheduleOfAssumptionsUsedToEstimateTheFairValuesOfTheShareOptionsGrantedAbstract" xlink:href="bmr-20221231.xsd#bmr_ScheduleOfAssumptionsUsedToEstimateTheFairValuesOfTheShareOptionsGrantedAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_ScheduleOfAssumptionsUsedToEstimateTheFairValuesOfTheShareOptionsGrantedAbstract_lbl" xml:lang="en-US">Schedule Of Assumptions Used To Estimate The Fair Values Of The Share Options Granted Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_ScheduleOfAssumptionsUsedToEstimateTheFairValuesOfTheShareOptionsGrantedAbstract" xlink:to="bmr_ScheduleOfAssumptionsUsedToEstimateTheFairValuesOfTheShareOptionsGrantedAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockDividend_lbl0" xml:lang="en-US">Stock Issued During Period, Value, Stock Dividend</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueStockDividend" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockDividend_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsUnderManagementCarryingAmount_lbl0" xml:lang="en-US">Assets under Management, Carrying Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsUnderManagementCarryingAmount" xlink:to="us-gaap_AssetsUnderManagementCarryingAmount_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquity_lbl2" xml:lang="en-US">Stockholders&apos; Equity Attributable to Parent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinancingInterestExpense_lbl0" xml:lang="en-US">Financing Interest Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinancingInterestExpense" xlink:to="us-gaap_FinancingInterestExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_AggregateGrossProceeds_lbl1" xml:lang="en-US">Aggregate Gross Proceeds</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_AggregateGrossProceeds" xlink:to="bmr_AggregateGrossProceeds_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_CarryingAmountAbstract_lbl0" xml:lang="en-US">Carrying Amount Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_CarryingAmountAbstract" xlink:to="bmr_CarryingAmountAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl0" xml:lang="en-US">Share-Based Payment Arrangement [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl0" xml:lang="en-US">Related Party Transactions Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl0" xml:lang="en-US">Share-Based Payment Arrangement, Option, Activity [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl0" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_CompareAndPeripheralEquipmentMember_lbl0" xml:lang="en-US">Compare And Peripheral Equipment Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_CompareAndPeripheralEquipmentMember" xlink:to="bmr_CompareAndPeripheralEquipmentMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOtherReceivables_lbl0" xml:lang="en-US">Increase (Decrease) in Other Receivables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherReceivables" xlink:to="us-gaap_IncreaseDecreaseInOtherReceivables_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_ConvertiblePreferredSharesMember_lbl0" xml:lang="en-US">Convertible Preferred Shares Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_ConvertiblePreferredSharesMember" xlink:to="bmr_ConvertiblePreferredSharesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_PerpetualBasedSoftwareLicenseMember_lbl0" xml:lang="en-US">Perpetual Based Software License Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_PerpetualBasedSoftwareLicenseMember" xlink:to="bmr_PerpetualBasedSoftwareLicenseMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_lbl0" xml:lang="en-US">Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl0" xml:lang="en-US">Sale of Stock, Number of Shares Issued in Transaction</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock_lbl0" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="us-gaap_SegmentReportingDisclosureTextBlock_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_lbl" xml:lang="en-US">Statement of Financial Position [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementOfFinancialPositionAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueOther_lbl0" xml:lang="en-US">Stock Issued During Period, Value, Other</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueOther" xlink:to="us-gaap_StockIssuedDuringPeriodValueOther_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_AllocationOfProceedsAndRelatedIssuanceCostsPolicyTextBlock_lbl0" xml:lang="en-US">Allocation Of Proceeds And Related Issuance Costs Policy Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_AllocationOfProceedsAndRelatedIssuanceCostsPolicyTextBlock" xlink:to="bmr_AllocationOfProceedsAndRelatedIssuanceCostsPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl0" xml:lang="en-US">Entity Address, Postal Zip Code</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityMethodInvestmentAggregateCost_lbl1" xml:lang="en-US">Equity Method Investment, Aggregate Cost</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestmentAggregateCost" xlink:to="us-gaap_EquityMethodInvestmentAggregateCost_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl0" xml:lang="en-US">Document Type</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueMeasurementPolicyPolicyTextBlock_lbl0" xml:lang="en-US">Fair Value Measurement, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:to="us-gaap_FairValueMeasurementPolicyPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl0" xml:lang="en-US">Stock Issued During Period, Shares, Conversion of Convertible Securities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl0" xml:lang="en-US">Document Fiscal Period Focus</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_FinancingExpenses_lbl1" xml:lang="en-US">Financing Expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_FinancingExpenses" xlink:to="bmr_FinancingExpenses_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_AgreementAmountReceived_lbl1" xml:lang="en-US">Agreement Amount Received</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_AgreementAmountReceived" xlink:to="bmr_AgreementAmountReceived_lbl1"/>
    <loc xlink:type="locator" xlink:label="bmr_ScheduleOfLongLivedAssetsNetByGeographicAreasAbstract" xlink:href="bmr-20221231.xsd#bmr_ScheduleOfLongLivedAssetsNetByGeographicAreasAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_ScheduleOfLongLivedAssetsNetByGeographicAreasAbstract_lbl" xml:lang="en-US">Schedule Of Long Lived Assets Net By Geographic Areas Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_ScheduleOfLongLivedAssetsNetByGeographicAreasAbstract" xlink:to="bmr_ScheduleOfLongLivedAssetsNetByGeographicAreasAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl0" xml:lang="en-US">Entity Interactive Data Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl0" xml:lang="en-US">Property, Plant and Equipment Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_lbl0" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:to="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentRelatedLiabilities_lbl1" xml:lang="en-US">Investment-related Liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentRelatedLiabilities" xlink:to="us-gaap_InvestmentRelatedLiabilities_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl1" xml:lang="en-US">Proceeds from Issuance of Common Stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_lbl0" xml:lang="en-US">Long-Term Debt, Maturity, Year Two</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentInterestRate_lbl0" xml:lang="en-US">Investment Interest Rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentInterestRate" xlink:to="us-gaap_InvestmentInterestRate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_SeriesOrdinarySharesMember_lbl0" xml:lang="en-US">Series Ordinary Shares Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_SeriesOrdinarySharesMember" xlink:to="bmr_SeriesOrdinarySharesMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="bmr_ScheduleOfDeferredIncomeTaxesReflectTheNetTaxEffectsOfNetOperatingLossAbstract" xlink:href="bmr-20221231.xsd#bmr_ScheduleOfDeferredIncomeTaxesReflectTheNetTaxEffectsOfNetOperatingLossAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_ScheduleOfDeferredIncomeTaxesReflectTheNetTaxEffectsOfNetOperatingLossAbstract_lbl" xml:lang="en-US">Schedule Of Deferred Income Taxes Reflect The Net Tax Effects Of Net Operating Loss Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_ScheduleOfDeferredIncomeTaxesReflectTheNetTaxEffectsOfNetOperatingLossAbstract" xlink:to="bmr_ScheduleOfDeferredIncomeTaxesReflectTheNetTaxEffectsOfNetOperatingLossAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_ScheduleOfMaturityDatesOfOutstandingLoanTableTextBlock_lbl0" xml:lang="en-US">Schedule Of Maturity Dates Of Outstanding Loan Table Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_ScheduleOfMaturityDatesOfOutstandingLoanTableTextBlock" xlink:to="bmr_ScheduleOfMaturityDatesOfOutstandingLoanTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_AdvertisingAtAPointOfTimeUponClicks_lbl1" xml:lang="en-US">Advertising At APoint Of Time Upon Clicks</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_AdvertisingAtAPointOfTimeUponClicks" xlink:to="bmr_AdvertisingAtAPointOfTimeUponClicks_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_ModificationOfTermsRelatingToStraightLoan_lbl0" xml:lang="en-US">Modification Of Terms Relating To Straight Loan</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_ModificationOfTermsRelatingToStraightLoan" xlink:to="bmr_ModificationOfTermsRelatingToStraightLoan_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInDueFromRelatedParties_lbl0" xml:lang="en-US">Increase (Decrease) in Due from Related Parties</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInDueFromRelatedParties" xlink:to="us-gaap_IncreaseDecreaseInDueFromRelatedParties_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensation_lbl0" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl0" xml:lang="en-US">Trading Symbol</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtCurrent_lbl0" xml:lang="en-US">Long-Term Debt, Current Maturities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtCurrent" xlink:to="us-gaap_LongTermDebtCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsOfFinancingCosts_lbl0" xml:lang="en-US">Payments of Financing Costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfFinancingCosts" xlink:to="us-gaap_PaymentsOfFinancingCosts_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl0" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl0"/>
    <loc xlink:type="locator" xlink:label="bmr_ScheduleOfFutureMinimumCommitmentUnderBindingLeaseAgreeementsAbstract" xlink:href="bmr-20221231.xsd#bmr_ScheduleOfFutureMinimumCommitmentUnderBindingLeaseAgreeementsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_ScheduleOfFutureMinimumCommitmentUnderBindingLeaseAgreeementsAbstract_lbl" xml:lang="en-US">Schedule Of Future Minimum Commitment Under Binding Lease Agreeements Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_ScheduleOfFutureMinimumCommitmentUnderBindingLeaseAgreeementsAbstract" xlink:to="bmr_ScheduleOfFutureMinimumCommitmentUnderBindingLeaseAgreeementsAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl0" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShortTermBorrowings_lbl0" xml:lang="en-US">Short-Term Debt</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermBorrowings" xlink:to="us-gaap_ShortTermBorrowings_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_lbl0" xml:lang="en-US">Share-Based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Remaining Contractual Term</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherCurrentAssetsTextBlock_lbl0" xml:lang="en-US">Other Current Assets [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherCurrentAssetsTextBlock" xlink:to="us-gaap_OtherCurrentAssetsTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl1" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl0" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredRevenue_lbl0" xml:lang="en-US">Deferred Revenue</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRevenue" xlink:to="us-gaap_DeferredRevenue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_AccumulatedAmortizationAbstract_lbl0" xml:lang="en-US">Accumulated Amortization Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_AccumulatedAmortizationAbstract" xlink:to="bmr_AccumulatedAmortizationAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl0" xml:lang="en-US">Research and Development Expense, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConvertibleDebtTableTextBlock_lbl0" xml:lang="en-US">Convertible Debt [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleDebtTableTextBlock" xlink:to="us-gaap_ConvertibleDebtTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GainLossOnDispositionOfAssets_lbl0" xml:lang="en-US">Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnDispositionOfAssets" xlink:to="us-gaap_GainLossOnDispositionOfAssets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl0" xml:lang="en-US">Document Period End Date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativesPolicyTextBlock_lbl0" xml:lang="en-US">Derivatives, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativesPolicyTextBlock" xlink:to="us-gaap_DerivativesPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeFixedInterestRate_lbl0" xml:lang="en-US">Derivative, Fixed Interest Rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeFixedInterestRate" xlink:to="us-gaap_DerivativeFixedInterestRate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl0" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_TotalConsideration_lbl0" xml:lang="en-US">Total Consideration</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_TotalConsideration" xlink:to="bmr_TotalConsideration_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConversionOfStockSharesIssued1_lbl0" xml:lang="en-US">Conversion of Stock, Shares Issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConversionOfStockSharesIssued1" xlink:to="us-gaap_ConversionOfStockSharesIssued1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_lbl0" xml:lang="en-US">Accretion (Amortization) of Discounts and Premiums, Investments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:to="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AmortizationOfDebtDiscountPremium_lbl1" xml:lang="en-US">Amortization of Debt Discount (Premium)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfDebtDiscountPremium" xlink:to="us-gaap_AmortizationOfDebtDiscountPremium_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInDeferredRevenue_lbl0" xml:lang="en-US">Increase (Decrease) in Deferred Revenue</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:to="us-gaap_IncreaseDecreaseInDeferredRevenue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_EmployeeCompensationPercentage_lbl1" xml:lang="en-US">Employee Compensation Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_EmployeeCompensationPercentage" xlink:to="bmr_EmployeeCompensationPercentage_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_ExercisePrice0000Member_lbl0" xml:lang="en-US">Exercise Price0000 Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_ExercisePrice0000Member" xlink:to="bmr_ExercisePrice0000Member_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentInterestRateEffectivePercentage_lbl0" xml:lang="en-US">Debt Instrument, Interest Rate, Effective Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:to="us-gaap_DebtInstrumentInterestRateEffectivePercentage_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_TradeReceivablesIncomeTaxRate_lbl0" xml:lang="en-US">Trade Receivables Income Tax Rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_TradeReceivablesIncomeTaxRate" xlink:to="bmr_TradeReceivablesIncomeTaxRate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_ConvertibleOrdinary1And2SharesAndPreferredSharesPolicyTextBlock_lbl1" xml:lang="en-US">Convertible Ordinary1 And2 Shares And Preferred Shares Policy Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_ConvertibleOrdinary1And2SharesAndPreferredSharesPolicyTextBlock" xlink:to="bmr_ConvertibleOrdinary1And2SharesAndPreferredSharesPolicyTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareBasic_lbl0" xml:lang="en-US">Earnings Per Share, Basic</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DepreciationExpenseOnReclassifiedAssets_lbl0" xml:lang="en-US">Depreciation Expense on Reclassified Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationExpenseOnReclassifiedAssets" xlink:to="us-gaap_DepreciationExpenseOnReclassifiedAssets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl0" xml:lang="en-US">Research and Development Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="us-gaap_ResearchAndDevelopmentExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_LoanAgreementsAxis_lbl0" xml:lang="en-US">Loan Agreements Axis</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_LoanAgreementsAxis" xlink:to="bmr_LoanAgreementsAxis_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract_lbl" xml:lang="en-US">Statement of Stockholders&apos; Equity [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementOfStockholdersEquityAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl0" xml:lang="en-US">Document Annual Report</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingencies_lbl0" xml:lang="en-US">Commitments and Contingencies</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingencies" xlink:to="us-gaap_CommitmentsAndContingencies_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_ExercisePrice0640Member_lbl0" xml:lang="en-US">Exercise Price0640 Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_ExercisePrice0640Member" xlink:to="bmr_ExercisePrice0640Member_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl0" xml:lang="en-US">Entity Address, City or Town</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_TechnologyMember_lbl0" xml:lang="en-US">Technology Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_TechnologyMember" xlink:to="bmr_TechnologyMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockValue_lbl0" xml:lang="en-US">Common Stock, Value, Issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeFinanceLeaseDiscountRate_lbl0" xml:lang="en-US">Lessee, Finance Lease, Discount Rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeFinanceLeaseDiscountRate" xlink:to="us-gaap_LesseeFinanceLeaseDiscountRate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_ExercisePrice0757Member_lbl0" xml:lang="en-US">Exercise Price0757 Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_ExercisePrice0757Member" xlink:to="bmr_ExercisePrice0757Member_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfRegulatoryLiabilitiesTextBlock_lbl0" xml:lang="en-US">Schedule of Regulatory Liabilities [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRegulatoryLiabilitiesTextBlock" xlink:to="us-gaap_ScheduleOfRegulatoryLiabilitiesTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AmortizationOfFinancingCosts_lbl0" xml:lang="en-US">Amortization of Debt Issuance Costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfFinancingCosts" xlink:to="us-gaap_AmortizationOfFinancingCosts_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_CashFlowsFromInvestingActivitiesAbstract_lbl0" xml:lang="en-US">Cash Flows From Investing Activities Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_CashFlowsFromInvestingActivitiesAbstract" xlink:to="bmr_CashFlowsFromInvestingActivitiesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_ShareholdersEquityDeficitAbstract_lbl0" xml:lang="en-US">Shareholders Equity Deficit Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_ShareholdersEquityDeficitAbstract" xlink:to="bmr_ShareholdersEquityDeficitAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_WeightedAverageRemainingContractualLifeExercised_lbl0" xml:lang="en-US">Weighted Average Remaining Contractual Life Exercised</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_WeightedAverageRemainingContractualLifeExercised" xlink:to="bmr_WeightedAverageRemainingContractualLifeExercised_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl0" xml:lang="en-US">Entity Voluntary Filers</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl0" xml:lang="en-US">Entity Filer Category</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_ModificationsOrExchangeOfLoansPolicyTextBlock_lbl1" xml:lang="en-US">Modifications Or Exchange Of Loans Policy Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_ModificationsOrExchangeOfLoansPolicyTextBlock" xlink:to="bmr_ModificationsOrExchangeOfLoansPolicyTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherNonoperatingExpense_lbl0" xml:lang="en-US">Other Nonoperating Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingExpense" xlink:to="us-gaap_OtherNonoperatingExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesNoncurrent_lbl0" xml:lang="en-US">Liabilities, Noncurrent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesNoncurrent" xlink:to="us-gaap_LiabilitiesNoncurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings_lbl0" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Repatriation of Foreign Earnings, Percent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_PublicOfferingPrice_lbl2" xml:lang="en-US">Public Offering Price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_PublicOfferingPrice" xlink:to="bmr_PublicOfferingPrice_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IPOMember_lbl0" xml:lang="en-US">IPO [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IPOMember" xlink:to="us-gaap_IPOMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Assets_lbl0" xml:lang="en-US">Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PostemploymentBenefitPlansPolicy_lbl0" xml:lang="en-US">Postemployment Benefit Plans, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PostemploymentBenefitPlansPolicy" xlink:to="us-gaap_PostemploymentBenefitPlansPolicy_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_ScheduleOfTheMemberEffectiveDateManagementByAssistanceOfThirdpartyTableTextBlock_lbl1" xml:lang="en-US">Schedule Of The Member Effective Date Management By Assistance Of Thirdparty Table Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_ScheduleOfTheMemberEffectiveDateManagementByAssistanceOfThirdpartyTableTextBlock" xlink:to="bmr_ScheduleOfTheMemberEffectiveDateManagementByAssistanceOfThirdpartyTableTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl0" xml:lang="en-US">Subsequent Events [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConvertiblePreferredStockMember_lbl1" xml:lang="en-US">Convertible Preferred Stock [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertiblePreferredStockMember" xlink:to="us-gaap_ConvertiblePreferredStockMember_lbl1"/>
    <loc xlink:type="locator" xlink:label="bmr_ScheduleOfComputingStraightLineDepreciationAbstract" xlink:href="bmr-20221231.xsd#bmr_ScheduleOfComputingStraightLineDepreciationAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_ScheduleOfComputingStraightLineDepreciationAbstract_lbl" xml:lang="en-US">Schedule Of Computing Straight Line Depreciation Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_ScheduleOfComputingStraightLineDepreciationAbstract" xlink:to="bmr_ScheduleOfComputingStraightLineDepreciationAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_GovernmentAuthorities_lbl1" xml:lang="en-US">Government Authorities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_GovernmentAuthorities" xlink:to="bmr_GovernmentAuthorities_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredRevenueCurrent_lbl0" xml:lang="en-US">Deferred Revenue, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRevenueCurrent" xlink:to="us-gaap_DeferredRevenueCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherResearchAndDevelopmentExpense_lbl0" xml:lang="en-US">Other Research and Development Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherResearchAndDevelopmentExpense" xlink:to="us-gaap_OtherResearchAndDevelopmentExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AmortizationOfIntangibleAssets_lbl0" xml:lang="en-US">Amortization of Intangible Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfIntangibleAssets" xlink:to="us-gaap_AmortizationOfIntangibleAssets_lbl0"/>
    <loc xlink:type="locator" xlink:label="bmr_ScheduleOfCompositionOfShareholdersEquityAbstract" xlink:href="bmr-20221231.xsd#bmr_ScheduleOfCompositionOfShareholdersEquityAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_ScheduleOfCompositionOfShareholdersEquityAbstract_lbl" xml:lang="en-US">Schedule Of Composition Of Shareholders Equity Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_ScheduleOfCompositionOfShareholdersEquityAbstract" xlink:to="bmr_ScheduleOfCompositionOfShareholdersEquityAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl0" xml:lang="en-US">Income Tax Expense (Benefit)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherIntangibleAssetsNet_lbl0" xml:lang="en-US">Other Intangible Assets, Net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherIntangibleAssetsNet" xlink:to="us-gaap_OtherIntangibleAssetsNet_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UseOfEstimates_lbl0" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NumberOfOperatingSegments_lbl0" xml:lang="en-US">Number of Operating Segments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NumberOfOperatingSegments" xlink:to="us-gaap_NumberOfOperatingSegments_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrentAndNoncurrent_lbl0" xml:lang="en-US">Other Accrued Liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAccruedLiabilitiesCurrentAndNoncurrent" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrentAndNoncurrent_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementAbstract_lbl" xml:lang="en-US">Income Statement [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeStatementAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_WeightedAverageRemainingContractualLifeOutstanding_lbl0" xml:lang="en-US">Weighted Average Remaining Contractual Life Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_WeightedAverageRemainingContractualLifeOutstanding" xlink:to="bmr_WeightedAverageRemainingContractualLifeOutstanding_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_RecognitionSubsequentToSubstantialModificationOfTerms_lbl1" xml:lang="en-US">Recognition Subsequent To Substantial Modification Of Terms</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_RecognitionSubsequentToSubstantialModificationOfTerms" xlink:to="bmr_RecognitionSubsequentToSubstantialModificationOfTerms_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_WeightedAverageRemainingContractualLifeForfeitedOrExpired_lbl0" xml:lang="en-US">Weighted Average Remaining Contractual Life Forfeited Or Expired</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_WeightedAverageRemainingContractualLifeForfeitedOrExpired" xlink:to="bmr_WeightedAverageRemainingContractualLifeForfeitedOrExpired_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherReceivables_lbl0" xml:lang="en-US">Other Receivables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherReceivables" xlink:to="us-gaap_OtherReceivables_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherCurrentLiabilitiesTableTextBlock_lbl0" xml:lang="en-US">Other Current Liabilities [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:to="us-gaap_OtherCurrentLiabilitiesTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_ConvertiblePreferredSharesOfNis005ParValueEachAbstract_lbl0" xml:lang="en-US">Convertible Preferred Shares Of Nis005 Par Value Each Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_ConvertiblePreferredSharesOfNis005ParValueEachAbstract" xlink:to="bmr_ConvertiblePreferredSharesOfNis005ParValueEachAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_lbl0" xml:lang="en-US">Share-Based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Remaining Contractual Term</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl0" xml:lang="en-US">Document Transition Report</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_lbl0" xml:lang="en-US">Share-Based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetAmountAtRiskByProductAndGuaranteeWeightedAveragePeriodRemaining1_lbl0" xml:lang="en-US">Net Amount at Risk by Product and Guarantee, Weighted Average Period Remaining</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetAmountAtRiskByProductAndGuaranteeWeightedAveragePeriodRemaining1" xlink:to="us-gaap_NetAmountAtRiskByProductAndGuaranteeWeightedAveragePeriodRemaining1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_ExercisePrice1024Member_lbl0" xml:lang="en-US">Exercise Price1024 Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_ExercisePrice1024Member" xlink:to="bmr_ExercisePrice1024Member_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_CashFlowsFromFinancingActivitiesAbstract_lbl0" xml:lang="en-US">Cash Flows From Financing Activities Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_CashFlowsFromFinancingActivitiesAbstract" xlink:to="bmr_CashFlowsFromFinancingActivitiesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense_lbl0" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Noncontrolling Interest Income (Loss), Percent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense_lbl0"/>
    <loc xlink:type="locator" xlink:label="bmr_ScheduleOfTheReconciliationOfTheCarryingAmountOfTheCompanyAbstract" xlink:href="bmr-20221231.xsd#bmr_ScheduleOfTheReconciliationOfTheCarryingAmountOfTheCompanyAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_ScheduleOfTheReconciliationOfTheCarryingAmountOfTheCompanyAbstract_lbl" xml:lang="en-US">Schedule Of The Reconciliation Of The Carrying Amount Of The Company Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_ScheduleOfTheReconciliationOfTheCarryingAmountOfTheCompanyAbstract" xlink:to="bmr_ScheduleOfTheReconciliationOfTheCarryingAmountOfTheCompanyAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_ExcessSharesIssuedAndOutstandingShares_lbl1" xml:lang="en-US">Excess Shares Issued And Outstanding Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_ExcessSharesIssuedAndOutstandingShares" xlink:to="bmr_ExcessSharesIssuedAndOutstandingShares_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_RecognitionofRevenue_lbl1" xml:lang="en-US">Recognitionof Revenue</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_RecognitionofRevenue" xlink:to="bmr_RecognitionofRevenue_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AmortizationOfFinancingCostsAndDiscounts_lbl0" xml:lang="en-US">Amortization of Debt Issuance Costs and Discounts</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:to="us-gaap_AmortizationOfFinancingCostsAndDiscounts_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableCurrent_lbl0" xml:lang="en-US">Accounts Payable, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrent" xlink:to="us-gaap_AccountsPayableCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_lbl0" xml:lang="en-US">Deferred Tax Assets, in Process Research and Development</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:to="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl0" xml:lang="en-US">Entity Shell Company</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl1" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_CapitalContributionFromAControllingShareholderPolicyTextBlock_lbl0" xml:lang="en-US">Capital Contribution From AControlling Shareholder Policy Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_CapitalContributionFromAControllingShareholderPolicyTextBlock" xlink:to="bmr_CapitalContributionFromAControllingShareholderPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_GovernmentAuthoritiesAssets_lbl1" xml:lang="en-US">Government Authorities Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_GovernmentAuthoritiesAssets" xlink:to="bmr_GovernmentAuthoritiesAssets_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_ExercisePrice0227Member_lbl0" xml:lang="en-US">Exercise Price0227 Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_ExercisePrice0227Member" xlink:to="bmr_ExercisePrice0227Member_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_ExercisePrice0833Member_lbl0" xml:lang="en-US">Exercise Price0833 Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_ExercisePrice0833Member" xlink:to="bmr_ExercisePrice0833Member_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl0" xml:lang="en-US">Property, Plant and Equipment, Gross</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentGross" xlink:to="us-gaap_PropertyPlantAndEquipmentGross_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_SoftwareLicenseAbstract_lbl0" xml:lang="en-US">Software License Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_SoftwareLicenseAbstract" xlink:to="bmr_SoftwareLicenseAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl0" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfStockholdersEquityTableTextBlock_lbl0" xml:lang="en-US">Schedule of Stockholders Equity [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfStockholdersEquityTableTextBlock" xlink:to="us-gaap_ScheduleOfStockholdersEquityTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentOfWarrantsGrantedForServices_lbl0" xml:lang="en-US">Adjustment of Warrants Granted for Services</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentOfWarrantsGrantedForServices" xlink:to="us-gaap_AdjustmentOfWarrantsGrantedForServices_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_LesseeOperatingLeasesLiabilityPaymentsDueNextTwelveMonths_lbl1" xml:lang="en-US">Lessee Operating Leases Liability Payments Due Next Twelve Months</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_LesseeOperatingLeasesLiabilityPaymentsDueNextTwelveMonths" xlink:to="bmr_LesseeOperatingLeasesLiabilityPaymentsDueNextTwelveMonths_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedAmortizationDeferredFinanceCosts_lbl0" xml:lang="en-US">Accumulated Amortization, Debt Issuance Costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedAmortizationDeferredFinanceCosts" xlink:to="us-gaap_AccumulatedAmortizationDeferredFinanceCosts_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl0" xml:lang="en-US">Share-Based Payment Arrangement [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrimeRateMember_lbl0" xml:lang="en-US">Prime Rate [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrimeRateMember" xlink:to="us-gaap_PrimeRateMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_NonCashFinancingActivitiesAbstract_lbl0" xml:lang="en-US">Non Cash Financing Activities Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_NonCashFinancingActivitiesAbstract" xlink:to="bmr_NonCashFinancingActivitiesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromNotesPayable_lbl1" xml:lang="en-US">Proceeds from Notes Payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromNotesPayable" xlink:to="us-gaap_ProceedsFromNotesPayable_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_ConvertibleOrdinary1And2SharesMember_lbl0" xml:lang="en-US">Convertible Ordinary1 And2 Shares Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_ConvertibleOrdinary1And2SharesMember" xlink:to="bmr_ConvertibleOrdinary1And2SharesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_LiabilitiesAndShareholdersEquityDeficitAbstract_lbl0" xml:lang="en-US">Liabilities And Shareholders Equity Deficit Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_LiabilitiesAndShareholdersEquityDeficitAbstract" xlink:to="bmr_LiabilitiesAndShareholdersEquityDeficitAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock_lbl0" xml:lang="en-US">Schedule of Revenue from External Customers Attributed to Foreign Countries by Geographic Area [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock" xlink:to="us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_RestOfTheWorldMember_lbl0" xml:lang="en-US">Rest Of The World Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_RestOfTheWorldMember" xlink:to="bmr_RestOfTheWorldMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl0" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl1" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_lbl0" xml:lang="en-US">Share-Based Payment Arrangement, Expense, after Tax</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:to="us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditorLocation_lbl0" xml:lang="en-US">Auditor Location</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorLocation" xlink:to="dei_AuditorLocation_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RepaymentsOfRelatedPartyDebt_lbl0" xml:lang="en-US">Repayments of Related Party Debt</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfRelatedPartyDebt" xlink:to="us-gaap_RepaymentsOfRelatedPartyDebt_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_OfficeFurnitureAndEquipmentMember_lbl0" xml:lang="en-US">Office Furniture And Equipment Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_OfficeFurnitureAndEquipmentMember" xlink:to="bmr_OfficeFurnitureAndEquipmentMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SellingAndMarketingExpense_lbl0" xml:lang="en-US">Selling and Marketing Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingAndMarketingExpense" xlink:to="us-gaap_SellingAndMarketingExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LoansHeldForSaleTerm_lbl0" xml:lang="en-US">Loans Held-for-sale, Term</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LoansHeldForSaleTerm" xlink:to="us-gaap_LoansHeldForSaleTerm_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl0" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherSellingAndMarketingExpense_lbl0" xml:lang="en-US">Other Selling and Marketing Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherSellingAndMarketingExpense" xlink:to="us-gaap_OtherSellingAndMarketingExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl0" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl0"/>
    <loc xlink:type="locator" xlink:label="bmr_ScheduleOfRevenuesByGeographicRegionAbstract" xlink:href="bmr-20221231.xsd#bmr_ScheduleOfRevenuesByGeographicRegionAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_ScheduleOfRevenuesByGeographicRegionAbstract_lbl" xml:lang="en-US">Schedule Of Revenues By Geographic Region Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_ScheduleOfRevenuesByGeographicRegionAbstract" xlink:to="bmr_ScheduleOfRevenuesByGeographicRegionAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_NonCurrentAssetsAbstract_lbl0" xml:lang="en-US">Non Current Assets Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_NonCurrentAssetsAbstract" xlink:to="bmr_NonCurrentAssetsAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_lbl0" xml:lang="en-US">Share-Based Payment Arrangement, Option, Exercise Price Range [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsCapitalLossCarryforwards_lbl0" xml:lang="en-US">Deferred Tax Assets, Capital Loss Carryforwards</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsCapitalLossCarryforwards" xlink:to="us-gaap_DeferredTaxAssetsCapitalLossCarryforwards_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl0" xml:lang="en-US">Entity Registrant Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentOwnedBalancePrincipalAmount_lbl0" xml:lang="en-US">Investment Owned, Balance, Principal Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentOwnedBalancePrincipalAmount" xlink:to="us-gaap_InvestmentOwnedBalancePrincipalAmount_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantMember_lbl0" xml:lang="en-US">Warrant [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantMember" xlink:to="us-gaap_WarrantMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PresentValueOfFutureInsuranceProfitsAmortizationExpenseAccruedInterest_lbl0" xml:lang="en-US">Present Value of Future Insurance Profits, Amortization Expense, Accrued Interest</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PresentValueOfFutureInsuranceProfitsAmortizationExpenseAccruedInterest" xlink:to="us-gaap_PresentValueOfFutureInsuranceProfitsAmortizationExpenseAccruedInterest_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventMember_lbl0" xml:lang="en-US">Subsequent Event [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventMember" xlink:to="us-gaap_SubsequentEventMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeLiabilityFairValueOfCollateral_lbl0" xml:lang="en-US">Derivative Liability, Fair Value of Collateral</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeLiabilityFairValueOfCollateral" xlink:to="us-gaap_DerivativeLiabilityFairValueOfCollateral_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsForRent_lbl0" xml:lang="en-US">Payments for Rent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForRent" xlink:to="us-gaap_PaymentsForRent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_PropertyPlantAndEquipmentDepreciationPercentage_lbl1" xml:lang="en-US">Property Plant And Equipment Depreciation Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_PropertyPlantAndEquipmentDepreciationPercentage" xlink:to="bmr_PropertyPlantAndEquipmentDepreciationPercentage_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherSellingGeneralAndAdministrativeExpense_lbl0" xml:lang="en-US">Other Selling, General and Administrative Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherSellingGeneralAndAdministrativeExpense" xlink:to="us-gaap_OtherSellingGeneralAndAdministrativeExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl0" xml:lang="en-US">Employee-related Liabilities, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl0" xml:lang="en-US">City Area Code</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl0" xml:lang="en-US">Amendment Flag</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredChargesPolicyTextBlock_lbl0" xml:lang="en-US">Deferred Charges, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredChargesPolicyTextBlock" xlink:to="us-gaap_DeferredChargesPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherGeneralAndAdministrativeExpense_lbl0" xml:lang="en-US">Other General and Administrative Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherGeneralAndAdministrativeExpense" xlink:to="us-gaap_OtherGeneralAndAdministrativeExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_VoluntaryConversionDescription_lbl1" xml:lang="en-US">Voluntary Conversion Description</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_VoluntaryConversionDescription" xlink:to="bmr_VoluntaryConversionDescription_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingIncomeLoss_lbl0" xml:lang="en-US">Operating Income (Loss)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl0" xml:lang="en-US">Entity Central Index Key</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_lbl0" xml:lang="en-US">Foreign Currency Transactions and Translations Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl0" xml:lang="en-US">Entity Address, Country</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl0" xml:lang="en-US">Equity Method Investment, Ownership Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:to="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_TwoThousandTwentyTwoLoanAgreementMember_lbl0" xml:lang="en-US">Two Thousand Twenty Two Loan Agreement Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_TwoThousandTwentyTwoLoanAgreementMember" xlink:to="bmr_TwoThousandTwentyTwoLoanAgreementMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_WarrantsPolicyTextBlock_lbl1" xml:lang="en-US">Warrants Policy Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_WarrantsPolicyTextBlock" xlink:to="bmr_WarrantsPolicyTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredCosts_lbl0" xml:lang="en-US">Deferred Costs, Noncurrent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredCosts" xlink:to="us-gaap_DeferredCosts_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl0" xml:lang="en-US">Liabilities, Current [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl0"/>
    <loc xlink:type="locator" xlink:label="bmr_ScheduleOfIntangibleAssetsNetAndGoodwilAbstract" xlink:href="bmr-20221231.xsd#bmr_ScheduleOfIntangibleAssetsNetAndGoodwilAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_ScheduleOfIntangibleAssetsNetAndGoodwilAbstract_lbl" xml:lang="en-US">Schedule Of Intangible Assets Net And Goodwil Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_ScheduleOfIntangibleAssetsNetAndGoodwilAbstract" xlink:to="bmr_ScheduleOfIntangibleAssetsNetAndGoodwilAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_ShareOptionsExercisableMember_lbl0" xml:lang="en-US">Share Options Exercisable Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_ShareOptionsExercisableMember" xlink:to="bmr_ShareOptionsExercisableMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DepreciationDepletionAndAmortization_lbl0" xml:lang="en-US">Depreciation, Depletion and Amortization</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationDepletionAndAmortization" xlink:to="us-gaap_DepreciationDepletionAndAmortization_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RepaymentsOfSecuredDebt_lbl0" xml:lang="en-US">Repayments of Secured Debt</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfSecuredDebt" xlink:to="us-gaap_RepaymentsOfSecuredDebt_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAssetsCurrent_lbl1" xml:lang="en-US">Other Assets, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsCurrent" xlink:to="us-gaap_OtherAssetsCurrent_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidExpenseCurrentAndNoncurrent_lbl0" xml:lang="en-US">Prepaid Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseCurrentAndNoncurrent" xlink:to="us-gaap_PrepaidExpenseCurrentAndNoncurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_ConsiderationReceivedFromPPPNote_lbl1" xml:lang="en-US">Consideration Received From PPPNote</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_ConsiderationReceivedFromPPPNote" xlink:to="bmr_ConsiderationReceivedFromPPPNote_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentAnnualPrincipalPayment_lbl0" xml:lang="en-US">Debt Instrument, Annual Principal Payment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentAnnualPrincipalPayment" xlink:to="us-gaap_DebtInstrumentAnnualPrincipalPayment_lbl0"/>
    <loc xlink:type="locator" xlink:label="bmr_ScheduleOfReconciliationOfTheFairValueOfDerivativeWarrantsLiabilitiesAbstract" xlink:href="bmr-20221231.xsd#bmr_ScheduleOfReconciliationOfTheFairValueOfDerivativeWarrantsLiabilitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_ScheduleOfReconciliationOfTheFairValueOfDerivativeWarrantsLiabilitiesAbstract_lbl" xml:lang="en-US">Schedule Of Reconciliation Of The Fair Value Of Derivative Warrants Liabilities Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_ScheduleOfReconciliationOfTheFairValueOfDerivativeWarrantsLiabilitiesAbstract" xlink:to="bmr_ScheduleOfReconciliationOfTheFairValueOfDerivativeWarrantsLiabilitiesAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed_lbl1" xml:lang="en-US">Debt Instrument, Redemption Price, Percentage of Principal Amount Redeemed</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed" xlink:to="us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentInProcess_lbl0" xml:lang="en-US">Research and Development in Process</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentInProcess" xlink:to="us-gaap_ResearchAndDevelopmentInProcess_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentDecreaseForgiveness_lbl0" xml:lang="en-US">Debt Instrument, Decrease, Forgiveness</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentDecreaseForgiveness" xlink:to="us-gaap_DebtInstrumentDecreaseForgiveness_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_ReconciliationOfTheCarryingAmount_lbl1" xml:lang="en-US">Reconciliation Of The Carrying Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_ReconciliationOfTheCarryingAmount" xlink:to="bmr_ReconciliationOfTheCarryingAmount_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_PCSServicesTransferredOverAPeriod_lbl0" xml:lang="en-US">PCSServices Transferred Over APeriod</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_PCSServicesTransferredOverAPeriod" xlink:to="bmr_PCSServicesTransferredOverAPeriod_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xml:lang="en-US">Statement of Cash Flows [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering_lbl1" xml:lang="en-US">Proceeds from Issuance Initial Public Offering</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl0" xml:lang="en-US">Income Tax Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_lbl0" xml:lang="en-US">Long-Term Debt, Maturity, Year One</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharePrice_lbl0" xml:lang="en-US">Share Price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharePrice" xlink:to="us-gaap_SharePrice_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl1" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_lbl0" xml:lang="en-US">Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:to="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisaggregationOfRevenueTableTextBlock_lbl0" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="us-gaap_DisaggregationOfRevenueTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtNoncurrent_lbl0" xml:lang="en-US">Long-Term Debt, Excluding Current Maturities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtNoncurrent" xlink:to="us-gaap_LongTermDebtNoncurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl0" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_lbl0" xml:lang="en-US">Accounts Payable and Accrued Liabilities, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MarketingAndAdvertisingExpense_lbl0" xml:lang="en-US">Marketing and Advertising Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketingAndAdvertisingExpense" xlink:to="us-gaap_MarketingAndAdvertisingExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_ConvertibleAdvanceInvestmentsMember_lbl0" xml:lang="en-US">Convertible Advance Investments Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_ConvertibleAdvanceInvestmentsMember" xlink:to="bmr_ConvertibleAdvanceInvestmentsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_SharesOfNis005ParValueAbstract_lbl0" xml:lang="en-US">Shares Of Nis005 Par Value Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_SharesOfNis005ParValueAbstract" xlink:to="bmr_SharesOfNis005ParValueAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrentAbstract_lbl0" xml:lang="en-US">Assets, Current [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_AdvanceInvestmentAgreementsMember_lbl0" xml:lang="en-US">Advance Investment Agreements Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_AdvanceInvestmentAgreementsMember" xlink:to="bmr_AdvanceInvestmentAgreementsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock_lbl0" xml:lang="en-US">Revenue [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RepaymentsOfOtherLongTermDebt_lbl0" xml:lang="en-US">Repayments of Other Long-Term Debt</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfOtherLongTermDebt" xlink:to="us-gaap_RepaymentsOfOtherLongTermDebt_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding_lbl0" xml:lang="en-US">Line of Credit Facility, Fair Value of Amount Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding" xlink:to="us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl0" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl0" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesFairValueDisclosure_lbl0" xml:lang="en-US">Accounts Payable and Accrued Liabilities, Fair Value Disclosure</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesFairValueDisclosure" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesFairValueDisclosure_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_IcfrAuditorAttestationFlag_lbl0" xml:lang="en-US">ICFR Auditor Attestation Flag</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_IcfrAuditorAttestationFlag" xlink:to="dei_IcfrAuditorAttestationFlag_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths_lbl0" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Next Rolling 12 Months</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeLiabilitiesNoncurrent_lbl0" xml:lang="en-US">Derivative Liability, Noncurrent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeLiabilitiesNoncurrent" xlink:to="us-gaap_DerivativeLiabilitiesNoncurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl0" xml:lang="en-US">Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_lbl0" xml:lang="en-US">Increase (Decrease) in Other Current Liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:to="us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DueToRelatedPartiesCurrent_lbl0" xml:lang="en-US">Due to Related Parties, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DueToRelatedPartiesCurrent" xlink:to="us-gaap_DueToRelatedPartiesCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherPrepaidExpenseCurrent_lbl0" xml:lang="en-US">Other Prepaid Expense, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherPrepaidExpenseCurrent" xlink:to="us-gaap_OtherPrepaidExpenseCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherLiabilitiesCurrent_lbl1" xml:lang="en-US">Other Liabilities, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesCurrent" xlink:to="us-gaap_OtherLiabilitiesCurrent_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_lbl0" xml:lang="en-US">Class of Warrant or Right, Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_ContactPersonnelEmailAddress_lbl0" xml:lang="en-US">Contact Personnel Email Address</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_ContactPersonnelEmailAddress" xlink:to="dei_ContactPersonnelEmailAddress_lbl0"/>
    <loc xlink:type="locator" xlink:label="bmr_ScheduleOfRevenueDisaggregatedByPrimaryMajorProductLinesAndServicesAbstract" xlink:href="bmr-20221231.xsd#bmr_ScheduleOfRevenueDisaggregatedByPrimaryMajorProductLinesAndServicesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_ScheduleOfRevenueDisaggregatedByPrimaryMajorProductLinesAndServicesAbstract_lbl" xml:lang="en-US">Schedule Of Revenue Disaggregated By Primary Major Product Lines And Services Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_ScheduleOfRevenueDisaggregatedByPrimaryMajorProductLinesAndServicesAbstract" xlink:to="bmr_ScheduleOfRevenueDisaggregatedByPrimaryMajorProductLinesAndServicesAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GrossProfit_lbl0" xml:lang="en-US">Gross Profit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_GrossProfit_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl0" xml:lang="en-US">Entity Ex Transition Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromStockOptionsExercised_lbl1" xml:lang="en-US">Proceeds from Stock Options Exercised</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromStockOptionsExercised" xlink:to="us-gaap_ProceedsFromStockOptionsExercised_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TradeNamesMember_lbl1" xml:lang="en-US">Trade Names [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TradeNamesMember" xlink:to="us-gaap_TradeNamesMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsForFees_lbl0" xml:lang="en-US">Payments for Other Fees</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForFees" xlink:to="us-gaap_PaymentsForFees_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Revenues_lbl0" xml:lang="en-US">Revenues</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_Revenues_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl0" xml:lang="en-US">Liabilities and Equity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_ConcentrationOfCreditRiskPolicyTextBlock_lbl1" xml:lang="en-US">Concentration Of Credit Risk Policy Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_ConcentrationOfCreditRiskPolicyTextBlock" xlink:to="bmr_ConcentrationOfCreditRiskPolicyTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_FloatingRateMember_lbl0" xml:lang="en-US">Floating Rate Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_FloatingRateMember" xlink:to="bmr_FloatingRateMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_SeriesConvertibleCPreferredSharesMember_lbl0" xml:lang="en-US">Series Convertible CPreferred Shares Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_SeriesConvertibleCPreferredSharesMember" xlink:to="bmr_SeriesConvertibleCPreferredSharesMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="bmr_ScheduleOfPropertyAndEquipmentNetAbstract" xlink:href="bmr-20221231.xsd#bmr_ScheduleOfPropertyAndEquipmentNetAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_ScheduleOfPropertyAndEquipmentNetAbstract_lbl" xml:lang="en-US">Schedule Of Property And Equipment Net Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_ScheduleOfPropertyAndEquipmentNetAbstract" xlink:to="bmr_ScheduleOfPropertyAndEquipmentNetAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_NumberOfSharesAbstract_lbl0" xml:lang="en-US">Number Of Shares Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_NumberOfSharesAbstract" xlink:to="bmr_NumberOfSharesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl0" xml:lang="en-US">General and Administrative Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpense" xlink:to="us-gaap_GeneralAndAdministrativeExpense_lbl0"/>
    <loc xlink:type="locator" xlink:label="bmr_ScheduleOfCompanySShareOptionActivityForEmployeesAndMembersOfTheBoardOfDirectorsAbstract" xlink:href="bmr-20221231.xsd#bmr_ScheduleOfCompanySShareOptionActivityForEmployeesAndMembersOfTheBoardOfDirectorsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_ScheduleOfCompanySShareOptionActivityForEmployeesAndMembersOfTheBoardOfDirectorsAbstract_lbl" xml:lang="en-US">Schedule Of Company SShare Option Activity For Employees And Members Of The Board Of Directors Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_ScheduleOfCompanySShareOptionActivityForEmployeesAndMembersOfTheBoardOfDirectorsAbstract" xlink:to="bmr_ScheduleOfCompanySShareOptionActivityForEmployeesAndMembersOfTheBoardOfDirectorsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="bmr_ScheduleOfOutstandingAndExercisableShareOptionsSeparatedRangesOfExercisePricesAbstract" xlink:href="bmr-20221231.xsd#bmr_ScheduleOfOutstandingAndExercisableShareOptionsSeparatedRangesOfExercisePricesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_ScheduleOfOutstandingAndExercisableShareOptionsSeparatedRangesOfExercisePricesAbstract_lbl" xml:lang="en-US">Schedule Of Outstanding And Exercisable Share Options Separated Ranges Of Exercise Prices Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_ScheduleOfOutstandingAndExercisableShareOptionsSeparatedRangesOfExercisePricesAbstract" xlink:to="bmr_ScheduleOfOutstandingAndExercisableShareOptionsSeparatedRangesOfExercisePricesAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ReceivablesNetCurrent_lbl0" xml:lang="en-US">Receivables, Net, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ReceivablesNetCurrent" xlink:to="us-gaap_ReceivablesNetCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_TotalGrossConsideration_lbl0" xml:lang="en-US">Total Gross Consideration</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_TotalGrossConsideration" xlink:to="bmr_TotalGrossConsideration_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentFaceAmount_lbl1" xml:lang="en-US">Debt Instrument, Face Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentFaceAmount" xlink:to="us-gaap_DebtInstrumentFaceAmount_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CapitalUnitsNetAmount_lbl0" xml:lang="en-US">Capital Units, Net Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CapitalUnitsNetAmount" xlink:to="us-gaap_CapitalUnitsNetAmount_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrent_lbl0" xml:lang="en-US">Liabilities, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StraightLineRent_lbl0" xml:lang="en-US">Straight Line Rent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StraightLineRent" xlink:to="us-gaap_StraightLineRent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock_lbl0" xml:lang="en-US">Long-Lived Assets by Geographic Areas [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock" xlink:to="us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_ScheduleOfPresentationReflectsTheReconciliationOfTheCarryingAmountTableTextBlock_lbl0" xml:lang="en-US">Schedule Of Presentation Reflects The Reconciliation Of The Carrying Amount Table Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_ScheduleOfPresentationReflectsTheReconciliationOfTheCarryingAmountTableTextBlock" xlink:to="bmr_ScheduleOfPresentationReflectsTheReconciliationOfTheCarryingAmountTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_lbl0" xml:lang="en-US">Schedule of Carrying Values and Estimated Fair Values of Debt Instruments [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" xlink:to="us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrent_lbl0" xml:lang="en-US">Assets, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsOfLoanCosts_lbl0" xml:lang="en-US">Payments of Loan Costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfLoanCosts" xlink:to="us-gaap_PaymentsOfLoanCosts_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromDebtNetOfIssuanceCosts_lbl0" xml:lang="en-US">Proceeds from Debt, Net of Issuance Costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:to="us-gaap_ProceedsFromDebtNetOfIssuanceCosts_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl0" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl0" xml:lang="en-US">Document Fiscal Year Focus</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssued1_lbl0" xml:lang="en-US">Stock Issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssued1" xlink:to="us-gaap_StockIssued1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl0" xml:lang="en-US">Lessee, Operating Lease, Liability, Maturity [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeFairValueOfDerivativeNet_lbl1" xml:lang="en-US">Derivative, Fair Value, Net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeFairValueOfDerivativeNet" xlink:to="us-gaap_DerivativeFairValueOfDerivativeNet_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl0" xml:lang="en-US">Entity Emerging Growth Company</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfPrivatePlacement_lbl0" xml:lang="en-US">Proceeds from Issuance of Private Placement</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:to="us-gaap_ProceedsFromIssuanceOfPrivatePlacement_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongDurationContractsAssumptionsByProductAndGuaranteeDiscountRate_lbl0" xml:lang="en-US">Long-Duration Contracts, Assumptions by Product and Guarantee, Discount Rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongDurationContractsAssumptionsByProductAndGuaranteeDiscountRate" xlink:to="us-gaap_LongDurationContractsAssumptionsByProductAndGuaranteeDiscountRate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesIssued_lbl0" xml:lang="en-US">Common Stock, Shares, Issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl1" xml:lang="en-US">Class of Warrant or Right, Exercise Price of Warrants or Rights</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl0" xml:lang="en-US">Entity Current Reporting Status</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ExtinguishmentOfDebtAmount_lbl0" xml:lang="en-US">Extinguishment of Debt, Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ExtinguishmentOfDebtAmount" xlink:to="us-gaap_ExtinguishmentOfDebtAmount_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl0" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueOptionChangesInFairValueGainLoss1_lbl0" xml:lang="en-US">Fair Value, Option, Changes in Fair Value, Gain (Loss)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueOptionChangesInFairValueGainLoss1" xlink:to="us-gaap_FairValueOptionChangesInFairValueGainLoss1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl0" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_ChangeInTheFairValueOfConvertibleAdvanceInvestments_lbl2" xml:lang="en-US">Change In The Fair Value Of Convertible Advance Investments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_ChangeInTheFairValueOfConvertibleAdvanceInvestments" xlink:to="bmr_ChangeInTheFairValueOfConvertibleAdvanceInvestments_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GainsLossesOnRestructuringOfDebt_lbl0" xml:lang="en-US">Gains (Losses) on Restructuring of Debt</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainsLossesOnRestructuringOfDebt" xlink:to="us-gaap_GainsLossesOnRestructuringOfDebt_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl0" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_lbl0" xml:lang="en-US">Share-Based Payment Arrangement, Cost by Plan [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:to="us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostOfRevenue_lbl0" xml:lang="en-US">Cost of Revenue</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfRevenue" xlink:to="us-gaap_CostOfRevenue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_CashFlowsFromOperatingActivitiesAbstract_lbl0" xml:lang="en-US">Cash Flows From Operating Activities Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_CashFlowsFromOperatingActivitiesAbstract" xlink:to="bmr_CashFlowsFromOperatingActivitiesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsNoncurrent_lbl0" xml:lang="en-US">Assets, Noncurrent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsNoncurrent" xlink:to="us-gaap_AssetsNoncurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl0" xml:lang="en-US">Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherCommitmentDueInSecondYear_lbl0" xml:lang="en-US">Other Commitment, to be Paid, Year Two</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherCommitmentDueInSecondYear" xlink:to="us-gaap_OtherCommitmentDueInSecondYear_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_AdjustmentsRequiredToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract_lbl0" xml:lang="en-US">Adjustments Required To Reconcile Net Loss To Net Cash Used In Operating Activities Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_AdjustmentsRequiredToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract" xlink:to="bmr_AdjustmentsRequiredToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl0" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapital_lbl0" xml:lang="en-US">Additional Paid in Capital</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapital" xlink:to="us-gaap_AdditionalPaidInCapital_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_scheduleOfFutureMinimumCommitmentUnderBindingLeaseAgreeementsTableTextBlock_lbl0" xml:lang="en-US">schedule Of Future Minimum Commitment Under Binding Lease Agreeements Table Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_scheduleOfFutureMinimumCommitmentUnderBindingLeaseAgreeementsTableTextBlock" xlink:to="bmr_scheduleOfFutureMinimumCommitmentUnderBindingLeaseAgreeementsTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_lbl0" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Foreign</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockAmountOfPreferredDividendsInArrears_lbl0" xml:lang="en-US">Preferred Stock, Amount of Preferred Dividends in Arrears</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockAmountOfPreferredDividendsInArrears" xlink:to="us-gaap_PreferredStockAmountOfPreferredDividendsInArrears_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditorFirmId_lbl0" xml:lang="en-US">Auditor Firm ID</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorFirmId" xlink:to="dei_AuditorFirmId_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_PercentageOfDividend_lbl1" xml:lang="en-US">Percentage Of Dividend</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_PercentageOfDividend" xlink:to="bmr_PercentageOfDividend_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LineOfCreditFacilityCommitmentFeeAmount_lbl0" xml:lang="en-US">Line of Credit Facility, Commitment Fee Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityCommitmentFeeAmount" xlink:to="us-gaap_LineOfCreditFacilityCommitmentFeeAmount_lbl0"/>
    <loc xlink:type="locator" xlink:label="bmr_ScheduleOfMaturityDatesAbstract" xlink:href="bmr-20221231.xsd#bmr_ScheduleOfMaturityDatesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_ScheduleOfMaturityDatesAbstract_lbl" xml:lang="en-US">Schedule Of Maturity Dates Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_ScheduleOfMaturityDatesAbstract" xlink:to="bmr_ScheduleOfMaturityDatesAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentSalvageValuePercentage_lbl0" xml:lang="en-US">Property, Plant and Equipment, Salvage Value, Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentSalvageValuePercentage" xlink:to="us-gaap_PropertyPlantAndEquipmentSalvageValuePercentage_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_PercentageOfDiscountOutstanding_lbl1" xml:lang="en-US">Percentage Of Discount Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_PercentageOfDiscountOutstanding" xlink:to="bmr_PercentageOfDiscountOutstanding_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLoss_lbl1" xml:lang="en-US">Net Income (Loss) Attributable to Parent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DepositLiabilitiesAccruedInterest_lbl0" xml:lang="en-US">Deposit Liabilities, Accrued Interest</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepositLiabilitiesAccruedInterest" xlink:to="us-gaap_DepositLiabilitiesAccruedInterest_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TechnologyEquipmentMember_lbl0" xml:lang="en-US">Technology Equipment [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TechnologyEquipmentMember" xlink:to="us-gaap_TechnologyEquipmentMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockValue_lbl0" xml:lang="en-US">Preferred Stock, Value, Issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockValue" xlink:to="us-gaap_PreferredStockValue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxesPaid_lbl0" xml:lang="en-US">Income Taxes Paid</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxesPaid" xlink:to="us-gaap_IncomeTaxesPaid_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_CommonStockValue1_lbl1" xml:lang="en-US">Common Stock Value1</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_CommonStockValue1" xlink:to="bmr_CommonStockValue1_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOtherCurrentAssets_lbl0" xml:lang="en-US">Increase (Decrease) in Other Current Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:to="us-gaap_IncreaseDecreaseInOtherCurrentAssets_lbl0"/>
    <loc xlink:type="locator" xlink:label="bmr_ScheduleOfOtherCurrentLiabiltiesAbstract" xlink:href="bmr-20221231.xsd#bmr_ScheduleOfOtherCurrentLiabiltiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_ScheduleOfOtherCurrentLiabiltiesAbstract_lbl" xml:lang="en-US">Schedule Of Other Current Liabilties Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_ScheduleOfOtherCurrentLiabiltiesAbstract" xlink:to="bmr_ScheduleOfOtherCurrentLiabiltiesAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl1" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsAbstract_lbl" xml:lang="en-US">Subsequent Events [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentIncomeAmortizationOfDiscount_lbl0" xml:lang="en-US">Investment Income, Amortization of Discount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentIncomeAmortizationOfDiscount" xlink:to="us-gaap_InvestmentIncomeAmortizationOfDiscount_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RepaymentsOfFederalHomeLoanBankBorrowings_lbl0" xml:lang="en-US">Payments of FHLBank Borrowings, Financing Activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfFederalHomeLoanBankBorrowings" xlink:to="us-gaap_RepaymentsOfFederalHomeLoanBankBorrowings_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_lbl0" xml:lang="en-US">Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredRevenueRevenueRecognized1_lbl0" xml:lang="en-US">Deferred Revenue, Revenue Recognized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRevenueRevenueRecognized1" xlink:to="us-gaap_DeferredRevenueRevenueRecognized1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl0" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConsolidationPolicyTextBlock_lbl0" xml:lang="en-US">Consolidation, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConsolidationPolicyTextBlock" xlink:to="us-gaap_ConsolidationPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesOutstanding_lbl1" xml:lang="en-US">Shares, Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_OrdinarySharesAvailableForFutureIssuance_lbl0" xml:lang="en-US">Ordinary Shares Available For Future Issuance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_OrdinarySharesAvailableForFutureIssuance" xlink:to="bmr_OrdinarySharesAvailableForFutureIssuance_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentInterestRateTerms_lbl0" xml:lang="en-US">Debt Instrument, Interest Rate Terms</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateTerms" xlink:to="us-gaap_DebtInstrumentInterestRateTerms_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_lbl0" xml:lang="en-US">Proceeds from Sale of Property, Plant, and Equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:to="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="country_IL_lbl0" xml:lang="en-US">ISRAEL</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_IL" xlink:to="country_IL_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtConversionConvertedInstrumentRate_lbl0" xml:lang="en-US">Debt Conversion, Converted Instrument, Rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtConversionConvertedInstrumentRate" xlink:to="us-gaap_DebtConversionConvertedInstrumentRate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl0" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock_lbl0" xml:lang="en-US">Lessee, Leases [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="us-gaap_LesseeLeasesPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DueToOtherRelatedPartiesClassifiedCurrent_lbl0" xml:lang="en-US">Due to Other Related Parties, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DueToOtherRelatedPartiesClassifiedCurrent" xlink:to="us-gaap_DueToOtherRelatedPartiesClassifiedCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_ConvertibleAdvanceInvestmentsPolicyTextBlock_lbl1" xml:lang="en-US">Convertible Advance Investments Policy Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_ConvertibleAdvanceInvestmentsPolicyTextBlock" xlink:to="bmr_ConvertibleAdvanceInvestmentsPolicyTextBlock_lbl1"/>
    <loc xlink:type="locator" xlink:label="bmr_ScheduleOfExpensesRelatedToServiceAgreementAndTheOfficeServicesAgreementAbstract" xlink:href="bmr-20221231.xsd#bmr_ScheduleOfExpensesRelatedToServiceAgreementAndTheOfficeServicesAgreementAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_ScheduleOfExpensesRelatedToServiceAgreementAndTheOfficeServicesAgreementAbstract_lbl" xml:lang="en-US">Schedule Of Expenses Related To Service Agreement And The Office Services Agreement Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_ScheduleOfExpensesRelatedToServiceAgreementAndTheOfficeServicesAgreementAbstract" xlink:to="bmr_ScheduleOfExpensesRelatedToServiceAgreementAndTheOfficeServicesAgreementAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmr_OrdinarySharesSubjectToAdjustments_lbl0" xml:lang="en-US">Ordinary Shares Subject To Adjustments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmr_OrdinarySharesSubjectToAdjustments" xlink:to="bmr_OrdinarySharesSubjectToAdjustments_lbl0"/>
  </labelLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>11
<FILENAME>bmr-20221231_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Mon Apr 24 19:58:56 UTC 2023 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_ConsolidatedBalanceSheet" roleURI="http://www.beil.com/role/ConsolidatedBalanceSheet"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_ConsolidatedBalanceSheet_Parentheticals" roleURI="http://www.beil.com/role/ConsolidatedBalanceSheet_Parentheticals"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_ConsolidatedIncomeStatement" roleURI="http://www.beil.com/role/ConsolidatedIncomeStatement"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_ConsolidatedIncomeStatement_Parentheticals" roleURI="http://www.beil.com/role/ConsolidatedIncomeStatement_Parentheticals"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_ShareholdersEquityType2or3" roleURI="http://www.beil.com/role/ShareholdersEquityType2or3"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_ConsolidatedCashFlow" roleURI="http://www.beil.com/role/ConsolidatedCashFlow"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_General" roleURI="http://www.beil.com/role/General"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_SignificantAccountingPolicies" roleURI="http://www.beil.com/role/SignificantAccountingPolicies"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_OtherCurrentAssets" roleURI="http://www.beil.com/role/OtherCurrentAssets"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_PropertyandEquipmentNet" roleURI="http://www.beil.com/role/PropertyandEquipmentNet"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_IntangibleAssetsNetandGoodwill" roleURI="http://www.beil.com/role/IntangibleAssetsNetandGoodwill"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_LoansNet" roleURI="http://www.beil.com/role/LoansNet"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_OtherCurrentLiabilities" roleURI="http://www.beil.com/role/OtherCurrentLiabilities"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_DerivativeWarrantsLiabilities" roleURI="http://www.beil.com/role/DerivativeWarrantsLiabilities"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_ConvertibleAdvanceInvestment" roleURI="http://www.beil.com/role/ConvertibleAdvanceInvestment"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_CommitmentsandContingentLiabilities" roleURI="http://www.beil.com/role/CommitmentsandContingentLiabilities"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_ShareholdersEquityDeficit" roleURI="http://www.beil.com/role/ShareholdersEquityDeficit"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_ShareOptions" roleURI="http://www.beil.com/role/ShareOptions"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_FinancingExpensesNet" roleURI="http://www.beil.com/role/FinancingExpensesNet"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_RelatedPartiesTransactions" roleURI="http://www.beil.com/role/RelatedPartiesTransactions"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_TaxesonIncome" roleURI="http://www.beil.com/role/TaxesonIncome"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_SegmentGeographicalInformationAndMajorCustomers" roleURI="http://www.beil.com/role/SegmentGeographicalInformationAndMajorCustomers"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_SubsequentEvents" roleURI="http://www.beil.com/role/SubsequentEvents"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_AccountingPoliciesByPolicy" roleURI="http://www.beil.com/role/AccountingPoliciesByPolicy"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_SignificantAccountingPoliciesTables" roleURI="http://www.beil.com/role/SignificantAccountingPoliciesTables"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_OtherCurrentAssetsTables" roleURI="http://www.beil.com/role/OtherCurrentAssetsTables"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_PropertyandEquipmentNetTables" roleURI="http://www.beil.com/role/PropertyandEquipmentNetTables"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_IntangibleAssetsNetandGoodwillTables" roleURI="http://www.beil.com/role/IntangibleAssetsNetandGoodwillTables"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_LoansNetTables" roleURI="http://www.beil.com/role/LoansNetTables"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_OtherCurrentLiabilitiesTables" roleURI="http://www.beil.com/role/OtherCurrentLiabilitiesTables"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_DerivativeWarrantsLiabilitiesTables" roleURI="http://www.beil.com/role/DerivativeWarrantsLiabilitiesTables"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_ConvertibleAdvanceInvestmentTables" roleURI="http://www.beil.com/role/ConvertibleAdvanceInvestmentTables"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_CommitmentsandContingentLiabilitiesTables" roleURI="http://www.beil.com/role/CommitmentsandContingentLiabilitiesTables"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_ShareholdersEquityDeficitTables" roleURI="http://www.beil.com/role/ShareholdersEquityDeficitTables"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_ShareOptionsTables" roleURI="http://www.beil.com/role/ShareOptionsTables"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_FinancingExpensesNetTables" roleURI="http://www.beil.com/role/FinancingExpensesNetTables"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_RelatedPartiesTransactionsTables" roleURI="http://www.beil.com/role/RelatedPartiesTransactionsTables"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_TaxesonIncomeTables" roleURI="http://www.beil.com/role/TaxesonIncomeTables"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_SegmentGeographicalInformationAndMajorCustomersTables" roleURI="http://www.beil.com/role/SegmentGeographicalInformationAndMajorCustomersTables"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_ScheduleofcomputingstraightlineamortizationTable" roleURI="http://www.beil.com/role/ScheduleofcomputingstraightlineamortizationTable"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_ScheduleofcomputingstraightlinedepreciationTable" roleURI="http://www.beil.com/role/ScheduleofcomputingstraightlinedepreciationTable"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_ScheduleofothercurrentassetsTable" roleURI="http://www.beil.com/role/ScheduleofothercurrentassetsTable"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_ScheduleofpropertyandequipmentnetTable" roleURI="http://www.beil.com/role/ScheduleofpropertyandequipmentnetTable"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_ScheduleofintangibleassetsnetandgoodwilTable" roleURI="http://www.beil.com/role/ScheduleofintangibleassetsnetandgoodwilTable"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_ScheduleoftheestimatedfutureamortizationexpenseofintangibleassetsTable" roleURI="http://www.beil.com/role/ScheduleoftheestimatedfutureamortizationexpenseofintangibleassetsTable"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_ScheduleoftheEffectiveDatemanagementbyassistanceofthirdpartyTable" roleURI="http://www.beil.com/role/ScheduleoftheEffectiveDatemanagementbyassistanceofthirdpartyTable"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_ScheduleofthereconciliationofthecarryingamountTable" roleURI="http://www.beil.com/role/ScheduleofthereconciliationofthecarryingamountTable"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_ScheduleofmaturitydatesofoutstandingloansTable" roleURI="http://www.beil.com/role/ScheduleofmaturitydatesofoutstandingloansTable"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_ScheduleofothercurrentliabiltiesTable" roleURI="http://www.beil.com/role/ScheduleofothercurrentliabiltiesTable"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_ScheduleofreconciliationofthefairvalueofderivativewarrantsliabilitiesTable" roleURI="http://www.beil.com/role/ScheduleofreconciliationofthefairvalueofderivativewarrantsliabilitiesTable"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_ScheduleofreconciliationofthecarryingamountoftheconvertibleadvanceinvestmentTable" roleURI="http://www.beil.com/role/ScheduleofreconciliationofthecarryingamountoftheconvertibleadvanceinvestmentTable"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_ScheduleoffutureminimumcommitmentunderbindingleaseagreeementsTable" roleURI="http://www.beil.com/role/ScheduleoffutureminimumcommitmentunderbindingleaseagreeementsTable"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_ScheduleofcompositionofshareholdersequityTable" roleURI="http://www.beil.com/role/ScheduleofcompositionofshareholdersequityTable"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_ScheduleofcompanysshareoptionactivityforemployeesandmembersoftheboardofdirectorsTable" roleURI="http://www.beil.com/role/ScheduleofcompanysshareoptionactivityforemployeesandmembersoftheboardofdirectorsTable"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_ScheduleofoutstandingandexercisableshareoptionsseparatedrangesofexercisepricesTable" roleURI="http://www.beil.com/role/ScheduleofoutstandingandexercisableshareoptionsseparatedrangesofexercisepricesTable"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_ScheduleofassumptionsusedtoestimatethefairvaluesoftheshareoptionsgrantedTable" roleURI="http://www.beil.com/role/ScheduleofassumptionsusedtoestimatethefairvaluesoftheshareoptionsgrantedTable"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_ScheduleofcompanysequitybasedawardsrecognizedTable" roleURI="http://www.beil.com/role/ScheduleofcompanysequitybasedawardsrecognizedTable"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_ScheduleoffinancingexpensesTable" roleURI="http://www.beil.com/role/ScheduleoffinancingexpensesTable"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_ScheduleofthereconciliationofthecarryingamountoftheCompanyTable" roleURI="http://www.beil.com/role/ScheduleofthereconciliationofthecarryingamountoftheCompanyTable"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_ScheduleofmaturitydatesTable" roleURI="http://www.beil.com/role/ScheduleofmaturitydatesTable"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_ScheduleofexpensesrelatedtoserviceagreementandtheofficeservicesagreementTable" roleURI="http://www.beil.com/role/ScheduleofexpensesrelatedtoserviceagreementandtheofficeservicesagreementTable"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_ScheduleoflossincomebeforetaxesonincomeTable" roleURI="http://www.beil.com/role/ScheduleoflossincomebeforetaxesonincomeTable"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_ScheduleofdeferredincometaxesreflectthenettaxeffectsofnetoperatinglossTable" roleURI="http://www.beil.com/role/ScheduleofdeferredincometaxesreflectthenettaxeffectsofnetoperatinglossTable"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_ScheduleofrevenuesbygeographicregionTable" roleURI="http://www.beil.com/role/ScheduleofrevenuesbygeographicregionTable"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_ScheduleofLonglivedassetsnetbygeographicareasTable" roleURI="http://www.beil.com/role/ScheduleofLonglivedassetsnetbygeographicareasTable"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_ScheduleofrevenuedisaggregatedbyprimarymajorproductlinesandservicesTable" roleURI="http://www.beil.com/role/ScheduleofrevenuedisaggregatedbyprimarymajorproductlinesandservicesTable"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_GeneralDetails" roleURI="http://www.beil.com/role/GeneralDetails"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_SignificantAccountingPoliciesDetails" roleURI="http://www.beil.com/role/SignificantAccountingPoliciesDetails"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_PropertyandEquipmentNetDetails" roleURI="http://www.beil.com/role/PropertyandEquipmentNetDetails"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_IntangibleAssetsNetandGoodwillDetails" roleURI="http://www.beil.com/role/IntangibleAssetsNetandGoodwillDetails"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_LoansNetDetails" roleURI="http://www.beil.com/role/LoansNetDetails"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_OtherCurrentLiabilitiesDetails" roleURI="http://www.beil.com/role/OtherCurrentLiabilitiesDetails"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_ConvertibleAdvanceInvestmentDetails" roleURI="http://www.beil.com/role/ConvertibleAdvanceInvestmentDetails"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_CommitmentsandContingentLiabilitiesDetails" roleURI="http://www.beil.com/role/CommitmentsandContingentLiabilitiesDetails"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_ShareholdersEquityDeficitDetails" roleURI="http://www.beil.com/role/ShareholdersEquityDeficitDetails"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_ShareOptionsDetails" roleURI="http://www.beil.com/role/ShareOptionsDetails"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_RelatedPartiesTransactionsDetails" roleURI="http://www.beil.com/role/RelatedPartiesTransactionsDetails"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_TaxesonIncomeDetails" roleURI="http://www.beil.com/role/TaxesonIncomeDetails"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_SegmentGeographicalInformationAndMajorCustomersDetails" roleURI="http://www.beil.com/role/SegmentGeographicalInformationAndMajorCustomersDetails"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#bmr_r_SubsequentEventsDetails" roleURI="http://www.beil.com/role/SubsequentEventsDetails"/>
  <roleRef xlink:type="simple" xlink:href="bmr-20221231.xsd#DocumentAndEntityInformation" roleURI="http://www.beil.com/role/DocumentAndEntityInformation"/>
  <presentationLink xlink:type="extended" xlink:role="http://www.beil.com/role/ConsolidatedBalanceSheet">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_AssetsCurrentAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ReceivablesNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesNetCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_ReceivablesNetCurrent" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_OtherAssetsCurrent" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherAssetsCurrent" xlink:to="us-gaap_AssetsCurrent" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="NonCurrentAssetsAbstract" xlink:href="bmr-20221231.xsd#bmr_NonCurrentAssetsAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="NonCurrentAssetsAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCosts"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NonCurrentAssetsAbstract" xlink:to="us-gaap_DeferredCosts" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NonCurrentAssetsAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NonCurrentAssetsAbstract" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NonCurrentAssetsAbstract" xlink:to="us-gaap_Goodwill" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsNoncurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_Goodwill" xlink:to="us-gaap_AssetsNoncurrent" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_Assets" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermBorrowings" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermBorrowings"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_ShortTermBorrowings" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableCurrent" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredRevenueCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredRevenueCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_DeferredRevenueCurrent" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DueToRelatedPartiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueToRelatedPartiesCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_DueToRelatedPartiesCurrent" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_OtherLiabilitiesCurrent" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherLiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="NonCurrentLiabilitiesAbstract" xlink:href="bmr-20221231.xsd#bmr_NonCurrentLiabilitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="NonCurrentLiabilitiesAbstract" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LongTermDebtNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NonCurrentLiabilitiesAbstract" xlink:to="us-gaap_LongTermDebtNoncurrent" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DueToRelatedPartiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueToRelatedPartiesNoncurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NonCurrentLiabilitiesAbstract" xlink:to="us-gaap_DueToRelatedPartiesNoncurrent" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DerivativeLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilitiesNoncurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NonCurrentLiabilitiesAbstract" xlink:to="us-gaap_DerivativeLiabilitiesNoncurrent" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ConvertibleAdvancedInvestments" xlink:href="bmr-20221231.xsd#bmr_ConvertibleAdvancedInvestments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NonCurrentLiabilitiesAbstract" xlink:to="ConvertibleAdvancedInvestments" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesNoncurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConvertibleAdvancedInvestments" xlink:to="us-gaap_LiabilitiesNoncurrent" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommitmentsAndContingencies" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ShareholdersEquityDeficitAbstract" xlink:href="bmr-20221231.xsd#bmr_ShareholdersEquityDeficitAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="ShareholdersEquityDeficitAbstract" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDeficitAbstract" xlink:to="us-gaap_CommonStockValue" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="CommonStockValue1" xlink:href="bmr-20221231.xsd#bmr_CommonStockValue1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDeficitAbstract" xlink:to="CommonStockValue1" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDeficitAbstract" xlink:to="us-gaap_PreferredStockValue" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDeficitAbstract" xlink:to="us-gaap_AdditionalPaidInCapital" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDeficitAbstract" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDeficitAbstract" xlink:to="us-gaap_StockholdersEquity" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.beil.com/role/ConsolidatedBalanceSheet_Parentheticals">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_CommonStockMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ConvertibleOrdinary1And2SharesMember" xlink:href="bmr-20221231.xsd#bmr_ConvertibleOrdinary1And2SharesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="ConvertibleOrdinary1And2SharesMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesIssued" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesAuthorized" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesIssued" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesOutstanding" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.beil.com/role/ConsolidatedIncomeStatement">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_Revenues" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CostOfRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfRevenue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_CostOfRevenue" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GrossProfit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_GrossProfit" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SellingAndMarketingExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingAndMarketingExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_SellingAndMarketingExpense" order="4.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_GeneralAndAdministrativeExpense" order="5.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherOperatingIncomeExpenseNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOperatingIncomeExpenseNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_OtherOperatingIncomeExpenseNet" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_OperatingIncomeLoss" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FinancingInterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingInterestExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_FinancingInterestExpense" order="8.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="10.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_EarningsPerShareBasic" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.beil.com/role/ConsolidatedIncomeStatement_Parentheticals">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_EarningsPerShareDiluted" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.beil.com/role/ShareholdersEquityType2or3">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_CommonStockMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ConvertibleOrdinary1And2SharesMember" xlink:href="bmr-20221231.xsd#bmr_ConvertibleOrdinary1And2SharesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="ConvertibleOrdinary1And2SharesMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ConvertiblePreferredSharesMember" xlink:href="bmr-20221231.xsd#bmr_ConvertiblePreferredSharesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="ConvertiblePreferredSharesMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_AdditionalPaidInCapitalMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_RetainedEarningsMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="5.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesOutstanding" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity_0" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesOutstanding_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesOutstanding_0" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueOther"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueOther" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.beil.com/role/ConsolidatedCashFlow">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <loc xlink:type="locator" xlink:label="CashFlowsFromOperatingActivitiesAbstract" xlink:href="bmr-20221231.xsd#bmr_CashFlowsFromOperatingActivitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="CashFlowsFromOperatingActivitiesAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashFlowsFromOperatingActivitiesAbstract" xlink:to="us-gaap_NetIncomeLoss" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="AdjustmentsRequiredToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract" xlink:href="bmr-20221231.xsd#bmr_AdjustmentsRequiredToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashFlowsFromOperatingActivitiesAbstract" xlink:to="AdjustmentsRequiredToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsRequiredToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_DepreciationDepletionAndAmortization" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsRequiredToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ShareBasedCompensation" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AmortizationOfDebtDiscountPremium" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfDebtDiscountPremium"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsRequiredToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AmortizationOfDebtDiscountPremium" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsRequiredToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AmortizationOfFinancingCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsRequiredToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AmortizationOfFinancingCosts" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueOptionChangesInFairValueGainLoss1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOptionChangesInFairValueGainLoss1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsRequiredToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_FairValueOptionChangesInFairValueGainLoss1" order="5.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsRequiredToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_GainLossOnSaleOfPropertyPlantEquipment" order="6.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GainLossOnDispositionOfAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnDispositionOfAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsRequiredToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_GainLossOnDispositionOfAssets" order="7.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ModificationOfTermsOfStraightLoan" xlink:href="bmr-20221231.xsd#bmr_ModificationOfTermsOfStraightLoan"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsRequiredToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract" xlink:to="ModificationOfTermsOfStraightLoan" order="8.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GainsLossesOnRestructuringOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnRestructuringOfDebt"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsRequiredToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_GainsLossesOnRestructuringOfDebt" order="9.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOtherReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherReceivables"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsRequiredToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInOtherReceivables" order="10.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherCurrentAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsRequiredToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInOtherCurrentAssets" order="11.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsRequiredToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsRequiredToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInDeferredRevenue" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInDueFromRelatedParties" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDueFromRelatedParties"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsRequiredToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInDueFromRelatedParties" order="14.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherCurrentLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsRequiredToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashFlowsFromOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="CashFlowsFromInvestingActivitiesAbstract" xlink:href="bmr-20221231.xsd#bmr_CashFlowsFromInvestingActivitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="CashFlowsFromInvestingActivitiesAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashFlowsFromInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashFlowsFromInvestingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashFlowsFromInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="CashFlowsFromFinancingActivitiesAbstract" xlink:href="bmr-20221231.xsd#bmr_CashFlowsFromFinancingActivitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="CashFlowsFromFinancingActivitiesAbstract" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsOfFinancingCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfFinancingCosts"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashFlowsFromFinancingActivitiesAbstract" xlink:to="us-gaap_PaymentsOfFinancingCosts" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashFlowsFromFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromNotesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromNotesPayable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashFlowsFromFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromNotesPayable" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RepaymentsOfRelatedPartyDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfRelatedPartyDebt"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashFlowsFromFinancingActivitiesAbstract" xlink:to="us-gaap_RepaymentsOfRelatedPartyDebt" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RepaymentsOfFederalHomeLoanBankBorrowings" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfFederalHomeLoanBankBorrowings"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashFlowsFromFinancingActivitiesAbstract" xlink:to="us-gaap_RepaymentsOfFederalHomeLoanBankBorrowings" order="4.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashFlowsFromFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOfPrivatePlacement" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromRelatedPartyDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRelatedPartyDebt"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashFlowsFromFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromRelatedPartyDebt" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashFlowsFromFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromStockOptionsExercised" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashFlowsFromFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="NonCashFinancingActivitiesAbstract" xlink:href="bmr-20221231.xsd#bmr_NonCashFinancingActivitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="NonCashFinancingActivitiesAbstract" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssued1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssued1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NonCashFinancingActivitiesAbstract" xlink:to="us-gaap_StockIssued1" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SupplementalDisclosureOfCashFlowInformationAbstract" xlink:href="bmr-20221231.xsd#bmr_SupplementalDisclosureOfCashFlowInformationAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="SupplementalDisclosureOfCashFlowInformationAbstract" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SupplementalDisclosureOfCashFlowInformationAbstract" xlink:to="us-gaap_InterestPaidNet" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxesPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaid"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SupplementalDisclosureOfCashFlowInformationAbstract" xlink:to="us-gaap_IncomeTaxesPaid" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.beil.com/role/General">
    <loc xlink:type="locator" xlink:label="GeneralAbstract" xlink:href="bmr-20221231.xsd#bmr_GeneralAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GeneralAbstract" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.beil.com/role/SignificantAccountingPolicies">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.beil.com/role/OtherCurrentAssets">
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureTextBlockSupplementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureTextBlockSupplementAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherCurrentAssetsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCurrentAssetsTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureTextBlockSupplementAbstract" xlink:to="us-gaap_OtherCurrentAssetsTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.beil.com/role/PropertyandEquipmentNet">
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.beil.com/role/IntangibleAssetsNetandGoodwill">
    <loc xlink:type="locator" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.beil.com/role/LoansNet">
    <loc xlink:type="locator" xlink:label="us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.beil.com/role/OtherCurrentLiabilities">
    <loc xlink:type="locator" xlink:label="us-gaap_OtherLiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesCurrentAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherLiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.beil.com/role/DerivativeWarrantsLiabilities">
    <loc xlink:type="locator" xlink:label="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.beil.com/role/ConvertibleAdvanceInvestment">
    <loc xlink:type="locator" xlink:label="InvestmentHoldingsAbstract" xlink:href="bmr-20221231.xsd#bmr_InvestmentHoldingsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentHoldingsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentHoldingsTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentHoldingsAbstract" xlink:to="us-gaap_InvestmentHoldingsTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.beil.com/role/CommitmentsandContingentLiabilities">
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.beil.com/role/ShareholdersEquityDeficit">
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.beil.com/role/ShareOptions">
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.beil.com/role/FinancingExpensesNet">
    <loc xlink:type="locator" xlink:label="FinancingExpensesAbstract" xlink:href="bmr-20221231.xsd#bmr_FinancingExpensesAbstract"/>
    <loc xlink:type="locator" xlink:label="FinancingExpenses" xlink:href="bmr-20221231.xsd#bmr_FinancingExpenses"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancingExpensesAbstract" xlink:to="FinancingExpenses" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.beil.com/role/RelatedPartiesTransactions">
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.beil.com/role/TaxesonIncome">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.beil.com/role/SegmentGeographicalInformationAndMajorCustomers">
    <loc xlink:type="locator" xlink:label="us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_SegmentReportingDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.beil.com/role/SubsequentEvents">
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.beil.com/role/AccountingPoliciesByPolicy">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_UseOfEstimates" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConsolidationPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ConsolidationPolicyTextBlock" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredChargesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredChargesPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_DeferredChargesPolicyTextBlock" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_LesseeLeasesPolicyTextBlock" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_IncomeTaxPolicyTextBlock" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PostemploymentBenefitPlansPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PostemploymentBenefitPlansPolicy"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_PostemploymentBenefitPlansPolicy" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesPolicyTextBlock" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ConcentrationOfCreditRiskPolicyTextBlock" xlink:href="bmr-20221231.xsd#bmr_ConcentrationOfCreditRiskPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ConcentrationOfCreditRiskPolicyTextBlock" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ConvertibleOrdinary1And2SharesAndPreferredSharesPolicyTextBlock" xlink:href="bmr-20221231.xsd#bmr_ConvertibleOrdinary1And2SharesAndPreferredSharesPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ConvertibleOrdinary1And2SharesAndPreferredSharesPolicyTextBlock" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AllocationOfProceedsAndRelatedIssuanceCostsPolicyTextBlock" xlink:href="bmr-20221231.xsd#bmr_AllocationOfProceedsAndRelatedIssuanceCostsPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="AllocationOfProceedsAndRelatedIssuanceCostsPolicyTextBlock" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="WarrantsPolicyTextBlock" xlink:href="bmr-20221231.xsd#bmr_WarrantsPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="WarrantsPolicyTextBlock" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DerivativesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_DerivativesPolicyTextBlock" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ModificationsOrExchangeOfLoansPolicyTextBlock" xlink:href="bmr-20221231.xsd#bmr_ModificationsOrExchangeOfLoansPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ModificationsOrExchangeOfLoansPolicyTextBlock" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ConvertibleAdvanceInvestmentsPolicyTextBlock" xlink:href="bmr-20221231.xsd#bmr_ConvertibleAdvanceInvestmentsPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ConvertibleAdvanceInvestmentsPolicyTextBlock" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="CapitalContributionFromAControllingShareholderPolicyTextBlock" xlink:href="bmr-20221231.xsd#bmr_CapitalContributionFromAControllingShareholderPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="CapitalContributionFromAControllingShareholderPolicyTextBlock" order="22.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" order="23.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.beil.com/role/SignificantAccountingPoliciesTables">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentAndIntangibleAssetsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAndIntangibleAssetsTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentAndIntangibleAssetsTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.beil.com/role/OtherCurrentAssetsTables">
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureTextBlockSupplementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureTextBlockSupplementAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureTextBlockSupplementAbstract" xlink:to="us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.beil.com/role/PropertyandEquipmentNetTables">
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.beil.com/role/IntangibleAssetsNetandGoodwillTables">
    <loc xlink:type="locator" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfImpairedIntangibleAssetsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfImpairedIntangibleAssetsTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_ScheduleOfImpairedIntangibleAssetsTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.beil.com/role/LoansNetTables">
    <loc xlink:type="locator" xlink:label="us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="ScheduleOfTheMemberEffectiveDateManagementByAssistanceOfThirdpartyTableTextBlock" xlink:href="bmr-20221231.xsd#bmr_ScheduleOfTheMemberEffectiveDateManagementByAssistanceOfThirdpartyTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="ScheduleOfTheMemberEffectiveDateManagementByAssistanceOfThirdpartyTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ScheduleOfPresentationReflectsTheReconciliationOfTheCarryingAmountTableTextBlock" xlink:href="bmr-20221231.xsd#bmr_ScheduleOfPresentationReflectsTheReconciliationOfTheCarryingAmountTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="ScheduleOfPresentationReflectsTheReconciliationOfTheCarryingAmountTableTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ScheduleOfMaturityDatesOfOutstandingLoanTableTextBlock" xlink:href="bmr-20221231.xsd#bmr_ScheduleOfMaturityDatesOfOutstandingLoanTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="ScheduleOfMaturityDatesOfOutstandingLoanTableTextBlock" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.beil.com/role/OtherCurrentLiabilitiesTables">
    <loc xlink:type="locator" xlink:label="us-gaap_OtherLiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesCurrentAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCurrentLiabilitiesTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherLiabilitiesCurrentAbstract" xlink:to="us-gaap_OtherCurrentLiabilitiesTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.beil.com/role/DerivativeWarrantsLiabilitiesTables">
    <loc xlink:type="locator" xlink:label="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.beil.com/role/ConvertibleAdvanceInvestmentTables">
    <loc xlink:type="locator" xlink:label="InvestmentHoldingsAbstract" xlink:href="bmr-20221231.xsd#bmr_InvestmentHoldingsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentHoldingsAbstract" xlink:to="us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.beil.com/role/CommitmentsandContingentLiabilitiesTables">
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="scheduleOfFutureMinimumCommitmentUnderBindingLeaseAgreeementsTableTextBlock" xlink:href="bmr-20221231.xsd#bmr_scheduleOfFutureMinimumCommitmentUnderBindingLeaseAgreeementsTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="scheduleOfFutureMinimumCommitmentUnderBindingLeaseAgreeementsTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.beil.com/role/ShareholdersEquityDeficitTables">
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfStockholdersEquityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockholdersEquityTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_ScheduleOfStockholdersEquityTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.beil.com/role/ShareOptionsTables">
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.beil.com/role/FinancingExpensesNetTables">
    <loc xlink:type="locator" xlink:label="FinancingExpensesAbstract" xlink:href="bmr-20221231.xsd#bmr_FinancingExpensesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertibleDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancingExpensesAbstract" xlink:to="us-gaap_ConvertibleDebtTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.beil.com/role/RelatedPartiesTransactionsTables">
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfRegulatoryLiabilitiesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRegulatoryLiabilitiesTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_ScheduleOfRegulatoryLiabilitiesTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.beil.com/role/TaxesonIncomeTables">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.beil.com/role/SegmentGeographicalInformationAndMajorCustomersTables">
    <loc xlink:type="locator" xlink:label="us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_DisaggregationOfRevenueTableTextBlock" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.beil.com/role/ScheduleofcomputingstraightlineamortizationTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfComputingStraightLineAmortizationAbstract" xlink:href="bmr-20221231.xsd#bmr_ScheduleOfComputingStraightLineAmortizationAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfComputingStraightLineAmortizationAbstract" xlink:to="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TechnologyEquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TechnologyEquipmentMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_TechnologyEquipmentMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CustomerRelationshipsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_CustomerRelationshipsMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TradeNamesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_TradeNamesMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="PropertyPlantAndEquipmentDepreciationPercentage" xlink:href="bmr-20221231.xsd#bmr_PropertyPlantAndEquipmentDepreciationPercentage"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="PropertyPlantAndEquipmentDepreciationPercentage" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.beil.com/role/ScheduleofcomputingstraightlinedepreciationTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfComputingStraightLineDepreciationAbstract" xlink:href="bmr-20221231.xsd#bmr_ScheduleOfComputingStraightLineDepreciationAbstract"/>
    <loc xlink:type="locator" xlink:label="SignificantAccountingPoliciesDetailsScheduleofcomputingstraightlinedepreciationTable" xlink:href="bmr-20221231.xsd#bmr_SignificantAccountingPoliciesDetailsScheduleofcomputingstraightlinedepreciationTable"/>
    <loc xlink:type="locator" xlink:label="SignificantAccountingPoliciesDetailsScheduleofcomputingstraightlinedepreciationLineItems" xlink:href="bmr-20221231.xsd#bmr_SignificantAccountingPoliciesDetailsScheduleofcomputingstraightlinedepreciationLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfComputingStraightLineDepreciationAbstract" xlink:to="SignificantAccountingPoliciesDetailsScheduleofcomputingstraightlinedepreciationTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantAccountingPoliciesDetailsScheduleofcomputingstraightlinedepreciationTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="CompareAndPeripheralEquipmentMember" xlink:href="bmr-20221231.xsd#bmr_CompareAndPeripheralEquipmentMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="CompareAndPeripheralEquipmentMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="OfficeFurnitureAndEquipmentMember" xlink:href="bmr-20221231.xsd#bmr_OfficeFurnitureAndEquipmentMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="OfficeFurnitureAndEquipmentMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantAccountingPoliciesDetailsScheduleofcomputingstraightlinedepreciationTable" xlink:to="srt_RangeAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_MinimumMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_MaximumMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantAccountingPoliciesDetailsScheduleofcomputingstraightlinedepreciationTable" xlink:to="SignificantAccountingPoliciesDetailsScheduleofcomputingstraightlinedepreciationLineItems" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentSalvageValuePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentSalvageValuePercentage"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantAccountingPoliciesDetailsScheduleofcomputingstraightlinedepreciationLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentSalvageValuePercentage" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.beil.com/role/ScheduleofothercurrentassetsTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfOtherCurrentAssetsAbstract" xlink:href="bmr-20221231.xsd#bmr_ScheduleOfOtherCurrentAssetsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseCurrentAndNoncurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfOtherCurrentAssetsAbstract" xlink:to="us-gaap_PrepaidExpenseCurrentAndNoncurrent" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="GovernmentAuthoritiesAssets" xlink:href="bmr-20221231.xsd#bmr_GovernmentAuthoritiesAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfOtherCurrentAssetsAbstract" xlink:to="GovernmentAuthoritiesAssets" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherPrepaidExpenseCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherPrepaidExpenseCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfOtherCurrentAssetsAbstract" xlink:to="us-gaap_OtherPrepaidExpenseCurrent" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfOtherCurrentAssetsAbstract" xlink:to="us-gaap_OtherAssetsCurrent" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.beil.com/role/ScheduleofpropertyandequipmentnetTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfPropertyAndEquipmentNetAbstract" xlink:href="bmr-20221231.xsd#bmr_ScheduleOfPropertyAndEquipmentNetAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfPropertyAndEquipmentNetAbstract" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ComputerEquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComputerEquipmentMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_ComputerEquipmentMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OfficeEquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OfficeEquipmentMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_OfficeEquipmentMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentGross" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.beil.com/role/ScheduleofintangibleassetsnetandgoodwilTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfIntangibleAssetsNetAndGoodwilAbstract" xlink:href="bmr-20221231.xsd#bmr_ScheduleOfIntangibleAssetsNetAndGoodwilAbstract"/>
    <loc xlink:type="locator" xlink:label="IntangibleAssetsNetandGoodwillDetailsScheduleofintangibleassetsnetandgoodwilTable" xlink:href="bmr-20221231.xsd#bmr_IntangibleAssetsNetandGoodwillDetailsScheduleofintangibleassetsnetandgoodwilTable"/>
    <loc xlink:type="locator" xlink:label="IntangibleAssetsNetandGoodwillDetailsScheduleofintangibleassetsnetandgoodwilLineItems" xlink:href="bmr-20221231.xsd#bmr_IntangibleAssetsNetandGoodwillDetailsScheduleofintangibleassetsnetandgoodwilLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfIntangibleAssetsNetAndGoodwilAbstract" xlink:to="IntangibleAssetsNetandGoodwillDetailsScheduleofintangibleassetsnetandgoodwilTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IntangibleAssetsNetandGoodwillDetailsScheduleofintangibleassetsnetandgoodwilTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="TechnologyMember" xlink:href="bmr-20221231.xsd#bmr_TechnologyMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="TechnologyMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CustomerRelationshipsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_CustomerRelationshipsMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TradeNamesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_TradeNamesMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IntangibleAssetsNetandGoodwillDetailsScheduleofintangibleassetsnetandgoodwilTable" xlink:to="IntangibleAssetsNetandGoodwillDetailsScheduleofintangibleassetsnetandgoodwilLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="CarryingAmountAbstract" xlink:href="bmr-20221231.xsd#bmr_CarryingAmountAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IntangibleAssetsNetandGoodwillDetailsScheduleofintangibleassetsnetandgoodwilLineItems" xlink:to="CarryingAmountAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsUnderManagementCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsUnderManagementCarryingAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CarryingAmountAbstract" xlink:to="us-gaap_AssetsUnderManagementCarryingAmount" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AccumulatedAmortizationAbstract" xlink:href="bmr-20221231.xsd#bmr_AccumulatedAmortizationAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IntangibleAssetsNetandGoodwillDetailsScheduleofintangibleassetsnetandgoodwilLineItems" xlink:to="AccumulatedAmortizationAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccumulatedAmortizationDeferredFinanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedAmortizationDeferredFinanceCosts"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccumulatedAmortizationAbstract" xlink:to="us-gaap_AccumulatedAmortizationDeferredFinanceCosts" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIntangibleAssetsNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IntangibleAssetsNetandGoodwillDetailsScheduleofintangibleassetsnetandgoodwilLineItems" xlink:to="us-gaap_OtherIntangibleAssetsNet" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.beil.com/role/ScheduleoftheestimatedfutureamortizationexpenseofintangibleassetsTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfTheEstimatedFutureAmortizationExpenseOfIntangibleAssetsAbstract" xlink:href="bmr-20221231.xsd#bmr_ScheduleOfTheEstimatedFutureAmortizationExpenseOfIntangibleAssetsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfTheEstimatedFutureAmortizationExpenseOfIntangibleAssetsAbstract" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfTheEstimatedFutureAmortizationExpenseOfIntangibleAssetsAbstract" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfTheEstimatedFutureAmortizationExpenseOfIntangibleAssetsAbstract" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.beil.com/role/ScheduleoftheEffectiveDatemanagementbyassistanceofthirdpartyTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfTheEffectiveDateManagementByAssistanceOfThirdPartyAbstract" xlink:href="bmr-20221231.xsd#bmr_ScheduleOfTheEffectiveDateManagementByAssistanceOfThirdPartyAbstract"/>
    <loc xlink:type="locator" xlink:label="DerivativeWarrantLiabilityseeNote8" xlink:href="bmr-20221231.xsd#bmr_DerivativeWarrantLiabilityseeNote8"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfTheEffectiveDateManagementByAssistanceOfThirdPartyAbstract" xlink:to="DerivativeWarrantLiabilityseeNote8" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StraightLineRent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StraightLineRent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfTheEffectiveDateManagementByAssistanceOfThirdPartyAbstract" xlink:to="us-gaap_StraightLineRent" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="TotalGrossConsideration" xlink:href="bmr-20221231.xsd#bmr_TotalGrossConsideration"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfTheEffectiveDateManagementByAssistanceOfThirdPartyAbstract" xlink:to="TotalGrossConsideration" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.beil.com/role/ScheduleofthereconciliationofthecarryingamountTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfTheReconciliationOfTheCarryingAmountAbstract" xlink:href="bmr-20221231.xsd#bmr_ScheduleOfTheReconciliationOfTheCarryingAmountAbstract"/>
    <loc xlink:type="locator" xlink:label="ReconciliationOfTheCarryingAmount" xlink:href="bmr-20221231.xsd#bmr_ReconciliationOfTheCarryingAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfTheReconciliationOfTheCarryingAmountAbstract" xlink:to="ReconciliationOfTheCarryingAmount" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ConsiderationReceivedFromPPPNote" xlink:href="bmr-20221231.xsd#bmr_ConsiderationReceivedFromPPPNote"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfTheReconciliationOfTheCarryingAmountAbstract" xlink:to="ConsiderationReceivedFromPPPNote" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="NetConsiderationReceivedFromIBILoan" xlink:href="bmr-20221231.xsd#bmr_NetConsiderationReceivedFromIBILoan"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfTheReconciliationOfTheCarryingAmountAbstract" xlink:to="NetConsiderationReceivedFromIBILoan" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DerivativeLiabilityFairValueOfCollateral" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilityFairValueOfCollateral"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfTheReconciliationOfTheCarryingAmountAbstract" xlink:to="us-gaap_DerivativeLiabilityFairValueOfCollateral" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentDecreaseForgiveness" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentDecreaseForgiveness"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfTheReconciliationOfTheCarryingAmountAbstract" xlink:to="us-gaap_DebtInstrumentDecreaseForgiveness" order="4.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfTheReconciliationOfTheCarryingAmountAbstract" xlink:to="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesFairValueDisclosure"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfTheReconciliationOfTheCarryingAmountAbstract" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesFairValueDisclosure" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RepaymentsOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfDebt"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfTheReconciliationOfTheCarryingAmountAbstract" xlink:to="us-gaap_RepaymentsOfDebt" order="7.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LoanProcessingFee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoanProcessingFee"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfTheReconciliationOfTheCarryingAmountAbstract" xlink:to="us-gaap_LoanProcessingFee" order="8.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RepaymentsOfOtherLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfOtherLongTermDebt"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfTheReconciliationOfTheCarryingAmountAbstract" xlink:to="us-gaap_RepaymentsOfOtherLongTermDebt" order="9.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ExtinguishmentOfDebtAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExtinguishmentOfDebtAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfTheReconciliationOfTheCarryingAmountAbstract" xlink:to="us-gaap_ExtinguishmentOfDebtAmount" order="10.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="RecognitionSubsequentToSubstantialModificationOfTerms" xlink:href="bmr-20221231.xsd#bmr_RecognitionSubsequentToSubstantialModificationOfTerms"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfTheReconciliationOfTheCarryingAmountAbstract" xlink:to="RecognitionSubsequentToSubstantialModificationOfTerms" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfTheReconciliationOfTheCarryingAmountAbstract" xlink:to="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" order="12.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ReconciliationOfCarryingAmount" xlink:href="bmr-20221231.xsd#bmr_ReconciliationOfCarryingAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfTheReconciliationOfTheCarryingAmountAbstract" xlink:to="ReconciliationOfCarryingAmount" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.beil.com/role/ScheduleofmaturitydatesofoutstandingloansTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfMaturityDatesOfOutstandingLoansAbstract" xlink:href="bmr-20221231.xsd#bmr_ScheduleOfMaturityDatesOfOutstandingLoansAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfMaturityDatesOfOutstandingLoansAbstract" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfMaturityDatesOfOutstandingLoansAbstract" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfMaturityDatesOfOutstandingLoansAbstract" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfMaturityDatesOfOutstandingLoansAbstract" xlink:to="us-gaap_LongTermDebt" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.beil.com/role/ScheduleofothercurrentliabiltiesTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfOtherCurrentLiabiltiesAbstract" xlink:href="bmr-20221231.xsd#bmr_ScheduleOfOtherCurrentLiabiltiesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfOtherCurrentLiabiltiesAbstract" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfOtherCurrentLiabiltiesAbstract" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="GovernmentAuthorities" xlink:href="bmr-20221231.xsd#bmr_GovernmentAuthorities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfOtherCurrentLiabiltiesAbstract" xlink:to="GovernmentAuthorities" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfOtherCurrentLiabiltiesAbstract" xlink:to="us-gaap_OtherLiabilitiesCurrent" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.beil.com/role/ScheduleofreconciliationofthefairvalueofderivativewarrantsliabilitiesTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfReconciliationOfTheFairValueOfDerivativeWarrantsLiabilitiesAbstract" xlink:href="bmr-20221231.xsd#bmr_ScheduleOfReconciliationOfTheFairValueOfDerivativeWarrantsLiabilitiesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DerivativeFairValueOfDerivativeNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfReconciliationOfTheFairValueOfDerivativeWarrantsLiabilitiesAbstract" xlink:to="us-gaap_DerivativeFairValueOfDerivativeNet" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfReconciliationOfTheFairValueOfDerivativeWarrantsLiabilitiesAbstract" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentOfWarrantsGrantedForServices" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentOfWarrantsGrantedForServices"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfReconciliationOfTheFairValueOfDerivativeWarrantsLiabilitiesAbstract" xlink:to="us-gaap_AdjustmentOfWarrantsGrantedForServices" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DerivativeFairValueOfDerivativeNet_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfReconciliationOfTheFairValueOfDerivativeWarrantsLiabilitiesAbstract" xlink:to="us-gaap_DerivativeFairValueOfDerivativeNet_0" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.beil.com/role/ScheduleofreconciliationofthecarryingamountoftheconvertibleadvanceinvestmentTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfReconciliationOfTheCarryingAmountOfTheConvertibleAdvanceInvestmentAbstract" xlink:href="bmr-20221231.xsd#bmr_ScheduleOfReconciliationOfTheCarryingAmountOfTheConvertibleAdvanceInvestmentAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertibleDebtFairValueDisclosures" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtFairValueDisclosures"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfReconciliationOfTheCarryingAmountOfTheConvertibleAdvanceInvestmentAbstract" xlink:to="us-gaap_ConvertibleDebtFairValueDisclosures" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfReconciliationOfTheCarryingAmountOfTheConvertibleAdvanceInvestmentAbstract" xlink:to="us-gaap_NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ChangeInTheFairValueOfConvertibleAdvanceInvestments" xlink:href="bmr-20221231.xsd#bmr_ChangeInTheFairValueOfConvertibleAdvanceInvestments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfReconciliationOfTheCarryingAmountOfTheConvertibleAdvanceInvestmentAbstract" xlink:to="ChangeInTheFairValueOfConvertibleAdvanceInvestments" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertibleDebtFairValueDisclosures_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtFairValueDisclosures"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfReconciliationOfTheCarryingAmountOfTheConvertibleAdvanceInvestmentAbstract" xlink:to="us-gaap_ConvertibleDebtFairValueDisclosures_0" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.beil.com/role/ScheduleoffutureminimumcommitmentunderbindingleaseagreeementsTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfFutureMinimumCommitmentUnderBindingLeaseAgreeementsAbstract" xlink:href="bmr-20221231.xsd#bmr_ScheduleOfFutureMinimumCommitmentUnderBindingLeaseAgreeementsAbstract"/>
    <loc xlink:type="locator" xlink:label="LesseeOperatingLeasesLiabilityPaymentsDueNextTwelveMonths" xlink:href="bmr-20221231.xsd#bmr_LesseeOperatingLeasesLiabilityPaymentsDueNextTwelveMonths"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfFutureMinimumCommitmentUnderBindingLeaseAgreeementsAbstract" xlink:to="LesseeOperatingLeasesLiabilityPaymentsDueNextTwelveMonths" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="LesseeOperatingLeasesLiabilityPaymentsDue" xlink:href="bmr-20221231.xsd#bmr_LesseeOperatingLeasesLiabilityPaymentsDue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfFutureMinimumCommitmentUnderBindingLeaseAgreeementsAbstract" xlink:to="LesseeOperatingLeasesLiabilityPaymentsDue" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.beil.com/role/ScheduleofcompositionofshareholdersequityTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfCompositionOfShareholdersEquityAbstract" xlink:href="bmr-20221231.xsd#bmr_ScheduleOfCompositionOfShareholdersEquityAbstract"/>
    <loc xlink:type="locator" xlink:label="ShareholdersEquityDeficitDetailsScheduleofcompositionofshareholdersequityTable" xlink:href="bmr-20221231.xsd#bmr_ShareholdersEquityDeficitDetailsScheduleofcompositionofshareholdersequityTable"/>
    <loc xlink:type="locator" xlink:label="ShareholdersEquityDeficitDetailsScheduleofcompositionofshareholdersequityLineItems" xlink:href="bmr-20221231.xsd#bmr_ShareholdersEquityDeficitDetailsScheduleofcompositionofshareholdersequityLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfCompositionOfShareholdersEquityAbstract" xlink:to="ShareholdersEquityDeficitDetailsScheduleofcompositionofshareholdersequityTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDeficitDetailsScheduleofcompositionofshareholdersequityTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="SeriesOrdinarySharesMember" xlink:href="bmr-20221231.xsd#bmr_SeriesOrdinarySharesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="SeriesOrdinarySharesMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SeriesConvertibleOrdinary1SharesMember" xlink:href="bmr-20221231.xsd#bmr_SeriesConvertibleOrdinary1SharesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="SeriesConvertibleOrdinary1SharesMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SeriesConvertibleOrdinary2SharesMember" xlink:href="bmr-20221231.xsd#bmr_SeriesConvertibleOrdinary2SharesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="SeriesConvertibleOrdinary2SharesMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SeriesConvertibleBPreferredSharesMember" xlink:href="bmr-20221231.xsd#bmr_SeriesConvertibleBPreferredSharesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="SeriesConvertibleBPreferredSharesMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt/tSeJz73kx1cLt0ZFF2SK/vxBCY0vdSrZb6DUpe9prgZNYqdZsfXqxEEXb49NXhOeJEcoYxL52lqzrxV1ixmGk3x5z3C+boGMFyF1bCAC6SzXA8EeoS+J4OsCx1oPIoujQb0ZEh03dOL9+qx7qvcGHsJ6a9scdOGp0N/fSOils3JiDVUH+POJSLwkIXq+NgTrCVG8rYfDvkQSvrvKPWWMVdspO/2YkGlpjR+bge7mNpA==] CSR-->
    <loc xlink:type="locator" xlink:label="SeriesConvertibleB1PreferredSharesBMember" xlink:href="bmr-20221231.xsd#bmr_SeriesConvertibleB1PreferredSharesBMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="SeriesConvertibleB1PreferredSharesBMember" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SeriesConvertibleCPreferredSharesMember" xlink:href="bmr-20221231.xsd#bmr_SeriesConvertibleCPreferredSharesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="SeriesConvertibleCPreferredSharesMember" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDeficitDetailsScheduleofcompositionofshareholdersequityTable" xlink:to="ShareholdersEquityDeficitDetailsScheduleofcompositionofshareholdersequityLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="NumberOfSharesAbstract" xlink:href="bmr-20221231.xsd#bmr_NumberOfSharesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDeficitDetailsScheduleofcompositionofshareholdersequityLineItems" xlink:to="NumberOfSharesAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ExcessStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExcessStockSharesAuthorized"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NumberOfSharesAbstract" xlink:to="us-gaap_ExcessStockSharesAuthorized" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ExcessSharesIssuedAndOutstandingShares" xlink:href="bmr-20221231.xsd#bmr_ExcessSharesIssuedAndOutstandingShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NumberOfSharesAbstract" xlink:to="ExcessSharesIssuedAndOutstandingShares" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.beil.com/role/ScheduleofcompanysshareoptionactivityforemployeesandmembersoftheboardofdirectorsTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfCompanySShareOptionActivityForEmployeesAndMembersOfTheBoardOfDirectorsAbstract" xlink:href="bmr-20221231.xsd#bmr_ScheduleOfCompanySShareOptionActivityForEmployeesAndMembersOfTheBoardOfDirectorsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfCompanySShareOptionActivityForEmployeesAndMembersOfTheBoardOfDirectorsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfCompanySShareOptionActivityForEmployeesAndMembersOfTheBoardOfDirectorsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfCompanySShareOptionActivityForEmployeesAndMembersOfTheBoardOfDirectorsAbstract" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfCompanySShareOptionActivityForEmployeesAndMembersOfTheBoardOfDirectorsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfCompanySShareOptionActivityForEmployeesAndMembersOfTheBoardOfDirectorsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfCompanySShareOptionActivityForEmployeesAndMembersOfTheBoardOfDirectorsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="WeightedAverageRemainingContractualLifeGranted" xlink:href="bmr-20221231.xsd#bmr_WeightedAverageRemainingContractualLifeGranted"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfCompanySShareOptionActivityForEmployeesAndMembersOfTheBoardOfDirectorsAbstract" xlink:to="WeightedAverageRemainingContractualLifeGranted" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfCompanySShareOptionActivityForEmployeesAndMembersOfTheBoardOfDirectorsAbstract" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="7.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfCompanySShareOptionActivityForEmployeesAndMembersOfTheBoardOfDirectorsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="WeightedAverageRemainingContractualLifeExercised" xlink:href="bmr-20221231.xsd#bmr_WeightedAverageRemainingContractualLifeExercised"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfCompanySShareOptionActivityForEmployeesAndMembersOfTheBoardOfDirectorsAbstract" xlink:to="WeightedAverageRemainingContractualLifeExercised" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfCompanySShareOptionActivityForEmployeesAndMembersOfTheBoardOfDirectorsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" order="10.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfCompanySShareOptionActivityForEmployeesAndMembersOfTheBoardOfDirectorsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="WeightedAverageRemainingContractualLifeForfeitedOrExpired" xlink:href="bmr-20221231.xsd#bmr_WeightedAverageRemainingContractualLifeForfeitedOrExpired"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfCompanySShareOptionActivityForEmployeesAndMembersOfTheBoardOfDirectorsAbstract" xlink:to="WeightedAverageRemainingContractualLifeForfeitedOrExpired" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfCompanySShareOptionActivityForEmployeesAndMembersOfTheBoardOfDirectorsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfCompanySShareOptionActivityForEmployeesAndMembersOfTheBoardOfDirectorsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="WeightedAverageRemainingContractualLifeOutstanding" xlink:href="bmr-20221231.xsd#bmr_WeightedAverageRemainingContractualLifeOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfCompanySShareOptionActivityForEmployeesAndMembersOfTheBoardOfDirectorsAbstract" xlink:to="WeightedAverageRemainingContractualLifeOutstanding" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfCompanySShareOptionActivityForEmployeesAndMembersOfTheBoardOfDirectorsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfCompanySShareOptionActivityForEmployeesAndMembersOfTheBoardOfDirectorsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfCompanySShareOptionActivityForEmployeesAndMembersOfTheBoardOfDirectorsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfCompanySShareOptionActivityForEmployeesAndMembersOfTheBoardOfDirectorsAbstract" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfCompanySShareOptionActivityForEmployeesAndMembersOfTheBoardOfDirectorsAbstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.beil.com/role/ScheduleofoutstandingandexercisableshareoptionsseparatedrangesofexercisepricesTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfOutstandingAndExercisableShareOptionsSeparatedRangesOfExercisePricesAbstract" xlink:href="bmr-20221231.xsd#bmr_ScheduleOfOutstandingAndExercisableShareOptionsSeparatedRangesOfExercisePricesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfOutstandingAndExercisableShareOptionsSeparatedRangesOfExercisePricesAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="ExercisePrice0000Member" xlink:href="bmr-20221231.xsd#bmr_ExercisePrice0000Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="ExercisePrice0000Member" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ExercisePrice0227Member" xlink:href="bmr-20221231.xsd#bmr_ExercisePrice0227Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="ExercisePrice0227Member" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ExercisePrice0333Member" xlink:href="bmr-20221231.xsd#bmr_ExercisePrice0333Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="ExercisePrice0333Member" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ExercisePrice0365Member" xlink:href="bmr-20221231.xsd#bmr_ExercisePrice0365Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="ExercisePrice0365Member" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ExercisePrice0640Member" xlink:href="bmr-20221231.xsd#bmr_ExercisePrice0640Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="ExercisePrice0640Member" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ExercisePrice0757Member" xlink:href="bmr-20221231.xsd#bmr_ExercisePrice0757Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="ExercisePrice0757Member" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ExercisePrice0833Member" xlink:href="bmr-20221231.xsd#bmr_ExercisePrice0833Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="ExercisePrice0833Member" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ExercisePrice1024Member" xlink:href="bmr-20221231.xsd#bmr_ExercisePrice1024Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="ExercisePrice1024Member" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="us-gaap_AwardTypeAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="ShareOptionsOutstandingMember" xlink:href="bmr-20221231.xsd#bmr_ShareOptionsOutstandingMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="ShareOptionsOutstandingMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ShareOptionsExercisableMember" xlink:href="bmr-20221231.xsd#bmr_ShareOptionsExercisableMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="ShareOptionsExercisableMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.beil.com/role/ScheduleofassumptionsusedtoestimatethefairvaluesoftheshareoptionsgrantedTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfAssumptionsUsedToEstimateTheFairValuesOfTheShareOptionsGrantedAbstract" xlink:href="bmr-20221231.xsd#bmr_ScheduleOfAssumptionsUsedToEstimateTheFairValuesOfTheShareOptionsGrantedAbstract"/>
    <loc xlink:type="locator" xlink:label="ShareOptionsDetailsScheduleofassumptionsusedtoestimatethefairvaluesoftheshareoptionsgrantedTable" xlink:href="bmr-20221231.xsd#bmr_ShareOptionsDetailsScheduleofassumptionsusedtoestimatethefairvaluesoftheshareoptionsgrantedTable"/>
    <loc xlink:type="locator" xlink:label="ShareOptionsDetailsScheduleofassumptionsusedtoestimatethefairvaluesoftheshareoptionsgrantedLineItems" xlink:href="bmr-20221231.xsd#bmr_ShareOptionsDetailsScheduleofassumptionsusedtoestimatethefairvaluesoftheshareoptionsgrantedLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfAssumptionsUsedToEstimateTheFairValuesOfTheShareOptionsGrantedAbstract" xlink:to="ShareOptionsDetailsScheduleofassumptionsusedtoestimatethefairvaluesoftheshareoptionsgrantedTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareOptionsDetailsScheduleofassumptionsusedtoestimatethefairvaluesoftheshareoptionsgrantedTable" xlink:to="srt_RangeAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_MinimumMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_MaximumMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareOptionsDetailsScheduleofassumptionsusedtoestimatethefairvaluesoftheshareoptionsgrantedTable" xlink:to="ShareOptionsDetailsScheduleofassumptionsusedtoestimatethefairvaluesoftheshareoptionsgrantedLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareOptionsDetailsScheduleofassumptionsusedtoestimatethefairvaluesoftheshareoptionsgrantedLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareOptionsDetailsScheduleofassumptionsusedtoestimatethefairvaluesoftheshareoptionsgrantedLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareOptionsDetailsScheduleofassumptionsusedtoestimatethefairvaluesoftheshareoptionsgrantedLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareOptionsDetailsScheduleofassumptionsusedtoestimatethefairvaluesoftheshareoptionsgrantedLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareOptionsDetailsScheduleofassumptionsusedtoestimatethefairvaluesoftheshareoptionsgrantedLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareOptionsDetailsScheduleofassumptionsusedtoestimatethefairvaluesoftheshareoptionsgrantedLineItems" xlink:to="us-gaap_SharePrice" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.beil.com/role/ScheduleofcompanysequitybasedawardsrecognizedTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfCompanySEquityBasedAwardsRecognizedAbstract" xlink:href="bmr-20221231.xsd#bmr_ScheduleOfCompanySEquityBasedAwardsRecognizedAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherResearchAndDevelopmentExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfCompanySEquityBasedAwardsRecognizedAbstract" xlink:to="us-gaap_OtherResearchAndDevelopmentExpense" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherSellingAndMarketingExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherSellingAndMarketingExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfCompanySEquityBasedAwardsRecognizedAbstract" xlink:to="us-gaap_OtherSellingAndMarketingExpense" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherGeneralAndAdministrativeExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfCompanySEquityBasedAwardsRecognizedAbstract" xlink:to="us-gaap_OtherGeneralAndAdministrativeExpense" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfCompanySEquityBasedAwardsRecognizedAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.beil.com/role/ScheduleoffinancingexpensesTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfFinancingExpensesAbstract" xlink:href="bmr-20221231.xsd#bmr_ScheduleOfFinancingExpensesAbstract"/>
    <loc xlink:type="locator" xlink:label="ChangeInTheFairValueOfConvertibleAdvanceInvestments" xlink:href="bmr-20221231.xsd#bmr_ChangeInTheFairValueOfConvertibleAdvanceInvestments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfFinancingExpensesAbstract" xlink:to="ChangeInTheFairValueOfConvertibleAdvanceInvestments" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PresentValueOfFutureInsuranceProfitsAmortizationExpenseAccruedInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PresentValueOfFutureInsuranceProfitsAmortizationExpenseAccruedInterest"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfFinancingExpensesAbstract" xlink:to="us-gaap_PresentValueOfFutureInsuranceProfitsAmortizationExpenseAccruedInterest" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ModificationOfTermsRelatingToStraightLoan" xlink:href="bmr-20221231.xsd#bmr_ModificationOfTermsRelatingToStraightLoan"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfFinancingExpensesAbstract" xlink:to="ModificationOfTermsRelatingToStraightLoan" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfFinancingExpensesAbstract" xlink:to="us-gaap_AmortizationOfFinancingCostsAndDiscounts" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ExchangeRateDifferencesAndOthers" xlink:href="bmr-20221231.xsd#bmr_ExchangeRateDifferencesAndOthers"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfFinancingExpensesAbstract" xlink:to="ExchangeRateDifferencesAndOthers" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherNonoperatingExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfFinancingExpensesAbstract" xlink:to="us-gaap_OtherNonoperatingExpense" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.beil.com/role/ScheduleofthereconciliationofthecarryingamountoftheCompanyTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfTheReconciliationOfTheCarryingAmountOfTheCompanyAbstract" xlink:href="bmr-20221231.xsd#bmr_ScheduleOfTheReconciliationOfTheCarryingAmountOfTheCompanyAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentRelatedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentRelatedLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfTheReconciliationOfTheCarryingAmountOfTheCompanyAbstract" xlink:to="us-gaap_InvestmentRelatedLiabilities" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrentAndNoncurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfTheReconciliationOfTheCarryingAmountOfTheCompanyAbstract" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrentAndNoncurrent" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PartnersCapitalAccountContributions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PartnersCapitalAccountContributions"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfTheReconciliationOfTheCarryingAmountOfTheCompanyAbstract" xlink:to="us-gaap_PartnersCapitalAccountContributions" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentIncomeAmortizationOfDiscount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeAmortizationOfDiscount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfTheReconciliationOfTheCarryingAmountOfTheCompanyAbstract" xlink:to="us-gaap_InvestmentIncomeAmortizationOfDiscount" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentRelatedLiabilities_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentRelatedLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfTheReconciliationOfTheCarryingAmountOfTheCompanyAbstract" xlink:to="us-gaap_InvestmentRelatedLiabilities_0" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.beil.com/role/ScheduleofmaturitydatesTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfMaturityDatesAbstract" xlink:href="bmr-20221231.xsd#bmr_ScheduleOfMaturityDatesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LongTermDebtCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfMaturityDatesAbstract" xlink:to="us-gaap_LongTermDebtCurrent" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherCommitmentDueInSecondYear" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentDueInSecondYear"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfMaturityDatesAbstract" xlink:to="us-gaap_OtherCommitmentDueInSecondYear" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherLongTermDebtCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLongTermDebtCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfMaturityDatesAbstract" xlink:to="us-gaap_OtherLongTermDebtCurrent" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.beil.com/role/ScheduleofexpensesrelatedtoserviceagreementandtheofficeservicesagreementTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfExpensesRelatedToServiceAgreementAndTheOfficeServicesAgreementAbstract" xlink:href="bmr-20221231.xsd#bmr_ScheduleOfExpensesRelatedToServiceAgreementAndTheOfficeServicesAgreementAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentInProcess" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentInProcess"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfExpensesRelatedToServiceAgreementAndTheOfficeServicesAgreementAbstract" xlink:to="us-gaap_ResearchAndDevelopmentInProcess" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MarketingAndAdvertisingExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketingAndAdvertisingExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfExpensesRelatedToServiceAgreementAndTheOfficeServicesAgreementAbstract" xlink:to="us-gaap_MarketingAndAdvertisingExpense" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherSellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherSellingGeneralAndAdministrativeExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfExpensesRelatedToServiceAgreementAndTheOfficeServicesAgreementAbstract" xlink:to="us-gaap_OtherSellingGeneralAndAdministrativeExpense" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInDueToOtherRelatedParties" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDueToOtherRelatedParties"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfExpensesRelatedToServiceAgreementAndTheOfficeServicesAgreementAbstract" xlink:to="us-gaap_IncreaseDecreaseInDueToOtherRelatedParties" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.beil.com/role/ScheduleoflossincomebeforetaxesonincomeTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfLossIncomeBeforeTaxesOnIncomeAbstract" xlink:href="bmr-20221231.xsd#bmr_ScheduleOfLossIncomeBeforeTaxesOnIncomeAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfLossIncomeBeforeTaxesOnIncomeAbstract" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfLossIncomeBeforeTaxesOnIncomeAbstract" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfLossIncomeBeforeTaxesOnIncomeAbstract" xlink:to="us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.beil.com/role/ScheduleofdeferredincometaxesreflectthenettaxeffectsofnetoperatinglossTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfDeferredIncomeTaxesReflectTheNetTaxEffectsOfNetOperatingLossAbstract" xlink:href="bmr-20221231.xsd#bmr_ScheduleOfDeferredIncomeTaxesReflectTheNetTaxEffectsOfNetOperatingLossAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsCapitalLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsCapitalLossCarryforwards"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfDeferredIncomeTaxesReflectTheNetTaxEffectsOfNetOperatingLossAbstract" xlink:to="us-gaap_DeferredTaxAssetsCapitalLossCarryforwards" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfDeferredIncomeTaxesReflectTheNetTaxEffectsOfNetOperatingLossAbstract" xlink:to="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfDeferredIncomeTaxesReflectTheNetTaxEffectsOfNetOperatingLossAbstract" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfDeferredIncomeTaxesReflectTheNetTaxEffectsOfNetOperatingLossAbstract" xlink:to="us-gaap_DeferredTaxAssetsGross" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfDeferredIncomeTaxesReflectTheNetTaxEffectsOfNetOperatingLossAbstract" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance" order="4.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfDeferredIncomeTaxesReflectTheNetTaxEffectsOfNetOperatingLossAbstract" xlink:to="us-gaap_DeferredTaxAssetsLiabilitiesNet" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.beil.com/role/ScheduleofrevenuesbygeographicregionTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfRevenuesByGeographicRegionAbstract" xlink:href="bmr-20221231.xsd#bmr_ScheduleOfRevenuesByGeographicRegionAbstract"/>
    <loc xlink:type="locator" xlink:label="SegmentGeographicalInformationAndMajorCustomersDetailsScheduleofrevenuesbygeographicregionTable" xlink:href="bmr-20221231.xsd#bmr_SegmentGeographicalInformationAndMajorCustomersDetailsScheduleofrevenuesbygeographicregionTable"/>
    <loc xlink:type="locator" xlink:label="SegmentGeographicalInformationAndMajorCustomersDetailsScheduleofrevenuesbygeographicregionLineItems" xlink:href="bmr-20221231.xsd#bmr_SegmentGeographicalInformationAndMajorCustomersDetailsScheduleofrevenuesbygeographicregionLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfRevenuesByGeographicRegionAbstract" xlink:to="SegmentGeographicalInformationAndMajorCustomersDetailsScheduleofrevenuesbygeographicregionTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SegmentGeographicalInformationAndMajorCustomersDetailsScheduleofrevenuesbygeographicregionTable" xlink:to="srt_StatementGeographicalAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="country_US" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementGeographicalAxis" xlink:to="country_US" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="country_IL" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_IL"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementGeographicalAxis" xlink:to="country_IL" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="RestOfTheWorldMember" xlink:href="bmr-20221231.xsd#bmr_RestOfTheWorldMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementGeographicalAxis" xlink:to="RestOfTheWorldMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SegmentGeographicalInformationAndMajorCustomersDetailsScheduleofrevenuesbygeographicregionTable" xlink:to="SegmentGeographicalInformationAndMajorCustomersDetailsScheduleofrevenuesbygeographicregionLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SegmentGeographicalInformationAndMajorCustomersDetailsScheduleofrevenuesbygeographicregionLineItems" xlink:to="us-gaap_Revenues" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.beil.com/role/ScheduleofLonglivedassetsnetbygeographicareasTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfLongLivedAssetsNetByGeographicAreasAbstract" xlink:href="bmr-20221231.xsd#bmr_ScheduleOfLongLivedAssetsNetByGeographicAreasAbstract"/>
    <loc xlink:type="locator" xlink:label="SegmentGeographicalInformationAndMajorCustomersDetailsScheduleofLonglivedassetsnetbygeographicareasTable" xlink:href="bmr-20221231.xsd#bmr_SegmentGeographicalInformationAndMajorCustomersDetailsScheduleofLonglivedassetsnetbygeographicareasTable"/>
    <loc xlink:type="locator" xlink:label="SegmentGeographicalInformationAndMajorCustomersDetailsScheduleofLonglivedassetsnetbygeographicareasLineItems" xlink:href="bmr-20221231.xsd#bmr_SegmentGeographicalInformationAndMajorCustomersDetailsScheduleofLonglivedassetsnetbygeographicareasLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfLongLivedAssetsNetByGeographicAreasAbstract" xlink:to="SegmentGeographicalInformationAndMajorCustomersDetailsScheduleofLonglivedassetsnetbygeographicareasTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SegmentGeographicalInformationAndMajorCustomersDetailsScheduleofLonglivedassetsnetbygeographicareasTable" xlink:to="srt_StatementGeographicalAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="country_IL" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_IL"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementGeographicalAxis" xlink:to="country_IL" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="country_US" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementGeographicalAxis" xlink:to="country_US" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="country_RU" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_RU"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementGeographicalAxis" xlink:to="country_RU" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SegmentGeographicalInformationAndMajorCustomersDetailsScheduleofLonglivedassetsnetbygeographicareasTable" xlink:to="SegmentGeographicalInformationAndMajorCustomersDetailsScheduleofLonglivedassetsnetbygeographicareasLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NoncurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncurrentAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SegmentGeographicalInformationAndMajorCustomersDetailsScheduleofLonglivedassetsnetbygeographicareasLineItems" xlink:to="us-gaap_NoncurrentAssets" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.beil.com/role/ScheduleofrevenuedisaggregatedbyprimarymajorproductlinesandservicesTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfRevenueDisaggregatedByPrimaryMajorProductLinesAndServicesAbstract" xlink:href="bmr-20221231.xsd#bmr_ScheduleOfRevenueDisaggregatedByPrimaryMajorProductLinesAndServicesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DisaggregationOfRevenueTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DisaggregationOfRevenueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfRevenueDisaggregatedByPrimaryMajorProductLinesAndServicesAbstract" xlink:to="us-gaap_DisaggregationOfRevenueTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisaggregationOfRevenueTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="PerpetualBasedSoftwareLicenseMember" xlink:href="bmr-20221231.xsd#bmr_PerpetualBasedSoftwareLicenseMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="PerpetualBasedSoftwareLicenseMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="TermbasedSoftwareLicenseMember" xlink:href="bmr-20221231.xsd#bmr_TermbasedSoftwareLicenseMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="TermbasedSoftwareLicenseMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisaggregationOfRevenueTable" xlink:to="us-gaap_DisaggregationOfRevenueLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="SoftwareLicenseAbstract" xlink:href="bmr-20221231.xsd#bmr_SoftwareLicenseAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="SoftwareLicenseAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsForSoftware" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForSoftware"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SoftwareLicenseAbstract" xlink:to="us-gaap_PaymentsForSoftware" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PCSServicesTransferredOverAPeriod" xlink:href="bmr-20221231.xsd#bmr_PCSServicesTransferredOverAPeriod"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="PCSServicesTransferredOverAPeriod" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AdvertisingAtAPointOfTimeUponClicks" xlink:href="bmr-20221231.xsd#bmr_AdvertisingAtAPointOfTimeUponClicks"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="AdvertisingAtAPointOfTimeUponClicks" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="RecognitionofRevenue" xlink:href="bmr-20221231.xsd#bmr_RecognitionofRevenue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="RecognitionofRevenue" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.beil.com/role/GeneralDetails">
    <loc xlink:type="locator" xlink:label="GeneralAbstract" xlink:href="bmr-20221231.xsd#bmr_GeneralAbstract"/>
    <loc xlink:type="locator" xlink:label="GeneralDetailsTable" xlink:href="bmr-20221231.xsd#bmr_GeneralDetailsTable"/>
    <loc xlink:type="locator" xlink:label="GeneralDetailsLineItems" xlink:href="bmr-20221231.xsd#bmr_GeneralDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GeneralAbstract" xlink:to="GeneralDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GeneralDetailsTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IPOMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IPOMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_IPOMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GeneralDetailsTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_CommonStockMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GeneralDetailsTable" xlink:to="GeneralDetailsLineItems" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GeneralDetailsLineItems" xlink:to="us-gaap_NetIncomeLoss" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GeneralDetailsLineItems" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_VariableInterestDifferenceBetweenCarryingAmountAndMaximumExposure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestDifferenceBetweenCarryingAmountAndMaximumExposure"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GeneralDetailsLineItems" xlink:to="us-gaap_VariableInterestDifferenceBetweenCarryingAmountAndMaximumExposure" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromNotesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromNotesPayable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GeneralDetailsLineItems" xlink:to="us-gaap_ProceedsFromNotesPayable" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GeneralDetailsLineItems" xlink:to="us-gaap_ProceedsFromStockOptionsExercised" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GeneralDetailsLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CapitalUnitsNetAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalUnitsNetAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GeneralDetailsLineItems" xlink:to="us-gaap_CapitalUnitsNetAmount" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GeneralDetailsLineItems" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PublicOfferingPrice" xlink:href="bmr-20221231.xsd#bmr_PublicOfferingPrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GeneralDetailsLineItems" xlink:to="PublicOfferingPrice" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AggregateGrossProceeds" xlink:href="bmr-20221231.xsd#bmr_AggregateGrossProceeds"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GeneralDetailsLineItems" xlink:to="AggregateGrossProceeds" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.beil.com/role/SignificantAccountingPoliciesDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="SignificantAccountingPoliciesDetailsTable" xlink:href="bmr-20221231.xsd#bmr_SignificantAccountingPoliciesDetailsTable"/>
    <loc xlink:type="locator" xlink:label="SignificantAccountingPoliciesDetailsLineItems" xlink:href="bmr-20221231.xsd#bmr_SignificantAccountingPoliciesDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="SignificantAccountingPoliciesDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantAccountingPoliciesDetailsTable" xlink:to="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_EquityMethodInvesteeNameDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="srt_EquityMethodInvesteeNameDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="ConvertibleAdvanceInvestmentsMember" xlink:href="bmr-20221231.xsd#bmr_ConvertibleAdvanceInvestmentsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="ConvertibleAdvanceInvestmentsMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantAccountingPoliciesDetailsTable" xlink:to="SignificantAccountingPoliciesDetailsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantAccountingPoliciesDetailsLineItems" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="EmployeeCompensationPercentage" xlink:href="bmr-20221231.xsd#bmr_EmployeeCompensationPercentage"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantAccountingPoliciesDetailsLineItems" xlink:to="EmployeeCompensationPercentage" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherReceivables"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantAccountingPoliciesDetailsLineItems" xlink:to="us-gaap_OtherReceivables" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredRevenue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantAccountingPoliciesDetailsLineItems" xlink:to="us-gaap_DeferredRevenue" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantAccountingPoliciesDetailsLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantAccountingPoliciesDetailsLineItems" xlink:to="us-gaap_DebtInstrumentRedemptionPricePercentage" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantAccountingPoliciesDetailsLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateEffectivePercentage" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PercentageOfDividend" xlink:href="bmr-20221231.xsd#bmr_PercentageOfDividend"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantAccountingPoliciesDetailsLineItems" xlink:to="PercentageOfDividend" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ExcessStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExcessStockSharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantAccountingPoliciesDetailsLineItems" xlink:to="us-gaap_ExcessStockSharesOutstanding" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantAccountingPoliciesDetailsLineItems" xlink:to="us-gaap_EquityMethodInvestmentOwnershipPercentage" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.beil.com/role/PropertyandEquipmentNetDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DepreciationExpenseOnReclassifiedAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationExpenseOnReclassifiedAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_DepreciationExpenseOnReclassifiedAssets" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.beil.com/role/IntangibleAssetsNetandGoodwillDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_AmortizationOfIntangibleAssets" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseDiscountRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseDiscountRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_LesseeOperatingLeaseDiscountRate" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LongDurationContractsAssumptionsByProductAndGuaranteeDiscountRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongDurationContractsAssumptionsByProductAndGuaranteeDiscountRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_LongDurationContractsAssumptionsByProductAndGuaranteeDiscountRate" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.beil.com/role/LoansNetDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="LoansNetDetailsTable" xlink:href="bmr-20221231.xsd#bmr_LoansNetDetailsTable"/>
    <loc xlink:type="locator" xlink:label="LoansNetDetailsLineItems" xlink:href="bmr-20221231.xsd#bmr_LoansNetDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="LoansNetDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LoansNetDetailsTable" xlink:to="us-gaap_ShortTermDebtTypeAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShortTermDebtTypeAxis" xlink:to="us-gaap_ShortTermDebtTypeDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="LoansAndSecurityAgreementMember" xlink:href="bmr-20221231.xsd#bmr_LoansAndSecurityAgreementMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShortTermDebtTypeAxis" xlink:to="LoansAndSecurityAgreementMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertiblePreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertiblePreferredStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShortTermDebtTypeAxis" xlink:to="us-gaap_ConvertiblePreferredStockMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LoansNetDetailsTable" xlink:to="us-gaap_AwardTypeAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="TwoZeroTwoTwoLoanAgreementMember" xlink:href="bmr-20221231.xsd#bmr_TwoZeroTwoTwoLoanAgreementMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="TwoZeroTwoTwoLoanAgreementMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LoansNetDetailsTable" xlink:to="us-gaap_RelatedPartyTransactionAxis" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="IBISpikesLtdMember" xlink:href="bmr-20221231.xsd#bmr_IBISpikesLtdMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="IBISpikesLtdMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LoansNetDetailsTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesCPreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesCPreferredStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_SeriesCPreferredStockMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LoansNetDetailsTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IPOMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IPOMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_IPOMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_VariableRateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LoansNetDetailsTable" xlink:to="us-gaap_VariableRateAxis" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_VariableRateDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VariableRateAxis" xlink:to="us-gaap_VariableRateDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="FloatingRateMember" xlink:href="bmr-20221231.xsd#bmr_FloatingRateMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VariableRateAxis" xlink:to="FloatingRateMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrimeRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrimeRateMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VariableRateAxis" xlink:to="us-gaap_PrimeRateMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LoansNetDetailsTable" xlink:to="srt_RangeAxis" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_MaximumMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_MinimumMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LoansNetDetailsTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_WarrantMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LoansNetDetailsTable" xlink:to="LoansNetDetailsLineItems" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LoansNetDetailsLineItems" xlink:to="us-gaap_DebtInstrumentFaceAmount" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermDebtPercentageBearingVariableInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtPercentageBearingVariableInterestRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LoansNetDetailsLineItems" xlink:to="us-gaap_ShortTermDebtPercentageBearingVariableInterestRate" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LoansReceivableBasisSpreadOnVariableRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansReceivableBasisSpreadOnVariableRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LoansNetDetailsLineItems" xlink:to="us-gaap_LoansReceivableBasisSpreadOnVariableRate" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LoansNetDetailsLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LoansNetDetailsLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LoansNetDetailsLineItems" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantsAndRightsOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LoansNetDetailsLineItems" xlink:to="us-gaap_WarrantsAndRightsOutstanding" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AmortizationOfDebtDiscountPremium" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfDebtDiscountPremium"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LoansNetDetailsLineItems" xlink:to="us-gaap_AmortizationOfDebtDiscountPremium" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentOwnedBalancePrincipalAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentOwnedBalancePrincipalAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LoansNetDetailsLineItems" xlink:to="us-gaap_InvestmentOwnedBalancePrincipalAmount" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LineOfCreditFacilityCommitmentFeeAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityCommitmentFeeAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LoansNetDetailsLineItems" xlink:to="us-gaap_LineOfCreditFacilityCommitmentFeeAmount" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LoansNetDetailsLineItems" xlink:to="us-gaap_DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueAdjustmentOfWarrants" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAdjustmentOfWarrants"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LoansNetDetailsLineItems" xlink:to="us-gaap_FairValueAdjustmentOfWarrants" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LoansNetDetailsLineItems" xlink:to="us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LineOfCreditFacilityCollateralFeesAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityCollateralFeesAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LoansNetDetailsLineItems" xlink:to="us-gaap_LineOfCreditFacilityCollateralFeesAmount" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentInterestRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LoansNetDetailsLineItems" xlink:to="us-gaap_InvestmentInterestRate" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DerivativeFixedInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFixedInterestRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LoansNetDetailsLineItems" xlink:to="us-gaap_DerivativeFixedInterestRate" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LoansNetDetailsLineItems" xlink:to="us-gaap_PreferredStockSharesIssued" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantExercisePriceIncrease" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantExercisePriceIncrease"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LoansNetDetailsLineItems" xlink:to="us-gaap_WarrantExercisePriceIncrease" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityMethodInvestmentAggregateCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentAggregateCost"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LoansNetDetailsLineItems" xlink:to="us-gaap_EquityMethodInvestmentAggregateCost" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableInterestBearingInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableInterestBearingInterestRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LoansNetDetailsLineItems" xlink:to="us-gaap_AccountsPayableInterestBearingInterestRate" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIncome"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LoansNetDetailsLineItems" xlink:to="us-gaap_OtherIncome" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AgreementAmountReceived" xlink:href="bmr-20221231.xsd#bmr_AgreementAmountReceived"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LoansNetDetailsLineItems" xlink:to="AgreementAmountReceived" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromRoyaltiesReceived" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRoyaltiesReceived"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LoansNetDetailsLineItems" xlink:to="us-gaap_ProceedsFromRoyaltiesReceived" order="22.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentAnnualPrincipalPayment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAnnualPrincipalPayment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LoansNetDetailsLineItems" xlink:to="us-gaap_DebtInstrumentAnnualPrincipalPayment" order="23.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PercentageOfOutstandingRepaymentAndPaymentAmount" xlink:href="bmr-20221231.xsd#bmr_PercentageOfOutstandingRepaymentAndPaymentAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LoansNetDetailsLineItems" xlink:to="PercentageOfOutstandingRepaymentAndPaymentAmount" order="24.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PercentageOfDiscountOutstanding" xlink:href="bmr-20221231.xsd#bmr_PercentageOfDiscountOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LoansNetDetailsLineItems" xlink:to="PercentageOfDiscountOutstanding" order="25.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestAndFeeIncomeOtherLoans" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestAndFeeIncomeOtherLoans"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LoansNetDetailsLineItems" xlink:to="us-gaap_InterestAndFeeIncomeOtherLoans" order="26.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LoansNetDetailsLineItems" xlink:to="us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed" order="27.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeFinanceLeaseDiscountRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeFinanceLeaseDiscountRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LoansNetDetailsLineItems" xlink:to="us-gaap_LesseeFinanceLeaseDiscountRate" order="28.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockDividend" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockDividend"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LoansNetDetailsLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockDividend" order="29.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LoansHeldForSaleTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansHeldForSaleTerm"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LoansNetDetailsLineItems" xlink:to="us-gaap_LoansHeldForSaleTerm" order="30.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LoansNetDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost" order="31.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsOfLoanCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfLoanCosts"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LoansNetDetailsLineItems" xlink:to="us-gaap_PaymentsOfLoanCosts" order="32.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RepaymentsOfSecuredDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfSecuredDebt"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LoansNetDetailsLineItems" xlink:to="us-gaap_RepaymentsOfSecuredDebt" order="33.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.beil.com/role/OtherCurrentLiabilitiesDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_OtherLiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesCurrentAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DepositLiabilitiesAccruedInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepositLiabilitiesAccruedInterest"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherLiabilitiesCurrentAbstract" xlink:to="us-gaap_DepositLiabilitiesAccruedInterest" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.beil.com/role/ConvertibleAdvanceInvestmentDetails">
    <loc xlink:type="locator" xlink:label="InvestmentHoldingsAbstract" xlink:href="bmr-20221231.xsd#bmr_InvestmentHoldingsAbstract"/>
    <loc xlink:type="locator" xlink:label="ConvertibleAdvanceInvestmentDetailsTable" xlink:href="bmr-20221231.xsd#bmr_ConvertibleAdvanceInvestmentDetailsTable"/>
    <loc xlink:type="locator" xlink:label="ConvertibleAdvanceInvestmentDetailsLineItems" xlink:href="bmr-20221231.xsd#bmr_ConvertibleAdvanceInvestmentDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentHoldingsAbstract" xlink:to="ConvertibleAdvanceInvestmentDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConvertibleAdvanceInvestmentDetailsTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="AdvanceInvestmentAgreementsMember" xlink:href="bmr-20221231.xsd#bmr_AdvanceInvestmentAgreementsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="AdvanceInvestmentAgreementsMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConvertibleAdvanceInvestmentDetailsTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertiblePreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertiblePreferredStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ConvertiblePreferredStockMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConvertibleAdvanceInvestmentDetailsTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IPOMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IPOMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_IPOMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConvertibleAdvanceInvestmentDetailsTable" xlink:to="srt_RangeAxis" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_MinimumMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_MaximumMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConvertibleAdvanceInvestmentDetailsTable" xlink:to="ConvertibleAdvanceInvestmentDetailsLineItems" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConvertibleAdvanceInvestmentDetailsLineItems" xlink:to="us-gaap_DebtInstrumentFaceAmount" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityMethodInvestmentAggregateCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentAggregateCost"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConvertibleAdvanceInvestmentDetailsLineItems" xlink:to="us-gaap_EquityMethodInvestmentAggregateCost" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConvertibleAdvanceInvestmentDetailsLineItems" xlink:to="us-gaap_DebtInstrumentRedemptionPricePercentage" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConvertibleAdvanceInvestmentDetailsLineItems" xlink:to="us-gaap_DebtConversionConvertedInstrumentAmount1" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConvertibleAdvanceInvestmentDetailsLineItems" xlink:to="us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtConversionConvertedInstrumentRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtConversionConvertedInstrumentRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConvertibleAdvanceInvestmentDetailsLineItems" xlink:to="us-gaap_DebtConversionConvertedInstrumentRate" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PublicOfferingPrice" xlink:href="bmr-20221231.xsd#bmr_PublicOfferingPrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConvertibleAdvanceInvestmentDetailsLineItems" xlink:to="PublicOfferingPrice" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.beil.com/role/CommitmentsandContingentLiabilitiesDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="CommitmentsandContingentLiabilitiesDetailsTable" xlink:href="bmr-20221231.xsd#bmr_CommitmentsandContingentLiabilitiesDetailsTable"/>
    <loc xlink:type="locator" xlink:label="CommitmentsandContingentLiabilitiesDetailsLineItems" xlink:href="bmr-20221231.xsd#bmr_CommitmentsandContingentLiabilitiesDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="CommitmentsandContingentLiabilitiesDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_TitleOfIndividualAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsandContingentLiabilitiesDetailsTable" xlink:to="srt_TitleOfIndividualAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="srt_BoardOfDirectorsChairmanMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_BoardOfDirectorsChairmanMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_BoardOfDirectorsChairmanMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_StatementScenarioAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsandContingentLiabilitiesDetailsTable" xlink:to="srt_StatementScenarioAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioUnspecifiedDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioForecastMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioForecastMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioForecastMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsandContingentLiabilitiesDetailsTable" xlink:to="CommitmentsandContingentLiabilitiesDetailsLineItems" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsForRent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsandContingentLiabilitiesDetailsLineItems" xlink:to="us-gaap_PaymentsForRent" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsForFees" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForFees"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsandContingentLiabilitiesDetailsLineItems" xlink:to="us-gaap_PaymentsForFees" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCost"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsandContingentLiabilitiesDetailsLineItems" xlink:to="us-gaap_LeaseCost" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsandContingentLiabilitiesDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.beil.com/role/ShareholdersEquityDeficitDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <loc xlink:type="locator" xlink:label="ShareholdersEquityDeficitDetailsTable" xlink:href="bmr-20221231.xsd#bmr_ShareholdersEquityDeficitDetailsTable"/>
    <loc xlink:type="locator" xlink:label="ShareholdersEquityDeficitDetailsLineItems" xlink:href="bmr-20221231.xsd#bmr_ShareholdersEquityDeficitDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="ShareholdersEquityDeficitDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDeficitDetailsTable" xlink:to="srt_RangeAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_MinimumMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_MaximumMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDeficitDetailsTable" xlink:to="ShareholdersEquityDeficitDetailsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockConvertibleConversionPrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockConvertibleConversionPrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDeficitDetailsLineItems" xlink:to="us-gaap_PreferredStockConvertibleConversionPrice" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockAmountOfPreferredDividendsInArrears" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockAmountOfPreferredDividendsInArrears"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDeficitDetailsLineItems" xlink:to="us-gaap_PreferredStockAmountOfPreferredDividendsInArrears" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDebtNetOfIssuanceCosts"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDeficitDetailsLineItems" xlink:to="us-gaap_ProceedsFromDebtNetOfIssuanceCosts" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ExcessStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExcessStockSharesAuthorized"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDeficitDetailsLineItems" xlink:to="us-gaap_ExcessStockSharesAuthorized" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="VoluntaryConversionDescription" xlink:href="bmr-20221231.xsd#bmr_VoluntaryConversionDescription"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDeficitDetailsLineItems" xlink:to="VoluntaryConversionDescription" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.beil.com/role/ShareOptionsDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <loc xlink:type="locator" xlink:label="OrdinarySharesSubjectToAdjustments" xlink:href="bmr-20221231.xsd#bmr_OrdinarySharesSubjectToAdjustments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="OrdinarySharesSubjectToAdjustments" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="OrdinarySharesAvailableForFutureIssuance" xlink:href="bmr-20221231.xsd#bmr_OrdinarySharesAvailableForFutureIssuance"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="OrdinarySharesAvailableForFutureIssuance" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="TotalConsideration" xlink:href="bmr-20221231.xsd#bmr_TotalConsideration"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="TotalConsideration" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetAmountAtRiskByProductAndGuaranteeWeightedAveragePeriodRemaining1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetAmountAtRiskByProductAndGuaranteeWeightedAveragePeriodRemaining1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_NetAmountAtRiskByProductAndGuaranteeWeightedAveragePeriodRemaining1" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.beil.com/role/RelatedPartiesTransactionsDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionDueFromToRelatedPartyCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDueFromToRelatedPartyCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_RelatedPartyTransactionDueFromToRelatedPartyCurrent" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DueToOtherRelatedPartiesClassifiedCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueToOtherRelatedPartiesClassifiedCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_DueToOtherRelatedPartiesClassifiedCurrent" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentInterestRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_InvestmentInterestRate" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalOther"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.beil.com/role/TaxesonIncomeDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherNonoperatingGainsLosses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingGainsLosses"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_OtherNonoperatingGainsLosses" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.beil.com/role/SegmentGeographicalInformationAndMajorCustomersDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NumberOfOperatingSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfOperatingSegments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_NumberOfOperatingSegments" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="TradeReceivablesIncomeTaxRate" xlink:href="bmr-20221231.xsd#bmr_TradeReceivablesIncomeTaxRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="TradeReceivablesIncomeTaxRate" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredRevenueRevenueRecognized1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredRevenueRevenueRecognized1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_DeferredRevenueRevenueRecognized1" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.beil.com/role/SubsequentEventsDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract"/>
    <loc xlink:type="locator" xlink:label="SubsequentEventsDetailsTable" xlink:href="bmr-20221231.xsd#bmr_SubsequentEventsDetailsTable"/>
    <loc xlink:type="locator" xlink:label="SubsequentEventsDetailsLineItems" xlink:href="bmr-20221231.xsd#bmr_SubsequentEventsDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="SubsequentEventsDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_StatementScenarioAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventsDetailsTable" xlink:to="srt_StatementScenarioAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioUnspecifiedDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioForecastMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioForecastMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioForecastMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventsDetailsTable" xlink:to="us-gaap_SubsequentEventTypeAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventsDetailsTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesCPreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesCPreferredStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_SeriesCPreferredStockMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventsDetailsTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IPOMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IPOMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_IPOMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="LoanAgreementsAxis" xlink:href="bmr-20221231.xsd#bmr_LoanAgreementsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventsDetailsTable" xlink:to="LoanAgreementsAxis" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="LoanAgreementsDomain" xlink:href="bmr-20221231.xsd#bmr_LoanAgreementsDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LoanAgreementsAxis" xlink:to="LoanAgreementsDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="TwoThousandTwentyTwoLoanAgreementMember" xlink:href="bmr-20221231.xsd#bmr_TwoThousandTwentyTwoLoanAgreementMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LoanAgreementsAxis" xlink:to="TwoThousandTwentyTwoLoanAgreementMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventsDetailsTable" xlink:to="srt_RangeAxis" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_MinimumMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_MaximumMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventsDetailsTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_CommonStockMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventsDetailsTable" xlink:to="SubsequentEventsDetailsLineItems" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventsDetailsLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PublicOfferingPrice" xlink:href="bmr-20221231.xsd#bmr_PublicOfferingPrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventsDetailsLineItems" xlink:to="PublicOfferingPrice" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventsDetailsLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentInterestRateTerms" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateTerms"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventsDetailsLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateTerms" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockConvertibleSharesIssuable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockConvertibleSharesIssuable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventsDetailsLineItems" xlink:to="us-gaap_PreferredStockConvertibleSharesIssuable" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConversionOfStockSharesIssued1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConversionOfStockSharesIssued1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventsDetailsLineItems" xlink:to="us-gaap_ConversionOfStockSharesIssued1" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TemporaryEquitySharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesAuthorized"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventsDetailsLineItems" xlink:to="us-gaap_TemporaryEquitySharesAuthorized" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.beil.com/role/DocumentAndEntityInformation">
    <loc xlink:type="locator" xlink:label="DocumentAndEntityInformationAbstract" xlink:href="bmr-20221231.xsd#bmr_DocumentAndEntityInformationAbstract"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentInformationTable" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentInformationTable"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentInformationLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_DocumentInformationTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressesAddressTypeAxis" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressesAddressTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable" xlink:to="dei_EntityAddressesAddressTypeAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="dei_AddressTypeDomain" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AddressTypeDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityAddressesAddressTypeAxis" xlink:to="dei_AddressTypeDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="dei_BusinessContactMember" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_BusinessContactMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityAddressesAddressTypeAxis" xlink:to="dei_BusinessContactMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable" xlink:to="dei_DocumentInformationLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_TradingSymbol" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CurrentFiscalYearEndDate" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCommonStockSharesOutstanding" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCurrentReportingStatus" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityVoluntaryFilers" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityVoluntaryFilers" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFilerCategory" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityWellKnownSeasonedIssuer" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityWellKnownSeasonedIssuer" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFiscalYearFocus" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFiscalPeriodFocus" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityShellCompany" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityExTransitionPeriod" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityExTransitionPeriod" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_IcfrAuditorAttestationFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_IcfrAuditorAttestationFlag"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_IcfrAuditorAttestationFlag" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentRegistrationStatement" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentRegistrationStatement"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentRegistrationStatement" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentAnnualReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentAnnualReport" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentTransitionReport" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentShellCompanyReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyReport"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentShellCompanyReport" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFileNumber" order="22.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" order="23.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" order="24.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine2" order="25.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" order="26.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" order="27.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressCountry" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCountry" order="28.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_LocalPhoneNumber" order="29.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CityAreaCode" order="30.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_ContactPersonnelName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_ContactPersonnelName"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_ContactPersonnelName" order="31.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_ContactPersonnelEmailAddress" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_ContactPersonnelEmailAddress"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_ContactPersonnelEmailAddress" order="32.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_Security12bTitle" order="33.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SecurityExchangeName" order="34.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityInteractiveDataCurrent" order="35.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentAccountingStandard" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAccountingStandard"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentAccountingStandard" order="36.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_AuditorFirmId" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorFirmId"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AuditorFirmId" order="37.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_AuditorName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorName"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AuditorName" order="38.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_AuditorLocation" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorLocation"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AuditorLocation" order="39.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" +1 C@# 2(  A$! Q$!_\0
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M6T];]/0_VI?^'N7_  3#_P"C^_V3?_#V>!O_ )=4O_#W7_@E_P#]'\?LI?\
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M ()\7_\ QY?MH_LT3_[GQ@\#G_W-U_C\>#/#R@?\>5K%U_U=E:CCO]Z!N_\
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MO^"=]J=D_P"VQ^S)!(1]V7XP^"!SWX_ML=O?\:_SI/VAG6RN[][NWT]DM?\
M5[[2UD!'3YS+%)G_ (#MK\EO&/B>&XUF9S%;O#'C&VV@P>G4[,'\,?K77D?M
MLWJNFZ3I1IN*E.S]_GYK/733D?;<TS!O U(\K=6-7F:6GN<EK[?S<W=['^MG
M/_P56_X)LVF%N_VZ_P!E:!_1_C5X% ]?^@R2/QJNO_!6'_@F@S;5_;O_ &53
M_P!UJ\"_I_Q.N:_QSO$FLI>7!>2*T<\\?8[;;]>(LXZYYQ],UDZ?/&\O-O9X
M_P"O2V_EY9_SGTKZR?#2A-VQ+E=+W;KW/2RZW_ \_P#M!_\ /EG^RBO_  50
M_P""<#C<O[<W[+FWU_X7%X)/ZC7?Z5"W_!5C_@FU&^R3]NK]E</Z?\+E\$CG
M_P '9_SZ5_D1::;2:TV);6A?WMX<GW^YC\>OZUS>N65JMUYRVD('_7O#MZ=.
M(Q]<YZ5G+(%"UZV_IT];#_M/E^*C>^Q_L&Z3_P %1_\ @G1K[R1:+^W%^RQJ
M$J=K7XU>!)OSQKJ?0\CVKTGPM^VU^RKXZ\0Z5X2\%?M&_ WQ7XG\07W]F^'?
M#_A_XC^&]4US6]1\NXN?[-L]+@U$3->?9+2Y? D(W)G9M!!_Q?M!1-,U1Y[5
M8;<R?>6%$MU_ 6XB/M]XY^M?LW_P1/\ %5U%_P %2_V$M"95$=W\>;-G"F8R
M1R7'@CQ6CRQRM.TI<&]=U$KRIYD4)9"%</SXG)E3H5*JJ_!;:W6_KV-*6/C6
MJPCR<B5[K6TKVMOVMWZG^EQXU_X**_L2?#7Q+K?@KXB?M:_LZ>"O&/AN_.F^
M(/"_B?XI>#=%U[1=0^PP72Z=?:9<>(I)DO=UW;;EWJ KE I.V0VM#_X*+?L+
M>(SC1/VM_P!GO5CZ:;\4?#-V?R6]6O\ ,+_X+7>,+4?\%7OV]-*N;2WE%G\?
M[R-&EC::9WMM%\*".9YIWED$G^A(&$+11_O9@$&]=GY?:+\2?$7@:^_M'P]<
MFVB/'E+#$D8]/EMDMV^OS'ID=ZVH\*YEB,!'%X-PK<T6VJKLUHFN6S6N]]]C
MHIUZ4L1*G4FH1O%*^RWO_P $_P!F-/VV?V2)!NC_ &C_ (,RKZQ>/_#S'I_L
MWS9_0\]/74A_; _9;N$\R#X__"65?5/'&@D?D+T_Y[U_E/\ P"_;^GMKRQTK
MQ-:03"?_ (^+B1+;:O)'[LNA /\ O;Q^E?MQ\&_C!X8\;:=:G3_LRK/P^V*V
M#]\[=R,!QP<AC^7/PV:O/\EYZF,RZ-2C=VE24FHJ'Q<S5[735N]C[' 9%@,P
ME3A2S"/M)I/D4H7UZ']T3?M??LUC[OQV^$Q^OC;0Q_[?_P"?:F7/[9/[+%GY
MANOVA/@_ J=Y/'>@9Z=3_IPR,^G;U[?Q]H+21<J($Z<O!:E?7M .WO\ G7B/
MQ*M[,6EP$M;9O<PQ9S_P%5[^O7FO&I\23Q"C)4/9:M.*3U];WVM^)Z.*X0]B
MFHU'>"]YZ6:=FG^#/[3KC]OK]BRU\P7'[4WP*@=.@D^(OAT8Z?>_TX>O\)JJ
M/^"A'[#S?=_:V_9Z//\ T57P7_\ +P5_G,^-(-,EOK@/961'''V(#],_SQ[9
MK!TW35>.*4VMJP?J%D4D=^/E;C/U[UW_ -LODO[+6W;^OR/FL1EL,//EE5W;
M_#T]3_2-7]OK]BYN/^&I?@6W^[\0O#P_]"O_ .GYTG_#?W[%/_1T_P "/_#D
M^'?_ )*K_.5DLX[8;FMK,)W+009Z]R$]OY=<565K5WVBTM5XSC^S;>5OR2$?
MRKSZG$=2E)1]BYN=[*S]VWIWNM^WJ<[PE+E;]KMZ'^CI;?M\?L97C^5;?M2?
M NXDY^6/X@:!_6_/\_PKJA^V+^RNR;T_:$^$!7^]_P )WH!&?I]M!_SUK_.@
M^&EA83>(-J65FA'7?;1;/<C]P.A]Z^X%>WM]/V?8K4/C_EI;I_(;><<],=\X
MKVLLQU7&JM4J4G3C24'&.JY^=3ONOL\J^\\VK.GAZD(2GS^T;2UVY;?GS(_M
M<NOV\?V-["1XKW]ISX(V\B=5?X@>'\_^EIR?89K/D_X*#_L0I][]K3]GR+_K
MK\4O!A_EKR_Y[U_GH_$+5+(>(;A;B"P*^AM8!_)1[9[YYKCG_L*_3YX[5I/0
MJN"?IQ_/GT)YKR*_$4X8FM1]@X1I.*BTOBOS)[]K?B>E3PD:T5-3Y$TO1W7_
M  +_ #/]%?\ X>(?L-_]';?L^?\ AT_!?_R^J1?^"AO[#O\ %^UG^S]^'Q3\
M%C_W.MQ7^=(OA6PN$W6B1R'_ &A$0?IM0?SY_*LK4?"\\#_NK>&:/GYD9<^@
M&1'C],^]8SXDJJ+<*+D^NFWW=_T(K86-'E]_GYK_ "M;\[_@?Z/(_P""@/[$
M[?<_:H^ Y^OQ*\-__)OZ4[_AO_\ 8I_Z.H^ _P#X<GPU_P#)]?YMB6TT3_N[
M*W=/233[:-_7/,('?T_^MJ6MC/-)MGL;"$>IM$!_'.FGW[5P_P"MF)@Y<V'D
M[O33:WR,'3YOATMN?Z/#_P#!0?\ 8AC^_P#M7_L_#_NJO@L?^YL_YS0G_!0?
M]B&3[G[5_P"S\?\ NJO@L_\ N;%?YOFJZ1>.F[RT4^B)/(/TL_KC_P#765;P
M7^FOMGA@Q[^G?^$#)_S[:0XNJN]\,WMT8>QEY_C_ )G^E.O[>O[%[+E?VHO@
M>??_ (6%X?./J/MF?U_&L23_ (**?L-Q';-^UI^SY _I)\4_!?\ +^W1_P"A
M =:_SI+3Q/9(I632X2/5;6$'OC_EF?Y=ZP[^7P[J=QOFM0IQT545>?8HQ]._
MN?>O]:J\VE'#-:ZZ/J5#"U)R5F[+?Y_\,?Z/T?\ P4,_8>G?R[?]K;]GF5O1
M/BIX,/\ [G1_GJ*G/_!03]B=?O?M4_ (?]U5\$#_ -SIK_.(TCP]9-=>;:^0
MC ] $V_RSV_O'W-=5+X;GF7S&MK=8_15P_ZL?IT_2NW_ %EJ1I.4L*[VT=GT
MW/3IY4ZD).4N1I*S[WN?Z(G_  \*_8E_Z.O_ &??_#I>#/\ Y?5T_AS]M']E
MWQB"OA3]HCX':W.!DP67Q,\(-)QUP+[6]-)/H "3^M?YO-SH;VWWH83USA1_
MG_/%8>HC:?M!BM!/D_O8[6!''_?,8 ]/NUY4.+Z[K.+P[<;K2SVN_+\#AJY9
M6C.*IU925W>S7E;IZH_U'H/$B7=D=1M'LKO3Y(?M5MJ5K<VTVGW%OCC[->B[
M%G,Y88)O+G2L YV-M^;274+AR[B..&*-/-D%V88TC3'5KNWO+N+.?2'&,DD5
M_F,?"W]I[]H?X!ZPNK_ _P"-GQ)^%]SO#/:>%/%6I0:#<)P1!?>%KZ:_\,:C
M#G'RZCHUTW^W7[Q_L>?\'&'C;PMJ.D>#_P!MSP!9>+-!<?91\:_A5806OB73
M+   7?C+X<6\EU9ZA < ->Z1J.E7@RS?\(X6)!^BP^?PKJ"G15%NUMUSWM?=
M]--NY=3+<33A&2@YJS;T>EK?F?V+EV[;<^X/^-35XI\)_CI\,OCG\/\ 1_B9
M\(O'7ACXB^"M=M3=Z9XE\-77VC3;D9Q]ED02RW-E?>NGW:QZJ.^F8YKVNO>A
M-5(1DMGJ<+YDW&4.1KUU^_M^H44450@HHHH **** "BBB@ HHHH *BWG9NP,
M_CCIGUJ6N0U;Q);:)83:CJ5Q:66EVD-[-J%_<N(8-/6QC:YO3<N\@18-,TVW
MO]1O;PNL+6]C,(Q&V#65>I[*E.H]%!78/X7WZ/Y,^6_VR/VW_A)^PU\"_''Q
MZ^-VL6EIH'A>.WL-$\-:7ON/$OC+QE=61FT[P)X?A,A%]XEUJ[&VWM(8&32]
M&!U^^DEM_P#11_F"_P#!2+_@I3^T?^W_ /$Z[\<?&76+_2? .FZQJB_"SX+6
MM^+GP#\,+2<YT>VM[>)Y+7QGXWU;./$/C/5!>7FI* I:%0 /U#_X*V?MKZI^
MWU^T3K7B'2M1U1OV?/A9J5]X<^!6B3.8;'6-+M=66WU_XNS6*$1R:QXGUL#5
M-(OY8HKVW\*@Z5 1:DU_/A\6/#\=M'.R0/"ZKL#,% 6-?]6D<*(EM!Y/'ER6
M\$4X/WI&KY"'$%/%YC2PL9WC"<HSC?27,XI7MK]EVU6YY]:->JING.2C36J5
MK.[=NC_E/E?7/%5S>>;!-<%K>Y?S+J!T6:.XEY_TEC<B>2&__P"HI:O;ZI_T
M^UY=?7C-)YA";OHV/?C=G!^OZ]-O6]D-S*JAL)T\P9)X[X"@].H ']>+O'/3
M*_KQC@]^_P#GK7Z7@L/1C&4HTXKF4'I?L^\GW/#:G5G*+;;IOKYW\O(22-6^
M[GMZ#\N/IZ=*BV1^K_\ CO\ A38;V'U/?\,^G'?_ ![5IQF!NKQ>V,_U/^>U
M=[C%VO%.VWE^(G&=*RNU>_X>J??R(VBC"[$4$9SSUS[=/K^=9SA58@9P/4C/
MY@?TK7AV>I/7'M^GZ>ASS3UM4E;<RX//"X ].^<X]<]>.:%"*VBEZ7_S$Y-_
M$V[7MT_)%*S63S>F>_.>W]/3_P#57JOAKQ#;Z>^VZM]X]74DD?F/R_I7 H!
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M?_$WP#;6'Q#DW-I'Q4\"2V?@[XA698YS>:KI^GOIWB4#D!/&.C^(U4'"J!M
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M7PCXV\?>-?"OA6UDU'P3X/2ZL;_6#XHN=4\0^&=(TC[/]KU>]??*_P!PZ?\
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M?CM\5?&GA&]O[7^U/#?P*\&W\.J_%_Q9;]?[3\5Z;JDDNF_"[PQP<ZIXM?\
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MO)O3HC\?XNXAEQ-G2S&OA<+@X8F=65/!4(J,:5W!R]V+NKWC;FD]M.I_H#?
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MK^/BL'&.CH1J4I7YI-::6M=]GK?576ET1.4DX.[O&]O+;M;LM[G\TW_!3O\
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M  7E\*V>J?\ !6/XU7D\-Q)YWPY^"<:K' TX,EOX!T"T0#;&>&CPS#/,ARI
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MR^Y!6O:^W*G>RW3VTMU\J.)Y&W"3BY6NTWK:]NKVN^Q]0R>/9U6T6WF,._\
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M(#J&CE-2M+_3[.\C_JBU+4XGOV4,D*PZK$\UKL=L6\7\$6YF/ER?\M Q;/\
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MEGI,&]VMVS;/;V43R@?,TS2,DB(5B3@O#7PPT2!TD\B",Q\ 21N5/U MU)_
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M*;3</E01;]^'#_T%5_FP?\%TH ?^"X/QI$LD^P?"[X%2+$)"L:/)\+] 5V5
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M#^8--\-4;.7U:%ULW&2:]/?_ *L?,SCA(125&G&,I)-I/2[_ ,1]DR?LJ_\
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MH **** "BBB@!K$@9'K_ (U_)9_P5)U?]E/P[^VOXXO_ (I?#_3-=\<MX5\
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MQ \+^'/&?AJ[@^RW&B>)M#TW5K":U!_X]I%N[:25XL] \I?_ &^M?GY\1_\
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MF7KQL(I/:9Y\>E?!^IZUJVB:G-HOB6QN]#U:VQ]KLKVUEANH<<?N[9WS=?\
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MIH,OPQUFZVZ?#IX?T:W3Z=E'Y=NQK]!_VP]*74[#5H659!'T+!=Q^I  [\X
M[5^0&E16_AZ[^V*SQKG[I*X^N JG]:^ X_Q^781SHXNK5HUG*24J7Q5+."?/
MHU[MURZ+=[]/Z_\ H^\!9KQ%DN&Q-+"8:M2?,Y+%4J<URI3<5#VD):))IV:Z
M7OI;]Z_V5O#_ (=AM+4Z?#!%%'P @4#/8' _EC]*_1C6VN;'P^CVC%62W\T$
MY.6[YV[25!YZ@X[U^7?[&6L)<Z;91-Y;,_!^]D=^,OGCZ$_S'ZH>*95L?#/F
MS!=OV/J!Z].I_#CC\:^AX"CEV+P>&EAZ]6J[)R5;JW?EY=([V=_D?AWCWEM?
M).(\1@JN#PE&5*==0EA:5.#A[U-2YO9QCY6YN;9VMK?\</VGO'_B_2+N]-AK
MEQ;^;U&)5 _W0LBXXSR<CVKXN\'?&WXH67B6UC'B^WO4GN/*<">XCPO'*[K@
M@-[MD>U=?_P4!_:)\.>"9W:YC;+S^40J@ +ZC!&&[9Z>U?DGX:_:<M-9\6Z2
MUD8C;3WGR$/&LAX]54+_ .._D,"O?S.-6EBJRE%PC'E]D]NKYK7_ .W;[GY5
MDV41S*A"7UEQJ--RC>/O=4GHMK.VVY_8M^SSXVUK5].TQ[Z;SVF@\U\&0@MU
MP-TKG:/<D^]=S\<K5KO0[MG&XO'Y1'& I[KD'GODDCMMKY9_8QUTZQHNAS&9
MV$EGR<C'IQG^I/KBOKSXTRK;Z!<-M4IY'F_-D_-]00,<_7WQ7J9=&=2BJG,W
M.$4UW=TWTMV/G,?2IX/,:E!Q5Z$XINVZ;:[_ -W\3^5']J?X7:;K/Q#U25;*
M.3S/O.MLF5[_ "GRR!CIR#],U2_9E^#6C'QS;V]UI43VO]R>!Y%QC_;!'IV^
MM>Y_M$_'OP1X5^(-W8:E81-<2<D[4(QTXZ'\#GV]]K]G#XZ>#/$?CVW@T_3[
M>)^OEJJK+S]21_X[UKY'-*V*Q&*JTZD)4X4Y)1NE::DVGO%Z)16UMS[RA+"5
M\NHRH4:<:].+;E!-2D[1:O:72SZ=3]=OA;^Q'\&O%&F@ZQH-LSW%OYKB%8HP
MC^B![>4A?8ECZFM;4?\ @D+^S/>3230:=J,!E',<6IZBL2Y_N*79@/\ @1^M
M?7?P1U2U;1[?4 (FC^Q_<5E4]?0H3Z>WXU[IJ'CWPEIB!M1UZPTV0CSC%<W]
MI;NL']US>W5B!,..O'^R>,^GA^&,+C,/2JTZ%*E4:;JSBI1E4;MR\UIV?+[U
MM%;F95#Q"SW*K8;"7BZ.DG.27E'EO'UOOT/R8U#_ ()8?LE^&99WUFWU&2%?
MN'[?J2E,\?+L90/7D'^6?/O%OP>_8S^%?@OQM:^ )-0M?&@\,WZZ1;07]^\,
M]W':_9/*NK<2!GCDBP9%B>!F?D.J_+7Z6_%CXB?"J73I(;[X@^&K&8]?M5]8
M122Y_P">4$NI0R+Z?,S^X]?Q5^-?B#X,G7M0N/#7Q,\(ZEKETD\FF:3:ZA';
MWVJR7!^>WLUN[R/.,?(I1F!^\3Q7U?!_"5*AQ'E55<L90QM!QDG*Z_>1O:\F
MNG9G@\6^(V<9CDN94,QE=5<'B$HQ<)*I^[DI<W[N_NW5K..[O?I^9?QPUPV'
MQ)UK5C,W]FZ[<S:?<(H79:7FG32R03R\<%HGCM)6+ &TMK9$V2(\C^T_L;_M
MP>*?V0_'%W<20ZGXN^%/C2X-O\2_!%M<.+Q[Q;QKVV\8^&)GE%EIWBFTDDEB
MCNY[2^TR>!HDOM)O'LM.DL_G3XSVZ)J>K6DLD=S'>7$ZI=-*$2X>XSOGB+(=
MLR_PL<J#]Y6S7RNWB&>W:?2[B)3)II^QJ[>:HNTY/FPNLJL9NAW$E<G[GI_I
M]2X=R/-L##*\UKSI3Q> PL</6BERPE&DU+VDK6@[RIN+NG=-K5'^;/\ :N=9
M5FM7.LKPM.JL%C<4YPDY*IR5JEVJ,>;WN90ESKEE:T=KZ_W-^!?C/X#^,/@C
M2_B1\+?%]AXO\%ZR@>TU:WG%M]@G_P"@5XH@;S9_#&L_].=[#,I_YZ\5;F\1
MQ@;E<2+V SO_ /0B#^60?QK^+OX'?M0?&']G+Q=+XO\ A-XDGTN6_?9XC\/Z
MA&;WPIXNT_\ Z!?B+05DMK:XMN_VRP;3];_ZBW2OZ ?V=?\ @H3\(?VB(=%T
M>^NK7X2_%BYB\B?P)XHU*%=&\3W7_/[X$\4XBLKR7_J5M96PU0Y_Y"G:OYYX
MR\,LZX?KXAX6-+%9>I3EA:^']^4HJSG[1KG2=G#EV^T?T;PAXB95G^'PD:TZ
MV$QL;+&8:NE""G4LHNGS*+=W&?-J[:;'Z;C5FEDVM,H'L>>?3)(Y^F!TJA/<
MB7H[?\!([Y[^O?\ 7VKR"?Q$VGW7V>[,EM+#_KTNE:!Q_P!=%#2):?\  I;C
MWYKHK3Q##*FX D@>I_S[?UXQ7Y;[&N[0Q%%TZE)M<S33DWO?;:W;J?I\_JT[
M2H555C)7:3NHZ*VSZZ]>AUXCE>7Y%'Z]>GK^7TXKI-,M;N)\,L3)_?EB28_]
M\S*\?'3_ %?;GTKG]-U*%W#GR@N^5G9IHTC6UL/^0A<B:4QVXMC_ ,NUY++%
M"/XQ(*\I^"'[77P)_:,\3_%?PI\%/$&L^-H?@QK^A^%_&OCFU\.ZS;_"M_$N
MO;ID\-^&?B'<6,=EXCU?2;=2FI+;:7! \Y5XVBB95.L%.E?5J^VBZ>L7W,?9
M4[WY5?UE_P#)6_!GU=;ZG,B0Q-+(Y;JCLT\9ZY_<3F6#I_TRIFF_M2_"/X.?
M'[]FWX5>/_$T4GQ#_:%^(VD^#?AIX)M9K74M8U.?4-%\1_VEKU[I>H7]M'8>
M%_#WV'4/M'B>VTZ_M-4/V;[%;PD,)/FC]I7XT>/_ ('_  [CUGX4?!'Q?\?/
MBWXJU[2_!'PU\ ^'XQ::3;^)]>_X\_$/Q,UYV,/A3P!HV/\ B>:JQC=A_J9K
M;%6OV#OV$/"/@?XY>!_V@_VESH?[2'[<'B;Q5+KOB3X[>)K"2XTWX97T=I/9
MV'@'X Z#<E['PGX&\'Q75RT4%BD]Y))/*U[JMVI"CR<]G-X.4G*5XJ?*[NRN
MM=$TNBWB]M+=>BDE*<:<DI4Y?%!I-.S5NE^KVDM^O3];_'J-/XUUY+Y))+*>
M]O+)$U:!9+:\,-K9VFIZ<TNH-J5ND?E6436EY;1:EM=I/,M95*JG(W7PO^%N
MOVK0:W\-/AMJOFC%P+[P#X0F:YSQ^]D.C"1/80/!^F:_)+X)ZK\;]+_X*=?\
M%2M<\%>(?BKX]_9 \/7GA:TT'P9XM%HUO=_M@?V-I/B+QMH'P*FU4"32M(T>
MPOK?1[LZ25T<:WXATAI(VBTW4+>]Z_\ 9M_X*U_ 3XJ^/8/@/\=M"\9?L4_M
M5Q7<.F7GP'_:.73_  _)K]Q/>8MM3^&GCLSV7A7Q[9ZK8_O-$L(+G2Y=4F!>
MVU%X\(>'"U<5/+\-.%:LJU%?N>6<X.&D&U&,912UBE9QDU9+0PK8; NO[&MA
M</.B^96G3A)*^F[][7K[SV//?VO?^":=SIC:C\2/V>M-FUKP>[_VSXB^$X#S
M:WH?&/M_@JYD .J^'C_T"9%N=2]-2ZBOY[/C9^S/X&^(FG75EKVC0S36S;+>
M4P2PZII+#^'^TR([RWU$?] 6^2ZN#_S]]<?W<PZE<6\\>'V74 -[MC-UN%O@
MY.GSR&"TN(_^F5JZ0GIY>*^'OVJ/V'OAU^T?#?\ B3PZ;'X??&0I]G@\01:=
M';>&?%][U&E^+](LXXH;F?\ ZC&C2Z'<$_\ +QUK]-X5\0<7@)X; 9Q&>)P5
M2T*SQ%Y)1C9+G;2;24FU)2B]^;F:YG^;\3<%3I5)9GE4N2<.>=*-!<OL]FU%
M*Z]ZRT:ELK6Z_P"<?\9_V9/'GPJNKG4=*%QXH\(O_J[VW1CK>A]?^0QI2(CW
MW_;D;/O[UXKI5CK&HR"*SMI[V9\E(+&"_N91VPZQV3']!_A_3_\ '[X#^-_A
M=XGN?A]\3/"^H^'O$ED//:REM4N]-U33<_\ (4\/ZXL4<7B'3,_\OL<J=,?9
M\5\7^"/ ^B_!_P"(\7C&/26CT>4^9K>F6S--%:Z=_P!!/3(YA,T2=?\ 0KAK
MJ?/\?%?HW$&4QQV58G..$J]"M75)5%E\)IJ\HN45"/-.725]7T/+X6XGFLYP
M65Y]@XT,).IR8[,:R<:BC%QC%J3<(WLY-^ZC\Q=&_9T^/6MI ]G\+_&"17/^
MJGU#2I[",'_;\SS#] "._P"/?3?L=?'2VLWN;WPO9?:7_P"/?2(_$?AJ&Z_[
M:W$NKR0_]\QKT]:_M.^ >E> O&/@O3-9TF'0/$VAZC%YEGJ=K*9K,/\ \^EL
MCR2R3W_/_'F9(9?85T/Q/^%/PXDT>ZDD\)Z.N>%D2S@22/\ ZYN$W#\2U?R3
MGW&7B+0G6P\LO^K8N@ZL5%6C+MHG3>]ET>Y_9_#&'\"88G!PQ&:9A6JXCV47
M.G3E*AS2Y5.,Y)VY;RLM4[7U/XT?!G[%>J^+]/M;7XQW,&A:?:7+W-CX:\*Z
MT[O*)?\ 7V^LZT!<64UO<?\ +9;:QLY&/*R+7;^)OV8_'WA[PA!X5T/QOH'A
M'P39ZEJ]W9>%_#=G<S0W^B7LWFZ?8ZS=M<R:MJ&J:[%_HGB&674!'<6O[NP@
MTY_WE?KU\?=)^''@#3KS4;>UL])O(_\ EK$T<:R=OWD./((_W(DYX'-?D9\>
M_P!IFQTK19TT2>#4M6E'_$M@MW!!E'^KGD%M)$S30'_5%&1!_%&W!K^=,;QM
MXAX[/GA<1@_83]K:I4=DZR<OM7IV]Q7M9+XW>_3_ $+R+PA\"I\"K-,9FDJ.
M5O+\16C3RV#GBW4]CS1;@JM65^:S6F[>G;V7]G_]A7]F7Q3XBT_3_&MKXC\0
M:E>)%)'I2^(/[&T2VN8DV?NH-&L],N4WG+R;KUF:3Y@5'%?HSX\_9P^'/PKT
M33_^$*\/V>B-:P?98KF3S]8UT6O_ #[G6]3EO-5\KIG%V&X^\:_(7]D[4_CW
MJNH+K.K6EC:W$LWG6LLFMVX>)O[N1,N$]NOJ>:_:ZU_9X_:"^,_@AKW1_'NF
MV.JQ_P"I@:ZCOPW?YYXOD/\ P';7[WEV/S-9;A8XJG&.)4'[U&4E)N48WY^6
M25]K7CW/\J>/LNP6$XDQM/)J;Q'#TL=BHY3B<1%QQLH4:MIO$QO%QY5*E[.\
M%O/XNGY,_%'Q#_PD^D>*/AAH$IO]8\8F_P##%NLLJ1W&IZYJHSH9-Y,&N["V
M?_E[!G#OQY<D)XK;^%__  2J_:0\9S)_PG.K?#3X7VJ?\? U+6)?'&N=O]5H
M'@.TU:$9_P!K6W],UZ]\1?\ @G/\?_A]=:GXSU5M'U:ZEO;?49-4MKU[=#>V
MN/L\X(8&)XOX#"T>*_66R^+'A3P1X%MO'?Q#\1:;X7T>PTBSU#6]0U*[,%M%
M,UE9M?K9Z9]H1-6CBOVOHHUM4#K%%$CN\BO))UY7AW6JXROC:LJ23HM.<Y+G
MNZO-O+[-EMW/C,3P+@>(L3AYN%2OF+?)1HTX2FJW.X*U;E>T+1Y+<OQ2U?3X
MI\'?\$>?@EIT=I/\1OB'\2/B+,T!E^P6$]AX#T<MCI;6DMEJ&I*N/^>NI2GO
MUKZ,T']@?]B[X3V!\1:E\+/AIHVE:2GVJ]\1_$[7K_4+"VM/2ZOO%6JV^GM-
MT&=*T?55_P!FOA?X\_\ !9.RBCU3PY^S=X<\ZX,?E6GQ \7Z?%-L3DYT_P /
MSO'<H?>6YG';%?E;X@^)?QS_ &I/'NDZ;XJ\1^,/BUXVUC4/L7AOPFXGUIK6
M0OY/V+1/"09-(T^YQ_Q-39A8;'^S/E_M_P S]_7=C,YR;"8?V&&>,Q&:U:U&
MG@J6"@ZJG:3555URUDE>5/ET5USZZ:?N/#GT8L7AL"LZS.IDF6X&6$K5<1'$
MSC3JTXPI\T;1J5[IM-W5MTC^D[1/VG?@-XK\1_"3P'\*]#T'4_@EH/Q_^'W@
M+Q)K5AX4C\.>$->^(%[K5KJ.GCP)&JZ-I/B&#PDNFPWM[?:K:WEO'<:E:2*(
MTW(W]&UWI)6ZN(Y!O>"3S;E^,R-CID#!7CZ^IXK^0G]BKXU>!/V;].T;]FCX
MK>&-"^-'@KQ7XPM_$_Q%N;1K>Y?P7XAO[.6RNM'\#2Z@+RVU'4Y$N/"\O]JZ
M;JWAC9/;2.NU6")_83X;U32_%.@:-XET.\&I:)XDTK3M8T;424\O5].U?_CR
MOX+I&>$VRC_7_)NZX9>W5Q1D^=/+L/4S&C/#TZU%5:6&G'EE%J,'*4X\L7%O
MFBULKWT/R5PP&5XZM@,CKQQ-+ XJM"K6H<OLI-SM'DE&+37N3ZO\3P3XO:#%
M<:'=.UNF6B\G*0PP[5_O'R8T\Y_>X\\>W-?R._\ !2O18]#U"2\0,GGZGY\\
MFYFDG/\ SS>=BTRQ_P"S#)&W/#$YK^S?XDZ?%+H-Q@,<?3MV'R_G^?-?R8_\
M%5=#@ATR:22.*,0WGS-,"2 /7!7L?3_Z_P"19EA>?!8A3BI.249MI^\H\RBG
MJOAN[6MON^GN8O&5,1AH\R<907O.[3DVEOMLUVZGY-? #6X[SQYX>LW9Y)EO
M<[Y.I^N-N??I7]D'[)&EVW_"/:,Z1!F%N)><\MZ'&,K[=?<XK^,+X!26B_$C
MPTT4D89[SEACUZ@Y'TYK^UW]CZ,-X<T?;\W^A]^??IC_ "*^:R'#4Z>)5-P7
M(W\+O;1OO+S[G1E>(FYT(U)RE%4ZSBG)I)I0=URN.NV[?H>R_%GQU<^$=.E=
M8)RR=#"P&>.X 'KZ_P!*_.[6/VEM<N-5E@62ZAV=!'*Z]^^9#QS[?2OT:^/6
M@I?:7<8@1,V_F_*&^][[BP(Z\=<CK7XE>/;(Z/XFN'VJ(N."3N[<9# ?A@U\
M-XO\0YKP]@Z5;+.5*/M[MN*]E;V/+R7B_BN[WO\ "MC^O/HW\$Y%QQFN,HYM
M!2='*L?6C=3G[2K#^#4G^\7O4+/V;5E[\KQGI;]!O@_\8M;\4WVR.;4%89^6
M:?/8]NO..W3)K[TM9Y[[0KAI89'/V?S?;=Z<Y.WVZ].>:_(G]F'4XY?$'EN
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M\V?J/O=!YH[;37",'D. [R?:#L9XC]JZ?;3)$Z2M>Y_Y>7D>7_;[U^6W@/\
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ME\4=9NYO!_A;PM>DAM0FN4L=2GVD0:I$#MK\._V?/&_QR_X)_3?&)/!.N_\
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M]^VW^TI^SS83>'=?BU'Q9:6D?E1M=03+?NH[RR^?# Q]UMU^E?"W[8/_  4
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M*]T]M&C[;^-ULTVD2,N5WV?S;, =<\9W$?0FOPD^,L;Q>+'4[RK\E&P0/H
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MONO&TB2#!SE'#[K?Z6Q@&.,8&:]_\!_'OQ)HKI:>*H+GQ!IB$X=)%BU+&?\
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MRG\1?M3>/;07>LWZ>$K75M/O9[2*\U.5(CK7BI;A[F31U#?K=^VK_P %$_\
MA4G_  4,_:N^%_Q2\)K=^!O#'QEUC1])\7^#HRNLZ'I4NG:!=BQ\1:%;S_9]
M;A20XCDBM+:X"<&=C\Q]B\#_ !1^&_QF\+W5_P"#?$WA?XC^%[JP:QU33939
M:A%;0%P\=CJW@;4?-F6WA"1)%Y^BW<Z1I*#,QOM1-Y^:Y1D%>GE-+$TJ3Y:J
M4HU(J7NV2;L^9K7G\]EO9'UU3-,-B,=*"DH.-N:E=:MO31N^G+;7N^[/G/\
M8?\ VQ?VIOVG_P!HB]\2-XV^'LO[+_P'\ :M\//B/XQ^'O@N6R\&_M,_&_7V
MF676?AM+XMM[C7H? _AEH[K?KEC?VD,8TZP9E8>,-*.G?M9K?QW\)_#KP=X@
M^(OQ*\1IX<\#>%%2?Q%K-U.SSW&L11^1;Z1I#S/(VL^)+>U_T6'0(5EA6#Y&
M5F^:OA.PU'PSX;\/ZM>ZC>V/@OX>> =(O]3\1&SM=)T/0?"FFCR_M<$6GJ\5
MA;IJ?E0?;XH;=(W^S6OV=;?[-!Y?X$?M>_MI:_\ M.>-8=/T^63P]\'/!4_D
M?#7X?P27Q2\7_H:=>MKQ+=4U?I_Q,KN6:7'\-?:\,Y%3Q^*P]+&XSW%.#E2F
MX\LE?JK1=E;OU/(SW,\5@\)BI8>C)7@U"<5JM'L[2WOV/H+]JS]MOQ9^UG\0
MU\1ZR^H^'_AYX8$]K\,OA\]QY0\/Z==_\A#7KC[/((;KQ+J&1YU]-&;:'_EP
ML+,'C'_9K\)3?&GXR^!/AK;6JZE'K.I2C5;1+DH!I-C_ ,A RR0*C*3_ ,N[
M$E!_$LE?G/!K4*^7M?:$3RRN^1A(G]QR[LY4#J%93Z<5^QW_  36\:^&_@9X
M>^(W[2'BAK._U>!8O!GPVTF6.)=1UGQ A_>/!&P65[.Y/_'S?0O%"_\  8Z_
MH7B?BCA7@S@RM&=?#1=+!5\/",91ARU:U-1C)6G%WYM=6]=;:N_\_P"3\(YY
MQ)Q9A:F(HUGA<5CZ#K5I\SC&$:J:3?NI*2;TTV/UJ_:L\=6GC+XU_#;]E#0K
M:#_A3/[+WAC1O&?CEK(@Z5J'QY\8>!M0A\':$7A86ES!H.BZI?>)Y-)>W,.A
M:S,EO?>;?6]J8>)UBTMK?38]-M8UQ8Z3;Z?;HP0H-.M;"'2[>P?"J3!'IUO#
M:*^1<^7'_P ?&\LY^*O"/Q=TZWDU+4+V]6:^\3ZWK_BKQ)J,?G,VI^)/$^L_
MV[K5]<2332R.]U?#$:F3%G:?Z'9"WM_D/KMG\2(=5MUG348"9X_*;<S1L%Y^
M[OE.#[G<,=NM?Y2<39]/$YACN:O4J1K8G$5TY3;YJ=6;E25[[16UK;ZW/]1\
MAQ,,HRW \,8;"TZ>&R_#827/""Y:E6I!6F^93;E!TVU[UKRV?3Y4^//PZL->
MM=6CN=/%UIU]#+#JMG@+,@?_ %;6;(H-N]L1_HQ4,$S\P<XKY ^"_P"SSH5I
MK\1UV>>:Q2;%YK,D(-V\']]UD1ANY/(B"^JU^HU_+I^M(4RDGVK_ %LCE2YQ
MZ<!>O'(/MWKP7QSX N;6'4;W29+J%;FQP]Q8%DND//S1[DD@#?[\##VZ5Y&2
M\30P.+A&NE5IN45#F2M2U?,T[)^]=7YI2^%6MK?T.*,DQN;X"I7IYC6IUJE"
M4*RC-1]K344J<)*,8QY8+F2M&+]YW<NGTS:^ ?V6(/#::=<6=FZ1VOV03S6V
M5*<?.=FP>9Q][A?]@"OQ?_; T/X+>'O$L4?P[TFTB,6?W]M#.KR?]=6><JW0
M\JJ_3)Q7TMX<M_&+;K/5));NU,W^BRQ-/]FOX,<LH:1VM6SWG9Q[5G?%?X Z
M-XGTR/5OLRI<FW\V7<)<*WHH!W@>Q<GWSS7[+1Q>%Q5".)I-356*=KMJ-E?3
MWG:]^EMON_ES%X*MEF)>"FWRT:E1P_Q3DN=[7O*R;NWY)'RC\/[:34](@D"9
M=/OK)'@C'7 $@_7(]^,U]%^ /B5X?^'PU;1O%=LFL>'?$.A:WX<URRFB@DCN
MM*\0V$FEZK PN/,&;C3G2T!(;9%;6^%WH[OYQX!^!MQ'J/V-->>V26X\J9&F
MD01KZQY/RG_>#\]O7WS6_P#@GS>>*[ 7K>)YR;C[RQ:G&D:_[@-JS#OU9A7D
M8JA0Q=;"QCRPK4<52Q5.>O-%4)PE)J[:TLMXR1ZV!SB> ;C7IO$X?$T:F'G&
M=^6,YQ4:;O'DDG>3M::VV9^1FJZ;;Z1KNK:7;WLFIVUAJ%[IUI?"-YO[3TZV
M^XK[I&@W'C<]M% #V"UT>E1J\9<Y!&,8Q@<^X/\ .OIK]H/]B_Q9\ _!NG?$
M"WG&M>&3KSZ)K$S7HDFT*ZU=?/LM5D,<4(73 ?\ B53"1'?^U/F698_W-?-.
MDY\K"<^N?K^'\J_NKPYS:AGD<OQL*GMJGL,+A:U1M-R>&BX13Y>6/NOFM:,?
M._3^?^-<)4R]XNE.\9RE7KQ3LW&%9J4$G)2=DM%=O8]$\/R,MZ #QP._?'H?
M\XK]IO\ @E'XZ\/^#?VL_"FB>(KS3+3P_P#$[P?XH^'NH3ZY?V^F65OJ>LZ9
M'K&B3WMS<(]N'&K^&+&VF8IM-I<WT4:1SRP3V_XH:-,D5W$Q(RY&<]!CTZ>G
MK7T!X>NHX[6T"2D2SZK]FTV0.1-:7:O>-'>13J5FCDA%Y,D;B3:J+&"K$,S_
M +SQ9D+XFX>JY!%^R^O4WRXG6^'E"*49)\UDVYWUO?E/YORC-GDO%,<>E;EJ
MOVDE:_+?9Z-6=WT1_73^TY^Q!X<^(.GW5Y9V L[N:#S4N(;*58RW_7>*PE0J
M/IZ<]:_E]_:W_8MO?">KW=GJ-HULB_ZK5K>R=XW]=[>0X..G !QR*^[/ W[;
M/QOT6QMM+L?B?XR&F"$Q?8+K6+J^MV7N2;R2><M_VV'TKUF']H?6_&,(@\9O
M8>(H5QE-4T^VF!Z$Y*A#^1[\^_\ (^8^ N9X&O.G+%5,7"$I\]>6OM8M^Y&3
M48IJ"O:UMWJ^G])X;Q0RRK2I1E"G%12=KVO*27,_BU;:5_4_&3]F3]C#PG)X
MSL-8U?Q%;*YU'S;6"18R0WI)OCC...BE".3D8P/[#OV6_!&B^%]&TF*RN[62
M*"S@V2SW$04_9O\ 5[A%$,Y_CZ9_AVU^/DP^"FHD7%W\,/A^DXE\U)+30- L
MFC;T0VNGPX7Z@GT/%>Z^!_VF)/ "0V_A;6'TIH(Q&EO/9-KEL5]63SH9"W&.
M)0/;T^.QO@-GCJJOERA%/F<E/2^W+RIO7K?7L?18'Q$R)J4INE"2Y>5\VK^*
M^\WV7WG[I>+[N&VT?=YB.3ZDQ_\ H2^O;K7P_P"*O%&GOJLD$:*,7'E1!@<L
MN?XL$<^XP!W]_G#6?V[_ (F:C8^6VJ?"G4;?UU31/&^DR_4&WDU->W]W]!7@
M.L_M)Z[>W<>I7$GPGL9HY?-"?VMXO>%F]&4:$7*^PD![Y]/+EX$<7XFM!2P>
M&7*VG4:OS7MJU)M.UOY>IZ$_$_+*,)2P^(26\^2=MK\MW%IK=[-?/I^IGAL8
MGBB@21E<Y,D8M7/X-Y^.W<=P:^IO#<LGV5B $6'F9P+A8^G2,26R$?B6.:_G
M*UW]L/XA+;,(?CCX"\-Q0<(/"'@Z]U^]/^\]T^GQ^G2$5YE:_M;P:QK^@Z;X
MS^/_ .T!K>FWUZ(=0ELM1TCPW +?^_&6L9MKCU?>O^QSSZ68?1^SS+,MQ&85
MZT*-2A0GB8_5U%/V="+G54K1:2MRKX5UU.;!>*.%SS&X?+YXB5:C[>G0]E.J
MY1]KB)*-*6_,W%P?+>;UZ,_>/]HS2KO6M$OA:ZA%"DT&(#)=6<):#^\2)) 6
M]P O^SSQ_,K\9/V8#XE\5ZO=:_\ $O2[2%G^UQVDVJVD#R0_W%#//F0XZ#U^
M[7[;>&_VT/A5';:=I;^)/B=J<,-K]DDFO/&6FZBY3IO9GT8IY@]=FW_8R#7Z
M > M3^%-_I7P8\576N1-J_C-?$WQ OE\6:+X.U>QM?AIX7S]IUF>&#PS93BW
MO_\ EP+W3+)GA7P<_B.%JRQZQ%3#P]I&A6EA96UYZE*4H2;MU;CKMZ'Z[F?#
M^,RE4\765*O44,.U0Q+M[>.-2>'27-!M4N5VL].97O<_(']@[X6>'O!.CZ1:
MV&I)JD62R30W$#-*D%GNNTM8D2.UN98[_P#=+_Q,8 (_E8,_[ROW-M(=_A7;
M!EA]B'^LY/\ XZ%]O\37Q/XYD_9&^&K?$/Q1X1TNU\(Z[X=^*O@./Q)J>C1W
MVD^&+BT^+NH7'B_5? A\+7][JFD6OC#X;^ ;2ZU+Q*^DVVG6D,ZVN_3(%OHK
M9/3OA]^TUX:\265WH>I^'?$N@VZS:S:Z+XQLM-/B+P3X@TJU/_$M\1/J%G+;
M:CH%G-_RWLKS3;RY?_EE-%Q7T-#@GB#&T5BJ>!J0IR3<)*$O>LDWJUT7+TZH
M\7%SI9=6CA<RJT*&+G"-98:G)7A"I9Q4HN3DDU91O:]F6_V<=/U-?VY?AA.U
MT/LT>@_$2-XP>"+CP7ER1TW \1]AW#<&OWHK\+?V=9X;C]M3X=WD,J26D^C>
M//LTB*Q27_BB_P"/YB;3'I-NX_"OW2KP*N'Q6$KUL+BZ3I5*+2]Y-.5[I[]K
M+TN:0E&2YH+W7LUU"BBBI+"BBB@ HHHH **** "O\W?_ (.0KU+7_@I_KD^R
M)2_@_P"#@+88$8\&'@'<.F._'Z5_I$5_FF_\'.%V--_X*0:]=NV&3PA\'-O/
MRG'@P]<8///&X<?F.?%T(XK#SPTHJ:J.+Y7M>&J>C3TOH?H7AM4J4<^E5I3E
M3J+"UH<T;)\DX34XZJ2M)+73T:/=?V!I8I[;1XR&(Y^;<-_IZ8_3_P"O_0=X
M/XL;<=?]# YYK^8;_@G=XSDGBT(>:"[]0I;'_ ?F[>Y-?TX^!;F*ZTJWD5OF
M,8BP/N[1CGGG=^..G%>?1_<UJ-"K[SBG%J79645I;9;?J?,9TDLTQT$K06*K
MS4>BG4FW.6[UDTF];::)'%>-'5)K@A2>.A''?L/3\N.HKB/#&H61GNT>)5$G
M4B-0W/H64C\P?UX]6\6Z=Y[7+?NP1GA1QS[')QZ=C^=>7:5HY@GN&VX/'7''
M(]ATK3,JS5.<:4G"/51VVTW3\^IYU.,5+F27-'X7U5][:^2Z'J_AN:PDN-H1
M<#N$C#>^3MQ^G>O>+9(?[/E6, !(/- &.ON<#Y?I@\=>*^>?"]H8;KY3N]0Q
M!^G0 ?\ ZOI7T#813)87&"IS9]^?Y$=N>OO6&"DUAY2O=\NJT][1[Z?EW.NC
M3E7Q>&<VW"-2/.WM9RC:]K=GV/D7XL2V,-OJ$E]P#[J.>1_$#^G7\.?A>]U#
MPC.TI0D2)]T&$ ?B-V?7_/-?8?QZL)M3M=0M()A"_(#;@I'ODY _$=>>_'YL
MW'PAUVYO)&@U*\4SMY<5F)R=0FY_X_;6VP!<V7;'F0/C_EI7XYQ?4Q.*J5\/
M2P6KG\2B[RU5M=]/*V^I_H[X.X[(<!D^#^MXZGAH_5DO:N<5[)JG*]N:3C[S
M:OS)[:6/TF_9_O-(D@MX+01-)ZDC'_CI'/?&:_0B*..;3\Q+*Z=.8_+R/^!'
M&/?&?SK\#M!_:C^ /[+J&P^*7Q1@/B:Q_P"/GP1X3@;QEX[C/_45T;39(+#P
MGW_Y&?6;#N/89GBG_@O'X/M+&YTOX5?LT>*/%$D?^IU7XC>.-/T*-NG+Z)X6
ML]?OB#[7R^]?>\%+&K*:=&M"5%X=0Y%;E^-2YK/E3=N5;N5KZ6/X]\<:V#Q?
M&V/JX2I'%8>52KR8E/F5;WH]8M1]W^ZH[ZW/V1\:Z.EYO\U#F3KM6.3'TPF!
MW'.>OO7Q'\:H;+2-,E)1!Y%OYSAX;< L1T.V\7CVX/7DU^4'B+_@N-\?=0:6
M33/@G\&_#]LGW6N=2^(6KR$>YMDM!C_@(ZCTKXJ^+/\ P5=_:$\;V]U;WWA[
MX2:;'=Q^5(VGZ'JUVZKZQG_A)V4-TP65@?3K7U?U9NK&I)7:=Y-[O;_@GY+2
MJ1A3G3>S24%VM>]OO7<^B?&/CGP_XG\>-IQ\/P3K!/E AE*F?^ZVYW!3G! P
M>^XU]G?#_P"!^G:KI]GJEK;S0326_FF-K2$(&YX53<;@IP>"S'MGM7\^/A#]
MJ_XJ6NOOK%O8>"K^[DNA=L+C2-4DB#\C8%378W\KV,A;ONK[=LO^"HW[3VG6
MT,=GX?\ @_!'!'Y2)'X/UL*5QG+ >+OO>XV^N*]IN%:A[+G]FXJUE9<UU;MT
MM^)Y<L*YUU4DN91DW&_2[UMMT1^B?Q&\,7_@Z.-(K&ZD63K<>7$P7_=,=PF.
M<GOZ9JE\$M2U.;Q=9+<6KK&_5G:(,,>A-WC]".U?F1XA_P""IW[3.K7B'4=%
M^$<T:=+<^"]3,)'NK>)W?Z?./IQ6;HO_  4B^.6FZC#?6GACX1130?< \(:I
ML./[ZKXG5C^#C''X?+8G)9*O"K"3E>4FVM;;6ZO?4]Q8F,:#I1=FXV:7H?V4
M?!H0R6%ON$L7[KROWB0'Y?7B\'S?IZ@]*]SU'PAX?N/,V:BS>9][R&-Q],81
M/PSGVK^1KP1_P6D_:B\-Q)##X%^!NHI'T-WX:\16+'Z[O'!'Y =*]WTO_@O-
M\?5EW:[^SW\&-?MO6PU_QYH,IZ\DRP7*]O[GY=:]:E3:A",US."M&_2^]K6W
MLN^QX,Z$U5<DVE-ZVZVV^ZY_2FVFVNFP^5%.7AYPJE"W7U\OI]1^7;FM<F"6
M5PR]?0EB/R+9_ _45^'/A'_@O!\-;^YMHOBA^S_XZ\+R2?Z[4/ WB'3/%]FO
M^YH4]AIU^/HVI-^%?66@_P#!2S]F#XGZ7<MX#\;1ZU=I_P ?6B7-I)I.OZ;Z
M?;].NYBSXQ_S"7U4CBNEX_#8"E.MBZE:%.-K*DDT[7YN;W);:6U74]S+<@QV
M<SCA,$Z2J5*M",HU'9S4I/W8ZIM;WLUNM3^?[_@Y0^&ZZGH7[.WQZL;17N-"
MUGQ5\(-?GB!\Q+#7[:S\<^$8[@+T2UEL/$>G*S$Q"UEB@6-9_,N)/Y#*_MZ_
MX*T^.O WQV_94^*G@W28KF;7K2W3Q[X?26)8GCU#PCJ$6K/+"98W&YO"UWJM
MJHCQ(3M59 H='_B*D0)C!/;KCW] /2BAFN"S2#J8.=6<:;M/VB2LY?#RKECO
MRN[UU21T\49!C^',?' 8W#TJ"5*$J2I7M)\L?:.3<IN]W'>77H&P>I_3_"ON
M#3])M-<\&^%-456<3:+!8R2Q%#(EQ;?<#$HRAF_CRO/10O4_$2_-]WFOO']F
MT?V[X&U_1682W.A:M9W44;G)%K<9\PKDGY0>5V@ <YS7Z/X<5$\]^JRLUB*=
MU%ZIRI*5G\N?37[S\ZXEJU</EDZ\)RA&%6FJG+97C-VL[IZ:/:V_W>?WG@]V
M;<J1Y],'&?3@Y_4_IBL&?PA'&FV2V8MQB12PD]N1\OO]VOJ$Z$B.5:(X]P,\
M#U*GCMV_2L272,2%3%O'3Y@"?Y#^7X&OVZ.%;<U-7G&I-.77EO[JTMHK::?-
MG@PQ=.2BZ=HP=*E+E3TYFGS/5RU;W/GV'3+W3;E+W39GT^\3[MU:,T4G'7*$
MM"3GTA'Z"O8M'^)>M)'!9^(8%OTM\[+NQC2.[8_[<C>9"WX0KWZ\4ZZT>)<8
MA'T(';Z ?R_D*SX],AB&(X43W!.?KR35>R]G.&^M[:OHUY^8JLH5H.\8OE\E
MU3[6['KMAX@L=47S+"[$R_\ /!EDCN/_ !YL?^.5^GW_  1QU"5/^"I?[#MJ
M ICG^.>EQ,6#;@O_  BFOW>5.X*#YGR\JPV<8W?-7Y%^&HS'J<095S)U. I'
M<8V;5]^03GIZU^O7_!'"-)/^"I7[#LI50Z?&_3)5P. W_"-:_:=#DX$9W8!!
MW\YQ\M<G$,'5R+->9N5.EE>,J\K;:56"I*G/=>]#FG;6WO/1]/.H>SI8J,81
MC&52]FDK^Z]=[]R3_@L%KL.G_P#!4O\ ;AB9Y(A!\<-3E0Q,8W9_[%T#_62+
M\[J>3AB3^%? &@^/M3\*:S;Z]X4U_5O#.O6<OG66N:%?2:=JULV,[3J$.+B]
M7VU-[XX[U^DO_!7/P%:>)/\ @IY^V]=M?RV<\_QSU2)UDMC)$%_L70.4"@,&
M^KL,]LU^5>J?#^^L;R\M;?7-+NKBR'[R"?S;!SQ_#YKR@]AG'3W-=N5Q66<)
MY5BL2E+!ULGPU;V4E[CJM5/:5'HI<TUR*3Y[>ZK)6U\REB\-5SZ>%A"*Q"A4
M<IJ_-S+X7\5KIIV]WU1^RWPJ_:1^//[0GPHUOPSXP^'?@']H[PGI%X_AGXK?
M#^R\1Z?X1^-7C+1]0T/2[U-0B\+$KIFKO%J=[+#):7FH^&)%MUC0CS0TS_-6
MJ_LN^!_B=_:)_8S^*EKJNJ:6/M/B3]F3XY7NL>%?B7X,NO\ H 6-SK-O>:GI
M5OC_ *&2SU_PP/\ HHM<1^QAXKT+0/!NJ^"/&][H>A>+]+\=:QK>@K/JVFZ7
MJ!EUEK-GNO">O6\]NSFP%E"FFQZ8UE;PHT@FAN,H4]\_:0^,?PW\%+X OOCI
MX6\3^,H=8U>\TSP]\3_!$R>$OC[\,I[;3Q=IXQ\*>*?#ZP1WMNTG#Z?#?("@
MP K98_A69\6YCE^95LPRVJEA:>(II4I3480BYRNH:7M-:2UELM5K?]7R3))9
MY@:>!JP5>O5CB5[2<>:7N*/)MR_#=VT^\^!=3T[Q)X7UZ\\)^,?#^N>#/%ND
MS_9]9\,^*;1=,U2UDA_X^Y+$0S7T.KZ5&.5UJT<0+U:U:OIFS\=:IING65JL
MDIM=,0PZ5;9D%OIEJ?\ EUM(XWC41GG][-YUW_T\UR/Q9^-VO_%[Q'X7TK5O
MB;;?%[P+\,H)[CX=_$C4O FF^!?&^J6>O:=]KNE\71VMM#>:QK,$F5LX8/[/
MT>-#B72)VRU/M+^RGA^659X">L:_O.W?E>/]T?3-?G'B3XC8[B"JLNQ=&,,)
M[.,G1ISDZ=>I:-IU$I7;IM7C:<5[[NGHC[WA#@NAD^%]GBH4L37E7O><4Y4O
M8RER6<7!KXO_ "7J>OZ-\89%E-I/?/!:F7SMJ$J0>A4%F8!.>A!/^UWKWOP[
M\8DGO$2]!$"?=4S%P<9Z^2Z#'TQ^(KXGNO!MEJES%!:ZF(I'X)BPOY95O?U_
ME2V'@[Q?X??S;"Z^VP><1F5I"_D9^]DNHW>^W;Z*">?P[$NI5J.I5BTI)1A>
M_P ,=$EMI%-);OS/URG1J1=*HFT[*,GI=QC;EBVUM%7MZO5GZW^'/'L%S!;3
MV\I89!V[B3U]FS_GBNWE^(<ZR*K@M'/%Y3Q; 8PO^RIR0P]R1[5^:7P[^)4>
MG:@D&HS26R)T@F+2/ZG.TJ/T'7FONKPG/:^(?LUS!+!<6^TR[H7#RI&>,O#M
M+ ^_ SQ@FL*=&BYJ].+DVFEKJU_V]^1]!2Q5!T94Z\U'W4E*3>ETU*RNEVZ'
M=6M];:=K$.L:191:I:W</DZQX9V$&5?[T4N5$3^Z$#VS7O.A6N@>.K20Z6L5
MU92Q>1-$5CCN+*;_ )\Y]R[1<_[7EA?]BOD3Q[\4?AE\([6UG\:^,;#0[N;_
M (]]"MIX=5UZ\S_SRT^R"3+Q_P!!.72*^8-#_P""DOAWX>^-KV^\&?"_6_$F
MD^*+*\TF:U\4:M:^'+>'61_QX^(+=;2"^,:2_P#+5I&D5^=@2OT#(,PS"A..
M'>'G]7GRJ*L^5*-[VOZK[1^6<:9!DT\'7S3"U:-3&8?GDZ,7[]9U+-72G=\K
MAI9+XF?3_P :?!U[\.[VYU?38@T93[5@(642#^$"(1'9TP"Q8?WCP3\]Z+^W
M=XGLM/N=*:V5+C3_ +ZS,-S<]L.N?P7^N?/OBW_P48\?^.[6XC'PI^'NDV?E
M"+)U?5]4EV^N;>ZA3/\ P#'MS7YG^+?BAXHN-<DU9=,T2V>;_616UM<);/R<
M;D>^=_3_ ):<]O6OLJE-NO3K0]V4(SB[:6C44>:/I)1L[J^FC1^18:FYX>-2
MK_R]FI/#M:4947[DDOB3?-I[UM-F?I]XS_:3\9_$?PKKG@?Q(8)O#WBJPEL-
M5M9AYC&.1O/CFMR&:.*XM;W_ (F%M(\4H2\Y9)(OW-?!MAJBZ5?SZ7J"^5+:
MW/V6;=&Z_O3_ !)EB/+/T/?GO7G^C?&[QQ:-&PLM"<IT\VQNV'OD?VB"1TZ8
MXKEO'/Q!\3Z_?/K4UOI-I)';?9[I--M[F%)#G_CX"S7MR_VG'\9<IUQ&*_7/
M#?CZCP=B%0KU,2L+4J4ITZ-'6$)0<W5;3A-ISYX_;L[.R1\UQ=PVN(*:JQ2^
ML*G.G5JV?/4C:*I1E9I6ARR4;13]YW<NGTY:W4#%)H9XB\?W1YP*GZ@("?S'
MH?6O1/#VKSM);DR(([:/9#NEQA_^?@\?Z_\ V@ OHE? &G?%7Q-;*522RE'/
MW;1[D\=?N7,0_3O72V?QP\;2M!:0)IJ375W96$)DLI;8"ZN?OE]U[)^['\.,
M$<99NW]=99](7@ZOAYTL0JT)TH4TW)-.;E&5]=-N7I;<_G+,?!C/*N*J5,&X
MM2DW/VCMU]WE[[RO\C].-)\?/9A,W,7R?=W7(Y/^U@#./; ]O7U2P^,D$"<7
MC*X[;B <>HW \CWZ'-?D#JWQ?\4V$U[;1WN@7\UDABD:UM;N*(ZGVL!YE_)^
M]YSU_H*YJY^/WCJP$5S=:%I\B/<>45M[BX7Y>,$!KM\,<]3D8[4ZOCOP-6A.
MCS5'&32NU>VK6[N_Q//J>#O%]&*E!TY*%WR\^G3T?XG[BI\9+4Q<WK/_ -<2
MH^G7=V_#CK5-OBC,[;H[YRQ_B662,_\ D&6,9.>U?CWH/[13W$,;7FDZC;K_
M ,MA:W"(R^H7S1,!WZ@_E7JV@?&+1]43=8ZR_F<_N+O,<O3_ 'D^O3']?;P?
MB#P+F%+#.&.A!^]>-:2C9RY;<OO1OMK>]M-NOAX[@7C&@XQ>#DE#F]ZAS/FM
MR_'\6WV=MWN?I _Q'U(KOBODM8/[EFJ6Q_*+;_+I6/>?$E1%M^U,7]"58>G1
ML]<]<U\0MX^F#86ZN"/^>AC;R/R\T-_X_P"]9-UXZB+>:U^N,?=$K+^DB*?U
MXZ^]?7?V_P 'RI4ZD<QPZ23;M4BNBM]L\G_5GBYR]E##8F,9:5&E+7M?W'MK
MV/J[Q#XSDF#ROJ$K._4BZN9/;@33R>_7(KRK6?$GVF.W022M'&,,T A+I[JT
ML4N#QU(P,>V:\.?QO9(D,<]\Y\[[LK">'/?(@U.'2Y,?\"/;FJ7_  G6G-82
M%;DJTD'FEXHVDA6?_GP2>-YT%UZYRO\ L5\CQ=Q=PC'(<UIT<PH2JULOQF%A
M^\3?/7I.$4KU);MZ66I]OP1P/G&!S[+L;B_:QH0QN$K5J<K\LY4ZG-3E*Z6L
M&Y-6:M=W4C] ?!?Q06_N]"\$^&QK;Z[XCU70=&TPVD%H]Q=:CK^K1Z%:V$!>
M\E N$U"^T]I#M8"#[3\H+(\?[W>./C7I/@S7=3MM'N-0N-,^%WAWP9\/M TZ
MQLY+W3_&_A[X8:79:??_  TT_P 0">.PTS4/B)X[U[1=%U.^N+.2TO;:Q\0Q
MVMK9SV9N;?\ F4_92\5^&?"WQE\)?$34_#WB&:/X=6E[XZT^'4O#L^G:'<^*
M-)TS=X;AN[QHKQ+9M2\8:CI<EHKSQL+2UVB3SE%Q74_%3]I'Q7XMOKOPEHVO
MM8^'#J4#ZE=:=K4C#QMJ]K#>FUU;2(8&"RV-OJ^K:YXC1K>.UN3KNMW]Q)=/
M:1:=8V/\5^&' \L1CI9>Y*2KYI7Q4FU=2IUZ\YPOY)7:VW/[/X]XLP2IT:^.
MY<14P6"P_L74;3A.E2BJ;7)*DKP<%R\T9VZIZW^W_C?^T/<Z[KFC> -$\:_\
M)#:>#]4\7>+/B-XSL+MKW1?B3\<?'>NI?_$SQ59V[DO-X5\+06%M\'O!.I-)
M)_PDVE>!9KJS:,:H;A_1_AA^T_XF\/68TN?Q)J;V<<T4-E=1W6H)/;7; _9%
MNKJSN%E1;C/[Z*>"\C?^!$K\K/!YUR_N;'2].T6;5[F:]LDTS3M+MO-U7SH8
MTB/V#2[14N+MXDC!TZT(DL+>4RW$=G]HFFE?]@_V9OV7-0TGQ2OA_P")7B#Q
M/\ /VK[.YT/Q9^SMI?C7P]I6K?#/QO9Z7IG]HM8&_FSIGBK5!*?[)U?09;S3
M=>M=0YTG3->7,=?VWF>59+P_P[0I4GAZN,P45%X51BW4]JHJ2:3YFERZ^NZ/
MY!EQ)GV>\88W-L34Q6*H3A"$)U9.25.ASJE%<L(12IIVC97[N1^V?_!,[P[\
M:/'?Q@^'?Q^U?4O#4/PXU6W\>::-+BUF>;Q5K-Y_8/\ 8?DW>@RVICT6<7_S
M_8=6U+1-7\C_ )A@;YJ_IDWGT'Z_XU_/!^PEX@U[5?CWHEM\7OAKKGP&^+/B
MF/XEZ9XHT?P]KL<OPK^.L^C>'1/>?$'2-.A\T7UXT0%]'XC&E1ZZ]T2[ZG);
ML8#_ $.5_"/B-.%3B;%5(48893C&3P\(N$:;;;TBVW=];R=[7M'8_HKA3$U\
M7D]&O7JSJ.4YQCSM-Q4;*RM&.FV]]MRQ1117P9]*%%%% !1110 4444 %?YJ
MW_!T]X8U:R_;M\2^($MI#IW_  A7PI(OIF<V]O-8>##YZW!AMV+*O7Y71N^>
MU?Z5-?C#^V)X=_9?\3_%[Q3HWQJ^'FB>+M2?2_#EM)/J^B6FJ>=%+X;^R?O7
MGMI6)CB^:(HRA7Y(93M+C.-*2JR2:IIWOTN?2\+9W1R+,I8NO!3IRPN(I)2V
M56<'&E+=>\F]-;;Z,_@__P"":/B/5=2U31+:P\Z]$/WVMPLF/Q:Z09P!V_+K
M7]@_P>M+VXT6W9XW*_9_-P$<,6]/FS\H],9Y'S=*Z+P[\/\ ]ACP-(LO@SX5
M>&/#LBCY7TGPOIMFWT!@T]/TQZ_3TJ'XG?"_3$2/1;::WC2+RE46QVE?4A54
MY]QP/PY\ZK[.M7EB%&.OP/K'O;6VNG<^>GB<1B*F(JXAR=6IBL15]I+XI4JD
M[THZ**Y8*ZC[JWW9RWB/3)8T=C:,-_)WHQQ]-N#U'0Y[?AX'>:E'IMPZ2-PX
MR<@QD=.F[OCV/UZU]C:;\7/AG.NW5Q+,.O-L<_\ CRL/T]JZ634/V8]>D\S4
M%L"W'$I51Z\;8%(Y]^?QK"O2]K;2][\WGVOZ:]BZ53EYN;6]K7^9\1^%O$5S
M/>X@A6Z0=X5D!SQW+D?IT_.OJK0WO[^P=5@9'DL^059<>PRW'ICFN_AU/]FW
M25WZ4VE0,<].1^00=_>HW^)7P]LVV65U9!?+\KELG;ZC:J_-[]..%%&'I^R:
MCM'HNF]G^9;QTJ$HJG&ZF[RMWC;EO][L?E-^UKJ?B?P[HNO7]AI;D:?;:C>3
M7$ET(+4:=I_WM9FNF1([73YL9C64ES_STZX_E+^-'_!0/XR>*8]5\'> =8U+
MPSX;OU\O4?$.GNT6J^([;G_1;*\FFGN-&M_:U$$F/X\5_0K_ ,%MOVSO"":#
MX=_91^&=Q;1:SXGTD>,?C9XCMI8X9K?P@S^1X-\"P/$(Y+(ZDO\ Q-O$\,HG
MGNM,^6PDTN3]]7\R9\-^#R9&\BT$DW^OD!.Z;_>4DQI_VQ2.MJV78"IRU*F$
MH3F[WE*+;>D?[Z_(^FPW&6=4,,\+'&XN.&DDO8QJ6A97TTI\VSZ31Y[X8O[N
MY21YVN7>?_CXDFDEDFGZ_>N9&:YBZ=;:: \UZM I>/\ ?HDJC.1<(MV[8]9[
MP3W!_P"_W]:=%::/;+MMEC SW"_^RA>?\]ZG+(5V\ >H!S^==5"G3IQ<:<(P
MBK644DEOZ_F>9C,RJYA[/VKF_9<[3FVW>IRWU:O]E;M_(L-#ILP=9HL!\95#
MY8 'IM _,Y/&,&N1UWPSX8F3+VUN&_Z9@1 _]^PN,#WYKHFE1NHQ],C^AKCM
M<EC6+@$^Y)[]CC';_P#56UEV1Q63MY;'$Z3IUM::A*EBI6./H206_'"@'TX
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M93NX\O\ V<EO]JOTY_X*N7J6W_!4+]N [AYA^/&J'YNG_(%T#L-IX^HK\O\
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M\B:(C'J23UZUUUU\%/!5S')=Z6NJZ)<Q0RW$8M;V-D2?3O\ 42@7UM>,'?\
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M-2;7H))O^)K%'#8_N*^B_P!HC_@H'^SCX<^'>CVWB7PQ8?$'Q;X_U*:\\8?
M+Q9JO]C^)/@K\0/#=C_9<NKG4QIZ:UX.NX?%G^FZ7J^D:S#KND]-'U:P%?B3
M_P %=?@?^VA_P3F^)?PXL-6\<S^.?A-IMGJ5O^SM^UMH>DZ?X5\5:W92VP@U
M/P+\1(=,UN6ST'Q5H&GDV1TR_EBT_5-"QXJL[9')B'Y3>-'\0:S\-_"_Q8\<
M^*O%DNN>/;Q[^+4_$[ZO9:=XHLIM<\0Z;<7NFZUK&DPZIXU,^L:9I=Q<:[IM
M_?VFW5X?^):CD%?UZOX@Y=F5:&-Q6)H1K>UH5/W=1-U*4'>M"I'G:MLK<J:;
MEK>[/BWP?C,NPU6AA(M2FXQ<Z<4W3C[UTFXRMS)N^[LNA_5%_P $8/VKOB5\
M;_\ @K+\)=!\?^(]9\81R_#+XRV]EJ.H7EQ<IX=ATOX?ZG8IHNEZA"T:Z?->
M)912WQ@*R2SM(T36ZLJ)_?WL'J?T_P *_P _G_@@E\$?CG\!_P!O_P#9?@^,
M/P/^*OP\TCXN_ KXH_$KX;^.-7\)K+X$\86/B'P+XKU-=2N?%%K%J!\-ZD=)
M2Q$/A/Q(=(\3)=S,TED\<D42_P"@37X%XD9SE^?<6X[,,KI4Z6#G0PU.,:2M
M!U*<9*I+XI:R=F[/KLC])X:RZIEN54*%6HYR=Y.+M[LGN[67Q-Z^FR"BBBOA
M3WPHHHH **** "BBB@ K\@OVJ],@N/CAXH>2WADD%GX6_>R0QO)_R!<?>92/
MTQ[U^OM?E/\ M+12-\9O%%P82\7V/PO^\C;S%_Y OLA_F.<\9XJ*DH*+A-*4
M9[Q>SM\T^O=&55*45&2O&Z=GM>.J?3;U^3/EQ/#FGO\ >M(?^_,/X<^4>#Z_
M_KJY%X:LL_\ 'A:CV$,8^G;KG_.>*ZR&UD]%[\[6Q_+';&/7GK5I+*8?ZL$]
M<[G_ ,$'Z^OI6-J5E&G",8QOI%::_-_F$JE2;3E)MI**O;1+9:):(XW_ (1K
M2_\ GPMO^_:?_$U)'X4T9OO:79G_ +=XAUZ<A!Q[_GQ7<?89Q]Z('_=//ZJ<
M?YX]+4-E)_SQ./7/_P!K_ICOR<X$DMDOZ^\EMO=O^ON.*A\(Z(%VG2K,CWMX
MC].=F,=>WY=:M_\ ",>'K(27=]8V<-C:V][J-_.\4(6#3;!+BYN9MQ3:CI:V
M=S)N;*!E#;=HVUW4-C+TVKGZGZ_W>^/P/8]:^>_VPO$<_P /_P!D?]IGQA'(
M+>YT'X'?$!X[@2D-;W=WX<DTFS>%D5'5A<>)KYD._/FV]B1\L4ZW%PC%MMQ3
M:M;3;[K=D72;YU_75'\._P >OB4_QV^-GQ5^,%['(9/B#X[UG7+"'8J+8^'I
M]:_LOPI8B)Q*4M;7P_\ Z*T._ C^9"A->2?8+;^Y_+_"KUE;3QV:1ER'6+RB
M>-TD83;&K\8_<GYXMH7#\G<.*?L'J?T_PJI[1717_0]1:PC>WW+LO(K+%&O1
M ?KDU9V#U/Z?X4P@!W4JX422*-P;STPMO<0VZ6J(\M]<W%M=VT<0MR@:Y<A4
M((C#Y)-G(BN]O_/4V-]L_+[+G]?_ *Y3Z_+]2)MJUM-]O^&),CT'Z_XURFNJ
MI7;M&.>>XKIHI!-'#)%B1;EMD*1+/=7)6!K.WN[B*RTVWU"[NA'<M?2+9B&W
MG6VCC+2,4=WYS6!YGF[5NOW?W?\ B6ZA^O\ H_/X8K0CFEW?]?(X[2;:-IY#
M\P+]<$<?3(/ZYKT>&S@\L/M(.#T.!P/IGOV->9Z9>+'=2'B2$R7,<<EHD^H0
MQB!_LSRSW=I"\ DAN_DGT\!;H+QN5N:]-M;E&2)96\A'^4W,T4T-FT<\<]S:
M7<=U<I;Q8>TM+F1K DW)9 5D5004TGNKAS2[O^OD2M90'.%*Y_NG'\P?\_C1
M]BA]7_[Z'_Q-:$%O<2R&-()KKR2T-^UM!*/[/G'^N:Z#JT=K#IG_ "__ -I3
M::6_Y9O'5:*:&4*4E2YB?Y8[JSWS1"X_Y\[Z"1(;G2Y_>Z1E_P!FERQ[+^OF
M'-+N_P"OD-6"->@)SZG/^%/F9<^G/^?S]/;)J"2Z$9YBN2@4R23BQO\ RH8A
MCYI!]FR3]"!4#S0S1)<6RW$]F9[V/[2D4\L4]M8.YN+NQ6PM]1NKMEE>#23:
M"TBF^T)/JV[[!BW29>[;ETO>]C2E'VC]ZHX6MU6M_ETL9NL6QDBDX1O,SG//
MITQ^'7/7IVKY8\;PZ]#J&_3V5DS_ !Q[AZ?P[>W^>AKZ+U/5WC27RTEG1,8"
M6FH;CGU_T3'Y+_7'GUR\5W,(RH?+W"-,\31-"PDL[:VBEMY"9A*EVU]'<@,,
MB.,*(V20R<U7&0PSC&H[^UNHW?\ +:_;^9'TV69/]>52-*LU**@VTU?7F\GV
M9Y#IWACQ1>-]H2[$;'^&-0J>O0@G]>AZCI7!?&7PAXCFT*./6)Q<0F&\FTJ4
MPCST-OC:IB+LX1OXMJJ>X(-?7%A 8QM2-%'L#^!SGZ=L=^U><?%_P^NI^'$U
MIH7&HZ7-/ 9HYIP%L+C[\K1F1T,PZHX"H.-T;8K?#S4I7CHI6;MUUT[^9Y&<
MX2IAZD</*JZDJ//>]O=OR]HK?EZWV/F'X'?LL_%/X^W>H^'_ (8:>-5U[39[
M-+G3]772/#-E#'<DAS+X@\7ZAX9LU=<?*IMP0,%@V5)_03X<_P#!$#]HOQE9
M:;JGB_\ :/\ V#OA!HUY#]JMKOQW^U=\,[V>]MOM_P!DW&R\!_\ ":3VLVS+
M#S]PW ?+CBOQ\T3Q5XI\%WETGAO7M9T1I9K=KU;"[F2&^%N?W=S=M#);I#;L
M3AU8;MO1U ^7K$^,OQ01YKQO%>HKJ4SF2^WQ+ 8K7[5]J$BAS):269E&W9:6
MT+[ ,.3AC[>'J4J5G.*;DTTW?[-G?1KN?,RA5;DG-M=G;S3Z6^\_I8^#_P#P
M1+\#_"N2:[\1?\%6_P!AN+3M>4Z?>V6CZ[:ZKILM_DD66GZP_CG0K>*ZP>LE
MO,AQG9GD^Z7'_!+K]E"X:UANO^"L'[+ZRSWODSS0^(_ 2V]K;#^.3?\ $5V\
MSD_-OV]/DK^1W7_B#XT\9K:6&NZU%?V5M=M/9VTFF62V*Z@RE7NA)%I20FX=
M2RO^X\ME)79@DGT^^_9PU_3;2*;4O%7A/39)(+*6]MKN_8FT-P<L9)H;)X[D
MJ!E?LY3:3@ENI_0,JXCSV&'E2R[$SE1HJ'-3J3BH03YN50O!M7Y7?5[+8\?,
M,'E7-3GF$YT9R<_9RIK6=N7GYK)WY?=L[=7N?T!:M_P3R^#D6@>'=4MOVU_A
MMJ&JZSHUYK.K^'M+\1?!W7;WPG]F\0#2X]-U2;P_\4-4BNKXZ7_Q/'^SI"#9
M_,$4&N1O?^">WPN$(N[']L?X>W9\K)@FU#X>V$WG_P!S][XWE^7MC&?<U^!R
M?"/Q5=7=G8Z1J.E:G?7WGG#):!2TZ>5(;6YU&1UU0?9O]'41^2JQX.SSLRUH
M6W[-OB:XFMYKC6="TC3_ #/,O=2U%V#6N#PC:-YL^L%!W#61)/4X'-UN,>*:
M;2I0I57KSWE%VMMLNNO1;'+3P7#]5J-/&XAOI%=;^7)Y']'G_#H?X:;(F_X>
M+_L[9DZ_\53\,<#Z?\76Y_7%??7_  34_P"";O@CX,_MV?LM>/\ 3OVS_A5\
M0=3\(_$W2]:LO!^B?\(@-7UV;^Q=?_XE=I'9_$G5F>\'.0B<?W:_D)\+?L2_
M$3QG%%=Z'K5O'I*RXN-5UW0O%N@06\/'SO:7>FMJ(;.>5L5'L<5^J'_!';]G
M-/@U_P %<OV!K^Y^*?A#Q1J"_'G2W;1/"UKXDG=V&BZ]AI'ATE;=\ =&C*#^
MZ!7GXWBSB7%86O3Q-*C",Z-2C)-I<]*HOWL'IK%\L6]GHM>C]C#<,P:EBJ"K
M3HTE'VCJI\K52_+9VC_+*]GVV/W6_P""@G_!._X5?$S]OC]J3XB>*OVOO"W@
M/4O%WQ1U37[WP>OA#1]:U?0[G^Q= SI5U'/\3=$9+K/\,B9/7:.@\&N?^"9O
M[$^L>'Y_"WB']NSQCJ]_/93F*'PK\%OAYJ5Z(+GA[VTLQ\;;V75(1_#Y/V9A
MW+<5^.__  5O_9S^(G[0G_!:_P#;H\'?#S3[?4M0O?CWJCWM[,8]/T;PU;?V
M+H ;4M?N&A,.EQ_].1W3$CDY)-?I[^Q=_P $^_A?^SCX;M-4DM;3Q/\ $#4H
MOM.O>/\ 5]-"RQCC_B4Z#:WT<UOI^F8 S&();IN]WS7QV9^+N8Y1ESRJK54?
MW"PU.E2E%\M*A&2A"5X2]V'M/=UO[TM6MO<RCPLP^;XZCB\7&>&P]:2E'$TH
MNU-1=Y>]>25_=M?L^Q\_G_@BO^QEX/\ &6A:UX<_:#^-WQO\,60N]2UCP_JW
MPL\,_"NPU6Y4@V%G_P )'=>,/$<QLI< 2QKH(G<<)<(":_4[P'X#\/?#SPM:
M>!/A=X+\.?"_P!:Q>3)HG@FP;2)=2'][7->EFNO$VO/GG.L:U>C_ &:[3[3H
MWASS9[>&">:(V9BF+1I<1_8O]6%N<+<;9?\ EOF4[OX"E>=:W\2)Y(2+*V6R
M@2X\J3SF(<+CJ"KJH;W*X[X[5_.V:\28_-<56J2JUJ<'*3M=)34WK?W-;6_$
M_HO)N'LDR?#?5*%-8QT(TU]:KP;E)V:]V7-%-Z:V6FAK#3M%TAFA60-.9?.^
M8%B6S]V64!9[E/47<MP3W:LW4?$*F- +95M4)"16V8"I_P!ED97'?^+\Q7BG
MB#XEP6,/VF[N5%S_ '1)&0.G89;V'/ /Y^&7?COQ/XIOO*\.-=6]GT\^8-Y?
M'KM*?7GO7SU2E[67,[N75W=W?OJ?04,9"A[11M&T>6-E'W8M-22;BVDU:]GT
MW/IK7M>M9)9;6V:::Z2X$88M&R;1W.U 2WKAOP->#^,?$.KZ;8%K9TAO(_NQ
MBZ8R6W_7'=D+_P ##BN<_MRY\.0@7&J1:A>22^;-(;M$VOWV[DR!_O%C[U\^
M?$KXC:I-!JRV=U;/,MA>W2WK7$)026_^K'RHHV'HPZGLR\UU8#!0J5XPG!3A
M*4>:,KM.STO[R_-'FU\VAA*%9T9.E.TI0E%ZQE*_,X\SFDY75[+6R/SN^,7Q
M/U#QI\3_ !/JTUT;R".[ET>P27S'@CTK3,FQ1%+D@P=BK*C?QH17F5QJ)!R0
MB#H$4$+TZD%B?U_'K62WDNTEPQS+))<2N20<M<GYR<\G!^[DG'\1;K63J%VK
M"5G!AC3I,Y 0G)Z\>W8CGU[?M> POL<'0ITE[."CI&.B6B[W?XGXGF.)]OC<
M5B*S=2K4DFZDG>3LY/IRK[HHZ&XOPJ2,D*3 9\J1'$4;>Q#EB>W1A^7-=UX6
MN?"/A[36U36-7NH]1OK#S+N*TT>74'T\_P#/G (KB-DOL9.YVD3/_+/->.V<
M$-W=7@FO+#[/"/L.E07%\HBFU'I]LNA&(VDTK'\$303?]/'>K8M-(_LV:6."
M6ZNDO/[!T?-VT US6_\ H-7X35HS#8_[I@.#_K*[Z=&:YK.2VZ^IX&(G.M)<
MLGRPOS+2S4K6OI_=?7N?3EH^AW=K#=#5;^#SND,VB2^8O^]_I2@?E7$ZAXH\
M#0W<]L?$&H3"U_UK1>&9>?\ =SK3 X'LWI[UX_XP&DZ#HDEG)+J#:W?2-!9O
M'?W;QJEA9:E_;&L6]O'JPFETL:S;QZ3HZ-+#+JDMCJ?V>9R\1@\F\UA@9C+2
MKYC.B9NIHYYOLMHL5FL<LUW>R7O^B-IL.VY:;Y 5;BNFG!J_/=[6OTWOV,+T
MWI"*4E\;6[[7U>UGV/I:\\<>&8H2UIX@N;B7^[<^'+VP'7TDO9#_ ./=:IZE
MXY\.V\9(O==O9D;RW6'2X-.LFE]$U.YO[N+CWA/M7S>;MV_>8O'7IMG>64\]
M#\]P3]?UZUN7&IVL_A^QTN'P\T.H:?>W%[J&NI;7.H%X@ES<VQFL5L7M[&5+
M2*![G3;FW:Z+7$95XPRBM.6/9?U\R)MJUG;<^A-)^,'@C3HN9/$NH\_\^6B)
MQQZZ_P"^?\*L^-_C7X5\5^$-;\-VFE>);:?5M-MS:7L\%B(()[>Z^UHMR$G3
M*F3Y6"E&*9 8-\U?+[7)")"T^I13+%>3S/=QWME%Y%O]R:4SVD*6$9ZNUS<.
M#V*FF6CM!+;37.G+)#<M;SVUI<Z1?_8KVQ\N\N;F?[1#9X='M%L9+9HY%4&6
M0MY@:-4:26RL$&W>[OL=;H'C#4- MKJSLHO-6[E\V2..]EBC5AVC$$T3!>/X
MFDY[UO\ _"S-6SG[%;[O[WVD[OSS6/)K'A/4=EO?^$K7P_YC;6N[.:\AEMHX
M9/LUW>G3+F.YU"\TN.[^1=1MT2!5X8L?FJ#5?"UKX9%I)XAUW3Y;?45$ED_A
M_5M#OKIXNFZYTF_NM-UNT^LNF8]JVIMJ]O+]?)BJ=/G^AT\'Q5O[;S OAG1;
MJ9TVQRW;M+);O_SWMRL\:K-D?>D61>/NGO;GUCQAXOM;:[M_ ^BZC:V7_'E<
M"XNWFM^O_'U ^I/(_?.SR^O%<%>:/INE7=I+=W&JQPW LYG^T>'[FS5(6_X_
ME,]^]M&)8O\ EGE2$Z2+)P:[+P9H6J6GCJPDT;[99Z-=7OE2:C=-(^G);X^_
M?SZ?<7L#2?[4=M"N?X.M$Y/37OV\O(4$G>ZOL<Q>^&?%=[JJQ+X=N_M\_P!^
MRTFW>6 ?[LL3JO0=V//K7NGPV^!>M:@NCS>+?&GBWX9Z+=>(-&LM7?PPDTOB
M32]'NM=^Q:E<6U^=3N!%<PZ9^_@DFMYX8[CYY8)8CY->]Z'X7GM4)O+I$2//
MDE%E%JX_VM4M[B,'_@,2]>G%=!=W&EBVGA%[:+*;>6"618E6282IM\V4J C3
M1G]Y&R(BK)RR,.*SYF]+OF?POJN]OP-))*G-I+9?J?UU?LQ_\$!?V*OV9?$^
MG_$[P?\ %[]JGQ]XWU;PW>^'+CQIXF^(_AZQC\7^&/%KZ-J,UC'H6F>$I+JS
MM##::7-"XOUE#9:667,>S])?#W[$G[)^A7EO?_\ "FM(\3ZC;?<U3X@ZYXG\
M<3N>_FVGB+7+[2&]/ETQ,UC_ +&/QX^!7C+]EC]F/5/$GQ'EM?$NL? _X?V^
ML6:Z?I=C++JUII&D:/=S7%W%<)<)/]GT:WG9DN$/VJ:ZD(\N2.&'\W_^"HO_
M  7-^#O_  33^,'@7X16'PBUK]H$>-?AG%\0Y/$&D^-K+P@V@RW_ (@U32M/
MT.]TK4_#U]-<3BVL8Y+FZAN(HC,9718TVQIM1IXI1JN=6<HOEY4VK+XKV]WK
MH>%*4G6:;NK[67?T/WBL[JWT+2H],\/V&G:)I\'_ ![Z5H^G6>F:7!S_  Z;
M8PP64@/<3PS&O /'7C?XE6AD;0;.W::,86XGMW>X?/\ %<7$4L4UXV>]X]P!
M7Y$?L1_\'#G[%_[6/C7P]\*/B1:7_P"S!\5O&D^F:=X!T_QCKMOXY^'WCC5M
M9U,Z78:=IWQ"T71M"C\-:J+\?V;+HWCS0O"T_P!L(87:JP0_OQ+9:'-]ICN8
M72X1_LDD*B ,+OO_ *R5<0X&<$;O]NO-Q.%E4OS590M?:3C>^^S6UOE?S.AP
MAS49<JYES6=M5?DOU_-,_.;Q-XM^-_C+3;WPQXQT'PCXF\.:D8?M^@>,/"FF
M^*="N?L;>9I[-HOB%-3TJ&ZL)OG@U&VLX-2FA/\ 9U]>7FE?Z!5@^"_%?BVU
M\):3XP^'OPD\6>&_!4AE\%:)KGPR\(:OIG@MO,6?9X0LK_2YX/#5K]IBM[K[
M#HR6=C]HM8'^S;?,63] 9?#_ (0GD\R7#-_NC'Y"+/ZU?M-.\*VFPQQ+&(^B
MJ#M/URA/ZC\SQYU*E4P]1N.,JQO>.E23T>C7O.6CZ^74[H*,(3DJ,:CJ6YVU
M=OE6E]?[SVL:'[-FH^*[CQU8Z;J[RPI?#4-0O4M99+.WNKV/0?(^VR64+K81
MW[VV;9]2M[6#4F@9D%V"=U?I37PY\)H;"/X@:-+:Q\/!J@CD*.K& :+]\C=R
MWN!CIQ7W'7JX>G&G!J-1S3=VF[V;U;UN_>>^NZTL<D6FY)4E32MLFKWOW;V_
M4****W+"BBB@ HHHH **** "OYT/V\_C'\;O#'[6'CSPSX%GT./0;'0_!5U$
MEY&\T[RS^%/M4@D:*Z@C,8EX4+$K!.&9FR]?T7U_-Y^W?$!^V5\2&65$_P"*
M;\!G:J)M_P"1+]-N?QS7C9Y4J4<"ZE*<J=15::4XNS2E)*2V:LUOI]QZ64T*
M.(QBIUZ<:L/959<LTVKI:/247=>I\[P_'K]ICRPWD^&LX_YY3?7_ )_^WUZ5
M>M_VAOVC(L9T7P^?J)3CK_T__3\/;BJ-NL)7:T^!STV?IE2.>_'T%2NJ/UF4
M?3']0?\ (%>)/&8J%2T:]2*=*E*R:W:=WK%ZLZJ>$PS@VZ%-OVM6-[/9/1?'
MLNAT%M^TW^T5 <2>&O";_6]NC_)?\BMBU_:A_:"?KX3\, \]+VY_^-GIS[=<
M5RD$*!\&ZF:/U:>4GZY# ?I_A75VB(OWI9!TS^_E'T_CQZ<41Q>+FU?&586_
MO1UO_P!P^GZE_4\+_P ^*?W2_P#DS1B_:D^/D>-W@709.G^JU*7MTZV[=/Y'
MOUKX_P#V_OVG?B]JO[&/[1VA:QX#TS3[#7? %MI%[=)J,1DMH[S7= ><EF>2
M,2,/W8+1,HCX*$X-?6T@) \J66/_ *YW$WY<R-Q^?3WKX/\ ^"BNE747[&/Q
MTNXYHA!-I_A^.:(JK+*MSXKT"T<."">(QN7:RX?DAA\M>E2J5W*%\;4UW]Z.
MMK;^Y_D3/"X>,;QHP3[I/LW_ #,_E=3Q%JSG)T^ #T%Q@<=\$D_AW/MFG_V[
MJO\ T#%_-O\ XNL]6N(?OHW?.U8__B/8^O\ +.S#<1O_ *Q<?[I(STZ9)KW'
M'EA!^T=1R3NVT[;=DM[_ ('$])-+9;+MJU^B/HC]C/6KNY_;#_8_LKK2([RR
MN_VJ?V>].NK.^M[>]M;G3;WXN^ ;"^TZX@NXIHKBTO;$M9W,<P<R0.Z!E)!K
M^T/]L#]JG_@HC\(OVU9O@S^S=_P2[\!_'_\ 9P2X^#\5O\78_AS=V5A.GB_3
M],N_B#]K\:37^E>"=,?PN][(MHTR7(MT6/[8MX0V[^-#]BR='_;/_8VCCA!F
MF_:P_9O-G"J&6XOMWQJ\$V\]Q9P>9$)[:WNK2YDE+S0E;9.7W R'^RG]NOX4
M?\%T=9_; UGQ'^Q3\7O#GA3]F:5OAC;^&;+Q%K_P]M['2]2M_#.D-X]N]8\.
M:_X<U+Q'?Z1>:A:W4:12:UYPC&!<.^7-4^OR_4SJ=/G^A\M_\(#^S5H'_!R/
M\)?"WP3\.^#(K+6_@5\2=0^.'A'P[IOAN?P5HGQ=TWX>>,-3@L9;&.,:58^,
M$T2+1]2U;1;2TM_[!UB_BN+LW,1-HFY\>?V[O^"MO@;XO_%SPC\-/^".OA'Q
MS\./"?Q)\>Z!X%\;2?!+Q1='Q9X#T/7]3TOPEXG:>UUJSMIY?$&EV4.N-/!:
M6UM)9M(T%M "A71\;1_""S_X.7OV2U^&?_"(CQQK7[,'QEUG]I1? ]E82QW'
MQ3@^&WCV/P]>W6GV<&HV<7B&?P]%#'J%[+>27NISZ;HQNVG$5Q#=YGQK^!G_
M  <?ZC\:OC-?_"#XU>%;#X0:M\2OB#>_"G2IO&_P;M#:?#6[U>YTSP'I5MH\
M_P ,I;ZS6PT"\9 ;J]EW%(93RA#Z&7]:GC__  2Q^)'QK\!?\$8?C+\;OV?_
M -F'0/VDOVA[']LCXBOH?POUSP7+XCU*\7Q%XU\"2^)[*PCT8ZAJ?V3P<GBC
M4AIUL-19;.'2)_M N]LS2?,O[3OQ._X*1?MY7O[.G[*/[3'[ .@?L4^#OBY^
MTW\._"^C_%K0? VO>$;U?$$NG:M#J6GS7>M:M;QWVWP3/XP\1QV\%DL(GT*W
MF:*2WAGMKGO_ -F/XQ?&?]EO_@WT_:2^+'P=\7WGP\^+G@_]M[Q9H;^,M,T[
MP]?:IIUQ<_%CX5:!XJ73YM=T35=,NXM5:/49I=10O:LMW.R($V+'^5GP^_X*
M]?MAZY\<_P!FKXD_M+_&WQA\;O WP#^.^@?&;_A$[[2O!FGFQBTU?$/@K6_[
M+30?#6D.VL6_@_Q3K5M8-=-=0Q/=M)+!.@\L@S]D/VN/^"IW@3_@E!\4;G]A
M3]@C]EKX376E_!G0_!]C\8_&?C:*_N9O&?B:YTNWU34O#-SJ6FS^'-2UF^GM
M[NV;Q?XIUZ35-,F\UA8Z7II"N/F?_@I-X'^ _P"UE_P3T^%G_!5[X _"JP^$
M'C>[\<6OPO\ VDOA_H,-I%I-YXBN=3U+PJVHR#1[>RTRZOHO$MIIEZEQIZ6,
M+Z!XDT>-[47:R7T_OW_!1;_@E!\8/V[?CW'^W!^P+K'PJ^,7P>_:>TGP[XAU
M'[7\03X5E\(^)(] TCPUK6O6G]MV49\1:!?6>BP7.NZ=;P)K&@WDMY)+HMQ"
M4MX///\ @I-=?#?_ ()Y_P#!+7X5_P#!+73/&OASXE_M%_$;QKI?QM_:'_X1
M*82:9X8M;#Q1:>)-3EDMK:Y9-*AUO5(O!7A?X>07DNF:WXF\-Z!J/C+4])\.
MVK"UMXFVK6=MR7&4K<K:MO8_2G_@JM_P49^._P"PC\;O@W\*_@-^PU\./CWX
M=\<_!W1_'&N3WOPF\77VJR:O<^+=?T74?#27OA?0X]+T^^CT?3M+NK>.[M9W
M2[N+B6<212QV\//^/_V=O@YX+_X+??\ !,;XD>#O@YX<^&FH?M+_ +/GQY\4
M?&CX21Z;ILOA[2?$_AGX0>(;TZMJ&APV\&@VVM:1#JUYX<O;VUTJ#3]:N_#T
M<^G6%G?137,OT?\ MK?\%0/%_P"Q'_P45_8P^!'BX>%;/]E_XP?"S0;SXI:K
MJ>A/;^(_"NN^./&6O^#=$\66OB:ZNU32_#^@>(K#3)]>TFZLKS4#875V8KRU
MEEBE@^ K/P'\?O!'_!S5\)+WXW^,?$_Q(\-^*_#GQP\1_ ;Q9K"O:Z;8_":Y
M^"WQ!@B\":/8:?I]KI=O-X \9IK-AJ*P1ZM<:[=1MJB$6.HV5M!G)MQ;;U6W
MEHR'&I&S47.[WU=M?+O\]CM/VD?VY/\ @KE\.?C[\9?!7P?_ ."//PV^(OPH
M\(_$GQAX?^''CS_A3WBNZ'C7P)I>H&U\*^)S<VEU9VUQ+K\7S>=;6EK;R/S%
M:PIA:_B"UN^U/7?'/BS6M2L+?2M:UCQ;XJU2_P!+M8G@MO#^K:_XFN[Y]"M[
M=Y)6AL_##WCQ202RS31PQP*UPS*TC_VQ_M/_  +_ .#C?4_V@/C;?_L^_'CP
MUHOP.UCXH>+;KX+:-_PGGPET[^S_ (9R>)=O@[3+;1[OX<7%[9_V9I_[V-KJ
M\D_>'<P9#Y=?Q1:WI^L:7XT\6Z=XAE+^)](\7>*=(\7R12I*&\6:?X@U?3=<
M_P!(4&*\DU/5-$NC/?VX2T:T:(0Q129E/S>:MMTFVVX.?*W]F[C>VV]E>]]D
M?J7"E-0P]2I[&-*I*-'WH\W-)?O%K>36CNE9+=IZ[=/I\$K]8C[X'3\#[9[9
M_(BKFN^'FUG0];T< ;[_ $?RL@C<DO\ >BR& ;W8.!CM5:QGE7&)&/7@XQQ]
M *U&OKJ*-YUV^9'!YPR&VD_W6^;)7MA2"?6O9RZHHT:#EJY+5OK:Q\QQ'3;Q
M<YP]V4G/G:WE9KEOOMKLEU^7Y8?":[\%:!^T/X#F^*VB:=K_ ,/K#XK^&H/B
M1H^KF^_L_5?!UUKUI:>(+2Z&E7NFW"&STLWUQ9M!<0K#<QQ23K<Q(\,GW%^U
M[^PYX*\&?$ZYD^ ^LZY9>";[]I;Q7^R[=>"/B28U\1?"#XO^&[S2HK'0M8\6
M:;:)HWBSX5>.--UNS\0^!_B+IVB:=-J>E1WO]J>&M(DL;B1ODW]KGX67GP?^
M/GC3P[<V21VFO:;X8^(FA+*08I-!^)_@BV\<:1."%C$B0:?KK00-&4"7-N=S
M2&-E?]:/B;KUW\3/@S\9_'NFZA<7/B3XD?LS_L8_\%"O#K1E+94^+/[,^HZU
M^R?^TA=6QMTCB3Q)J=[JOB?QGKMW J_VSID$E[K_ /:@M[1K?ZAQHU(4VH1N
MKZZ];?WO(^-E[2$G>3U].GR/!=7_ &/?@'9#XP>&M*^$?[1M_P"!?@+XU\9?
M#3QW^U[IWC?P1?:E8^-?APT5CX]\<6/[,4^EZ3XC\1_#?P_/<Z=XAU/1O#_C
MN\U_1?#E_!]N\0R7&Z\'W7X#_8<^+FH> -#O;;]HR/SH])M(3%)\/O!>N:'8
MZGI4HL+^_L]<ETF47_A35Y[>;6="UAS,$T/4]($XNY1+<W"^*K[PC9?&OXBR
M7^CV-QX9E_X*!>#O$VLM+!"S67P;_P""J7[*]_X:\>+I]E(S6EAITNIQ:)<7
MQMPD.GZA8V4MLJF/RY.]\$_$#]H3X3_L*VFN_#W2].\3:K^SSKVI_![XTZ%%
M8I>ZOX:_X1;4[[X+V7COP[ ',>HZ)H7B?X>Z+8:SI-];W<3P:G-K(CM+6YB6
MWZ:&8X/+(U*F+G6ITI*-XTK\L^7FOSVOMS+EU6[W'A\@J<38["99&K0H>UE)
M/$UG&,J"?(O<;LO>^U=2O9;'CMU^Q%KUO%+/\1?CCXN\5*R^=*NE6EKX.T2.
M#NMMJ4[2RVDW_7J\0_V?7P_QQJ_[-_[-2S_8(-#U_P 9"'*:5IEZ?$_BN^G[
M)K/B.\-PVAKR>+A96YZ],^<>-?%O[:OQ;TUAX]U*];3;N]-])J6I_P!G:-$F
M?^7:.QM((85M>?\ 5M"TG_3;(KY?F^#Q6\O;G7_$!O9[B8S74UG9O#-=$\E;
MF6<W$DR$]0SDGJ6YS7C8CB_+8^W67>U=2M:TJCDG#DYK.%VU=N3YM'LC]4PO
MA'E7#\Z-3-L71Q$8I2HUJ%INM9)U/:.,FGR7ARZ1^*6Y7^*7[1WQ#^+-U+;:
M=YOAK0$(ACT;2[F6;4?LX((EU/75D&IZC)TR;.\LXR,YCK])O^"(7P7UF/\
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M%7B-?"FA>+$A\0SP>#+KQ)IXBG@ET4>(Q/J$=Z+V3S/.O^"HGA#X+?MI2_\
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M33)-1\!:5X4@LXK*_DUY[?3KC2&O!!<PF29RA=OJ;]DO_@HU^TE_P4(\(?\
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MWG_?M(R[498DW/B]_P &R_[/WQ\\7P^-_C[_ ,%)?VD_B1/IVER:%H2O\/\
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MJ7%C+)JEW=3?\3./*Q1MC<(O)_=U^AFF_$+Q!\(_$7Q'^*'A755T7QC\,/\
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MGE.D%QXO^$-TDT$USC;(+R\\+>+-,L&>6=S-9:5&D"0^2[/E?\$[(?&OQO\
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M^?)>7$US+975Q>75[_Q,+DNWV1[SYEM(X281^1?[<_[.7BS]HO\ X+'?!_\
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MKTO6(WN'U&S\+2RV@B)O)YK635(=(N[JZU#3[N>7]X?^#7_X$_LQ?$C]G/\
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MTW3I=3O]5U74-3L-)L='TV. [KW4-5U&[33+!84(6\N[0R)*B2))HO=VTO\
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M$(^9_$7[8?[67C+0[CPQXM_:]_:#\1^&KI=/6?PYXD^+7CS6/#TBZ5=Q7^F
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M=K<VB]/\B^GP@_:XM?\ 4_MNVTW4<FY(^N!=C^G>M!OAW^VG&?W'[96FW/\
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M>GW5GITIU2]T'5;[4TU/4+K2X['3M/\ 6/\ @A5X(_X+"_ J#_@HQ\-OV,/
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M[4GP>^*J?L^WO[%'QK_8^\?:1X"\/?LS:5964>C>+M4\=^)+7XK_  Z?P*/
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MJCEV+D^:4YM1[I+?_MU7VU["CBN62L[<V]K:V[W3[OL?DW:^*]4>UM\_8O\
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MAN-%M/"/]JZLVGV^LW^@VEGJ>J606TN;UDP0-M[NXU"4?B;=]K^1_2%^V/\
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MSL<#I@=<G]1^6*Q+81/,,J./I^7!S^OIFE\279GUW5Y94($EY>",H=H/V?\
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M)8MPQTE1Y)Q<N2I)I0^.+DG>>GO=/N\!U*'7O"^I'1_B%HFO^!;U/]9:^+_
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MG")_#)C']T"O(_AYX5U[QO(+C7]5UF3PO:7WV:9;O5+Z6/6=6[:9:8F ,/\
MT]D/#FNJO=/N?&'Q%\9Z?X:OY;/PO=V]FGCW4[=@81%9<)I]LZJ([F]E_P"6
M[(C[OX$C[^Y8L/#FEVECIUO#:V-C!]FM+>(?ZF#.0BY).['69@TY[RU"26RL
M;%#4);>SMS9PPPQP^7Y-K!$I6-8/^>+ -E$QWB,3=?F->3>-/$:^&(6@MY8Y
MM=U/D319(T\=/F ;*],\M_\ 6W/$GB)-$LY[^[7?<W6?L<+$F)/4E 5?C_?!
MKY?NKR\UB^GO)I&+W/\ K""V.?[N\L5_.AI/=7+@D[W5]AIEENIC=2R,R-_K
MI'.9)NW[PD8/_ 0G\J@EE,JK&518E,C&%5_<NTG\1B8M&IC_ .68C6-5[JU2
MW00D11L50]E( Y]>O/\ D55K.:2M96W-5[NVE_ZZW'B1Q)YF^7:/-VQ">=84
M\W_GFJ2J4V?\L]K#'\6ZF445 [OO^"_R/;/@IK\4>JW7@_5%%W:>)8//LXY%
M!B:_:/9+%+T7RI3^\E1 LADY610,5]&^,/"\/B7P7JNB0Q!YFM;.YTA9@EQ)
M'=V3VC)FZNDGO2DOV)$G N SQRS!60LI3X8TIK\:C:-HXG&JV5W]LMVMAO>-
M^/W891_JO]D,&S_'7Z ^%M<37=(M-;CC-LTT<K36;<36-W8S?V=J.F3J<XN?
M[4R;<'&+3AA(_P"]JX).]U?8SJ-NU_/]/)'P]KVB7D4>D:G9V2RZ-XCAEGM+
M.WF%Q=:?J>EC_BH-,U'2&CD,MV__ "QGFE-V/XYI.\VE_#GQ5J/WK:UL?^PA
M<K:?^AA_\^M?0CQ7OACQMK/ABVT\SZ#JTE_XNTZ!+ />6T]Y_P A8V=VY,D?
M^RAW[>KE^E:SL?+WI@GT=$E'7N)5?'3&>/>B:2M96W,U)QV=K^GZIGBMO\';
MG_E[UR!?^N5C,,_]]2O7H_PY_9MLOB#X\\&> K'7-7DU3QCXDL]#MOL]O%B"
M)K\6U]=R;K63:L6G_P#$ZC=@46PY<.?GKH\S%O+D!:8#SGB$IB6&#^[+/(6C
M,W'&% _V*_5K_@G/\%+V:^U'X_Z[8S6^F)9W?A7P%%<Q,LMS*MA_9?BCQG C
MKYGD>']/_P!$M9D=!J47-N&?YZ4(1G-<T5*VU_-KS1-6I/D?O/\ #L_(\SU_
M_@@A\#+SSVT+]I/XHVEV))Y?,\0>#?"%W:E[G[X*V6KV$A4<%1YF1W)XKY6^
M)?\ P02^*GAS3KG5/A_^T%\.O&,T1_<Z/XA\*^-/!%ZXQT::2QUR$GJ2PB48
MXV\$G^FN*2Z<.I6=ED RDDX('7[O0_F>G-9FO74\2PQ/MP^<HAA4'O\ >5 _
MI_%WS7J1A!05HI7WM==%Y^;/+=2?/+WF_6SZONC^*/XG?\$Z/VQ_AA;7MYK'
MP7\4>(O#NFLHN_$_P^:#Q]H1!.,QW?AB._O5 XR6TK SDM@$CXG_ +)D+SH5
MN8TMGQ<EK:;%L">/,FF2VMDXZ_;)=/\ F_ '_1%TZ\:V@2Y-U=/=W&1<2SS-
M.T__ %T\X/NZ^PYX-?+'[07['O[,'[2T5S+\5?A)H\GBV<YC^)/@VV@\)_$2
M+&1FX\1:7 G]N<$X_P"$GM-<P"?K5)3_ .7<I1[V>_:^_GV-(5%KSI/M?YW[
M'\(U/1RG0#\<^WH1Z5^R/[6'_!'OXI_!*QU?Q]\(-9N/C)\+]/\ ](O[6ULU
MM_B9X3LL,?M6K^%DB@D\2:)G:%\1^%X'G;)SX83'/X^_V=)YDD3I+$\'_'P&
M4E8.O-RS+$UMS_STB/IG-'M:E*45.<GS;7?;>VB[_D4Y1E\*2MO;S(T,F_:@
M# #N"3^A X[?ETKJ+.TMY8R;A"X*;=OFR1KO_P">P6)D43?[0&W'5:P[,1[M
MV23SUP?Z9QZ^O/X[ZS[5B48P^<]<CZ<_F#GCUKNA44XZ?.W6^QSUI2CR\K:O
M>]OEY'>:%XIAL+%_"WBF ZQX,OY5NX6B7=<^&M33_5:KI=S()/L]Z@_URW*7
M=EJ'_,3L[X5]O_L/?ML_'C_@G%^T%X%^+/PM\37%K96^]=*NK,W#^&?&_AQM
MJ:GHFOV<5U 9=-U(%1K6D7%S'<^#'/\ Q*)K)FRWY\PW$#QO"Z^7!)_K84'[
MN3IG>'#MW_A9>:ZK0=5LK6&;PAXG+WGA?7+P3Z;<N_[_ $#7D&R/4[:8_NK:
M4;OW\:PFUOP2=2@O=I(YZ^'C42?(KQOKZVMU\BJ$Y/FO)]/U\OZ]3_9V_P""
M>G_!0;X4?\%$?V?_  S\<_A7?Z9;RW$::-X_\"277VCQ%\//'EHBR:WX<U@1
MR%18Q#?)X8UHQI:^,='V^(M.%M:YLJ_0*O\ ']_X(V_\%-OB3_P2^_:DT769
M+S6M>^%NOG3/#OQ3\#6TX_L[X@_#Z>/[9%=VD#L@7Q)X6M&.M>&-5$LATZS#
M>&;FVO;8BVK_ %H_A/\ &/PC\:?A[X0^*WP\US2?$_@'Q]X>T;Q=X3U_3)&>
MVU'PYKZ>?IMR66654O%\PZ5J5BQ2;2M4T^^^U@*\<$7C5:;IRMT=[?+<ZH-N
M]W?8]?HHHK(L**** "OXTO\ @L%/&/V^/B6)-O[OP=\+L9S_ -"5SGGOZ#'\
MA7]EM?Q4?\%E];T?3_V^OB?'>W4\,O\ PA_PNSMA)09\%\<YSP<_SQ71AOXB
M]4<]?[/_ &]^A^<TE[;22;1F,8S^[.#^N[^7MFOSS_;Z_:/L/A7X'D\$Z#JK
M#Q%XBL,Z[+:RLD]C8?\ /G&P=?+7)X$BRMTYZU]=:_\ $/P9X<T;4_$-]J3&
MRTG2KS4;IE 0-(O_ !XQ1EE(_>_\M%^9F'W&C-?S!_'CXC7GQF^*&M:UK-U.
M--LY_MVKN\A91 "#]FMR"X5,9 5MS9.0^17TKG&C@ZG*N6<TK-;Z)^O?L9TT
MKN_2WZGDXU6]M8KKQ?J4H_X2'6W^SZ#P3<6,>/\ D+K&Y95CP.&8,.3@9-<.
MC'][/+\TD\OFRLY)+G).PDG)0DG(R2>QJSJ.KR:SJ=U=%8TB2$VMG'$KB*WM
M5R!;Q*[OMCY;@LS8/WN:I3.NW9T''U_R?H3CDXK@H0E*+G5;GS/W7+I9N]MO
M(V;;LF]OUL_\BK+*[?=.>GK^G/\ /^52>:OHO_?)JNOR=.?KV^G3_.:J2.J]
M#^?_ -;'Y>G)K2I.-&+LE'FWMUM]_<(1C)W:3:VOTO\ /R1.UW)#(LL3F.6/
M[DB%@Z]_E.>,_3./2O??#7B^SUM8]/U!UM]8)P;5@4AN.X%O,S,@]?F>3\N:
M^;R2>M76N)3Y85C&(?\ 4^62K1?[DF3+_P!].U>-5;KRT;]V_P"-O\CIA4]G
MII9VT]#ZY)7L2$_Y[E28OT(/Z^^<4M?.VC>./$-DIMC<K=P9XCO%>0#('>.2
M)OS)->@6OQ*L"?+O].N[>7_IG(CI_P"@,<^V:F.%J3O9O2WX^IM"NG>]GMV/
M2:EV#U/Z?X5Q!\?^&!]ZXO8A_P!-+*3KG'0,*U;7QAX=NTWQWL^?^O*0C_T/
M/^<^U*="K2M[CJ<U]U>UO3O?\ GB(JUK+?L=AO']Q/R/_P 53) J8PB]NH/O
MZ$>E8D?B/1GZW>/HI_G^?TQS4[ZYI#];U?P0^_J3ZTX4ISOS4^2UK:-7O?\
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M(WV2ZI]G?GA@@X_'_P"OT[U^?0PU7V,*\VY.4>7F?6%)6A'1)6BFTM+]VS]
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M65],'&HJ$)5:TJTYKWN9IN-O11WOVZ??<X1J.T%RJ._+UOMU>UOO?W?U8?\
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M\SU)X]:/[0Q7:?X?Y%_4Z'_/Q?>?T-)^R+^R^\8DD^)VML/1?%L0/ZVQSW[
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MX*9S'=>)?!^M:?IDBE1,=>M?#4FN:40TBR)YF;&^C.$WF9;01E"K^9_K_?\
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M_P"._P#Q-58]9U4JH2W'F(NV.8$"2-_^>JA2(A+_ +31D'/W34__  D6K_\
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M.TC8./W$\R,'+9']D/F1_P#/Y;?E+_\ ':_E$_X-Q],A?XH?M5ZE';I</9^
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M.CVYLXKR2"7P;8V]]H^GZQX>OUT[Q79RRZ5XV\;/%+!JFN#4[3UKQQ_P3^^
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M*!),_P ?-9WBK^V]4\3Z7IB;3%H_ACQ+XAN%0KM>YEL_L-N\X)*F6[C'FS[
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MWSR2&<_=_P"R'*(?V4_@)I46(7D^'?A.:ZB4",231Z?]L\UPFTEWD^63LT?
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M<F<?1D/KUQ_3#II*]DNGZ^H<TN[_ *^0UK+5M;ES=2O%8_\ /)T8#KVZGO\
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M_:23]Y+W5:VM_85=8S+H*K5;KX*/+>35W&HDE'9:1]GIIUZGS4(XNY?\Q_\
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MS>R2-'?B4<>"?M<L:Z=:+>?\R]=:E>:7%#_R\B\K]]+2?PXKMALWGG^258O
M]OCCS%:577R_0[2>O>O+DDY--:+;RU?^10VUMC&^^X:!P?X""4_[Y+9_6M8>
M7,<L54'^!,!/88.X\_7GIVJ@S:6$+K<2N?\ ;7/\E'IZ]*SYIK*W3*7<YDYX
M89'/'("*?U%"26RL :HP:;RHI8S'QP>?Y$>OI[D=*O\ V9[1-F01ZX7/Z#'M
MT[5DVB6D[^<[DCV1L?D<^WK6W(]N1D/._P#O%3GGVC&<<4P.2\2J/L-I;@()
M)KOSG D',6>W7Y>1UST]*W].T^VM=/LT4_-%98"LRX)_O, H)/N, GMVKF=;
M2RGU6&/RSLMV^R)M9L%.F]LDYE_VL!?]BNO^RV.$']I-A(O* V]5]3\GWO<8
M'M0!DV]K;)J[HKP[9,9&V7C/4#]YCU[9]:W4T:"9;A;BVC9+B+R73?+M4 ??
M3,A(?W.X>V!7,-;6T.I^;'J\LK>@5-O3./\ 59QCKSZ=*WC):+][5=17CM:M
MS^8Z4 <WHT(TG4[O29(RT$O^J:64%HQW,9&U!^*-TQ77BS@D.Q8HXH_60N6^
MN0X'XX!^E<?XAL]-9TU"&YO0+?[S"!]_XD$9[]ACD#BMO3-6L)K -++,]Q_=
M9EV^W 0,>/\ :XY- %BYTG38V^T6<(B;NJL2G3CALG_Q[]*73KFV;_6*%Y[C
M'/7OT%6/.M$ 5'D?_>*,?I\J+[=>/I6-=FWGYMY!'QCY< _R^OOZTFD]U<B;
M:M9VW.IDB6/DQ1E/4.A[^HR/TKYW_:I_:,\/?LL?!/Q9\5-2ETV?7+&&#1_!
MGAYK@>?XF\;:LYAT_3(R71I=,T<?\377KJ%H=^F96">TD/G5W>N^)/#O@[P]
M?:]XGUZUTS1M+MOM>IZA=7BE+&+^Y,=J@R^PP/;@U_(+_P %,OVX)OVCOB)=
M:?X?N+N#X:^"8I]'\)Z9*ZJBV5TGD75Y=%2$FU&XLA_9\EW%'"1:?+&D<W[^
MKIPBYJ\5_37F83E6;BH3E%._,E;7:U]'M=]MS\T?C!\2M1\3>)?$/B'5=3FO
M]<U_4;_5]5O[AEEN+K5-4N/M>I7[L^YC<7MP?-F8DIG*HB)A:\,74(Y6W,XS
MZ \>_4GI]<9].16%KFI/?WCSNR[WZJF[9^ 9G;U_B/Y=,)9RIR"W^?QKUH.$
M(*\8Z]_)+S\S=4)-)MZOKM?\.ESL/-?UC_,_XU@:@<RI'G+6L0\X#@&8G[H[
M[?;[VW(SW%'[6_J?R_\ KUNV=HK3M>LEQ/%;B2]E2,)+Y\-O)]FEF>7Y$MX)
M+H;(5E5FP=I9FPU*5:GSP5DD^:Z76UK7UZ&U*FX<UW>]NM]K^2[G]$O_  ;*
M_L>-^T]_P5(^#WBS5=*CO_AS^RO8ZG^T1XUO95DET^'6M%U&+2OA':W$9$BO
M<R>/=4T_7-*MU,<^S2=0<RL+"9J_UF39Q,<L6)VB-<[/DA+AGA7"#]W* $DW
M;G*<!E;YJ_EF_P"#67]@B;]DW_@GI8?''Q;H0TGXQ?M?^(=.^*5\=2MQ%K.B
M_"31TNK;X1^&KR-H8I[>#4])OM?^)+V\S2^</&D]G$+>YCL&LOZHZ\/&U?:5
MY13]V&ROHK[V7G8Z:?7Y?J%%%%<AH%?R7_\ !5(LG[;WQ%"GA/"'PQP"D9_Y
MDUNOR9/TR,=L8&/ZT*_D@_X*M74D7[<_Q)B(39_PA_PPY(8G)\&$G)#8XY[=
M,5I2?O6Z/==]495$GRW6U_T/A&*73I8Y;>]MK*_L[FUGL+RQEC:6TO;"Z5H+
MBRNHG=O,MI;*:[TYD#!OLEY<J'\YHYHOXW/V\_V;-3_96^._B_P'I\%U%\.O
M%K77C#X:W V?9-2\):G/+!_9K3B".,W7AR_AO-%NEA$ 6;3)-5$:V5_;0Q_V
M#Q20G[LMO'S_ ,LXY1T_WI&QUZ_AZ5\F_MU?LMP_M9?!C4/#6FKI9^*'@O[7
MKWPENKN$JFI:I8P1V>N_#Z:Z#!XM-\4V%O9V.F.LL)$-G%,UQ+>RW5U<^O1]
MDE&$X*7.G9.[U27=^9A\$DH7BI_&D_BY6N6^^UW;;=G\5JOMZ*OXY/\ 6JE=
M7K&@76@7]_I.KV-_8:MIMW+I][I]VHMKNUO[!L:A:W=M)#YUN_\ S[EU.,'<
M)#D#E*\O$0=.M-;1O>"6R75+TTZL[>9N$$W=*]MM-%V7ZL4'!S4\-S+ ^^,@
M'T.<?D"/YU7HK-3E>/O/1JWEJO(1V?V:/4K3[3$V).GV8$>9^1!R/P_^MSD]
MM) <,K >I!_G@#\:6UNYK.;SXFR_^WDJ?J%*UZ-916/B&'?'LCG'2W!57X_W
M@V?3C@_K7I1<JD$IMNVU^ETKVT78B;:M;S^9Y;L'J?T_PHV#U/Z?X5U5_P"'
M[JRDV!3<#^\O[L?FX(]OKVKFF1E^\I'U%3*@IQ;2OR]^E_2W8(R<KWMI8JT4
M[8WI^HI^P>I_3_"N%T97:[%D52>9@ !=I&<L#\S9_O$@@X[8 I=@]3^G^%-*
M'/R\_EG/Z5<*=2-[0Y[VOH]/QZ_H!LV_B'4+:6VGBD*SVDDDD$ZRW"7$+M_J
MS;3QS)-8?9_^6']G/9[>C[QQ6MIWQ!\9Z1L72O$VO:;$EX;Y8+#7-9LX1<G_
M );!;?4(R+CG O POAVNA@8Y182WW0Q^G_ZJT%TJ=OO1B+_KI(H_3/\ 7TK>
MG1KU+VC*G:VUE>]_YK[6Z=P/5=(_:$^-6A'.F?$GQ7$!.+@+=:M<ZHHF  R!
MJKWV8>.;0DV1.2;<DDUZAX9_;>_:2\+-*VE^.HR\GW#)H>BPQ08_YYVEA965
MB_\ V\6T]?*BP*_W7S_G_/OUJW:V4CCS"I\K/MN_D1QZD8%;1HU*;_>2;OLG
M;IOLO-$3DTM.O4^X(OV^_C#?R7MQXG\,_#?Q:;G[/A-:\.O>1.;?A/MJW6J3
M2:T#U;^W7U3/0!:M6_[7/AK4+B^;Q#^SE\*-9BUBS_L^>;3M(\*Z?J-[#P5T
M*6:'PT(K/2<DYNM)M=-\1  $:^Q.%^)9K"ZN9(XHP?)C!PQ1%8^[%%4'_OD#
MVYKI+..#3H4>52TR*0CM)+E6_P">JA9%_>?[73T7%6M-M/N_R,VV]]3[ M/C
M=^S7>S7CZU^R7I%G!=Z+Y"/HOB._NY[&X/\ RWLF^W:.D<_^U,DP_P"F>,5J
MGQQ^Q1J$EI;WWPN^+/A<_9)[</#XJUZ\M["XF.'U2Y6Y\07DOB#4AD[)-.?2
MK=A@FV< $?#=YJX9]LL N%SG%R@N0!QQB??QQVYK.;4P<@11*O\ "OEAA'_U
MQ\S>T'_;%HZZZ-2;YKR;2M:]M-_)$M)[H^U9/"'[#FIW.EVFG?$;XR:)G[:)
M(=9LM%BGL?LY(3_A(KJ/PN(-$S@AS:1:\">FVI3^S]^S)?MHT?AW]K#S&O;A
M8KB/6?"EA::I.I)"_9]''B-+>P9CD+]LUZX!/ ':OA]M1G9402LL47G>3$6E
ME6#SQA_L[3O+);X_A,,B'/+%JJ2:M*8&AC.Q)9!)/!\S6\K$YRT+LT:#M^Y6
M,^^ ,37J12BII-OFY;]+6O;\.XTELE:Y]N6W[&ECXH&G/X:_:(^#^N-?7_V7
M;%J,@V0#@FR&FW&MG4]4[?V/']GF_P"GBHM1_8,^.L#V_P#9@^'VM6EQ>&QM
MQ;>-='T]DL">=<+>)%TYAI_^SDZOZ:*!7Q^H(62'<UT0GDR37$ :*UD^7-G#
MML=0;[;D9%[8-;7?)(G S77:')XBTN,/;:GK5L3<"]MTL-0U6"-=2  &KB2P
M>U4:LH 4:AO:YP,>;@<;Y5E&.S'%IT'3<*;BZBJM*+4[\MKVVY97U[!*O3I0
MDI6;G\-]U:][:];J^A]N_#'P!^V-^S5JUWXM\"^$]>L=%O;_ ,,VOB >&X_"
MGBO3/$FF:4S&"PC31;S6=5U71;C.ZZUNRL[1G).P1'./V)^%_P"T]X:\<_:K
M'QCHFM?"#QM;>);GPW)X*\6VFL7$UJ\G_()O;77[70H="T\WN?DMO$-UI=A?
M]-!U_6,<_P [T7QA^,6G$2V_Q-\<>?#=6]XQ?Q-K>H79GMO]68;O5?*N[>$_
MQV=K/%9M_P ^X'-=WIW[5/[0-JK^5XQAU9!]G6W&I>'="U.'3X8/OVFG6*:#
M=:?8:=>_\Q'3+:T33K_@W5K+7V.*R#&2A&G*&";C%\OO*\6[7M::WLNYY,L1
M.%2_.[3>BOI[OJO/^MC]TM)^$/B'PCXM\6>,[WQ%JGBXZWH=WI!T_P (^)-0
M^&6HZX^MW?VO[;KDGB"QM[BWU7P[)\NF:CXC\2ZU=ZDAQI$FD-\U?:/_  3+
MM/C='_P4:_8PE\06_P 1M1\ P?&/QRRV^J:_\.-5\6^%-$U319/^$<?XF^(X
M;BUU;4;&W_XJ,$>'9C(/)T[;(#'<?:OYP_#O_!17X_>&=TRVOALV,DTDJK;)
MXJTG2[DWAQJBWT,FI7.G7*:J?]>'L%^Q?\P5M*ZU^O'_  1]_P""@OC3XK_\
M%1/V(O!VM^'&LH_%'QABTFXU&#7-'GB1]1T76MVGR6]MX:A:RTZW\L_98]-%
MC.@GF\VXEW+L^2S+AS&8>E.OBO9RI13:C2G)I+5OFY:B\K?TCLAB5*MA[M/X
M^BZ\ODOQN?=W_!6'X0_$'XB?MZ_M"SZ3K>D66G2_$#QCX&U#3/L?BRSAM/"G
MC30_#_V76/#MKI>JW.C^)_%.E?V=JGV&]OK'2=/@-T?M&EW);)^2M/\ AO\
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MW7\&'^?PJ2P>P,7[R6,=^%D_J_?Z=.E $,DLDT4\#30Q1W'WO,,I*X_YYXE
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MJGC#X:?#CX<_$.YG\,MX'UW7/A_<:+I,T^M>&/!:VL]IKS^+-0=X]=N(]:6
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MOQV^>#R^?^!./Y5^PES_ ,$G/VA)#F3XR>&V_P"!>)5'M]VZ'!_$?C5_1/\
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MJ:V@OQ_S8>WCV1PBF^D_B@3D_<A48QW&<XY_SUK0CLY9Q\C0KZ?N81^FS/\
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MUU[    &H@   8Q7TM16D:M2%^2<HWT=G:]MNGF*45*W,D[;7_X%C\>_$_\
MP0K_ ."=_B2]N;R'X>^._#*W/6R\,_%+QA:V4/\ UPCU&^U69?\ @4[UR?\
MPX"_X)[?] ?XQ?\ AV-7_P#D*OVPHK3ZUB/^?T_O7_R)G*A1E;FIQ=MKWZ^D
MD?B>_P#P0"_X)Z/UT3XP?A\6-8_K9FF?\0_W_!/'_H!?%_\ \.QK'_R)7[9T
M4?6L1_S^G]Z_^1)^K8?_ )]0_P#)O_DS\3_^' 7_  3T_P"@)\8/_#L:Q_\
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MX_9WU._MM+21KM662K\"_P!ISX3_ +1,'B#4/AC<^-WA\+W&F6NK-XZ^&WQ
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M$/@D[BQ\*_M+?LH? #]L/X4RC,=@GCB#P-X'\"_M%Z=8VOR6L.K1ZMIGP_\
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MHOVEJ9)*UE8L****@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MS,R(H!4C) 22V5C\_?BO_P %$O@#:_L\?'OXM_ OXK>!?C5KWPB\'PP6VF>
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MW<V,^G+!;W1RG8? ']H=/CMIOQ8U&#PO-X83X6?';XO?!243WT6K_P#"0O\
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M._GG*W4B^9\*_%5O\LERDS_)!>/"A9F(CCB4EL2>8 =!\)OVYY/$_P 4M$^
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M"?"'A?P\(4N+Z^BU+XC>(-*TBPV62+'8VFV11/')<( >K_ ?]O'0?CG^T/\
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M7\:J?$G2?'/Q)_:#_P"">OQ9T7X=?$'2_#NC7OQMU[X@6FK6RV^O?"^#XA?
M,V6EZ7\0[634GN='O9M6SH<C:-/?NFI96(QCY3^D?E+C&9?^_P!-G\_,S6<N
MD6RI&GF7+I'(DQ\V42O)+&,H[32(T\92<?:5^SRP@3YX\IFB(+ECV7]?,_-/
MX[^ OB9\)/VEOAS^UG\$/ ^J^.K3QJWASX,?M5_#SPO;6=OKOBSX97FI3?\
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MVEG;QVUL]Q!#%$D$<<,BP1I;PQ^3:V\<,$<4,,%I;@001PQQJ(U4R>9*/,H
M_*KP)<?%_P#:S_:G^%O[0&N?"#QK\%O@#^S1X=^(#?#/3OBEI,/A7XC_ !E^
M*?Q;L8?#>K>+F\*?VIK3^%OAY\._!"3S:;K]\KZOXMUO4+JYT[2K*Q*Z:N/=
M?%?XB_L[?MK_ +7?BN\_97_:7^+7A'XP:3^S??\ A7Q?\$O >C^-/#KI\//
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M_@_XJZ):VNLZM:7?_".:DEGJFB0KJ ,=YH\\EQ'<J$4>/>#OVS/CO\*M @\
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MA]HGTU]4S%J$=E=6%Q+:C9;75O(1*>S@T'3K:.""WB>WM[;"P6MM*UM:0P@
M+:0VML8K>"R 5 ]G#'';SA%^TQS8JU_9UN',BM.C$8Q%<30Q\-NC/D1.EN3$
M %0F(G;PV[K0,_+72?V[_B3H%B=%^+_["G[7.D_&W38/[-U/PM\,OAYIWQ9^
M'WB/5B,F;P1\8)O%VF^#/^$.+$DZKXRO/"+ '[^1\WH/[ 7P?\?_  ?^#/BB
M+XI:#I7@7XA?&CXW_%?X_P#C#X?:1<)>Z?\ #C4_C7XNO?%5AX*T_6;81Z9J
MMWH6FK80ZHVC6ECIZ^)99IX;:"Q:.P3]"%TZ$8)DG9A"(2Y=4DXV_.DD21M
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MFNFBN9KJ[$UW+//+<7ERUQ+-&8HX@#\_&_;[U]I"C?L$?\% RA7&S_A3_@D
M>XQ\7 ?;KT[8YK]!K"]:XM;2Z\B2 WD E,$H_>VQ('$^"/E!P#A5-:?E+G.9
M?^_TV/R\S%-\E"78EBTD?ELW&2,$9X  //88]J )J*** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *^ +/]I;]HWX@WGC
M'Q9\$O@G\-/%WPK\$>.O%?PZBM?$WQ:E\,_$[XDZYX UVX\->-M3\#Z?!X:U
M7PGHFFV&OZ9KFDZ!IWCK7=%UOQ -+75;NV\.V=_;15]_U^)/QTU#]ES0$^./
MQA^"_P"T5JG[,_[1'A_7?$5_XJ\&:=XQU3PW;_%3XJ6,%OI>CZ;\2?V5?&"2
M:3\2+7QWK5I;6UKXF\(>$[+Q9\4;$226WBKQ!J$T]_( ?=O[3'[46N_L_> ?
M#?B;3/AY)\0/%?B+7"$\ VNIKI&LP>$/#6DZ[X[^*GB!&2/6%NY/ WPT\*Z]
MJ^G6\*!O&&M2:1IFG)9O?PPR]J/V@8/^%P?"KP$-/L9_!GQN^%_B7QS\-/'=
MM>"1-=UWPA-X<U2_\,1V&_+RZ[X&\2IXMT"9)% LM#U@S&Y"J(?B/1?''QX^
M*/[0"^-/"?P;\*>,;7X(_![P;\,?%6D>(?B5;^"-/\*_'GXN:1X>^*OQ5L=+
M?3?!_C8:LWAW0$^&GA*"Y266UTZYU?7+)X[BW%W$OFOA>+QYHW[,6HZ-=^&O
ML?QI_P""<WQFL?%FD>$M%UB7Q,^K?!K1A_PDUOX;T#Q9-HNC_P!H6FN?L_>.
M-=\ 62VBPRMK'AFS,\DJ6LUK= 'W/\:/VL+WX5^)_'_AS3O"FG>)A\,OV;OB
M%^T1XPU$:M/80:7;>'9(M.\$>#IHGM)7CU?QSJ6G^+KA[EW$6A:;X;N?.ANY
M"9CJ_"[XA?M:>)M3\(ZCX[^&7P)T3P-KME8:IK%YX3^*'C#7O$6CV.J:!_:E
MF4M-5\ Z%IUS(MT1'*R795H" @#$2U\;^</B'^QS^W/^U#$LVHK^TE\-?C'K
M?PZU"8ZE"][\"O!WPV\2>$_V=;!8KVSEU2SD\0:=;7_Q1M[.71'N1=_%.YM-
M=&HW$*Q)WO[-#?LWC5OA-)X0_;D\0_%/Q='X:T4:'\,M4_:K\/?$&PUBXF\.
M?9;N"/P987EUJ=_;Z?$2]HK:= \+C=-).#L !]C>/?C'K/@[XE? SX?P:!97
M\?Q@U_QEI%WJYNF6/PY'X7\%:IXJ1H(?-1M:F>2QC2=H/(C-N9%1(I2LB0>/
M/C?>^"/BM\)_ATVAV^IVGQ)\._%_Q%=:W;SNBZ';?"K0?#&JLK0F1VN/[<GU
MNYCLV1<>1%"3M9)9)/G[]J'Q!;^ /B)^RQ\=O%$BV?PT^'/Q3\867CG7+B&^
M:R\)6WQ6^&'BKX>:%XAU^_L=/O\ 2-/\+:+XN;0M'UG58=1CCCE\366J+Y-I
M9727'/ZOXX\'?'3]JWX4'X3^)-!^(&E_!GX._'+7O'/B3P7J>E>*= \+R?$&
MU\(>$O!/A)=0T&ZO=(U?Q5J=WHOB35[31(-1$VEZ5X:O/[0ENI=1LYH0"'0?
MVR_CSI?P]^$OQK^*?P6^&VE_!SXI:?\ "O5+W6? /Q-USQ)XN^'6E?&23PC:
M>&=>\3>&/$?@CPA:ZUHGAS5/&.DZ9XPN?"FMZI+;SW4;VD6R*7/V1\2M?^-M
MII6F2?!SPC\//$NM7&K!;RS^(7BGQ)X7TN/0SG,L6K>%/"OCB-;[I\\D3P^D
M!SQ^?7[+/[,>K?$']GC]E*]^+?QL^*OC_P ":+\)_@GX[LO@WJ%EX&\.?#ZV
M\2^'/!7@_P 5^!]*\3CPWX"T'5_$FA>"M7M[34K#1/$.K:A;WNK>']$?Q*=<
MAM[JWO?UD2SB6-HB6="> PB"JO&$6)(TA"#' ,9/)R3Q@ _/+X2_MB?%'6?A
M+K/[0_QJ^'_PU\!_!;3O"_B37!=>#?&WBOQMXXBU'PQXKU'P>^BMX??P1I=G
MJ%WXAU?3##H26>HQ,7U738W^T2+(LMG6/VH/VF_!.@M\6OB/^SIX7T'X06=E
M+XB\5^&=%\>:WXD^.7P_\ VD=G=:GXQUS1+7P?#X UB[\.V9U"7QOX-TWQE:
M:KX4$"/9ZAXJ5&$GB7@SP?XF\8?\$R= MO"^B7'B'Q%X:U@?$O2O"L4L@F\7
M6_PC_:9G^*5UX1M].NU:U6]\2Z%X,;0=.BO+6>.2]U:S$B.K2+)ZE\6?VR_@
M9XD^#?B#_A7_ (OTCXC>-_B-X;UOPC\.O@KX?"2_%CQ7X]UW0;SPW:^#-8^'
M49M_$GAW5-#UR\8>-M0\4Z=9Z'X.CAB;5M4T,*\K 'VMXK^)-OHOPUU_XC:.
M+77+'3O &N^/=%6%F^SZ_8:1X<_MZ/R)Q*%MTN 5"B1F9XSA6#9<?/GP3^+W
M[4WQ#M? GB[QC\,O@IX>^'GC3PQHOBB6Y\-_$/QKKWC#3+76=(76XK6W\/W_
M (!TB'4=1MH;C3],U2QOKS0/L>HW\+:7<>(HP83U?A;P,W@']F+PO\*_',=[
MJ]KX2^!FB>"?'#:#;2WVI^($L?AT/#OB8^'=-!FNKZYN6!>-HY50SG>T+(#%
M7YW^&_\ AF/P?\0OV7(?V-/B=>^,_B!K?C3PAH'B;P]I?QA\:?$W6?%/P"T'
M0GTKQW<_&;X>:_JNL)X6@\!VBV5[HT^H^&_#VL:-\0-'TSPJ+SPWK,=SH%P
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M!!H%C\-?&]W+!<>/M?UOPC+KNEW%I_:]UX"L]2LV6T%G&/,?@W\5-7\#:O\
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M)F\0:^OABVN9O#VB?:\Z@GC/79]-TC[8=YUT1Y@H \TTW]I[]H;XI1ZQXP^
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M@UC3);_]S#I\>I"^V$1_:6E(8\)^RIXIU"7XN_&/X5>%/CAK?[37P3\)^$?
M?B7PYX_\0>)-.^(&H>#/''BN^\0Z3X@^$[?%S0Y5G^)=CJOAG2]*\<3WFI6E
M]K/@.WU>"RUS6-8NI%,7I'[*\]OIWA;]I_4M0LKJYL+3]JK]HJ\O[86CWL<V
MGQ:ZTC3Z?IETKQ7,6K*76=+6%8)D+>5'%DM0 _X6?M#_ +3'Q%'PZ^(9^ _@
M2/X'_%C_ (135-"ETSXGB[^+/@GP9XQM[:Z\-^,/&_AV;2(O"&HQ:QIVIZ+K
M6I:+X2\7:A?^%+?49-+CE\6WMA<3M]Y5^'/_  D/P4^'L'PW\7_L/_'&^@U/
MQU\4_ VD67[(VF>,KGQ+\//&&D^//B%IVG_$G39O@MXT6Y\7? 35_!FCZUXH
M\0ZQ=>'[#P)H/A;5/#4Q^)6A7>ES6.CVO[C4 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5QMS\/O!
MEYK&F^(KSPWH=WK^CQRQZ7K5SHVE2ZGI_FS_ &GS+&Z:R,EC/'<?OHY[,P3*
M_)=@2#V5% &#;^&M)M1.L$!1+BZGOY4)5_,U&ZB>&YU"=Y$:6[O9HI&C:>\D
MN66-8HX]D<$"1PIX=TM9;J5K>.0WUJ+*]26&VDCN[6*-H;."[5X#]KCL();B
M"T^U&8B*YF2<S Q^7TE5Z.J75[#YHQ3<OD<;#865M;2Z=:V\;VXMUTXV;6[P
MI!;+$(6L3:65G/;1Z:P,Q%O"L<,"7,T%L(+<6\,$-CX.\+::XEL?#>GVMPI?
MRKJUT2*TN+8/:_9-MD]IH\ L L6"OV%;<[QN8L"0?YXOVW?VN?C#XD^-?C_X
M=^$?&_BCX?\ @#X=:G<^$+31?"NJ7.AR>(Y-#E_L[Q#KNI7]E*NH(3JG.FVT
M5S:RK:8$IN'_ 'I^+_\ A=/QF_Z*[\3_ /PO/$__ ,LZZ5@JS2E>5I;;?JO,
MY/K*YFM-/^"?V!:AI=KJ<,D%W#-(DK9GW6TK_:8BTF^TNTETZ2&]LI()7M6M
M+R.> 1%)41+R&&ZCR]*\%>&]!L!I6@Z%I^A:6'N'.EZ-IXTK2Y3>PP6U^;C3
M+'2X-/NI;V" Q375S;2WD:W%U]EN+<SN:_D/_P"%T?&C_HL7Q3_\+[Q-_P#+
M*D_X7+\8O^BM?$[_ ,+WQ5_\M::R^K/>K*G;S6M_\OU*CB*3OSS4.VJ5^^_;
M3[S^PRQT^#388K:RMOLUK;P16MM:00W4-G;6=N!':V=O9PV$=K%;6MJJ64$:
MPY2UC2,LS#>=7[5+_P \C_X#WW_R)7\;/_"X/C!_T5SXH_\ A?\ BG_Y:4O_
M  N+XS?]%B^*G_A>^)/_ )84_P"S*G_03+[X_P"17M\/_P _U_X$C^PJWT:U
MM+'^S;:V6VLUE:XA@M;9K*.VN6O9-1-Q;I9Z9;QQR?;7%P?D*/)'&9$<>8),
MNT\$^%K'5[SQ%9^&=&M/$>I6MK9:IXBLM(CT_6M6M;2X%U';ZG?Z?I=K+>V[
M7&9I+:??;.Y_U(  '\AO_"Y?C%_T5KXG?^%[XJ_^6M'_  N7XQ?]%:^)W_A>
M^*O_ ):T?V94_P"@F7WQ_P @]OA_^?Z_\"1_8C+:M*23YR;AMD,7VI'="^]T
M$HL3- DOW9!:R093A2IP:Y>U\"^&K&ZU.]L_#^DVU[K<4$&N7D.B6J7>NQ6:
M"WTV/7;I=#%QK<>E:>/[+TZ/59;R."R)!62Y_P!)K^1;_A<OQB_Z*U\3O_"]
M\5?_ "UIG_"XOC!_T5OXG_\ A?>*?_EI1_9E3_H)E]\?\A/$T([34[[ZIVM\
M^OZ']?-QX5T.\U&SUB\T/3KS6-.@DMM/U:]TY[W4[**1KKBVOKO3)KB)A'?W
M\$CK)NO(;Z\74#>-<RL^K/I\5Q<1W31%+F-41;A+>7SPJ75O>8$SZ8\J+)/;
M(9XXW2.Y4[;A)1%;^3_'C_PN+XP?]%;^)_\ X7WBG_Y:4W_A<'Q@_P"BN?%'
M_P +_P 4_P#RTH_LRI_T$R^^/^0+$T);S4+;:I7O\^GZG]?]IX5T'3[J_OM.
MT/3]-O=5OI]2U:[TVP.G3ZM?W$D+R7NJR66G0'4;[%O;JNH7GG:@/L\$QNC<
MP0SH[4O#.EZQ%+!J6GV][#<&(7<5U8I<PWD<$D31174-QI,L,OE1QO;VUQY8
MO+&"XG6PN;5F1X_Y _\ A<OQB_Z*U\3O_"]\5?\ RUH_X7+\8O\ HK7Q._\
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M^@+$KF2ON?T;:9X.\.:!:II_A_1]/T'2UEFG;2M&L;/3M,DGN&#SSRV5M;I
M99I$A>:0(KS"WBAE+VYDADTH-"TZU9GM85M6>:XN9#:QP6PFN[RX^TWUW.D$
M,<<]S>R ?:I)D?S /N@DL=922,GU_P *=7$HRBY7;:TMY=^GH=:DI)6MZ_YG
M%6_P[\%V6K7NOV'AS1K#7]1+-?Z]:Z5ID>M7[M"D0DU'4VLWO-4E0QQS+-J<
MMY*9E+.[))*DG:T450!1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !68;A@N<+N],''\^_;T')]
M!IUS=T[1V\D@&9%' _A/&<,!R,^S#J/>A0K3G35&%)WDE*=237(FTO=5U>^M
M[[61QXW%8?#8>JZZJI>RJ5(SI1;</91YFKI-)RNK)IW2?8_%?]M#]B;0?%?C
M_7OBKX2^(_@SX>7?C2[.I>+]&\<7*Z=X=O-:MH1%;Z_H_B$RPH;S5Y +O5M$
M,4[7%U^\@N;6/,=?$_\ PQ/JO_1Q?[-O_A;2?_&Z^:OVZ/B;XS^(G[2OQ>L/
M&=WJ3Z3X \7W_A'PIX=:\GC\/Z!X;T'G2F2T$OV":?Q&<F#4)+-[MR3MF48Q
M\D?V;:_\]U_\#9__ (Y7]<\#?1^Q/%N18;,IYY@L'S4Z<E%SIW?M(W:NZBOR
M<J2TTOUT9_G)XE?3&S+@[BG'Y!@,@Q>+I8*K4A]:J4YKVR4N6+35.SMRN]MK
MH_4G_ABG6O\ HX/]FS_POS_\C4[_ (8IU+_HXO\ 9N_\+:3_ .,U^67DQ_\
M/TW_ (%M_A3?LMI_>7_P.N?_ (]7V:^BA6J?\U-@I6_Z>4]+^E7R/SJK].S/
MY<O-PQ6=KVO"IY?W#]2_^&*]5_Z./_9B_P#"^F_^1:/^&*]5_P"CC_V8O_"^
MF_\ D6ORW\J+_GNG_?V/_P"-T>5%_P ]T_[^Q_\ QNLJOT3ZT.6_$V!5[_\
M+RFMK=ZWF9?\3U9Y_P!$M6_\ J?_ "!^I'_#%>J_]''_ +,7_A?3?_(M2_\
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M2RD357T70?[3C?3O^/$IJ*::EZOV;"^5^_\ EV+Z<[ME_P $BFT[3[S2=/\
MV@/BM8Z7J+S3:AIMIINDV^GZA<7/_'W=7]C';+:7T]WA?M#W4,P?8N%7!S^U
MFR/T3_OVO^%.V0?\]D_[X;_"L9>)'&<HQC+%3<8Q<(KGCI!I)Q_A-VLDM_F=
M$/HP>'%.;J4^'LT51MR<EB:=[O=O]XU=^B/PXN/^".>FWB/'>_'3XF722:C=
M:K(LNBZ:HDU&]A\N[O9_)BB-S>3R_P"ER7ER9KMKO]YY^S]W67_PY?\ "_\
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M15C[.O\ >?\ \=_^(J>BDX1>Z7X_YB5*G&]DU??WZK_.J_T(/LZ_WG_\=_\
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M_P"._P#Q%3T467G]\O\ Y(?)'S_\#J?_ "P@^SK_ 'G_ /'?_B*/LZ_WG_\
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M_:T>)"SP1@/Y<;O)'M:3NI G!/T!!I9M0EC53^Y4.1$LACED F(/+0I(LGE
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(4 %%%% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>image_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" +/ A(# 2(  A$! Q$!_\0
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M&#R?3\JMS71QB.1U>3Y=P=CRW /)('/3O[UT1P6'FM)K33[]3NC](CB>:36
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M@-_PNC5RK$#CX?>-._8?\2#.?3)_&GG_ (+I?\$X54M_PN363M!)S\/O&HX
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M;;K^%O\ ,PK5Z.&4Z^*J>QPU.E.4ZCV4E=I/5;I;WT\]C\\O^"MW_!5KPO\
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M:Z=C@Q\U*&B25G=)63UZI6N<]J>IA(R&?DJ<'CJ1@=O7';_"O-[BX:62<[N
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M8T4F!,8 V,,9&#USP03R,X)Q7GVG.RK&0>K)G@<\C/6NQCNFVHV[YAM ("G
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M525[)VNOO=S/+\"Y8CF2]R+]Z-O=;W3:V>FGEMMH>#7\Q=BS'+#D'I@CD=,
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M(&!C!K^-[_@ZP_:LOM)\/_L[?L<^'KUX?^$\OKWXZ?$R*UGA"RZ3X$N$\.>
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MSDGHY2=Y2?+HG)WM][L44451]B%%%% %6["F(JPRI!!!]",'WZ$\]:_R:?\
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M^RZG!B?X$WU[_(RC#MD3 P-RYZGC(S[_ (_@:M%0 2HPP&0>3R.G'/?VJW+
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ML:>S]?T/@XT)JK4LVK7MJ^S/*7X0$=3G/Y@?RJ(.R\9X[\#I]3_C2L?E.7!
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M7\S2.%7LY^ZMUT\OF<"EYM(P3C([J>_XU>2X9QG=D=^%Z=^WY]*Y!I"K#Y9
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M (IX-N> H+*6R<DXZYSGVQV],_:-3/QP^*QC&/\ BKK_  >3_P N6D?7//\
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MJUM/W,]M.I_4Y_P:BJ%_;$_:4(&"?V:_#V>2>OQ/T[U)K^]!>H^H_G7\&O\
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MZ@ \U_=<O4?4?SJJLU-IJVB:T];]D?TCX;0]GPOA%W;?X6)Z***R/O@HHHH
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M'V;2=6%S=*<X"2QO;%!DX7@K[,O6O9CPAQ,Z?M:N6<L=X7H_%&UV_AUU_P"
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MU/+=0AO-C?+2/,7SC#[,[5RP(0$X&0!CJ>]5GO$(8NJ*N#N=9T!5<<L !@D
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M)('XDC_Z^?R[Y/I?[-MH4\:>)XS$1-#\"OVC6<*ER861_@AXL*,'>(G> <A
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MG<]67XD7/^BRR:]HU_):7D4ZVTFH^(%D!259#'#/!>+ C.5VJTRR0!B#+&Z
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M @G!F5< Y.0UO%'C'7?)&F,[G1<L+,7B=F,F)[3=@[2);0$''!&;\KG/.6&
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MG[.+A=\JJ-V5UHKI)+H>%C:.#JU*E.,HIQ4%HENX)MJW=[_>>U66JQ*L9"
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M7N$5][%A+##;B1(@K951N'WD"N<X+$<5[G\!M3LX&^/=Q=7TC7"?L@?M!QK
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MHR9UJX,23*H(2W^5-PR>(?X1GDY->J>#O%/B:+2-6@@UN[:W6UTQ]N]0N#=
ML2-@WC!.5;<IZ$8)KYLADE3]]E078-*202PSEC@Y R,CY0/Z5Z]X.NX[FVUV
M%"?DM;8*%8@8CUB"%,@$9VQN5YSG.6W,,CZN@L=2I^TG6KT^:DU[M2<>:&[3
ML]5?=;'UO&W"V&PO#>%H4:%&T:]*$U&E!*S2]UV2T:W6QZ8/%GB$$'^UY^"#
MPL /X$1@@^A!!':IQXP\1<JFL7FYQM +H02> ""IXR?0UQ$2/).$0G"NNX<G
M@'GOGH#^?:K4C+#;3S2#RVB#LA)(W; 2%ZX&=N,CGO7R,\?5>(K4XU:CE"IR
MPASMK6[=DW97EO9:L^!CPK1J*G".%H*RIQBE1A[JE%-J-HZ)O5VW>NYL:EXY
MU^T0^?JDK8#;E_<_,,<@CROF!Q@@@C![UW/@KQ]K3^&Y&^VRHH\4+%&1' /+
M1/#]P\>#Y6,HWS9/)Q@D@5\N271UF^@2ZO#;H97^;Y=ORL-IZ 84_,0>, [@
M<XKZ \+PV]OX4N4MG2:$Z_)-#(2,[HK!K=V7GYOW#/'M.5!.X#> P]/"5\:J
M.-E5YZ,OJE3V;BW!RC9W=U;:6AIQ?PA@L%D&%5; MU:^(IU(3H4E%J*2@[N,
M;WYG=:['JP\<ZU& T6LW0=^.!#DDGC!\K*GG&1@@G@YP::?%6N*DD\FMW@W(
MW#2E@W!^7RR,-GG*X^;..AQ7G?G*!&6 V[E)X'3<">@!' ]CW%5-8D^V65S;
MI<2VX:VG1)X?];;L\3JLT8Z-)%D.BN""RJ&!&17PN'Q=50IJ56HYRG6M)SDY
M)*JUHV[K4_-(<(T_K<ZE.A44'[-2CB(\UY.":<5-;):>IZM8>/\ Q$O":HCB
M,@H)(563*$$;=L8!<D#;O!&[J",UT>H^-_$<>A>%9;C47?[7_P )&KYCMLC=
MJ40# B$,NW(Z$9QWSS\?Z;K%SI=U;6QN[NX;$K">[;+W$D?,8*?<7<PQA5 Y
MZ8KTG5]:U270_!;*GR;?$;L,@CC4XB2,@XP!GCK_ #^EP<\;##UI1Q6(BY2B
MTXUJB?P/JI+0K->"5AYX>=51@J]*=2FN5)*,:B@^731<SUL>L/XQUYA^[U.8
M =#M@XP, \Q9X/KUJ ^,/$,8:1M7F95!9U*6^&11EE/[OH0"/;M7A,OC2[B\
MR);,YA5FD=AA65 2<\?*,9!*X('0C%2:=XODU*UDN)+1XT5S$\<9+*RGAG+,
M2X4#))5@0.E>55CC:WM6\3B)6E9WK5'TOUDSRY<*4DG-R34?)>I[Y;^/-7D'
MRWSC.!GRK<X]^8N@ST/\A78:[XIUM[K3'75'W-H.B.Q$5L#ND@EG9@1"-I,J
M*_R_=( 7"\'Y^LKR%IHK5&PLR!RXYVANJ9]<<9SGTYKJ/$.KKIRZ7(\S7)/A
M?PVX4*JX9XID<G8!C*<<Y '( /-94IXRAAL3%RJ5;SBUSSE+EM!JRNW:^]EU
M5SRJV08*KB:4:D:=3DA.*YX0E;WT]+KN=W<^+/%0#>5KERIVG&%M\YQQ@F(G
MKP#GCKVJ_:>,?%2Q(#K5[Y@(WDLAR >>"F!VZ#Z9KSNWU&&9(94&WS%#;,GY
M6P.2"3T)!YX]1VK=M;B(C+<^O)'ID]ACZ =J^<JX['^SKZU-)J"]Z6D&FW%=
MHMZM;7W/G,XRC#8=3A2ITW&2<K*$;)IV5DE9.VIU9\8^)Q,N-:O,,RA@61E8
M$KD,I0J0<G((P<\BM3Q5XAUA_$>JQO?OY8EM208H"OSVRA]RF+#J1D,CAE89
M!4@D5Q,RD+YR\  LI]".G!SG&!P<CCG.36QXK;'B;6_1-2DA'3B*!;9(UYZ[
M4=AN/S-G+$D CV,#F6,HY9."K5J"]I%QC3JS@O@=VE&25[]3\UQU:I@DZJG*
M]*7N0YG9)._NI-6U70YW6;?^UDD6Z:VNBRN(S-8V3-&Q!"M$_P!GWPLIP4>)
MD=#AD*L 1\Q^-?@?JFNPW$F@:VMA=R2.\J16MJK&,Y+*S&!FE&,@AR0P.#D'
M!^HV>,JP'4J0-NW=R.WOZ>]0&2-1DI*'"G#!50<9QOV@97IN+9X!ZU];PSXA
M<8\,UJ.)R3-L;"FJD*E:B\=B8QJ5(6C"\552:]G>.WD?H/!/C3F_#^)H1=.K
M+"I*,YN=1J"2Y>7632BXW;6S['Y9Z=:?M#?"'QWI=WI?C+63:WNM>%;34E2V
ML9+;5-..NVB366KQO8NFJ6DD!>%X;X7">4S( %)!^8_BCHWA3]H:9K73O'VN
M?LF_&FTMI['1_$O@7PWI$_PE\81:?=S+:O\ $;X7QV"3Z'?B9@7\1>';S3KB
M:-GN)H;B15%?O'!HVEZQJ>EV=W90W"OK>A01@J=X_P")C;E K(0Y(D(()8DG
M@Y'%?&OQ2_9<T#Q#%=2:7$%EE:ZF>T5&CB2Y-W(4N"BN%:YB?#PW#*9HG57B
MD1@IK^X?#[Z4N>8G"4<#Q/2AAE&I15/'0;C4<%22DI56^9\TULW9IGZY3S#P
M;\7<=+ <9X.A0QV)HSI8;'TL+A[4_:MRFJ]3V5W4]NU*+E+FY;VT/Y<?VB(/
MV]?V7=9AT[XM>,?$B^']02XN?#/Q3\,#1->^%?C73T#/%/X?\5VNCBU2Y$8#
M:E9:H+*?1<N9X[\1,K_/,7[3_P"T&S1L?BSXG>/9OB2WA\-RO=*PS]J^T'2#
M:R6EN#OE\A4D9%;!SBOZ6;ZR\;?#C3M3\&^)_#VG_$KX:ZA*;;6_A[XMTJUU
MWPU?AP8O-&DWL+PPWC1,Z17UD]GJ$;,)8+V"8+,GYT?';_@F#X1^)=O>^.?V
M([[['XCF-Q?ZQ^R_XNU2.Y?4+MU>:^/P5\:ZGJ5C#%<2.&M[;P1XNU.1KZ[>
M'3]/U331*+F+^R."O%W).(*5.EBZT*.%@Z=*&-YDJE1S@IINJVF]6E=R/XO\
M>?H9U^'*F*SW@>MB^(,OJPKXK#TL+*=6E1IQJOEISA34H1;A[Z5E[J;V1\5?
M!3]HGXZ7WC+7%N/B7X@ECM_@_P#M!:K&WV3PX)4OM/\ A!X]FM)Q/'I*W&89
M+&U;RQ($<Q .CAWW^8I^U#^T%M9C\6/%!P"<_9](P, G_H&^V!GJ<UC?!W1=
M=\*?%+QUX6\4:3JWAWQ3H/P;_:,L-8\-ZYI5S8ZOI%U'\#OB@]W%JNFW<6E:
MEHC^=%FTGU>WM[6^*K_8QUU'2.;PY+U4&V1B01@C)Y'<<8(P#CL?3%?L6&Q%
M+$?O,-5E6PKLZ%1R<O:0:OS7N[]-;L_ANMEN;93[3!XW U\%BZ-3DJTJT91D
MG&\?=32:6EG:RN?1!_:J_:""LJ_%GQ/RI&/LVB\Y!_O:65_%@1Z\5R5Y^U1^
MT0LSX^*_BD @@G[-X;?@C!^4Z021CG Y.<"O$7OU57;=P6VQY/'/ !ZYZ^^>
M_%84TWF2J1C)8<A5!Y(]!D=L$8/'%>U2I.;BXZ=';2[T>O<^@P%6K3H4_:IQ
M<I1DNE[)*[VOKH?UF_\ !KO\5?BK\4/VO_VB[3QUXQO_ !98:/\ L[Z;<:;#
MK,-@6LI%^+6A6WFV_P!FLX2)$MK>)8RY(1T#C$A+G^Z.)"BX8\U_ [_P:;2.
M?VS/VGE+94?LUV#8(&<CXK>%I <XS]^YF;&<?/CHJ!?[X0S$CGN.P_PKW</3
M=.&O5W7R5C]AR6I[3!0E>]N5;_W26BBBMSUPHHHH H7[$1'G VDGI[^M?YA'
M_!2P-_P\3_;054$TDG[0OCL*I)4.[3P,%)! 7<]U,201@2#D!4"_Z>FI;?(?
M>ZQIY;[I&956-<'+LSX15498LQ"@ EN :_RX/^"NFG_%*R_;K_;.B\%_##XD
M^(=3\0_M!>/H["^T#P/XEUFQM+(7-Q;S7,.I:7I6I64S/'!"Z,'!39OCD3+M
M2C0K8JO2PU.+<*CO-]%:227S1^0^+>15^(,OR[!4:?.GB$YNU[?O8O[K)L_,
MCXJ?$^VFN4\&:&\TGF.9]=OU6-41[<Y-N6"\H@# A<;P,/N!KPCQ%=)!937O
MVMQ%]HM4LX5PK(V]?,D+C$DBGJ4D9TQD;2.*V(?@S\=6NS<WWP@^,1C:0RSP
MK\-?&1DEE)RX:4>'_-;>>-K.5Y^[BK6O?!?XWW=O %^#/Q:6W7A()_AKXS1B
M& RH*: K;FZ*Q)()!!'6OTK 9?AL%AX4Z<*?.TG5:A%/G225VE=NW<Z>&,AH
M9!A%AZ=.G&O%4'.I"$8S4E14;<R2EKON:OP)NC-J/[0\L;&7R_V.?VA2I8#:
M,V'A'<20IQG/WPI9>J\C%>06>DWFH0-=SVY=8BBHXGE>.*-K)0^Z,6J[P%))
M (<@81U)!'U#^S?\,_C/9W7Q_DB^#GQ4T_=^R)\=8(KW4_AKXS19;R;1O"DB
M06X&@;6:2Y6/8S*1G"Y"Y4\99^!OVCA;V[+\*OB[*1<1N1/\./&$-G)Y5JK(
MJ1Q>'DCN%8C;Y4ZR12YV2(ZLRGTJ48N:;BFULVEIZ=CW,PE+ZK4E=\S<;RN^
M9[[N]^IXW>:=?647DSPW5G.\#LJ-81&[FL]A+M#!+$UHL)CS_I)A$\8.]90P
MS7#LJ/> 6-K+'@A)9[QH'(<G'F+&ZL@*GYMJ*,D8QZ_0-U\,/CIJDV_4?A%\
M:;DQ,_GW0^'GCC)<G,=FI&A@QVKMB-XH]L3(2&4C(/&7WP5^-0>9+?X)?%Q1
M(6,>?AMXT)\W!V'>=!+_ '\?Q=LUZ=2\H8>*=I/$05UOR65XWWY6]6MGU1\Y
M144XSDDTU:5TG=NUF[[M+JSSV2ZM[>QEB9G,Z.S^=$X$^Y03F%GRL;Y'[O "
M!\$C&17Z6_\ !&K]EO3OVC?VXO!M[XKT2#4OA_\ !6"Z^,7CJUOK+^V+"X?0
M;FQG\%^%-3G</'Y>L:Y/93W"O)_I,%G/;70GLI;B"3\[]2^"?QTMT1H_@C\8
MKJU5F$]S_P *U\9BW15:<I)>2MH*QVXGE26SB5WCC=[%\@,92?[+/^"1G[(G
MBG]D7]C9_$?B_P %>*]%^+?[0UY9^(/%4=QHNN)J>D>&='2X?PIH-S;6]CNL
M[</=-<3S20"2=64W[744$2)_,WTJ/$ZKP3P%GV$RY-YCCJ7U/"0IMPG&56C*
MFZE/E:E&47*_,DG=JSNM/W_P&X&J<1<8X2K5IJM@HUZ/M*-6"J46G:=I0FG!
MJR>C73:Q^C7Q$\5_;=1NK=H)KFY\0WNHWB@110P6,DOEI)*T4$<<32RK!"%D
MD1I$6-/+9,5X?\0?B--\*_A;XO\ &\;QPG2K.8:=%<74T%NNHWT$L&CR7%P@
MEF2 :B8GD(24; W[F5?W;=]=/XAU*7%SX:UF&59HT2Z&FZSYDGS* H1M&2)=
MW&<;%8G#G&:^;/VR?"?C"?\ 9O\ &4NC>$/%]S/9WOA*58;#P]XLN+HFP\56
M9MW@.FV1N!,@XC,"-,[E<*[[17^1'A#D%?B+Q,X3P^>N4JN89Q3Q692Q+=:5
M2<L7!PIUY5>9U$Z<FDJC:Y=-M#_5CCVO@^%?##.:62TJ/UK 9#B:=##T*<*:
MH3=&3<J4*:BJ<DU>\$G=>1^&?QM_:1E^%=MH'A"T\6:WX/U_X@VVOZ]XH^*N
MAZ!=Z[XD\.Z?J?G[=:ET&VU%9AX@UP2MI>NWL?EIIV@;KZPTV*\1&KU/]CW]
MJ/X+?"[]AK]J;QS+^R[\+/VA_BYX1UCP=H]SJ?QBT+1/B_)\4?&'CCQ#XG%W
MXHL=2AL;#6=%^'W@GP];Z4]YI<]]:Q7]Y87]OJNLI%K-D]O^<W[1GP2^+VLW
MVB:W;?"/XHRW5_X:D0W-K\/_ !S"LNL:-J=Q#?2M=3>%UN9M<>UO-.U*.X-P
M-0V6JI'<1QR2!_B'P[\//VK_  9<^)HM"^'G[0/A^P\3:)JFAZQ%H'A#XCZ)
M%JVCW(#3:3>+I>DV@FT^?R8(IK-@8);>&&V>-K:*.)/^@K#9CA\IKX#AZ.&H
M9;E>6X#"TL/6PM*&%BTZ-.3<?9*G%7DDW;=O5G^%4,FKYYB\=G.8UJU7$XK'
MXJIB57J3JOF5>IRQDZCDW:%XKF;M'97LSWG7OC/J?AOQY:>*O@W=/I_@VZ7Q
M+=:EIE_;^(/"_@SQ+<G5X]?O?!.F^#/'E[J3:#)H.A:Q;Z+X>BTK4YTU633H
MO(M[FXGE\W]8OV:_BW8>&_B'\-?B_P"&[N&'3O'.I:3I.LZ.]XLHGTW5EAT/
M47GCF,HFN?#6JW(U2TF8?:$>W2%9/LY,5?@/-\'?VD?$.KW$FJ_"+XQW,^I7
MUMJ%_JMY\.O&AFGEAACM(WN[S^P!,Z0VL:(%>38GEB4)YB!Q^S_[-GP0^*UM
MX ^%EKJ7P=^(.FO-K6J:WI'VGX?>+XIK+3[_ %ZRMHDGDGT)3"MK>@7R23.-
MP7;(YA++6G$%7#<:<'<=<+9I1HXW*/\ 5W'8JC/&4Z>*I.O2H58TZZC7C4BJ
ML591J)\T5HGI<]K 8VMPAQ-PEG61XBO@L72SK"82<,#6GAI5J-6K2E)570E3
M=2.\6I)W3:>FA^H__!8'1+'6?V7]-M=086K>"_C3X!U"QG*!94M-0NI_#%_&
M)QB55O=-DBM99&<N&5+I76[1)Q_.+^T'K'@B6.P@T"2]58+XW=]=WXFEFL+@
M6*^;J>H0[WAMQ%(HTVQ$$<<$D\D;2H\Q#U_3W_P6.\%>-]=_9'^)VGZ9\/\
MQW>^(A?>&9HK;3_"VKBZN7M?&>BI)>6(?3'B2[MUN;AH46(Q>:R^9"X55'\X
M?P@\!^++S2?BA+X^^!WQK\,VMAX2UE-#UG3/AGXE\07.HW6NZUX<E\->"O%U
MMXO\.ZM;1>&Y-1FD\3ZQXUT^.UUK2+-9[*TUFSTM%M%_D/Z-&'AEG /$V43E
M9T<QS"A@GHN?"K#XB-H]>13]U1^%6M%+6_\ 1'T@*5/-^+.%\R48O$8O!X3%
M8I-)RCB%BL,E*3WYW%M\U^;JV?T^?LF6EQ:_LH?LX0333WTEO\(_#UR]W<*D
M6H20RQ8A811B.%[=8[:W^>1&DVIG=EG+?0%KJD$3%GE5'0;D$A(;>OS+@+A2
M2P& P*D]<C->-? ?1_'&F?LN_![P]K7@3Q9I^MV?@'0+36HK;0M:=+*UM+6>
M]TJZL[Y+"21(;U-D,UM&YM8]Q!@(!!['P]H/BJ2.=+WPYKB&60I!+=:5K+S%
M&^55"?V*I+'("D%6R1AU.&'^67BQDF,I>(W$=Z"Y)YYSTUR*RC[Z?*K65Y.[
MMN_,_P!8?"G&4,5X9<.TZU2\\+D:HMR=Y.\835VW=V2TUV/<M>OXI-3A=4*-
M_P (_P"&)UDW'!FETC1T9@"=IW+@;=NP#H,UE_:V)),C8/WAD8(/48!Z'T _
M"I?$5CKB7FGQIH&MM&OA?PRK$:!KBCS8])TC:6D_L]BNQQ\VY6 VG<C $5S=
MNFOS!U;P]K"E'(WG2]74%0><[](BC QW:2)1U:1!EA^6YQE&.>98GDI<J_=W
M23BF^1;I+6R[GV&3U,##+Z*<X.[J/=/[;ZW?]>AN&9G*[2< C R.N1@9'OWS
M_*IFFN)@QP(S"C$,3G*J"Q !R,D #N?P-926^N*1C0]4QD9 L+DDC/(&Q99"
M>N-D<CY^ZCG"F<VVO3O&@T+6L,ZKQIFM#&2 ,_\ $DYZ\YSGO7#0R7'*IAVJ
M33^M4]4G?;O:YIFM7+_[.QLKPYE0FE*T;I6;T>ZU.E\5SLFLZXS-\BZYJDC#
M@#Y;C4V/0<=#TKS&;4?,N_*=MQ/SJ#@#:/H!G@>F<FO1/&UGKG]M:[;KH&LL
M'UG548C3-:Y5Y]44D$:+W!X(Y],'FO*?[&UUKTRMX?UG>JE W]F:V,(>""!H
MH4\=R,]>>./?J9)C?KN-;HW?/1U:U_@][!PK7P/]D8-\\->=MJW\^FOIMT[%
MR>\E(VH^% .!M3@8Y&2,CV/%:?A.XBG\3:(4  CU?30X$C']X+R#!QN['''*
MGTQ6)=:7K<4,I.@ZRVZ*0(%TO6F<L5(4*JZ,I9L]%#*2>,KUKFOAK'XD3Q?I
M-M/X:\2N7URRD!.@ZZ@79?0E&+"P*JJX!.Y&7&2R.!@^SE&08^MBU>DWRQ:U
M3:5]>JT/<SF>"J9+GTN>-Z.2RJTGI^[K+&0BJM-_9J*-XJ<;24;J]CMK:XB7
MR6D)+M9V,A.YAEY#=(S8!P,KQ@ +GD 'DPZW=LUBBQMP9  ."#SP"3G/;J>G
MK60UEX@(CV>']>&%M8P!I>KD^4B73J /[#R<-@[L;OX22.#1U6'Q!'9)NT'Q
M"!YJY(T?5G8#(SA1HB%B!DA0ZDG #+G-16X:QL<RJN-!1;O=J%MV^MOD=.23
MP-/#X"\H7>7X.3?NWO*@I3;>_-.7O2>[;N]3I_"_B*32[X2E0L<@6"1Q@C#D
M*2000, DG SGGK7T9IVK>;+-<13@*]AKI)VQG(_LJ;U4_C@>F.:^,[.T\23*
MT,/ASQ+)&S9R_A[6XL$GAC)_9Q* =2<$ <E6QBO?/!JZ[>6U[$-%U]'MK'7H
MRDFE:NJLXTJ90H8Z'N.X_+@,2<X':OG\;PKB5BY5%A8*;C*\U2CSMWWNHW?K
M<^3XYPN KX6I4I>R@U*TW&,(N4F[J4FDKM+9O7IY'L,>K11N<-O:-(?+;/"E
ML$DJ/E/..&!'H.H/+>.]21M-2*!MOFY\T9!W%EP2,Y*YS_!MQZYK"B.MH1')
MI.M12M$ R_V3JY#,.$&6T(E>0 2,=.:Y+Q-=:\?*A_L+69#N )&EZQ@#(4GC
M0^ /\].?F,-PKCJF9RJ.A=1EK>":[K=;Z'F\/X+"4U@9RG%N-)V;Y6XIS3LK
MNZ3\NUS(6X*+AF8XY W$9QTZ<\]/3OZUZI\.[QXHO$DQ;<1%I("X7*K/J,4T
MO;G?(@;)R5QM7"\5XG%#KTLF?[!UDA2#QI6LEAR.BC1!N.!T[].:]0^'<&O-
MIWBJ>/1=47S+/PXZ&;1]?5QG4XTN2H_L79N:,,!E2%Z@ Y(^PCD.*J4JU.6'
MC)Q7+&\$^5.#;4;IV5];([>-JN#J9.DJB]W'4$U=?R>OR1Z_:ZI%&\DBIAB&
MR>N1@]CD#OR!]#7(^-_$P@L4M6F^>9L%4"(=CG:1N50P&#C.01U![A\']KK+
MM?1]4 )VL1I6M.0#P2$_L9=QQG"[EW<#<N<UY7XIM==O=4);P[K\T*$*L_\
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M<"BBB@"E=I(X!0KC_; *#'/S9SE?7(QC-?Y#G_!7?X@>.8?^"LG[?%I%XO\
M&<EGH_[4/Q*T[2+"'Q/KW]FZ;';ZA.MM#:V2W_V6T$1;A[>*.1>JN"JX_P!>
MJ4E0H&,%@I! (() P0>WZ^]?X[O_  6'O)(/^"K7_!0\6T5RT@_:U^* 8PJ
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MVM&#D,O0@/G< U?/J?$?QM \*R^-_&DBQOYBQGQ;XB";TM 5VI_:05/F QM
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M A2,7-A=Z5),CM^]D=/WKN&8-] VEU&PG3"K"JN^=Q^;:"3@Y)R><8/MBO\
M,GQ6GF+\0^(/;8C$+_A:]Q.K4LHWG=13>BYNB5KG^JWA LBGX<Y/1IT\-.I3
MRF,*TG2IN7.Z<6KMJ[?*NK/8O$-_J<.K6JQ:CJ")_8/AM3_IMR3A="TA^&,I
M92'YR&!'0]A6>FL:NN%75M44;PW&HW@.X'((83[@<^AJ/7K^)M7M(I2#+)HG
MA0J?N_)-X2TZ=CA< [I%5LD9 & 0I(.7)<1H058'!R%]<=O7D_EGG%?F6:U<
M3#,<4G7K.[IM7JS_ .?:7<_1\FRK*Y9=0E*AAFW[1J]&F[>^]%[NAT)UG6G!
M4ZUK!#?*0=5U @@\$$?:.0<X(J/^V-6@(QJVJ*P/'_$RO3R.G6<_X^W%9-M<
M"1R[8"I\Y3/)"G.T<YRV,#U-+<%50N[.[EO,52%4*G4YV@'&.IY(&><\UST*
MN*G5PW+B*Z7UJFFE5GKHGW+S;)\N>68WV>$PLE["=_\ 9Z6CL_[O8ZGQ7XEU
M>/Q)K>[5]48OKVIA@=1O.0;K5 >LW&>F1@@=.QK@IO$.LK-*3JFIJCAES_:5
MYQG(R"9NV<^M:/C1HW\3^(L!0L>O7Q!#ME0;K4]QSNR>.<$GV [<1<-I[*5F
MN@.#P)"&.1V&>3CIGCL:^MDL0\=BOWU7XJ/_ "\G_P ^?74OA#(\NGE."Y\+
MA8ZS27L*6JY[N_NZ]A/$GBS4XK-+;^V-4::4[2PU&\.$?@Y7SL8P>>_N,5S?
MPNU+6&\:>'YI]3U1475+>&6;[?>KEI+R)8F4K,-K*<$;<'(!-<]>--J-ZZ&.
M53"VU8T*'?:@_-(K%7Q($R5&'&[&5/W3Z-X3MK#3=<\.6S$22/J^E2;7N0%F
M#7T'[XNEJFUK<G<R"1$;&'!7->[@*];#U%%5:D9S7,I*<E+3W=T[[^9[_%F
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MMS<,QE5O(,F%V*B;/[[HOF&3R1_B?3Z5_';_ ,$(OV.#^R?_ ,%#_P!HS6/
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M:9O(C:51'XAT^2.56*[D,>T,&7:01GDXK<N;BUO'8I^[<=3N8],G/)(].P_
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MN47)9C=6C':I'FQC+#^@^'O'"OAJ,:.=QH22G3A"K&S:AR6DY2?7GUW/\_\
MQ5^@I#&XW'XKA+&JG2HTYS^HR2A44G>K&.$A%)PIN%U*--).I9[V/F3]F[Q/
M'>>._$<+V[0+)\ /VBY%$Q=)8VB^ 7Q3+(FU@=_RD*"?O8 %<7I%\J-Y),<4
M$I1X3*\@D:,$&?:2Q,C,N[ <L 3T'?[%^!W[-UOX<^(OB*36OC+\!M7L)OA7
M^T%917V@^)O&2ZG'IEY\(/B-9W5]>VMQX)N(X!'9SRNX@MBT8!,<9<+7"_\
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MTNK@^#?&=RDR%54".WTVY562/",?-N)B692QW[22BH!\PC5<I)'-+Y;B.,Q
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ML@@Y"O 58C&0K JQX8$$BN9L=,#[6*B, J2<#( .20>2".3E3D>HK9;3XRI
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M8YSP06)P?<8^HJ*TLWN9E##<-X]!W'ICZ'U]*[_3;3R%"@;3V/)YSQ@'/?\
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MHO3<.2 ,E@1WSR?\:V+'PS>R+\H<\ X\L<GW^7(S^?H>:[.Q\/7EO"&\HK@
MDA<_='4<'GTQ@YQCFKC-3NUTTVMY]D>DIQJQ3LG96V[ZF=:Z5-L)D1?NGG.,
M>^%('H>1R*DDTS:CM\ORHS=?0$^GM6VMC=C&%E/MM//L<COTR:>UC=%2#!)@
M@@Y'&",<XYK:GL_7]!.G3>\(/UBCAYD**Q[!22.O '/J<8'7\#7I/Q3&_P"#
M?[.;+C TSXO$^V/B3?$UR=[I[A)$:(@LCCJW\2XXYQW_ $S7??$RP9?@W^SN
MKCC^R_C!Z]_B/??B>G_UZUNULVB9RA2@XJ,4I:M))7MH?+SPF0C'0G!&/7&>
M>/YYY]:OV%H02-I&/J?ZCU_GZ<WH[0JRC'R[AD8;D9YY/U-;EE;("QV@8!/4
M_EP?\Y]2:3;>[N>5.O)1G[*<J:;]Y0DXINVC?*U=I:+R(K6R&W<5Y'(.3U'/
M0'IGZCD<5HI9QOR8P6['D<]>@.#ZXQ]>IK0@10A '!&#UY!R.O7H*O00H0 %
MY) !R>"2<=_7%85:OLW%=TW]SMV9Y<JDY2DY3E)K9N3??N4([$.%5D7@C!V@
M8/8Y !QZ>GOUJX=*0*A &<C/7G]>/;'Z5O1VF$4E>"1NZC*YY[\9Z<$'/-6+
MB!$C&Q<,#\OS,>1C'!)!P?4'TZ5BZTI?#*2MO9M?E8%*4FHRDW%ZN+=XMW>M
MGH>>WUM' & 0K]Y_O-D,!G/7/X=/:N__ &J98O\ AH'XS&, 3)XZNF#G+$,-
M(T9@1N)'! /3KV%<3K<J_9W/_+8$J6SC.0>@^[_X[D^O:M[]J!F_X:+^,PR?
MF\>7(/T.DZ/_ )XKHHRE)2YI-ZK=M]/,^DRZ,949QE%2BIQM%I-+W.B>A\[2
M67FLS[$;<V]V9%8YZYRP)!./X2,=NU/6V8 *.%S]T*0.3R.,=?>NB@M9'0E0
M?NGMZ@YSG_ZW/X5;AT]V*EESR,\D<9&>XZ=.O^-%35J^NC_/T/5AB8T+)[KX
M-;<J6EHZJROK9=3.CM6:6+*+\B C:JHQ(P>2@4MDCHQ()(R.U;UIIL3LK-9P
ML^1AI(4<ALCG+@\@]Q_.K,-NB.A*C<"H!YZ9]">?3D'Z\FNHM,!0<#A<]!Z_
M3VI4Z<)RM.$)+^]%/OW1UPX@QF&:^KUZ\>MX5ZL7%K16<:BMH)I]HUCMD@DN
M+61F&7@N)X2IS]]1'(H1E/(*@%2 1C'%B?Q=XFT^)C;>(K]O+<XCN9!=Q.%Y
M$<L=RLPEC8?*R.&5U)5@02*GNY0D*,#M(Y/ /UXY'^<GK7"ZS<A494(&[.<8
MR6(X()^8'G(((]L5Z$<KP->*E.AAXN.G\&GK>SO\)[6#\0N,LO7M\NSG,**I
MSBY1EF.,C>27NVMB%HHZ6[GN7P-^*.MR^-_%*:K8Z)JEN/@C^T7<RJ]O]@F=
MK;X)>*Y$,;6"VQ60;?D 8*6^\IZ5XU;_ !3\+R%EO_#?B/29&!5)M%O(+U9&
M/"[;;4Y9GD).-L<;Q.YPJ2(2&&[\"4=_&OBEP=W_ !8C]I/EOGX'P/\ %V?O
M;O?G\NM?-FH6_GX58XG8$ [XHY/;HZD#/8C!';I6-;A_)*D;5Z<E4LU!X>"A
M:/7FY$M>:UO(_7N&/I/>)?#U3#588VO74>64N?&8F:GR6BN;FK2O==]SZ?TC
MQOX2U<_9].\6VL=WD*-,\1J_A^_,A.%B5ITN;:XD9B$6.&6,NQ"JZDAAMWT5
MY;!IQ:W,MOY3RM-"#>6TRJA9E\^U(EEB< AHG=HG4E74J<'X\@TF5V0-$S#<
M,*Y=HUY_AB8F-?7Y5&!S7H6@ZAKFCR(+/5]3M4+*A1+J:6%$) .RTG:6VX!.
M%,6PXP0037R^9<'8>5)RP%7$J/,I2IU9SM*HOA:3=M(Z7MN?TYPU]/K%RE0P
M'&&1T:^'FX0]K&C&I3Y7%0E*KS1DG4YG=2E[W)=)V/8?$FEZ+XTL3-<1;?%N
MAK'/X9U[3IS8:I-<P@RVVE:U/,P;4["2X6.%EU<7J6\)/E"-0!7!Q:9>)K30
M^(;I(]<6UFGO/LJO%_;/A<E;FQ\7Z+:?+%-:'48UM[[2IHGU"Q,;7EYNTXF,
M_HW_ ,$__P!@[XG?\%*/$_Q>^'WPX\2>!O#/Q&^%_P -HO'^G1>)_P"T;+1_
M%,TOB&'0+_PO/JEE;7HL+FPCG6YCOUT^]=)7W3V]Y$AMG\S_ &FOV2?VB/V6
M?$<WP\_:/^%OB?X8^-+*^O=3\ ^+=9TZ)_"OB2986@E?P_XZM9-8T35='U=4
M6UOK*UO=0DFLY)(=2AT0-)Y?V_!&?<3\(5\/3G4QM?+:DH.4:E>M.C2Y;4E&
M,)2<(IQ?-9);'=XEP\+_ !ER&KG>2TL!@LV]E.ZAA\-2Q$YU?]INIQA&HU&W
M*[/1VNS\WM5UR*TAO8)I&::[FN(56XRCW46&2,X3 0D$8C0*C$[65AD5_4__
M ,&>GP_NM?\ VEOVEOBRD$LNB> /@=I?@&.Z*L(H-;\<>-M$OOL2R+A9)(M.
M\'7EP5F,CB.Z4@X"8_D[\>WNF1#6;R=9+(VL$FL69O LRNT08,UH\"@MI[W,
M>6D.]TCSL(P!7^CU_P &MW[&NK?LP?\ !.RU^)?C73+O1?B'^USXP/QJN-'O
M,Q7VE_#:R@C\,_#.-K>=5VPZKIEKJ/BJ3"FY^Q^*],,Q#+$R_K_&&91S?#8#
M%<W/&IAYU'"3YHPJ>VBTU%MI22V:29_*W"F6/*<1C<!*G%/"8F-*-112E4C[
M*3NW9-[6U?4_I9HJ;8OI^I_QHKX#VE3^>?\ X$_\S[WFA_+^"))\;&STV/GZ
M8K_'+_X+'2/)_P %8/\ @H5"D9G<_M9?%!(H!M'FR'5)E6('*<R-A.64?-RP
MK_8TG&Y"H[JX_,8K_'(_X+)HB_\ !5O_ (*&R*J^8O[6OQ1SYF60J-5G)#J3
MM*'G=QT)&?3[C@_7-9):-T)I/KO]Y\?Q'[M"C/\ EFM?^WMOFC]"O^""GQ4F
M\&?&;XK_  KTJRABU/XI>'_#NH3^);/1A?>(8_!GA?7X+WQ)H,]U)-<6VD:5
MJD&K:?->7%E';7$UII,T,DK6]Q=13_V3FQTQK)+N62XO1<01BTB4EMSQH,+Y
M61'N)  +*2I/!%?RV?\ !('X=:;X(^#?PL\3> M"T&#XA_$>*ZO_ !9X@M_*
MU;QKJ?ANTUR#2!8JQ^T:-H6E:5ILDLMS::?9Z?>:E&@.I/=S .O]+FAR75M!
MI[,ES;7%Y 4BM)Y';[)&@Q=S_,S%7E7>R@G$9P8MF!C^FL'AY4,CPJE_R^HU
M:C3U4G&7(F[[M+2_8_DGB7$1K<39HZ>CI5H0;6C;Y9.^FUTEHVWYN^FU:Z-Y
M+>)K[$88>"?%T,5M!\\_E);:*Z07 8MLC+\2.FUPN<,"./$=3TWS[EH)(%:[
MDC@87"H(DM8B!N8QQ!(96C&6W2H[DCYCS7TQIT(23Q$LK@H_A'Q>.@5VS'%&
M0SJ%D;*VT"G<QSLR02[EO-]4CMP)%1$8M%"H4G!?@ (7SOP_W2=W<D$]O@*$
MI.MC8N3:5=)*[LO<ELMD9T?>C=ZON]7LNK/'+K2+>2'[-!NN@BD7LTDDO[B
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M2E.>+;DYR;EHII)MMO1=&W;:[M=PZ3>75X?$4TD@2&/PGXN8$A0$40:7(6)
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MN?A$"#_P@'Q#&"#_ ,E=TCMS_P!$2H-W\(V=6_X0+XA%0RD_\7<TCH",@_\
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MIQ',\+'GYB5(.._  QQWZ?CFOUEO/"WP+>=Y/^%5?%4D?,?^+Q^'?FQR>/\
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M1_07">4RRC*H82:M9Q<8M:17)9J*Z)O5VZZDU%%%=1]19+96"BBB@""?A N
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MH7*J%F!^26*V# AS(#M1B"P)!5E/-<_=7:+%O8"*6+]Y]LX:26)!N*?/G:&
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MRAG#POO.5"'C@= 3SC&?H#7H?@^X3_A5G[3"@C']D_!H ''/_%U;GG\?4_\
MUQX8NMHJE%< ,"N,+R#QC)R1GU'->A^!M0DG^$G[2L@=3(=%^"+YR/O/\7KB
M-FQ@+RO&""!U')!K2GAVD[76O?R_Q'!3;O-7=KK3Y,\_M[EF.TME5[!5&".^
M0 <_CGL<5L6]TZ8*N1C&.AZ'(Z\<'J#U]Q7%VDDY&XE2?PY/TXZ]/?CI6I'=
M2I@.H&2.XSC/7N/6O1P>&;;OK[RWUZ>K%-)-625UK]YVL-],2"9.XYVH._\
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MGC'<YZYZXKPMA+(1O)//IC_V4?KQGFO;_AJA3X,?M.R=QH_P'Y[;1\89LX_
M=_KGD4KM;-KT9,**G=I):V=DE?\ %'#65Y.FUC*V%VL>G."#Z>@K?CU!9"I<
M,>5YR<=?0$#W]/3J:XZRFS@9ZX7MZ_SY[?TYZ" !@!ZD#\"2/K7=A&^6;N[\
MRUO_ '3GQ-/V<H+O%O[I6[LZ_3[R)G",>"0 .<<D>Y_^O_/JXIXU1@C+G:<9
MQUP1UP>N>O\ 6O-[2$HY(R,'/4GI[GO[]#QCI6F7G4%D<A5!)&!R!R1DCCIU
MSGGCM78Y2>\I.VUVW8\[$5(PC9I.Z;U79V/2;6=B%,A4JI&<$= <D\<]JU1+
M&ZDH.<'')],@_P#UJ\EL=2N(Y#YK.T>1M!P!@?3!QZ\GO73V6OPAQ&X(!(7@
M] 3C('J/Q![\5I3E))VE):]WV/#G*-2JM%9+5675W._MU+QE>I9,#_>.0/U-
M7EM/+5=R]< YSR#U_P#K\?C65I-];2MD-(=I&W*KC(((S@#C/!_&NH=UEB#
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M'Q$HQ 9 T6@HRDJ2-RE64\A@0"/J'Q/JOB6W\:^(8XKS341==ONOAKPVV/\
M1+3)RVDL3CT)Q]*'448OFLWT;U:5NG;4_>N'^"<-AU3YHTVE*#=X1MI%*^V_
MJ?&?A/P)9Q1JL*0OO(7<;A@>3CC-EC/ID?G7T#X>\+PV4,8)0 %<YG7& 1U/
MV'(&.<@@]2#WKV'3O$_B>!0?[3L,#!*+X?\ #J9 Y(!32@06Z!@<CJ".HZ3_
M (3GQ.JH%OK49.,?V/HI!RP'0Z<?I7DUL6U*T9-;[-]_F?K^$RO#T:,(1A3G
MRI;QC[NFRVMWT]3@H;6U@B5FDMR44<"[QPO4#%EU(&.F<]QGADMW;89 T(5P
M4.+L]&!&/^/+CCDD'.>A%=[+XZ\5\#[=:8';^Q-"Z?\ @LY'&>>.Q%,3QEXK
M?<9+VS*D'8?[#T$;200#QI@X!YP>">OI4*M*JG>4G;3=^OD=GL_8^['W5+5J
M.B=M-4GV/+9DB4DM+#L ^7%V3M[@C_0@3R>A)!P<YK(O+>VVF1+B(<$G_2<\
M8YY-CQQW'MBO7KKQQXH0!7U&R(7H#HF@]O7_ (EF3P.A]Q6#J7Q)\30PLBZE
M8@LC+_R ?#QY*D=]+)[GZ?A64]U_7446^=:O[_-GCE\8(EW+=19 )YNC@X&>
M?]"/''..@KE+O5+9"2\UME1D;;QMV1DY4?8\9]!R">N1DUZ7J/Q/\7J3C5+'
M"Y('_"/^&R..Q!TGG/3!.#Z')SQM[\3O&DD@(U'3P,C./#7A?CD$D?\ $FQC
M&/3/MUJ#LJ2=H:O9]?-'GT^K6\TI_?J0#D9G &!SDE; <>O7CK4/VVUD8 S6
M[$D#'VISG.!C:MG&3GI@.A/0,IY'>#XD^,025U33RQS@'PSX6()/8YT@C![]
MJ5OB5XT$;AK_ $LL4;&?"WA7'(/4-HFTCU!!! YR"1750;C"33:?/'5.SV[H
MY*Z4HR;2;4)6;U:WVOL?=7_!+"\BE^+OQ#CC;EOAQ9[AL=5.SQ1;[=K2<\9[
M=<_G^ZR]1]1_.OQ!_P""9GB37O$/QD^($.K7-C+#:_#;3I(5M-&T32R&'BFV
M8Y?2M.LGD!QR)'=3Z5^WR]1]1_.OO\M;>&@WJVHW;]#\:SG_ 'ZIZO\ "3L3
MT445WGE!1110!5N&<*R*=N58#A3@[1@_,#G!.>0?<&O\@_\ X*WJ=4_X*N_M
M\:;IL5U=7[?M3_%"64,TD$"1S:O+ EC(T3)Y:PS'[3)*NV8(2&DV<#_7PNA\
MF0,DY& 2"<@#&0>,],C!'4'-?Y G_!7OQ/9>$?\ @J!_P44CM9S<:QJ'[4WQ
M6D5@%#V[7^I7%I*BG!QF)]BC&(W_ 'L02;#U]GP-)T\ZIS3<?=<79M7B]T[6
MNGU3T/F.)J/MZ$*;5TXRT:NOB1\$>,]>4WL5M)/ITEQ&D$.H-;VEG#!;I!@/
M906\$$=M;"904N9;>**6Y!8W+RDDGF[+7[*]GCN_$37;QZ7;-<:A!,CW^GZ7
MI=TQMXM-2RF\R*97CS+*PC:["':DH.*\]-UY-O>3W4R%KY9&EF?:[(KJV\8<
M$!P"2" '!&00>1#8Z_;264C7*M#:"[,C.)9$:ZD9?+:25E=9&C"8V1EO+B(#
MQ(K#=7ZQB\<IU*].+M"G43Y$_=4N5OF4=E+SM<^=R[)HTESU'RJ4'%):)QEO
M&RLK7MIW1_2[_P $D/VHS\4-<\3>#9],M)?B'X:_9^^)UE<WC7<XU'Q_X2TV
M7PV-)O3XAUR6YU-].@2QM;!]#FO3HFA1Q->Z;I]E<!Y:_6S5_&FE>*K>VMXK
MRTANHXF.HC1;=I=1GF2,QRI<21?Z)(MHH*^381P_;-NUA(S$G^/+]AWX@ZWX
M2\8_'WQ;I-Y#INJ>'/V6/VA]>L+Q0'43'3?#,30+;A2D=C<6]Q<0O801I;#S
MFFBA6X6.5/Z!?V8?VC_AY\9/AUHWB/PI'J6D^+K6#2K/Q%X*2[;[?IOBVT2-
MKB(7!D,<EA.BB_MKVR$20,X74C-"LD9\KVTJSG*4I2:=FY-MOW7:[?9:+R/B
ML]X3IX+%/&4*<(X>JW)PC"*@I.?9:;:ZZZ]K6_1#6OB#$D%M9P1-8V\=LMM%
M<LZ7-Q=J$V2Q2V@#2V9E!*&:0!X-Q<,NW-<$^LI<W:J"8;8D/(Q ;>O5CE\M
MR,X /7TS7D_^FR337+FWM[Z0R%]MU]IMEAD#>;%=7L!\U[ME)'ERR-%O."NW
M(J1_$;O(B",P-;KM(NE5+:5EZ-%(%65\GLSE3T(P<'\\S3$SC7JQG.<DF^52
MDVDKNZ2;T5]=.IV8'*5&G"4:<(JHE*T8I7M[O1?(Z:\UB1DU"[<[(S-Y4:85
MVN&0XC # E 2 OR;>#SUS61?WF8KFZ\P(J0*L,9"[DE9.""07+;\'DG!QC!'
M'-)JL5RSRM(TDD<H9EB53%"%.3)M(VG8!NY!R 0<BLW4KYI\K*2('D1PRX'F
MLA!4,%'R G .S&><]J^1Q59N:Y).*L[J+:3=]&[;Z:>A]!1R^,''FA%M[-Q5
MUMY?A_PY;N+PS&)8R"8HI,*.%.X'=N X);IN(++R5((K%NG$Q5924<$",#&-
M^0$R?KCJ2/:H1(4,C*<&1&0$8XW @8]^>O/KGO4"[TMI9I3N89$;$*-O&01Q
M@D8'6O,Q%=TXV<GJF]WZ'L4\/*+@HMQ5MHZ+?R_K]/3-179\%O#Y=PP;XQ>.
M'<< ,T?@/P05R!R,8Q@'![BO#K^=\/Y+$$JVW^+G!VXW ]_2O7=;G4?!GP_S
MPOQC\:#J/NOX$\#AQU_B!(SU':O%VE_?J50R*CJQC'63:<[ >""^-@P>">#D
M5\]C<4HTIU&[V?+KKOJ?491AYU*OLVY-N/-JV]$K=3S?]H7QS:_#']G/XN^)
M7N?LNH:MX>U3P5X9&X-(VJ^([.>#SH4EWK*R6$TB!75PF?-0+*JR#^;$;EBC
M= 5#D*$.6(RCQ9);<22LCAB22Q.XDL 1^LO_  4R^(1B_P"%:?!:R:1YM)1?
M'GB;9Y95+BY@:RTNSN3@LKV4$F[9E?-^].LC\U^4LY/RD'!9@,@#H2.V,=_2
MIRNG.,95)RE)5I1G"[;223B[7V5W?32Y\9Q;B8SQU/#S2FL/"<>62YDI>TNG
M9II.VE]'8PKKS0V%(YR/N*>#P?X20,=^OYU J.48C&X*2#M'! )!X&/?'8#F
MM&>(DDEP3UZ#DGZ8X[#WI/+*JN. 2 >YP3DC\L]/KQBOH?LQ]/\ (^4<HS=T
MDN]E:_:^BO9:+R*R0R%58^H)XQQWZ=/3CGO3VB)BN"V3MAE(R3CA&(SV_/(/
M3UK3A&Y0IYY&/J2?3FI)+?$4P"\-%(K<MRI4@CGID$\\?6N>NVG&S:T?YCCI
M-);/ITW9]!?M$('\>>%L@9/P*^ (!'!!/PE\.CC'?I7F>ARFV*$,1\ZYR2<C
M(SP21@\_IR<5ZK^T/"1X^\,8!^7X'_L_@=N/^%3>'..<_P")[=*\?@$@P%.#
MP!P/Y8]\X[=Z\[$-N4;N^C_,ZYZ*%M+IWMI?5;GKVB:@FXDL<GW['^7X<_SK
MO[+5(U *L<@Y +'G'.#DGGZX[_6O!K*]-JI+M@XR> <CTZ<=_2ND@UU0J $@
M,5#<CH3@GVZXX(/>BC5]FGT;:?W*W9E4Y22=I26O=]CWE=;)B&  >H^;OZX_
M^MBFSZ_Y49)"@X/S<<<$],'IP<$?48KQC^WPHXE)"\XR.P_.LO4?$Q:,@.P8
MJ<8QUP<<=#SVQ@]Z[*>,G9^_+?N^WH*I.=U[TMN[[G;>)?%R;#'%/M=U9& "
MY^=2I R#M.#U7!SR,'FM?]E*6XNOVG_V>YFE=U_X7)\/2NXDCC5M//L.>.N0
M1Q[5\Y75Z]W/EMS'=P<XQSD'Y<<#@CMZ]Z^HOV3;'R/VC_@&ZJ L?QC\!>5G
M)VE/$>DPKRQ.2(W9><]=Q^;!&6(JNK&[;=DUJV][,YZDFVKMO3JV^IXY9HR6
MT>T8'V:W'13@1W"PH,D$_+$[)G.3G<<L 1>#L!C/RG@CCIWY/M[U';H_EE.P
M+Q@8&=B2I(J^N _.>IXSE>*5L*=K=2=N/K_GZUY"24I625VKV5NYY^)C'E7N
MK9]%Y$@:/(QUR,<CKGCO0\:%'!48Y;O][&<_GSCI[5$%&>!@]NIY[<=ZFE60
M1$@\E3V!Z@D9[>W'U-,\.I2YI.VENVG?S155S$/EP !R,*>!R>H/YU1GU%$;
M:Y')QT Y/T&1Z>H[&GW$OE1%FYPK%AP"0 >.,=1QQWZ5Q5U,;B?*MM4$';QT
M!R1GKSCU[>V*J-+VEWVT^_7NCHPN&O&=U?WEOK]GU.ZM]3B& K$=.-QXZ>_X
MGCTZ&OI+X8W0?X,?M/%2<'0?@3D]>#\7Y^Y/3]1ZU\>0-M&\Y(4[CR>0"2?S
M Q7TM\,-3V?!?]J/9\NW2/@'&N><*_QBE#C+9R"">3DC&1CJ(JX9\MU_7XLZ
MGA5R2M%?=Y?,Y2*4!2<G(!.<\@]?7&1Q^A!JQ')(Y!#L1D$Y.1C/.>O^%<[:
MW+2H3E?NGN,\9[?3H.O2M:&Z0* GWE +#KD#J.<_F.:\]0E!R4FW=Z7=[=/S
M/GL?AFFK::2V]?(U8;B59  PP"N!L3MSUVYZ^]=?IMU$%S)RWJ2?U (Z_0_0
M=O._M#[@R CD9XSGM@<'M_/Z5TNG"690V[&,':<8;_9SC/S=,]?<$9IGS->A
M+G6KV?5]_5'I4#0.BX488@-UY!Z_3.3SD5KQ+$J850, E3SD$=.I['''?@\U
MQ]@;E=@V@*"N>AP,C)YZ\>GIBNCM?.D9@&^4=.%/&>.<9Z'\OTZL.VHRLVM5
M^1%'"J56/,E+UUZ^;9?WL._Z#_"LF\/S,3W)!XQQCGI_/K6B8YPZC=\I901A
M>A(XZ<''Y#UZUGW\3^0[*<.6(#$<#.1R.@'KQV]ZV;;W=SZ>GAYTJ48T*44Y
MM-N,4G>UMTK['GFK3 !V!&X/@9.!C/0X.0.Q/7'?BN*?4[@S&"S4RSO\BI!N
M=@[$A<8W'=N(Q[^U>LZ9X!\1^++K[+I4 G$DJHS.C*D6]@IDR "0F=V&R#C!
M!&:^U_@U^R:MI)!?ZI9+/=N8I2(UEE4R*RMR)&95&X#) & :PK2E%QY92C=.
M]FUU\C[S(^&LPS&>'?)+V6D:CL[-MIJ_?W=-3YN^#_PK\6^+YK9M4AN;+32T
M)8R!\RQEUWKV8;D)'RD'GKFOUM^#OP0L=.M+2""S1\>47DV2*YP5R2X8.2!S
MRW^->P?#+X#QH+.,Z=(BKY6S]VZHI#*02%(!4'&[(8>N>E?>G@7X01V$5K)Y
M2AM\0888!EW#<N-V!D9!( /(YSS40G)IWE)Z]6WT/W#+?#W#8>%*K.G2<VHR
M;=.#DFDKZV;\]#RWP;\-(88[53:KM14;[C$C:1R6SN/(YRW/I7TWX:\(06[P
M[8L?(ORC< >F!UQ@].G->DZ5X+6VA0B%%PN._"]^I/;_ .L:ZZ+34LT#84.%
MQG&#C'8=/QP3[YZZ*KR:/6^NNOEV9]WEV1T:,>6$(3LXJ[A%VTV6FBZZ:7,*
MPT:"- K0+@$''(]/0_@3Z^G;TKQJ\<?C+Q/D*&_M6X(P "&D2TC8_BG'/ ZC
M#<CBY;MHFVA@,G'W5[G&/N^GISCTK>\=SY\9>)F))QJ<Q[ <"T/;@^O/':N;
M%5'**<7:R:=M.SZ)'UF$P"IV7+'5IK1=K=OZ_$@BD7'./Y?_ %L_7V(-6Q<9
M*C=T8$?=ZY!_G7-1W@"G![>W;OR.G;_#I5F.[4\DY/X#D=_3'\SZ=*\9^]*5
M];/2^O?N?04Z?LJ3LK7=]--E8Z>1U* D9)].O/7C@#],]:;->K'$J$CD8' Z
MG@=LCV]#Z<UA?;B0 6X'3[G'.>PS5*^O!\AW9Y'X?H>O\\?AK1TE9:)VNEHG
MN>9B92U]Z6E[:O3T(]2O%+'+''<#CCUX_/Z5YSJ^HAI&7>2%SM!.,$#CD8/'
MX@^AS6OJNJ(-R["S%64,"< D'!QP.#Z^G.:X*>.>[D<J#R&P<=#@\XZ?YP>E
M>ERQ:C>,7H^B\CSZ=>47.\FW=6;;=E9[73MJ4[F8RN#N/4?Y(_+''.*1+5W(
M;&0#N.1CIR>A]^GZ5?@TQA\TJD[?F/4<+R>F/3O2RSBVRJ8'48P#G/&"2#V[
MYS[BL:E+F:Y5:R=[:=?)HV6+;E%.3:[-OO\ (RIR(CC !SQP/PZ]L]ZR+F\1
M"0Y!R"#SCCI@8QV]\XYR#3-0U555VD0!E? <-@@ GL/E/KDC\Q7GFIZ\ICE?
MS &5B <+P.?8>G6I473C:[UFGN^EEW9WTY1JO9->SDFFDT_5>A^LG_!*FZBN
M?C9\35C_ .6?PRL#]XGIXGMQZ_S]QTX'[RKU'U'\Z_GF_P""06IK>_'7XI(C
M9Q\)K65AQ]]?'5G;ANG&(V*X!VG.[!;#5_0RO4?4?SK[[*FWA8W=](_^DGXS
MGFF98E+1*;22V6K>GWD]%%%>F>0%%%% %6<G(&-V.0O3)&"!GW-?XUO_  6>
MEAM_^"LO_!1-YI0K1_M7_%(PP@*S9BU2>6%=Q!8_O #R2#T(*\5_LK2J.O0X
M/S>G3GGCCW&/6O\ &I_X+):5;7?_  5J_P""BVJZI.UAHT?[6WQ3A:Z3YKB6
M8:K/\D43EE).!M(4<X&, 8^GX3E*.:0<6X^[NFUU7;3:_G\CS\QA"5!N48R:
MV;BFUKLKIO?L?EM++)<#%Z$BL6<2G=),99.<LJ!7R"W*JO"EB/EYXO1*94$0
MM]EHPV0N2YSO^495B1GYL\C^=74OTDFEM]-LQ]@@#$W]_%&[R1H,LRI,KHKE
M<[?+"D'&,'&,XZPLMRZL/W$:LJL  BR ?*X"@#[PR%QM.,$'-?I,G>K6>]YI
MOS?+N^YX=252,::A34DH-NZ34=4K*]]7OI]R/L;]FFR6!OVCV@00/)^QO^T&
MTTH!(;R].\)$,JMD1E0,@Q!&SWS6A^R-^TJ_[/GQ%GT_7=2DTSP+XKN-(T[Q
M1<QV5K=ZMHL:&#9=6RRP2W-KI\BLTFJR:8]O<W]F)+>ZDF1O+,_[+FJZ9*O[
M0]M<DSRVO[&O[0TMQ,.-_P#Q+?";Q1;%*QDD(1C9AN0V0<'XXUB"&9SJ%BDL
MYAGD;#_-*\8M QB>4YE=3C:H=V\L<1XHIPIRFX>T]FY)Z1?+?S:5KM7M?>VE
MR*E%X_#3P]:DKNSA[L6[<LK\K::7O6OIYV[_ -I.D:_X=BT+2-7M+JSFAUG2
M+6_B33Y8+R(65_$K03W8AW6U[>74;@QM9(HL9&!O=P1\X]TUS>VLU]<(RZC=
MLUGI]@RH((+.?]VNI/M  :W5O.*GY<H/E-?@O_P3Y_:\T[P1J-A\'OB5JKKX
M?N89W\(:_JS&4^']0O#Y::-$% E:UO9W2&2*1Y,HQ5-H(%?N%;WL-R8E=IXT
MO/(E,[O/'<XNRHLH[:&>1XVTV]9D6:50)8HG8QNC %?B,\RQTZTIQG*::DW=
MMV?-M]S_ %/'PF%GA<1'#U&Y1C?EC*[2C=K2+O9>7<L)=&T\M$ACDB&X0,DD
MB-JS)_Q\/*J,%B$&#M2,(DF,.K FH)IY(X0FYI[ER_F@@!8/-R(E  V[DR,?
M+N) R3FNBE2#:\MJT<UU.\4$:!(R(4!5)!"FTHK$9!90&8]236:UI*&>*[AD
M@,TL;QR;5)DG0@PE^,JGF;=RC"$9#JPX/P&,JQIJ2LDU?7K]YZRBO:M65D]%
M967IV(3*IMHAL(F&W+C.<]B1G!QP<$$$=:;?W:"-+88 *;F7CEL=21\W/7 (
M]/H]W1$=BPD6+*N>."!R> ,<#H,?F*YF><2SO(23\I$9Z;20<= -WU;/OU(K
MYF6*<Y3YI.23LN9\UEV5T['J4:*J3IV2LE9Z+NCT37+D_P#"D?#\A8;O^%R>
M.<EL ?N_ ?@@@-MZ 8Y(Y Y^GE^F7.EVMI=:QK-T+?3M'M;G5M7NV;RH;:TT
M^)[R6 R97:98(7"L")!G*L& -=YJW[WX'^'4<OM?XR>.E;RU5I,-X%\$J=B$
M%6?!^52"&; ((-?GU^WA\2(?!/PELOA_:2RV6N?%+4+AKSR'$-Q#X;TZT;SI
M9!%M,*:A&9( 8Q&6+$!@W->?BG'$5*6'25IIS<4E9M2M=JR3]=3Z26(HY-@*
MV.G3IIPCRJ7*E)7@W\5KI7\S\F/C5\0[_P"+OQ4\8_$2]6;/B35KR6VMY)6"
MVVE:9*]E:Q*J%%C58HQ<*@"B0<N'!->3SLK#'UVX)Z]CZ]<?4]!6K=,L<<BQ
M2%_.D:5V(P?,=/*)48&U63@QIMB8Y8INRQQ9XV&UAPVX$=3Z8XZ?C^6:]W#J
M,:4*:BDZ*4-$EOJ?@N8XQX_'8G%N<I1JU'*'-)RLKO17;LK]$5O()(+ G!!Z
MMV.?I_2KL:*ZX89 ]R.Y]"/04L:,P^;GUXQQWZ>WY#J:G50.%&,^Y_KGUK2<
MI)JTI+3N^YP<THSBE*236J3:3UMJD(D:*1M7'([D]_<FK\<:R0S[ADB.7;R1
M@A6QT(_7\:3R )%&W(V;L<\D#/KW],\#K4L>X).%0J3')CJ0#M;U]/K7/4E)
MM7DWH^K[GH4FVXWUT_4^A_VAX!_PGWAC(.!\$?V?SW'_ #2;PYZG_P"OZ=*\
M7C549<# !'Y9SW->X?M!L9/'7A('ES\$/@(9#_>"_"7P[CC&!T[ =^<UXH54
M DCH,]3V_&N:HVVKN^C_ #.Z>T/1_FB&8H3G'/;!/7H.XX_0]A38)I&RK-D*
MN0,*,$9[@ _K44S)G(Z]N3UZ \GM^O.!2PC@D?>(QGZY'3_ZU9-)[I,TI)>S
MF[*_,M?^W2R9'P?F/0U5E9G!W') R,XX(Z=!SCT.15@8 (?DD8].>>.W^1TJ
MK+D':O?C'X#U^M.R6RL9PU<[ZV:M?6VCV)["S:=R2N1QGMQWQTZ]S_\ K/UW
M^RM!(/VCO@.I'R)\8O I XQA?$^CG.<9/ [D_P!:^9=!A+!@1G(^GUQ_^K [
MU]=?LLVX/[27P(0+PWQC\"J1R"0?$^C@\G^?7H1R:QJUG3:5W:2;MZ.W9F5=
M).-E;1_F?.D"#[*C ?.T*2$]<O)<(C-CIRO& ,#L >:BN8  KD8.0V<G^73^
MGUK4AM6%I9G&-UN-W4YV7B;1[8'IU[^\ES "@&W&?KT]./\ /I12DJBD[+1I
M;+M?LCBK)..J3W_0P!P0?0BK4DBF(#U!'Y\],?SZT]K8!6)7@*3U?L*K,%"D
MX^Z"P]L<_P QWK6R[+[D>!BI2A)<C<;M7Y6U?7K8Y?6+C 9(VP0"#P#D =.0
M<<?UKC S/*2QR001T'.">@P#SZUO:Q* \Q4\['QWP=IQCJ.O;\2*YJ%B<L3S
MZX'N/ITKJPZ2C*RMJOR/H\)&/U>F[*[BFW97;MNWU?J;,+,5(S^@]3[5[Q\.
MY9/^%*_M6+NX&C? ,#@9 _X7#,.N,YQWSD<'.0*\"MY4 PPR?Q'//7'OG''.
M:]Z^';)_PI;]JSCKHWP$.>>WQ@F/ _+K4U]XKHT]/F=,HQY)>ZON7D>.V.H2
MVX 65A@C@X/3USGTXZ5U=CJT>X;W^9CM).WN0.@P,<YQBO/V:-45@.>IP3GU
M_#C_ !%2PR;BNQB#N&,'/.>OX''4>E8>PC4A*7+&Z=KV757['S^.HJ;NDM$U
MMW;9[+:72.5*R*0",C"<^N.._3V_EU-E<QC:>.",XX[@D\8XZ^G;'.*\>TZX
MDB W.>H/8#KZ$=<CI^><8KO+&Z0QH6;@D!O]WC. ._!Z8^OIYE:FZ<K=[O[G
M8^:KX*4IIQNK7V=NIZ=970S@L2K<*">A)XZ'UZYSVS76VMP89$"$!2@+ C(.
M!DY)&1GO@\#W KS&RO;:2/"2L#"-^=N2"OS XP<XQT/!QC!&:]U^''P[\7?$
M&_MUTJS,=JC1"2\F0[3$77>VU@5.%^8X'8T4VTG9M:_H:8+*L57Q$(THN:ND
M^MG?;;L9PF%U=106X\R20H/+B5G(=R% S\W5C@\]?QQ[EX#^!&M^)KB*YU8R
M6NG,R311&/!E(96",R@2 /\ =(#CKFOKOX5?LK6ME#'>70%]J3E!(5@RD7S#
M+==H"'))500.0:^^? _P&$,5JK(6150B,1D\#^%?0GH#U_+-:2D^1N[O?N^Q
M^T\-<$5:_+4Q<4DIPY8RBFI+E3;::L];(^3OA?\  FPM$M[6SLDC<>66<0$F
M1LCAG;<<$CUQS^7WO\//@LENT!>WPQ5,X,JC@C. K@=3TP/0]J^@/ WPGM[+
MR0;1EP@R6A'3&3EB,@ <Y!!':OH_0_!]K9K$0JJ_R*#@]R!@@DCO]>3UYKSW
M.;D[RD[;7;=M]C]\RGAVA@</'V5.G9<K;5."LU&W1=CS3P;\.X+6--R;2 !G
MY\!1C_:(X]Q7NVE^&+>"&,;U(0J0N .5(.,@ C/KD=SZ&MN"PBLXMH526!&0
M,=NOMQZ?7@]->.-1$H48SC')ZD@>O^>U:4V[/5[]WV/H8*+CRV7NZ6MY>AF3
MV*PQ?(0,+TY.2!SR<]?QK N8-XY!)'*\G (Z' /(R,^AZ$5V3VY=2".@./O#
M!Q^'Z_C67-;H@)=>@)ZL.V?7'_ZJJ>L&WJULWJUHCMPJ49.R2NTW9)7=FKNW
MD>=WMJ0WF$<K\P//\.3T!]>N<CKGBK'CJ60^-?%";N#J4XQ@>EH/2KE_(ID>
M/@A@R@=_F!')Z]\=?QY%9WQ"DCA\;^*<_+C4YN<GH1:'OG.*\]QG-RM*22=K
M*32Z]+H]F%2,'!-)W3>OJD<S'<8+(QR2N%!]3TZ?7N/7%3"XD3GY<#DC)Y Y
MQR/_ -5<9>:M%&\@$HSA@,%<Y.<=LC)(X'2LU=8!8 R-@D \]B?]VLI0<'KU
MU[[:=V=&(J\WL^5V7*[I:)NZM=+R_ [HZK(LA! "KUSMR!U)SCTSCBLVYU:2
M9G42\ $*-J$Y[?PY[>O '>N1FO&9OW;MR>>2<Y..^1T]O2H[::0R'+9[]!U_
M+VHA44)I.VNOW.QQSC%P;:3=^J3Z'1;9)@68[N#DE1Z?0<\<8J_! (U4HH&X
M@$_>SD\_>SCT[$=>V:KVS'RAS]XA3P.0001T_7J.V*TG;9$"., GM_"1Z@]J
M]BC.-2-[+2RV[JY\_C)QI5(I)*\6]ETDUV9BW]R(8'.0"6V9PI^4\$<@]0>N
M..QS7F.MZPL1D&\!@C8/R\$ X[#C/7U%=AK][$L;(3@D''/\1'!SG/!Q_L^W
M:O _%6H(#*K-]Y' PV#DJ1P0!_CGG-5/1JVFG33J8TJ\>972^Y?Y(P-<\3R1
MR21;MPY(.1@-SAN.N.N#D>HQ7EFL>*95$BAAM(8X^3KCDY*D_KV[5@Z[K*0F
M<LY)4NN"QY&#QZ\] 1R!Z<5XUKOB)VDVQKM4Y7[Y/!R#C).>O!_KQ64Z<JB3
M3>DDM^^I[&'Q$5425DO9RT6B^:/WM_X(GZJ-0_:#^,,2@%8O@]:,N&!QGQ_8
MECZ]L\YZ8XSBOZ75ZCZC^=?RK?\ !!O43=_M(?&E,L2OP3MI#R2,CQOX;DW>
M@^>YF8@8&'P1A4 _JJB^89/)'^)]/I7W.60<,+!/JD_P/R?/9*69XAI)+F>R
MMKK<FHHHKT#QPHHHH CEQM&>F0#]">1^(K_&5_X+4RR7/_!6W_@HA;R2L;:+
M]K3XI$19VQKMU2;Y]J[07 ^;<<MGG.<FO]FF7[N.V"?Q'2O\8;_@M//Y?_!6
M_P#X*+)G[_[6'Q6'N2=3N%X.,@^^<@]LU]'PO-0S.#?6+2^^YR8Z#GAY6;5F
MEI]]S\RKV\:93:0.T:Q*W0G# #D=<G.>F3^N*KP2QQV[PR@$$%L="6QU+##=
M><$X]16?F1 \S<X;Y2<<@$GL.^.3S4?SS+*['&$<Q@8&6"G'3DC( YR/45^A
M5ZKE.LXMJTE>SL_AOT/.ITN2$4];K1O7LMWYGV+^R)<LY_:@DF.]1^QO\=I$
MX .YK?PFI.5"MR@VXZ8YQUS\ASZQ=^;-%'-(L+A2Z*0 2\:QR#.-R[XR5&TC
M:>5PW-?5_P"R*K%?VGD'.S]C[X](PQUCBLO"KA?7AAG/WL\'(KY#D.V:8B/!
M5(2.#@$!3G!R.,?SZYQ7F4JE26+A>I-Z/>4GU=UOMH=,(Q5FDDTM'972=WOO
MJK7-NPU&ZM[F*^CED66WF@N59-HG#VKK+&8)"NZ"4%!LDC*L'&XDD9K]^_V+
MOVJ]7\;>$=&\+^(YF\67N@Z0^G:MJNK7EG!XA-Q#EHI/#45NML-2@TRVPTZW
M*SE?+ROSG-?SW1RB0;70X.0>2IQT/((P>YY''I6[X?UC7]$O;>]T74-0TW4;
M2Z>ZLKK3+F2RGMWF 24PM R(BR( KQD&%@?G0CKTXBG.O&K#V<9QD[.<DI..
MFR;3:NM?4X\7AJ52<:MU"K%.S2LYW=];6;L_^#T/[&-$\0:7;QVUW/J-W-:0
M7UPL5M-:"*[BE,(DMTF:%$/EK+M+.S-\O4E015Z\\2M]F$L3O/<SF>5'=B=D
M2ABI$9_=_*.1\F3U))K\)O@)_P %)[OPLEGX9^-?AV?Q7I4;PP/XL\+O+%K]
MG$VV":74;"5H]-U P0;G=8;;[1/M*QN)&!K]7/#OQ<^'?CNUTK7/#6K36<6L
M[XM(TO5XS8ZI%8W%F9;":\M)SE&U*P,VJR@J&CE@%O$5B<Q-^;Y[PW4E)2H5
M)VE";FDVK2Y]%9>1IE_L*,IU<=3II1DHP4XQ:G%QNY:K6ST/;[;483 UH9/G
MNLR32YZ;^&7!^4'!(^4 ^F.*I7\L,"QF JR1G=,P8EMBG+E0S$%MH...3QQF
MN+O-6TG2#:VLE_!'/=S0F.?4Y&AM9Y7=0D$+0LC-YK$(%4@\X'.*\D^*OQ>^
M'OPQM+J]\5Z[/';6UO+<W$!O[&SU*XVQ-+]EL+4X\RWF"^4DS(9L,")-W-?
MU.'\RI57[.$ZE-MNI-WERM/17=[7C=GU&#HX&O+VE-PC%^\E%1222Z66Q]8^
M+?&6@^"OV<+7Q[XIU&QT;PGX;^,/C35+_4[N8QH99/ O@DVWA[2T+"2[U25T
M'DJXE9IG1&)0[:_GS^-_Q/U?XQ>-+OQ;J<<L-J((]*T&PF82KIGA^QN?M%AY
M98%F>^8*TLLIDN&5S$\K1?)7J7Q?_: \3_M6_!OP/<S6QTCX>:!^TY\5;;0/
M"VGQQQPW$6E?"SX97=IJ&N,4,.HR">62X_?&:="Y6$H1&%\'?PY=RJ(U,@7
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M.?E#:A8Y'7G([G.!R.U<L_>J0YO>T^UK]KS)G152+:2TTO;OJ?/\=OFUMUP
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M?A\F2K C_A-OAM\P((QD^,!UY&<^O2O-+W]DKXZM*[CX?HFT$A1XU^&S$XZ
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MI*?,D[/2ZOT\SW.?]FCXY[75? 462C  >-/AX.<$=6\9$ 9[G@=>@X\^U?\
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MFJN=^#C&HW2LG*4ERMI.RM:R;VU[=3Z;G_98_:)G)B_X5VP8Y&YO&/PR4,2
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M170< 4444 5[A-PRQ_=K\S@A6^4?>X((((SD$$8SQ7\1'_!Y-^Q/J_CWX)?
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M;K8[^YN[<)NWC/<9//J/Z _RKE+_ %"%FV @;CMZY'S<'N3W[>Y]ZXR\\0A
MI$AP,,1D<CTY'Z_KT-<Y=^(4D)8$C )!]"!UQC!P<'MTKW(1BXJZ3]4GV/FJ
MU9TY[N[5[_-^3.QG:W<R*SJ1M8#G&#CCD'.!]>OL37*7KQ1N"&PH8$C<>0#D
MCD_U_P#K\Q=>(T4XCEQ)_$?E(/4'.00,].,8[5QVM^+H[926D4/M/.5/('!
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MXT9"PC?<<J<X1L]<@'/X@X^M>(:]XL$S.Y88PQ)!&  .N!CGCIR/6N#\1>+
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ML[F&XF@_W)YX1/#-%D RQ/%N9$E5=ZLH8Q2!XI-N<E71E8#:P*DBOS^_;O\
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MMWMIZNQQ5W?3@RQAG"_,>23AL'DY_D>"001BN-O79G9RQ+9;G/MZ=/TKL;S
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M]N!65:M75.35)7MNDKKYV/V+(>$\MH0YIU(-RG"4DU%V:A;9GRW\/?@U'8-
MT]M:X"JP*JZL,$$$$')(/3)//7-?9OA/P=:V*P%4565591\V,J01U)!Y X((
MQU]#UMIX<M;-0/L4@"+P_ES (H_B):QB0 #.2\L8 &6D098;\"QQ(2A'RH0
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M2!D$]TBR$REV0#RXBD1*'ZJHK6&'H-.]&D]?^?<.WH"Q%=)I5JJ3W2J3U_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MANGM;@VJO;W,UM%=2*\R.T?S?JX)HPP5G#;O,&"0<E9(44<G./G7@<')X)H
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M:3E@V",'#*=P//4$$<$$$9H'9+96/R/^&OBO]OSX!>!=+^!6M?LP^'/VFY/
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M76(XY7^SW.I:G<74B-=1"XA^W4ACC0I&"@((X9\C(QD$L2".Q!!&!@\5 ME
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MA_#?PY::Q:C4;.:SEN='N;>RAGM-3C64RV4UM)#+'>+#/&ZS*KCYS\ >"O\
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M_'WP5I'C_P 5>/?'<4VN:SHZ^(K>WUS2]"^'6MSSF^^'7A/PM8:O'H?A:]\
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MVMM;\/?A]X>_9QOM;^.<GQ*_8;\<?'+QI=?M._'PZA\4=!_9XT'X@VKVMO\
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MDZYJFEZ>MYJ%]/<:AJ#+!%([3W]U<SREC-/))+EZ^VJ "BBB@ HHHH ****
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M6>58VWO'$P7+D&O./ 'Q,\7-^T+\:?@WXWO;&^ALO#7@GXL_!F?3K%8;^_\
MAAX@L%\->(]*DG"16^K2^$?B#IMZL[W#SZC)IGC#P^;BXVR0QI\_7_[0?Q9U
M3QK/KNC:GHEK\)]:_;7\*?LQ^%;!O#L<M[J_A?PQH.NZ5\5O$-MK(S,(]4\?
MPZMI6GZ@M[LLHO L<U@]K%J%^+H ^E_B%\*[SQKI/P"TR'7+'2Y?A3\4_AIX
MXU&[(D6WUFW\':5X@TZ^TO3Q"PN;)M1DG@*ABELGF+YT14OOZ'XS?"BY^)=S
M\'KJRU>UT-_AG\;_  ?\6[BVFL5?^V;7PW:^)='FT>&>) D5UJ0\2V@AGD8!
M&M5+,1)(3\D?#J7]K?XLZ)\0OB7X5_:"\.:-<Z1\9/C)X2T#X:^(O@UX-U'P
M$;'P+XV\0^'="T;6/$6C36_CZ"+45T_3['4M;CU6^NK6W,UZ(+BY ,V3X@_:
M1^)?Q7LOV7;'PE\08_V>=8^)OCGXX>#OBVMQX?\ "'Q E\,>-O@EH?B'3-=^
M'EC<^*$LO#5G:KXNTF\DM-6G\S4-3M(K6VCN$NIHS0!Z-X5^%7[5GPQO?B#:
M_#;Q?^SE?>#_ !1\4_'/Q2T5/&W@[XH3:_9V/Q"\2W7B2[L[F_T;Q?8Z2+K2
M([V017@TRZ9'=7EC952)O?\ XZ_#K5OB]\!?B%\)8+K2="U;XC^!-6\)WEY!
M%*VDV%_KFERVDTEM"I\V]LKF]N6<.?,"1,1JIF@$L1^>?$/Q!^(/P*^&NN^*
MKKXRVW[5GC'6/%/@3P+\*=+/A?X=>&+>#Q]\1M8T[PMX.T?6KSX>06MC:>'=
M4U&;3]<U74&M5U6RTRSE?3[BWCF:*7+^(5S^U1\ / US\:]:^,NG_'-/ ,$7
MB?XO_"1OAIX9\&:%)X+CC6]\;2?![Q!H=E9^*='UCPYI<-WK'AFU\7Z_XIL_
M$ND:9=6&NH^I7L-W$":3W29]2?M)_"BZ^.?P.^(_PEL=8M?#]QXYT5=&L]:N
MX7EL[(F?3M42Z$2K*DC1R:<5A9XY3!D+&5  /COB?X5_&31/BCXF^+?[/?BO
MX=VE_P#$OPOX0TOXB>$OBKX8\3ZSX5U2Z\)6]Q#X5\;>$KWPYK6AZPE^-$UR
M3PU>Z2U_!I+^5%>7-LVH1QW,7IOQY^+&N_#_ /9V^(_QA\!:9%XVU3PO\.K_
M ,=^&M(2+4);74(!"^JZ5J-];Z9&VI7>D:9I,L>O:W;:$JZO)8Z5/;Z43-<Q
M1MXA\"9?B]XO@T#QSIO[7WP__:+^'FO:+J<OB&XM?AU\.%BT?6[NP%UIDOPU
MU_P1KFGOH]KX>U)+>QUSPAX_T/Q3JFIK:M')J7AR]DFGA!V2V5B'1OV9_$]O
MX T/3?$'Q!L-?^)NK_M,?"[]IOXH^+I=*.E>'?$6L^%/$_A+4KG0O"?AAKAM
M2TGPQI^@^#O"_P /_"D]_?7NN1:E;QZ[XCFOY+B^>]9J/[&VC'5/VS-:T3QC
M?VUQ^U3\/O$'@C0K6>V=]/\ A-<^)?#^K:9XVFT.. QSLGC3QEJ=IXLU:!)
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M:9>WD4&G>)O#%Y)<1:C#?B"?3QI-UH^KR-JFE/);AG-M-6;6GZGBMIXEU?\
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MWP5\.Z3JGBC3-!\.^+@%L_%_CC2=45GM?$&D01W\]K+<6A,4]ND<B<Z'C/\
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M'O#VAV<>GZ/HNB:=::9IFF644GFI;6-G9PPP6\/G S,D:@/.S3/NE9F/3=*
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MNGZCL?\ "G8Z^_6BB@ Q]?S-%%% !1110 4444 %%%% !1110 4444 %%%%
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K HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>image_003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_003.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" +3 AH# 2(  A$! Q$!_\0
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M #Q[ XJ[%_P<7_\ !6UX]Q^/W@$XR&(^ _P_'<XX\GTQT_&NA^''$?2G2_\
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M[8^M.% 7>_PS^$[LY48+EIO",TI#D%@'D9@I"\8VAO\ Q$"_\%A Q1?VRM7
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MA_X."/\ @L%M"']L;6F89R?^%7_""4')R/WLG@N%FX('*+C[HR "9_\ A_\
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MC_F3\=,5<B_X+\_\%?=I+?MC:SD@]?A?\(@3VZ+X/Q[=<$ 9P:/^(?\ $/\
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MH=SFWMKG6_AS\+M$NWNC.\00Z;<^!DO%$FS='((3'+$8Y0^)!7[S_LB?M?\
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M!&0K'Z*P/_?)&[]/YBO\RGQ#_P %X_\ @JTWE+:_M6R:>TN62TA^'GPODD1
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MR[#PQH]Z0R_>SJ;').UHUVHOW;\$/^#KO]NOP5/;P?'/X/?!'X[:*;A7O)M
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MG('O%G\#/'VH^-K/P3+HMW9WD]F]]=SF-)[6"W0X1FFCDDB60+M#6[N+C=N
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M\$WOCG!I?B/4M8U#]E'XM:O8:=\8O!]N#<S>"]59[:VTWXR^$M/07-K8ZOI
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M1WMY1-/Q5\);07EAJNCZ#;75T\N[29YK"SO([*:1LF)2Q8P%7+ 20@J."6#
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MN2XG]@VN6G!U%O?F3;L];<ODE?S.6N824SMQGKT(&..W7I],YS[8_D _P_\
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M$ZD)+18QJZT=K^=S^7O$BHJ/%U64G9.C)[^IDI;J%P!P,^GU/49[U=M[=;A
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M+IQ]!TZ=S]*]:U"T4JPVY([?AW[<9]?_ *_%7MLB[E8$'(XP3C(!&" 1W_\
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M$:/7?#<$\DVBVDD=OH5W>PS@6RF..62>&*--R,TS2L@**R9 <*P('EW@[0_
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M^TL[I--7/T_#5L5B%4>)HX66*<FY1M5Y74;O+3VKE\5^OXFQ\-OB5\*OAO\
M%#]FGP3H7CE->\"_"CQQ\2OB!\1?BQ-H]]I6B>+OB3XX\(V/A/4K[0O#MTU[
MKO\ PC.AV.D^#O ]E_:=O%>:CK<7B76[*TCTW4+=E\+N_B5\$_!W[/\ \'O@
MEK/PD\*?'H0:+J?Q9\<7VH_$SXJ> Y-)\?\ Q0_XI^3P'<IX&N=$:^\0>$?
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M[ZTGTE/#7ASQ'#?:'H^KW5\U^=,L+>2R>:T59!X+\,_A9^SE\=?CG\$OA'X
M\3?'KP=H_CKQF-"\?>+/B#:_#35D\)^&;'3=:NK>ZT!/#-KJ3WMY9:OIDQUM
M[I&T_5=)C^SVTMQ?B2!?L\NXUR?#X:E0PT:M3"4J,(5*M1<U9*G!1;3A%1YK
M1>G(VWLG=(\;'8#'?6J<Y<BG)J4XJZAS2U:5Y7LFW;7U9\2R6]Q!P0%3:SHS
M.BK(BHDH>(EP)4ECD26V>/<MW"Z36QFC=7-,AO,)=HRK&-,K+&ZB1PI6%V5V
M$=PP*XMW*SG?'^[_ 'D>[ZT\,_LWZA/^TYI'[/\ XRUQ8++5EU#Q!HGC/PQ]
MAGTGQ7X3NO!-_P".? OQ(\/%5@L[GP[XST<V%U"NGQFWTJ\:]T"[6VU'2;VT
M@Z;X+?#/]E;XC_"SXH>+/%GBK]J#2_$/P6^$%C\4_%<7AC3_ (2/I.JW%_X^
M\%>!GM?"HU9Y+\7NWQ':ZU=7&O26_DW.G7MM9L8VLXY?=J\;Y;25!45[6G.$
M'&]Y3Y9)<M^5I7L]?=26KLDCSWD5;%XF4W*4)J<F]4H7YKNUTW;MKJNI\7&!
M<!MQ 958?*3\K*&4\+W4@XZC." <BE2)&R%RQ'4D;??^)1GTKI/%*^%H_$>L
M1^ V\31^#5OI1X>C\:#26\4Q6&04BUQM"']D/?1.9(Y'T_=;NJHZR2%B[9\$
M$<P&7P4R2P!^<YR.,9[XY/;K7W^7PACL-AL2HR4,30I5XI734:L(S5[^4CY3
M,:E3 8C$4ZTDU2K5:?NMW]R<H]VNFNAD@!7=>1V ((Y(7'8#F@(WIW/<=R?>
MMR:WC),@&&( (Z_=4 #N.=N?;\ZK>4#C@DGC(7KV]#Z>OOTKU5E\++XMEU1Y
MM/&V;J1U4WSI3N]):K:W<IJ953;&L3$YSN!#=>YZ=.^>!Q2I;@ >8%#J2<+G
M ))(QU[$=>]:L6G;OG.5SVX[<=![#I[\8JT+15^7YCCOMR.>?O$8_7BG]0A_
M>^]!/,I2C.G[.DE)N[2FI:O>][?@6-&?6 LALM0FL;?K/LN73<J\8"1G=D@8
MX'7)ZFFZSJNH:REO:SZG<SVMEN6TCEDFE))9GF^9^1F8R$;L<$ <5/"1;(8Q
M$[F4$%HP7!R?]C<. <'Z$5&MFJRQJ(W4!6.UD<$;B7/4#KG\L<5T1PE!I14+
M222;G:S:T;V6E_-^KU9Q1Q5>C&474<Z4OAA=OECK9)7T:5NFG9:(P8X5W@/@
M*20/4D<'@#/WL]< \8Q6];Z3).C+!]T%6(G8F,#&3]G"G*MW;?CY\D9!%.L=
M(EO;[RXXY'"H]Q(51BL4*,59Y&^Y& RG"R;692&565@3Z7;Z)/)"(K&WDGVQ
MAF>/!RKC?D%B-P /\.<$8.".-%"GAFHU*M&,I?!&Z2MTTN92Q-6JE&%*;TLK
M1EMTZ=D<3%9VT$HE=W:.- &-P1E2%PQ4GY9%W X*%@HPK$%2!M:3HE_K,.H-
MI5H\RZ<=,E+E"Z3WFL:C_9NF11KC<YDF 5E0-Y2CSYS';LLA]@^$?[._CGXX
M^(;OP[X/CT^WDM;-DU*ZU5R(X;;S#/*ZJ740D(Q0,Q&2-P^\"?UQ^$7P(T];
M[3?"UOX;T72[+PM:Z7#>7K0+)_;6M6CH[7XG;<LL=K*6D0$G)4+'EABOD^+N
M+,)D^"G4592JTDXN-[Q4HW35HM.R:TUV/O\ @O@W%9W7C[2E*$:EI)I).TK-
M7YHRUU['I/[$'[ ?A;P!-%XP^($UKXQ\820Z;?06]Q9VTFF^';PR"XN;.WD!
M=Y9+1V,4DL?F1M.DGDO)'L8_KA-X1$VH7>J6TLMI</;2VUF]OL^TVR#,2+;R
M28C2"1%$A1F5E5MF 5Q7(?#?3X],M#!;IO\ *4+)(!M$LF299PK;2%GD+SJI
M&5$@!"D%1[9:W#2A4\O" #YN.O.>.N V1TQQD<<U_$W%W$^89SF&(Q=2LW2>
M(KU*%).:IJE*K.5-.+FWI&RT:/[9X1R' \/Y9A<-0PU/VRPM"%:K.,74]K&E
M&,Y*4(P5W)-W:9R/P[^'-IX<%S<WYBO+_4'D:ZFM+: 2N6D?9YTMR$#D1;%E
MV,59PVS(P3[OI^@VMC9)#I4-LL)D:^N;<!;.WGE5V"0B"S:W:5F4!Y#<RB-Y
M2Y#[2M86G*K*D0&",_-]2S=\^I'^.<UU<$26IB>1FVR>Y(ZD<@<C&#_];-?G
M-;,<;)UHPQ-6BJDYM^QG*/+S2;M&[=DKV5[Z'WM.EAJT8PK83#U4DE>=/F;L
MFKO6UW;73<V['7-0MIH89GD:V13)L"K;1+(7+"!88;B[55C4B(.)W#[3(VPN
M8U]CTW6-"FM1,\MO; (HE#.WR2MRPRRAFRQ+9 (YX.*\?6&&20DL/)(4QI@Y
MR5&[YL8Y<L>H'\ZI:G8&^B:TB MU3!=PXR<@,,E20>"  ,X&<@$&O+E.4[K$
M2EBN_P!8G.?,^K=IQ5WN[)*^R1UPP^&HPG2HX>C2BV[.$$I16R47LDNFC,/]
MH#3;+6K>S33I8[O[)(DTRQR*5+E$:,X8@.1&5^[G'(.""!\>:MX3;]X< [L-
MDJ ,LJL1AL,,$E0<8. 0<$$_6LNE"".2*20S2N57YF++A0%4@$G^$#.?I6#K
M'AF*2V,H0.64$L%P. %.%;!XV@=.Q(ZU^W^&V?T,%@GELG3I0=3VL%&ZG!MW
M4(MS:4%LDTW;=O<_#_$CAGZ[BX8^*JS<*2HN+Y'3<8KENU[._,UJWS6OT/A/
MQ!X715<-&"S="-F" HYZ\8Y':O!/%7AY5)\H#"AE<$ ;>,>V[VQGTK[Q\3:
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M;3[NW>YL+:2%7A9KF1)91O\ ,X]3UOPIX;_:-UGXA_#7X>7_ (JNM"^%,O\
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MDG#;O*$OE^> $9<QJJ+M S@[5SQP3DUZYX5T;2M*ND:*%I)?E!=R#C  4^G
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MGF7OQ \9W)Y.;GQ%=2JV,CG-H6., <@=,=!FL,>)/&<]QO?Q7KL@R,G^T9I
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M1P>AJ6::[:, W,Y;D'Y@>Y]^>.GOZ5A3))(S>9.Y8XSN))Z#'3(Z=.>/K1+
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M7%25U4JSFF[N5VT^Y_9N#HQP^&PU+VU9^QH4:;YI1O+DIPC>5J:NW;5Z>A]
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M:E6W7[N<L.OR^O3DCW_SBMU"-EIT75]CJ>*H)VE*?,M':UKK>WNO2_F<P;<
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M0.05!09P>B%1[XJJ]L67Y0#U_B49_49_F#T[U]1^)_!,-P&4P!)&P2RA>0%
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M];;FZVNF[7O;7YL_0\LQK;B[QU2[]O4^VM%\6K;1HQ=&50!NW<YR<C;][@Y
M. #C(X(KT"Q\722IDG (X'/3)QT![=NW<5\4Z7K;29D#,5++\NX@<  \'U(/
M;O7L.BZ\"RH9 GRJ &)X^4=P"O/7K7Q^*P25U:5TVNG2_E_7F?:87&/W=5LN
M_9>?]>1[_P#VNMR%$B$')P^<9Y]/TY_D:Z*PO6DM6B W;#D[F&0"2PY)&>#T
M!.!]17@5QXE%N1"K@NF. &8?, X^8 KGYAW//4Y''4^'=?FN#,-W+E<*<\@
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M(?\ A'K% P. -:TK ^8]CJ0(^O&3ZUW^E_ 7XL!P?^$:M&P1EAK6D <],?\
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M!ST'^'I]0:ZR2U4@CN!SVP#@_KGG\L<<9$L);<D(W.P. /EZ<').%7GC+$9
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M2II2DKM^\]7:^_H>-OIVH6R8DM75ER"!@ <G'0Y&1C\\C(J>RM[F3Y\%<9W
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M/A(E;32[>&YC:5OM/VBXNKES)*\N7N)LLQ'F8&XD*JA5X4"M[48X &7<25P
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MRSG(/.>,\'/;\^,^6:_X#,&YK=F)ZA0A'0#/WL?_ %_TK] +_P *O'$1Y((
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M=+GM+FS-M:^/M"U6[%XFH6=K'JO]H6_A/R+H64)N+<I"6=?LYB <A6;\FS;
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M\V-1&VP8 ..N<D_7DG\?2N:\/Z4LDL:HA+=QC'<XR20/U/Y\'Z \*>'I&DB
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MJ9^=<49'@L4\57J4W+$58SII6ARN+O9I.#ES6=V^9KR/FO6?"ZQF6/8%VMC
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MAN%')/H>@..1[=<\\5U<))*,QR#_  ]<9.![9/7'7UYKR[3+PMEG8 1GGG+
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M!X5U8MM6<HP;]ZR5U=;)Q=NI\E?MG?ML_#[]E7PY<Z$+1?&WQ4U:&>XT+P)
MX>TL&1,1ZYXJNE4_9=)B#13IIEO,UY?Q,+B"UE2=9*_FW^(/Q'^+?[6GQ4T2
M_P#&&KV6J>,?$5SH'A?P\T5O;:;X=T:QGNM1U*.RMVD:$6NF6X25[F]O#!!8
MPQO<ZI+:D.1U_P 0['Q'\3/%_B+Q]XPO);_Q;XGU.?5-0U*5WDN((Y%"1Z*A
M8M$+32[:.'2[4P,T9M;.%@[ Y+_A=\-;ZRTGXJ^,;75M!\/W]MX3N?A[X1F\
M0:]:^%;4:S\08[NWUW4;/6;N40"]TKP;IVOA9 4:Q?4K1G*-<VGG_P!C<(\#
MY5X;<'/B&KA88W/\9RU*<L4E5]G*K!5+4X452J1:E*UO:=%?R_S$\7N/^*?$
MKBEX&.*GALFH8RO0I1POM*:^K4Z\X4KRK5*T'^[2UY+=CP.R^''B:3Q]J7P^
MDMM+@\1:=/X@M[AK>[_T7S_#%C-J>L_9[EW^S3H]E!-?V<T$TL&K1,LNCRWT
M<T#26_!>AZIXFU&;2-)-M%]F\/ZWXE,M[JEQ:6$VC:#:7FJ:K!&J6SRJS6-G
M<ZFR$^<Y<P1(;G;!7U0WAV>W^)GP#\87FK>'=>U7Q5X-UKX?^(6\/>*M/\26
M$GQ*\$>"-4\'^%=+;6XY8UN=:UOP6?"M[/;R*CSW$TJHTP@E<>$?L]126/B7
MQ.\VZ"W\)?"SXMS:_J=U"QM]'MM+\':IX7,.K)<*J6%UJ.LWME:6>GW7E7M[
M>W4EO:VTT]K=I!]%@N/\VS/ OVF+I8;$0IQ4:4:=:,8-12Y)*=24FX[/WD]-
M3\LJ\-X?*<>I5L7.<8U&KRJ4FY)2WE:"3;W=DE?9(]:\(_!#4-7TD^*H?BG\
M"=/TJS'A^'4Y-5\;ZO N@0>*GN(]%AUV&Z\&W<5O?7=Q;3PV:_:YFCMXX+BX
M%M%-&*YZS^&-UXV@UB[DUOP5H_A32=7;0Y?'^O\ BI+?PO?:Y&C26VGV$T%G
M;ZQXGNIK*.*[BAT'P_=RZ=83V:WJH#'--6\'*LOP;^,CM!"A&J_!?>9K>UC\
MBYMO$GB))(+NQ\F2"26+"J1=NLMMQ"ZH\1C6_P"-TGU#X)_ J:QD,7AC2[CX
ME^'=;4S!M,TWQ]K&J/?ZA%<6JV@6#4-8\#MX;31M3 9X7$UK82NT#QQ_)XKB
M3B>G7<YXVO[&4Y2E."DHV<F[T[MVC_+>^EKL_4\HCD^(IT84[2FJ5-2U@_>Y
M(W^SW$T_X/\ BBR\3^ _".ERZ#J4?Q*NX;#P5XCT+64UOPUJ][->6^GO*NL7
M*6<FE7UIJMTNDW.A>)(='UBSN8W0V!M(DN6H'X>>,)_B:OPDDTV&U\:GQ5_P
MA\%A).+<R:Q*URT"17#2KI[Q:W':S:O8W4=TUG/87,-Y'<&WFAE?Z9_9WT6Z
ML[7X)1ZU&[6^N_MD>!+_ ,"6=\)+=3IVDZ3K+^,[FWC6.-Y=/_MX>'+6.Z$:
M1ZEJ.G.T)N+JX<'=^!SR?%_XF_"_6HD)^)_P@^(6A1:S.S"ZO_&/PJE\1ZCH
M^E:@(H]TEWXO^&6J7UOI.I%/,O)O!CV@@AGCTG5&LOF<;QKCY?65.$JOLJE2
M*J2A4<Y\LY+GDU-)N25VTE&][6V7ZWDN48%TJ5&A.-*K5IP?Q03YI13T]U=6
M?)_@_P"'>K>,X=1U1=:\'^#?#6E:LNA77C+QIJ]QIV@76LM;QW<&DV%M:)>:
MYKFIRV,UG<F#1-)OWLX;RR:Y6);FW,NU<_"OQC8:]X%TI6\/ZG;_ !$OK*V\
M#>*-,UU]9\-ZU<:Q?VOAB&>WU:X2T>SN[#5;B"TO= UN#2]9TB5MEY80VR+<
M/UOBW3Y[[X,_""]L%(\/6?B+XPV.JV8?S;;1/&WB7Q<FJS6]S:);2FTGO?!M
MEX8'A[4)3]KM;71I;"'9<,+<^E?!6RCA\$_":74K._C3Q)^UW\-KOX?6,K-/
M=_V=H^D);_$&_MH)UCM8M!341X+T]=0@*V^IZQX;U-XGN-4-_'%\]B.*\PE0
M<XPI^UE%.$'&K9WU7,O:*5]==;=C[S+,H]G6A2G4;IT[0J34ES7C92:=FM6K
MK1GA>I^ ?$WA;QU>_#;5K.!/%^D>(X_!]S:6KEH9-8,QM+>47=L\L5Y#JI07
M\-Q;336SQ7*NDQC*D^M#X-^-=+^('B'X874>CVOB+P=;B\\6WPUB#2O#.@:4
MUC;ZC/J6I>(UEGC_ +/A%XMLUX6:VN=026ST^2YD$:-Z7"'FMA^T]JTL%U<_
M#'0OB!X=\0KMD:WU/XI^";N;PU\*))WD7,EUKNB^,_#^L^>HDM4;PM?BYN(G
MMYE3IOB&;BXTO]IB+3)'U'7K74OV>?%7B:WLT:\O+[X=V'@!K2^NM5@(-Q/I
M2>,Y]"UB^L8U>SGL+<75V!')*Z_/5N)L7BY0IJ#4THK$/EFHQJJRJ*%Y:14K
MJ*ES.UKMGV^&RJCAY<\G&5)OF@[Q<G!ZQ<FE9R:LVTDK]$>1:O\ #S5?"FEK
MXMT_Q!X.\?>%;.]%AK.N> =:O-=70M5DBFGL(->AU^VTK4[33KRQB26SUHZ7
M%HE[YEO'8:A=FZLVN>JU/PMJ?A.\B355M9KR;1]!\0)LEF>W32O$NB6/B+3[
MD+&'Y.F:C;NT0!E5]R>6KX6K'P0MS;^'/C3J,8M&\.V7PENO#&I7;V4-KH%[
MXA6_-]X.M;=K??9ZCJ%UJ036+-YV\JWTFSBL8)A;/8^?Z'\7)I%\6^' /+N?
M^$D^&'PKCTT1[5;4;B;P'X?T,P:;;-B:Y:WU>&;3[B*VCD^PR02?:!%#&9!Y
M&+S7%)R2NTFTG:6R;MU/JL)@XRC!QE:+BG%75TFKI;=F>@>'OA!XD.I:O8ZC
MJ.DZ38>%;#2-3\0:[JFJ3V>C:0GB"..YTRU0Q6\TE]>70G7%CIQO;U=WFO;Q
MQ,I'=1Z%>^'=;TJT2]T75HKRW:ZLM2\.ZHFIZ3>6T;LLDBW#E9[::*17@NK7
M48K2ZBNXIXA 516/IDWB.RT?Q=X_MK_0[+Q7X,O7\&V7BFVEN+JP@TG6=&\/
M:?'#*->M8;K3-+U>V=8XX3KDMC!E0%=D&ZH!X'TB*7PUXH\,RZR=!\302W5Q
MI6M74>I:C8WEG<2Z=<VG]HVL4=G>0SW5I-<PW5CYEJ]O-&3,Y!D;YK$YC[1R
M6(3BKN[BFF]=7K?<^RP=*A2A3Y).510CSIM-<W*N:UDG:^VNW<[G0K!]4M$F
MCE.;7/F!3R"7)48SDY!!^4$#H3G-7M9L;Z6+[(\=Q$6B+%N0K@#*G<"5'&.I
MSUS@@X[;PEIMOI\SQ1P",2!7DPZ2JA95<(3&SJ=@;:0"<,"#R#CK]<M8;FRN
M)"&=XHB $VQ@#:/NEMO89[\_0U\_.I[/$+V?O0J2<ESZNTG=;<JZ]CZ&$%6P
M[E+W7"*2Y--M-;W?3N?$<FJ7-O?SZ6\I0J)%CW.,L/O9SG Y) #8S@8&*\ZD
M+RW<B>87(F;)Y'1B2!G&<<@'IQQ7=^/O#X34UU.SFDCPYRC-\PP K[CG!R02
M"">/?-<E!:MOW!27)R>1R3U[XX.>^*^FH>SC"$K.[C%M=+M)NWN[7\WZG@5?
M:2E*-U9-I/K9.RO[V]O)>AM6<*HD;&0@G/&#V8CG Z$_U[YK2DN+N$$0,'5L
M;P2!L&.N7VY_O$+SV]J=8:;).(B1@Y.1N7CYB/[V.1S7;6WA<7B% &SM.2!G
M\,]&X]"3G(XP:)5*?,].KZOOZ&D:?NQO*5^57V[>C_,\W\UE;<9R[')( ;CU
M' P/3OV(XI[Z@V(X<A>2&.0.&8G\>#GIQQWKKKO2+/0S+YT?F@_Q$@D9 /W<
M$C )[<@9&00:\^U:XMVGS#&VPRA ZY W")9"#G&Q0K?>;"DY )84J;=2?LU%
M<TG[B][5/;KOMV)J0:BYQFHQC\3J6LK;V>AW-M]G%MQ-&70$N"ZAU4DMYK*V
M&$*@X:?_ %*,"CN&5@,74-5TS1;::^UC5+'2+)59UNM3NX+"VF0=6M9KIXH[
MQ>",VC3#<"N0P(KP+XO?'#P[\&?#":QJ7G:AKVH>9:>%-"B:*.2_N/*,KRWD
MLI6$:)$[,;A;B2(R3B1(@YQG\HO&?Q3\;_$_5FU;Q?XANK]))!-;:8HDCT31
MX]B+':66GD(1$L:KR$*NY>0,0X)_1>#_  OS[BB-?&RINCEN'E+VLXIQJN*;
M=Z<IJ4;-*Z?*T?C?''B]D_!U=8"I7P]?'U9.-*"]^FG>R510J*5T])6DNNQ^
MO>H?M&_!FP)MI?'-O-(KLA:QLM0OX7;))"2VMC.C[?NL0Q"N&7@@@2:7\9OA
MAK0GN[+Q;8M%9!I;JTO8[O3I[D>5N0QI>VUL9.P"1!V( .W-?CE872QN"$B0
M'H(K:)-N3C<%!*#<?G&WG!RWS$BNLMIXI&5W5)W_ .>LL2B08.!MV\9 & #D
M845^D+PHRS TX5*=3&SDXQ;]M4P\M6KZ\N&@]_,_/<-XY9OBJLHPH:<SM[&%
M54[7TY$ZLFH6MRIMNUM6SVOQEXVNO&GBG5/$5RTA\RYFM+"#++%'8VK"R@D1
M6P%$D-NDQ!"EB^[')K.M+R1"@W[@, 'D?0$'!^7[O09[<$5Q4%P#CYY&_P!J
M0*'P#CG9E0!T7!Y0#=\V:U()I&=0G(7KR !^9]/_ -?:NJ65PPE!8:GS15.*
MIW]VZY%RZ-12Z=ATL[K9GBIXVNH^TKU)UY1?-I*K)U&I)R>J<M;/='H<-S*Q
MSW[\_EUZ\<C]<'-;%O=KLPS?-@]03T) YQCG/KBN/LYR03G!Q[_E]/I6G!*6
MZ<X)[^Y]?SP!C'%?.XK!)77O.S:N[7=KZO1:_(^NP.-E-I-I+M&ZM][Z&\DL
MIF 7) (_S_D8'KVK:W$@,_!8#_#\N*YV*[6)%) R<C.,]"<?A]>..*F?4-VW
M+8/]W!..< Y (S@9/).3UZUXE:@Z=[1[[W_2Q]9AZRFHIRT22TM?9=T:EP<Y
M0_YR 1GL>N?:C3@$E93&'W8'S$84GOS^?'?'&>:A3=,OF#G(R3D \<="<UKZ
M+:&]N"B G:1DX(Q^>,_0?I7G23BVZBLFV]--/G<]BB^=)=$K)]6E>S_ <;)5
ME88&,@]1_$ 2.O09Z\X]ZFVA#Y8/W?Z\]>G?U^M=)>:#/'!YD2ELCABRJ202
M#PS*W!!'(YQGD<GE7@NH"S2H0H/WBZ'KTX#,>GM@CK7,YPN[7W?7S]#LY)+1
M6LMK[VZ=31MT;=G'7'<=CSWKNM%C9%$Y<(%)QD9(.XCH.3GKG&!7->'H/M-R
MB2#Y6( XX//]!_GK7LUEX7B8Q-NVQ.N7QC@YP,#))SCJ >M<%>4(MR4G=MO6
MUM7Z7T.K#T9-[/7]?^'_ .')=(U:2TF<W:">.1 JCY?D!7 (R>I')QTSSS6A
M:I%=;AN9%WNR(<DJ&=F R 1@Y)]L^U9-UI36MRZY?RU*A& )R"JD_=!/4XYY
MSZD5J:8OED YP3P2#D\G/&,CDXY SVKR*K=1RNW:[V]?F>K!>S=[)OK?OU[%
MY[>2) 8V.23NP<<9./3L <#/Y\5O>&8))M;T8 ;O+UK223D#&=3L3_%]>W''
M8U72%W;;M],]._/K^-=KX4TUDU32I2F =8TOG*G.-3L1TW''3TP/IBN3,)0C
M@9J[TBEJU]E?U<Z*=1O$T=([+I_P3^A>)@%&>#A1C_=&#_\ 7]ZEWKZ_H?\
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MJS#.0P8@$=!GIDCZ]![>_%<;#]^/\>>W)!'/2N\TQ 8XB>N#QW^\1QW].O\
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M$B, &0HN&KSL*ISQ$:4$FI/5V=[MZV^_L>I*$%0JXB3?+3;YG=65KWOH?/\
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MRXB4J&+ GY@-CE?SS&8>=1-SG3@W>\;ZQ>MT[O=/0_:\IQU.<:<O?]Z$)?\
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MM%)<L8KHNT5W/B[4?V??AYYN;6\\6&0D;W?6 #P!CA+8H>.!M).!SSD5)9_
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M2PZI!'XPACU16EL]DT6G@26%PI+,RS^9!'N:+J>J>&?AM\6/^%@>"_ 7C+Q
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M]]+[ZK737YVL>A4H0BDU=W2>^FMMK=-=#YW@LXK<JB @#!;(Y&[YLD$9YSG
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M:235"6O+Z3S&;S9+W;)*^YE#(58I9W;EHR6&1QPJH JG"?*N!G:%R1\S'YF
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M8Z*5!Z9()]*V]FEI=Z:=.GR.*3J.4G%^ZVW&Z5[-Z7U6MB.W\4V>E'SKF)0
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M8["3FYKET4I)66MKZ=S]:RK,TU#6/PQ[]EYG=Z>FYE5O?^;>AKT/1(AN$84
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M:!*WR%Y%T]0"&8LN&,8!PI ^4\$$'# BM+1?#%E=37+7YCN"D(C"RHVTNN
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MLU%QEU[GU!:_%VRDG6.:*1%4@%T8[,CKC:#T.02/0_4])+\5[&W >TE5XY%
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M*^B7X'I83-?K%HU8W226TM-+=6SLK& 1PE.3\PZ GD_-VZ]?Y@]*ZR"R+R!
MC-)'&DCH@,CJA4$$J@+#((8#[Q!!QSFJ_@[2/[=OHK07/V?=]YBCG#9('\)W
M'@= ?SK[U^#GA33O#MFYUF"SU)[AVB,\EFCS" R. Q9UW?*,(H(SM48& "?A
M^*<^P^782<D_]H2?NRNXN2WT34GK_>/U'AK(_P"V'3C1YE>,+:Q6Z7>+*'PM
M^%WA;Q'\-8=8DT?'B6PNII+JXN&F"W=I]MN6B(C0$+Y=MY,.S[YV$[>>:[^
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MK%8J9[K:%#'>V5;'S,0-J%CP,9P/KZ5?OY+.YM);J"ZVQM^["ON6$.%"@*C
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M!>&6(JFT?,KHKF0DL" =OH1Q7Q#KESJ>I7<TRP2O'%(ZN^4/*G9N W D/M+
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M<DMC)W'MP>#SQCTYY]16*VGR1G:Q8D8Z@YSCITS]/4=.*=]ED11DD#V/U/(
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M.#GLS#G'&3@'UY]J(W<8MMIM)M:;M:]"UHK=CSGQK;"*+S([9I K#?("/E#
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MQC-.2:YTDI6M9VOYLX\.O;5)1=!<JDTG&#O:[MO?H<PFFH&)EM5Q@%3A#G\
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M-K=XAF@"NK,"R/&P#"XV1F.<ECC8% B*$YRI8K@@GZA\3:%'\6=3T7Q]\/\
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M=[/7;GW/L?[%PBT4JJ71*4+)=E[AYEH/AB.^FGU2^L3=Q6!R(&AA-J<=U,C
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M%617VF3Y"N1'N/;&>GA<<<@1=S,3SDX([GW]*FAGN],N(=0M)O(GC;(F*2L
M <%'5%8N&QU ( P"1@X>!Q<\#CZ?LFE2G*]1RO=-O6UG%;]TV<F.P5/'8>5.
MJG*:34$N7;9;IZ[;6_([/Q+H:>9,Q3<%W%F"GDD9X7 /L0 2#Z5\U^*M(3;/
MA"/F) (QV'8X(^I ^OK]1R^*[37+4I?VSVEV8P&EC!$4K ;0R@!BNY0K,&P=
MQ/ YKQ3Q9:*5G(^8<$-E2Q&Q<'Y2<\>PQWP:_9>&,XH5L0XQKQBU*UY2LM'Z
MH_#N+N'L11I5X^RJN$IU'[JNTG)VM[G;R/B_QEI*!3\F/E;H/;VQGKZGGCCF
MOC+XA:8D#&95PWF$G( /   /3_/K7WYXTMY%\PJV%5<'*DXRH// SG/;. <5
M\:?$:"(P3B1@948D@ Y&0&7H#_"0<_\ ZJ_HS@_-L)3DJ>)QN'C3:6OM(J5K
M+O-K\#^*_%?A?&RHU)TLOQE=QE/D_=N6EW;X:7;T/#;.<AB6R,@ =^F![_\
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MUZU<L;%!-'+*?*@C#&3C=Y@R> $W,..#D#.,^E333,LI149OD\P$*V-HX(/
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MCJUXRQ=>R;2:GJUM=MMZ]]#TJ6#RZ$8VP=!/E6T+6TZ:%C3-%LHY/M$>GZ7
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M".#(C(=K$N064%&#&YX>U*3QKH0U!-0\+>'M.AN!IVJ!E^SW[0>:P%P\LJH
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M[<^M6]&TFV@0-,J;B6RH7C[[ 8R/[N">F<Y[UUUY>37"DAE2)AA5(Z8X/ Y
M+<Y([^AK$$7SDEVP3U57P<@<C"]<\&NK#N[OW;?_ *48-QBW&4I7BVG:UKIV
M=O=?7S+LT@A58X$0(3P, #!.3UQWR>O4_C6'J=Q%;#;*L0D?;@!=^20,<H&
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ME)U/9;)W;DHWYK).Z5[Z=3[VCB\/#DIU9VO&*IV:3E&R46][MJS=DEY':R7
M$C ,J@8P >,8&,$';R.>.F><&J\LD3AB\D8P,MEUX&.X)STKDI=0CGB7[/*0
M& (+*Z-R,D,LBJRL&R&5@&4@JP!&!S-VMR9#^\<[C\Q#CI@8X#>GZC-32RM5
M7=2DH/6-W&_*]5?3>V^GR,L7F2PZ;IRDTKVOJK=+62T^9W=SJ&FPQX5UE?GA
M0QR<G ''&.@YYK#;5 [G:LR XP@) ' Z9('/4_4FL6TTN6:0;3(JJ<M*S @=
M#G!.XXY'0Y(XK8-G,"RVZFY" ?O?ECW?*"V!(4;Y3E.G5<C((-;3PE##:*<W
M*.CNXM75T[6BM+W."EBL17?.U&TWS*T7>TM5N^MRU;7EVTN%8K'V#\MT&<GG
M^+)'?!'2NEA::0(?/ ;G*@$$<GU'4C'?@8S7,V]I<F(3%A%R0RL1E<,RCO\
MQ ;N,XSR16G 9;=@S,'?@D Y&,9 &..1CITY!YKGJ153>]NEOEZ]CU(UIJ,4
MU&ZBEL^B]3TO2VLXK?=?W$:9#;68Y)P3R57<R].I49QD$@@G+U&YT] \MO=1
M2;^"J[LX VC@KW _7FN0GFEN%WLH&X#@J^>/ER<#'.. /;WK+:U3EU+"4]2"
M0GIPK$$< 9XZ\BL?J$GJI:/57:O9[7+EB)S234=$EHGTMY^1;N;JW:4C$BD$
M9*\#UXSR/?CKG Z&M_0;F![J!%D9F:[MU7<KY+2SVBH-VW;RT;@<X4*-V 1G
MEXH@&Q,PSD\]?IP >V.OM[UV>@VD<M[I<$*AI)]6TZ"  @-)*+D3,GS$$81@
M=S$)G@,3P%7O2PE6*LW%.+OWCIT]#.@^;%THO966A^F,)!C5AR&W,I]59BRG
M\00<'D=" :DJO;@1011D\H@4Y!X(ZC\#D?A4V]?7]#_A7R][ZOKK]Y]+:VG;
M3[AU%%% !2'D'Z&EHH \D^,6CMJO@?5=D9DGT\KJ"$ ;HDB7#LN2-WW22J%G
MZG::^)%GWJA0\&.(G(8?,T:EB<XP2Q).><YSR#7Z3ZA"MQ;36TJ+)!=*UO.K
M#($$D;*[$9&<$XQR2#TXS7YY^,]"N?"_B'4-&EBD6(323V4Y3]W/:S8N%,;J
M"I\L2^7Y>1(NP@J",5WX2I*$9025I;WO?KMM^IP8F";;UU_X'D9J*S[#P3WY
M'J3U)]"#6S%<?95+>8HR!E2I.,#'4 CGKCU^AQQ,FI0VBHIN8P7!*DNIW#))
M!P2%(/!#8;((QUK+N?$EN L8NHVD?=A$)D8;21EU0$H, %3(%#*=PRI!KO\
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MQ]Y-R]ZKA.KOTPB[G\,%W_P0D_X*(WZ)=2>"_A/!J$; [D^+.D2++M. =_\
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M/TWXW:=I\ 21"MH)8O\ A'R@15"(ZJ[,Q#.P7=@?VBF),\#C\/\ "CRH_?\
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MHA;W+QV/@GX3/;I(QBF?XLZ4A*.V\ H-(##9NV?=&0@(ZYK^\WR_1ACM\O\
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M86^TCP_\&[EK.Y58[V/XF644UU;':1+%!=Z##'#)&IV$2A"[HSX._)]&L/\
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MO;0(^AX=TGXB_L+_ +0OPA^%G_"?^,OB+^RK^T=XAU;P%X!L?BGK]QXT\3_
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MAO[2'[,GPR_:6\)6GA3XC:5?J-"URQ\8>#O&?A/6+SPK\1? /C735$.E>*?
M7BS3F-UX?UNP3=]JO)8+^TU+3_+TG4-+U*S18HODC5_^"?OC'XC6\?A#X_?M
MI?M(_';X+07%L;OX.:O9?#'X?:/XRL=.:%K'1_B;XM^$_@;P+XO\?^'F:!;O
M4=!U&_L8->U'S(M6N?L#KM .L^+VH0ZG_P %%?V#+ZTF@N+6_P#@A^V//9SV
MT\5Q;W=M+9? ^:WNK6>&1X[FSN(9(I;>[A9[:='#12N.GMG[<_@#6/B[^Q_^
MTQ\,?#+S+XB\;_!#XCZ#H"0@_:KS6+SPY-'I>GV!!56NM5OGM]-M(V=#-=7
M1> Q' ?&[]CRR^+7B/X*^+? GQ;^)G[.?BCX&^$_$O@;P9J'P<L_!*16G@_Q
M7;:!9WN@'3O&?AWQ#I]C;6UIX:TN"VMK.WN8+2WBAMX9[D0"5NC^$?[-'Q2^
M&/C>+Q9XN_; ^/GQOT.*QU&RB\!?$VT^%2^%Q=7,VG36&N33^#?AQX7U5]0T
M9M/%QIT4;)$E[<2&5GC+3. =K^R3\8/#/QH_9J^"7Q)\'RVLVD>)/ASX76:R
MLP?^*>\1Z3I<&C^+/!U[;%(YM-U;P9XET_5_#6KZ5>0P7FEWNDW-K=01/ X'
MR]^W1K=MXP^+7["/P/T66.Z\;ZC^U;X+_:%O+.WGB9]%^%7[/^BZ[X@\9>+M
M216+0^'Y;[5_#/A;^U-PMKV_\11:79?;+N.[@@N>)/V![O1O&OBWQQ^RQ^TI
M\8/V1]3^(>NG6_'WA;P'IO@+XA?"K7=8DFBFOO%VG_"WXM>%O%GAOP=X^UUT
M\SQ'XM\)O82ZK<O<ZC<Z;=:E?7%P/5?@5^R+X-^!'B?Q=\3KWQ/XY^,/Q[\>
MVUG:>,?C9\5]5L_$'C2;3[0LUKX;\-PZ;HNA>&?"G@W1XY'ETKPSH.A:?8:G
MJ:6%YKR_:+"*^4 \J^$6KP:'_P %/_VU-$U!UM;SQ7^SE^R9XQT>VE!2XO\
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MOHR> !<_#!?&BZ');Q6\VC_\+\?X>R_%]],GLT&E//'KMGJ44,2W4!^TD3D
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M\8_A?\6/BS>>%M<^$/[4GBC]GS1X8;B+5;/P?\/_ (<>.[3QJE^\EW8W@O\
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M* $;I]W=[<?UXI%Z?="CL!C^G%.HH 8$7)8H QZGOZ?R I3D\%<CZC^5.HH
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M-MN3#/"\=8?P9^-U[\#O^"9WQ&\1ZM>3MXC_ &,_"_QV^"<UOJCFWN]0UGX
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M_$OP9XMUW3H(V9)I;[2-!UF_U&T2VDCDBNVN+>,6DL<D=QY4B,HPOC_^SO\
M#[]HGPA:^!_BG;ZOJO@F+Q7X2\6Z_P"&M(UG4='M/%#^%;RZU*S\,>+QIQ5O
M$O@:]U*\-]KGABZGLK6["[[BZ%NRH/S^_;_^#OP>^'?PC^&GCCX6_#WP)X"^
M/7A+X_\ [/GAG]G+6?AGX1\.^#_$$OC;7/B5H5G>^$+(:#'I\MWX2\2>"?\
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MQ-<+'%\#O&UV[21/>30""TAF>XMDBD+O/9>7))##;AIGEE"VRR';$X!P4?\
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M$X_#.I6!UAK+^Q?B5X7UWP[X7UR^OO"!@>22>3PM_P )9I.CZWI8WZK;3_\
M$R:T3298;J;COVF+>+_AM[_@FZ7CR9/%O[43N<C[P^ LZKGGD;47]?:OBGQ-
M\!_%GQ@^-W_!0?QA\'KNTT']I'X"_M,_!WXF_ /Q#<(B)+XHTW]F#X;->> /
M%%Z'CF_X5U\3M&AU;P/KFG1.T9U+7[36I$6XT>TD !^JOQ\^/>G? ?P9X,\9
M:UX9OO$UOXR^+GPB^$T-KHU_9QC3K[XP^-=&\%1:Q/-=7$<5SI&FOK=M=SPV
MWVBXGD#&"(H%E3Z'A>2.W4R(%G\N)GBW@1I-*2ODQN2$*++F*,!B=H09.5)_
M&WX_?M ^&?VH/V,/V=?BQX9L;W0;K4_VSOV1]+\8>!M85+?Q)\._'GAG]H[P
M)HOC?P!X@L,K):ZKX2UVUN;!XMA6XTP:=K%JT^E:C8WEQ^R;[',@)=0RJI;8
M?D*2EHGRZF,,'?(5@6QLD(\LA@ ?GIXV_;9^(E]\1?&?PV_9V_9(^+7[1E[\
M,KV32OB'XNBUOPC\'OAMX?\ $T=AIVK1^$])\5_%"]TMO&/B'^S-2M;UKWPO
M9R>';%KE+:]UV*6&8UZ_^SG^U;X>_:'T'Q6]IX-\:?#?XC_#+Q1!X)^*WPE^
M(5K:V'C/X?\ B2[TZ/7=-L]66SU#4M)U72O$'ARYL?$GA/Q7X?U35O#WB;0M
M1L;_ $W43-+/8VOONOSZ3HVDZOK%Q>Z9IMGIUO?ZAJ^L7,\>FP:1;VT,=[K>
MHS7UFGE6,]E8Q3:D\MREU/=,CI(R62EU_+G]E3Q+KWC8_MX_M_Z)H>IV_@KX
M[6WAB/X :=.DMAK7C7X<_LY?#SQ%H6@?$^:SAA>*:?XE>)M0UO4O#?GJDDOA
M*Q\/!($L%M/, /4]?_;T\8>)O%'Q"TW]F?\ 9)^*7[3_ (&^%GB'4?"/CWXE
M>%?&'PU\&>%KWQMX96&;Q+X3^$4'CS7+*;XM^(?"\JW&G:K-H:Z;H-OXBTS4
M=&BU>\O;+,GT%X _:U^$?CW]GF?]IS3-3UBS^%MGX?\ %NO^)AJ>DZXOC+P=
M=^#I]0M_%_@_6_!B6-YK-KXW\-ZQ87^B7WA6);G4Y-0LV@TBSN;22T5O,?\
M@FWX0TGPW^P;^R=;6GEW\VI?!?P=XNU_6;:/9<:_XL^(&DV_B_Q?XH1[>2!H
M]1U[Q)KNI:UJ%W%&+TW+7D<BBX9A7F_['&F)X9_:G_X*4?#JPB*:);_M!?#+
MXGZ?8VUF+2QTS7?C-\$O!NI?$!-/5Q=6R:;JFO\ A/4_$6HRSVNW5-8\0:BS
MRIJ5W+ H!E7?_!0CXPZ?X=F^+NJ_\$_/VE-/_9UL+:77;SXBMX@^&;^/+;P%
M'$L\WQ$D^ MMXID\;WOAU--?^V+G1[:UD\8V>CJ^K3^&HHXY_L_TC\>?VNO"
M/P8_9IN/VE_#_A^_^+'AF\M? 5]X4T/PIK6E:7J'BQ/B1KFC^'_#HTG4O$E]
MIFDV2SSZ[IB3BZO(+?3;F6X@NIXA:32+B?MO_'/PW^S_ / ;Q)?V^E6_BWXD
M_$)=8^&WP8^%]@DUWK?Q*^+OC>QN=(\-^%],TZ":2Y%@U_<VD_C"\G%GHNB>
M%1JNH:W=Z99AB/E#XW?LW^/_ (<?\$L/A_\ LY>"-$U;XN^/OA#X3_9ET*[\
M/>"[.S;5O%\OPD\;_#C6?$=_I%C+K'A^PBE?^S)KV*YU76KC3AHD5IJERDDM
MRJ$ ]DL_VPOVO)]0@L+C_@F+\>+"U:^TNUN-3N/CC^S#=6MAIE_J9L+O5)+7
M3?BY>ZAJ4&F6(2\N5TVUNIBQ<1*TAVG]$=,U,W8$1A:)E$@\MA*KQK#*T#1O
MYRJS21,ACDD&8Y75I8&D@>.1ORW^(G[67[;GP*TS7_C1\:/V3_A/_P ,VZ!M
MU;QW;_##XZ:QX\^.WP]\%[?,U;QOXC\,7WPUT#P-XHT?PQIS/K'B#1O!GCW7
M-1TS32'TZ+4=)BMM0G_3?PQJ>FZ[8Z5KFE7]IJFFZSHMGJ^E:E8-))97^D:D
MJW6E7EO([R[EN=/>";"RL%W_ +O$)CR <'\>?B_X;^ 'PE^(7QA\4VD]WHWP
M]\*ZUXL>TL@AOM9O].M88=-\.:8' #^(/%%W=0:%HL>'62ZN(U=E0NH\[_9V
M_:6TW]H_]G?0_CQX2\ ^)-)U#5M(\4V^H_"K6[S1QXT\/>-/!6K:KX>U;X::
MS>+>G0+;Q#;^(]+N]*GNWU!=,A$MK=7-Y';W$,Y\ _;1_P"+R?'7]D[]DRS\
MV;2]:\;)^TW\:O+.ZUL?A-^SIJNC^(_">G:M"S+F'QC\;I_ 5D0%D%QHN@>)
M;*>/9.,YWP.D7X$?MS_M,_ &],5AX(_:#LM#_;!^%,9=[:W7Q3J<MEX#_: T
M73)W40-=W7BO1/#'Q'N+&"X25QXEO)X+>Y\RXD@ ."\7?\%(OVD/ &H?#S1_
M&G_!-'X\Z/JWQ3\6V?@/P/;?\+G_ &8[A==\7WN@ZQXF@T9'M/BS<IICMHN@
M:O=F\UE].L%-D;=[I+JXM8)OMG]G/XS?&#XPVGBV\^+'[,7CC]FU]&O='M]!
ML/''CCX7>.9O%UC>6LMQJ&H6S_#'Q?XMM=)73I&BMFM]6DM;FZ+++$DD2,$^
M=?VZ?,?XL?\ !.")Y)06_;IT&9B)NKP_!'XS-+;L%)!CWAF5<[ F$X8%:_2&
M%"59F9R)&+XRI78Q)11D;AB/:ISCD$=,4 ?+G[5/[4W@K]D7X3ZS\4O'^F:Y
MKCV>GP6_A3P9X/@.J>-?B+XJDM[J[_X0KP;H< GEU+5TT_2[_6+N^E2/3M*T
M>VNM0U"[L[*TN;N.IXA_:T\ >#OV<O#_ .U!XQM]4T?PCKO@OPGXLM?#=E;-
MXG\:37?Q!TW3&\%^!M TKPV=3@U[Q?XAUS4[+1--6TDEL[_4)'AL;B>V/G1U
MOVQ/A;X$\2?"3XG_ !+UOPAHVJ^-OAI\"_C\/ WB74/M#7?A1_&'PPU31?$-
M[I20R[+:]O\ 2+&&PO=6B@;5[31&O;#1Y-VI7D,OY4_$[QW8^&OA5_P17T?4
MO#6L^.]/@T30?B7X7^&V@V=K<:WXX^)_PQ_9EL$^$GA2.SG34=*M+JWU3Q5+
MJ5UK-WGP]X:U?3-*\9:AJ.EVUN;\ 'W?X4_;9^+R>)O &F_&S]AWXY_!7P-\
M4_$6B^&/#7C_ %/6O ?Q(L-#UK7XB^D6GQ0\,^!]?U77_AV)O+8WVL:G:?V!
MI-P3%X@U+3-2\^RA]'\??M:>*M.^)GC/X8_ _P" /BCX]ZO\,M$TK7_BKJFF
M>./"?@?0?"8URTN-0T+PAHE[XIFFB\5?$76O#UG'XHL?"NFQZ?IL.AZGHM[K
MOB#2IM9LA<_/NM?M5?M2_ /4/#WBO]JW]F?X9>!?@'XU\9>%/".I?$?X2?&7
M4/B;XL^"_P#PF&M1:;X8U/XU:5XC^&/@_2K[0K37;W3/#WB3Q+X*U+Q38VNI
MZG#K,MV=/O[6XG]$\2?#G]H_X0?&WXQ_%3X >%_A1\5M+_:'7PAKFO\ AGXB
M_$OQ'\-M2^'WQ8\)>$K7X=:;KD&N6OP^\>?\)7\/?$?AJRT^WU3PKC0-8\/:
MGX6^S>&#JDFL:A#I8!ZOK'[7'@?_ (4)X ^./A+1_$/C*T^+E]X9\,_#OP#"
MB:/XW\0>/O%FM+I0\"RC5KF.WT3Q!X)OK+Q./&T.J7UM8^&8O#7B&XO;NUT_
M1KN:W^K].U&2[=XIH1&R95E#*Y25"5FC<QED+Q2!XY&0F)G5FC9HRK'\&?V?
MO&_P6^"WB#P+KOQG^,FG:GX0^ >A_$/P7\ IH_#GB/5+_P")'Q#U;Q;K&K?M
M:?M1Z3X \%:7XGO=+\'6OB?Q1J?PA^'&M2VHT:PT4^,8[+4KB/6-/GO/V\\&
M>*=!\7Z'IGB?PCK&FZ[X;US3;35M#U_1[RTU?2]7TF^B6:POK'4--ENK/48[
MFV:.8W%G-/',6:8.RN&(!Y=^TE^TU\-?V8?!Q\7?$"YUBZNM1U&P\-^"_!OA
M/3+OQ#X^^(WB[66==-\%_#WPM817-YXA\13>4;V]6.$6^BZ1OU;6+C3]+!O4
M^1]9_;V^/?P\TIO'WQA_X)]_'KP+\'[9XKWQ%XQT?QI\-?B-XL\$>'II%$GB
M;Q5\*/ ^N:GXV.FZ/ IN_$MIX5C\4ZAI=DK:UJ=E86$I9;>KZ;9?$O\ X*FV
M\'B]?[4L/V:_V/;+Q?\ #;29I7N1IOQ ^.'Q'\1^&=?\?^&=,DMUM+/Q#IG@
MSP-)X4N-6\Z2[@L==B$2I$\K)^B\=II6H0/-)%;7%O*;F F7]\9DDMQ*3!+=
MW31M!=V:K'>$K+;:U:+'-,)-.D^8 R/"?C70?&_AK0/&'@[4X-=\+^)]'TOQ
M!X;\0V<UQ/8:GHOB"-;FQUB,73;_ "I[;SY;2"21ID3R+62.%YH(J^3OV5/V
MZ?A]^U9XP^-G@[PIX3\4^%V^#?B."RT;4/$\NE3V/Q4\$3Z_X@\(:?\ %7P+
M)975P1X3N/$?A+Q'HC27ABN+>_TJZ%S#&DD4T\_[;OQ6UKX,?LN>,W^'=L3\
M3_&=EH?P7^!N@6"1))/\1OBUJFG>!?A[+IMM;106HC\,ZEK,/B*2.UV:;I6E
M^'[U9+J.QMS<M\O>+?A-X?\ V(?B#^P'X^\'VME!\//#/AC2OV"?C'>PQ3 Z
MGX0^(R:=K/PI\<ZF"5BAAT#X_>&;R37KBYQ=)_PM#Q UT5M99I@ ?>'[0O[3
M_P -OV:?!R>,/'Q\07DVN:SIOA7P#X2\(:1/XF^(7Q*\;:W,R:3X)\ ^$=.M
MKC5M=U6Z$4M]JG[E8O#VG"ZU;6)=/TBT>]A^6=2_;L_:$\%6)\<?%O\ X)W_
M !W\(?!^*!M5UGQAX6^('PE^)_C#P=X<C@2YN?$OBSX6>$?$4_BF&WTVSS=W
MMGX.G\8:G:6&+W4+.QG:>QM,^ZT^U^('_!5N^L_$\?\ :=O^SW^QIX9\:_".
MTN9%33[3QE\?/BAXT\,?$CQ38CRF>U\52^&?AGX3\,?VWI<-S>:/X6NY[73)
M&O-8U"&O0/BE_P %!O@'\*_&?BWX?^,- _:%NM<\(R):ZIJ'AW]E?X^_$'PU
M!#<6>GZG)>:3XS\*?#G6/#?B.SU'1=4TY9;K1-1U72+>Y:X76;JWT>WDG0 Z
M#XW_ +9]O\,/A?\ !'XA_"SX4^*?VBV_:%\;>&_"7PM\.^"_$.@>$M2U^;Q5
MHFH>)-(OIM2^).KZ!I>GA]'TJ_GFMM6U*S:SDLS83M#=&&W;RV7_ (*&^//A
M[J&C7?[4/[%'QZ_9M^'&N^)M%\*P?&'7_%'P=^(GP]\/:OXAU)-&T63XAR?#
MWQ[K^L^ ='NM1>&+_A)-1T__ (1RS2YM;C5]5T_[2L8\9_:P_:)^$?B7X9_\
M$Y_VGO"MUK>I?!O7/VK?A]XNT._T7X>^*M7\2R^&9?AW\58+2:S\#Z!H;^+&
MG58&1]/TWPQ*ENZF.S-U9K!>3\A^U+^UQX%_;@^$'Q/_ &//V6O!'Q=^)7Q>
M^,7A_1_ /B-O%_P9^(OP^\-_!GP?\0Y%F;XJ_%+6_B+X>\+G2M"T/1M+U'6]
M!TC3K/4/$FN:E:V,&BZ=>7L,UL@!^Z%JXD@CD!9ED!=69F8LCLS(P+)&Q4H0
M4W(K!"H(R"38K-T>T_L_2=,L!<378LK"TM%N[@EKBZ6W@2);BX<\O/,J"2:0
MA3)*SN43=L72H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H_S_G\Z*3N/H?Z?
MX4 ? ?[1VAZ]K/[8_P#P3[\1Z+HNJZIH'@SQ5^T9)XPUFPL+NYTWPW'KOP9;
M1](.M7D,3P:?_:&H7,-O;+<NC.'\[ MPTHJ?LS^'O$.G_M*?\% ]9U#P[JVG
M:1XK^-WPJU/PEK-[IMUI\'B73(_@%\+=!U:\T6\OH8;;4K72-5T6:.UN;1Y4
MM=7M[])'3+;ON?\ LRX>:5G:40RE4\H3K#'%N:4SW C@#"[DEB\B "[(:-59
M4_=A5-JWL[E#Y\DLHF=0I"2*RQ0X5F@BA?\ <1,74;I(R^2O!VXP ?A/^W%^
MR_\ %3P%\:_ _C_X&^%]3\6?"+]HK]J']F'Q-^U#X%\-6=Q>WO@KX@_##XF:
M;KVE_M%:5IVGI_Q)M,\6^'M"G\*?%6XAM]E]K%EX>U5VE@AN+P?NVC1/#'(L
ML;%G$GG"7_1_,NF:(2QL<I<J) 1:QN3\IB4%<1D,FT]IF9MJ0LSP%65Y9$"V
M,LEQ9O*B26S,XFFD:2V9Y[:1AYC'<2&E6UE*>7-L9!YH>)2)([J-H@JK,TB*
MT+^<3)&L"B&","%,J!0!_/G^T]^T+KOQX^.7B;X+?%SX"?MLZ=^Q[\.-7M]'
M\5Z3\+?V:/BOXS\1_M=:SI+":?2=<\=^%X(]*\)? ?P]K%K<V>K>%="%WJWQ
M4U&?9JMWH_A^S$E[^I'[.OQT\'_M'Z!XKT'0_@Y\??ACI'A;1=*\/W>E_&+X
M#^*?@I'<Z5>:?<6UGHW@>/Q1:Z+'/%HT1N5?^S(9=/L;:ZAL;24BWV6_U[9V
M%U;FWWS*4BB2-E,LT\I*J%.9Y0&DS@\L!@$+\P )MR0REG9%(;$C*\@65E=%
M18?($DYCB+!Y02(U#8_> '#2 'XM_ WX\Z_^PM\/!^RA\<?@G^T)XC@^"D&I
M:'\!OB!\'_A#XL^+_A/XN_"*35Y'^%4=AK'A^QO(? /Q!\/>&-6MO &MVGCB
M;P[:S:EX?U'6VF-E=6DTWKWP)LOB+^SO\#/VFOVK?C'\)O%6L?&GXW_$'7?V
MD_$'P&\ Z:/%WCOP_I$VF:5X ^"OPBLX],FO(KOQ[X?^'WA/POIGC76-,GNM
M"T?Q ^OS:(M[:0&]N?T]ELKB24NKJJ%XU,;-.Z".!O-AG7%Q$#=>8$P60)&%
MV'S%C5Y;$=NXWG8%=RTC,$2(KYF2T$0MY0XW2@SS-).X>XEDD5B&"P@'\[OP
M-_:2)^(]Q^U/^U7^SW^W9XI_:!NK#4=%\ ^$=!_8P^,^L_"O]F;P;,MZMWX8
M\#&?2+>3Q1XDUZQO(KSXG^/(8%U7Q7K=NFDZ:UIH>B:?/>?K1XW^*'Q5N?V>
M+7XT? 7X2>(_&WC6/1M'\8:1\(?B@=7^&WCG5=)2[0>(- ET;4Q87&G>/+K2
M'NKK3H=<N[?0]8U!$34)[.RNK>.OK5K:Z(AC6654W$R2JY:9)4!DBEC-S-<Y
MAD(,$T)9B=PP!&SLL2Z<=J#R+5$8&25#&TFR:4F20PQB5%MCYKNSM!,PD<F3
M +&@#\<_CM^V#J_[2GP@\?\ [-_P _9R_:5N_C1\<O"_B#X37&F?&GX*>,/A
M!\/_ (9Z3X\T;4_!WB'Q;\1_&NM6%AX7U32?"6CZC=ZH=.\%:QX@U'Q&8M'M
M](M]4T]3<K^I'PS\&#X9_#3X<_#M;NYN(_ /@?PMX$AU>YE'GW\_A[0=%\*6
M6IRNZ1*9+J'3IKAU"!3(=J@[X3)Z3'8S@D22HR M\A:ZECF5L8\Z.>XD(*#"
M*!+(I"@X4812ZT\7B^1,6$+F-)5B$8BD@@=98XW1SOB<2%A&]N2P5078$@*
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MR?'9>X2Q%3G2C&^J;=DDV]DF[)OS;?4V5Z#Z#^5+2*"  >M+7F1NHI/>RO\
M<?6+74****8!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 1,QR1GC_ZU,(SP:** 3:VT]"5%7:.!W[9[GUIV!Z#\A110
M8R;N]7N^K[^H8'H/R%&!Z#\A110"^&7RZOOZA@>@_(48'H/R%%%!-WW?WO\
MS%HHHH-ULO1?D0O]X_A_(4VBBMTE9:+9=%V]#BG\<O\ $_S)5'RCKW[GU/O3
ML#W_ #/^-%%8M*[T6[Z+OZ'9#X(_X5^0FU?3]3_C2[0.F1^)_P :**FR[+[E
M_D.+;OJ_B?5B;5]/U/\ C2@ <"BBE%N\O)V7DNPQ:***H HHHH **** "BBB
D@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>image_004.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_004.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" &X F\# 2(  A$! Q$!_\0
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MC_A)S_SP3_ONN6\F^_Y\Y_\ OBCR;W_GSG_[XH ZG_A)C_SP7_OJE_X28_\
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MQ12XH 3%&*6C% "8HQ2XHQ0 F*,4N*,4 )BC%+BC% "8HQ2XHQ0 F*3%+10
M8HQ2XHQ0 F*,4OXT8H 3%&*7%&* $Q1BBEQ0 F*,4N*,4 )BC%%% !BC%%%
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M% !12T4 )12XHH 2BEQ10 E%%+0 E%+BB@!**7%% "44M% "44M% "44M'%
M"44M% "444IH 2BBEH 2BEHH 2BEHH 2BEHH 2BEQ10 E%+10 E%+BC% "44
MN*,4 )BBEHH 3%%+10 E%+0: $HI:2@ HHHH **7%)0 4444 %%%% !24M!H
M :16=J_&FW'^X:T36=K'_(,G_P!PT <E'TKM/#__ "#X_I7%1]*[7P__ ,@Z
M/Z4 0>(_]0O^\*Y*7O76^(O]2O\ O"N2E[T =M!_JD^E2LB2+M=0PZX-1P?Z
MI/I4PH 8+>'(_=+QTI?(A*@>6N![4\4M ###$>J+3U55SM&,G)HI: "BBB@
MHHHH *7BDI<4 '%)2T8H 2EI*7M0 E+FDHH 6BDI: "BBB@ HHHH *!1BB@
MHS2[6]#^5&/:@!*,CTHHH ***.* "BBB@ HHHH **** "BBB@ HHHH ****
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M!;2,?B]KZ;1M.GV_/?B@!K^!KIN5\::\&[DLI_2G'P?JFT!?'&M#'JB5U=%
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MW>H6\8MD2RN;G[/#.+N-I=Q. S0CYE4GO7?$8- "4M)10 4&B@T --9NL_\
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M'O$GB2_U#37N;*>6SO>9@-/:)+92,JRR[CO'U% '>4V61(87ED;;'&I=F/8
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M&-?WT@Z[GSPOY9KU_0] T[P[I_V'2[?R("Q<C<6+,0 22?H*T_J:* "@T4E
M"&LO7/\ D%3_ .[6H:R]<_Y!<_\ NT <JG2NWT+_ )!D?^Z*XB/H:[?1/^09
M%_NB@"OXD_X\_P 17'R_=-=AXD_X\_Q%<?*>#0!VMI_Q[1_[H_E5D56L_P#C
MVB_W!_*K(H 44M%% "T444 +12"EH ***.: .6^)$>_X=ZT1U2%9!_P%U/\
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M Y9.E=QHO_(-C_W17#)TKNM&_P"0='_NB@"KXD_X\3]1_.N/E^Z?I78^(_\
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M;1CN_P"^J[R@ HHHH **** "BBB@ -(:6D- "&LK7O\ D%S?0?SK4-9.O?\
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M!X=RJ/*(8MN8*".>1DT :%%,,L6W=YT>W!.=PQ@=3098Q&)#)&(ST<L,'\:
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MD=UW?G3+S3_#VE>*C9ZY!%%HJ68;3H[C<;=7+,9?;=TP/3I7H(55 VJH"\#
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M#KLJ "BBB@ HHHH **2B@!:2E-)0 AK(U_\ Y!DGU'\ZUS6/X@_Y!DGU'\Z
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M?]#3KG_@10!UN#Z&C!]*Y3_A7<Q&'\3:\P]/M0_PJ(_#"%QA]<UQ@>H-T/\
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M ***#0 AK&\0?\@Q_P#>7^=;!K'\0_\ (-;_ 'E_G0!S2=/PKO=,_P"/"/\
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M/_OH4HGB/_+1/^^A3Y'V#VL>Y0\0L$\,ZLQ. +.8Y/\ N&L[X?OYGP^T%O\
MIS5?RR*UM3@@U32KNPDGV1W431,Z,,J&&,BH=$TZUT+1+/2H+CS(;6/RU>1A
MN;W.*7*^P>TCW-.BH_.B_P">J?\ ?0I#<0CK-&/^!BGR/L'M8]R6BH/M=O\
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M +HKS]/NUZ#I_%G'_NB@"IX@_P"0=)]*XEZ[;7_^0=)]*XEZ .MTG_D&V_\
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MB::/I:I_A4Z:-I4?W-+L5^ENG^% &8/'7A/_ *&+3O\ O]0/'/A0]/$6G?\
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M )!TO^[7#O7<Z_\ \@V;_=KAG- '5Z/_ ,@V#_=K0'6L[1S_ ,2V#_<K1!H
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M,T4 +124<T +1244 +F@4E+F@!:*2B@!:6FYI: %I*#29H #6'XC_P"/%?\
MKHM;AK#\1G_05_ZZ+0!@1]!7H=E_QY)]!7GD?:O0['_CS7Z"@"KKW_(-F_W:
MX62N[UW_ )!<W^X:X.2@#J]'/_$M@_W*T169HQ_XEL'^[6D#0 ZC-)FC- "Y
MHS3<T9H =1FFYHS0 [-)FDS29H =FC--S29H =FC--S[TF?>@!V:,TW-)F@!
M^:,TPFC- #LT9IN:,T .S1FFYHS0 [-&:;FC- #LT9IM&: '9HS3<T9H =FC
M--S1F@!V:,TW-&: '9HS3:,T .S1FFYHH =FC--S1F@!V:,TW-&: '9HIN?>
MB@!V:,TW-% #LT9IN:* '9HS3<TN?>@!<T9IN:7- #LT9IN:,F@!V:*;FB@!
MV:,^E-S1F@!U&>*3-&: %YI>:;FC- "YI<TW-&: '9HS3<T9H =FC--S2YH
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MR/\ &@"Y_P )!_T[C_ONC_A(/^G<?]]53_L?_IY/_?(_QI/['_Z>3_WR/\:
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M--_Y_;G_ ,=_PH_X0S3?^?RY_-?\* ,;_A(7_P">4?YFC_A(7_YYQ_F:VO\
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M^><?Y4 <:/#);[^HWC?\# _I2CPI:'[\UT_UF:NQ\^U'\$7Y4>?:_P#/./\
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)48B0**** /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>image_005.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_005.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" $Q ?D# 2(  A$! Q$!_\0
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M0B\=U,V=FQ"V<8]/K5:Q\6Z3J%V+:&9Q,WW5DC9-WTR*QO''GG6M"^S%//\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M-H]* %I/XC]*-H]*3 W'CM0 ZBDVCTHVCTH 6BDVCTHVCTH 6BDVCTHVCTH
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M@!:*3:/04;1Z"@!:;GYC]*7:/04F!D\"@!U%)M'H*-H]!0 M%)M'H*-H]!0
MM%)M'H*-H]!0 A/S"G4T@9' I=H]!0 M%)M'H*-H]!0 M%)M'H*-H]!0 M(>
MWUHVCT%(0..!UH =12;1Z"C:/04  -%)M'H*BGGAMXS)*Z(@ZDG%2W;5AN35
M4N;V&VP';+M]U%&6;Z"JXENKSB!#;P_\]77YC]%[?C^5206D%NQ,:&21OOR$
MY)^I_I4<TGL59+<K7-I=:G;R)-(UK"P^[&?G_$]OH/SJW;0);0"*W48 ^^>A
M..OO4PBRN7()'.!T!J4*,=!3C'KU$Y-Z#1&-VYCN;W[5+2;1Z"C:/05H(6BD
MVCT%&T>@H 6BDVCT%&T>@H %/RBEIJ@8' I=H]!0 N:*3 ':EH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ I%^Z*6D7[HH 6BBB@ HHHH ***
M* $'?ZTM(._UI: "BBB@ HHHH *3^(_2EI/XC]* %HHHH **** "BBB@!#U%
M+2'J*6@ HHHH **** "D/;ZTM,;^M #J:S!02Q  [FJ,VH!7,-NAFF'55/"_
M[Q[5&;1IL/?R>9W$"#Y?RZM^/Y5FY7T0[6%:]DN6V6*>8.\S<(/I_>_#\Z(K
M-$D$LKM<W Z%OX?H.BU<"MTX1?0=>M2JBHN%&!0HWU87L1[&D'[P84_PC^M3
M  #@8I:*T$(WW32TC?=-+0 4444 %%%% !1110 B_=%+2+]T4M !1110 444
M4 %%%% !1110 4444 %%%% !44LJ01M)*P1%&2Q/ J6LW6_^0+><J,PL,R#(
MZ>F#_*@"6+4+6:U>YAF#PH2&8 GD=:@&LZ=D?Z9'SC'X_P"?PJAH,<T^E36\
MZ^4OF,@.09 .FULH!G'MTJ9?#%BB*@:?8JE0N_C:?O+TZ-@9_3% &I;7<%W'
MYD$JN@)&1ZU8W#U%4["RCL8#'&SL"<DN<GH !^  'X5=Q0 FX>HI%(VCD4[%
M-4?** %W#U%&X>HI<48H 3</44;AZBEQ1B@!-P]11N'J*7%&* &@CGD=:7</
M44@'7ZT[% ";AZBC</44N*,4 )N'J*-P]12XHQ0 FX>HIN1N/(Z4_%-_B/TH
M 7</44;AZBEQ1B@!-P]11N'J*7%&* $W#U%&X>HI<48H :2,CD4NX>HI"/F%
M.Q0 FX>HI,CU%.Q1B@!F1ZBER,=:BGN(K:,O-(J+ZFJ)ENKL9C'V:'O(X^<C
MV';\?RJ'/H-*^I9N+Z&VPK$M(WW8T&6/X5G3V=UJ.QKB=K6-7#".)OF/LS?T
M%7H+:.W4^2GS-]Z1\DM_4U:"!3DDLW3)I<K>XT[;%>")8XE2"-8D^F#^7K]:
MLJJ)T/)ZDGFGYHJDDM$3>X;AZBC</44N*,50";AZBC</44N*,4 -8C:>12[A
MZBD;[IIV* $W#U%&X>HI<48H 3</44;AZBEXHQ0 FX>HHW#U%+10 U2-HY%+
MN'J*:I!4$$$>HI] "9![TM%% #316!JOB_0M$NOLU_J444^-Q3#,5'J=H.T?
M6M)-1M)=/^WQW$;VOEF7SE;*[0,YSZ469/,K[EZC%9&DZ_IVNVKWFF72W$"L
M49PI&"!G&" >XK*7XC>%78*NK(,G 9HI%7_OHKBGROL+GCW.LHK#U;Q9HNAR
M0Q:C>B%YE+Q@1L^Y?7Y0:=H_B/2=?$ITV\2X\HXD !5ESZ@@$46=KV'SJ]KF
MW1112*"BBB@ K.U6R:_T][=$@8M_SV3<![X]:T:RM=.W0[PX)_='.) AQ_O&
M@"/0+<VFG_9GFMY9XW;S3 FQ0Q.?N_P_2MFN?\,N#I"E96E&\C<QR>, =!Q]
M*Z"@ HHHH *1?NBEI%^Z* %HHHH **** "BBB@!!W^M+2#O]:6@ HHHH ***
M* "D_B/TI:3^(_2@!:*** "BBB@ HHHH ;_$*6FD\BL^6_7>8;96FF'4+]U?
M]X]OYU+DD-)LOLRJI9B !U)K/:^ENLK8H&7O.WW!]/[W\O>F?9'E;==OY[#I
M"O$:GW]?QK0\K(^<C'91P*CWI>2'HBG!:()!,S&YF_YZ/T7_ '>P_"K@CR07
M.XCMV'%3 8I>*N,4A-W"D/;ZTM(>WUJA"T444 %%%% !111F@!K?=-+6/JWB
M#3M&MY);NY4;!S&AW/\ ]\]:;'K,UW&KV6FW4JL 5>4")<'_ 'N?TIV=B.97
ML;5&161LUN<'=+:6J_["F5OS.T?I1_8HES]LO;RXSU!EV+^28HL/F;V+5SJ5
ME98%S<PQ'J [@$_A54ZVDPQ:6=Y<D]&6+8O_ 'T^!5FVTRRLF)MK2&(]RJ $
M_C5W HN@U9E>9K5Q]R&TM%/>1S*WY# _6HWTB>Z1DO=3NI%8$%(<1*1_P'YO
MUK:HS1S=@Y>YG:1IEOI&G0V-KO\ )B!V[VW'DYZ_C6C0O044KW&E9"T444#/
M/? SVZW/B?[>8Q?#49C<>:1GROX<Y_AQGVJGXEUC2A\/(+7P\A%KJ4WV:%;>
M%@=NXF0JO4\!OSKKM4\):%K5TESJ&F0SS@;=[ @D>AQU'UJR^B:<;BQG%I&D
MEB&6UVC B##!P!QTJ^97,>1V:.#\-:C;6_CF_LK>UN[6SU&U66&*Y@:$^9&N
MUMH;U7G-8MA;Z]+\*GV7.FC2?)E9XW1A,4#L6 8G:"><<>E>LW>D6-]>6MY<
MP*]Q:%C#)D@IN&#T]:Q1\./":-N&C1G!S@R.1^1;%6IHS=.6QREY<W=SXD\)
MW&B0PB5]+=H8[QF "X'!(YSBM'P(TFH^(]9U>^:.'5AMM9[*-2HA"]"23\V<
M=:[1M&L&U*WOS;(+FUC:*&09&Q#U '2D71=/367U5;55OGC\IY@2"R^A'0U+
MG=6+5-IWN:M%%%9FX4444 %9>MS&'2;AQNSLPN I.?HW!K4K(UV)9],:-KAK
M=2R_.$9OPPI!H BT6=!I331PJJ"1CB%/O<]=H+<_C4HU_3RI82L5! )V-QD;
ML].@'4]JBTNPA;0WM?M#30RE@60-%P>H&3D?GW-2R:%92N'D61F"A 3(?N_W
M?H>XH LV=[#>QM)"<J#@Y4@^O?V(/XU=W#UJG9V45E$T<.0I.X@L6/IW]@!^
M%7: $W#UI%(VCFG4B_=% !N'K1N'K2T4 )N'K1N'K2T4 )N'K1N'K2T4 ,##
MGGO3MP]:!W^M+0 FX>M&X>M+10 FX>M&X>M+10 FX>M)N&3S3J3^(_2@ W#U
MHW#UI:* &Y'K1N'K2@U5N+J*V4-*X&> .Y/L.])M+5@E<L[AZU3N;V&W(3EY
M3]V-!EC_ )]:@,EW<CG-M">A/,C?0=OU-36]HD"GREV!OO,>7;W)-1S-[%6L
M47MKN[NHY+BX,$(!S;1G)8'^\1_2M*&!8HQ&BK'&!PB5,%5#P,9)-/[41@EJ
M)ROH(NQ5 7  IVX>M+16@A-P]:3</6G44 -R/6D+#CGO3LUBZMXCT[2#$MS/
M^\ED$:1QJ7?)_P!D<T)-B<DC8R*7(]:R#J&H7'%GIL@'_/2Z<1#\AEOT%+]@
MU.Y'^E:EY0/5+2,+_P"/-D_RIV[D\W9&A-<PVT1DGF2)!U9VVC]:H'7K60[;
M.*XO6Z?N(R5_[Z.%_6G1:)81/YAMQ++_ ,])V,C?FV:T\ #BC0/>9D;]9N?N
MQ6MFA[R,97_(8'ZFD_L?SQF]O;FY)ZH7\M/^^5Q^N:V:*+CY>Y2@L+2SC9+>
MWAB4CD(@&?K5S*TK'Y31Q2N-)(-P]:-P]:6B@8FX>M&X>M+10 FX>M&X>M+1
M0 U2-HYI=P]:%^Z*6@! 0>]+110 4444 %%%% !1110 4444 %%%% !5'4D2
M339TDSL:,@\G^G-7JR=?^SC1;G[1GRBN#B(R<YX^4=>: *_AF VNFR1;"BK.
M^ 01QVX(!'XUO5B>'&,NDK/Y<4:S.9%2+&T*>G2MN@ HHHH *1?NBEI%^Z*
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MT;OK2T4 )N^M&[ZTM% ";OK1N^M+10 P'KUZ^E.W?6@=_K2T )N^M&[ZTM%
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M@!-WUHW?6EHH 3=]:-WUI:* &*?E'7\J=N^M"_=%+0 F:6BB@ HHHH ****
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$4 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>image_006.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_006.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" $A >L# 2(  A$! Q$!_\0
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MI69J^IW=MI<>HZ3<60LEA!VR*26/8+C^51FTBUU--OVO_L6KM;AU,1'S*?\
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M&+6IO5G--)'5Q>(;:756TXQ2I.L G.Y0 !Z=>O-6-$U>'6M.%W DBQEBN)
M>/I7,QJ4^(5RKMEAIX!;&,G(YJQX#N(H_#:*TB*WF/P2!WJI4THW1$:T[V>Q
M<N?%\$&I3V":??W,L! ?R(@PY&?6IX_$L&+1KFUN[3[5,84$\>W#8XS]>U<P
MD%U/XRU@6NI?82"FXF-7W?*/[U7?$T$T7@V4W%^+N>*1'68(J\[AV'UI."T'
M"M)MG=@YIU5;-V>UB=QAF4$_E5CM6#5G8[HNZN.HHHH*"BBB@ HHHH ****
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M/4K;R+R".6+T<=#ZCTJC8>%M)TZ?[1:VJK*. Q9F(^F3Q6R'(_Y9M^E*7/\
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M>]_^>1_,4;W_ .>1_,4 245'O?\ YY'\Q1O?_GD?S% $E%1[G_YY'\Q1E_\
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M]D:]34MI:L$F]BR._P!:AGN8;=-TSA!T&>_TJB+NYO0&M@(H&Y$T@Y/^ZO\
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MB@!G.>W2G9/M1_%^%+0 F3[49/M2T4 )D^U&3[4M% #.=W;I3LGVH_B_"EH
M3)]J,GVI:* $R?:C)]J6B@!@SN/2G9/M1_%2T -R?:C)]JCEE2)"\CA5'4DX
M%9SW\LX"VJ[58X$T@X/^ZO5JB4D@29H37$=O&7E=44=R:SWNKFX(6W4PH?\
MEI(N6/T7^IIT5AEQ*Y9Y/^>C\L/]T=%[U?2)4^ZN">I[U-F]RM$4X+!$;S#N
M\UOO.YRYXZ9[?A5Q4"#Y549Y..]2=S2\5:BEL)ML.?:DR?:G450A.?:C)]J6
MB@!@SD].M.R?:@=_K2T )D^U&3[4M% "9/M1D^U+10 T9YZ=:7)]J!W^M+0
MF3[49/M2T4 )D^U&3[4M% #1G':ER?:D7I3J $R?:C)]J6B@!,GVHR?:EHH
M1?NBEI%Z4M !1110 4444 %%%% !1110 4444 5;M#):R(&=3M)!5BIS]16?
MH#2M:R^=,TKK+MW%B>P]2:O7IE%C.8<&41MM#9QG'MS5/123;RG*'YQ\R,S
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MO#'$GI&H45/FEQ1@>E(+6#(]:,CUHP/2C ]*!B9&[J.E+D>M)@;^G:EP/2@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
1BB@ HHHH **** "BBB@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>image_007.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_007.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" %Y FX# 2(  A$! Q$!_\0
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M &:OG6J2&>\?\-#6O_0"O/\ O^E'_#0UK_T KS_O^E>#T4[#LCWC_AH:U_Z
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MS_O\E>#T46"R/>/^&AK7_H!WG_?Y*/\ AH:U_P"@%>?]_P!*\'HHL*R/>/\
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MM /D,Z3J8ZZ;>CZV[_X4TZ??+]ZRN1]86_PKZNO'\A"9)Y&]JXC6;IYWV+G
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M?+6YDR/WOY-6S!/(5SO_ %I&=SYJ_LG4_P#H&WO_ (#O_A2?V5J6?^0=>?\
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M0!;F[4#/R]<U4E<8Z\5IZ+#CYWB+!JVI;C3.LTZ)$C&, ?6N@MG3':N?MB%
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M3]*^FO"7_("M/^N*?R%8R-#SOX]?\BDO_7W%_P"S5\ZU]%?'K_D4E_Z^XO\
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MMCY]EUZX25E/D*1UR.:@?7YQ_P O$ ]BM>N^(/!MAJ:EIK99O1U^65?HW?\
M&O,-:^'^J6N^72O+U"-?^6++LF'X=&_#GVK?D5KIFL*L9.TM&9;:M)+DFSTF
MX_ZZ\4V*_DENH85TO1HM[A=T?S$?A7*W,GE3O#<Z6!*APR/E6'U%5A=112K(
MFGB-E.00_2HVZFKI)JZ/<O#]_HVHQ-&NF0R6418^=*P"-(IXPG3\6KH-;U33
MK33E_M6:W%M(HVQD91AVP/2N26QT[4OAZ+:RW12RC>0O=CUKP_Q!/J%MJ'V2
MYN)V6!=L:R$_(/1?05,FSA5.*;1[-'I/A?Q[(\>ER6T]Q%G]T$\AB/4=-PIA
MT35_!S*+4W440ZQ2L9(V']/J*\:T#Q)J&A7:36=S+#M=7(C;&2*^C/#'Q+\/
M^+].>WN'^QW^WFWDZ/[H>_TJH56F1.BFM#%N/"VB>+HO,18[;4V4M&\3%5GQ
MUR.[#N.H]Q7 7?AZ]TB^>VGT^>-EZ.'W*P]0:[".YMKV^U"STZYD66W?S4^7
M:\<B]&Q[CY?RK6M+^W\=Z3)IUV'AU6SDV,2-C!^Q_P"!#^57**GJMR(U)4VK
M['G\*R*<;F4^A%:44DH4'S3FKMO:>5,T$R,)(VVL'ZYK>@L8P@RJ_P#?-<MS
MT+<RNC!AU":,#Y_YU8;4Y]ORL2?8UN?88<_<7_OFAM/@*X*#_OFM$9LYB;5K
MD9!\S_OJH8M3N';EG'_ JVKVP5%8JJ$#U6N?DW0.7\M=O^[2!&@;B1U_ULF?
M9J2*XVO\TC?B:I+K5K$/G'_D,TCZ_IQ'^K'_ '[-3(TC<ZZPNX\#Y_UK5,Z%
M,[_UKS^#Q%IH;@X_X U::>(+%T^1\GZ&N6HCLA<ZE9T#?>JRDZG^(_G7$MJZ
M$_(:LP:S@]:YM4='*=S%/&2JESCU)K>LWCVC:P_ UYW#J:,/O5=@U5HCE'Q[
M5K#$<NYC/#WV/2$:,]<U*-G78QKC+3Q)&,++\OO6LFMP%<B08^M=4*T9''.A
M)&X[*J_<;\*R[F>,9RDI_#_Z]5GUZW'_ "TJO)J]M(/]8,UNI)F+IM$<USC.
MRW;ZL:RKR[DP=S!/84Z_O552ROD>QKEKS6XPY&'-:)BY&RU/."W?ZXIHN16/
M)KT2CF.3\*IOXCMP2"LH_"M5.)#IR-FYOT4$;P/PJA_:,6[ 1C[UAW.N6\K$
M*S_BM4OM^6^5J/:(7LV:WB.[2;09$52#YT7_ *&*P*74;EY+':3QYL?_ *$*
M0]:SF[L=K"-]T_2OIGPE_P @"T_ZXI_Z"*^9F^Z?I7TUX2_Y 5I_UQ3^0K.0
MSSOX]?\ (I+_ -?<7_LU?.M?17QZ_P"127_K[B_]FKYUH12V#N/K786[IP/(
MC4?]<Q7(#[PKK5U#8!\OY5E59O15V:'R$?=3_OG_ .O371-GRE0?7938-7&
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M>[V"6&Y5N:&JZ1;7(;S(=H]4:J.B>'K#2K]=12$/.AW(9>0OT'K4CR00%6F
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M.HZY_"N^\/:=H$2B2VLH0Y_B\OFH4E(UDY4UL<5!X*U&6)7\S&X9Z5.G@K4
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MIPF$HZ&)>LQM #_ST3_T(5,>M/U6#9:!A_SU3_T(4RMSED(WW3]*^F?"7_(
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MQNMZ*P#%?Y5V4VNH_"J361>3S7>0BH![FB."J]C66,I6M<\MG^U6TA0R$?\
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MDW^JZ>Z'R]0M2?:44U1GV8_;P[GEEW'XJ@N6ACUJ[=1_$TK+_6ECMO%CC/\
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M53C?<\/G2B.Y7_CWO4Z/[-4FK>(4G5+:XM5&I1MM>5&X*U1FT;&JZ=;:[:$
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M=4 IJ5..U8R9+8@&:=LI"Z(N7=5'JQQ2?:K?_GO%_P!]BN=U4NIHJ<GT';:
M*8;FW_Y^(O\ OL4@N;?_ )^(O^_@J?;1[E>RGV)<8IPX.14'VJW_ .?B'_OX
M*475O_S\1?\ ?P4O;0[E>RGV)RS'N:C9,]S3/M=O_P ]XO\ OX*/M5O_ ,]X
MO^^Q2]I 7LIB&$_WC3A'@<DGZTAN;<_\MXO^^Q0;FWQ_KXO^^Q1[2"'[&8N.
M>E+MS3!<V_\ SWB_[^"E^TV_3[1%_P!]BK]M'N-49+H.V8I"M'VFW_Y^(?\
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M/=/>ZMX@L"?NWDY3/KN;%"6<$TUO+MQB5"/^^A6-XGN#:>-=5;. ;Z4D_P#
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MO0H*^AQ578A?3O.DSO(^@JQ'X?5P,S'Z;:Y:].IK/\CW 'LQJ$3:TO2:['_
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MVC!96M].\Q%X!ZCZT7 \%"L&!4D$<@BGRO<3D&::67'0R.6Q^==!XHNM'O\
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MI>";*"&-+ W1=F"HGG'[W:NZT+2;3PII(A\QIKM_FGF=MQ9O3Z#M0FV*7>Q
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MDQ-,!&A42*IPRLO8C!Y'I1<+'BV*"AQ7OMEX:\,>!/"-OJNHZ,VKW4BH97$
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M^=A_"@ZG\JT/$_A:7P_?%DS)8NV8Y!SC_9/O2;6P[/=&=/-?2PB06\T4;?\
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M[YKV?*4A$1_A4_@*5H]BN9]SR./5'/\  X^JU-_:&[JC?]\5ZMY4!_Y9Q_\
M?(I#!;G_ )91_P#? I))$.*9Y2;M2/NO_P!^ZJ3RJV>67_MF:]@-G:D<PQ?]
M\"F'3K,_\NT'_? IW1/LT>(RQ[FR+F1?I&U36<D5M*'E>6;'16W 5[(VDZ>W
M6S@_[XJ-M"TQNME!_P!\U?/H/EL<#8^)-/MF^?3(9?\ ?9O\*Z&U\=Z*@&_1
M85_W'_\ K5JOX6T9_O6$?X9_QJ!_!>@N.;'\I&']:.<3AYD\?C[02O&F2?\
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M]_!2C6=-_P"?^V_[^"ERL.9&B)9!Z?G2B5N_\ZS?[8TS_G_MO^_@I1K&F?\
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M#DJ=S2_L:\':#_P(3_&E_L6\](/_  (3_&LS=%_?6C=%_?3\Z.>(<E3N:?\
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ME6M,LOMEQ\P_=)RWO[4 :.BV/EQ_:I!\[#Y >P]:UZ ,#&**"0HHHH$%%%%
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ME_W_ /\ [&C_ (4Q9_\ /]J7_?\ _P#L:]DHIW \;_X4Q9_\_P!J7_?_ /\
ML:/^%,6?_/\ :E_W_P#_ +&O9**+@>-_\*8L_P#G^U+_ +__ /V-'_"F+/\
MY_M2_P# C_[&O9**5P/'%^"]BQP]]J>T^EQ_]C7J.D:<MA80VJLY6-%0,3R<
+#'/O6EWI:-P/_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>image_008.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_008.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" %? G # 2(  A$! Q$!_\0
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MZ3H5[?QQ&5K>)G"CV'6I=UH:+4T**\1\,_%77K\SZC?>2^GI<1P^4D04C><
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M>A:=>W/VB>W5Y,_,3_%QT-:WD2>B_G1Y$G^S^=7&36S)E&+W1 B+&BHHPJC
M'M5;5-.MM8TNZTZ\5FMKF,QR!6VG!]#6AY$OHOYT>1+Z+^=1?J4>267P1M;>
M5(;C6IGTH2"1[../89B#QO.XC\0*]/N+*UNH!!<6\<L0&T(ZY&,8_EQ5S[/)
M_L_G2?9Y?1?SIMW SCI&FF;S390[_7;[Y_G5W/-2?9Y?1?SICJ4;:W7K2 :
M%4*H"@<  8 I:** .8/Q MO^?&?_ +Z6E_X6!;_\^<W_ 'TM<$?NFNVBTS39
MFM%@T]'=HF:02*T8)PO.2.?P]:]G$8:E2M='B4\14E>S)_\ A8-M_P ^<_\
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MTZEG/DN$;"'KG'7V/%;0.0".]9QTJS=)4> %9N9 &8!OPS_^NKX4*H51A1P
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MOI%BT?EM;H5X&.>Q)_FS?G2C2;%)EE6V02*RNI Z%5VC].* -&BBB@ HHHH
MS[*6699O.SE9W1?W3)\H/'7K]>AI9_\ CZ'^Z*E@MH[99/*4CS':1LL3\QZ]
M:BG_ ./H?[HH ;1110!Y6=$U4C!TVZY_Z9FM!9/%"%-L-V/*7:G[@<#\O85Z
MB!ZXI=HKOGC93^)7//C@U'9GD+Z5J[S-,UC=^8S%RXC(.X]Z3^RM9'_+G??>
MW?=;KZ_6O8,#VHP*/KLNP_JB[GD TK60VX6=Z&]=K9IG]C:J>NGW?_?LU[%@
M4FT>E5',)QV1+P47U/'ET;5"1C3[H'M^[(KJ_#7AR;3I6O+P 3LNU(U.=@/4
MGWKM0!5>?_6GZ5E5QE2JK,TI82--WN,@_P"/I?\ =-7ZH0?\?2_[IJ6XD:*W
M>1(WD95)$:8W-[#/%<9VEJBN:TF]U237;RVU$0H!;0SI!$,^3N:0;2_\1^4>
M@]*U-2U&/3+*2ZE5FVX"HHRSL>%51W).!0!HT5@>';K4+J._34WC:>&Z*8C7
M"H"B-L]\;L9[TFO7%\+O2K*PNQ:R7<[JTGE*Y"K&S< \=0* .@HK)T^RU*VD
M=[W5FO$9<*C0)'M/KE:H13ZCK-S<O:79LK"&5H4=(E>29E.&;+9 4-D#C)P:
M .EHK+N;+4);2**WU1[>9/OR^2C&3CT/ _"L*0:U::[I=E_;;7+32-)-&UI&
MH$*#YCD<C)*J/]Z@#L:*** "LN/[@K4K+C^X* +-E]U_]_\ I5NJEE]U_P#?
M_I5;4+N[MDC2SLWN996V+EL(G^T[=E^F2: -2BL7P[?7.HZ+#<W90SEI%<QJ
M54E79> ?I6?:W&MZRD]W97MK:0K/+%% \!D)V,5S(=PQDJ>!T&.M '545DZ)
MJ']KZ3:Z@R"-IDRR!L@'.#@]QD<5K4 %%%% !1110 4444 5KO\ U!_WA_.J
MK_</TJU=_P"H/^\/YU5?[A^E %^+_5)_NBG;U]:;'_J5_P!T5DZCK"Z9<6\+
M0EUECDD9AGY50+G@ ^O? ]Z -C>OK1O7UKG3XIM$98S:7?F,0JQ[5RS84E?O
M=0&7.?6ID\1VSV<5V(I(XWE\MA*0A7,?F ]<<C;W[T ;F]?6C>OK7/P>*;>Y
M\D06]PYF9%7(5?O,5)Y;G:1SBG2>)[2"ZDA>WNU2-F#3;!LX;:3US][CI0!O
M;U]:-Z^M<X_BNU2.1C:7>Z-<NI5?E."0I^;J=O\ CBKFFZR-0N)(#;S02(6_
MUF"&"MM."#Z_Y- &OO7UHWKZTZB@!N]?6E!!Z'-4;Z]^P0B4V\\^6"[8$W$9
M]LU:0Y(.""5Z'M0!+1110 4444 %%%% !1110 4444 %%%% !5:]_P!2O^^*
MLU6O?]2O^^* *LO^K;Z5HK]P?2LZ7_5M]*FU'C2+K''[A_\ T$T 8TOCSPC!
M,\4OB72ED1BK*;I,@CMUI/\ A8G@W_H:-(_\"T_QKXP6+)'':I?)_P!FKY2;
MGV7_ ,+#\&_]#1I/_@6G^-)_PL/P;_T-&D_^!:?XU\<"$8Z4Y;?+=*.4.8^Q
M_P#A87@[_H9])_\  I/\:3_A8/@__H9])_\  I/\:^.O();BE* <'FCE#F/L
M3_A8?@[_ *&?2?\ P+3_ !I1\0?!Y_YF?2O_  *3_&OC9H\G@4Y5P/2CE"Y]
MC_\ "P?!X_YF?2O_  *3_&D/Q#\'#KXHTG_P+3_&OCDKG-57'-+E"Y]R:9J^
MFZU;?:=-O[>\AW%3)!('&?3(I\__ !]#_=%>-_LW?\@K7_3[1%Q_P$U[)/\
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M;+[K_P"__2L?5]<DT6]=[L;=/6 NA6,NTK@,2F<_*< $9'///%;%E]U_]_\
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MM>_ZE?\ ?%6:K7O^I7_?% %67_5M]*GU#G2+K_K@_P#Z":@E_P!6WTJ?4?\
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MYZ_*/>K$'@ZVAMI(FF,K,CJ'D4D@L5^;[WWOE'(QFNH\V/\ YZ)_WU1YL?\
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M(HR23@"L_4F#-9D'(-PN"*:5R92L4=1_Y&_2/^N<W\A6S>_ZE?\ >%8VH_\
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M<RW*R&:$1/&Y0@-N!]P<#UJMK=Y>6EO;FU4CS+@)+-Y+2^2NUCNV+R>0J_\
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M0S=_[B46L/GN[(OO]T_2N6U/_D1+C_KF?_0JZE_NFN6U/_D1+C_KF?\ T*G
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MP_K3]"_UFN?]?DG\A4>J?\B'-_UP_K1U$MB_-_Q[:7_UT3^55[__ )'+2O\
MKC-_(58G_P"/;2_^NB?RJO?_ /(Y:5_UQF_D*.H^AH1LQUBX7<=HC7C/'>LS
MPU_J-5_Z_9:T8_\ D-7'_7)?ZUG>&O\ 4:I_U_2T+9B?Q(2__P"1'N/^O=JM
M/_R#-+_WXOY55O\ _D1[C_KW:K3_ /(,TO\ WXOY4GL'4AU/_D;='_W)O_01
M5^W_ .0S>?[B?RJAJ?\ R-NC_P"Y-_Z"*OV__(9O/]Q/Y4,<>I0\/RR22:L'
M=FVWL@4$YP/2JVI_\B+<_P#7,_\ H56/#G^MUG_K^D_I5?4_^1&N?^N9_P#0
MJ:%K8T[G_D&6'_72*JM[_P CIIO_ %[R_P!*M7/_ "#+#_KI%56]_P"1TTW_
M *]Y?Z4(3V1?@_Y#EU_UR6L[03B\UW_K[/\ Z"*T8/\ D.7/_7):SM"_X^]=
M_P"OL_\ H(H13&:FS-X&N68DDP'D_6K?_,/TK_?C_E5/4?\ D0Y_^N!_G5P_
M\@[2?]^/^5+H+J1:C_R-VC_]<YOY"MJ[_P!2O^\*Q=1_Y&[1_P#KG-_(5M7?
M^I7_ 'A4R+I[LJR_ZMOI4]]_R#I_^N+?RJ"7_5M]*L7G_(/F_P"N3?RI1W1I
M+8^7]-TJWU6XG%SN,-E")1'CB1ST!/MUK.55+O)Y\>\_\LBN:ZG0$7&J*W $
M2,2.H&#G'X5G:#!>:QK4-C9H@21^4\L%53N6_"NC$15U=[G1@XWBY6T1SU[I
M]U?B-/L>"W&].>/?TKL/"MM.=&@2XC=7C!7YQS@$BNIN]!L+&ZU>VM(Q,D:Y
MAS@M$W\0S[57T=-]J6ZC>0*]'"4E&-TSR,96YI6:.:UF!9/"EDI^1$)9B!T&
M36'I@C::.&.P1R[!5&YMY)Z<YZ_A71ZTQ_X1.",8W-C;GN <G_/M5/PKK?AO
MPS*NIWL\E_>K_JH;9-RQ>Y8]ZXZZJ2J6CL>KA/91HMO<Z*;PL=)UEM/NG9T,
M/G(R-R!W!XZBN2\8C;X=0I@.2%# <@$\BNML-9N=>U6;4K]!$]PIEC@QE8XU
MVA ?KC(]3CUK&U"W%]!;0LB,'+'##@=_TKT8P_=/FWL>4Y<U5<O<X321ID-K
MB:Z*RD9^[T]LTRUNAIEWY\,OFVDC8F 'W??'K79Z;H.D7]]%8PVDCS2ML24(
MN,^NW'3\:GU+PI!IFCWGGQQ"5)_)DC5!@XY# UYU"G[]TST<2^2"4EN>C_!U
M MKJQ'0RQG_QTUZ)/_Q]?\!%>?\ P@0)8:@!TW1?^@UW\_\ Q\_@*PK_ ,1F
M-+X4-HHHK V-&BBN?F\6Z-!,T371PC%9'$;%4(['C^5 '045#%,D\*31L&CD
M4,K#N#TJ:@ HHHH *IW'^N/TJY5.X_UQ^E #(/\ CZ7_ '35^J$'_'TO^Z:O
MT )5.[-QA! "3NRW/8=OQJY14M75@O8RT>^+[=@"\<L,GK4UL]R9 LN2,')V
MXYS5ZBI4+=1N5^@M%%%:""BBB@ HHHH *RX_N"M2LN/[@H LV?W7_P![^E87
MB/0YM1FAN;9E\V+^%^ PSGKVK=M/NO\ [_\ 2K59U(*<;,J$W"5T<WX<T2;2
MQ-+<,IEF/(7D*/KWZULW=LUQ%L!0 ]0R;JM"@TH4U!<JV'.;E+F>YGOIX=$'
MFOE$V*3S]<^N:;_9J9?<V[=NZCU__76G2FGR(7,T4[:W\EG(;(;' & *MTM)
MVJTK";N+1113$%%%% %:[_U!_P!X?SJJ_P!P_2K5W_J#_O#^=57^X?I0!?B_
MU2?[HJ""S@M1*(8E3S7,CX_B8]34\7^J3_=%-"*C2%?XCN/Y8_I0*Q!+IUM-
M:&TDA5K=A@QGIUS4SP1R*BLH(0AE'H149M%-D;8LQ4K@MWITL E:)B[CRVW
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MMGTA\(&W6.H?[T7_ *#7H$__ !]?\!%>=?!H.=,U!V!QYD:[NQ(7G%>BS_\
M'U_P$5Q5FG4;15)6BAE%%%8&AHUYM<:;KD5M?6T&FW#M+-*5;>-A5F/^V.WM
M7I-% &5;V4I\/VUHQ\N58(T;/." ,_RJ$V=[$H"S,R#:H17V\9&>W'?\\5MT
M4 9$=I>[EWW65RN\AC\PXX'IW^N:EM8+F)AOD+((\<L6^;U%:5% !5.X_P!<
M?I5RJ=Q_KC]* (2[1.LBKN(XQ3O[0E_Y]O\ Q_\ ^M2 9.!R:78_]QORH /[
M0E_Y]O\ Q_\ ^M1_:$O_ #[?^/\ _P!:C8_]QORHV/\ W&_*@ _M"7_GV_\
M'_\ ZU']H2_\^W_C_P#]:C8_]QORHV/_ '&_*@ _M"7_ )]O_'__ *U']H2_
M\^W_ (__ /6HV/\ W&_*C8_]QORH /[0E_Y]O_'_ /ZU']H2_P#/M_X__P#6
MHV/_ '&_*CRV_N-^5 !_:$O_ #[?^/\ _P!:C^T)?^?;_P ?_P#K4;'_ +C?
ME1L?^XWY4  OY3_R[X_X%3$&% I^Q_[C?E1L?^XWY4 -2=X-P6+>&.>N*=]O
ME_Y]O_'_ /ZU&Q_[C?E1L?\ N-^5 !_:$O\ S[?^/_\ UJ/[0E_Y]O\ Q_\
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M$O\ S[?^/_\ UJ/[0E_Y]O\ Q_\ ^M1L?^XWY4;'_N-^5 !_:$O_ #[?^/\
M_P!:C^T)?^?;_P ?_P#K4;'_ +C?E1L?^XWY4 ']H2_\^W_C_P#]:C^T)?\
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M^J$__'T/]T4 -HHHH T:**J2WMM%=Q6DDZ+<3 F.,GE@.N* +=%%% !1110
M53N/]<?I5RJ=Q_KC]* &0'_2E'^R:L7-S%:VTEQ,VR.-=S-Z"J\'_'TO^Z:+
M^R6^@6"21T3>KML."V#G&?KB@ 74;1B<3H $1]QX&UL[>3ZXIS7]HDBH]S$K
MLVT*7&=WI^E9+>&+>2(1-/*P7:$W8;"KNP#Z\.1^%6!H,"L&C8JXG:;)13G*
M[=I]L4 :T4T<R;XI%=?53D5+6?IM@-.M1;I(TBJQ(SQM]A[5H4 %%%% !35Z
MM]:=35ZM]: *AOK=;PVWF?O%7>PVG"CW/0=#3_M=L=G^D1?/]SYQ\WTK.O\
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MZQEE 7.3CT[U7E_U;?2M%?NCZ4 <+I7B#Q#-<:>;RU00R+(;C; X**N[YO\
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M;7;VHM;!KHF/&^1OFP 2. -O/U%4? >NWVIQW5K?R>>]NJ2),1@E6SPWTVT
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M1U_#FJOV.W_YYBMXR3U1Z=/+9S@FF>D?!<_Z%J__ %VC_P#037HL_P#Q\_\
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M^>O_ (Z*EHJA$6Q_^>O_ (Z*-C_\]?\ QT5+10!%L?\ YZ_^.BC8_P#SU_\
M'14M% $6Q_\ GK_XZ*-C_P#/7_QT5+10!%L?_GK_ ..BC8__ #U_\=%2T4 1
M;'_YZ_\ CHHV/_SU_P#'14M% $$P(MI,MNXIZ=/R_E3;G_CVD_W:<G3\OY4
M*5<MD/@>F*;L?_GK_P".BN?\0^*4\/7-G;?V=>7T]TLC)':J&;" $\$^]6_#
MFNQ>(]&CU*"*2&.1F79+C<"K$'I]* -7#_\ /3]!1M?_ )Z_H*KO>P(&W/RN
M<COP:>;R !6,J@,<+GO4<R[CY62;)/\ GI_XZ*7;)_SU/_?(J 7UMU$J]OUJ
M:*5)5W(P8 XR*:DGLPLQ=C_\]?\ QT4;'_YZ_P#CHJ6BJ$1;'_YZ_P#CHHV/
M_P ]?_'14M% $6Q_^>O_ (Z*-C_\]?\ QT5+10!%L?\ YZ_^.BC8_P#SU_\
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)Q0 ZBBB@#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>image_009.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_009.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" +( @@# 2(  A$! Q$!_\0
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MX?\ !_\ T)^JZR_5LYJO'_$?*K9LE[\%LN[TT1^U9_X+8:U&2!^SUIO4D?\
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MN*A.F4P"&_$DC\/2G_V9IMFADO9@S EE3U'8]?7/KT_"N*6/G.KRXK^%J_\
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M^C_0S_LW\77''7_]77/IQZ^DJ1[P3GOC]!['UJWY'O\ K_\ 6IZ0_,._X_\
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M5*[YG\QL\'KA>H7MT)8Y]36;)<C:$B^]C]>1D]\<#_(!KTX0JSI\M'X[Q?\
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M(>.O^?R-7DM/*!7/5BV/3.!CH?3_ .M3'@Y'/;U]S[4&$OA?I_D5/(]_U_\
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MH%/N#N)P>A'%62EU/]]-A^ZHYY4<@COU)P!Z XIATE7=3-][&!] 2??OG_\
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M^W^%CHA[/F_V;^+9V_P_:V\K'$?V%J+#<+>2-&;)D?J"<9(]L8_R*TX_#R;
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M^1Q_P'WKUZ'M>5<O\#];>[_3-@?2;&,&3?OV]3[]<'Z9![_XY[ZAIUJ&C/\
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MTZ%%R=BR$;BN  1[<8]S^N=/X@O7YA%O;$# C3_6-C/S#OSG;]5/UIKKZ/\
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M)F_"'P1:VGQ=^..@:7?+I&L^-_$WP]^$VM>)(?[3U^7X?>%I[.+6?%&H:O\
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M=6C.'(XT^Z]H]-;WY5:RN?TMF_#/#BX*I0QW$/\ :6%K9?6E5PO\R<&_:?\
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M;_?I^'3_ #FK'S_]L_\ V;O_ .R^WXXIXV;#LZ9^;_>X_ICIQZ<5^LU=J?\
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M&UC][I^@WWAO[.;1_&@'_'QH\$%U#'I^C?\ +.\CN9_^7FOTF\:_#/PC\3?
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M$#[['7G\#2(KJ"$Z$D_Q=<#T^@K^H$[<\O\ H*A0K?@I?^W'\N8ZKS2H4O\
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MQ6<;.;)S.<]^M:DDCJQ#V_/],D?S!JI--'_&FPXP!U]>?YCUXXKU*?P?=^:
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MP!^..*JLUH[$O&C') ,?W0.N#[Y)S[$5Z/UFG['][\'-'[];%0Q7O?\ (O\
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MN.JCB<FYUMM+OV1@3:]IF.-#^3'S'_:YR,8],?YXJC_;VA%3_P 2/')STSR
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MUO CVUV9(+8 6ER$R3]_['>>N?;/IUK^\[]G39_PH/X+>4BI#_PJCX=>2$&
M8O\ A#=$V'CKQQGT K_/[U.TU5;6X9=+C5A;W ,D>-H7[)=\''?J3[8]:_T
M?V<,_P##/OP/W+M8?"/X;!E]&_X0S1,CO_.OY>^D5_OV1?\ 8/4_](@?L'A-
M@_8/-Y_VA]9_>I>R_P 7VO\ MW?Y^I[31117\TG[2%?"O_!0"'[1\#[*/&[/
MCOPX=OK^[U#^7TQ7W57PU^WTMPWP2L1:G;*?'?AO#_W1Y>H?X^_3WKT\F_Y&
MN _[":7_ *4CFQ?\"?R_4_&2'3LG'V3R]NQ<>OR*=_T.<'V'YVGT[:0P6),
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MV!\!?A+^SUK?[3O_  G6C>./AC -2@\,)X%N3K<GQ \7Z)+?:?;^!/ ,-O\
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M9U1;1='OYEE@U36CI$]YH=O9--I<[W=X\4/J8;,\KSKB/,.(L;_N&4<]!_\
M7V24*/\ Y-2D=6)R;.,LX1R[AC#?\CS.JF'K8K_L2QE*65?^25D>MP6D=T'M
M)8HK@ZD+BTFMCCSKJVOQ=M+;KZ*D,JN#ZL:_F#^&WQG\;^%OV<?'?[$'[,SZ
MDOBWQ-\5?VEO'7Q-^*&IK)IWAWX"_L\6&JVY\6/9ZW"?/BUS6+_0M2T>2ZMP
M9_#EMK-E>V6-<U30R-+_ (>#?MP?&+4O'7AKX'_$CP3?WUCX"TR_^)7BE_"^
MA:!\$?@]#JT][_:TOPFNX])TWXO_ !;\3PZ.)M"L[XQ7,]S)::YJT\MSHUU
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M;CX>ZO'!HUP&5G236?!-Y_Q*-3MK=Y6>1-6_T5HE2(?-$PKR/_@G)^T;\/\
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M?4D#YN_7 '?[O?ON22&,$S=#\O\ P'CWX.2?7'I5%]+L[B-F7[[$D\9QP/\
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MR4GBG& "TG4'.=@]@"#V^\:RKWP]ITX)2.W<%<93_69RQP/P.>V<FL"9+"X
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MW9;';IG^7Z 4UM1>Z"0V"?/L $I[+DX7Z9YQ[^^:M6NA></,U&7S%#9S_=.
M=O;IUZ\YK]MJ0]A5Q%3:WL5_X$K=UV/GJU'DE*7DU]]C.61I2(]-C."!OEYX
M?^(?4+M/X_E=CTKD/<2>9(<9/=1UV_@=WTW5OQ)!'$8[?_5HVT?4!<_IBJIR
M'#>HV_S_ ,:PEB^5-WOTW[_-GBU_B^?^9 (UB 5!@=?QZ?R KXH_;[\":UXL
M^ &H>(?#232>(_AKXBT'Q_X?BC^[+KGAV[_M+1XS[W&H6L&G?3417W/]DBB
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MP']#UY^G7\<"KL=S;7416:/RVW%<>HVK\W7H22,^W R,50GT^./,EL.@R/\
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M7RQ^UZP3X7Z<_E[_ /BM?#ZGV'E:B0/SSCMUKV,I_P"1G@/^PJC_ .EHSJ_
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M7]E5]GZO[OR/*+J&//[R/(V_+(.QR>/P^]CI\WM5.*^NM/8B23S(&.5/7"D
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MUJ&MW'BR*?Q=(-9/]FZ;%X,ANP-TLM?<\_A2#PEX3T#38FDGOKRW_M34C/\
M\>3>7I<]_K\@_P"FOGN%_P!U5K^4K]H'PS\3?VC?BW^T)XBDTBSU30+#QAIO
MA2TUMF\K7M&U:71-)7PZ\0_YB'AJRADC@DT_MK6NZ=(?]<:_/_ VGA<]XTGQ
M3C,0L-1R;'5L6JO_ $]I58>QBO.4[W\DSU/$RI6H</5,HH?'BL/"_P#@49.?
MX21[1\8O^"COC[_@IA^UI^SO\"O%8/P9_8H\=_M'_"KPWXB^$O\ :][97?C_
M ,$3>,(EU#5_C]XKT_%WXBMM1TRUN=;MO ^G?\2.P-T)XL7E_?&OZ+O^"E_[
M;/@3XI^!Y_@G\.=7A\%?LM^"K>*P^(NKV,@\/P?$?2?#L171O!NF:7:XNF^$
MVGS6<FJZG:2A=:\17%A<>'H -'U36A7\/GPR\!_%WX+?$J_^*UW\-=-^)TOP
MCMM8U#3].U][B33+?Q7;!(+.PU_1-$9?$.D^(;4P7%I'<J5L7\6Z;"B,)4G:
MOWL_86^!GB'_ (*MW6F?$OXS:3J^B_L6^!KW3;S6;+3IM4\.P_M&_%B,VU[J
M/@2VO+W_ (F2^!_!5W-I\7Q)\6+G4;WQ*NO>&++_ (EM[XA(_OK-Z'$WB#F=
M*EEN8?6<LSE4</7@O>3HPMS-))-<M.RU=V[ZI)H_EZ&%X8X&RVGF^;7^L.G7
M=%=/K=:ZH2[MJ<9)+9)WM>S7N_[%W[-&H_MX>,_"/[47Q;\/W6F?L??#34//
M_9M^$NO+':VW[0OC+PVT=E8?%3QIH47[JT^"GAF[B>\\(Z3;_P"@^,?%-JU[
MI6-)DL!7]$]RYEC64LS[UC'F&'RPYCC2%R'_ .6LB/&T5TO_ "XWJ7.E?\P^
MJT.G6FGP6VG:=966EZ?IFG66E:?I&EV<6G:5H^GZ5 FFV&EZ5IT7[G3=-L[*
MT@BL].MO^)?IT 6STG_B3P6%:TGR68C&/FB#<^Y9>,?3..:_J+@CA3+^$LEI
M9-@=)Y:H0Q">K52LK/6RN[IW>GHD?R#X@\7YKQ9FM;$8S_=*-1PPW_7M2:A^
M%C%D_P!2/]X_S%9UY_Q[CZG^M;LT/^CP].4!S]6;Z\_7IQCI67/'M"G/\('U
MY;_.?TYK[.'Q?)GYY+X7Z?Y%$?ZE?Q_FM2E<@/Z#'ZGG]<?TI4;=$QZ8D8?D
M$JTL;L,_\LP,'ZY)/Z8_^O751^*7_7N?Y(\/&_#_ -O+]3)NVWQ9],CZ^_Z_
M_6K+7_5?E_[+6_Y"2"2-.FYF/^\1S^' ]<<UCF++.,_<8IZ=,>Q]:VP7PS_Q
M/\SSEU]'^AF>7O)/HO\ (G_'IW_"J.W8S#_:)_0?X5T?DX0]^?7Z>P_P]:HS
M0CRST^\?Y#H/_P!>.U>A#XODSB?\5>DOR,5^K_\ 7(_S:JLOW%_W%_\ 0C6\
MMJ'C)]!CH/\ /7KGK^.*S(8O*F=?7+?GD?R%:/IZK]2ISY(2E_=:^]'/R6J7
M@,)_U@4NO3IR,?F#_P#KK##+#,8YNJ$JO^Z#Q_X\3S_]8#M;R+#_ &C^ZH3\
MB6_]F_SS6!>V:749!_U@/F =L=OU!XY_P]+#[-?S+D_\"LCBPE;VD*D/YY<O
MWW7]?H-9HY%P?]21_P"/]_;IM]/;&16/>6DJM&R_=W':?1>W^?R-2Q7?FD6T
MG^LB.U?]Q>1GJ>N[ [?I6DF]P4<<@84?[(]>GKG%0L-]4KJG_P _+S^Y7_4P
MJ8;ZI/V?_/R\_NU_4Y@2-&\A>/>2Q7/M@<?7KFLN>VF0O- FR0DL1SRI[_S_
M "KH-0LY=K;#P22?K_\ JQW]<\UCQNUFVV6(N&7)8GH"<8ZGN,_C7MT/A^7^
M1)FI=ELJWWPQ#\9^88)_+CU^GK.G0_7^@I+O34N(VN+)-LH8Y'T 8G@\YSCN
M<#TYJE:W;%_)F)\]/D'^Z.W/N3]*WY/:>[OU^[Y,F4.=./S^XONEO(OESQ[\
MY*GT)X _0FN?U/1;E(C,L'[G^''IR?Y'/Y9]:VY8YW4M[XY_#'7^N?Y8#<&U
M CFBWAP&S[$D8[\\9]>?4<M+ZJU6M:S4=OY].R['E5?:X6?MJ/QI\O\ V[/2
M7X)'F-S:H_)3RY%7;CU ).2?J2,=,C\L*ZA* QS1Y5AN\ST7D8]#C!(.>I].
M:]>O-)2:,W%DFR5EY'XDDYX..?ZUPU_ILN6\WE]O(]>3S_/T/ZU]+A<;3KTE
M3J_ [2^<=5^;/4P68TI22E_'<9?=9<WZ'G3)+:2>?I[^?MY=3V8$Y7\MOUR?
M>M2S\413R""[@\B8#:5P/F']_P#%MR\?W3V%6Y;*6+<4Y&"3Z9Y!]_3K^AR:
MYNXAMKAGANX_W@)*2_W1V7_OH,>V2:]50P52ERONFO57M^+/3^JTL1[];X'K
M_P!O?9_&YUDMI;WA+Q==F.?7D],=,$>G^'(:AIEY9L9$^Z/F_G_09^GH:I^=
MJFD#S4D\VU5L Y^Z./EY]  3[GTKH-/\0VU\%27[YP#]../7J3BB%%TY*4_]
MULU_V\_@_&YE6PE;#4_;0_@1<?Q;M?[F8MGK=S 0'^\I[>@P/U.<]_YUT(UZ
MVO(_+OHX75LIN?J%P.G/ R6_$GK2W6EV=ZC*H^9LD?3\^WIZFN'OM+N;)]T,
MH1$XV^I!/7UR,#J>G?K5SH8?$1]G3^.ZETVAJ_S1QO"X#,[55_O,6H+YZ/\
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M\/-+[_=M^I[#1117\UG].!7RQ^UT)?\ A6>G&+K_ ,)GX?!Z]!'J6>GL3_\
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MVC>)?$=_K,DOA'46T7Q%J=E<V8L)9XX-<M]$U>WOM4@OH=3OOTM^&OPA\.?
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M4^^X,SJMFV!Q'#^8?[XHU,7AO^O&"7M)KYPJ1_X)_G7>5.5<R2"9ED$C2RL
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M_GI'D@/VZL&'X?4U*JPZS:?9+OJH8)].P[]\UIWEE]H!MI&\F1 &6?\ V Q
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MA) ]L9!],=JI:]I46IVIDBCE,JI_K8^@VDD ^_.3]1767=IYT$B2?ZW)9?\
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M;+]GJ@A;[/=_>)VM], ?7J#[]^M)J/ARQU6W=[?/F$%@.V[&3GMW'I]*KO\
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MK3'RS' 0CA8[&SZ^5\S8../7U/'TJ+4=0BGB2ZG3[/#"HCL8.?WDL>563WW
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M6Z;3[_\ >V9;?%-@?)N)0)[8\L-_P/UZ7X[J72YDN+:3S()55E(YVHS,-OT
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MUA?R5_X2WP_)<2_], -2#+^!P3]<<U].UX1\>K26^\+:;:QR;(Y/%&F?:?\
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MMO&WQE.D?L[_  R@/^MU/QK\9KL^##"OHNF^&=1\1:QWYLS7Q%_P3_T?PO\
M!#P)=?$#5H)++P;\*/AEJ7B2_DER630_"/A^76YE7_9-IH\FECT-B<>M?+O_
M  4X^,1_:?\ ^"@WP\_9TT&6*^^%_P"QK:6WC7QS-9;A'K7Q[^).BP#3(-0W
M(%:S\!>"[?\ M$,CG:_C&=67D$=)^W[XSU'X$?\ !+OXM6.@H(?$GQXO/!G[
M/WAHQ?\ 'LG_  GNI1OXKAM#U$%OI.E7MJN./-BD[5_#WTD<YI<5\:\'^'V(
MUP6=UJ6%S%?]0%&<<3B/N^K4F_3Y'[MP+A8X7*,^S%[8>/LOG.,H_G'[S^=C
M]I?]H#Q+)^R-XJ\1Z_-,GC[]M+XN>,OBYKL23G9I&E^*-;EGL[)[88R)O"EC
M%,LIQC[<@/*<_6W_  2Q^ OC3P+^RQ\2OVJ]0\.W"^$-#N-.\-V\X)L[N[P;
M6?7K[3D/,KL=1BAO9C]ZV@C4_<J+]G'_ ()F:_\ \%&OCQX?\,:EK]_X,_9?
M_9A\->&O#?Q(\8V<'VG5_$6M:A9PW>D^ / UD08Y?$$NC6FDSZ]K3^9%X2T?
M5['4I8R+U W](_[5GA;X9? +]AGXB_"3X=^'K7PM\//!?P(\9Z'X8\/VTOVH
MQP#3Y;ZY2ZU'.=6O[D2:K=7NJ?\ +Y<3O+7RWBKX@</Y#'A[PUP\HKB+,JF
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MX;_KU15W_P"2RB=[<01SQ^=;]8S@_P"\!N/IV<<^V.F*TM$UN0-]FN?4J/\
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M-X[NY_$WQ)^(WBSQ!\0OBEXAN.=8\1>/_'>K2:UKS7//W=.U*X?1!R!_Q*V
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M:]8O9/['LH-'A^Z<->_]>:*'''^_YG-?H4O@I_X5^1^Q5*?M8X>'_3GF_P#
M8Q?ZD.O:JSQRS)_JW/V>W_ZZ@\GZX9?SZUU?A'3(-!TI]8NU\Z]O@T<4'I*R
M(=_Y,!ZY7\:X+PU8-XIUL73_ /('LYM]N?:,#\N>V?6O1M3U*.>Z5&_X]+$2
MQQG_ &XT!YZ]BOM_.L9_#\T>56J6E*CY-_\ @-BG///-+#8)^_O=1D"/;_\
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M+;DW*W_A77_"^CZ7_P 3;PGXVM8S;VVGV^39WJ:F\*GS!-7S]J$<=WI[V_\
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M/O@A9VNHZ8EUH/Q1\6^)+[3Q<>7<V-EK.H_#"XT[5=13J;-]/T?4H-W4O;2
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M-:O],\'_  [AT_4]0LH]1NM1CO6T^X\JXG2/PM=FW)7)S&9-Z@D#G('3BO\
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M*M?U#X<P_%CP?IXT6YOO(\/Z38)=:*]JB6?!D9=;EM"9.K1E%P-E>M_\%#?
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MVD2,GK"/,8JRM_M 8)]F&?;H/C5XJC\)^%++P7IDL27MUL6418V[9OD);/\
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MVXM4D_M#OA;Y%^S \;=V2'X\#BN/(N89_611^/'^/MVZ<UU_Q ?S-)T34/\
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M0^L8B,/Y7[7_ ,%M2_4X_P )1RZMK-WKER^]KJ1EMSC'SJPPOY$'/_UJ]O\
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M>5XGU]#_ ,O-BX^H9IN>G'K[9QQTKJH_&O27Y(Z,)#GK9E'_ *B:#^Z4CEO
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M?%\F?+Y[DU7VL,?1^.#B_P#MU_%^"1QFHZ?>:)=9238LK8\_T^8_N_PP&/\
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M[ Y=@\ZKM_QX8=R?I&$.;RM;^MS]LO\ @EMX12#6OCSXI2\TN[BT#2_@_P#
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MB^)O$/AJZM_%'@WQ+H]QI'B"]UOPK!'J0U"QBO+[39AJ=M?PV;R-Y!1/?/\
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M_P#MIV_CKPWH-WK6C2_$/Q%\(HO *>+[,+)X877+:#PWC4_#0U:6$ZW9Z?\
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M$E.P8 8#GKS7N5L?Q=.#C'@NHKVM><':2O=Z1C>+NKK=6T>I\Q_9/#=6T?\
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MXD?_ #-4?\,H_M1_]&V_'W_PSWQ(_P#F:H ^?**^@_\ AE']J/\ Z-M^/O\
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M^W=_F>=AE><L1_+45#_P:^7_ -M/(]1==>T:'5+7_C^M\!SQG8BJ_P#-V_\
MK5H>$-<#S"UG_P!3<#9==_FP ?QP%_\ K56\.^#_ !YI6O76DS?#_P =R6ES
M/((I1X/\4>4JN%0*?LFDW\>1LW'=,KX89C"[6>*?P!X^T+7[M8?!'C(P7#!_
MW7@_QE@%V8$-_P 4W]\*HSCMCI77_:6#Z5_JW_3VVW]W_M[;Y'?C\+=+"_\
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M5BB@!B)L!'OG]![#TI]%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M+:1,\OTG^TG\8_&7P?\ $O[)^F^%#HBZ;\:_VHO"GP?\6QZI9R7US;^&=?\
M!GCKQ#>VND3I,8[+5;/5O"L-M%.4$5M9Q6MD(P;8U\*?#O\ 9]G_ &AOAK^V
M]HOAC7$\$?&'P%_P4K^//Q,^ 7Q-2V-W<_#SXP>&(/!+>&-:EMD+27GAC4A<
MW'A+Q_I/DLFL^"/$^MV3/$VV6.?QA^T9!^TKX?\ ^">?B35-'N? OQ3\ _\
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MTI^T)\-/VD8OA_XS^%WP\^)/PV_:Q^+WP<\(>)=?\!:EXM\*VO@+X=:KI-C
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M9/C'^U&NJW>G1W]OIEUJ8_:7^*_]I3Z;::E<75S963WWV@16IG=8R';)=W)
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M6'PL\"^$;^PU#0]!^&7B6RBDAUCPK>2I++?17<AN5BEM$CABEN._\6K_ ,%
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MQ'X@\33BX*E5*E0=RE1]=2JC(5?&.,>O^>.O]:B6W@08QUYZ>OX>U 'YR?\
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MYOX<^%ND_L5?MK_L^?#'X$ZKK^F_ []JWP;\;]-\2?!76O$WB?Q#X+\(^/\
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MQ)^.WP5_:.^&_P 5_$/@C_A<^N67B[XI_"+XA_!V+0=:U^PC\=6MAIE[\1/
M_C?2O%DS'3O$<5SK^A:MX>@:6\>RNK6,>=7_ (&_:*\9_P#!1C]M ? CX[>%
M?@NME\(/V2Y-?77_ ()Z=\5KGQ,O]D?%/R;6UOM1\:>"HM$M[4M')<P_;;@7
M*N=T.TLZ^JZG\+]1_9,T[XN?MT?M0_'34OVC?BI\)_@KXNT[P/=CP/HOPO\
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MR XPL"2D^8#\N &Y '4XK;N=0T^PBDGOKJ"TC+11^;>SV\<#O*2%QY3!"S9
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M=H5 VET^N--\1>&M<EEATG7-%UB:%%>9=.U2UODCB(.!OM7>-2.6,9(900[
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M'M]4U'PU\2_A!8:_I&L:?HT$::)\4]+US0?$NB>'%\51C/V;5/"&H^*M8O\
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M._ZJ5^=__!1Y&?P%^S<8F"2K^W%^R4@?O&)OBIIHAF'_ %Z7D=KJ!_Z\AR*
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MK\8O^"R%Q#Y2L+_X?7RK&\L-Q*;?]E#2)IS=%QAX#/<2Q+&N(R@)',AQZ_\
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M1+W0M9USX;>&?"NA:[<>'UO;.<VFIZAI\8OI+!+C3]/(1]\44V)"%) 'DO\
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M!^(NDZ=K&A:1XEL_C5\/39WFG)J^Z".],<A\Z)_^/>,!RQD#,?+;W]F[P/\
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M^V3\ /@Q^S_^RSX#\$_!GX6^ ?A7X-N/VUOV1O%E_P"%_ 7AVR\,Z#?:_/\
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M=LLOA72C\9/BW'I%P2#"L_C#Q[I7ATVQ91!KO@>TF8[I51^=^/'@CP]^R/\
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M^.'^)'P[D74;^SMM,\9)X5\3^$DO9+.U(BU5SX>\5>(4-HV6PJE@58 ^W44
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M\,M+\::#X&U-;F^@AT33_'XT^T\1+-9V[F"6:ZL=!M%>:0%GBQ$0 J.OL]%
M'D/Q9^%7@CXS>&]-\)^/-(EUO1]-\:^#/'FGV*7&I:41XE^'GB:R\=^%;E[J
M(JTAM=>T"SN'C  "G@*"A>+XI?"CX??&WP5K/PT^*O@C0/B+X#\106J:OX>\
M2Z6-6TR]V*9+>[9;Z2UG6\L$$+V.L:+?6^LV5ZHN%,;HI'L=% 'YJ6G_  2\
M_9:,^DP>*K?XT?%3P;X?N[34?#/PG^+O[0GQO^*?PHT>\T\A['S/A[XP^(VI
M^&/$4.E2I$-&L]:T^YLM(CC15B41J@^L_%WP>\!^/]6^%.K>(M"$EW\$?&4?
MCSX7_9KJXTVW\->)['P9XB\%VTT6F:5'#IE_"/#/BC7M/33;%'LX8;>.-)"X
ME"^\44 ?-WQQ_9Y^$'[2'A*T\$?&?P-9>,=$L[[3]6\/7$XN="USPIXKM6D%
MGXG\*>(%U"QUSPMK"3(WD3Z 1?((XIQ++O6,>%> /^"=O[.?@GQUX;^(^I+\
M5?C#XH\$W,M[X#U3]H/XR_$GXTQ^ =5DE:*XU'PKI?C_ %74;'3-1S&;:/4I
MW%ZJQHD92*& U^@U% '-:YX?T?Q)I.K:#X@TRSUC1=>L;C2M=TO4[:"ZT_4]
M.O;4V]W9:O:W!:WNK>>%VB81+\JL$0>7NS^<\?\ P2H_9$>R?PU=Z;\8I?A8
MU]=3)\!3\>?BW<? :**XGCO9+"7X7C7;7PVFCI=QK<KHU];-HL;R,Z*S2RJ/
MT]HH \8\4?";X>>-?A]>_"KQ;X#\+>(OAIK7AD>&-1\ W^D:-<>$KOP[IUO;
MVNE:5%H$]S)!;:5IEK!"=*BTS4;9-,O-]Y$EO-()1\7Z?_P2Q_95C_L[2-1B
M^-WBKX=6-S8:E8_!CQS^T/\ &KQ?\%K2;3W6?2K>[^'FI>-M0\.:[I^D7"K)
MI>C7N?#VE(J&VLEF:X>;]-Z* .7@M+.PLK&"SL8M/L+2*VLHK.&WC6WTO3+&
MSELX+6SAT^XF2V2&.2..$6;K!!"R)M1UE+>9^!/@GX"^'/CCXJ_%+P]HMQ!X
MY^-.M>%M7^)6LWNL:IKE_K<W@CPY;^%O">F6#ZPS3Z;I6FV4*W%KI=OY=G!<
M7U],BEKR39[I10!Y5\2_AGX0^+7@3QA\,?B%I5OXB\%?$'PGJO@OQ9H4LMTL
M6KZ1J]E!IM_;S7%J5%G<K!+=PVURLB2^;<I@XBPWDWCG]ESX-_$_0/@AX>^(
M/A:[\3:?^SKXN\&?$7X7'4M<UHZGHGB?P+I,VE:!J&IZTDI&LW1CN<M82%,H
M()V4+,L5?5U% '@_QN^"W@/]HSX4^-?@K\7/#Q\5_#SXA^'Y=!\7Z(LVK:8U
M_97EY97TBV]TKJ]O+9W&E)<VT2Y OX].9_*%PS5A^)O@!\,/&<7P5AU7PV;C
M3?V?_$=CXJ^$FFIJ&LQ:5H6OZ%X2U/P9X:UF[TU98T\61Z%HVH7/]CQ2.RV:
MO'<;6$A(^E** ,78LEO*\*[)Q]H-N)/-O)$-Q,7AGEBE+.IFV"5-^S[/$ZP8
M5(0*^6?$/[(OP-\3Z?\ 'K2=9\(W?]E?M*^*/"WC/XPZ4OB353::]XC\$KHK
M:;K%K]EE6'P[J,3^&/#BW-S&\;ZA'I\%JZQ"WA\O[ HH \R\7^%-"\<^&-<\
M$^+M)B\0>%/%6@:OX>\3:)J5E/+%KGA_4].GT[4-!U>=W&IM)=PWJ+;7.D@W
ML$L O@Q6X51\[>./V+?@?\1?A#\+_@/XGTOQR_@/X(W?AG5/AZFD_%3X@Z)X
MGT'4O#&F76E^&C#XXT.\M/&]Y;:=87^H:;;3S:FD<45E':^0K087[6HH _/G
MP+_P35_9(\&>*]&\;7G@OQ9\2_$'ANZM+_PO?_''XK?$WXW0Z!J%O%$(-1\-
M:=\2_&7B6QTG4UBC@07ZV:3C8IC1 -[?5_Q%^''A+XM^%-?^'?Q)\%>'_'G@
M3Q;9-HGBOPSXJT^+5-%UW2[TA)CJFGSZ+!#//:I"HLIK6\2:QF,=S%+$T:2-
MZO10!^9FF?\ !+G]E?S=.TO7;;XW>,_ .BWEE=Z9\'?'7[1GQO\ %_P3CDT>
M8_V##+\.-9\<2^'=<TO05CM+C0]'U#29O#FDOD1PF3[2I_2;3X+2UM(;:PAA
MM[.WCB@MH+:&&"V@MX8HX[>WMH[:..W6WMK=8K>%8 T<<<2Q!B8R!=HH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHII8 X.: '44@((R*0NJG!(!Z\T .HIGF+V.?I1
MYB=SCZT /HIGF+V.?I1O'H?T_P : 'T4S>/0_I_C3@01D4 +132P!P<TGF)W
M./K0 ^BD#!AD'(Z4A=5."0#UYH =13/,7L<_2C>/0_I_C0 ^BD!!&12T %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MVU/6-2TBY\&W-C:7UY>Z]:V]F5,UTK2(;06B3?+\GS CD,1XM\-_^":7P^\
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M1^I1C /NV3]<#.***YZLG.HY/=N5SU,/1IX:C&A25J<;67:Q)1114FH4444
K%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>image_010.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_010.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  5 -X# 2(  A$! Q$!_\0
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M'?\ H'_^1I/_ (JC_A%?^H]KG_@9_P#6H_X17_J/:Y_X&?\ UJ #_A"/#O\
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$0!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>image_011.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_011.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !# 1$# 2(  A$! Q$!_\0
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M** "BBB@ HJ-W6-&=F"JHR23@ 57T_4[#5H&N-.O;>[A5RADMY5==PZC([T
M7**** "BBB@ HHHH \X\97Z0ZQ<R3,?*MXE'Z9_K7CVJ7-WJ]V9IV(0?<C'W
M4'^>]>G_ !)MW&K;?X)PK_7 Q_2N(%CR.*];#V44SIAHCL_A;X&MC OB#48A
M*Y8_9(W&0H'&_'KGIZ5ZP\:21LCJK(PP5(R"*\E^%_C>&!G\.:G,(R)6^QR.
M< Y/,9_'I]<5ZS+-'!$\LKK'&@+,[' 4>I-<.(Y_:.YE._-J>'^-?!\?A;Q+
M#?V"[--N@V$'2*3NOT/4?C6(;[WK0^(OCF+Q%J:6NGL3I]H3MD_YZOW;Z=A^
M-8_AW2Y]5N5FF5ELT.23_P M/]D5Z%-/V:<]S97Y=3UWX;2L+*>!_P"(++CZ
MY_\ K5WG>N/\$P$/>SXP/E0?J?\ "NP[UY=76;.>6YX3<1IXT_:2-G?KYMCH
MD.Z.%N5)55/(_P!]\_@*]S9@BEF8!0.2:\*,R>#_ -I::>_;RK368ML4S<+\
MZKCG_?3;^->U:MIEMK6DW>F7@8VUU$T4H5L':1@\UF2++)I\SQ22O:R/$V^,
MN5)1L8R/0X)KA?'OQ/?P1XETS33I37L-W"9,Q.?,W9(557'.3C\Z\R^,/PV\
M.^"] T^]T:&X2::\$3F28N-NQC_,"NJ\=*&^-W@ ,N1Y:GG_ 'C0!M6?Q(U_
M2O#VL:UXS\.G2X+;RQ90QYWW#/N^3D]1@<\=^*SW\??$O^PSXA7P78KI B^T
M>6UP?.\KKNQG/3G[OX5TGQ/\<R^"M&M/L=G'=:E?S>3:QR_<4]V/KU Q[U@Z
MGI/Q2/A^]N=0\4Z1!$+:1Y[>.S!"KM)9=Q7T[T ='#\0H+_X87'C*QM2WDV[
MR-;2/]UU."I;'Z^E<M9_%/Q?XGTJ*[\)^##=!4_TF>>7;&).Z1\KNQZY_"L#
MP7_R;+XA_P"WG^2UZ/\ "&-8_A7H(10H,+,<>I=LF@#(\)_%#4/$_A[6O*T(
MKXBTH -IX<@2G)'&>5Y!!!KS?X<^(?%%EXY\3SZ?X7:\N+R\!OH1+M^R$R/D
M>_5O^^:['X:?\EJ\?_\ 75O_ $8:3X0?\E*^(G_7]_[5EH ]GKQ2Z_Y.JLO^
MO$_^B'KVNO%+O_DZFR_Z\3_Z)>@#T#XE_P#),_$?_7C)_*O+_ OC3Q:O@'3+
M#PCX3;4DLHF2XN[B0)&7W%MJ#(W8!'?\*]0^)G_),_$7_7C)_*J'P?C2+X5:
M$$4+NB=CCN3(W- $7PV^(K>-DU"TOM/.GZMI[A;B#)QR2,C/(P000:R+KXHZ
MWKNO7>E> _#R:JMFVV:]N)=D.?;D>AQSSCI7.>&#,OQ*^*1ML^>+:<QXZ[LG
M'ZUO_L]"U_X5W+Y.WS_MTGGXZYPN,_AB@"UX>^*&H#Q9%X6\9:(-(U2?'V>2
M-]T4I/0=^O0$$\\<4GBWXL77AOQO)X;M]!?4)FME>V$+G?)*WW5VXZ>]8/QX
M"?V_X+-OC^T?M;"/'WL;H\?^/58N%#?M26I(!QIQ(]OW34 :%]\2?%/A[P%-
MKWB#PU%:WRWZVT=L79%:-ESOS\W<$5!>_$WQM>6#ZSX>\$M+HBJ76XNG_>2H
M.K*@(./SJQ^T+_R35/\ K_B_]!>O1=-B2/P]:1(H$:VJ*%'0#8.* //9/B+?
M^)OA=)K>A:$UW=.[VMY:^;_J!L)9P>XY4_C7*_ C7/$$&FVVE6_A]IM&EO)6
MFU+S,>6VP<;?P7_OJK?P1&/A=XI_Z^)__1*U;^#)F'P4U8V^?/$MUY>.N[RU
MQ^M &C=_%'6M<\07>D> _#Z:M]C;;/>SR[(0?;D>AP<\XX%3:!\4=17Q9%X6
M\9Z&-'U*XQ]GEC?=%*3T'?KT!!//'%4_V>!;?\*^N/)V^?\ ;I/.QUSM7&?P
MK,^/@3^UO!YM\?VC]K;RMOWL;DQ_X]B@#HO%7Q5E\,^.QX<71)+\R6RO +=S
MYDLK9VIC' XZUB:A\6/&7A:]M9_%G@Z.RTJXDV"2*7<R_B"03CG!QG%/O$1O
MVHK LH.W32RY['8]:'[0(!^&?(Y%]%C\FH ]#_X2#2O^?Z+\Z*\9HH ]/\::
M*=2TY+B)=TUMEL#JR]_\:\Y%J/2O;JY/6?"@DD:YL  6Y:'H"?\ 9_PKHI5>
M71FD9=#P;Q!ISV&K,^W]S.=Z'MGN*O\ ]H7VJ6$=C>W]W-:I]V)IFV_EWKMM
M5TF*XA:TU"!T[C<-I4^HKEFT"YLI/W3K/%V(X/XBO14XR6IM=,;8:'IRL','
MF$?\]&R/RKK+.-G*11)DG"JJC]*S]'TC4+Z0);VDK^^W"CZGI7IOA_PTFEJ)
M[DB6Z(ZC[J?3_&N>M52ZD2E8TM(L!INFQP<;_O.1W8]:T:**\YNY@<GXX\!:
M1X\TQ+740\4\)+6]S%]^(GK]0>XKC+7P;\6-$A^QZ7XUL+BS0;8S>Q%G5>W5
M&_\ 0J]?HH \FLOA#?:QJ<.I>//$<VMO"=T=G&"D"G]./8!:W_$7@2XUOXA>
M'_$D5[%##I0PT#(27Y)X/;K7=44 <5\1O 47CW1H+=;LV=[:2^;;3[=P![@C
MT/'3T%8 \#>/==L#I7BCQA VF%-LB6,&V2<8X#N5''KZUZI10!YOH?PUNM)^
M%>I>#WU&&2>[\W;<",A5WX[?A74^#- D\+^$=.T6:=+B2TC*&1%P&^8GI^-;
M]% '"^%O ESX?\=^(_$,M]%-%JSEDB5"#'\V[D]ZYP_#?QCH?C/6-:\)Z_86
M]OJLIEFCNXBS+EBV,;2#@DX/'6O7:* &J"%&[D]S7"S> KF3XNV_C07T0@B@
M\DVVP[S^[9<YZ=Z[RB@#&\4Z._B#PMJ>CQ3+#)>6[0K(PR%SWQ4'@S0)/"WA
M'3M$EG2XDM$*&1%VALL6Z?C7044 <+X8\!W&@>/?$7B*6]BFBU8DK"J$&/YM
MW)[U@2_"[Q!X>UV[U'P%XABTV"\;=-8W4>Z('VX/J<<9'K7K-% 'F7A[X9:A
M_P )5%XH\9:U_;.JP8^S1QIMAA/8@>W;@<\\UJ/X%N7^+<7C/[=$($M?(^S;
M#OSM*YST[UW-% ''?$CP9/XY\+KI%O>1VKBX2;S)%+#"AACCZUU%O;F#3XK8
ML"4B5,X]!BK-% '!?#WX?3>#_#.IZ/>7T=V+V=Y"\2%<*R!<<]^*P_ _P_\
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,0 4444 %%%% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140231435512864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document And Entity Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2022 </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information Line Items</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Beamr Imaging Ltd.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BMR<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">20-F<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="nump">10,932,896<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001899005<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">No<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2022<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2022<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentRegistrationStatement', window );">Document Registration Statement</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentShellCompanyReport', window );">Document Shell Company Report</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-41523<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">L3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">10 HaManofim Street<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Herzeliya<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">4672561<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Israel<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address, Country</a></td>
<td class="text">IL<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_ContactPersonnelName', window );">Contact Personnel Name</a></td>
<td class="text">Sharon CarmelChief Executive Officer<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Ordinary shares, par value NIS 0.05 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentAccountingStandard', window );">Document Accounting Standard</a></td>
<td class="text">U.S. GAAP<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm ID</a></td>
<td class="text">1375<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">Fahn Kanne & Co. Grant Thornton Israel<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">Tel Aviv, Israel<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember', window );">Business Contact</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information Line Items</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">10 HaManofim Street<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Herzeliya<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">4672561<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Israel<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address, Country</a></td>
<td class="text">IL<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">520-8735<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">1-888<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_ContactPersonnelName', window );">Contact Personnel Name</a></td>
<td class="text">Sharon CarmelChief Executive Officer<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_ContactPersonnelEmailAddress', window );">Contact Personnel Email Address</a></td>
<td class="text">sharon@beamr.com<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_ContactPersonnelEmailAddress">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Email address of contact personnel.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_ContactPersonnelEmailAddress</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_ContactPersonnelName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of contact personnel</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_ContactPersonnelName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAccountingStandard">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAccountingStandard</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:accountingStandardItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentRegistrationStatement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a registration statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentRegistrationStatement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentShellCompanyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentShellCompanyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCountry">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>ISO 3166-1 alpha-2 country code.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCountry</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:countryCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140231429227760">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 693<span></span>
</td>
<td class="nump">$ 1,028<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesNetCurrent', window );">Trade receivables</a></td>
<td class="nump">581<span></span>
</td>
<td class="nump">891<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other current assets</a></td>
<td class="nump">64<span></span>
</td>
<td class="nump">66<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">1,338<span></span>
</td>
<td class="nump">1,985<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_NonCurrentAssetsAbstract', window );"><strong>Non-current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCosts', window );">Deferred offering costs</a></td>
<td class="nump">313<span></span>
</td>
<td class="nump">215<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">15<span></span>
</td>
<td class="nump">21<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">67<span></span>
</td>
<td class="nump">87<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">4,379<span></span>
</td>
<td class="nump">4,379<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsNoncurrent', window );">Total non-current assets</a></td>
<td class="nump">4,774<span></span>
</td>
<td class="nump">4,702<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">6,112<span></span>
</td>
<td class="nump">6,687<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Current maturities of loans, net</a></td>
<td class="nump">330<span></span>
</td>
<td class="nump">508<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Account payables</a></td>
<td class="nump">33<span></span>
</td>
<td class="nump">27<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredRevenueCurrent', window );">Deferred revenues</a></td>
<td class="nump">31<span></span>
</td>
<td class="nump">33<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DueToRelatedPartiesCurrent', window );">Liability from related party, net</a></td>
<td class="nump">126<span></span>
</td>
<td class="nump">345<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other current liabilities</a></td>
<td class="nump">425<span></span>
</td>
<td class="nump">500<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">945<span></span>
</td>
<td class="nump">1,413<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_NonCurrentLiabilitiesAbstract', window );"><strong>Non-current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Loans, net of current maturities</a></td>
<td class="nump">387<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DueToRelatedPartiesNoncurrent', window );">Liability from related party, net</a></td>
<td class="nump">262<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilitiesNoncurrent', window );">Derivative warrants liability</a></td>
<td class="nump">138<span></span>
</td>
<td class="nump">50<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_ConvertibleAdvancedInvestments', window );">Convertible advanced investments</a></td>
<td class="nump">4,840<span></span>
</td>
<td class="nump">4,770<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrent', window );">Total non-current liabilities</a></td>
<td class="nump">5,627<span></span>
</td>
<td class="nump">4,820<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingent liabilities</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_ShareholdersEquityDeficitAbstract', window );"><strong>Shareholders&#8217; equity (deficit):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Ordinary Shares of NIS 0.05 par value each: Authorized: 14,307,116 and 14,316,880 shares at December 31, 2022 and 2021, respectively; Issued and outstanding: 2,578,760 shares at December 31, 2022 and 2021</a></td>
<td class="nump">51<span></span>
</td>
<td class="nump">51<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_CommonStockValue1', window );">Convertible Ordinary 1 and 2 Shares of NIS 0.05 par value each: Authorized: 1,496,880 shares at December 31, 2022 and 2021; Issued and outstanding: 1,496,880 shares at December 31, 2022 and 2021</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Convertible Preferred Shares of NIS 0.05 par value each: Authorized: 6,196,004 and 6,186,240 shares at December 31, 2022 and 2021, respectively; Issued and outstanding: 5,714,400 shares at December 31, 2022 and 2021</a></td>
<td class="nump">78<span></span>
</td>
<td class="nump">78<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">30,375<span></span>
</td>
<td class="nump">30,041<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(30,969)<span></span>
</td>
<td class="num">(29,721)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total shareholders&#8217; equity (deficit)</a></td>
<td class="num">(460)<span></span>
</td>
<td class="nump">454<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and shareholders&#8217; equity (deficit)</a></td>
<td class="nump">$ 6,112<span></span>
</td>
<td class="nump">$ 6,687<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmr_CommonStockValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Common Stock Value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmr_CommonStockValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmr_ConvertibleAdvancedInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Convertible advanced investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmr_ConvertibleAdvancedInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmr_NonCurrentAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmr_NonCurrentAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmr_NonCurrentLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmr_NonCurrentLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmr_ShareholdersEquityDeficitAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmr_ShareholdersEquityDeficitAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred cost, excluding capitalized cost related to contract with customer; classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled after one year or the normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DueToRelatedPartiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of obligations due all related parties. For classified balance sheets, represents the current portion of such liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(C))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DueToRelatedPartiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DueToRelatedPartiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Portion of the carrying amount as of the balance sheet date of obligations due all related parties that is payable after one year or beyond the normal operating cycle if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.23)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(C))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DueToRelatedPartiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(26))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount due to the entity within one year of the balance sheet date (or one operating cycle, if longer) from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such receivables to an amount that approximates their net realizable value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-06(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120401414&amp;loc=d3e604059-122996<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140231429154944">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets (Parentheticals) - &#8362; / shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Convertible preferred shares, par value (in New Shekels per share)</a></td>
<td class="nump">&#8362; 0.05<span></span>
</td>
<td class="nump">&#8362; 0.05<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Convertible preferred shares, authorized</a></td>
<td class="nump">6,196,004<span></span>
</td>
<td class="nump">6,186,240<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Convertible preferred shares, issued</a></td>
<td class="nump">5,714,400<span></span>
</td>
<td class="nump">5,714,400<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Convertible preferred shares, outstanding</a></td>
<td class="nump">5,714,400<span></span>
</td>
<td class="nump">5,714,400<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Ordinary shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Ordinary shares, par value (in New Shekels per share)</a></td>
<td class="nump">&#8362; 0.05<span></span>
</td>
<td class="nump">&#8362; 0.05<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Ordinary shares, authorized</a></td>
<td class="nump">14,307,116<span></span>
</td>
<td class="nump">14,316,880<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Ordinary shares, issued</a></td>
<td class="nump">2,578,760<span></span>
</td>
<td class="nump">2,578,760<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ordinary shares, outstanding</a></td>
<td class="nump">2,578,760<span></span>
</td>
<td class="nump">2,578,760<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=bmr_ConvertibleOrdinary1And2SharesMember', window );">Convertible Ordinary 1 and 2 shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Ordinary shares, par value (in New Shekels per share)</a></td>
<td class="nump">&#8362; 0.05<span></span>
</td>
<td class="nump">&#8362; 0.05<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Ordinary shares, authorized</a></td>
<td class="nump">1,496,880<span></span>
</td>
<td class="nump">1,496,880<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Ordinary shares, issued</a></td>
<td class="nump">1,496,880<span></span>
</td>
<td class="nump">1,496,880<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ordinary shares, outstanding</a></td>
<td class="nump">1,496,880<span></span>
</td>
<td class="nump">1,496,880<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=bmr_ConvertibleOrdinary1And2SharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=bmr_ConvertibleOrdinary1And2SharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140231435350064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Operations and Comprehensive Loss - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 2,863<span></span>
</td>
<td class="nump">$ 3,300<span></span>
</td>
<td class="nump">$ 3,176<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of revenues</a></td>
<td class="num">(98)<span></span>
</td>
<td class="num">(90)<span></span>
</td>
<td class="num">(94)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">2,765<span></span>
</td>
<td class="nump">3,210<span></span>
</td>
<td class="nump">3,082<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development expenses</a></td>
<td class="num">(2,063)<span></span>
</td>
<td class="num">(2,032)<span></span>
</td>
<td class="num">(2,727)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingAndMarketingExpense', window );">Sales and marketing expenses</a></td>
<td class="num">(905)<span></span>
</td>
<td class="num">(959)<span></span>
</td>
<td class="num">(1,371)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative expenses</a></td>
<td class="num">(828)<span></span>
</td>
<td class="num">(773)<span></span>
</td>
<td class="num">(671)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherOperatingIncomeExpenseNet', window );">Other income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">129<span></span>
</td>
<td class="nump">20<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating loss</a></td>
<td class="num">(1,031)<span></span>
</td>
<td class="num">(425)<span></span>
</td>
<td class="num">(1,667)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingInterestExpense', window );">Financing expenses, net</a></td>
<td class="num">(165)<span></span>
</td>
<td class="num">(475)<span></span>
</td>
<td class="num">(697)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Loss before taxes on income</a></td>
<td class="num">(1,196)<span></span>
</td>
<td class="num">(900)<span></span>
</td>
<td class="num">(2,364)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Taxes on income</a></td>
<td class="num">(52)<span></span>
</td>
<td class="num">(52)<span></span>
</td>
<td class="num">(95)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Net loss and comprehensive loss for the year</a></td>
<td class="num">$ (1,248)<span></span>
</td>
<td class="num">$ (952)<span></span>
</td>
<td class="num">$ (2,459)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic and diluted net loss per share (in Dollars per share)</a></td>
<td class="num">$ (0.48)<span></span>
</td>
<td class="num">$ (0.37)<span></span>
</td>
<td class="num">$ (0.96)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average number of Ordinary Shares used in computing basic and diluted net loss per share (in Shares)</a></td>
<td class="nump">2,578,760<span></span>
</td>
<td class="nump">2,578,760<span></span>
</td>
<td class="nump">2,574,814<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate cost of goods produced and sold and services rendered during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancingInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents interest incurred for borrowed money which was used to produce goods or render services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancingInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 18: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941158&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherOperatingIncomeExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net amount of other operating income and expenses, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherOperatingIncomeExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingAndMarketingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total amount of expenses directly related to the marketing or selling of products or services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingAndMarketingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140231428982304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Operations and Comprehensive Loss (Parentheticals) - $ / shares<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Basic and diluted net loss per share (in Dollars per share)</a></td>
<td class="num">$ (0.48)<span></span>
</td>
<td class="num">$ (0.37)<span></span>
</td>
<td class="num">$ (0.96)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average number of Ordinary Shares used in computing diluted net loss per share</a></td>
<td class="nump">2,578,760<span></span>
</td>
<td class="nump">2,578,760<span></span>
</td>
<td class="nump">2,574,814<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140231435388352">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>onsolidated Statements of Changes in Shareholders&#8217; Equity (Deficit) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2"><div>Ordinary shares</div></th>
<th class="th"><div>Convertible Ordinary 1 and 2 shares</div></th>
<th class="th"><div>Convertible Preferred shares</div></th>
<th class="th"><div>Additional paid-in capital</div></th>
<th class="th"><div>Accumulated deficit</div></th>
<th class="th"><div>Total</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2019</a></td>
<td class="nump">$ 51<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 5<span></span>
</td>
<td class="nump">$ 78<span></span>
</td>
<td class="nump">$ 29,753<span></span>
</td>
<td class="num">$ (26,310)<span></span>
</td>
<td class="nump">$ 3,577<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance (in Shares) at Dec. 31, 2019</a></td>
<td class="nump">2,568,960<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,496,880<span></span>
</td>
<td class="nump">5,714,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss for the year</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(2,459)<span></span>
</td>
<td class="num">(2,459)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2020</a></td>
<td class="nump">$ 51<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 5<span></span>
</td>
<td class="nump">$ 78<span></span>
</td>
<td class="nump">29,884<span></span>
</td>
<td class="num">(28,769)<span></span>
</td>
<td class="nump">1,249<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance (in Shares) at Dec. 31, 2020</a></td>
<td class="nump">2,578,760<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,496,880<span></span>
</td>
<td class="nump">5,714,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of share options into Ordinary Shares (Note 12)</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">11<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Exercise of share options into Ordinary Shares (Note 12) (in Shares)</a></td>
<td class="nump">9,800<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Share-based compensation (Note 12)</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">120<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">120<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Share-based compensation (Note 12) (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss for the year</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(952)<span></span>
</td>
<td class="num">(952)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2021</a></td>
<td class="nump">$ 51<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 5<span></span>
</td>
<td class="nump">$ 78<span></span>
</td>
<td class="nump">30,041<span></span>
</td>
<td class="num">(29,721)<span></span>
</td>
<td class="nump">454<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance (in Shares) at Dec. 31, 2021</a></td>
<td class="nump">2,578,760<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,496,880<span></span>
</td>
<td class="nump">5,714,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Share-based compensation (Note 12)</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">157<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">157<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss for the year</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(1,248)<span></span>
</td>
<td class="num">(1,248)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2022</a></td>
<td class="nump">$ 51<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 5<span></span>
</td>
<td class="nump">$ 78<span></span>
</td>
<td class="nump">30,375<span></span>
</td>
<td class="num">(30,969)<span></span>
</td>
<td class="num">(460)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance (in Shares) at Dec. 31, 2022</a></td>
<td class="nump">2,578,760<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,496,880<span></span>
</td>
<td class="nump">5,714,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueOther', window );">Contribution to equity due to free interest loan from controlling shareholder (Note 14)</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">112<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">112<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Share-based compensation (Note 12)</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 222<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 222<span></span>
</td>
</tr>
<tr><td colspan="8"></td></tr>
<tr><td colspan="8"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Representing an amount less than $1.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-30)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of shares of stock issued attributable to transactions classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140231429087760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_CashFlowsFromOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (1,248)<span></span>
</td>
<td class="num">$ (952)<span></span>
</td>
<td class="num">$ (2,459)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_AdjustmentsRequiredToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments required to reconcile net loss to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">28<span></span>
</td>
<td class="nump">193<span></span>
</td>
<td class="nump">679<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation (Note 12)</a></td>
<td class="nump">222<span></span>
</td>
<td class="nump">157<span></span>
</td>
<td class="nump">120<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfDebtDiscountPremium', window );">Amortization of discount relating to straight loan received from commercial bank (Note 6)</a></td>
<td class="nump">14<span></span>
</td>
<td class="nump">14<span></span>
</td>
<td class="nump">29<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Exchange rate differences on straight loan received from commercial bank (Note 6)</a></td>
<td class="num">(12)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCosts', window );">Amortization of discount relating to liability to related party (see Note 14)</a></td>
<td class="nump">40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOptionChangesInFairValueGainLoss1', window );">Change in the fair value of convertible advanced investments (Note 9)</a></td>
<td class="nump">70<span></span>
</td>
<td class="nump">288<span></span>
</td>
<td class="nump">436<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment', window );">Capital gain from selling of property and equipment</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnDispositionOfAssets', window );">Capital loss from disposal of property and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_ModificationOfTermsOfStraightLoan', window );">Modification of terms of straight loan (Note 6A)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">90<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnRestructuringOfDebt', window );">Forgiveness of loan under paycheck protection program notes (Note 6B)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(129)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherReceivables', window );">Decrease (increase) in trade receivables</a></td>
<td class="nump">310<span></span>
</td>
<td class="nump">704<span></span>
</td>
<td class="num">(113)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherCurrentAssets', window );">Decrease (increase) in other current assets</a></td>
<td class="nump">2<span></span>
</td>
<td class="num">(26)<span></span>
</td>
<td class="nump">366<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Increase (decrease) in account payables</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">16<span></span>
</td>
<td class="num">(14)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredRevenue', window );">Increase (decrease) in deferred revenues</a></td>
<td class="num">(2)<span></span>
</td>
<td class="num">(32)<span></span>
</td>
<td class="nump">31<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDueFromRelatedParties', window );">Increase in liability from related party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">177<span></span>
</td>
<td class="nump">168<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities', window );">Increase (decrease) in other current liabilities</a></td>
<td class="num">(75)<span></span>
</td>
<td class="nump">63<span></span>
</td>
<td class="num">(258)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by (used in) operating activities</a></td>
<td class="num">(645)<span></span>
</td>
<td class="nump">569<span></span>
</td>
<td class="num">(1,020)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_CashFlowsFromInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchase of property and equipment</a></td>
<td class="num">(2)<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="num">(7)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment', window );">Selling of property and equipment</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash provided by (used in) investing activities</a></td>
<td class="num">(2)<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_CashFlowsFromFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfFinancingCosts', window );">Deferred offering costs (Note 2F)</a></td>
<td class="num">(98)<span></span>
</td>
<td class="num">(215)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds received from issuance of convertible advanced investments (Note 9)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">560<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromNotesPayable', window );">Proceeds received from paycheck protection program note (Note 6B)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">54<span></span>
</td>
<td class="nump">75<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfRelatedPartyDebt', window );">Repayment of principal relating to straight loan received from commercial bank (Note 6)</a></td>
<td class="num">(582)<span></span>
</td>
<td class="num">(500)<span></span>
</td>
<td class="num">(504)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfFederalHomeLoanBankBorrowings', window );">Repayment of Facility Fee relating to straight loan received from commercial bank (Note 6)</a></td>
<td class="num">(10)<span></span>
</td>
<td class="num">(40)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement', window );">Proceeds from issuance of unit consist of straight loan and warrant granted to commercial bank, net (Note 6C)</a></td>
<td class="nump">887<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromRelatedPartyDebt', window );">Proceeds from loan received from related party</a></td>
<td class="nump">115<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds received from exercise of share options into Ordinary Shares (Note 12)</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by (used in) financing activities</a></td>
<td class="nump">312<span></span>
</td>
<td class="num">(141)<span></span>
</td>
<td class="num">(418)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Change in cash, cash equivalents</a></td>
<td class="num">(335)<span></span>
</td>
<td class="nump">424<span></span>
</td>
<td class="num">(1,437)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents at beginning of year</a></td>
<td class="nump">1,028<span></span>
</td>
<td class="nump">604<span></span>
</td>
<td class="nump">2,041<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents at end of year</a></td>
<td class="nump">693<span></span>
</td>
<td class="nump">1,028<span></span>
</td>
<td class="nump">604<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_NonCashFinancingActivitiesAbstract', window );"><strong>Non-cash financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssued1', window );">Contribution to equity due to free interest loan from controlling shareholder (Note 14)</a></td>
<td class="nump">112<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_SupplementalDisclosureOfCashFlowInformationAbstract', window );"><strong>Supplemental disclosure of cash flow information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Interest paid</a></td>
<td class="num">(77)<span></span>
</td>
<td class="num">(90)<span></span>
</td>
<td class="num">(91)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaid', window );">Taxes paid</a></td>
<td class="num">$ (54)<span></span>
</td>
<td class="num">$ (49)<span></span>
</td>
<td class="num">$ (99)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmr_AdjustmentsRequiredToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmr_AdjustmentsRequiredToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmr_CashFlowsFromFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmr_CashFlowsFromFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmr_CashFlowsFromInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmr_CashFlowsFromInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmr_CashFlowsFromOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmr_CashFlowsFromOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmr_ModificationOfTermsOfStraightLoan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of modification of terms of straight loan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmr_ModificationOfTermsOfStraightLoan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmr_NonCashFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmr_NonCashFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmr_SupplementalDisclosureOfCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmr_SupplementalDisclosureOfCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfDebtDiscountPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfDebtDiscountPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOptionChangesInFairValueGainLoss1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For each line item in the statement of financial position, the amounts of gains and losses from fair value changes included in earnings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14172-108612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOptionChangesInFairValueGainLoss1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnDispositionOfAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of property, plant and equipment assets, excluding oil and gas property and timber property.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2443-110228<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnDispositionOfAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfPropertyPlantEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnRestructuringOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For a debtor, the aggregate gain (loss) recognized on the restructuring of payables arises from the difference between the book value of the debt before the restructuring and the fair value of the payments on the debt after restructuring is complete.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 60<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6402221&amp;loc=d3e15743-112638<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnRestructuringOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDueFromRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in receivables to be collected from other entities that could exert significant influence over the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDueFromRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherCurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherCurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in current liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in receivables classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for loan and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfPrivatePlacement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a borrowing supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRelatedPartyDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRelatedPartyDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfFederalHomeLoanBankBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for repayment of Federal Home Loan Bank (FHLBank) borrowing, classified as financing activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfFederalHomeLoanBankBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfRelatedPartyDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the payment of a long-term borrowing made from a related party where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Payments for Advances from Affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfRelatedPartyDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value of stock issued in noncash financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4332-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4313-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140231433381536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>General<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_GeneralAbstract', window );"><strong>General [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">GENERAL</a></td>
<td class="text"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2cm; text-align: justify; text-indent: -2cm">NOTE 1 - GENERAL</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: left; text-indent: -1cm"><b>&#160;</b></p><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0%"/><td style="width: 0.5in"><b>A.</b></td><td style="text-align: left"><b>Operations</b></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Beamr Imaging Ltd. (the &#8220;Company&#8221;
or &#8220;Beamr&#8221;) was incorporated on October 1, 2009 under the laws of the State of Israel and it engages in the development of
optimization technologies for video and photo compression.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: left; text-indent: -1cm"><b>&#160;</b></p><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0%"/><td style="width: 0.5in"><b>B.</b></td><td style="text-align: left"><b>Foreign operations</b></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.5pt; text-align: justify; text-indent: -22.5pt"><b>&#160;</b></p><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><b>1.</b></td><td style="text-align: justify"><b>Beamr Inc.</b></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.5pt; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">In 2012, the Company incorporated a
wholly-owned U.S. subsidiary, Beamr Inc. (&#8220;Beamr Inc.&#8221;), for the purpose of reselling the Company&#8217;s software and products
in the U.S. and Canadian markets.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.5pt; text-align: justify; text-indent: -22.5pt"><b>&#160;</b></p><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><b>2.</b></td><td style="text-align: justify"><b>Beamr Imaging RU LLC </b></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.5pt; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">In 2016, the Company incorporated a
wholly-owned Russian limited partnership, Beamr Imaging RU LLC, (&#8220;Beamr Imaging RU&#8221;) for the purpose of conducting research
and development services to the Company.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company and its subsidiaries, Beamr
Inc. and Beamr Imaging RU, are collectively referred to as the &#8220;Group&#8221;.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: left; text-indent: -1cm"><b>&#160;</b></p><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0%"/><td style="width: 0.5in"><b>C.</b></td><td style="text-align: left"><b>Liquidity and capital resources </b></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company has devoted substantially
all of its efforts to research and development, the commercialization of its software and products and raising capital for such purposes.
The development and commercialization of the Company&#8217;s software and products are expected to require substantial further expenditures.
To date, the Company has not yet generated sufficient revenues from operations to support its activities, and therefore it is dependent
upon external sources for financing its operations. In 2022, the Company had net losses of $1,248. As of December 31, 2022, the Company
had an accumulated deficit of $30,969. The Company plans to finance its operations through the sales of equity (including the Company&#8217;s
Initial Public Offering (IPO) of its ordinary shares, par value NIS 0.05 per share, of the Company (the &#8220;Ordinary Shares&#8221;)
that closed in March 2023) and to the extent available, refinancing of liabilities on a long-term basis and through revenues from sales
of its software, products and related services. In addition, the Company has recently commenced collaborating with a strategic partner
in development of the Company&#8217;s next generation product, the Beamr HW-Accelerated Content Adaptive Encoding, which is expected to allow
the Company to potentially access new customers and new markets with relatively low sales investment.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">During the year ended December 31, 2020,
the Company raised net amounts of $75 and $11 through the paycheck protection program and exercise of share options into Ordinary Shares,
respectively (see also Note 6B and Note 12, respectively). During the year ended December 31, 2021, the Company raised net amounts of
$54 and $560 through the paycheck protection program and issuance of convertible advanced investment, respectively (see also Note 6B and
Note 9, respectively). During the year ended December 31, 2022, the Company raised net amounts of $887 through a Funding Agreement with
IBI Spikes Ltd (see also Note 6C).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Management has considered the significance
of such conditions in relation to the Company&#8217;s ability to meet its current obligations and to achieve its business targets and determined
that these conditions are not raising substantial doubt about the Company&#8217;s ability to continue as a going concern taking into consideration,
among others (i) an agreement from February 2022 with the Company&#8217;s founder and significant shareholder (the &#8220;Founder&#8221;) under
which the Company&#8217;s outstanding current liability towards an entity controlled by the Founder (the &#8220;Service Provider&#8221;), as
noted in Note 14, will be paid in 18 equal installments pending availability of sufficient liquidity funds and (ii) the execution of a
definitive agreement (the &#8220;Definitive Agreement&#8221;) with another commercial bank for receiving straight loan and issuance of
warrants, as noted in Note 6C. As of December 31, 2022, it was agreed to extend the term of liability to the Service Provider (including
with respect to amount relating to services provided to the Company by the Service Provider throughout fiscal year ended December 31,
2022).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">On February 27, 2023, the Company announced
the pricing of its initial public offering of 1,950,000 Ordinary Shares at a public offering price of $4.00 per share, for aggregate gross
proceeds of $7,800 prior to deducting underwriting discounts and other offering expenses. For additional information, see also Note 17.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: left; text-indent: -1cm"><b>&#160;</b></p><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0%"/><td style="width: 0.5in"><b>D.</b></td><td style="text-align: left"><b>The impact of COVID-19</b></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">During the year ended December 31, 2022,
there were no material adverse impacts on the consolidated financial statements. The duration, scope and effects of the ongoing COVID-19
pandemic, government and other third-party responses to it, the related macroeconomic effects, and the extent of its impact on the Company&#8217;s
operational and financial performance will depend on future developments. As events continue to evolve and additional information becomes
available, the Company&#8217;s estimates and assumptions may change in future periods.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0%"/><td style="width: 0.5in"><b>E.</b></td><td style="text-align: left"><b>The impact of the Russian Invasion of Ukraine</b></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">On February 24, 2022, Russia invaded Ukraine.
The Company has an operation in Russia through its wholly-owned subsidiary, Beamr Imaging RU. The Company undertakes some of its software
development and design, quality assurance and support in Russia using personnel located there. While most of the Company&#8217;s developers
are located in Russia, its research and development leadership are all located in Israel. The Company has no manufacturing operations
in Russia, and the Company does not sell any products in Russia. The Company constantly evaluates its activities in Russia and currently
believes there was no significant impact on its activities.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmr_GeneralAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmr_GeneralAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI https://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI https://asc.fasb.org/topic&amp;trid=2197479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140231432634144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">SIGNIFICANT ACCOUNTING POLICIES</a></td>
<td class="text"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2cm; text-align: justify; text-indent: -2cm">NOTE 2 - SIGNIFICANT
ACCOUNTING POLICIES</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The financial statements have been prepared in
accordance with accounting principles generally accepted in the United States of America (&#8220;US GAAP&#8221;).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: left; text-indent: -1cm"><b>&#160;</b></p><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0%"/><td style="width: 0.5in"><b>A.</b></td><td style="text-align: left"><b>Use of estimates in the preparation of financial statements </b></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The preparation of the financial statements
in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities
and the disclosure of contingent assets and liabilities at the dates of the financial statements, and the reported amounts of revenue
and expenses during the reported periods. Actual results could differ from those estimates. As applicable to these financial statements,
the most significant estimates and assumptions include (i) revenues recognition; (ii) identification of and measurement of financial instruments
in funding transactions; (iii) recoverability of the Company&#8217;s goodwill upon subsequent periods (iv) measurement of fair value of
equity awards and (v) evaluation of going concern.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: left; text-indent: -1cm"><b>&#160;</b></p><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0%"/><td style="width: 0.5in"><b>B.</b></td><td style="text-align: left"><b>Functional currency</b></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The functional currency of the Company
and all of its subsidiaries all of which are primarily a direct and integral component of the Company&#8217;s operation is the US dollar (&#8220;$&#8221;
or &#8220;dollar&#8221;), as the dollar is the primary currency of the economic environment in which the Company and its subsidiaries
have operated (which is the currency of the environment in which an entity primarily generates cash) and expects to continue to operate
in the foreseeable future.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In accordance with ASC 830, &#8220;Foreign
Currency Matters&#8221;, balances denominated in or linked to foreign currency are stated on the basis of the exchange rates prevailing
at the applicable balance sheet date. For foreign currency transactions included in the consolidated Statement of Operations and Comprehensive
Loss, the exchange rates applicable on the relevant transaction dates are used. Gains or losses arising from changes in the exchange rates
used in the translation of such transactions are presented within financing income or expenses.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: left; text-indent: -1cm"><b>&#160;</b></p><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0%"/><td style="width: 0.5in"><b>C.</b></td><td style="text-align: left"><b>Principles of Consolidation</b></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The consolidated financial statements
include the accounts of the Group. Intercompany transactions and balances have been eliminated upon consolidation.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: left; text-indent: -1cm"><b>&#160;</b></p><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0%"/><td style="width: 0.5in"><b>D.</b></td><td style="text-align: left"><b>Cash and cash equivalents</b></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Cash equivalents are short-term highly
liquid investments which include short term bank deposits (up to three months from date of deposit), that are not restricted as to withdrawals
or use and that are readily convertible to cash with maturities of three months or less as of the date acquired.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: left; text-indent: -1cm"><b>&#160;</b></p><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0%"/><td style="width: 0.5in"><b>E.</b></td><td style="text-align: left"><b>Research and development expenses </b></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Research and development expenses are
charged to operations, as incurred.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">ASC 985-20, &#8220;Software - Costs of
Computer Software to be Sold, Leased or Otherwise Marketed&#8221;, requires capitalization of certain software development costs subsequent
to the establishment of technological feasibility. In accordance with ASC 985-20, capitalization ceases when the related product is available
for general release to customers. Costs of maintenance and customer support are charged to expenses, as incurred. Based on the Company&#8217;s
product development process, technological feasibility is established upon completion of a working model. Costs incurred by the Company
between completion of the working models and the point at which the products are ready for general release have been insignificant. Therefore,
all research and development costs have been expensed.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0%"/><td style="width: 0.5in"><b>F.</b></td><td style="text-align: left"><b>Deferred offering costs </b></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Prior to the effective
date of an offering of equity securities, specific incremental costs directly (i.e. accounting, consulting, legal and printing fees) attributable
to a proposed or actual offering of securities are deferred and charged against the gross proceeds of the offering, unless the offering
of equity securities has been delayed but is currently in process, under which such specific incremental and direct costs are charged
immediately to operations. As of December 31, 2022, the Company deferred specific incremental costs directly attributable to offering
of securities through its IPO that closed in March 2023 in total amount of $313, which was classified as non-current asset in the Company&#8217;s
Consolidated Balance Sheet.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: left; text-indent: -1cm"><b>&#160;</b></p><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0%"/><td style="width: 0.5in"><b>G.</b></td><td style="text-align: left"><b>Goodwill and Intangible Assets</b></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Goodwill is the amount
by which the purchase price of acquired net assets in a business combination exceeded the fair values of the net identifiable assets on
the date of acquisition.&#160;Goodwill is not amortized but evaluated for impairment annually or more frequently if events or changes
in circumstances indicate that the asset might be impaired. The provisions of ASC 350 &#8220;Intangibles-Goodwill and Other&#8221; (&#8220;ASC
350&#8221;) require that the impairment test be performed on goodwill at the level of the reporting unit. As required by ASC 350, the
Company chooses either to perform a qualitative assessment whether a goodwill impairment test is necessary or proceeds directly to the
goodwill impairment test. Such determination is made for each reporting unit on a stand-alone basis. The qualitative assessment includes
various factors such as macroeconomic conditions, industry and market considerations, cost factors, overall financial performance, earnings
multiples, gross margin and cash flows from operating activities and other relevant factors. When the Company chooses to perform a qualitative
assessment and determines that it is more likely than not (more than 50 percent likelihood) that the fair value of the reporting unit
is less than its carrying value, then the Company proceeds to the goodwill impairment test. If the Company determines otherwise, no further
evaluation is necessary.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">When the Company decides
or is required to perform the quantitative goodwill impairment test, the Company compares the fair value of the reporting unit to its
carrying value and an impairment charge is recognized for the amount by which the carrying amount exceeds the reporting unit&#8217;s fair
value, if any.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company determined
that its operations represent a single reporting unit. The Company determines the fair value of its reporting unit by using the income
approach, which utilizes a discounted cash flow model, as it believes that this approach best approximates the reporting unit&#8217;s
fair value. Judgments and assumptions related to revenue, operating income, future short-term and long-term growth rates, weighted average
cost of capital, interest, capital expenditures, cash flows, and market conditions are inherent in developing the discounted cash flow
model. The Company considers historical rates and current market conditions when determining the discount and growth rates to use in its
analyses. If these estimates or their related assumptions change in the future, the Company may be required to record impairment charges
for its goodwill. As of December 31, 2022 and 2021, the Company has performed the annual impairment test and has determined that impairment
loss is not required to be recognized.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Finite lived intangible
assets acquired in business combinations, which include technology, customer relationships and trade names, are initially recorded at
fair value.&#160;They are amortized on a straight-line basis over their estimated useful lives.&#160;The intangible asset lives have been
determined based upon the anticipated period over which the Company will derive future cash flows from the intangible assets.&#160;The
Company has considered the effects of legal, regulatory, contractual, competitive, and other economic factors in determining these useful
lives.&#160;Recoverability of these assets is assessed when triggering events have occurred that may give rise to an impairment loss and
is determined by a comparison of the carrying amount of the asset to the future undiscounted net cash flows expected to be generated by
the asset.&#160;When it is determined that the carrying value of the asset is not recoverable, the asset is written down to its estimated
fair value.&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">As a result of continued
losses, the management performed an impairment test with respect to its intangible assets by maintaining an external valuation which utilized
discounted cash flow model. Accordingly,&#160;certain assumptions and judgments were made to determine the discount rate as well as future
cash flows of the Company.&#160;During the years ended December 31, 2022, 2021 and 2020, no impairment losses were identified through
the impairment test.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27.35pt">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The lives used in computing straight-line amortization
for financial reporting purposes are as follows:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: left; border-bottom: Black 1.5pt solid">Rate of depreciation</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">%</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%; text-align: left">Technology</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">20</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Customer relationships</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">20</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Trade names</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10</td><td style="text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0%"/><td style="width: 0.5in"><b>H.</b></td><td style="text-align: left"><b>Property and equipment</b></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Property and equipment
are stated at cost, net of accumulated depreciation. Depreciation is calculated using the straight-line method over the estimated useful
lives of the assets. When an asset is retired or otherwise disposed of, the related cost and accumulated depreciation are removed from
the respective accounts and the net difference less any amount realized from disposition is reflected in the consolidated Statements of
Operations and Comprehensive Loss.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company&#8217;s long-lived
assets are reviewed for impairment in accordance with ASC 360, &#8220;Property, Plant and Equipment&#8221;, whenever events or changes
in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is
measured by a comparison of the carrying amount of an asset to the future undiscounted cash flows expected to be generated by the asset.
If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of
the asset exceeds its fair value. To date, the Company has not incurred any impairment losses.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27.35pt">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The lives used in computing straight-line depreciation
for financial reporting purposes are as follows:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: left; border-bottom: Black 1.5pt solid">Rate of depreciation</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">%</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%; text-align: left">Computers and peripheral equipment</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">33</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Office furniture and equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-size: 10pt">7-15</span></td><td style="text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; background-color: white">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0%"/><td style="width: 0.5in"><b>I.</b></td><td style="text-align: left"><b>Leases</b></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company entered
into several non-cancelable lease agreements for offices for use in its operations, which are classified as operating leases (see below).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company applies
ASC Topic 842, Leases (&#8220;ASC 842&#8221;).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Accordingly, the Company
determines if an arrangement is a lease at inception. The Company&#8217;s assessment is based on: (i) whether the contract involves the
use of an identified asset, (ii) whether the Company obtains the right to substantially all of the economic benefits from the use of the
asset throughout the period of use, and (iii) whether the Company has the right to direct the use of the asset.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Leases are classified
as either finance leases or operating leases. A lease is classified as a finance lease if any one of the following criteria are met: (i)
the lease transfers ownership of the asset by the end of the lease term, (ii) the lease contains an option to purchase the asset that
is reasonably certain to be exercised, (iii) the lease term is for a major part of the remaining useful life of the asset, (iv) the present
value of the lease payments equals or exceeds substantially all of the fair value of the asset, or (v) the underlying asset is of such
a specialized nature that it is expected to have no alternative use to the lessor at the end of lease term. A lease is classified as an
operating lease if it does not meet any one of these criteria. Since all the Company&#8217;s lease contracts for premises do not meet
any of the criteria above, the Company concluded that all its lease contracts should be classified as operating leases.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Right of Use (&#8220;ROU&#8221;)
assets and liabilities are recognized on the commencement date based on the present value of remaining lease payments over the lease term.
For this purpose, the Company considers only payments that are fixed and determinable at the time of commencement. As most of the Company&#8217;s
leases do not provide an implicit rate, the Company uses its incremental borrowing rate (&#8220;IBR&#8221;) based on the information available
on the commencement date in determining the present value of lease payments. The Company&#8217;s IBR is estimated to approximate the interest
rate for collateralized borrowing with similar terms and payments and in economic environments where the leased asset is located. The
ROU asset also includes any lease payments made prior to commencement and is recorded net of any lease incentives received. Moreover,
the ROU asset may also include initial direct costs, which are incremental costs of a lease that would not have been incurred if the lease
had not been obtained. The Company uses the long-lived assets impairment guidance in ASC 360-10, &#8220;Property, Plant, and Equipment
- Overall&#8221;, to determine whether a ROU asset is impaired, and if so, the amount of the impairment loss to recognize. Certain leases
include options to extend or terminate the lease. An option to extend the lease is considered in connection with determining the ROU asset
and lease liability when it is reasonably certain that the Company will exercise that option. An option to terminate is considered unless
it is reasonably certain that the Company will not exercise the option.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company also elected
the short-term lease recognition exemption for all leases that qualify (leases with a term shorter than 12 months). For those leases,
ROU assets or lease liabilities are not recognized and rent&#160;expense is recognized on a straight-line basis over the lease term. See
also Note 10A for further discussion.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: center; background-color: white">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0%"/><td style="width: 0.5in"><b>J.</b></td><td style="text-align: left"><b>Deferred income taxes</b></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company accounts
for income taxes in accordance with ASC Topic 740, &#8220;Income Taxes&#8221;. Accordingly, deferred income taxes are determined utilizing
the asset and liability method based on the estimated future tax effects of differences between the financial accounting and the tax bases
of assets and liabilities under the applicable tax law. Deferred tax balances are computed using the enacted tax rates expected to be
in effect when these differences reverse. Valuation allowance in respect of deferred tax assets is provided for, if necessary, to reduce
deferred tax assets is amounts more likely than not to be realized.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; background-color: white">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company accounts
for uncertain tax positions in accordance with ASC Topic 740-10, which prescribes detailed guidance for the financial statement recognition,
measurement and disclosure of uncertain tax positions recognized in an enterprise&#8217;s financial statements. According to ASC Topic
740-10, tax positions must meet a more-likely-than-not recognition threshold. The Company&#8217;s accounting policy is to classify interest
and penalties relating to uncertain tax positions under income taxes, however the Company did not recognize such items in its consolidated
financial statements during the years ended December 31, 2022, 2021 and 2020 and did not recognize any liability with respect to an unrecognized
tax position in its balance sheets.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; background-color: white">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0%"/><td style="width: 0.5in"><b>K.</b></td><td style="text-align: left"><b>Employees benefit plans </b></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company&#8217;s
liability for severance pay to its Israeli employees is pursuant to Section 14 of the Israeli Severance Compensation Act, 1963 (&#8220;Section
14&#8221;), pursuant to which all the Company&#8217;s employees are included under Section 14, and are entitled only to monthly deposits,
at a rate of 8.33% of their monthly salary, made in the employee&#8217;s name with insurance companies. Under Israeli employment law,
payments in accordance with Section 14 release the Company from any future severance payments in respect of those employees. The fund
is made available to the employee at the time the employer-employee relationship is terminated, regardless of cause of termination. The
severance pay liabilities and deposits under Section 14 are not reflected in the balance sheets as the severance pay risks have been irrevocably
transferred to the severance funds. All deposits required through December 31, 2022 have been made.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: left; text-indent: -1cm"><b>&#160;</b></p><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0%"/><td style="width: 0.5in"><b>L.</b></td><td style="text-align: left"><b>Contingencies</b></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company and its
subsidiaries may be involved in certain legal proceedings and certain business relationships that arise from time to time in the ordinary
course of their business and in connection with certain agreements with third parties. Except for income tax contingencies, the Company
applies the provisions of ASC Topic 450, Contingencies. Thus, the Company records accruals for contingencies to the extent that the management
concludes that the occurrence is probable and that the related liabilities are estimable. Legal expenses associated with contingencies
are expensed as incurred.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: left; text-indent: -1cm"><b>&#160;</b></p><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0%"/><td style="width: 0.5in"><b>M.</b></td><td style="text-align: left"><b>Concentrations of credit risk and allowance for doubtful accounts</b></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Financial instruments
that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents and trade receivables
as well as certain other current assets that do not amount to a significant amount. Cash and cash equivalents, which are primarily held
in US Dollars and New Israeli Shekels (NIS), are deposited with major banks in Israel, U.S. and Russian Federation. Management believes
that such financial institutions are financially sound and, accordingly, minimal credit risk exists with respect to these financial instruments.
The Company does not have any significant off-balance-sheet concentration of credit risk, such as foreign exchange contracts, option contracts
or other foreign hedging arrangements. Most of the Company&#8217;s sales are mainly derived from sales to a diverse set of customers located
primarily in the United States. Management periodically evaluates the collectability of the trade receivables to determine the amounts
that are doubtful of collection and determine a proper allowance for doubtful accounts, as described below. Accordingly, management believes
that the Company&#8217;s trade receivables do not represent a substantial concentration of credit risk.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company extends credit to customers
in the normal course of business and does not require collateral or any other security to support amounts due. Management performs ongoing
credit evaluations of its customers. The allowance for doubtful accounts is determined with respect to amounts the Group has determined
to be doubtful of collection. In determining the allowance for doubtful accounts, the Company considers, among other things, its past
experience with customers, the length of time that the balance is past due, the customer&#8217;s current ability to pay and available information
about the credit risk on such customers.&#160;Provisions for the allowance for doubtful accounts are recorded under general and administrative
expenses in the consolidated Statements of Operations and Comprehensive Loss. During the years ended December 31, 2022, 2021 and 2020,
the Company has not recorded allowance in respect of accounts receivable.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: center; background-color: white"><b>&#160;</b></p><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0%"/><td style="width: 0.5in"><b>N.</b></td><td style="text-align: left"><b>Revenue recognition</b></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company recognizes revenues in accordance
with ASC 606, &#8220;Revenue from Contracts with Customers&#8221; (&#8220;ASC 606&#8221;) under which the Company determines revenue recognition
through the following five steps:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.5pt; text-align: justify; text-indent: -22.5pt">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span>&#9726;</span></td><td style="text-align: justify">Identification of the contract, or contracts, with a customer;</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.5pt; text-align: justify; text-indent: -22.5pt">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span>&#9726;</span></td><td style="text-align: justify">Identification of the performance obligations in the contract;</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.5pt; text-align: justify; text-indent: -22.5pt">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span>&#9726;</span></td><td style="text-align: justify">Determination of the transaction price;</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.5pt; text-align: justify; text-indent: -22.5pt">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span>&#9726;</span></td><td style="text-align: justify">Allocation of the transaction price to the performance obligations in the contract; and</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.5pt; text-align: justify; text-indent: -22.5pt">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span>&#9726;</span></td><td style="text-align: justify">Recognition of revenue when, or as, the Company satisfies a performance obligation.</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company enters into contracts that
mostly include software and software related services (i.e. Post-Contract Customer Support (&#8220;PCS&#8221;)), which are generally capable
as being distinct from each other and accounted for as separate performance obligations.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company derives its revenues from
licensing the rights to use its software for a limited term (mainly for a period of one to three years) or on a perpetual basis for enterprises
that incorporate the Company&#8217;s perpetual license in their own products delivered to end users and for the Company&#8217;s products&#160;sold
to thousands private consumers, as applicable to each contract, and from, provision of related maintenance and technical support. The
Company sells its products through direct sales force and indirectly through distributors and consumer platforms.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Revenues are recognized when control of
the promised goods or services are transferred to the customers, in an amount that reflects the consideration that the company expects
to receive in exchange for those goods or services. However, when the consideration for the license is based on sales of the related customer,
the company applies the provisions of ASC 606 with respect to sales-based or usage-based royalties promised in exchange for a license
of intellectual property and recognizes revenues only when the underlying sales occur, as long as this approach does not result in the
acceleration of revenue ahead of the company&#8217;s performance.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Under ASC 606, an entity recognizes revenue
when or as it satisfies a performance obligation by transferring software license (either timely-based or perpetual) or software related
services to the customer, either at a point in time or over time. The Company recognizes its revenues from software sales at a point in
time upon delivery of its software license. The software license is considered a distinct performance obligation, as the customer can
benefit from the software on its own. The Company&#8217;s revenues from PCS are derived from annual maintenance providing for unspecified
upgrades on a when-and-if-available basis. The right for an unspecified upgrade for the version acquired by the customer and enhancements
on a when-and-if-available basis that do not specify the features, functionality and release date of future product enhancements for the
customer to know what will be made available and the general timeframe in which it will be delivered. The Company considers the PCS performance
obligation as a distinct performance obligation that is satisfied over time and recognized on a straight-line basis over the contractual
period (mainly over a period of one year either for timely-based license or for perpetual license).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">As the Company bundles software licenses
(either time-based or perpetual) together with PCS, the transaction price is allocated to the separate performance obligations on a relative
standalone selling price basis.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Since the Company does not sell PCS on
a stand-alone basis and due to the fact that these services are usually involved with limited customer support, mainly based on several
hours of technical support per contract (as management believes the technology and products covered under the software license component
are mature and fully functional), the standalone selling prices of the PCS are determined based on the expected cost plus a margin (&#8220;cost-plus
approach&#8221;) based on estimation of direct fulfillment cost (an hourly service) and a reasonable margin. Such estimate is also corroborated
with the price that the company would have to pay to a third-party service provider for a similar support service.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The stand-alone selling price of the software
licenses (either timely-based or perpetual) is estimated by management based on adjusted market assessment approach which represents management
estimation of the price that a customer in the market will be willing to pay for such license on a stand-alone basis (i.e. without any
PCS).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Due to the fact that the PCS services
are usually involved with limited customer support, mainly based on several hours of technical support per contract, the transaction price
allocated to the PCS is considered insignificant. Consequently, most of the transaction price is allocated to the software licenses as
management believes the technology and products covered under the software license component are mature and fully functional.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">During the reported periods, costs to
obtain contracts were in an insignificant amount.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company does not grant a right of
return to its customers. When product delivered to the customer is subject to evaluation, the Company defers revenue until evaluation
is completed subject to formal selling agreement with the customer, at which time revenue is recognized provided that all other revenue
recognition criteria are met.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Commencing 2022, revenue is also derived
from the traffic operations in the Google AdSense program, a web advertising platform, that the Company makes available on its websites.&#160;Google
pays the Company on a cost-per-click basis. The Company recognizes as revenue the fees paid to it by Google based on the volume of clicks
through to Google AdSense advertisements.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company receives payments from customers
based upon contractual payment schedules. Trade receivables are recorded when right to consideration becomes unconditional, and an invoice
is issued to the customer. Unbilled receivables include amounts related to the Company&#8217;s contractual right to consideration for
completed performance obligations not yet invoiced. As of December 31, 2022 and 2021, unbilled receivables balance amounted to $35&#160;and
$29, respectively, and are included within trade receivables balance in the Company&#8217;s Consolidated Balance Sheets.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">As of December 31, 2022 and 2021, the
Company had $31&#160;and $33, respectively, of remaining performance obligations not yet satisfied or partly satisfied related to revenues
(mostly PCS). Such amounts are presented as deferred revenues which are expected to be recognized as revenues during the next twelve months.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">See also Note 16 for further discussion
related to disaggregation of revenues.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: left; text-indent: -1cm"><b>&#160;</b></p><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0%"/><td style="width: 0.5in"><b>O.</b></td><td style="text-align: left"><b>Fair Value Measurements</b></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company measures
and discloses fair value in accordance with the ASC 820, &#8220;Fair Value Measurements and Disclosures&#8221; which defines fair value,
establishes a framework and gives guidance regarding the methods used for measuring fair value, and expands disclosures about fair value
measurements. Fair value is an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability
in an orderly transaction between market participants at the measurement date. As such, fair value is a market-based measurement that
should be determined based on assumptions that market participants would use in pricing an asset or liability. As a basis for considering
such assumptions there exists a three-tier fair-value hierarchy, which prioritizes the inputs used in measuring fair value as follows:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Level 1 - unadjusted
quoted prices are available in active markets for identical assets or liabilities that the Company has the ability to access as of the
measurement date.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Level 2 - pricing inputs
are other than quoted prices in active markets that are directly observable for the asset or liability or indirectly observable through
corroboration with observable market data.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Level 3 - pricing inputs
are unobservable for the non-financial asset or liability and only used when there is little, if any, market activity for the non-financial
asset or liability at the measurement date. The inputs into the determination of fair value require significant management judgment or
estimation. Level 3 inputs are considered as the lowest priority within the fair value hierarchy. The valuation of certain financial instruments
classified under fair value through profit or loss category and the fair value of reporting units for purposes of goodwill impairment
analysis, fall under this category.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">This hierarchy requires
the Company to use observable market data, when available, and to minimize the use of unobservable inputs when determining fair value.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The fair value of cash
and cash equivalents is based on its demand value, which is equal to its carrying value. Additionally, the carrying value of all other
short-term monetary assets and liabilities are estimated to be equal to their fair value due to the short-term nature of these instruments.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: left; text-indent: -1cm"><b>&#160;</b></p><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0%"/><td style="width: 0.5in"><b>P.</b></td><td style="text-align: left"><b>Convertible Ordinary 1 and 2 Shares and Preferred Shares</b></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Convertible Ordinary 1 and 2 Shares
and Convertible Preferred Shares are not subject to redemption feature upon any events that are considered not solely within the control
of the Company. In addition, upon occurrence of liquidation event, as defined in the Company&#8217;s Articles of Association, all holders of
the Ordinary Shares, Convertible Ordinary 1 and 2 Shares and Convertible Preferred Shares will be entitled to receive the same form of
consideration. Thus, the Company classifies its Convertible Ordinary 1 and 2 Shares and Convertible Preferred Shares as part of permanent
equity.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0%"/><td style="width: 0.5in"><b>Q.</b></td><td style="text-align: left"><b>Allocation of proceeds and related issuance costs</b></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">When multiple instruments are issued in
a single transaction (package issuance), the total net proceeds from the transaction are allocated among the individual freestanding instruments
identified. The allocation occurs after identifying all the freestanding instruments and the subsequent measurement basis for those instruments.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Financial instruments that are required
to be subsequently measured at fair value (such as derivative warrants liability) are measured at fair value and the remaining consideration
is allocated to other financial instruments that are not required to be subsequently measured at fair value (i.e. straight loan), based
on the relative fair value basis for such instruments.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The allocation of issuance costs to freestanding
instruments was based on an approach that is consistent with the allocation of the proceeds, as described above.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Issuance costs allocated to the derivative
warrant liability were immediately expensed.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Issuance costs allocated to straight loan
are recorded as a discount of the straight loan and accreted over the contractual term of straight loan up to face value of such loans
using the effective interest method.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: left; text-indent: -1cm"><b>&#160;</b></p><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0%"/><td style="width: 0.5in"><b>R.</b></td><td style="text-align: left"><b>Warrants</b></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Certain warrants that
were issued to a commercial bank as part of entering into a straight loan and to seller through transaction in which certain identified
intangible assets have been purchased are classified as a component of permanent equity since they are freestanding financial instruments
that are legally detachable and separately exercisable, do not embody an obligation for the Company to repurchase its own shares, and
permit the holders to receive a fixed number of Ordinary Shares upon exercise for a fixed exercise price and thus, are considered as indexed
to the Company&#8217;s own shares. In addition, the warrants must require physical settlement and may not provide any guarantee of value or
return. As such warrants were issued together with financial instruments that are not subsequently measured at fair value the warrants
were measured based on allocation of the proceeds received by the Company in accordance with the relative fair value basis. When applicable,
direct issuance expenses that were allocated to such warrants were deducted from additional paid-in capital.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Commencing January 1,
2018 and following the early adoption of ASU 2017-11, &#8220;Earnings Per Share&#8221; (ASU 2017-11), the Company disregards the down
round feature when assessing whether an instrument is indexed to its own shares, for purposes of determining liability or equity classification.
Based on its evaluation, management has determined that certain warrants with down-round protection are eligible for equity classification.
In accordance with the provisions of ASU 2017-11, upon the occurrence of an event that triggers down round protection (i.e., when the
exercise price of the warrants is adjusted downward because of the down round feature), the effect is accounted for as a deemed dividend
and as a reduction of income available to common shareholders for purposes of basic earnings per share (EPS) calculation. However, during
the reported periods there were no events that trigger a down round protection.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: left; text-indent: -1cm"><b>&#160;</b></p><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0%"/><td style="width: 0.5in"><b>S.</b></td><td style="text-align: left"><b>Derivative Warrants Liability</b></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Certain warrants that
were granted by the Company for commercial bank through funding transaction entitle the bank to exercise the warrants for a variable number
of shares and/or for a variable exercise price and thus the fixed-for-fixed criteria is not met. Accordingly, the warrants were classified
as a non-current liability according to the provisions of ASC 815-40, &#8220;Derivatives and Hedging - Contracts in Entity&#8217;s Own
Equity&#8221; (&#8220;ASC 815-40&#8221;). The Company accounted for these warrants as a financial derivative liability measured upon initial
recognition and on subsequent periods at fair value by using the Hybrid Method by combining the OPM and an IPO scenario.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The fair value of the
aforesaid warrants derivative liability is estimated using the Black-Scholes Model which requires inputs such as the expected term of
the warrants, share price volatility and risk-free interest rate. These assumptions are reviewed on a regular basis and changes in the
estimated fair value of the outstanding warrants are recognized each reporting period as part of the &#8220;Financing (income) expenses,
net&#8221; line in the consolidated statements of operations and comprehensive loss, until such warrants are exercised or expired. When
applicable, direct issuance expenses that were allocated to the above warrants were expensed as incurred.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0%"/><td style="width: 0.5in"><b>T.</b></td><td style="text-align: left"><b>Modifications or exchanges of loans</b></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Modifications to, or
exchanges of, financial instruments such as loans or convertible loans, are accounted for as a modification or an extinguishment, following
to provisions of ASC 470-50, &#8220;Debt &#8211; Modification and Extinguishments&#8221; (ASC 470-50<span style="font-family: Times New Roman, Times, Serif">)</span>.
Such an assessment done by management either qualitatively or quantitatively based on the facts and circumstances of each transaction<span style="font-family: Times New Roman, Times, Serif">.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Under ASC 470-50, modifications
or exchanges are generally considered extinguishments with gains or losses recognized in current earnings if the terms of the new debt
and original instrument are substantially different. The instruments are considered &#8220;substantially different&#8221; when the present
value of the cash flows under the terms of the new debt instrument is at least 10% different from the present value of the remaining cash
flows under the terms of the original instrument<span style="font-family: Times New Roman, Times, Serif">.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">If the terms of a debt
instrument are changed or modified and the present value of the cash flows under the terms of the new debt instrument is less than 10%,
the debt instruments are not considered to be substantially different, except in the following two circumstances: (i)<span style="font-family: Times New Roman, Times, Serif">&#160;&#160;</span>the
transaction significantly affects the terms of an embedded conversion option, such that the change in the fair value of the embedded conversion
option (calculated as the difference between the fair value of the embedded conversion option immediately before and after the modification
or exchange) is at least 10% of the carrying amount of the original debt instrument immediately before the modification or exchange or
(ii)<span style="font-family: Times New Roman, Times, Serif">&#160;&#160;</span>the transaction adds a substantive conversion option or
eliminates a conversion option that was substantive at the date of the modification or exchange<span style="font-family: Times New Roman, Times, Serif">.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">If the original and
new debt instruments are considered as &#8220;substantially different&#8221;, the original debt is derecognized and the new debt is initially
recorded at fair value, with the difference recognized as an extinguishment gain or loss under financial expense or income as applicable<span style="font-family: Times New Roman, Times, Serif">.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">If a convertible debt
instrument with a beneficial conversion option that was separately accounted for in equity, is extinguished prior to its conversion or
stated maturity date, a portion of the reacquisition price is allocated to the repurchase of the beneficial conversion option. The amount
of the reacquisition price allocated to the beneficial conversion option is measured using the intrinsic value of that conversion option
at the extinguishment date. The residual amount, if any, is allocated to the convertible debt instrument<span style="font-family: Times New Roman, Times, Serif">.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The gain or loss on
the extinguishment of the convertible debt instrument is determined based on the difference between the carrying amount and the fair value
of the allocated reacquisition price.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: left; text-indent: -1cm"><b>&#160;</b></p><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0%"/><td style="width: 0.5in"><b>U.</b></td><td style="text-align: left"><b>Basic and diluted net loss per Ordinary Share </b></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company applies
the two-class method as required by ASC&#160;260-10, &#8220;Earnings Per Share&#8221; (&#8220;ASC&#160;260-10&#8221;) which requires the
income or loss per share for each class of shares (ordinary and all other shares with preferences over Ordinary Shares) to be calculated
assuming 100% of the Company&#8217;s earnings are distributed as dividends to each class of shares based on their contractual rights. No dividends
were declared or paid during the reported periods. According to the provisions of ASC&#160;260-10, the Company&#8217;s Convertible Preferred
Shares and Convertible Ordinary 1 and 2 Shares do not have contractual obligation to share losses of the Company and therefore are not
included in the computation in period of net loss per share.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Basic net loss per Ordinary
Share is computed by dividing the net loss for the period applicable to ordinary shareholders, by the weighted average number of Ordinary
Shares outstanding during the period. Diluted loss per share gives effect to all potentially dilutive common shares outstanding during
the year using the treasury stock method with respect to shares with preferences over Ordinary Shares (Convertible Ordinary 1 and 2 shares
and Convertible Preferred Shares), share options and certain warrants and using the if-converted method with respect to convertible advance
investments and certain warrants accounted for as derivative liability. In computing diluted loss per share, the average share price for
the period is used in determining the number of shares assumed to be purchased from the exercise of share options or warrants.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">During the years ended
December 31, 2022, 2021 and 2020, the total weighted average number of Ordinary Shares related to outstanding shares with preferences
over Ordinary Shares (Convertible Ordinary 1 and 2 shares and Convertible Preferred Shares), share options, warrants and convertible advance
investments excluded from the calculation of the diluted loss per share was 9,067,438, 8,957,327 and 8,842,202, respectively.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0%"/><td style="width: 0.5in"><b>V.</b></td><td style="text-align: left"><b>Convertible Advance Investments</b></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Upon initial recognition, the Company
has considered the provisions of ASC 480-10 &#8220;Distinguishing Liabilities from Equity&#8221; with respect to certain obligations to
issue a variable number of shares and has determined that the convertible advance investments represent a financial liability since most
of its settlement alternatives embody either a conditional or an unconditional obligation to issue a variable number of the Company&#8217;s
shares with monetary value based predominantly on a fixed monetary amount known at inception (the original issue price of the convertible
advance investments together with a fixed &#160;return to the investors).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Upon initial recognition, the Company
has considered the provisions of ASC 815-15,&#160;&#8220;Derivatives and Hedging - Embedded Derivatives&#8221;, and determined that the
embedded conversion feature of the convertible advance investments cannot be considered as clearly and closely related to the host debt
instrument. However, it was determined that the embedded conversion feature should not be separated from the host instrument because the
embedded conversion option, if freestanding, did not meet a derivative definition based on the provisions of ASC 815-10, &#8220;Derivatives
and Hedging&#8221;&#160;since its terms did not require or permit net settlement. Thus, it was determined that the conversion feature
does not meet the characteristic of being readily convertible to cash. However, the Company has determined that the redemption feature
upon certain events is not solely within the Company&#8217;s control under which the Company will be required to repay an amount equal to 200%
of the original investment was determined to represent a contingent interest feature that requires bifurcation from a host debt contract
because the contingent interest feature meets a derivative definition and the economic characteristics of the embedded feature are not
clearly and closely related to those of host debt instrument as such feature is not directly credit risk related.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Furthermore, the Company applied ASC 470-20,
&#8220;Debt - Debt with Conversion and Other Options&#8221; (&#8220;ASC 470-20&#8221;) which clarifies the accounting for instruments with
Beneficial Conversion Features (BCF) or contingently adjustable conversion ratios and has applied the BCFs guidance to determine whether
the conversion feature is beneficial to investors. However, as the convertible advance investments were not convertible upon inception
(such instrument would have become convertible if the Company would have completed qualified financing by August 5, 2020), it was determined
that no BCF was required to be recognized upon initial recognition of the instrument.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Based on the characteristics of the convertible
advance investments, the Company elected to measure this liability in its entirety, at its fair value in accordance with ASC 825-10, &#8220;Financial
Instruments&#8221; due to the existence of certain redemption option and the potential requirement to recognize contingent BCF. Accordingly,
upon initial recognition and in subsequent periods, the Company measures the liability related to the convertible advance investments
based on its fair value taking into consideration, among others all relevant settlement possibilities and their respective likelihood.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: left; text-indent: -1cm"><b>&#160;</b></p><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0%"/><td style="width: 0.5in"><b>W.</b></td><td style="text-align: left"><b>Capital contribution from a controlling shareholder</b></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The fair value of the benefit received
in respect of loan received from the controlling shareholder is calculated on the basis of the difference between the interest rate that
the Company would have required to pay for similar loan from commercial bank and the interest rate that the Company is actually charged
under the agreement with the controlling shareholders. Such benefit is accounted for as capital contribution received from the controlling
shareholder as additional paid-in capital and it is recorded as discount on the loan received against at the initial measurement date.
Subsequently, such discount is expensed over the economic life of the loan based on the effective interest rate method.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0%"/><td style="width: 0.5in"><b>X.</b></td><td style="text-align: left"><b>Share-based compensation</b></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: 0in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0in">The Company measures
and recognizes compensation expense for all equity-based payments to employees based on their estimated fair values in accordance with
ASC 718, &#8220;Compensation-Stock Compensation&#8221;. Share-based payments are recognized in the Statement of Operations and Comprehensive
Loss as an operating expense based on fair value of the award at the grant date by using Black-Scholes option-pricing model. The inputs
for the valuation analysis of the share options include several assumptions of which the most significant are the fair market value of
the underlying Ordinary Share, the expected share price volatility and the expected option term. Expected volatility was calculated based
upon historical volatility of peer companies in the same industry on daily basis since the Company&#8217;s marketability is considered low.
The expected option term represents the period that the Company&#8217;s share options are expected to be outstanding and is determined
based on the simplified method until sufficient historical exercise data will support using expected life assumptions. The risk-free interest
rate is based on the yield from U.S. treasury bonds with an equivalent term. The expected dividend yield assumption is based on the Company&#8217;s
historical experience and expectation of no future dividend payouts. The Company has historically not paid cash dividends and has no foreseeable
plans to pay cash dividends in the future. The Company expensed compensation costs net of estimated forfeitures over the requisite service
period by applying the straight-line method.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: 0in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0in">The fair value of
Ordinary Shares underlying the share options was determined by the Company&#8217;s management with the assistance of an independent valuation
firm. Because there has been no public market for the Ordinary Shares, the Company&#8217;s management has determined fair value of the Ordinary
Shares at the time of grant by considering several objective and subjective factors including data from other comparable companies, sales
of Convertible Preferred Shares to unrelated third parties, operating and financial performance, the lack of liquidity of share capital
and general and industry specific economic outlook, amongst other factors. The fair value of the underlying Ordinary Shares shall be determined
by management until such time as the ordinary shares are listed on an established stock exchange, national market system or other quotation
system. For all reported periods through December&#160;31, 2020, the valuations were performed using the Option Pricing Method (&#8220;OPM&#8221;).
Commencing June&#160;30, 2021, the valuations were performed using Hybrid Method by combining the OPM and an IPO scenario.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: 0in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0in">Commencing January
1, 2019, following the adoption of ASU 2018-07 which aligns the measurement and classification guidance for share-based payments to nonemployees
with the guidance for share-based payments to employees (with certain exceptions), share-based payments to non-employees are accounted
in accordance with ASC 718.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: 0in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0in">When applicable,
a modification to the terms and/or conditions of an award (i.e. a change of award&#8217;s fair value, vesting conditions or classification
as an equity or a liability instrument) is accounted for as an exchange of the original award for a new award resulting in total compensation
cost equal to the grant-date fair value of the original award, plus the incremental value of the modification to the award. The calculation
of the incremental value is based on the excess of the fair value of the modified award following the modification over the fair value
of the original award measured immediately before its terms were modified.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18726-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI https://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140231432792544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Current Assets<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureTextBlockSupplementAbstract', window );"><strong>Other Current Assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCurrentAssetsTextBlock', window );">OTHER CURRENT ASSETS</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63.8pt; text-align: left; text-indent: -63.8pt"><b>NOTE 3 - OTHER
CURRENT ASSETS</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63.8pt; text-align: left; text-indent: -63.8pt"><b>&#160;</b></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: justify">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of<br/>
 December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; text-indent: -14.15pt; padding-left: 14.15pt">Prepaid expenses</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">32</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">33</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -14.15pt; padding-left: 14.15pt">Government authorities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">15</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">22</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -14.15pt; padding-left: 14.15pt">Others</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">17</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">11</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 4pt; text-indent: -14.15pt; padding-left: 14.15pt">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">64</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">66</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureTextBlockSupplementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureTextBlockSupplementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCurrentAssetsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for other current assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCurrentAssetsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140231433446464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment, Net<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property and Equipment, Net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">PROPERTY AND EQUIPMENT, NET</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><b>NOTE 4 - PROPERTY AND EQUIPMENT,
NET</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><b>&#160;</b></p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: justify">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">As of<br/>
 December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: justify">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">Computers and peripheral equipment</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">95</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">93</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt; text-align: left">Office furniture and equipment</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">42</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">42</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">137</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">135</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt; text-align: left">Less - accumulated depreciation</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(122</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(114</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; text-align: left">Total property and equipment, net</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">15</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">21</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.65pt; text-align: left; text-indent: -5.65pt">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">During the years ended December
31, 2022, 2021 and 2020, total depreciation expenses were $8, $16 and $32, respectively.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99893-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI https://asc.fasb.org/topic&amp;trid=2155823<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=SL120174063-112916<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99779-112916<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140231518655680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets, Net and Goodwill<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Intangible Assets, Net and Goodwill [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">INTANGIBLE ASSETS, NET AND GOODWILL</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><b>NOTE 5 - INTANGIBLE ASSETS,
NET AND GOODWILL</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><b>&#160;</b></p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="text-align: center; border-bottom: Black 1.5pt solid"><b>As of<br/>
 December 31,</b></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">Carrying amount:</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: left">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; width: 76%; text-align: left">Technology</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right">2,007</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right">2,007</td>
    <td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-align: left">Customer relationships</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">1,127</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">1,127</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Trade names</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">201</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">201</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 4pt">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; text-align: right">3,335</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; text-align: right">3,335</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Accumulated amortization:</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-align: left">Technology</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">2,007</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">2,007</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-align: left">Customer relationships</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">1,127</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">1,127</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Trade names</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">134</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">114</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">3,268</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">3,248</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 4pt">Intangible assets, net</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; text-align: right">67</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; text-align: right">87</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.65pt; text-align: left; text-indent: -5.65pt">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">During the years ended December
31, 2022, 2021 and 2020, total amortization expenses were $20, $177 and $647, respectively.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">As of December 31, 2022, the
estimated future amortization expense of intangible assets is as follows:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%; text-align: left">2023</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">20</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">2024-2026</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">47</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 4pt; padding-left: 2.85pt">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">67</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">As of December 31, 2022 and 2021, the Company performed an annual impairment analysis with respect to goodwill and due to continued losses,
an impairment analysis was performed also with respect to the remaining balance of intangible assets. The analysis was based on valuation
performed by management using the assistance of third-party appraiser by using the income approach. The significant assumptions used for
the assessment were a discount rate of 25.3% and 25.5% as of December 31, 2022 and 2021, respectively, and long-term growth rate of 3%
as of December 31, 2022 and 2021.&#160;The measurement was classified at level 3 in the fair value hierarchy whereby it was determined
that impairment is not required to be recognized with respect to goodwill or intangible assets as of December 31, 2022 and 2021.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI https://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140231518721040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Loans, Net<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Loans, Net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">LOANS, NET</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.65pt; text-align: left; text-indent: -5.65pt"><b>NOTE 6 - LOANS,
NET</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.65pt; text-align: left; text-indent: -5.65pt"><b>&#160;</b></p><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"><b>A.</b></td><td style="text-align: justify"><b>Loan and Security Agreements with Silicon Valley Bank</b></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.3pt; text-align: justify; text-indent: -0.25in">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">1.</td><td style="text-align: justify">On February 19, 2017, the Company and Beamr Inc. entered into a Loan and Security Agreement (the &#8220;2017
Loan Agreement&#8221;) with Silicon Valley Bank (the &#8220;SVB&#8221;), under which the Company had a right to borrow from SVB up to
$3,000 bearing interest at a floating per annum rate equal to the Wall Street Journal Prime Rate plus 3.5% (upon occurrence of &#8217;default
event&#8217; as defined in the 2017 Loan Agreement, the Aggregate Loan Principal Amount shall bear interest at a rate per annum which is 5%
above the rate that is otherwise applicable thereto) which shall be payable monthly.</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: 0in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: 0in">In June 2018, the
Company drew down a cash amount in the aggregate principal amount of $3,000 (the &#8220;Loan&#8221;) payable in 36 equal installments
on a monthly basis commencing the following month after drawing down. The Loan is sometimes referred to herein as a &#8220;straight loan&#8221;.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: 0in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: 0in">In connection with
the execution of the 2017 Loan Agreement, the Company issued to SVB a warrant to purchase over a period of 15-years from the issuance
date of the warrant (i) 41,040 Series C Convertible Preferred Shares at an exercise price of $5.12 per share or (ii) 41,040 shares to
be issued in the &#8216;next round&#8217; (as defined in the Agreement) at an exercise price equal to the lowest price per share at which the Company
will sell and issue shares of the Next Round Shares (the &#8220;2017 Warrant&#8221;).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: 0in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: 0in">Upon initial recognition,
the management by assistance of third-party appraiser allocated the net cash proceeds received based on the relative fair value of the
Loan and the detachable 2017 Warrant in total amount of $2,875 and $125, respectively. The amount allocated to the 2017 Warrant was classified
as a component of permanent equity (as their terms permit the holder to receive a fixed number of Ordinary Shares upon exercise for a
fixed exercise price) and the same amount was presented as a discount of the loan component.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: 0in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: 0in">In subsequent periods,
the Loan is accounted for using the effective interest method over the Loan term, until its stated maturity. Consequently, the Company
recorded expenses amounting to $12 and $59 related to amortization of discount and interest expenses of the Loan under finance expenses
line in the consolidated Statement of Operations and Comprehensive Loss for the years ended December 31, 2022 and 2021, respectively.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: 0in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: 0in">To secure its obligations
under the 2017 Loan Agreement, the Company provided a fixed and floating collateral on all its assets (including its intellectual property).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: 0in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: 0in">On April 15, 2020,
the Company entered into deferral agreement with SVB in connection with the 2017 Loan Agreement under which the original monthly repayment
date for the remaining principal due from May 2020 to October 2020 was extended by a period of six months commencing November 2020. However,
management has determined that such modification of terms does not represent extinguishment of the original Loan, as the Loan before and
after the modification was not considered as &#8220;substantially different&#8221; in accordance with the provisions of ASC 470-50.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: 0in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: 0in">On April 29, 2021
(the &#8220;Deferral Effective Date&#8221;), the Company entered into a second deferral agreement in connection with the straight loan
made under the 2017 Loan Agreement with SVB, under which it was agreed that the original monthly repayment dates for the remaining balance
of the principal due from May 2021 to October 2021 (amounting to $667 as of that date) shall be extended by a period of six months commencing
November 2021. In consideration, the Company was required to (i) pay SVB a deferral facility fee equal to $50 which shall be fully earned
at the Deferral Effective Date, and payable in 10 monthly equal installments over the period commencing April 29, 2021 through January
29, 2022 (the &#8220;Facility Fee&#8221;); (ii) reimburse SVB for all reasonable legal fees and expenses incurred in connection with the
Deferral Agreement and (iii) issue SVB warrants to purchase 9,764 shares (the &#8220;2021 Warrant&#8221;) at an exercise price of $5.12
per share (subject to standard adjustments) over a period of 15-years at SVB&#8217;s discretion into either to Series C Convertible Preferred
Shares or class of securities sold and issued by the Company in the next equity financing round (as determined in accordance with the
warrant agreement for the 2021 Warrant (the &#8220;Warrant Agreement&#8221;)) . If SVB exercises the 2021 Warrant and the Warrant Value
(as defined in and determined in the Warrant Agreement) will be lower than an amount of $50 (the &#8220;Minimum Value&#8221;), then immediately
following such exercise, the Company shall pay SVB an amount in cash equal to the difference between the Minimum Value and Warrant Value.
The 2021 Warrant was issued on April 29, 2021.</p><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">1.</td><td style="text-align: justify">(Cont.)</td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.3pt; text-align: justify; text-indent: 0in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: 0in">Upon the modification
of the terms under the 2017 Loan Agreement, the Company has considered the provisions of ASC 470-50 &#8220;Debt - Modification or Extinguishment&#8221;
(&#8220;ASC 470-50&#8221;), and based on such assessment, management has determined by using the assistance of a third-party appraiser
that the fair value of the modified loan (including the Facility Fee) plus the fair value of the 2021 Warrant granted are considered as
substantially different than the fair value of the original straight loan prior to the modification date. As per the provisions of ASC
470-50, it was determined that the modification represents an extinguishment of the original straight loan. Accordingly, the Company derecognized
the remaining balance of the original straight loan in the total amount of $672 and recorded an amount of $712 which represented the fair
value of the modified loan (including the Facility Fee) and the fair value of the issued 2021 Warrant in a total amount of $50 as non-current
financial liability as their terms permit the holders to receive a variable number of Ordinary Shares upon exercise and as such, the 2021
Warrant is subject to a minimum fair value mechanism. Changes in the estimated fair value of the 2021 Warrant are recognized each reporting
period under Financing Expenses, net in the consolidated Statement of Operations and Comprehensive Loss, until the 2021 Warrant is exercised
or expired, as earlier. See also Note 8.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.3pt; text-align: justify; text-indent: 0in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: 0in">In June 2022, the
Loan was fully repaid.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.3pt; text-align: justify; text-indent: -0.25in">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">2.</td><td style="text-align: justify">On February 17, 2022, the Company entered into a Loan and Securities Agreement (the &#8220;2022 Loan Agreement&#8221;)
with SVB, according to which commencing as of August 1, 2022 through December 31, 2022, SVB may, in its sole discretion in each instance,
pursuant to the Company&#8217;s request, finance specific eligible accounts receivables of the Company, as determined in the 2022 Loan
Agreement, in a total amount equal to the face amount of the eligible account multiplied by a rate of 80%, subject to reduction by SVB
in its discretion (the &#8220;Advance&#8221;), provided that the aggregate amount of all outstanding Advances shall not exceed the lesser
of (i) an aggregate principal amount equal to $350, the (&#8220;Revolving Line&#8221;), or (ii) 80% of all eligible accounts minus the
sum of all outstanding principal amounts of any Advances, subject to reduction by SVB in its discretion. The outstanding principal amount
of any Advance shall accrue interest at a floating rate per annum equal to the greater of (i) 8.25% and (ii) a floating per annum rate
equal to the Wall Street Journal Prime Rate plus 5% (upon occurrence of a &#8216;default event&#8217; as defined in the 2022 Loan Agreement, the aggregate
loan principal amount shall bear interest at a rate per annum which is 5% above the rate that is otherwise applicable thereto). Interest
on the principal amount of each Advance will be payable in monthly arrears (i) on each the last day of each month and (ii) on December
31, 2022 (the &#8220;Revolving Line Maturity Date&#8221;). The security interest granted in the 2022 Loan Agreement shall at all times
continue to be a first priority preferred security interest in the collateral and a first priority fixed and floating charges.</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.3pt; text-align: justify; text-indent: 0in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: 0in">Upon making of the
initial Advance, the Company agreed to issue to SVB a warrant to purchase (i) 4,785 Series C Convertible Preferred Shares, or (ii) Ordinary
Shares in the event that the Company has listed its securities for trading on Nasdaq, or (iii) upon SVB&#8217;s written irrevocable election
in its sole discretion, the same class and series, or other designation, of convertible preferred share or other senior equity security
sold and issued by the Company in the next equity financing over a 15-years period commencing the issuance date of such warrant, at an
exercise price of $5.12 per share, provided that if the class is the next equity financing securities, then the exercise price shall be
the lowest price per share for which next equity financing securities are sold or issued by the Company.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.3pt; text-align: justify; text-indent: 0in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: 0in">On July 26, 2022,
the 2022 Loan Agreement was terminated, and all related collateral was released.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify; text-indent: -21.3pt"><b>&#160;</b></p><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0%"/><td style="width: 0.5in"><b>B.</b></td><td style="text-align: justify"><b>Paycheck Protection Program Notes</b></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify; text-indent: 0in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0in">On May 7, 2020 and
March 25, 2021, Beamr Inc. entered into separate Paycheck Protection Program Notes (the &#8220;PPP Notes&#8221;) with SVB under which
Beamr Inc. borrowed amounts of $75 and $54, respectively, (in aggregate the &#8220;PPP Amount&#8221;). The PPP Amount bears interest of
1.0% per annum. Beamr Inc. was required make a monthly payment of principal and interest on the applicable PPP Amount, each monthly payment
to be in equal amounts such that the applicable PPP Amount was fully amortized by the maturity date which was determined as 24 months
from the date of the first PPP Note or 60 months from the date of the second PPP Note. At any time, Beamr Inc. was entitled to fully prepay
the PPP Amount without payment of penalty or premium.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify; text-indent: 0in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0in">The Company used
the PPP Amount for qualifying expenses which may be forgiven if it is utilized for qualifying expenses as described in the CARES Act.
In 2021, the PPP Amount was fully forgiven due to qualification for used expenses under the CARES Act and consequently the Company recorded
an amount of $129 under other income in the consolidated Statement of Operations and Comprehensive Loss for the year ended December 31,
2021.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: 0in">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0%"/><td style="width: 0.5in"><b>C.</b></td><td style="text-align: justify"><b>Funding Agreement with IBI Spikes Ltd.</b></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify; text-indent: 0in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0in">On July 7, 2022 (the
&#8220;Effective Date&#8221;), the Company entered into the Definitive Agreement with IBI Spikes Ltd. (the &#8220;IBI&#8221;), according
to which the Company received an amount of NIS 3.1 million (approximately $900) (the &#8220;IBI Loan&#8221;). The Company granted IBI
a right to receive consecutive monthly repayments equal to Net Cash Receipts multiplied by the Royalty Rate, as both defined in the Definitive
Agreement, until such time as IBI receives an amount equal to NIS 4,172,760 (approximately $1.2 million) (the &#8220;Repayment Amount&#8221;)
with any amount on account of the Repayment Amount which remains outstanding on the 42nd month anniversary of the later of (i) the Closing
Date, and (ii) the last payment provided by IBI (the &#8220;Final Repayment Date&#8221;) to be paid to IBI at such time. Notwithstanding
the above, Company&#8217;s minimum annual payment during any Annual Calculation Period will not be less than the lower of (i) $330 and
(ii) the outstanding Repayment Amount in recent year.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify; text-indent: 0in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0in">The Company may repay
the Repayment Amount at any time prior to the Final Repayment Date. If early repayment (such amount, the &#8220;Payment Amount&#8221;)
occurs prior to 12-month anniversary date of the Effective Date, then, a 50% discount will be applied on the outstanding difference between
the Repayment Amount and the Payment Amount (the &#8220;Rev-Share Amount&#8221;) component of the outstanding Repayment Amount; or if
early repayment occurs after 12-month anniversary date of the Closing Date but before 18-month anniversary date of the Closing Date, then,
a 35% discount will be applied on the outstanding Rev-Share Amount of the outstanding Repayment Amount (the &#8220;Early Repayment Amount&#8221;).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify; text-indent: 0in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0in">In case the Company
and/or its subsidiaries consummates a change of control, merger transaction, IPO (excluding an IPO on the Nasdaq Capital Market (the &#8220;Nasdaq&#8221;))
or sale of all or substantially all of assets (the &#8220;Exit Event&#8221;), the Company shall fully pay IBI the Repayment Amount or
the Early Repayment Amount, as the case may be.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify; text-indent: 0in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0in">The Company incurred
non-refundable one-time fee of $13, reflecting 1.5% of the Payment Amount plus VAT.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify; text-indent: 0in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0in">Upon making of the
Payment Amount, the Company issued warrant to IBI to purchase 65,563 of (i) the most senior class of shares outstanding or (ii) Ordinary
Shares in case of an exercise following to completion of an IPO transaction (the &#8220;Warrant Share&#8221;). The exercise price for
each of the Warrant Share, shall be as follows:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify; text-indent: 0in">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">1.</td><td style="text-align: justify">If financing round in consideration for an aggregate investment of at least $10,000 (including the Investment
Amount and any additional amount provided to the Company under any additional AIA) (the &#8220;Qualified Financing&#8221;) occurs within
12 months following the Effective Date consummates, the exercise price for each Warrant Share, will be the price per share in such Qualified
Financing, less a 20% discount and the shares type upon conversion of the Warrant Share shall have the same rights and preferences as
attached to the shares issued to the investors in such Qualified Financing. If transactions consummated in such closings are not on the
same terms and conditions and/or involve the issuance of more than one type of Company&#8217;s securities, then, the shares type upon conversion
of the Warrant Share shall have the most favorable terms of such closing.</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt; text-align: justify; text-indent: -21.25pt">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">2.</td><td style="text-align: justify">If a Non-Qualified Financing occurs, IBI shall have the right but not the obligation to elect, by delivery
of written notice to the Company no later than 30 days from the receipt of a written notice from the Company setting forth the terms and
conditions of such Non-Qualified Financing, to determine that the exercise price for each Warrant Share, will be the price per share in
such Non-Qualified Financing, less a 20% discount and the shares type upon conversion of the Warrant Share shall have the same rights
and preferences as attached to the shares issued to the investors in such Non-Qualified Financing. If transactions consummated in such
closings are not on the same terms and conditions and/or involve the issuance of more than one type of Company&#8217;s securities, then, the
shares type upon conversion of the Warrant Share shall have the most favorable terms of such closing.</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt; text-align: justify; text-indent: -21.25pt">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">3.</td><td style="text-align: justify">In the event the Company has not consummated (a Qualified Financing or an Realization Event (as defined
in the Definitive Agreement) within period of 12 months of the Effective Date of the Definitive Agreement, IBI shall have the right but
not the obligation to elect, by delivery of written notice to the Company no later than 30-days from the receipt of a written notice from
the Company, to determine that the exercise price for each Warrant Share will be based on Company value of $62,500 divided by the then
fully diluted number of Company shares and the shares type upon conversion of the Warrant Share shall have the same rights of the Company&#8217;s
most senior class of shares then outstanding.</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt; text-align: justify; text-indent: -21.25pt">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">4.</td><td style="text-align: justify">In the event of Realization Event, the exercise price for each Warrant Share will be the price per share
in such Financing, less a 20% discount, and the shares type upon conversion of the Warrant Share shall have the Company&#8217;s Most Senior
Shares, or Ordinary Shares in case the Realization Event is an IPO.</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify; text-indent: 0in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0in">Each Warrant Share
is exercisable until the earlier of (a) M&amp;A, (b) IPO, or (c) a 10-years period from the issuance date and shall be in customary form
approved by IBI and shall contain standard and customary provisions.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify; text-indent: 0in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0in">As the exercise price
of the Warrant Share will be determined based on the occurrence of one of the aforesaid trigger events, the Warrant Share was accounted
for as a derivative financial liability. (See note 8).</p><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0in">Pursuant to the above,
at the Effective Date, management by assistance of third-party appraiser allocated the IBI Loan to identified components as follows:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify; text-indent: 0in">&#160;</p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>As of Closing Date</b></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%; text-align: left">Derivative warrant liability (see Note 8)</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right">&#160;&#160;&#160;&#160;&#160;78</td>
    <td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Straight loan</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">822</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Total gross consideration</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; text-align: right">900</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify; text-indent: 0in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0in">Total incremental and direct debt costs of $1 and $12 were allocated to Warrant Share and straight loan, respectively, based on their
relative value at the Effective Date. The portion of issuance costs allocated to Warrant Share was recognized immediately as finance expenses
in the consolidated statements of operations and comprehensive loss and the portion of issuance costs allocated to straight loan was deducted
from the principal amount.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify; text-indent: -21.3pt"><b>&#160;</b></p><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0%"/><td style="width: 0.5in"><b>D.</b></td><td style="text-align: justify">The following tabular presentation reflects the reconciliation of the carrying amount of the Company&#8217;s
loans during the years ended December 31, 2022, 2021:</td></tr></table><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="text-align: center; border-bottom: Black 1.5pt solid"><b>Year ended  December 31,</b></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2020</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left; text-indent: -14.15pt; padding-left: 14.15pt">Opening balance</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right">508</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right">1,069</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right">1,469</td>
    <td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -14.15pt; padding-left: 14.15pt">Consideration received from PPP Note</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-55">-</div></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">54</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">75</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -14.15pt; padding-left: 14.15pt">Net consideration received from IBI Loan</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">887</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-56">-</div></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-57">-</div></td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -14.15pt; padding-left: 14.15pt">Recognition of fair value of derivative warrant liability</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">(88</td>
    <td style="text-align: left">)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-58">-</div></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-59">-</div></td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -14.15pt; padding-left: 14.15pt">PPP Note forgiveness (see also Note 6B)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-60">-</div></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">(129</td>
    <td style="text-align: left">)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-61">-</div></td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -14.15pt; padding-left: 14.15pt">Amortization of discounts relating to straight loan (see also Note 13)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">14</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">14</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">29</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -14.15pt; padding-left: 14.15pt">Accrued interest expenses relating to straight loan (see also Note 13)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">77</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">45</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">91</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -14.15pt; padding-left: 14.15pt">Repayment of accrued interest relating to straight loan</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">(77</td>
    <td style="text-align: left">)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">(45</td>
    <td style="text-align: left">)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">(91</td>
    <td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -14.15pt; padding-left: 14.15pt">Repayment of Facility Fee relating to straight loan</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">(10</td>
    <td style="text-align: left">)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">(40</td>
    <td style="text-align: left">)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-62">-</div></td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -14.15pt; padding-left: 14.15pt">Repayment of principal relating to straight loans</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">(582</td>
    <td style="text-align: left">)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">(500</td>
    <td style="text-align: left">)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">(504</td>
    <td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -14.15pt; padding-left: 14.15pt">Derecognition due to extinguishment of original straight loan</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-63">-</div></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">(672</td>
    <td style="text-align: left">)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-64">-</div></td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -14.15pt; padding-left: 14.15pt">Recognition subsequent to substantial modification of terms</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-65">-</div></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">712</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-66">-</div></td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -14.15pt; padding-left: 14.15pt">Exchange rate differences</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">(12</td>
    <td style="padding-bottom: 1.5pt; text-align: left">)</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-67">-</div></td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-68">-</div></td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 4pt; text-indent: -14.15pt; padding-left: 14.15pt">Closing balance</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; text-align: right">717</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; text-align: right">508</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; text-align: right">1,069</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify; text-indent: 0in">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0%"/><td style="width: 0.5in"><b>E.</b></td><td style="text-align: justify">Maturity dates of outstanding loans:</td></tr></table><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="text-align: center; border-bottom: Black 1.5pt solid"><b>As of <br/>
December 31,</b></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; text-indent: -14.15pt; padding-left: 14.15pt">First year (current maturities) (*)</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right">164</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right">508</td>
    <td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -14.15pt; padding-left: 14.15pt">Second year</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">288</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-69">-</div></td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -14.15pt; padding-left: 14.15pt">Third year</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">265</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-70">-</div></td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 4pt; text-indent: -14.15pt; padding-left: 14.15pt">Closing balance</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; text-align: right">717</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; text-align: right">508</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left">(*)</td><td style="text-align: justify">As described in Note 6C above, the Company is required to repay
each year a minimum amount of $330 with respect to Repayment Amount (principal and interest).</td>
</tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI https://asc.fasb.org/topic&amp;trid=2208564<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140231518706896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Current Liabilities<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrentAbstract', window );"><strong>Other Current Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock', window );">OTHER CURRENT LIABILITIES</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63.8pt; text-align: left; text-indent: -63.8pt"><b>NOTE 7 - OTHER
CURRENT LIABILITIES</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63.8pt; text-align: left; text-indent: -63.8pt"><b>&#160;</b></p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: justify">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"><b>As of <br/>
December 31,</b></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; text-indent: -14.15pt; padding-left: 14.15pt">Employees and payroll accruals</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right">298</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right">341</td>
    <td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -14.15pt; padding-left: 14.15pt">Accrued expenses (*)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">85</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">126</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -14.15pt; padding-left: 14.15pt">Government authorities</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">42</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">33</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 4pt; text-indent: -14.15pt; padding-left: 14.15pt">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; text-align: right">425</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; text-align: right">500</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left">(*)</td><td style="text-align: justify">Including accrued interest relating to straight loan amounted
to $11 as of December 31, 2022. See also Note 13.</td>
</tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140231435298544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Warrants Liabilities<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Warrants Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock', window );">DERIVATIVE WARRANTS LIABILITIES</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.65pt; text-align: left; text-indent: -5.65pt"><b>NOTE 8 - DERIVATIVE
WARRANTS LIABILITIES</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.65pt; text-align: left; text-indent: -5.65pt"><b>&#160;</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">The following tabular presentation
reflects the reconciliation of the fair value of derivative warrants liabilities during the years ended December 31, 2022, 2021 and 2020:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -0.125in; text-align: justify">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Year ended  December 31,</b></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: justify">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; width: 76%; text-align: left">Opening balance</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right">50</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-71">-</div></td>
    <td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Recognition of fair value of 2021 Warrant issued upon substantial modification of terms (see Note 6A1)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-72">&#160;&#160;&#160;&#160;&#160;&#160;-</div></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">50</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Recognition of fair value of Warrant Share issued at Effective Date (see Note 6C)</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">88</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-73">-</div></td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Closing balance</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; text-align: right">138</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; text-align: right">50</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">The fair values of the 2021
Warrant and the Warrant Share were determined by the Company&#8217;s management with the assistance of an independent valuation firm by using
the Hybrid Method by combining the OPM and an IPO scenario. Because there has been no public market for the Ordinary Shares, the Company&#8217;s
management has determined fair value of the Ordinary Shares at the time of grant by considering several objective and subjective factors
including data from other comparable companies, the lack of liquidity of share capital and general and industry specific economic outlook,
amongst other factors. The fair value of the underlying Ordinary Shares shall be determined by management until such time as the Ordinary
Shares are listed on an established stock exchange, national market system or other quotation system.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">Through December 31, 2022, the
estimated fair values of derivative liability for the 2021 Warrant and Warrant Share have not changed significantly and the 2021 Warrant
and Warrant Share have not been exercised.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -URI https://asc.fasb.org/topic&amp;trid=2229140<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126731327&amp;loc=d3e90205-114008<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140231435477744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Convertible Advance Investment<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_InvestmentHoldingsAbstract', window );"><strong>Convertible Advance Investment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentHoldingsTextBlock', window );">CONVERTIBLE ADVANCE INVESTMENT</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.65pt; text-align: left; text-indent: -5.65pt"><b>NOTE 9 - CONVERTIBLE
ADVANCE INVESTMENT</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.65pt; text-align: left; text-indent: -5.65pt"><b>&#160;</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">On August 25, 2021 and August
6, 2019, the Company entered into separate Advance Investment Agreements (the &#8220;AIA&#8221;) with several current shareholders (the
&#8220;2021 AIA Investors&#8221;, &#8220;2019 AIA Investors&#8221; and together the &#8220;AIA Investors&#8221;) under which the Company
raised an amount of $560 and $3,097, respectively, (together the &#8220;AIA Investment Amounts&#8221;) which is not interest bearing but
is eligible for conversion into shares of the Company, based on the following terms:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify; text-indent: -21.3pt">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0%"/><td style="width: 0.25in">1.</td><td style="text-align: justify">In the event of a consummation by the Company of a transaction or series of related transactions in which
the Company issues preferred shares for an aggregate investment of at least $10,000 (including the AIA Investment Amounts and any additional
amount provided to the Company under any additional AIA Agreement(s)) (the &#8220;AIA Qualifying Financing&#8221;), the AIA Investment
Amounts shall automatically be converted immediately prior to the consummation of such Qualified Financing into such number of preferred
shares (or a sub-class thereof) issued in such Qualified Financing (the &#8220;Next Round Shares&#8221;), as is obtained by dividing the
AIA Investment Amounts by a price per share which shall reflect a 20% discount off the lowest price per share paid in the AIA Qualified
Financing.</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify; text-indent: -21.3pt">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0%"/><td style="width: 0.25in">2.</td><td style="text-align: justify">In the event of a consummation by the Company of a transaction or series of related transactions in which
the Company issues preferred shares in consideration for an aggregate investment of less than $10,000 (including the AIA Investment Amounts
and any additional amount provided to the Company under any additional AIA Agreement(s)), or which for any other reason would not be deemed
as a AIA Qualified Financing (the &#8220;AIA Non-Qualified Financing&#8221;), then each time when the Company consummates such Non-Qualified
Financing, the AIA Investors shall have the right (but not the obligation) to elect to be converted immediately prior to the consummation
of such Non-Qualified Financing the AIA Investment Amounts into the shares and/or securities issued and sold at the closing of such Non-Qualified
Financing in accordance with 20% discount off the price per share paid in the Non-Qualified Financing.</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify; text-indent: -21.3pt">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0%"/><td style="width: 0.25in">3.</td><td style="text-align: justify">In the event that the Company has not consummated a AIA Qualified Financing or an Exit Event (as defined
below) and the AIA Investment Amounts or any portion thereof has not been converted in accordance with the terms of the AIA Agreements
by August 26, 2022, then, the 2021 AIA Investors shall have the right (but not the obligation) to elect, by delivery of written notice
to the Company no later than 30 days from the receipt of a written notice from the Company, to convert their AIA Investment Amount into
such number of shares of the Company of the most senior class then outstanding (the &#8220;Most Senior Shares&#8221;), equal to the quotient
received by dividing their AIA Investment Amount by a price per share reflecting a pre-money valuation of the Company (determined on a
fully diluted basis as of the date of the conversion) of $62,500 (&#8220;AIA Target Valuation&#8221;).</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify; text-indent: -21.3pt">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0%"/><td style="width: 0.25in">4.</td><td style="text-align: justify">In the event of the consummation of an Acquisition or an Asset Transfer (as defined in the Company&#8217;s Articles
of Association), each, an &#8220;Exit Event&#8221;, then immediately prior to the closing of such Acquisition or Asset Transfer, the AIA
Investors shall either elect, at its discretion, to (i) convert the AIA Investment Amounts into such number of Most Senior Shares, as
is obtained by dividing the AIA Investment Amounts by the quotient obtained by dividing (A) the AIA Target Valuation by (B) the issued
and outstanding share capital of the Company, on a fully diluted basis, as of immediately prior to the closing of the Acquisition or Asset
Transfer, as applicable, excluding any shares to be issued under the AIA Agreement); or (ii) receive, prior and in preference to payment
in respect of other Company securities, a redemption payment equal to 200% of the AIA Investment Amounts.</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify; text-indent: -21.3pt">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0%"/><td style="width: 0.25in">5.</td><td style="text-align: justify">In connection with the effectiveness of the Company&#8217;s initial public offering of its Ordinary Shares
on the Nasdaq (see Note 17), the AIA Investment Amounts automatically converted into Ordinary Shares at a conversion price equal to 80%
of the initial public offering price of $4.00.</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">In addition to the mechanism
for the repayment of the investment through shares, subject to the scenarios set out above, the AIA Agreements provide that upon the occurrence
of certain bankruptcy related events, the Company will be required to pay the AIA Investors in cash the amount of their original investment.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">Moreover, upon entry into the
AIA, the Company entered into a subordination agreement under which the AIA Investors agreed that all of the Company&#8217;s indebtedness
and obligations to the AIA Investors pursuant to the AIA is subordinated to all of the Company&#8217;s indebtedness and obligations to
SVB under the Loan Agreement. See also Note 6A.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">As described in Note 2V, based
on the characteristics of the convertible advance investments (and its embedded derivatives), the Company elected to measure this liability
in its entirety, at its fair value (the &#8220;Fair Value Option&#8221;) in accordance with ASC 825-10, &#8220;Financial Instruments&#8221;
due to the existence of a certain redemption option and the potential requirement to recognize contingent BCF. Measurement of the fair
value of the convertible advance investments was classified as level 3 of the fair value hierarchy, using the scenario method.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">The following tabular presentation
reflects the reconciliation of the carrying amount of the convertible advance investment during the years ended December 31, 2022, 2021
and 2020:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="text-align: center; border-bottom: Black 1.5pt solid"><b>Year ended December 31,</b></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2020</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left; text-indent: -14.15pt; padding-left: 14.15pt">Opening balance</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right">4,770</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right">3,922</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right">3,486</td>
    <td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -14.15pt; padding-left: 14.15pt">Net consideration received</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-74">-</div></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">560</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-75">-</div></td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -14.15pt; padding-left: 14.15pt">Change in the fair value of convertible advance investments (see also Note 13)</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">70</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">288</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">436</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 4pt; text-indent: -14.15pt; padding-left: 14.15pt">Closing balance</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; text-align: right">4,840</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; text-align: right">4,770</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; text-align: right">3,922</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmr_InvestmentHoldingsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmr_InvestmentHoldingsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentHoldingsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for investment holdings. This includes the long positions of investments for the entity. It contains investments in affiliated and unaffiliated issuers. The investments include securities and non securities (i.e. commodities and futures contracts).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 320<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14)<br> -URI https://asc.fasb.org/extlink&amp;oid=122147990&amp;loc=d3e611322-123010<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 320<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B)<br> -URI https://asc.fasb.org/extlink&amp;oid=122147990&amp;loc=d3e611197-123010<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 320<br> -Section S99<br> -Paragraph 5D<br> -Subparagraph (SX 210.12-13D)<br> -URI https://asc.fasb.org/extlink&amp;oid=122147990&amp;loc=SL120429264-123010<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 320<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12)<br> -URI https://asc.fasb.org/extlink&amp;oid=122147990&amp;loc=d3e611133-123010<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 320<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SX 210.12-13)<br> -URI https://asc.fasb.org/extlink&amp;oid=122147990&amp;loc=d3e611282-123010<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentHoldingsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140231518655680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingent Liabilities<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingent Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">COMMITMENTS AND CONTINGENT LIABILITIES</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63.8pt; text-align: left; text-indent: -63.8pt"><b>NOTE 10 - COMMITMENTS
AND CONTINGENT LIABILITIES</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63.8pt; text-align: left; text-indent: -63.8pt"><b>&#160;</b></p><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0%"/><td style="width: 0.5in">A.</td><td style="text-align: justify">Lease commitments</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.3pt; text-align: justify; text-indent: -0.25in">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">1.</td><td style="text-align: justify">On July 29, 2020, the Company entered into a lease agreement for premises with an unrelated party over
a period commencing August 24, 2020 through February 28, 2021, for a monthly rental fee amounted of NIS 18 (approximately $5.6).</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.3pt; text-align: justify; text-indent: 0in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: 0in">In January 2021,
the Company renewed its lease agreement with an unrelated party for the period commencing March 1, 2021 through August 31, 2021 for a
monthly fee of NIS 17 thousand (approximately $5.3). In August 2021, the Company renewed its lease agreement with an unrelated party for
a further period commencing September 1, 2021 through February 28, 2022 for a monthly fee of NIS 21 thousand (approximately $6.5).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.3pt; text-align: justify; text-indent: 0in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: 0in">In February 2022,
the Company renewed its lease agreement with an unrelated party for a period commencing March 1, 2022 through August 31, 2022 for a monthly
fee of NIS 23 thousand (approximately $7.4). In August 2022, the Company renewed its lease agreement with an unrelated party for the period
commencing September 1, 2022 through August 31, 2023 for a monthly fee of NIS 25 thousand (approximately $7.1).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.3pt; text-align: justify; text-indent: -0.25in">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">2.</td><td style="text-align: justify">On November 1, 2020, Beamr Imaging RU entered into a lease agreement for premises with an unrelated party
over a period until September 30, 2021, for a monthly a rental fee of Russian Ruble 200 (approximately $3).</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.3pt; text-align: justify; text-indent: 0in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: 0in">On October 1, 2021,
Beamr Imaging RU entered into a lease agreement for premises with an unrelated party over a period until August 30, 2022, for a monthly
a rental fee of Russian Ruble 213 (approximately $3). In September 2022, Beamr Imaging RU renewed its lease agreement for the period commencing
September 1, 2022 through July 31, 2023 for a monthly fee of Russian Ruble 213 (approximately $3).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify; text-indent: 0in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0in">As of December 31,
2022, the future minimum commitment under binding short-term operating lease agreements is as follows:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify; text-indent: 0in">&#160;</p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Lease of<br/>
 premises</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%; text-align: left; padding-bottom: 1.5pt">2023</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;77</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 4pt; padding-left: 2.85pt">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">77</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify; text-indent: 0in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0in">The payments above are associated with short-term operating leases of premises with a lease term of twelve months or less. As the Company
elected the short-term recognition exemption (see also Note 2I), such leases are out of scope of ASC 842 &#8220;Leases&#8221;. Consequently,
these payments are recognized on a straight-line basis as an operating expense in the Consolidated Statements of Operations and Comprehensive
Loss.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify; text-indent: 0in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0in">During the years
ended December 31, 2022, 2021 and 2020, the total lease expenses were $119, $115 and $167, respectively.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify; text-indent: -21.3pt">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0%"/><td style="width: 0.5in">B.</td><td style="text-align: justify">Grant of share options upon completion of an IPO transaction</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify; text-indent: 0in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0in">On March 14, 2022,
the Company&#8217;s shareholders approved, among other matters, that upon completion of the IPO transaction, each of the member of the Company&#8217;s
Board of Directors (except the Founder which serves inter alia as the Board chairman) will be entitled to 19,000 share options to purchase
the same number of Ordinary Shares at an exercise price that will be equal to the listing price per share over a vesting schedule on a
monthly basis over 36-months period commencing the listing date. However, as the grant is contingent upon a performance condition (successful
IPO) which is out of the Company&#8217;s control, the related expenses will be recognized when the IPO will occur. Accordingly, compensation
cost relating to such obligation has not been recorded in 2022.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI https://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI https://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140231433590112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders&#8217; Equity (Deficit)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Shareholders&#8217; Equity (Deficit) [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">SHAREHOLDERS&#8217; EQUITY (DEFICIT)</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><b>NOTE 11 - SHAREHOLDERS&#8217; EQUITY
(DEFICIT)</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Composition of shareholders&#8217; equity (deficit):</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">As of <br/> December 31, 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">As of <br/> December 31, 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Authorized</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Issued and<br/> outstanding</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Authorized</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Issued and<br/> outstanding</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="14" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number of shares</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">Shares of NIS&#160;0.05 par value:</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left">Series Ordinary Shares (A)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">14,307,116</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">2,578,760</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">14,316,880</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">2,578,760</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Series Convertible Ordinary 1 Shares (B)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">607,680</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">607,680</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">607,680</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">607,680</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Series Convertible Ordinary 2 Shares (B)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">889,200</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">889,200</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">889,200</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">889,200</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Series Convertible B Preferred Shares (B)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,047,200</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,047,200</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,047,200</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,047,200</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Series Convertible B1 Preferred Shares B)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">738,240</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">738,240</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">738,240</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">738,240</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Series Convertible C Preferred Shares (B)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,410,564</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,928,960</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,400,800</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,928,960</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 4pt">Total</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">22,000,000</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">9,790,040</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">22,000,000</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">9,790,040</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.3pt; text-align: justify"><b>&#160;</b></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left">A.</td><td style="text-align: justify">The Ordinary Shares confer upon the holders thereof all rights
accruing to a shareholder of the Company, as provided in the Company&#8217;s Articles of Association (the &#8220;Articles&#8221;), including,
without limitation, the right to receive notices of, and to attend, all general meetings, the right to vote thereat with each Ordinary
Share held entitling the holder thereof to one vote at all general meetings (and written actions in lieu of meetings), the right to participate
and share on a per share basis, in any distribution and in distribution of surplus assets and funds of the Company in the event of a
liquidation event, and certain other rights as may be expressly provided for herein or under the Companies Law. All Ordinary Shares rank
pari passu amongst themselves for all intents and purposes, including, without limitation, in relation to the amounts of capital paid
or credited as paid on their nominal value. The voting, dividend and liquidation rights of the holders of Ordinary Shares are subject
to and qualified by the rights, powers and preferences of the holders of the Convertible Preferred Shares and the Convertible Ordinary
1 and 2 Shares as set below.</td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify; text-indent: -21.3pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left">B.</td><td style="text-align: justify">The Convertible Ordinary 1 Shares, Convertible Ordinary 2 Shares,
Convertible B Preferred Shares, Convertible B1 Preferred Shares and the Convertible C Preferred Shares (referring together herein as
&#8220;Convertible Preferred Shares&#8221;) shall confer upon the holders thereof all rights conferred upon the holders of Ordinary Shares
in the Company. In addition, the holders of Convertible Preferred Shares shall have rights, preferences and privileges, as follows:</td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify">Liquidation preference&#160;- Based
on preference of distribution, in the event of any liquidation, dissolution or winding up of the Company, whether voluntary or involuntary,
change in control or distribution, the Company&#8217;s assets or surplus funds legally available for distribution shall be distributed to the
holders of Convertible Preferred Shares pursuant to which each Convertible Preferred Share will be entitled to receive 1.2 of the applicable
original issue price paid by each Convertible Preferred shareholder plus all accrued but unpaid dividends and less the aggregate of all
amounts previously paid in preference. The aggregate liquidation preference of all shares with preferences over Ordinary Shares as of
December&#160;31, 2022 and 2021 amounted to $33,785. None of the foregoing dollar amounts include dividends, as the Board of Directors
has not declared any dividends since inception.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify">The Convertible Preferred Shares have
been classified as part of the permanent equity of the Company since upon occurrence of liquidation event all holder of the Ordinary Shares
and the Convertible Preferred Shares will be entitled to receive the same form of consideration.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify">Voting&#160;- Each shareholder shall
have one vote for each Ordinary Share held by such shareholder of record or such Ordinary Shares as would be held by each holder of Convertible
Preferred Share if all Convertible Preferred Shares were converted to Ordinary Shares at the then effective conversion rate, on every
resolution.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify">Conversion&#160;- Each holder of a
Convertible Preferred Share shall be entitled to convert, at any time and from time to time, and without payment of additional consideration,
into such number of fully paid and non-assessable shares of Ordinary Share in ratio as determined in the Articles, which initially shall
be one to one. The conversion price initially shall be the applicable Original Issue Price subject to adjustments as describe in the Articles.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify">All outstanding Convertible Preferred
Shares shall automatically be converted into Ordinary Shares at the then-effective conversion rate applicable upon the earlier of (i)
closing of sale of Ordinary Shares in an initial firm-commitment underwritten public offering, with net proceeds to the Company of $50,000
and at an offering price per share equal to at least 5 times the Preferred C Original Issue Price (Qualified IPO) or (ii) affirmative
vote or written consent of majority shareholders of the then outstanding Convertible Preferred Shares, with respect to each series.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0%"/><td style="width: 0.5in">C.</td><td style="text-align: justify">On March 14, 2022, the Company&#8217;s shareholders approved, among other matters, the following matters as
were originally approved by the Company&#8217;s Board of Directors on March&#160;1, 2022&#160;-</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify; text-indent: -21.3pt">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">1.</td><td style="text-align: justify">In connection with listing of the Company&#8217;s Ordinary Shares on
Nasdaq, increase the Company&#8217;s authorized shares from 22,000,000 to 222,000,000.</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt; text-align: justify; text-indent: -21.25pt">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">2.</td><td style="text-align: justify">Approve and ratify (i) subject to the listing of the Company&#8217;s Ordinary Shares on Nasdaq, the voluntary
conversion of all the Ordinary 1, Ordinary 2, Preferred B, Preferred B-1 and Preferred B shares of the Company into Ordinary Shares (collectively,
the &#8220;Voluntary Conversion&#8221;), (ii) subject to the listing of the Company&#8217;s Ordinary Shares on Nasdaq, a reverse share
split of all outstanding Ordinary Shares of the Company at a ratio of 5:1 so that each 5 ordinary shares nominal value NIS 0.01 each shall
be consolidated into 1 Ordinary Share each, and (the &#8220;Reverse Share Split&#8221;) (iii) subject to the listing of the Company&#8217;s
Ordinary Shares on Nasdaq, the recapitalization and redistribution of the entire share capital of the Company (the &#8220;Recapitalization&#8221;),
so that following such Voluntary Conversion and Recapitalization, the share capital of the Company shall consist of NIS 11,100,000 divided
into 222,000,000 Ordinary Shares each of which 9,790,040 are issued and outstanding (post the aforesaid Reverse Share Split).</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt; text-align: justify; text-indent: -21.25pt">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify">For accounting purposes, following
the completion of the IPO transaction as noted in Note 17 below, all shares, options and warrants to purchase Ordinary Shares and loss
per share amounts have been adjusted to give retroactive effect to the Reverse Share Split for all periods presented in these consolidated
financial statements. Any fractional shares resulting from the Reverse Share Split were rounded up to the nearest whole share.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI https://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496180-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126731327&amp;loc=SL126733271-114008<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140231432600160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share Options<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share Options [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">SHARE OPTIONS</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><b>NOTE 12 - SHARE OPTIONS</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><b>&#160;</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Share option plan:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On January 11, 2015, the Company&#8217;s Board
of Directors approved and adopted the 2015 Share Incentive Plan (the &#8220;Plan&#8221;), pursuant to which the Company&#8217;s Board
of Directors may award share options to purchase the Company&#8217;s Ordinary Shares as well as restricted shares, RSUs and other share-based
awards to designated participants. Subject to the terms and conditions of the Plan, the Company&#8217;s Board of Directors has full authority
in its discretion, from time to time and at any time, to determine (i) the designate participants; (ii) the terms and provisions of the
respective award agreements, including, but not limited to, the number of share options to be granted to each optionee, the number of
shares to be covered by each share option, provisions concerning the time and the extent to which the share options may be exercised and
the nature and duration of restrictions as to the transferability or restrictions constituting substantial risk of forfeiture and to cancel
or suspend awards, as necessary; (iii) determine the fair market value of the shares covered by each award; (iv) make an election as to
the type of approved 102 Option under Israeli tax law; (v) designate the type of share options; (vi) take any measures, and to take actions,
as deemed necessary or advisable for the administration and implementation of the Plan; (vii) interpret the provisions of the Plan and
to amend from time to time the terms of the Plan.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Plan permits the grant of up to 2,069,280
share Ordinary Shares subject to adjustments set in the Plan. As of December 31, 2022, considering the effect of previously exercised
share options, there were 355,530 Ordinary Shares available for future issuance under the Plan.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table presents the Company&#8217;s
share option activity for employees and members of the Board of Directors of the Company under the Plan for the years ended December 31,
2022, 2021 and 2020:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: left"><b>&#160;</b></td>
    <td style="font-weight: bold; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><b>Number of<br/>
    Share<br/>
    Options</b></td>
    <td style="padding-bottom: 1.5pt; font-weight: bold"><b>&#160;</b></td>
    <td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><b>Weighted<br/>
    Average<br/>
    Exercise<br/>
    Price <br/>
$</b></td>
    <td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td style="font-weight: bold; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><b>Weighted<br/> average<br/>
    remaining<br/> contractual<br/> life (years)</b></td>
    <td style="padding-bottom: 1.5pt; font-weight: bold"><b>&#160;</b></td>
    <td style="font-weight: bold; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><b>Intrinsic<br/> value<br/>
 $</b></td>
    <td style="padding-bottom: 1.5pt; font-weight: bold"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left">Outstanding as of December 31, 2019</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 9%; text-align: right">1,291,810</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 9%; text-align: right">1.65</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: center">&#160;</td>
    <td style="width: 9%; text-align: right">5.94</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 9%; text-align: right">194</td>
    <td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Granted</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">353,960</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">1.80</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: right">9.35</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Exercised</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">(9,800</td>
    <td style="text-align: left">)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">1.15</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-76">-</div></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Forfeited or expired</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">(381,970</td>
    <td style="padding-bottom: 1.5pt; text-align: left">)</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">1.75</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-77">-</div></td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 4pt">Outstanding as of December 31, 2020</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: right">1,254,000</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: right">1.70</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: center">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: right">6.12</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: right">125</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 4pt">Exercisable as of December&#160;31, 2020</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: right">839,665</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: right">1.50</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: center">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: right">4.73</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: right">252</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: left"><b>&#160;</b></td>
    <td style="font-weight: bold; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><b>Number of<br/>
    Share<br/>
    Options</b></td>
    <td style="padding-bottom: 1.5pt; font-weight: bold"><b>&#160;</b></td>
    <td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><b>Weighted<br/>
    Average<br/>
    Exercise<br/>
    Price<br/>
    $</b></td>
    <td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td style="font-weight: bold; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><b>Weighted<br/> average<br/>
    remaining<br/> contractual<br/> life (years)</b></td>
    <td style="padding-bottom: 1.5pt; font-weight: bold"><b>&#160;</b></td>
    <td style="font-weight: bold; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><b>Intrinsic<br/> value<br/>
 $</b></td>
    <td style="padding-bottom: 1.5pt; font-weight: bold"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left">Outstanding as of December 31, 2020</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 9%; text-align: right">1,254,000</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 9%; text-align: right">1.70</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: center">&#160;</td>
    <td style="width: 9%; text-align: right">6.12</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 9%; text-align: right">125</td>
    <td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Granted</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">214,688</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">2.05</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: right">9.64</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Forfeited or expired</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">(101,520</td>
    <td style="padding-bottom: 1.5pt; text-align: left">)</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">1.80</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-78">-</div></td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Outstanding as of December 31, 2021</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: right">1,367,168</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: right">1.75</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: center">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: right">5.72</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: right">4,860</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Exercisable as of December&#160;31, 2021</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: right">927,988</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: right">1.60</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: center">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: right">4.25</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: right">3,429</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><b>&#160;</b></p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: left"><b>&#160;</b></td>
    <td style="font-weight: bold; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><b>Number of<br/>
    Share<br/>
    Options</b></td>
    <td style="padding-bottom: 1.5pt; font-weight: bold"><b>&#160;</b></td>
    <td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><b>Weighted<br/>
    Average<br/>
    Exercise<br/>
    Price<br/>
    $</b></td>
    <td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td style="font-weight: bold; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><b>Weighted<br/> average<br/>
    remaining<br/> contractual<br/> life (years)</b></td>
    <td style="padding-bottom: 1.5pt; font-weight: bold"><b>&#160;</b></td>
    <td style="font-weight: bold; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><b>Intrinsic<br/> value<br/>
    $</b></td>
    <td style="padding-bottom: 1.5pt; font-weight: bold"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left">Outstanding as of December 31, 2021</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 9%; text-align: right">1,367,168</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 9%; text-align: right">1.75</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: center">&#160;</td>
    <td style="width: 9%; text-align: right">5.72</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 9%; text-align: right">4,860</td>
    <td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Granted</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">286,875</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">1.83</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Forfeited or expired</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">(83,052</td>
    <td style="padding-bottom: 1.5pt; text-align: left">)</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">1.45</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">-</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Outstanding as of December 31, 2022</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: right">1,570,991</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: right">1.78</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: center">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: right">4.97</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: right">2,435</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Exercisable as of December&#160;31, 2022</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: right">1,048,297</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: right">1.70</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: center">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: right">3.2</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: right">1,677</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The aggregate intrinsic value in the table above represents the total intrinsic value (the difference between the deemed fair value of
the Company&#8217;s Ordinary Shares on the last day of each of the applicable reported period and the exercise price, multiplied by the number
of in-the-money share options) that would have been received by the share option holders had all share options holders exercised their
share options on December&#160;31 of each of the reported period. This amount is impacted by the changes in the fair market value of the
Company&#8217;s Ordinary Share.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The outstanding and exercisable share options
as of December&#160;31, 2022 have been separated into ranges of exercise prices, as follows:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; text-align: justify"><b>Exercise price</b></td>
    <td style="font-weight: bold; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><b>Share options<br/> outstanding<br/>
    as of<br/> December&#160;31,<br/> 2022</b></td>
    <td style="padding-bottom: 1.5pt; font-weight: bold"><b>&#160;</b></td>
    <td style="font-weight: bold; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><b>Weighted<br/> average<br/>
remaining<br/> contractual<br/> term (years)</b></td>
    <td style="padding-bottom: 1.5pt; font-weight: bold"><b>&#160;</b></td>
    <td style="font-weight: bold; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><b>Share options<br/> exercisable<br/>
    as of<br/> December&#160;31,<br/> 2022</b></td>
    <td style="padding-bottom: 1.5pt; font-weight: bold"><b>&#160;</b></td>
    <td style="font-weight: bold; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><b>Weighted<br/> average<br/>
    remaining<br/> contractual<br/> term (years)</b></td>
    <td style="padding-bottom: 1.5pt; font-weight: bold"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left"><b>$</b></td>
    <td><b>&#160;</b></td>
    <td colspan="2" style="text-align: right"><b>&#160;</b></td>
    <td><b>&#160;</b></td>
    <td><b>&#160;</b></td>
    <td colspan="2" style="text-align: center"><b>$</b></td>
    <td><b>&#160;</b></td>
    <td><b>&#160;</b></td>
    <td colspan="2" style="text-align: right"><b>&#160;</b></td>
    <td><b>&#160;</b></td>
    <td><b>&#160;</b></td>
    <td colspan="2" style="text-align: center"><b>$</b></td>
    <td><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left">0.00</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 9%; text-align: right">152,640</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: center">&#160;</td>
    <td style="width: 9%; text-align: right">2.42</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 9%; text-align: right">152,640</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: center">&#160;</td>
    <td style="width: 9%; text-align: right">1.03</td>
    <td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">1.14</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">228,480</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: right">1.39</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">228,480</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: right">1.39</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">1.67</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">43,200</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: right">2.21</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">43,200</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: right">2.21</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">1.83</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">982,870</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: right">6.75</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">489,239</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: right">4.70</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">3.2</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">35,001</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: right">6.45</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">10,938</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: right">6.45</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">3.79</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">60,000</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: right">1.59</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">60,000</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: right">1.59</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">4.17</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">28,800</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: right">3.03</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">28,800</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: right">3.03</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">5.12</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">40,000</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: right">6.54</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">35,000</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: right">6.54</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 4pt">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: right">1,570,991</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="padding-bottom: 4pt; text-align: center">&#160;</td>
    <td style="padding-bottom: 4pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: right">1,048,297</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="padding-bottom: 4pt; text-align: center">&#160;</td>
    <td style="padding-bottom: 4pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The weighted average grant date fair value of share options granted during the years ended December&#160;31, 2022, 2021 and 2020 was $0.51,
$0.44 and $0.20 per share option, respectively.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During the years ended December 31, 2022 and 2021,
share options have not been exercised into Ordinary Shares. During the year ended December 31, 2020, certain employees exercised 9,800
share options into the same number of Ordinary Shares for total consideration of $11.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table presents the assumptions used
to estimate the fair values of the share options granted in the reported periods presented:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="text-align: center; border-bottom: Black 1.5pt solid"><b>Year ended December 31</b></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2020</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">Volatility (%)</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 9%; text-align: right">61.49</td>
    <td style="width: 1%; text-align: left">%</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 9%; text-align: right">64.75</td>
    <td style="width: 1%; text-align: left">%</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="white-space: nowrap; width: 9%; text-align: right"><span style="font-size: 10pt">61.89%-61.91</span></td>
    <td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Risk-free interest rate (%)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="white-space: nowrap; text-align: right"><span style="font-size: 10pt">3.64%-3.85</span></td>
    <td style="text-align: left">%</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">0.09</td>
    <td style="text-align: left">%</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="white-space: nowrap; text-align: right"><span style="font-size: 10pt">0.03%-0.04</span></td>
    <td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Dividend yield (%)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-79">-</span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-80">-</span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">-</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Expected life (years)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">6.25</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">6.25</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">6.25</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Exercise price ($)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">1.83</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">1.80-3.20</span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">1.80</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Share price ($)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">3.30</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">3.20</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">1.80</td>
    <td style="text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of December 31, 2022, there was $1,029 of unrecognized
compensation expense related to unvested share options. The Company recognizes compensation expense on a straight-line basis over the
requisite service periods, which results in a weighted average period of approximately 1.72 years over which the unrecognized compensation
expense is expected to be recognized.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The total compensation cost related to all of
the Company&#8217;s equity-based awards recognized during the years ended December&#160;31, 2022, 2021 and 2020 was comprised as follows:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="text-align: center; border-bottom: Black 1.5pt solid"><b>Year ended December 31</b></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2020</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">Research and development</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right">144</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right">94</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right">60</td>
    <td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Sales and marketing</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">49</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">45</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">48</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">General and administrative</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">29</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">18</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">12</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; text-align: right">222</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; text-align: right">157</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; text-align: right">120</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI https://asc.fasb.org/topic&amp;trid=2228938<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140231433590112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financing Expenses, Net<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_FinancingExpensesAbstract', window );"><strong>Financing Expenses [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_FinancingExpenses', window );">FINANCING EXPENSES, NET</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63.8pt; text-align: left; text-indent: -63.8pt"><b>NOTE 13 - FINANCING
EXPENSES, NET</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63.8pt; text-align: left; text-indent: -63.8pt"><b>&#160;</b></p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="text-align: center; border-bottom: Black 1.5pt solid"><b>Year ended  December 31</b></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2020</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; width: 64%; text-align: left">Change in fair value of convertible advance investment (see Note 9)</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right">70</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right">288</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right">436</td>
    <td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Amortization of discount and accrued interest relating to straight loan received from commercial Bank (see Note 6 and Note 7)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">102</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">59</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">120</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Modification of terms relating to straight loan (see Note 6A1)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-81">-</div></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">90</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-82">-</div></td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Amortization of discount relating to liability to related party (see Note 14)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">40</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-83">-</div></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-84">-</div></td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Exchange rate differences and others</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">(47</td>
    <td style="padding-bottom: 1.5pt; text-align: left">)</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">38</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">141</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; text-align: right">165</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; text-align: right">475</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; text-align: right">697</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmr_FinancingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Financing expenses text block.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmr_FinancingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmr_FinancingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmr_FinancingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140231429152720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Parties Transactions<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">RELATED PARTIES TRANSACTIONS</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63.8pt; text-align: left; text-indent: -63.8pt"><b>NOTE 14 - RELATED
PARTIES TRANSACTIONS</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63.8pt; text-align: left; text-indent: -63.8pt"><b>&#160;</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The liability to related party derives from a
service agreement with the Company&#8217;s Founder under which the Company receives consulting services on recurring basis from the Founder
as Chief Executive Officer indirectly through an entity controlled by the Founder (the &#8220;Service Provider&#8221;) for total current
monthly gross amount of NIS 45 thousand. On March 14, 2022, the Company&#8217;s shareholders approved, among other matters, to renew the service
agreement with the Founder for a period ending December 31, 2025.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On February 16, 2022, the Company entered into
an addendum to the aforesaid service agreement with the Service Provider under which it was agreed that (i) the term of the service agreement
with the Service Provider was extended to December 31, 2025 and (ii) the then current liability towards the Service Provider as was accrued
for services rendered under the service agreement over a period commencing January 1, 2020 through the date hereof in total nominal amount
of $357 (the &#8220;Current Liability&#8221;) will be paid in 18 equal installments (without an interest) starting on March 1, 2022 (the
&#8220;Commencement Date&#8221;). However, in the event that the Company shall not have available sufficient funds in any such payment
date from and after the Commencement Date to repay the installments of the Current Liability and/or the on-going fee owed to the Service
Provider or in the event that the Company determines that according to the following 12-months period budget that it shall not have available
sufficient funds to pay such installments and/or the on-going fee, then the Service Provider hereby agrees to postpone such payments owed
to it until the Company will have such sufficient funds. Any unpaid on-going fee payments will be added to the Current Liability.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Since the liability towards the Founder was considered
as free interest loan which did not represent the applicable rate of risk for the Company, the aforesaid addendum was accounted for as
a capital contribution from a controlling shareholder. Thus, the liability towards the Founder was measured at fair value based on future
cash payments discounted using an interest rate of 15.45% which represented the applicable rate of risk for the Company, as determined
by management using the assistance of third-party appraiser. As a result, the Company recorded a discount on the balance of liability
towards the Founder in total amount of $112 against additional paid-in capital (including in respect to amounts due for services period
through fiscal year for 2022). The Company will record a discount expense over the economic life of the loan based on the effective interest
rate method. As of December 31, 2022, management has updated the repayments schedule of the obligation based on its current projection
of the availability of funds. Accordingly, the obligation is expected to be repaid over the following 24-months period.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following tabular presentation reflects the
reconciliation of the carrying amount of the Company&#8217;s Liability to related party, net during the years ended December 31, 2022,
2021 and 2020:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="text-align: center; border-bottom: Black 1.5pt solid"><b>Year ended  December 31,</b></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2020</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left; text-indent: -14.15pt; padding-left: 14.15pt">Opening balance</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right">345</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right">168</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-85">-</div></td>
    <td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -14.15pt; padding-left: 14.15pt">Accrued liability in respect to additional services rendered</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">115</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">177</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">168</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -14.15pt; padding-left: 14.15pt">Recognition of capital contribution from a controlling shareholder</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">(112</td>
    <td style="text-align: left">)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-86">-</div></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-87">-</div></td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -14.15pt; padding-left: 14.15pt">Amortization of discount relating to liability to related party</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">40</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-88">-</div></td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-89">-</div></td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 4pt; text-indent: -14.15pt; padding-left: 14.15pt">Closing balance</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; text-align: right">388</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; text-align: right">345</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; text-align: right">168</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Maturity dates:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="text-align: center; border-bottom: Black 1.5pt solid"><b>As of<br/>
 December 31,</b></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; text-indent: -14.15pt; padding-left: 14.15pt">First year (current maturities)</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right">126</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right">345</td>
    <td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -14.15pt; padding-left: 14.15pt">Second year</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">262</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-90">-</div></td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 4pt; text-indent: -14.15pt; padding-left: 14.15pt">Closing balance</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; text-align: right">388</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; text-align: right">345</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company allocated the expenses related to
the above service agreement and addendum as follows:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="text-align: center; border-bottom: Black 1.5pt solid"><b>Year ended  December 31</b></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2020</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left; text-indent: -8.6pt; padding-left: 8.6pt">Research and development</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right">42</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right">44</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right">82</td>
    <td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -8.6pt; padding-left: 8.6pt">Sales and marketing</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">42</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">44</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">58</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -8.6pt; padding-left: 8.6pt">General and administrative</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">83</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">89</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">108</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; text-align: right">167</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; text-align: right">177</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; text-align: right">248</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The allocation was done based on the management estimation to reflect the contribution to the related activity.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -URI https://asc.fasb.org/topic&amp;trid=2122745<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39691-107864<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140231433560656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Taxes on Income<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Taxes on Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">TAXES ON INCOME</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><b>NOTE 15 - TAXES ON INCOME</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><b>&#160;</b></p><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0%"/><td style="width: 0.5in"><b>A.</b></td><td style="text-align: justify">Israeli taxation:</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify">Taxable income of the Company is subject
to the Israeli corporate tax at the rate of 23%.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify">As of December 31, 2022, the Company
has net operating losses and capital losses carryforward for Israeli income tax purposes of approximately $27,169 and $409 respectively,
which can be offset against future taxable income for an indefinite period of time.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify">The Company has final (considered
final) tax assessments through the 2017 tax year.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: -28.35pt"><b>&#160;</b></p><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0%"/><td style="width: 0.5in"><b>B.</b></td><td style="text-align: justify">Foreign entities:</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 46.35pt; text-align: justify; text-indent: -0.25in">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">1.</td><td style="text-align: justify">Beamr Inc. is taxed under United States federal and state tax rules. Income tax is calculated based on
a U.S. federal tax rate of 21%.</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 46.35pt; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify">Beamr Inc. have not received final
tax assessments for the tax years ended December 31, 2019 through 2022.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 46.35pt; text-align: justify; text-indent: -0.25in">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">2.</td><td style="text-align: justify">Beamr Imaging RU is taxed under the Russian tax code at the rate of 0% (Clause 1.15 of Article 284 of
the Tax Code of the Russian Federation, with changes provided by Federal Law No. 321-FZ of 14.07.2022).</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 46.35pt; text-align: justify; text-indent: -0.25in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify">Beamr Imaging RU have not received
final tax assessments for the tax years ended December 31, 2020 through 2022.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 46.35pt; text-align: justify">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0%"/><td style="width: 0.5in"><b>C.</b></td><td style="text-align: justify">Taxes on income are comprised from taxes incurred as result of (i) withholding tax deducted at source
in accordance with U.S. - Israel tax treaty related to selling of software and (ii) implementation of the intercompany agreement between
the Company and&#160;Beamr Inc. for conducting reseller services and implementation of the intercompany agreement between the Company
and Beamr Imaging RU for conducting research and development services on behalf of the Company (see also Note 1B).</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: -28.35pt"><b>&#160;</b></p><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0%"/><td style="width: 0.5in"><b>D.</b></td><td style="text-align: justify">Loss (income) before taxes on income consists of the following:</td></tr></table><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="text-align: center; border-bottom: Black 1.5pt solid"><b>Year ended  December 31</b></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2020</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">Domestic</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right">1,293</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right">1,104</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right">2,529</td>
    <td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Foreign operations (Beamr Inc and Imaging RU)</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">(97</td>
    <td style="padding-bottom: 1.5pt; text-align: left">)</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">(204</td>
    <td style="padding-bottom: 1.5pt; text-align: left">)</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">(165</td>
    <td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; text-align: right">1,196</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; text-align: right">900</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; text-align: right">2,364</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0%"/><td style="width: 0.5in"><b>E.</b></td><td style="text-align: justify">Deferred income taxes reflect the net tax effects of net operating loss and temporary differences between
the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Significant
components of the Company&#8217;s deferred tax assets are as follows:</td></tr></table><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="text-align: center; border-bottom: Black 1.5pt solid"><b>As of <br/>
December 31</b></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">Composition of deferred tax assets:</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">Net operating loss and capital losses carry-forward</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right">6,343</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right">6,254</td>
    <td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Research and development credits</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">438</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">588</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Vacation accrual</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">48</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">62</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Net deferred tax asset before deferred tax liabilities and valuation allowance</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: right">6,829</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: right">6,904</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Valuation allowance</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">(6,829</td>
    <td style="padding-bottom: 1.5pt; text-align: left">)</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">(6,904</td>
    <td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Net deferred tax assets</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-91">-</div></td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-92">-</div></td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify">In assessing the realization of deferred
tax assets, management considers whether it is more likely than not that all or some portion of the deferred tax assets will not be realized.
The ultimate realization of the deferred tax assets is dependent upon the generation of future taxable income during the periods in which
temporary differences are deductible and net operating losses are utilized. Based on consideration of these factors, the Company recorded
a full valuation allowance as of December 31, 2022 and 2021.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: -28.35pt"><b>&#160;</b></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 28.35pt"><b>F.</b></td><td style="text-align: justify">During the years ended December 31, 2022, 2021 and 2020, the main reconciling item between the statutory
tax rate of the Company (as noted in Note 15A) and the effective tax rate at the rate of 4.4%, 5.8% and 4.0%, respectively, is the recognition
of valuation allowance in respect of deferred taxes relating to accumulated net operating losses carried forward and other permanent and
temporary differences due to the uncertainty of the realization of such deferred taxes and withholding taxes that were deducted by the
Company&#8217;s customers.</td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI https://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140231518828480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Geographical Information And Major Customers<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Geographical Information And Major Customers [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">SEGMENT GEOGRAPHICAL INFORMATION AND MAJOR CUSTOMERS</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><b>NOTE 16 - SEGMENT GEOGRAPHICAL
INFORMATION AND MAJOR CUSTOMERS</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0%"/><td style="width: 0.5in"><b>A.</b></td><td style="text-align: justify"><b>General information</b></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: -28.35pt"><b>&#160;</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify">Since inception date, the operation
of the Company is conducted through one operating segment, the optimization technology for video and photo compression, which represents
a single reporting unit. This activity also represents the reportable segment of the Group.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0%"/><td style="width: 0.5in"><b>B.</b></td><td style="text-align: justify"><b>Revenues by geographic region are as follows:</b></td></tr></table><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="text-align: center; border-bottom: Black 1.5pt solid"><b>Year ended December 31</b></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2020</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">United States</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right">2,134</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right">2,597</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right">2,558</td>
    <td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Israel</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">22</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">101</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">61</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Rest of the world</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">707</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">602</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">557</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; text-align: right">2,863</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; text-align: right">3,300</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; text-align: right">3,176</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify">Revenues were attributed to countries
based on customer location.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0%"/><td style="width: 0.5in"><b>C.</b></td><td style="text-align: justify"><b>Long-lived assets, net, by geographic areas:</b></td></tr></table><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: justify">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"><b>As of<br/>
 December 31,</b></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; text-indent: -14.15pt; padding-left: 14.15pt">Israel</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right">12</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right">13</td>
    <td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -14.15pt; padding-left: 14.15pt">United States</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">1</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">4</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -14.15pt; padding-left: 14.15pt">Russia</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">2</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">4</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 4pt; text-indent: -14.15pt; padding-left: 14.15pt">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; text-align: right">15</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; text-align: right">21</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify">Such balance is comprised of property
and equipment that are attributed to the geographic area in which they are located or originated, as applicable.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify"><b>&#160;</b></p><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0%"/><td style="width: 0.5in"><b>D.</b></td><td style="text-align: justify"><b>Major customers</b></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: -28.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify">During the years ended December 31,
2022, 2021 and 2020, the Company had one customer which accounted for 26%, 23% and 23% of the Company&#8217;s total revenues, respectively.
In addition, as of December 31, 2022 and 2021, the Company had one customer which accounted for 28% and 44% of the Company&#8217;s total trade
receivables, respectively.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt">&#160;</span></p><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0%"/><td style="width: 0.5in"><b>E.</b></td><td style="text-align: justify"><b>Major product lines and services and timing of revenue recognition</b></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: -28.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify">In the following table, revenue is
disaggregated by primary major product lines and services, and timing of revenue recognition for the years ended December 31, 2022, 2021
and 2020:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt">&#160;</span></p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><b>Year ended  December 31,</b></td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2020</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">Software license:</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: justify">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; width: 64%; text-align: left">Perpetual based software license - transferred at a point of time</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right">1,068</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right">1,156</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right">1,043</td>
    <td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Term-based software license - transferred at a point of time</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">1,630</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">2,032</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">1,976</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Total software license (*)</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">2,740</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">3,188</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">3,019</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">PCS services transferred over a period of time</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">123</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">112</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">157</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Advertising at a point of time upon clicks</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">42</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-93">-</div></td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-94">-</div></td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 4pt">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; text-align: right">2,863</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; text-align: right">3,300</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; text-align: right">3,176</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.65pt; text-align: justify; text-indent: -21.3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt">&#160;</span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left">(*)</td><td style="text-align: justify">Revenue recognized from sales-based software license was $48,
$45 and $99 during the years ended December 31, 2022, 2021 and 2020, respectively (see also Note 2N).</td>
</tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI https://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140231435477744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">SUBSEQUENT EVENTS</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><b>NOTE 17 - SUBSEQUENT EVENTS</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">The Company evaluated subsequent
events and transactions that occurred after the balance sheet date up to the date that the consolidated financial statements were available
to be issued (April 17, 2023). Based upon this review, the Company did not identify any other subsequent events that would have required
adjustment or disclosure in the financial statements except as disclosed below.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><b>Completion of an Initial
Public Offering Transaction</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">On February 27, 2023, the Company
announced the pricing of its initial public offering of 1,950,000 Ordinary Shares at a public offering price of $4.00 per share, for aggregate
gross proceeds of $7,800 prior to deducting underwriting discounts and other offering expenses. In addition, the Company granted the underwriters
(i) 97,500 warrants which shall be exercisable into Ordinary Shares of the Company at an exercise price of $5.00 per Ordinary Share over
a period of 5-years commencing August 26, 2023 and (ii) a 45-day option to purchase up to an additional 292,500 ordinary shares at the
public offering price less discounts, to cover over-allotments. The over-allotment option was not exercised and has expired as of the
date of filing of these consolidated financial statements.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">The Ordinary Shares began trading
on the Nasdaq Capital Market under the ticker symbol &#8220;BMR&#8221; on February 28, 2023. The Company&#8217;s IPO closed on March 2,
2023.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">For accounting purposes, following
the completion of the above IPO transaction, all shares, options and warrants to purchase Ordinary Shares and loss per share amounts have
been adjusted to give retroactive effect to the Reverse Share Split for all periods presented in these consolidated financial statements.
Any fractional shares resulting from the Reverse Share Split were rounded up to the nearest whole share.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">In addition, the holders of&#160;all
other shares with preferences over Ordinary Shares (i.e. Convertible Preferred Shares and Convertible Ordinary 1 and 2 Shares) effected
a conversion of all such shares to 7,211,280 Ordinary Shares, effective as of the pricing of the IPO on February 27, 2023.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">Further, in connection with the above IPO, on March 14, 2022, the Company's
shareholders approved to increase the Company's authorized shares from 22,000,000 to 222,000,000. These consolidated financial statements
exclude the aforesaid increase of authorized shares, as if such change to the Company&#8217;s capital structure had not yet occurred.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -URI https://asc.fasb.org/topic&amp;trid=2122774<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6842918&amp;loc=SL6314017-165662<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140231520299776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accounting Policies, by Policy (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of estimates in the preparation of financial statements</a></td>
<td class="text"><b>Use of estimates in the preparation of financial statements </b><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The preparation of the financial statements
in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities
and the disclosure of contingent assets and liabilities at the dates of the financial statements, and the reported amounts of revenue
and expenses during the reported periods. Actual results could differ from those estimates. As applicable to these financial statements,
the most significant estimates and assumptions include (i) revenues recognition; (ii) identification of and measurement of financial instruments
in funding transactions; (iii) recoverability of the Company&#8217;s goodwill upon subsequent periods (iv) measurement of fair value of
equity awards and (v) evaluation of going concern.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: left; text-indent: -1cm"><b>&#160;</b></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock', window );">Functional currency</a></td>
<td class="text"><b>Functional currency</b><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The functional currency of the Company
and all of its subsidiaries all of which are primarily a direct and integral component of the Company&#8217;s operation is the US dollar (&#8220;$&#8221;
or &#8220;dollar&#8221;), as the dollar is the primary currency of the economic environment in which the Company and its subsidiaries
have operated (which is the currency of the environment in which an entity primarily generates cash) and expects to continue to operate
in the foreseeable future.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In accordance with ASC 830, &#8220;Foreign
Currency Matters&#8221;, balances denominated in or linked to foreign currency are stated on the basis of the exchange rates prevailing
at the applicable balance sheet date. For foreign currency transactions included in the consolidated Statement of Operations and Comprehensive
Loss, the exchange rates applicable on the relevant transaction dates are used. Gains or losses arising from changes in the exchange rates
used in the translation of such transactions are presented within financing income or expenses.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: left; text-indent: -1cm"><b>&#160;</b></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Principles of Consolidation</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0%"/><td style="width: 0.5in"><b>C.</b></td><td style="text-align: left"><b>Principles of Consolidation</b></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The consolidated financial statements
include the accounts of the Group. Intercompany transactions and balances have been eliminated upon consolidation.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: left; text-indent: -1cm"><b>&#160;</b></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and cash equivalents</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0%"/><td style="width: 0.5in"><b>D.</b></td><td style="text-align: left"><b>Cash and cash equivalents</b></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Cash equivalents are short-term highly
liquid investments which include short term bank deposits (up to three months from date of deposit), that are not restricted as to withdrawals
or use and that are readily convertible to cash with maturities of three months or less as of the date acquired.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: left; text-indent: -1cm"><b>&#160;</b></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpensePolicy', window );">Research and development expenses</a></td>
<td class="text"><b>Research and development expenses </b><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Research and development expenses are
charged to operations, as incurred.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">ASC 985-20, &#8220;Software - Costs of
Computer Software to be Sold, Leased or Otherwise Marketed&#8221;, requires capitalization of certain software development costs subsequent
to the establishment of technological feasibility. In accordance with ASC 985-20, capitalization ceases when the related product is available
for general release to customers. Costs of maintenance and customer support are charged to expenses, as incurred. Based on the Company&#8217;s
product development process, technological feasibility is established upon completion of a working model. Costs incurred by the Company
between completion of the working models and the point at which the products are ready for general release have been insignificant. Therefore,
all research and development costs have been expensed.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify">&#160;</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredChargesPolicyTextBlock', window );">Deferred offering costs</a></td>
<td class="text"><b>Deferred offering costs </b><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Prior to the effective
date of an offering of equity securities, specific incremental costs directly (i.e. accounting, consulting, legal and printing fees) attributable
to a proposed or actual offering of securities are deferred and charged against the gross proceeds of the offering, unless the offering
of equity securities has been delayed but is currently in process, under which such specific incremental and direct costs are charged
immediately to operations. As of December 31, 2022, the Company deferred specific incremental costs directly attributable to offering
of securities through its IPO that closed in March 2023 in total amount of $313, which was classified as non-current asset in the Company&#8217;s
Consolidated Balance Sheet.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: left; text-indent: -1cm"><b>&#160;</b></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock', window );">Goodwill and Intangible Assets</a></td>
<td class="text"><b>Goodwill and Intangible Assets</b><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Goodwill is the amount
by which the purchase price of acquired net assets in a business combination exceeded the fair values of the net identifiable assets on
the date of acquisition.&#160;Goodwill is not amortized but evaluated for impairment annually or more frequently if events or changes
in circumstances indicate that the asset might be impaired. The provisions of ASC 350 &#8220;Intangibles-Goodwill and Other&#8221; (&#8220;ASC
350&#8221;) require that the impairment test be performed on goodwill at the level of the reporting unit. As required by ASC 350, the
Company chooses either to perform a qualitative assessment whether a goodwill impairment test is necessary or proceeds directly to the
goodwill impairment test. Such determination is made for each reporting unit on a stand-alone basis. The qualitative assessment includes
various factors such as macroeconomic conditions, industry and market considerations, cost factors, overall financial performance, earnings
multiples, gross margin and cash flows from operating activities and other relevant factors. When the Company chooses to perform a qualitative
assessment and determines that it is more likely than not (more than 50 percent likelihood) that the fair value of the reporting unit
is less than its carrying value, then the Company proceeds to the goodwill impairment test. If the Company determines otherwise, no further
evaluation is necessary.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">When the Company decides
or is required to perform the quantitative goodwill impairment test, the Company compares the fair value of the reporting unit to its
carrying value and an impairment charge is recognized for the amount by which the carrying amount exceeds the reporting unit&#8217;s fair
value, if any.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company determined
that its operations represent a single reporting unit. The Company determines the fair value of its reporting unit by using the income
approach, which utilizes a discounted cash flow model, as it believes that this approach best approximates the reporting unit&#8217;s
fair value. Judgments and assumptions related to revenue, operating income, future short-term and long-term growth rates, weighted average
cost of capital, interest, capital expenditures, cash flows, and market conditions are inherent in developing the discounted cash flow
model. The Company considers historical rates and current market conditions when determining the discount and growth rates to use in its
analyses. If these estimates or their related assumptions change in the future, the Company may be required to record impairment charges
for its goodwill. As of December 31, 2022 and 2021, the Company has performed the annual impairment test and has determined that impairment
loss is not required to be recognized.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Finite lived intangible
assets acquired in business combinations, which include technology, customer relationships and trade names, are initially recorded at
fair value.&#160;They are amortized on a straight-line basis over their estimated useful lives.&#160;The intangible asset lives have been
determined based upon the anticipated period over which the Company will derive future cash flows from the intangible assets.&#160;The
Company has considered the effects of legal, regulatory, contractual, competitive, and other economic factors in determining these useful
lives.&#160;Recoverability of these assets is assessed when triggering events have occurred that may give rise to an impairment loss and
is determined by a comparison of the carrying amount of the asset to the future undiscounted net cash flows expected to be generated by
the asset.&#160;When it is determined that the carrying value of the asset is not recoverable, the asset is written down to its estimated
fair value.&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">As a result of continued
losses, the management performed an impairment test with respect to its intangible assets by maintaining an external valuation which utilized
discounted cash flow model. Accordingly,&#160;certain assumptions and judgments were made to determine the discount rate as well as future
cash flows of the Company.&#160;During the years ended December 31, 2022, 2021 and 2020, no impairment losses were identified through
the impairment test.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27.35pt">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The lives used in computing straight-line amortization
for financial reporting purposes are as follows:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: left; border-bottom: Black 1.5pt solid">Rate of depreciation</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">%</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%; text-align: left">Technology</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">20</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Customer relationships</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">20</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Trade names</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10</td><td style="text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property and equipment</a></td>
<td class="text"><b>Property and equipment</b><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Property and equipment
are stated at cost, net of accumulated depreciation. Depreciation is calculated using the straight-line method over the estimated useful
lives of the assets. When an asset is retired or otherwise disposed of, the related cost and accumulated depreciation are removed from
the respective accounts and the net difference less any amount realized from disposition is reflected in the consolidated Statements of
Operations and Comprehensive Loss.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company&#8217;s long-lived
assets are reviewed for impairment in accordance with ASC 360, &#8220;Property, Plant and Equipment&#8221;, whenever events or changes
in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is
measured by a comparison of the carrying amount of an asset to the future undiscounted cash flows expected to be generated by the asset.
If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of
the asset exceeds its fair value. To date, the Company has not incurred any impairment losses.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27.35pt">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The lives used in computing straight-line depreciation
for financial reporting purposes are as follows:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: left; border-bottom: Black 1.5pt solid">Rate of depreciation</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">%</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%; text-align: left">Computers and peripheral equipment</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">33</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Office furniture and equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-size: 10pt">7-15</span></td><td style="text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; background-color: white">&#160;</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeasesPolicyTextBlock', window );">Leases</a></td>
<td class="text"><b>Leases</b><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company entered
into several non-cancelable lease agreements for offices for use in its operations, which are classified as operating leases (see below).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company applies
ASC Topic 842, Leases (&#8220;ASC 842&#8221;).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Accordingly, the Company
determines if an arrangement is a lease at inception. The Company&#8217;s assessment is based on: (i) whether the contract involves the
use of an identified asset, (ii) whether the Company obtains the right to substantially all of the economic benefits from the use of the
asset throughout the period of use, and (iii) whether the Company has the right to direct the use of the asset.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Leases are classified
as either finance leases or operating leases. A lease is classified as a finance lease if any one of the following criteria are met: (i)
the lease transfers ownership of the asset by the end of the lease term, (ii) the lease contains an option to purchase the asset that
is reasonably certain to be exercised, (iii) the lease term is for a major part of the remaining useful life of the asset, (iv) the present
value of the lease payments equals or exceeds substantially all of the fair value of the asset, or (v) the underlying asset is of such
a specialized nature that it is expected to have no alternative use to the lessor at the end of lease term. A lease is classified as an
operating lease if it does not meet any one of these criteria. Since all the Company&#8217;s lease contracts for premises do not meet
any of the criteria above, the Company concluded that all its lease contracts should be classified as operating leases.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Right of Use (&#8220;ROU&#8221;)
assets and liabilities are recognized on the commencement date based on the present value of remaining lease payments over the lease term.
For this purpose, the Company considers only payments that are fixed and determinable at the time of commencement. As most of the Company&#8217;s
leases do not provide an implicit rate, the Company uses its incremental borrowing rate (&#8220;IBR&#8221;) based on the information available
on the commencement date in determining the present value of lease payments. The Company&#8217;s IBR is estimated to approximate the interest
rate for collateralized borrowing with similar terms and payments and in economic environments where the leased asset is located. The
ROU asset also includes any lease payments made prior to commencement and is recorded net of any lease incentives received. Moreover,
the ROU asset may also include initial direct costs, which are incremental costs of a lease that would not have been incurred if the lease
had not been obtained. The Company uses the long-lived assets impairment guidance in ASC 360-10, &#8220;Property, Plant, and Equipment
- Overall&#8221;, to determine whether a ROU asset is impaired, and if so, the amount of the impairment loss to recognize. Certain leases
include options to extend or terminate the lease. An option to extend the lease is considered in connection with determining the ROU asset
and lease liability when it is reasonably certain that the Company will exercise that option. An option to terminate is considered unless
it is reasonably certain that the Company will not exercise the option.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company also elected
the short-term lease recognition exemption for all leases that qualify (leases with a term shorter than 12 months). For those leases,
ROU assets or lease liabilities are not recognized and rent&#160;expense is recognized on a straight-line basis over the lease term. See
also Note 10A for further discussion.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: center; background-color: white">&#160;</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Deferred income taxes</a></td>
<td class="text"><b>Deferred income taxes</b><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company accounts
for income taxes in accordance with ASC Topic 740, &#8220;Income Taxes&#8221;. Accordingly, deferred income taxes are determined utilizing
the asset and liability method based on the estimated future tax effects of differences between the financial accounting and the tax bases
of assets and liabilities under the applicable tax law. Deferred tax balances are computed using the enacted tax rates expected to be
in effect when these differences reverse. Valuation allowance in respect of deferred tax assets is provided for, if necessary, to reduce
deferred tax assets is amounts more likely than not to be realized.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; background-color: white">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company accounts
for uncertain tax positions in accordance with ASC Topic 740-10, which prescribes detailed guidance for the financial statement recognition,
measurement and disclosure of uncertain tax positions recognized in an enterprise&#8217;s financial statements. According to ASC Topic
740-10, tax positions must meet a more-likely-than-not recognition threshold. The Company&#8217;s accounting policy is to classify interest
and penalties relating to uncertain tax positions under income taxes, however the Company did not recognize such items in its consolidated
financial statements during the years ended December 31, 2022, 2021 and 2020 and did not recognize any liability with respect to an unrecognized
tax position in its balance sheets.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; background-color: white">&#160;</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PostemploymentBenefitPlansPolicy', window );">Employees benefit plans</a></td>
<td class="text"><b>Employees benefit plans </b><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company&#8217;s
liability for severance pay to its Israeli employees is pursuant to Section 14 of the Israeli Severance Compensation Act, 1963 (&#8220;Section
14&#8221;), pursuant to which all the Company&#8217;s employees are included under Section 14, and are entitled only to monthly deposits,
at a rate of 8.33% of their monthly salary, made in the employee&#8217;s name with insurance companies. Under Israeli employment law,
payments in accordance with Section 14 release the Company from any future severance payments in respect of those employees. The fund
is made available to the employee at the time the employer-employee relationship is terminated, regardless of cause of termination. The
severance pay liabilities and deposits under Section 14 are not reflected in the balance sheets as the severance pay risks have been irrevocably
transferred to the severance funds. All deposits required through December 31, 2022 have been made.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: left; text-indent: -1cm"><b>&#160;</b></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesPolicyTextBlock', window );">Contingencies</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0%"/><td style="width: 0.5in"><b>L.</b></td><td style="text-align: left"><b>Contingencies</b></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company and its
subsidiaries may be involved in certain legal proceedings and certain business relationships that arise from time to time in the ordinary
course of their business and in connection with certain agreements with third parties. Except for income tax contingencies, the Company
applies the provisions of ASC Topic 450, Contingencies. Thus, the Company records accruals for contingencies to the extent that the management
concludes that the occurrence is probable and that the related liabilities are estimable. Legal expenses associated with contingencies
are expensed as incurred.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: left; text-indent: -1cm"><b>&#160;</b></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_ConcentrationOfCreditRiskPolicyTextBlock', window );">Concentrations of credit risk and allowance for doubtful accounts</a></td>
<td class="text"><b>Concentrations of credit risk and allowance for doubtful accounts</b><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Financial instruments
that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents and trade receivables
as well as certain other current assets that do not amount to a significant amount. Cash and cash equivalents, which are primarily held
in US Dollars and New Israeli Shekels (NIS), are deposited with major banks in Israel, U.S. and Russian Federation. Management believes
that such financial institutions are financially sound and, accordingly, minimal credit risk exists with respect to these financial instruments.
The Company does not have any significant off-balance-sheet concentration of credit risk, such as foreign exchange contracts, option contracts
or other foreign hedging arrangements. Most of the Company&#8217;s sales are mainly derived from sales to a diverse set of customers located
primarily in the United States. Management periodically evaluates the collectability of the trade receivables to determine the amounts
that are doubtful of collection and determine a proper allowance for doubtful accounts, as described below. Accordingly, management believes
that the Company&#8217;s trade receivables do not represent a substantial concentration of credit risk.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company extends credit to customers
in the normal course of business and does not require collateral or any other security to support amounts due. Management performs ongoing
credit evaluations of its customers. The allowance for doubtful accounts is determined with respect to amounts the Group has determined
to be doubtful of collection. In determining the allowance for doubtful accounts, the Company considers, among other things, its past
experience with customers, the length of time that the balance is past due, the customer&#8217;s current ability to pay and available information
about the credit risk on such customers.&#160;Provisions for the allowance for doubtful accounts are recorded under general and administrative
expenses in the consolidated Statements of Operations and Comprehensive Loss. During the years ended December 31, 2022, 2021 and 2020,
the Company has not recorded allowance in respect of accounts receivable.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: center; background-color: white"><b>&#160;</b></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRecognitionPolicyTextBlock', window );">Revenue recognition</a></td>
<td class="text"><b>Revenue recognition</b><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company recognizes revenues in accordance
with ASC 606, &#8220;Revenue from Contracts with Customers&#8221; (&#8220;ASC 606&#8221;) under which the Company determines revenue recognition
through the following five steps:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.5pt; text-align: justify; text-indent: -22.5pt">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span>&#9726;</span></td><td style="text-align: justify">Identification of the contract, or contracts, with a customer;</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.5pt; text-align: justify; text-indent: -22.5pt">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span>&#9726;</span></td><td style="text-align: justify">Identification of the performance obligations in the contract;</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.5pt; text-align: justify; text-indent: -22.5pt">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span>&#9726;</span></td><td style="text-align: justify">Determination of the transaction price;</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.5pt; text-align: justify; text-indent: -22.5pt">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span>&#9726;</span></td><td style="text-align: justify">Allocation of the transaction price to the performance obligations in the contract; and</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.5pt; text-align: justify; text-indent: -22.5pt">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span>&#9726;</span></td><td style="text-align: justify">Recognition of revenue when, or as, the Company satisfies a performance obligation.</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company enters into contracts that
mostly include software and software related services (i.e. Post-Contract Customer Support (&#8220;PCS&#8221;)), which are generally capable
as being distinct from each other and accounted for as separate performance obligations.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company derives its revenues from
licensing the rights to use its software for a limited term (mainly for a period of one to three years) or on a perpetual basis for enterprises
that incorporate the Company&#8217;s perpetual license in their own products delivered to end users and for the Company&#8217;s products&#160;sold
to thousands private consumers, as applicable to each contract, and from, provision of related maintenance and technical support. The
Company sells its products through direct sales force and indirectly through distributors and consumer platforms.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Revenues are recognized when control of
the promised goods or services are transferred to the customers, in an amount that reflects the consideration that the company expects
to receive in exchange for those goods or services. However, when the consideration for the license is based on sales of the related customer,
the company applies the provisions of ASC 606 with respect to sales-based or usage-based royalties promised in exchange for a license
of intellectual property and recognizes revenues only when the underlying sales occur, as long as this approach does not result in the
acceleration of revenue ahead of the company&#8217;s performance.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Under ASC 606, an entity recognizes revenue
when or as it satisfies a performance obligation by transferring software license (either timely-based or perpetual) or software related
services to the customer, either at a point in time or over time. The Company recognizes its revenues from software sales at a point in
time upon delivery of its software license. The software license is considered a distinct performance obligation, as the customer can
benefit from the software on its own. The Company&#8217;s revenues from PCS are derived from annual maintenance providing for unspecified
upgrades on a when-and-if-available basis. The right for an unspecified upgrade for the version acquired by the customer and enhancements
on a when-and-if-available basis that do not specify the features, functionality and release date of future product enhancements for the
customer to know what will be made available and the general timeframe in which it will be delivered. The Company considers the PCS performance
obligation as a distinct performance obligation that is satisfied over time and recognized on a straight-line basis over the contractual
period (mainly over a period of one year either for timely-based license or for perpetual license).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">As the Company bundles software licenses
(either time-based or perpetual) together with PCS, the transaction price is allocated to the separate performance obligations on a relative
standalone selling price basis.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Since the Company does not sell PCS on
a stand-alone basis and due to the fact that these services are usually involved with limited customer support, mainly based on several
hours of technical support per contract (as management believes the technology and products covered under the software license component
are mature and fully functional), the standalone selling prices of the PCS are determined based on the expected cost plus a margin (&#8220;cost-plus
approach&#8221;) based on estimation of direct fulfillment cost (an hourly service) and a reasonable margin. Such estimate is also corroborated
with the price that the company would have to pay to a third-party service provider for a similar support service.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The stand-alone selling price of the software
licenses (either timely-based or perpetual) is estimated by management based on adjusted market assessment approach which represents management
estimation of the price that a customer in the market will be willing to pay for such license on a stand-alone basis (i.e. without any
PCS).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Due to the fact that the PCS services
are usually involved with limited customer support, mainly based on several hours of technical support per contract, the transaction price
allocated to the PCS is considered insignificant. Consequently, most of the transaction price is allocated to the software licenses as
management believes the technology and products covered under the software license component are mature and fully functional.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">During the reported periods, costs to
obtain contracts were in an insignificant amount.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company does not grant a right of
return to its customers. When product delivered to the customer is subject to evaluation, the Company defers revenue until evaluation
is completed subject to formal selling agreement with the customer, at which time revenue is recognized provided that all other revenue
recognition criteria are met.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Commencing 2022, revenue is also derived
from the traffic operations in the Google AdSense program, a web advertising platform, that the Company makes available on its websites.&#160;Google
pays the Company on a cost-per-click basis. The Company recognizes as revenue the fees paid to it by Google based on the volume of clicks
through to Google AdSense advertisements.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company receives payments from customers
based upon contractual payment schedules. Trade receivables are recorded when right to consideration becomes unconditional, and an invoice
is issued to the customer. Unbilled receivables include amounts related to the Company&#8217;s contractual right to consideration for
completed performance obligations not yet invoiced. As of December 31, 2022 and 2021, unbilled receivables balance amounted to $35&#160;and
$29, respectively, and are included within trade receivables balance in the Company&#8217;s Consolidated Balance Sheets.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">As of December 31, 2022 and 2021, the
Company had $31&#160;and $33, respectively, of remaining performance obligations not yet satisfied or partly satisfied related to revenues
(mostly PCS). Such amounts are presented as deferred revenues which are expected to be recognized as revenues during the next twelve months.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">See also Note 16 for further discussion
related to disaggregation of revenues.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: left; text-indent: -1cm"><b>&#160;</b></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock', window );">Fair Value Measurements</a></td>
<td class="text"><b>Fair Value Measurements</b><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company measures
and discloses fair value in accordance with the ASC 820, &#8220;Fair Value Measurements and Disclosures&#8221; which defines fair value,
establishes a framework and gives guidance regarding the methods used for measuring fair value, and expands disclosures about fair value
measurements. Fair value is an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability
in an orderly transaction between market participants at the measurement date. As such, fair value is a market-based measurement that
should be determined based on assumptions that market participants would use in pricing an asset or liability. As a basis for considering
such assumptions there exists a three-tier fair-value hierarchy, which prioritizes the inputs used in measuring fair value as follows:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Level 1 - unadjusted
quoted prices are available in active markets for identical assets or liabilities that the Company has the ability to access as of the
measurement date.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Level 2 - pricing inputs
are other than quoted prices in active markets that are directly observable for the asset or liability or indirectly observable through
corroboration with observable market data.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Level 3 - pricing inputs
are unobservable for the non-financial asset or liability and only used when there is little, if any, market activity for the non-financial
asset or liability at the measurement date. The inputs into the determination of fair value require significant management judgment or
estimation. Level 3 inputs are considered as the lowest priority within the fair value hierarchy. The valuation of certain financial instruments
classified under fair value through profit or loss category and the fair value of reporting units for purposes of goodwill impairment
analysis, fall under this category.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">This hierarchy requires
the Company to use observable market data, when available, and to minimize the use of unobservable inputs when determining fair value.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The fair value of cash
and cash equivalents is based on its demand value, which is equal to its carrying value. Additionally, the carrying value of all other
short-term monetary assets and liabilities are estimated to be equal to their fair value due to the short-term nature of these instruments.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: left; text-indent: -1cm"><b>&#160;</b></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_ConvertibleOrdinary1And2SharesAndPreferredSharesPolicyTextBlock', window );">Convertible Ordinary 1 and 2 Shares and Preferred Shares</a></td>
<td class="text"><b>Convertible Ordinary 1 and 2 Shares and Preferred Shares</b><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Convertible Ordinary 1 and 2 Shares
and Convertible Preferred Shares are not subject to redemption feature upon any events that are considered not solely within the control
of the Company. In addition, upon occurrence of liquidation event, as defined in the Company&#8217;s Articles of Association, all holders of
the Ordinary Shares, Convertible Ordinary 1 and 2 Shares and Convertible Preferred Shares will be entitled to receive the same form of
consideration. Thus, the Company classifies its Convertible Ordinary 1 and 2 Shares and Convertible Preferred Shares as part of permanent
equity.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm">&#160;</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_AllocationOfProceedsAndRelatedIssuanceCostsPolicyTextBlock', window );">Allocation of proceeds and related issuance costs</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0%"/><td style="width: 0.5in"><b>Q.</b></td><td style="text-align: left"><b>Allocation of proceeds and related issuance costs</b></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">When multiple instruments are issued in
a single transaction (package issuance), the total net proceeds from the transaction are allocated among the individual freestanding instruments
identified. The allocation occurs after identifying all the freestanding instruments and the subsequent measurement basis for those instruments.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Financial instruments that are required
to be subsequently measured at fair value (such as derivative warrants liability) are measured at fair value and the remaining consideration
is allocated to other financial instruments that are not required to be subsequently measured at fair value (i.e. straight loan), based
on the relative fair value basis for such instruments.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The allocation of issuance costs to freestanding
instruments was based on an approach that is consistent with the allocation of the proceeds, as described above.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Issuance costs allocated to the derivative
warrant liability were immediately expensed.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Issuance costs allocated to straight loan
are recorded as a discount of the straight loan and accreted over the contractual term of straight loan up to face value of such loans
using the effective interest method.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: left; text-indent: -1cm"><b>&#160;</b></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_WarrantsPolicyTextBlock', window );">Warrants</a></td>
<td class="text"><b>Warrants</b><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Certain warrants that
were issued to a commercial bank as part of entering into a straight loan and to seller through transaction in which certain identified
intangible assets have been purchased are classified as a component of permanent equity since they are freestanding financial instruments
that are legally detachable and separately exercisable, do not embody an obligation for the Company to repurchase its own shares, and
permit the holders to receive a fixed number of Ordinary Shares upon exercise for a fixed exercise price and thus, are considered as indexed
to the Company&#8217;s own shares. In addition, the warrants must require physical settlement and may not provide any guarantee of value or
return. As such warrants were issued together with financial instruments that are not subsequently measured at fair value the warrants
were measured based on allocation of the proceeds received by the Company in accordance with the relative fair value basis. When applicable,
direct issuance expenses that were allocated to such warrants were deducted from additional paid-in capital.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Commencing January 1,
2018 and following the early adoption of ASU 2017-11, &#8220;Earnings Per Share&#8221; (ASU 2017-11), the Company disregards the down
round feature when assessing whether an instrument is indexed to its own shares, for purposes of determining liability or equity classification.
Based on its evaluation, management has determined that certain warrants with down-round protection are eligible for equity classification.
In accordance with the provisions of ASU 2017-11, upon the occurrence of an event that triggers down round protection (i.e., when the
exercise price of the warrants is adjusted downward because of the down round feature), the effect is accounted for as a deemed dividend
and as a reduction of income available to common shareholders for purposes of basic earnings per share (EPS) calculation. However, during
the reported periods there were no events that trigger a down round protection.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: left; text-indent: -1cm"><b>&#160;</b></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesPolicyTextBlock', window );">Derivative Warrants Liability</a></td>
<td class="text"><b>Derivative Warrants Liability</b><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Certain warrants that
were granted by the Company for commercial bank through funding transaction entitle the bank to exercise the warrants for a variable number
of shares and/or for a variable exercise price and thus the fixed-for-fixed criteria is not met. Accordingly, the warrants were classified
as a non-current liability according to the provisions of ASC 815-40, &#8220;Derivatives and Hedging - Contracts in Entity&#8217;s Own
Equity&#8221; (&#8220;ASC 815-40&#8221;). The Company accounted for these warrants as a financial derivative liability measured upon initial
recognition and on subsequent periods at fair value by using the Hybrid Method by combining the OPM and an IPO scenario.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The fair value of the
aforesaid warrants derivative liability is estimated using the Black-Scholes Model which requires inputs such as the expected term of
the warrants, share price volatility and risk-free interest rate. These assumptions are reviewed on a regular basis and changes in the
estimated fair value of the outstanding warrants are recognized each reporting period as part of the &#8220;Financing (income) expenses,
net&#8221; line in the consolidated statements of operations and comprehensive loss, until such warrants are exercised or expired. When
applicable, direct issuance expenses that were allocated to the above warrants were expensed as incurred.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_ModificationsOrExchangeOfLoansPolicyTextBlock', window );">Modifications or exchanges of loans</a></td>
<td class="text"><b>Modifications or exchanges of loans</b><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Modifications to, or
exchanges of, financial instruments such as loans or convertible loans, are accounted for as a modification or an extinguishment, following
to provisions of ASC 470-50, &#8220;Debt &#8211; Modification and Extinguishments&#8221; (ASC 470-50<span style="font-family: Times New Roman, Times, Serif">)</span>.
Such an assessment done by management either qualitatively or quantitatively based on the facts and circumstances of each transaction<span style="font-family: Times New Roman, Times, Serif">.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Under ASC 470-50, modifications
or exchanges are generally considered extinguishments with gains or losses recognized in current earnings if the terms of the new debt
and original instrument are substantially different. The instruments are considered &#8220;substantially different&#8221; when the present
value of the cash flows under the terms of the new debt instrument is at least 10% different from the present value of the remaining cash
flows under the terms of the original instrument<span style="font-family: Times New Roman, Times, Serif">.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">If the terms of a debt
instrument are changed or modified and the present value of the cash flows under the terms of the new debt instrument is less than 10%,
the debt instruments are not considered to be substantially different, except in the following two circumstances: (i)<span style="font-family: Times New Roman, Times, Serif">&#160;&#160;</span>the
transaction significantly affects the terms of an embedded conversion option, such that the change in the fair value of the embedded conversion
option (calculated as the difference between the fair value of the embedded conversion option immediately before and after the modification
or exchange) is at least 10% of the carrying amount of the original debt instrument immediately before the modification or exchange or
(ii)<span style="font-family: Times New Roman, Times, Serif">&#160;&#160;</span>the transaction adds a substantive conversion option or
eliminates a conversion option that was substantive at the date of the modification or exchange<span style="font-family: Times New Roman, Times, Serif">.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">If the original and
new debt instruments are considered as &#8220;substantially different&#8221;, the original debt is derecognized and the new debt is initially
recorded at fair value, with the difference recognized as an extinguishment gain or loss under financial expense or income as applicable<span style="font-family: Times New Roman, Times, Serif">.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">If a convertible debt
instrument with a beneficial conversion option that was separately accounted for in equity, is extinguished prior to its conversion or
stated maturity date, a portion of the reacquisition price is allocated to the repurchase of the beneficial conversion option. The amount
of the reacquisition price allocated to the beneficial conversion option is measured using the intrinsic value of that conversion option
at the extinguishment date. The residual amount, if any, is allocated to the convertible debt instrument<span style="font-family: Times New Roman, Times, Serif">.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The gain or loss on
the extinguishment of the convertible debt instrument is determined based on the difference between the carrying amount and the fair value
of the allocated reacquisition price.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: left; text-indent: -1cm"><b>&#160;</b></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Basic and diluted net loss per ordinary share</a></td>
<td class="text"><b>Basic and diluted net loss per Ordinary Share </b><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company applies
the two-class method as required by ASC&#160;260-10, &#8220;Earnings Per Share&#8221; (&#8220;ASC&#160;260-10&#8221;) which requires the
income or loss per share for each class of shares (ordinary and all other shares with preferences over Ordinary Shares) to be calculated
assuming 100% of the Company&#8217;s earnings are distributed as dividends to each class of shares based on their contractual rights. No dividends
were declared or paid during the reported periods. According to the provisions of ASC&#160;260-10, the Company&#8217;s Convertible Preferred
Shares and Convertible Ordinary 1 and 2 Shares do not have contractual obligation to share losses of the Company and therefore are not
included in the computation in period of net loss per share.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Basic net loss per Ordinary
Share is computed by dividing the net loss for the period applicable to ordinary shareholders, by the weighted average number of Ordinary
Shares outstanding during the period. Diluted loss per share gives effect to all potentially dilutive common shares outstanding during
the year using the treasury stock method with respect to shares with preferences over Ordinary Shares (Convertible Ordinary 1 and 2 shares
and Convertible Preferred Shares), share options and certain warrants and using the if-converted method with respect to convertible advance
investments and certain warrants accounted for as derivative liability. In computing diluted loss per share, the average share price for
the period is used in determining the number of shares assumed to be purchased from the exercise of share options or warrants.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">During the years ended
December 31, 2022, 2021 and 2020, the total weighted average number of Ordinary Shares related to outstanding shares with preferences
over Ordinary Shares (Convertible Ordinary 1 and 2 shares and Convertible Preferred Shares), share options, warrants and convertible advance
investments excluded from the calculation of the diluted loss per share was 9,067,438, 8,957,327 and 8,842,202, respectively.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm">&#160;</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_ConvertibleAdvanceInvestmentsPolicyTextBlock', window );">Convertible Advance Investments</a></td>
<td class="text"><b>Convertible Advance Investments</b><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Upon initial recognition, the Company
has considered the provisions of ASC 480-10 &#8220;Distinguishing Liabilities from Equity&#8221; with respect to certain obligations to
issue a variable number of shares and has determined that the convertible advance investments represent a financial liability since most
of its settlement alternatives embody either a conditional or an unconditional obligation to issue a variable number of the Company&#8217;s
shares with monetary value based predominantly on a fixed monetary amount known at inception (the original issue price of the convertible
advance investments together with a fixed &#160;return to the investors).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Upon initial recognition, the Company
has considered the provisions of ASC 815-15,&#160;&#8220;Derivatives and Hedging - Embedded Derivatives&#8221;, and determined that the
embedded conversion feature of the convertible advance investments cannot be considered as clearly and closely related to the host debt
instrument. However, it was determined that the embedded conversion feature should not be separated from the host instrument because the
embedded conversion option, if freestanding, did not meet a derivative definition based on the provisions of ASC 815-10, &#8220;Derivatives
and Hedging&#8221;&#160;since its terms did not require or permit net settlement. Thus, it was determined that the conversion feature
does not meet the characteristic of being readily convertible to cash. However, the Company has determined that the redemption feature
upon certain events is not solely within the Company&#8217;s control under which the Company will be required to repay an amount equal to 200%
of the original investment was determined to represent a contingent interest feature that requires bifurcation from a host debt contract
because the contingent interest feature meets a derivative definition and the economic characteristics of the embedded feature are not
clearly and closely related to those of host debt instrument as such feature is not directly credit risk related.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Furthermore, the Company applied ASC 470-20,
&#8220;Debt - Debt with Conversion and Other Options&#8221; (&#8220;ASC 470-20&#8221;) which clarifies the accounting for instruments with
Beneficial Conversion Features (BCF) or contingently adjustable conversion ratios and has applied the BCFs guidance to determine whether
the conversion feature is beneficial to investors. However, as the convertible advance investments were not convertible upon inception
(such instrument would have become convertible if the Company would have completed qualified financing by August 5, 2020), it was determined
that no BCF was required to be recognized upon initial recognition of the instrument.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Based on the characteristics of the convertible
advance investments, the Company elected to measure this liability in its entirety, at its fair value in accordance with ASC 825-10, &#8220;Financial
Instruments&#8221; due to the existence of certain redemption option and the potential requirement to recognize contingent BCF. Accordingly,
upon initial recognition and in subsequent periods, the Company measures the liability related to the convertible advance investments
based on its fair value taking into consideration, among others all relevant settlement possibilities and their respective likelihood.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: left; text-indent: -1cm"><b>&#160;</b></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_CapitalContributionFromAControllingShareholderPolicyTextBlock', window );">Capital contribution from a controlling shareholder</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0%"/><td style="width: 0.5in"><b>W.</b></td><td style="text-align: left"><b>Capital contribution from a controlling shareholder</b></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The fair value of the benefit received
in respect of loan received from the controlling shareholder is calculated on the basis of the difference between the interest rate that
the Company would have required to pay for similar loan from commercial bank and the interest rate that the Company is actually charged
under the agreement with the controlling shareholders. Such benefit is accounted for as capital contribution received from the controlling
shareholder as additional paid-in capital and it is recorded as discount on the loan received against at the initial measurement date.
Subsequently, such discount is expensed over the economic life of the loan based on the effective interest rate method.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify">&#160;</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Share-based compensation</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0%"/><td style="width: 0.5in"><b>X.</b></td><td style="text-align: left"><b>Share-based compensation</b></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: 0in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0in">The Company measures
and recognizes compensation expense for all equity-based payments to employees based on their estimated fair values in accordance with
ASC 718, &#8220;Compensation-Stock Compensation&#8221;. Share-based payments are recognized in the Statement of Operations and Comprehensive
Loss as an operating expense based on fair value of the award at the grant date by using Black-Scholes option-pricing model. The inputs
for the valuation analysis of the share options include several assumptions of which the most significant are the fair market value of
the underlying Ordinary Share, the expected share price volatility and the expected option term. Expected volatility was calculated based
upon historical volatility of peer companies in the same industry on daily basis since the Company&#8217;s marketability is considered low.
The expected option term represents the period that the Company&#8217;s share options are expected to be outstanding and is determined
based on the simplified method until sufficient historical exercise data will support using expected life assumptions. The risk-free interest
rate is based on the yield from U.S. treasury bonds with an equivalent term. The expected dividend yield assumption is based on the Company&#8217;s
historical experience and expectation of no future dividend payouts. The Company has historically not paid cash dividends and has no foreseeable
plans to pay cash dividends in the future. The Company expensed compensation costs net of estimated forfeitures over the requisite service
period by applying the straight-line method.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: 0in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0in">The fair value of
Ordinary Shares underlying the share options was determined by the Company&#8217;s management with the assistance of an independent valuation
firm. Because there has been no public market for the Ordinary Shares, the Company&#8217;s management has determined fair value of the Ordinary
Shares at the time of grant by considering several objective and subjective factors including data from other comparable companies, sales
of Convertible Preferred Shares to unrelated third parties, operating and financial performance, the lack of liquidity of share capital
and general and industry specific economic outlook, amongst other factors. The fair value of the underlying Ordinary Shares shall be determined
by management until such time as the ordinary shares are listed on an established stock exchange, national market system or other quotation
system. For all reported periods through December&#160;31, 2020, the valuations were performed using the Option Pricing Method (&#8220;OPM&#8221;).
Commencing June&#160;30, 2021, the valuations were performed using Hybrid Method by combining the OPM and an IPO scenario.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: 0in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0in">Commencing January
1, 2019, following the adoption of ASU 2018-07 which aligns the measurement and classification guidance for share-based payments to nonemployees
with the guidance for share-based payments to employees (with certain exceptions), share-based payments to non-employees are accounted
in accordance with ASC 718.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: 0in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0in">When applicable,
a modification to the terms and/or conditions of an award (i.e. a change of award&#8217;s fair value, vesting conditions or classification
as an equity or a liability instrument) is accounted for as an exchange of the original award for a new award resulting in total compensation
cost equal to the grant-date fair value of the original award, plus the incremental value of the modification to the award. The calculation
of the incremental value is based on the excess of the fair value of the modified award following the modification over the fair value
of the original award measured immediately before its terms were modified.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmr_AllocationOfProceedsAndRelatedIssuanceCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmr_AllocationOfProceedsAndRelatedIssuanceCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmr_CapitalContributionFromAControllingShareholderPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmr_CapitalContributionFromAControllingShareholderPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmr_ConcentrationOfCreditRiskPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of concentration of credit risks.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmr_ConcentrationOfCreditRiskPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmr_ConvertibleAdvanceInvestmentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy of convertible advance investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmr_ConvertibleAdvanceInvestmentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmr_ConvertibleOrdinary1And2SharesAndPreferredSharesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy of convertible ordinary 1 and 2 shares and preferred shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmr_ConvertibleOrdinary1And2SharesAndPreferredSharesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmr_ModificationsOrExchangeOfLoansPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy modifications or exchange of loans.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmr_ModificationsOrExchangeOfLoansPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmr_WarrantsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy of warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmr_WarrantsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4273-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126907703&amp;loc=d3e12565-110249<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 450<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6491354&amp;loc=d3e6049-115624<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredChargesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for deferral and amortization of significant deferred charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredChargesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for its derivative instruments and hedging activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41620-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41638-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41675-113959<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(n))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579240-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -URI https://asc.fasb.org/topic&amp;trid=2175825<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32247-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32847-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32840-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL116659661-227067<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32280-109318<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangement entered into by lessee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918666-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PostemploymentBenefitPlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for postemployment benefits. Postemployment benefits are benefits provided to former or inactive employees, their beneficiaries, and covered dependents after employment but before retirement, except for: a) benefits provided through a pension or postretirement benefit plan, b) individual deferred compensation arrangements, c) special or contractual termination benefits, and d) stock compensation plans.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 712<br> -URI https://asc.fasb.org/topic&amp;trid=2197446<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PostemploymentBenefitPlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99779-112916<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99893-112916<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpensePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpensePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI https://asc.fasb.org/topic&amp;trid=2228938<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2.Q6)<br> -URI https://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140231433564896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock', window );">Schedule of computing straight-line amortization</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: left; border-bottom: Black 1.5pt solid">Rate of depreciation</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">%</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%; text-align: left">Technology</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">20</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Customer relationships</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">20</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Trade names</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10</td><td style="text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndIntangibleAssetsTextBlock', window );">Schedule of computing straight-line depreciation</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: left; border-bottom: Black 1.5pt solid">Rate of depreciation</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">%</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%; text-align: left">Computers and peripheral equipment</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">33</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Office furniture and equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-size: 10pt">7-15</span></td><td style="text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; background-color: white">&#160;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAndIntangibleAssetsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for intangible assets and long-lived, physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, accounting policies and methodology, roll forwards, depreciation, depletion and amortization expense, including composite depreciation, accumulated depreciation, depletion and amortization expense, useful lives and method used, income statement disclosures, assets held for sale and public utility disclosures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI https://asc.fasb.org/topic&amp;trid=2144416<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI https://asc.fasb.org/topic&amp;trid=2155823<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAndIntangibleAssetsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140231433393520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Current Assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureTextBlockSupplementAbstract', window );"><strong>Other Current Assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock', window );">Schedule of other current assets</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: justify">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of<br/>
 December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; text-indent: -14.15pt; padding-left: 14.15pt">Prepaid expenses</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">32</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">33</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -14.15pt; padding-left: 14.15pt">Government authorities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">15</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">22</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -14.15pt; padding-left: 14.15pt">Others</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">17</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">11</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 4pt; text-indent: -14.15pt; padding-left: 14.15pt">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">64</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">66</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureTextBlockSupplementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureTextBlockSupplementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amounts of other current assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140231433319824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment, Net (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property and Equipment, Net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of property and equipment net</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: justify">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">As of<br/>
 December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: justify">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">Computers and peripheral equipment</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">95</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">93</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt; text-align: left">Office furniture and equipment</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">42</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">42</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">137</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">135</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt; text-align: left">Less - accumulated depreciation</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(122</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(114</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; text-align: left">Total property and equipment, net</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">15</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">21</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.65pt; text-align: left; text-indent: -5.65pt">&#160;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140231432101408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets, Net and Goodwill (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Intangible Assets, Net and Goodwill [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfImpairedIntangibleAssetsTextBlock', window );">Schedule of intangible assets, net and goodwil</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="text-align: center; border-bottom: Black 1.5pt solid"><b>As of<br/>
 December 31,</b></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">Carrying amount:</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: left">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; width: 76%; text-align: left">Technology</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right">2,007</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right">2,007</td>
    <td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-align: left">Customer relationships</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">1,127</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">1,127</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Trade names</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">201</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">201</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 4pt">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; text-align: right">3,335</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; text-align: right">3,335</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Accumulated amortization:</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-align: left">Technology</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">2,007</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">2,007</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-align: left">Customer relationships</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">1,127</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">1,127</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Trade names</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">134</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">114</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">3,268</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">3,248</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 4pt">Intangible assets, net</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; text-align: right">67</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; text-align: right">87</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.65pt; text-align: left; text-indent: -5.65pt">&#160;</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Schedule of the estimated future amortization expense of intangible assets</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%; text-align: left">2023</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">20</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">2024-2026</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">47</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 4pt; padding-left: 2.85pt">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">67</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfImpairedIntangibleAssetsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of impaired intangible assets excluding goodwill. This may include a description of the facts and circumstances leading to the recording of impairment charges of intangible assets in the period, the amount of the impairment charges, the methods of determining fair value of the associated assets, the caption in the income statement in which the impairment losses are aggregated, and the segment in which the impaired intangible assets are reported.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfImpairedIntangibleAssetsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140231435469840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Loans, Net (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Loans, Net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_ScheduleOfTheMemberEffectiveDateManagementByAssistanceOfThirdpartyTableTextBlock', window );">Schedule of the Effective Date, management by assistance of third-party</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>As of Closing Date</b></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%; text-align: left">Derivative warrant liability (see Note 8)</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right">&#160;&#160;&#160;&#160;&#160;78</td>
    <td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Straight loan</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">822</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Total gross consideration</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; text-align: right">900</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify; text-indent: 0in">&#160;</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_ScheduleOfPresentationReflectsTheReconciliationOfTheCarryingAmountTableTextBlock', window );">Schedule of the reconciliation of the carrying amount</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="text-align: center; border-bottom: Black 1.5pt solid"><b>Year ended  December 31,</b></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2020</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left; text-indent: -14.15pt; padding-left: 14.15pt">Opening balance</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right">508</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right">1,069</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right">1,469</td>
    <td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -14.15pt; padding-left: 14.15pt">Consideration received from PPP Note</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-55">-</div></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">54</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">75</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -14.15pt; padding-left: 14.15pt">Net consideration received from IBI Loan</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">887</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-56">-</div></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-57">-</div></td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -14.15pt; padding-left: 14.15pt">Recognition of fair value of derivative warrant liability</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">(88</td>
    <td style="text-align: left">)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-58">-</div></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-59">-</div></td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -14.15pt; padding-left: 14.15pt">PPP Note forgiveness (see also Note 6B)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-60">-</div></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">(129</td>
    <td style="text-align: left">)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-61">-</div></td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -14.15pt; padding-left: 14.15pt">Amortization of discounts relating to straight loan (see also Note 13)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">14</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">14</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">29</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -14.15pt; padding-left: 14.15pt">Accrued interest expenses relating to straight loan (see also Note 13)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">77</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">45</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">91</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -14.15pt; padding-left: 14.15pt">Repayment of accrued interest relating to straight loan</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">(77</td>
    <td style="text-align: left">)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">(45</td>
    <td style="text-align: left">)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">(91</td>
    <td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -14.15pt; padding-left: 14.15pt">Repayment of Facility Fee relating to straight loan</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">(10</td>
    <td style="text-align: left">)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">(40</td>
    <td style="text-align: left">)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-62">-</div></td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -14.15pt; padding-left: 14.15pt">Repayment of principal relating to straight loans</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">(582</td>
    <td style="text-align: left">)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">(500</td>
    <td style="text-align: left">)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">(504</td>
    <td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -14.15pt; padding-left: 14.15pt">Derecognition due to extinguishment of original straight loan</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-63">-</div></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">(672</td>
    <td style="text-align: left">)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-64">-</div></td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -14.15pt; padding-left: 14.15pt">Recognition subsequent to substantial modification of terms</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-65">-</div></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">712</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-66">-</div></td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -14.15pt; padding-left: 14.15pt">Exchange rate differences</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">(12</td>
    <td style="padding-bottom: 1.5pt; text-align: left">)</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-67">-</div></td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-68">-</div></td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 4pt; text-indent: -14.15pt; padding-left: 14.15pt">Closing balance</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; text-align: right">717</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; text-align: right">508</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; text-align: right">1,069</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify; text-indent: 0in">&#160;</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_ScheduleOfMaturityDatesOfOutstandingLoanTableTextBlock', window );">Schedule of maturity dates of outstanding loans</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="text-align: center; border-bottom: Black 1.5pt solid"><b>As of <br/>
December 31,</b></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; text-indent: -14.15pt; padding-left: 14.15pt">First year (current maturities) (*)</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right">164</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right">508</td>
    <td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -14.15pt; padding-left: 14.15pt">Second year</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">288</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-69">-</div></td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -14.15pt; padding-left: 14.15pt">Third year</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">265</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-70">-</div></td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 4pt; text-indent: -14.15pt; padding-left: 14.15pt">Closing balance</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; text-align: right">717</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; text-align: right">508</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left">(*)</td><td style="text-align: justify">As described in Note 6C above, the Company is required to repay
each year a minimum amount of $330 with respect to Repayment Amount (principal and interest).</td>
</tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmr_ScheduleOfMaturityDatesOfOutstandingLoanTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmr_ScheduleOfMaturityDatesOfOutstandingLoanTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmr_ScheduleOfPresentationReflectsTheReconciliationOfTheCarryingAmountTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmr_ScheduleOfPresentationReflectsTheReconciliationOfTheCarryingAmountTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmr_ScheduleOfTheMemberEffectiveDateManagementByAssistanceOfThirdpartyTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of effective date, management by assistance of third-party.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmr_ScheduleOfTheMemberEffectiveDateManagementByAssistanceOfThirdpartyTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140231433434096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Current Liabilities (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrentAbstract', window );"><strong>Other Current Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCurrentLiabilitiesTableTextBlock', window );">Schedule of other current liabilties</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: justify">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"><b>As of <br/>
December 31,</b></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; text-indent: -14.15pt; padding-left: 14.15pt">Employees and payroll accruals</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right">298</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right">341</td>
    <td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -14.15pt; padding-left: 14.15pt">Accrued expenses (*)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">85</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">126</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -14.15pt; padding-left: 14.15pt">Government authorities</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">42</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">33</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 4pt; text-indent: -14.15pt; padding-left: 14.15pt">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; text-align: right">425</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; text-align: right">500</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left">(*)</td><td style="text-align: justify">Including accrued interest relating to straight loan amounted
to $11 as of December 31, 2022. See also Note 13.</td>
</tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCurrentLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of other current liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCurrentLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140231435501264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Warrants Liabilities (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Warrants Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock', window );">Schedule of reconciliation of the fair value of derivative warrants liabilities</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -0.125in; text-align: justify">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Year ended  December 31,</b></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: justify">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; width: 76%; text-align: left">Opening balance</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right">50</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-71">-</div></td>
    <td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Recognition of fair value of 2021 Warrant issued upon substantial modification of terms (see Note 6A1)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-72">&#160;&#160;&#160;&#160;&#160;&#160;-</div></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">50</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Recognition of fair value of Warrant Share issued at Effective Date (see Note 6C)</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">88</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-73">-</div></td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Closing balance</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; text-align: right">138</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; text-align: right">50</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to carrying amount and estimated fair value of short-term and long-term debt instruments or arrangements, including but not limited to, identification of terms, features, and collateral requirements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140231433319824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Convertible Advance Investment (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_InvestmentHoldingsAbstract', window );"><strong>Convertible Advance Investment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock', window );">Schedule of reconciliation of the carrying amount of the convertible advance investment</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="text-align: center; border-bottom: Black 1.5pt solid"><b>Year ended December 31,</b></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2020</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left; text-indent: -14.15pt; padding-left: 14.15pt">Opening balance</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right">4,770</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right">3,922</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right">3,486</td>
    <td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -14.15pt; padding-left: 14.15pt">Net consideration received</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-74">-</div></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">560</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-75">-</div></td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -14.15pt; padding-left: 14.15pt">Change in the fair value of convertible advance investments (see also Note 13)</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">70</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">288</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">436</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 4pt; text-indent: -14.15pt; padding-left: 14.15pt">Closing balance</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; text-align: right">4,840</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; text-align: right">4,770</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; text-align: right">3,922</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmr_InvestmentHoldingsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmr_InvestmentHoldingsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of data and information required in the supplementary schedule applicable to management investment companies listing holdings of unaffiliated investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140231429272304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingent Liabilities (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingent Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_scheduleOfFutureMinimumCommitmentUnderBindingLeaseAgreeementsTableTextBlock', window );">Schedule of future minimum commitment under binding lease agreeements</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Lease of<br/>
 premises</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%; text-align: left; padding-bottom: 1.5pt">2023</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;77</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 4pt; padding-left: 2.85pt">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">77</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify; text-indent: 0in">&#160;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmr_scheduleOfFutureMinimumCommitmentUnderBindingLeaseAgreeementsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmr_scheduleOfFutureMinimumCommitmentUnderBindingLeaseAgreeementsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140231433598128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders&#8217; Equity (Deficit) (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Shareholders&#8217; Equity (Deficit) [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfStockholdersEquityTableTextBlock', window );">Schedule of composition of shareholders' equity</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">As of <br/> December 31, 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">As of <br/> December 31, 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Authorized</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Issued and<br/> outstanding</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Authorized</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Issued and<br/> outstanding</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="14" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number of shares</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">Shares of NIS&#160;0.05 par value:</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left">Series Ordinary Shares (A)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">14,307,116</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">2,578,760</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">14,316,880</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">2,578,760</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Series Convertible Ordinary 1 Shares (B)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">607,680</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">607,680</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">607,680</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">607,680</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Series Convertible Ordinary 2 Shares (B)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">889,200</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">889,200</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">889,200</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">889,200</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Series Convertible B Preferred Shares (B)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,047,200</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,047,200</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,047,200</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,047,200</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Series Convertible B1 Preferred Shares B)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">738,240</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">738,240</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">738,240</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">738,240</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Series Convertible C Preferred Shares (B)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,410,564</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,928,960</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,400,800</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,928,960</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 4pt">Total</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">22,000,000</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">9,790,040</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">22,000,000</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">9,790,040</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.3pt; text-align: justify"><b>&#160;</b></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left">A.</td><td style="text-align: justify">The Ordinary Shares confer upon the holders thereof all rights
accruing to a shareholder of the Company, as provided in the Company&#8217;s Articles of Association (the &#8220;Articles&#8221;), including,
without limitation, the right to receive notices of, and to attend, all general meetings, the right to vote thereat with each Ordinary
Share held entitling the holder thereof to one vote at all general meetings (and written actions in lieu of meetings), the right to participate
and share on a per share basis, in any distribution and in distribution of surplus assets and funds of the Company in the event of a
liquidation event, and certain other rights as may be expressly provided for herein or under the Companies Law. All Ordinary Shares rank
pari passu amongst themselves for all intents and purposes, including, without limitation, in relation to the amounts of capital paid
or credited as paid on their nominal value. The voting, dividend and liquidation rights of the holders of Ordinary Shares are subject
to and qualified by the rights, powers and preferences of the holders of the Convertible Preferred Shares and the Convertible Ordinary
1 and 2 Shares as set below.</td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify; text-indent: -21.3pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left">B.</td><td style="text-align: justify">The Convertible Ordinary 1 Shares, Convertible Ordinary 2 Shares,
Convertible B Preferred Shares, Convertible B1 Preferred Shares and the Convertible C Preferred Shares (referring together herein as
&#8220;Convertible Preferred Shares&#8221;) shall confer upon the holders thereof all rights conferred upon the holders of Ordinary Shares
in the Company. In addition, the holders of Convertible Preferred Shares shall have rights, preferences and privileges, as follows:</td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify">Liquidation preference&#160;- Based
on preference of distribution, in the event of any liquidation, dissolution or winding up of the Company, whether voluntary or involuntary,
change in control or distribution, the Company&#8217;s assets or surplus funds legally available for distribution shall be distributed to the
holders of Convertible Preferred Shares pursuant to which each Convertible Preferred Share will be entitled to receive 1.2 of the applicable
original issue price paid by each Convertible Preferred shareholder plus all accrued but unpaid dividends and less the aggregate of all
amounts previously paid in preference. The aggregate liquidation preference of all shares with preferences over Ordinary Shares as of
December&#160;31, 2022 and 2021 amounted to $33,785. None of the foregoing dollar amounts include dividends, as the Board of Directors
has not declared any dividends since inception.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify">The Convertible Preferred Shares have
been classified as part of the permanent equity of the Company since upon occurrence of liquidation event all holder of the Ordinary Shares
and the Convertible Preferred Shares will be entitled to receive the same form of consideration.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify">Voting&#160;- Each shareholder shall
have one vote for each Ordinary Share held by such shareholder of record or such Ordinary Shares as would be held by each holder of Convertible
Preferred Share if all Convertible Preferred Shares were converted to Ordinary Shares at the then effective conversion rate, on every
resolution.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify">Conversion&#160;- Each holder of a
Convertible Preferred Share shall be entitled to convert, at any time and from time to time, and without payment of additional consideration,
into such number of fully paid and non-assessable shares of Ordinary Share in ratio as determined in the Articles, which initially shall
be one to one. The conversion price initially shall be the applicable Original Issue Price subject to adjustments as describe in the Articles.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify">All outstanding Convertible Preferred
Shares shall automatically be converted into Ordinary Shares at the then-effective conversion rate applicable upon the earlier of (i)
closing of sale of Ordinary Shares in an initial firm-commitment underwritten public offering, with net proceeds to the Company of $50,000
and at an offering price per share equal to at least 5 times the Preferred C Original Issue Price (Qualified IPO) or (ii) affirmative
vote or written consent of majority shareholders of the then outstanding Convertible Preferred Shares, with respect to each series.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0%"/><td style="width: 0.5in">C.</td><td style="text-align: justify">On March 14, 2022, the Company&#8217;s shareholders approved, among other matters, the following matters as
were originally approved by the Company&#8217;s Board of Directors on March&#160;1, 2022&#160;-</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify; text-indent: -21.3pt">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">1.</td><td style="text-align: justify">In connection with listing of the Company&#8217;s Ordinary Shares on
Nasdaq, increase the Company&#8217;s authorized shares from 22,000,000 to 222,000,000.</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt; text-align: justify; text-indent: -21.25pt">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">2.</td><td style="text-align: justify">Approve and ratify (i) subject to the listing of the Company&#8217;s Ordinary Shares on Nasdaq, the voluntary
conversion of all the Ordinary 1, Ordinary 2, Preferred B, Preferred B-1 and Preferred B shares of the Company into Ordinary Shares (collectively,
the &#8220;Voluntary Conversion&#8221;), (ii) subject to the listing of the Company&#8217;s Ordinary Shares on Nasdaq, a reverse share
split of all outstanding Ordinary Shares of the Company at a ratio of 5:1 so that each 5 ordinary shares nominal value NIS 0.01 each shall
be consolidated into 1 Ordinary Share each, and (the &#8220;Reverse Share Split&#8221;) (iii) subject to the listing of the Company&#8217;s
Ordinary Shares on Nasdaq, the recapitalization and redistribution of the entire share capital of the Company (the &#8220;Recapitalization&#8221;),
so that following such Voluntary Conversion and Recapitalization, the share capital of the Company shall consist of NIS 11,100,000 divided
into 222,000,000 Ordinary Shares each of which 9,790,040 are issued and outstanding (post the aforesaid Reverse Share Split).</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt; text-align: justify; text-indent: -21.25pt">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify">For accounting purposes, following
the completion of the IPO transaction as noted in Note 17 below, all shares, options and warrants to purchase Ordinary Shares and loss
per share amounts have been adjusted to give retroactive effect to the Reverse Share Split for all periods presented in these consolidated
financial statements. Any fractional shares resulting from the Reverse Share Split were rounded up to the nearest whole share.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfStockholdersEquityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of changes in the separate accounts comprising stockholders' equity (in addition to retained earnings) and of the changes in the number of shares of equity securities during at least the most recent annual fiscal period and any subsequent interim period presented is required to make the financial statements sufficiently informative if both financial position and results of operations are presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfStockholdersEquityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140231437240784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share Options (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share Options [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule of company&#8217;s share option activity for employees and members of the board of directors</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: left"><b>&#160;</b></td>
    <td style="font-weight: bold; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><b>Number of<br/>
    Share<br/>
    Options</b></td>
    <td style="padding-bottom: 1.5pt; font-weight: bold"><b>&#160;</b></td>
    <td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><b>Weighted<br/>
    Average<br/>
    Exercise<br/>
    Price <br/>
$</b></td>
    <td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td style="font-weight: bold; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><b>Weighted<br/> average<br/>
    remaining<br/> contractual<br/> life (years)</b></td>
    <td style="padding-bottom: 1.5pt; font-weight: bold"><b>&#160;</b></td>
    <td style="font-weight: bold; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><b>Intrinsic<br/> value<br/>
 $</b></td>
    <td style="padding-bottom: 1.5pt; font-weight: bold"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left">Outstanding as of December 31, 2019</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 9%; text-align: right">1,291,810</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 9%; text-align: right">1.65</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: center">&#160;</td>
    <td style="width: 9%; text-align: right">5.94</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 9%; text-align: right">194</td>
    <td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Granted</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">353,960</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">1.80</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: right">9.35</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Exercised</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">(9,800</td>
    <td style="text-align: left">)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">1.15</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-76">-</div></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Forfeited or expired</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">(381,970</td>
    <td style="padding-bottom: 1.5pt; text-align: left">)</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">1.75</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-77">-</div></td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 4pt">Outstanding as of December 31, 2020</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: right">1,254,000</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: right">1.70</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: center">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: right">6.12</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: right">125</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 4pt">Exercisable as of December&#160;31, 2020</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: right">839,665</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: right">1.50</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: center">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: right">4.73</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: right">252</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: left"><b>&#160;</b></td>
    <td style="font-weight: bold; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><b>Number of<br/>
    Share<br/>
    Options</b></td>
    <td style="padding-bottom: 1.5pt; font-weight: bold"><b>&#160;</b></td>
    <td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><b>Weighted<br/>
    Average<br/>
    Exercise<br/>
    Price<br/>
    $</b></td>
    <td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td style="font-weight: bold; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><b>Weighted<br/> average<br/>
    remaining<br/> contractual<br/> life (years)</b></td>
    <td style="padding-bottom: 1.5pt; font-weight: bold"><b>&#160;</b></td>
    <td style="font-weight: bold; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><b>Intrinsic<br/> value<br/>
 $</b></td>
    <td style="padding-bottom: 1.5pt; font-weight: bold"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left">Outstanding as of December 31, 2020</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 9%; text-align: right">1,254,000</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 9%; text-align: right">1.70</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: center">&#160;</td>
    <td style="width: 9%; text-align: right">6.12</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 9%; text-align: right">125</td>
    <td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Granted</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">214,688</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">2.05</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: right">9.64</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Forfeited or expired</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">(101,520</td>
    <td style="padding-bottom: 1.5pt; text-align: left">)</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">1.80</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-78">-</div></td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Outstanding as of December 31, 2021</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: right">1,367,168</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: right">1.75</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: center">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: right">5.72</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: right">4,860</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Exercisable as of December&#160;31, 2021</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: right">927,988</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: right">1.60</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: center">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: right">4.25</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: right">3,429</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><b>&#160;</b></p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: left"><b>&#160;</b></td>
    <td style="font-weight: bold; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><b>Number of<br/>
    Share<br/>
    Options</b></td>
    <td style="padding-bottom: 1.5pt; font-weight: bold"><b>&#160;</b></td>
    <td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><b>Weighted<br/>
    Average<br/>
    Exercise<br/>
    Price<br/>
    $</b></td>
    <td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td style="font-weight: bold; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><b>Weighted<br/> average<br/>
    remaining<br/> contractual<br/> life (years)</b></td>
    <td style="padding-bottom: 1.5pt; font-weight: bold"><b>&#160;</b></td>
    <td style="font-weight: bold; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><b>Intrinsic<br/> value<br/>
    $</b></td>
    <td style="padding-bottom: 1.5pt; font-weight: bold"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left">Outstanding as of December 31, 2021</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 9%; text-align: right">1,367,168</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 9%; text-align: right">1.75</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: center">&#160;</td>
    <td style="width: 9%; text-align: right">5.72</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 9%; text-align: right">4,860</td>
    <td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Granted</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">286,875</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">1.83</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Forfeited or expired</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">(83,052</td>
    <td style="padding-bottom: 1.5pt; text-align: left">)</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">1.45</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">-</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Outstanding as of December 31, 2022</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: right">1,570,991</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: right">1.78</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: center">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: right">4.97</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: right">2,435</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Exercisable as of December&#160;31, 2022</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: right">1,048,297</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: right">1.70</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: center">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: right">3.2</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: right">1,677</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock', window );">Schedule of outstanding and exercisable share options separated ranges of exercise prices</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; text-align: justify"><b>Exercise price</b></td>
    <td style="font-weight: bold; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><b>Share options<br/> outstanding<br/>
    as of<br/> December&#160;31,<br/> 2022</b></td>
    <td style="padding-bottom: 1.5pt; font-weight: bold"><b>&#160;</b></td>
    <td style="font-weight: bold; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><b>Weighted<br/> average<br/>
remaining<br/> contractual<br/> term (years)</b></td>
    <td style="padding-bottom: 1.5pt; font-weight: bold"><b>&#160;</b></td>
    <td style="font-weight: bold; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><b>Share options<br/> exercisable<br/>
    as of<br/> December&#160;31,<br/> 2022</b></td>
    <td style="padding-bottom: 1.5pt; font-weight: bold"><b>&#160;</b></td>
    <td style="font-weight: bold; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><b>Weighted<br/> average<br/>
    remaining<br/> contractual<br/> term (years)</b></td>
    <td style="padding-bottom: 1.5pt; font-weight: bold"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left"><b>$</b></td>
    <td><b>&#160;</b></td>
    <td colspan="2" style="text-align: right"><b>&#160;</b></td>
    <td><b>&#160;</b></td>
    <td><b>&#160;</b></td>
    <td colspan="2" style="text-align: center"><b>$</b></td>
    <td><b>&#160;</b></td>
    <td><b>&#160;</b></td>
    <td colspan="2" style="text-align: right"><b>&#160;</b></td>
    <td><b>&#160;</b></td>
    <td><b>&#160;</b></td>
    <td colspan="2" style="text-align: center"><b>$</b></td>
    <td><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left">0.00</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 9%; text-align: right">152,640</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: center">&#160;</td>
    <td style="width: 9%; text-align: right">2.42</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 9%; text-align: right">152,640</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: center">&#160;</td>
    <td style="width: 9%; text-align: right">1.03</td>
    <td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">1.14</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">228,480</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: right">1.39</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">228,480</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: right">1.39</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">1.67</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">43,200</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: right">2.21</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">43,200</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: right">2.21</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">1.83</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">982,870</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: right">6.75</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">489,239</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: right">4.70</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">3.2</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">35,001</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: right">6.45</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">10,938</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: right">6.45</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">3.79</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">60,000</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: right">1.59</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">60,000</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: right">1.59</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">4.17</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">28,800</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: right">3.03</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">28,800</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: right">3.03</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">5.12</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">40,000</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: right">6.54</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">35,000</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: right">6.54</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 4pt">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: right">1,570,991</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="padding-bottom: 4pt; text-align: center">&#160;</td>
    <td style="padding-bottom: 4pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: right">1,048,297</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="padding-bottom: 4pt; text-align: center">&#160;</td>
    <td style="padding-bottom: 4pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock', window );">Schedule of assumptions used to estimate the fair values of the share options granted</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="text-align: center; border-bottom: Black 1.5pt solid"><b>Year ended December 31</b></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2020</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">Volatility (%)</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 9%; text-align: right">61.49</td>
    <td style="width: 1%; text-align: left">%</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 9%; text-align: right">64.75</td>
    <td style="width: 1%; text-align: left">%</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="white-space: nowrap; width: 9%; text-align: right"><span style="font-size: 10pt">61.89%-61.91</span></td>
    <td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Risk-free interest rate (%)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="white-space: nowrap; text-align: right"><span style="font-size: 10pt">3.64%-3.85</span></td>
    <td style="text-align: left">%</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">0.09</td>
    <td style="text-align: left">%</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="white-space: nowrap; text-align: right"><span style="font-size: 10pt">0.03%-0.04</span></td>
    <td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Dividend yield (%)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-79">-</span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-80">-</span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">-</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Expected life (years)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">6.25</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">6.25</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">6.25</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Exercise price ($)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">1.83</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">1.80-3.20</span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">1.80</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Share price ($)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">3.30</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">3.20</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">1.80</td>
    <td style="text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock', window );">Schedule of company&#8217;s equity-based awards recognized</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="text-align: center; border-bottom: Black 1.5pt solid"><b>Year ended December 31</b></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2020</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">Research and development</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right">144</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right">94</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right">60</td>
    <td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Sales and marketing</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">49</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">45</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">48</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">General and administrative</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">29</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">18</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">12</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; text-align: right">222</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; text-align: right">157</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; text-align: right">120</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the weighted-average grant-date fair value of equity options or other equity instruments granted during the year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140231433638944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financing Expenses, Net (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_FinancingExpensesAbstract', window );"><strong>Financing Expenses [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebtTableTextBlock', window );">Schedule of financing expenses</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="text-align: center; border-bottom: Black 1.5pt solid"><b>Year ended  December 31</b></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2020</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; width: 64%; text-align: left">Change in fair value of convertible advance investment (see Note 9)</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right">70</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right">288</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right">436</td>
    <td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Amortization of discount and accrued interest relating to straight loan received from commercial Bank (see Note 6 and Note 7)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">102</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">59</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">120</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Modification of terms relating to straight loan (see Note 6A1)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-81">-</div></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">90</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-82">-</div></td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Amortization of discount relating to liability to related party (see Note 14)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">40</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-83">-</div></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-84">-</div></td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Exchange rate differences and others</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">(47</td>
    <td style="padding-bottom: 1.5pt; text-align: left">)</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">38</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">141</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; text-align: right">165</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; text-align: right">475</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; text-align: right">697</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmr_FinancingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmr_FinancingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of convertible debt instrument. Includes, but is not limited to, principal amount and amortized premium or discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140231435319440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Parties Transactions (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRegulatoryLiabilitiesTextBlock', window );">Schedule of the reconciliation of the carrying amount of the Company</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="text-align: center; border-bottom: Black 1.5pt solid"><b>Year ended  December 31,</b></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2020</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left; text-indent: -14.15pt; padding-left: 14.15pt">Opening balance</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right">345</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right">168</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-85">-</div></td>
    <td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -14.15pt; padding-left: 14.15pt">Accrued liability in respect to additional services rendered</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">115</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">177</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">168</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -14.15pt; padding-left: 14.15pt">Recognition of capital contribution from a controlling shareholder</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">(112</td>
    <td style="text-align: left">)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-86">-</div></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-87">-</div></td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -14.15pt; padding-left: 14.15pt">Amortization of discount relating to liability to related party</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">40</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-88">-</div></td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-89">-</div></td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 4pt; text-indent: -14.15pt; padding-left: 14.15pt">Closing balance</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; text-align: right">388</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; text-align: right">345</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; text-align: right">168</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock', window );">Schedule of maturity dates</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="text-align: center; border-bottom: Black 1.5pt solid"><b>As of<br/>
 December 31,</b></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; text-indent: -14.15pt; padding-left: 14.15pt">First year (current maturities)</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right">126</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right">345</td>
    <td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -14.15pt; padding-left: 14.15pt">Second year</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">262</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-90">-</div></td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 4pt; text-indent: -14.15pt; padding-left: 14.15pt">Closing balance</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; text-align: right">388</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; text-align: right">345</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Schedule of expenses related to service agreement and the office services agreement</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="text-align: center; border-bottom: Black 1.5pt solid"><b>Year ended  December 31</b></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2020</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left; text-indent: -8.6pt; padding-left: 8.6pt">Research and development</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right">42</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right">44</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right">82</td>
    <td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -8.6pt; padding-left: 8.6pt">Sales and marketing</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">42</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">44</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">58</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -8.6pt; padding-left: 8.6pt">General and administrative</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">83</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">89</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">108</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; text-align: right">167</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; text-align: right">177</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; text-align: right">248</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRegulatoryLiabilitiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of regulatory liabilities. Detailed information about liabilities that result from rate actions of a regulator. Rate actions of a regulator can impose a liability on a regulated enterprise resulting in a regulatory liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 980<br> -SubTopic 405<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6500807&amp;loc=d3e48068-110394<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRegulatoryLiabilitiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140231437478736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Taxes on Income (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Taxes on Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Schedule of loss (income) before taxes on income</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="text-align: center; border-bottom: Black 1.5pt solid"><b>Year ended  December 31</b></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2020</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">Domestic</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right">1,293</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right">1,104</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right">2,529</td>
    <td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Foreign operations (Beamr Inc and Imaging RU)</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">(97</td>
    <td style="padding-bottom: 1.5pt; text-align: left">)</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">(204</td>
    <td style="padding-bottom: 1.5pt; text-align: left">)</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">(165</td>
    <td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; text-align: right">1,196</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; text-align: right">900</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; text-align: right">2,364</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify">&#160;</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of deferred income taxes reflect the net tax effects of net operating loss</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="text-align: center; border-bottom: Black 1.5pt solid"><b>As of <br/>
December 31</b></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">Composition of deferred tax assets:</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">Net operating loss and capital losses carry-forward</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right">6,343</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right">6,254</td>
    <td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Research and development credits</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">438</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">588</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Vacation accrual</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">48</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">62</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Net deferred tax asset before deferred tax liabilities and valuation allowance</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: right">6,829</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: right">6,904</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Valuation allowance</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">(6,829</td>
    <td style="padding-bottom: 1.5pt; text-align: left">)</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">(6,904</td>
    <td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Net deferred tax assets</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-91">-</div></td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-92">-</div></td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify">&#160;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140231428989376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Geographical Information And Major Customers (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Geographical Information And Major Customers [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock', window );">Schedule of revenues by geographic region</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="text-align: center; border-bottom: Black 1.5pt solid"><b>Year ended December 31</b></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2020</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">United States</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right">2,134</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right">2,597</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right">2,558</td>
    <td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Israel</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">22</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">101</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">61</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Rest of the world</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">707</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">602</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">557</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; text-align: right">2,863</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; text-align: right">3,300</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; text-align: right">3,176</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify">&#160;</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock', window );">Schedule of Long-lived assets net by geographic areas</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: justify">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"><b>As of<br/>
 December 31,</b></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; text-indent: -14.15pt; padding-left: 14.15pt">Israel</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right">12</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right">13</td>
    <td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -14.15pt; padding-left: 14.15pt">United States</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">1</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">4</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -14.15pt; padding-left: 14.15pt">Russia</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">2</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">4</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 4pt; text-indent: -14.15pt; padding-left: 14.15pt">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; text-align: right">15</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; text-align: right">21</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify">&#160;</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Schedule of revenue disaggregated by primary major product lines and services</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><b>Year ended  December 31,</b></td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2020</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">Software license:</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: justify">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; width: 64%; text-align: left">Perpetual based software license - transferred at a point of time</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right">1,068</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right">1,156</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right">1,043</td>
    <td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Term-based software license - transferred at a point of time</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">1,630</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">2,032</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">1,976</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Total software license (*)</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">2,740</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">3,188</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">3,019</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">PCS services transferred over a period of time</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">123</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">112</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">157</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Advertising at a point of time upon clicks</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">42</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-93">-</div></td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-94">-</div></td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 4pt">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; text-align: right">2,863</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; text-align: right">3,300</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; text-align: right">3,176</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.65pt; text-align: justify; text-indent: -21.3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt">&#160;</span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left">(*)</td><td style="text-align: justify">Revenue recognized from sales-based software license was $48,
$45 and $99 during the years ended December 31, 2022, 2021 and 2020, respectively (see also Note 2N).</td>
</tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of long-lived assets, excluding financial instruments, long-term customer relationships of a financial institution, mortgage rights, deferred policy acquisition costs, and deferred tax assets, by geographic areas located in the entity's country of domicile and foreign countries in which the entity holds assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph b<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the names of foreign countries from which revenue is material and the amount of revenue from external customers attributed to those countries. An entity may also provide subtotals of geographic information about groups of countries.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140231432140704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>General (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Feb. 27, 2023 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>ILS (&#8362;)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_GeneralDetailsLineItems', window );"><strong>General (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,248,000)<span></span>
</td>
<td class="num">$ (952,000)<span></span>
</td>
<td class="num">$ (2,459,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulative deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(30,969,000)<span></span>
</td>
<td class="num">(29,721,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromNotesPayable', window );">Net amounts raised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">54,000<span></span>
</td>
<td class="nump">75,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Exercise of share option value through paycheck protection</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Issuance of convertible debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">560,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalUnitsNetAmount', window );">Net amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">887,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering', window );">Public offering price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">313,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_PublicOfferingPrice', window );">Public offering price (in Dollars per share) | $ / shares</a></td>
<td class="nump">$ 4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_AggregateGrossProceeds', window );">Aggregate gross proceeds</a></td>
<td class="nump">$ 7,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Ordinary shares [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_GeneralDetailsLineItems', window );"><strong>General (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestDifferenceBetweenCarryingAmountAndMaximumExposure', window );">Ordinary shares per value (in New Shekels) | &#8362;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8362; 0.05<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">IPO [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_GeneralDetailsLineItems', window );"><strong>General (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,248,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering', window );">Public offering price</a></td>
<td class="nump">$ 1,950,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_PublicOfferingPrice', window );">Public offering price (in Dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmr_AggregateGrossProceeds">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of aggregate gross proceeds.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmr_AggregateGrossProceeds</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmr_GeneralDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmr_GeneralDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmr_PublicOfferingPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Public offering price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmr_PublicOfferingPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalUnitsNetAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net amount applicable to investors of capital units or shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04.16(b)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120401414&amp;loc=d3e603758-122996<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalUnitsNetAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's first offering of stock to the public.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceInitialPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a borrowing supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableInterestDifferenceBetweenCarryingAmountAndMaximumExposure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Difference between the carrying amount of assets and liabilities in the reporting entity's statement of financial position that relate to the reporting entity's variable interest in the variable interest entity (VIE) and the reporting entity's maximum exposure to loss as a result of its involvement with the VIE, where the reporting entity is not the VIE's primary beneficiary.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5728-111685<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableInterestDifferenceBetweenCarryingAmountAndMaximumExposure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140231434637408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_SignificantAccountingPoliciesDetailsLineItems', window );"><strong>Significant Accounting Policies (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering', window );">Initial public offering total amount (in Dollars)</a></td>
<td class="nump">$ 313<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_EmployeeCompensationPercentage', window );">Employee compensation percentage</a></td>
<td class="nump">8.33%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherReceivables', window );">Receivable amount (in Dollars)</a></td>
<td class="nump">$ 35<span></span>
</td>
<td class="nump">$ 29<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredRevenue', window );">Deferred revenue (in Dollars)</a></td>
<td class="nump">$ 31<span></span>
</td>
<td class="nump">$ 33<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument percent</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentage', window );">New debt instrument percentage</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Carrying amount percentage</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_PercentageOfDividend', window );">Percentage of dividend</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExcessStockSharesOutstanding', window );">Weighted average number of ordinary shares related to outstanding (in Shares)</a></td>
<td class="nump">9,067,438<span></span>
</td>
<td class="nump">8,957,327<span></span>
</td>
<td class="nump">8,842,202<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=bmr_ConvertibleAdvanceInvestmentsMember', window );">Convertible Advance Investments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_SignificantAccountingPoliciesDetailsLineItems', window );"><strong>Significant Accounting Policies (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Investment percentage</a></td>
<td class="nump">200.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmr_EmployeeCompensationPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Employee compensation percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmr_EmployeeCompensationPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmr_PercentageOfDividend">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of dividend.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmr_PercentageOfDividend</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmr_SignificantAccountingPoliciesDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmr_SignificantAccountingPoliciesDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateEffectivePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPricePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage price of original principal amount of debt at which debt can be redeemed by the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph e<br> -URI https://asc.fasb.org/extlink&amp;oid=123599511&amp;loc=d3e64711-112823<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPricePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ExcessStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of excess stock held by shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ExcessStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount due from parties in nontrade transactions, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's first offering of stock to the public.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceInitialPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=bmr_ConvertibleAdvanceInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=bmr_ConvertibleAdvanceInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140231520296240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies (Details) - Schedule of computing straight-line amortization<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_TechnologyEquipmentMember', window );">Technology {Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_PropertyPlantAndEquipmentDepreciationPercentage', window );">Property, plant and equipment, depreciation percentage</a></td>
<td class="nump">20.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_CustomerRelationshipsMember', window );">Customer Relationships [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_PropertyPlantAndEquipmentDepreciationPercentage', window );">Property, plant and equipment, depreciation percentage</a></td>
<td class="nump">20.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_TradeNamesMember', window );">Trade Names [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_PropertyPlantAndEquipmentDepreciationPercentage', window );">Property, plant and equipment, depreciation percentage</a></td>
<td class="nump">10.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmr_PropertyPlantAndEquipmentDepreciationPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The annual rate of depreciation (related to property, plant and equipment, but not including land) that has been recognized during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmr_PropertyPlantAndEquipmentDepreciationPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_TechnologyEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_TechnologyEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140231428847376">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Significant Accounting Policies (Details) - Schedule of computing straight-line depreciation<br></strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=bmr_CompareAndPeripheralEquipmentMember', window );">Compare and Peripheral equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_SignificantAccountingPoliciesDetailsScheduleofcomputingstraightlinedepreciationLineItems', window );"><strong>Significant Accounting Policies (Details) - Schedule of computing straight-line depreciation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentSalvageValuePercentage', window );">Property, plant and equipment, depreciation percentage</a></td>
<td class="nump">33.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=bmr_OfficeFurnitureAndEquipmentMember', window );">Office furniture and equipment [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_SignificantAccountingPoliciesDetailsScheduleofcomputingstraightlinedepreciationLineItems', window );"><strong>Significant Accounting Policies (Details) - Schedule of computing straight-line depreciation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentSalvageValuePercentage', window );">Property, plant and equipment, depreciation percentage</a></td>
<td class="nump">7.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=bmr_OfficeFurnitureAndEquipmentMember', window );">Office furniture and equipment [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_SignificantAccountingPoliciesDetailsScheduleofcomputingstraightlinedepreciationLineItems', window );"><strong>Significant Accounting Policies (Details) - Schedule of computing straight-line depreciation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentSalvageValuePercentage', window );">Property, plant and equipment, depreciation percentage</a></td>
<td class="nump">15.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmr_SignificantAccountingPoliciesDetailsScheduleofcomputingstraightlinedepreciationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmr_SignificantAccountingPoliciesDetailsScheduleofcomputingstraightlinedepreciationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentSalvageValuePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stated as a percentage, the estimated or actual value of the asset at the end of its useful life or when it is no longer serviceable (cannot be used for its original purpose) divided by its [historical] capitalized cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentSalvageValuePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=bmr_CompareAndPeripheralEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=bmr_CompareAndPeripheralEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=bmr_OfficeFurnitureAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=bmr_OfficeFurnitureAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140231429131424">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Other Current Assets (Details) - Schedule of other current assets - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_ScheduleOfOtherCurrentAssetsAbstract', window );"><strong>Schedule of Other Current Assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseCurrentAndNoncurrent', window );">Prepaid expenses</a></td>
<td class="nump">$ 32<span></span>
</td>
<td class="nump">$ 33<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_GovernmentAuthoritiesAssets', window );">Government authorities</a></td>
<td class="nump">15<span></span>
</td>
<td class="nump">22<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherPrepaidExpenseCurrent', window );">Others</a></td>
<td class="nump">17<span></span>
</td>
<td class="nump">11<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Total other current assets</a></td>
<td class="nump">$ 64<span></span>
</td>
<td class="nump">$ 66<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmr_GovernmentAuthoritiesAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Government authorities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmr_GovernmentAuthoritiesAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmr_ScheduleOfOtherCurrentAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmr_ScheduleOfOtherCurrentAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherPrepaidExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for other costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6387103&amp;loc=d3e6435-108320<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherPrepaidExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of expenditures made in advance of when the economic benefit of the cost will be realized, and which will be expensed in future periods with the passage of time or when a triggering event occurs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.10)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.10)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140231433534992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment, Net (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property and Equipment, Net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationExpenseOnReclassifiedAssets', window );">Total depreciation expenses</a></td>
<td class="nump">$ 8<span></span>
</td>
<td class="nump">$ 16<span></span>
</td>
<td class="nump">$ 32<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationExpenseOnReclassifiedAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the asset that is reclassified back to held and use from held-for-sale, the depreciation expense recognized when the asset is reclassified. This represents the difference between the carrying value at the time the decision to reclassify is made and the carrying amount that the asset would have had if it had never been classified as held for sale (including consideration of depreciation expense).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 35<br> -Paragraph 44<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=29634951&amp;loc=d3e1756-110224<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2459-110228<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationExpenseOnReclassifiedAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140231429117504">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Property and Equipment, Net (Details) - Schedule of property and equipment net - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">$ 137<span></span>
</td>
<td class="nump">$ 135<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less - accumulated depreciation</a></td>
<td class="num">(122)<span></span>
</td>
<td class="num">(114)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Total property and equipment, net</a></td>
<td class="nump">15<span></span>
</td>
<td class="nump">21<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember', window );">Computers and peripheral equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">95<span></span>
</td>
<td class="nump">93<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OfficeEquipmentMember', window );">Office furniture and equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">$ 42<span></span>
</td>
<td class="nump">$ 42<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OfficeEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OfficeEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140231520296944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets, Net and Goodwill (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Intangible Assets, Net and Goodwill [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Total amortization expenses (in Dollars)</a></td>
<td class="nump">$ 20<span></span>
</td>
<td class="nump">$ 177<span></span>
</td>
<td class="nump">$ 647<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseDiscountRate', window );">Discount rate</a></td>
<td class="nump">25.30%<span></span>
</td>
<td class="nump">25.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongDurationContractsAssumptionsByProductAndGuaranteeDiscountRate', window );">Long-term growth rate</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Discount rate used by lessee to determine present value of operating lease payments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongDurationContractsAssumptionsByProductAndGuaranteeDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage discount rate used to calculate present value of an expected stream of future payments, which is included in the calculation of the amount of the specified guaranteed benefit obligation as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=d3e14931-158439<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124508989&amp;loc=d3e19393-158473<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 20<br> -Section 55<br> -Paragraph 15<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=124504833&amp;loc=d3e7104-158389<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongDurationContractsAssumptionsByProductAndGuaranteeDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140231427493312">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Intangible Assets, Net and Goodwill (Details) - Schedule of intangible assets, net and goodwil - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_CarryingAmountAbstract', window );"><strong>Carrying amount:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsUnderManagementCarryingAmount', window );">Carrying amount</a></td>
<td class="nump">$ 3,335<span></span>
</td>
<td class="nump">$ 3,335<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_AccumulatedAmortizationAbstract', window );"><strong>Accumulated amortization:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedAmortizationDeferredFinanceCosts', window );">Accumulated amortization</a></td>
<td class="nump">3,268<span></span>
</td>
<td class="nump">3,248<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherIntangibleAssetsNet', window );">Intangible assets, net</a></td>
<td class="nump">67<span></span>
</td>
<td class="nump">87<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=bmr_TechnologyMember', window );">Technology [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_CarryingAmountAbstract', window );"><strong>Carrying amount:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsUnderManagementCarryingAmount', window );">Carrying amount</a></td>
<td class="nump">2,007<span></span>
</td>
<td class="nump">2,007<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_AccumulatedAmortizationAbstract', window );"><strong>Accumulated amortization:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedAmortizationDeferredFinanceCosts', window );">Accumulated amortization</a></td>
<td class="nump">2,007<span></span>
</td>
<td class="nump">2,007<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer relationships [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_CarryingAmountAbstract', window );"><strong>Carrying amount:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsUnderManagementCarryingAmount', window );">Carrying amount</a></td>
<td class="nump">1,127<span></span>
</td>
<td class="nump">1,127<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_AccumulatedAmortizationAbstract', window );"><strong>Accumulated amortization:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedAmortizationDeferredFinanceCosts', window );">Accumulated amortization</a></td>
<td class="nump">1,127<span></span>
</td>
<td class="nump">1,127<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember', window );">Trade names [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_CarryingAmountAbstract', window );"><strong>Carrying amount:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsUnderManagementCarryingAmount', window );">Carrying amount</a></td>
<td class="nump">201<span></span>
</td>
<td class="nump">201<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_AccumulatedAmortizationAbstract', window );"><strong>Accumulated amortization:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedAmortizationDeferredFinanceCosts', window );">Accumulated amortization</a></td>
<td class="nump">$ 134<span></span>
</td>
<td class="nump">$ 114<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmr_AccumulatedAmortizationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmr_AccumulatedAmortizationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmr_CarryingAmountAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmr_CarryingAmountAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedAmortizationDeferredFinanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated amortization of debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedAmortizationDeferredFinanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsUnderManagementCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying amount of assets an investment adviser manages on behalf of investors.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsUnderManagementCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated amortization of finite-lived and indefinite-lived intangible assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=bmr_TechnologyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=bmr_TechnologyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140231433563424">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Intangible Assets, Net and Goodwill (Details) - Schedule of the estimated future amortization expense of intangible assets<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_ScheduleOfTheEstimatedFutureAmortizationExpenseOfIntangibleAssetsAbstract', window );"><strong>Schedule of the Estimated Future Amortization Expense of Intangible Assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths', window );">2023</a></td>
<td class="nump">$ 20<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo', window );">2024-2026</a></td>
<td class="nump">47<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Total</a></td>
<td class="nump">$ 67<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmr_ScheduleOfTheEstimatedFutureAmortizationExpenseOfIntangibleAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmr_ScheduleOfTheEstimatedFutureAmortizationExpenseOfIntangibleAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized in the next rolling twelve months following the latest balance sheet. For interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized in the second rolling twelve months following the latest balance sheet. For interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140231425301712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Loans, Net (Details)<br> $ / shares in Units, &#8362; in Thousands</strong></div></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jul. 07, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jul. 07, 2022 </div>
<div>ILS (&#8362;)</div>
</th>
<th class="th">
<div>Apr. 29, 2021 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Feb. 17, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 25, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>May 07, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 01, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Feb. 19, 2017 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_LoansNetDetailsLineItems', window );"><strong>Loans, Net (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 350,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Issuance of warrants (in Shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">65,563<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of per share (in Dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfDebtDiscountPremium', window );">Amortization of discount and interest expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14,000<span></span>
</td>
<td class="nump">$ 14,000<span></span>
</td>
<td class="nump">$ 29,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1', window );">Warrants purchase (in Shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,764<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Warrant value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding', window );">Line of Credit Facility, Fair Value of Amount Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">672,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCollateralFeesAmount', window );">Represent value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 712,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentInterestRate', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.45%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Principal amounts interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred Stock, Shares Issued (in Shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,714,400<span></span>
</td>
<td class="nump">5,714,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantExercisePriceIncrease', window );">Exercise price (in Dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentAggregateCost', window );">Aggregate cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 54,000<span></span>
</td>
<td class="nump">$ 75,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableInterestBearingInterestRate', window );">PPP Amount bears interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherIncome', window );">Other income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 129,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_AgreementAmountReceived', window );">Agreement amount received</a></td>
<td class="nump">$ 900,000<span></span>
</td>
<td class="nump">&#8362; 3,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromRoyaltiesReceived', window );">Royalty amount received</a></td>
<td class="nump">1,200,000<span></span>
</td>
<td class="nump">&#8362; 4,172,760<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAnnualPrincipalPayment', window );">Minimum annual payment</a></td>
<td class="nump">$ 330,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_PercentageOfOutstandingRepaymentAndPaymentAmount', window );">Percentage of outstanding repayment and payment amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_PercentageOfDiscountOutstanding', window );">Percentage of discount outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestAndFeeIncomeOtherLoans', window );">Non-refundable one-time fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed', window );">Percentage of payment amount plus VAT</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeFinanceLeaseDiscountRate', window );">Financing, less rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockDividend', window );">Value of divided</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 62,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LoansHeldForSaleTerm', window );">Issuance term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost', window );">Total incremental</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfLoanCosts', window );">Payments of Loan Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfSecuredDebt', window );">Repayment amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 330,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember', window );">Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_LoansNetDetailsLineItems', window );"><strong>Loans, Net (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeFinanceLeaseDiscountRate', window );">Financing, less rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_LoansNetDetailsLineItems', window );"><strong>Loans, Net (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Warrant total amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,875,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfDebtDiscountPremium', window );">Amortization of discount and interest expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_LoansNetDetailsLineItems', window );"><strong>Loans, Net (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Warrant total amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 125,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfDebtDiscountPremium', window );">Amortization of discount and interest expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 59,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Warrant value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableRateAxis=bmr_FloatingRateMember', window );">Floating rate [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_LoansNetDetailsLineItems', window );"><strong>Loans, Net (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Principal amounts interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableRateAxis=us-gaap_PrimeRateMember', window );">Prime Rate [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_LoansNetDetailsLineItems', window );"><strong>Loans, Net (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Principal amounts interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">IPO [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_LoansNetDetailsLineItems', window );"><strong>Loans, Net (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeFinanceLeaseDiscountRate', window );">Financing, less rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesCPreferredStockMember', window );">Series C Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_LoansNetDetailsLineItems', window );"><strong>Loans, Net (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred Stock, Shares Issued (in Shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,785<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=bmr_IBISpikesLtdMember', window );">IBI Spikes Ltd [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_LoansNetDetailsLineItems', window );"><strong>Loans, Net (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed', window );">Percentage of payment amount plus VAT</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=bmr_TwoZeroTwoTwoLoanAgreementMember', window );">2022 Loan Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_LoansNetDetailsLineItems', window );"><strong>Loans, Net (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentInterestRate', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=bmr_LoansAndSecurityAgreementMember', window );">Loans and Security Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_LoansNetDetailsLineItems', window );"><strong>Loans, Net (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,000,000<span></span>
</td>
<td class="nump">$ 3,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtPercentageBearingVariableInterestRate', window );">Bearing interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.50%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LoansReceivableBasisSpreadOnVariableRate', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Shares issued (in Shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41,040<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedBalancePrincipalAmount', window );">Remaining balance principal due</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">667,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeeAmount', window );">Line of Credit Facility, Commitment Fee Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_ConvertiblePreferredStockMember', window );">Convertible Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_LoansNetDetailsLineItems', window );"><strong>Loans, Net (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Issuance of warrants (in Shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41,040<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of per share (in Dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmr_AgreementAmountReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of agreement amount received.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmr_AgreementAmountReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmr_LoansNetDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmr_LoansNetDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmr_PercentageOfDiscountOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of discount outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmr_PercentageOfDiscountOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmr_PercentageOfOutstandingRepaymentAndPaymentAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of outstanding repayment and payment amount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmr_PercentageOfOutstandingRepaymentAndPaymentAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableInterestBearingInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reflects the effective interest rate as of the balance sheet date on interest-bearing trade payables.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 25<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=29642582&amp;loc=d3e27881-108397<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 25<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=29642582&amp;loc=d3e27862-108397<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableInterestBearingInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfDebtDiscountPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfDebtDiscountPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of warrants issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4332-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAnnualPrincipalPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the total principal payments made during the annual reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAnnualPrincipalPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of principal amount of debt redeemed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFixedInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fixed interest rate related to the interest rate derivative.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFixedInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentAggregateCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents the aggregate cost of investments accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentAggregateCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAdjustmentOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (income) related to adjustment to fair value of warrant liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section 25<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=109262497&amp;loc=d3e20148-110875<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAdjustmentOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestAndFeeIncomeOtherLoans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest and fee income from loans classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.1)<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestAndFeeIncomeOtherLoans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Rate of interest on investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27232-111563<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentOwnedBalancePrincipalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For investments which are quantified by principal amount, the principle balance held at close of period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=99383244&amp;loc=d3e12121-115841<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 320<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column B))<br> -URI https://asc.fasb.org/extlink&amp;oid=122147990&amp;loc=d3e611197-123010<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentOwnedBalancePrincipalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeFinanceLeaseDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Discount rate used by lessee to determine present value of finance lease payments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeFinanceLeaseDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityCollateralFeesAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the fees associated with providing collateral for the credit facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityCollateralFeesAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityCommitmentFeeAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the fee for available but unused credit capacity under the credit facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityCommitmentFeeAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of the amount outstanding under the credit facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LoansHeldForSaleTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period between issuance and maturity of loan held for sale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LoansHeldForSaleTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LoansReceivableBasisSpreadOnVariableRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage added to reference rate used to compute variable rate on loan receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LoansReceivableBasisSpreadOnVariableRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue and income classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfLoanCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for loan origination associated cost which is usually collected through escrow.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfLoanCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRoyaltiesReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash received for royalties during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a),(c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRoyaltiesReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfSecuredDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to repay long-term debt that is wholly or partially secured by collateral. Excludes repayments of tax exempt secured debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfSecuredDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>An excess of the fair value of the modified award over the fair value of the award immediately before the modification.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtPercentageBearingVariableInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of the carrying amount of short-term borrowings outstanding as of the balance sheet date, which accrues interest at a rate subject to change from time to time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtPercentageBearingVariableInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockDividend">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued to shareholders as a dividend during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockDividend</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantExercisePriceIncrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share increase in exercise price of warrant. Excludes change due to standard antidilution provision.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantExercisePriceIncrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=bmr_FloatingRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=bmr_FloatingRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_PrimeRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_PrimeRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesCPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesCPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=bmr_IBISpikesLtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=bmr_IBISpikesLtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=bmr_TwoZeroTwoTwoLoanAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=bmr_TwoZeroTwoTwoLoanAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=bmr_LoansAndSecurityAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=bmr_LoansAndSecurityAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_ConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=us-gaap_ConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140231433443856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Loans, Net (Details) - Schedule of the Effective Date, management by assistance of third-party<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_ScheduleOfTheEffectiveDateManagementByAssistanceOfThirdPartyAbstract', window );"><strong>Schedule of the Effective Date Management by Assistance of Third Party [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_DerivativeWarrantLiabilityseeNote8', window );">Derivative warrant liability (see Note 8)</a></td>
<td class="nump">$ 78<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StraightLineRent', window );">Straight loan</a></td>
<td class="nump">822<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_TotalGrossConsideration', window );">Total gross consideration</a></td>
<td class="nump">$ 900<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmr_DerivativeWarrantLiabilityseeNote8">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmr_DerivativeWarrantLiabilityseeNote8</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmr_ScheduleOfTheEffectiveDateManagementByAssistanceOfThirdPartyAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmr_ScheduleOfTheEffectiveDateManagementByAssistanceOfThirdPartyAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmr_TotalGrossConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmr_TotalGrossConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StraightLineRent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Difference between actual rental income due and rental income recognized on a straight-line basis.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StraightLineRent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140231427472864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Loans, Net (Details) - Schedule of the reconciliation of the carrying amount - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_ScheduleOfTheReconciliationOfTheCarryingAmountAbstract', window );"><strong>Schedule of the Reconciliation of the Carrying Amount [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_ReconciliationOfTheCarryingAmount', window );">Opening balance</a></td>
<td class="nump">$ 508<span></span>
</td>
<td class="nump">$ 1,069<span></span>
</td>
<td class="nump">$ 1,469<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_ConsiderationReceivedFromPPPNote', window );">Consideration received from PPP Note</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">54<span></span>
</td>
<td class="nump">75<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_NetConsiderationReceivedFromIBILoan', window );">Net consideration received from IBI Loan</a></td>
<td class="nump">887<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityFairValueOfCollateral', window );">Recognition of fair value of derivative warrant liability</a></td>
<td class="num">(88)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentDecreaseForgiveness', window );">PPP Note forgiveness (see also Note 6B)</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(129)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments', window );">Amortization of discounts relating to straight loan (see also Note 13)</a></td>
<td class="nump">14<span></span>
</td>
<td class="nump">14<span></span>
</td>
<td class="nump">29<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesFairValueDisclosure', window );">Accrued interest expenses relating to straight loan (see also Note 13)</a></td>
<td class="nump">77<span></span>
</td>
<td class="nump">45<span></span>
</td>
<td class="nump">91<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Repayment of accrued interest relating to straight loan</a></td>
<td class="num">(77)<span></span>
</td>
<td class="num">(45)<span></span>
</td>
<td class="num">(91)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LoanProcessingFee', window );">Repayment of Facility Fee relating to straight loan</a></td>
<td class="num">(10)<span></span>
</td>
<td class="num">(40)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfOtherLongTermDebt', window );">Repayment of principal relating to straight loans</a></td>
<td class="num">(582)<span></span>
</td>
<td class="num">(500)<span></span>
</td>
<td class="num">(504)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtAmount', window );">Derecognition due to extinguishment of original straight loan</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(672)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_RecognitionSubsequentToSubstantialModificationOfTerms', window );">Recognition subsequent to substantial modification of terms</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">712<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential', window );">Exchange rate differences</a></td>
<td class="num">(12)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_ReconciliationOfCarryingAmount', window );">Closing balance</a></td>
<td class="nump">$ 717<span></span>
</td>
<td class="nump">$ 508<span></span>
</td>
<td class="nump">$ 1,069<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmr_ConsiderationReceivedFromPPPNote">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of consideration received from PPP Note.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmr_ConsiderationReceivedFromPPPNote</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmr_NetConsiderationReceivedFromIBILoan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net consideration received from IBI Loan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmr_NetConsiderationReceivedFromIBILoan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmr_RecognitionSubsequentToSubstantialModificationOfTerms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of recognition subsequent to substantial modification of terms.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmr_RecognitionSubsequentToSubstantialModificationOfTerms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmr_ReconciliationOfCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of reconciliation of the carrying amount of closing balance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmr_ReconciliationOfCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmr_ReconciliationOfTheCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of reconciliation of the carrying amount at the opening balance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmr_ReconciliationOfTheCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmr_ScheduleOfTheReconciliationOfTheCarryingAmountAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmr_ScheduleOfTheReconciliationOfTheCarryingAmountAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of trade and related party payables and accrued expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentDecreaseForgiveness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Decrease for amounts of indebtedness forgiven by the holder of the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentDecreaseForgiveness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilityFairValueOfCollateral">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of securities pledged as collateral against derivative liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226013-175313<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilityFairValueOfCollateral</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ExtinguishmentOfDebtAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross amount of debt extinguished.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ExtinguishmentOfDebtAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LoanProcessingFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expenses paid for obtaining loans which includes expenses such as application and origination fees.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LoanProcessingFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfOtherLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for the payment of debt classified as other, maturing after one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfOtherLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140231437185712">
<tr>
<th class="tl" colspan="2" rowspan="1"><div style="width: 200px;"><strong>Loans, Net (Details) - Schedule of maturity dates of outstanding loans - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_ScheduleOfMaturityDatesOfOutstandingLoansAbstract', window );"><strong>Schedule of Maturity Dates of Outstanding Loans [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">First year (current maturities)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 164<span></span>
</td>
<td class="nump">$ 508<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">Second year</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">288<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree', window );">Third year</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">265<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Closing balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 717<span></span>
</td>
<td class="nump">$ 508<span></span>
</td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">As described in Note 6C above, the Company is required to repay
each year a minimum amount of $330 with respect to Repayment Amount (principal and interest).</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmr_ScheduleOfMaturityDatesOfOutstandingLoansAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmr_ScheduleOfMaturityDatesOfOutstandingLoansAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140231433639472">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Other Current Liabilities (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrentAbstract', window );"><strong>Other Current Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepositLiabilitiesAccruedInterest', window );">Accrued interest</a></td>
<td class="nump">$ 11<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepositLiabilitiesAccruedInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accrued but unpaid interest on deposit liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepositLiabilitiesAccruedInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140231428347696">
<tr>
<th class="tl" colspan="2" rowspan="1"><div style="width: 200px;"><strong>Other Current Liabilities (Details) - Schedule of other current liabilties - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_ScheduleOfOtherCurrentLiabiltiesAbstract', window );"><strong>Schedule Of Other Current Liabilties Abstract</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Employees and payroll accruals</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 298<span></span>
</td>
<td class="nump">$ 341<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">85<span></span>
</td>
<td class="nump">126<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_GovernmentAuthorities', window );">Government authorities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">42<span></span>
</td>
<td class="nump">33<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Total other current liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 425<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Including accrued interest relating to straight loan amounted
to $11 as of December 31, 2022. See also Note 13.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmr_GovernmentAuthorities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of government authorities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmr_GovernmentAuthorities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmr_ScheduleOfOtherCurrentLiabiltiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmr_ScheduleOfOtherCurrentLiabiltiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140231429194416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Warrants Liabilities (Details) - Schedule of reconciliation of the fair value of derivative warrants liabilities - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_ScheduleOfReconciliationOfTheFairValueOfDerivativeWarrantsLiabilitiesAbstract', window );"><strong>Schedule Of Reconciliation Of The Fair Value Of Derivative Warrants Liabilities Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Opening balance</a></td>
<td class="nump">$ 50<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet', window );">Recognition of fair value of 2021 Warrant issued upon substantial modification of terms (see Note 6A1)</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">50<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentOfWarrantsGrantedForServices', window );">Recognition of fair value of Warrant Share issued at Effective Date (see Note 6C)</a></td>
<td class="nump">88<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Closing balance</a></td>
<td class="nump">$ 138<span></span>
</td>
<td class="nump">$ 50<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmr_ScheduleOfReconciliationOfTheFairValueOfDerivativeWarrantsLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmr_ScheduleOfReconciliationOfTheFairValueOfDerivativeWarrantsLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentOfWarrantsGrantedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustment for noncash service expenses paid for by granting of warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentOfWarrantsGrantedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of the assets less the liabilities of a derivative or group of derivatives.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of transfers of financial instrument classified as a liability into (out of) level 3 of the fair value hierarchy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140231432345568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Convertible Advance Investment (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Feb. 27, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Feb. 17, 2022</div></th>
<th class="th"><div>Aug. 25, 2021</div></th>
<th class="th"><div>Mar. 25, 2021</div></th>
<th class="th"><div>May 07, 2020</div></th>
<th class="th"><div>Aug. 06, 2019</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_ConvertibleAdvanceInvestmentDetailsLineItems', window );"><strong>Convertible Advance Investment (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Amount raised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 350,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentAggregateCost', window );">Aggregate investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 54,000<span></span>
</td>
<td class="nump">$ 75,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentage', window );">Discount percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed', window );">Redemption payment percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentRate', window );">Conversion price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_PublicOfferingPrice', window );">Public offering price (in Dollars per share)</a></td>
<td class="nump">$ 4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">IPO [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_ConvertibleAdvanceInvestmentDetailsLineItems', window );"><strong>Convertible Advance Investment (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_PublicOfferingPrice', window );">Public offering price (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=bmr_AdvanceInvestmentAgreementsMember', window );">Advance Investment Agreements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_ConvertibleAdvanceInvestmentDetailsLineItems', window );"><strong>Convertible Advance Investment (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentAggregateCost', window );">Aggregate investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentage', window );">Discount percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=bmr_AdvanceInvestmentAgreementsMember', window );">Advance Investment Agreements [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_ConvertibleAdvanceInvestmentDetailsLineItems', window );"><strong>Convertible Advance Investment (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Amount raised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 560,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=bmr_AdvanceInvestmentAgreementsMember', window );">Advance Investment Agreements [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_ConvertibleAdvanceInvestmentDetailsLineItems', window );"><strong>Convertible Advance Investment (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Amount raised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,097,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=bmr_AdvanceInvestmentAgreementsMember', window );">Advance Investment Agreements [Member] | Convertible Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_ConvertibleAdvanceInvestmentDetailsLineItems', window );"><strong>Convertible Advance Investment (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentAggregateCost', window );">Aggregate investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentage', window );">Discount percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentAmount1', window );">Conversion amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 62,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmr_ConvertibleAdvanceInvestmentDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmr_ConvertibleAdvanceInvestmentDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmr_PublicOfferingPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Public offering price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmr_PublicOfferingPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionConvertedInstrumentAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4332-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionConvertedInstrumentAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionConvertedInstrumentRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Dividend or interest rate associated with the financial instrument issued in exchange for the original debt being converted in a noncash or part noncash transaction. Noncash are transactions that affect recognized assets or liabilities but that do not result in cash receipts or cash payments. Part noncash refers to that portion of the transaction not resulting in cash receipts or cash payments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4332-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionConvertedInstrumentRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPricePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage price of original principal amount of debt at which debt can be redeemed by the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph e<br> -URI https://asc.fasb.org/extlink&amp;oid=123599511&amp;loc=d3e64711-112823<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPricePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of principal amount of debt redeemed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentAggregateCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents the aggregate cost of investments accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentAggregateCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=bmr_AdvanceInvestmentAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=bmr_AdvanceInvestmentAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_ConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_ConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140231437441440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Convertible Advance Investment (Details) - Schedule of reconciliation of the carrying amount of the convertible advance investment - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_ScheduleOfReconciliationOfTheCarryingAmountOfTheConvertibleAdvanceInvestmentAbstract', window );"><strong>Schedule Of Reconciliation Of The Carrying Amount Of The Convertible Advance Investment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebtFairValueDisclosures', window );">Opening balance</a></td>
<td class="nump">$ 4,770<span></span>
</td>
<td class="nump">$ 3,922<span></span>
</td>
<td class="nump">$ 3,486<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1', window );">Net consideration received</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">560<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_ChangeInTheFairValueOfConvertibleAdvanceInvestments', window );">Change in the fair value of convertible advance investments (see also Note 13)</a></td>
<td class="nump">70<span></span>
</td>
<td class="nump">288<span></span>
</td>
<td class="nump">436<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebtFairValueDisclosures', window );">Closing balance</a></td>
<td class="nump">$ 4,840<span></span>
</td>
<td class="nump">$ 4,770<span></span>
</td>
<td class="nump">$ 3,922<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmr_ChangeInTheFairValueOfConvertibleAdvanceInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Change in the fair value of convertible advance investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmr_ChangeInTheFairValueOfConvertibleAdvanceInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmr_ScheduleOfReconciliationOfTheCarryingAmountOfTheConvertibleAdvanceInvestmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmr_ScheduleOfReconciliationOfTheCarryingAmountOfTheConvertibleAdvanceInvestmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebtFairValueDisclosures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebtFairValueDisclosures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash consideration received for selling an asset or business through a noncash (or part noncash) transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4332-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4313-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140231427525696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingent Liabilities (Details)<br> &#8362; in Thousands</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="8">6 Months Ended</th>
<th class="th" colspan="1">11 Months Ended</th>
<th class="th" colspan="5">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Aug. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Aug. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Aug. 31, 2022 </div>
<div>ILS (&#8362;)</div>
</th>
<th class="th">
<div>Feb. 28, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Feb. 28, 2022 </div>
<div>ILS (&#8362;)</div>
</th>
<th class="th">
<div>Aug. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Aug. 31, 2021 </div>
<div>ILS (&#8362;)</div>
</th>
<th class="th">
<div>Feb. 28, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Feb. 28, 2021 </div>
<div>ILS (&#8362;)</div>
</th>
<th class="th">
<div>Jul. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Aug. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Aug. 31, 2023 </div>
<div>ILS (&#8362;)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_CommitmentsandContingentLiabilitiesDetailsLineItems', window );"><strong>Commitments and Contingent Liabilities (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRent', window );">Rental fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,600<span></span>
</td>
<td class="nump">&#8362; 18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForFees', window );">Monthly fee</a></td>
<td class="nump">$ 3,000<span></span>
</td>
<td class="nump">$ 7,400<span></span>
</td>
<td class="nump">&#8362; 23<span></span>
</td>
<td class="nump">$ 6,500<span></span>
</td>
<td class="nump">&#8362; 21<span></span>
</td>
<td class="nump">$ 5,300<span></span>
</td>
<td class="nump">&#8362; 17<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCost', window );">Lease expenses | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 119,000<span></span>
</td>
<td class="nump">$ 115,000<span></span>
</td>
<td class="nump">$ 167,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Options to purchase (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,048,297<span></span>
</td>
<td class="nump">927,988<span></span>
</td>
<td class="nump">839,665<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember', window );">Forecast [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_CommitmentsandContingentLiabilitiesDetailsLineItems', window );"><strong>Commitments and Contingent Liabilities (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForFees', window );">Monthly fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,000<span></span>
</td>
<td class="nump">$ 7,100<span></span>
</td>
<td class="nump">&#8362; 25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=srt_BoardOfDirectorsChairmanMember', window );">Board of Directors [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_CommitmentsandContingentLiabilitiesDetailsLineItems', window );"><strong>Commitments and Contingent Liabilities (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Options to purchase (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmr_CommitmentsandContingentLiabilitiesDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmr_CommitmentsandContingentLiabilitiesDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lease cost recognized by lessee for lease contract.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for fees classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash payments to lessor's for use of assets under operating leases.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=srt_ScenarioForecastMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_BoardOfDirectorsChairmanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_BoardOfDirectorsChairmanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140231437133472">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitments and Contingent Liabilities (Details) - Schedule of future minimum commitment under binding lease agreeements<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_ScheduleOfFutureMinimumCommitmentUnderBindingLeaseAgreeementsAbstract', window );"><strong>Schedule Of Future Minimum Commitment Under Binding Lease Agreeements Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_LesseeOperatingLeasesLiabilityPaymentsDueNextTwelveMonths', window );">2023</a></td>
<td class="nump">$ 77<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_LesseeOperatingLeasesLiabilityPaymentsDue', window );">Total</a></td>
<td class="nump">$ 77<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmr_LesseeOperatingLeasesLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmr_LesseeOperatingLeasesLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmr_LesseeOperatingLeasesLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmr_LesseeOperatingLeasesLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmr_ScheduleOfFutureMinimumCommitmentUnderBindingLeaseAgreeementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmr_ScheduleOfFutureMinimumCommitmentUnderBindingLeaseAgreeementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140231434607024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders&#8217; Equity (Deficit) (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_ShareholdersEquityDeficitDetailsLineItems', window );"><strong>Shareholders&#8217; Equity (Deficit) (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockConvertibleConversionPrice', window );">Original issue price per share (in Dollars per share)</a></td>
<td class="nump">$ 1.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockAmountOfPreferredDividendsInArrears', window );">Aggregate liquidation preference of shares</a></td>
<td class="nump">$ 33,785<span></span>
</td>
<td class="nump">$ 33,785<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromDebtNetOfIssuanceCosts', window );">Net proceeds</a></td>
<td class="nump">$ 50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExcessStockSharesAuthorized', window );">Shares authorized (in Shares)</a></td>
<td class="nump">22,000,000<span></span>
</td>
<td class="nump">22,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_VoluntaryConversionDescription', window );">Voluntary conversion description</a></td>
<td class="text">subject to the listing of the Company&#8217;s Ordinary Shares on Nasdaq, the voluntary
conversion of all the Ordinary 1, Ordinary 2, Preferred B, Preferred B-1 and Preferred B shares of the Company into Ordinary Shares (collectively,
the &#8220;Voluntary Conversion&#8221;), (ii) subject to the listing of the Company&#8217;s Ordinary Shares on Nasdaq, a reverse share
split of all outstanding Ordinary Shares of the Company at a ratio of 5:1 so that each 5 ordinary shares nominal value NIS 0.01 each shall
be consolidated into 1 Ordinary Share each, and (the &#8220;Reverse Share Split&#8221;) (iii) subject to the listing of the Company&#8217;s
Ordinary Shares on Nasdaq, the recapitalization and redistribution of the entire share capital of the Company (the &#8220;Recapitalization&#8221;),
so that following such Voluntary Conversion and Recapitalization, the share capital of the Company shall consist of NIS 11,100,000 divided
into 222,000,000 Ordinary Shares each of which 9,790,040 are issued and outstanding (post the aforesaid Reverse Share Split).<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_ShareholdersEquityDeficitDetailsLineItems', window );"><strong>Shareholders&#8217; Equity (Deficit) (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExcessStockSharesAuthorized', window );">Shares authorized (in Shares)</a></td>
<td class="nump">22,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_ShareholdersEquityDeficitDetailsLineItems', window );"><strong>Shareholders&#8217; Equity (Deficit) (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExcessStockSharesAuthorized', window );">Shares authorized (in Shares)</a></td>
<td class="nump">222,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmr_ShareholdersEquityDeficitDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmr_ShareholdersEquityDeficitDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmr_VoluntaryConversionDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Voluntary conversion description.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmr_VoluntaryConversionDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ExcessStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum number of excess stock shares permitted to be issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ExcessStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockAmountOfPreferredDividendsInArrears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate amount of cumulative preferred dividends in arrears.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21488-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockAmountOfPreferredDividendsInArrears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockConvertibleConversionPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share conversion price of preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockConvertibleConversionPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDebtNetOfIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from additional borrowings, net of cash paid to third parties in connection with debt origination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDebtNetOfIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140231428812240">
<tr>
<th class="tl" colspan="2" rowspan="1"><div style="width: 200px;"><strong>Shareholders&#8217; Equity (Deficit) (Details) - Schedule of composition of shareholders' equity - shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_NumberOfSharesAbstract', window );"><strong>Number of shares</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExcessStockSharesAuthorized', window );">Authorized shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">22,000,000<span></span>
</td>
<td class="nump">22,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_ExcessSharesIssuedAndOutstandingShares', window );">Issued and outstanding shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">9,790,040<span></span>
</td>
<td class="nump">9,790,040<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=bmr_SeriesOrdinarySharesMember', window );">Series Ordinary Shares [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_NumberOfSharesAbstract', window );"><strong>Number of shares</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExcessStockSharesAuthorized', window );">Authorized shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">14,307,116<span></span>
</td>
<td class="nump">14,316,880<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_ExcessSharesIssuedAndOutstandingShares', window );">Issued and outstanding shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">2,578,760<span></span>
</td>
<td class="nump">2,578,760<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=bmr_SeriesConvertibleOrdinary1SharesMember', window );">Series Convertible Ordinary 1 Shares [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_NumberOfSharesAbstract', window );"><strong>Number of shares</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExcessStockSharesAuthorized', window );">Authorized shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">607,680<span></span>
</td>
<td class="nump">607,680<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_ExcessSharesIssuedAndOutstandingShares', window );">Issued and outstanding shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">607,680<span></span>
</td>
<td class="nump">607,680<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=bmr_SeriesConvertibleOrdinary2SharesMember', window );">Series Convertible Ordinary 2 Shares [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_NumberOfSharesAbstract', window );"><strong>Number of shares</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExcessStockSharesAuthorized', window );">Authorized shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">889,200<span></span>
</td>
<td class="nump">889,200<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_ExcessSharesIssuedAndOutstandingShares', window );">Issued and outstanding shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">889,200<span></span>
</td>
<td class="nump">889,200<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=bmr_SeriesConvertibleBPreferredSharesMember', window );">Series Convertible B Preferred Shares [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_NumberOfSharesAbstract', window );"><strong>Number of shares</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExcessStockSharesAuthorized', window );">Authorized shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">2,047,200<span></span>
</td>
<td class="nump">2,047,200<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_ExcessSharesIssuedAndOutstandingShares', window );">Issued and outstanding shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">2,047,200<span></span>
</td>
<td class="nump">2,047,200<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=bmr_SeriesConvertibleB1PreferredSharesBMember', window );">Series Convertible B1 Preferred Shares [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_NumberOfSharesAbstract', window );"><strong>Number of shares</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExcessStockSharesAuthorized', window );">Authorized shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">738,240<span></span>
</td>
<td class="nump">738,240<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_ExcessSharesIssuedAndOutstandingShares', window );">Issued and outstanding shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">738,240<span></span>
</td>
<td class="nump">738,240<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=bmr_SeriesConvertibleCPreferredSharesMember', window );">Series Convertible C Preferred Shares [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_NumberOfSharesAbstract', window );"><strong>Number of shares</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExcessStockSharesAuthorized', window );">Authorized shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">3,410,564<span></span>
</td>
<td class="nump">3,400,800<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_ExcessSharesIssuedAndOutstandingShares', window );">Issued and outstanding shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">2,928,960<span></span>
</td>
<td class="nump">2,928,960<span></span>
</td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">The Ordinary Shares confer upon the holders thereof all rights
accruing to a shareholder of the Company, as provided in the Company&#8217;s Articles of Association (the &#8220;Articles&#8221;), including,
without limitation, the right to receive notices of, and to attend, all general meetings, the right to vote thereat with each Ordinary
Share held entitling the holder thereof to one vote at all general meetings (and written actions in lieu of meetings), the right to participate
and share on a per share basis, in any distribution and in distribution of surplus assets and funds of the Company in the event of a
liquidation event, and certain other rights as may be expressly provided for herein or under the Companies Law. All Ordinary Shares rank
pari passu amongst themselves for all intents and purposes, including, without limitation, in relation to the amounts of capital paid
or credited as paid on their nominal value. The voting, dividend and liquidation rights of the holders of Ordinary Shares are subject
to and qualified by the rights, powers and preferences of the holders of the Convertible Preferred Shares and the Convertible Ordinary
1 and 2 Shares as set below.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">The Convertible Ordinary 1 Shares, Convertible Ordinary 2 Shares, Convertible B Preferred Shares, Convertible B1 Preferred Shares and the Convertible C Preferred Shares (referring together herein as &#8220;Convertible Preferred Shares&#8221;) shall confer upon the holders thereof all rights conferred upon the holders of Ordinary Shares in the Company. In addition, the holders of Convertible Preferred Shares shall have rights, preferences and privileges, as follows:

Liquidation preference - Based on preference of distribution, in the event of any liquidation, dissolution or winding up of the Company, whether voluntary or involuntary, change in control or distribution, the Company&#8217;s assets or surplus funds legally available for distribution shall be distributed to the holders of Convertible Preferred Shares pursuant to which each Convertible Preferred Share will be entitled to receive 1.2 of the applicable original issue price paid by each Convertible Preferred shareholder plus all accrued but unpaid dividends and less the aggregate of all amounts previously paid in preference. The aggregate liquidation preference of all shares with preferences over Ordinary Shares as of December 31, 2022 and 2021 amounted to $33,785. None of the foregoing dollar amounts include dividends, as the Board of Directors has not declared any dividends since inception.

The Convertible Preferred Shares have been classified as part of the permanent equity of the Company since upon occurrence of liquidation event all holder of the Ordinary Shares and the Convertible Preferred Shares will be entitled to receive the same form of consideration.

Voting - Each shareholder shall have one vote for each Ordinary Share held by such shareholder of record or such Ordinary Shares as would be held by each holder of Convertible Preferred Share if all Convertible Preferred Shares were converted to Ordinary Shares at the then effective conversion rate, on every resolution.

Conversion - Each holder of a Convertible Preferred Share shall be entitled to convert, at any time and from time to time, and without payment of additional consideration, into such number of fully paid and non-assessable shares of Ordinary Share in ratio as determined in the Articles, which initially shall be one to one. The conversion price initially shall be the applicable Original Issue Price subject to adjustments as describe in the Articles.

All outstanding Convertible Preferred Shares shall automatically be converted into Ordinary Shares at the then-effective conversion rate applicable upon the earlier of (i) closing of sale of Ordinary Shares in an initial firm-commitment underwritten public offering, with net proceeds to the Company of $50,000 and at an offering price per share equal to at least 5 times the Preferred C Original Issue Price (Qualified IPO) or (ii) affirmative vote or written consent of majority shareholders of the then outstanding Convertible Preferred Shares, with respect to each series.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmr_ExcessSharesIssuedAndOutstandingShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issued and outstanding shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmr_ExcessSharesIssuedAndOutstandingShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmr_NumberOfSharesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmr_NumberOfSharesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ExcessStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum number of excess stock shares permitted to be issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ExcessStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=bmr_SeriesOrdinarySharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=bmr_SeriesOrdinarySharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=bmr_SeriesConvertibleOrdinary1SharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=bmr_SeriesConvertibleOrdinary1SharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=bmr_SeriesConvertibleOrdinary2SharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=bmr_SeriesConvertibleOrdinary2SharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=bmr_SeriesConvertibleBPreferredSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=bmr_SeriesConvertibleBPreferredSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=bmr_SeriesConvertibleB1PreferredSharesBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=bmr_SeriesConvertibleB1PreferredSharesBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=bmr_SeriesConvertibleCPreferredSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=bmr_SeriesConvertibleCPreferredSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140231428308736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share Options (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share Options [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_OrdinarySharesSubjectToAdjustments', window );">Ordinary shares subject to adjustments</a></td>
<td class="nump">2,069,280<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_OrdinarySharesAvailableForFutureIssuance', window );">Ordinary shares available for future issuance</a></td>
<td class="nump">355,530<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Weighted average grant date fair value of share options granted</a></td>
<td class="nump">$ 0.51<span></span>
</td>
<td class="nump">$ 0.2<span></span>
</td>
<td class="nump">$ 0.44<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised share options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_TotalConsideration', window );">Total consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax', window );">Unrecognized compensation expense</a></td>
<td class="nump">$ 1,029<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetAmountAtRiskByProductAndGuaranteeWeightedAveragePeriodRemaining1', window );">Weighted average period</a></td>
<td class="text">1 year 8 months 19 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmr_OrdinarySharesAvailableForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmr_OrdinarySharesAvailableForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmr_OrdinarySharesSubjectToAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmr_OrdinarySharesSubjectToAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmr_TotalConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmr_TotalConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of expense for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetAmountAtRiskByProductAndGuaranteeWeightedAveragePeriodRemaining1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average period until annuitization or benefit payment is expected to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 20<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124504833&amp;loc=d3e7104-158389<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetAmountAtRiskByProductAndGuaranteeWeightedAveragePeriodRemaining1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140231432221920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share Options (Details) - Schedule of company&#8217;s share option activity for employees and members of the board of directors - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_ScheduleOfCompanySShareOptionActivityForEmployeesAndMembersOfTheBoardOfDirectorsAbstract', window );"><strong>Schedule Of Company SShare Option Activity For Employees And Members Of The Board Of Directors Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Number of Share Options, Outstanding</a></td>
<td class="nump">1,367,168<span></span>
</td>
<td class="nump">1,254,000<span></span>
</td>
<td class="nump">1,291,810<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Outstanding</a></td>
<td class="nump">$ 1.75<span></span>
</td>
<td class="nump">$ 1.7<span></span>
</td>
<td class="nump">$ 1.65<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Weighted average remaining contractual life, Outstanding</a></td>
<td class="text">5 years 8 months 19 days<span></span>
</td>
<td class="text">6 years 1 month 13 days<span></span>
</td>
<td class="text">5 years 11 months 8 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Intrinsic value, Outstanding</a></td>
<td class="nump">$ 4,860<span></span>
</td>
<td class="nump">$ 125<span></span>
</td>
<td class="nump">$ 194<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of Share Options, Granted</a></td>
<td class="nump">286,875<span></span>
</td>
<td class="nump">214,688<span></span>
</td>
<td class="nump">353,960<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Granted</a></td>
<td class="nump">$ 1.83<span></span>
</td>
<td class="nump">$ 2.05<span></span>
</td>
<td class="nump">$ 1.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_WeightedAverageRemainingContractualLifeGranted', window );">Weighted average remaining contractual life, Granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">9 years 7 months 20 days<span></span>
</td>
<td class="text">9 years 4 months 6 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Number of Share Options, Exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9,800)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.15<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_WeightedAverageRemainingContractualLifeExercised', window );">Weighted average remaining contractual life, Exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod', window );">Number of Share Options, Forfeited or expired</a></td>
<td class="num">(83,052)<span></span>
</td>
<td class="num">(101,520)<span></span>
</td>
<td class="num">(381,970)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Forfeited or expired</a></td>
<td class="nump">$ 1.45<span></span>
</td>
<td class="nump">$ 1.8<span></span>
</td>
<td class="nump">$ 1.75<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_WeightedAverageRemainingContractualLifeForfeitedOrExpired', window );">Weighted average remaining contractual life, Forfeited or expired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Number of Share Options, Outstanding</a></td>
<td class="nump">1,570,991<span></span>
</td>
<td class="nump">1,367,168<span></span>
</td>
<td class="nump">1,254,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Outstanding</a></td>
<td class="nump">$ 1.78<span></span>
</td>
<td class="nump">$ 1.75<span></span>
</td>
<td class="nump">$ 1.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_WeightedAverageRemainingContractualLifeOutstanding', window );">Weighted average remaining contractual life, Outstanding</a></td>
<td class="text">4 years 11 months 19 days<span></span>
</td>
<td class="text">5 years 8 months 19 days<span></span>
</td>
<td class="text">6 years 1 month 13 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Intrinsic value, Outstanding</a></td>
<td class="nump">$ 2,435<span></span>
</td>
<td class="nump">$ 4,860<span></span>
</td>
<td class="nump">$ 125<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Number of Share Options, Exercisable</a></td>
<td class="nump">1,048,297<span></span>
</td>
<td class="nump">927,988<span></span>
</td>
<td class="nump">839,665<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Exercisable</a></td>
<td class="nump">$ 1.7<span></span>
</td>
<td class="nump">$ 1.6<span></span>
</td>
<td class="nump">$ 1.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2', window );">Weighted average remaining contractual life, Exercisable</a></td>
<td class="text">3 years 2 months 12 days<span></span>
</td>
<td class="text">4 years 3 months<span></span>
</td>
<td class="text">4 years 8 months 23 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Intrinsic value, Exercisable</a></td>
<td class="nump">$ 1,677<span></span>
</td>
<td class="nump">$ 3,429<span></span>
</td>
<td class="nump">$ 252<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmr_ScheduleOfCompanySShareOptionActivityForEmployeesAndMembersOfTheBoardOfDirectorsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmr_ScheduleOfCompanySShareOptionActivityForEmployeesAndMembersOfTheBoardOfDirectorsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmr_WeightedAverageRemainingContractualLifeExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmr_WeightedAverageRemainingContractualLifeExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmr_WeightedAverageRemainingContractualLifeForfeitedOrExpired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmr_WeightedAverageRemainingContractualLifeForfeitedOrExpired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmr_WeightedAverageRemainingContractualLifeGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmr_WeightedAverageRemainingContractualLifeGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmr_WeightedAverageRemainingContractualLifeOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmr_WeightedAverageRemainingContractualLifeOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price of options that were either forfeited or expired.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term of exercisable stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term of outstanding stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140231428763696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share Options (Details) - Schedule of outstanding and exercisable share options separated ranges of exercise prices<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2022 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=bmr_ShareOptionsOutstandingMember', window );">Share options outstanding [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Share options outstanding</a></td>
<td class="nump">1,570,991<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=bmr_ShareOptionsExercisableMember', window );">Share options exercisable [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Share options exercisable</a></td>
<td class="nump">1,048,297,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=bmr_ExercisePrice0000Member', window );">0.000 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Exercise price (in Dollars per share) | $ / shares</a></td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=bmr_ExercisePrice0000Member', window );">0.000 [Member] | Share options outstanding [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Share options outstanding</a></td>
<td class="nump">152,640<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1', window );">Weighted average remaining contractual term (years)</a></td>
<td class="text">2 years 5 months 1 day<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=bmr_ExercisePrice0000Member', window );">0.000 [Member] | Share options exercisable [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1', window );">Weighted average remaining contractual term (years)</a></td>
<td class="text">1 year 10 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Share options exercisable</a></td>
<td class="nump">152,640,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=bmr_ExercisePrice0227Member', window );">1.14 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Exercise price (in Dollars per share) | $ / shares</a></td>
<td class="nump">$ 1.14<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=bmr_ExercisePrice0227Member', window );">1.14 [Member] | Share options outstanding [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Share options outstanding</a></td>
<td class="nump">228,480<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1', window );">Weighted average remaining contractual term (years)</a></td>
<td class="text">1 year 4 months 20 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=bmr_ExercisePrice0227Member', window );">1.14 [Member] | Share options exercisable [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1', window );">Weighted average remaining contractual term (years)</a></td>
<td class="text">1 year 4 months 20 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Share options exercisable</a></td>
<td class="nump">228,480,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=bmr_ExercisePrice0333Member', window );">1.67 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Exercise price (in Dollars per share) | $ / shares</a></td>
<td class="nump">$ 1.67<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=bmr_ExercisePrice0333Member', window );">1.67 [Member] | Share options outstanding [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Share options outstanding</a></td>
<td class="nump">43,200<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1', window );">Weighted average remaining contractual term (years)</a></td>
<td class="text">2 years 2 months 15 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=bmr_ExercisePrice0333Member', window );">1.67 [Member] | Share options exercisable [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1', window );">Weighted average remaining contractual term (years)</a></td>
<td class="text">2 years 2 months 15 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Share options exercisable</a></td>
<td class="nump">43,200,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=bmr_ExercisePrice0365Member', window );">1.83 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Exercise price (in Dollars per share) | $ / shares</a></td>
<td class="nump">$ 1.83<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=bmr_ExercisePrice0365Member', window );">1.83 [Member] | Share options outstanding [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Share options outstanding</a></td>
<td class="nump">982,870<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1', window );">Weighted average remaining contractual term (years)</a></td>
<td class="text">6 years 9 months<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=bmr_ExercisePrice0365Member', window );">1.83 [Member] | Share options exercisable [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1', window );">Weighted average remaining contractual term (years)</a></td>
<td class="text">4 years 8 months 12 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Share options exercisable</a></td>
<td class="nump">489,239,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=bmr_ExercisePrice0640Member', window );">3.2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Exercise price (in Dollars per share) | $ / shares</a></td>
<td class="nump">$ 3.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=bmr_ExercisePrice0640Member', window );">3.2 [Member] | Share options outstanding [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Share options outstanding</a></td>
<td class="nump">35,001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1', window );">Weighted average remaining contractual term (years)</a></td>
<td class="text">6 years 5 months 12 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=bmr_ExercisePrice0640Member', window );">3.2 [Member] | Share options exercisable [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1', window );">Weighted average remaining contractual term (years)</a></td>
<td class="text">6 years 5 months 12 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Share options exercisable</a></td>
<td class="nump">10,938,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=bmr_ExercisePrice0757Member', window );">3.79 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Exercise price (in Dollars per share) | $ / shares</a></td>
<td class="nump">$ 3.79<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=bmr_ExercisePrice0757Member', window );">3.79 [Member] | Share options outstanding [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Share options outstanding</a></td>
<td class="nump">60,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1', window );">Weighted average remaining contractual term (years)</a></td>
<td class="text">1 year 7 months 2 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=bmr_ExercisePrice0757Member', window );">3.79 [Member] | Share options exercisable [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1', window );">Weighted average remaining contractual term (years)</a></td>
<td class="text">1 year 7 months 2 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Share options exercisable</a></td>
<td class="nump">60,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=bmr_ExercisePrice0833Member', window );">4.17 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Exercise price (in Dollars per share) | $ / shares</a></td>
<td class="nump">$ 4.17<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=bmr_ExercisePrice0833Member', window );">4.17 [Member] | Share options outstanding [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Share options outstanding</a></td>
<td class="nump">28,800<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1', window );">Weighted average remaining contractual term (years)</a></td>
<td class="text">3 years 10 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=bmr_ExercisePrice0833Member', window );">4.17 [Member] | Share options exercisable [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1', window );">Weighted average remaining contractual term (years)</a></td>
<td class="text">3 years 10 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Share options exercisable</a></td>
<td class="nump">28,800,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=bmr_ExercisePrice1024Member', window );">5.12 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Exercise price (in Dollars per share) | $ / shares</a></td>
<td class="nump">$ 5.12<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=bmr_ExercisePrice1024Member', window );">5.12 [Member] | Share options outstanding [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Share options outstanding</a></td>
<td class="nump">40,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1', window );">Weighted average remaining contractual term (years)</a></td>
<td class="text">6 years 6 months 14 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=bmr_ExercisePrice1024Member', window );">5.12 [Member] | Share options exercisable [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1', window );">Weighted average remaining contractual term (years)</a></td>
<td class="text">6 years 6 months 14 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Share options exercisable</a></td>
<td class="nump">35,000,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The floor of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares reserved for issuance pertaining to the outstanding exercisable stock options as of the balance sheet date in the customized range of exercise prices for which the market and performance vesting condition has been satisfied.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares reserved for issuance pertaining to the outstanding stock options as of the balance sheet date for all option plans in the customized range of exercise prices.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for fully vested and expected to vest exercisable or convertible options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=bmr_ShareOptionsOutstandingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=bmr_ShareOptionsOutstandingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=bmr_ShareOptionsExercisableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=bmr_ShareOptionsExercisableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=bmr_ExercisePrice0000Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=bmr_ExercisePrice0000Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=bmr_ExercisePrice0227Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=bmr_ExercisePrice0227Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=bmr_ExercisePrice0333Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=bmr_ExercisePrice0333Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=bmr_ExercisePrice0365Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=bmr_ExercisePrice0365Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=bmr_ExercisePrice0640Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=bmr_ExercisePrice0640Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=bmr_ExercisePrice0757Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=bmr_ExercisePrice0757Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=bmr_ExercisePrice0833Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=bmr_ExercisePrice0833Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=bmr_ExercisePrice1024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=bmr_ExercisePrice1024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140231434623072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share Options (Details) - Schedule of assumptions used to estimate the fair values of the share options granted - $ / shares<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_ShareOptionsDetailsScheduleofassumptionsusedtoestimatethefairvaluesoftheshareoptionsgrantedLineItems', window );"><strong>Share Options (Details) - Schedule of assumptions used to estimate the fair values of the share options granted [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Volatility (%)</a></td>
<td class="nump">61.49%<span></span>
</td>
<td class="nump">64.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate (%)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.09%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Dividend yield (%)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected life (years)</a></td>
<td class="text">6 years 3 months<span></span>
</td>
<td class="text">6 years 3 months<span></span>
</td>
<td class="text">6 years 3 months<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice', window );">Exercise price ($) (in Dollars per share)</a></td>
<td class="nump">$ 1.83<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price ($) (in Dollars per share)</a></td>
<td class="nump">$ 3.3<span></span>
</td>
<td class="nump">$ 3.2<span></span>
</td>
<td class="nump">$ 1.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_ShareOptionsDetailsScheduleofassumptionsusedtoestimatethefairvaluesoftheshareoptionsgrantedLineItems', window );"><strong>Share Options (Details) - Schedule of assumptions used to estimate the fair values of the share options granted [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Volatility (%)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">61.89%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate (%)</a></td>
<td class="nump">3.64%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.03%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice', window );">Exercise price ($) (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_ShareOptionsDetailsScheduleofassumptionsusedtoestimatethefairvaluesoftheshareoptionsgrantedLineItems', window );"><strong>Share Options (Details) - Schedule of assumptions used to estimate the fair values of the share options granted [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Volatility (%)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">61.91%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate (%)</a></td>
<td class="nump">3.85%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.04%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice', window );">Exercise price ($) (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmr_ShareOptionsDetailsScheduleofassumptionsusedtoestimatethefairvaluesoftheshareoptionsgrantedLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmr_ShareOptionsDetailsScheduleofassumptionsusedtoestimatethefairvaluesoftheshareoptionsgrantedLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Agreed-upon price for the exchange of the underlying asset relating to the share-based payment award.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140231434795600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share Options (Details) - Schedule of company&#8217;s equity-based awards recognized - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_ScheduleOfCompanySEquityBasedAwardsRecognizedAbstract', window );"><strong>Schedule Of Company SEquity Based Awards Recognized Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">$ 144<span></span>
</td>
<td class="nump">$ 94<span></span>
</td>
<td class="nump">$ 60<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherSellingAndMarketingExpense', window );">Sales and marketing</a></td>
<td class="nump">49<span></span>
</td>
<td class="nump">45<span></span>
</td>
<td class="nump">48<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherGeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">29<span></span>
</td>
<td class="nump">18<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Total compensation</a></td>
<td class="nump">$ 222<span></span>
</td>
<td class="nump">$ 157<span></span>
</td>
<td class="nump">$ 120<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmr_ScheduleOfCompanySEquityBasedAwardsRecognizedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmr_ScheduleOfCompanySEquityBasedAwardsRecognizedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of general and administrative expense classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other research and development expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherSellingAndMarketingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of selling and marketing expense classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherSellingAndMarketingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140231432636880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financing Expenses, Net (Details) - Schedule of financing expenses - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_ScheduleOfFinancingExpensesAbstract', window );"><strong>Schedule Of Financing Expenses [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_ChangeInTheFairValueOfConvertibleAdvanceInvestments', window );">Change in fair value of convertible advance investment (see Note 9)</a></td>
<td class="nump">$ 70<span></span>
</td>
<td class="nump">$ 288<span></span>
</td>
<td class="nump">$ 436<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PresentValueOfFutureInsuranceProfitsAmortizationExpenseAccruedInterest', window );">Amortization of discount and accrued interest relating to straight loan received from commercial Bank (see Note 6 and Note 7)</a></td>
<td class="nump">102<span></span>
</td>
<td class="nump">59<span></span>
</td>
<td class="nump">120<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_ModificationOfTermsRelatingToStraightLoan', window );">Modification of terms relating to straight loan (see Note 6A1)</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">90<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts', window );">Amortization of discount relating to liability to related party (see Note 14)</a></td>
<td class="nump">40<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_ExchangeRateDifferencesAndOthers', window );">Exchange rate differences and others</a></td>
<td class="num">(47)<span></span>
</td>
<td class="nump">38<span></span>
</td>
<td class="nump">141<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingExpense', window );">Total</a></td>
<td class="nump">$ 165<span></span>
</td>
<td class="nump">$ 475<span></span>
</td>
<td class="nump">$ 697<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmr_ChangeInTheFairValueOfConvertibleAdvanceInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Change in the fair value of convertible advance investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmr_ChangeInTheFairValueOfConvertibleAdvanceInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmr_ExchangeRateDifferencesAndOthers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of exchange rate differences and others.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmr_ExchangeRateDifferencesAndOthers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmr_ModificationOfTermsRelatingToStraightLoan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmr_ModificationOfTermsRelatingToStraightLoan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmr_ScheduleOfFinancingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmr_ScheduleOfFinancingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69F<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495745-112612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCostsAndDiscounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PresentValueOfFutureInsuranceProfitsAmortizationExpenseAccruedInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for present value of future profits of insurance contract acquired in business combination from accrued interest on unamortized balance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PresentValueOfFutureInsuranceProfitsAmortizationExpenseAccruedInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140231435452368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Parties Transactions (Details)<br> &#8362; in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>ILS (&#8362;)</div>
</th>
<th class="th"><div>Feb. 17, 2022</div></th>
<th class="th">
<div>Jan. 01, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionDueFromToRelatedPartyCurrent', window );">Gross amount (in New Shekels) | &#8362;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8362; 45<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DueToOtherRelatedPartiesClassifiedCurrent', window );">Current liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 357<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentInterestRate', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.45%<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther', window );">Additional paid-in capital</a></td>
<td class="nump">$ 112<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other increase (decrease) in additional paid in capital (APIC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DueToOtherRelatedPartiesClassifiedCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount payable to related parties classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DueToOtherRelatedPartiesClassifiedCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Rate of interest on investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27232-111563<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionDueFromToRelatedPartyCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Receivables to be collected from (obligations owed to) related parties, net as of the balance sheet date within one year where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionDueFromToRelatedPartyCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140231434592896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Parties Transactions (Details) - Schedule of the reconciliation of the carrying amount of the Company - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_ScheduleOfTheReconciliationOfTheCarryingAmountOfTheCompanyAbstract', window );"><strong>Schedule Of The Reconciliation Of The Carrying Amount Of The Company Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentRelatedLiabilities', window );">Opening balance</a></td>
<td class="nump">$ 345<span></span>
</td>
<td class="nump">$ 168<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrentAndNoncurrent', window );">Accrued liability in respect to additional services rendered</a></td>
<td class="nump">115<span></span>
</td>
<td class="nump">177<span></span>
</td>
<td class="nump">168<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PartnersCapitalAccountContributions', window );">Recognition of capital contribution from a controlling shareholder</a></td>
<td class="num">(112)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeAmortizationOfDiscount', window );">Amortization of discount relating to liability to related party</a></td>
<td class="nump">40<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentRelatedLiabilities', window );">Closing balance</a></td>
<td class="nump">$ 388<span></span>
</td>
<td class="nump">$ 345<span></span>
</td>
<td class="nump">$ 168<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmr_ScheduleOfTheReconciliationOfTheCarryingAmountOfTheCompanyAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmr_ScheduleOfTheReconciliationOfTheCarryingAmountOfTheCompanyAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeAmortizationOfDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accretion of purchase discount on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeAmortizationOfDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentRelatedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of liabilities as of the balance sheet date for obligations incurred in connection with the entity's investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.15)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentRelatedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.15(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PartnersCapitalAccountContributions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total contributions made by each class of partners (i.e., general, limited and preferred partners).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 4.F)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PartnersCapitalAccountContributions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140231434769984">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Related Parties Transactions (Details) - Schedule of maturity dates - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_ScheduleOfMaturityDatesAbstract', window );"><strong>Schedule Of Maturity Dates Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">First year (current maturities)</a></td>
<td class="nump">$ 126<span></span>
</td>
<td class="nump">$ 345<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentDueInSecondYear', window );">Second year</a></td>
<td class="nump">262<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLongTermDebtCurrent', window );">Closing balance</a></td>
<td class="nump">$ 388<span></span>
</td>
<td class="nump">$ 345<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmr_ScheduleOfMaturityDatesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmr_ScheduleOfMaturityDatesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitmentDueInSecondYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of commitment classified as other to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitmentDueInSecondYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt classified as other, payable within one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140231428840160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Parties Transactions (Details) - Schedule of expenses related to service agreement and the office services agreement - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_ScheduleOfExpensesRelatedToServiceAgreementAndTheOfficeServicesAgreementAbstract', window );"><strong>Schedule Of Expenses Related To Service Agreement And The Office Services Agreement Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentInProcess', window );">Research and development</a></td>
<td class="nump">$ 42<span></span>
</td>
<td class="nump">$ 44<span></span>
</td>
<td class="nump">$ 82<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketingAndAdvertisingExpense', window );">Sales and marketing</a></td>
<td class="nump">42<span></span>
</td>
<td class="nump">44<span></span>
</td>
<td class="nump">58<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherSellingGeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">83<span></span>
</td>
<td class="nump">89<span></span>
</td>
<td class="nump">108<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDueToOtherRelatedParties', window );">Total</a></td>
<td class="nump">$ 167<span></span>
</td>
<td class="nump">$ 177<span></span>
</td>
<td class="nump">$ 248<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmr_ScheduleOfExpensesRelatedToServiceAgreementAndTheOfficeServicesAgreementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmr_ScheduleOfExpensesRelatedToServiceAgreementAndTheOfficeServicesAgreementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDueToOtherRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in related party payables classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDueToOtherRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketingAndAdvertisingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total expense recognized in the period for promotion, public relations, and brand or product advertising.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketingAndAdvertisingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherSellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of selling, general and administrative expense classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherSellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentInProcess">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of purchased research and development assets that are acquired in a business combination have no alternative future use and are therefore written off in the period of acquisition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentInProcess</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140231432220384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Taxes on Income (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Taxes on Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings', window );">Corporate tax rate</a></td>
<td class="nump">23.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingGainsLosses', window );">Net operating losses (in Dollars)</a></td>
<td class="nump">$ 27,169<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal', window );">Capital losses carryforward (in Dollars)</a></td>
<td class="nump">$ 409<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Federal tax rate</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Effective tax rate</a></td>
<td class="nump">4.40%<span></span>
</td>
<td class="nump">5.80%<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible state and local operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to the repatriation of foreign earnings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingGainsLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7,9)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingGainsLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140231427477264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Taxes on Income (Details) - Schedule of loss (income) before taxes on income - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_ScheduleOfLossIncomeBeforeTaxesOnIncomeAbstract', window );"><strong>Schedule Of Loss Income Before Taxes On Income Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic', window );">Domestic</a></td>
<td class="nump">$ 1,293<span></span>
</td>
<td class="nump">$ 1,104<span></span>
</td>
<td class="nump">$ 2,529<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign', window );">Foreign operations (Beamr Inc and Imaging RU)</a></td>
<td class="num">(97)<span></span>
</td>
<td class="num">(204)<span></span>
</td>
<td class="num">(165)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest', window );">Total</a></td>
<td class="nump">$ 1,196<span></span>
</td>
<td class="nump">$ 900<span></span>
</td>
<td class="nump">$ 2,364<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmr_ScheduleOfLossIncomeBeforeTaxesOnIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmr_ScheduleOfLossIncomeBeforeTaxesOnIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140231432204864">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Taxes on Income (Details) - Schedule of deferred income taxes reflect the net tax effects of net operating loss - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_ScheduleOfDeferredIncomeTaxesReflectTheNetTaxEffectsOfNetOperatingLossAbstract', window );"><strong>Schedule Of Deferred Income Taxes Reflect The Net Tax Effects Of Net Operating Loss Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsCapitalLossCarryforwards', window );">Net operating loss and capital losses carry-forward</a></td>
<td class="nump">$ 6,343<span></span>
</td>
<td class="nump">$ 6,254<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment', window );">Research and development credits</a></td>
<td class="nump">438<span></span>
</td>
<td class="nump">588<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities', window );">Vacation accrual</a></td>
<td class="nump">48<span></span>
</td>
<td class="nump">62<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Net deferred tax asset before deferred tax liabilities and valuation allowance</a></td>
<td class="nump">6,829<span></span>
</td>
<td class="nump">6,904<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="num">(6,829)<span></span>
</td>
<td class="num">(6,904)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsLiabilitiesNet', window );">Net deferred tax assets</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmr_ScheduleOfDeferredIncomeTaxesReflectTheNetTaxEffectsOfNetOperatingLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmr_ScheduleOfDeferredIncomeTaxesReflectTheNetTaxEffectsOfNetOperatingLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsCapitalLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible capital loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsCapitalLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from in-process research and development costs expensed in connection with a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140231427620000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Geographical Information And Major Customers (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>Segment</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Geographical Information And Major Customers [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of operating segments (in Segment) | Segment</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense', window );">Total revenue rate</a></td>
<td class="nump">26.00%<span></span>
</td>
<td class="nump">23.00%<span></span>
</td>
<td class="nump">23.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_TradeReceivablesIncomeTaxRate', window );">Trade receivables interest rate</a></td>
<td class="nump">28.00%<span></span>
</td>
<td class="nump">44.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredRevenueRevenueRecognized1', window );">Revenue recognized (in Dollars) | $</a></td>
<td class="nump">$ 48<span></span>
</td>
<td class="nump">$ 45<span></span>
</td>
<td class="nump">$ 99<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmr_TradeReceivablesIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmr_TradeReceivablesIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueRevenueRecognized1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized that was previously reported as deferred or unearned revenue.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueRevenueRecognized1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to noncontrolling interest income (loss) exempt from income taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140231423799328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Geographical Information And Major Customers (Details) - Schedule of revenues by geographic region - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_SegmentGeographicalInformationAndMajorCustomersDetailsScheduleofrevenuesbygeographicregionLineItems', window );"><strong>Segment Geographical Information And Major Customers (Details) - Schedule of revenues by geographic region [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 2,863<span></span>
</td>
<td class="nump">$ 3,300<span></span>
</td>
<td class="nump">$ 3,176<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_SegmentGeographicalInformationAndMajorCustomersDetailsScheduleofrevenuesbygeographicregionLineItems', window );"><strong>Segment Geographical Information And Major Customers (Details) - Schedule of revenues by geographic region [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">2,134<span></span>
</td>
<td class="nump">2,597<span></span>
</td>
<td class="nump">2,558<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_IL', window );">Israel [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_SegmentGeographicalInformationAndMajorCustomersDetailsScheduleofrevenuesbygeographicregionLineItems', window );"><strong>Segment Geographical Information And Major Customers (Details) - Schedule of revenues by geographic region [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">22<span></span>
</td>
<td class="nump">101<span></span>
</td>
<td class="nump">61<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=bmr_RestOfTheWorldMember', window );">Rest of the world [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_SegmentGeographicalInformationAndMajorCustomersDetailsScheduleofrevenuesbygeographicregionLineItems', window );"><strong>Segment Geographical Information And Major Customers (Details) - Schedule of revenues by geographic region [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 707<span></span>
</td>
<td class="nump">$ 602<span></span>
</td>
<td class="nump">$ 557<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmr_SegmentGeographicalInformationAndMajorCustomersDetailsScheduleofrevenuesbygeographicregionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmr_SegmentGeographicalInformationAndMajorCustomersDetailsScheduleofrevenuesbygeographicregionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_IL">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_IL</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=bmr_RestOfTheWorldMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=bmr_RestOfTheWorldMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140231428765056">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Segment Geographical Information And Major Customers (Details) - Schedule of Long-lived assets net by geographic areas - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_SegmentGeographicalInformationAndMajorCustomersDetailsScheduleofLonglivedassetsnetbygeographicareasLineItems', window );"><strong>Segment Geographical Information And Major Customers (Details) - Schedule of Long-lived assets net by geographic areas [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Long-lived assets, net</a></td>
<td class="nump">$ 15<span></span>
</td>
<td class="nump">$ 21<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_IL', window );">Israel [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_SegmentGeographicalInformationAndMajorCustomersDetailsScheduleofLonglivedassetsnetbygeographicareasLineItems', window );"><strong>Segment Geographical Information And Major Customers (Details) - Schedule of Long-lived assets net by geographic areas [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Long-lived assets, net</a></td>
<td class="nump">12<span></span>
</td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_SegmentGeographicalInformationAndMajorCustomersDetailsScheduleofLonglivedassetsnetbygeographicareasLineItems', window );"><strong>Segment Geographical Information And Major Customers (Details) - Schedule of Long-lived assets net by geographic areas [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Long-lived assets, net</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_RU', window );">Russia [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_SegmentGeographicalInformationAndMajorCustomersDetailsScheduleofLonglivedassetsnetbygeographicareasLineItems', window );"><strong>Segment Geographical Information And Major Customers (Details) - Schedule of Long-lived assets net by geographic areas [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Long-lived assets, net</a></td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmr_SegmentGeographicalInformationAndMajorCustomersDetailsScheduleofLonglivedassetsnetbygeographicareasLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmr_SegmentGeographicalInformationAndMajorCustomersDetailsScheduleofLonglivedassetsnetbygeographicareasLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_IL">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_IL</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_RU">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_RU</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140231434820416">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Segment Geographical Information And Major Customers (Details) - Schedule of revenue disaggregated by primary major product lines and services - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_SoftwareLicenseAbstract', window );"><strong>Software license:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForSoftware', window );">Software license - transferred at a point of time</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 2,740<span></span>
</td>
<td class="nump">$ 3,188<span></span>
</td>
<td class="nump">$ 3,019<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_PCSServicesTransferredOverAPeriod', window );">PCS services transferred over a period of time</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">123<span></span>
</td>
<td class="nump">112<span></span>
</td>
<td class="nump">157<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_AdvertisingAtAPointOfTimeUponClicks', window );">Advertising at a point of time upon clicks</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">42<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_RecognitionofRevenue', window );">Total</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,863<span></span>
</td>
<td class="nump">3,300<span></span>
</td>
<td class="nump">3,176<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=bmr_PerpetualBasedSoftwareLicenseMember', window );">Perpetual based software license [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_SoftwareLicenseAbstract', window );"><strong>Software license:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForSoftware', window );">Software license - transferred at a point of time</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,068<span></span>
</td>
<td class="nump">1,156<span></span>
</td>
<td class="nump">1,043<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=bmr_TermbasedSoftwareLicenseMember', window );">Term-based software license [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_SoftwareLicenseAbstract', window );"><strong>Software license:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForSoftware', window );">Software license - transferred at a point of time</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 1,630<span></span>
</td>
<td class="nump">$ 2,032<span></span>
</td>
<td class="nump">$ 1,976<span></span>
</td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Revenue recognized from sales-based software license was $48,
$45 and $99 during the years ended December 31, 2022, 2021 and 2020, respectively (see also Note 2N).</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmr_AdvertisingAtAPointOfTimeUponClicks">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Advertising at a point of time upon clicks.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmr_AdvertisingAtAPointOfTimeUponClicks</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmr_PCSServicesTransferredOverAPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmr_PCSServicesTransferredOverAPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmr_RecognitionofRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Recognition of revenue amount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmr_RecognitionofRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmr_SoftwareLicenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmr_SoftwareLicenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForSoftware">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the development, modification or acquisition of software programs or applications for internal use (that is, not to be sold, leased or otherwise marketed to others) that qualify for capitalization.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForSoftware</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=bmr_PerpetualBasedSoftwareLicenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=bmr_PerpetualBasedSoftwareLicenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=bmr_TermbasedSoftwareLicenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=bmr_TermbasedSoftwareLicenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>R81.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140231432374608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Feb. 27, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Mar. 14, 2022</div></th>
<th class="th"><div>Apr. 29, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_SubsequentEventsDetailsLineItems', window );"><strong>Subsequent Events (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_PublicOfferingPrice', window );">Offering price (in Dollars per share)</a></td>
<td class="nump">$ 4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Aggregate gross proceeds (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.12<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateTerms', window );">Second loan and securities agreement, description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">In addition, the Company granted the underwriters
(i) 97,500 warrants which shall be exercisable into Ordinary Shares of the Company at an exercise price of $5.00 per Ordinary Share over
a period of 5-years commencing August 26, 2023 and (ii) a 45-day option to purchase up to an additional 292,500 ordinary shares at the
public offering price less discounts, to cover over-allotments.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">IPO [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_SubsequentEventsDetailsLineItems', window );"><strong>Subsequent Events (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_PublicOfferingPrice', window );">Offering price (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">IPO [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_SubsequentEventsDetailsLineItems', window );"><strong>Subsequent Events (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Authorized shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">IPO [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_SubsequentEventsDetailsLineItems', window );"><strong>Subsequent Events (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Authorized shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">222,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_SubsequentEventsDetailsLineItems', window );"><strong>Subsequent Events (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_PublicOfferingPrice', window );">Offering price (in Dollars per share)</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Aggregate gross proceeds (in Dollars per share)</a></td>
<td class="nump">$ 7,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Series C Convertible Preferred Shares [Member] | 2022 Loan Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_SubsequentEventsDetailsLineItems', window );"><strong>Subsequent Events (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight', window );">Initial public offering</a></td>
<td class="nump">1,950,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember', window );">Forecast [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_SubsequentEventsDetailsLineItems', window );"><strong>Subsequent Events (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockConvertibleSharesIssuable', window );">Convertible preferred shares</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember', window );">Forecast [Member] | Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bmr_SubsequentEventsDetailsLineItems', window );"><strong>Subsequent Events (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockConvertibleSharesIssuable', window );">Convertible preferred shares</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesIssued1', window );">Conversion shares</a></td>
<td class="nump">7,211,280<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmr_PublicOfferingPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Public offering price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmr_PublicOfferingPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmr_SubsequentEventsDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmr_SubsequentEventsDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockSharesIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of new shares issued in the conversion of stock in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4313-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockSharesIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateTerms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of the interest rate as being fixed or variable, and, if variable, identification of the index or rate on which the interest rate is based and the number of points or percentage added to that index or rate to set the rate, and other pertinent information, such as frequency of rate resets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateTerms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockConvertibleSharesIssuable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of common shares issuable upon conversion of preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockConvertibleSharesIssuable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of securities classified as temporary equity that are permitted to be issued by an entity's charter and bylaws. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesCPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesCPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmr_LoanAgreementsAxis=bmr_TwoThousandTwentyTwoLoanAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmr_LoanAgreementsAxis=bmr_TwoThousandTwentyTwoLoanAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=srt_ScenarioForecastMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>f20f2022_beamrimaging_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:bmr="http://www.beil.com/20221231"
  xmlns:country="http://xbrl.sec.gov/country/2022"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2022"
  xmlns:us-gaap="http://fasb.org/us-gaap/2022"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="bmr-20221231.xsd" xlink:type="simple"/>
    <context id="c0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:EntityAddressesAddressTypeAxis">dei:BusinessContactMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">bmr:ConvertibleOrdinary1And2SharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">bmr:ConvertibleOrdinary1And2SharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="c11">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">bmr:ConvertibleOrdinary1And2SharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="c12">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">bmr:ConvertiblePreferredSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="c13">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="c14">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="c15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="c16">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c17">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">bmr:ConvertibleOrdinary1And2SharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c18">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">bmr:ConvertiblePreferredSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c19">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c20">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c21">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c22">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">bmr:ConvertibleOrdinary1And2SharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c23">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">bmr:ConvertiblePreferredSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c24">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c25">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c26">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c27">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">bmr:ConvertibleOrdinary1And2SharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">bmr:ConvertiblePreferredSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c32">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">bmr:ConvertiblePreferredSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c33">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c34">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c35">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c36">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">bmr:ConvertibleOrdinary1And2SharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c37">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">bmr:ConvertiblePreferredSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c38">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c39">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c40">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">bmr:ConvertiblePreferredSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c41">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c42">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c43">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c44">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-02-27</startDate>
            <endDate>2023-02-27</endDate>
        </period>
    </context>
    <context id="c45">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
        </entity>
        <period>
            <startDate>2023-02-27</startDate>
            <endDate>2023-02-27</endDate>
        </period>
    </context>
    <context id="c46">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
        </entity>
        <period>
            <instant>2023-02-27</instant>
        </period>
    </context>
    <context id="c47">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">bmr:ConvertibleAdvanceInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c48">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:TechnologyEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c49">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c50">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c51">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">bmr:CompareAndPeripheralEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c52">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">bmr:OfficeFurnitureAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c53">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">bmr:OfficeFurnitureAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c54">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c55">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c56">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c57">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c58">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">bmr:TechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c59">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">bmr:TechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c60">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c61">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c62">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c63">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c64">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">bmr:LoansAndSecurityAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-02-19</instant>
        </period>
    </context>
    <context id="c65">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">bmr:LoansAndSecurityAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-06-01</instant>
        </period>
    </context>
    <context id="c66">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c67">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">bmr:LoansAndSecurityAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c68">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c69">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c70">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c71">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c72">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">bmr:LoansAndSecurityAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-29</instant>
        </period>
    </context>
    <context id="c73">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">bmr:LoansAndSecurityAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-29</startDate>
            <endDate>2021-04-29</endDate>
        </period>
    </context>
    <context id="c74">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
        </entity>
        <period>
            <startDate>2021-04-29</startDate>
            <endDate>2021-04-29</endDate>
        </period>
    </context>
    <context id="c75">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
        </entity>
        <period>
            <instant>2021-04-29</instant>
        </period>
    </context>
    <context id="c76">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-29</startDate>
            <endDate>2021-04-29</endDate>
        </period>
    </context>
    <context id="c77">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">bmr:TwoZeroTwoTwoLoanAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-02-17</instant>
        </period>
    </context>
    <context id="c78">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
        </entity>
        <period>
            <instant>2022-02-17</instant>
        </period>
    </context>
    <context id="c79">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">bmr:FloatingRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-02-17</instant>
        </period>
    </context>
    <context id="c80">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:PrimeRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-02-17</instant>
        </period>
    </context>
    <context id="c81">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c82">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
        </entity>
        <period>
            <instant>2020-05-07</instant>
        </period>
    </context>
    <context id="c83">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
        </entity>
        <period>
            <instant>2021-03-25</instant>
        </period>
    </context>
    <context id="c84">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-07-07</endDate>
        </period>
    </context>
    <context id="c85">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
        </entity>
        <period>
            <instant>2022-07-07</instant>
        </period>
    </context>
    <context id="c86">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">bmr:IBISpikesLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c87">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c88">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c89">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">bmr:AdvanceInvestmentAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-08-25</instant>
        </period>
    </context>
    <context id="c90">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">bmr:AdvanceInvestmentAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-08-06</instant>
        </period>
    </context>
    <context id="c91">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">bmr:AdvanceInvestmentAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c92">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">bmr:AdvanceInvestmentAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c93">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">bmr:AdvanceInvestmentAgreementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c94">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">bmr:AdvanceInvestmentAgreementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c95">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
        </entity>
        <period>
            <startDate>2020-08-24</startDate>
            <endDate>2021-02-28</endDate>
        </period>
    </context>
    <context id="c96">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
        </entity>
        <period>
            <startDate>2021-03-01</startDate>
            <endDate>2021-08-31</endDate>
        </period>
    </context>
    <context id="c97">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
        </entity>
        <period>
            <startDate>2021-09-01</startDate>
            <endDate>2022-02-28</endDate>
        </period>
    </context>
    <context id="c98">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
        </entity>
        <period>
            <startDate>2022-03-01</startDate>
            <endDate>2022-08-31</endDate>
        </period>
    </context>
    <context id="c99">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-01</startDate>
            <endDate>2023-08-31</endDate>
        </period>
    </context>
    <context id="c100">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
        </entity>
        <period>
            <startDate>2022-08-01</startDate>
            <endDate>2022-08-30</endDate>
        </period>
    </context>
    <context id="c101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-01</startDate>
            <endDate>2023-07-31</endDate>
        </period>
    </context>
    <context id="c102">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c103">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bmr:SeriesOrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bmr:SeriesOrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c105">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bmr:SeriesConvertibleOrdinary1SharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c106">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bmr:SeriesConvertibleOrdinary1SharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c107">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bmr:SeriesConvertibleOrdinary2SharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c108">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bmr:SeriesConvertibleOrdinary2SharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c109">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bmr:SeriesConvertibleBPreferredSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c110">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bmr:SeriesConvertibleBPreferredSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c111">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bmr:SeriesConvertibleB1PreferredSharesBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c112">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bmr:SeriesConvertibleB1PreferredSharesBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c113">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bmr:SeriesConvertibleCPreferredSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c114">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bmr:SeriesConvertibleCPreferredSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c115">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">bmr:ExercisePrice0000Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c116">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">bmr:ShareOptionsOutstandingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">bmr:ExercisePrice0000Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c117">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">bmr:ShareOptionsOutstandingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">bmr:ExercisePrice0000Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c118">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">bmr:ShareOptionsExercisableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">bmr:ExercisePrice0000Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c119">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">bmr:ShareOptionsExercisableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">bmr:ExercisePrice0000Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">bmr:ExercisePrice0227Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c121">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">bmr:ShareOptionsOutstandingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">bmr:ExercisePrice0227Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c122">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">bmr:ShareOptionsOutstandingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">bmr:ExercisePrice0227Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c123">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">bmr:ShareOptionsExercisableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">bmr:ExercisePrice0227Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c124">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">bmr:ShareOptionsExercisableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">bmr:ExercisePrice0227Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c125">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">bmr:ExercisePrice0333Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c126">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">bmr:ShareOptionsOutstandingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">bmr:ExercisePrice0333Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">bmr:ShareOptionsOutstandingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">bmr:ExercisePrice0333Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c128">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">bmr:ShareOptionsExercisableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">bmr:ExercisePrice0333Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c129">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">bmr:ShareOptionsExercisableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">bmr:ExercisePrice0333Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">bmr:ExercisePrice0365Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">bmr:ShareOptionsOutstandingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">bmr:ExercisePrice0365Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c132">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">bmr:ShareOptionsOutstandingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">bmr:ExercisePrice0365Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c133">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">bmr:ShareOptionsExercisableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">bmr:ExercisePrice0365Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c134">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">bmr:ShareOptionsExercisableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">bmr:ExercisePrice0365Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c135">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">bmr:ExercisePrice0640Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c136">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">bmr:ShareOptionsOutstandingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">bmr:ExercisePrice0640Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c137">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">bmr:ShareOptionsOutstandingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">bmr:ExercisePrice0640Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c138">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">bmr:ShareOptionsExercisableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">bmr:ExercisePrice0640Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c139">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">bmr:ShareOptionsExercisableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">bmr:ExercisePrice0640Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c140">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">bmr:ExercisePrice0757Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c141">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">bmr:ShareOptionsOutstandingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">bmr:ExercisePrice0757Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c142">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">bmr:ShareOptionsOutstandingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">bmr:ExercisePrice0757Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c143">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">bmr:ShareOptionsExercisableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">bmr:ExercisePrice0757Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c144">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">bmr:ShareOptionsExercisableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">bmr:ExercisePrice0757Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c145">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">bmr:ExercisePrice0833Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c146">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">bmr:ShareOptionsOutstandingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">bmr:ExercisePrice0833Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c147">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">bmr:ShareOptionsOutstandingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">bmr:ExercisePrice0833Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c148">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">bmr:ShareOptionsExercisableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">bmr:ExercisePrice0833Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c149">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">bmr:ShareOptionsExercisableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">bmr:ExercisePrice0833Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c150">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">bmr:ExercisePrice1024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c151">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">bmr:ShareOptionsOutstandingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">bmr:ExercisePrice1024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c152">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">bmr:ShareOptionsOutstandingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">bmr:ExercisePrice1024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c153">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">bmr:ShareOptionsExercisableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">bmr:ExercisePrice1024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c154">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">bmr:ShareOptionsExercisableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">bmr:ExercisePrice1024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c155">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">bmr:ShareOptionsOutstandingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c156">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">bmr:ShareOptionsExercisableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c157">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c158">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c159">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c160">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c161">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c162">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
        </entity>
        <period>
            <instant>2020-01-01</instant>
        </period>
    </context>
    <context id="c163">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c164">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c165">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c166">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c167">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c168">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c169">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bmr:RestOfTheWorldMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c170">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bmr:RestOfTheWorldMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c171">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bmr:RestOfTheWorldMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c172">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c173">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c174">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c175">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c176">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:RU</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c177">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:RU</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c178">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">bmr:PerpetualBasedSoftwareLicenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c179">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">bmr:PerpetualBasedSoftwareLicenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c180">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">bmr:PerpetualBasedSoftwareLicenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c181">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">bmr:TermbasedSoftwareLicenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c182">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">bmr:TermbasedSoftwareLicenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c183">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">bmr:TermbasedSoftwareLicenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c184">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bmr:LoanAgreementsAxis">bmr:TwoThousandTwentyTwoLoanAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-02-27</instant>
        </period>
    </context>
    <context id="c185">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-02-27</startDate>
            <endDate>2023-02-27</endDate>
        </period>
    </context>
    <context id="c186">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-02-27</instant>
        </period>
    </context>
    <context id="c187">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-02-27</instant>
        </period>
    </context>
    <context id="c188">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-02-27</instant>
        </period>
    </context>
    <context id="c189">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-02-27</startDate>
            <endDate>2023-02-27</endDate>
        </period>
    </context>
    <context id="c190">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-14</instant>
        </period>
    </context>
    <context id="c191">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899005</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-14</instant>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="ilsPershares">
        <divide>
            <unitNumerator>
                <measure>iso4217:ILS</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="usdPershares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="ils">
        <measure>iso4217:ILS</measure>
    </unit>
    <unit id="pure">
        <measure>pure</measure>
    </unit>
    <unit id="Segment">
        <measure>bmr:Segment</measure>
    </unit>
    <dei:DocumentType contextRef="c0">20-F</dei:DocumentType>
    <dei:DocumentRegistrationStatement contextRef="c0">false</dei:DocumentRegistrationStatement>
    <dei:DocumentAnnualReport contextRef="c0">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate contextRef="c0">2022-12-31</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate contextRef="c0">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus contextRef="c0">2022</dei:DocumentFiscalYearFocus>
    <dei:DocumentTransitionReport contextRef="c0">false</dei:DocumentTransitionReport>
    <dei:DocumentShellCompanyReport contextRef="c0">false</dei:DocumentShellCompanyReport>
    <dei:EntityFileNumber contextRef="c0">001-41523</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="c0">Beamr Imaging Ltd.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c0">L3</dei:EntityIncorporationStateCountryCode>
    <dei:EntityAddressAddressLine1 contextRef="c0">10 HaManofim Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="c0">Herzeliya</dei:EntityAddressAddressLine2>
    <dei:EntityAddressPostalZipCode contextRef="c0">4672561</dei:EntityAddressPostalZipCode>
    <dei:EntityAddressCountry contextRef="c0">IL</dei:EntityAddressCountry>
    <dei:EntityAddressCityOrTown contextRef="c0">Israel</dei:EntityAddressCityOrTown>
    <dei:ContactPersonnelName contextRef="c0">Sharon CarmelChief Executive Officer</dei:ContactPersonnelName>
    <dei:ContactPersonnelName contextRef="c1">Sharon CarmelChief Executive Officer</dei:ContactPersonnelName>
    <dei:ContactPersonnelEmailAddress contextRef="c1">sharon@beamr.com</dei:ContactPersonnelEmailAddress>
    <dei:EntityAddressAddressLine1 contextRef="c1">10 HaManofim Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="c1">Herzeliya</dei:EntityAddressAddressLine2>
    <dei:EntityAddressPostalZipCode contextRef="c1">4672561</dei:EntityAddressPostalZipCode>
    <dei:EntityAddressCityOrTown contextRef="c1">Israel</dei:EntityAddressCityOrTown>
    <dei:EntityAddressCountry contextRef="c1">IL</dei:EntityAddressCountry>
    <dei:Security12bTitle contextRef="c0">Ordinary shares, par value NIS 0.05 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c0">BMR</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c0">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCommonStockSharesOutstanding contextRef="c2" decimals="INF" unitRef="shares">10932896</dei:EntityCommonStockSharesOutstanding>
    <dei:EntityWellKnownSeasonedIssuer contextRef="c0">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers contextRef="c0">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus contextRef="c0">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="c0">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="c0">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntityEmergingGrowthCompany contextRef="c0">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="c0">true</dei:EntityExTransitionPeriod>
    <dei:IcfrAuditorAttestationFlag contextRef="c0">false</dei:IcfrAuditorAttestationFlag>
    <dei:EntityShellCompany contextRef="c0">false</dei:EntityShellCompany>
    <dei:AuditorFirmId contextRef="c0">1375</dei:AuditorFirmId>
    <dei:AuditorName contextRef="c0">Fahn Kanne &amp; Co. Grant Thornton Israel</dei:AuditorName>
    <dei:AuditorLocation contextRef="c0">Tel Aviv, Israel</dei:AuditorLocation>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c2" decimals="-3" unitRef="usd">693000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c3" decimals="-3" unitRef="usd">1028000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:ReceivablesNetCurrent contextRef="c2" decimals="-3" unitRef="usd">581000</us-gaap:ReceivablesNetCurrent>
    <us-gaap:ReceivablesNetCurrent contextRef="c3" decimals="-3" unitRef="usd">891000</us-gaap:ReceivablesNetCurrent>
    <us-gaap:OtherAssetsCurrent contextRef="c2" decimals="-3" unitRef="usd">64000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent contextRef="c3" decimals="-3" unitRef="usd">66000</us-gaap:OtherAssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c2" decimals="-3" unitRef="usd">1338000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c3" decimals="-3" unitRef="usd">1985000</us-gaap:AssetsCurrent>
    <us-gaap:DeferredCosts contextRef="c2" decimals="-3" unitRef="usd">313000</us-gaap:DeferredCosts>
    <us-gaap:DeferredCosts contextRef="c3" decimals="-3" unitRef="usd">215000</us-gaap:DeferredCosts>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c2" decimals="-3" unitRef="usd">15000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c3" decimals="-3" unitRef="usd">21000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="c2" decimals="-3" unitRef="usd">67000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="c3" decimals="-3" unitRef="usd">87000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:Goodwill contextRef="c2" decimals="-3" unitRef="usd">4379000</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="c3" decimals="-3" unitRef="usd">4379000</us-gaap:Goodwill>
    <us-gaap:AssetsNoncurrent contextRef="c2" decimals="-3" unitRef="usd">4774000</us-gaap:AssetsNoncurrent>
    <us-gaap:AssetsNoncurrent contextRef="c3" decimals="-3" unitRef="usd">4702000</us-gaap:AssetsNoncurrent>
    <us-gaap:Assets contextRef="c2" decimals="-3" unitRef="usd">6112000</us-gaap:Assets>
    <us-gaap:Assets contextRef="c3" decimals="-3" unitRef="usd">6687000</us-gaap:Assets>
    <us-gaap:ShortTermBorrowings contextRef="c2" decimals="-3" unitRef="usd">330000</us-gaap:ShortTermBorrowings>
    <us-gaap:ShortTermBorrowings contextRef="c3" decimals="-3" unitRef="usd">508000</us-gaap:ShortTermBorrowings>
    <us-gaap:AccountsPayableCurrent contextRef="c2" decimals="-3" unitRef="usd">33000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="c3" decimals="-3" unitRef="usd">27000</us-gaap:AccountsPayableCurrent>
    <us-gaap:DeferredRevenueCurrent contextRef="c2" decimals="-3" unitRef="usd">31000</us-gaap:DeferredRevenueCurrent>
    <us-gaap:DeferredRevenueCurrent contextRef="c3" decimals="-3" unitRef="usd">33000</us-gaap:DeferredRevenueCurrent>
    <us-gaap:DueToRelatedPartiesCurrent contextRef="c2" decimals="-3" unitRef="usd">126000</us-gaap:DueToRelatedPartiesCurrent>
    <us-gaap:DueToRelatedPartiesCurrent contextRef="c3" decimals="-3" unitRef="usd">345000</us-gaap:DueToRelatedPartiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent contextRef="c2" decimals="-3" unitRef="usd">425000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent contextRef="c3" decimals="-3" unitRef="usd">500000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c2" decimals="-3" unitRef="usd">945000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c3" decimals="-3" unitRef="usd">1413000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermDebtNoncurrent contextRef="c2" decimals="-3" unitRef="usd">387000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DueToRelatedPartiesNoncurrent contextRef="c2" decimals="-3" unitRef="usd">262000</us-gaap:DueToRelatedPartiesNoncurrent>
    <us-gaap:DerivativeLiabilitiesNoncurrent contextRef="c2" decimals="-3" unitRef="usd">138000</us-gaap:DerivativeLiabilitiesNoncurrent>
    <us-gaap:DerivativeLiabilitiesNoncurrent contextRef="c3" decimals="-3" unitRef="usd">50000</us-gaap:DerivativeLiabilitiesNoncurrent>
    <bmr:ConvertibleAdvancedInvestments contextRef="c2" decimals="-3" unitRef="usd">4840000</bmr:ConvertibleAdvancedInvestments>
    <bmr:ConvertibleAdvancedInvestments contextRef="c3" decimals="-3" unitRef="usd">4770000</bmr:ConvertibleAdvancedInvestments>
    <us-gaap:LiabilitiesNoncurrent contextRef="c2" decimals="-3" unitRef="usd">5627000</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:LiabilitiesNoncurrent contextRef="c3" decimals="-3" unitRef="usd">4820000</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:CommonStockSharesAuthorized contextRef="c4" decimals="INF" unitRef="shares">14307116</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="c5" decimals="INF" unitRef="shares">14316880</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued contextRef="c4" decimals="INF" unitRef="shares">2578760</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued contextRef="c5" decimals="INF" unitRef="shares">2578760</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="c4" decimals="INF" unitRef="shares">2578760</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding contextRef="c5" decimals="INF" unitRef="shares">2578760</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue contextRef="c2" decimals="-3" unitRef="usd">51000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="c3" decimals="-3" unitRef="usd">51000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockSharesAuthorized contextRef="c6" decimals="INF" unitRef="shares">1496880</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued contextRef="c6" decimals="INF" unitRef="shares">1496880</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="c6" decimals="INF" unitRef="shares">1496880</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesAuthorized contextRef="c7" decimals="INF" unitRef="shares">1496880</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued contextRef="c7" decimals="INF" unitRef="shares">1496880</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="c7" decimals="INF" unitRef="shares">1496880</us-gaap:CommonStockSharesOutstanding>
    <bmr:CommonStockValue1 contextRef="c2" decimals="-3" unitRef="usd">5000</bmr:CommonStockValue1>
    <bmr:CommonStockValue1 contextRef="c3" decimals="-3" unitRef="usd">5000</bmr:CommonStockValue1>
    <us-gaap:PreferredStockSharesAuthorized contextRef="c2" decimals="INF" unitRef="shares">6196004</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized contextRef="c3" decimals="INF" unitRef="shares">6186240</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued contextRef="c2" decimals="INF" unitRef="shares">5714400</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued contextRef="c3" decimals="INF" unitRef="shares">5714400</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding contextRef="c2" decimals="INF" unitRef="shares">5714400</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding contextRef="c3" decimals="INF" unitRef="shares">5714400</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockValue contextRef="c2" decimals="-3" unitRef="usd">78000</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue contextRef="c3" decimals="-3" unitRef="usd">78000</us-gaap:PreferredStockValue>
    <us-gaap:AdditionalPaidInCapital contextRef="c2" decimals="-3" unitRef="usd">30375000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital contextRef="c3" decimals="-3" unitRef="usd">30041000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c2" decimals="-3" unitRef="usd">-30969000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c3" decimals="-3" unitRef="usd">-29721000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity contextRef="c2" decimals="-3" unitRef="usd">-460000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c3" decimals="-3" unitRef="usd">454000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c2" decimals="-3" unitRef="usd">6112000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c3" decimals="-3" unitRef="usd">6687000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:Revenues contextRef="c0" decimals="-3" unitRef="usd">2863000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c8" decimals="-3" unitRef="usd">3300000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c9" decimals="-3" unitRef="usd">3176000</us-gaap:Revenues>
    <us-gaap:CostOfRevenue contextRef="c0" decimals="-3" unitRef="usd">98000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue contextRef="c8" decimals="-3" unitRef="usd">90000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue contextRef="c9" decimals="-3" unitRef="usd">94000</us-gaap:CostOfRevenue>
    <us-gaap:GrossProfit contextRef="c0" decimals="-3" unitRef="usd">2765000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit contextRef="c8" decimals="-3" unitRef="usd">3210000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit contextRef="c9" decimals="-3" unitRef="usd">3082000</us-gaap:GrossProfit>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c0" decimals="-3" unitRef="usd">2063000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c8" decimals="-3" unitRef="usd">2032000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c9" decimals="-3" unitRef="usd">2727000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:SellingAndMarketingExpense contextRef="c0" decimals="-3" unitRef="usd">905000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense contextRef="c8" decimals="-3" unitRef="usd">959000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense contextRef="c9" decimals="-3" unitRef="usd">1371000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c0" decimals="-3" unitRef="usd">828000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c8" decimals="-3" unitRef="usd">773000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c9" decimals="-3" unitRef="usd">671000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:OtherOperatingIncomeExpenseNet contextRef="c8" decimals="-3" unitRef="usd">129000</us-gaap:OtherOperatingIncomeExpenseNet>
    <us-gaap:OtherOperatingIncomeExpenseNet contextRef="c9" decimals="-3" unitRef="usd">20000</us-gaap:OtherOperatingIncomeExpenseNet>
    <us-gaap:OperatingIncomeLoss contextRef="c0" decimals="-3" unitRef="usd">-1031000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c8" decimals="-3" unitRef="usd">-425000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c9" decimals="-3" unitRef="usd">-1667000</us-gaap:OperatingIncomeLoss>
    <us-gaap:FinancingInterestExpense contextRef="c0" decimals="-3" unitRef="usd">165000</us-gaap:FinancingInterestExpense>
    <us-gaap:FinancingInterestExpense contextRef="c8" decimals="-3" unitRef="usd">475000</us-gaap:FinancingInterestExpense>
    <us-gaap:FinancingInterestExpense contextRef="c9" decimals="-3" unitRef="usd">697000</us-gaap:FinancingInterestExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c0" decimals="-3" unitRef="usd">-1196000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c8" decimals="-3" unitRef="usd">-900000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c9" decimals="-3" unitRef="usd">-2364000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c0" decimals="-3" unitRef="usd">52000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c8" decimals="-3" unitRef="usd">52000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c9" decimals="-3" unitRef="usd">95000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c0" decimals="-3" unitRef="usd">-1248000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c8" decimals="-3" unitRef="usd">-952000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c9" decimals="-3" unitRef="usd">-2459000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:EarningsPerShareBasic contextRef="c0" decimals="2" unitRef="usdPershares">-0.48</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic contextRef="c8" decimals="2" unitRef="usdPershares">-0.37</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic contextRef="c9" decimals="2" unitRef="usdPershares">-0.96</us-gaap:EarningsPerShareBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c0" decimals="INF" unitRef="shares">2578760</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c8" decimals="INF" unitRef="shares">2578760</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c9" decimals="INF" unitRef="shares">2574814</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:SharesOutstanding contextRef="c10" decimals="0" unitRef="shares">2568960</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c10" decimals="-3" unitRef="usd">51000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding contextRef="c11" decimals="0" unitRef="shares">1496880</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c11" decimals="-3" unitRef="usd">5000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding contextRef="c12" decimals="0" unitRef="shares">5714400</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c12" decimals="-3" unitRef="usd">78000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c13" decimals="-3" unitRef="usd">29753000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c14" decimals="-3" unitRef="usd">-26310000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c15" decimals="-3" unitRef="usd">3577000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities contextRef="c16" decimals="0" unitRef="shares">9800</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c19" decimals="-3" unitRef="usd">11000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c9" decimals="-3" unitRef="usd">11000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c19" decimals="-3" unitRef="usd">120000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c9" decimals="-3" unitRef="usd">120000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:NetIncomeLoss contextRef="c20" decimals="-3" unitRef="usd">-2459000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c9" decimals="-3" unitRef="usd">-2459000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding contextRef="c21" decimals="0" unitRef="shares">2578760</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c21" decimals="-3" unitRef="usd">51000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding contextRef="c22" decimals="0" unitRef="shares">1496880</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c22" decimals="-3" unitRef="usd">5000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding contextRef="c23" decimals="0" unitRef="shares">5714400</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c23" decimals="-3" unitRef="usd">78000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c24" decimals="-3" unitRef="usd">29884000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c25" decimals="-3" unitRef="usd">-28769000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c26" decimals="-3" unitRef="usd">1249000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c30" decimals="-3" unitRef="usd">157000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c8" decimals="-3" unitRef="usd">157000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:NetIncomeLoss contextRef="c31" decimals="-3" unitRef="usd">-952000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c8" decimals="-3" unitRef="usd">-952000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding contextRef="c5" decimals="0" unitRef="shares">2578760</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c5" decimals="-3" unitRef="usd">51000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding contextRef="c7" decimals="0" unitRef="shares">1496880</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c7" decimals="-3" unitRef="usd">5000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding contextRef="c32" decimals="0" unitRef="shares">5714400</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c32" decimals="-3" unitRef="usd">78000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c33" decimals="-3" unitRef="usd">30041000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c34" decimals="-3" unitRef="usd">-29721000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c3" decimals="-3" unitRef="usd">454000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodValueOther contextRef="c38" decimals="-3" unitRef="usd">112000</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:StockIssuedDuringPeriodValueOther contextRef="c0" decimals="-3" unitRef="usd">112000</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c38" decimals="-3" unitRef="usd">222000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c0" decimals="-3" unitRef="usd">222000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:NetIncomeLoss contextRef="c39" decimals="-3" unitRef="usd">-1248000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c0" decimals="-3" unitRef="usd">-1248000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding contextRef="c4" decimals="0" unitRef="shares">2578760</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c4" decimals="-3" unitRef="usd">51000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding contextRef="c6" decimals="0" unitRef="shares">1496880</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c6" decimals="-3" unitRef="usd">5000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding contextRef="c40" decimals="0" unitRef="shares">5714400</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c40" decimals="-3" unitRef="usd">78000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c41" decimals="-3" unitRef="usd">30375000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c42" decimals="-3" unitRef="usd">-30969000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c2" decimals="-3" unitRef="usd">-460000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss contextRef="c0" decimals="-3" unitRef="usd">-1248000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c8" decimals="-3" unitRef="usd">-952000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c9" decimals="-3" unitRef="usd">-2459000</us-gaap:NetIncomeLoss>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c0" decimals="-3" unitRef="usd">28000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c8" decimals="-3" unitRef="usd">193000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c9" decimals="-3" unitRef="usd">679000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:ShareBasedCompensation contextRef="c0" decimals="-3" unitRef="usd">222000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c8" decimals="-3" unitRef="usd">157000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c9" decimals="-3" unitRef="usd">120000</us-gaap:ShareBasedCompensation>
    <us-gaap:AmortizationOfDebtDiscountPremium contextRef="c0" decimals="-3" unitRef="usd">14000</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfDebtDiscountPremium contextRef="c8" decimals="-3" unitRef="usd">14000</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfDebtDiscountPremium contextRef="c9" decimals="-3" unitRef="usd">29000</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt contextRef="c0" decimals="-3" unitRef="usd">12000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:AmortizationOfFinancingCosts contextRef="c0" decimals="-3" unitRef="usd">40000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:FairValueOptionChangesInFairValueGainLoss1 contextRef="c0" decimals="-3" unitRef="usd">-70000</us-gaap:FairValueOptionChangesInFairValueGainLoss1>
    <us-gaap:FairValueOptionChangesInFairValueGainLoss1 contextRef="c8" decimals="-3" unitRef="usd">-288000</us-gaap:FairValueOptionChangesInFairValueGainLoss1>
    <us-gaap:FairValueOptionChangesInFairValueGainLoss1 contextRef="c9" decimals="-3" unitRef="usd">-436000</us-gaap:FairValueOptionChangesInFairValueGainLoss1>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment contextRef="c9" decimals="-3" unitRef="usd">5000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:GainLossOnDispositionOfAssets contextRef="c8" decimals="-3" unitRef="usd">-6000</us-gaap:GainLossOnDispositionOfAssets>
    <bmr:ModificationOfTermsOfStraightLoan contextRef="c8" decimals="-3" unitRef="usd">-90000</bmr:ModificationOfTermsOfStraightLoan>
    <us-gaap:GainsLossesOnRestructuringOfDebt contextRef="c8" decimals="-3" unitRef="usd">129000</us-gaap:GainsLossesOnRestructuringOfDebt>
    <us-gaap:IncreaseDecreaseInOtherReceivables contextRef="c0" decimals="-3" unitRef="usd">-310000</us-gaap:IncreaseDecreaseInOtherReceivables>
    <us-gaap:IncreaseDecreaseInOtherReceivables contextRef="c8" decimals="-3" unitRef="usd">-704000</us-gaap:IncreaseDecreaseInOtherReceivables>
    <us-gaap:IncreaseDecreaseInOtherReceivables contextRef="c9" decimals="-3" unitRef="usd">113000</us-gaap:IncreaseDecreaseInOtherReceivables>
    <us-gaap:IncreaseDecreaseInOtherCurrentAssets contextRef="c0" decimals="-3" unitRef="usd">-2000</us-gaap:IncreaseDecreaseInOtherCurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherCurrentAssets contextRef="c8" decimals="-3" unitRef="usd">26000</us-gaap:IncreaseDecreaseInOtherCurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherCurrentAssets contextRef="c9" decimals="-3" unitRef="usd">-366000</us-gaap:IncreaseDecreaseInOtherCurrentAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable contextRef="c0" decimals="-3" unitRef="usd">6000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable contextRef="c8" decimals="-3" unitRef="usd">16000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable contextRef="c9" decimals="-3" unitRef="usd">-14000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInDeferredRevenue contextRef="c0" decimals="-3" unitRef="usd">-2000</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:IncreaseDecreaseInDeferredRevenue contextRef="c8" decimals="-3" unitRef="usd">-32000</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:IncreaseDecreaseInDeferredRevenue contextRef="c9" decimals="-3" unitRef="usd">31000</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:IncreaseDecreaseInDueFromRelatedParties contextRef="c8" decimals="-3" unitRef="usd">-177000</us-gaap:IncreaseDecreaseInDueFromRelatedParties>
    <us-gaap:IncreaseDecreaseInDueFromRelatedParties contextRef="c9" decimals="-3" unitRef="usd">-168000</us-gaap:IncreaseDecreaseInDueFromRelatedParties>
    <us-gaap:IncreaseDecreaseInOtherCurrentLiabilities contextRef="c0" decimals="-3" unitRef="usd">-75000</us-gaap:IncreaseDecreaseInOtherCurrentLiabilities>
    <us-gaap:IncreaseDecreaseInOtherCurrentLiabilities contextRef="c8" decimals="-3" unitRef="usd">63000</us-gaap:IncreaseDecreaseInOtherCurrentLiabilities>
    <us-gaap:IncreaseDecreaseInOtherCurrentLiabilities contextRef="c9" decimals="-3" unitRef="usd">-258000</us-gaap:IncreaseDecreaseInOtherCurrentLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c0" decimals="-3" unitRef="usd">-645000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c8" decimals="-3" unitRef="usd">569000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c9" decimals="-3" unitRef="usd">-1020000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="c0" decimals="-3" unitRef="usd">2000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="c8" decimals="-3" unitRef="usd">4000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="c9" decimals="-3" unitRef="usd">7000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment contextRef="c9" decimals="-3" unitRef="usd">8000</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c0" decimals="-3" unitRef="usd">-2000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c8" decimals="-3" unitRef="usd">-4000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c9" decimals="-3" unitRef="usd">1000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:PaymentsOfFinancingCosts contextRef="c0" decimals="-3" unitRef="usd">98000</us-gaap:PaymentsOfFinancingCosts>
    <us-gaap:PaymentsOfFinancingCosts contextRef="c8" decimals="-3" unitRef="usd">215000</us-gaap:PaymentsOfFinancingCosts>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="c8" decimals="-3" unitRef="usd">560000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromNotesPayable contextRef="c8" decimals="-3" unitRef="usd">54000</us-gaap:ProceedsFromNotesPayable>
    <us-gaap:ProceedsFromNotesPayable contextRef="c9" decimals="-3" unitRef="usd">75000</us-gaap:ProceedsFromNotesPayable>
    <us-gaap:RepaymentsOfRelatedPartyDebt contextRef="c0" decimals="-3" unitRef="usd">582000</us-gaap:RepaymentsOfRelatedPartyDebt>
    <us-gaap:RepaymentsOfRelatedPartyDebt contextRef="c8" decimals="-3" unitRef="usd">500000</us-gaap:RepaymentsOfRelatedPartyDebt>
    <us-gaap:RepaymentsOfRelatedPartyDebt contextRef="c9" decimals="-3" unitRef="usd">504000</us-gaap:RepaymentsOfRelatedPartyDebt>
    <us-gaap:RepaymentsOfFederalHomeLoanBankBorrowings contextRef="c0" decimals="-3" unitRef="usd">10000</us-gaap:RepaymentsOfFederalHomeLoanBankBorrowings>
    <us-gaap:RepaymentsOfFederalHomeLoanBankBorrowings contextRef="c8" decimals="-3" unitRef="usd">40000</us-gaap:RepaymentsOfFederalHomeLoanBankBorrowings>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement contextRef="c0" decimals="-3" unitRef="usd">887000</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
    <us-gaap:ProceedsFromRelatedPartyDebt contextRef="c0" decimals="-3" unitRef="usd">115000</us-gaap:ProceedsFromRelatedPartyDebt>
    <us-gaap:ProceedsFromStockOptionsExercised contextRef="c9" decimals="-3" unitRef="usd">11000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c0" decimals="-3" unitRef="usd">312000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c8" decimals="-3" unitRef="usd">-141000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c9" decimals="-3" unitRef="usd">-418000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c0" decimals="-3" unitRef="usd">-335000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c8" decimals="-3" unitRef="usd">424000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c9" decimals="-3" unitRef="usd">-1437000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c3" decimals="-3" unitRef="usd">1028000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c26" decimals="-3" unitRef="usd">604000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c15" decimals="-3" unitRef="usd">2041000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c2" decimals="-3" unitRef="usd">693000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c3" decimals="-3" unitRef="usd">1028000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c26" decimals="-3" unitRef="usd">604000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:StockIssued1 contextRef="c0" decimals="-3" unitRef="usd">112000</us-gaap:StockIssued1>
    <us-gaap:InterestPaidNet contextRef="c0" decimals="-3" unitRef="usd">77000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet contextRef="c8" decimals="-3" unitRef="usd">90000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet contextRef="c9" decimals="-3" unitRef="usd">91000</us-gaap:InterestPaidNet>
    <us-gaap:IncomeTaxesPaid contextRef="c0" decimals="-3" unitRef="usd">54000</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid contextRef="c8" decimals="-3" unitRef="usd">49000</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid contextRef="c9" decimals="-3" unitRef="usd">99000</us-gaap:IncomeTaxesPaid>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock contextRef="c0">&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2cm; text-align: justify; text-indent: -2cm"&gt;NOTE 1 - GENERAL&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: left; text-indent: -1cm"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0%"/&gt;&lt;td style="width: 0.5in"&gt;&lt;b&gt;A.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;b&gt;Operations&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Beamr Imaging Ltd. (the &#x201c;Company&#x201d;
or &#x201c;Beamr&#x201d;) was incorporated on October 1, 2009 under the laws of the State of Israel and it engages in the development of
optimization technologies for video and photo compression.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: left; text-indent: -1cm"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0%"/&gt;&lt;td style="width: 0.5in"&gt;&lt;b&gt;B.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;b&gt;Foreign operations&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.5pt; text-align: justify; text-indent: -22.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"/&gt;&lt;td style="width: 0.25in"&gt;&lt;b&gt;1.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;Beamr Inc.&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.5pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;In 2012, the Company incorporated a
wholly-owned U.S. subsidiary, Beamr Inc. (&#x201c;Beamr Inc.&#x201d;), for the purpose of reselling the Company&#x2019;s software and products
in the U.S. and Canadian markets.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.5pt; text-align: justify; text-indent: -22.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"/&gt;&lt;td style="width: 0.25in"&gt;&lt;b&gt;2.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;Beamr Imaging RU LLC &lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.5pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;In 2016, the Company incorporated a
wholly-owned Russian limited partnership, Beamr Imaging RU LLC, (&#x201c;Beamr Imaging RU&#x201d;) for the purpose of conducting research
and development services to the Company.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The Company and its subsidiaries, Beamr
Inc. and Beamr Imaging RU, are collectively referred to as the &#x201c;Group&#x201d;.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: left; text-indent: -1cm"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0%"/&gt;&lt;td style="width: 0.5in"&gt;&lt;b&gt;C.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;b&gt;Liquidity and capital resources &lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The Company has devoted substantially
all of its efforts to research and development, the commercialization of its software and products and raising capital for such purposes.
The development and commercialization of the Company&#x2019;s software and products are expected to require substantial further expenditures.
To date, the Company has not yet generated sufficient revenues from operations to support its activities, and therefore it is dependent
upon external sources for financing its operations. In 2022, the Company had net losses of $1,248. As of December 31, 2022, the Company
had an accumulated deficit of $30,969. The Company plans to finance its operations through the sales of equity (including the Company&#x2019;s
Initial Public Offering (IPO) of its ordinary shares, par value NIS 0.05 per share, of the Company (the &#x201c;Ordinary Shares&#x201d;)
that closed in March 2023) and to the extent available, refinancing of liabilities on a long-term basis and through revenues from sales
of its software, products and related services. In addition, the Company has recently commenced collaborating with a strategic partner
in development of the Company&#x2019;s next generation product, the Beamr HW-Accelerated Content Adaptive Encoding, which is expected to allow
the Company to potentially access new customers and new markets with relatively low sales investment.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;During the year ended December 31, 2020,
the Company raised net amounts of $75 and $11 through the paycheck protection program and exercise of share options into Ordinary Shares,
respectively (see also Note 6B and Note 12, respectively). During the year ended December 31, 2021, the Company raised net amounts of
$54 and $560 through the paycheck protection program and issuance of convertible advanced investment, respectively (see also Note 6B and
Note 9, respectively). During the year ended December 31, 2022, the Company raised net amounts of $887 through a Funding Agreement with
IBI Spikes Ltd (see also Note 6C).&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Management has considered the significance
of such conditions in relation to the Company&#x2019;s ability to meet its current obligations and to achieve its business targets and determined
that these conditions are not raising substantial doubt about the Company&#x2019;s ability to continue as a going concern taking into consideration,
among others (i) an agreement from February 2022 with the Company&#x2019;s founder and significant shareholder (the &#x201c;Founder&#x201d;) under
which the Company&#x2019;s outstanding current liability towards an entity controlled by the Founder (the &#x201c;Service Provider&#x201d;), as
noted in Note 14, will be paid in 18 equal installments pending availability of sufficient liquidity funds and (ii) the execution of a
definitive agreement (the &#x201c;Definitive Agreement&#x201d;) with another commercial bank for receiving straight loan and issuance of
warrants, as noted in Note 6C. As of December 31, 2022, it was agreed to extend the term of liability to the Service Provider (including
with respect to amount relating to services provided to the Company by the Service Provider throughout fiscal year ended December 31,
2022).&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;On February 27, 2023, the Company announced
the pricing of its initial public offering of 1,950,000 Ordinary Shares at a public offering price of $4.00 per share, for aggregate gross
proceeds of $7,800 prior to deducting underwriting discounts and other offering expenses. For additional information, see also Note 17.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: left; text-indent: -1cm"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0%"/&gt;&lt;td style="width: 0.5in"&gt;&lt;b&gt;D.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;b&gt;The impact of COVID-19&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;During the year ended December 31, 2022,
there were no material adverse impacts on the consolidated financial statements. The duration, scope and effects of the ongoing COVID-19
pandemic, government and other third-party responses to it, the related macroeconomic effects, and the extent of its impact on the Company&#x2019;s
operational and financial performance will depend on future developments. As events continue to evolve and additional information becomes
available, the Company&#x2019;s estimates and assumptions may change in future periods.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0%"/&gt;&lt;td style="width: 0.5in"&gt;&lt;b&gt;E.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;b&gt;The impact of the Russian Invasion of Ukraine&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;On February 24, 2022, Russia invaded Ukraine.
The Company has an operation in Russia through its wholly-owned subsidiary, Beamr Imaging RU. The Company undertakes some of its software
development and design, quality assurance and support in Russia using personnel located there. While most of the Company&#x2019;s developers
are located in Russia, its research and development leadership are all located in Israel. The Company has no manufacturing operations
in Russia, and the Company does not sell any products in Russia. The Company constantly evaluates its activities in Russia and currently
believes there was no significant impact on its activities.&lt;/p&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <us-gaap:NetIncomeLoss contextRef="c43" decimals="-3" unitRef="usd">1248000</us-gaap:NetIncomeLoss>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c2" decimals="-3" unitRef="usd">-30969000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:VariableInterestDifferenceBetweenCarryingAmountAndMaximumExposure contextRef="c4" decimals="2" unitRef="ils">0.05</us-gaap:VariableInterestDifferenceBetweenCarryingAmountAndMaximumExposure>
    <us-gaap:ProceedsFromNotesPayable contextRef="c9" decimals="-3" unitRef="usd">75000</us-gaap:ProceedsFromNotesPayable>
    <us-gaap:ProceedsFromStockOptionsExercised contextRef="c9" decimals="-3" unitRef="usd">11000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromNotesPayable contextRef="c8" decimals="-3" unitRef="usd">54000</us-gaap:ProceedsFromNotesPayable>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="c8" decimals="-3" unitRef="usd">560000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:CapitalUnitsNetAmount contextRef="c2" decimals="-3" unitRef="usd">887000</us-gaap:CapitalUnitsNetAmount>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering contextRef="c44" decimals="0" unitRef="usd">1950000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <bmr:PublicOfferingPrice contextRef="c45" decimals="2" unitRef="usdPershares">4</bmr:PublicOfferingPrice>
    <bmr:AggregateGrossProceeds contextRef="c46" decimals="-3" unitRef="usd">7800000</bmr:AggregateGrossProceeds>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="c0">&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2cm; text-align: justify; text-indent: -2cm"&gt;NOTE 2 - SIGNIFICANT
ACCOUNTING POLICIES&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The financial statements have been prepared in
accordance with accounting principles generally accepted in the United States of America (&#x201c;US GAAP&#x201d;).&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: left; text-indent: -1cm"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0%"/&gt;&lt;td style="width: 0.5in"&gt;&lt;b&gt;A.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;b&gt;Use of estimates in the preparation of financial statements &lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The preparation of the financial statements
in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities
and the disclosure of contingent assets and liabilities at the dates of the financial statements, and the reported amounts of revenue
and expenses during the reported periods. Actual results could differ from those estimates. As applicable to these financial statements,
the most significant estimates and assumptions include (i) revenues recognition; (ii) identification of and measurement of financial instruments
in funding transactions; (iii) recoverability of the Company&#x2019;s goodwill upon subsequent periods (iv) measurement of fair value of
equity awards and (v) evaluation of going concern.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: left; text-indent: -1cm"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0%"/&gt;&lt;td style="width: 0.5in"&gt;&lt;b&gt;B.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;b&gt;Functional currency&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The functional currency of the Company
and all of its subsidiaries all of which are primarily a direct and integral component of the Company&#x2019;s operation is the US dollar (&#x201c;$&#x201d;
or &#x201c;dollar&#x201d;), as the dollar is the primary currency of the economic environment in which the Company and its subsidiaries
have operated (which is the currency of the environment in which an entity primarily generates cash) and expects to continue to operate
in the foreseeable future.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;In accordance with ASC 830, &#x201c;Foreign
Currency Matters&#x201d;, balances denominated in or linked to foreign currency are stated on the basis of the exchange rates prevailing
at the applicable balance sheet date. For foreign currency transactions included in the consolidated Statement of Operations and Comprehensive
Loss, the exchange rates applicable on the relevant transaction dates are used. Gains or losses arising from changes in the exchange rates
used in the translation of such transactions are presented within financing income or expenses.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: left; text-indent: -1cm"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0%"/&gt;&lt;td style="width: 0.5in"&gt;&lt;b&gt;C.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;b&gt;Principles of Consolidation&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The consolidated financial statements
include the accounts of the Group. Intercompany transactions and balances have been eliminated upon consolidation.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: left; text-indent: -1cm"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0%"/&gt;&lt;td style="width: 0.5in"&gt;&lt;b&gt;D.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;b&gt;Cash and cash equivalents&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Cash equivalents are short-term highly
liquid investments which include short term bank deposits (up to three months from date of deposit), that are not restricted as to withdrawals
or use and that are readily convertible to cash with maturities of three months or less as of the date acquired.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: left; text-indent: -1cm"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0%"/&gt;&lt;td style="width: 0.5in"&gt;&lt;b&gt;E.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;b&gt;Research and development expenses &lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Research and development expenses are
charged to operations, as incurred.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;ASC 985-20, &#x201c;Software - Costs of
Computer Software to be Sold, Leased or Otherwise Marketed&#x201d;, requires capitalization of certain software development costs subsequent
to the establishment of technological feasibility. In accordance with ASC 985-20, capitalization ceases when the related product is available
for general release to customers. Costs of maintenance and customer support are charged to expenses, as incurred. Based on the Company&#x2019;s
product development process, technological feasibility is established upon completion of a working model. Costs incurred by the Company
between completion of the working models and the point at which the products are ready for general release have been insignificant. Therefore,
all research and development costs have been expensed.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0%"/&gt;&lt;td style="width: 0.5in"&gt;&lt;b&gt;F.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;b&gt;Deferred offering costs &lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Prior to the effective
date of an offering of equity securities, specific incremental costs directly (i.e. accounting, consulting, legal and printing fees) attributable
to a proposed or actual offering of securities are deferred and charged against the gross proceeds of the offering, unless the offering
of equity securities has been delayed but is currently in process, under which such specific incremental and direct costs are charged
immediately to operations. As of December 31, 2022, the Company deferred specific incremental costs directly attributable to offering
of securities through its IPO that closed in March 2023 in total amount of $313, which was classified as non-current asset in the Company&#x2019;s
Consolidated Balance Sheet.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: left; text-indent: -1cm"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0%"/&gt;&lt;td style="width: 0.5in"&gt;&lt;b&gt;G.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;b&gt;Goodwill and Intangible Assets&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Goodwill is the amount
by which the purchase price of acquired net assets in a business combination exceeded the fair values of the net identifiable assets on
the date of acquisition.&#160;Goodwill is not amortized but evaluated for impairment annually or more frequently if events or changes
in circumstances indicate that the asset might be impaired. The provisions of ASC 350 &#x201c;Intangibles-Goodwill and Other&#x201d; (&#x201c;ASC
350&#x201d;) require that the impairment test be performed on goodwill at the level of the reporting unit. As required by ASC 350, the
Company chooses either to perform a qualitative assessment whether a goodwill impairment test is necessary or proceeds directly to the
goodwill impairment test. Such determination is made for each reporting unit on a stand-alone basis. The qualitative assessment includes
various factors such as macroeconomic conditions, industry and market considerations, cost factors, overall financial performance, earnings
multiples, gross margin and cash flows from operating activities and other relevant factors. When the Company chooses to perform a qualitative
assessment and determines that it is more likely than not (more than 50 percent likelihood) that the fair value of the reporting unit
is less than its carrying value, then the Company proceeds to the goodwill impairment test. If the Company determines otherwise, no further
evaluation is necessary.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;When the Company decides
or is required to perform the quantitative goodwill impairment test, the Company compares the fair value of the reporting unit to its
carrying value and an impairment charge is recognized for the amount by which the carrying amount exceeds the reporting unit&#x2019;s fair
value, if any.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The Company determined
that its operations represent a single reporting unit. The Company determines the fair value of its reporting unit by using the income
approach, which utilizes a discounted cash flow model, as it believes that this approach best approximates the reporting unit&#x2019;s
fair value. Judgments and assumptions related to revenue, operating income, future short-term and long-term growth rates, weighted average
cost of capital, interest, capital expenditures, cash flows, and market conditions are inherent in developing the discounted cash flow
model. The Company considers historical rates and current market conditions when determining the discount and growth rates to use in its
analyses. If these estimates or their related assumptions change in the future, the Company may be required to record impairment charges
for its goodwill. As of December 31, 2022 and 2021, the Company has performed the annual impairment test and has determined that impairment
loss is not required to be recognized.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Finite lived intangible
assets acquired in business combinations, which include technology, customer relationships and trade names, are initially recorded at
fair value.&#160;They are amortized on a straight-line basis over their estimated useful lives.&#160;The intangible asset lives have been
determined based upon the anticipated period over which the Company will derive future cash flows from the intangible assets.&#160;The
Company has considered the effects of legal, regulatory, contractual, competitive, and other economic factors in determining these useful
lives.&#160;Recoverability of these assets is assessed when triggering events have occurred that may give rise to an impairment loss and
is determined by a comparison of the carrying amount of the asset to the future undiscounted net cash flows expected to be generated by
the asset.&#160;When it is determined that the carrying value of the asset is not recoverable, the asset is written down to its estimated
fair value.&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;As a result of continued
losses, the management performed an impairment test with respect to its intangible assets by maintaining an external valuation which utilized
discounted cash flow model. Accordingly,&#160;certain assumptions and judgments were made to determine the discount rate as well as future
cash flows of the Company.&#160;During the years ended December 31, 2022, 2021 and 2020, no impairment losses were identified through
the impairment test.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27.35pt"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The lives used in computing straight-line amortization
for financial reporting purposes are as follows:&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: left; border-bottom: Black 1.5pt solid"&gt;Rate of depreciation&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 88%; text-align: left"&gt;Technology&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;20&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Customer relationships&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;20&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Trade names&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;10&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0%"/&gt;&lt;td style="width: 0.5in"&gt;&lt;b&gt;H.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;b&gt;Property and equipment&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Property and equipment
are stated at cost, net of accumulated depreciation. Depreciation is calculated using the straight-line method over the estimated useful
lives of the assets. When an asset is retired or otherwise disposed of, the related cost and accumulated depreciation are removed from
the respective accounts and the net difference less any amount realized from disposition is reflected in the consolidated Statements of
Operations and Comprehensive Loss.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The Company&#x2019;s long-lived
assets are reviewed for impairment in accordance with ASC 360, &#x201c;Property, Plant and Equipment&#x201d;, whenever events or changes
in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is
measured by a comparison of the carrying amount of an asset to the future undiscounted cash flows expected to be generated by the asset.
If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of
the asset exceeds its fair value. To date, the Company has not incurred any impairment losses.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27.35pt"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The lives used in computing straight-line depreciation
for financial reporting purposes are as follows:&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: left; border-bottom: Black 1.5pt solid"&gt;Rate of depreciation&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 88%; text-align: left"&gt;Computers and peripheral equipment&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;33&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Office furniture and equipment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;7-15&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0%"/&gt;&lt;td style="width: 0.5in"&gt;&lt;b&gt;I.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;b&gt;Leases&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The Company entered
into several non-cancelable lease agreements for offices for use in its operations, which are classified as operating leases (see below).&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The Company applies
ASC Topic 842, Leases (&#x201c;ASC 842&#x201d;).&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Accordingly, the Company
determines if an arrangement is a lease at inception. The Company&#x2019;s assessment is based on: (i) whether the contract involves the
use of an identified asset, (ii) whether the Company obtains the right to substantially all of the economic benefits from the use of the
asset throughout the period of use, and (iii) whether the Company has the right to direct the use of the asset.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Leases are classified
as either finance leases or operating leases. A lease is classified as a finance lease if any one of the following criteria are met: (i)
the lease transfers ownership of the asset by the end of the lease term, (ii) the lease contains an option to purchase the asset that
is reasonably certain to be exercised, (iii) the lease term is for a major part of the remaining useful life of the asset, (iv) the present
value of the lease payments equals or exceeds substantially all of the fair value of the asset, or (v) the underlying asset is of such
a specialized nature that it is expected to have no alternative use to the lessor at the end of lease term. A lease is classified as an
operating lease if it does not meet any one of these criteria. Since all the Company&#x2019;s lease contracts for premises do not meet
any of the criteria above, the Company concluded that all its lease contracts should be classified as operating leases.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Right of Use (&#x201c;ROU&#x201d;)
assets and liabilities are recognized on the commencement date based on the present value of remaining lease payments over the lease term.
For this purpose, the Company considers only payments that are fixed and determinable at the time of commencement. As most of the Company&#x2019;s
leases do not provide an implicit rate, the Company uses its incremental borrowing rate (&#x201c;IBR&#x201d;) based on the information available
on the commencement date in determining the present value of lease payments. The Company&#x2019;s IBR is estimated to approximate the interest
rate for collateralized borrowing with similar terms and payments and in economic environments where the leased asset is located. The
ROU asset also includes any lease payments made prior to commencement and is recorded net of any lease incentives received. Moreover,
the ROU asset may also include initial direct costs, which are incremental costs of a lease that would not have been incurred if the lease
had not been obtained. The Company uses the long-lived assets impairment guidance in ASC 360-10, &#x201c;Property, Plant, and Equipment
- Overall&#x201d;, to determine whether a ROU asset is impaired, and if so, the amount of the impairment loss to recognize. Certain leases
include options to extend or terminate the lease. An option to extend the lease is considered in connection with determining the ROU asset
and lease liability when it is reasonably certain that the Company will exercise that option. An option to terminate is considered unless
it is reasonably certain that the Company will not exercise the option.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The Company also elected
the short-term lease recognition exemption for all leases that qualify (leases with a term shorter than 12 months). For those leases,
ROU assets or lease liabilities are not recognized and rent&#160;expense is recognized on a straight-line basis over the lease term. See
also Note 10A for further discussion.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: center; background-color: white"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0%"/&gt;&lt;td style="width: 0.5in"&gt;&lt;b&gt;J.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;b&gt;Deferred income taxes&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The Company accounts
for income taxes in accordance with ASC Topic 740, &#x201c;Income Taxes&#x201d;. Accordingly, deferred income taxes are determined utilizing
the asset and liability method based on the estimated future tax effects of differences between the financial accounting and the tax bases
of assets and liabilities under the applicable tax law. Deferred tax balances are computed using the enacted tax rates expected to be
in effect when these differences reverse. Valuation allowance in respect of deferred tax assets is provided for, if necessary, to reduce
deferred tax assets is amounts more likely than not to be realized.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The Company accounts
for uncertain tax positions in accordance with ASC Topic 740-10, which prescribes detailed guidance for the financial statement recognition,
measurement and disclosure of uncertain tax positions recognized in an enterprise&#x2019;s financial statements. According to ASC Topic
740-10, tax positions must meet a more-likely-than-not recognition threshold. The Company&#x2019;s accounting policy is to classify interest
and penalties relating to uncertain tax positions under income taxes, however the Company did not recognize such items in its consolidated
financial statements during the years ended December 31, 2022, 2021 and 2020 and did not recognize any liability with respect to an unrecognized
tax position in its balance sheets.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0%"/&gt;&lt;td style="width: 0.5in"&gt;&lt;b&gt;K.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;b&gt;Employees benefit plans &lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The Company&#x2019;s
liability for severance pay to its Israeli employees is pursuant to Section 14 of the Israeli Severance Compensation Act, 1963 (&#x201c;Section
14&#x201d;), pursuant to which all the Company&#x2019;s employees are included under Section 14, and are entitled only to monthly deposits,
at a rate of 8.33% of their monthly salary, made in the employee&#x2019;s name with insurance companies. Under Israeli employment law,
payments in accordance with Section 14 release the Company from any future severance payments in respect of those employees. The fund
is made available to the employee at the time the employer-employee relationship is terminated, regardless of cause of termination. The
severance pay liabilities and deposits under Section 14 are not reflected in the balance sheets as the severance pay risks have been irrevocably
transferred to the severance funds. All deposits required through December 31, 2022 have been made.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: left; text-indent: -1cm"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0%"/&gt;&lt;td style="width: 0.5in"&gt;&lt;b&gt;L.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;b&gt;Contingencies&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The Company and its
subsidiaries may be involved in certain legal proceedings and certain business relationships that arise from time to time in the ordinary
course of their business and in connection with certain agreements with third parties. Except for income tax contingencies, the Company
applies the provisions of ASC Topic 450, Contingencies. Thus, the Company records accruals for contingencies to the extent that the management
concludes that the occurrence is probable and that the related liabilities are estimable. Legal expenses associated with contingencies
are expensed as incurred.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: left; text-indent: -1cm"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0%"/&gt;&lt;td style="width: 0.5in"&gt;&lt;b&gt;M.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;b&gt;Concentrations of credit risk and allowance for doubtful accounts&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Financial instruments
that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents and trade receivables
as well as certain other current assets that do not amount to a significant amount. Cash and cash equivalents, which are primarily held
in US Dollars and New Israeli Shekels (NIS), are deposited with major banks in Israel, U.S. and Russian Federation. Management believes
that such financial institutions are financially sound and, accordingly, minimal credit risk exists with respect to these financial instruments.
The Company does not have any significant off-balance-sheet concentration of credit risk, such as foreign exchange contracts, option contracts
or other foreign hedging arrangements. Most of the Company&#x2019;s sales are mainly derived from sales to a diverse set of customers located
primarily in the United States. Management periodically evaluates the collectability of the trade receivables to determine the amounts
that are doubtful of collection and determine a proper allowance for doubtful accounts, as described below. Accordingly, management believes
that the Company&#x2019;s trade receivables do not represent a substantial concentration of credit risk.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The Company extends credit to customers
in the normal course of business and does not require collateral or any other security to support amounts due. Management performs ongoing
credit evaluations of its customers. The allowance for doubtful accounts is determined with respect to amounts the Group has determined
to be doubtful of collection. In determining the allowance for doubtful accounts, the Company considers, among other things, its past
experience with customers, the length of time that the balance is past due, the customer&#x2019;s current ability to pay and available information
about the credit risk on such customers.&#160;Provisions for the allowance for doubtful accounts are recorded under general and administrative
expenses in the consolidated Statements of Operations and Comprehensive Loss. During the years ended December 31, 2022, 2021 and 2020,
the Company has not recorded allowance in respect of accounts receivable.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: center; background-color: white"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0%"/&gt;&lt;td style="width: 0.5in"&gt;&lt;b&gt;N.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;b&gt;Revenue recognition&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The Company recognizes revenues in accordance
with ASC 606, &#x201c;Revenue from Contracts with Customers&#x201d; (&#x201c;ASC 606&#x201d;) under which the Company determines revenue recognition
through the following five steps:&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.5pt; text-align: justify; text-indent: -22.5pt"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"/&gt;&lt;td style="width: 0.25in"&gt;&lt;span&gt;&#x25fe;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Identification of the contract, or contracts, with a customer;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.5pt; text-align: justify; text-indent: -22.5pt"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"/&gt;&lt;td style="width: 0.25in"&gt;&lt;span&gt;&#x25fe;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Identification of the performance obligations in the contract;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.5pt; text-align: justify; text-indent: -22.5pt"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"/&gt;&lt;td style="width: 0.25in"&gt;&lt;span&gt;&#x25fe;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Determination of the transaction price;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.5pt; text-align: justify; text-indent: -22.5pt"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"/&gt;&lt;td style="width: 0.25in"&gt;&lt;span&gt;&#x25fe;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Allocation of the transaction price to the performance obligations in the contract; and&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.5pt; text-align: justify; text-indent: -22.5pt"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"/&gt;&lt;td style="width: 0.25in"&gt;&lt;span&gt;&#x25fe;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Recognition of revenue when, or as, the Company satisfies a performance obligation.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The Company enters into contracts that
mostly include software and software related services (i.e. Post-Contract Customer Support (&#x201c;PCS&#x201d;)), which are generally capable
as being distinct from each other and accounted for as separate performance obligations.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The Company derives its revenues from
licensing the rights to use its software for a limited term (mainly for a period of one to three years) or on a perpetual basis for enterprises
that incorporate the Company&#x2019;s perpetual license in their own products delivered to end users and for the Company&#x2019;s products&#160;sold
to thousands private consumers, as applicable to each contract, and from, provision of related maintenance and technical support. The
Company sells its products through direct sales force and indirectly through distributors and consumer platforms.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Revenues are recognized when control of
the promised goods or services are transferred to the customers, in an amount that reflects the consideration that the company expects
to receive in exchange for those goods or services. However, when the consideration for the license is based on sales of the related customer,
the company applies the provisions of ASC 606 with respect to sales-based or usage-based royalties promised in exchange for a license
of intellectual property and recognizes revenues only when the underlying sales occur, as long as this approach does not result in the
acceleration of revenue ahead of the company&#x2019;s performance.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Under ASC 606, an entity recognizes revenue
when or as it satisfies a performance obligation by transferring software license (either timely-based or perpetual) or software related
services to the customer, either at a point in time or over time. The Company recognizes its revenues from software sales at a point in
time upon delivery of its software license. The software license is considered a distinct performance obligation, as the customer can
benefit from the software on its own. The Company&#x2019;s revenues from PCS are derived from annual maintenance providing for unspecified
upgrades on a when-and-if-available basis. The right for an unspecified upgrade for the version acquired by the customer and enhancements
on a when-and-if-available basis that do not specify the features, functionality and release date of future product enhancements for the
customer to know what will be made available and the general timeframe in which it will be delivered. The Company considers the PCS performance
obligation as a distinct performance obligation that is satisfied over time and recognized on a straight-line basis over the contractual
period (mainly over a period of one year either for timely-based license or for perpetual license).&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;As the Company bundles software licenses
(either time-based or perpetual) together with PCS, the transaction price is allocated to the separate performance obligations on a relative
standalone selling price basis.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Since the Company does not sell PCS on
a stand-alone basis and due to the fact that these services are usually involved with limited customer support, mainly based on several
hours of technical support per contract (as management believes the technology and products covered under the software license component
are mature and fully functional), the standalone selling prices of the PCS are determined based on the expected cost plus a margin (&#x201c;cost-plus
approach&#x201d;) based on estimation of direct fulfillment cost (an hourly service) and a reasonable margin. Such estimate is also corroborated
with the price that the company would have to pay to a third-party service provider for a similar support service.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The stand-alone selling price of the software
licenses (either timely-based or perpetual) is estimated by management based on adjusted market assessment approach which represents management
estimation of the price that a customer in the market will be willing to pay for such license on a stand-alone basis (i.e. without any
PCS).&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Due to the fact that the PCS services
are usually involved with limited customer support, mainly based on several hours of technical support per contract, the transaction price
allocated to the PCS is considered insignificant. Consequently, most of the transaction price is allocated to the software licenses as
management believes the technology and products covered under the software license component are mature and fully functional.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;During the reported periods, costs to
obtain contracts were in an insignificant amount.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The Company does not grant a right of
return to its customers. When product delivered to the customer is subject to evaluation, the Company defers revenue until evaluation
is completed subject to formal selling agreement with the customer, at which time revenue is recognized provided that all other revenue
recognition criteria are met.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Commencing 2022, revenue is also derived
from the traffic operations in the Google AdSense program, a web advertising platform, that the Company makes available on its websites.&#160;Google
pays the Company on a cost-per-click basis. The Company recognizes as revenue the fees paid to it by Google based on the volume of clicks
through to Google AdSense advertisements.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The Company receives payments from customers
based upon contractual payment schedules. Trade receivables are recorded when right to consideration becomes unconditional, and an invoice
is issued to the customer. Unbilled receivables include amounts related to the Company&#x2019;s contractual right to consideration for
completed performance obligations not yet invoiced. As of December 31, 2022 and 2021, unbilled receivables balance amounted to $35&#160;and
$29, respectively, and are included within trade receivables balance in the Company&#x2019;s Consolidated Balance Sheets.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;As of December 31, 2022 and 2021, the
Company had $31&#160;and $33, respectively, of remaining performance obligations not yet satisfied or partly satisfied related to revenues
(mostly PCS). Such amounts are presented as deferred revenues which are expected to be recognized as revenues during the next twelve months.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;See also Note 16 for further discussion
related to disaggregation of revenues.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: left; text-indent: -1cm"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0%"/&gt;&lt;td style="width: 0.5in"&gt;&lt;b&gt;O.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;b&gt;Fair Value Measurements&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The Company measures
and discloses fair value in accordance with the ASC 820, &#x201c;Fair Value Measurements and Disclosures&#x201d; which defines fair value,
establishes a framework and gives guidance regarding the methods used for measuring fair value, and expands disclosures about fair value
measurements. Fair value is an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability
in an orderly transaction between market participants at the measurement date. As such, fair value is a market-based measurement that
should be determined based on assumptions that market participants would use in pricing an asset or liability. As a basis for considering
such assumptions there exists a three-tier fair-value hierarchy, which prioritizes the inputs used in measuring fair value as follows:&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Level 1 - unadjusted
quoted prices are available in active markets for identical assets or liabilities that the Company has the ability to access as of the
measurement date.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Level 2 - pricing inputs
are other than quoted prices in active markets that are directly observable for the asset or liability or indirectly observable through
corroboration with observable market data.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Level 3 - pricing inputs
are unobservable for the non-financial asset or liability and only used when there is little, if any, market activity for the non-financial
asset or liability at the measurement date. The inputs into the determination of fair value require significant management judgment or
estimation. Level 3 inputs are considered as the lowest priority within the fair value hierarchy. The valuation of certain financial instruments
classified under fair value through profit or loss category and the fair value of reporting units for purposes of goodwill impairment
analysis, fall under this category.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;This hierarchy requires
the Company to use observable market data, when available, and to minimize the use of unobservable inputs when determining fair value.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The fair value of cash
and cash equivalents is based on its demand value, which is equal to its carrying value. Additionally, the carrying value of all other
short-term monetary assets and liabilities are estimated to be equal to their fair value due to the short-term nature of these instruments.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: left; text-indent: -1cm"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0%"/&gt;&lt;td style="width: 0.5in"&gt;&lt;b&gt;P.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;b&gt;Convertible Ordinary 1 and 2 Shares and Preferred Shares&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The Convertible Ordinary 1 and 2 Shares
and Convertible Preferred Shares are not subject to redemption feature upon any events that are considered not solely within the control
of the Company. In addition, upon occurrence of liquidation event, as defined in the Company&#x2019;s Articles of Association, all holders of
the Ordinary Shares, Convertible Ordinary 1 and 2 Shares and Convertible Preferred Shares will be entitled to receive the same form of
consideration. Thus, the Company classifies its Convertible Ordinary 1 and 2 Shares and Convertible Preferred Shares as part of permanent
equity.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0%"/&gt;&lt;td style="width: 0.5in"&gt;&lt;b&gt;Q.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;b&gt;Allocation of proceeds and related issuance costs&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;When multiple instruments are issued in
a single transaction (package issuance), the total net proceeds from the transaction are allocated among the individual freestanding instruments
identified. The allocation occurs after identifying all the freestanding instruments and the subsequent measurement basis for those instruments.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Financial instruments that are required
to be subsequently measured at fair value (such as derivative warrants liability) are measured at fair value and the remaining consideration
is allocated to other financial instruments that are not required to be subsequently measured at fair value (i.e. straight loan), based
on the relative fair value basis for such instruments.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The allocation of issuance costs to freestanding
instruments was based on an approach that is consistent with the allocation of the proceeds, as described above.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Issuance costs allocated to the derivative
warrant liability were immediately expensed.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Issuance costs allocated to straight loan
are recorded as a discount of the straight loan and accreted over the contractual term of straight loan up to face value of such loans
using the effective interest method.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: left; text-indent: -1cm"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0%"/&gt;&lt;td style="width: 0.5in"&gt;&lt;b&gt;R.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;b&gt;Warrants&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Certain warrants that
were issued to a commercial bank as part of entering into a straight loan and to seller through transaction in which certain identified
intangible assets have been purchased are classified as a component of permanent equity since they are freestanding financial instruments
that are legally detachable and separately exercisable, do not embody an obligation for the Company to repurchase its own shares, and
permit the holders to receive a fixed number of Ordinary Shares upon exercise for a fixed exercise price and thus, are considered as indexed
to the Company&#x2019;s own shares. In addition, the warrants must require physical settlement and may not provide any guarantee of value or
return. As such warrants were issued together with financial instruments that are not subsequently measured at fair value the warrants
were measured based on allocation of the proceeds received by the Company in accordance with the relative fair value basis. When applicable,
direct issuance expenses that were allocated to such warrants were deducted from additional paid-in capital.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Commencing January 1,
2018 and following the early adoption of ASU 2017-11, &#x201c;Earnings Per Share&#x201d; (ASU 2017-11), the Company disregards the down
round feature when assessing whether an instrument is indexed to its own shares, for purposes of determining liability or equity classification.
Based on its evaluation, management has determined that certain warrants with down-round protection are eligible for equity classification.
In accordance with the provisions of ASU 2017-11, upon the occurrence of an event that triggers down round protection (i.e., when the
exercise price of the warrants is adjusted downward because of the down round feature), the effect is accounted for as a deemed dividend
and as a reduction of income available to common shareholders for purposes of basic earnings per share (EPS) calculation. However, during
the reported periods there were no events that trigger a down round protection.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: left; text-indent: -1cm"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0%"/&gt;&lt;td style="width: 0.5in"&gt;&lt;b&gt;S.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;b&gt;Derivative Warrants Liability&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Certain warrants that
were granted by the Company for commercial bank through funding transaction entitle the bank to exercise the warrants for a variable number
of shares and/or for a variable exercise price and thus the fixed-for-fixed criteria is not met. Accordingly, the warrants were classified
as a non-current liability according to the provisions of ASC 815-40, &#x201c;Derivatives and Hedging - Contracts in Entity&#x2019;s Own
Equity&#x201d; (&#x201c;ASC 815-40&#x201d;). The Company accounted for these warrants as a financial derivative liability measured upon initial
recognition and on subsequent periods at fair value by using the Hybrid Method by combining the OPM and an IPO scenario.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The fair value of the
aforesaid warrants derivative liability is estimated using the Black-Scholes Model which requires inputs such as the expected term of
the warrants, share price volatility and risk-free interest rate. These assumptions are reviewed on a regular basis and changes in the
estimated fair value of the outstanding warrants are recognized each reporting period as part of the &#x201c;Financing (income) expenses,
net&#x201d; line in the consolidated statements of operations and comprehensive loss, until such warrants are exercised or expired. When
applicable, direct issuance expenses that were allocated to the above warrants were expensed as incurred.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0%"/&gt;&lt;td style="width: 0.5in"&gt;&lt;b&gt;T.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;b&gt;Modifications or exchanges of loans&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Modifications to, or
exchanges of, financial instruments such as loans or convertible loans, are accounted for as a modification or an extinguishment, following
to provisions of ASC 470-50, &#x201c;Debt &#x2013; Modification and Extinguishments&#x201d; (ASC 470-50&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;.
Such an assessment done by management either qualitatively or quantitatively based on the facts and circumstances of each transaction&lt;span style="font-family: Times New Roman, Times, Serif"&gt;.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Under ASC 470-50, modifications
or exchanges are generally considered extinguishments with gains or losses recognized in current earnings if the terms of the new debt
and original instrument are substantially different. The instruments are considered &#x201c;substantially different&#x201d; when the present
value of the cash flows under the terms of the new debt instrument is at least 10% different from the present value of the remaining cash
flows under the terms of the original instrument&lt;span style="font-family: Times New Roman, Times, Serif"&gt;.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;If the terms of a debt
instrument are changed or modified and the present value of the cash flows under the terms of the new debt instrument is less than 10%,
the debt instruments are not considered to be substantially different, except in the following two circumstances: (i)&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&#160;&lt;/span&gt;the
transaction significantly affects the terms of an embedded conversion option, such that the change in the fair value of the embedded conversion
option (calculated as the difference between the fair value of the embedded conversion option immediately before and after the modification
or exchange) is at least 10% of the carrying amount of the original debt instrument immediately before the modification or exchange or
(ii)&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&#160;&lt;/span&gt;the transaction adds a substantive conversion option or
eliminates a conversion option that was substantive at the date of the modification or exchange&lt;span style="font-family: Times New Roman, Times, Serif"&gt;.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;If the original and
new debt instruments are considered as &#x201c;substantially different&#x201d;, the original debt is derecognized and the new debt is initially
recorded at fair value, with the difference recognized as an extinguishment gain or loss under financial expense or income as applicable&lt;span style="font-family: Times New Roman, Times, Serif"&gt;.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;If a convertible debt
instrument with a beneficial conversion option that was separately accounted for in equity, is extinguished prior to its conversion or
stated maturity date, a portion of the reacquisition price is allocated to the repurchase of the beneficial conversion option. The amount
of the reacquisition price allocated to the beneficial conversion option is measured using the intrinsic value of that conversion option
at the extinguishment date. The residual amount, if any, is allocated to the convertible debt instrument&lt;span style="font-family: Times New Roman, Times, Serif"&gt;.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The gain or loss on
the extinguishment of the convertible debt instrument is determined based on the difference between the carrying amount and the fair value
of the allocated reacquisition price.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: left; text-indent: -1cm"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0%"/&gt;&lt;td style="width: 0.5in"&gt;&lt;b&gt;U.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;b&gt;Basic and diluted net loss per Ordinary Share &lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The Company applies
the two-class method as required by ASC&#160;260-10, &#x201c;Earnings Per Share&#x201d; (&#x201c;ASC&#160;260-10&#x201d;) which requires the
income or loss per share for each class of shares (ordinary and all other shares with preferences over Ordinary Shares) to be calculated
assuming 100% of the Company&#x2019;s earnings are distributed as dividends to each class of shares based on their contractual rights. No dividends
were declared or paid during the reported periods. According to the provisions of ASC&#160;260-10, the Company&#x2019;s Convertible Preferred
Shares and Convertible Ordinary 1 and 2 Shares do not have contractual obligation to share losses of the Company and therefore are not
included in the computation in period of net loss per share.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Basic net loss per Ordinary
Share is computed by dividing the net loss for the period applicable to ordinary shareholders, by the weighted average number of Ordinary
Shares outstanding during the period. Diluted loss per share gives effect to all potentially dilutive common shares outstanding during
the year using the treasury stock method with respect to shares with preferences over Ordinary Shares (Convertible Ordinary 1 and 2 shares
and Convertible Preferred Shares), share options and certain warrants and using the if-converted method with respect to convertible advance
investments and certain warrants accounted for as derivative liability. In computing diluted loss per share, the average share price for
the period is used in determining the number of shares assumed to be purchased from the exercise of share options or warrants.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;During the years ended
December 31, 2022, 2021 and 2020, the total weighted average number of Ordinary Shares related to outstanding shares with preferences
over Ordinary Shares (Convertible Ordinary 1 and 2 shares and Convertible Preferred Shares), share options, warrants and convertible advance
investments excluded from the calculation of the diluted loss per share was 9,067,438, 8,957,327 and 8,842,202, respectively.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0%"/&gt;&lt;td style="width: 0.5in"&gt;&lt;b&gt;V.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;b&gt;Convertible Advance Investments&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Upon initial recognition, the Company
has considered the provisions of ASC 480-10 &#x201c;Distinguishing Liabilities from Equity&#x201d; with respect to certain obligations to
issue a variable number of shares and has determined that the convertible advance investments represent a financial liability since most
of its settlement alternatives embody either a conditional or an unconditional obligation to issue a variable number of the Company&#x2019;s
shares with monetary value based predominantly on a fixed monetary amount known at inception (the original issue price of the convertible
advance investments together with a fixed &#160;return to the investors).&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Upon initial recognition, the Company
has considered the provisions of ASC 815-15,&#160;&#x201c;Derivatives and Hedging - Embedded Derivatives&#x201d;, and determined that the
embedded conversion feature of the convertible advance investments cannot be considered as clearly and closely related to the host debt
instrument. However, it was determined that the embedded conversion feature should not be separated from the host instrument because the
embedded conversion option, if freestanding, did not meet a derivative definition based on the provisions of ASC 815-10, &#x201c;Derivatives
and Hedging&#x201d;&#160;since its terms did not require or permit net settlement. Thus, it was determined that the conversion feature
does not meet the characteristic of being readily convertible to cash. However, the Company has determined that the redemption feature
upon certain events is not solely within the Company&#x2019;s control under which the Company will be required to repay an amount equal to 200%
of the original investment was determined to represent a contingent interest feature that requires bifurcation from a host debt contract
because the contingent interest feature meets a derivative definition and the economic characteristics of the embedded feature are not
clearly and closely related to those of host debt instrument as such feature is not directly credit risk related.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Furthermore, the Company applied ASC 470-20,
&#x201c;Debt - Debt with Conversion and Other Options&#x201d; (&#x201c;ASC 470-20&#x201d;) which clarifies the accounting for instruments with
Beneficial Conversion Features (BCF) or contingently adjustable conversion ratios and has applied the BCFs guidance to determine whether
the conversion feature is beneficial to investors. However, as the convertible advance investments were not convertible upon inception
(such instrument would have become convertible if the Company would have completed qualified financing by August 5, 2020), it was determined
that no BCF was required to be recognized upon initial recognition of the instrument.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Based on the characteristics of the convertible
advance investments, the Company elected to measure this liability in its entirety, at its fair value in accordance with ASC 825-10, &#x201c;Financial
Instruments&#x201d; due to the existence of certain redemption option and the potential requirement to recognize contingent BCF. Accordingly,
upon initial recognition and in subsequent periods, the Company measures the liability related to the convertible advance investments
based on its fair value taking into consideration, among others all relevant settlement possibilities and their respective likelihood.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: left; text-indent: -1cm"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0%"/&gt;&lt;td style="width: 0.5in"&gt;&lt;b&gt;W.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;b&gt;Capital contribution from a controlling shareholder&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The fair value of the benefit received
in respect of loan received from the controlling shareholder is calculated on the basis of the difference between the interest rate that
the Company would have required to pay for similar loan from commercial bank and the interest rate that the Company is actually charged
under the agreement with the controlling shareholders. Such benefit is accounted for as capital contribution received from the controlling
shareholder as additional paid-in capital and it is recorded as discount on the loan received against at the initial measurement date.
Subsequently, such discount is expensed over the economic life of the loan based on the effective interest rate method.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0%"/&gt;&lt;td style="width: 0.5in"&gt;&lt;b&gt;X.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;b&gt;Share-based compensation&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0in"&gt;The Company measures
and recognizes compensation expense for all equity-based payments to employees based on their estimated fair values in accordance with
ASC 718, &#x201c;Compensation-Stock Compensation&#x201d;. Share-based payments are recognized in the Statement of Operations and Comprehensive
Loss as an operating expense based on fair value of the award at the grant date by using Black-Scholes option-pricing model. The inputs
for the valuation analysis of the share options include several assumptions of which the most significant are the fair market value of
the underlying Ordinary Share, the expected share price volatility and the expected option term. Expected volatility was calculated based
upon historical volatility of peer companies in the same industry on daily basis since the Company&#x2019;s marketability is considered low.
The expected option term represents the period that the Company&#x2019;s share options are expected to be outstanding and is determined
based on the simplified method until sufficient historical exercise data will support using expected life assumptions. The risk-free interest
rate is based on the yield from U.S. treasury bonds with an equivalent term. The expected dividend yield assumption is based on the Company&#x2019;s
historical experience and expectation of no future dividend payouts. The Company has historically not paid cash dividends and has no foreseeable
plans to pay cash dividends in the future. The Company expensed compensation costs net of estimated forfeitures over the requisite service
period by applying the straight-line method.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0in"&gt;The fair value of
Ordinary Shares underlying the share options was determined by the Company&#x2019;s management with the assistance of an independent valuation
firm. Because there has been no public market for the Ordinary Shares, the Company&#x2019;s management has determined fair value of the Ordinary
Shares at the time of grant by considering several objective and subjective factors including data from other comparable companies, sales
of Convertible Preferred Shares to unrelated third parties, operating and financial performance, the lack of liquidity of share capital
and general and industry specific economic outlook, amongst other factors. The fair value of the underlying Ordinary Shares shall be determined
by management until such time as the ordinary shares are listed on an established stock exchange, national market system or other quotation
system. For all reported periods through December&#160;31, 2020, the valuations were performed using the Option Pricing Method (&#x201c;OPM&#x201d;).
Commencing June&#160;30, 2021, the valuations were performed using Hybrid Method by combining the OPM and an IPO scenario.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0in"&gt;Commencing January
1, 2019, following the adoption of ASU 2018-07 which aligns the measurement and classification guidance for share-based payments to nonemployees
with the guidance for share-based payments to employees (with certain exceptions), share-based payments to non-employees are accounted
in accordance with ASC 718.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0in"&gt;When applicable,
a modification to the terms and/or conditions of an award (i.e. a change of award&#x2019;s fair value, vesting conditions or classification
as an equity or a liability instrument) is accounted for as an exchange of the original award for a new award resulting in total compensation
cost equal to the grant-date fair value of the original award, plus the incremental value of the modification to the award. The calculation
of the incremental value is based on the excess of the fair value of the modified award following the modification over the fair value
of the original award measured immediately before its terms were modified.&lt;/p&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:UseOfEstimates contextRef="c0">&lt;b&gt;Use of estimates in the preparation of financial statements &lt;/b&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The preparation of the financial statements
in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities
and the disclosure of contingent assets and liabilities at the dates of the financial statements, and the reported amounts of revenue
and expenses during the reported periods. Actual results could differ from those estimates. As applicable to these financial statements,
the most significant estimates and assumptions include (i) revenues recognition; (ii) identification of and measurement of financial instruments
in funding transactions; (iii) recoverability of the Company&#x2019;s goodwill upon subsequent periods (iv) measurement of fair value of
equity awards and (v) evaluation of going concern.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: left; text-indent: -1cm"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;</us-gaap:UseOfEstimates>
    <us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock contextRef="c0">&lt;b&gt;Functional currency&lt;/b&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The functional currency of the Company
and all of its subsidiaries all of which are primarily a direct and integral component of the Company&#x2019;s operation is the US dollar (&#x201c;$&#x201d;
or &#x201c;dollar&#x201d;), as the dollar is the primary currency of the economic environment in which the Company and its subsidiaries
have operated (which is the currency of the environment in which an entity primarily generates cash) and expects to continue to operate
in the foreseeable future.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;In accordance with ASC 830, &#x201c;Foreign
Currency Matters&#x201d;, balances denominated in or linked to foreign currency are stated on the basis of the exchange rates prevailing
at the applicable balance sheet date. For foreign currency transactions included in the consolidated Statement of Operations and Comprehensive
Loss, the exchange rates applicable on the relevant transaction dates are used. Gains or losses arising from changes in the exchange rates
used in the translation of such transactions are presented within financing income or expenses.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: left; text-indent: -1cm"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;</us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0%"/&gt;&lt;td style="width: 0.5in"&gt;&lt;b&gt;C.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;b&gt;Principles of Consolidation&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The consolidated financial statements
include the accounts of the Group. Intercompany transactions and balances have been eliminated upon consolidation.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: left; text-indent: -1cm"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0%"/&gt;&lt;td style="width: 0.5in"&gt;&lt;b&gt;D.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;b&gt;Cash and cash equivalents&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Cash equivalents are short-term highly
liquid investments which include short term bank deposits (up to three months from date of deposit), that are not restricted as to withdrawals
or use and that are readily convertible to cash with maturities of three months or less as of the date acquired.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: left; text-indent: -1cm"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:ResearchAndDevelopmentExpensePolicy contextRef="c0">&lt;b&gt;Research and development expenses &lt;/b&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Research and development expenses are
charged to operations, as incurred.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;ASC 985-20, &#x201c;Software - Costs of
Computer Software to be Sold, Leased or Otherwise Marketed&#x201d;, requires capitalization of certain software development costs subsequent
to the establishment of technological feasibility. In accordance with ASC 985-20, capitalization ceases when the related product is available
for general release to customers. Costs of maintenance and customer support are charged to expenses, as incurred. Based on the Company&#x2019;s
product development process, technological feasibility is established upon completion of a working model. Costs incurred by the Company
between completion of the working models and the point at which the products are ready for general release have been insignificant. Therefore,
all research and development costs have been expensed.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify"&gt;&#160;&lt;/p&gt;</us-gaap:ResearchAndDevelopmentExpensePolicy>
    <us-gaap:DeferredChargesPolicyTextBlock contextRef="c0">&lt;b&gt;Deferred offering costs &lt;/b&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Prior to the effective
date of an offering of equity securities, specific incremental costs directly (i.e. accounting, consulting, legal and printing fees) attributable
to a proposed or actual offering of securities are deferred and charged against the gross proceeds of the offering, unless the offering
of equity securities has been delayed but is currently in process, under which such specific incremental and direct costs are charged
immediately to operations. As of December 31, 2022, the Company deferred specific incremental costs directly attributable to offering
of securities through its IPO that closed in March 2023 in total amount of $313, which was classified as non-current asset in the Company&#x2019;s
Consolidated Balance Sheet.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: left; text-indent: -1cm"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;</us-gaap:DeferredChargesPolicyTextBlock>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering contextRef="c0" decimals="-3" unitRef="usd">313000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock contextRef="c0">&lt;b&gt;Goodwill and Intangible Assets&lt;/b&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Goodwill is the amount
by which the purchase price of acquired net assets in a business combination exceeded the fair values of the net identifiable assets on
the date of acquisition.&#160;Goodwill is not amortized but evaluated for impairment annually or more frequently if events or changes
in circumstances indicate that the asset might be impaired. The provisions of ASC 350 &#x201c;Intangibles-Goodwill and Other&#x201d; (&#x201c;ASC
350&#x201d;) require that the impairment test be performed on goodwill at the level of the reporting unit. As required by ASC 350, the
Company chooses either to perform a qualitative assessment whether a goodwill impairment test is necessary or proceeds directly to the
goodwill impairment test. Such determination is made for each reporting unit on a stand-alone basis. The qualitative assessment includes
various factors such as macroeconomic conditions, industry and market considerations, cost factors, overall financial performance, earnings
multiples, gross margin and cash flows from operating activities and other relevant factors. When the Company chooses to perform a qualitative
assessment and determines that it is more likely than not (more than 50 percent likelihood) that the fair value of the reporting unit
is less than its carrying value, then the Company proceeds to the goodwill impairment test. If the Company determines otherwise, no further
evaluation is necessary.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;When the Company decides
or is required to perform the quantitative goodwill impairment test, the Company compares the fair value of the reporting unit to its
carrying value and an impairment charge is recognized for the amount by which the carrying amount exceeds the reporting unit&#x2019;s fair
value, if any.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The Company determined
that its operations represent a single reporting unit. The Company determines the fair value of its reporting unit by using the income
approach, which utilizes a discounted cash flow model, as it believes that this approach best approximates the reporting unit&#x2019;s
fair value. Judgments and assumptions related to revenue, operating income, future short-term and long-term growth rates, weighted average
cost of capital, interest, capital expenditures, cash flows, and market conditions are inherent in developing the discounted cash flow
model. The Company considers historical rates and current market conditions when determining the discount and growth rates to use in its
analyses. If these estimates or their related assumptions change in the future, the Company may be required to record impairment charges
for its goodwill. As of December 31, 2022 and 2021, the Company has performed the annual impairment test and has determined that impairment
loss is not required to be recognized.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Finite lived intangible
assets acquired in business combinations, which include technology, customer relationships and trade names, are initially recorded at
fair value.&#160;They are amortized on a straight-line basis over their estimated useful lives.&#160;The intangible asset lives have been
determined based upon the anticipated period over which the Company will derive future cash flows from the intangible assets.&#160;The
Company has considered the effects of legal, regulatory, contractual, competitive, and other economic factors in determining these useful
lives.&#160;Recoverability of these assets is assessed when triggering events have occurred that may give rise to an impairment loss and
is determined by a comparison of the carrying amount of the asset to the future undiscounted net cash flows expected to be generated by
the asset.&#160;When it is determined that the carrying value of the asset is not recoverable, the asset is written down to its estimated
fair value.&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;As a result of continued
losses, the management performed an impairment test with respect to its intangible assets by maintaining an external valuation which utilized
discounted cash flow model. Accordingly,&#160;certain assumptions and judgments were made to determine the discount rate as well as future
cash flows of the Company.&#160;During the years ended December 31, 2022, 2021 and 2020, no impairment losses were identified through
the impairment test.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27.35pt"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The lives used in computing straight-line amortization
for financial reporting purposes are as follows:&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: left; border-bottom: Black 1.5pt solid"&gt;Rate of depreciation&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 88%; text-align: left"&gt;Technology&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;20&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Customer relationships&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;20&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Trade names&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;10&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&#160;&lt;/p&gt;</us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: left; border-bottom: Black 1.5pt solid"&gt;Rate of depreciation&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 88%; text-align: left"&gt;Technology&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;20&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Customer relationships&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;20&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Trade names&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;10&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&#160;&lt;/p&gt;</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
    <bmr:PropertyPlantAndEquipmentDepreciationPercentage contextRef="c48" decimals="2" unitRef="pure">0.20</bmr:PropertyPlantAndEquipmentDepreciationPercentage>
    <bmr:PropertyPlantAndEquipmentDepreciationPercentage contextRef="c49" decimals="2" unitRef="pure">0.20</bmr:PropertyPlantAndEquipmentDepreciationPercentage>
    <bmr:PropertyPlantAndEquipmentDepreciationPercentage contextRef="c50" decimals="2" unitRef="pure">0.10</bmr:PropertyPlantAndEquipmentDepreciationPercentage>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock contextRef="c0">&lt;b&gt;Property and equipment&lt;/b&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Property and equipment
are stated at cost, net of accumulated depreciation. Depreciation is calculated using the straight-line method over the estimated useful
lives of the assets. When an asset is retired or otherwise disposed of, the related cost and accumulated depreciation are removed from
the respective accounts and the net difference less any amount realized from disposition is reflected in the consolidated Statements of
Operations and Comprehensive Loss.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The Company&#x2019;s long-lived
assets are reviewed for impairment in accordance with ASC 360, &#x201c;Property, Plant and Equipment&#x201d;, whenever events or changes
in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is
measured by a comparison of the carrying amount of an asset to the future undiscounted cash flows expected to be generated by the asset.
If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of
the asset exceeds its fair value. To date, the Company has not incurred any impairment losses.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27.35pt"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The lives used in computing straight-line depreciation
for financial reporting purposes are as follows:&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: left; border-bottom: Black 1.5pt solid"&gt;Rate of depreciation&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 88%; text-align: left"&gt;Computers and peripheral equipment&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;33&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Office furniture and equipment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;7-15&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentAndIntangibleAssetsTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: left; border-bottom: Black 1.5pt solid"&gt;Rate of depreciation&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 88%; text-align: left"&gt;Computers and peripheral equipment&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;33&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Office furniture and equipment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;7-15&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;</us-gaap:PropertyPlantAndEquipmentAndIntangibleAssetsTextBlock>
    <us-gaap:PropertyPlantAndEquipmentSalvageValuePercentage contextRef="c51" decimals="2" unitRef="pure">0.33</us-gaap:PropertyPlantAndEquipmentSalvageValuePercentage>
    <us-gaap:PropertyPlantAndEquipmentSalvageValuePercentage contextRef="c52" decimals="2" unitRef="pure">0.07</us-gaap:PropertyPlantAndEquipmentSalvageValuePercentage>
    <us-gaap:PropertyPlantAndEquipmentSalvageValuePercentage contextRef="c53" decimals="2" unitRef="pure">0.15</us-gaap:PropertyPlantAndEquipmentSalvageValuePercentage>
    <us-gaap:LesseeLeasesPolicyTextBlock contextRef="c0">&lt;b&gt;Leases&lt;/b&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The Company entered
into several non-cancelable lease agreements for offices for use in its operations, which are classified as operating leases (see below).&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The Company applies
ASC Topic 842, Leases (&#x201c;ASC 842&#x201d;).&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Accordingly, the Company
determines if an arrangement is a lease at inception. The Company&#x2019;s assessment is based on: (i) whether the contract involves the
use of an identified asset, (ii) whether the Company obtains the right to substantially all of the economic benefits from the use of the
asset throughout the period of use, and (iii) whether the Company has the right to direct the use of the asset.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Leases are classified
as either finance leases or operating leases. A lease is classified as a finance lease if any one of the following criteria are met: (i)
the lease transfers ownership of the asset by the end of the lease term, (ii) the lease contains an option to purchase the asset that
is reasonably certain to be exercised, (iii) the lease term is for a major part of the remaining useful life of the asset, (iv) the present
value of the lease payments equals or exceeds substantially all of the fair value of the asset, or (v) the underlying asset is of such
a specialized nature that it is expected to have no alternative use to the lessor at the end of lease term. A lease is classified as an
operating lease if it does not meet any one of these criteria. Since all the Company&#x2019;s lease contracts for premises do not meet
any of the criteria above, the Company concluded that all its lease contracts should be classified as operating leases.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Right of Use (&#x201c;ROU&#x201d;)
assets and liabilities are recognized on the commencement date based on the present value of remaining lease payments over the lease term.
For this purpose, the Company considers only payments that are fixed and determinable at the time of commencement. As most of the Company&#x2019;s
leases do not provide an implicit rate, the Company uses its incremental borrowing rate (&#x201c;IBR&#x201d;) based on the information available
on the commencement date in determining the present value of lease payments. The Company&#x2019;s IBR is estimated to approximate the interest
rate for collateralized borrowing with similar terms and payments and in economic environments where the leased asset is located. The
ROU asset also includes any lease payments made prior to commencement and is recorded net of any lease incentives received. Moreover,
the ROU asset may also include initial direct costs, which are incremental costs of a lease that would not have been incurred if the lease
had not been obtained. The Company uses the long-lived assets impairment guidance in ASC 360-10, &#x201c;Property, Plant, and Equipment
- Overall&#x201d;, to determine whether a ROU asset is impaired, and if so, the amount of the impairment loss to recognize. Certain leases
include options to extend or terminate the lease. An option to extend the lease is considered in connection with determining the ROU asset
and lease liability when it is reasonably certain that the Company will exercise that option. An option to terminate is considered unless
it is reasonably certain that the Company will not exercise the option.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The Company also elected
the short-term lease recognition exemption for all leases that qualify (leases with a term shorter than 12 months). For those leases,
ROU assets or lease liabilities are not recognized and rent&#160;expense is recognized on a straight-line basis over the lease term. See
also Note 10A for further discussion.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: center; background-color: white"&gt;&#160;&lt;/p&gt;</us-gaap:LesseeLeasesPolicyTextBlock>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="c0">&lt;b&gt;Deferred income taxes&lt;/b&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The Company accounts
for income taxes in accordance with ASC Topic 740, &#x201c;Income Taxes&#x201d;. Accordingly, deferred income taxes are determined utilizing
the asset and liability method based on the estimated future tax effects of differences between the financial accounting and the tax bases
of assets and liabilities under the applicable tax law. Deferred tax balances are computed using the enacted tax rates expected to be
in effect when these differences reverse. Valuation allowance in respect of deferred tax assets is provided for, if necessary, to reduce
deferred tax assets is amounts more likely than not to be realized.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The Company accounts
for uncertain tax positions in accordance with ASC Topic 740-10, which prescribes detailed guidance for the financial statement recognition,
measurement and disclosure of uncertain tax positions recognized in an enterprise&#x2019;s financial statements. According to ASC Topic
740-10, tax positions must meet a more-likely-than-not recognition threshold. The Company&#x2019;s accounting policy is to classify interest
and penalties relating to uncertain tax positions under income taxes, however the Company did not recognize such items in its consolidated
financial statements during the years ended December 31, 2022, 2021 and 2020 and did not recognize any liability with respect to an unrecognized
tax position in its balance sheets.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:PostemploymentBenefitPlansPolicy contextRef="c0">&lt;b&gt;Employees benefit plans &lt;/b&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The Company&#x2019;s
liability for severance pay to its Israeli employees is pursuant to Section 14 of the Israeli Severance Compensation Act, 1963 (&#x201c;Section
14&#x201d;), pursuant to which all the Company&#x2019;s employees are included under Section 14, and are entitled only to monthly deposits,
at a rate of 8.33% of their monthly salary, made in the employee&#x2019;s name with insurance companies. Under Israeli employment law,
payments in accordance with Section 14 release the Company from any future severance payments in respect of those employees. The fund
is made available to the employee at the time the employer-employee relationship is terminated, regardless of cause of termination. The
severance pay liabilities and deposits under Section 14 are not reflected in the balance sheets as the severance pay risks have been irrevocably
transferred to the severance funds. All deposits required through December 31, 2022 have been made.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: left; text-indent: -1cm"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;</us-gaap:PostemploymentBenefitPlansPolicy>
    <bmr:EmployeeCompensationPercentage contextRef="c0" decimals="4" unitRef="pure">0.0833</bmr:EmployeeCompensationPercentage>
    <us-gaap:CommitmentsAndContingenciesPolicyTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0%"/&gt;&lt;td style="width: 0.5in"&gt;&lt;b&gt;L.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;b&gt;Contingencies&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The Company and its
subsidiaries may be involved in certain legal proceedings and certain business relationships that arise from time to time in the ordinary
course of their business and in connection with certain agreements with third parties. Except for income tax contingencies, the Company
applies the provisions of ASC Topic 450, Contingencies. Thus, the Company records accruals for contingencies to the extent that the management
concludes that the occurrence is probable and that the related liabilities are estimable. Legal expenses associated with contingencies
are expensed as incurred.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: left; text-indent: -1cm"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;</us-gaap:CommitmentsAndContingenciesPolicyTextBlock>
    <bmr:ConcentrationOfCreditRiskPolicyTextBlock contextRef="c0">&lt;b&gt;Concentrations of credit risk and allowance for doubtful accounts&lt;/b&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Financial instruments
that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents and trade receivables
as well as certain other current assets that do not amount to a significant amount. Cash and cash equivalents, which are primarily held
in US Dollars and New Israeli Shekels (NIS), are deposited with major banks in Israel, U.S. and Russian Federation. Management believes
that such financial institutions are financially sound and, accordingly, minimal credit risk exists with respect to these financial instruments.
The Company does not have any significant off-balance-sheet concentration of credit risk, such as foreign exchange contracts, option contracts
or other foreign hedging arrangements. Most of the Company&#x2019;s sales are mainly derived from sales to a diverse set of customers located
primarily in the United States. Management periodically evaluates the collectability of the trade receivables to determine the amounts
that are doubtful of collection and determine a proper allowance for doubtful accounts, as described below. Accordingly, management believes
that the Company&#x2019;s trade receivables do not represent a substantial concentration of credit risk.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The Company extends credit to customers
in the normal course of business and does not require collateral or any other security to support amounts due. Management performs ongoing
credit evaluations of its customers. The allowance for doubtful accounts is determined with respect to amounts the Group has determined
to be doubtful of collection. In determining the allowance for doubtful accounts, the Company considers, among other things, its past
experience with customers, the length of time that the balance is past due, the customer&#x2019;s current ability to pay and available information
about the credit risk on such customers.&#160;Provisions for the allowance for doubtful accounts are recorded under general and administrative
expenses in the consolidated Statements of Operations and Comprehensive Loss. During the years ended December 31, 2022, 2021 and 2020,
the Company has not recorded allowance in respect of accounts receivable.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: center; background-color: white"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;</bmr:ConcentrationOfCreditRiskPolicyTextBlock>
    <us-gaap:RevenueRecognitionPolicyTextBlock contextRef="c0">&lt;b&gt;Revenue recognition&lt;/b&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The Company recognizes revenues in accordance
with ASC 606, &#x201c;Revenue from Contracts with Customers&#x201d; (&#x201c;ASC 606&#x201d;) under which the Company determines revenue recognition
through the following five steps:&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.5pt; text-align: justify; text-indent: -22.5pt"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"/&gt;&lt;td style="width: 0.25in"&gt;&lt;span&gt;&#x25fe;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Identification of the contract, or contracts, with a customer;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.5pt; text-align: justify; text-indent: -22.5pt"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"/&gt;&lt;td style="width: 0.25in"&gt;&lt;span&gt;&#x25fe;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Identification of the performance obligations in the contract;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.5pt; text-align: justify; text-indent: -22.5pt"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"/&gt;&lt;td style="width: 0.25in"&gt;&lt;span&gt;&#x25fe;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Determination of the transaction price;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.5pt; text-align: justify; text-indent: -22.5pt"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"/&gt;&lt;td style="width: 0.25in"&gt;&lt;span&gt;&#x25fe;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Allocation of the transaction price to the performance obligations in the contract; and&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.5pt; text-align: justify; text-indent: -22.5pt"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"/&gt;&lt;td style="width: 0.25in"&gt;&lt;span&gt;&#x25fe;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Recognition of revenue when, or as, the Company satisfies a performance obligation.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The Company enters into contracts that
mostly include software and software related services (i.e. Post-Contract Customer Support (&#x201c;PCS&#x201d;)), which are generally capable
as being distinct from each other and accounted for as separate performance obligations.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The Company derives its revenues from
licensing the rights to use its software for a limited term (mainly for a period of one to three years) or on a perpetual basis for enterprises
that incorporate the Company&#x2019;s perpetual license in their own products delivered to end users and for the Company&#x2019;s products&#160;sold
to thousands private consumers, as applicable to each contract, and from, provision of related maintenance and technical support. The
Company sells its products through direct sales force and indirectly through distributors and consumer platforms.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Revenues are recognized when control of
the promised goods or services are transferred to the customers, in an amount that reflects the consideration that the company expects
to receive in exchange for those goods or services. However, when the consideration for the license is based on sales of the related customer,
the company applies the provisions of ASC 606 with respect to sales-based or usage-based royalties promised in exchange for a license
of intellectual property and recognizes revenues only when the underlying sales occur, as long as this approach does not result in the
acceleration of revenue ahead of the company&#x2019;s performance.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Under ASC 606, an entity recognizes revenue
when or as it satisfies a performance obligation by transferring software license (either timely-based or perpetual) or software related
services to the customer, either at a point in time or over time. The Company recognizes its revenues from software sales at a point in
time upon delivery of its software license. The software license is considered a distinct performance obligation, as the customer can
benefit from the software on its own. The Company&#x2019;s revenues from PCS are derived from annual maintenance providing for unspecified
upgrades on a when-and-if-available basis. The right for an unspecified upgrade for the version acquired by the customer and enhancements
on a when-and-if-available basis that do not specify the features, functionality and release date of future product enhancements for the
customer to know what will be made available and the general timeframe in which it will be delivered. The Company considers the PCS performance
obligation as a distinct performance obligation that is satisfied over time and recognized on a straight-line basis over the contractual
period (mainly over a period of one year either for timely-based license or for perpetual license).&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;As the Company bundles software licenses
(either time-based or perpetual) together with PCS, the transaction price is allocated to the separate performance obligations on a relative
standalone selling price basis.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Since the Company does not sell PCS on
a stand-alone basis and due to the fact that these services are usually involved with limited customer support, mainly based on several
hours of technical support per contract (as management believes the technology and products covered under the software license component
are mature and fully functional), the standalone selling prices of the PCS are determined based on the expected cost plus a margin (&#x201c;cost-plus
approach&#x201d;) based on estimation of direct fulfillment cost (an hourly service) and a reasonable margin. Such estimate is also corroborated
with the price that the company would have to pay to a third-party service provider for a similar support service.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The stand-alone selling price of the software
licenses (either timely-based or perpetual) is estimated by management based on adjusted market assessment approach which represents management
estimation of the price that a customer in the market will be willing to pay for such license on a stand-alone basis (i.e. without any
PCS).&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Due to the fact that the PCS services
are usually involved with limited customer support, mainly based on several hours of technical support per contract, the transaction price
allocated to the PCS is considered insignificant. Consequently, most of the transaction price is allocated to the software licenses as
management believes the technology and products covered under the software license component are mature and fully functional.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;During the reported periods, costs to
obtain contracts were in an insignificant amount.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The Company does not grant a right of
return to its customers. When product delivered to the customer is subject to evaluation, the Company defers revenue until evaluation
is completed subject to formal selling agreement with the customer, at which time revenue is recognized provided that all other revenue
recognition criteria are met.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Commencing 2022, revenue is also derived
from the traffic operations in the Google AdSense program, a web advertising platform, that the Company makes available on its websites.&#160;Google
pays the Company on a cost-per-click basis. The Company recognizes as revenue the fees paid to it by Google based on the volume of clicks
through to Google AdSense advertisements.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The Company receives payments from customers
based upon contractual payment schedules. Trade receivables are recorded when right to consideration becomes unconditional, and an invoice
is issued to the customer. Unbilled receivables include amounts related to the Company&#x2019;s contractual right to consideration for
completed performance obligations not yet invoiced. As of December 31, 2022 and 2021, unbilled receivables balance amounted to $35&#160;and
$29, respectively, and are included within trade receivables balance in the Company&#x2019;s Consolidated Balance Sheets.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;As of December 31, 2022 and 2021, the
Company had $31&#160;and $33, respectively, of remaining performance obligations not yet satisfied or partly satisfied related to revenues
(mostly PCS). Such amounts are presented as deferred revenues which are expected to be recognized as revenues during the next twelve months.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;See also Note 16 for further discussion
related to disaggregation of revenues.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: left; text-indent: -1cm"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;</us-gaap:RevenueRecognitionPolicyTextBlock>
    <us-gaap:OtherReceivables contextRef="c2" decimals="-3" unitRef="usd">35000</us-gaap:OtherReceivables>
    <us-gaap:OtherReceivables contextRef="c3" decimals="-3" unitRef="usd">29000</us-gaap:OtherReceivables>
    <us-gaap:DeferredRevenue contextRef="c2" decimals="-3" unitRef="usd">31000</us-gaap:DeferredRevenue>
    <us-gaap:DeferredRevenue contextRef="c3" decimals="-3" unitRef="usd">33000</us-gaap:DeferredRevenue>
    <us-gaap:FairValueMeasurementPolicyPolicyTextBlock contextRef="c0">&lt;b&gt;Fair Value Measurements&lt;/b&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The Company measures
and discloses fair value in accordance with the ASC 820, &#x201c;Fair Value Measurements and Disclosures&#x201d; which defines fair value,
establishes a framework and gives guidance regarding the methods used for measuring fair value, and expands disclosures about fair value
measurements. Fair value is an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability
in an orderly transaction between market participants at the measurement date. As such, fair value is a market-based measurement that
should be determined based on assumptions that market participants would use in pricing an asset or liability. As a basis for considering
such assumptions there exists a three-tier fair-value hierarchy, which prioritizes the inputs used in measuring fair value as follows:&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Level 1 - unadjusted
quoted prices are available in active markets for identical assets or liabilities that the Company has the ability to access as of the
measurement date.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Level 2 - pricing inputs
are other than quoted prices in active markets that are directly observable for the asset or liability or indirectly observable through
corroboration with observable market data.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Level 3 - pricing inputs
are unobservable for the non-financial asset or liability and only used when there is little, if any, market activity for the non-financial
asset or liability at the measurement date. The inputs into the determination of fair value require significant management judgment or
estimation. Level 3 inputs are considered as the lowest priority within the fair value hierarchy. The valuation of certain financial instruments
classified under fair value through profit or loss category and the fair value of reporting units for purposes of goodwill impairment
analysis, fall under this category.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;This hierarchy requires
the Company to use observable market data, when available, and to minimize the use of unobservable inputs when determining fair value.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The fair value of cash
and cash equivalents is based on its demand value, which is equal to its carrying value. Additionally, the carrying value of all other
short-term monetary assets and liabilities are estimated to be equal to their fair value due to the short-term nature of these instruments.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: left; text-indent: -1cm"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;</us-gaap:FairValueMeasurementPolicyPolicyTextBlock>
    <bmr:ConvertibleOrdinary1And2SharesAndPreferredSharesPolicyTextBlock contextRef="c0">&lt;b&gt;Convertible Ordinary 1 and 2 Shares and Preferred Shares&lt;/b&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The Convertible Ordinary 1 and 2 Shares
and Convertible Preferred Shares are not subject to redemption feature upon any events that are considered not solely within the control
of the Company. In addition, upon occurrence of liquidation event, as defined in the Company&#x2019;s Articles of Association, all holders of
the Ordinary Shares, Convertible Ordinary 1 and 2 Shares and Convertible Preferred Shares will be entitled to receive the same form of
consideration. Thus, the Company classifies its Convertible Ordinary 1 and 2 Shares and Convertible Preferred Shares as part of permanent
equity.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm"&gt;&#160;&lt;/p&gt;</bmr:ConvertibleOrdinary1And2SharesAndPreferredSharesPolicyTextBlock>
    <bmr:AllocationOfProceedsAndRelatedIssuanceCostsPolicyTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0%"/&gt;&lt;td style="width: 0.5in"&gt;&lt;b&gt;Q.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;b&gt;Allocation of proceeds and related issuance costs&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;When multiple instruments are issued in
a single transaction (package issuance), the total net proceeds from the transaction are allocated among the individual freestanding instruments
identified. The allocation occurs after identifying all the freestanding instruments and the subsequent measurement basis for those instruments.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Financial instruments that are required
to be subsequently measured at fair value (such as derivative warrants liability) are measured at fair value and the remaining consideration
is allocated to other financial instruments that are not required to be subsequently measured at fair value (i.e. straight loan), based
on the relative fair value basis for such instruments.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The allocation of issuance costs to freestanding
instruments was based on an approach that is consistent with the allocation of the proceeds, as described above.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Issuance costs allocated to the derivative
warrant liability were immediately expensed.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Issuance costs allocated to straight loan
are recorded as a discount of the straight loan and accreted over the contractual term of straight loan up to face value of such loans
using the effective interest method.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: left; text-indent: -1cm"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;</bmr:AllocationOfProceedsAndRelatedIssuanceCostsPolicyTextBlock>
    <bmr:WarrantsPolicyTextBlock contextRef="c0">&lt;b&gt;Warrants&lt;/b&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Certain warrants that
were issued to a commercial bank as part of entering into a straight loan and to seller through transaction in which certain identified
intangible assets have been purchased are classified as a component of permanent equity since they are freestanding financial instruments
that are legally detachable and separately exercisable, do not embody an obligation for the Company to repurchase its own shares, and
permit the holders to receive a fixed number of Ordinary Shares upon exercise for a fixed exercise price and thus, are considered as indexed
to the Company&#x2019;s own shares. In addition, the warrants must require physical settlement and may not provide any guarantee of value or
return. As such warrants were issued together with financial instruments that are not subsequently measured at fair value the warrants
were measured based on allocation of the proceeds received by the Company in accordance with the relative fair value basis. When applicable,
direct issuance expenses that were allocated to such warrants were deducted from additional paid-in capital.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Commencing January 1,
2018 and following the early adoption of ASU 2017-11, &#x201c;Earnings Per Share&#x201d; (ASU 2017-11), the Company disregards the down
round feature when assessing whether an instrument is indexed to its own shares, for purposes of determining liability or equity classification.
Based on its evaluation, management has determined that certain warrants with down-round protection are eligible for equity classification.
In accordance with the provisions of ASU 2017-11, upon the occurrence of an event that triggers down round protection (i.e., when the
exercise price of the warrants is adjusted downward because of the down round feature), the effect is accounted for as a deemed dividend
and as a reduction of income available to common shareholders for purposes of basic earnings per share (EPS) calculation. However, during
the reported periods there were no events that trigger a down round protection.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: left; text-indent: -1cm"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;</bmr:WarrantsPolicyTextBlock>
    <us-gaap:DerivativesPolicyTextBlock contextRef="c0">&lt;b&gt;Derivative Warrants Liability&lt;/b&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Certain warrants that
were granted by the Company for commercial bank through funding transaction entitle the bank to exercise the warrants for a variable number
of shares and/or for a variable exercise price and thus the fixed-for-fixed criteria is not met. Accordingly, the warrants were classified
as a non-current liability according to the provisions of ASC 815-40, &#x201c;Derivatives and Hedging - Contracts in Entity&#x2019;s Own
Equity&#x201d; (&#x201c;ASC 815-40&#x201d;). The Company accounted for these warrants as a financial derivative liability measured upon initial
recognition and on subsequent periods at fair value by using the Hybrid Method by combining the OPM and an IPO scenario.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The fair value of the
aforesaid warrants derivative liability is estimated using the Black-Scholes Model which requires inputs such as the expected term of
the warrants, share price volatility and risk-free interest rate. These assumptions are reviewed on a regular basis and changes in the
estimated fair value of the outstanding warrants are recognized each reporting period as part of the &#x201c;Financing (income) expenses,
net&#x201d; line in the consolidated statements of operations and comprehensive loss, until such warrants are exercised or expired. When
applicable, direct issuance expenses that were allocated to the above warrants were expensed as incurred.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;</us-gaap:DerivativesPolicyTextBlock>
    <bmr:ModificationsOrExchangeOfLoansPolicyTextBlock contextRef="c0">&lt;b&gt;Modifications or exchanges of loans&lt;/b&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Modifications to, or
exchanges of, financial instruments such as loans or convertible loans, are accounted for as a modification or an extinguishment, following
to provisions of ASC 470-50, &#x201c;Debt &#x2013; Modification and Extinguishments&#x201d; (ASC 470-50&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;.
Such an assessment done by management either qualitatively or quantitatively based on the facts and circumstances of each transaction&lt;span style="font-family: Times New Roman, Times, Serif"&gt;.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Under ASC 470-50, modifications
or exchanges are generally considered extinguishments with gains or losses recognized in current earnings if the terms of the new debt
and original instrument are substantially different. The instruments are considered &#x201c;substantially different&#x201d; when the present
value of the cash flows under the terms of the new debt instrument is at least 10% different from the present value of the remaining cash
flows under the terms of the original instrument&lt;span style="font-family: Times New Roman, Times, Serif"&gt;.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;If the terms of a debt
instrument are changed or modified and the present value of the cash flows under the terms of the new debt instrument is less than 10%,
the debt instruments are not considered to be substantially different, except in the following two circumstances: (i)&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&#160;&lt;/span&gt;the
transaction significantly affects the terms of an embedded conversion option, such that the change in the fair value of the embedded conversion
option (calculated as the difference between the fair value of the embedded conversion option immediately before and after the modification
or exchange) is at least 10% of the carrying amount of the original debt instrument immediately before the modification or exchange or
(ii)&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&#160;&lt;/span&gt;the transaction adds a substantive conversion option or
eliminates a conversion option that was substantive at the date of the modification or exchange&lt;span style="font-family: Times New Roman, Times, Serif"&gt;.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;If the original and
new debt instruments are considered as &#x201c;substantially different&#x201d;, the original debt is derecognized and the new debt is initially
recorded at fair value, with the difference recognized as an extinguishment gain or loss under financial expense or income as applicable&lt;span style="font-family: Times New Roman, Times, Serif"&gt;.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;If a convertible debt
instrument with a beneficial conversion option that was separately accounted for in equity, is extinguished prior to its conversion or
stated maturity date, a portion of the reacquisition price is allocated to the repurchase of the beneficial conversion option. The amount
of the reacquisition price allocated to the beneficial conversion option is measured using the intrinsic value of that conversion option
at the extinguishment date. The residual amount, if any, is allocated to the convertible debt instrument&lt;span style="font-family: Times New Roman, Times, Serif"&gt;.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The gain or loss on
the extinguishment of the convertible debt instrument is determined based on the difference between the carrying amount and the fair value
of the allocated reacquisition price.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: left; text-indent: -1cm"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;</bmr:ModificationsOrExchangeOfLoansPolicyTextBlock>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c2" decimals="2" unitRef="pure">0.10</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentRedemptionPricePercentage contextRef="c0" decimals="2" unitRef="pure">0.10</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage contextRef="c2" decimals="2" unitRef="pure">0.10</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="c0">&lt;b&gt;Basic and diluted net loss per Ordinary Share &lt;/b&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The Company applies
the two-class method as required by ASC&#160;260-10, &#x201c;Earnings Per Share&#x201d; (&#x201c;ASC&#160;260-10&#x201d;) which requires the
income or loss per share for each class of shares (ordinary and all other shares with preferences over Ordinary Shares) to be calculated
assuming 100% of the Company&#x2019;s earnings are distributed as dividends to each class of shares based on their contractual rights. No dividends
were declared or paid during the reported periods. According to the provisions of ASC&#160;260-10, the Company&#x2019;s Convertible Preferred
Shares and Convertible Ordinary 1 and 2 Shares do not have contractual obligation to share losses of the Company and therefore are not
included in the computation in period of net loss per share.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Basic net loss per Ordinary
Share is computed by dividing the net loss for the period applicable to ordinary shareholders, by the weighted average number of Ordinary
Shares outstanding during the period. Diluted loss per share gives effect to all potentially dilutive common shares outstanding during
the year using the treasury stock method with respect to shares with preferences over Ordinary Shares (Convertible Ordinary 1 and 2 shares
and Convertible Preferred Shares), share options and certain warrants and using the if-converted method with respect to convertible advance
investments and certain warrants accounted for as derivative liability. In computing diluted loss per share, the average share price for
the period is used in determining the number of shares assumed to be purchased from the exercise of share options or warrants.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;During the years ended
December 31, 2022, 2021 and 2020, the total weighted average number of Ordinary Shares related to outstanding shares with preferences
over Ordinary Shares (Convertible Ordinary 1 and 2 shares and Convertible Preferred Shares), share options, warrants and convertible advance
investments excluded from the calculation of the diluted loss per share was 9,067,438, 8,957,327 and 8,842,202, respectively.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: 0cm"&gt;&#160;&lt;/p&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <bmr:PercentageOfDividend contextRef="c0" decimals="2" unitRef="pure">1</bmr:PercentageOfDividend>
    <us-gaap:ExcessStockSharesOutstanding contextRef="c2" decimals="0" unitRef="shares">9067438</us-gaap:ExcessStockSharesOutstanding>
    <us-gaap:ExcessStockSharesOutstanding contextRef="c3" decimals="0" unitRef="shares">8957327</us-gaap:ExcessStockSharesOutstanding>
    <us-gaap:ExcessStockSharesOutstanding contextRef="c26" decimals="0" unitRef="shares">8842202</us-gaap:ExcessStockSharesOutstanding>
    <bmr:ConvertibleAdvanceInvestmentsPolicyTextBlock contextRef="c0">&lt;b&gt;Convertible Advance Investments&lt;/b&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Upon initial recognition, the Company
has considered the provisions of ASC 480-10 &#x201c;Distinguishing Liabilities from Equity&#x201d; with respect to certain obligations to
issue a variable number of shares and has determined that the convertible advance investments represent a financial liability since most
of its settlement alternatives embody either a conditional or an unconditional obligation to issue a variable number of the Company&#x2019;s
shares with monetary value based predominantly on a fixed monetary amount known at inception (the original issue price of the convertible
advance investments together with a fixed &#160;return to the investors).&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Upon initial recognition, the Company
has considered the provisions of ASC 815-15,&#160;&#x201c;Derivatives and Hedging - Embedded Derivatives&#x201d;, and determined that the
embedded conversion feature of the convertible advance investments cannot be considered as clearly and closely related to the host debt
instrument. However, it was determined that the embedded conversion feature should not be separated from the host instrument because the
embedded conversion option, if freestanding, did not meet a derivative definition based on the provisions of ASC 815-10, &#x201c;Derivatives
and Hedging&#x201d;&#160;since its terms did not require or permit net settlement. Thus, it was determined that the conversion feature
does not meet the characteristic of being readily convertible to cash. However, the Company has determined that the redemption feature
upon certain events is not solely within the Company&#x2019;s control under which the Company will be required to repay an amount equal to 200%
of the original investment was determined to represent a contingent interest feature that requires bifurcation from a host debt contract
because the contingent interest feature meets a derivative definition and the economic characteristics of the embedded feature are not
clearly and closely related to those of host debt instrument as such feature is not directly credit risk related.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Furthermore, the Company applied ASC 470-20,
&#x201c;Debt - Debt with Conversion and Other Options&#x201d; (&#x201c;ASC 470-20&#x201d;) which clarifies the accounting for instruments with
Beneficial Conversion Features (BCF) or contingently adjustable conversion ratios and has applied the BCFs guidance to determine whether
the conversion feature is beneficial to investors. However, as the convertible advance investments were not convertible upon inception
(such instrument would have become convertible if the Company would have completed qualified financing by August 5, 2020), it was determined
that no BCF was required to be recognized upon initial recognition of the instrument.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Based on the characteristics of the convertible
advance investments, the Company elected to measure this liability in its entirety, at its fair value in accordance with ASC 825-10, &#x201c;Financial
Instruments&#x201d; due to the existence of certain redemption option and the potential requirement to recognize contingent BCF. Accordingly,
upon initial recognition and in subsequent periods, the Company measures the liability related to the convertible advance investments
based on its fair value taking into consideration, among others all relevant settlement possibilities and their respective likelihood.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: left; text-indent: -1cm"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;</bmr:ConvertibleAdvanceInvestmentsPolicyTextBlock>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage contextRef="c47" decimals="2" unitRef="pure">2</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <bmr:CapitalContributionFromAControllingShareholderPolicyTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0%"/&gt;&lt;td style="width: 0.5in"&gt;&lt;b&gt;W.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;b&gt;Capital contribution from a controlling shareholder&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The fair value of the benefit received
in respect of loan received from the controlling shareholder is calculated on the basis of the difference between the interest rate that
the Company would have required to pay for similar loan from commercial bank and the interest rate that the Company is actually charged
under the agreement with the controlling shareholders. Such benefit is accounted for as capital contribution received from the controlling
shareholder as additional paid-in capital and it is recorded as discount on the loan received against at the initial measurement date.
Subsequently, such discount is expensed over the economic life of the loan based on the effective interest rate method.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify"&gt;&#160;&lt;/p&gt;</bmr:CapitalContributionFromAControllingShareholderPolicyTextBlock>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0%"/&gt;&lt;td style="width: 0.5in"&gt;&lt;b&gt;X.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;b&gt;Share-based compensation&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0in"&gt;The Company measures
and recognizes compensation expense for all equity-based payments to employees based on their estimated fair values in accordance with
ASC 718, &#x201c;Compensation-Stock Compensation&#x201d;. Share-based payments are recognized in the Statement of Operations and Comprehensive
Loss as an operating expense based on fair value of the award at the grant date by using Black-Scholes option-pricing model. The inputs
for the valuation analysis of the share options include several assumptions of which the most significant are the fair market value of
the underlying Ordinary Share, the expected share price volatility and the expected option term. Expected volatility was calculated based
upon historical volatility of peer companies in the same industry on daily basis since the Company&#x2019;s marketability is considered low.
The expected option term represents the period that the Company&#x2019;s share options are expected to be outstanding and is determined
based on the simplified method until sufficient historical exercise data will support using expected life assumptions. The risk-free interest
rate is based on the yield from U.S. treasury bonds with an equivalent term. The expected dividend yield assumption is based on the Company&#x2019;s
historical experience and expectation of no future dividend payouts. The Company has historically not paid cash dividends and has no foreseeable
plans to pay cash dividends in the future. The Company expensed compensation costs net of estimated forfeitures over the requisite service
period by applying the straight-line method.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0in"&gt;The fair value of
Ordinary Shares underlying the share options was determined by the Company&#x2019;s management with the assistance of an independent valuation
firm. Because there has been no public market for the Ordinary Shares, the Company&#x2019;s management has determined fair value of the Ordinary
Shares at the time of grant by considering several objective and subjective factors including data from other comparable companies, sales
of Convertible Preferred Shares to unrelated third parties, operating and financial performance, the lack of liquidity of share capital
and general and industry specific economic outlook, amongst other factors. The fair value of the underlying Ordinary Shares shall be determined
by management until such time as the ordinary shares are listed on an established stock exchange, national market system or other quotation
system. For all reported periods through December&#160;31, 2020, the valuations were performed using the Option Pricing Method (&#x201c;OPM&#x201d;).
Commencing June&#160;30, 2021, the valuations were performed using Hybrid Method by combining the OPM and an IPO scenario.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0in"&gt;Commencing January
1, 2019, following the adoption of ASU 2018-07 which aligns the measurement and classification guidance for share-based payments to nonemployees
with the guidance for share-based payments to employees (with certain exceptions), share-based payments to non-employees are accounted
in accordance with ASC 718.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0in"&gt;When applicable,
a modification to the terms and/or conditions of an award (i.e. a change of award&#x2019;s fair value, vesting conditions or classification
as an equity or a liability instrument) is accounted for as an exchange of the original award for a new award resulting in total compensation
cost equal to the grant-date fair value of the original award, plus the incremental value of the modification to the award. The calculation
of the incremental value is based on the excess of the fair value of the modified award following the modification over the fair value
of the original award measured immediately before its terms were modified.&lt;/p&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:OtherCurrentAssetsTextBlock contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63.8pt; text-align: left; text-indent: -63.8pt"&gt;&lt;b&gt;NOTE 3 - OTHER
CURRENT ASSETS&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63.8pt; text-align: left; text-indent: -63.8pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of&lt;br/&gt;
 December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left; text-indent: -14.15pt; padding-left: 14.15pt"&gt;Prepaid expenses&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;32&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;33&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -14.15pt; padding-left: 14.15pt"&gt;Government authorities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;15&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;22&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; text-indent: -14.15pt; padding-left: 14.15pt"&gt;Others&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;17&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;11&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 4pt; text-indent: -14.15pt; padding-left: 14.15pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;64&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;66&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:OtherCurrentAssetsTextBlock>
    <us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of&lt;br/&gt;
 December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left; text-indent: -14.15pt; padding-left: 14.15pt"&gt;Prepaid expenses&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;32&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;33&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -14.15pt; padding-left: 14.15pt"&gt;Government authorities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;15&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;22&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; text-indent: -14.15pt; padding-left: 14.15pt"&gt;Others&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;17&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;11&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 4pt; text-indent: -14.15pt; padding-left: 14.15pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;64&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;66&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock>
    <us-gaap:PrepaidExpenseCurrentAndNoncurrent contextRef="c2" decimals="-3" unitRef="usd">32000</us-gaap:PrepaidExpenseCurrentAndNoncurrent>
    <us-gaap:PrepaidExpenseCurrentAndNoncurrent contextRef="c3" decimals="-3" unitRef="usd">33000</us-gaap:PrepaidExpenseCurrentAndNoncurrent>
    <bmr:GovernmentAuthoritiesAssets contextRef="c2" decimals="-3" unitRef="usd">15000</bmr:GovernmentAuthoritiesAssets>
    <bmr:GovernmentAuthoritiesAssets contextRef="c3" decimals="-3" unitRef="usd">22000</bmr:GovernmentAuthoritiesAssets>
    <us-gaap:OtherPrepaidExpenseCurrent contextRef="c2" decimals="-3" unitRef="usd">17000</us-gaap:OtherPrepaidExpenseCurrent>
    <us-gaap:OtherPrepaidExpenseCurrent contextRef="c3" decimals="-3" unitRef="usd">11000</us-gaap:OtherPrepaidExpenseCurrent>
    <us-gaap:OtherAssetsCurrent contextRef="c2" decimals="-3" unitRef="usd">64000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent contextRef="c3" decimals="-3" unitRef="usd">66000</us-gaap:OtherAssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"&gt;&lt;b&gt;NOTE 4 - PROPERTY AND EQUIPMENT,
NET&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;As of&lt;br/&gt;
 December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left"&gt;Computers and peripheral equipment&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;95&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;93&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;Office furniture and equipment&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;42&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;42&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;137&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;135&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;Less - accumulated depreciation&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(122&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(114&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;Total property and equipment, net&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;15&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;21&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.65pt; text-align: left; text-indent: -5.65pt"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"&gt;During the years ended December
31, 2022, 2021 and 2020, total depreciation expenses were $8, $16 and $32, respectively.&lt;/p&gt;</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;As of&lt;br/&gt;
 December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left"&gt;Computers and peripheral equipment&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;95&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;93&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;Office furniture and equipment&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;42&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;42&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;137&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;135&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;Less - accumulated depreciation&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(122&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(114&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;Total property and equipment, net&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;15&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;21&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.65pt; text-align: left; text-indent: -5.65pt"&gt;&#160;&lt;/p&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c54" decimals="-3" unitRef="usd">95000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c55" decimals="-3" unitRef="usd">93000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c56" decimals="-3" unitRef="usd">42000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c57" decimals="-3" unitRef="usd">42000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c2" decimals="-3" unitRef="usd">137000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c3" decimals="-3" unitRef="usd">135000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="c2" decimals="-3" unitRef="usd">122000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="c3" decimals="-3" unitRef="usd">114000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c2" decimals="-3" unitRef="usd">15000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c3" decimals="-3" unitRef="usd">21000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:DepreciationExpenseOnReclassifiedAssets contextRef="c0" decimals="-3" unitRef="usd">8000</us-gaap:DepreciationExpenseOnReclassifiedAssets>
    <us-gaap:DepreciationExpenseOnReclassifiedAssets contextRef="c8" decimals="-3" unitRef="usd">16000</us-gaap:DepreciationExpenseOnReclassifiedAssets>
    <us-gaap:DepreciationExpenseOnReclassifiedAssets contextRef="c9" decimals="-3" unitRef="usd">32000</us-gaap:DepreciationExpenseOnReclassifiedAssets>
    <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"&gt;&lt;b&gt;NOTE 5 - INTANGIBLE ASSETS,
NET AND GOODWILL&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;b&gt;As of&lt;br/&gt;
 December 31,&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2022&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2021&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;Carrying amount:&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; width: 76%; text-align: left"&gt;Technology&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;2,007&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;2,007&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-align: left"&gt;Customer relationships&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;1,127&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;1,127&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt"&gt;Trade names&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;201&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;201&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;3,335&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;3,335&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Accumulated amortization:&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-align: left"&gt;Technology&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;2,007&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;2,007&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-align: left"&gt;Customer relationships&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;1,127&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;1,127&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt"&gt;Trade names&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;134&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;114&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;3,268&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;3,248&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 4pt"&gt;Intangible assets, net&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;67&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;87&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.65pt; text-align: left; text-indent: -5.65pt"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"&gt;During the years ended December
31, 2022, 2021 and 2020, total amortization expenses were $20, $177 and $647, respectively.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"&gt;As of December 31, 2022, the
estimated future amortization expense of intangible assets is as follows:&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 88%; text-align: left"&gt;2023&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;20&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;2024-2026&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;47&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 4pt; padding-left: 2.85pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;67&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"&gt;As of December 31, 2022 and 2021, the Company performed an annual impairment analysis with respect to goodwill and due to continued losses,
an impairment analysis was performed also with respect to the remaining balance of intangible assets. The analysis was based on valuation
performed by management using the assistance of third-party appraiser by using the income approach. The significant assumptions used for
the assessment were a discount rate of 25.3% and 25.5% as of December 31, 2022 and 2021, respectively, and long-term growth rate of 3%
as of December 31, 2022 and 2021.&#160;The measurement was classified at level 3 in the fair value hierarchy whereby it was determined
that impairment is not required to be recognized with respect to goodwill or intangible assets as of December 31, 2022 and 2021.&lt;/p&gt;</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfImpairedIntangibleAssetsTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;b&gt;As of&lt;br/&gt;
 December 31,&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2022&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2021&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;Carrying amount:&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; width: 76%; text-align: left"&gt;Technology&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;2,007&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;2,007&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-align: left"&gt;Customer relationships&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;1,127&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;1,127&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt"&gt;Trade names&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;201&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;201&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;3,335&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;3,335&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Accumulated amortization:&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-align: left"&gt;Technology&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;2,007&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;2,007&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-align: left"&gt;Customer relationships&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;1,127&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;1,127&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt"&gt;Trade names&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;134&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;114&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;3,268&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;3,248&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 4pt"&gt;Intangible assets, net&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;67&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;87&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.65pt; text-align: left; text-indent: -5.65pt"&gt;&#160;&lt;/p&gt;</us-gaap:ScheduleOfImpairedIntangibleAssetsTextBlock>
    <us-gaap:AssetsUnderManagementCarryingAmount contextRef="c58" decimals="-3" unitRef="usd">2007000</us-gaap:AssetsUnderManagementCarryingAmount>
    <us-gaap:AssetsUnderManagementCarryingAmount contextRef="c59" decimals="-3" unitRef="usd">2007000</us-gaap:AssetsUnderManagementCarryingAmount>
    <us-gaap:AssetsUnderManagementCarryingAmount contextRef="c60" decimals="-3" unitRef="usd">1127000</us-gaap:AssetsUnderManagementCarryingAmount>
    <us-gaap:AssetsUnderManagementCarryingAmount contextRef="c61" decimals="-3" unitRef="usd">1127000</us-gaap:AssetsUnderManagementCarryingAmount>
    <us-gaap:AssetsUnderManagementCarryingAmount contextRef="c62" decimals="-3" unitRef="usd">201000</us-gaap:AssetsUnderManagementCarryingAmount>
    <us-gaap:AssetsUnderManagementCarryingAmount contextRef="c63" decimals="-3" unitRef="usd">201000</us-gaap:AssetsUnderManagementCarryingAmount>
    <us-gaap:AssetsUnderManagementCarryingAmount contextRef="c2" decimals="-3" unitRef="usd">3335000</us-gaap:AssetsUnderManagementCarryingAmount>
    <us-gaap:AssetsUnderManagementCarryingAmount contextRef="c3" decimals="-3" unitRef="usd">3335000</us-gaap:AssetsUnderManagementCarryingAmount>
    <us-gaap:AccumulatedAmortizationDeferredFinanceCosts contextRef="c58" decimals="-3" unitRef="usd">2007000</us-gaap:AccumulatedAmortizationDeferredFinanceCosts>
    <us-gaap:AccumulatedAmortizationDeferredFinanceCosts contextRef="c59" decimals="-3" unitRef="usd">2007000</us-gaap:AccumulatedAmortizationDeferredFinanceCosts>
    <us-gaap:AccumulatedAmortizationDeferredFinanceCosts contextRef="c60" decimals="-3" unitRef="usd">1127000</us-gaap:AccumulatedAmortizationDeferredFinanceCosts>
    <us-gaap:AccumulatedAmortizationDeferredFinanceCosts contextRef="c61" decimals="-3" unitRef="usd">1127000</us-gaap:AccumulatedAmortizationDeferredFinanceCosts>
    <us-gaap:AccumulatedAmortizationDeferredFinanceCosts contextRef="c62" decimals="-3" unitRef="usd">134000</us-gaap:AccumulatedAmortizationDeferredFinanceCosts>
    <us-gaap:AccumulatedAmortizationDeferredFinanceCosts contextRef="c63" decimals="-3" unitRef="usd">114000</us-gaap:AccumulatedAmortizationDeferredFinanceCosts>
    <us-gaap:AccumulatedAmortizationDeferredFinanceCosts contextRef="c2" decimals="-3" unitRef="usd">3268000</us-gaap:AccumulatedAmortizationDeferredFinanceCosts>
    <us-gaap:AccumulatedAmortizationDeferredFinanceCosts contextRef="c3" decimals="-3" unitRef="usd">3248000</us-gaap:AccumulatedAmortizationDeferredFinanceCosts>
    <us-gaap:OtherIntangibleAssetsNet contextRef="c2" decimals="-3" unitRef="usd">67000</us-gaap:OtherIntangibleAssetsNet>
    <us-gaap:OtherIntangibleAssetsNet contextRef="c3" decimals="-3" unitRef="usd">87000</us-gaap:OtherIntangibleAssetsNet>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="c0" decimals="-3" unitRef="usd">20000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="c8" decimals="-3" unitRef="usd">177000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="c9" decimals="-3" unitRef="usd">647000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 88%; text-align: left"&gt;2023&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;20&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;2024-2026&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;47&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 4pt; padding-left: 2.85pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;67&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths contextRef="c2" decimals="-3" unitRef="usd">20000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo contextRef="c2" decimals="-3" unitRef="usd">47000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c2" decimals="-3" unitRef="usd">67000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:LesseeOperatingLeaseDiscountRate contextRef="c2" decimals="3" unitRef="pure">0.253</us-gaap:LesseeOperatingLeaseDiscountRate>
    <us-gaap:LesseeOperatingLeaseDiscountRate contextRef="c3" decimals="3" unitRef="pure">0.255</us-gaap:LesseeOperatingLeaseDiscountRate>
    <us-gaap:LongDurationContractsAssumptionsByProductAndGuaranteeDiscountRate contextRef="c2" decimals="2" unitRef="pure">0.03</us-gaap:LongDurationContractsAssumptionsByProductAndGuaranteeDiscountRate>
    <us-gaap:LongDurationContractsAssumptionsByProductAndGuaranteeDiscountRate contextRef="c3" decimals="2" unitRef="pure">0.03</us-gaap:LongDurationContractsAssumptionsByProductAndGuaranteeDiscountRate>
    <us-gaap:DebtDisclosureTextBlock contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.65pt; text-align: left; text-indent: -5.65pt"&gt;&lt;b&gt;NOTE 6 - LOANS,
NET&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.65pt; text-align: left; text-indent: -5.65pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;b&gt;A.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;Loan and Security Agreements with Silicon Valley Bank&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.3pt; text-align: justify; text-indent: -0.25in"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"/&gt;&lt;td style="width: 0.25in"&gt;1.&lt;/td&gt;&lt;td style="text-align: justify"&gt;On February 19, 2017, the Company and Beamr Inc. entered into a Loan and Security Agreement (the &#x201c;2017
Loan Agreement&#x201d;) with Silicon Valley Bank (the &#x201c;SVB&#x201d;), under which the Company had a right to borrow from SVB up to
$3,000 bearing interest at a floating per annum rate equal to the Wall Street Journal Prime Rate plus 3.5% (upon occurrence of &#x2019;default
event&#x2019; as defined in the 2017 Loan Agreement, the Aggregate Loan Principal Amount shall bear interest at a rate per annum which is 5%
above the rate that is otherwise applicable thereto) which shall be payable monthly.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;In June 2018, the
Company drew down a cash amount in the aggregate principal amount of $3,000 (the &#x201c;Loan&#x201d;) payable in 36 equal installments
on a monthly basis commencing the following month after drawing down. The Loan is sometimes referred to herein as a &#x201c;straight loan&#x201d;.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;In connection with
the execution of the 2017 Loan Agreement, the Company issued to SVB a warrant to purchase over a period of 15-years from the issuance
date of the warrant (i) 41,040 Series C Convertible Preferred Shares at an exercise price of $5.12 per share or (ii) 41,040 shares to
be issued in the &#x2018;next round&#x2019; (as defined in the Agreement) at an exercise price equal to the lowest price per share at which the Company
will sell and issue shares of the Next Round Shares (the &#x201c;2017 Warrant&#x201d;).&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;Upon initial recognition,
the management by assistance of third-party appraiser allocated the net cash proceeds received based on the relative fair value of the
Loan and the detachable 2017 Warrant in total amount of $2,875 and $125, respectively. The amount allocated to the 2017 Warrant was classified
as a component of permanent equity (as their terms permit the holder to receive a fixed number of Ordinary Shares upon exercise for a
fixed exercise price) and the same amount was presented as a discount of the loan component.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;In subsequent periods,
the Loan is accounted for using the effective interest method over the Loan term, until its stated maturity. Consequently, the Company
recorded expenses amounting to $12 and $59 related to amortization of discount and interest expenses of the Loan under finance expenses
line in the consolidated Statement of Operations and Comprehensive Loss for the years ended December 31, 2022 and 2021, respectively.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;To secure its obligations
under the 2017 Loan Agreement, the Company provided a fixed and floating collateral on all its assets (including its intellectual property).&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;On April 15, 2020,
the Company entered into deferral agreement with SVB in connection with the 2017 Loan Agreement under which the original monthly repayment
date for the remaining principal due from May 2020 to October 2020 was extended by a period of six months commencing November 2020. However,
management has determined that such modification of terms does not represent extinguishment of the original Loan, as the Loan before and
after the modification was not considered as &#x201c;substantially different&#x201d; in accordance with the provisions of ASC 470-50.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;On April 29, 2021
(the &#x201c;Deferral Effective Date&#x201d;), the Company entered into a second deferral agreement in connection with the straight loan
made under the 2017 Loan Agreement with SVB, under which it was agreed that the original monthly repayment dates for the remaining balance
of the principal due from May 2021 to October 2021 (amounting to $667 as of that date) shall be extended by a period of six months commencing
November 2021. In consideration, the Company was required to (i) pay SVB a deferral facility fee equal to $50 which shall be fully earned
at the Deferral Effective Date, and payable in 10 monthly equal installments over the period commencing April 29, 2021 through January
29, 2022 (the &#x201c;Facility Fee&#x201d;); (ii) reimburse SVB for all reasonable legal fees and expenses incurred in connection with the
Deferral Agreement and (iii) issue SVB warrants to purchase 9,764 shares (the &#x201c;2021 Warrant&#x201d;) at an exercise price of $5.12
per share (subject to standard adjustments) over a period of 15-years at SVB&#x2019;s discretion into either to Series C Convertible Preferred
Shares or class of securities sold and issued by the Company in the next equity financing round (as determined in accordance with the
warrant agreement for the 2021 Warrant (the &#x201c;Warrant Agreement&#x201d;)) . If SVB exercises the 2021 Warrant and the Warrant Value
(as defined in and determined in the Warrant Agreement) will be lower than an amount of $50 (the &#x201c;Minimum Value&#x201d;), then immediately
following such exercise, the Company shall pay SVB an amount in cash equal to the difference between the Minimum Value and Warrant Value.
The 2021 Warrant was issued on April 29, 2021.&lt;/p&gt;&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.5in"/&gt;&lt;td style="width: 0.25in; text-align: left"&gt;1.&lt;/td&gt;&lt;td style="text-align: justify"&gt;(Cont.)&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.3pt; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;Upon the modification
of the terms under the 2017 Loan Agreement, the Company has considered the provisions of ASC 470-50 &#x201c;Debt - Modification or Extinguishment&#x201d;
(&#x201c;ASC 470-50&#x201d;), and based on such assessment, management has determined by using the assistance of a third-party appraiser
that the fair value of the modified loan (including the Facility Fee) plus the fair value of the 2021 Warrant granted are considered as
substantially different than the fair value of the original straight loan prior to the modification date. As per the provisions of ASC
470-50, it was determined that the modification represents an extinguishment of the original straight loan. Accordingly, the Company derecognized
the remaining balance of the original straight loan in the total amount of $672 and recorded an amount of $712 which represented the fair
value of the modified loan (including the Facility Fee) and the fair value of the issued 2021 Warrant in a total amount of $50 as non-current
financial liability as their terms permit the holders to receive a variable number of Ordinary Shares upon exercise and as such, the 2021
Warrant is subject to a minimum fair value mechanism. Changes in the estimated fair value of the 2021 Warrant are recognized each reporting
period under Financing Expenses, net in the consolidated Statement of Operations and Comprehensive Loss, until the 2021 Warrant is exercised
or expired, as earlier. See also Note 8.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.3pt; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;In June 2022, the
Loan was fully repaid.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.3pt; text-align: justify; text-indent: -0.25in"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"/&gt;&lt;td style="width: 0.25in"&gt;2.&lt;/td&gt;&lt;td style="text-align: justify"&gt;On February 17, 2022, the Company entered into a Loan and Securities Agreement (the &#x201c;2022 Loan Agreement&#x201d;)
with SVB, according to which commencing as of August 1, 2022 through December 31, 2022, SVB may, in its sole discretion in each instance,
pursuant to the Company&#x2019;s request, finance specific eligible accounts receivables of the Company, as determined in the 2022 Loan
Agreement, in a total amount equal to the face amount of the eligible account multiplied by a rate of 80%, subject to reduction by SVB
in its discretion (the &#x201c;Advance&#x201d;), provided that the aggregate amount of all outstanding Advances shall not exceed the lesser
of (i) an aggregate principal amount equal to $350, the (&#x201c;Revolving Line&#x201d;), or (ii) 80% of all eligible accounts minus the
sum of all outstanding principal amounts of any Advances, subject to reduction by SVB in its discretion. The outstanding principal amount
of any Advance shall accrue interest at a floating rate per annum equal to the greater of (i) 8.25% and (ii) a floating per annum rate
equal to the Wall Street Journal Prime Rate plus 5% (upon occurrence of a &#x2018;default event&#x2019; as defined in the 2022 Loan Agreement, the aggregate
loan principal amount shall bear interest at a rate per annum which is 5% above the rate that is otherwise applicable thereto). Interest
on the principal amount of each Advance will be payable in monthly arrears (i) on each the last day of each month and (ii) on December
31, 2022 (the &#x201c;Revolving Line Maturity Date&#x201d;). The security interest granted in the 2022 Loan Agreement shall at all times
continue to be a first priority preferred security interest in the collateral and a first priority fixed and floating charges.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.3pt; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;Upon making of the
initial Advance, the Company agreed to issue to SVB a warrant to purchase (i) 4,785 Series C Convertible Preferred Shares, or (ii) Ordinary
Shares in the event that the Company has listed its securities for trading on Nasdaq, or (iii) upon SVB&#x2019;s written irrevocable election
in its sole discretion, the same class and series, or other designation, of convertible preferred share or other senior equity security
sold and issued by the Company in the next equity financing over a 15-years period commencing the issuance date of such warrant, at an
exercise price of $5.12 per share, provided that if the class is the next equity financing securities, then the exercise price shall be
the lowest price per share for which next equity financing securities are sold or issued by the Company.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.3pt; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;On July 26, 2022,
the 2022 Loan Agreement was terminated, and all related collateral was released.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify; text-indent: -21.3pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0%"/&gt;&lt;td style="width: 0.5in"&gt;&lt;b&gt;B.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;Paycheck Protection Program Notes&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0in"&gt;On May 7, 2020 and
March 25, 2021, Beamr Inc. entered into separate Paycheck Protection Program Notes (the &#x201c;PPP Notes&#x201d;) with SVB under which
Beamr Inc. borrowed amounts of $75 and $54, respectively, (in aggregate the &#x201c;PPP Amount&#x201d;). The PPP Amount bears interest of
1.0% per annum. Beamr Inc. was required make a monthly payment of principal and interest on the applicable PPP Amount, each monthly payment
to be in equal amounts such that the applicable PPP Amount was fully amortized by the maturity date which was determined as 24 months
from the date of the first PPP Note or 60 months from the date of the second PPP Note. At any time, Beamr Inc. was entitled to fully prepay
the PPP Amount without payment of penalty or premium.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0in"&gt;The Company used
the PPP Amount for qualifying expenses which may be forgiven if it is utilized for qualifying expenses as described in the CARES Act.
In 2021, the PPP Amount was fully forgiven due to qualification for used expenses under the CARES Act and consequently the Company recorded
an amount of $129 under other income in the consolidated Statement of Operations and Comprehensive Loss for the year ended December 31,
2021.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0%"/&gt;&lt;td style="width: 0.5in"&gt;&lt;b&gt;C.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;Funding Agreement with IBI Spikes Ltd.&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0in"&gt;On July 7, 2022 (the
&#x201c;Effective Date&#x201d;), the Company entered into the Definitive Agreement with IBI Spikes Ltd. (the &#x201c;IBI&#x201d;), according
to which the Company received an amount of NIS 3.1 million (approximately $900) (the &#x201c;IBI Loan&#x201d;). The Company granted IBI
a right to receive consecutive monthly repayments equal to Net Cash Receipts multiplied by the Royalty Rate, as both defined in the Definitive
Agreement, until such time as IBI receives an amount equal to NIS 4,172,760 (approximately $1.2 million) (the &#x201c;Repayment Amount&#x201d;)
with any amount on account of the Repayment Amount which remains outstanding on the 42nd month anniversary of the later of (i) the Closing
Date, and (ii) the last payment provided by IBI (the &#x201c;Final Repayment Date&#x201d;) to be paid to IBI at such time. Notwithstanding
the above, Company&#x2019;s minimum annual payment during any Annual Calculation Period will not be less than the lower of (i) $330 and
(ii) the outstanding Repayment Amount in recent year.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0in"&gt;The Company may repay
the Repayment Amount at any time prior to the Final Repayment Date. If early repayment (such amount, the &#x201c;Payment Amount&#x201d;)
occurs prior to 12-month anniversary date of the Effective Date, then, a 50% discount will be applied on the outstanding difference between
the Repayment Amount and the Payment Amount (the &#x201c;Rev-Share Amount&#x201d;) component of the outstanding Repayment Amount; or if
early repayment occurs after 12-month anniversary date of the Closing Date but before 18-month anniversary date of the Closing Date, then,
a 35% discount will be applied on the outstanding Rev-Share Amount of the outstanding Repayment Amount (the &#x201c;Early Repayment Amount&#x201d;).&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0in"&gt;In case the Company
and/or its subsidiaries consummates a change of control, merger transaction, IPO (excluding an IPO on the Nasdaq Capital Market (the &#x201c;Nasdaq&#x201d;))
or sale of all or substantially all of assets (the &#x201c;Exit Event&#x201d;), the Company shall fully pay IBI the Repayment Amount or
the Early Repayment Amount, as the case may be.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0in"&gt;The Company incurred
non-refundable one-time fee of $13, reflecting 1.5% of the Payment Amount plus VAT.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0in"&gt;Upon making of the
Payment Amount, the Company issued warrant to IBI to purchase 65,563 of (i) the most senior class of shares outstanding or (ii) Ordinary
Shares in case of an exercise following to completion of an IPO transaction (the &#x201c;Warrant Share&#x201d;). The exercise price for
each of the Warrant Share, shall be as follows:&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"/&gt;&lt;td style="width: 0.25in"&gt;1.&lt;/td&gt;&lt;td style="text-align: justify"&gt;If financing round in consideration for an aggregate investment of at least $10,000 (including the Investment
Amount and any additional amount provided to the Company under any additional AIA) (the &#x201c;Qualified Financing&#x201d;) occurs within
12 months following the Effective Date consummates, the exercise price for each Warrant Share, will be the price per share in such Qualified
Financing, less a 20% discount and the shares type upon conversion of the Warrant Share shall have the same rights and preferences as
attached to the shares issued to the investors in such Qualified Financing. If transactions consummated in such closings are not on the
same terms and conditions and/or involve the issuance of more than one type of Company&#x2019;s securities, then, the shares type upon conversion
of the Warrant Share shall have the most favorable terms of such closing.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt; text-align: justify; text-indent: -21.25pt"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"/&gt;&lt;td style="width: 0.25in"&gt;2.&lt;/td&gt;&lt;td style="text-align: justify"&gt;If a Non-Qualified Financing occurs, IBI shall have the right but not the obligation to elect, by delivery
of written notice to the Company no later than 30 days from the receipt of a written notice from the Company setting forth the terms and
conditions of such Non-Qualified Financing, to determine that the exercise price for each Warrant Share, will be the price per share in
such Non-Qualified Financing, less a 20% discount and the shares type upon conversion of the Warrant Share shall have the same rights
and preferences as attached to the shares issued to the investors in such Non-Qualified Financing. If transactions consummated in such
closings are not on the same terms and conditions and/or involve the issuance of more than one type of Company&#x2019;s securities, then, the
shares type upon conversion of the Warrant Share shall have the most favorable terms of such closing.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt; text-align: justify; text-indent: -21.25pt"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"/&gt;&lt;td style="width: 0.25in"&gt;3.&lt;/td&gt;&lt;td style="text-align: justify"&gt;In the event the Company has not consummated (a Qualified Financing or an Realization Event (as defined
in the Definitive Agreement) within period of 12 months of the Effective Date of the Definitive Agreement, IBI shall have the right but
not the obligation to elect, by delivery of written notice to the Company no later than 30-days from the receipt of a written notice from
the Company, to determine that the exercise price for each Warrant Share will be based on Company value of $62,500 divided by the then
fully diluted number of Company shares and the shares type upon conversion of the Warrant Share shall have the same rights of the Company&#x2019;s
most senior class of shares then outstanding.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt; text-align: justify; text-indent: -21.25pt"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"/&gt;&lt;td style="width: 0.25in"&gt;4.&lt;/td&gt;&lt;td style="text-align: justify"&gt;In the event of Realization Event, the exercise price for each Warrant Share will be the price per share
in such Financing, less a 20% discount, and the shares type upon conversion of the Warrant Share shall have the Company&#x2019;s Most Senior
Shares, or Ordinary Shares in case the Realization Event is an IPO.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0in"&gt;Each Warrant Share
is exercisable until the earlier of (a) M&amp;amp;A, (b) IPO, or (c) a 10-years period from the issuance date and shall be in customary form
approved by IBI and shall contain standard and customary provisions.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0in"&gt;As the exercise price
of the Warrant Share will be determined based on the occurrence of one of the aforesaid trigger events, the Warrant Share was accounted
for as a derivative financial liability. (See note 8).&lt;/p&gt;&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0in"&gt;Pursuant to the above,
at the Effective Date, management by assistance of third-party appraiser allocated the IBI Loan to identified components as follows:&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;As of Closing Date&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 88%; text-align: left"&gt;Derivative warrant liability (see Note 8)&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&#160;&#160;&#160;&#160;&#160;78&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Straight loan&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;822&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Total gross consideration&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;900&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0in"&gt;Total incremental and direct debt costs of $1 and $12 were allocated to Warrant Share and straight loan, respectively, based on their
relative value at the Effective Date. The portion of issuance costs allocated to Warrant Share was recognized immediately as finance expenses
in the consolidated statements of operations and comprehensive loss and the portion of issuance costs allocated to straight loan was deducted
from the principal amount.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify; text-indent: -21.3pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0%"/&gt;&lt;td style="width: 0.5in"&gt;&lt;b&gt;D.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;The following tabular presentation reflects the reconciliation of the carrying amount of the Company&#x2019;s
loans during the years ended December 31, 2022, 2021:&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;b&gt;Year ended  December 31,&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2022&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2021&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2020&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left; text-indent: -14.15pt; padding-left: 14.15pt"&gt;Opening balance&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;508&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;1,069&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;1,469&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -14.15pt; padding-left: 14.15pt"&gt;Consideration received from PPP Note&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-55"&gt;-&lt;/div&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;54&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;75&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -14.15pt; padding-left: 14.15pt"&gt;Net consideration received from IBI Loan&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;887&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-56"&gt;-&lt;/div&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-57"&gt;-&lt;/div&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -14.15pt; padding-left: 14.15pt"&gt;Recognition of fair value of derivative warrant liability&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;(88&lt;/td&gt;
    &lt;td style="text-align: left"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-58"&gt;-&lt;/div&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-59"&gt;-&lt;/div&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -14.15pt; padding-left: 14.15pt"&gt;PPP Note forgiveness (see also Note 6B)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-60"&gt;-&lt;/div&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;(129&lt;/td&gt;
    &lt;td style="text-align: left"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-61"&gt;-&lt;/div&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -14.15pt; padding-left: 14.15pt"&gt;Amortization of discounts relating to straight loan (see also Note 13)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;14&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;14&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;29&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -14.15pt; padding-left: 14.15pt"&gt;Accrued interest expenses relating to straight loan (see also Note 13)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;77&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;45&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;91&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -14.15pt; padding-left: 14.15pt"&gt;Repayment of accrued interest relating to straight loan&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;(77&lt;/td&gt;
    &lt;td style="text-align: left"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;(45&lt;/td&gt;
    &lt;td style="text-align: left"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;(91&lt;/td&gt;
    &lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -14.15pt; padding-left: 14.15pt"&gt;Repayment of Facility Fee relating to straight loan&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;(10&lt;/td&gt;
    &lt;td style="text-align: left"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;(40&lt;/td&gt;
    &lt;td style="text-align: left"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-62"&gt;-&lt;/div&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -14.15pt; padding-left: 14.15pt"&gt;Repayment of principal relating to straight loans&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;(582&lt;/td&gt;
    &lt;td style="text-align: left"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;(500&lt;/td&gt;
    &lt;td style="text-align: left"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;(504&lt;/td&gt;
    &lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -14.15pt; padding-left: 14.15pt"&gt;Derecognition due to extinguishment of original straight loan&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-63"&gt;-&lt;/div&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;(672&lt;/td&gt;
    &lt;td style="text-align: left"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-64"&gt;-&lt;/div&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -14.15pt; padding-left: 14.15pt"&gt;Recognition subsequent to substantial modification of terms&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-65"&gt;-&lt;/div&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;712&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-66"&gt;-&lt;/div&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; text-indent: -14.15pt; padding-left: 14.15pt"&gt;Exchange rate differences&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(12&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-67"&gt;-&lt;/div&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-68"&gt;-&lt;/div&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 4pt; text-indent: -14.15pt; padding-left: 14.15pt"&gt;Closing balance&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;717&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;508&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;1,069&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0%"/&gt;&lt;td style="width: 0.5in"&gt;&lt;b&gt;E.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Maturity dates of outstanding loans:&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;b&gt;As of &lt;br/&gt;
December 31,&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2022&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2021&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left; text-indent: -14.15pt; padding-left: 14.15pt"&gt;First year (current maturities) (*)&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;164&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;508&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -14.15pt; padding-left: 14.15pt"&gt;Second year&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;288&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-69"&gt;-&lt;/div&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; text-indent: -14.15pt; padding-left: 14.15pt"&gt;Third year&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;265&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-70"&gt;-&lt;/div&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 4pt; text-indent: -14.15pt; padding-left: 14.15pt"&gt;Closing balance&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;717&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;508&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"/&gt;&lt;td style="width: 0.25in; text-align: left"&gt;(*)&lt;/td&gt;&lt;td style="text-align: justify"&gt;As described in Note 6C above, the Company is required to repay
each year a minimum amount of $330 with respect to Repayment Amount (principal and interest).&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c64" decimals="-3" unitRef="usd">3000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:ShortTermDebtPercentageBearingVariableInterestRate contextRef="c64" decimals="3" unitRef="pure">0.035</us-gaap:ShortTermDebtPercentageBearingVariableInterestRate>
    <us-gaap:LoansReceivableBasisSpreadOnVariableRate contextRef="c64" decimals="2" unitRef="pure">0.05</us-gaap:LoansReceivableBasisSpreadOnVariableRate>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c65" decimals="-3" unitRef="usd">3000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="c66" decimals="0" unitRef="shares">41040</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="c66" decimals="2" unitRef="usdPershares">5.12</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction contextRef="c67" decimals="0" unitRef="shares">41040</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:WarrantsAndRightsOutstanding contextRef="c68" decimals="-3" unitRef="usd">2875000</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:WarrantsAndRightsOutstanding contextRef="c69" decimals="-3" unitRef="usd">125000</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:AmortizationOfDebtDiscountPremium contextRef="c70" decimals="-3" unitRef="usd">12000</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfDebtDiscountPremium contextRef="c71" decimals="-3" unitRef="usd">59000</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c72" decimals="-3" unitRef="usd">667000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:LineOfCreditFacilityCommitmentFeeAmount contextRef="c73" decimals="-3" unitRef="usd">50000</us-gaap:LineOfCreditFacilityCommitmentFeeAmount>
    <us-gaap:DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1 contextRef="c74" decimals="0" unitRef="shares">9764</us-gaap:DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="c75" decimals="2" unitRef="usdPershares">5.12</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:FairValueAdjustmentOfWarrants contextRef="c76" decimals="-3" unitRef="usd">50000</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:LineOfCreditFacilityFairValueOfAmountOutstanding contextRef="c2" decimals="-3" unitRef="usd">672000</us-gaap:LineOfCreditFacilityFairValueOfAmountOutstanding>
    <us-gaap:LineOfCreditFacilityCollateralFeesAmount contextRef="c0" decimals="-3" unitRef="usd">712000</us-gaap:LineOfCreditFacilityCollateralFeesAmount>
    <us-gaap:FairValueAdjustmentOfWarrants contextRef="c0" decimals="-3" unitRef="usd">50000</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:InvestmentInterestRate contextRef="c77" decimals="2" unitRef="pure">0.80</us-gaap:InvestmentInterestRate>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c78" decimals="-3" unitRef="usd">350000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DerivativeFixedInterestRate contextRef="c78" decimals="2" unitRef="pure">0.80</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeFixedInterestRate contextRef="c79" decimals="4" unitRef="pure">0.0825</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeFixedInterestRate contextRef="c80" decimals="2" unitRef="pure">0.05</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:InvestmentInterestRate contextRef="c78" decimals="2" unitRef="pure">0.05</us-gaap:InvestmentInterestRate>
    <us-gaap:PreferredStockSharesIssued contextRef="c81" decimals="0" unitRef="shares">4785</us-gaap:PreferredStockSharesIssued>
    <us-gaap:WarrantExercisePriceIncrease contextRef="c0" decimals="2" unitRef="usdPershares">5.12</us-gaap:WarrantExercisePriceIncrease>
    <us-gaap:EquityMethodInvestmentAggregateCost contextRef="c82" decimals="-3" unitRef="usd">75000</us-gaap:EquityMethodInvestmentAggregateCost>
    <us-gaap:EquityMethodInvestmentAggregateCost contextRef="c83" decimals="-3" unitRef="usd">54000</us-gaap:EquityMethodInvestmentAggregateCost>
    <us-gaap:AccountsPayableInterestBearingInterestRate contextRef="c3" decimals="3" unitRef="pure">0.01</us-gaap:AccountsPayableInterestBearingInterestRate>
    <us-gaap:OtherIncome contextRef="c8" decimals="-3" unitRef="usd">129000</us-gaap:OtherIncome>
    <bmr:AgreementAmountReceived contextRef="c84" decimals="-5" unitRef="ils">3100000</bmr:AgreementAmountReceived>
    <bmr:AgreementAmountReceived contextRef="c84" decimals="-3" unitRef="usd">900000</bmr:AgreementAmountReceived>
    <us-gaap:ProceedsFromRoyaltiesReceived contextRef="c84" decimals="-3" unitRef="ils">4172760000</us-gaap:ProceedsFromRoyaltiesReceived>
    <us-gaap:ProceedsFromRoyaltiesReceived contextRef="c84" decimals="-5" unitRef="usd">1200000</us-gaap:ProceedsFromRoyaltiesReceived>
    <us-gaap:DebtInstrumentAnnualPrincipalPayment contextRef="c85" decimals="-3" unitRef="usd">330000</us-gaap:DebtInstrumentAnnualPrincipalPayment>
    <bmr:PercentageOfOutstandingRepaymentAndPaymentAmount contextRef="c0" decimals="2" unitRef="pure">0.50</bmr:PercentageOfOutstandingRepaymentAndPaymentAmount>
    <bmr:PercentageOfDiscountOutstanding contextRef="c0" decimals="2" unitRef="pure">0.35</bmr:PercentageOfDiscountOutstanding>
    <us-gaap:InterestAndFeeIncomeOtherLoans contextRef="c0" decimals="-3" unitRef="usd">13000</us-gaap:InterestAndFeeIncomeOtherLoans>
    <us-gaap:DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed contextRef="c86" decimals="3" unitRef="pure">0.015</us-gaap:DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed>
    <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="c2" decimals="0" unitRef="shares">65563</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:EquityMethodInvestmentAggregateCost contextRef="c2" decimals="0" unitRef="usd">10000</us-gaap:EquityMethodInvestmentAggregateCost>
    <us-gaap:LesseeFinanceLeaseDiscountRate contextRef="c87" decimals="2" unitRef="pure">0.20</us-gaap:LesseeFinanceLeaseDiscountRate>
    <us-gaap:LesseeFinanceLeaseDiscountRate contextRef="c2" decimals="2" unitRef="pure">0.20</us-gaap:LesseeFinanceLeaseDiscountRate>
    <us-gaap:StockIssuedDuringPeriodValueStockDividend contextRef="c0" decimals="-3" unitRef="usd">62500000</us-gaap:StockIssuedDuringPeriodValueStockDividend>
    <us-gaap:LesseeFinanceLeaseDiscountRate contextRef="c88" decimals="2" unitRef="pure">0.20</us-gaap:LesseeFinanceLeaseDiscountRate>
    <us-gaap:LoansHeldForSaleTerm contextRef="c2">P10Y</us-gaap:LoansHeldForSaleTerm>
    <bmr:ScheduleOfTheMemberEffectiveDateManagementByAssistanceOfThirdpartyTableTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;As of Closing Date&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 88%; text-align: left"&gt;Derivative warrant liability (see Note 8)&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&#160;&#160;&#160;&#160;&#160;78&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Straight loan&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;822&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Total gross consideration&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;900&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;</bmr:ScheduleOfTheMemberEffectiveDateManagementByAssistanceOfThirdpartyTableTextBlock>
    <bmr:DerivativeWarrantLiabilityseeNote8 contextRef="c2" decimals="-3" unitRef="usd">78000</bmr:DerivativeWarrantLiabilityseeNote8>
    <us-gaap:StraightLineRent contextRef="c0" decimals="-3" unitRef="usd">822000</us-gaap:StraightLineRent>
    <bmr:TotalGrossConsideration contextRef="c2" decimals="-3" unitRef="usd">900000</bmr:TotalGrossConsideration>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost contextRef="c0" decimals="-3" unitRef="usd">1000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost>
    <us-gaap:PaymentsOfLoanCosts contextRef="c0" decimals="-6" unitRef="usd">12000000</us-gaap:PaymentsOfLoanCosts>
    <bmr:ScheduleOfPresentationReflectsTheReconciliationOfTheCarryingAmountTableTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;b&gt;Year ended  December 31,&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2022&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2021&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2020&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left; text-indent: -14.15pt; padding-left: 14.15pt"&gt;Opening balance&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;508&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;1,069&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;1,469&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -14.15pt; padding-left: 14.15pt"&gt;Consideration received from PPP Note&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-55"&gt;-&lt;/div&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;54&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;75&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -14.15pt; padding-left: 14.15pt"&gt;Net consideration received from IBI Loan&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;887&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-56"&gt;-&lt;/div&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-57"&gt;-&lt;/div&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -14.15pt; padding-left: 14.15pt"&gt;Recognition of fair value of derivative warrant liability&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;(88&lt;/td&gt;
    &lt;td style="text-align: left"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-58"&gt;-&lt;/div&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-59"&gt;-&lt;/div&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -14.15pt; padding-left: 14.15pt"&gt;PPP Note forgiveness (see also Note 6B)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-60"&gt;-&lt;/div&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;(129&lt;/td&gt;
    &lt;td style="text-align: left"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-61"&gt;-&lt;/div&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -14.15pt; padding-left: 14.15pt"&gt;Amortization of discounts relating to straight loan (see also Note 13)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;14&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;14&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;29&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -14.15pt; padding-left: 14.15pt"&gt;Accrued interest expenses relating to straight loan (see also Note 13)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;77&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;45&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;91&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -14.15pt; padding-left: 14.15pt"&gt;Repayment of accrued interest relating to straight loan&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;(77&lt;/td&gt;
    &lt;td style="text-align: left"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;(45&lt;/td&gt;
    &lt;td style="text-align: left"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;(91&lt;/td&gt;
    &lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -14.15pt; padding-left: 14.15pt"&gt;Repayment of Facility Fee relating to straight loan&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;(10&lt;/td&gt;
    &lt;td style="text-align: left"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;(40&lt;/td&gt;
    &lt;td style="text-align: left"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-62"&gt;-&lt;/div&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -14.15pt; padding-left: 14.15pt"&gt;Repayment of principal relating to straight loans&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;(582&lt;/td&gt;
    &lt;td style="text-align: left"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;(500&lt;/td&gt;
    &lt;td style="text-align: left"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;(504&lt;/td&gt;
    &lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -14.15pt; padding-left: 14.15pt"&gt;Derecognition due to extinguishment of original straight loan&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-63"&gt;-&lt;/div&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;(672&lt;/td&gt;
    &lt;td style="text-align: left"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-64"&gt;-&lt;/div&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -14.15pt; padding-left: 14.15pt"&gt;Recognition subsequent to substantial modification of terms&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-65"&gt;-&lt;/div&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;712&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-66"&gt;-&lt;/div&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; text-indent: -14.15pt; padding-left: 14.15pt"&gt;Exchange rate differences&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(12&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-67"&gt;-&lt;/div&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-68"&gt;-&lt;/div&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 4pt; text-indent: -14.15pt; padding-left: 14.15pt"&gt;Closing balance&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;717&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;508&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;1,069&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;</bmr:ScheduleOfPresentationReflectsTheReconciliationOfTheCarryingAmountTableTextBlock>
    <bmr:ReconciliationOfTheCarryingAmount contextRef="c0" decimals="-3" unitRef="usd">508000</bmr:ReconciliationOfTheCarryingAmount>
    <bmr:ReconciliationOfTheCarryingAmount contextRef="c8" decimals="-3" unitRef="usd">1069000</bmr:ReconciliationOfTheCarryingAmount>
    <bmr:ReconciliationOfTheCarryingAmount contextRef="c9" decimals="-3" unitRef="usd">1469000</bmr:ReconciliationOfTheCarryingAmount>
    <bmr:ConsiderationReceivedFromPPPNote contextRef="c8" decimals="-3" unitRef="usd">54000</bmr:ConsiderationReceivedFromPPPNote>
    <bmr:ConsiderationReceivedFromPPPNote contextRef="c9" decimals="-3" unitRef="usd">75000</bmr:ConsiderationReceivedFromPPPNote>
    <bmr:NetConsiderationReceivedFromIBILoan contextRef="c0" decimals="-3" unitRef="usd">887000</bmr:NetConsiderationReceivedFromIBILoan>
    <us-gaap:DerivativeLiabilityFairValueOfCollateral contextRef="c2" decimals="-3" unitRef="usd">88000</us-gaap:DerivativeLiabilityFairValueOfCollateral>
    <us-gaap:DebtInstrumentDecreaseForgiveness contextRef="c8" decimals="-3" unitRef="usd">129000</us-gaap:DebtInstrumentDecreaseForgiveness>
    <us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments contextRef="c0" decimals="-3" unitRef="usd">14000</us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments>
    <us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments contextRef="c8" decimals="-3" unitRef="usd">14000</us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments>
    <us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments contextRef="c9" decimals="-3" unitRef="usd">29000</us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesFairValueDisclosure contextRef="c2" decimals="-3" unitRef="usd">77000</us-gaap:AccountsPayableAndAccruedLiabilitiesFairValueDisclosure>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesFairValueDisclosure contextRef="c3" decimals="-3" unitRef="usd">45000</us-gaap:AccountsPayableAndAccruedLiabilitiesFairValueDisclosure>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesFairValueDisclosure contextRef="c26" decimals="-3" unitRef="usd">91000</us-gaap:AccountsPayableAndAccruedLiabilitiesFairValueDisclosure>
    <us-gaap:RepaymentsOfDebt contextRef="c0" decimals="-3" unitRef="usd">77000</us-gaap:RepaymentsOfDebt>
    <us-gaap:RepaymentsOfDebt contextRef="c8" decimals="-3" unitRef="usd">45000</us-gaap:RepaymentsOfDebt>
    <us-gaap:RepaymentsOfDebt contextRef="c9" decimals="-3" unitRef="usd">91000</us-gaap:RepaymentsOfDebt>
    <us-gaap:LoanProcessingFee contextRef="c0" decimals="-3" unitRef="usd">10000</us-gaap:LoanProcessingFee>
    <us-gaap:LoanProcessingFee contextRef="c8" decimals="-3" unitRef="usd">40000</us-gaap:LoanProcessingFee>
    <us-gaap:RepaymentsOfOtherLongTermDebt contextRef="c0" decimals="-3" unitRef="usd">582000</us-gaap:RepaymentsOfOtherLongTermDebt>
    <us-gaap:RepaymentsOfOtherLongTermDebt contextRef="c8" decimals="-3" unitRef="usd">500000</us-gaap:RepaymentsOfOtherLongTermDebt>
    <us-gaap:RepaymentsOfOtherLongTermDebt contextRef="c9" decimals="-3" unitRef="usd">504000</us-gaap:RepaymentsOfOtherLongTermDebt>
    <us-gaap:ExtinguishmentOfDebtAmount contextRef="c8" decimals="-3" unitRef="usd">672000</us-gaap:ExtinguishmentOfDebtAmount>
    <bmr:RecognitionSubsequentToSubstantialModificationOfTerms contextRef="c8" decimals="-3" unitRef="usd">712000</bmr:RecognitionSubsequentToSubstantialModificationOfTerms>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential contextRef="c0" decimals="-3" unitRef="usd">12000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <bmr:ReconciliationOfCarryingAmount contextRef="c0" decimals="-3" unitRef="usd">717000</bmr:ReconciliationOfCarryingAmount>
    <bmr:ReconciliationOfCarryingAmount contextRef="c8" decimals="-3" unitRef="usd">508000</bmr:ReconciliationOfCarryingAmount>
    <bmr:ReconciliationOfCarryingAmount contextRef="c9" decimals="-3" unitRef="usd">1069000</bmr:ReconciliationOfCarryingAmount>
    <bmr:ScheduleOfMaturityDatesOfOutstandingLoanTableTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;b&gt;As of &lt;br/&gt;
December 31,&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2022&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2021&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left; text-indent: -14.15pt; padding-left: 14.15pt"&gt;First year (current maturities) (*)&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;164&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;508&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -14.15pt; padding-left: 14.15pt"&gt;Second year&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;288&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-69"&gt;-&lt;/div&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; text-indent: -14.15pt; padding-left: 14.15pt"&gt;Third year&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;265&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-70"&gt;-&lt;/div&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 4pt; text-indent: -14.15pt; padding-left: 14.15pt"&gt;Closing balance&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;717&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;508&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"/&gt;&lt;td style="width: 0.25in; text-align: left"&gt;(*)&lt;/td&gt;&lt;td style="text-align: justify"&gt;As described in Note 6C above, the Company is required to repay
each year a minimum amount of $330 with respect to Repayment Amount (principal and interest).&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;</bmr:ScheduleOfMaturityDatesOfOutstandingLoanTableTextBlock>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths contextRef="c2" decimals="-3" id="ix_0_fact" unitRef="usd">164000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths contextRef="c3" decimals="-3" id="ix_1_fact" unitRef="usd">508000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo contextRef="c2" decimals="-3" unitRef="usd">288000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree contextRef="c2" decimals="-3" unitRef="usd">265000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree>
    <us-gaap:LongTermDebt contextRef="c2" decimals="-3" unitRef="usd">717000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt contextRef="c3" decimals="-3" unitRef="usd">508000</us-gaap:LongTermDebt>
    <us-gaap:RepaymentsOfSecuredDebt contextRef="c0" decimals="-3" unitRef="usd">330000</us-gaap:RepaymentsOfSecuredDebt>
    <us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63.8pt; text-align: left; text-indent: -63.8pt"&gt;&lt;b&gt;NOTE 7 - OTHER
CURRENT LIABILITIES&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63.8pt; text-align: left; text-indent: -63.8pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;As of &lt;br/&gt;
December 31,&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2022&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2021&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left; text-indent: -14.15pt; padding-left: 14.15pt"&gt;Employees and payroll accruals&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;298&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;341&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -14.15pt; padding-left: 14.15pt"&gt;Accrued expenses (*)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;85&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;126&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; text-indent: -14.15pt; padding-left: 14.15pt"&gt;Government authorities&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;42&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;33&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 4pt; text-indent: -14.15pt; padding-left: 14.15pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;425&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;500&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"/&gt;&lt;td style="width: 0.25in; text-align: left"&gt;(*)&lt;/td&gt;&lt;td style="text-align: justify"&gt;Including accrued interest relating to straight loan amounted
to $11 as of December 31, 2022. See also Note 13.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;</us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock>
    <us-gaap:OtherCurrentLiabilitiesTableTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;As of &lt;br/&gt;
December 31,&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2022&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2021&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left; text-indent: -14.15pt; padding-left: 14.15pt"&gt;Employees and payroll accruals&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;298&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;341&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -14.15pt; padding-left: 14.15pt"&gt;Accrued expenses (*)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;85&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;126&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; text-indent: -14.15pt; padding-left: 14.15pt"&gt;Government authorities&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;42&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;33&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 4pt; text-indent: -14.15pt; padding-left: 14.15pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;425&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;500&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"/&gt;&lt;td style="width: 0.25in; text-align: left"&gt;(*)&lt;/td&gt;&lt;td style="text-align: justify"&gt;Including accrued interest relating to straight loan amounted
to $11 as of December 31, 2022. See also Note 13.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;</us-gaap:OtherCurrentLiabilitiesTableTextBlock>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="c2" decimals="-3" unitRef="usd">298000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="c3" decimals="-3" unitRef="usd">341000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent contextRef="c2" decimals="-3" id="ix_2_fact" unitRef="usd">85000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent contextRef="c3" decimals="-3" id="ix_3_fact" unitRef="usd">126000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <bmr:GovernmentAuthorities contextRef="c2" decimals="-3" unitRef="usd">42000</bmr:GovernmentAuthorities>
    <bmr:GovernmentAuthorities contextRef="c3" decimals="-3" unitRef="usd">33000</bmr:GovernmentAuthorities>
    <us-gaap:OtherLiabilitiesCurrent contextRef="c2" decimals="-3" unitRef="usd">425000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent contextRef="c3" decimals="-3" unitRef="usd">500000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:DepositLiabilitiesAccruedInterest contextRef="c2" decimals="-3" unitRef="usd">11000</us-gaap:DepositLiabilitiesAccruedInterest>
    <us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.65pt; text-align: left; text-indent: -5.65pt"&gt;&lt;b&gt;NOTE 8 - DERIVATIVE
WARRANTS LIABILITIES&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.65pt; text-align: left; text-indent: -5.65pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"&gt;The following tabular presentation
reflects the reconciliation of the fair value of derivative warrants liabilities during the years ended December 31, 2022, 2021 and 2020:&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -0.125in; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;Year ended  December 31,&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2022&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2021&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; width: 76%; text-align: left"&gt;Opening balance&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;50&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-71"&gt;-&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;Recognition of fair value of 2021 Warrant issued upon substantial modification of terms (see Note 6A1)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-72"&gt;&#160;&#160;&#160;&#160;&#160;&#160;-&lt;/div&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;50&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;Recognition of fair value of Warrant Share issued at Effective Date (see Note 6C)&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;88&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-73"&gt;-&lt;/div&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;Closing balance&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;138&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;50&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"&gt;The fair values of the 2021
Warrant and the Warrant Share were determined by the Company&#x2019;s management with the assistance of an independent valuation firm by using
the Hybrid Method by combining the OPM and an IPO scenario. Because there has been no public market for the Ordinary Shares, the Company&#x2019;s
management has determined fair value of the Ordinary Shares at the time of grant by considering several objective and subjective factors
including data from other comparable companies, the lack of liquidity of share capital and general and industry specific economic outlook,
amongst other factors. The fair value of the underlying Ordinary Shares shall be determined by management until such time as the Ordinary
Shares are listed on an established stock exchange, national market system or other quotation system.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"&gt;Through December 31, 2022, the
estimated fair values of derivative liability for the 2021 Warrant and Warrant Share have not changed significantly and the 2021 Warrant
and Warrant Share have not been exercised.&lt;/p&gt;</us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock>
    <us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -0.125in; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;Year ended  December 31,&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2022&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2021&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; width: 76%; text-align: left"&gt;Opening balance&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;50&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-71"&gt;-&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;Recognition of fair value of 2021 Warrant issued upon substantial modification of terms (see Note 6A1)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-72"&gt;&#160;&#160;&#160;&#160;&#160;&#160;-&lt;/div&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;50&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;Recognition of fair value of Warrant Share issued at Effective Date (see Note 6C)&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;88&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-73"&gt;-&lt;/div&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;Closing balance&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;138&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;50&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;</us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock>
    <us-gaap:DerivativeFairValueOfDerivativeNet contextRef="c3" decimals="-3" unitRef="usd">50000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet contextRef="c8" decimals="-3" unitRef="usd">50000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet>
    <us-gaap:AdjustmentOfWarrantsGrantedForServices contextRef="c0" decimals="-3" unitRef="usd">88000</us-gaap:AdjustmentOfWarrantsGrantedForServices>
    <us-gaap:DerivativeFairValueOfDerivativeNet contextRef="c2" decimals="-3" unitRef="usd">138000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFairValueOfDerivativeNet contextRef="c3" decimals="-3" unitRef="usd">50000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:InvestmentHoldingsTextBlock contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.65pt; text-align: left; text-indent: -5.65pt"&gt;&lt;b&gt;NOTE 9 - CONVERTIBLE
ADVANCE INVESTMENT&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.65pt; text-align: left; text-indent: -5.65pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"&gt;On August 25, 2021 and August
6, 2019, the Company entered into separate Advance Investment Agreements (the &#x201c;AIA&#x201d;) with several current shareholders (the
&#x201c;2021 AIA Investors&#x201d;, &#x201c;2019 AIA Investors&#x201d; and together the &#x201c;AIA Investors&#x201d;) under which the Company
raised an amount of $560 and $3,097, respectively, (together the &#x201c;AIA Investment Amounts&#x201d;) which is not interest bearing but
is eligible for conversion into shares of the Company, based on the following terms:&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify; text-indent: -21.3pt"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0%"/&gt;&lt;td style="width: 0.25in"&gt;1.&lt;/td&gt;&lt;td style="text-align: justify"&gt;In the event of a consummation by the Company of a transaction or series of related transactions in which
the Company issues preferred shares for an aggregate investment of at least $10,000 (including the AIA Investment Amounts and any additional
amount provided to the Company under any additional AIA Agreement(s)) (the &#x201c;AIA Qualifying Financing&#x201d;), the AIA Investment
Amounts shall automatically be converted immediately prior to the consummation of such Qualified Financing into such number of preferred
shares (or a sub-class thereof) issued in such Qualified Financing (the &#x201c;Next Round Shares&#x201d;), as is obtained by dividing the
AIA Investment Amounts by a price per share which shall reflect a 20% discount off the lowest price per share paid in the AIA Qualified
Financing.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify; text-indent: -21.3pt"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0%"/&gt;&lt;td style="width: 0.25in"&gt;2.&lt;/td&gt;&lt;td style="text-align: justify"&gt;In the event of a consummation by the Company of a transaction or series of related transactions in which
the Company issues preferred shares in consideration for an aggregate investment of less than $10,000 (including the AIA Investment Amounts
and any additional amount provided to the Company under any additional AIA Agreement(s)), or which for any other reason would not be deemed
as a AIA Qualified Financing (the &#x201c;AIA Non-Qualified Financing&#x201d;), then each time when the Company consummates such Non-Qualified
Financing, the AIA Investors shall have the right (but not the obligation) to elect to be converted immediately prior to the consummation
of such Non-Qualified Financing the AIA Investment Amounts into the shares and/or securities issued and sold at the closing of such Non-Qualified
Financing in accordance with 20% discount off the price per share paid in the Non-Qualified Financing.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify; text-indent: -21.3pt"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0%"/&gt;&lt;td style="width: 0.25in"&gt;3.&lt;/td&gt;&lt;td style="text-align: justify"&gt;In the event that the Company has not consummated a AIA Qualified Financing or an Exit Event (as defined
below) and the AIA Investment Amounts or any portion thereof has not been converted in accordance with the terms of the AIA Agreements
by August 26, 2022, then, the 2021 AIA Investors shall have the right (but not the obligation) to elect, by delivery of written notice
to the Company no later than 30 days from the receipt of a written notice from the Company, to convert their AIA Investment Amount into
such number of shares of the Company of the most senior class then outstanding (the &#x201c;Most Senior Shares&#x201d;), equal to the quotient
received by dividing their AIA Investment Amount by a price per share reflecting a pre-money valuation of the Company (determined on a
fully diluted basis as of the date of the conversion) of $62,500 (&#x201c;AIA Target Valuation&#x201d;).&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify; text-indent: -21.3pt"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0%"/&gt;&lt;td style="width: 0.25in"&gt;4.&lt;/td&gt;&lt;td style="text-align: justify"&gt;In the event of the consummation of an Acquisition or an Asset Transfer (as defined in the Company&#x2019;s Articles
of Association), each, an &#x201c;Exit Event&#x201d;, then immediately prior to the closing of such Acquisition or Asset Transfer, the AIA
Investors shall either elect, at its discretion, to (i) convert the AIA Investment Amounts into such number of Most Senior Shares, as
is obtained by dividing the AIA Investment Amounts by the quotient obtained by dividing (A) the AIA Target Valuation by (B) the issued
and outstanding share capital of the Company, on a fully diluted basis, as of immediately prior to the closing of the Acquisition or Asset
Transfer, as applicable, excluding any shares to be issued under the AIA Agreement); or (ii) receive, prior and in preference to payment
in respect of other Company securities, a redemption payment equal to 200% of the AIA Investment Amounts.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify; text-indent: -21.3pt"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0%"/&gt;&lt;td style="width: 0.25in"&gt;5.&lt;/td&gt;&lt;td style="text-align: justify"&gt;In connection with the effectiveness of the Company&#x2019;s initial public offering of its Ordinary Shares
on the Nasdaq (see Note 17), the AIA Investment Amounts automatically converted into Ordinary Shares at a conversion price equal to 80%
of the initial public offering price of $4.00.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"&gt;In addition to the mechanism
for the repayment of the investment through shares, subject to the scenarios set out above, the AIA Agreements provide that upon the occurrence
of certain bankruptcy related events, the Company will be required to pay the AIA Investors in cash the amount of their original investment.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"&gt;Moreover, upon entry into the
AIA, the Company entered into a subordination agreement under which the AIA Investors agreed that all of the Company&#x2019;s indebtedness
and obligations to the AIA Investors pursuant to the AIA is subordinated to all of the Company&#x2019;s indebtedness and obligations to
SVB under the Loan Agreement. See also Note 6A.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"&gt;As described in Note 2V, based
on the characteristics of the convertible advance investments (and its embedded derivatives), the Company elected to measure this liability
in its entirety, at its fair value (the &#x201c;Fair Value Option&#x201d;) in accordance with ASC 825-10, &#x201c;Financial Instruments&#x201d;
due to the existence of a certain redemption option and the potential requirement to recognize contingent BCF. Measurement of the fair
value of the convertible advance investments was classified as level 3 of the fair value hierarchy, using the scenario method.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"&gt;The following tabular presentation
reflects the reconciliation of the carrying amount of the convertible advance investment during the years ended December 31, 2022, 2021
and 2020:&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;b&gt;Year ended December 31,&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2022&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2021&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2020&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left; text-indent: -14.15pt; padding-left: 14.15pt"&gt;Opening balance&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;4,770&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;3,922&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;3,486&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -14.15pt; padding-left: 14.15pt"&gt;Net consideration received&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-74"&gt;-&lt;/div&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;560&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-75"&gt;-&lt;/div&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; text-indent: -14.15pt; padding-left: 14.15pt"&gt;Change in the fair value of convertible advance investments (see also Note 13)&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;70&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;288&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;436&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 4pt; text-indent: -14.15pt; padding-left: 14.15pt"&gt;Closing balance&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;4,840&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;4,770&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;3,922&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:InvestmentHoldingsTextBlock>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c89" decimals="-3" unitRef="usd">560000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c90" decimals="-3" unitRef="usd">3097000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:EquityMethodInvestmentAggregateCost contextRef="c91" decimals="-3" unitRef="usd">10000000</us-gaap:EquityMethodInvestmentAggregateCost>
    <us-gaap:DebtInstrumentRedemptionPricePercentage contextRef="c92" decimals="2" unitRef="pure">0.20</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <us-gaap:EquityMethodInvestmentAggregateCost contextRef="c93" decimals="-3" unitRef="usd">10000000</us-gaap:EquityMethodInvestmentAggregateCost>
    <us-gaap:DebtInstrumentRedemptionPricePercentage contextRef="c94" decimals="2" unitRef="pure">0.20</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <us-gaap:DebtConversionConvertedInstrumentAmount1 contextRef="c94" decimals="-3" unitRef="usd">62500000</us-gaap:DebtConversionConvertedInstrumentAmount1>
    <us-gaap:DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed contextRef="c0" decimals="2" unitRef="pure">2</us-gaap:DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed>
    <us-gaap:DebtConversionConvertedInstrumentRate contextRef="c0" decimals="2" unitRef="pure">0.80</us-gaap:DebtConversionConvertedInstrumentRate>
    <bmr:PublicOfferingPrice contextRef="c43" decimals="-1" unitRef="usdPershares">4000</bmr:PublicOfferingPrice>
    <us-gaap:InvestmentHoldingsScheduleOfInvestmentsTableTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;b&gt;Year ended December 31,&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2022&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2021&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2020&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left; text-indent: -14.15pt; padding-left: 14.15pt"&gt;Opening balance&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;4,770&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;3,922&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;3,486&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -14.15pt; padding-left: 14.15pt"&gt;Net consideration received&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-74"&gt;-&lt;/div&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;560&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-75"&gt;-&lt;/div&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; text-indent: -14.15pt; padding-left: 14.15pt"&gt;Change in the fair value of convertible advance investments (see also Note 13)&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;70&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;288&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;436&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 4pt; text-indent: -14.15pt; padding-left: 14.15pt"&gt;Closing balance&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;4,840&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;4,770&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;3,922&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:InvestmentHoldingsScheduleOfInvestmentsTableTextBlock>
    <us-gaap:ConvertibleDebtFairValueDisclosures contextRef="c3" decimals="-3" unitRef="usd">4770000</us-gaap:ConvertibleDebtFairValueDisclosures>
    <us-gaap:ConvertibleDebtFairValueDisclosures contextRef="c26" decimals="-3" unitRef="usd">3922000</us-gaap:ConvertibleDebtFairValueDisclosures>
    <us-gaap:ConvertibleDebtFairValueDisclosures contextRef="c15" decimals="-3" unitRef="usd">3486000</us-gaap:ConvertibleDebtFairValueDisclosures>
    <us-gaap:NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1 contextRef="c8" decimals="-3" unitRef="usd">560000</us-gaap:NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1>
    <bmr:ChangeInTheFairValueOfConvertibleAdvanceInvestments contextRef="c0" decimals="-3" unitRef="usd">70000</bmr:ChangeInTheFairValueOfConvertibleAdvanceInvestments>
    <bmr:ChangeInTheFairValueOfConvertibleAdvanceInvestments contextRef="c8" decimals="-3" unitRef="usd">288000</bmr:ChangeInTheFairValueOfConvertibleAdvanceInvestments>
    <bmr:ChangeInTheFairValueOfConvertibleAdvanceInvestments contextRef="c9" decimals="-3" unitRef="usd">436000</bmr:ChangeInTheFairValueOfConvertibleAdvanceInvestments>
    <us-gaap:ConvertibleDebtFairValueDisclosures contextRef="c2" decimals="-3" unitRef="usd">4840000</us-gaap:ConvertibleDebtFairValueDisclosures>
    <us-gaap:ConvertibleDebtFairValueDisclosures contextRef="c3" decimals="-3" unitRef="usd">4770000</us-gaap:ConvertibleDebtFairValueDisclosures>
    <us-gaap:ConvertibleDebtFairValueDisclosures contextRef="c26" decimals="-3" unitRef="usd">3922000</us-gaap:ConvertibleDebtFairValueDisclosures>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63.8pt; text-align: left; text-indent: -63.8pt"&gt;&lt;b&gt;NOTE 10 - COMMITMENTS
AND CONTINGENT LIABILITIES&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63.8pt; text-align: left; text-indent: -63.8pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0%"/&gt;&lt;td style="width: 0.5in"&gt;A.&lt;/td&gt;&lt;td style="text-align: justify"&gt;Lease commitments&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.3pt; text-align: justify; text-indent: -0.25in"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"/&gt;&lt;td style="width: 0.25in"&gt;1.&lt;/td&gt;&lt;td style="text-align: justify"&gt;On July 29, 2020, the Company entered into a lease agreement for premises with an unrelated party over
a period commencing August 24, 2020 through February 28, 2021, for a monthly rental fee amounted of NIS 18 (approximately $5.6).&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.3pt; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;In January 2021,
the Company renewed its lease agreement with an unrelated party for the period commencing March 1, 2021 through August 31, 2021 for a
monthly fee of NIS 17 thousand (approximately $5.3). In August 2021, the Company renewed its lease agreement with an unrelated party for
a further period commencing September 1, 2021 through February 28, 2022 for a monthly fee of NIS 21 thousand (approximately $6.5).&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.3pt; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;In February 2022,
the Company renewed its lease agreement with an unrelated party for a period commencing March 1, 2022 through August 31, 2022 for a monthly
fee of NIS 23 thousand (approximately $7.4). In August 2022, the Company renewed its lease agreement with an unrelated party for the period
commencing September 1, 2022 through August 31, 2023 for a monthly fee of NIS 25 thousand (approximately $7.1).&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.3pt; text-align: justify; text-indent: -0.25in"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"/&gt;&lt;td style="width: 0.25in"&gt;2.&lt;/td&gt;&lt;td style="text-align: justify"&gt;On November 1, 2020, Beamr Imaging RU entered into a lease agreement for premises with an unrelated party
over a period until September 30, 2021, for a monthly a rental fee of Russian Ruble 200 (approximately $3).&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.3pt; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;On October 1, 2021,
Beamr Imaging RU entered into a lease agreement for premises with an unrelated party over a period until August 30, 2022, for a monthly
a rental fee of Russian Ruble 213 (approximately $3). In September 2022, Beamr Imaging RU renewed its lease agreement for the period commencing
September 1, 2022 through July 31, 2023 for a monthly fee of Russian Ruble 213 (approximately $3).&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0in"&gt;As of December 31,
2022, the future minimum commitment under binding short-term operating lease agreements is as follows:&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Lease of&lt;br/&gt;
 premises&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 88%; text-align: left; padding-bottom: 1.5pt"&gt;2023&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"&gt;&#160;&#160;&#160;&#160;&#160;&#160;77&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 4pt; padding-left: 2.85pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;77&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0in"&gt;The payments above are associated with short-term operating leases of premises with a lease term of twelve months or less. As the Company
elected the short-term recognition exemption (see also Note 2I), such leases are out of scope of ASC 842 &#x201c;Leases&#x201d;. Consequently,
these payments are recognized on a straight-line basis as an operating expense in the Consolidated Statements of Operations and Comprehensive
Loss.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0in"&gt;During the years
ended December 31, 2022, 2021 and 2020, the total lease expenses were $119, $115 and $167, respectively.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify; text-indent: -21.3pt"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0%"/&gt;&lt;td style="width: 0.5in"&gt;B.&lt;/td&gt;&lt;td style="text-align: justify"&gt;Grant of share options upon completion of an IPO transaction&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0in"&gt;On March 14, 2022,
the Company&#x2019;s shareholders approved, among other matters, that upon completion of the IPO transaction, each of the member of the Company&#x2019;s
Board of Directors (except the Founder which serves inter alia as the Board chairman) will be entitled to 19,000 share options to purchase
the same number of Ordinary Shares at an exercise price that will be equal to the listing price per share over a vesting schedule on a
monthly basis over 36-months period commencing the listing date. However, as the grant is contingent upon a performance condition (successful
IPO) which is out of the Company&#x2019;s control, the related expenses will be recognized when the IPO will occur. Accordingly, compensation
cost relating to such obligation has not been recorded in 2022.&lt;/p&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:PaymentsForRent contextRef="c95" decimals="-3" unitRef="ils">18000</us-gaap:PaymentsForRent>
    <us-gaap:PaymentsForRent contextRef="c95" decimals="-2" unitRef="usd">5600</us-gaap:PaymentsForRent>
    <us-gaap:PaymentsForFees contextRef="c96" decimals="-3" unitRef="ils">17000</us-gaap:PaymentsForFees>
    <us-gaap:PaymentsForFees contextRef="c96" decimals="-2" unitRef="usd">5300</us-gaap:PaymentsForFees>
    <us-gaap:PaymentsForFees contextRef="c97" decimals="-3" unitRef="ils">21000</us-gaap:PaymentsForFees>
    <us-gaap:PaymentsForFees contextRef="c97" decimals="-2" unitRef="usd">6500</us-gaap:PaymentsForFees>
    <us-gaap:PaymentsForFees contextRef="c98" decimals="-3" unitRef="ils">23000</us-gaap:PaymentsForFees>
    <us-gaap:PaymentsForFees contextRef="c98" decimals="-2" unitRef="usd">7400</us-gaap:PaymentsForFees>
    <us-gaap:PaymentsForFees contextRef="c99" decimals="-3" unitRef="ils">25000</us-gaap:PaymentsForFees>
    <us-gaap:PaymentsForFees contextRef="c99" decimals="-2" unitRef="usd">7100</us-gaap:PaymentsForFees>
    <us-gaap:PaymentsForFees contextRef="c100" decimals="-3" unitRef="usd">3000</us-gaap:PaymentsForFees>
    <us-gaap:PaymentsForFees contextRef="c101" decimals="-3" unitRef="usd">3000</us-gaap:PaymentsForFees>
    <bmr:scheduleOfFutureMinimumCommitmentUnderBindingLeaseAgreeementsTableTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Lease of&lt;br/&gt;
 premises&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 88%; text-align: left; padding-bottom: 1.5pt"&gt;2023&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"&gt;&#160;&#160;&#160;&#160;&#160;&#160;77&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 4pt; padding-left: 2.85pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;77&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;</bmr:scheduleOfFutureMinimumCommitmentUnderBindingLeaseAgreeementsTableTextBlock>
    <bmr:LesseeOperatingLeasesLiabilityPaymentsDueNextTwelveMonths contextRef="c2" decimals="-3" unitRef="usd">77000</bmr:LesseeOperatingLeasesLiabilityPaymentsDueNextTwelveMonths>
    <bmr:LesseeOperatingLeasesLiabilityPaymentsDue contextRef="c2" decimals="-3" unitRef="usd">77000</bmr:LesseeOperatingLeasesLiabilityPaymentsDue>
    <us-gaap:LeaseCost contextRef="c0" decimals="-3" unitRef="usd">119000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost contextRef="c8" decimals="-3" unitRef="usd">115000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost contextRef="c9" decimals="-3" unitRef="usd">167000</us-gaap:LeaseCost>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber contextRef="c102" decimals="0" unitRef="shares">19000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"&gt;&lt;b&gt;NOTE 11 - SHAREHOLDERS&#x2019; EQUITY
(DEFICIT)&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Composition of shareholders&#x2019; equity (deficit):&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;As of &lt;br/&gt; December 31, 2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;As of &lt;br/&gt; December 31, 2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Authorized&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Issued and&lt;br/&gt; outstanding&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Authorized&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Issued and&lt;br/&gt; outstanding&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Number of shares&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;Shares of NIS&#160;0.05 par value:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; text-align: left"&gt;Series Ordinary Shares (A)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;14,307,116&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;2,578,760&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;14,316,880&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;2,578,760&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Series Convertible Ordinary 1 Shares (B)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;607,680&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;607,680&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;607,680&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;607,680&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Series Convertible Ordinary 2 Shares (B)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;889,200&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;889,200&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;889,200&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;889,200&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Series Convertible B Preferred Shares (B)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,047,200&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,047,200&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,047,200&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,047,200&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Series Convertible B1 Preferred Shares B)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;738,240&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;738,240&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;738,240&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;738,240&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Series Convertible C Preferred Shares (B)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;3,410,564&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;2,928,960&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;3,400,800&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;2,928,960&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 4pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;22,000,000&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;9,790,040&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;22,000,000&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;9,790,040&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.3pt; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"/&gt;&lt;td style="width: 0.25in; text-align: left"&gt;A.&lt;/td&gt;&lt;td style="text-align: justify"&gt;The Ordinary Shares confer upon the holders thereof all rights
accruing to a shareholder of the Company, as provided in the Company&#x2019;s Articles of Association (the &#x201c;Articles&#x201d;), including,
without limitation, the right to receive notices of, and to attend, all general meetings, the right to vote thereat with each Ordinary
Share held entitling the holder thereof to one vote at all general meetings (and written actions in lieu of meetings), the right to participate
and share on a per share basis, in any distribution and in distribution of surplus assets and funds of the Company in the event of a
liquidation event, and certain other rights as may be expressly provided for herein or under the Companies Law. All Ordinary Shares rank
pari passu amongst themselves for all intents and purposes, including, without limitation, in relation to the amounts of capital paid
or credited as paid on their nominal value. The voting, dividend and liquidation rights of the holders of Ordinary Shares are subject
to and qualified by the rights, powers and preferences of the holders of the Convertible Preferred Shares and the Convertible Ordinary
1 and 2 Shares as set below.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify; text-indent: -21.3pt"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"/&gt;&lt;td style="width: 0.25in; text-align: left"&gt;B.&lt;/td&gt;&lt;td style="text-align: justify"&gt;The Convertible Ordinary 1 Shares, Convertible Ordinary 2 Shares,
Convertible B Preferred Shares, Convertible B1 Preferred Shares and the Convertible C Preferred Shares (referring together herein as
&#x201c;Convertible Preferred Shares&#x201d;) shall confer upon the holders thereof all rights conferred upon the holders of Ordinary Shares
in the Company. In addition, the holders of Convertible Preferred Shares shall have rights, preferences and privileges, as follows:&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;Liquidation preference&#160;- Based
on preference of distribution, in the event of any liquidation, dissolution or winding up of the Company, whether voluntary or involuntary,
change in control or distribution, the Company&#x2019;s assets or surplus funds legally available for distribution shall be distributed to the
holders of Convertible Preferred Shares pursuant to which each Convertible Preferred Share will be entitled to receive 1.2 of the applicable
original issue price paid by each Convertible Preferred shareholder plus all accrued but unpaid dividends and less the aggregate of all
amounts previously paid in preference. The aggregate liquidation preference of all shares with preferences over Ordinary Shares as of
December&#160;31, 2022 and 2021 amounted to $33,785. None of the foregoing dollar amounts include dividends, as the Board of Directors
has not declared any dividends since inception.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;The Convertible Preferred Shares have
been classified as part of the permanent equity of the Company since upon occurrence of liquidation event all holder of the Ordinary Shares
and the Convertible Preferred Shares will be entitled to receive the same form of consideration.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;Voting&#160;- Each shareholder shall
have one vote for each Ordinary Share held by such shareholder of record or such Ordinary Shares as would be held by each holder of Convertible
Preferred Share if all Convertible Preferred Shares were converted to Ordinary Shares at the then effective conversion rate, on every
resolution.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;Conversion&#160;- Each holder of a
Convertible Preferred Share shall be entitled to convert, at any time and from time to time, and without payment of additional consideration,
into such number of fully paid and non-assessable shares of Ordinary Share in ratio as determined in the Articles, which initially shall
be one to one. The conversion price initially shall be the applicable Original Issue Price subject to adjustments as describe in the Articles.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;All outstanding Convertible Preferred
Shares shall automatically be converted into Ordinary Shares at the then-effective conversion rate applicable upon the earlier of (i)
closing of sale of Ordinary Shares in an initial firm-commitment underwritten public offering, with net proceeds to the Company of $50,000
and at an offering price per share equal to at least 5 times the Preferred C Original Issue Price (Qualified IPO) or (ii) affirmative
vote or written consent of majority shareholders of the then outstanding Convertible Preferred Shares, with respect to each series.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0%"/&gt;&lt;td style="width: 0.5in"&gt;C.&lt;/td&gt;&lt;td style="text-align: justify"&gt;On March 14, 2022, the Company&#x2019;s shareholders approved, among other matters, the following matters as
were originally approved by the Company&#x2019;s Board of Directors on March&#160;1, 2022&#160;-&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify; text-indent: -21.3pt"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"/&gt;&lt;td style="width: 0.25in"&gt;1.&lt;/td&gt;&lt;td style="text-align: justify"&gt;In connection with listing of the Company&#x2019;s Ordinary Shares on
Nasdaq, increase the Company&#x2019;s authorized shares from 22,000,000 to 222,000,000.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt; text-align: justify; text-indent: -21.25pt"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"/&gt;&lt;td style="width: 0.25in"&gt;2.&lt;/td&gt;&lt;td style="text-align: justify"&gt;Approve and ratify (i) subject to the listing of the Company&#x2019;s Ordinary Shares on Nasdaq, the voluntary
conversion of all the Ordinary 1, Ordinary 2, Preferred B, Preferred B-1 and Preferred B shares of the Company into Ordinary Shares (collectively,
the &#x201c;Voluntary Conversion&#x201d;), (ii) subject to the listing of the Company&#x2019;s Ordinary Shares on Nasdaq, a reverse share
split of all outstanding Ordinary Shares of the Company at a ratio of 5:1 so that each 5 ordinary shares nominal value NIS 0.01 each shall
be consolidated into 1 Ordinary Share each, and (the &#x201c;Reverse Share Split&#x201d;) (iii) subject to the listing of the Company&#x2019;s
Ordinary Shares on Nasdaq, the recapitalization and redistribution of the entire share capital of the Company (the &#x201c;Recapitalization&#x201d;),
so that following such Voluntary Conversion and Recapitalization, the share capital of the Company shall consist of NIS 11,100,000 divided
into 222,000,000 Ordinary Shares each of which 9,790,040 are issued and outstanding (post the aforesaid Reverse Share Split).&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt; text-align: justify; text-indent: -21.25pt"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify"&gt;For accounting purposes, following
the completion of the IPO transaction as noted in Note 17 below, all shares, options and warrants to purchase Ordinary Shares and loss
per share amounts have been adjusted to give retroactive effect to the Reverse Share Split for all periods presented in these consolidated
financial statements. Any fractional shares resulting from the Reverse Share Split were rounded up to the nearest whole share.&lt;/p&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:ScheduleOfStockholdersEquityTableTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;As of &lt;br/&gt; December 31, 2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;As of &lt;br/&gt; December 31, 2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Authorized&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Issued and&lt;br/&gt; outstanding&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Authorized&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Issued and&lt;br/&gt; outstanding&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Number of shares&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;Shares of NIS&#160;0.05 par value:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; text-align: left"&gt;Series Ordinary Shares (A)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;14,307,116&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;2,578,760&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;14,316,880&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;2,578,760&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Series Convertible Ordinary 1 Shares (B)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;607,680&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;607,680&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;607,680&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;607,680&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Series Convertible Ordinary 2 Shares (B)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;889,200&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;889,200&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;889,200&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;889,200&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Series Convertible B Preferred Shares (B)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,047,200&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,047,200&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,047,200&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,047,200&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Series Convertible B1 Preferred Shares B)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;738,240&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;738,240&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;738,240&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;738,240&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Series Convertible C Preferred Shares (B)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;3,410,564&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;2,928,960&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;3,400,800&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;2,928,960&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 4pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;22,000,000&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;9,790,040&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;22,000,000&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;9,790,040&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.3pt; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"/&gt;&lt;td style="width: 0.25in; text-align: left"&gt;A.&lt;/td&gt;&lt;td style="text-align: justify"&gt;The Ordinary Shares confer upon the holders thereof all rights
accruing to a shareholder of the Company, as provided in the Company&#x2019;s Articles of Association (the &#x201c;Articles&#x201d;), including,
without limitation, the right to receive notices of, and to attend, all general meetings, the right to vote thereat with each Ordinary
Share held entitling the holder thereof to one vote at all general meetings (and written actions in lieu of meetings), the right to participate
and share on a per share basis, in any distribution and in distribution of surplus assets and funds of the Company in the event of a
liquidation event, and certain other rights as may be expressly provided for herein or under the Companies Law. All Ordinary Shares rank
pari passu amongst themselves for all intents and purposes, including, without limitation, in relation to the amounts of capital paid
or credited as paid on their nominal value. The voting, dividend and liquidation rights of the holders of Ordinary Shares are subject
to and qualified by the rights, powers and preferences of the holders of the Convertible Preferred Shares and the Convertible Ordinary
1 and 2 Shares as set below.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify; text-indent: -21.3pt"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"/&gt;&lt;td style="width: 0.25in; text-align: left"&gt;B.&lt;/td&gt;&lt;td style="text-align: justify"&gt;The Convertible Ordinary 1 Shares, Convertible Ordinary 2 Shares,
Convertible B Preferred Shares, Convertible B1 Preferred Shares and the Convertible C Preferred Shares (referring together herein as
&#x201c;Convertible Preferred Shares&#x201d;) shall confer upon the holders thereof all rights conferred upon the holders of Ordinary Shares
in the Company. In addition, the holders of Convertible Preferred Shares shall have rights, preferences and privileges, as follows:&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;Liquidation preference&#160;- Based
on preference of distribution, in the event of any liquidation, dissolution or winding up of the Company, whether voluntary or involuntary,
change in control or distribution, the Company&#x2019;s assets or surplus funds legally available for distribution shall be distributed to the
holders of Convertible Preferred Shares pursuant to which each Convertible Preferred Share will be entitled to receive 1.2 of the applicable
original issue price paid by each Convertible Preferred shareholder plus all accrued but unpaid dividends and less the aggregate of all
amounts previously paid in preference. The aggregate liquidation preference of all shares with preferences over Ordinary Shares as of
December&#160;31, 2022 and 2021 amounted to $33,785. None of the foregoing dollar amounts include dividends, as the Board of Directors
has not declared any dividends since inception.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;The Convertible Preferred Shares have
been classified as part of the permanent equity of the Company since upon occurrence of liquidation event all holder of the Ordinary Shares
and the Convertible Preferred Shares will be entitled to receive the same form of consideration.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;Voting&#160;- Each shareholder shall
have one vote for each Ordinary Share held by such shareholder of record or such Ordinary Shares as would be held by each holder of Convertible
Preferred Share if all Convertible Preferred Shares were converted to Ordinary Shares at the then effective conversion rate, on every
resolution.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;Conversion&#160;- Each holder of a
Convertible Preferred Share shall be entitled to convert, at any time and from time to time, and without payment of additional consideration,
into such number of fully paid and non-assessable shares of Ordinary Share in ratio as determined in the Articles, which initially shall
be one to one. The conversion price initially shall be the applicable Original Issue Price subject to adjustments as describe in the Articles.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;All outstanding Convertible Preferred
Shares shall automatically be converted into Ordinary Shares at the then-effective conversion rate applicable upon the earlier of (i)
closing of sale of Ordinary Shares in an initial firm-commitment underwritten public offering, with net proceeds to the Company of $50,000
and at an offering price per share equal to at least 5 times the Preferred C Original Issue Price (Qualified IPO) or (ii) affirmative
vote or written consent of majority shareholders of the then outstanding Convertible Preferred Shares, with respect to each series.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0%"/&gt;&lt;td style="width: 0.5in"&gt;C.&lt;/td&gt;&lt;td style="text-align: justify"&gt;On March 14, 2022, the Company&#x2019;s shareholders approved, among other matters, the following matters as
were originally approved by the Company&#x2019;s Board of Directors on March&#160;1, 2022&#160;-&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify; text-indent: -21.3pt"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"/&gt;&lt;td style="width: 0.25in"&gt;1.&lt;/td&gt;&lt;td style="text-align: justify"&gt;In connection with listing of the Company&#x2019;s Ordinary Shares on
Nasdaq, increase the Company&#x2019;s authorized shares from 22,000,000 to 222,000,000.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt; text-align: justify; text-indent: -21.25pt"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"/&gt;&lt;td style="width: 0.25in"&gt;2.&lt;/td&gt;&lt;td style="text-align: justify"&gt;Approve and ratify (i) subject to the listing of the Company&#x2019;s Ordinary Shares on Nasdaq, the voluntary
conversion of all the Ordinary 1, Ordinary 2, Preferred B, Preferred B-1 and Preferred B shares of the Company into Ordinary Shares (collectively,
the &#x201c;Voluntary Conversion&#x201d;), (ii) subject to the listing of the Company&#x2019;s Ordinary Shares on Nasdaq, a reverse share
split of all outstanding Ordinary Shares of the Company at a ratio of 5:1 so that each 5 ordinary shares nominal value NIS 0.01 each shall
be consolidated into 1 Ordinary Share each, and (the &#x201c;Reverse Share Split&#x201d;) (iii) subject to the listing of the Company&#x2019;s
Ordinary Shares on Nasdaq, the recapitalization and redistribution of the entire share capital of the Company (the &#x201c;Recapitalization&#x201d;),
so that following such Voluntary Conversion and Recapitalization, the share capital of the Company shall consist of NIS 11,100,000 divided
into 222,000,000 Ordinary Shares each of which 9,790,040 are issued and outstanding (post the aforesaid Reverse Share Split).&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt; text-align: justify; text-indent: -21.25pt"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify"&gt;For accounting purposes, following
the completion of the IPO transaction as noted in Note 17 below, all shares, options and warrants to purchase Ordinary Shares and loss
per share amounts have been adjusted to give retroactive effect to the Reverse Share Split for all periods presented in these consolidated
financial statements. Any fractional shares resulting from the Reverse Share Split were rounded up to the nearest whole share.&lt;/p&gt;</us-gaap:ScheduleOfStockholdersEquityTableTextBlock>
    <us-gaap:ExcessStockSharesAuthorized
      contextRef="c103"
      decimals="INF"
      id="ix_4_fact"
      unitRef="shares">14307116</us-gaap:ExcessStockSharesAuthorized>
    <bmr:ExcessSharesIssuedAndOutstandingShares
      contextRef="c103"
      decimals="0"
      id="ix_5_fact"
      unitRef="shares">2578760</bmr:ExcessSharesIssuedAndOutstandingShares>
    <us-gaap:ExcessStockSharesAuthorized
      contextRef="c104"
      decimals="INF"
      id="ix_6_fact"
      unitRef="shares">14316880</us-gaap:ExcessStockSharesAuthorized>
    <bmr:ExcessSharesIssuedAndOutstandingShares
      contextRef="c104"
      decimals="0"
      id="ix_7_fact"
      unitRef="shares">2578760</bmr:ExcessSharesIssuedAndOutstandingShares>
    <us-gaap:ExcessStockSharesAuthorized
      contextRef="c105"
      decimals="INF"
      id="ix_8_fact"
      unitRef="shares">607680</us-gaap:ExcessStockSharesAuthorized>
    <bmr:ExcessSharesIssuedAndOutstandingShares
      contextRef="c105"
      decimals="0"
      id="ix_9_fact"
      unitRef="shares">607680</bmr:ExcessSharesIssuedAndOutstandingShares>
    <us-gaap:ExcessStockSharesAuthorized
      contextRef="c106"
      decimals="INF"
      id="ix_10_fact"
      unitRef="shares">607680</us-gaap:ExcessStockSharesAuthorized>
    <bmr:ExcessSharesIssuedAndOutstandingShares
      contextRef="c106"
      decimals="0"
      id="ix_11_fact"
      unitRef="shares">607680</bmr:ExcessSharesIssuedAndOutstandingShares>
    <us-gaap:ExcessStockSharesAuthorized
      contextRef="c107"
      decimals="INF"
      id="ix_12_fact"
      unitRef="shares">889200</us-gaap:ExcessStockSharesAuthorized>
    <bmr:ExcessSharesIssuedAndOutstandingShares
      contextRef="c107"
      decimals="0"
      id="ix_13_fact"
      unitRef="shares">889200</bmr:ExcessSharesIssuedAndOutstandingShares>
    <us-gaap:ExcessStockSharesAuthorized
      contextRef="c108"
      decimals="INF"
      id="ix_14_fact"
      unitRef="shares">889200</us-gaap:ExcessStockSharesAuthorized>
    <bmr:ExcessSharesIssuedAndOutstandingShares
      contextRef="c108"
      decimals="0"
      id="ix_15_fact"
      unitRef="shares">889200</bmr:ExcessSharesIssuedAndOutstandingShares>
    <us-gaap:ExcessStockSharesAuthorized
      contextRef="c109"
      decimals="INF"
      id="ix_16_fact"
      unitRef="shares">2047200</us-gaap:ExcessStockSharesAuthorized>
    <bmr:ExcessSharesIssuedAndOutstandingShares
      contextRef="c109"
      decimals="0"
      id="ix_17_fact"
      unitRef="shares">2047200</bmr:ExcessSharesIssuedAndOutstandingShares>
    <us-gaap:ExcessStockSharesAuthorized
      contextRef="c110"
      decimals="INF"
      id="ix_18_fact"
      unitRef="shares">2047200</us-gaap:ExcessStockSharesAuthorized>
    <bmr:ExcessSharesIssuedAndOutstandingShares
      contextRef="c110"
      decimals="0"
      id="ix_19_fact"
      unitRef="shares">2047200</bmr:ExcessSharesIssuedAndOutstandingShares>
    <us-gaap:ExcessStockSharesAuthorized
      contextRef="c111"
      decimals="INF"
      id="ix_20_fact"
      unitRef="shares">738240</us-gaap:ExcessStockSharesAuthorized>
    <bmr:ExcessSharesIssuedAndOutstandingShares
      contextRef="c111"
      decimals="0"
      id="ix_21_fact"
      unitRef="shares">738240</bmr:ExcessSharesIssuedAndOutstandingShares>
    <us-gaap:ExcessStockSharesAuthorized
      contextRef="c112"
      decimals="INF"
      id="ix_22_fact"
      unitRef="shares">738240</us-gaap:ExcessStockSharesAuthorized>
    <bmr:ExcessSharesIssuedAndOutstandingShares
      contextRef="c112"
      decimals="0"
      id="ix_23_fact"
      unitRef="shares">738240</bmr:ExcessSharesIssuedAndOutstandingShares>
    <us-gaap:ExcessStockSharesAuthorized
      contextRef="c113"
      decimals="INF"
      id="ix_24_fact"
      unitRef="shares">3410564</us-gaap:ExcessStockSharesAuthorized>
    <bmr:ExcessSharesIssuedAndOutstandingShares
      contextRef="c113"
      decimals="0"
      id="ix_25_fact"
      unitRef="shares">2928960</bmr:ExcessSharesIssuedAndOutstandingShares>
    <us-gaap:ExcessStockSharesAuthorized
      contextRef="c114"
      decimals="INF"
      id="ix_26_fact"
      unitRef="shares">3400800</us-gaap:ExcessStockSharesAuthorized>
    <bmr:ExcessSharesIssuedAndOutstandingShares
      contextRef="c114"
      decimals="0"
      id="ix_27_fact"
      unitRef="shares">2928960</bmr:ExcessSharesIssuedAndOutstandingShares>
    <us-gaap:ExcessStockSharesAuthorized contextRef="c2" decimals="INF" unitRef="shares">22000000</us-gaap:ExcessStockSharesAuthorized>
    <bmr:ExcessSharesIssuedAndOutstandingShares contextRef="c2" decimals="0" unitRef="shares">9790040</bmr:ExcessSharesIssuedAndOutstandingShares>
    <us-gaap:ExcessStockSharesAuthorized contextRef="c3" decimals="INF" unitRef="shares">22000000</us-gaap:ExcessStockSharesAuthorized>
    <bmr:ExcessSharesIssuedAndOutstandingShares contextRef="c3" decimals="0" unitRef="shares">9790040</bmr:ExcessSharesIssuedAndOutstandingShares>
    <us-gaap:PreferredStockConvertibleConversionPrice contextRef="c2" decimals="1" unitRef="usdPershares">1.2</us-gaap:PreferredStockConvertibleConversionPrice>
    <us-gaap:PreferredStockAmountOfPreferredDividendsInArrears contextRef="c8" decimals="-3" unitRef="usd">33785000</us-gaap:PreferredStockAmountOfPreferredDividendsInArrears>
    <us-gaap:PreferredStockAmountOfPreferredDividendsInArrears contextRef="c0" decimals="-3" unitRef="usd">33785000</us-gaap:PreferredStockAmountOfPreferredDividendsInArrears>
    <us-gaap:ProceedsFromDebtNetOfIssuanceCosts contextRef="c0" decimals="-3" unitRef="usd">50000000</us-gaap:ProceedsFromDebtNetOfIssuanceCosts>
    <us-gaap:ExcessStockSharesAuthorized contextRef="c69" decimals="0" unitRef="shares">22000000</us-gaap:ExcessStockSharesAuthorized>
    <us-gaap:ExcessStockSharesAuthorized contextRef="c68" decimals="0" unitRef="shares">222000000</us-gaap:ExcessStockSharesAuthorized>
    <bmr:VoluntaryConversionDescription contextRef="c0">subject to the listing of the Company&#x2019;s Ordinary Shares on Nasdaq, the voluntary
conversion of all the Ordinary 1, Ordinary 2, Preferred B, Preferred B-1 and Preferred B shares of the Company into Ordinary Shares (collectively,
the &#x201c;Voluntary Conversion&#x201d;), (ii) subject to the listing of the Company&#x2019;s Ordinary Shares on Nasdaq, a reverse share
split of all outstanding Ordinary Shares of the Company at a ratio of 5:1 so that each 5 ordinary shares nominal value NIS 0.01 each shall
be consolidated into 1 Ordinary Share each, and (the &#x201c;Reverse Share Split&#x201d;) (iii) subject to the listing of the Company&#x2019;s
Ordinary Shares on Nasdaq, the recapitalization and redistribution of the entire share capital of the Company (the &#x201c;Recapitalization&#x201d;),
so that following such Voluntary Conversion and Recapitalization, the share capital of the Company shall consist of NIS 11,100,000 divided
into 222,000,000 Ordinary Shares each of which 9,790,040 are issued and outstanding (post the aforesaid Reverse Share Split).</bmr:VoluntaryConversionDescription>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"&gt;&lt;b&gt;NOTE 12 - SHARE OPTIONS&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Share option plan:&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;On January 11, 2015, the Company&#x2019;s Board
of Directors approved and adopted the 2015 Share Incentive Plan (the &#x201c;Plan&#x201d;), pursuant to which the Company&#x2019;s Board
of Directors may award share options to purchase the Company&#x2019;s Ordinary Shares as well as restricted shares, RSUs and other share-based
awards to designated participants. Subject to the terms and conditions of the Plan, the Company&#x2019;s Board of Directors has full authority
in its discretion, from time to time and at any time, to determine (i) the designate participants; (ii) the terms and provisions of the
respective award agreements, including, but not limited to, the number of share options to be granted to each optionee, the number of
shares to be covered by each share option, provisions concerning the time and the extent to which the share options may be exercised and
the nature and duration of restrictions as to the transferability or restrictions constituting substantial risk of forfeiture and to cancel
or suspend awards, as necessary; (iii) determine the fair market value of the shares covered by each award; (iv) make an election as to
the type of approved 102 Option under Israeli tax law; (v) designate the type of share options; (vi) take any measures, and to take actions,
as deemed necessary or advisable for the administration and implementation of the Plan; (vii) interpret the provisions of the Plan and
to amend from time to time the terms of the Plan.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Plan permits the grant of up to 2,069,280
share Ordinary Shares subject to adjustments set in the Plan. As of December 31, 2022, considering the effect of previously exercised
share options, there were 355,530 Ordinary Shares available for future issuance under the Plan.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The following table presents the Company&#x2019;s
share option activity for employees and members of the Board of Directors of the Company under the Plan for the years ended December 31,
2022, 2021 and 2020:&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;b&gt;Number of&lt;br/&gt;
    Share&lt;br/&gt;
    Options&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;b&gt;Weighted&lt;br/&gt;
    Average&lt;br/&gt;
    Exercise&lt;br/&gt;
    Price &lt;br/&gt;
$&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;b&gt;Weighted&lt;br/&gt; average&lt;br/&gt;
    remaining&lt;br/&gt; contractual&lt;br/&gt; life (years)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;b&gt;Intrinsic&lt;br/&gt; value&lt;br/&gt;
 $&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; text-align: left"&gt;Outstanding as of December 31, 2019&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;1,291,810&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;1.65&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;5.94&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;194&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Granted&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;353,960&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;1.80&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;9.35&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Exercised&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;(9,800&lt;/td&gt;
    &lt;td style="text-align: left"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;1.15&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-76"&gt;-&lt;/div&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Forfeited or expired&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(381,970&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;1.75&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-77"&gt;-&lt;/div&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 4pt"&gt;Outstanding as of December 31, 2020&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;1,254,000&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;1.70&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;6.12&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;125&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 4pt"&gt;Exercisable as of December&#160;31, 2020&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;839,665&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;1.50&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;4.73&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;252&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;b&gt;Number of&lt;br/&gt;
    Share&lt;br/&gt;
    Options&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;b&gt;Weighted&lt;br/&gt;
    Average&lt;br/&gt;
    Exercise&lt;br/&gt;
    Price&lt;br/&gt;
    $&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;b&gt;Weighted&lt;br/&gt; average&lt;br/&gt;
    remaining&lt;br/&gt; contractual&lt;br/&gt; life (years)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;b&gt;Intrinsic&lt;br/&gt; value&lt;br/&gt;
 $&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; text-align: left"&gt;Outstanding as of December 31, 2020&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;1,254,000&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;1.70&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;6.12&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;125&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Granted&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;214,688&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;2.05&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;9.64&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Forfeited or expired&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(101,520&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;1.80&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-78"&gt;-&lt;/div&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Outstanding as of December 31, 2021&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;1,367,168&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;1.75&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;5.72&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;4,860&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Exercisable as of December&#160;31, 2021&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;927,988&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;1.60&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;4.25&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;3,429&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;b&gt;Number of&lt;br/&gt;
    Share&lt;br/&gt;
    Options&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;b&gt;Weighted&lt;br/&gt;
    Average&lt;br/&gt;
    Exercise&lt;br/&gt;
    Price&lt;br/&gt;
    $&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;b&gt;Weighted&lt;br/&gt; average&lt;br/&gt;
    remaining&lt;br/&gt; contractual&lt;br/&gt; life (years)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;b&gt;Intrinsic&lt;br/&gt; value&lt;br/&gt;
    $&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; text-align: left"&gt;Outstanding as of December 31, 2021&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;1,367,168&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;1.75&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;5.72&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;4,860&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Granted&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;286,875&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;1.83&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Forfeited or expired&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(83,052&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;1.45&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;-&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Outstanding as of December 31, 2022&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;1,570,991&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;1.78&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;4.97&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;2,435&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Exercisable as of December&#160;31, 2022&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;1,048,297&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;1.70&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;3.2&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;1,677&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The aggregate intrinsic value in the table above represents the total intrinsic value (the difference between the deemed fair value of
the Company&#x2019;s Ordinary Shares on the last day of each of the applicable reported period and the exercise price, multiplied by the number
of in-the-money share options) that would have been received by the share option holders had all share options holders exercised their
share options on December&#160;31 of each of the reported period. This amount is impacted by the changes in the fair market value of the
Company&#x2019;s Ordinary Share.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The outstanding and exercisable share options
as of December&#160;31, 2022 have been separated into ranges of exercise prices, as follows:&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: justify"&gt;&lt;b&gt;Exercise price&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;b&gt;Share options&lt;br/&gt; outstanding&lt;br/&gt;
    as of&lt;br/&gt; December&#160;31,&lt;br/&gt; 2022&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;b&gt;Weighted&lt;br/&gt; average&lt;br/&gt;
remaining&lt;br/&gt; contractual&lt;br/&gt; term (years)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;b&gt;Share options&lt;br/&gt; exercisable&lt;br/&gt;
    as of&lt;br/&gt; December&#160;31,&lt;br/&gt; 2022&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;b&gt;Weighted&lt;br/&gt; average&lt;br/&gt;
    remaining&lt;br/&gt; contractual&lt;br/&gt; term (years)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/td&gt;
    &lt;td&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/td&gt;
    &lt;td&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/td&gt;
    &lt;td&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; text-align: left"&gt;0.00&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;152,640&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;2.42&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;152,640&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;1.03&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;1.14&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;228,480&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;1.39&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;228,480&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;1.39&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;1.67&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;43,200&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;2.21&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;43,200&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;2.21&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;1.83&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;982,870&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;6.75&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;489,239&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;4.70&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;3.2&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;35,001&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;6.45&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;10,938&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;6.45&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;3.79&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;60,000&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;1.59&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;60,000&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;1.59&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;4.17&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;28,800&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;3.03&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;28,800&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;3.03&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;5.12&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;40,000&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;6.54&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;35,000&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;6.54&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;1,570,991&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;1,048,297&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The weighted average grant date fair value of share options granted during the years ended December&#160;31, 2022, 2021 and 2020 was $0.51,
$0.44 and $0.20 per share option, respectively.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;During the years ended December 31, 2022 and 2021,
share options have not been exercised into Ordinary Shares. During the year ended December 31, 2020, certain employees exercised 9,800
share options into the same number of Ordinary Shares for total consideration of $11.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The following table presents the assumptions used
to estimate the fair values of the share options granted in the reported periods presented:&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;b&gt;Year ended December 31&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2022&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2021&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2020&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left"&gt;Volatility (%)&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;61.49&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;64.75&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; width: 9%; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;61.89%-61.91&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Risk-free interest rate (%)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;3.64%-3.85&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;%&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;0.09&lt;/td&gt;
    &lt;td style="text-align: left"&gt;%&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;0.03%-0.04&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Dividend yield (%)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-79"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-80"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;-&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Expected life (years)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;6.25&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;6.25&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;6.25&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Exercise price ($)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;1.83&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;1.80-3.20&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;1.80&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Share price ($)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;3.30&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;3.20&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;1.80&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;As of December 31, 2022, there was $1,029 of unrecognized
compensation expense related to unvested share options. The Company recognizes compensation expense on a straight-line basis over the
requisite service periods, which results in a weighted average period of approximately 1.72 years over which the unrecognized compensation
expense is expected to be recognized.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The total compensation cost related to all of
the Company&#x2019;s equity-based awards recognized during the years ended December&#160;31, 2022, 2021 and 2020 was comprised as follows:&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;b&gt;Year ended December 31&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2022&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2021&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2020&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left"&gt;Research and development&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;144&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;94&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;60&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Sales and marketing&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;49&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;45&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;48&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;General and administrative&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;29&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;18&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;12&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;222&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;157&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;120&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <bmr:OrdinarySharesSubjectToAdjustments contextRef="c2" decimals="0" unitRef="shares">2069280</bmr:OrdinarySharesSubjectToAdjustments>
    <bmr:OrdinarySharesAvailableForFutureIssuance contextRef="c2" decimals="0" unitRef="shares">355530</bmr:OrdinarySharesAvailableForFutureIssuance>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;b&gt;Number of&lt;br/&gt;
    Share&lt;br/&gt;
    Options&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;b&gt;Weighted&lt;br/&gt;
    Average&lt;br/&gt;
    Exercise&lt;br/&gt;
    Price &lt;br/&gt;
$&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;b&gt;Weighted&lt;br/&gt; average&lt;br/&gt;
    remaining&lt;br/&gt; contractual&lt;br/&gt; life (years)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;b&gt;Intrinsic&lt;br/&gt; value&lt;br/&gt;
 $&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; text-align: left"&gt;Outstanding as of December 31, 2019&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;1,291,810&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;1.65&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;5.94&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;194&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Granted&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;353,960&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;1.80&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;9.35&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Exercised&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;(9,800&lt;/td&gt;
    &lt;td style="text-align: left"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;1.15&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-76"&gt;-&lt;/div&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Forfeited or expired&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(381,970&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;1.75&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-77"&gt;-&lt;/div&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 4pt"&gt;Outstanding as of December 31, 2020&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;1,254,000&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;1.70&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;6.12&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;125&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 4pt"&gt;Exercisable as of December&#160;31, 2020&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;839,665&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;1.50&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;4.73&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;252&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;b&gt;Number of&lt;br/&gt;
    Share&lt;br/&gt;
    Options&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;b&gt;Weighted&lt;br/&gt;
    Average&lt;br/&gt;
    Exercise&lt;br/&gt;
    Price&lt;br/&gt;
    $&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;b&gt;Weighted&lt;br/&gt; average&lt;br/&gt;
    remaining&lt;br/&gt; contractual&lt;br/&gt; life (years)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;b&gt;Intrinsic&lt;br/&gt; value&lt;br/&gt;
 $&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; text-align: left"&gt;Outstanding as of December 31, 2020&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;1,254,000&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;1.70&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;6.12&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;125&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Granted&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;214,688&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;2.05&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;9.64&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Forfeited or expired&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(101,520&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;1.80&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-78"&gt;-&lt;/div&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Outstanding as of December 31, 2021&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;1,367,168&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;1.75&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;5.72&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;4,860&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Exercisable as of December&#160;31, 2021&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;927,988&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;1.60&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;4.25&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;3,429&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;b&gt;Number of&lt;br/&gt;
    Share&lt;br/&gt;
    Options&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;b&gt;Weighted&lt;br/&gt;
    Average&lt;br/&gt;
    Exercise&lt;br/&gt;
    Price&lt;br/&gt;
    $&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;b&gt;Weighted&lt;br/&gt; average&lt;br/&gt;
    remaining&lt;br/&gt; contractual&lt;br/&gt; life (years)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;b&gt;Intrinsic&lt;br/&gt; value&lt;br/&gt;
    $&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; text-align: left"&gt;Outstanding as of December 31, 2021&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;1,367,168&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;1.75&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;5.72&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;4,860&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Granted&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;286,875&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;1.83&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Forfeited or expired&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(83,052&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;1.45&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;-&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Outstanding as of December 31, 2022&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;1,570,991&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;1.78&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;4.97&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;2,435&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Exercisable as of December&#160;31, 2022&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;1,048,297&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;1.70&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;3.2&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;1,677&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="c15" decimals="INF" unitRef="shares">1291810</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="c15" decimals="2" unitRef="usdPershares">1.65</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2 contextRef="c9">P5Y11M8D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue contextRef="c15" decimals="-3" unitRef="usd">194000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="c9" decimals="INF" unitRef="shares">353960</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="c9" decimals="2" unitRef="usdPershares">1.8</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <bmr:WeightedAverageRemainingContractualLifeGranted contextRef="c9">P9Y4M6D</bmr:WeightedAverageRemainingContractualLifeGranted>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="c9" decimals="INF" unitRef="shares">9800</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice contextRef="c9" decimals="2" unitRef="usdPershares">1.15</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod contextRef="c9" decimals="INF" unitRef="shares">381970</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice contextRef="c9" decimals="2" unitRef="usdPershares">1.75</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="c26" decimals="INF" unitRef="shares">1254000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="c26" decimals="2" unitRef="usdPershares">1.7</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <bmr:WeightedAverageRemainingContractualLifeOutstanding contextRef="c9">P6Y1M13D</bmr:WeightedAverageRemainingContractualLifeOutstanding>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue contextRef="c26" decimals="-3" unitRef="usd">125000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber contextRef="c26" decimals="INF" unitRef="shares">839665</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice contextRef="c26" decimals="2" unitRef="usdPershares">1.5</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2 contextRef="c9">P4Y8M23D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 contextRef="c26" decimals="-3" unitRef="usd">252000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="c26" decimals="INF" unitRef="shares">1254000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="c26" decimals="2" unitRef="usdPershares">1.7</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2 contextRef="c8">P6Y1M13D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue contextRef="c26" decimals="-3" unitRef="usd">125000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="c8" decimals="INF" unitRef="shares">214688</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="c8" decimals="2" unitRef="usdPershares">2.05</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <bmr:WeightedAverageRemainingContractualLifeGranted contextRef="c8">P9Y7M20D</bmr:WeightedAverageRemainingContractualLifeGranted>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod contextRef="c8" decimals="INF" unitRef="shares">101520</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice contextRef="c8" decimals="2" unitRef="usdPershares">1.8</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="c3" decimals="INF" unitRef="shares">1367168</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="c3" decimals="2" unitRef="usdPershares">1.75</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <bmr:WeightedAverageRemainingContractualLifeOutstanding contextRef="c8">P5Y8M19D</bmr:WeightedAverageRemainingContractualLifeOutstanding>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue contextRef="c3" decimals="-3" unitRef="usd">4860000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber contextRef="c3" decimals="INF" unitRef="shares">927988</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice contextRef="c3" decimals="2" unitRef="usdPershares">1.6</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2 contextRef="c8">P4Y3M</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 contextRef="c3" decimals="-3" unitRef="usd">3429000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="c3" decimals="INF" unitRef="shares">1367168</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="c3" decimals="2" unitRef="usdPershares">1.75</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2 contextRef="c0">P5Y8M19D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue contextRef="c3" decimals="-3" unitRef="usd">4860000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="c0" decimals="INF" unitRef="shares">286875</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="c0" decimals="2" unitRef="usdPershares">1.83</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod contextRef="c0" decimals="INF" unitRef="shares">83052</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice contextRef="c0" decimals="2" unitRef="usdPershares">1.45</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="c2" decimals="INF" unitRef="shares">1570991</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="c2" decimals="2" unitRef="usdPershares">1.78</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <bmr:WeightedAverageRemainingContractualLifeOutstanding contextRef="c0">P4Y11M19D</bmr:WeightedAverageRemainingContractualLifeOutstanding>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue contextRef="c2" decimals="-3" unitRef="usd">2435000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber contextRef="c2" decimals="INF" unitRef="shares">1048297</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice contextRef="c2" decimals="2" unitRef="usdPershares">1.7</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2 contextRef="c0">P3Y2M12D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 contextRef="c2" decimals="-3" unitRef="usd">1677000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: justify"&gt;&lt;b&gt;Exercise price&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;b&gt;Share options&lt;br/&gt; outstanding&lt;br/&gt;
    as of&lt;br/&gt; December&#160;31,&lt;br/&gt; 2022&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;b&gt;Weighted&lt;br/&gt; average&lt;br/&gt;
remaining&lt;br/&gt; contractual&lt;br/&gt; term (years)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;b&gt;Share options&lt;br/&gt; exercisable&lt;br/&gt;
    as of&lt;br/&gt; December&#160;31,&lt;br/&gt; 2022&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;b&gt;Weighted&lt;br/&gt; average&lt;br/&gt;
    remaining&lt;br/&gt; contractual&lt;br/&gt; term (years)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/td&gt;
    &lt;td&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/td&gt;
    &lt;td&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/td&gt;
    &lt;td&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; text-align: left"&gt;0.00&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;152,640&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;2.42&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;152,640&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;1.03&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;1.14&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;228,480&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;1.39&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;228,480&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;1.39&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;1.67&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;43,200&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;2.21&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;43,200&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;2.21&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;1.83&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;982,870&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;6.75&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;489,239&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;4.70&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;3.2&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;35,001&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;6.45&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;10,938&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;6.45&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;3.79&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;60,000&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;1.59&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;60,000&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;1.59&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;4.17&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;28,800&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;3.03&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;28,800&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;3.03&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;5.12&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;40,000&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;6.54&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;35,000&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;6.54&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;1,570,991&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;1,048,297&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;</us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit contextRef="c115" decimals="2" unitRef="usdPershares">0</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions contextRef="c116" decimals="INF" unitRef="shares">152640</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1 contextRef="c117">P2Y5M1D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions contextRef="c118" decimals="INF" unitRef="shares">152640000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1 contextRef="c119">P1Y10D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit contextRef="c120" decimals="2" unitRef="usdPershares">1.14</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions contextRef="c121" decimals="INF" unitRef="shares">228480</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1 contextRef="c122">P1Y4M20D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions contextRef="c123" decimals="INF" unitRef="shares">228480000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1 contextRef="c124">P1Y4M20D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit contextRef="c125" decimals="2" unitRef="usdPershares">1.67</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions contextRef="c126" decimals="INF" unitRef="shares">43200</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1 contextRef="c127">P2Y2M15D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions contextRef="c128" decimals="INF" unitRef="shares">43200000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1 contextRef="c129">P2Y2M15D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit contextRef="c130" decimals="2" unitRef="usdPershares">1.83</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions contextRef="c131" decimals="INF" unitRef="shares">982870</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1 contextRef="c132">P6Y9M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions contextRef="c133" decimals="INF" unitRef="shares">489239000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1 contextRef="c134">P4Y8M12D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit contextRef="c135" decimals="1" unitRef="usdPershares">3.2</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions contextRef="c136" decimals="INF" unitRef="shares">35001</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1 contextRef="c137">P6Y5M12D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions contextRef="c138" decimals="INF" unitRef="shares">10938000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1 contextRef="c139">P6Y5M12D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit contextRef="c140" decimals="2" unitRef="usdPershares">3.79</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions contextRef="c141" decimals="INF" unitRef="shares">60000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1 contextRef="c142">P1Y7M2D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions contextRef="c143" decimals="INF" unitRef="shares">60000000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1 contextRef="c144">P1Y7M2D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit contextRef="c145" decimals="2" unitRef="usdPershares">4.17</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions contextRef="c146" decimals="INF" unitRef="shares">28800</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1 contextRef="c147">P3Y10D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions contextRef="c148" decimals="INF" unitRef="shares">28800000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1 contextRef="c149">P3Y10D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit contextRef="c150" decimals="2" unitRef="usdPershares">5.12</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions contextRef="c151" decimals="INF" unitRef="shares">40000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1 contextRef="c152">P6Y6M14D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions contextRef="c153" decimals="INF" unitRef="shares">35000000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1 contextRef="c154">P6Y6M14D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions contextRef="c155" decimals="INF" unitRef="shares">1570991</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions contextRef="c156" decimals="INF" unitRef="shares">1048297000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue contextRef="c2" decimals="2" unitRef="usdPershares">0.51</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue contextRef="c3" decimals="2" unitRef="usdPershares">0.44</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue contextRef="c26" decimals="2" unitRef="usdPershares">0.2</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="c9" decimals="0" unitRef="shares">9800</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <bmr:TotalConsideration contextRef="c26" decimals="-3" unitRef="usd">11000</bmr:TotalConsideration>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;b&gt;Year ended December 31&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2022&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2021&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2020&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left"&gt;Volatility (%)&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;61.49&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;64.75&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; width: 9%; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;61.89%-61.91&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Risk-free interest rate (%)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;3.64%-3.85&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;%&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;0.09&lt;/td&gt;
    &lt;td style="text-align: left"&gt;%&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;0.03%-0.04&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Dividend yield (%)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-79"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-80"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;-&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Expected life (years)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;6.25&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;6.25&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;6.25&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Exercise price ($)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;1.83&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;1.80-3.20&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;1.80&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Share price ($)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;3.30&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;3.20&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;1.80&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="c0" decimals="4" unitRef="pure">0.6149</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="c8" decimals="4" unitRef="pure">0.6475</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="c157" decimals="4" unitRef="pure">0.6189</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="c158" decimals="4" unitRef="pure">0.6191</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="c159" decimals="4" unitRef="pure">0.0364</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="c70" decimals="4" unitRef="pure">0.0385</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="c8" decimals="4" unitRef="pure">0.0009</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="c157" decimals="4" unitRef="pure">0.0003</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="c158" decimals="4" unitRef="pure">0.0004</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c0">P6Y3M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c8">P6Y3M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c9">P6Y3M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice contextRef="c2" decimals="2" unitRef="usdPershares">1.83</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice contextRef="c160" decimals="2" unitRef="usdPershares">1.8</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice contextRef="c161" decimals="2" unitRef="usdPershares">3.2</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice contextRef="c26" decimals="2" unitRef="usdPershares">1.8</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice>
    <us-gaap:SharePrice contextRef="c2" decimals="2" unitRef="usdPershares">3.3</us-gaap:SharePrice>
    <us-gaap:SharePrice contextRef="c3" decimals="2" unitRef="usdPershares">3.2</us-gaap:SharePrice>
    <us-gaap:SharePrice contextRef="c26" decimals="2" unitRef="usdPershares">1.8</us-gaap:SharePrice>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax contextRef="c0" decimals="-3" unitRef="usd">1029000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:NetAmountAtRiskByProductAndGuaranteeWeightedAveragePeriodRemaining1 contextRef="c0">P1Y8M19D</us-gaap:NetAmountAtRiskByProductAndGuaranteeWeightedAveragePeriodRemaining1>
    <us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;b&gt;Year ended December 31&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2022&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2021&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2020&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left"&gt;Research and development&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;144&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;94&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;60&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Sales and marketing&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;49&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;45&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;48&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;General and administrative&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;29&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;18&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;12&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;222&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;157&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;120&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock>
    <us-gaap:OtherResearchAndDevelopmentExpense contextRef="c0" decimals="-3" unitRef="usd">144000</us-gaap:OtherResearchAndDevelopmentExpense>
    <us-gaap:OtherResearchAndDevelopmentExpense contextRef="c8" decimals="-3" unitRef="usd">94000</us-gaap:OtherResearchAndDevelopmentExpense>
    <us-gaap:OtherResearchAndDevelopmentExpense contextRef="c9" decimals="-3" unitRef="usd">60000</us-gaap:OtherResearchAndDevelopmentExpense>
    <us-gaap:OtherSellingAndMarketingExpense contextRef="c0" decimals="-3" unitRef="usd">49000</us-gaap:OtherSellingAndMarketingExpense>
    <us-gaap:OtherSellingAndMarketingExpense contextRef="c8" decimals="-3" unitRef="usd">45000</us-gaap:OtherSellingAndMarketingExpense>
    <us-gaap:OtherSellingAndMarketingExpense contextRef="c9" decimals="-3" unitRef="usd">48000</us-gaap:OtherSellingAndMarketingExpense>
    <us-gaap:OtherGeneralAndAdministrativeExpense contextRef="c0" decimals="-3" unitRef="usd">29000</us-gaap:OtherGeneralAndAdministrativeExpense>
    <us-gaap:OtherGeneralAndAdministrativeExpense contextRef="c8" decimals="-3" unitRef="usd">18000</us-gaap:OtherGeneralAndAdministrativeExpense>
    <us-gaap:OtherGeneralAndAdministrativeExpense contextRef="c9" decimals="-3" unitRef="usd">12000</us-gaap:OtherGeneralAndAdministrativeExpense>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue contextRef="c0" decimals="-3" unitRef="usd">222000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue contextRef="c8" decimals="-3" unitRef="usd">157000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue contextRef="c9" decimals="-3" unitRef="usd">120000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <bmr:FinancingExpenses contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63.8pt; text-align: left; text-indent: -63.8pt"&gt;&lt;b&gt;NOTE 13 - FINANCING
EXPENSES, NET&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63.8pt; text-align: left; text-indent: -63.8pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;b&gt;Year ended  December 31&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2022&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2021&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2020&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; width: 64%; text-align: left"&gt;Change in fair value of convertible advance investment (see Note 9)&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;70&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;288&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;436&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;Amortization of discount and accrued interest relating to straight loan received from commercial Bank (see Note 6 and Note 7)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;102&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;59&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;120&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;Modification of terms relating to straight loan (see Note 6A1)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-81"&gt;-&lt;/div&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;90&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-82"&gt;-&lt;/div&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;Amortization of discount relating to liability to related party (see Note 14)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;40&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-83"&gt;-&lt;/div&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-84"&gt;-&lt;/div&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;Exchange rate differences and others&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(47&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;38&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;141&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;165&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;475&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;697&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</bmr:FinancingExpenses>
    <us-gaap:ConvertibleDebtTableTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;b&gt;Year ended  December 31&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2022&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2021&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2020&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; width: 64%; text-align: left"&gt;Change in fair value of convertible advance investment (see Note 9)&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;70&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;288&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;436&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;Amortization of discount and accrued interest relating to straight loan received from commercial Bank (see Note 6 and Note 7)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;102&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;59&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;120&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;Modification of terms relating to straight loan (see Note 6A1)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-81"&gt;-&lt;/div&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;90&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-82"&gt;-&lt;/div&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;Amortization of discount relating to liability to related party (see Note 14)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;40&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-83"&gt;-&lt;/div&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-84"&gt;-&lt;/div&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;Exchange rate differences and others&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(47&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;38&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;141&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;165&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;475&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;697&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ConvertibleDebtTableTextBlock>
    <bmr:ChangeInTheFairValueOfConvertibleAdvanceInvestments contextRef="c0" decimals="-3" unitRef="usd">70000</bmr:ChangeInTheFairValueOfConvertibleAdvanceInvestments>
    <bmr:ChangeInTheFairValueOfConvertibleAdvanceInvestments contextRef="c8" decimals="-3" unitRef="usd">288000</bmr:ChangeInTheFairValueOfConvertibleAdvanceInvestments>
    <bmr:ChangeInTheFairValueOfConvertibleAdvanceInvestments contextRef="c9" decimals="-3" unitRef="usd">436000</bmr:ChangeInTheFairValueOfConvertibleAdvanceInvestments>
    <us-gaap:PresentValueOfFutureInsuranceProfitsAmortizationExpenseAccruedInterest contextRef="c0" decimals="-3" unitRef="usd">102000</us-gaap:PresentValueOfFutureInsuranceProfitsAmortizationExpenseAccruedInterest>
    <us-gaap:PresentValueOfFutureInsuranceProfitsAmortizationExpenseAccruedInterest contextRef="c8" decimals="-3" unitRef="usd">59000</us-gaap:PresentValueOfFutureInsuranceProfitsAmortizationExpenseAccruedInterest>
    <us-gaap:PresentValueOfFutureInsuranceProfitsAmortizationExpenseAccruedInterest contextRef="c9" decimals="-3" unitRef="usd">120000</us-gaap:PresentValueOfFutureInsuranceProfitsAmortizationExpenseAccruedInterest>
    <bmr:ModificationOfTermsRelatingToStraightLoan contextRef="c8" decimals="-3" unitRef="usd">90000</bmr:ModificationOfTermsRelatingToStraightLoan>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts contextRef="c0" decimals="-3" unitRef="usd">40000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <bmr:ExchangeRateDifferencesAndOthers contextRef="c0" decimals="-3" unitRef="usd">-47000</bmr:ExchangeRateDifferencesAndOthers>
    <bmr:ExchangeRateDifferencesAndOthers contextRef="c8" decimals="-3" unitRef="usd">38000</bmr:ExchangeRateDifferencesAndOthers>
    <bmr:ExchangeRateDifferencesAndOthers contextRef="c9" decimals="-3" unitRef="usd">141000</bmr:ExchangeRateDifferencesAndOthers>
    <us-gaap:OtherNonoperatingExpense contextRef="c0" decimals="-3" unitRef="usd">165000</us-gaap:OtherNonoperatingExpense>
    <us-gaap:OtherNonoperatingExpense contextRef="c8" decimals="-3" unitRef="usd">475000</us-gaap:OtherNonoperatingExpense>
    <us-gaap:OtherNonoperatingExpense contextRef="c9" decimals="-3" unitRef="usd">697000</us-gaap:OtherNonoperatingExpense>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63.8pt; text-align: left; text-indent: -63.8pt"&gt;&lt;b&gt;NOTE 14 - RELATED
PARTIES TRANSACTIONS&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63.8pt; text-align: left; text-indent: -63.8pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The liability to related party derives from a
service agreement with the Company&#x2019;s Founder under which the Company receives consulting services on recurring basis from the Founder
as Chief Executive Officer indirectly through an entity controlled by the Founder (the &#x201c;Service Provider&#x201d;) for total current
monthly gross amount of NIS 45 thousand. On March 14, 2022, the Company&#x2019;s shareholders approved, among other matters, to renew the service
agreement with the Founder for a period ending December 31, 2025.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;On February 16, 2022, the Company entered into
an addendum to the aforesaid service agreement with the Service Provider under which it was agreed that (i) the term of the service agreement
with the Service Provider was extended to December 31, 2025 and (ii) the then current liability towards the Service Provider as was accrued
for services rendered under the service agreement over a period commencing January 1, 2020 through the date hereof in total nominal amount
of $357 (the &#x201c;Current Liability&#x201d;) will be paid in 18 equal installments (without an interest) starting on March 1, 2022 (the
&#x201c;Commencement Date&#x201d;). However, in the event that the Company shall not have available sufficient funds in any such payment
date from and after the Commencement Date to repay the installments of the Current Liability and/or the on-going fee owed to the Service
Provider or in the event that the Company determines that according to the following 12-months period budget that it shall not have available
sufficient funds to pay such installments and/or the on-going fee, then the Service Provider hereby agrees to postpone such payments owed
to it until the Company will have such sufficient funds. Any unpaid on-going fee payments will be added to the Current Liability.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Since the liability towards the Founder was considered
as free interest loan which did not represent the applicable rate of risk for the Company, the aforesaid addendum was accounted for as
a capital contribution from a controlling shareholder. Thus, the liability towards the Founder was measured at fair value based on future
cash payments discounted using an interest rate of 15.45% which represented the applicable rate of risk for the Company, as determined
by management using the assistance of third-party appraiser. As a result, the Company recorded a discount on the balance of liability
towards the Founder in total amount of $112 against additional paid-in capital (including in respect to amounts due for services period
through fiscal year for 2022). The Company will record a discount expense over the economic life of the loan based on the effective interest
rate method. As of December 31, 2022, management has updated the repayments schedule of the obligation based on its current projection
of the availability of funds. Accordingly, the obligation is expected to be repaid over the following 24-months period.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The following tabular presentation reflects the
reconciliation of the carrying amount of the Company&#x2019;s Liability to related party, net during the years ended December 31, 2022,
2021 and 2020:&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;b&gt;Year ended  December 31,&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2022&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2021&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2020&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left; text-indent: -14.15pt; padding-left: 14.15pt"&gt;Opening balance&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;345&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;168&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-85"&gt;-&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -14.15pt; padding-left: 14.15pt"&gt;Accrued liability in respect to additional services rendered&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;115&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;177&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;168&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -14.15pt; padding-left: 14.15pt"&gt;Recognition of capital contribution from a controlling shareholder&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;(112&lt;/td&gt;
    &lt;td style="text-align: left"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-86"&gt;-&lt;/div&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-87"&gt;-&lt;/div&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; text-indent: -14.15pt; padding-left: 14.15pt"&gt;Amortization of discount relating to liability to related party&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;40&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-88"&gt;-&lt;/div&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-89"&gt;-&lt;/div&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 4pt; text-indent: -14.15pt; padding-left: 14.15pt"&gt;Closing balance&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;388&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;345&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;168&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Maturity dates:&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;b&gt;As of&lt;br/&gt;
 December 31,&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2022&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2021&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left; text-indent: -14.15pt; padding-left: 14.15pt"&gt;First year (current maturities)&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;126&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;345&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; text-indent: -14.15pt; padding-left: 14.15pt"&gt;Second year&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;262&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-90"&gt;-&lt;/div&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 4pt; text-indent: -14.15pt; padding-left: 14.15pt"&gt;Closing balance&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;388&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;345&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company allocated the expenses related to
the above service agreement and addendum as follows:&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;b&gt;Year ended  December 31&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2022&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2021&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2020&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left; text-indent: -8.6pt; padding-left: 8.6pt"&gt;Research and development&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;42&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;44&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;82&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -8.6pt; padding-left: 8.6pt"&gt;Sales and marketing&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;42&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;44&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;58&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; text-indent: -8.6pt; padding-left: 8.6pt"&gt;General and administrative&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;83&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;89&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;108&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;167&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;177&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;248&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The allocation was done based on the management estimation to reflect the contribution to the related activity.&lt;/p&gt;</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:RelatedPartyTransactionDueFromToRelatedPartyCurrent contextRef="c2" decimals="-3" unitRef="ils">45000</us-gaap:RelatedPartyTransactionDueFromToRelatedPartyCurrent>
    <us-gaap:DueToOtherRelatedPartiesClassifiedCurrent contextRef="c162" decimals="-3" unitRef="usd">357000</us-gaap:DueToOtherRelatedPartiesClassifiedCurrent>
    <us-gaap:InvestmentInterestRate contextRef="c2" decimals="4" unitRef="pure">0.1545</us-gaap:InvestmentInterestRate>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalOther contextRef="c0" decimals="-3" unitRef="usd">112000</us-gaap:AdjustmentsToAdditionalPaidInCapitalOther>
    <us-gaap:ScheduleOfRegulatoryLiabilitiesTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;b&gt;Year ended  December 31,&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2022&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2021&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2020&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left; text-indent: -14.15pt; padding-left: 14.15pt"&gt;Opening balance&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;345&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;168&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-85"&gt;-&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -14.15pt; padding-left: 14.15pt"&gt;Accrued liability in respect to additional services rendered&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;115&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;177&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;168&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -14.15pt; padding-left: 14.15pt"&gt;Recognition of capital contribution from a controlling shareholder&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;(112&lt;/td&gt;
    &lt;td style="text-align: left"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-86"&gt;-&lt;/div&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-87"&gt;-&lt;/div&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; text-indent: -14.15pt; padding-left: 14.15pt"&gt;Amortization of discount relating to liability to related party&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;40&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-88"&gt;-&lt;/div&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-89"&gt;-&lt;/div&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 4pt; text-indent: -14.15pt; padding-left: 14.15pt"&gt;Closing balance&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;388&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;345&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;168&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;</us-gaap:ScheduleOfRegulatoryLiabilitiesTextBlock>
    <us-gaap:InvestmentRelatedLiabilities contextRef="c3" decimals="-3" unitRef="usd">345000</us-gaap:InvestmentRelatedLiabilities>
    <us-gaap:InvestmentRelatedLiabilities contextRef="c26" decimals="-3" unitRef="usd">168000</us-gaap:InvestmentRelatedLiabilities>
    <us-gaap:OtherAccruedLiabilitiesCurrentAndNoncurrent contextRef="c2" decimals="-3" unitRef="usd">115000</us-gaap:OtherAccruedLiabilitiesCurrentAndNoncurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrentAndNoncurrent contextRef="c3" decimals="-3" unitRef="usd">177000</us-gaap:OtherAccruedLiabilitiesCurrentAndNoncurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrentAndNoncurrent contextRef="c26" decimals="-3" unitRef="usd">168000</us-gaap:OtherAccruedLiabilitiesCurrentAndNoncurrent>
    <us-gaap:PartnersCapitalAccountContributions contextRef="c0" decimals="-3" unitRef="usd">112000</us-gaap:PartnersCapitalAccountContributions>
    <us-gaap:InvestmentIncomeAmortizationOfDiscount contextRef="c0" decimals="-3" unitRef="usd">40000</us-gaap:InvestmentIncomeAmortizationOfDiscount>
    <us-gaap:InvestmentRelatedLiabilities contextRef="c2" decimals="-3" unitRef="usd">388000</us-gaap:InvestmentRelatedLiabilities>
    <us-gaap:InvestmentRelatedLiabilities contextRef="c3" decimals="-3" unitRef="usd">345000</us-gaap:InvestmentRelatedLiabilities>
    <us-gaap:InvestmentRelatedLiabilities contextRef="c26" decimals="-3" unitRef="usd">168000</us-gaap:InvestmentRelatedLiabilities>
    <us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;b&gt;As of&lt;br/&gt;
 December 31,&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2022&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2021&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left; text-indent: -14.15pt; padding-left: 14.15pt"&gt;First year (current maturities)&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;126&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;345&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; text-indent: -14.15pt; padding-left: 14.15pt"&gt;Second year&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;262&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-90"&gt;-&lt;/div&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 4pt; text-indent: -14.15pt; padding-left: 14.15pt"&gt;Closing balance&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;388&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;345&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;</us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock>
    <us-gaap:LongTermDebtCurrent contextRef="c2" decimals="-3" unitRef="usd">126000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent contextRef="c3" decimals="-3" unitRef="usd">345000</us-gaap:LongTermDebtCurrent>
    <us-gaap:OtherCommitmentDueInSecondYear contextRef="c2" decimals="-3" unitRef="usd">262000</us-gaap:OtherCommitmentDueInSecondYear>
    <us-gaap:OtherLongTermDebtCurrent contextRef="c2" decimals="-3" unitRef="usd">388000</us-gaap:OtherLongTermDebtCurrent>
    <us-gaap:OtherLongTermDebtCurrent contextRef="c3" decimals="-3" unitRef="usd">345000</us-gaap:OtherLongTermDebtCurrent>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;b&gt;Year ended  December 31&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2022&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2021&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2020&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left; text-indent: -8.6pt; padding-left: 8.6pt"&gt;Research and development&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;42&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;44&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;82&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -8.6pt; padding-left: 8.6pt"&gt;Sales and marketing&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;42&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;44&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;58&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; text-indent: -8.6pt; padding-left: 8.6pt"&gt;General and administrative&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;83&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;89&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;108&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;167&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;177&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;248&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:ResearchAndDevelopmentInProcess contextRef="c0" decimals="-3" unitRef="usd">42000</us-gaap:ResearchAndDevelopmentInProcess>
    <us-gaap:ResearchAndDevelopmentInProcess contextRef="c8" decimals="-3" unitRef="usd">44000</us-gaap:ResearchAndDevelopmentInProcess>
    <us-gaap:ResearchAndDevelopmentInProcess contextRef="c9" decimals="-3" unitRef="usd">82000</us-gaap:ResearchAndDevelopmentInProcess>
    <us-gaap:MarketingAndAdvertisingExpense contextRef="c0" decimals="-3" unitRef="usd">42000</us-gaap:MarketingAndAdvertisingExpense>
    <us-gaap:MarketingAndAdvertisingExpense contextRef="c8" decimals="-3" unitRef="usd">44000</us-gaap:MarketingAndAdvertisingExpense>
    <us-gaap:MarketingAndAdvertisingExpense contextRef="c9" decimals="-3" unitRef="usd">58000</us-gaap:MarketingAndAdvertisingExpense>
    <us-gaap:OtherSellingGeneralAndAdministrativeExpense contextRef="c0" decimals="-3" unitRef="usd">83000</us-gaap:OtherSellingGeneralAndAdministrativeExpense>
    <us-gaap:OtherSellingGeneralAndAdministrativeExpense contextRef="c8" decimals="-3" unitRef="usd">89000</us-gaap:OtherSellingGeneralAndAdministrativeExpense>
    <us-gaap:OtherSellingGeneralAndAdministrativeExpense contextRef="c9" decimals="-3" unitRef="usd">108000</us-gaap:OtherSellingGeneralAndAdministrativeExpense>
    <us-gaap:IncreaseDecreaseInDueToOtherRelatedParties contextRef="c0" decimals="-3" unitRef="usd">167000</us-gaap:IncreaseDecreaseInDueToOtherRelatedParties>
    <us-gaap:IncreaseDecreaseInDueToOtherRelatedParties contextRef="c8" decimals="-3" unitRef="usd">177000</us-gaap:IncreaseDecreaseInDueToOtherRelatedParties>
    <us-gaap:IncreaseDecreaseInDueToOtherRelatedParties contextRef="c9" decimals="-3" unitRef="usd">248000</us-gaap:IncreaseDecreaseInDueToOtherRelatedParties>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"&gt;&lt;b&gt;NOTE 15 - TAXES ON INCOME&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0%"/&gt;&lt;td style="width: 0.5in"&gt;&lt;b&gt;A.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Israeli taxation:&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"&gt;Taxable income of the Company is subject
to the Israeli corporate tax at the rate of 23%.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"&gt;As of December 31, 2022, the Company
has net operating losses and capital losses carryforward for Israeli income tax purposes of approximately $27,169 and $409 respectively,
which can be offset against future taxable income for an indefinite period of time.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"&gt;The Company has final (considered
final) tax assessments through the 2017 tax year.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: -28.35pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0%"/&gt;&lt;td style="width: 0.5in"&gt;&lt;b&gt;B.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Foreign entities:&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 46.35pt; text-align: justify; text-indent: -0.25in"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"/&gt;&lt;td style="width: 0.25in"&gt;1.&lt;/td&gt;&lt;td style="text-align: justify"&gt;Beamr Inc. is taxed under United States federal and state tax rules. Income tax is calculated based on
a U.S. federal tax rate of 21%.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 46.35pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify"&gt;Beamr Inc. have not received final
tax assessments for the tax years ended December 31, 2019 through 2022.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 46.35pt; text-align: justify; text-indent: -0.25in"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"/&gt;&lt;td style="width: 0.25in"&gt;2.&lt;/td&gt;&lt;td style="text-align: justify"&gt;Beamr Imaging RU is taxed under the Russian tax code at the rate of 0% (Clause 1.15 of Article 284 of
the Tax Code of the Russian Federation, with changes provided by Federal Law No. 321-FZ of 14.07.2022).&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 46.35pt; text-align: justify; text-indent: -0.25in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify"&gt;Beamr Imaging RU have not received
final tax assessments for the tax years ended December 31, 2020 through 2022.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 46.35pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0%"/&gt;&lt;td style="width: 0.5in"&gt;&lt;b&gt;C.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Taxes on income are comprised from taxes incurred as result of (i) withholding tax deducted at source
in accordance with U.S. - Israel tax treaty related to selling of software and (ii) implementation of the intercompany agreement between
the Company and&#160;Beamr Inc. for conducting reseller services and implementation of the intercompany agreement between the Company
and Beamr Imaging RU for conducting research and development services on behalf of the Company (see also Note 1B).&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: -28.35pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0%"/&gt;&lt;td style="width: 0.5in"&gt;&lt;b&gt;D.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Loss (income) before taxes on income consists of the following:&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;b&gt;Year ended  December 31&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2022&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2021&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2020&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left"&gt;Domestic&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;1,293&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;1,104&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;2,529&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Foreign operations (Beamr Inc and Imaging RU)&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(97&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(204&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(165&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;1,196&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;900&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;2,364&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0%"/&gt;&lt;td style="width: 0.5in"&gt;&lt;b&gt;E.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Deferred income taxes reflect the net tax effects of net operating loss and temporary differences between
the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Significant
components of the Company&#x2019;s deferred tax assets are as follows:&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;b&gt;As of &lt;br/&gt;
December 31&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;Composition of deferred tax assets:&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2022&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2021&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left"&gt;Net operating loss and capital losses carry-forward&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;6,343&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;6,254&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Research and development credits&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;438&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;588&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Vacation accrual&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;48&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;62&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Net deferred tax asset before deferred tax liabilities and valuation allowance&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;6,829&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;6,904&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Valuation allowance&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(6,829&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(6,904&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Net deferred tax assets&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-91"&gt;-&lt;/div&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-92"&gt;-&lt;/div&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify"&gt;In assessing the realization of deferred
tax assets, management considers whether it is more likely than not that all or some portion of the deferred tax assets will not be realized.
The ultimate realization of the deferred tax assets is dependent upon the generation of future taxable income during the periods in which
temporary differences are deductible and net operating losses are utilized. Based on consideration of these factors, the Company recorded
a full valuation allowance as of December 31, 2022 and 2021.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: -28.35pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"/&gt;&lt;td style="width: 28.35pt"&gt;&lt;b&gt;F.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;During the years ended December 31, 2022, 2021 and 2020, the main reconciling item between the statutory
tax rate of the Company (as noted in Note 15A) and the effective tax rate at the rate of 4.4%, 5.8% and 4.0%, respectively, is the recognition
of valuation allowance in respect of deferred taxes relating to accumulated net operating losses carried forward and other permanent and
temporary differences due to the uncertainty of the realization of such deferred taxes and withholding taxes that were deducted by the
Company&#x2019;s customers.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings contextRef="c0" decimals="2" unitRef="pure">0.23</us-gaap:EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings>
    <us-gaap:OtherNonoperatingGainsLosses contextRef="c0" decimals="-3" unitRef="usd">27169000</us-gaap:OtherNonoperatingGainsLosses>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal contextRef="c2" decimals="-3" unitRef="usd">409000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate contextRef="c0" decimals="2" unitRef="pure">0.21</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;b&gt;Year ended  December 31&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2022&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2021&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2020&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left"&gt;Domestic&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;1,293&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;1,104&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;2,529&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Foreign operations (Beamr Inc and Imaging RU)&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(97&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(204&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(165&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;1,196&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;900&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;2,364&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify"&gt;&#160;&lt;/p&gt;</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic contextRef="c0" decimals="-3" unitRef="usd">1293000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic contextRef="c8" decimals="-3" unitRef="usd">1104000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic contextRef="c9" decimals="-3" unitRef="usd">2529000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign contextRef="c0" decimals="-3" unitRef="usd">-97000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign contextRef="c8" decimals="-3" unitRef="usd">-204000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign contextRef="c9" decimals="-3" unitRef="usd">-165000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest contextRef="c0" decimals="-3" unitRef="usd">1196000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest contextRef="c8" decimals="-3" unitRef="usd">900000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest contextRef="c9" decimals="-3" unitRef="usd">2364000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;b&gt;As of &lt;br/&gt;
December 31&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;Composition of deferred tax assets:&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2022&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2021&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left"&gt;Net operating loss and capital losses carry-forward&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;6,343&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;6,254&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Research and development credits&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;438&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;588&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Vacation accrual&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;48&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;62&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Net deferred tax asset before deferred tax liabilities and valuation allowance&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;6,829&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;6,904&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Valuation allowance&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(6,829&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(6,904&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Net deferred tax assets&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-91"&gt;-&lt;/div&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-92"&gt;-&lt;/div&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify"&gt;&#160;&lt;/p&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsCapitalLossCarryforwards contextRef="c2" decimals="-3" unitRef="usd">6343000</us-gaap:DeferredTaxAssetsCapitalLossCarryforwards>
    <us-gaap:DeferredTaxAssetsCapitalLossCarryforwards contextRef="c3" decimals="-3" unitRef="usd">6254000</us-gaap:DeferredTaxAssetsCapitalLossCarryforwards>
    <us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment contextRef="c2" decimals="-3" unitRef="usd">438000</us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment>
    <us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment contextRef="c3" decimals="-3" unitRef="usd">588000</us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities contextRef="c2" decimals="-3" unitRef="usd">48000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities contextRef="c3" decimals="-3" unitRef="usd">62000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities>
    <us-gaap:DeferredTaxAssetsGross contextRef="c2" decimals="-3" unitRef="usd">6829000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross contextRef="c3" decimals="-3" unitRef="usd">6904000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="c2" decimals="-3" unitRef="usd">6829000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="c3" decimals="-3" unitRef="usd">6904000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="c0" decimals="3" unitRef="pure">0.044</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="c8" decimals="3" unitRef="pure">0.058</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="c9" decimals="3" unitRef="pure">0.04</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:SegmentReportingDisclosureTextBlock contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"&gt;&lt;b&gt;NOTE 16 - SEGMENT GEOGRAPHICAL
INFORMATION AND MAJOR CUSTOMERS&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0%"/&gt;&lt;td style="width: 0.5in"&gt;&lt;b&gt;A.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;General information&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: -28.35pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"&gt;Since inception date, the operation
of the Company is conducted through one operating segment, the optimization technology for video and photo compression, which represents
a single reporting unit. This activity also represents the reportable segment of the Group.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0%"/&gt;&lt;td style="width: 0.5in"&gt;&lt;b&gt;B.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;Revenues by geographic region are as follows:&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;b&gt;Year ended December 31&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2022&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2021&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2020&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left"&gt;United States&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;2,134&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;2,597&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;2,558&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Israel&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;22&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;101&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;61&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Rest of the world&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;707&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;602&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;557&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;2,863&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;3,300&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;3,176&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"&gt;Revenues were attributed to countries
based on customer location.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0%"/&gt;&lt;td style="width: 0.5in"&gt;&lt;b&gt;C.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;Long-lived assets, net, by geographic areas:&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;As of&lt;br/&gt;
 December 31,&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2022&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2021&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left; text-indent: -14.15pt; padding-left: 14.15pt"&gt;Israel&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;12&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;13&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -14.15pt; padding-left: 14.15pt"&gt;United States&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;1&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;4&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; text-indent: -14.15pt; padding-left: 14.15pt"&gt;Russia&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;2&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;4&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 4pt; text-indent: -14.15pt; padding-left: 14.15pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;15&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;21&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"&gt;Such balance is comprised of property
and equipment that are attributed to the geographic area in which they are located or originated, as applicable.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0%"/&gt;&lt;td style="width: 0.5in"&gt;&lt;b&gt;D.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;Major customers&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: -28.35pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 6pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"&gt;During the years ended December 31,
2022, 2021 and 2020, the Company had one customer which accounted for 26%, 23% and 23% of the Company&#x2019;s total revenues, respectively.
In addition, as of December 31, 2022 and 2021, the Company had one customer which accounted for 28% and 44% of the Company&#x2019;s total trade
receivables, respectively.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 6pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0%"/&gt;&lt;td style="width: 0.5in"&gt;&lt;b&gt;E.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;Major product lines and services and timing of revenue recognition&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: -28.35pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 6pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"&gt;In the following table, revenue is
disaggregated by primary major product lines and services, and timing of revenue recognition for the years ended December 31, 2022, 2021
and 2020:&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 6pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;b&gt;Year ended  December 31,&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2022&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2021&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2020&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;Software license:&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; width: 64%; text-align: left"&gt;Perpetual based software license - transferred at a point of time&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;1,068&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;1,156&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;1,043&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt"&gt;Term-based software license - transferred at a point of time&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;1,630&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;2,032&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;1,976&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Total software license (*)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;2,740&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;3,188&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;3,019&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;PCS services transferred over a period of time&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;123&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;112&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;157&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Advertising at a point of time upon clicks&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;42&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-93"&gt;-&lt;/div&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-94"&gt;-&lt;/div&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;2,863&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;3,300&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;3,176&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.65pt; text-align: justify; text-indent: -21.3pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 6pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"/&gt;&lt;td style="width: 0.25in; text-align: left"&gt;(*)&lt;/td&gt;&lt;td style="text-align: justify"&gt;Revenue recognized from sales-based software license was $48,
$45 and $99 during the years ended December 31, 2022, 2021 and 2020, respectively (see also Note 2N).&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfOperatingSegments contextRef="c0" decimals="0" unitRef="Segment">1</us-gaap:NumberOfOperatingSegments>
    <us-gaap:ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;b&gt;Year ended December 31&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2022&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2021&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2020&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left"&gt;United States&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;2,134&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;2,597&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;2,558&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Israel&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;22&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;101&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;61&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Rest of the world&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;707&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;602&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;557&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;2,863&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;3,300&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;3,176&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify"&gt;&#160;&lt;/p&gt;</us-gaap:ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock>
    <us-gaap:Revenues contextRef="c163" decimals="-3" unitRef="usd">2134000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c164" decimals="-3" unitRef="usd">2597000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c165" decimals="-3" unitRef="usd">2558000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c166" decimals="-3" unitRef="usd">22000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c167" decimals="-3" unitRef="usd">101000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c168" decimals="-3" unitRef="usd">61000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c169" decimals="-3" unitRef="usd">707000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c170" decimals="-3" unitRef="usd">602000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c171" decimals="-3" unitRef="usd">557000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c0" decimals="-3" unitRef="usd">2863000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c8" decimals="-3" unitRef="usd">3300000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c9" decimals="-3" unitRef="usd">3176000</us-gaap:Revenues>
    <us-gaap:LongLivedAssetsByGeographicAreasTableTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;As of&lt;br/&gt;
 December 31,&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2022&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2021&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left; text-indent: -14.15pt; padding-left: 14.15pt"&gt;Israel&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;12&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;13&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -14.15pt; padding-left: 14.15pt"&gt;United States&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;1&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;4&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; text-indent: -14.15pt; padding-left: 14.15pt"&gt;Russia&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;2&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;4&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 4pt; text-indent: -14.15pt; padding-left: 14.15pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;15&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;21&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify"&gt;&#160;&lt;/p&gt;</us-gaap:LongLivedAssetsByGeographicAreasTableTextBlock>
    <us-gaap:NoncurrentAssets contextRef="c172" decimals="-3" unitRef="usd">12000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets contextRef="c173" decimals="-3" unitRef="usd">13000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets contextRef="c174" decimals="-3" unitRef="usd">1000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets contextRef="c175" decimals="-3" unitRef="usd">4000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets contextRef="c176" decimals="-3" unitRef="usd">2000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets contextRef="c177" decimals="-3" unitRef="usd">4000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets contextRef="c2" decimals="-3" unitRef="usd">15000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets contextRef="c3" decimals="-3" unitRef="usd">21000</us-gaap:NoncurrentAssets>
    <us-gaap:EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense contextRef="c0" decimals="2" unitRef="pure">0.26</us-gaap:EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense>
    <us-gaap:EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense contextRef="c8" decimals="2" unitRef="pure">0.23</us-gaap:EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense>
    <us-gaap:EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense contextRef="c9" decimals="2" unitRef="pure">0.23</us-gaap:EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense>
    <bmr:TradeReceivablesIncomeTaxRate contextRef="c0" decimals="2" unitRef="pure">0.28</bmr:TradeReceivablesIncomeTaxRate>
    <bmr:TradeReceivablesIncomeTaxRate contextRef="c8" decimals="2" unitRef="pure">0.44</bmr:TradeReceivablesIncomeTaxRate>
    <us-gaap:DisaggregationOfRevenueTableTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;b&gt;Year ended  December 31,&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2022&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2021&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2020&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;Software license:&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; width: 64%; text-align: left"&gt;Perpetual based software license - transferred at a point of time&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;1,068&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;1,156&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;1,043&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt"&gt;Term-based software license - transferred at a point of time&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;1,630&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;2,032&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;1,976&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Total software license (*)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;2,740&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;3,188&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;3,019&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;PCS services transferred over a period of time&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;123&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;112&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;157&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Advertising at a point of time upon clicks&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;42&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-93"&gt;-&lt;/div&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-94"&gt;-&lt;/div&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;2,863&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;3,300&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;3,176&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.65pt; text-align: justify; text-indent: -21.3pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 6pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"/&gt;&lt;td style="width: 0.25in; text-align: left"&gt;(*)&lt;/td&gt;&lt;td style="text-align: justify"&gt;Revenue recognized from sales-based software license was $48,
$45 and $99 during the years ended December 31, 2022, 2021 and 2020, respectively (see also Note 2N).&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:PaymentsForSoftware contextRef="c178" decimals="-3" unitRef="usd">1068000</us-gaap:PaymentsForSoftware>
    <us-gaap:PaymentsForSoftware contextRef="c179" decimals="-3" unitRef="usd">1156000</us-gaap:PaymentsForSoftware>
    <us-gaap:PaymentsForSoftware contextRef="c180" decimals="-3" unitRef="usd">1043000</us-gaap:PaymentsForSoftware>
    <us-gaap:PaymentsForSoftware contextRef="c181" decimals="-3" unitRef="usd">1630000</us-gaap:PaymentsForSoftware>
    <us-gaap:PaymentsForSoftware contextRef="c182" decimals="-3" unitRef="usd">2032000</us-gaap:PaymentsForSoftware>
    <us-gaap:PaymentsForSoftware contextRef="c183" decimals="-3" unitRef="usd">1976000</us-gaap:PaymentsForSoftware>
    <us-gaap:PaymentsForSoftware contextRef="c0" decimals="-3" id="ix_28_fact" unitRef="usd">2740000</us-gaap:PaymentsForSoftware>
    <us-gaap:PaymentsForSoftware contextRef="c8" decimals="-3" id="ix_29_fact" unitRef="usd">3188000</us-gaap:PaymentsForSoftware>
    <us-gaap:PaymentsForSoftware contextRef="c9" decimals="-3" id="ix_30_fact" unitRef="usd">3019000</us-gaap:PaymentsForSoftware>
    <bmr:PCSServicesTransferredOverAPeriod contextRef="c0" decimals="-3" unitRef="usd">123000</bmr:PCSServicesTransferredOverAPeriod>
    <bmr:PCSServicesTransferredOverAPeriod contextRef="c8" decimals="-3" unitRef="usd">112000</bmr:PCSServicesTransferredOverAPeriod>
    <bmr:PCSServicesTransferredOverAPeriod contextRef="c9" decimals="-3" unitRef="usd">157000</bmr:PCSServicesTransferredOverAPeriod>
    <bmr:AdvertisingAtAPointOfTimeUponClicks contextRef="c0" decimals="-3" unitRef="usd">42000</bmr:AdvertisingAtAPointOfTimeUponClicks>
    <bmr:RecognitionofRevenue contextRef="c0" decimals="-3" unitRef="usd">2863000</bmr:RecognitionofRevenue>
    <bmr:RecognitionofRevenue contextRef="c8" decimals="-3" unitRef="usd">3300000</bmr:RecognitionofRevenue>
    <bmr:RecognitionofRevenue contextRef="c9" decimals="-3" unitRef="usd">3176000</bmr:RecognitionofRevenue>
    <us-gaap:DeferredRevenueRevenueRecognized1 contextRef="c0" decimals="-3" unitRef="usd">48000</us-gaap:DeferredRevenueRevenueRecognized1>
    <us-gaap:DeferredRevenueRevenueRecognized1 contextRef="c8" decimals="-3" unitRef="usd">45000</us-gaap:DeferredRevenueRevenueRecognized1>
    <us-gaap:DeferredRevenueRevenueRecognized1 contextRef="c9" decimals="-3" unitRef="usd">99000</us-gaap:DeferredRevenueRevenueRecognized1>
    <us-gaap:SubsequentEventsTextBlock contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"&gt;&lt;b&gt;NOTE 17 - SUBSEQUENT EVENTS&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 6pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"&gt;The Company evaluated subsequent
events and transactions that occurred after the balance sheet date up to the date that the consolidated financial statements were available
to be issued (April 17, 2023). Based upon this review, the Company did not identify any other subsequent events that would have required
adjustment or disclosure in the financial statements except as disclosed below.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 6pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"&gt;&lt;b&gt;Completion of an Initial
Public Offering Transaction&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 6pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"&gt;On February 27, 2023, the Company
announced the pricing of its initial public offering of 1,950,000 Ordinary Shares at a public offering price of $4.00 per share, for aggregate
gross proceeds of $7,800 prior to deducting underwriting discounts and other offering expenses. In addition, the Company granted the underwriters
(i) 97,500 warrants which shall be exercisable into Ordinary Shares of the Company at an exercise price of $5.00 per Ordinary Share over
a period of 5-years commencing August 26, 2023 and (ii) a 45-day option to purchase up to an additional 292,500 ordinary shares at the
public offering price less discounts, to cover over-allotments. The over-allotment option was not exercised and has expired as of the
date of filing of these consolidated financial statements.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 6pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"&gt;The Ordinary Shares began trading
on the Nasdaq Capital Market under the ticker symbol &#x201c;BMR&#x201d; on February 28, 2023. The Company&#x2019;s IPO closed on March 2,
2023.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 6pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"&gt;For accounting purposes, following
the completion of the above IPO transaction, all shares, options and warrants to purchase Ordinary Shares and loss per share amounts have
been adjusted to give retroactive effect to the Reverse Share Split for all periods presented in these consolidated financial statements.
Any fractional shares resulting from the Reverse Share Split were rounded up to the nearest whole share.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 6pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"&gt;In addition, the holders of&#160;all
other shares with preferences over Ordinary Shares (i.e. Convertible Preferred Shares and Convertible Ordinary 1 and 2 Shares) effected
a conversion of all such shares to 7,211,280 Ordinary Shares, effective as of the pricing of the IPO on February 27, 2023.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 6pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"&gt;Further, in connection with the above IPO, on March 14, 2022, the Company's
shareholders approved to increase the Company's authorized shares from 22,000,000 to 222,000,000. These consolidated financial statements
exclude the aforesaid increase of authorized shares, as if such change to the Company&#x2019;s capital structure had not yet occurred.&lt;/p&gt;</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight contextRef="c184" decimals="0" unitRef="shares">1950000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight>
    <bmr:PublicOfferingPrice contextRef="c185" decimals="2" unitRef="usdPershares">4</bmr:PublicOfferingPrice>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="c186" decimals="-3" unitRef="usdPershares">7800000</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:DebtInstrumentInterestRateTerms contextRef="c0">In addition, the Company granted the underwriters
(i) 97,500 warrants which shall be exercisable into Ordinary Shares of the Company at an exercise price of $5.00 per Ordinary Share over
a period of 5-years commencing August 26, 2023 and (ii) a 45-day option to purchase up to an additional 292,500 ordinary shares at the
public offering price less discounts, to cover over-allotments.</us-gaap:DebtInstrumentInterestRateTerms>
    <us-gaap:PreferredStockConvertibleSharesIssuable contextRef="c187" decimals="0" unitRef="shares">1</us-gaap:PreferredStockConvertibleSharesIssuable>
    <us-gaap:PreferredStockConvertibleSharesIssuable contextRef="c188" decimals="0" unitRef="shares">2</us-gaap:PreferredStockConvertibleSharesIssuable>
    <us-gaap:ConversionOfStockSharesIssued1 contextRef="c189" decimals="0" unitRef="shares">7211280</us-gaap:ConversionOfStockSharesIssued1>
    <us-gaap:TemporaryEquitySharesAuthorized contextRef="c190" decimals="0" unitRef="shares">22000000</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesAuthorized contextRef="c191" decimals="0" unitRef="shares">222000000</us-gaap:TemporaryEquitySharesAuthorized>
    <dei:LocalPhoneNumber contextRef="c1" id="hidden-fact-0">520-8735</dei:LocalPhoneNumber>
    <dei:CityAreaCode contextRef="c1" id="hidden-fact-1">1-888</dei:CityAreaCode>
    <dei:DocumentAccountingStandard contextRef="c0" id="hidden-fact-2">U.S. GAAP</dei:DocumentAccountingStandard>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="c3"
      id="hidden-fact-3"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:DueToRelatedPartiesNoncurrent
      contextRef="c3"
      id="hidden-fact-4"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="c2"
      id="hidden-fact-5"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="c3"
      id="hidden-fact-6"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c4"
      decimals="2"
      id="hidden-fact-7"
      unitRef="ilsPershares">0.05</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c5"
      decimals="2"
      id="hidden-fact-8"
      unitRef="ilsPershares">0.05</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c6"
      decimals="2"
      id="hidden-fact-9"
      unitRef="ilsPershares">0.05</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c7"
      decimals="2"
      id="hidden-fact-10"
      unitRef="ilsPershares">0.05</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="c2"
      decimals="2"
      id="hidden-fact-11"
      unitRef="ilsPershares">0.05</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="c3"
      decimals="2"
      id="hidden-fact-12"
      unitRef="ilsPershares">0.05</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c8"
      decimals="2"
      id="hidden-fact-13"
      unitRef="usdPershares">-0.37</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c0"
      decimals="2"
      id="hidden-fact-14"
      unitRef="usdPershares">-0.48</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c9"
      decimals="2"
      id="hidden-fact-15"
      unitRef="usdPershares">-0.96</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="c9"
      decimals="INF"
      id="hidden-fact-16"
      unitRef="shares">2574814</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="c0"
      decimals="INF"
      id="hidden-fact-17"
      unitRef="shares">2578760</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="c8"
      decimals="INF"
      id="hidden-fact-18"
      unitRef="shares">2578760</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="c16"
      id="hidden-fact-19"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="c17"
      id="hidden-fact-20"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="c18"
      id="hidden-fact-21"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="c20"
      id="hidden-fact-22"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="c16"
      id="hidden-fact-23"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="c17"
      id="hidden-fact-24"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="c17"
      id="hidden-fact-25"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="c18"
      id="hidden-fact-26"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="c18"
      id="hidden-fact-27"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="c20"
      id="hidden-fact-28"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="c16"
      id="hidden-fact-29"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="c17"
      id="hidden-fact-30"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="c18"
      id="hidden-fact-31"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="c19"
      id="hidden-fact-32"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="c27"
      id="hidden-fact-33"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="c28"
      id="hidden-fact-34"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="c29"
      id="hidden-fact-35"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="c31"
      id="hidden-fact-36"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="c27"
      id="hidden-fact-37"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="c28"
      id="hidden-fact-38"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="c29"
      id="hidden-fact-39"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="c30"
      id="hidden-fact-40"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="c35"
      id="hidden-fact-41"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="c36"
      id="hidden-fact-42"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="c37"
      id="hidden-fact-43"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="c35"
      id="hidden-fact-44"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="c36"
      id="hidden-fact-45"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="c37"
      id="hidden-fact-46"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="c39"
      id="hidden-fact-47"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="c35"
      id="hidden-fact-48"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="c36"
      id="hidden-fact-49"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="c37"
      id="hidden-fact-50"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="c38"
      id="hidden-fact-51"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment
      contextRef="c0"
      id="hidden-fact-52"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment
      contextRef="c0"
      id="hidden-fact-53"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="c0"
      id="hidden-fact-54"
      unitRef="usd"
      xsi:nil="true"/>
    <bmr:ConsiderationReceivedFromPPPNote
      contextRef="c0"
      id="hidden-fact-55"
      unitRef="usd"
      xsi:nil="true"/>
    <bmr:NetConsiderationReceivedFromIBILoan
      contextRef="c8"
      id="hidden-fact-56"
      unitRef="usd"
      xsi:nil="true"/>
    <bmr:NetConsiderationReceivedFromIBILoan
      contextRef="c9"
      id="hidden-fact-57"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:DerivativeLiabilityFairValueOfCollateral
      contextRef="c3"
      id="hidden-fact-58"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:DerivativeLiabilityFairValueOfCollateral
      contextRef="c26"
      id="hidden-fact-59"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:DebtInstrumentDecreaseForgiveness
      contextRef="c0"
      id="hidden-fact-60"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:DebtInstrumentDecreaseForgiveness
      contextRef="c9"
      id="hidden-fact-61"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:LoanProcessingFee
      contextRef="c9"
      id="hidden-fact-62"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ExtinguishmentOfDebtAmount
      contextRef="c0"
      id="hidden-fact-63"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ExtinguishmentOfDebtAmount
      contextRef="c9"
      id="hidden-fact-64"
      unitRef="usd"
      xsi:nil="true"/>
    <bmr:RecognitionSubsequentToSubstantialModificationOfTerms
      contextRef="c0"
      id="hidden-fact-65"
      unitRef="usd"
      xsi:nil="true"/>
    <bmr:RecognitionSubsequentToSubstantialModificationOfTerms
      contextRef="c9"
      id="hidden-fact-66"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential
      contextRef="c8"
      id="hidden-fact-67"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential
      contextRef="c9"
      id="hidden-fact-68"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
      contextRef="c3"
      id="hidden-fact-69"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
      contextRef="c3"
      id="hidden-fact-70"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="c26"
      id="hidden-fact-71"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet
      contextRef="c0"
      id="hidden-fact-72"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:AdjustmentOfWarrantsGrantedForServices
      contextRef="c8"
      id="hidden-fact-73"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1
      contextRef="c0"
      id="hidden-fact-74"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1
      contextRef="c9"
      id="hidden-fact-75"
      unitRef="usd"
      xsi:nil="true"/>
    <bmr:WeightedAverageRemainingContractualLifeExercised contextRef="c9" id="hidden-fact-76" xsi:nil="true"/>
    <bmr:WeightedAverageRemainingContractualLifeForfeitedOrExpired contextRef="c9" id="hidden-fact-77" xsi:nil="true"/>
    <bmr:WeightedAverageRemainingContractualLifeForfeitedOrExpired contextRef="c8" id="hidden-fact-78" xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="c0"
      id="hidden-fact-79"
      unitRef="pure"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="c8"
      id="hidden-fact-80"
      unitRef="pure"
      xsi:nil="true"/>
    <bmr:ModificationOfTermsRelatingToStraightLoan
      contextRef="c0"
      id="hidden-fact-81"
      unitRef="usd"
      xsi:nil="true"/>
    <bmr:ModificationOfTermsRelatingToStraightLoan
      contextRef="c9"
      id="hidden-fact-82"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="c8"
      id="hidden-fact-83"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="c9"
      id="hidden-fact-84"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:InvestmentRelatedLiabilities
      contextRef="c15"
      id="hidden-fact-85"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:PartnersCapitalAccountContributions
      contextRef="c8"
      id="hidden-fact-86"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:PartnersCapitalAccountContributions
      contextRef="c9"
      id="hidden-fact-87"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:InvestmentIncomeAmortizationOfDiscount
      contextRef="c8"
      id="hidden-fact-88"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:InvestmentIncomeAmortizationOfDiscount
      contextRef="c9"
      id="hidden-fact-89"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:OtherCommitmentDueInSecondYear
      contextRef="c3"
      id="hidden-fact-90"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="c2"
      id="hidden-fact-91"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="c3"
      id="hidden-fact-92"
      unitRef="usd"
      xsi:nil="true"/>
    <bmr:AdvertisingAtAPointOfTimeUponClicks
      contextRef="c8"
      id="hidden-fact-93"
      unitRef="usd"
      xsi:nil="true"/>
    <bmr:AdvertisingAtAPointOfTimeUponClicks
      contextRef="c9"
      id="hidden-fact-94"
      unitRef="usd"
      xsi:nil="true"/>
    <dei:AmendmentFlag contextRef="c0">false</dei:AmendmentFlag>
    <dei:DocumentFiscalPeriodFocus contextRef="c0">FY</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey contextRef="c0">0001899005</dei:EntityCentralIndexKey>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#hidden-fact-19"
          xlink:label="hidden-fact-19"
          xlink:type="locator"/>
        <link:footnote id="ix_0_footnote" xlink:label="ix_0_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Representing an amount less than $1.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-19"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#ix_0_fact"
          xlink:label="ix_0_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_1_fact"
          xlink:label="ix_1_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_1_footnote" xlink:label="ix_1_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">As described in Note 6C above, the Company is required to repay
each year a minimum amount of $330 with respect to Repayment Amount (principal and interest).</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_0_fact"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_1_fact"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#ix_2_fact"
          xlink:label="ix_2_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_3_fact"
          xlink:label="ix_3_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_2_footnote" xlink:label="ix_2_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Including accrued interest relating to straight loan amounted
to $11 as of December 31, 2022. See also Note 13.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_2_fact"
          xlink:to="ix_2_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_3_fact"
          xlink:to="ix_2_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#ix_6_fact"
          xlink:label="ix_6_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_4_fact"
          xlink:label="ix_4_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_7_fact"
          xlink:label="ix_7_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_5_fact"
          xlink:label="ix_5_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_3_footnote" xlink:label="ix_3_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The Ordinary Shares confer upon the holders thereof all rights
accruing to a shareholder of the Company, as provided in the Company&#x2019;s Articles of Association (the &#x201c;Articles&#x201d;), including,
without limitation, the right to receive notices of, and to attend, all general meetings, the right to vote thereat with each Ordinary
Share held entitling the holder thereof to one vote at all general meetings (and written actions in lieu of meetings), the right to participate
and share on a per share basis, in any distribution and in distribution of surplus assets and funds of the Company in the event of a
liquidation event, and certain other rights as may be expressly provided for herein or under the Companies Law. All Ordinary Shares rank
pari passu amongst themselves for all intents and purposes, including, without limitation, in relation to the amounts of capital paid
or credited as paid on their nominal value. The voting, dividend and liquidation rights of the holders of Ordinary Shares are subject
to and qualified by the rights, powers and preferences of the holders of the Convertible Preferred Shares and the Convertible Ordinary
1 and 2 Shares as set below.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_6_fact"
          xlink:to="ix_3_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_4_fact"
          xlink:to="ix_3_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_7_fact"
          xlink:to="ix_3_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_5_fact"
          xlink:to="ix_3_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#ix_26_fact"
          xlink:label="ix_26_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_24_fact"
          xlink:label="ix_24_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_27_fact"
          xlink:label="ix_27_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_23_fact"
          xlink:label="ix_23_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_15_fact"
          xlink:label="ix_15_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_19_fact"
          xlink:label="ix_19_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_8_fact"
          xlink:label="ix_8_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_20_fact"
          xlink:label="ix_20_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_13_fact"
          xlink:label="ix_13_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_25_fact"
          xlink:label="ix_25_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_10_fact"
          xlink:label="ix_10_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_17_fact"
          xlink:label="ix_17_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_18_fact"
          xlink:label="ix_18_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_14_fact"
          xlink:label="ix_14_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_21_fact"
          xlink:label="ix_21_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_9_fact"
          xlink:label="ix_9_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_16_fact"
          xlink:label="ix_16_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_11_fact"
          xlink:label="ix_11_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_12_fact"
          xlink:label="ix_12_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_22_fact"
          xlink:label="ix_22_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_4_footnote" xlink:label="ix_4_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The Convertible Ordinary 1 Shares, Convertible Ordinary 2 Shares, Convertible B Preferred Shares, Convertible B1 Preferred Shares and the Convertible C Preferred Shares (referring together herein as &#x201c;Convertible Preferred Shares&#x201d;) shall confer upon the holders thereof all rights conferred upon the holders of Ordinary Shares in the Company. In addition, the holders of Convertible Preferred Shares shall have rights, preferences and privileges, as follows:

Liquidation preference - Based on preference of distribution, in the event of any liquidation, dissolution or winding up of the Company, whether voluntary or involuntary, change in control or distribution, the Company&#x2019;s assets or surplus funds legally available for distribution shall be distributed to the holders of Convertible Preferred Shares pursuant to which each Convertible Preferred Share will be entitled to receive 1.2 of the applicable original issue price paid by each Convertible Preferred shareholder plus all accrued but unpaid dividends and less the aggregate of all amounts previously paid in preference. The aggregate liquidation preference of all shares with preferences over Ordinary Shares as of December 31, 2022 and 2021 amounted to $33,785. None of the foregoing dollar amounts include dividends, as the Board of Directors has not declared any dividends since inception.

The Convertible Preferred Shares have been classified as part of the permanent equity of the Company since upon occurrence of liquidation event all holder of the Ordinary Shares and the Convertible Preferred Shares will be entitled to receive the same form of consideration.

Voting - Each shareholder shall have one vote for each Ordinary Share held by such shareholder of record or such Ordinary Shares as would be held by each holder of Convertible Preferred Share if all Convertible Preferred Shares were converted to Ordinary Shares at the then effective conversion rate, on every resolution.

Conversion - Each holder of a Convertible Preferred Share shall be entitled to convert, at any time and from time to time, and without payment of additional consideration, into such number of fully paid and non-assessable shares of Ordinary Share in ratio as determined in the Articles, which initially shall be one to one. The conversion price initially shall be the applicable Original Issue Price subject to adjustments as describe in the Articles.

All outstanding Convertible Preferred Shares shall automatically be converted into Ordinary Shares at the then-effective conversion rate applicable upon the earlier of (i) closing of sale of Ordinary Shares in an initial firm-commitment underwritten public offering, with net proceeds to the Company of $50,000 and at an offering price per share equal to at least 5 times the Preferred C Original Issue Price (Qualified IPO) or (ii) affirmative vote or written consent of majority shareholders of the then outstanding Convertible Preferred Shares, with respect to each series.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_26_fact"
          xlink:to="ix_4_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_24_fact"
          xlink:to="ix_4_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_27_fact"
          xlink:to="ix_4_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_23_fact"
          xlink:to="ix_4_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_15_fact"
          xlink:to="ix_4_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_19_fact"
          xlink:to="ix_4_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_8_fact"
          xlink:to="ix_4_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_20_fact"
          xlink:to="ix_4_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_13_fact"
          xlink:to="ix_4_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_25_fact"
          xlink:to="ix_4_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_10_fact"
          xlink:to="ix_4_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_17_fact"
          xlink:to="ix_4_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_18_fact"
          xlink:to="ix_4_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_14_fact"
          xlink:to="ix_4_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_21_fact"
          xlink:to="ix_4_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_9_fact"
          xlink:to="ix_4_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_16_fact"
          xlink:to="ix_4_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_11_fact"
          xlink:to="ix_4_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_12_fact"
          xlink:to="ix_4_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_22_fact"
          xlink:to="ix_4_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#ix_28_fact"
          xlink:label="ix_28_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_30_fact"
          xlink:label="ix_30_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_29_fact"
          xlink:label="ix_29_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_5_footnote" xlink:label="ix_5_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Revenue recognized from sales-based software license was $48,
$45 and $99 during the years ended December 31, 2022, 2021 and 2020, respectively (see also Note 2N).</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_28_fact"
          xlink:to="ix_5_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_30_fact"
          xlink:to="ix_5_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_29_fact"
          xlink:to="ix_5_footnote"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>105
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
M" !4@IA6Y(@NA^H&   Z(0  &    'AL+W=O<FMS:&5E=',O<VAE970Q+GAM
M;*V::W/:.!2&_XJ&G>GLS@2P99.0-F&6D- RS6U#VIWN-\46X(EML;*<R_[Z
M/9+!HEUQ[+;[)<'&>OU8E_><(W/R+.1CL>)<D9<LS8O3SDJI]=M^OXA6/&-%
M3ZQY#M\LA,R8@D.Y[!=KR5EL&F5IGWK>83]C2=X9G9ASMW)T(DJ5)CF_E:0H
MLXS)US.>BN?3CM_9GKA+EBNE3_1')VNVY'.N/JUO)1SU:Y4XR7A>)"(GDB].
M.V/_[=G -#!7?$[X<['SF>A'>1#B41_,XM..IXEXRB.E)1C\>^(3GJ9:"3C^
MWHAVZGOJAKN?M^I3\_#P, ^LX!.1_IG$:G7:&79(S!>L3-6=>/[ -P\TT'J1
M2 OSESQ7UX9AAT1EH42V:0P$69)7_]G+IB-V&QSN:4 W#:CAKFYD*,^98J,3
M*9Z)U%>#FOY@'M6T!K@DUZ,R5Q*^3:"=&IV+J(1.5F2<Q^0B5XEZ);.\&FWH
MM9.^@IOH2_O11O"L$J1[!'U*KD2N5@6HQ3S^6J /=#4BW2*>453QG$<]$O@'
MA'J4DF+%)"\0V:!^\L#(!DU/OO.XY!(N(C/%L\+UY)5@Z!;4Z^=ML681/^W
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M7P#?+X10VP-]@_KG$J-_ 5!+ P04    " !4@IA6&^9/D6X&  #V'0  &
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M%ZO;Q.K:O"^66&R FC40EP_D1T%W.%7!&V>Q=A54KLH"L%L$<_=RMNL&H]M
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M?F$/R\ZSSCRB M^1Y+\XHIN;@3\ $5ZA74(_DN<%KCOD<+XE28KR$SS76&,
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MYKWKR^+>O;R^%%N=I3F_ET1MUVLF7VYY)IZN>D%O?^-'NEQI<Z-_?;EA2_[
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M=7&YX@Q"BQ& _R\$!)CJBWG X0<9U_\'4$L#!!0    ( %2"F%;>VTTWMPH
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MG7)N7LZ+#T LMELR'DM0I76[(Q8)9L'7GP X#=!LMV:I$&2Z)\D,N$16!2Y
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M5A!A(408($+2YY2J>AI^:N>H;YZ3'M0 &B*G8DJ@<]D!/C6K-C8KXB(,OCK
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MH[0UC772V3U-0@<TO8?)7)VJE!7'?FKJZ&6!$Q$W*IR6\IN*SU./+DT!)J&
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MC<XO+PBHMB];P\C:]\)*&MM9?EO848;*.=C[M91F;[@ W7!,_P)02P,$%
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M-A$Z+ZN@UZ+Q#>$=<L7V\L<003H:P<(H:N+NC!.?L:9]'@U.Z#&"P3@*&KQ
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MJFL%6H5B#Z]#O"_KV&I'R?G9F%;N#T?C!,XP*TU #7T%6I-].""Y;-7>;?T
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M8J_BX ;X#0@0&$R P[ *1-GB;Q0?>HXJ)5/RXB/],V0D0.'D]E*>G T.QX-
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M3%=]0 K RMR4D)I!/G@>UI-'HZ0M1J$%,M)$D)ZE?3'J=#?.DG;-M@2DV\Y
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MD)%+Y!UNN;<HO5[+GG)(/Y#W&-7:T$OY=J7(9< ]/RF3JC_<,7 .65Y8<7B
MA36FJT#6?<DJ[ :"Q.:HF;3=&2XV(*,-W9=.(K, >S7976&K9<#H6<"'0,2N
MA<F+ !1C>F&+$$[^XF?J%[;VXBLNZY4OAY7)!EWKEO)"*^*$2T'BV5YL-P)F
M'(^92YG9064K0EL^J+F1'9[G/)>HM[=<4?[LN9X[AZ N,1:6;.0KH<'?&O ^
MHU,+J,0V.T<PR6@&\2[GV%SPX]Y58+%<+<TU9N!]\;8OK]73;*%GW\ \ +%R
M8(0?P;LL"<,:I .+P(Q'!U36_ZC Y.2(^S#@V+8-W!C MN2TGS\E=(O7U]?\
M:6?F!F=BVC*X"$[ET1ET.RT"V'>=V_%)W/%*,*<+D$SG9)Y(B=UO^SD%+],Z
MQ7(NAGV +SYV]4-N1,5I\'LZ&.)PM7EL_[;!*6PEVM 5Q+>6CB2(..UF@MTZ
M(FN"!HX=9% M+MRT89"2V$9GJY.NI\H&RBK>J2' ;Z,36\L7?B@CG,7@,.%D
MBXI_.G#%_XT+;'O%K>C+24VH"R-9TN4R7#ZK<XX5?(L5M3_(:,);@B8!M(NX
MKP$JP>6 (EBSS%"&7P(/UQA;JPBV05-'#F?S)[1L7T!GWD#60ZV$LKH#C2O0
M%64$6AK(+(FQV]834\'79],VM%].;JYNY616]P5DDVQQW5MYV?DS4PZ7?(BK
MZ7"G/6Q\MV5#?PPIX2QHGD?^WA581%Q@&8XN[%X<3$"AR^5?WMS>T-L67"R]
M[,OWC4UIXO;9A[<?Y.TJ^P:7_;U.6[]Z%@ R8>W_AYN MCM$(.9>/W=TZ.3@
MNZ JZA)OX1/O#L]YX"7B^:</M_*X/X0$*<\I.\329_E(M1:XW_[%8-#K'BG#
MJ;-8S1V@A*=$,)7H:DJD$#C:=:_7&XRFS6=PF/422^8WN'"%"5R4 ",]-^43
M6=P--]$,^&_@5B?):-D:)N1<G&%_AKD-+,9K62I-P*&6(N#323(\&R5GX'&Z
M7!KV1XZ#O0XX=SXBC@A<+R%T:D51^%S?>J[N4E]ZQ%JGB5)+Z^-/1J#\+GTH
MX":5P2J0FZX)LT-2C+S$8KAHNY $9'U2XH[WB @8CVR*^H=476U)#37>I@=8
MF<(?<:F;&T"N]]$A(QO<-<@]4J*6K!5M7*T0HZ/*/6EI0_.LE$;S-Y<JGS4Y
M.ZIK!HJ4E&%-8LJUB+9FSETBRY+]XV,&)IX+(8O7I)$5I"_P$_J4V K0=;>!
M8VVI:D-07(W?Q$WJH6%I,&S%'W#3PP;Q$'MLUC;*U$U[V'!TN*XG8=CL]J@1
MT8*.R#&@%#^RY+)=@@+M#%W(MO4NUQ:6V!IX3'\WSSVDW*ISN7@([CFYO22P
M/!==CEH.\:S)L^RQID/,D=.F=N,JP_,?6&BY"G[R>/QC7.VRXGLN'O'RBFZ_
MS3GQM 1FPT'\@%"='B'O" E.399FBA)D].GXM@L"<(59>G&G;;I85V6>R*6&
MO)V2VL*H&:>3'ZX_RP/]Z)HB8(_XB;TJY[Q@RJL,:Z:0*'S3,?W\A&\T8R7=
MJ%S[PEXEXWX9?3CWLV(A)QX!5%VY2M5ZH.:4S8)!Q0YPHP:7%6GV9L[ZV2;B
M*B.[V&6XH0F!/1Q(K@&&$+8&Q3XD1X$C)X21CC$1F5."#YP;XLR]%7_'>*A8
M]W7R96/%Y+I#7Y2-<RX9E$?HUD&5Y'2<C$^/PV"R+"%BV.2_'6"P,PUAJ-I>
M+B'>4%$TG#)U?7<X'@T]UV[6S.I,H%8;QQ)H_QBL=+)RL%Q!>9!E8[0R:8=Z
M$!X3.>8%MM7!+7=G+++.D!%/S81I8E8 OJ@=;H5 @%ET#5(=\&A_W"?\X)\6
M@9\DU)"F-!W=EB+;ND74]K!XNK-F\F$2XY3_9(0/RWU3S/M7ZQHQ5&>%&(Y\
MOM7*9BUBA%XAV50*0<X0TSO<=M[/EENCTDAFF_V>6.&)33BR*T#CO\0SM90$
MVHGZIY7F^AF7LDSPAD%$AI7Y0MF:,57*",QR@L'5+TTM#V6$JG$8O&6]/:Y]
M)X'J4R3+DM+^SC5:GI-6!1H=>M?4+YQQ$.$"$ (;]IN"R.36KLV^6.#T*_GN
M DO%.JZ7 0.6&+L(%8&[83;!IUT,UJUP)<_Q5GP/;\EQS-5]67'QG<AWY3M[
M4VIL?L 6PR?PCAOX9G4T(4?5.8"3$ S2R"H*DWXZ&85#M=($P6VJ<PS:3TBW
MJZK"&E3"CE$5I873Q#3 C:EZ"@H0%6<MW!7I[.0?\A%&U^3)P2+LA*<7H0A$
MZ%BRA0.)I(EE6TIIRS1_B=F)W2?_'YF>6#<]^2=-;\M5OLO\Q!;SD_\?YB=^
MEK_?9W['! G#?D;<RG!SV(Y5!VJ3=Y,<#6\T?&/?@"#D%;Z])-82]WB\#V-0
M.(;IH]'&Q,5]NFFWW<Y"?*^SD#_L+ Y_S%F$+RC\E)5[(_>C<XY"/TVS?SI*
MQH!#TLQG_.200-T$8^ TRYLZ>DTH0,J5'07^JV-N/'KA+$+LPIQ(<@@\^^*D
MH\/P[)HF_@!4V>4RA?,SNYUD\I<QJ^LK/B)G;HDS(FA4=J>WLB#-6[?*S%B,
MW8>LIGM]T4XRD>-HYYWL&!,E!ZHG/_ZJEJN7DT0>3'NX&;<R9SB1,!S$';VU
MUS Y=:;FI /A2#+]Q0"\!OZ]!D&EN/NV/-4^CAFH0E'XD6YTRWYU.]U(0X_K
MDM^,7YS<P[G2\!7">"H"/;K=1F&)P% U#/0:4V)21(N/.X>HX-TV06D$O3$'
MC+JW+RBNS_?UY0&.CA4T-0:YSG5G$HIK:^Y]A&Z)YV=?L72%86JTI]A*(>_O
MJS,F2J F9*QA.42\:R_G4L]V=/' P,UX'JXG]^79N;B-1CHA5Q%?:,3JKL*"
M?YR'[<L+\&K\/:18%5W3=LK2K,*IGA2'DV=@-]SW&[H7-N6#QO>0PE<S8U&1
MOH6T=!N%H79DE?"OF++7W2@-SE-I:)$]@+<(IG '.=PM]/./P1 [\;_[]N"F
MWHIQO15B11DW5V91<R4O3>OROY/>>!:76X X3H6*[CQ =]*F+]XQ3X*D4TV;
M7%7NI5(W;TR5$>,B:UG@I&W[?AJ58*J*^F7QR%TWN"!QQA68Z\4S[T5R$_N%
M^*_M_:413X)B_UM\!NZ'X\K[<CPXA_\/D\'I!?U[<GHA+B,=]OT;8I)O@1[*
M\8D\&PMLF<QV+/#F>7Y^!HL.Q4W[CC7R(!ZK37?:XOFY[-$>G@K7,<0@1Z;:
MSJ^>OL5G#["W!S]@(6/C"[#&OGO-I9Y81SH[#H][<GB"_XTNQ(0&YC:]._M#
M^YV=R9.QO!B*MG2'@*R[^8X]88>>/(!-X/\70]F+=PI'OG?M,AS0+@/B5;1#
M:Q);EP/OQ^<CW !!'/US H2\T\'[]*ZGNSZ+OV58'F2'<_&]CLH$;V8C&6VY
M=<M+H8<2Q^</Q=6C+1'33$?;'S"H(E:M7%AHS>-L>!8;B;CJMZ-N_&8B7B&H
M-!)#;*!I[4^\IPD"Z@,?V%EY-YH J17P[#\PO@Q/3_@\<<L#!+1@!(I_*+Y@
M,+0?G(YWDRMPNTFG'\]F<>EZ77'I-7H/D9M(!#[IO'9H/ORK(,<#[A3;L(,+
MUZO_F\=#>OU-?]SG*/A;2U2]Q[\HA3$5=N(_N^0_]7^T:L)_JZE]G/_BU4<%
MC@$4,]=S6#KHGXWW&-6[7^IR17^Y:5K6@,OHQX56X'_P ?A^7@*W["]X@/]3
M7F_^%U!+ P04    " !4@IA6X*K/_;T"  "[!0  &0   'AL+W=O<FMS:&5E
M=',O<VAE970Q-"YX;6R5E&UOVC 0Q]_G4YRR:MJFC3Q!RSI @I:M2'T2T.W%
MM!<F.8A5Q\YLI[3??N<$&),HTM[$3W<__^^<N]Y:Z4>3(UIX+H0T?3^WMCP/
M I/F6##34B5*.EDJ73!+2[T*3*F19;53(8(X#$^#@G'I#WKUWKT>]%1E!9=X
MK\%41<'TRPB%6O?]R-]N3/DJMVXC&/1*ML(9VH?R7M,JV%$R7J T7$G0N.S[
MP^A\U';VM<%WCFNS-P<7R4*I1[>89'T_=()08&H=@='PA!<HA .1C-\;IK^[
MTCGNS[?TKW7L%,N"&;Q0X@?/;-[WNSYDN&25L%.UOL)-/!W'2Y4P]1?6C6UR
MYD-:&:N*C3,I*+AL1O:\R<.>0S=\Q2'>.,2U[N:B6N4ELVS0TVH-VED3S4WJ
M4&MO$L>E>Y29U73*R<\.[FR.&BXJK5%:N.9LP06W'$TOL(1W1D&Z08T:5/P*
M*HKA1DF;&QC+#+-_ 0'IVHF+M^)&\5'B):8M2**/$(=Q?(27[()-:E[RO\'"
MS^'"6$V_R*]#<3?4]F&J*YMS4[(4^S[5A4']A/[@[9OH-/QR1'-[I[E]C#ZX
MFU^-IW#Q,)V.;^=P/1F.)M>3^60\.R3T..KV;CZ&,_@$-=,[P/2&!M32<^EV
M.8^\<5$*]8*4(28S*-F+5D)0*:6Z8L+ "<2?N_1-VI$W=)N8 3Y3PS#D\>[#
M>^AV((I/O6_J";4L7-9997.EFZRW8T@2[X3&#D$Z8>@YGXE,195QN6KN(227
M%BFSEKJ 8-:=6 7NO5S)@5",JKM0%5EE'IV<1!$P%PC0#X3%@MY\^Q.U8(8(
M)%W!K;((4=(Z]$;!7D$5J%=UVS"0NCN:VMKM[CK3L"G(O^9-6[MA>L6E 8%+
M<@U;9QT?=-,JFH5595V>"V6IV.MI3MT5M3.@\Z4BH9N%NV#7KP=_ %!+ P04
M    " !4@IA6^L>>A<($  "W"@  &0   'AL+W=O<FMS:&5E=',O<VAE970Q
M-2YX;6R=5EEOXS80?M>O&&B+11?(QD>.-;*) ><HUD N)&X61=$'2AI9;"A2
M(:DX_O>=H23'#KQ^Z(M-4C/?S#<7>;HP]MD5B![>2J7=65QX7YWT>BXML!1N
MWU2HZ4MN;"D\;>V\YRJ+(@M*I>H-^_WC7BFDCL>GX>S>CD]-[974>&_!U64I
M[/(<E5F<Q8.X.WB0\\+S06]\6HDY/J+_L[JWM.NM4#)9HG;2:+"8G\63P<GY
M(<L'@2>)"[>V!F:2&//,FVEV%O?9(528>D80]/>*%Z@4 Y$;+RUFO#+)BNOK
M#OV/P)VX),+AA5$_9>:+LW@40X:YJ)5_,(L?V/(Y8KS4*!=^8='('A[$D-;.
MF[)5)@]*J9M_\=;&84UAU/^%PK!5& :_&T/!RTOAQ?C4F@58EB8T7@2J09N<
MDYJ3\N@M?96DY\>7:.6KX,C 3V&MT-[!M12)5-)+=*<]3T98M)>V@.<-X/ 7
M@(,AW!CM"P=7.L-L$Z!'WJU<''8NG@]W(EYBN@\'@ST8]H?#'7@'*\H' >_@
M_U&&OR>)\Y;*Y9]M[!OLP^W8W$(GKA(IGL74(P[M*\;CSY\&Q_WO.SP_7'E^
MN M]?'GU,'V:S*9/5_!S\O PN9T]PO5T<CZ]GLZF5X_;W-T->'LWNX(1?(5W
MY&@;,LP*A-PH:F&IY^!%4BMA(5#47G!_1=1-W&H./,E:3(U.*:+A&Y@\G.9"
M6G@5JD8^R=[SL.CRH-;RD-4V&"/%)0KK +F@@,H!RP3MJB3"[P"$SGC1/XG^
M(NDMPA$+!]GHCF8:8R=""9TB_ 9'??KY&CV0WW,M.Z<W'0YFVI(!Z5Q-!NJ*
M)%U-%4.'4B@H329SF;[S1ELZ^-TAPJWQ",>3P1<*^%%_MZW.S&,A+';&A(>K
M/,<PR(#:'==Q+[[ B%(972CC-KD-#D8-P]E&#ER7EA"2SB"'D0\W'5@@_63(
M9*B$,DB60>C"E)70R\^?1L/!M^^.!I.F24XSV],8\T60$<Y)CDX:> D-DC)3
M<7I(BAUI0I5+6S)LS<Y'K/ACF5B9P0WZP@2+J2D3J;N:N+N_"<X2XO3^#ER*
M6EAI]N$<4U$[9"%RNA .$D0-VD!5)TJFY*5]INN.;K0&R&:25)<-5;>WC5FT
MQHP1UT*QF;<M@)PV/O9TF;'(/,0U\*&[C;N &#E\14OE8Y)_V_PR-RJL;IO3
M0#+615*GJLY8):-Y#[DU)1BFRN&IA!6)PF:I94=&B?29+2OY4LM,^B5O7$AL
M*BKIR2Y;FZ,./O":DD27#W%P%:9<T, =;4I:\-5.M^Q>)$JCY\ZWYEL']S]4
M61>4FA)NU9(=_Q@?\D0I2M*' EL+>4V]I2@::=%$4;B-0$==H(F0HF(C?;[P
M-2 5'J6<KD>*I3<4!7Q+"Z'GN <ZU!UW;%,.;DF*%$O;\GFI33/9VB],S)IZ
M7FR;0*01D3%)SX2-DG ?!ETWWY:KZML8*ASYS<8K!&EIXZ%QFVA(FAD\8+17
MRU6WKJ-$.U!")^ ;VE0ZS/:WW4F]M<=$B78>GDR.2HJ2T+PK5J>K5]FD>8R\
MBS=/NAMAYU+35,><5/O[WXYBL,TSJ=EX4X6G26(\/73"LJ"7)5H6H.^YH='6
M;MC ZJTZ_@]02P,$%     @ 5(*85G&Y -8W"@  91P  !D   !X;"]W;W)K
M<VAE971S+W-H965T,38N>&ULS5E;;]LX%G[7KR \G8$-.([M7-NF 9PTQ0:8
M)MTFF\5BL0^T1-O<2J)*4DF\OWZ_0U*RY%L[@WW8ET2FR,-S^<YW#JF+%Z6_
MF840EKUF:6X^=!;6%N\.#TV\$!DW U6('&]F2F?<XJ>>'YI""YZX15EZ.!X.
M3P\S+O/.Y84;^Z(O+U1I4YF++YJ9,LNX7EZ)5+U\Z(PZU<!7.5]8&CB\O"CX
M7#P(^[?BB\:OPUI*(C.1&ZERIL7L0V<R>G=U3//=A"<I7DSCF9$E4Z6^T8_;
MY$-G2 J)5,26)'#\>Q;7(DU)$-3X'F1VZBUI8?.YDO[)V0Y;IMR(:Y7^729V
M\:%SWF&)F/$RM5_5RU]$L.>$Y,4J->XO>_%SC\<=%I?&JBPLA@:9S/U__AK\
MT%AP/MRQ8!P6C)W>?B.GY4=N^>6%5B],TVQ(HP=GJEL-Y61.07FP&F\EUMG+
M:Y4_"VWE-!5LDCSS/!;L%D/&PO/VXM!B#YIY& =Y5U[>>(>\T9A]5KE=&':3
M)R)I"SB$<K6&XTK#J_%>B1]%/&!'HSX;#\?C/?*.:HN/G+RC/V4Q^^=D:JP&
M6/ZUS7@O^GB[:$J@=Z;@L?C00888H9]%Y_*W7T:GP_=[%#^N%3_>)_WR^O[N
MZ>;KX^W5[S=L\O%I<G=]PVXQ]/#X^>;N<9NV>^5MU_;N_O&&O64'K+%;M+D;
MN\_9I)P#GVQ\XD(S8CQ/PEAT2D.CMWUF%X)=JZS@^9+!NT*+A,G<*F9$P36W
M6T,PF6LAZ,FP+@GX[9?S\7CX?G([<4^C]STDB5U !@+)4Z2)UK3.++@6"Y4F
M0ON545CIU,/RL(G2)@CJLWK&Z.W6&<XJJ^8"XC1K:[,QN<=*@%ZSEX6,%TW;
M(\VE@>D<-)2I$KJJ&7MS<CITXM\<]8=OS_K@.%,(QU+IL@\#]N[J/>6$K;;W
M&TO#<F7)S_ W(C057,M\SJ:EC?!.I'+NT ]*9['+!D>Q/B[D0T/J-=3O.^)+
M&";1Z$REX'*2B TR\RX:#:"4>X6(>.,X279,[\AWNFQ!P4U EN6&>W*&)@"@
M]#MKD0(927."@7;>NJ@I1QI38@W@.Q.:L!74)\O(UW,@:4XHDRN?T=Z6I8+#
M,V]&P_YP.&1=F<=IF3B3('Z[EUVL:%>>))*4XFD4HEEH]2P34EFU[/1P:*]Q
MTFN(=TVOMXYR]M>2IW*V)'4^R1SI@:<JQOTM&D:5AC _31DO437@]Q@_EHA^
M"#*Y5&:92"0\@A>%EG!3T+@5+;C(E "2UT-B7:U&0 F]S<ML"NLPN?9_%/S?
M)?]CUO0@3KDQM(,6:M;S 2,*V+U!TQEWXM6RK[ M80].\LH+W!#.U=2B\<!Z
M "R1B$$(8;0CA)C&R7 03@'=G;HA:[SO8 DU#)@U'OX*D28.Z>H3 KBGC%J7
M4'#IC*I"4]L5U78-HO'_6Y9@,FT/X&J__P_2)A4NE)CQA_(FVLP;]C_)FSXY
MQ ?/:PZ7.<)$=VI@SHLJT\11(7(@H75)!-CP=HAV0(_FW*G\8,N\5BKF3' B
M>W2JT$7D+3OJZ,+;#O MB2MPK"<U2DK XX(_"_=24WO)NN!P9Q$-J2F8W$6N
M1PYTG2X]_/&,CZJ,WV'Q/E9TA$#O ZH0[4,'5)1EA(YPYI.>8&!0G8E^G0*I
M,B1[Z]Y1DW'0N\=*)ZY/<)5_:V[N2\H==@VBH[6D!+QM*X0+[JOI*I3)'@3Y
M!+IYE9;=.'E=+,<A@3@JFM(1J.<[BMW^#$@NE'8Y&:BSUF,J1-X,[Z9S2+8K
MS%45;R6.B< R5>MVZKMJ#V0/PLU>Z4\BL>\X&<T&-'5<]@(X6"B/10A4M);R
MN6+$9]H3S-&0)7R)0JY5YC<5L9!%(,VVI-6DNEV![. B&I=ZNZ\==*.U6K:U
M :I^9@I>,R*G-*HK&WBYM,8BK.L<\IFF/_CIZ_5+? =\JES\7L(2*N3.S.?-
M>K;3A*T%+10Q6DLOQ4&F<K%DSSPMZP+?M*Z;" *,*Z1T4HYF)74.B4Q+PAB:
M/Y1:7CLEH=(0GE?]8\_UM*?C_@D5A@:+/G*-1I8]5;M7/AA$QYL5<5LO CQ,
MXN^E-+*J@C1B#(0^4O%#56OF697SP3K:;G3VWK )$BI&#2.RPVH52X_8OF/P
M/@D-6J_RMSXGN#COYM(U*EM3MZUK3?;1>HH)Z<I72!\0D00?$,]I0:(<KKNR
MU\3V7E9>@_8F'*F-BO:T4;NDAT:E@NWV]=U)KY:QC@&:V+WR[WUY<%U",Y$\
ME&->2(M$63^0$$S9%ICV TY_)E1.N2V1BE:1HG:A*%*TTC@P 2BO5;M#:1.H
MPE?<4.1\Y[+!NKWW)+TK$;R0XOV@%ID-P/KF3!")0U[!EZZOEWEU*"1]?7-3
M)>VJP$)-3$M$5C@SPN(5PXR'*)>-6K 9T$%TXE(1P,K#=5E=2L1LY@^E.;5_
M[3C4N25S:(+=BA*5(*:2+'3P,F'X7L-I'&7 PRX*!\D[;A+^G76-H H-4AF=
M;3W?K$Y@K9--LPK"S+5-*']X\WSK6;+VROGPURA8LTM[OX)H[7@P'#H/5?UH
M!:=,Q*A7TF01M:"^4E4!J*77=MB%5N5\$9#3IQ/2OT/3YCJH6,  J< '2!8D
M ^-315#9K.)5Z^P;EK(('E6QOPQ!?<7N,;R#O$1FY-]T6=AX69\:'.&:]@7-
MBP0'3<D"Y(3V73ELV=*;TLF!&X^/U86&KU,*_8&D?GUE]P#4@R;FF3+*J8HQ
MQ*GJ'.FPMN>JR!TDE0NNO\BMG+!QV])6TLU+O(.(77="-Q%3N(3@[4FH;F9,
M%9BVX*+4IN2Y;;Z5IJ&E=]U/[LDV]XP>GJX:3/*[HGI763T A</KJ5$^9TXG
M ] 6BA_*A)SZ\N=>C)_"O4V5;D J76P"VP8I9-HEW%^(\G ;MXH=#O..HO @
M4$@2.JU!,?G,B1-,;RUP5+J\^1D.8:4F@,(WJ>13F4J[)$ISLG(+B-EE7>9F
M'-BA#D6T6JA/-/SDAN^+9O>PK?.=/%RS\_') 4ZG]7K?F@..M[FQNG0F!1E1
M4HHJAN(53G'TZX_E(7,:M*K\OZI[+^#BW+%&2!>?X(KX7<US^1_G6.K!:/SJ
M^A.2P'NDR0UD=>2M_LEHO* DN=;3'SWP*T4NI^RH*3(X<B%QLM?Q EXN3572
M*Y)!@.Q")0/VV+[2X],RY9JY*^'<^N-A:"A-U8HKN#25K5XRYEJ[&ZL6'_S
M'):4NM)K*;@F7!# /J)&NJZENO?W5\PN/?$P?!?] [.W3(YHLC_#T+SHOD"[
M0U>?/'5;OV''_;.S(?X?]=]B)OT_/C^-[H1=NPNI._$#1O>T!]$U>'XNJN:R
MX64BVA^ED&FE[.BHQZ#$^/R<'1^=1M>A)6DJ>7X\W%!VVS>$P\:GGTR@R:(/
M7$ (Q<!_!:I'ZV]H$__I:#7=?X#[C!Y-YH2G&98.!V<G'7_6JWY85;@/25-E
M48;=XT)P>(PFX/U,P;CP@S:HORQ>_A=02P,$%     @ 5(*85A:<@"NV!@
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M[+&K]46-DA1-2*X4:#16]RV_8;UO3[F[9G9B-^WFMSFQ:[L4U=NAYT1"DVA
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MYG:_0C1R67.B6W-M9"ZQ(["3W;;S/R$NK2%1C-"5XY:KNI!.7BA%<V25)SS
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M238$T59PK!74.QV8TW/FQ&=H]\,@N/(^#UCXA^TV030,/M6 !!@_]VY:0QA
ML$H)]M!1X8R%?C0+_2P,6#B>I"P=SQ(6SA+OYPY/XS3V9Q.:S0(V&\>I]W&
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M(&-YOZL22MA3W_G92S9!79RQ,S9)*%?.Z#F;G5W@"P%[YGW%>>]B@<.U.V5
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M\ V!N!&(&7=]$*/\)+V\/+=F)2SMAC:Z8%-9&N!T24%Y]!9/->3\Y7?YK)R
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MQM%RN;3F6:-L5;X6'^+3?G0R9<4?QL,IZ,0M%1-"ONX'JX5.%CBB%#,R(7,
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M^TR3@! M[A=/'CDLLUZ8#J#3;3RN0\7143[V+/"Q9T?YV >0:*MZV["L?!U
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MU_P)V,X=&+ODIH1=4P@==2]D8-?>$5M# YP-X 5%!7K"4?F*C2'@E3 -\L'
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M.51FJV/;11P2^?%;6X>TH2$Y8 [\8C(Z/*V5;=)8!I .3F+2"&E&*O,D0['
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MQ3/D.45:S! 5,+.A]5T0#!6W-NIV0XEJ$*SP%E=$3558HI;33J)T;)'$:28
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M0IGQ%#&0-%?AFCK*2J'GBY,?/WP\#7<.D*T8\M8Y1N9R*1GB["3:;+O$=!>
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M"T4QL61UP"K6,I:>8+7.%B-2DK+&I<#K&K'F572GP.0W=#&'QWNWB^UNV8#
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MLI]6U#K!N  Z+[7&S<(5Z)MQ]AM02P,$%     @ 5(*85K9\+DS4 @  ^ 8
M !D   !X;"]W;W)K<VAE971S+W-H965T,CDN>&ULK57);MLP$+WK*P9J4+2
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MH,^_<.+-HD@7Y*3,+%(8+. KD6OP._%&(^@/8!(0+;G8N@HCX\1[\ 9,0NA
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M!6-DA<(Y9/@M^L-V]FF5*W1T1XKK[JY#"LPVG64Q$P1(OST[2Z^N+R;B(Q4
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M-"'DR^$!V^>XJ3#F@3;5-Z4 \*\BF/R!9R'TPK&(_EWV!T]T,+)][L2<CXK
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M<R]S:&5E=#,W+GAM;(U5R6[;,!"]^RL&:E#40!)M7E/;@)T%[2%!D'1!4?1
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M$T@#T/-K(?"Y8\I?_]JE_P!02P,$%     @ 5(*85IU3O1!Q @  E@8  !D
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M\'$:BFNZ_0%%0@/%Y]*09[]H6\0:&G)3+FA4@*6"B,3Y/WXLC*@ S/XK *L
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M#DP%R/<^I6(W4<U@V?P[_P!02P,$%     @ 5(*85H(#75C- @  D @  !D
M  !X;"]W;W)K<VAE971S+W-H965T-#@N>&ULK59M;]HP$/XK5E9-K=22%R!L
M'42"9B^5UJGJR_9AV@>3'(E5QV:V@6Z_?K834J A8EN_$+_<\]P]=^$NPQ47
M#S('4.BQH$R.G%RI^;GKRB2' LL.GP/3-S,N"JST5F2NG O J045U T\+W0+
M3)@3#>W9M8B&?*$H87 MD%P4!1:_)D#Y:N3XSOK@AF2Y,@=N-)SC#&Y!W<^O
MA=ZY-4M*"F"2<(8$S$;.V#^/0V-O#;X26,F--3)*IIP_F,UE.G(\$Q!02)1A
MP/JQA N@U!#I,'Y6G$[MT@ WUVOV#U:[UC+%$BXX_492E8^<-PY*88875-WP
MU2>H]/0-7\*IM+]H5=H.M,=D(14O*K#>%X253_Q8Y6$#X(=[ $$%"'8!O3V
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M<J7GBUWF^I,!A#'0]S/.U7IC'-0?(=$?4$L#!!0    ( %2"F%:;A 3(MP,
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MB,0$A"EY/'G*X\D^>32^QLM[V1<[[>Y#8T=B-HDY)UL9[CE0X9)#>B3FDUA
M8B&)120F($S)G3GJSFR.M,EK3EI4D\F+7%XGI>'&BV29E#_>5E\EN?%[G<?Z
MK\^;0Z7&+_=E45;3S22][4NI?JRA,44U&]6<5E..TLRM[:BBHWJHYJ-:@&HA
MJD6H)BA-3>RS+H*I3>PGV;"Z5TN],#B'I&:CFM-JS]^?S<V^')*C>JCFHUJ
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M;^[3Z_CSLDIG*O]6)BMIW,C>(ZAZ;7 DT68,JCFMIASS'&^?#40']5#-1[4
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MI>'&BV29E#_>&A?9:I64S=D35TKC_.7#.&B/"-7L5MMUD7QT4!?5/%3S42U
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M,=3N:MEQ"RLM?X@2JXR^IZ2$/6\EWNON$PSUS#Q?H:4-7]+UL3.7L6@MZGH
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MX-,,E'7 ]87$9-<3NT'SV$M^ U!+ P04    " !4@IA6T(Q0XP8&  "$/@
M&0   'AL+W=O<FMS:&5E=',O<VAE970V,"YX;6R]VV^/FD@<!_"W,K%-LTTN
M*X."NG5-NB**@I+N]>Y!<P]8'964/QZ,N]OD7OP!(A5A$9MO^F17<'Z?&1SY
M*@+]%S_X'FX9X^35=;SPOK'E?'?7;(;++7.M\-;?,2]Z9NT'KL6CQ6#3#'<!
MLU9)D>LT14&0FZYE>XU!/UEG!H.^O^>.[3$S(.'>=:W@QP-S_)?[!FT<5WRQ
M-UL>KV@.^CMKPQX9_[HS@VBIF2DKVV5>:/L>"=CZOO&9WIFT%1<D+?ZRV4MX
M\IC$F_+D^]_C!6UUWQ#B$3&'+7E,6-&_9S9DCA-+T3C^3=%&UF=<>/KXJ*O)
MQD<;\V2%;.@[?]LKOKUO=!MDQ=;6WN%?_)<)2S=(BKVE[X3)7_)R:"NW&V2Y
M#[GOIL71"%S;._RW7M,7XJ1 %-\H$-,"L6Y!*RUHU2UHIP7MN@526B#5+9#3
M KEN02<MZ-0MZ*8%W;H%O;2@5[> "L>9$VJ79)-=>[;I<;II[?FFQPFGA1GO
MO55RG'):F/,W2XZ33@NS_F;)<=II,N_-PTZ2[&&*Q:U!/_!?2!"WC[SX0;*;
M)O71CF5[<:(\\B!ZUH[J^&#HNZ[-HXC@(;&\%1GZ'K>]3;1,=-MZLAV;VRPD
M-PKCENV$'\F'=]V6+'XBMD?^W/K[,"H*^TT>#24&F\NTVX=#M^(;W5)B1!UM
M0S+R5FQ54C^LKI<OU<\N]']Q /H%0*P FM$D9#,A'F?B0:P4/^\WMZ0E_$%$
M013)UT>%W+S_6/;*U&'H14:YAM'T1W*3SGP9-JK&5/9T2\3NQ3&IUS"7QC2N
MOX&T8DR3:YA+8]+J;V#5F*;7,)?&-*O&IGLGV\!6Q9CT^J]3%6-<PUS:M'DU
MIK!E<5<AX=8*6%FD+>IK]+)FUM>$2BT7-JTL]EL)WT+%_C<]$HC&F1O^4Q;W
MA^[:Y=W%7XOOPIVU9/>-Z'MOR()GUAA\>$=EX5-9PB$Q!8F-D)B*Q,9(;(+$
M-"0V16(S)*8C,0.)S9'8 HF9("P7@>TL MM5^N!+%':60]:,E>599>VU>8;$
M%"0V0F(J$ALCL0D2TPZ8G&#Q#S;/ TD6A'[S^32G#HTH/6E%N_DV,^2H="1F
M(+$Y$EL@,1.$Y>)'RN)'JHR?Y.C1^?%6_DB%-UE+.'^3#8N-.NWS1HI4?">*
MK7R;41&2I7-(+8-HOLVX"$FM<VA2 M%.OHU6^>)=^Z4!B<V0F([$#"0V1V(+
M)&:"L-Q>*V=[K5RYU^K,"AEAKSOFA='QT7_D?=G.6VE<^^4!B2E(;(3$5"0V
M1F(3)*8AL2D2FR$Q'8D92&PN%SZA*.T5/EH79<VD0C.SI)G<.6V62YE.EC*=
MRI19[.*S;2'A/MGM@^4VSIP;VR./R<\_9;]T/52"UT8.$E.0V B)J4ALC,0F
M2$Q#8E,D-D-B.A(SD-C\@$FG(2&TNV+O[#OOHMBN)W9ZW;/#1K/8K-OJR;)4
MGCG=+'.ZE9FC^@%;6B$GWPSF/K&@]%?>2N+:E$%B"A(;(3$5B8V1V 2):4AL
MBL1F2$Q'8@82FR.Q!1(S05@NUGI9K/5^[XFN'C("D9B"Q$9(3$5B8R0V06(:
M$ILBL1D2TY&8@<3F2&R!Q$P0EHM *F09&%]']^N_-5=77YMI4$V!:B.HID*U
M,52;0#4-JDVAVBS5JD^5Z"6M.O2\E9&VRI_CD/*-YM#A+Z":B=+R07-R,2FM
M#)H'WPI6Q%\3Q8Z.)KD?A)6'D]7:U<&#U!2H-H)J*E0;0[4)5-.@VA2JS:":
M#M4,J#:':@NH9J*T?.*)/Q-/_+W'EVE_J$Q$:@I4&T$U%:J-H=H$JFE0;0K5
M9E!-AVH&5)M#M054,U%:/A-_7EM.*Z_;_)73E]7BU:D'O8 <JHV@F@K5QE!M
M M4TJ#:%:C.HID,U ZK-4RUW+K/DZ@EHIR9*.\19\^1F29<%F^1VYI L_;W'
M#S?09&NS6Z8_)S>.GJT?TKLI+5FOQ[=8)S=G_N0/]V<;5K"QHV!TV#KJ2KCM
M1*]C<+CE^;# _5URJ^:3S[GO)@^WS%JQ(&X0/;_V?7Y<B#O(;CP?_ ]02P,$
M%     @ 5(*85F55I6E+ @  _P0  !D   !X;"]W;W)K<VAE971S+W-H965T
M-C$N>&ULA51M3]LP$/XKIPQ-(&TD30N=6!J)MD)# @U1V#Z[R:6Q\$MF.RW[
M]SL[(>NDEGUI?+;O>;G>.=MI\V)K1 >O4B@[BVKGFJLXMD6-DMESW:"BDTH;
MR1R%9A/;QB K0Y(4<9HDE[%D7$5Y%O8>3)[IU@FN\,& ;:5DYO<<A=[-HE'T
MMO'(-[7S&W&>-6R#*W3/S8.A*!Y02BY16:X5&*QFT?7H:C[Q]\.%'QQW=F\-
MWLE:ZQ<?W):S*/&"4&#A/ *CSQ87*(0'(AF_>LQHH/2)^^LW])O@G;RLF<6%
M%C]YZ>I9]"6"$BO6"O>H=]^P]W/A\0HM;/B%77\WB:!HK=.R3R8%DJONRU[[
M.NPEI.F1A+1/2(/NCBBH7#+'\LSH'1A_F]#\(E@-V22.*_^GK)RA4TYY+E]H
M*;FC*CL+3)6PT,IQM:$8[CA;<\$=1PNG2W2,"WL&GV%%C5&V D%74+6N->B%
M<=E** 8T:%6)5#"N2H(#@50Y8!N#B!W9"7 %3[5N+=':+'9DQDN*BU[XO!.>
M'A&^Q.(<QJ-/D"9I"L^K)9R>G/T+$U,MAH*D0T'2@#L^@CNX^U[!3>?NOG?W
MMU;P'-S->W=WP=WUGKOKM76&.NZ0KXY_<IC?#^&5;5B!LXBFS*+98I1__#"Z
M3+Z^XVX\N!N_AYY3L<:'-'59ER'+S_$VGTZS>'N :3(P3=YE>M*.B4-4D_]3
MQ7O][)^&>V8V7%GJHHJ2DO/I102F&[<N<+H)+;[6C@8F+&MZH=#X"W1>:>W>
M C\UPYN7_P%02P,$%     @ 5(*85K1RSLH1!0  +Q,  !D   !X;"]W;W)K
M<VAE971S+W-H965T-C(N>&ULO5C;;MLX$'WW5Q!N4<2 :TOR+1?'0"Y=;(!-
M&L2;[D.Q#[0TMKBE1(6D[*1?OT-*EBU'52XPF@>'HCAGSAF.AI?Q2L@?*@30
MY#'BL3IMAEHGQ]VN\D.(J.J(!&)\,Q<RHAH?Y:*K$@DTL$81[WJ.,^Q&E,7-
MR=CVW<K)6*2:LQAN)5%I%%'Y= Y<K$Z;;G/=<<<6H38=W<DXH0N8@KY/;B4^
M=0N4@$40*R9B(F%^VCQSCR_<OC&P([XQ6*FM-C%29D+\, ]7P6G3,8R @Z\-
M!,5_2[@ S@T2\GC(09N%3V.XW5ZC_V'%HY@957 A^#\LT.%I\[!) IC3E.L[
ML?H3<D$#@^<+KNPO6>5CG2;Q4Z5%E!LC@XC%V7_ZF ?B-09>;N#M&&!DJ@UZ
MN4'/"LV865F75-/)6(H5D68THIF&C8VU1C4L-M,XU1+?,K33DVE()82"!R#5
MIP^'GCLZ(5\>4J:?R,$ES)G/=,NT-&5<M<AG<C^]) <?6^0CZ1)EC!5A,;F/
MF59M[,3VWZ%(%8T#->YJ9&C\=/V<S7G&QOL%&]<CUR+6H2)?X@"",D 7I17Z
MO+6^<Z\6\1+\#NFY;>(YGE=!Z.+UYFX-G5X1[I[%Z^TGW-__0GMRI2%2_U9%
M,W/6KW9F*L"Q2J@/ITW\Q!7()30GGSZX0^>D*A)[ BO%I5_$I5^'/ODJV8+%
ME!.F5 HDD<S'7Y!9BI$#3*M+P3F5:M/;JHI(YL;-YM/4L.7$[>#$+[>5UG)Y
MI])!H710J_1LL9"PH!H(9SCQ ;75#!W-04*,JL4\_ZZJY&78PRUUO=[H<+"C
M[Z51)>+#@OBPEO@-KBF)%#Y ]9<]?.9TX.#?#K5:'^\,_:A0,*I5,,W*%4UU
M*"3["8'-JZRW,IDRN,&6),]SG I5KQA88GQ8,#ZL9?Q-\#36N+P27\1+K!DF
M5P)0OF2)R9LJTO6(*IW]ARLHT8+HT.2@TBQ>F*0SCQ<B2FC\E%<F1;[* +]*
M=)^'#KW?4!70A[8=OES3:VS10RC*N7U?F&,!+=I>F]S:;)<X >>EA\\NP75C
MNV>]Q)3YX2J#_'?)'>!::'<'2^!/[889;X1XSLDFC!<%3_O*/6FU,0E8B^PM
M+A0W-\8%9-0;*N%,KX."^RBE4:*!?H91EDBU@3+5P;P9'+M$&6K8#=0/R8"(
MM7T>HEA$MH(N*<<*>G,U)4['<;/1.(3SQ@Q,&BG!3=7!Z-HHNCM$K$';SL/!
M5@CO<E'9F*D1M8Z@">!;(]AX(;,D^#1AFG+V,RN0A@]F!()*-DMUGFAF*,2:
MR3S:)+?:#69921FZ2(3&.L!SS".Q,N15BL&KRA[+9Q<IHUY+Q$Z$G0548EZ:
M>7+=MNLX;:P6)&!+AAN?AIT:S_-,IWVQ&R\[K6B_"ADVCMJC(QS7=XCQ;=?0
MP%+<3KB#1*!/PX;B]A\494;"LVEM=:HV![55Y9UU^ZBH@D>U->N:Q2Q*(_+]
M&J(9R,J=4"W"6W=">P(KB76=S8[<^9U[Q-S;GD*S+[1R;+9.*^Y^E_ <[Q5K
M>+WG]RKS-LJ\^B2GCR\F>3W$FZ=R3VAEP9N3D/M;CT+N7L]"^T(KQV9S&G+K
MCT-O3_-^19K_(L_W>OKI;ET]1" 7]D9&X0J'2V9V2B]ZBUN?,WO7L=-_;FZ#
M[)7&!B:[2KJF$L^&BG"8(Z33&:%*F=W.9 ]:)/:"8R:T%I%MAD QK\P ?#\7
M0J\?C(/BCFSR/U!+ P04    " !4@IA6(E&#LK<*  #0+0  &0   'AL+W=O
M<FMS:&5E=',O<VAE970V,RYX;6RU6FUOVS@2_IY?07@7>PG@Q)+LV$Z:!FB2
M/5R!W6UON[?WH=@/M$3;;"51)2F[N5]_,R3U9LFR<_$5:&M)G.',,R]\2.EN
M*^17M69,D^])G*JW@[76V>UHI,(U2ZBZ$AE+X<E2R(1JN)2KD<HDHY$12N)1
MX'G344)Y.KB_,_<^ROL[D>N8I^RC)"I/$BJ?'U@LMF\'_J"X\3M?K37>&-W?
M973%/C']K^RCA*M1J27B"4L5%RF1;/EV\,Z_?1I[*&!&_,G95M5^$W1E(<17
MO'@?O1UX:!&+6:A1!87_-NR1Q3%J CN^.:6#<DX4K/\NM/_=. _.+*ABCR+^
M-X_T^NU@/B 16](\UK^+[3^8<^@:]84B5N9?LG5CO0$)<Z5%XH3!@H2G]G_Z
MW0%1$_#'>P0")Q#L"DSV"(R=P/A8@8D3F!ADK"L&AR>JZ?V=%%LB<31HPQ\&
M3",-[O,4X_Y)2WC*04[??UI3R=8BCIA4/_TP#_S9&_+SMYSK9W+^Q)8\Y/H"
M?VG*8W5!+LDGR+PHCQD12Q**)!.*FP#"I:KI^AMA5LNEO:WN1AK,Q4E'H3/M
MT9H6[#'MB8579.P/2> %08?XT_'B?E-\!""52 4E4H'1-]ZC[[<\63!9^MGI
MD-4PZ=: )7RK,AJRMP.H4<7DA@WN?_K!GWIONMP[D;*&L^/2V7&?]OMWN5X+
MR?_#HAYOK8IKHP+[R^8^@':#?^Y&F[HG1PQL6#DIK9ST6OE>J1PLI&E$H*4I
M#3]XNNJQ>-(RY&9VXWF378,/CVO8>UW:>]UK[R<F.5/D@P0SH<D24WR*?/Z5
M86K]U65QK\*79M2)E#5\GY:^3U]=/M-3.GLB90UG9Z6SLU>7ST._BL]^9S[,
M6IGI3\;>S/>G.RG<.="?SN=[<GA>NC8_:<T]]*O;X^:\W3&N9_/9=+=0#X]K
M.'E3.GES3*$^BG3#I.8+6.[*HO6/*=M>]2_-Y!,I:R#A>Q5!\%Y=N$[%B?P]
ME;:FPS5&Y+^^> _H^!QTIH63JN?KU)M-Y[MI?7A<T[>*P_B]K.'EU7M WSX_
M@R/]/#BNZ6=%7_Q^_M)7P,$Q!=RO_\49?2)M330JFN1/7E_"O53KQ0Z?2%O3
MX8IG^?U$Z[@2[M>Q+[6O6RD[G]\$+<Y[>%S3MXI'^;W,Y7\HX7Y]^_R<'NGG
MP7%-/RL*Y?<3H(X2?B ?)5LR*<'_8VJX=X(7I_2)M#7AJ&B7/W]]#?=RK1<[
M?")M38<K"N;W<[#C:KA?Q[[<OFG31F\RZTCNPP.;9PD5JPIZ2<S+J_B OCV>
M.JG#GAXQL.EI1:>"?BK45<?^RPJY?X87GZN<2%L3C]HQT@G.D4Y[D/3_.$D*
M*BX6O/XLZ>& CGWIW3Y9FHWG0>L\Y_"XIF\5LPI.>P+U<$#?/C_;!U+=?AX<
MU_2S(E3!42=7]2)^?&$-G_0DZU3:FG!4'"QX_6%6<-+3K%-I:SI<D;'@! =:
M!W3LR^WV2=5XXGO7T\EN<G<-]+SYWB6JXE;!B<^T#NC;YVG':=5-,+]IG6H=
M,;#I*9*JYCE_143&!XB#_]<?:]8ZDPY%"K5-\DRD1,-S]UH'?TL&>4_CF$A\
MIZ;.:!C*'/'2@M#Z2R"L#Y1]%$E&T^<AH8ID4FQX!&#SM/[,O7I2Y!UTES &
M T#VG5(BY-2\7CK'P3@J\-X48\RE_^9B",K".,>8#<^V'#(UUR3F"==&=F@F
M,L:BB9*%C&\8205H,1,-3>31>JU9&@V-<RN6,DECDC"F0;':T;(1FEDPJ"8X
M)V$T7)<PGAD8R9K%$6&IYOB^=54#LL015(F4676@J6MF<H[F;25'Z\R+4I$J
MQ"_F+$><BH$7.S9F%('B&=7L#%68T!!\V4HR,,%>+JCB"A$$$)Y)Q)66?)';
M=[*I"5/C'K:\7&9QKB":BFEE1BWS-%([X2XBS#8  #ZC9S'_EO/(!M3<MLB'
ML*10&"T0%)=5F"L)?28+4/ =6YJ*GZOD60I)$$ 4@B1-':)N:ERI?J';*_(.
MT-Q-;$G3KV> # =XH.P)301 IU$\42S>P!#4CH'@*0#N/,S ::&8JN<:Z<HU
MCJ_#8^LCQ "M@BERU(-O3&D&(V.8FT=G,$T(JR?7V'N4N4=LN7$)Z9F W3'9
MT#AG5P1K%)+$3!MQ1"&U#:N.J8/.Q:$H6;C<!0$#K_+%%Q;J,\Q[T/,MIS%?
M<C!E\5RE$?B;B2UJ,2"8!9^EMFQV)[$!J A"BQZ8*ML95!:,;QZ79W. !V07
MA#\6VROHIW_LD2N/XX?]AWW# P<)PX,;E"[K.SC0N;UA^^&*F91VJ0H^N0[6
M!U/1U; ^(0F/;\1N*&IJC>[(@68#OB+OP< HXE7'K,GVAM7:N::;6L[4$L4F
M#J1LS%:(,\4"BR&LZI; GS/\^TLMB2M9<DD>J&*F*&IWP9YZ2QJV&PTTGUI9
M8,' 2A*[!B:A;.WZGF>M%6J[MA';P/!4(UHPGJ?EY9"$:YJN&,X)<&LI8AS1
MM*=K77/-4LBR?=J>":  >L^$;BB/*>*[W-'G\(5&6-YE4=%:CHT1M"^5T]0L
M"]LU#]URU2,#*-E9[?)EIRS63O\J**"C61;ST%@.!'%E>A9'/H5!AVB9K@8M
MI6>^.F6P*PO,;%@%=B/HKWEJM!1]S^84$ !E+5BM)*"H36884==O(6<V7.1F
MY4!Y7D\CVU(KV;@[!9U*2P7M0M_H@N!.N[N:>#P!5F:74'S"8AN<%_C.0 OI
MC^/Q<#:_OB*_(0]PH$(.L)7 '(V@5*@L7;*+#ZN@,/6$(@^"RLC,RR%*6D!2
MK.$1L!P2L1!T&(+[7 -1<700_\G0ZRM7B[N=MI5+IM(7#+@(J%7*+AIF_9*Z
M< #X14)3K$?W&= .-[!SFS8EPC"7)=@MBF#@;_+)%MX=G;EE=5\ZH["BB<$]
ML1\VI0I0DM0!4_2I/\T*#'WI9\SF>M[6FF#)Y["2&ZR0U%@AE(3*=Y3 S&"2
MP#A*^[0CM;8B1_%*C9FBTM!7T]QF<S]0D-L( (ZP,+6,,&P)_T*,EDMF/MUS
M(O9[0"BH(;$1!#&0<=VWR+'':JS#LK*?]GI0-L-Z')VU0\.@(;LTAU@:7BI%
M8J^P7\+_EG 6O"VCSTFQ9KBEC\;-X./J K(F&&FYZU_F<=%44%\JTDML\$J9
M/NB:16O--=P0M6(8(Z:A1F S5FZ%BFW-T'5HGH)%9G$HG<;4LCL&V[YJF-MN
MVR&STZ0_%$W:;'H!7Q1S7-#L@:(ON=*));YHI@IAS6&[1A:11(I=WS,?P11H
MKD4",(3&SD4]V0S6/>EVN3?=ZBZ6[(=1"7LD$[%S?@'M2BBT$?<PU'[!V$&*
M:%J@2)9<)I>A2(#=FSPQ&XUB(Y;E"Y@0E("/Y6Z I$!:89L2,@8=UBW21=.#
M^7Z\]H:>YYFL,<E:RA?+9;DQ8\C([:X4UCH*6Y1KD\*VW5?8/G:']/R?):%_
M__'#!7:4<PX@T"5Z10V&IDLA(7(N8>:[>DCH%UC.]7/CH\ZB 9O*/S;J#ACX
ME;D4,PU+F1/%JZ[3J5'M<]:$R97Y+!CI+2R!]A/&\F[YZ?&#^4)W]WYP<_L8
MW'0]&7NWC_9KY5$UA?W6^5<J 4ZD9DN8SKN:70\LL2TNM,C,![4+H2&3S<\U
MHP 0#H#G2P&XN@N<H/R(^_Z_4$L#!!0    ( %2"F%:X8TTNHP,  *@-   9
M    >&PO=V]R:W-H965T<R]S:&5E=#8T+GAM;*V7;6_;-A#'OPJA%4,+=-&#
M+3]DMH#$ZK"]*!HTS?IBV M:.EML)5(C*3O9I]^1DE7+4;08\!N;HN[^Q_OI
M="(7>R&_JPQ D\<BYVKI9%J7UZZKD@P*JJY$"1SO;(0LJ,9+N755*8&FUJG(
MW<#S)FY!&7>BA9V[D]%"5#IG'.XD45514/ET"[G8+QW?.4Q\9MM,FPDW6I1T
M"_>@'\H[B5=NJY*R KAB@A,)FZ5SXU_'OF<<K,6?#/;J:$Q,*FLAOIN+/]*E
MXYD500Z)-A(4_W:P@CPW2KB.?QI1IXUI'(_'!_7?;/*8S)HJ6(G\*TMUMG1F
M#DEA0ZM<?Q;[WZ%)*#1ZB<B5_27[VG;J.22IE!9%XXPK*!BO_^EC ^+((1B_
MX! T#L&)@_^2PZAQ&+W68=PXC"V9.A7+(:::1@LI]D0::U0S PO3>F/ZC)OG
M?J\EWF7HIZ/[C$H@GTKS$!1Y&X.F+%?OR"_DX3XF;]^\(V^(2Y2Q4H1Q\L"9
M5N]Q$L=?,E$IRE.U<#4NQ0BZ21/VM@X;O!#6#\A'P76FR >>0MH5<#&'-I'@
MD,AM,*@80W)%1OY[$GA!T+.@U>O=O1[W^/7N_D VH_:QC*S>Z%6/Y:^;M=(2
M7Y&_^TC72N-^)=,WKE5)$U@ZV!@4R!TXT<\_^1/OUSY*EQ2++R36(3AN"8Z'
MU*-/,F4<.]FA=E6U_H:]AFA!:/H-7RQL7KJW<FO=T.J:MKF+ F\R#V98%KMC
M5(/QST5U(;$.JK!%%9Z%BNZP!]!U#@2_*V13Z0IKD2E549Y '['P&;%1&(:C
M4V"#JS@7V(7$.L F+;#)(+"O]FL"*9("B5]'LI64:Y)2C<@HDV1'\PJ(V-1$
MB6C>8VMVVNUJA'7 V1%"[RKT3P#61G[0L0JZ1G&?TGC<&G42GK8)3P<3_O (
M,F$*,^XDU)?(H-"YW6CZK+#F,^^DK.(+1>R F;5@9H-@O@A-<Y(@"Y9B*1@J
M?5 &1<Z%4HM-CJ#X)X427RA>!\F\13(?1/+ )21BR]F_6"Z)*'"'JBP8 H]F
MW-M!YL]S\H+Y2?D/QCVW?UQ(K(/(]W[LNKSS.D@)DHG>SO _2CYY BK)C!3U
M?LJ?8Q]ZZGLU5\-*YP*\E%I-T#W:PA8@M_8HH+!^*J[K36 [VQXW;NPF^V3^
MUK]>U8>&'S+U&>8CE5N&73B'#4IZ5U/L*[(^%M076I1VH[P6&K?==ICA40JD
M,<#[&R'TX<($: ]GT7]02P,$%     @ 5(*85DB-D=&N!0  31P  !D   !X
M;"]W;W)K<VAE971S+W-H965T-C4N>&ULK5E;<YLX%/XK&MKIM#--0.)B2!W/
M)*;=[4,WF:;9/LM&CID"\DIR+O]^)<!<!;83OR2 S_G0=XZ.]!TT?:+L#U\3
M(L!SFF3\TE@+L;DP3;Y<DQ3S<[HAF?QE15F*A;QE#R;?,(*CW"E-3&19GIGB
M.#-FT_S9+9M-Z58D<49N&>#;-,7LY9HD].G2@,;NP<_X82W4 W,VW> '<D?$
M_>:6R3NS0HGBE&0\IAE@9'5I7,&+$#G*(;?X-R9/O'$-%)4%I7_4S??HTK#4
MB$A"ED)!8/GOD<Q)DB@D.8[_2E"C>J=R;%[OT+_EY"69!>9D3I/?<236EX9O
M@(BL\#81/^G3WZ0DY"J\)4UX_A<\E;:6 99;+FA:.LL1I'%6_,?/92 :#L@;
M<$"E ^HZN ,.=NE@'^K@E YYJ,V"2AZ'$ L\FS+Z!)BREFCJ(@]F[BWIQYG*
M^YU@\M=8^HG9W1HS FXV*@D<? R)P''"/X$S<">G6+1-"* KL*3I!F<O'][Y
M"$Z^<,!S+[JI4Q>+%R!G(2#I)J$OA'" LPBD)%T0QA6$6!.PH)A%ZB:*F<P[
ME;^<@?N[$'Q\_PF\!V:!RT&<@?LL%ORS?"BO?ZWIEDLX/C6%I*P&;BY+>M<%
M/31 #R+P@V9BS<'7+")1&\"4L:H"AG8!NT:CB"%9G@,;?@;(0D@SH/GA[E#C
M'A[N;HVPL:OTVSF>/93^79)O5F!>)!G<-><$N-IE5Y89^%IE]TIF]T>97>G[
M2V;W.L^NO FK[%XMN&!R?N@25PS,T0],+7<7?(.7Y-*0ZQDG[)$8LP_OH&=]
MT07]E&#AB<!:"7&JA#ACZ+-_MBJFJD9:E?D9W&P%%[((XNQ!%\T"U<U1U5K_
M.(.V-X&>/S4?FX'2V"'7L2RK;1?J[ +HP]JN1<^MZ+FC]'[GZS")P-4C87)?
M 5^?"5O&G(!;%B_)7IH%NM\<UOG$[7 LC"!J6W4(ZI \5\_.J]AYA['#)3M&
MU-8KN<@5-,LK88L3D,2K_4S'W^2"%X)E@?D@+98W&( (O^A6R/DXDE<BP0()
M0'L(*#QL2!#NQN1KD%IQG51QG8Q"?Y>QBZ746()'G&SWQZY \QJY=7RO,\/G
M?2-9"9U)HK$)'/T<\2LN_NL*_"^&,]'=H@H^?J\8D>_YO7FO,8..YW>6@+!O
M9KMVX U4=E#Q"MY6V2/\ DTM^G:'7=\(G5O=A 6ZTO?US*!5:R3K='4]PG/\
M-<?N>7L&'93U.-F5([(&*_M *&<'Y>VK;-C0G_!U];";/_I(CH(>'<E3HH4E
M6K/ S@+?&J@OB.I(H;=5V'C$1L&/CM@IT<(2K;T P('-&-;:%HXJM>/*=CQX
M)Q6K)T4+7X,&QDJWEJKPE5I5M@HK$JO(JX[P>2/[ 7U8^RKSS+<M%W66?IT=
MM*"+NJI59VC[,)@,%5^M6^$;A>O!G'7"T^ENY5"K8;L[N19K,E0WM8J%)Y2Q
M!_,>?>?1)?0*-*"MGK<#M:-<:UHX+FI?V^F5L*W6S)U800"[<TACJ.L)0YUA
MIREL<ZRU+AP7NV]M]TKXS@3O]K1ZJZXT+*T&V\(VQ5KVP@-U[PEZOCVO<GH=
MUDC7MP?KB 8RW -U4 ?9_M96*V\TKCR/[?Q*N&;'AAR[N[IJK/H-8JBQ:G:(
M;4:UWD5OT[MXD1 ML[ZJA);CHV#2)=<W#- DZ+6!&CM?MH%#WT!0K5/1:73J
M(%-TP/>;N=[*ZY+46@U1K)4E.KVR'*0[_BJ[K"Y4%2H:K/D]4+OUPRZAM)^?
M#X.HE@VTO]AK/8G&]62OV/=%SND7J#?I392^E>V@H#M1^E:HH4,+1F;CG"4E
M["$_K^(RY=M,%"<(U=/J3.PJ/PGJ/+^&%V%QLE7#% =M/S![D#$ "5E)2$MN
M8P9@Q=E5<2/H)C_-65 A:)I?K@F."%,&\O<5I6)WHUY0G2#._@=02P,$%
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MK^(UN4R3),IRLI'9E@.OR7\--AQMQ-8);ZBC11240<U8!UFH*MBA!/=BV[^
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MU+I=LK0&X&M;S4G$<UGK! *T='%:]C07&[SLXGI6Q_6^<3(&5KJ&@ Y5^JG
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M$:)M A' 2O$B>5:#%U<'7N:]T@( *?!@#A?XJ93'G=AJ $ HQESE%$,D=@5
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MQ]\%J%7JU(*'SZ_HGS/GE3./1, MB_ZDH5S/K+&%0EB2323OV>Y7*!P::+R
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M,U@Q#1R3[;F;.(RBL;_93\QAS.=6R.PP9! T(2],]!L3_:,FYBP'[1Q@?W\
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MTKF\HD2*>HK5"\47IJ]/N:(I86XS&OPH=  ]GW&N-@M]0/M7(OH'4$L#!!0
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M]EJIO8-2?]*8-L,SE@O*;=)ZN])>*]M-Z?MV8?U66/_-'F@GC!DB%!^Z)C/
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M/;_OU,=!T^FL9U7WZ%2L)D-F;A<$2MB.ROIDV/:V-QCGYMS>Z[_0-QOFM/U
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M@ 3 E(#\OJ;2Z^I%35!?',V^ U!+ P04    " !4@IA6EZ3B;W<&  !",
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M\2#C^?(O>ZP#L680]'88T-J OC#8V<)I;7#ZUA9ZM4'OK0;]VJ!Z],[RV:O
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M>K:"NE*8>][WVZ85VU== !$/(-\Q^PD7B;VS?_($ME_'(C,1CFV]N2IG9M9
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M@24@[0WF\ZD0^OG$-K#ZMX'1_U!+ P04    " !4@IA6\0LQ,%P#   F%0
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M;T7Z**>/<@S+AHR++Q;'SHGTQ[[2* J",,0R.AY;'8RQO(4A_-C5,&_ P.)
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M<',O87!P+GAM;%!+ 0(4 Q0    ( %2"F%9KQ:+C[P   "L"   1
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M965T,BYX;6Q02P$"% ,4    " !4@IA6N4GL=D<#   "#@  &
M    @('2%0  >&PO=V]R:W-H965T<R]S:&5E=#,N>&UL4$L! A0#%     @
M5(*85E)L%F6W!   J1$  !@              ("!3QD  'AL+W=O<FMS:&5E
M=',O<VAE970T+GAM;%!+ 0(4 Q0    ( %2"F%:2"  NX@(  .,'   8
M          " @3P>  !X;"]W;W)K<VAE971S+W-H965T-2YX;6Q02P$"% ,4
M    " !4@IA6'&T"S#@&   +)@  &               @(%4(0  >&PO=V]R
M:W-H965T<R]S:&5E=#8N>&UL4$L! A0#%     @ 5(*85@^U8>@K"0  G#$
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M:&5E=#$Q+GAM;%!+ 0(4 Q0    ( %2"F%;Q-LX;=00  #,*   9
M      " @5UM  !X;"]W;W)K<VAE971S+W-H965T,3(N>&UL4$L! A0#%
M  @ 5(*85CNAVYKN%P  UDL  !D              ("!"7(  'AL+W=O<FMS
M:&5E=',O<VAE970Q,RYX;6Q02P$"% ,4    " !4@IA6X*K/_;T"  "[!0
M&0              @($NB@  >&PO=V]R:W-H965T<R]S:&5E=#$T+GAM;%!+
M 0(4 Q0    ( %2"F%;ZQYZ%P@0  +<*   9              " @2*-  !X
M;"]W;W)K<VAE971S+W-H965T,34N>&UL4$L! A0#%     @ 5(*85G&Y -8W
M"@  91P  !D              ("!&Y(  'AL+W=O<FMS:&5E=',O<VAE970Q
M-BYX;6Q02P$"% ,4    " !4@IA6%IR *[8&  "O$0  &0
M@(&)G   >&PO=V]R:W-H965T<R]S:&5E=#$W+GAM;%!+ 0(4 Q0    ( %2"
MF%:.(,EM0 L  #H?   9              " @7:C  !X;"]W;W)K<VAE971S
M+W-H965T,3@N>&UL4$L! A0#%     @ 5(*85CI'$8LN"@  "QH  !D
M         ("![:X  'AL+W=O<FMS:&5E=',O<VAE970Q.2YX;6Q02P$"% ,4
M    " !4@IA6Z#,=#1\#  "T!@  &0              @(%2N0  >&PO=V]R
M:W-H965T<R]S:&5E=#(P+GAM;%!+ 0(4 Q0    ( %2"F%;SN'RO.0@  %04
M   9              " @:B\  !X;"]W;W)K<VAE971S+W-H965T,C$N>&UL
M4$L! A0#%     @ 5(*85LHZCO&N!P  /1(  !D              ("!&,4
M 'AL+W=O<FMS:&5E=',O<VAE970R,BYX;6Q02P$"% ,4    " !4@IA63I B
MA:4%   4#0  &0              @(']S   >&PO=V]R:W-H965T<R]S:&5E
M=#(S+GAM;%!+ 0(4 Q0    ( %2"F%9C0K:U/ 8  $8.   9
M  " @=G2  !X;"]W;W)K<VAE971S+W-H965T,C0N>&UL4$L! A0#%     @
M5(*85H"+%#PK.0  7\0  !D              ("!3-D  'AL+W=O<FMS:&5E
M=',O<VAE970R-2YX;6Q02P$"% ,4    " !4@IA6\(ZK7I@"  !#!@  &0
M            @(&N$@$ >&PO=V]R:W-H965T<R]S:&5E=#(V+GAM;%!+ 0(4
M Q0    ( %2"F%94]_^S3P(  !\%   9              " @7T5 0!X;"]W
M;W)K<VAE971S+W-H965T,C<N>&UL4$L! A0#%     @ 5(*85E<2"R&" @
MF 4  !D              ("! Q@! 'AL+W=O<FMS:&5E=',O<VAE970R."YX
M;6Q02P$"% ,4    " !4@IA6MGPN3-0"  #X!@  &0              @(&\
M&@$ >&PO=V]R:W-H965T<R]S:&5E=#(Y+GAM;%!+ 0(4 Q0    ( %2"F%9
MPW9#KP0  #0+   9              " @<<= 0!X;"]W;W)K<VAE971S+W-H
M965T,S N>&UL4$L! A0#%     @ 5(*85B8O!#NN @  K 4  !D
M     ("!K2(! 'AL+W=O<FMS:&5E=',O<VAE970S,2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( %2"F%9LG36Z4P4  .(-   9              "
M@2HY 0!X;"]W;W)K<VAE971S+W-H965T,S8N>&UL4$L! A0#%     @ 5(*8
M5M2K]A0. P  H@8  !D              ("!M#X! 'AL+W=O<FMS:&5E=',O
M<VAE970S-RYX;6Q02P$"% ,4    " !4@IA6OK,F^)X#  #&"   &0
M        @('Y00$ >&PO=V]R:W-H965T<R]S:&5E=#,X+GAM;%!+ 0(4 Q0
M   ( %2"F%9!H$-12@,  )L'   9              " @<Y% 0!X;"]W;W)K
M<VAE971S+W-H965T,SDN>&UL4$L! A0#%     @ 5(*85OC!Q _Y P  I@D
M !D              ("!3TD! 'AL+W=O<FMS:&5E=',O<VAE970T,"YX;6Q0
M2P$"% ,4    " !4@IA63SMI.EP%  #$)@  &0              @(%_30$
M>&PO=V]R:W-H965T<R]S:&5E=#0Q+GAM;%!+ 0(4 Q0    ( %2"F%:QF^;O
M. 0  &(3   9              " @1)3 0!X;"]W;W)K<VAE971S+W-H965T
M-#(N>&UL4$L! A0#%     @ 5(*85M3B.N[L @  K@D  !D
M ("!@5<! 'AL+W=O<FMS:&5E=',O<VAE970T,RYX;6Q02P$"% ,4    " !4
M@IA6U'@!PL$"  !!"@  &0              @(&D6@$ >&PO=V]R:W-H965T
M<R]S:&5E=#0T+GAM;%!+ 0(4 Q0    ( %2"F%:EYW>#@@(  /D&   9
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M970T.2YX;6Q02P$"% ,4    " !4@IA6\=J HV "  !W!0  &0
M    @(%!;0$ >&PO=V]R:W-H965T<R]S:&5E=#4P+GAM;%!+ 0(4 Q0    (
M %2"F%9X<>.2BQ$  !() 0 9              " @=AO 0!X;"]W;W)K<VAE
M971S+W-H965T-3$N>&UL4$L! A0#%     @ 5(*85CS7",VG @  (P8  !D
M             ("!FH$! 'AL+W=O<FMS:&5E=',O<VAE970U,BYX;6Q02P$"
M% ,4    " !4@IA6B.$G).8$  !&%   &0              @(%XA $ >&PO
M=V]R:W-H965T<R]S:&5E=#4S+GAM;%!+ 0(4 Q0    ( %2"F%:12;6$3@,
M !\)   9              " @96) 0!X;"]W;W)K<VAE971S+W-H965T-30N
M>&UL4$L! A0#%     @ 5(*85K\Z;$/^ 0  (00  !D              ("!
M&HT! 'AL+W=O<FMS:&5E=',O<VAE970U-2YX;6Q02P$"% ,4    " !4@IA6
M..F!0RX#  "]"   &0              @(%/CP$ >&PO=V]R:W-H965T<R]S
M:&5E=#4V+GAM;%!+ 0(4 Q0    ( %2"F%9<H#-='P,   0)   9
M      " @;22 0!X;"]W;W)K<VAE971S+W-H965T-3<N>&UL4$L! A0#%
M  @ 5(*85GBBF(A!!@  WD(  !D              ("!"I8! 'AL+W=O<FMS
M:&5E=',O<VAE970U."YX;6Q02P$"% ,4    " !4@IA64#Z#H4 #  #X"0
M&0              @(&"G $ >&PO=V]R:W-H965T<R]S:&5E=#4Y+GAM;%!+
M 0(4 Q0    ( %2"F%;0C%#C!@8  (0^   9              " @?F? 0!X
M;"]W;W)K<VAE971S+W-H965T-C N>&UL4$L! A0#%     @ 5(*85F55I6E+
M @  _P0  !D              ("!-J8! 'AL+W=O<FMS:&5E=',O<VAE970V
M,2YX;6Q02P$"% ,4    " !4@IA6M'+.RA$%   O$P  &0
M@(&XJ $ >&PO=V]R:W-H965T<R]S:&5E=#8R+GAM;%!+ 0(4 Q0    ( %2"
MF%8B48.RMPH  - M   9              " @0"N 0!X;"]W;W)K<VAE971S
M+W-H965T-C,N>&UL4$L! A0#%     @ 5(*85KAC32ZC P  J T  !D
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M=#8X+GAM;%!+ 0(4 Q0    ( %2"F%:%4#,;OP,   D,   9
M  " @>/2 0!X;"]W;W)K<VAE971S+W-H965T-CDN>&UL4$L! A0#%     @
M5(*85I%8]E4R P  $@P  !D              ("!V=8! 'AL+W=O<FMS:&5E
M=',O<VAE970W,"YX;6Q02P$"% ,4    " !4@IA6!/TOS8<#   Y"P  &0
M            @(%"V@$ >&PO=V]R:W-H965T<R]S:&5E=#<Q+GAM;%!+ 0(4
M Q0    ( %2"F%8$_Q,U? (  (<&   9              " @0#> 0!X;"]W
M;W)K<VAE971S+W-H965T-S(N>&UL4$L! A0#%     @ 5(*85H_O$UXA P
M6PD  !D              ("!L^ ! 'AL+W=O<FMS:&5E=',O<VAE970W,RYX
M;6Q02P$"% ,4    " !4@IA64*O@-@8#  #T"@  &0              @($+
MY $ >&PO=V]R:W-H965T<R]S:&5E=#<T+GAM;%!+ 0(4 Q0    ( %2"F%8J
M,9ZBZ0(  %8(   9              " @4CG 0!X;"]W;W)K<VAE971S+W-H
M965T-S4N>&UL4$L! A0#%     @ 5(*85JP ]P E P  60D  !D
M     ("!:.H! 'AL+W=O<FMS:&5E=',O<VAE970W-BYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( %2"F%:7I.)O=P8  $(P   9              "
M@<G\ 0!X;"]W;W)K<VAE971S+W-H965T.#$N>&UL4$L! A0#%     @ 5(*8
M5O$+,3!< P  )A4   T              ( !=P," 'AL+W-T>6QE<RYX;6Q0
M2P$"% ,4    " !4@IA6EXJ[',     3 @  "P              @ '^!@(
M7W)E;',O+G)E;'-02P$"% ,4    " !4@IA69(IA3)\%  "0-0  #P
M        @ 'G!P( >&PO=V]R:V)O;VLN>&UL4$L! A0#%     @ 5(*85JN<
M,4MN @  VB\  !H              ( !LPT" 'AL+U]R96QS+W=O<FMB;V]K
M+GAM;"YR96QS4$L! A0#%     @ 5(*85D3DWU@> @  ERX  !,
M     ( !61 " %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&     %D 60!F&
&J!("

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>107
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>108
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>192</ContextCount>
  <ElementCount>394</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>56</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>7</UnitCount>
  <MyReports>
    <Report instance="f20f2022_beamrimaging.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000 - Document - Document And Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.beil.com/role/DocumentAndEntityInformation</Role>
      <ShortName>Document And Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="f20f2022_beamrimaging.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>001 - Statement - Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.beil.com/role/ConsolidatedBalanceSheet</Role>
      <ShortName>Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="f20f2022_beamrimaging.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>002 - Statement - Consolidated Balance Sheets (Parentheticals)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.beil.com/role/ConsolidatedBalanceSheet_Parentheticals</Role>
      <ShortName>Consolidated Balance Sheets (Parentheticals)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="f20f2022_beamrimaging.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>003 - Statement - Consolidated Statements of Operations and Comprehensive Loss</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.beil.com/role/ConsolidatedIncomeStatement</Role>
      <ShortName>Consolidated Statements of Operations and Comprehensive Loss</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="f20f2022_beamrimaging.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>004 - Statement - Consolidated Statements of Operations and Comprehensive Loss (Parentheticals)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.beil.com/role/ConsolidatedIncomeStatement_Parentheticals</Role>
      <ShortName>Consolidated Statements of Operations and Comprehensive Loss (Parentheticals)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="f20f2022_beamrimaging.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>005 - Statement - onsolidated Statements of Changes in Shareholders??? Equity (Deficit)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.beil.com/role/ShareholdersEquityType2or3</Role>
      <ShortName>onsolidated Statements of Changes in Shareholders??? Equity (Deficit)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="f20f2022_beamrimaging.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>006 - Statement - Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.beil.com/role/ConsolidatedCashFlow</Role>
      <ShortName>Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="f20f2022_beamrimaging.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>007 - Disclosure - General</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.beil.com/role/General</Role>
      <ShortName>General</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="f20f2022_beamrimaging.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>008 - Disclosure - Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.beil.com/role/SignificantAccountingPolicies</Role>
      <ShortName>Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="f20f2022_beamrimaging.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>009 - Disclosure - Other Current Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.beil.com/role/OtherCurrentAssets</Role>
      <ShortName>Other Current Assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="f20f2022_beamrimaging.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>010 - Disclosure - Property and Equipment, Net</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.beil.com/role/PropertyandEquipmentNet</Role>
      <ShortName>Property and Equipment, Net</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="f20f2022_beamrimaging.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>011 - Disclosure - Intangible Assets, Net and Goodwill</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.beil.com/role/IntangibleAssetsNetandGoodwill</Role>
      <ShortName>Intangible Assets, Net and Goodwill</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="f20f2022_beamrimaging.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>012 - Disclosure - Loans, Net</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.beil.com/role/LoansNet</Role>
      <ShortName>Loans, Net</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="f20f2022_beamrimaging.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>013 - Disclosure - Other Current Liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.beil.com/role/OtherCurrentLiabilities</Role>
      <ShortName>Other Current Liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="f20f2022_beamrimaging.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>014 - Disclosure - Derivative Warrants Liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.beil.com/role/DerivativeWarrantsLiabilities</Role>
      <ShortName>Derivative Warrants Liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="f20f2022_beamrimaging.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>015 - Disclosure - Convertible Advance Investment</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.beil.com/role/ConvertibleAdvanceInvestment</Role>
      <ShortName>Convertible Advance Investment</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="f20f2022_beamrimaging.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>016 - Disclosure - Commitments and Contingent Liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.beil.com/role/CommitmentsandContingentLiabilities</Role>
      <ShortName>Commitments and Contingent Liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="f20f2022_beamrimaging.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>017 - Disclosure - Shareholders??? Equity (Deficit)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.beil.com/role/ShareholdersEquityDeficit</Role>
      <ShortName>Shareholders??? Equity (Deficit)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="f20f2022_beamrimaging.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>018 - Disclosure - Share Options</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.beil.com/role/ShareOptions</Role>
      <ShortName>Share Options</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="f20f2022_beamrimaging.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>019 - Disclosure - Financing Expenses, Net</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.beil.com/role/FinancingExpensesNet</Role>
      <ShortName>Financing Expenses, Net</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="f20f2022_beamrimaging.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>020 - Disclosure - Related Parties Transactions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.beil.com/role/RelatedPartiesTransactions</Role>
      <ShortName>Related Parties Transactions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="f20f2022_beamrimaging.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>021 - Disclosure - Taxes on Income</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.beil.com/role/TaxesonIncome</Role>
      <ShortName>Taxes on Income</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="f20f2022_beamrimaging.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>022 - Disclosure - Segment Geographical Information And Major Customers</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.beil.com/role/SegmentGeographicalInformationAndMajorCustomers</Role>
      <ShortName>Segment Geographical Information And Major Customers</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="f20f2022_beamrimaging.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>023 - Disclosure - Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.beil.com/role/SubsequentEvents</Role>
      <ShortName>Subsequent Events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="f20f2022_beamrimaging.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>024 - Disclosure - Accounting Policies, by Policy (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.beil.com/role/AccountingPoliciesByPolicy</Role>
      <ShortName>Accounting Policies, by Policy (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.beil.com/role/SignificantAccountingPolicies</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="f20f2022_beamrimaging.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>025 - Disclosure - Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.beil.com/role/SignificantAccountingPoliciesTables</Role>
      <ShortName>Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.beil.com/role/SignificantAccountingPolicies</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="f20f2022_beamrimaging.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>026 - Disclosure - Other Current Assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.beil.com/role/OtherCurrentAssetsTables</Role>
      <ShortName>Other Current Assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.beil.com/role/OtherCurrentAssets</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="f20f2022_beamrimaging.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>027 - Disclosure - Property and Equipment, Net (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.beil.com/role/PropertyandEquipmentNetTables</Role>
      <ShortName>Property and Equipment, Net (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.beil.com/role/PropertyandEquipmentNet</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="f20f2022_beamrimaging.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>028 - Disclosure - Intangible Assets, Net and Goodwill (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.beil.com/role/IntangibleAssetsNetandGoodwillTables</Role>
      <ShortName>Intangible Assets, Net and Goodwill (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.beil.com/role/IntangibleAssetsNetandGoodwill</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="f20f2022_beamrimaging.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>029 - Disclosure - Loans, Net (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.beil.com/role/LoansNetTables</Role>
      <ShortName>Loans, Net (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.beil.com/role/LoansNet</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="f20f2022_beamrimaging.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>030 - Disclosure - Other Current Liabilities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.beil.com/role/OtherCurrentLiabilitiesTables</Role>
      <ShortName>Other Current Liabilities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.beil.com/role/OtherCurrentLiabilities</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="f20f2022_beamrimaging.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>031 - Disclosure - Derivative Warrants Liabilities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.beil.com/role/DerivativeWarrantsLiabilitiesTables</Role>
      <ShortName>Derivative Warrants Liabilities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.beil.com/role/DerivativeWarrantsLiabilities</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="f20f2022_beamrimaging.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>032 - Disclosure - Convertible Advance Investment (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.beil.com/role/ConvertibleAdvanceInvestmentTables</Role>
      <ShortName>Convertible Advance Investment (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.beil.com/role/ConvertibleAdvanceInvestment</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="f20f2022_beamrimaging.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>033 - Disclosure - Commitments and Contingent Liabilities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.beil.com/role/CommitmentsandContingentLiabilitiesTables</Role>
      <ShortName>Commitments and Contingent Liabilities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.beil.com/role/CommitmentsandContingentLiabilities</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="f20f2022_beamrimaging.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>034 - Disclosure - Shareholders??? Equity (Deficit) (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.beil.com/role/ShareholdersEquityDeficitTables</Role>
      <ShortName>Shareholders??? Equity (Deficit) (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.beil.com/role/ShareholdersEquityDeficit</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="f20f2022_beamrimaging.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>035 - Disclosure - Share Options (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.beil.com/role/ShareOptionsTables</Role>
      <ShortName>Share Options (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.beil.com/role/ShareOptions</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="f20f2022_beamrimaging.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>036 - Disclosure - Financing Expenses, Net (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.beil.com/role/FinancingExpensesNetTables</Role>
      <ShortName>Financing Expenses, Net (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.beil.com/role/FinancingExpensesNet</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="f20f2022_beamrimaging.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>037 - Disclosure - Related Parties Transactions (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.beil.com/role/RelatedPartiesTransactionsTables</Role>
      <ShortName>Related Parties Transactions (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.beil.com/role/RelatedPartiesTransactions</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="f20f2022_beamrimaging.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>038 - Disclosure - Taxes on Income (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.beil.com/role/TaxesonIncomeTables</Role>
      <ShortName>Taxes on Income (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.beil.com/role/TaxesonIncome</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="f20f2022_beamrimaging.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>039 - Disclosure - Segment Geographical Information And Major Customers (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.beil.com/role/SegmentGeographicalInformationAndMajorCustomersTables</Role>
      <ShortName>Segment Geographical Information And Major Customers (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.beil.com/role/SegmentGeographicalInformationAndMajorCustomers</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="f20f2022_beamrimaging.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>040 - Disclosure - General (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.beil.com/role/GeneralDetails</Role>
      <ShortName>General (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.beil.com/role/General</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="f20f2022_beamrimaging.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>041 - Disclosure - Significant Accounting Policies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.beil.com/role/SignificantAccountingPoliciesDetails</Role>
      <ShortName>Significant Accounting Policies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.beil.com/role/SignificantAccountingPoliciesTables</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="f20f2022_beamrimaging.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>042 - Disclosure - Significant Accounting Policies (Details) - Schedule of computing straight-line amortization</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.beil.com/role/ScheduleofcomputingstraightlineamortizationTable</Role>
      <ShortName>Significant Accounting Policies (Details) - Schedule of computing straight-line amortization</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.beil.com/role/SignificantAccountingPoliciesTables</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="f20f2022_beamrimaging.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>043 - Disclosure - Significant Accounting Policies (Details) - Schedule of computing straight-line depreciation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.beil.com/role/ScheduleofcomputingstraightlinedepreciationTable</Role>
      <ShortName>Significant Accounting Policies (Details) - Schedule of computing straight-line depreciation</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.beil.com/role/SignificantAccountingPoliciesTables</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="f20f2022_beamrimaging.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>044 - Disclosure - Other Current Assets (Details) - Schedule of other current assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.beil.com/role/ScheduleofothercurrentassetsTable</Role>
      <ShortName>Other Current Assets (Details) - Schedule of other current assets</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.beil.com/role/OtherCurrentAssetsTables</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="f20f2022_beamrimaging.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>045 - Disclosure - Property and Equipment, Net (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.beil.com/role/PropertyandEquipmentNetDetails</Role>
      <ShortName>Property and Equipment, Net (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.beil.com/role/PropertyandEquipmentNetTables</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="f20f2022_beamrimaging.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>046 - Disclosure - Property and Equipment, Net (Details) - Schedule of property and equipment net</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.beil.com/role/ScheduleofpropertyandequipmentnetTable</Role>
      <ShortName>Property and Equipment, Net (Details) - Schedule of property and equipment net</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.beil.com/role/PropertyandEquipmentNetTables</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="f20f2022_beamrimaging.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>047 - Disclosure - Intangible Assets, Net and Goodwill (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.beil.com/role/IntangibleAssetsNetandGoodwillDetails</Role>
      <ShortName>Intangible Assets, Net and Goodwill (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.beil.com/role/IntangibleAssetsNetandGoodwillTables</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="f20f2022_beamrimaging.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>048 - Disclosure - Intangible Assets, Net and Goodwill (Details) - Schedule of intangible assets, net and goodwil</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.beil.com/role/ScheduleofintangibleassetsnetandgoodwilTable</Role>
      <ShortName>Intangible Assets, Net and Goodwill (Details) - Schedule of intangible assets, net and goodwil</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.beil.com/role/IntangibleAssetsNetandGoodwillTables</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="f20f2022_beamrimaging.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>049 - Disclosure - Intangible Assets, Net and Goodwill (Details) - Schedule of the estimated future amortization expense of intangible assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.beil.com/role/ScheduleoftheestimatedfutureamortizationexpenseofintangibleassetsTable</Role>
      <ShortName>Intangible Assets, Net and Goodwill (Details) - Schedule of the estimated future amortization expense of intangible assets</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.beil.com/role/IntangibleAssetsNetandGoodwillTables</ParentRole>
      <Position>50</Position>
    </Report>
    <Report instance="f20f2022_beamrimaging.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>050 - Disclosure - Loans, Net (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.beil.com/role/LoansNetDetails</Role>
      <ShortName>Loans, Net (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.beil.com/role/LoansNetTables</ParentRole>
      <Position>51</Position>
    </Report>
    <Report instance="f20f2022_beamrimaging.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>051 - Disclosure - Loans, Net (Details) - Schedule of the Effective Date, management by assistance of third-party</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.beil.com/role/ScheduleoftheEffectiveDatemanagementbyassistanceofthirdpartyTable</Role>
      <ShortName>Loans, Net (Details) - Schedule of the Effective Date, management by assistance of third-party</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.beil.com/role/LoansNetTables</ParentRole>
      <Position>52</Position>
    </Report>
    <Report instance="f20f2022_beamrimaging.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>052 - Disclosure - Loans, Net (Details) - Schedule of the reconciliation of the carrying amount</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.beil.com/role/ScheduleofthereconciliationofthecarryingamountTable</Role>
      <ShortName>Loans, Net (Details) - Schedule of the reconciliation of the carrying amount</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.beil.com/role/LoansNetTables</ParentRole>
      <Position>53</Position>
    </Report>
    <Report instance="f20f2022_beamrimaging.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>053 - Disclosure - Loans, Net (Details) - Schedule of maturity dates of outstanding loans</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.beil.com/role/ScheduleofmaturitydatesofoutstandingloansTable</Role>
      <ShortName>Loans, Net (Details) - Schedule of maturity dates of outstanding loans</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.beil.com/role/LoansNetTables</ParentRole>
      <Position>54</Position>
    </Report>
    <Report instance="f20f2022_beamrimaging.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>054 - Disclosure - Other Current Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.beil.com/role/OtherCurrentLiabilitiesDetails</Role>
      <ShortName>Other Current Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.beil.com/role/OtherCurrentLiabilitiesTables</ParentRole>
      <Position>55</Position>
    </Report>
    <Report instance="f20f2022_beamrimaging.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>055 - Disclosure - Other Current Liabilities (Details) - Schedule of other current liabilties</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.beil.com/role/ScheduleofothercurrentliabiltiesTable</Role>
      <ShortName>Other Current Liabilities (Details) - Schedule of other current liabilties</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.beil.com/role/OtherCurrentLiabilitiesTables</ParentRole>
      <Position>56</Position>
    </Report>
    <Report instance="f20f2022_beamrimaging.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>056 - Disclosure - Derivative Warrants Liabilities (Details) - Schedule of reconciliation of the fair value of derivative warrants liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.beil.com/role/ScheduleofreconciliationofthefairvalueofderivativewarrantsliabilitiesTable</Role>
      <ShortName>Derivative Warrants Liabilities (Details) - Schedule of reconciliation of the fair value of derivative warrants liabilities</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.beil.com/role/DerivativeWarrantsLiabilitiesTables</ParentRole>
      <Position>57</Position>
    </Report>
    <Report instance="f20f2022_beamrimaging.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>057 - Disclosure - Convertible Advance Investment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.beil.com/role/ConvertibleAdvanceInvestmentDetails</Role>
      <ShortName>Convertible Advance Investment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.beil.com/role/ConvertibleAdvanceInvestmentTables</ParentRole>
      <Position>58</Position>
    </Report>
    <Report instance="f20f2022_beamrimaging.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>058 - Disclosure - Convertible Advance Investment (Details) - Schedule of reconciliation of the carrying amount of the convertible advance investment</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.beil.com/role/ScheduleofreconciliationofthecarryingamountoftheconvertibleadvanceinvestmentTable</Role>
      <ShortName>Convertible Advance Investment (Details) - Schedule of reconciliation of the carrying amount of the convertible advance investment</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.beil.com/role/ConvertibleAdvanceInvestmentTables</ParentRole>
      <Position>59</Position>
    </Report>
    <Report instance="f20f2022_beamrimaging.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>059 - Disclosure - Commitments and Contingent Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.beil.com/role/CommitmentsandContingentLiabilitiesDetails</Role>
      <ShortName>Commitments and Contingent Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.beil.com/role/CommitmentsandContingentLiabilitiesTables</ParentRole>
      <Position>60</Position>
    </Report>
    <Report instance="f20f2022_beamrimaging.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>060 - Disclosure - Commitments and Contingent Liabilities (Details) - Schedule of future minimum commitment under binding lease agreeements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.beil.com/role/ScheduleoffutureminimumcommitmentunderbindingleaseagreeementsTable</Role>
      <ShortName>Commitments and Contingent Liabilities (Details) - Schedule of future minimum commitment under binding lease agreeements</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.beil.com/role/CommitmentsandContingentLiabilitiesTables</ParentRole>
      <Position>61</Position>
    </Report>
    <Report instance="f20f2022_beamrimaging.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>061 - Disclosure - Shareholders??? Equity (Deficit) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.beil.com/role/ShareholdersEquityDeficitDetails</Role>
      <ShortName>Shareholders??? Equity (Deficit) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.beil.com/role/ShareholdersEquityDeficitTables</ParentRole>
      <Position>62</Position>
    </Report>
    <Report instance="f20f2022_beamrimaging.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>062 - Disclosure - Shareholders??? Equity (Deficit) (Details) - Schedule of composition of shareholders' equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.beil.com/role/ScheduleofcompositionofshareholdersequityTable</Role>
      <ShortName>Shareholders??? Equity (Deficit) (Details) - Schedule of composition of shareholders' equity</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.beil.com/role/ShareholdersEquityDeficitTables</ParentRole>
      <Position>63</Position>
    </Report>
    <Report instance="f20f2022_beamrimaging.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>063 - Disclosure - Share Options (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.beil.com/role/ShareOptionsDetails</Role>
      <ShortName>Share Options (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.beil.com/role/ShareOptionsTables</ParentRole>
      <Position>64</Position>
    </Report>
    <Report instance="f20f2022_beamrimaging.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>064 - Disclosure - Share Options (Details) - Schedule of company???s share option activity for employees and members of the board of directors</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.beil.com/role/ScheduleofcompanysshareoptionactivityforemployeesandmembersoftheboardofdirectorsTable</Role>
      <ShortName>Share Options (Details) - Schedule of company???s share option activity for employees and members of the board of directors</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.beil.com/role/ShareOptionsTables</ParentRole>
      <Position>65</Position>
    </Report>
    <Report instance="f20f2022_beamrimaging.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>065 - Disclosure - Share Options (Details) - Schedule of outstanding and exercisable share options separated ranges of exercise prices</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.beil.com/role/ScheduleofoutstandingandexercisableshareoptionsseparatedrangesofexercisepricesTable</Role>
      <ShortName>Share Options (Details) - Schedule of outstanding and exercisable share options separated ranges of exercise prices</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.beil.com/role/ShareOptionsTables</ParentRole>
      <Position>66</Position>
    </Report>
    <Report instance="f20f2022_beamrimaging.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>066 - Disclosure - Share Options (Details) - Schedule of assumptions used to estimate the fair values of the share options granted</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.beil.com/role/ScheduleofassumptionsusedtoestimatethefairvaluesoftheshareoptionsgrantedTable</Role>
      <ShortName>Share Options (Details) - Schedule of assumptions used to estimate the fair values of the share options granted</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.beil.com/role/ShareOptionsTables</ParentRole>
      <Position>67</Position>
    </Report>
    <Report instance="f20f2022_beamrimaging.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>067 - Disclosure - Share Options (Details) - Schedule of company???s equity-based awards recognized</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.beil.com/role/ScheduleofcompanysequitybasedawardsrecognizedTable</Role>
      <ShortName>Share Options (Details) - Schedule of company???s equity-based awards recognized</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.beil.com/role/ShareOptionsTables</ParentRole>
      <Position>68</Position>
    </Report>
    <Report instance="f20f2022_beamrimaging.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>068 - Disclosure - Financing Expenses, Net (Details) - Schedule of financing expenses</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.beil.com/role/ScheduleoffinancingexpensesTable</Role>
      <ShortName>Financing Expenses, Net (Details) - Schedule of financing expenses</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.beil.com/role/FinancingExpensesNetTables</ParentRole>
      <Position>69</Position>
    </Report>
    <Report instance="f20f2022_beamrimaging.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>069 - Disclosure - Related Parties Transactions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.beil.com/role/RelatedPartiesTransactionsDetails</Role>
      <ShortName>Related Parties Transactions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.beil.com/role/RelatedPartiesTransactionsTables</ParentRole>
      <Position>70</Position>
    </Report>
    <Report instance="f20f2022_beamrimaging.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>070 - Disclosure - Related Parties Transactions (Details) - Schedule of the reconciliation of the carrying amount of the Company</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.beil.com/role/ScheduleofthereconciliationofthecarryingamountoftheCompanyTable</Role>
      <ShortName>Related Parties Transactions (Details) - Schedule of the reconciliation of the carrying amount of the Company</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.beil.com/role/RelatedPartiesTransactionsTables</ParentRole>
      <Position>71</Position>
    </Report>
    <Report instance="f20f2022_beamrimaging.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>071 - Disclosure - Related Parties Transactions (Details) - Schedule of maturity dates</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.beil.com/role/ScheduleofmaturitydatesTable</Role>
      <ShortName>Related Parties Transactions (Details) - Schedule of maturity dates</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.beil.com/role/RelatedPartiesTransactionsTables</ParentRole>
      <Position>72</Position>
    </Report>
    <Report instance="f20f2022_beamrimaging.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>072 - Disclosure - Related Parties Transactions (Details) - Schedule of expenses related to service agreement and the office services agreement</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.beil.com/role/ScheduleofexpensesrelatedtoserviceagreementandtheofficeservicesagreementTable</Role>
      <ShortName>Related Parties Transactions (Details) - Schedule of expenses related to service agreement and the office services agreement</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.beil.com/role/RelatedPartiesTransactionsTables</ParentRole>
      <Position>73</Position>
    </Report>
    <Report instance="f20f2022_beamrimaging.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>073 - Disclosure - Taxes on Income (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.beil.com/role/TaxesonIncomeDetails</Role>
      <ShortName>Taxes on Income (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.beil.com/role/TaxesonIncomeTables</ParentRole>
      <Position>74</Position>
    </Report>
    <Report instance="f20f2022_beamrimaging.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>074 - Disclosure - Taxes on Income (Details) - Schedule of loss (income) before taxes on income</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.beil.com/role/ScheduleoflossincomebeforetaxesonincomeTable</Role>
      <ShortName>Taxes on Income (Details) - Schedule of loss (income) before taxes on income</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.beil.com/role/TaxesonIncomeTables</ParentRole>
      <Position>75</Position>
    </Report>
    <Report instance="f20f2022_beamrimaging.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>075 - Disclosure - Taxes on Income (Details) - Schedule of deferred income taxes reflect the net tax effects of net operating loss</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.beil.com/role/ScheduleofdeferredincometaxesreflectthenettaxeffectsofnetoperatinglossTable</Role>
      <ShortName>Taxes on Income (Details) - Schedule of deferred income taxes reflect the net tax effects of net operating loss</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.beil.com/role/TaxesonIncomeTables</ParentRole>
      <Position>76</Position>
    </Report>
    <Report instance="f20f2022_beamrimaging.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>076 - Disclosure - Segment Geographical Information And Major Customers (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.beil.com/role/SegmentGeographicalInformationAndMajorCustomersDetails</Role>
      <ShortName>Segment Geographical Information And Major Customers (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.beil.com/role/SegmentGeographicalInformationAndMajorCustomersTables</ParentRole>
      <Position>77</Position>
    </Report>
    <Report instance="f20f2022_beamrimaging.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>077 - Disclosure - Segment Geographical Information And Major Customers (Details) - Schedule of revenues by geographic region</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.beil.com/role/ScheduleofrevenuesbygeographicregionTable</Role>
      <ShortName>Segment Geographical Information And Major Customers (Details) - Schedule of revenues by geographic region</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.beil.com/role/SegmentGeographicalInformationAndMajorCustomersTables</ParentRole>
      <Position>78</Position>
    </Report>
    <Report instance="f20f2022_beamrimaging.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>078 - Disclosure - Segment Geographical Information And Major Customers (Details) - Schedule of Long-lived assets net by geographic areas</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.beil.com/role/ScheduleofLonglivedassetsnetbygeographicareasTable</Role>
      <ShortName>Segment Geographical Information And Major Customers (Details) - Schedule of Long-lived assets net by geographic areas</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.beil.com/role/SegmentGeographicalInformationAndMajorCustomersTables</ParentRole>
      <Position>79</Position>
    </Report>
    <Report instance="f20f2022_beamrimaging.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>079 - Disclosure - Segment Geographical Information And Major Customers (Details) - Schedule of revenue disaggregated by primary major product lines and services</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.beil.com/role/ScheduleofrevenuedisaggregatedbyprimarymajorproductlinesandservicesTable</Role>
      <ShortName>Segment Geographical Information And Major Customers (Details) - Schedule of revenue disaggregated by primary major product lines and services</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.beil.com/role/SegmentGeographicalInformationAndMajorCustomersTables</ParentRole>
      <Position>80</Position>
    </Report>
    <Report instance="f20f2022_beamrimaging.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R81.htm</HtmlFileName>
      <LongName>080 - Disclosure - Subsequent Events (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.beil.com/role/SubsequentEventsDetails</Role>
      <ShortName>Subsequent Events (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.beil.com/role/SubsequentEvents</ParentRole>
      <Position>81</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Warning">[dq-0542-Deprecated-Concept] Concept DueToRelatedPartiesCurrent in us-gaap/2022 used in 2 facts was deprecated in us-gaap/2023 as of 2023 and should not be used. f20f2022_beamrimaging.htm 12520, 12521</Log>
    <Log type="Warning">[dq-0542-Deprecated-Concept] Concept DueToRelatedPartiesNoncurrent in us-gaap/2022 used in 2 facts was deprecated in us-gaap/2023 as of 2023 and should not be used. f20f2022_beamrimaging.htm 12550, 18500</Log>
    <Log type="Warning">[dq-0542-Deprecated-Concept] Concept RelatedPartyTransactionDueFromToRelatedPartyCurrent in us-gaap/2022 used in 1 facts was deprecated in us-gaap/2023 as of 2023 and should not be used. f20f2022_beamrimaging.htm 17372</Log>
    <Log type="Warning">[dq-0542-Deprecated-Concept] Concept DueToOtherRelatedPartiesClassifiedCurrent in us-gaap/2022 used in 1 facts was deprecated in us-gaap/2023 as of 2023 and should not be used. f20f2022_beamrimaging.htm 17381</Log>
    <Log type="Warning">[dq-0542-Deprecated-Concept] Concept ResearchAndDevelopmentInProcess in us-gaap/2022 used in 3 facts was deprecated in us-gaap/2023 as of 2023 and should not be used. f20f2022_beamrimaging.htm 17591, 17595, 17599</Log>
    <Log type="Warning">[ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 15 fact(s) appearing in ix:hidden were eligible for transformation: dei:CityAreaCode, dei:DocumentAccountingStandard, dei:LocalPhoneNumber, us-gaap:CommonStockParOrStatedValuePerShare, us-gaap:EarningsPerShareDiluted, us-gaap:PreferredStockParOrStatedValuePerShare, us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding -  f20f2022_beamrimaging.htm 18496, 18497, 18498, 18503, 18504, 18505, 18506, 18507, 18508, 18509, 18510, 18511, 18512, 18513, 18514</Log>
  </Logs>
  <InputFiles>
    <File doctype="20-F" original="f20f2022_beamrimaging.htm">f20f2022_beamrimaging.htm</File>
    <File>bmr-20221231.xsd</File>
    <File>bmr-20221231_cal.xml</File>
    <File>bmr-20221231_def.xml</File>
    <File>bmr-20221231_lab.xml</File>
    <File>bmr-20221231_pre.xml</File>
    <File>f20f2022ex12-1_beamrimaging.htm</File>
    <File>f20f2022ex12-2_beamrimaging.htm</File>
    <File>f20f2022ex13-1_beamrimaging.htm</File>
    <File>f20f2022ex13-2_beamrimaging.htm</File>
    <File>f20f2022ex2-1_beamrimaging.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>image_001.jpg</File>
    <File>image_002.jpg</File>
    <File>image_003.jpg</File>
    <File>image_004.jpg</File>
    <File>image_005.jpg</File>
    <File>image_006.jpg</File>
    <File>image_007.jpg</File>
    <File>image_008.jpg</File>
    <File>image_009.jpg</File>
    <File>image_010.jpg</File>
    <File>image_011.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="817">http://fasb.org/us-gaap/2022</BaseTaxonomy>
    <BaseTaxonomy items="46">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>111
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "f20f2022_beamrimaging.htm": {
   "axisCustom": 1,
   "axisStandard": 18,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2022": 817,
    "http://xbrl.sec.gov/dei/2022": 46
   },
   "contextCount": 192,
   "dts": {
    "calculationLink": {
     "local": [
      "bmr-20221231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "bmr-20221231_def.xml"
     ]
    },
    "inline": {
     "local": [
      "f20f2022_beamrimaging.htm"
     ]
    },
    "labelLink": {
     "local": [
      "bmr-20221231_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "bmr-20221231_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "bmr-20221231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd",
      "https://xbrl.sec.gov/sic/2022/sic-2022.xsd"
     ]
    }
   },
   "elementCount": 587,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2022": 80,
    "http://www.beil.com/20221231": 12,
    "http://xbrl.sec.gov/dei/2022": 6,
    "total": 98
   },
   "keyCustom": 50,
   "keyStandard": 344,
   "memberCustom": 31,
   "memberStandard": 22,
   "nsprefix": "bmr",
   "nsuri": "http://www.beil.com/20221231",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityRegistrantName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "000 - Document - Document And Entity Information",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://www.beil.com/role/DocumentAndEntityInformation",
     "shortName": "Document And Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityRegistrantName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherCurrentAssetsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "009 - Disclosure - Other Current Assets",
     "menuCat": "Notes",
     "order": "10",
     "role": "http://www.beil.com/role/OtherCurrentAssets",
     "shortName": "Other Current Assets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherCurrentAssetsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "010 - Disclosure - Property and Equipment, Net",
     "menuCat": "Notes",
     "order": "11",
     "role": "http://www.beil.com/role/PropertyandEquipmentNet",
     "shortName": "Property and Equipment, Net",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "011 - Disclosure - Intangible Assets, Net and Goodwill",
     "menuCat": "Notes",
     "order": "12",
     "role": "http://www.beil.com/role/IntangibleAssetsNetandGoodwill",
     "shortName": "Intangible Assets, Net and Goodwill",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "012 - Disclosure - Loans, Net",
     "menuCat": "Notes",
     "order": "13",
     "role": "http://www.beil.com/role/LoansNet",
     "shortName": "Loans, Net",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "013 - Disclosure - Other Current Liabilities",
     "menuCat": "Notes",
     "order": "14",
     "role": "http://www.beil.com/role/OtherCurrentLiabilities",
     "shortName": "Other Current Liabilities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "014 - Disclosure - Derivative Warrants Liabilities",
     "menuCat": "Notes",
     "order": "15",
     "role": "http://www.beil.com/role/DerivativeWarrantsLiabilities",
     "shortName": "Derivative Warrants Liabilities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentHoldingsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "015 - Disclosure - Convertible Advance Investment",
     "menuCat": "Notes",
     "order": "16",
     "role": "http://www.beil.com/role/ConvertibleAdvanceInvestment",
     "shortName": "Convertible Advance Investment",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentHoldingsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "016 - Disclosure - Commitments and Contingent Liabilities",
     "menuCat": "Notes",
     "order": "17",
     "role": "http://www.beil.com/role/CommitmentsandContingentLiabilities",
     "shortName": "Commitments and Contingent Liabilities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "017 - Disclosure - Shareholders\u2019 Equity (Deficit)",
     "menuCat": "Notes",
     "order": "18",
     "role": "http://www.beil.com/role/ShareholdersEquityDeficit",
     "shortName": "Shareholders\u2019 Equity (Deficit)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "018 - Disclosure - Share Options",
     "menuCat": "Notes",
     "order": "19",
     "role": "http://www.beil.com/role/ShareOptions",
     "shortName": "Share Options",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c2",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "001 - Statement - Consolidated Balance Sheets",
     "menuCat": "Statements",
     "order": "2",
     "role": "http://www.beil.com/role/ConsolidatedBalanceSheet",
     "shortName": "Consolidated Balance Sheets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c2",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "bmr:FinancingExpenses",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "019 - Disclosure - Financing Expenses, Net",
     "menuCat": "Notes",
     "order": "20",
     "role": "http://www.beil.com/role/FinancingExpensesNet",
     "shortName": "Financing Expenses, Net",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "bmr:FinancingExpenses",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "020 - Disclosure - Related Parties Transactions",
     "menuCat": "Notes",
     "order": "21",
     "role": "http://www.beil.com/role/RelatedPartiesTransactions",
     "shortName": "Related Parties Transactions",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "021 - Disclosure - Taxes on Income",
     "menuCat": "Notes",
     "order": "22",
     "role": "http://www.beil.com/role/TaxesonIncome",
     "shortName": "Taxes on Income",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "022 - Disclosure - Segment Geographical Information And Major Customers",
     "menuCat": "Notes",
     "order": "23",
     "role": "http://www.beil.com/role/SegmentGeographicalInformationAndMajorCustomers",
     "shortName": "Segment Geographical Information And Major Customers",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "023 - Disclosure - Subsequent Events",
     "menuCat": "Notes",
     "order": "24",
     "role": "http://www.beil.com/role/SubsequentEvents",
     "shortName": "Subsequent Events",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UseOfEstimates",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "024 - Disclosure - Accounting Policies, by Policy (Policies)",
     "menuCat": "Policies",
     "order": "25",
     "role": "http://www.beil.com/role/AccountingPoliciesByPolicy",
     "shortName": "Accounting Policies, by Policy (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UseOfEstimates",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "025 - Disclosure - Significant Accounting Policies (Tables)",
     "menuCat": "Tables",
     "order": "26",
     "role": "http://www.beil.com/role/SignificantAccountingPoliciesTables",
     "shortName": "Significant Accounting Policies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "026 - Disclosure - Other Current Assets (Tables)",
     "menuCat": "Tables",
     "order": "27",
     "role": "http://www.beil.com/role/OtherCurrentAssetsTables",
     "shortName": "Other Current Assets (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "027 - Disclosure - Property and Equipment, Net (Tables)",
     "menuCat": "Tables",
     "order": "28",
     "role": "http://www.beil.com/role/PropertyandEquipmentNetTables",
     "shortName": "Property and Equipment, Net (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfImpairedIntangibleAssetsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "028 - Disclosure - Intangible Assets, Net and Goodwill (Tables)",
     "menuCat": "Tables",
     "order": "29",
     "role": "http://www.beil.com/role/IntangibleAssetsNetandGoodwillTables",
     "shortName": "Intangible Assets, Net and Goodwill (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfImpairedIntangibleAssetsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c2",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:PreferredStockSharesAuthorized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "002 - Statement - Consolidated Balance Sheets (Parentheticals)",
     "menuCat": "Statements",
     "order": "3",
     "role": "http://www.beil.com/role/ConsolidatedBalanceSheet_Parentheticals",
     "shortName": "Consolidated Balance Sheets (Parentheticals)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c2",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:PreferredStockSharesAuthorized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "bmr:ScheduleOfTheMemberEffectiveDateManagementByAssistanceOfThirdpartyTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "029 - Disclosure - Loans, Net (Tables)",
     "menuCat": "Tables",
     "order": "30",
     "role": "http://www.beil.com/role/LoansNetTables",
     "shortName": "Loans, Net (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "bmr:ScheduleOfTheMemberEffectiveDateManagementByAssistanceOfThirdpartyTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherCurrentLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "030 - Disclosure - Other Current Liabilities (Tables)",
     "menuCat": "Tables",
     "order": "31",
     "role": "http://www.beil.com/role/OtherCurrentLiabilitiesTables",
     "shortName": "Other Current Liabilities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherCurrentLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "031 - Disclosure - Derivative Warrants Liabilities (Tables)",
     "menuCat": "Tables",
     "order": "32",
     "role": "http://www.beil.com/role/DerivativeWarrantsLiabilitiesTables",
     "shortName": "Derivative Warrants Liabilities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentHoldingsScheduleOfInvestmentsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "032 - Disclosure - Convertible Advance Investment (Tables)",
     "menuCat": "Tables",
     "order": "33",
     "role": "http://www.beil.com/role/ConvertibleAdvanceInvestmentTables",
     "shortName": "Convertible Advance Investment (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentHoldingsScheduleOfInvestmentsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "bmr:scheduleOfFutureMinimumCommitmentUnderBindingLeaseAgreeementsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "033 - Disclosure - Commitments and Contingent Liabilities (Tables)",
     "menuCat": "Tables",
     "order": "34",
     "role": "http://www.beil.com/role/CommitmentsandContingentLiabilitiesTables",
     "shortName": "Commitments and Contingent Liabilities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "bmr:scheduleOfFutureMinimumCommitmentUnderBindingLeaseAgreeementsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfStockholdersEquityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "034 - Disclosure - Shareholders\u2019 Equity (Deficit) (Tables)",
     "menuCat": "Tables",
     "order": "35",
     "role": "http://www.beil.com/role/ShareholdersEquityDeficitTables",
     "shortName": "Shareholders\u2019 Equity (Deficit) (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfStockholdersEquityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "035 - Disclosure - Share Options (Tables)",
     "menuCat": "Tables",
     "order": "36",
     "role": "http://www.beil.com/role/ShareOptionsTables",
     "shortName": "Share Options (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConvertibleDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "036 - Disclosure - Financing Expenses, Net (Tables)",
     "menuCat": "Tables",
     "order": "37",
     "role": "http://www.beil.com/role/FinancingExpensesNetTables",
     "shortName": "Financing Expenses, Net (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConvertibleDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRegulatoryLiabilitiesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "037 - Disclosure - Related Parties Transactions (Tables)",
     "menuCat": "Tables",
     "order": "38",
     "role": "http://www.beil.com/role/RelatedPartiesTransactionsTables",
     "shortName": "Related Parties Transactions (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRegulatoryLiabilitiesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "038 - Disclosure - Taxes on Income (Tables)",
     "menuCat": "Tables",
     "order": "39",
     "role": "http://www.beil.com/role/TaxesonIncomeTables",
     "shortName": "Taxes on Income (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c0",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "003 - Statement - Consolidated Statements of Operations and Comprehensive Loss",
     "menuCat": "Statements",
     "order": "4",
     "role": "http://www.beil.com/role/ConsolidatedIncomeStatement",
     "shortName": "Consolidated Statements of Operations and Comprehensive Loss",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c0",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:CostOfRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "039 - Disclosure - Segment Geographical Information And Major Customers (Tables)",
     "menuCat": "Tables",
     "order": "40",
     "role": "http://www.beil.com/role/SegmentGeographicalInformationAndMajorCustomersTables",
     "shortName": "Segment Geographical Information And Major Customers (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c0",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "040 - Disclosure - General (Details)",
     "menuCat": "Details",
     "order": "41",
     "role": "http://www.beil.com/role/GeneralDetails",
     "shortName": "General (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c2",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:CapitalUnitsNetAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c0",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ProceedsFromIssuanceInitialPublicOffering",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "041 - Disclosure - Significant Accounting Policies (Details)",
     "menuCat": "Details",
     "order": "42",
     "role": "http://www.beil.com/role/SignificantAccountingPoliciesDetails",
     "shortName": "Significant Accounting Policies (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c0",
      "decimals": "4",
      "lang": null,
      "name": "bmr:EmployeeCompensationPercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "pure",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c48",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "bmr:PropertyPlantAndEquipmentDepreciationPercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "pure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "042 - Disclosure - Significant Accounting Policies (Details) - Schedule of computing straight-line amortization",
     "menuCat": "Details",
     "order": "43",
     "role": "http://www.beil.com/role/ScheduleofcomputingstraightlineamortizationTable",
     "shortName": "Significant Accounting Policies (Details) - Schedule of computing straight-line amortization",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c48",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "bmr:PropertyPlantAndEquipmentDepreciationPercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "pure",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "us-gaap:PropertyPlantAndEquipmentAndIntangibleAssetsTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c51",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "us-gaap:PropertyPlantAndEquipmentSalvageValuePercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "pure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "043 - Disclosure - Significant Accounting Policies (Details) - Schedule of computing straight-line depreciation",
     "menuCat": "Details",
     "order": "44",
     "role": "http://www.beil.com/role/ScheduleofcomputingstraightlinedepreciationTable",
     "shortName": "Significant Accounting Policies (Details) - Schedule of computing straight-line depreciation",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "us-gaap:PropertyPlantAndEquipmentAndIntangibleAssetsTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c51",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "us-gaap:PropertyPlantAndEquipmentSalvageValuePercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "pure",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c2",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:PrepaidExpenseCurrentAndNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "044 - Disclosure - Other Current Assets (Details) - Schedule of other current assets",
     "menuCat": "Details",
     "order": "45",
     "role": "http://www.beil.com/role/ScheduleofothercurrentassetsTable",
     "shortName": "Other Current Assets (Details) - Schedule of other current assets",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c2",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:PrepaidExpenseCurrentAndNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c0",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:DepreciationExpenseOnReclassifiedAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "045 - Disclosure - Property and Equipment, Net (Details)",
     "menuCat": "Details",
     "order": "46",
     "role": "http://www.beil.com/role/PropertyandEquipmentNetDetails",
     "shortName": "Property and Equipment, Net (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c0",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:DepreciationExpenseOnReclassifiedAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c2",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "046 - Disclosure - Property and Equipment, Net (Details) - Schedule of property and equipment net",
     "menuCat": "Details",
     "order": "47",
     "role": "http://www.beil.com/role/ScheduleofpropertyandequipmentnetTable",
     "shortName": "Property and Equipment, Net (Details) - Schedule of property and equipment net",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c2",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c0",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "047 - Disclosure - Intangible Assets, Net and Goodwill (Details)",
     "menuCat": "Details",
     "order": "48",
     "role": "http://www.beil.com/role/IntangibleAssetsNetandGoodwillDetails",
     "shortName": "Intangible Assets, Net and Goodwill (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c0",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfImpairedIntangibleAssetsTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c2",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AssetsUnderManagementCarryingAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "048 - Disclosure - Intangible Assets, Net and Goodwill (Details) - Schedule of intangible assets, net and goodwil",
     "menuCat": "Details",
     "order": "49",
     "role": "http://www.beil.com/role/ScheduleofintangibleassetsnetandgoodwilTable",
     "shortName": "Intangible Assets, Net and Goodwill (Details) - Schedule of intangible assets, net and goodwil",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfImpairedIntangibleAssetsTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c2",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AssetsUnderManagementCarryingAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": null,
     "groupType": "statement",
     "isDefault": "false",
     "longName": "004 - Statement - Consolidated Statements of Operations and Comprehensive Loss (Parentheticals)",
     "menuCat": "Statements",
     "order": "5",
     "role": "http://www.beil.com/role/ConsolidatedIncomeStatement_Parentheticals",
     "shortName": "Consolidated Statements of Operations and Comprehensive Loss (Parentheticals)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": null
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c2",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "049 - Disclosure - Intangible Assets, Net and Goodwill (Details) - Schedule of the estimated future amortization expense of intangible assets",
     "menuCat": "Details",
     "order": "50",
     "role": "http://www.beil.com/role/ScheduleoftheestimatedfutureamortizationexpenseofintangibleassetsTable",
     "shortName": "Intangible Assets, Net and Goodwill (Details) - Schedule of the estimated future amortization expense of intangible assets",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c2",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c78",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:DebtInstrumentFaceAmount",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "050 - Disclosure - Loans, Net (Details)",
     "menuCat": "Details",
     "order": "51",
     "role": "http://www.beil.com/role/LoansNetDetails",
     "shortName": "Loans, Net (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c2",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:ClassOfWarrantOrRightOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "bmr:ScheduleOfTheMemberEffectiveDateManagementByAssistanceOfThirdpartyTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c2",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "bmr:DerivativeWarrantLiabilityseeNote8",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "051 - Disclosure - Loans, Net (Details) - Schedule of the Effective Date, management by assistance of third-party",
     "menuCat": "Details",
     "order": "52",
     "role": "http://www.beil.com/role/ScheduleoftheEffectiveDatemanagementbyassistanceofthirdpartyTable",
     "shortName": "Loans, Net (Details) - Schedule of the Effective Date, management by assistance of third-party",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "bmr:ScheduleOfTheMemberEffectiveDateManagementByAssistanceOfThirdpartyTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c2",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "bmr:DerivativeWarrantLiabilityseeNote8",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "bmr:ScheduleOfPresentationReflectsTheReconciliationOfTheCarryingAmountTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c0",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "bmr:ReconciliationOfTheCarryingAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "052 - Disclosure - Loans, Net (Details) - Schedule of the reconciliation of the carrying amount",
     "menuCat": "Details",
     "order": "53",
     "role": "http://www.beil.com/role/ScheduleofthereconciliationofthecarryingamountTable",
     "shortName": "Loans, Net (Details) - Schedule of the reconciliation of the carrying amount",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "bmr:ScheduleOfPresentationReflectsTheReconciliationOfTheCarryingAmountTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c0",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "bmr:ReconciliationOfTheCarryingAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "bmr:ScheduleOfMaturityDatesOfOutstandingLoanTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c2",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "053 - Disclosure - Loans, Net (Details) - Schedule of maturity dates of outstanding loans",
     "menuCat": "Details",
     "order": "54",
     "role": "http://www.beil.com/role/ScheduleofmaturitydatesofoutstandingloansTable",
     "shortName": "Loans, Net (Details) - Schedule of maturity dates of outstanding loans",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "bmr:ScheduleOfMaturityDatesOfOutstandingLoanTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c2",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "link:footnote",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c2",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:DepositLiabilitiesAccruedInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "054 - Disclosure - Other Current Liabilities (Details)",
     "menuCat": "Details",
     "order": "55",
     "role": "http://www.beil.com/role/OtherCurrentLiabilitiesDetails",
     "shortName": "Other Current Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "link:footnote",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c2",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:DepositLiabilitiesAccruedInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:OtherCurrentLiabilitiesTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c2",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "055 - Disclosure - Other Current Liabilities (Details) - Schedule of other current liabilties",
     "menuCat": "Details",
     "order": "56",
     "role": "http://www.beil.com/role/ScheduleofothercurrentliabiltiesTable",
     "shortName": "Other Current Liabilities (Details) - Schedule of other current liabilties",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:OtherCurrentLiabilitiesTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c2",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c3",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:DerivativeFairValueOfDerivativeNet",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "056 - Disclosure - Derivative Warrants Liabilities (Details) - Schedule of reconciliation of the fair value of derivative warrants liabilities",
     "menuCat": "Details",
     "order": "57",
     "role": "http://www.beil.com/role/ScheduleofreconciliationofthefairvalueofderivativewarrantsliabilitiesTable",
     "shortName": "Derivative Warrants Liabilities (Details) - Schedule of reconciliation of the fair value of derivative warrants liabilities",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c8",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c78",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:DebtInstrumentFaceAmount",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "057 - Disclosure - Convertible Advance Investment (Details)",
     "menuCat": "Details",
     "order": "58",
     "role": "http://www.beil.com/role/ConvertibleAdvanceInvestmentDetails",
     "shortName": "Convertible Advance Investment (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c0",
      "decimals": "2",
      "lang": null,
      "name": "us-gaap:DebtConversionConvertedInstrumentRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "pure",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:InvestmentHoldingsScheduleOfInvestmentsTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c3",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ConvertibleDebtFairValueDisclosures",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "058 - Disclosure - Convertible Advance Investment (Details) - Schedule of reconciliation of the carrying amount of the convertible advance investment",
     "menuCat": "Details",
     "order": "59",
     "role": "http://www.beil.com/role/ScheduleofreconciliationofthecarryingamountoftheconvertibleadvanceinvestmentTable",
     "shortName": "Convertible Advance Investment (Details) - Schedule of reconciliation of the carrying amount of the convertible advance investment",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:InvestmentHoldingsScheduleOfInvestmentsTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c15",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:ConvertibleDebtFairValueDisclosures",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c10",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "005 - Statement - onsolidated Statements of Changes in Shareholders\u2019 Equity (Deficit)",
     "menuCat": "Statements",
     "order": "6",
     "role": "http://www.beil.com/role/ShareholdersEquityType2or3",
     "shortName": "onsolidated Statements of Changes in Shareholders\u2019 Equity (Deficit)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c10",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c95",
      "decimals": "-2",
      "first": true,
      "lang": null,
      "name": "us-gaap:PaymentsForRent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "059 - Disclosure - Commitments and Contingent Liabilities (Details)",
     "menuCat": "Details",
     "order": "60",
     "role": "http://www.beil.com/role/CommitmentsandContingentLiabilitiesDetails",
     "shortName": "Commitments and Contingent Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c95",
      "decimals": "-2",
      "first": true,
      "lang": null,
      "name": "us-gaap:PaymentsForRent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "bmr:scheduleOfFutureMinimumCommitmentUnderBindingLeaseAgreeementsTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c2",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "bmr:LesseeOperatingLeasesLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "060 - Disclosure - Commitments and Contingent Liabilities (Details) - Schedule of future minimum commitment under binding lease agreeements",
     "menuCat": "Details",
     "order": "61",
     "role": "http://www.beil.com/role/ScheduleoffutureminimumcommitmentunderbindingleaseagreeementsTable",
     "shortName": "Commitments and Contingent Liabilities (Details) - Schedule of future minimum commitment under binding lease agreeements",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "bmr:scheduleOfFutureMinimumCommitmentUnderBindingLeaseAgreeementsTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c2",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "bmr:LesseeOperatingLeasesLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c2",
      "decimals": "1",
      "first": true,
      "lang": null,
      "name": "us-gaap:PreferredStockConvertibleConversionPrice",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPershares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "061 - Disclosure - Shareholders\u2019 Equity (Deficit) (Details)",
     "menuCat": "Details",
     "order": "62",
     "role": "http://www.beil.com/role/ShareholdersEquityDeficitDetails",
     "shortName": "Shareholders\u2019 Equity (Deficit) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c2",
      "decimals": "1",
      "first": true,
      "lang": null,
      "name": "us-gaap:PreferredStockConvertibleConversionPrice",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPershares",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfStockholdersEquityTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c2",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ExcessStockSharesAuthorized",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "062 - Disclosure - Shareholders\u2019 Equity (Deficit) (Details) - Schedule of composition of shareholders' equity",
     "menuCat": "Details",
     "order": "63",
     "role": "http://www.beil.com/role/ScheduleofcompositionofshareholdersequityTable",
     "shortName": "Shareholders\u2019 Equity (Deficit) (Details) - Schedule of composition of shareholders' equity",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfStockholdersEquityTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c2",
      "decimals": "0",
      "lang": null,
      "name": "bmr:ExcessSharesIssuedAndOutstandingShares",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c2",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "bmr:OrdinarySharesSubjectToAdjustments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "063 - Disclosure - Share Options (Details)",
     "menuCat": "Details",
     "order": "64",
     "role": "http://www.beil.com/role/ShareOptionsDetails",
     "shortName": "Share Options (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c2",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "bmr:OrdinarySharesSubjectToAdjustments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c3",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "064 - Disclosure - Share Options (Details) - Schedule of company\u2019s share option activity for employees and members of the board of directors",
     "menuCat": "Details",
     "order": "65",
     "role": "http://www.beil.com/role/ScheduleofcompanysshareoptionactivityforemployeesandmembersoftheboardofdirectorsTable",
     "shortName": "Share Options (Details) - Schedule of company\u2019s share option activity for employees and members of the board of directors",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c15",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c155",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "065 - Disclosure - Share Options (Details) - Schedule of outstanding and exercisable share options separated ranges of exercise prices",
     "menuCat": "Details",
     "order": "66",
     "role": "http://www.beil.com/role/ScheduleofoutstandingandexercisableshareoptionsseparatedrangesofexercisepricesTable",
     "shortName": "Share Options (Details) - Schedule of outstanding and exercisable share options separated ranges of exercise prices",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c155",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c0",
      "decimals": "4",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "pure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "066 - Disclosure - Share Options (Details) - Schedule of assumptions used to estimate the fair values of the share options granted",
     "menuCat": "Details",
     "order": "67",
     "role": "http://www.beil.com/role/ScheduleofassumptionsusedtoestimatethefairvaluesoftheshareoptionsgrantedTable",
     "shortName": "Share Options (Details) - Schedule of assumptions used to estimate the fair values of the share options granted",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c0",
      "decimals": "4",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "pure",
      "xsiNil": "false"
     }
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c0",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:OtherResearchAndDevelopmentExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "067 - Disclosure - Share Options (Details) - Schedule of company\u2019s equity-based awards recognized",
     "menuCat": "Details",
     "order": "68",
     "role": "http://www.beil.com/role/ScheduleofcompanysequitybasedawardsrecognizedTable",
     "shortName": "Share Options (Details) - Schedule of company\u2019s equity-based awards recognized",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c0",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:OtherResearchAndDevelopmentExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R69": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:InvestmentHoldingsScheduleOfInvestmentsTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c0",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "bmr:ChangeInTheFairValueOfConvertibleAdvanceInvestments",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "068 - Disclosure - Financing Expenses, Net (Details) - Schedule of financing expenses",
     "menuCat": "Details",
     "order": "69",
     "role": "http://www.beil.com/role/ScheduleoffinancingexpensesTable",
     "shortName": "Financing Expenses, Net (Details) - Schedule of financing expenses",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ConvertibleDebtTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c0",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:PresentValueOfFutureInsuranceProfitsAmortizationExpenseAccruedInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c0",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "006 - Statement - Consolidated Statements of Cash Flows",
     "menuCat": "Statements",
     "order": "7",
     "role": "http://www.beil.com/role/ConsolidatedCashFlow",
     "shortName": "Consolidated Statements of Cash Flows",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c0",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:DepreciationDepletionAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R70": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c2",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:RelatedPartyTransactionDueFromToRelatedPartyCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "ils",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "069 - Disclosure - Related Parties Transactions (Details)",
     "menuCat": "Details",
     "order": "70",
     "role": "http://www.beil.com/role/RelatedPartiesTransactionsDetails",
     "shortName": "Related Parties Transactions (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c2",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:RelatedPartyTransactionDueFromToRelatedPartyCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "ils",
      "xsiNil": "false"
     }
    },
    "R71": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfRegulatoryLiabilitiesTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c3",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:InvestmentRelatedLiabilities",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "070 - Disclosure - Related Parties Transactions (Details) - Schedule of the reconciliation of the carrying amount of the Company",
     "menuCat": "Details",
     "order": "71",
     "role": "http://www.beil.com/role/ScheduleofthereconciliationofthecarryingamountoftheCompanyTable",
     "shortName": "Related Parties Transactions (Details) - Schedule of the reconciliation of the carrying amount of the Company",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfRegulatoryLiabilitiesTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c2",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:OtherAccruedLiabilitiesCurrentAndNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R72": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c2",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:LongTermDebtCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "071 - Disclosure - Related Parties Transactions (Details) - Schedule of maturity dates",
     "menuCat": "Details",
     "order": "72",
     "role": "http://www.beil.com/role/ScheduleofmaturitydatesTable",
     "shortName": "Related Parties Transactions (Details) - Schedule of maturity dates",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c2",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:LongTermDebtCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R73": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c0",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ResearchAndDevelopmentInProcess",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "072 - Disclosure - Related Parties Transactions (Details) - Schedule of expenses related to service agreement and the office services agreement",
     "menuCat": "Details",
     "order": "73",
     "role": "http://www.beil.com/role/ScheduleofexpensesrelatedtoserviceagreementandtheofficeservicesagreementTable",
     "shortName": "Related Parties Transactions (Details) - Schedule of expenses related to service agreement and the office services agreement",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c0",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ResearchAndDevelopmentInProcess",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R74": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c0",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings",
      "reportCount": 1,
      "unique": true,
      "unitRef": "pure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "073 - Disclosure - Taxes on Income (Details)",
     "menuCat": "Details",
     "order": "74",
     "role": "http://www.beil.com/role/TaxesonIncomeDetails",
     "shortName": "Taxes on Income (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c0",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings",
      "reportCount": 1,
      "unique": true,
      "unitRef": "pure",
      "xsiNil": "false"
     }
    },
    "R75": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c0",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "074 - Disclosure - Taxes on Income (Details) - Schedule of loss (income) before taxes on income",
     "menuCat": "Details",
     "order": "75",
     "role": "http://www.beil.com/role/ScheduleoflossincomebeforetaxesonincomeTable",
     "shortName": "Taxes on Income (Details) - Schedule of loss (income) before taxes on income",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c0",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R76": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c2",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:DeferredTaxAssetsCapitalLossCarryforwards",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "075 - Disclosure - Taxes on Income (Details) - Schedule of deferred income taxes reflect the net tax effects of net operating loss",
     "menuCat": "Details",
     "order": "76",
     "role": "http://www.beil.com/role/ScheduleofdeferredincometaxesreflectthenettaxeffectsofnetoperatinglossTable",
     "shortName": "Taxes on Income (Details) - Schedule of deferred income taxes reflect the net tax effects of net operating loss",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c2",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:DeferredTaxAssetsCapitalLossCarryforwards",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R77": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c0",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:NumberOfOperatingSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "076 - Disclosure - Segment Geographical Information And Major Customers (Details)",
     "menuCat": "Details",
     "order": "77",
     "role": "http://www.beil.com/role/SegmentGeographicalInformationAndMajorCustomersDetails",
     "shortName": "Segment Geographical Information And Major Customers (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c0",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:NumberOfOperatingSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Segment",
      "xsiNil": "false"
     }
    },
    "R78": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c0",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "077 - Disclosure - Segment Geographical Information And Major Customers (Details) - Schedule of revenues by geographic region",
     "menuCat": "Details",
     "order": "78",
     "role": "http://www.beil.com/role/ScheduleofrevenuesbygeographicregionTable",
     "shortName": "Segment Geographical Information And Major Customers (Details) - Schedule of revenues by geographic region",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c163",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R79": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:LongLivedAssetsByGeographicAreasTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c2",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:NoncurrentAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "078 - Disclosure - Segment Geographical Information And Major Customers (Details) - Schedule of Long-lived assets net by geographic areas",
     "menuCat": "Details",
     "order": "79",
     "role": "http://www.beil.com/role/ScheduleofLonglivedassetsnetbygeographicareasTable",
     "shortName": "Segment Geographical Information And Major Customers (Details) - Schedule of Long-lived assets net by geographic areas",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:LongLivedAssetsByGeographicAreasTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c2",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:NoncurrentAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "007 - Disclosure - General",
     "menuCat": "Notes",
     "order": "8",
     "role": "http://www.beil.com/role/General",
     "shortName": "General",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R80": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c0",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:PaymentsForSoftware",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "079 - Disclosure - Segment Geographical Information And Major Customers (Details) - Schedule of revenue disaggregated by primary major product lines and services",
     "menuCat": "Details",
     "order": "80",
     "role": "http://www.beil.com/role/ScheduleofrevenuedisaggregatedbyprimarymajorproductlinesandservicesTable",
     "shortName": "Segment Geographical Information And Major Customers (Details) - Schedule of revenue disaggregated by primary major product lines and services",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c0",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:PaymentsForSoftware",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R81": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c45",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "bmr:PublicOfferingPrice",
      "reportCount": 1,
      "unitRef": "usdPershares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "080 - Disclosure - Subsequent Events (Details)",
     "menuCat": "Details",
     "order": "81",
     "role": "http://www.beil.com/role/SubsequentEventsDetails",
     "shortName": "Subsequent Events (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c0",
      "decimals": null,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentInterestRateTerms",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "008 - Disclosure - Significant Accounting Policies",
     "menuCat": "Notes",
     "order": "9",
     "role": "http://www.beil.com/role/SignificantAccountingPolicies",
     "shortName": "Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_beamrimaging.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 56,
   "tag": {
    "bmr_AccumulatedAmortizationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accumulated Amortization Abstract",
        "terseLabel": "Accumulated amortization:"
       }
      }
     },
     "localname": "AccumulatedAmortizationAbstract",
     "nsuri": "http://www.beil.com/20221231",
     "presentation": [
      "http://www.beil.com/role/ScheduleofintangibleassetsnetandgoodwilTable"
     ],
     "xbrltype": "stringItemType"
    },
    "bmr_AdjustmentsRequiredToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments Required To Reconcile Net Loss To Net Cash Used In Operating Activities Abstract",
        "terseLabel": "Adjustments required to reconcile net loss to net cash used in operating activities:"
       }
      }
     },
     "localname": "AdjustmentsRequiredToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract",
     "nsuri": "http://www.beil.com/20221231",
     "presentation": [
      "http://www.beil.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "stringItemType"
    },
    "bmr_AdvanceInvestmentAgreementsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Advance Investment Agreements Member",
        "terseLabel": "Advance Investment Agreements [Member]"
       }
      }
     },
     "localname": "AdvanceInvestmentAgreementsMember",
     "nsuri": "http://www.beil.com/20221231",
     "presentation": [
      "http://www.beil.com/role/ConvertibleAdvanceInvestmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmr_AdvertisingAtAPointOfTimeUponClicks": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Advertising at a point of time upon clicks.",
        "label": "Advertising At APoint Of Time Upon Clicks",
        "terseLabel": "Advertising at a point of time upon clicks"
       }
      }
     },
     "localname": "AdvertisingAtAPointOfTimeUponClicks",
     "nsuri": "http://www.beil.com/20221231",
     "presentation": [
      "http://www.beil.com/role/ScheduleofrevenuedisaggregatedbyprimarymajorproductlinesandservicesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmr_AggregateGrossProceeds": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of aggregate gross proceeds.",
        "label": "Aggregate Gross Proceeds",
        "terseLabel": "Aggregate gross proceeds"
       }
      }
     },
     "localname": "AggregateGrossProceeds",
     "nsuri": "http://www.beil.com/20221231",
     "presentation": [
      "http://www.beil.com/role/GeneralDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmr_AgreementAmountReceived": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of agreement amount received.",
        "label": "Agreement Amount Received",
        "terseLabel": "Agreement amount received"
       }
      }
     },
     "localname": "AgreementAmountReceived",
     "nsuri": "http://www.beil.com/20221231",
     "presentation": [
      "http://www.beil.com/role/LoansNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmr_AllocationOfProceedsAndRelatedIssuanceCostsPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Allocation Of Proceeds And Related Issuance Costs Policy Text Block",
        "terseLabel": "Allocation of proceeds and related issuance costs"
       }
      }
     },
     "localname": "AllocationOfProceedsAndRelatedIssuanceCostsPolicyTextBlock",
     "nsuri": "http://www.beil.com/20221231",
     "presentation": [
      "http://www.beil.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "bmr_CapitalContributionFromAControllingShareholderPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Capital Contribution From AControlling Shareholder Policy Text Block",
        "terseLabel": "Capital contribution from a controlling shareholder"
       }
      }
     },
     "localname": "CapitalContributionFromAControllingShareholderPolicyTextBlock",
     "nsuri": "http://www.beil.com/20221231",
     "presentation": [
      "http://www.beil.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "bmr_CarryingAmountAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carrying Amount Abstract",
        "terseLabel": "Carrying amount:"
       }
      }
     },
     "localname": "CarryingAmountAbstract",
     "nsuri": "http://www.beil.com/20221231",
     "presentation": [
      "http://www.beil.com/role/ScheduleofintangibleassetsnetandgoodwilTable"
     ],
     "xbrltype": "stringItemType"
    },
    "bmr_CashFlowsFromFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Flows From Financing Activities Abstract",
        "terseLabel": "Cash flows from financing activities:"
       }
      }
     },
     "localname": "CashFlowsFromFinancingActivitiesAbstract",
     "nsuri": "http://www.beil.com/20221231",
     "presentation": [
      "http://www.beil.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "stringItemType"
    },
    "bmr_CashFlowsFromInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Flows From Investing Activities Abstract",
        "terseLabel": "Cash flows from investing activities:"
       }
      }
     },
     "localname": "CashFlowsFromInvestingActivitiesAbstract",
     "nsuri": "http://www.beil.com/20221231",
     "presentation": [
      "http://www.beil.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "stringItemType"
    },
    "bmr_CashFlowsFromOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Flows From Operating Activities Abstract",
        "terseLabel": "Cash flows from operating activities:"
       }
      }
     },
     "localname": "CashFlowsFromOperatingActivitiesAbstract",
     "nsuri": "http://www.beil.com/20221231",
     "presentation": [
      "http://www.beil.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "stringItemType"
    },
    "bmr_ChangeInTheFairValueOfConvertibleAdvanceInvestments": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change in the fair value of convertible advance investments.",
        "label": "Change In The Fair Value Of Convertible Advance Investments",
        "terseLabel": "Change in the fair value of convertible advance investments (see also Note 13)",
        "verboseLabel": "Change in fair value of convertible advance investment (see Note 9)"
       }
      }
     },
     "localname": "ChangeInTheFairValueOfConvertibleAdvanceInvestments",
     "nsuri": "http://www.beil.com/20221231",
     "presentation": [
      "http://www.beil.com/role/ScheduleoffinancingexpensesTable",
      "http://www.beil.com/role/ScheduleofreconciliationofthecarryingamountoftheconvertibleadvanceinvestmentTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmr_CommitmentsandContingentLiabilitiesDetailsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingent Liabilities (Details) [Line Items]"
       }
      }
     },
     "localname": "CommitmentsandContingentLiabilitiesDetailsLineItems",
     "nsuri": "http://www.beil.com/20221231",
     "presentation": [
      "http://www.beil.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bmr_CommitmentsandContingentLiabilitiesDetailsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingent Liabilities (Details) [Table]"
       }
      }
     },
     "localname": "CommitmentsandContingentLiabilitiesDetailsTable",
     "nsuri": "http://www.beil.com/20221231",
     "presentation": [
      "http://www.beil.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bmr_CommonStockValue1": {
     "auth_ref": [],
     "calculation": {
      "http://www.beil.com/role/ConsolidatedBalanceSheet": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common Stock Value.",
        "label": "Common Stock Value1",
        "terseLabel": "Convertible Ordinary 1 and 2 Shares of NIS 0.05 par value each: Authorized: 1,496,880 shares at December 31, 2022 and 2021; Issued and outstanding: 1,496,880 shares at December 31, 2022 and 2021"
       }
      }
     },
     "localname": "CommonStockValue1",
     "nsuri": "http://www.beil.com/20221231",
     "presentation": [
      "http://www.beil.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmr_CompareAndPeripheralEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compare And Peripheral Equipment Member",
        "terseLabel": "Compare and Peripheral equipment [Member]"
       }
      }
     },
     "localname": "CompareAndPeripheralEquipmentMember",
     "nsuri": "http://www.beil.com/20221231",
     "presentation": [
      "http://www.beil.com/role/ScheduleofcomputingstraightlinedepreciationTable"
     ],
     "xbrltype": "domainItemType"
    },
    "bmr_ConcentrationOfCreditRiskPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of concentration of credit risks.",
        "label": "Concentration Of Credit Risk Policy Text Block",
        "terseLabel": "Concentrations of credit risk and allowance for doubtful accounts"
       }
      }
     },
     "localname": "ConcentrationOfCreditRiskPolicyTextBlock",
     "nsuri": "http://www.beil.com/20221231",
     "presentation": [
      "http://www.beil.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "bmr_ConsiderationReceivedFromPPPNote": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of consideration received from PPP Note.",
        "label": "Consideration Received From PPPNote",
        "terseLabel": "Consideration received from PPP Note"
       }
      }
     },
     "localname": "ConsiderationReceivedFromPPPNote",
     "nsuri": "http://www.beil.com/20221231",
     "presentation": [
      "http://www.beil.com/role/ScheduleofthereconciliationofthecarryingamountTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmr_ConvertibleAdvanceInvestmentDetailsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Convertible Advance Investment (Details) [Line Items]"
       }
      }
     },
     "localname": "ConvertibleAdvanceInvestmentDetailsLineItems",
     "nsuri": "http://www.beil.com/20221231",
     "presentation": [
      "http://www.beil.com/role/ConvertibleAdvanceInvestmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bmr_ConvertibleAdvanceInvestmentDetailsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Convertible Advance Investment (Details) [Table]"
       }
      }
     },
     "localname": "ConvertibleAdvanceInvestmentDetailsTable",
     "nsuri": "http://www.beil.com/20221231",
     "presentation": [
      "http://www.beil.com/role/ConvertibleAdvanceInvestmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bmr_ConvertibleAdvanceInvestmentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Convertible Advance Investments Member",
        "terseLabel": "Convertible Advance Investments [Member]"
       }
      }
     },
     "localname": "ConvertibleAdvanceInvestmentsMember",
     "nsuri": "http://www.beil.com/20221231",
     "presentation": [
      "http://www.beil.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmr_ConvertibleAdvanceInvestmentsPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy of convertible advance investments.",
        "label": "Convertible Advance Investments Policy Text Block",
        "terseLabel": "Convertible Advance Investments"
       }
      }
     },
     "localname": "ConvertibleAdvanceInvestmentsPolicyTextBlock",
     "nsuri": "http://www.beil.com/20221231",
     "presentation": [
      "http://www.beil.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "bmr_ConvertibleAdvancedInvestments": {
     "auth_ref": [],
     "calculation": {
      "http://www.beil.com/role/ConsolidatedBalanceSheet": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Convertible advanced investments.",
        "label": "Convertible Advanced Investments",
        "terseLabel": "Convertible advanced investments"
       }
      }
     },
     "localname": "ConvertibleAdvancedInvestments",
     "nsuri": "http://www.beil.com/20221231",
     "presentation": [
      "http://www.beil.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmr_ConvertibleOrdinary1And2SharesAndPreferredSharesPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy of convertible ordinary 1 and 2 shares and preferred shares.",
        "label": "Convertible Ordinary1 And2 Shares And Preferred Shares Policy Text Block",
        "terseLabel": "Convertible Ordinary 1 and 2 Shares and Preferred Shares"
       }
      }
     },
     "localname": "ConvertibleOrdinary1And2SharesAndPreferredSharesPolicyTextBlock",
     "nsuri": "http://www.beil.com/20221231",
     "presentation": [
      "http://www.beil.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "bmr_ConvertibleOrdinary1And2SharesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Convertible Ordinary1 And2 Shares Member",
        "terseLabel": "Convertible Ordinary 1 and 2 shares"
       }
      }
     },
     "localname": "ConvertibleOrdinary1And2SharesMember",
     "nsuri": "http://www.beil.com/20221231",
     "presentation": [
      "http://www.beil.com/role/ConsolidatedBalanceSheet_Parentheticals",
      "http://www.beil.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "domainItemType"
    },
    "bmr_ConvertiblePreferredSharesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Convertible Preferred Shares Member",
        "terseLabel": "Convertible Preferred shares"
       }
      }
     },
     "localname": "ConvertiblePreferredSharesMember",
     "nsuri": "http://www.beil.com/20221231",
     "presentation": [
      "http://www.beil.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "domainItemType"
    },
    "bmr_DerivativeWarrantLiabilityseeNote8": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Warrant Liabilitysee Note8",
        "terseLabel": "Derivative warrant liability (see Note 8)"
       }
      }
     },
     "localname": "DerivativeWarrantLiabilityseeNote8",
     "nsuri": "http://www.beil.com/20221231",
     "presentation": [
      "http://www.beil.com/role/ScheduleoftheEffectiveDatemanagementbyassistanceofthirdpartyTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmr_DocumentAndEntityInformationAbstract": {
     "auth_ref": [],
     "localname": "DocumentAndEntityInformationAbstract",
     "nsuri": "http://www.beil.com/20221231",
     "xbrltype": "stringItemType"
    },
    "bmr_EmployeeCompensationPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employee compensation percentage.",
        "label": "Employee Compensation Percentage",
        "terseLabel": "Employee compensation percentage"
       }
      }
     },
     "localname": "EmployeeCompensationPercentage",
     "nsuri": "http://www.beil.com/20221231",
     "presentation": [
      "http://www.beil.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "bmr_ExcessSharesIssuedAndOutstandingShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Issued and outstanding shares.",
        "label": "Excess Shares Issued And Outstanding Shares",
        "terseLabel": "Issued and outstanding shares"
       }
      }
     },
     "localname": "ExcessSharesIssuedAndOutstandingShares",
     "nsuri": "http://www.beil.com/20221231",
     "presentation": [
      "http://www.beil.com/role/ScheduleofcompositionofshareholdersequityTable"
     ],
     "xbrltype": "sharesItemType"
    },
    "bmr_ExchangeRateDifferencesAndOthers": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of exchange rate differences and others.",
        "label": "Exchange Rate Differences And Others",
        "terseLabel": "Exchange rate differences and others"
       }
      }
     },
     "localname": "ExchangeRateDifferencesAndOthers",
     "nsuri": "http://www.beil.com/20221231",
     "presentation": [
      "http://www.beil.com/role/ScheduleoffinancingexpensesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmr_ExercisePrice0000Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise Price0000 Member",
        "terseLabel": "0.000 [Member]"
       }
      }
     },
     "localname": "ExercisePrice0000Member",
     "nsuri": "http://www.beil.com/20221231",
     "presentation": [
      "http://www.beil.com/role/ScheduleofoutstandingandexercisableshareoptionsseparatedrangesofexercisepricesTable"
     ],
     "xbrltype": "domainItemType"
    },
    "bmr_ExercisePrice0227Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise Price0227 Member",
        "terseLabel": "1.14 [Member]"
       }
      }
     },
     "localname": "ExercisePrice0227Member",
     "nsuri": "http://www.beil.com/20221231",
     "presentation": [
      "http://www.beil.com/role/ScheduleofoutstandingandexercisableshareoptionsseparatedrangesofexercisepricesTable"
     ],
     "xbrltype": "domainItemType"
    },
    "bmr_ExercisePrice0333Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise Price0333 Member",
        "terseLabel": "1.67\t[Member]"
       }
      }
     },
     "localname": "ExercisePrice0333Member",
     "nsuri": "http://www.beil.com/20221231",
     "presentation": [
      "http://www.beil.com/role/ScheduleofoutstandingandexercisableshareoptionsseparatedrangesofexercisepricesTable"
     ],
     "xbrltype": "domainItemType"
    },
    "bmr_ExercisePrice0365Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise Price0365 Member",
        "terseLabel": "1.83\t[Member]"
       }
      }
     },
     "localname": "ExercisePrice0365Member",
     "nsuri": "http://www.beil.com/20221231",
     "presentation": [
      "http://www.beil.com/role/ScheduleofoutstandingandexercisableshareoptionsseparatedrangesofexercisepricesTable"
     ],
     "xbrltype": "domainItemType"
    },
    "bmr_ExercisePrice0640Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise Price0640 Member",
        "terseLabel": "3.2 [Member]"
       }
      }
     },
     "localname": "ExercisePrice0640Member",
     "nsuri": "http://www.beil.com/20221231",
     "presentation": [
      "http://www.beil.com/role/ScheduleofoutstandingandexercisableshareoptionsseparatedrangesofexercisepricesTable"
     ],
     "xbrltype": "domainItemType"
    },
    "bmr_ExercisePrice0757Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise Price0757 Member",
        "terseLabel": "3.79 [Member]"
       }
      }
     },
     "localname": "ExercisePrice0757Member",
     "nsuri": "http://www.beil.com/20221231",
     "presentation": [
      "http://www.beil.com/role/ScheduleofoutstandingandexercisableshareoptionsseparatedrangesofexercisepricesTable"
     ],
     "xbrltype": "domainItemType"
    },
    "bmr_ExercisePrice0833Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise Price0833 Member",
        "terseLabel": "4.17 [Member]"
       }
      }
     },
     "localname": "ExercisePrice0833Member",
     "nsuri": "http://www.beil.com/20221231",
     "presentation": [
      "http://www.beil.com/role/ScheduleofoutstandingandexercisableshareoptionsseparatedrangesofexercisepricesTable"
     ],
     "xbrltype": "domainItemType"
    },
    "bmr_ExercisePrice1024Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise Price1024 Member",
        "terseLabel": "5.12 [Member]"
       }
      }
     },
     "localname": "ExercisePrice1024Member",
     "nsuri": "http://www.beil.com/20221231",
     "presentation": [
      "http://www.beil.com/role/ScheduleofoutstandingandexercisableshareoptionsseparatedrangesofexercisepricesTable"
     ],
     "xbrltype": "domainItemType"
    },
    "bmr_FinancingExpenses": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financing expenses text block.",
        "label": "Financing Expenses",
        "terseLabel": "FINANCING EXPENSES, NET"
       }
      }
     },
     "localname": "FinancingExpenses",
     "nsuri": "http://www.beil.com/20221231",
     "presentation": [
      "http://www.beil.com/role/FinancingExpensesNet"
     ],
     "xbrltype": "textBlockItemType"
    },
    "bmr_FinancingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financing Expenses [Abstract]"
       }
      }
     },
     "localname": "FinancingExpensesAbstract",
     "nsuri": "http://www.beil.com/20221231",
     "xbrltype": "stringItemType"
    },
    "bmr_FloatingRateMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Floating Rate Member",
        "terseLabel": "Floating rate [Member]"
       }
      }
     },
     "localname": "FloatingRateMember",
     "nsuri": "http://www.beil.com/20221231",
     "presentation": [
      "http://www.beil.com/role/LoansNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmr_GeneralAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "General [Abstract]"
       }
      }
     },
     "localname": "GeneralAbstract",
     "nsuri": "http://www.beil.com/20221231",
     "xbrltype": "stringItemType"
    },
    "bmr_GeneralDetailsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "General (Details) [Line Items]"
       }
      }
     },
     "localname": "GeneralDetailsLineItems",
     "nsuri": "http://www.beil.com/20221231",
     "presentation": [
      "http://www.beil.com/role/GeneralDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bmr_GeneralDetailsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "General (Details) [Table]"
       }
      }
     },
     "localname": "GeneralDetailsTable",
     "nsuri": "http://www.beil.com/20221231",
     "presentation": [
      "http://www.beil.com/role/GeneralDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bmr_GovernmentAuthorities": {
     "auth_ref": [],
     "calculation": {
      "http://www.beil.com/role/ScheduleofothercurrentliabiltiesTable": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of government authorities.",
        "label": "Government Authorities",
        "terseLabel": "Government authorities"
       }
      }
     },
     "localname": "GovernmentAuthorities",
     "nsuri": "http://www.beil.com/20221231",
     "presentation": [
      "http://www.beil.com/role/ScheduleofothercurrentliabiltiesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmr_GovernmentAuthoritiesAssets": {
     "auth_ref": [],
     "calculation": {
      "http://www.beil.com/role/ScheduleofothercurrentassetsTable": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Government authorities",
        "label": "Government Authorities Assets",
        "terseLabel": "Government authorities"
       }
      }
     },
     "localname": "GovernmentAuthoritiesAssets",
     "nsuri": "http://www.beil.com/20221231",
     "presentation": [
      "http://www.beil.com/role/ScheduleofothercurrentassetsTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmr_IBISpikesLtdMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "IBISpikes Ltd Member",
        "terseLabel": "IBI Spikes Ltd [Member]"
       }
      }
     },
     "localname": "IBISpikesLtdMember",
     "nsuri": "http://www.beil.com/20221231",
     "presentation": [
      "http://www.beil.com/role/LoansNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmr_IntangibleAssetsNetandGoodwillDetailsScheduleofintangibleassetsnetandgoodwilLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Intangible Assets, Net and Goodwill (Details) - Schedule of intangible assets, net and goodwil [Line Items]"
       }
      }
     },
     "localname": "IntangibleAssetsNetandGoodwillDetailsScheduleofintangibleassetsnetandgoodwilLineItems",
     "nsuri": "http://www.beil.com/20221231",
     "presentation": [
      "http://www.beil.com/role/ScheduleofintangibleassetsnetandgoodwilTable"
     ],
     "xbrltype": "stringItemType"
    },
    "bmr_IntangibleAssetsNetandGoodwillDetailsScheduleofintangibleassetsnetandgoodwilTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Intangible Assets, Net and Goodwill (Details) - Schedule of intangible assets, net and goodwil [Table]"
       }
      }
     },
     "localname": "IntangibleAssetsNetandGoodwillDetailsScheduleofintangibleassetsnetandgoodwilTable",
     "nsuri": "http://www.beil.com/20221231",
     "presentation": [
      "http://www.beil.com/role/ScheduleofintangibleassetsnetandgoodwilTable"
     ],
     "xbrltype": "stringItemType"
    },
    "bmr_InvestmentHoldingsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Convertible Advance Investment [Abstract]"
       }
      }
     },
     "localname": "InvestmentHoldingsAbstract",
     "nsuri": "http://www.beil.com/20221231",
     "xbrltype": "stringItemType"
    },
    "bmr_LesseeOperatingLeasesLiabilityPaymentsDue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee Operating Leases Liability Payments Due",
        "terseLabel": "Total"
       }
      }
     },
     "localname": "LesseeOperatingLeasesLiabilityPaymentsDue",
     "nsuri": "http://www.beil.com/20221231",
     "presentation": [
      "http://www.beil.com/role/ScheduleoffutureminimumcommitmentunderbindingleaseagreeementsTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmr_LesseeOperatingLeasesLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee Operating Leases Liability Payments Due Next Twelve Months",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LesseeOperatingLeasesLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://www.beil.com/20221231",
     "presentation": [
      "http://www.beil.com/role/ScheduleoffutureminimumcommitmentunderbindingleaseagreeementsTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmr_LoanAgreementsAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loan Agreements Axis",
        "terseLabel": "Loan Agreement [Axis]"
       }
      }
     },
     "localname": "LoanAgreementsAxis",
     "nsuri": "http://www.beil.com/20221231",
     "presentation": [
      "http://www.beil.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bmr_LoanAgreementsDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "LoanAgreements [Domain]"
       }
      }
     },
     "localname": "LoanAgreementsDomain",
     "nsuri": "http://www.beil.com/20221231",
     "presentation": [
      "http://www.beil.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmr_LoansAndSecurityAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loans And Security Agreement Member",
        "terseLabel": "Loans and Security Agreement [Member]"
       }
      }
     },
     "localname": "LoansAndSecurityAgreementMember",
     "nsuri": "http://www.beil.com/20221231",
     "presentation": [
      "http://www.beil.com/role/LoansNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmr_LoansNetDetailsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loans, Net (Details) [Line Items]"
       }
      }
     },
     "localname": "LoansNetDetailsLineItems",
     "nsuri": "http://www.beil.com/20221231",
     "presentation": [
      "http://www.beil.com/role/LoansNetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bmr_LoansNetDetailsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loans, Net (Details) [Table]"
       }
      }
     },
     "localname": "LoansNetDetailsTable",
     "nsuri": "http://www.beil.com/20221231",
     "presentation": [
      "http://www.beil.com/role/LoansNetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bmr_ModificationOfTermsOfStraightLoan": {
     "auth_ref": [],
     "calculation": {
      "http://www.beil.com/role/ConsolidatedCashFlow": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of modification of terms of straight loan.",
        "label": "Modification Of Terms Of Straight Loan",
        "negatedLabel": "Modification of terms of straight loan (Note 6A)"
       }
      }
     },
     "localname": "ModificationOfTermsOfStraightLoan",
     "nsuri": "http://www.beil.com/20221231",
     "presentation": [
      "http://www.beil.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmr_ModificationOfTermsRelatingToStraightLoan": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Modification Of Terms Relating To Straight Loan",
        "terseLabel": "Modification of terms relating to straight loan (see Note 6A1)"
       }
      }
     },
     "localname": "ModificationOfTermsRelatingToStraightLoan",
     "nsuri": "http://www.beil.com/20221231",
     "presentation": [
      "http://www.beil.com/role/ScheduleoffinancingexpensesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmr_ModificationsOrExchangeOfLoansPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy modifications or exchange of loans.",
        "label": "Modifications Or Exchange Of Loans Policy Text Block",
        "terseLabel": "Modifications or exchanges of loans"
       }
      }
     },
     "localname": "ModificationsOrExchangeOfLoansPolicyTextBlock",
     "nsuri": "http://www.beil.com/20221231",
     "presentation": [
      "http://www.beil.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "bmr_NetConsiderationReceivedFromIBILoan": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net consideration received from IBI Loan.",
        "label": "Net Consideration Received From IBILoan",
        "terseLabel": "Net consideration received from IBI Loan"
       }
      }
     },
     "localname": "NetConsiderationReceivedFromIBILoan",
     "nsuri": "http://www.beil.com/20221231",
     "presentation": [
      "http://www.beil.com/role/ScheduleofthereconciliationofthecarryingamountTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmr_NonCashFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non Cash Financing Activities Abstract",
        "terseLabel": "Non-cash financing activities:"
       }
      }
     },
     "localname": "NonCashFinancingActivitiesAbstract",
     "nsuri": "http://www.beil.com/20221231",
     "presentation": [
      "http://www.beil.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "stringItemType"
    },
    "bmr_NonCurrentAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non Current Assets Abstract",
        "terseLabel": "Non-current assets:"
       }
      }
     },
     "localname": "NonCurrentAssetsAbstract",
     "nsuri": "http://www.beil.com/20221231",
     "presentation": [
      "http://www.beil.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "stringItemType"
    },
    "bmr_NonCurrentLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non Current Liabilities Abstract",
        "terseLabel": "Non-current liabilities:"
       }
      }
     },
     "localname": "NonCurrentLiabilitiesAbstract",
     "nsuri": "http://www.beil.com/20221231",
     "presentation": [
      "http://www.beil.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "stringItemType"
    },
    "bmr_NumberOfSharesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number Of Shares Abstract",
        "terseLabel": "Number of shares"
       }
      }
     },
     "localname": "NumberOfSharesAbstract",
     "nsuri": "http://www.beil.com/20221231",
     "presentation": [
      "http://www.beil.com/role/ScheduleofcompositionofshareholdersequityTable"
     ],
     "xbrltype": "stringItemType"
    },
    "bmr_OfficeFurnitureAndEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Office Furniture And Equipment Member",
        "terseLabel": "Office furniture and equipment [Member]"
       }
      }
     },
     "localname": "OfficeFurnitureAndEquipmentMember",
     "nsuri": "http://www.beil.com/20221231",
     "presentation": [
      "http://www.beil.com/role/ScheduleofcomputingstraightlinedepreciationTable"
     ],
     "xbrltype": "domainItemType"
    },
    "bmr_OrdinarySharesAvailableForFutureIssuance": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ordinary Shares Available For Future Issuance",
        "terseLabel": "Ordinary shares available for future issuance"
       }
      }
     },
     "localname": "OrdinarySharesAvailableForFutureIssuance",
     "nsuri": "http://www.beil.com/20221231",
     "presentation": [
      "http://www.beil.com/role/ShareOptionsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "bmr_OrdinarySharesSubjectToAdjustments": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ordinary Shares Subject To Adjustments",
        "terseLabel": "Ordinary shares subject to adjustments"
       }
      }
     },
     "localname": "OrdinarySharesSubjectToAdjustments",
     "nsuri": "http://www.beil.com/20221231",
     "presentation": [
      "http://www.beil.com/role/ShareOptionsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "bmr_PCSServicesTransferredOverAPeriod": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "PCSServices Transferred Over APeriod",
        "terseLabel": "PCS services transferred over a period of time"
       }
      }
     },
     "localname": "PCSServicesTransferredOverAPeriod",
     "nsuri": "http://www.beil.com/20221231",
     "presentation": [
      "http://www.beil.com/role/ScheduleofrevenuedisaggregatedbyprimarymajorproductlinesandservicesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmr_PercentageOfDiscountOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of discount outstanding.",
        "label": "Percentage Of Discount Outstanding",
        "terseLabel": "Percentage of discount outstanding"
       }
      }
     },
     "localname": "PercentageOfDiscountOutstanding",
     "nsuri": "http://www.beil.com/20221231",
     "presentation": [
      "http://www.beil.com/role/LoansNetDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "bmr_PercentageOfDividend": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of dividend.",
        "label": "Percentage Of Dividend",
        "terseLabel": "Percentage of dividend"
       }
      }
     },
     "localname": "PercentageOfDividend",
     "nsuri": "http://www.beil.com/20221231",
     "presentation": [
      "http://www.beil.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "bmr_PercentageOfOutstandingRepaymentAndPaymentAmount": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of outstanding repayment and payment amount.",
        "label": "Percentage Of Outstanding Repayment And Payment Amount",
        "terseLabel": "Percentage of outstanding repayment and payment amount"
       }
      }
     },
     "localname": "PercentageOfOutstandingRepaymentAndPaymentAmount",
     "nsuri": "http://www.beil.com/20221231",
     "presentation": [
      "http://www.beil.com/role/LoansNetDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "bmr_PerpetualBasedSoftwareLicenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Perpetual Based Software License Member",
        "terseLabel": "Perpetual based software license [Member]"
       }
      }
     },
     "localname": "PerpetualBasedSoftwareLicenseMember",
     "nsuri": "http://www.beil.com/20221231",
     "presentation": [
      "http://www.beil.com/role/ScheduleofrevenuedisaggregatedbyprimarymajorproductlinesandservicesTable"
     ],
     "xbrltype": "domainItemType"
    },
    "bmr_PropertyPlantAndEquipmentDepreciationPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The annual rate of depreciation (related to property, plant and equipment, but not including land) that has been recognized during the period.",
        "label": "Property Plant And Equipment Depreciation Percentage",
        "terseLabel": "Property, plant and equipment, depreciation percentage"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentDepreciationPercentage",
     "nsuri": "http://www.beil.com/20221231",
     "presentation": [
      "http://www.beil.com/role/ScheduleofcomputingstraightlineamortizationTable"
     ],
     "xbrltype": "percentItemType"
    },
    "bmr_PublicOfferingPrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Public offering price.",
        "label": "Public Offering Price",
        "terseLabel": "Public offering price (in Dollars per share)",
        "verboseLabel": "Offering price (in Dollars per share)"
       }
      }
     },
     "localname": "PublicOfferingPrice",
     "nsuri": "http://www.beil.com/20221231",
     "presentation": [
      "http://www.beil.com/role/ConvertibleAdvanceInvestmentDetails",
      "http://www.beil.com/role/GeneralDetails",
      "http://www.beil.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "bmr_RecognitionSubsequentToSubstantialModificationOfTerms": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of recognition subsequent to substantial modification of terms.",
        "label": "Recognition Subsequent To Substantial Modification Of Terms",
        "terseLabel": "Recognition subsequent to substantial modification of terms"
       }
      }
     },
     "localname": "RecognitionSubsequentToSubstantialModificationOfTerms",
     "nsuri": "http://www.beil.com/20221231",
     "presentation": [
      "http://www.beil.com/role/ScheduleofthereconciliationofthecarryingamountTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmr_RecognitionofRevenue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Recognition of revenue amount.",
        "label": "Recognitionof Revenue",
        "terseLabel": "Total"
       }
      }
     },
     "localname": "RecognitionofRevenue",
     "nsuri": "http://www.beil.com/20221231",
     "presentation": [
      "http://www.beil.com/role/ScheduleofrevenuedisaggregatedbyprimarymajorproductlinesandservicesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmr_ReconciliationOfCarryingAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of reconciliation of the carrying amount of closing balance.",
        "label": "Reconciliation Of Carrying Amount",
        "terseLabel": "Closing balance"
       }
      }
     },
     "localname": "ReconciliationOfCarryingAmount",
     "nsuri": "http://www.beil.com/20221231",
     "presentation": [
      "http://www.beil.com/role/ScheduleofthereconciliationofthecarryingamountTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmr_ReconciliationOfTheCarryingAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of reconciliation of the carrying amount at the opening balance.",
        "label": "Reconciliation Of The Carrying Amount",
        "terseLabel": "Opening balance"
       }
      }
     },
     "localname": "ReconciliationOfTheCarryingAmount",
     "nsuri": "http://www.beil.com/20221231",
     "presentation": [
      "http://www.beil.com/role/ScheduleofthereconciliationofthecarryingamountTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmr_RestOfTheWorldMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rest Of The World Member",
        "terseLabel": "Rest of the world [Member]"
       }
      }
     },
     "localname": "RestOfTheWorldMember",
     "nsuri": "http://www.beil.com/20221231",
     "presentation": [
      "http://www.beil.com/role/ScheduleofrevenuesbygeographicregionTable"
     ],
     "xbrltype": "domainItemType"
    },
    "bmr_ScheduleOfAssumptionsUsedToEstimateTheFairValuesOfTheShareOptionsGrantedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Assumptions Used To Estimate The Fair Values Of The Share Options Granted Abstract"
       }
      }
     },
     "localname": "ScheduleOfAssumptionsUsedToEstimateTheFairValuesOfTheShareOptionsGrantedAbstract",
     "nsuri": "http://www.beil.com/20221231",
     "xbrltype": "stringItemType"
    },
    "bmr_ScheduleOfCompanySEquityBasedAwardsRecognizedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Company SEquity Based Awards Recognized Abstract"
       }
      }
     },
     "localname": "ScheduleOfCompanySEquityBasedAwardsRecognizedAbstract",
     "nsuri": "http://www.beil.com/20221231",
     "xbrltype": "stringItemType"
    },
    "bmr_ScheduleOfCompanySShareOptionActivityForEmployeesAndMembersOfTheBoardOfDirectorsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Company SShare Option Activity For Employees And Members Of The Board Of Directors Abstract"
       }
      }
     },
     "localname": "ScheduleOfCompanySShareOptionActivityForEmployeesAndMembersOfTheBoardOfDirectorsAbstract",
     "nsuri": "http://www.beil.com/20221231",
     "xbrltype": "stringItemType"
    },
    "bmr_ScheduleOfCompositionOfShareholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Composition Of Shareholders Equity Abstract"
       }
      }
     },
     "localname": "ScheduleOfCompositionOfShareholdersEquityAbstract",
     "nsuri": "http://www.beil.com/20221231",
     "xbrltype": "stringItemType"
    },
    "bmr_ScheduleOfComputingStraightLineAmortizationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Computing Straight Line Amortization Abstract"
       }
      }
     },
     "localname": "ScheduleOfComputingStraightLineAmortizationAbstract",
     "nsuri": "http://www.beil.com/20221231",
     "xbrltype": "stringItemType"
    },
    "bmr_ScheduleOfComputingStraightLineDepreciationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Computing Straight Line Depreciation Abstract"
       }
      }
     },
     "localname": "ScheduleOfComputingStraightLineDepreciationAbstract",
     "nsuri": "http://www.beil.com/20221231",
     "xbrltype": "stringItemType"
    },
    "bmr_ScheduleOfDeferredIncomeTaxesReflectTheNetTaxEffectsOfNetOperatingLossAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Deferred Income Taxes Reflect The Net Tax Effects Of Net Operating Loss Abstract"
       }
      }
     },
     "localname": "ScheduleOfDeferredIncomeTaxesReflectTheNetTaxEffectsOfNetOperatingLossAbstract",
     "nsuri": "http://www.beil.com/20221231",
     "xbrltype": "stringItemType"
    },
    "bmr_ScheduleOfExpensesRelatedToServiceAgreementAndTheOfficeServicesAgreementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Expenses Related To Service Agreement And The Office Services Agreement Abstract"
       }
      }
     },
     "localname": "ScheduleOfExpensesRelatedToServiceAgreementAndTheOfficeServicesAgreementAbstract",
     "nsuri": "http://www.beil.com/20221231",
     "xbrltype": "stringItemType"
    },
    "bmr_ScheduleOfFinancingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Financing Expenses [Abstract]"
       }
      }
     },
     "localname": "ScheduleOfFinancingExpensesAbstract",
     "nsuri": "http://www.beil.com/20221231",
     "xbrltype": "stringItemType"
    },
    "bmr_ScheduleOfFutureMinimumCommitmentUnderBindingLeaseAgreeementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Future Minimum Commitment Under Binding Lease Agreeements Abstract"
       }
      }
     },
     "localname": "ScheduleOfFutureMinimumCommitmentUnderBindingLeaseAgreeementsAbstract",
     "nsuri": "http://www.beil.com/20221231",
     "xbrltype": "stringItemType"
    },
    "bmr_ScheduleOfIntangibleAssetsNetAndGoodwilAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Intangible Assets Net And Goodwil Abstract"
       }
      }
     },
     "localname": "ScheduleOfIntangibleAssetsNetAndGoodwilAbstract",
     "nsuri": "http://www.beil.com/20221231",
     "xbrltype": "stringItemType"
    },
    "bmr_ScheduleOfLongLivedAssetsNetByGeographicAreasAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Long Lived Assets Net By Geographic Areas Abstract"
       }
      }
     },
     "localname": "ScheduleOfLongLivedAssetsNetByGeographicAreasAbstract",
     "nsuri": "http://www.beil.com/20221231",
     "xbrltype": "stringItemType"
    },
    "bmr_ScheduleOfLossIncomeBeforeTaxesOnIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Loss Income Before Taxes On Income Abstract"
       }
      }
     },
     "localname": "ScheduleOfLossIncomeBeforeTaxesOnIncomeAbstract",
     "nsuri": "http://www.beil.com/20221231",
     "xbrltype": "stringItemType"
    },
    "bmr_ScheduleOfMaturityDatesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Maturity Dates Abstract"
       }
      }
     },
     "localname": "ScheduleOfMaturityDatesAbstract",
     "nsuri": "http://www.beil.com/20221231",
     "xbrltype": "stringItemType"
    },
    "bmr_ScheduleOfMaturityDatesOfOutstandingLoanTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Maturity Dates Of Outstanding Loan Table Text Block",
        "terseLabel": "Schedule of maturity dates of outstanding loans"
       }
      }
     },
     "localname": "ScheduleOfMaturityDatesOfOutstandingLoanTableTextBlock",
     "nsuri": "http://www.beil.com/20221231",
     "presentation": [
      "http://www.beil.com/role/LoansNetTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "bmr_ScheduleOfMaturityDatesOfOutstandingLoansAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Maturity Dates of Outstanding Loans [Abstract]"
       }
      }
     },
     "localname": "ScheduleOfMaturityDatesOfOutstandingLoansAbstract",
     "nsuri": "http://www.beil.com/20221231",
     "xbrltype": "stringItemType"
    },
    "bmr_ScheduleOfOtherCurrentAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Other Current Assets [Abstract]"
       }
      }
     },
     "localname": "ScheduleOfOtherCurrentAssetsAbstract",
     "nsuri": "http://www.beil.com/20221231",
     "xbrltype": "stringItemType"
    },
    "bmr_ScheduleOfOtherCurrentLiabiltiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Other Current Liabilties Abstract"
       }
      }
     },
     "localname": "ScheduleOfOtherCurrentLiabiltiesAbstract",
     "nsuri": "http://www.beil.com/20221231",
     "xbrltype": "stringItemType"
    },
    "bmr_ScheduleOfOutstandingAndExercisableShareOptionsSeparatedRangesOfExercisePricesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Outstanding And Exercisable Share Options Separated Ranges Of Exercise Prices Abstract"
       }
      }
     },
     "localname": "ScheduleOfOutstandingAndExercisableShareOptionsSeparatedRangesOfExercisePricesAbstract",
     "nsuri": "http://www.beil.com/20221231",
     "xbrltype": "stringItemType"
    },
    "bmr_ScheduleOfPresentationReflectsTheReconciliationOfTheCarryingAmountTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Presentation Reflects The Reconciliation Of The Carrying Amount Table Text Block",
        "terseLabel": "Schedule of the reconciliation of the carrying amount"
       }
      }
     },
     "localname": "ScheduleOfPresentationReflectsTheReconciliationOfTheCarryingAmountTableTextBlock",
     "nsuri": "http://www.beil.com/20221231",
     "presentation": [
      "http://www.beil.com/role/LoansNetTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "bmr_ScheduleOfPropertyAndEquipmentNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Property And Equipment Net Abstract"
       }
      }
     },
     "localname": "ScheduleOfPropertyAndEquipmentNetAbstract",
     "nsuri": "http://www.beil.com/20221231",
     "xbrltype": "stringItemType"
    },
    "bmr_ScheduleOfReconciliationOfTheCarryingAmountOfTheConvertibleAdvanceInvestmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Reconciliation Of The Carrying Amount Of The Convertible Advance Investment [Abstract]"
       }
      }
     },
     "localname": "ScheduleOfReconciliationOfTheCarryingAmountOfTheConvertibleAdvanceInvestmentAbstract",
     "nsuri": "http://www.beil.com/20221231",
     "xbrltype": "stringItemType"
    },
    "bmr_ScheduleOfReconciliationOfTheFairValueOfDerivativeWarrantsLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Reconciliation Of The Fair Value Of Derivative Warrants Liabilities Abstract"
       }
      }
     },
     "localname": "ScheduleOfReconciliationOfTheFairValueOfDerivativeWarrantsLiabilitiesAbstract",
     "nsuri": "http://www.beil.com/20221231",
     "xbrltype": "stringItemType"
    },
    "bmr_ScheduleOfRevenueDisaggregatedByPrimaryMajorProductLinesAndServicesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Revenue Disaggregated By Primary Major Product Lines And Services Abstract"
       }
      }
     },
     "localname": "ScheduleOfRevenueDisaggregatedByPrimaryMajorProductLinesAndServicesAbstract",
     "nsuri": "http://www.beil.com/20221231",
     "xbrltype": "stringItemType"
    },
    "bmr_ScheduleOfRevenuesByGeographicRegionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Revenues By Geographic Region Abstract"
       }
      }
     },
     "localname": "ScheduleOfRevenuesByGeographicRegionAbstract",
     "nsuri": "http://www.beil.com/20221231",
     "xbrltype": "stringItemType"
    },
    "bmr_ScheduleOfTheEffectiveDateManagementByAssistanceOfThirdPartyAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of the Effective Date Management by Assistance of Third Party [Abstract]"
       }
      }
     },
     "localname": "ScheduleOfTheEffectiveDateManagementByAssistanceOfThirdPartyAbstract",
     "nsuri": "http://www.beil.com/20221231",
     "xbrltype": "stringItemType"
    },
    "bmr_ScheduleOfTheEstimatedFutureAmortizationExpenseOfIntangibleAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of the Estimated Future Amortization Expense of Intangible Assets [Abstract]"
       }
      }
     },
     "localname": "ScheduleOfTheEstimatedFutureAmortizationExpenseOfIntangibleAssetsAbstract",
     "nsuri": "http://www.beil.com/20221231",
     "xbrltype": "stringItemType"
    },
    "bmr_ScheduleOfTheMemberEffectiveDateManagementByAssistanceOfThirdpartyTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of effective date, management by assistance of third-party.",
        "label": "Schedule Of The Member Effective Date Management By Assistance Of Thirdparty Table Text Block",
        "terseLabel": "Schedule of the Effective Date, management by assistance of third-party"
       }
      }
     },
     "localname": "ScheduleOfTheMemberEffectiveDateManagementByAssistanceOfThirdpartyTableTextBlock",
     "nsuri": "http://www.beil.com/20221231",
     "presentation": [
      "http://www.beil.com/role/LoansNetTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "bmr_ScheduleOfTheReconciliationOfTheCarryingAmountAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of the Reconciliation of the Carrying Amount [Abstract]"
       }
      }
     },
     "localname": "ScheduleOfTheReconciliationOfTheCarryingAmountAbstract",
     "nsuri": "http://www.beil.com/20221231",
     "xbrltype": "stringItemType"
    },
    "bmr_ScheduleOfTheReconciliationOfTheCarryingAmountOfTheCompanyAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of The Reconciliation Of The Carrying Amount Of The Company Abstract"
       }
      }
     },
     "localname": "ScheduleOfTheReconciliationOfTheCarryingAmountOfTheCompanyAbstract",
     "nsuri": "http://www.beil.com/20221231",
     "xbrltype": "stringItemType"
    },
    "bmr_SegmentGeographicalInformationAndMajorCustomersDetailsScheduleofLonglivedassetsnetbygeographicareasLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Geographical Information And Major Customers (Details) - Schedule of Long-lived assets net by geographic areas [Line Items]"
       }
      }
     },
     "localname": "SegmentGeographicalInformationAndMajorCustomersDetailsScheduleofLonglivedassetsnetbygeographicareasLineItems",
     "nsuri": "http://www.beil.com/20221231",
     "presentation": [
      "http://www.beil.com/role/ScheduleofLonglivedassetsnetbygeographicareasTable"
     ],
     "xbrltype": "stringItemType"
    },
    "bmr_SegmentGeographicalInformationAndMajorCustomersDetailsScheduleofLonglivedassetsnetbygeographicareasTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Geographical Information And Major Customers (Details) - Schedule of Long-lived assets net by geographic areas [Table]"
       }
      }
     },
     "localname": "SegmentGeographicalInformationAndMajorCustomersDetailsScheduleofLonglivedassetsnetbygeographicareasTable",
     "nsuri": "http://www.beil.com/20221231",
     "presentation": [
      "http://www.beil.com/role/ScheduleofLonglivedassetsnetbygeographicareasTable"
     ],
     "xbrltype": "stringItemType"
    },
    "bmr_SegmentGeographicalInformationAndMajorCustomersDetailsScheduleofrevenuesbygeographicregionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Geographical Information And Major Customers (Details) - Schedule of revenues by geographic region [Line Items]"
       }
      }
     },
     "localname": "SegmentGeographicalInformationAndMajorCustomersDetailsScheduleofrevenuesbygeographicregionLineItems",
     "nsuri": "http://www.beil.com/20221231",
     "presentation": [
      "http://www.beil.com/role/ScheduleofrevenuesbygeographicregionTable"
     ],
     "xbrltype": "stringItemType"
    },
    "bmr_SegmentGeographicalInformationAndMajorCustomersDetailsScheduleofrevenuesbygeographicregionTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Geographical Information And Major Customers (Details) - Schedule of revenues by geographic region [Table]"
       }
      }
     },
     "localname": "SegmentGeographicalInformationAndMajorCustomersDetailsScheduleofrevenuesbygeographicregionTable",
     "nsuri": "http://www.beil.com/20221231",
     "presentation": [
      "http://www.beil.com/role/ScheduleofrevenuesbygeographicregionTable"
     ],
     "xbrltype": "stringItemType"
    },
    "bmr_SeriesConvertibleB1PreferredSharesBMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series Convertible B1 Preferred Shares BMember",
        "terseLabel": "Series Convertible B1 Preferred Shares [Member]"
       }
      }
     },
     "localname": "SeriesConvertibleB1PreferredSharesBMember",
     "nsuri": "http://www.beil.com/20221231",
     "presentation": [
      "http://www.beil.com/role/ScheduleofcompositionofshareholdersequityTable"
     ],
     "xbrltype": "domainItemType"
    },
    "bmr_SeriesConvertibleBPreferredSharesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series Convertible BPreferred Shares Member",
        "terseLabel": "Series Convertible B Preferred Shares [Member]"
       }
      }
     },
     "localname": "SeriesConvertibleBPreferredSharesMember",
     "nsuri": "http://www.beil.com/20221231",
     "presentation": [
      "http://www.beil.com/role/ScheduleofcompositionofshareholdersequityTable"
     ],
     "xbrltype": "domainItemType"
    },
    "bmr_SeriesConvertibleCPreferredSharesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series Convertible CPreferred Shares Member",
        "terseLabel": "Series Convertible C Preferred Shares [Member]"
       }
      }
     },
     "localname": "SeriesConvertibleCPreferredSharesMember",
     "nsuri": "http://www.beil.com/20221231",
     "presentation": [
      "http://www.beil.com/role/ScheduleofcompositionofshareholdersequityTable"
     ],
     "xbrltype": "domainItemType"
    },
    "bmr_SeriesConvertibleOrdinary1SharesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series Convertible Ordinary1 Shares Member",
        "terseLabel": "Series Convertible Ordinary 1 Shares [Member]"
       }
      }
     },
     "localname": "SeriesConvertibleOrdinary1SharesMember",
     "nsuri": "http://www.beil.com/20221231",
     "presentation": [
      "http://www.beil.com/role/ScheduleofcompositionofshareholdersequityTable"
     ],
     "xbrltype": "domainItemType"
    },
    "bmr_SeriesConvertibleOrdinary2SharesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series Convertible Ordinary2 Shares Member",
        "terseLabel": "Series Convertible Ordinary 2 Shares [Member]"
       }
      }
     },
     "localname": "SeriesConvertibleOrdinary2SharesMember",
     "nsuri": "http://www.beil.com/20221231",
     "presentation": [
      "http://www.beil.com/role/ScheduleofcompositionofshareholdersequityTable"
     ],
     "xbrltype": "domainItemType"
    },
    "bmr_SeriesOrdinarySharesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series Ordinary Shares Member",
        "terseLabel": "Series Ordinary Shares [Member]"
       }
      }
     },
     "localname": "SeriesOrdinarySharesMember",
     "nsuri": "http://www.beil.com/20221231",
     "presentation": [
      "http://www.beil.com/role/ScheduleofcompositionofshareholdersequityTable"
     ],
     "xbrltype": "domainItemType"
    },
    "bmr_ShareOptionsDetailsScheduleofassumptionsusedtoestimatethefairvaluesoftheshareoptionsgrantedLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Options (Details) - Schedule of assumptions used to estimate the fair values of the share options granted [Line Items]"
       }
      }
     },
     "localname": "ShareOptionsDetailsScheduleofassumptionsusedtoestimatethefairvaluesoftheshareoptionsgrantedLineItems",
     "nsuri": "http://www.beil.com/20221231",
     "presentation": [
      "http://www.beil.com/role/ScheduleofassumptionsusedtoestimatethefairvaluesoftheshareoptionsgrantedTable"
     ],
     "xbrltype": "stringItemType"
    },
    "bmr_ShareOptionsDetailsScheduleofassumptionsusedtoestimatethefairvaluesoftheshareoptionsgrantedTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Options (Details) - Schedule of assumptions used to estimate the fair values of the share options granted [Table]"
       }
      }
     },
     "localname": "ShareOptionsDetailsScheduleofassumptionsusedtoestimatethefairvaluesoftheshareoptionsgrantedTable",
     "nsuri": "http://www.beil.com/20221231",
     "presentation": [
      "http://www.beil.com/role/ScheduleofassumptionsusedtoestimatethefairvaluesoftheshareoptionsgrantedTable"
     ],
     "xbrltype": "stringItemType"
    },
    "bmr_ShareOptionsExercisableMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Options Exercisable Member",
        "terseLabel": "Share options exercisable [Member]"
       }
      }
     },
     "localname": "ShareOptionsExercisableMember",
     "nsuri": "http://www.beil.com/20221231",
     "presentation": [
      "http://www.beil.com/role/ScheduleofoutstandingandexercisableshareoptionsseparatedrangesofexercisepricesTable"
     ],
     "xbrltype": "domainItemType"
    },
    "bmr_ShareOptionsOutstandingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Options Outstanding Member",
        "terseLabel": "Share options outstanding [Member]"
       }
      }
     },
     "localname": "ShareOptionsOutstandingMember",
     "nsuri": "http://www.beil.com/20221231",
     "presentation": [
      "http://www.beil.com/role/ScheduleofoutstandingandexercisableshareoptionsseparatedrangesofexercisepricesTable"
     ],
     "xbrltype": "domainItemType"
    },
    "bmr_ShareholdersEquityDeficitAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shareholders Equity Deficit Abstract",
        "terseLabel": "Shareholders\u2019 equity (deficit):"
       }
      }
     },
     "localname": "ShareholdersEquityDeficitAbstract",
     "nsuri": "http://www.beil.com/20221231",
     "presentation": [
      "http://www.beil.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "stringItemType"
    },
    "bmr_ShareholdersEquityDeficitDetailsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shareholders\u2019 Equity (Deficit) (Details) [Line Items]"
       }
      }
     },
     "localname": "ShareholdersEquityDeficitDetailsLineItems",
     "nsuri": "http://www.beil.com/20221231",
     "presentation": [
      "http://www.beil.com/role/ShareholdersEquityDeficitDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bmr_ShareholdersEquityDeficitDetailsScheduleofcompositionofshareholdersequityLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shareholders\u2019 Equity (Deficit) (Details) - Schedule of composition of shareholders' equity [Line Items]"
       }
      }
     },
     "localname": "ShareholdersEquityDeficitDetailsScheduleofcompositionofshareholdersequityLineItems",
     "nsuri": "http://www.beil.com/20221231",
     "presentation": [
      "http://www.beil.com/role/ScheduleofcompositionofshareholdersequityTable"
     ],
     "xbrltype": "stringItemType"
    },
    "bmr_ShareholdersEquityDeficitDetailsScheduleofcompositionofshareholdersequityTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shareholders\u2019 Equity (Deficit) (Details) - Schedule of composition of shareholders' equity [Table]"
       }
      }
     },
     "localname": "ShareholdersEquityDeficitDetailsScheduleofcompositionofshareholdersequityTable",
     "nsuri": "http://www.beil.com/20221231",
     "presentation": [
      "http://www.beil.com/role/ScheduleofcompositionofshareholdersequityTable"
     ],
     "xbrltype": "stringItemType"
    },
    "bmr_ShareholdersEquityDeficitDetailsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shareholders\u2019 Equity (Deficit) (Details) [Table]"
       }
      }
     },
     "localname": "ShareholdersEquityDeficitDetailsTable",
     "nsuri": "http://www.beil.com/20221231",
     "presentation": [
      "http://www.beil.com/role/ShareholdersEquityDeficitDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bmr_SignificantAccountingPoliciesDetailsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Significant Accounting Policies (Details) [Line Items]"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesDetailsLineItems",
     "nsuri": "http://www.beil.com/20221231",
     "presentation": [
      "http://www.beil.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bmr_SignificantAccountingPoliciesDetailsScheduleofcomputingstraightlinedepreciationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Significant Accounting Policies (Details) - Schedule of computing straight-line depreciation [Line Items]"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesDetailsScheduleofcomputingstraightlinedepreciationLineItems",
     "nsuri": "http://www.beil.com/20221231",
     "presentation": [
      "http://www.beil.com/role/ScheduleofcomputingstraightlinedepreciationTable"
     ],
     "xbrltype": "stringItemType"
    },
    "bmr_SignificantAccountingPoliciesDetailsScheduleofcomputingstraightlinedepreciationTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Significant Accounting Policies (Details) - Schedule of computing straight-line depreciation [Table]"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesDetailsScheduleofcomputingstraightlinedepreciationTable",
     "nsuri": "http://www.beil.com/20221231",
     "presentation": [
      "http://www.beil.com/role/ScheduleofcomputingstraightlinedepreciationTable"
     ],
     "xbrltype": "stringItemType"
    },
    "bmr_SignificantAccountingPoliciesDetailsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Significant Accounting Policies (Details) [Table]"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesDetailsTable",
     "nsuri": "http://www.beil.com/20221231",
     "presentation": [
      "http://www.beil.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bmr_SoftwareLicenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Software License Abstract",
        "terseLabel": "Software license:"
       }
      }
     },
     "localname": "SoftwareLicenseAbstract",
     "nsuri": "http://www.beil.com/20221231",
     "presentation": [
      "http://www.beil.com/role/ScheduleofrevenuedisaggregatedbyprimarymajorproductlinesandservicesTable"
     ],
     "xbrltype": "stringItemType"
    },
    "bmr_SubsequentEventsDetailsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events (Details) [Line Items]"
       }
      }
     },
     "localname": "SubsequentEventsDetailsLineItems",
     "nsuri": "http://www.beil.com/20221231",
     "presentation": [
      "http://www.beil.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bmr_SubsequentEventsDetailsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events (Details) [Table]"
       }
      }
     },
     "localname": "SubsequentEventsDetailsTable",
     "nsuri": "http://www.beil.com/20221231",
     "presentation": [
      "http://www.beil.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bmr_SupplementalDisclosureOfCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Disclosure Of Cash Flow Information Abstract",
        "terseLabel": "Supplemental disclosure of cash flow information:"
       }
      }
     },
     "localname": "SupplementalDisclosureOfCashFlowInformationAbstract",
     "nsuri": "http://www.beil.com/20221231",
     "presentation": [
      "http://www.beil.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "stringItemType"
    },
    "bmr_TechnologyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Technology Member",
        "terseLabel": "Technology [Member]"
       }
      }
     },
     "localname": "TechnologyMember",
     "nsuri": "http://www.beil.com/20221231",
     "presentation": [
      "http://www.beil.com/role/ScheduleofintangibleassetsnetandgoodwilTable"
     ],
     "xbrltype": "domainItemType"
    },
    "bmr_TermbasedSoftwareLicenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Termbased Software License Member",
        "terseLabel": "Term-based software license [Member]"
       }
      }
     },
     "localname": "TermbasedSoftwareLicenseMember",
     "nsuri": "http://www.beil.com/20221231",
     "presentation": [
      "http://www.beil.com/role/ScheduleofrevenuedisaggregatedbyprimarymajorproductlinesandservicesTable"
     ],
     "xbrltype": "domainItemType"
    },
    "bmr_TotalConsideration": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Consideration",
        "terseLabel": "Total consideration"
       }
      }
     },
     "localname": "TotalConsideration",
     "nsuri": "http://www.beil.com/20221231",
     "presentation": [
      "http://www.beil.com/role/ShareOptionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmr_TotalGrossConsideration": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Gross Consideration",
        "terseLabel": "Total gross consideration"
       }
      }
     },
     "localname": "TotalGrossConsideration",
     "nsuri": "http://www.beil.com/20221231",
     "presentation": [
      "http://www.beil.com/role/ScheduleoftheEffectiveDatemanagementbyassistanceofthirdpartyTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmr_TradeReceivablesIncomeTaxRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trade Receivables Income Tax Rate",
        "terseLabel": "Trade receivables interest rate"
       }
      }
     },
     "localname": "TradeReceivablesIncomeTaxRate",
     "nsuri": "http://www.beil.com/20221231",
     "presentation": [
      "http://www.beil.com/role/SegmentGeographicalInformationAndMajorCustomersDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "bmr_TwoThousandTwentyTwoLoanAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Two Thousand Twenty Two Loan Agreement Member",
        "terseLabel": "2022 Loan Agreement [Member]"
       }
      }
     },
     "localname": "TwoThousandTwentyTwoLoanAgreementMember",
     "nsuri": "http://www.beil.com/20221231",
     "presentation": [
      "http://www.beil.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmr_TwoZeroTwoTwoLoanAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Two Zero Two Two Loan Agreement Member",
        "terseLabel": "2022 Loan Agreement [Member]"
       }
      }
     },
     "localname": "TwoZeroTwoTwoLoanAgreementMember",
     "nsuri": "http://www.beil.com/20221231",
     "presentation": [
      "http://www.beil.com/role/LoansNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmr_VoluntaryConversionDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Voluntary conversion description.",
        "label": "Voluntary Conversion Description",
        "terseLabel": "Voluntary conversion description"
       }
      }
     },
     "localname": "VoluntaryConversionDescription",
     "nsuri": "http://www.beil.com/20221231",
     "presentation": [
      "http://www.beil.com/role/ShareholdersEquityDeficitDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bmr_WarrantsPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy of warrants.",
        "label": "Warrants Policy Text Block",
        "terseLabel": "Warrants"
       }
      }
     },
     "localname": "WarrantsPolicyTextBlock",
     "nsuri": "http://www.beil.com/20221231",
     "presentation": [
      "http://www.beil.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "bmr_WeightedAverageRemainingContractualLifeExercised": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Remaining Contractual Life Exercised",
        "terseLabel": "Weighted average remaining contractual life, Exercised"
       }
      }
     },
     "localname": "WeightedAverageRemainingContractualLifeExercised",
     "nsuri": "http://www.beil.com/20221231",
     "presentation": [
      "http://www.beil.com/role/ScheduleofcompanysshareoptionactivityforemployeesandmembersoftheboardofdirectorsTable"
     ],
     "xbrltype": "durationItemType"
    },
    "bmr_WeightedAverageRemainingContractualLifeForfeitedOrExpired": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Remaining Contractual Life Forfeited Or Expired",
        "terseLabel": "Weighted average remaining contractual life, Forfeited or expired"
       }
      }
     },
     "localname": "WeightedAverageRemainingContractualLifeForfeitedOrExpired",
     "nsuri": "http://www.beil.com/20221231",
     "presentation": [
      "http://www.beil.com/role/ScheduleofcompanysshareoptionactivityforemployeesandmembersoftheboardofdirectorsTable"
     ],
     "xbrltype": "durationItemType"
    },
    "bmr_WeightedAverageRemainingContractualLifeGranted": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Remaining Contractual Life Granted",
        "terseLabel": "Weighted average remaining contractual life, Granted"
       }
      }
     },
     "localname": "WeightedAverageRemainingContractualLifeGranted",
     "nsuri": "http://www.beil.com/20221231",
     "presentation": [
      "http://www.beil.com/role/ScheduleofcompanysshareoptionactivityforemployeesandmembersoftheboardofdirectorsTable"
     ],
     "xbrltype": "durationItemType"
    },
    "bmr_WeightedAverageRemainingContractualLifeOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Remaining Contractual Life Outstanding",
        "terseLabel": "Weighted average remaining contractual life, Outstanding"
       }
      }
     },
     "localname": "WeightedAverageRemainingContractualLifeOutstanding",
     "nsuri": "http://www.beil.com/20221231",
     "presentation": [
      "http://www.beil.com/role/ScheduleofcompanysshareoptionactivityforemployeesandmembersoftheboardofdirectorsTable"
     ],
     "xbrltype": "durationItemType"
    },
    "bmr_scheduleOfFutureMinimumCommitmentUnderBindingLeaseAgreeementsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "schedule Of Future Minimum Commitment Under Binding Lease Agreeements Table Text Block",
        "terseLabel": "Schedule of future minimum commitment under binding lease agreeements"
       }
      }
     },
     "localname": "scheduleOfFutureMinimumCommitmentUnderBindingLeaseAgreeementsTableTextBlock",
     "nsuri": "http://www.beil.com/20221231",
     "presentation": [
      "http://www.beil.com/role/CommitmentsandContingentLiabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "country_IL": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "ISRAEL",
        "terseLabel": "Israel [Member]"
       }
      }
     },
     "localname": "IL",
     "nsuri": "http://xbrl.sec.gov/country/2022",
     "presentation": [
      "http://www.beil.com/role/ScheduleofLonglivedassetsnetbygeographicareasTable",
      "http://www.beil.com/role/ScheduleofrevenuesbygeographicregionTable"
     ],
     "xbrltype": "domainItemType"
    },
    "country_RU": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "RUSSIAN FEDERATION",
        "terseLabel": "Russia [Member]"
       }
      }
     },
     "localname": "RU",
     "nsuri": "http://xbrl.sec.gov/country/2022",
     "presentation": [
      "http://www.beil.com/role/ScheduleofLonglivedassetsnetbygeographicareasTable"
     ],
     "xbrltype": "domainItemType"
    },
    "country_US": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED STATES",
        "terseLabel": "United States [Member]"
       }
      }
     },
     "localname": "US",
     "nsuri": "http://xbrl.sec.gov/country/2022",
     "presentation": [
      "http://www.beil.com/role/ScheduleofLonglivedassetsnetbygeographicareasTable",
      "http://www.beil.com/role/ScheduleofrevenuesbygeographicregionTable"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AddressTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An entity may have several addresses for different purposes and this domain represents all such types.",
        "label": "Address Type [Domain]"
       }
      }
     },
     "localname": "AddressTypeDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.beil.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.beil.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditorFirmId": {
     "auth_ref": [
      "r530",
      "r531",
      "r532"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "PCAOB issued Audit Firm Identifier",
        "label": "Auditor Firm ID",
        "terseLabel": "Auditor Firm ID"
       }
      }
     },
     "localname": "AuditorFirmId",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.beil.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "nonemptySequenceNumberItemType"
    },
    "dei_AuditorLocation": {
     "auth_ref": [
      "r530",
      "r531",
      "r532"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location",
        "terseLabel": "Auditor Location"
       }
      }
     },
     "localname": "AuditorLocation",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.beil.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_AuditorName": {
     "auth_ref": [
      "r530",
      "r531",
      "r532"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name",
        "terseLabel": "Auditor Name"
       }
      }
     },
     "localname": "AuditorName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.beil.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_BusinessContactMember": {
     "auth_ref": [
      "r531",
      "r532"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business contact for the entity",
        "label": "Business Contact [Member]",
        "terseLabel": "Business Contact"
       }
      }
     },
     "localname": "BusinessContactMember",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.beil.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.beil.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_ContactPersonnelEmailAddress": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Email address of contact personnel.",
        "label": "Contact Personnel Email Address",
        "terseLabel": "Contact Personnel Email Address"
       }
      }
     },
     "localname": "ContactPersonnelEmailAddress",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.beil.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_ContactPersonnelName": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of contact personnel",
        "label": "Contact Personnel Name",
        "terseLabel": "Contact Personnel Name"
       }
      }
     },
     "localname": "ContactPersonnelName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.beil.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.beil.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r531"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard",
        "terseLabel": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.beil.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r530",
      "r531",
      "r532"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report",
        "terseLabel": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.beil.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.beil.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.beil.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "localname": "DocumentInformationLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.beil.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentInformationTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
       }
      }
     },
     "localname": "DocumentInformationTable",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.beil.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.beil.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r526"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement",
        "terseLabel": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.beil.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r531"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report",
        "terseLabel": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.beil.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r533"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.beil.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.beil.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.beil.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two",
        "terseLabel": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.beil.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.beil.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country",
        "terseLabel": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.beil.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.beil.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressesAddressTypeAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table.",
        "label": "Entity Addresses, Address Type [Axis]"
       }
      }
     },
     "localname": "EntityAddressesAddressTypeAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.beil.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r528"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.beil.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.beil.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.beil.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r528"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.beil.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r536"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Entity Ex Transition Period",
        "terseLabel": "Entity Ex Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.beil.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.beil.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r528"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.beil.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.beil.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r534"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.beil.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r528"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.beil.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r528"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.beil.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers",
        "terseLabel": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.beil.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r535"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer",
        "terseLabel": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.beil.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_IcfrAuditorAttestationFlag": {
     "auth_ref": [
      "r530",
      "r531",
      "r532"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag",
        "terseLabel": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "localname": "IcfrAuditorAttestationFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.beil.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.beil.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r527"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.beil.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r529"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.beil.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.beil.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "srt_BoardOfDirectorsChairmanMember": {
     "auth_ref": [
      "r559"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Board of Directors Chairman [Member]",
        "terseLabel": "Board of Directors [Member]"
       }
      }
     },
     "localname": "BoardOfDirectorsChairmanMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.beil.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_EquityMethodInvesteeNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment, Name [Domain]"
       }
      }
     },
     "localname": "EquityMethodInvesteeNameDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.beil.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r295",
      "r296",
      "r297",
      "r298",
      "r350",
      "r448",
      "r472",
      "r496",
      "r497",
      "r511",
      "r519",
      "r525",
      "r572",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum [Member]"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.beil.com/role/ConvertibleAdvanceInvestmentDetails",
      "http://www.beil.com/role/LoansNetDetails",
      "http://www.beil.com/role/ScheduleofassumptionsusedtoestimatethefairvaluesoftheshareoptionsgrantedTable",
      "http://www.beil.com/role/ScheduleofcomputingstraightlinedepreciationTable",
      "http://www.beil.com/role/ShareholdersEquityDeficitDetails",
      "http://www.beil.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r295",
      "r296",
      "r297",
      "r298",
      "r350",
      "r448",
      "r472",
      "r496",
      "r497",
      "r511",
      "r519",
      "r525",
      "r572",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum [Member]"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.beil.com/role/ConvertibleAdvanceInvestmentDetails",
      "http://www.beil.com/role/LoansNetDetails",
      "http://www.beil.com/role/ScheduleofassumptionsusedtoestimatethefairvaluesoftheshareoptionsgrantedTable",
      "http://www.beil.com/role/ScheduleofcomputingstraightlinedepreciationTable",
      "http://www.beil.com/role/ShareholdersEquityDeficitDetails",
      "http://www.beil.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r295",
      "r296",
      "r297",
      "r298",
      "r348",
      "r350",
      "r378",
      "r379",
      "r380",
      "r447",
      "r448",
      "r472",
      "r496",
      "r497",
      "r511",
      "r519",
      "r525",
      "r568",
      "r572",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.beil.com/role/ConvertibleAdvanceInvestmentDetails",
      "http://www.beil.com/role/LoansNetDetails",
      "http://www.beil.com/role/ScheduleofassumptionsusedtoestimatethefairvaluesoftheshareoptionsgrantedTable",
      "http://www.beil.com/role/ScheduleofcomputingstraightlinedepreciationTable",
      "http://www.beil.com/role/ShareholdersEquityDeficitDetails",
      "http://www.beil.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r295",
      "r296",
      "r297",
      "r298",
      "r348",
      "r350",
      "r378",
      "r379",
      "r380",
      "r447",
      "r448",
      "r472",
      "r496",
      "r497",
      "r511",
      "r519",
      "r525",
      "r568",
      "r572",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.beil.com/role/ConvertibleAdvanceInvestmentDetails",
      "http://www.beil.com/role/LoansNetDetails",
      "http://www.beil.com/role/ScheduleofassumptionsusedtoestimatethefairvaluesoftheshareoptionsgrantedTable",
      "http://www.beil.com/role/ScheduleofcomputingstraightlinedepreciationTable",
      "http://www.beil.com/role/ShareholdersEquityDeficitDetails",
      "http://www.beil.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioForecastMember": {
     "auth_ref": [
      "r351",
      "r556"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forecast [Member]",
        "terseLabel": "Forecast [Member]"
       }
      }
     },
     "localname": "ScenarioForecastMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.beil.com/role/CommitmentsandContingentLiabilitiesDetails",
      "http://www.beil.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioUnspecifiedDomain": {
     "auth_ref": [
      "r242",
      "r351",
      "r538",
      "r556"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Domain]"
       }
      }
     },
     "localname": "ScenarioUnspecifiedDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.beil.com/role/CommitmentsandContingentLiabilitiesDetails",
      "http://www.beil.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": {
     "auth_ref": [
      "r285"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment, Name [Axis]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.beil.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r280",
      "r281",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r513",
      "r524",
      "r574"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.beil.com/role/ScheduleofLonglivedassetsnetbygeographicareasTable",
      "http://www.beil.com/role/ScheduleofrevenuesbygeographicregionTable"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r280",
      "r281",
      "r481",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r513",
      "r524",
      "r574"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.beil.com/role/ScheduleofLonglivedassetsnetbygeographicareasTable",
      "http://www.beil.com/role/ScheduleofrevenuesbygeographicregionTable"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_StatementScenarioAxis": {
     "auth_ref": [
      "r242",
      "r351",
      "r538",
      "r539",
      "r556"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Axis]"
       }
      }
     },
     "localname": "StatementScenarioAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.beil.com/role/CommitmentsandContingentLiabilitiesDetails",
      "http://www.beil.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualAxis": {
     "auth_ref": [
      "r559",
      "r586"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of Individual [Axis]"
       }
      }
     },
     "localname": "TitleOfIndividualAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.beil.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of Individual [Domain]"
       }
      }
     },
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.beil.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period.",
        "label": "Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block]",
        "terseLabel": "OTHER CURRENT LIABILITIES"
       }
      }
     },
     "localname": "AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/OtherCurrentLiabilities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r21"
     ],
     "calculation": {
      "http://www.beil.com/role/ScheduleofothercurrentliabiltiesTable": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.",
        "label": "Accounts Payable and Accrued Liabilities, Current",
        "terseLabel": "Accrued expenses"
       }
      }
     },
     "localname": "AccountsPayableAndAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ScheduleofothercurrentliabiltiesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of trade and related party payables and accrued expenses.",
        "label": "Accounts Payable and Accrued Liabilities, Fair Value Disclosure",
        "terseLabel": "Accrued interest expenses relating to straight loan (see also Note 13)"
       }
      }
     },
     "localname": "AccountsPayableAndAccruedLiabilitiesFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ScheduleofthereconciliationofthecarryingamountTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r18",
      "r523"
     ],
     "calculation": {
      "http://www.beil.com/role/ConsolidatedBalanceSheet": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Account payables"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsPayableInterestBearingInterestRate": {
     "auth_ref": [
      "r136",
      "r137",
      "r139",
      "r140"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the effective interest rate as of the balance sheet date on interest-bearing trade payables.",
        "label": "Accounts Payable, Interest-Bearing, Interest Rate",
        "terseLabel": "PPP Amount bears interest rate"
       }
      }
     },
     "localname": "AccountsPayableInterestBearingInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/LoansNetDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments": {
     "auth_ref": [
      "r53"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Accretion (Amortization) of Discounts and Premiums, Investments",
        "terseLabel": "Amortization of discounts relating to straight loan (see also Note 13)"
       }
      }
     },
     "localname": "AccretionAmortizationOfDiscountsAndPremiumsInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ScheduleofthereconciliationofthecarryingamountTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedAmortizationDeferredFinanceCosts": {
     "auth_ref": [
      "r140"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated amortization of debt issuance costs.",
        "label": "Accumulated Amortization, Debt Issuance Costs",
        "terseLabel": "Accumulated amortization"
       }
      }
     },
     "localname": "AccumulatedAmortizationDeferredFinanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ScheduleofintangibleassetsnetandgoodwilTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r88",
      "r190"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "negatedLabel": "Less - accumulated depreciation"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ScheduleofpropertyandequipmentnetTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r12",
      "r523"
     ],
     "calculation": {
      "http://www.beil.com/role/ConsolidatedBalanceSheet": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.",
        "label": "Additional Paid in Capital",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r386",
      "r387",
      "r388",
      "r553",
      "r554",
      "r555",
      "r580"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentOfWarrantsGrantedForServices": {
     "auth_ref": [
      "r52"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustment for noncash service expenses paid for by granting of warrants.",
        "label": "Adjustment of Warrants Granted for Services",
        "terseLabel": "Recognition of fair value of Warrant Share issued at Effective Date (see Note 6C)"
       }
      }
     },
     "localname": "AdjustmentOfWarrantsGrantedForServices",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ScheduleofreconciliationofthefairvalueofderivativewarrantsliabilitiesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalOther": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other increase (decrease) in additional paid in capital (APIC).",
        "label": "Adjustments to Additional Paid in Capital, Other",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/RelatedPartiesTransactionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of expense for award under share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Expense, after Tax",
        "terseLabel": "Unrecognized compensation expense"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpenseNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ShareOptionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfDebtDiscountPremium": {
     "auth_ref": [
      "r38",
      "r52",
      "r138",
      "r323"
     ],
     "calculation": {
      "http://www.beil.com/role/ConsolidatedCashFlow": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.",
        "label": "Amortization of Debt Discount (Premium)",
        "terseLabel": "Amortization of discount relating to straight loan received from commercial bank (Note 6)",
        "verboseLabel": "Amortization of discount and interest expenses"
       }
      }
     },
     "localname": "AmortizationOfDebtDiscountPremium",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ConsolidatedCashFlow",
      "http://www.beil.com/role/LoansNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfFinancingCosts": {
     "auth_ref": [
      "r32",
      "r323",
      "r433",
      "r548"
     ],
     "calculation": {
      "http://www.beil.com/role/ConsolidatedCashFlow": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to debt issuance costs.",
        "label": "Amortization of Debt Issuance Costs",
        "terseLabel": "Amortization of discount relating to liability to related party (see Note 14)"
       }
      }
     },
     "localname": "AmortizationOfFinancingCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfFinancingCostsAndDiscounts": {
     "auth_ref": [
      "r323",
      "r433",
      "r509",
      "r510",
      "r548"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.",
        "label": "Amortization of Debt Issuance Costs and Discounts",
        "terseLabel": "Amortization of discount relating to liability to related party (see Note 14)"
       }
      }
     },
     "localname": "AmortizationOfFinancingCostsAndDiscounts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ScheduleoffinancingexpensesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r52",
      "r76",
      "r82"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "terseLabel": "Total amortization expenses (in Dollars)"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/IntangibleAssetsNetandGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r145",
      "r159",
      "r193",
      "r223",
      "r266",
      "r270",
      "r275",
      "r286",
      "r299",
      "r300",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r308",
      "r309",
      "r414",
      "r416",
      "r424",
      "r523",
      "r570",
      "r571",
      "r588"
     ],
     "calculation": {
      "http://www.beil.com/role/ConsolidatedBalanceSheet": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r186",
      "r201",
      "r223",
      "r286",
      "r299",
      "r300",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r308",
      "r309",
      "r414",
      "r416",
      "r424",
      "r523",
      "r570",
      "r571",
      "r588"
     ],
     "calculation": {
      "http://www.beil.com/role/ConsolidatedBalanceSheet": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsNoncurrent": {
     "auth_ref": [
      "r223",
      "r286",
      "r299",
      "r300",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r308",
      "r309",
      "r414",
      "r416",
      "r424",
      "r570",
      "r571",
      "r588"
     ],
     "calculation": {
      "http://www.beil.com/role/ConsolidatedBalanceSheet": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.",
        "label": "Assets, Noncurrent",
        "totalLabel": "Total non-current assets"
       }
      }
     },
     "localname": "AssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsUnderManagementCarryingAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying amount of assets an investment adviser manages on behalf of investors.",
        "label": "Assets under Management, Carrying Amount",
        "terseLabel": "Carrying amount"
       }
      }
     },
     "localname": "AssetsUnderManagementCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ScheduleofintangibleassetsnetandgoodwilTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r353",
      "r354",
      "r355",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/LoansNetDetails",
      "http://www.beil.com/role/ScheduleofoutstandingandexercisableshareoptionsseparatedrangesofexercisepricesTable"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CapitalUnitsNetAmount": {
     "auth_ref": [
      "r176"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net amount applicable to investors of capital units or shares.",
        "label": "Capital Units, Net Amount",
        "terseLabel": "Net amount"
       }
      }
     },
     "localname": "CapitalUnitsNetAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/GeneralDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r54",
      "r188",
      "r499"
     ],
     "calculation": {
      "http://www.beil.com/role/ConsolidatedBalanceSheet": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "auth_ref": [
      "r55"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.",
        "label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r46",
      "r54",
      "r60"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "periodEndLabel": "Cash, cash equivalents at end of year",
        "periodStartLabel": "Cash, cash equivalents at beginning of year"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r46",
      "r135"
     ],
     "calculation": {
      "http://www.beil.com/role/ConsolidatedCashFlow": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Change in cash, cash equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [
      "r195",
      "r196",
      "r197",
      "r223",
      "r245",
      "r246",
      "r248",
      "r250",
      "r253",
      "r254",
      "r286",
      "r299",
      "r302",
      "r303",
      "r304",
      "r308",
      "r309",
      "r329",
      "r330",
      "r333",
      "r337",
      "r343",
      "r424",
      "r498",
      "r537",
      "r549",
      "r557"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.",
        "label": "Class of Stock [Domain]"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ConvertibleAdvanceInvestmentDetails",
      "http://www.beil.com/role/LoansNetDetails",
      "http://www.beil.com/role/ScheduleofcompositionofshareholdersequityTable",
      "http://www.beil.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": {
     "auth_ref": [
      "r344"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise price per share or per unit of warrants or rights outstanding.",
        "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights",
        "terseLabel": "Exercise price of per share (in Dollars per share)",
        "verboseLabel": "Aggregate gross proceeds (in Dollars per share)"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/LoansNetDetails",
      "http://www.beil.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares.",
        "label": "Class of Warrant or Right, Number of Securities Called by Each Warrant or Right",
        "terseLabel": "Initial public offering"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ClassOfWarrantOrRightOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of warrants or rights outstanding.",
        "label": "Class of Warrant or Right, Outstanding",
        "terseLabel": "Issuance of warrants (in Shares)"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/LoansNetDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r26",
      "r151",
      "r166"
     ],
     "calculation": {
      "http://www.beil.com/role/ConsolidatedBalanceSheet": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and contingent liabilities"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingent Liabilities [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r91",
      "r293",
      "r294",
      "r482",
      "r569"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "COMMITMENTS AND CONTINGENT LIABILITIES"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/CommitmentsandContingentLiabilities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommitmentsAndContingenciesPolicyTextBlock": {
     "auth_ref": [
      "r92",
      "r483"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies.",
        "label": "Commitments and Contingencies, Policy [Policy Text Block]",
        "terseLabel": "Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r553",
      "r554",
      "r580"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "netLabel": "Ordinary Shares [Member]",
        "terseLabel": "Ordinary shares",
        "verboseLabel": "Ordinary shares [Member]"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ConsolidatedBalanceSheet_Parentheticals",
      "http://www.beil.com/role/GeneralDetails",
      "http://www.beil.com/role/ShareholdersEquityType2or3",
      "http://www.beil.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Ordinary shares, par value (in New Shekels per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ConsolidatedBalanceSheet_Parentheticals"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Ordinary shares, authorized"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ConsolidatedBalanceSheet_Parentheticals"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Ordinary shares, issued"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ConsolidatedBalanceSheet_Parentheticals"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r11",
      "r99"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "terseLabel": "Ordinary shares, outstanding"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ConsolidatedBalanceSheet_Parentheticals"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r11",
      "r523"
     ],
     "calculation": {
      "http://www.beil.com/role/ConsolidatedBalanceSheet": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Ordinary Shares of NIS 0.05 par value each: Authorized: 14,307,116 and 14,316,880 shares at December 31, 2022 and 2021, respectively; Issued and outstanding: 2,578,760 shares at December 31, 2022 and 2021"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r29",
      "r205",
      "r207",
      "r213",
      "r465",
      "r469"
     ],
     "calculation": {
      "http://www.beil.com/role/ConsolidatedIncomeStatement": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Net loss and comprehensive loss for the year"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComputerEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long lived, depreciable assets that are used in the creation, maintenance and utilization of information systems.",
        "label": "Computer Equipment [Member]",
        "terseLabel": "Computers and peripheral equipment [Member]"
       }
      }
     },
     "localname": "ComputerEquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ScheduleofpropertyandequipmentnetTable"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "auth_ref": [
      "r125",
      "r501"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.",
        "label": "Consolidation, Policy [Policy Text Block]",
        "terseLabel": "Principles of Consolidation"
       }
      }
     },
     "localname": "ConsolidationPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConversionOfStockSharesIssued1": {
     "auth_ref": [
      "r57",
      "r58",
      "r59"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of new shares issued in the conversion of stock in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Conversion of Stock, Shares Issued",
        "terseLabel": "Conversion shares"
       }
      }
     },
     "localname": "ConversionOfStockSharesIssued1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ConvertibleDebtFairValueDisclosures": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock.",
        "label": "Convertible Debt, Fair Value Disclosures",
        "periodEndLabel": "Closing balance",
        "periodStartLabel": "Opening balance"
       }
      }
     },
     "localname": "ConvertibleDebtFairValueDisclosures",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ScheduleofreconciliationofthecarryingamountoftheconvertibleadvanceinvestmentTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConvertibleDebtTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of convertible debt instrument. Includes, but is not limited to, principal amount and amortized premium or discount.",
        "label": "Convertible Debt [Table Text Block]",
        "terseLabel": "Schedule of financing expenses"
       }
      }
     },
     "localname": "ConvertibleDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/FinancingExpensesNetTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConvertiblePreferredStockMember": {
     "auth_ref": [
      "r329",
      "r330",
      "r333"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Preferred stock that may be exchanged into common shares or other types of securities at the owner's option.",
        "label": "Convertible Preferred Stock [Member]",
        "terseLabel": "Convertible Preferred Shares [Member]",
        "verboseLabel": "Convertible Preferred Stock [Member]"
       }
      }
     },
     "localname": "ConvertiblePreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ConvertibleAdvanceInvestmentDetails",
      "http://www.beil.com/role/LoansNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfRevenue": {
     "auth_ref": [
      "r35",
      "r223",
      "r286",
      "r299",
      "r300",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r308",
      "r309",
      "r424",
      "r570"
     ],
     "calculation": {
      "http://www.beil.com/role/ConsolidatedIncomeStatement": {
       "order": 2.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period.",
        "label": "Cost of Revenue",
        "negatedLabel": "Cost of revenues"
       }
      }
     },
     "localname": "CostOfRevenue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CustomerRelationshipsMember": {
     "auth_ref": [
      "r123"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.",
        "label": "Customer Relationships [Member]",
        "terseLabel": "Customer Relationships [Member]",
        "verboseLabel": "Customer relationships [Member]"
       }
      }
     },
     "localname": "CustomerRelationshipsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ScheduleofcomputingstraightlineamortizationTable",
      "http://www.beil.com/role/ScheduleofintangibleassetsnetandgoodwilTable"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtConversionConvertedInstrumentAmount1": {
     "auth_ref": [
      "r57",
      "r59"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Debt Conversion, Converted Instrument, Amount",
        "terseLabel": "Conversion amount"
       }
      }
     },
     "localname": "DebtConversionConvertedInstrumentAmount1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ConvertibleAdvanceInvestmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtConversionConvertedInstrumentRate": {
     "auth_ref": [
      "r57",
      "r59"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Dividend or interest rate associated with the financial instrument issued in exchange for the original debt being converted in a noncash or part noncash transaction. Noncash are transactions that affect recognized assets or liabilities but that do not result in cash receipts or cash payments. Part noncash refers to that portion of the transaction not resulting in cash receipts or cash payments.",
        "label": "Debt Conversion, Converted Instrument, Rate",
        "terseLabel": "Conversion price"
       }
      }
     },
     "localname": "DebtConversionConvertedInstrumentRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ConvertibleAdvanceInvestmentDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1": {
     "auth_ref": [
      "r57",
      "r59"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of warrants issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Debt Conversion, Converted Instrument, Warrants or Options Issued",
        "terseLabel": "Warrants purchase (in Shares)"
       }
      }
     },
     "localname": "DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/LoansNetDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loans, Net [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r97",
      "r221",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r320",
      "r324",
      "r325",
      "r326"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "terseLabel": "LOANS, NET"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/LoansNet"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAnnualPrincipalPayment": {
     "auth_ref": [
      "r7"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the total principal payments made during the annual reporting period.",
        "label": "Debt Instrument, Annual Principal Payment",
        "terseLabel": "Minimum annual payment"
       }
      }
     },
     "localname": "DebtInstrumentAnnualPrincipalPayment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/LoansNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentDecreaseForgiveness": {
     "auth_ref": [
      "r550"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Decrease for amounts of indebtedness forgiven by the holder of the debt instrument.",
        "label": "Debt Instrument, Decrease, Forgiveness",
        "negatedLabel": "PPP Note forgiveness (see also Note 6B)"
       }
      }
     },
     "localname": "DebtInstrumentDecreaseForgiveness",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ScheduleofthereconciliationofthecarryingamountTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r139",
      "r141",
      "r310",
      "r434",
      "r507",
      "r508"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "terseLabel": "Aggregate principal amount",
        "verboseLabel": "Amount raised"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ConvertibleAdvanceInvestmentDetails",
      "http://www.beil.com/role/LoansNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateEffectivePercentage": {
     "auth_ref": [
      "r24",
      "r139",
      "r328",
      "r434"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.",
        "label": "Debt Instrument, Interest Rate, Effective Percentage",
        "terseLabel": "Carrying amount percentage"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateEffectivePercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r24",
      "r311"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Debt instrument percent"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentInterestRateTerms": {
     "auth_ref": [
      "r24"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of the interest rate as being fixed or variable, and, if variable, identification of the index or rate on which the interest rate is based and the number of points or percentage added to that index or rate to set the rate, and other pertinent information, such as frequency of rate resets.",
        "label": "Debt Instrument, Interest Rate Terms",
        "terseLabel": "Second loan and securities agreement, description"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateTerms",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPricePercentage": {
     "auth_ref": [
      "r155"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage price of original principal amount of debt at which debt can be redeemed by the issuer.",
        "label": "Debt Instrument, Redemption Price, Percentage",
        "terseLabel": "New debt instrument percentage",
        "verboseLabel": "Discount percentage"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPricePercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ConvertibleAdvanceInvestmentDetails",
      "http://www.beil.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of principal amount of debt redeemed.",
        "label": "Debt Instrument, Redemption Price, Percentage of Principal Amount Redeemed",
        "terseLabel": "Percentage of payment amount plus VAT",
        "verboseLabel": "Redemption payment percentage"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ConvertibleAdvanceInvestmentDetails",
      "http://www.beil.com/role/LoansNetDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DeferredChargesPolicyTextBlock": {
     "auth_ref": [
      "r192"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for deferral and amortization of significant deferred charges.",
        "label": "Deferred Charges, Policy [Policy Text Block]",
        "terseLabel": "Deferred offering costs"
       }
      }
     },
     "localname": "DeferredChargesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DeferredCosts": {
     "auth_ref": [
      "r144",
      "r158",
      "r540"
     ],
     "calculation": {
      "http://www.beil.com/role/ConsolidatedBalanceSheet": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred cost, excluding capitalized cost related to contract with customer; classified as noncurrent.",
        "label": "Deferred Costs, Noncurrent",
        "terseLabel": "Deferred offering costs"
       }
      }
     },
     "localname": "DeferredCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredRevenue": {
     "auth_ref": [
      "r542"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.",
        "label": "Deferred Revenue",
        "terseLabel": "Deferred revenue (in Dollars)"
       }
      }
     },
     "localname": "DeferredRevenue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredRevenueCurrent": {
     "auth_ref": [
      "r541"
     ],
     "calculation": {
      "http://www.beil.com/role/ConsolidatedBalanceSheet": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.",
        "label": "Deferred Revenue, Current",
        "terseLabel": "Deferred revenues"
       }
      }
     },
     "localname": "DeferredRevenueCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredRevenueRevenueRecognized1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized that was previously reported as deferred or unearned revenue.",
        "label": "Deferred Revenue, Revenue Recognized",
        "terseLabel": "Revenue recognized (in Dollars)"
       }
      }
     },
     "localname": "DeferredRevenueRevenueRecognized1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/SegmentGeographicalInformationAndMajorCustomersDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsCapitalLossCarryforwards": {
     "auth_ref": [
      "r120",
      "r578"
     ],
     "calculation": {
      "http://www.beil.com/role/ScheduleofdeferredincometaxesreflectthenettaxeffectsofnetoperatinglossTable": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible capital loss carryforwards.",
        "label": "Deferred Tax Assets, Capital Loss Carryforwards",
        "terseLabel": "Net operating loss and capital losses carry-forward"
       }
      }
     },
     "localname": "DeferredTaxAssetsCapitalLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ScheduleofdeferredincometaxesreflectthenettaxeffectsofnetoperatinglossTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "auth_ref": [
      "r398"
     ],
     "calculation": {
      "http://www.beil.com/role/ScheduleofdeferredincometaxesreflectthenettaxeffectsofnetoperatinglossTable": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Gross",
        "totalLabel": "Net deferred tax asset before deferred tax liabilities and valuation allowance"
       }
      }
     },
     "localname": "DeferredTaxAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ScheduleofdeferredincometaxesreflectthenettaxeffectsofnetoperatinglossTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment": {
     "auth_ref": [
      "r120",
      "r578"
     ],
     "calculation": {
      "http://www.beil.com/role/ScheduleofdeferredincometaxesreflectthenettaxeffectsofnetoperatinglossTable": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from in-process research and development costs expensed in connection with a business combination.",
        "label": "Deferred Tax Assets, in Process Research and Development",
        "terseLabel": "Research and development credits"
       }
      }
     },
     "localname": "DeferredTaxAssetsInProcessResearchAndDevelopment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ScheduleofdeferredincometaxesreflectthenettaxeffectsofnetoperatinglossTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsLiabilitiesNet": {
     "auth_ref": [
      "r577"
     ],
     "calculation": {
      "http://www.beil.com/role/ScheduleofdeferredincometaxesreflectthenettaxeffectsofnetoperatinglossTable": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.",
        "label": "Deferred Tax Assets, Net",
        "totalLabel": "Net deferred tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ScheduleofdeferredincometaxesreflectthenettaxeffectsofnetoperatinglossTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal": {
     "auth_ref": [
      "r120",
      "r578"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible state and local operating loss carryforwards.",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards, State and Local",
        "terseLabel": "Capital losses carryforward (in Dollars)"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/TaxesonIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities": {
     "auth_ref": [
      "r120",
      "r578"
     ],
     "calculation": {
      "http://www.beil.com/role/ScheduleofdeferredincometaxesreflectthenettaxeffectsofnetoperatinglossTable": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from accrued liabilities.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities",
        "terseLabel": "Vacation accrual"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ScheduleofdeferredincometaxesreflectthenettaxeffectsofnetoperatinglossTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r399"
     ],
     "calculation": {
      "http://www.beil.com/role/ScheduleofdeferredincometaxesreflectthenettaxeffectsofnetoperatinglossTable": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "negatedLabel": "Valuation allowance"
       }
      }
     },
     "localname": "DeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ScheduleofdeferredincometaxesreflectthenettaxeffectsofnetoperatinglossTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepositLiabilitiesAccruedInterest": {
     "auth_ref": [
      "r150"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accrued but unpaid interest on deposit liabilities.",
        "label": "Deposit Liabilities, Accrued Interest",
        "terseLabel": "Accrued interest"
       }
      }
     },
     "localname": "DepositLiabilitiesAccruedInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/OtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r52",
      "r264"
     ],
     "calculation": {
      "http://www.beil.com/role/ConsolidatedCashFlow": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationExpenseOnReclassifiedAssets": {
     "auth_ref": [
      "r85",
      "r86"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the asset that is reclassified back to held and use from held-for-sale, the depreciation expense recognized when the asset is reclassified. This represents the difference between the carrying value at the time the decision to reclassify is made and the carrying amount that the asset would have had if it had never been classified as held for sale (including consideration of depreciation expense).",
        "label": "Depreciation Expense on Reclassified Assets",
        "terseLabel": "Total depreciation expenses"
       }
      }
     },
     "localname": "DepreciationExpenseOnReclassifiedAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/PropertyandEquipmentNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeNet": {
     "auth_ref": [
      "r423"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of the assets less the liabilities of a derivative or group of derivatives.",
        "label": "Derivative, Fair Value, Net",
        "periodEndLabel": "Closing balance",
        "periodStartLabel": "Opening balance"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ScheduleofreconciliationofthefairvalueofderivativewarrantsliabilitiesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeFixedInterestRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fixed interest rate related to the interest rate derivative.",
        "label": "Derivative, Fixed Interest Rate",
        "terseLabel": "Principal amounts interest rate"
       }
      }
     },
     "localname": "DerivativeFixedInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/LoansNetDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative Warrants Liabilities [Abstract]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r133",
      "r418"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.",
        "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]",
        "terseLabel": "DERIVATIVE WARRANTS LIABILITIES"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/DerivativeWarrantsLiabilities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DerivativeLiabilitiesNoncurrent": {
     "auth_ref": [
      "r202"
     ],
     "calculation": {
      "http://www.beil.com/role/ConsolidatedBalanceSheet": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled after one year or the normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Liability, Noncurrent",
        "terseLabel": "Derivative warrants liability"
       }
      }
     },
     "localname": "DerivativeLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLiabilityFairValueOfCollateral": {
     "auth_ref": [
      "r203"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of securities pledged as collateral against derivative liabilities.",
        "label": "Derivative Liability, Fair Value of Collateral",
        "negatedLabel": "Recognition of fair value of derivative warrant liability"
       }
      }
     },
     "localname": "DerivativeLiabilityFairValueOfCollateral",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ScheduleofthereconciliationofthecarryingamountTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativesPolicyTextBlock": {
     "auth_ref": [
      "r128",
      "r129",
      "r130",
      "r131",
      "r132",
      "r227"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities.",
        "label": "Derivatives, Policy [Policy Text Block]",
        "terseLabel": "Derivative Warrants Liability"
       }
      }
     },
     "localname": "DerivativesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ScheduleofrevenuedisaggregatedbyprimarymajorproductlinesandservicesTable"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [
      "r346",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ScheduleofrevenuedisaggregatedbyprimarymajorproductlinesandservicesTable"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r574"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "terseLabel": "Schedule of revenue disaggregated by primary major product lines and services"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/SegmentGeographicalInformationAndMajorCustomersTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r352",
      "r382",
      "r383",
      "r385",
      "r390",
      "r520"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement [Text Block]",
        "terseLabel": "SHARE OPTIONS"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ShareOptions"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Options [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisclosureTextBlockSupplementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Current Assets [Abstract]"
       }
      }
     },
     "localname": "DisclosureTextBlockSupplementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DueToOtherRelatedPartiesClassifiedCurrent": {
     "auth_ref": [
      "r18",
      "r142",
      "r552"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount payable to related parties classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Due to Other Related Parties, Current",
        "terseLabel": "Current liability"
       }
      }
     },
     "localname": "DueToOtherRelatedPartiesClassifiedCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/RelatedPartiesTransactionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DueToRelatedPartiesCurrent": {
     "auth_ref": [
      "r18",
      "r301",
      "r302",
      "r303",
      "r307",
      "r308",
      "r309",
      "r441",
      "r552"
     ],
     "calculation": {
      "http://www.beil.com/role/ConsolidatedBalanceSheet": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of obligations due all related parties. For classified balance sheets, represents the current portion of such liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Due to Related Parties, Current",
        "terseLabel": "Liability from related party, net"
       }
      }
     },
     "localname": "DueToRelatedPartiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DueToRelatedPartiesNoncurrent": {
     "auth_ref": [
      "r25",
      "r301",
      "r302",
      "r303",
      "r307",
      "r308",
      "r309",
      "r441",
      "r552"
     ],
     "calculation": {
      "http://www.beil.com/role/ConsolidatedBalanceSheet": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Portion of the carrying amount as of the balance sheet date of obligations due all related parties that is payable after one year or beyond the normal operating cycle if longer.",
        "label": "Due to Related Parties, Noncurrent",
        "terseLabel": "Liability from related party, net"
       }
      }
     },
     "localname": "DueToRelatedPartiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r214",
      "r234",
      "r235",
      "r236",
      "r237",
      "r238",
      "r243",
      "r245",
      "r248",
      "r249",
      "r250",
      "r251",
      "r421",
      "r422",
      "r466",
      "r470",
      "r504"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Basic and diluted net loss per share (in Dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r214",
      "r234",
      "r235",
      "r236",
      "r237",
      "r238",
      "r245",
      "r248",
      "r249",
      "r250",
      "r251",
      "r421",
      "r422",
      "r466",
      "r470",
      "r504"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Basic and diluted net loss per share (in Dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ConsolidatedIncomeStatement_Parentheticals"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "auth_ref": [
      "r62",
      "r63"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "terseLabel": "Basic and diluted net loss per ordinary share"
       }
      }
     },
     "localname": "EarningsPerSharePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r225",
      "r394",
      "r408"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).",
        "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent",
        "terseLabel": "Federal tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/TaxesonIncomeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r576",
      "r579"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.",
        "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent",
        "terseLabel": "Effective tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/TaxesonIncomeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense": {
     "auth_ref": [
      "r576",
      "r579"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to noncontrolling interest income (loss) exempt from income taxes.",
        "label": "Effective Income Tax Rate Reconciliation, Noncontrolling Interest Income (Loss), Percent",
        "terseLabel": "Total revenue rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/SegmentGeographicalInformationAndMajorCustomersDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings": {
     "auth_ref": [
      "r576",
      "r579"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to the repatriation of foreign earnings.",
        "label": "Effective Income Tax Rate Reconciliation, Repatriation of Foreign Earnings, Percent",
        "terseLabel": "Corporate tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/TaxesonIncomeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r22"
     ],
     "calculation": {
      "http://www.beil.com/role/ScheduleofothercurrentliabiltiesTable": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employee-related Liabilities, Current",
        "terseLabel": "Employees and payroll accruals"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ScheduleofothercurrentliabiltiesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r99",
      "r184",
      "r209",
      "r210",
      "r211",
      "r229",
      "r230",
      "r231",
      "r233",
      "r239",
      "r241",
      "r252",
      "r287",
      "r345",
      "r386",
      "r387",
      "r388",
      "r403",
      "r404",
      "r420",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r437",
      "r473",
      "r474",
      "r475"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ConsolidatedBalanceSheet_Parentheticals",
      "http://www.beil.com/role/GeneralDetails",
      "http://www.beil.com/role/LoansNetDetails",
      "http://www.beil.com/role/ShareholdersEquityType2or3",
      "http://www.beil.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestmentAggregateCost": {
     "auth_ref": [
      "r17"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the aggregate cost of investments accounted for under the equity method of accounting.",
        "label": "Equity Method Investment, Aggregate Cost",
        "terseLabel": "Aggregate cost",
        "verboseLabel": "Aggregate investment"
       }
      }
     },
     "localname": "EquityMethodInvestmentAggregateCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ConvertibleAdvanceInvestmentDetails",
      "http://www.beil.com/role/LoansNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityMethodInvestmentOwnershipPercentage": {
     "auth_ref": [
      "r73"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.",
        "label": "Equity Method Investment, Ownership Percentage",
        "terseLabel": "Investment percentage"
       }
      }
     },
     "localname": "EquityMethodInvestmentOwnershipPercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ExcessStockSharesAuthorized": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum number of excess stock shares permitted to be issued.",
        "label": "Excess Stock, Shares Authorized",
        "terseLabel": "Authorized shares",
        "verboseLabel": "Shares authorized (in Shares)"
       }
      }
     },
     "localname": "ExcessStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ScheduleofcompositionofshareholdersequityTable",
      "http://www.beil.com/role/ShareholdersEquityDeficitDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ExcessStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of excess stock held by shareholders.",
        "label": "Excess Stock, Shares Outstanding",
        "terseLabel": "Weighted average number of ordinary shares related to outstanding (in Shares)"
       }
      }
     },
     "localname": "ExcessStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ExtinguishmentOfDebtAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross amount of debt extinguished.",
        "label": "Extinguishment of Debt, Amount",
        "negatedLabel": "Derecognition due to extinguishment of original straight loan"
       }
      }
     },
     "localname": "ExtinguishmentOfDebtAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ScheduleofthereconciliationofthecarryingamountTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueAdjustmentOfWarrants": {
     "auth_ref": [
      "r52",
      "r98"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense (income) related to adjustment to fair value of warrant liability.",
        "label": "Fair Value Adjustment of Warrants",
        "terseLabel": "Warrant value"
       }
      }
     },
     "localname": "FairValueAdjustmentOfWarrants",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/LoansNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.",
        "label": "Fair Value Measurement, Policy [Policy Text Block]",
        "terseLabel": "Fair Value Measurements"
       }
      }
     },
     "localname": "FairValueMeasurementPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transfers of financial instrument classified as a liability into (out of) level 3 of the fair value hierarchy.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Transfers, Net",
        "terseLabel": "Recognition of fair value of 2021 Warrant issued upon substantial modification of terms (see Note 6A1)"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ScheduleofreconciliationofthefairvalueofderivativewarrantsliabilitiesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueOptionChangesInFairValueGainLoss1": {
     "auth_ref": [
      "r134"
     ],
     "calculation": {
      "http://www.beil.com/role/ConsolidatedCashFlow": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For each line item in the statement of financial position, the amounts of gains and losses from fair value changes included in earnings.",
        "label": "Fair Value, Option, Changes in Fair Value, Gain (Loss)",
        "negatedLabel": "Change in the fair value of convertible advanced investments (Note 9)"
       }
      }
     },
     "localname": "FairValueOptionChangesInFairValueGainLoss1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinancingInterestExpense": {
     "auth_ref": [
      "r35"
     ],
     "calculation": {
      "http://www.beil.com/role/ConsolidatedIncomeStatement": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents interest incurred for borrowed money which was used to produce goods or render services.",
        "label": "Financing Interest Expense",
        "negatedLabel": "Financing expenses, net"
       }
      }
     },
     "localname": "FinancingInterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths": {
     "auth_ref": [],
     "calculation": {
      "http://www.beil.com/role/ScheduleoftheestimatedfutureamortizationexpenseofintangibleassetsTable": {
       "order": 1.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized in the next rolling twelve months following the latest balance sheet. For interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Finite-Lived Intangible Assets, Amortization Expense, Next Rolling 12 Months",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ScheduleoftheestimatedfutureamortizationexpenseofintangibleassetsTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo": {
     "auth_ref": [],
     "calculation": {
      "http://www.beil.com/role/ScheduleoftheestimatedfutureamortizationexpenseofintangibleassetsTable": {
       "order": 2.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized in the second rolling twelve months following the latest balance sheet. For interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Finite-Lived Intangible Assets, Amortization Expense, Rolling Year Two",
        "terseLabel": "2024-2026"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ScheduleoftheestimatedfutureamortizationexpenseofintangibleassetsTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r289",
      "r290",
      "r291",
      "r292",
      "r450",
      "r451"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ScheduleofintangibleassetsnetandgoodwilTable"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Finite-Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ScheduleofcomputingstraightlineamortizationTable"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r77",
      "r80"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ScheduleofintangibleassetsnetandgoodwilTable"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "auth_ref": [
      "r81",
      "r450"
     ],
     "calculation": {
      "http://www.beil.com/role/ScheduleoftheestimatedfutureamortizationexpenseofintangibleassetsTable": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Net",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ScheduleoftheestimatedfutureamortizationexpenseofintangibleassetsTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": {
     "auth_ref": [
      "r432"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.",
        "label": "Foreign Currency Transactions and Translations Policy [Policy Text Block]",
        "terseLabel": "Functional currency"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GainLossOnDispositionOfAssets": {
     "auth_ref": [
      "r548",
      "r566",
      "r567"
     ],
     "calculation": {
      "http://www.beil.com/role/ConsolidatedCashFlow": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, excluding oil and gas property and timber property.",
        "label": "Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property",
        "negatedLabel": "Capital loss from disposal of property and equipment"
       }
      }
     },
     "localname": "GainLossOnDispositionOfAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnSaleOfPropertyPlantEquipment": {
     "auth_ref": [
      "r52"
     ],
     "calculation": {
      "http://www.beil.com/role/ConsolidatedCashFlow": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.",
        "label": "Gain (Loss) on Disposition of Property Plant Equipment",
        "negatedLabel": "Capital gain from selling of property and equipment"
       }
      }
     },
     "localname": "GainLossOnSaleOfPropertyPlantEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainsLossesOnExtinguishmentOfDebt": {
     "auth_ref": [
      "r52",
      "r94",
      "r95"
     ],
     "calculation": {
      "http://www.beil.com/role/ConsolidatedCashFlow": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.",
        "label": "Gain (Loss) on Extinguishment of Debt",
        "negatedLabel": "Exchange rate differences on straight loan received from commercial bank (Note 6)"
       }
      }
     },
     "localname": "GainsLossesOnExtinguishmentOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainsLossesOnRestructuringOfDebt": {
     "auth_ref": [
      "r96"
     ],
     "calculation": {
      "http://www.beil.com/role/ConsolidatedCashFlow": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For a debtor, the aggregate gain (loss) recognized on the restructuring of payables arises from the difference between the book value of the debt before the restructuring and the fair value of the payments on the debt after restructuring is complete.",
        "label": "Gains (Losses) on Restructuring of Debt",
        "negatedLabel": "Forgiveness of loan under paycheck protection program notes (Note 6B)"
       }
      }
     },
     "localname": "GainsLossesOnRestructuringOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r36"
     ],
     "calculation": {
      "http://www.beil.com/role/ConsolidatedIncomeStatement": {
       "order": 5.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
        "label": "General and Administrative Expense",
        "negatedLabel": "General and administrative expenses"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r191",
      "r288",
      "r464",
      "r506",
      "r523",
      "r564",
      "r565"
     ],
     "calculation": {
      "http://www.beil.com/role/ConsolidatedBalanceSheet": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Intangible Assets, Net and Goodwill [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r84"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets Disclosure [Text Block]",
        "terseLabel": "INTANGIBLE ASSETS, NET AND GOODWILL"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/IntangibleAssetsNetandGoodwill"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock": {
     "auth_ref": [
      "r74",
      "r78"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets, Policy [Policy Text Block]",
        "terseLabel": "Goodwill and Intangible Assets"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r34",
      "r223",
      "r266",
      "r269",
      "r274",
      "r277",
      "r286",
      "r299",
      "r300",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r308",
      "r309",
      "r424",
      "r505",
      "r570"
     ],
     "calculation": {
      "http://www.beil.com/role/ConsolidatedIncomeStatement": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross Profit",
        "totalLabel": "Gross profit"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IPOMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "First sale of stock by a private company to the public.",
        "label": "IPO [Member]",
        "terseLabel": "IPO [Member]"
       }
      }
     },
     "localname": "IPOMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ConvertibleAdvanceInvestmentDetails",
      "http://www.beil.com/role/GeneralDetails",
      "http://www.beil.com/role/LoansNetDetails",
      "http://www.beil.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic": {
     "auth_ref": [
      "r224",
      "r407"
     ],
     "calculation": {
      "http://www.beil.com/role/ScheduleoflossincomebeforetaxesonincomeTable": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Domestic",
        "terseLabel": "Domestic"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ScheduleoflossincomebeforetaxesonincomeTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r30",
      "r143",
      "r152",
      "r171",
      "r266",
      "r269",
      "r274",
      "r277",
      "r467",
      "r505"
     ],
     "calculation": {
      "http://www.beil.com/role/ConsolidatedIncomeStatement": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "totalLabel": "Loss before taxes on income"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign": {
     "auth_ref": [
      "r224",
      "r407"
     ],
     "calculation": {
      "http://www.beil.com/role/ScheduleoflossincomebeforetaxesonincomeTable": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Foreign",
        "terseLabel": "Foreign operations (Beamr Inc and Imaging RU)"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ScheduleoflossincomebeforetaxesonincomeTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r124",
      "r223",
      "r232",
      "r266",
      "r269",
      "r274",
      "r277",
      "r286",
      "r299",
      "r300",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r308",
      "r309",
      "r422",
      "r424",
      "r505",
      "r570"
     ],
     "calculation": {
      "http://www.beil.com/role/ScheduleoflossincomebeforetaxesonincomeTable": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ScheduleoflossincomebeforetaxesonincomeTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Taxes on Income [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r225",
      "r395",
      "r396",
      "r401",
      "r405",
      "r409",
      "r411",
      "r412",
      "r413"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "TAXES ON INCOME"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/TaxesonIncome"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r226",
      "r240",
      "r241",
      "r265",
      "r393",
      "r406",
      "r410",
      "r471"
     ],
     "calculation": {
      "http://www.beil.com/role/ConsolidatedIncomeStatement": {
       "order": 3.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "negatedLabel": "Taxes on income"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "auth_ref": [
      "r208",
      "r391",
      "r392",
      "r396",
      "r397",
      "r400",
      "r402"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
        "label": "Income Tax, Policy [Policy Text Block]",
        "terseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "IncomeTaxPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential": {
     "auth_ref": [
      "r576"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit).",
        "label": "Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount",
        "negatedLabel": "Exchange rate differences"
       }
      }
     },
     "localname": "IncomeTaxReconciliationForeignIncomeTaxRateDifferential",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ScheduleofthereconciliationofthecarryingamountTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesPaid": {
     "auth_ref": [
      "r48",
      "r56"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.",
        "label": "Income Taxes Paid",
        "negatedLabel": "Taxes paid"
       }
      }
     },
     "localname": "IncomeTaxesPaid",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r51"
     ],
     "calculation": {
      "http://www.beil.com/role/ConsolidatedCashFlow": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase (Decrease) in Accounts Payable",
        "terseLabel": "Increase (decrease) in account payables"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInDeferredRevenue": {
     "auth_ref": [
      "r500"
     ],
     "calculation": {
      "http://www.beil.com/role/ConsolidatedCashFlow": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.",
        "label": "Increase (Decrease) in Deferred Revenue",
        "terseLabel": "Increase (decrease) in deferred revenues"
       }
      }
     },
     "localname": "IncreaseDecreaseInDeferredRevenue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInDueFromRelatedParties": {
     "auth_ref": [
      "r51"
     ],
     "calculation": {
      "http://www.beil.com/role/ConsolidatedCashFlow": {
       "order": 17.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in receivables to be collected from other entities that could exert significant influence over the reporting entity.",
        "label": "Increase (Decrease) in Due from Related Parties",
        "negatedLabel": "Increase in liability from related party"
       }
      }
     },
     "localname": "IncreaseDecreaseInDueFromRelatedParties",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInDueToOtherRelatedParties": {
     "auth_ref": [
      "r51"
     ],
     "calculation": {
      "http://www.beil.com/role/ScheduleofexpensesrelatedtoserviceagreementandtheofficeservicesagreementTable": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in related party payables classified as other.",
        "label": "Increase (Decrease) in Due to Other Related Parties",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "IncreaseDecreaseInDueToOtherRelatedParties",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ScheduleofexpensesrelatedtoserviceagreementandtheofficeservicesagreementTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherCurrentAssets": {
     "auth_ref": [
      "r547"
     ],
     "calculation": {
      "http://www.beil.com/role/ConsolidatedCashFlow": {
       "order": 16.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in current assets classified as other.",
        "label": "Increase (Decrease) in Other Current Assets",
        "negatedLabel": "Decrease (increase) in other current assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherCurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherCurrentLiabilities": {
     "auth_ref": [
      "r547"
     ],
     "calculation": {
      "http://www.beil.com/role/ConsolidatedCashFlow": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in current liabilities classified as other.",
        "label": "Increase (Decrease) in Other Current Liabilities",
        "terseLabel": "Increase (decrease) in other current liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherCurrentLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherReceivables": {
     "auth_ref": [
      "r51"
     ],
     "calculation": {
      "http://www.beil.com/role/ConsolidatedCashFlow": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in receivables classified as other.",
        "label": "Increase (Decrease) in Other Receivables",
        "negatedLabel": "Decrease (increase) in trade receivables"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherReceivables",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r75",
      "r79"
     ],
     "calculation": {
      "http://www.beil.com/role/ConsolidatedBalanceSheet": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "terseLabel": "Intangible assets, net"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestAndFeeIncomeOtherLoans": {
     "auth_ref": [
      "r154"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest and fee income from loans classified as other.",
        "label": "Interest and Fee Income, Other Loans",
        "terseLabel": "Non-refundable one-time fee"
       }
      }
     },
     "localname": "InterestAndFeeIncomeOtherLoans",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/LoansNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r216",
      "r218",
      "r219"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "negatedLabel": "Interest paid"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of data and information required in the supplementary schedule applicable to management investment companies listing holdings of unaffiliated investments.",
        "label": "Investment Holdings, Schedule of Investments [Table Text Block]",
        "terseLabel": "Schedule of reconciliation of the carrying amount of the convertible advance investment"
       }
      }
     },
     "localname": "InvestmentHoldingsScheduleOfInvestmentsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ConvertibleAdvanceInvestmentTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InvestmentHoldingsTextBlock": {
     "auth_ref": [
      "r178",
      "r179",
      "r180",
      "r479",
      "r480"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for investment holdings. This includes the long positions of investments for the entity. It contains investments in affiliated and unaffiliated issuers. The investments include securities and non securities (i.e. commodities and futures contracts).",
        "label": "Investment Holdings [Text Block]",
        "terseLabel": "CONVERTIBLE ADVANCE INVESTMENT"
       }
      }
     },
     "localname": "InvestmentHoldingsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ConvertibleAdvanceInvestment"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InvestmentIncomeAmortizationOfDiscount": {
     "auth_ref": [
      "r38"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accretion of purchase discount on nonoperating securities.",
        "label": "Investment Income, Amortization of Discount",
        "terseLabel": "Amortization of discount relating to liability to related party"
       }
      }
     },
     "localname": "InvestmentIncomeAmortizationOfDiscount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ScheduleofthereconciliationofthecarryingamountoftheCompanyTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentInterestRate": {
     "auth_ref": [
      "r560",
      "r561"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rate of interest on investment.",
        "label": "Investment Interest Rate",
        "terseLabel": "Interest rate"
       }
      }
     },
     "localname": "InvestmentInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/LoansNetDetails",
      "http://www.beil.com/role/RelatedPartiesTransactionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_InvestmentOwnedBalancePrincipalAmount": {
     "auth_ref": [
      "r175",
      "r478"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For investments which are quantified by principal amount, the principle balance held at close of period.",
        "label": "Investment Owned, Balance, Principal Amount",
        "terseLabel": "Remaining balance principal due"
       }
      }
     },
     "localname": "InvestmentOwnedBalancePrincipalAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/LoansNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentRelatedLiabilities": {
     "auth_ref": [
      "r169"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of liabilities as of the balance sheet date for obligations incurred in connection with the entity's investments.",
        "label": "Investment-related Liabilities",
        "periodEndLabel": "Closing balance",
        "periodStartLabel": "Opening balance"
       }
      }
     },
     "localname": "InvestmentRelatedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ScheduleofthereconciliationofthecarryingamountoftheCompanyTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments.",
        "label": "Investments Classified by Contractual Maturity Date [Table Text Block]",
        "terseLabel": "Schedule of maturity dates"
       }
      }
     },
     "localname": "InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/RelatedPartiesTransactionsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeaseCost": {
     "auth_ref": [
      "r436",
      "r522"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lease cost recognized by lessee for lease contract.",
        "label": "Lease, Cost",
        "terseLabel": "Lease expenses"
       }
      }
     },
     "localname": "LeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeFinanceLeaseDiscountRate": {
     "auth_ref": [
      "r583"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discount rate used by lessee to determine present value of finance lease payments.",
        "label": "Lessee, Finance Lease, Discount Rate",
        "terseLabel": "Financing, less rate"
       }
      }
     },
     "localname": "LesseeFinanceLeaseDiscountRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/LoansNetDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LesseeLeasesPolicyTextBlock": {
     "auth_ref": [
      "r435"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee.",
        "label": "Lessee, Leases [Policy Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeLeasesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseDiscountRate": {
     "auth_ref": [
      "r521"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discount rate used by lessee to determine present value of operating lease payments.",
        "label": "Lessee, Operating Lease, Discount Rate",
        "terseLabel": "Discount rate"
       }
      }
     },
     "localname": "LesseeOperatingLeaseDiscountRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/IntangibleAssetsNetandGoodwillDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r584"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.",
        "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]",
        "terseLabel": "Schedule of the estimated future amortization expense of intangible assets"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/IntangibleAssetsNetandGoodwillTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r16",
      "r148",
      "r163",
      "r523",
      "r551",
      "r562",
      "r582"
     ],
     "calculation": {
      "http://www.beil.com/role/ConsolidatedBalanceSheet": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and shareholders\u2019 equity (deficit)"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r23",
      "r187",
      "r223",
      "r286",
      "r299",
      "r300",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r308",
      "r309",
      "r415",
      "r416",
      "r417",
      "r424",
      "r523",
      "r570",
      "r588",
      "r589"
     ],
     "calculation": {
      "http://www.beil.com/role/ConsolidatedBalanceSheet": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesNoncurrent": {
     "auth_ref": [
      "r1",
      "r2",
      "r3",
      "r7",
      "r8",
      "r223",
      "r286",
      "r299",
      "r300",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r308",
      "r309",
      "r415",
      "r416",
      "r417",
      "r424",
      "r570",
      "r588",
      "r589"
     ],
     "calculation": {
      "http://www.beil.com/role/ConsolidatedBalanceSheet": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation due after one year or beyond the normal operating cycle, if longer.",
        "label": "Liabilities, Noncurrent",
        "totalLabel": "Total non-current liabilities"
       }
      }
     },
     "localname": "LiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityCollateralFeesAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the fees associated with providing collateral for the credit facility.",
        "label": "Line of Credit Facility, Collateral Fees, Amount",
        "terseLabel": "Represent value"
       }
      }
     },
     "localname": "LineOfCreditFacilityCollateralFeesAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/LoansNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityCommitmentFeeAmount": {
     "auth_ref": [
      "r19"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the fee for available but unused credit capacity under the credit facility.",
        "label": "Line of Credit Facility, Commitment Fee Amount",
        "terseLabel": "Line of Credit Facility, Commitment Fee Amount"
       }
      }
     },
     "localname": "LineOfCreditFacilityCommitmentFeeAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/LoansNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding": {
     "auth_ref": [
      "r423"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of the amount outstanding under the credit facility.",
        "label": "Line of Credit Facility, Fair Value of Amount Outstanding",
        "terseLabel": "Line of Credit Facility, Fair Value of Amount Outstanding"
       }
      }
     },
     "localname": "LineOfCreditFacilityFairValueOfAmountOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/LoansNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LoanProcessingFee": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expenses paid for obtaining loans which includes expenses such as application and origination fees.",
        "label": "Loan Processing Fee",
        "negatedLabel": "Repayment of Facility Fee relating to straight loan"
       }
      }
     },
     "localname": "LoanProcessingFee",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ScheduleofthereconciliationofthecarryingamountTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LoansHeldForSaleTerm": {
     "auth_ref": [
      "r581"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period between issuance and maturity of loan held for sale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Loans Held-for-sale, Term",
        "terseLabel": "Issuance term"
       }
      }
     },
     "localname": "LoansHeldForSaleTerm",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/LoansNetDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LoansReceivableBasisSpreadOnVariableRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage added to reference rate used to compute variable rate on loan receivable.",
        "label": "Loans Receivable, Basis Spread on Variable Rate",
        "terseLabel": "Interest rate"
       }
      }
     },
     "localname": "LoansReceivableBasisSpreadOnVariableRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/LoansNetDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LongDurationContractsAssumptionsByProductAndGuaranteeDiscountRate": {
     "auth_ref": [
      "r156",
      "r173",
      "r174"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage discount rate used to calculate present value of an expected stream of future payments, which is included in the calculation of the amount of the specified guaranteed benefit obligation as of the balance sheet date.",
        "label": "Long-Duration Contracts, Assumptions by Product and Guarantee, Discount Rate",
        "terseLabel": "Long-term growth rate"
       }
      }
     },
     "localname": "LongDurationContractsAssumptionsByProductAndGuaranteeDiscountRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/IntangibleAssetsNetandGoodwillDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock": {
     "auth_ref": [
      "r71"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of long-lived assets, excluding financial instruments, long-term customer relationships of a financial institution, mortgage rights, deferred policy acquisition costs, and deferred tax assets, by geographic areas located in the entity's country of domicile and foreign countries in which the entity holds assets.",
        "label": "Long-Lived Assets by Geographic Areas [Table Text Block]",
        "terseLabel": "Schedule of Long-lived assets net by geographic areas"
       }
      }
     },
     "localname": "LongLivedAssetsByGeographicAreasTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/SegmentGeographicalInformationAndMajorCustomersTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r7",
      "r147",
      "r161",
      "r319",
      "r327",
      "r507",
      "r508"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.",
        "label": "Long-Term Debt",
        "terseLabel": "Closing balance"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ScheduleofmaturitydatesofoutstandingloansTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtCurrent": {
     "auth_ref": [
      "r21"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-Term Debt, Current Maturities",
        "terseLabel": "First year (current maturities)"
       }
      }
     },
     "localname": "LongTermDebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ScheduleofmaturitydatesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": {
     "auth_ref": [
      "r93",
      "r228",
      "r322"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year One",
        "terseLabel": "First year (current maturities)"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ScheduleofmaturitydatesofoutstandingloansTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": {
     "auth_ref": [
      "r93",
      "r228",
      "r322"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Three",
        "terseLabel": "Third year"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ScheduleofmaturitydatesofoutstandingloansTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": {
     "auth_ref": [
      "r93",
      "r228",
      "r322"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Two",
        "terseLabel": "Second year"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ScheduleofmaturitydatesofoutstandingloansTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "auth_ref": [
      "r194"
     ],
     "calculation": {
      "http://www.beil.com/role/ConsolidatedBalanceSheet": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.",
        "label": "Long-Term Debt, Excluding Current Maturities",
        "terseLabel": "Loans, net of current maturities"
       }
      }
     },
     "localname": "LongTermDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MarketingAndAdvertisingExpense": {
     "auth_ref": [
      "r36"
     ],
     "calculation": {
      "http://www.beil.com/role/ScheduleofexpensesrelatedtoserviceagreementandtheofficeservicesagreementTable": {
       "order": 2.0,
       "parentTag": "us-gaap_IncreaseDecreaseInDueToOtherRelatedParties",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total expense recognized in the period for promotion, public relations, and brand or product advertising.",
        "label": "Marketing and Advertising Expense",
        "terseLabel": "Sales and marketing"
       }
      }
     },
     "localname": "MarketingAndAdvertisingExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ScheduleofexpensesrelatedtoserviceagreementandtheofficeservicesagreementTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetAmountAtRiskByProductAndGuaranteeWeightedAveragePeriodRemaining1": {
     "auth_ref": [
      "r157"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average period until annuitization or benefit payment is expected to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Net Amount at Risk by Product and Guarantee, Weighted Average Period Remaining",
        "terseLabel": "Weighted average period"
       }
      }
     },
     "localname": "NetAmountAtRiskByProductAndGuaranteeWeightedAveragePeriodRemaining1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ShareOptionsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r217"
     ],
     "calculation": {
      "http://www.beil.com/role/ConsolidatedCashFlow": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash provided by (used in) financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r217"
     ],
     "calculation": {
      "http://www.beil.com/role/ConsolidatedCashFlow": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash provided by (used in) investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r46",
      "r50",
      "r53"
     ],
     "calculation": {
      "http://www.beil.com/role/ConsolidatedCashFlow": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by (used in) operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r31",
      "r53",
      "r153",
      "r170",
      "r185",
      "r204",
      "r206",
      "r211",
      "r223",
      "r232",
      "r234",
      "r235",
      "r236",
      "r237",
      "r240",
      "r241",
      "r247",
      "r266",
      "r269",
      "r274",
      "r277",
      "r286",
      "r299",
      "r300",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r308",
      "r309",
      "r422",
      "r424",
      "r505",
      "r570"
     ],
     "calculation": {
      "http://www.beil.com/role/ConsolidatedCashFlow": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net loss for the year",
        "verboseLabel": "Net loss"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ConsolidatedCashFlow",
      "http://www.beil.com/role/GeneralDetails",
      "http://www.beil.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1": {
     "auth_ref": [
      "r57",
      "r58",
      "r59"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash consideration received for selling an asset or business through a noncash (or part noncash) transaction.",
        "label": "Noncash or Part Noncash Divestiture, Amount of Consideration Received",
        "terseLabel": "Net consideration received"
       }
      }
     },
     "localname": "NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ScheduleofreconciliationofthecarryingamountoftheconvertibleadvanceinvestmentTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NoncurrentAssets": {
     "auth_ref": [
      "r281"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets.",
        "label": "Long-Lived Assets",
        "terseLabel": "Long-lived assets, net"
       }
      }
     },
     "localname": "NoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ScheduleofLonglivedassetsnetbygeographicareasTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NumberOfOperatingSegments": {
     "auth_ref": [
      "r558"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.",
        "label": "Number of Operating Segments",
        "terseLabel": "Number of operating segments (in Segment)"
       }
      }
     },
     "localname": "NumberOfOperatingSegments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/SegmentGeographicalInformationAndMajorCustomersDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OfficeEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tangible personal property used in an office setting. Examples include, but are not limited to, computers, copiers and fax machine.",
        "label": "Office Equipment [Member]",
        "terseLabel": "Office furniture and equipment [Member]"
       }
      }
     },
     "localname": "OfficeEquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ScheduleofpropertyandequipmentnetTable"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r266",
      "r269",
      "r274",
      "r277",
      "r505"
     ],
     "calculation": {
      "http://www.beil.com/role/ConsolidatedIncomeStatement": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Operating loss"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": {
     "auth_ref": [
      "r0",
      "r127"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.",
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]",
        "terseLabel": "GENERAL"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/General"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesCurrentAndNoncurrent": {
     "auth_ref": [
      "r150",
      "r168"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other.",
        "label": "Other Accrued Liabilities",
        "terseLabel": "Accrued liability in respect to additional services rendered"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ScheduleofthereconciliationofthecarryingamountoftheCompanyTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsCurrent": {
     "auth_ref": [
      "r200",
      "r523"
     ],
     "calculation": {
      "http://www.beil.com/role/ConsolidatedBalanceSheet": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.beil.com/role/ScheduleofothercurrentassetsTable": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current assets classified as other.",
        "label": "Other Assets, Current",
        "terseLabel": "Other current assets",
        "totalLabel": "Total other current assets"
       }
      }
     },
     "localname": "OtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ConsolidatedBalanceSheet",
      "http://www.beil.com/role/ScheduleofothercurrentassetsTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCommitmentDueInSecondYear": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of commitment classified as other to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Other Commitment, to be Paid, Year Two",
        "terseLabel": "Second year"
       }
      }
     },
     "localname": "OtherCommitmentDueInSecondYear",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ScheduleofmaturitydatesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCurrentAssetsTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for other current assets.",
        "label": "Other Current Assets [Text Block]",
        "terseLabel": "OTHER CURRENT ASSETS"
       }
      }
     },
     "localname": "OtherCurrentAssetsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/OtherCurrentAssets"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherCurrentLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of other current liabilities.",
        "label": "Other Current Liabilities [Table Text Block]",
        "terseLabel": "Schedule of other current liabilties"
       }
      }
     },
     "localname": "OtherCurrentLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/OtherCurrentLiabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r36"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of general and administrative expense classified as other.",
        "label": "Other General and Administrative Expense",
        "terseLabel": "General and administrative"
       }
      }
     },
     "localname": "OtherGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ScheduleofcompanysequitybasedawardsrecognizedTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherIncome": {
     "auth_ref": [
      "r172"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue and income classified as other.",
        "label": "Other Income",
        "terseLabel": "Other income"
       }
      }
     },
     "localname": "OtherIncome",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/LoansNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherIntangibleAssetsNet": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated amortization of finite-lived and indefinite-lived intangible assets classified as other.",
        "label": "Other Intangible Assets, Net",
        "terseLabel": "Intangible assets, net"
       }
      }
     },
     "localname": "OtherIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ScheduleofintangibleassetsnetandgoodwilTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesCurrent": {
     "auth_ref": [
      "r22",
      "r523"
     ],
     "calculation": {
      "http://www.beil.com/role/ConsolidatedBalanceSheet": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://www.beil.com/role/ScheduleofothercurrentliabiltiesTable": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Current",
        "terseLabel": "Other current liabilities",
        "totalLabel": "Total other current liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ConsolidatedBalanceSheet",
      "http://www.beil.com/role/ScheduleofothercurrentliabiltiesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Current Liabilities [Abstract]"
       }
      }
     },
     "localname": "OtherLiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherLongTermDebtCurrent": {
     "auth_ref": [
      "r5",
      "r6"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt classified as other, payable within one year or the operating cycle, if longer.",
        "label": "Other Long-Term Debt, Current",
        "terseLabel": "Closing balance"
       }
      }
     },
     "localname": "OtherLongTermDebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ScheduleofmaturitydatesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingExpense": {
     "auth_ref": [
      "r39"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Expense",
        "terseLabel": "Total"
       }
      }
     },
     "localname": "OtherNonoperatingExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ScheduleoffinancingexpensesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingGainsLosses": {
     "auth_ref": [
      "r37"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Gains (Losses)",
        "terseLabel": "Net operating losses (in Dollars)"
       }
      }
     },
     "localname": "OtherNonoperatingGainsLosses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/TaxesonIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherOperatingIncomeExpenseNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.beil.com/role/ConsolidatedIncomeStatement": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net amount of other operating income and expenses, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operations.",
        "label": "Other Operating Income (Expense), Net",
        "terseLabel": "Other income"
       }
      }
     },
     "localname": "OtherOperatingIncomeExpenseNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherPrepaidExpenseCurrent": {
     "auth_ref": [
      "r545",
      "r563"
     ],
     "calculation": {
      "http://www.beil.com/role/ScheduleofothercurrentassetsTable": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for other costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.",
        "label": "Other Prepaid Expense, Current",
        "terseLabel": "Others"
       }
      }
     },
     "localname": "OtherPrepaidExpenseCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ScheduleofothercurrentassetsTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherReceivables": {
     "auth_ref": [
      "r198"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount due from parties in nontrade transactions, classified as other.",
        "label": "Other Receivables",
        "terseLabel": "Receivable amount (in Dollars)"
       }
      }
     },
     "localname": "OtherReceivables",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r118"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other research and development expense.",
        "label": "Other Research and Development Expense",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "OtherResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ScheduleofcompanysequitybasedawardsrecognizedTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherSellingAndMarketingExpense": {
     "auth_ref": [
      "r36"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of selling and marketing expense classified as other.",
        "label": "Other Selling and Marketing Expense",
        "terseLabel": "Sales and marketing"
       }
      }
     },
     "localname": "OtherSellingAndMarketingExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ScheduleofcompanysequitybasedawardsrecognizedTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherSellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r36"
     ],
     "calculation": {
      "http://www.beil.com/role/ScheduleofexpensesrelatedtoserviceagreementandtheofficeservicesagreementTable": {
       "order": 3.0,
       "parentTag": "us-gaap_IncreaseDecreaseInDueToOtherRelatedParties",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of selling, general and administrative expense classified as other.",
        "label": "Other Selling, General and Administrative Expense",
        "terseLabel": "General and administrative"
       }
      }
     },
     "localname": "OtherSellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ScheduleofexpensesrelatedtoserviceagreementandtheofficeservicesagreementTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PartnersCapitalAccountContributions": {
     "auth_ref": [
      "r102",
      "r103"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total contributions made by each class of partners (i.e., general, limited and preferred partners).",
        "label": "Partners' Capital Account, Contributions",
        "negatedLabel": "Recognition of capital contribution from a controlling shareholder"
       }
      }
     },
     "localname": "PartnersCapitalAccountContributions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ScheduleofthereconciliationofthecarryingamountoftheCompanyTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForFees": {
     "auth_ref": [
      "r49"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for fees classified as other.",
        "label": "Payments for Other Fees",
        "terseLabel": "Monthly fee"
       }
      }
     },
     "localname": "PaymentsForFees",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRent": {
     "auth_ref": [
      "r49"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash payments to lessor's for use of assets under operating leases.",
        "label": "Payments for Rent",
        "terseLabel": "Rental fee"
       }
      }
     },
     "localname": "PaymentsForRent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForSoftware": {
     "auth_ref": [
      "r41"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the development, modification or acquisition of software programs or applications for internal use (that is, not to be sold, leased or otherwise marketed to others) that qualify for capitalization.",
        "label": "Payments for Software",
        "terseLabel": "Software license - transferred at a point of time"
       }
      }
     },
     "localname": "PaymentsForSoftware",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ScheduleofrevenuedisaggregatedbyprimarymajorproductlinesandservicesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfFinancingCosts": {
     "auth_ref": [
      "r45"
     ],
     "calculation": {
      "http://www.beil.com/role/ConsolidatedCashFlow": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for loan and debt issuance costs.",
        "label": "Payments of Financing Costs",
        "negatedLabel": "Deferred offering costs (Note 2F)"
       }
      }
     },
     "localname": "PaymentsOfFinancingCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfLoanCosts": {
     "auth_ref": [
      "r45"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for loan origination associated cost which is usually collected through escrow.",
        "label": "Payments of Loan Costs",
        "terseLabel": "Payments of Loan Costs"
       }
      }
     },
     "localname": "PaymentsOfLoanCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/LoansNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r41"
     ],
     "calculation": {
      "http://www.beil.com/role/ConsolidatedCashFlow": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Purchase of property and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PostemploymentBenefitPlansPolicy": {
     "auth_ref": [
      "r347"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for postemployment benefits. Postemployment benefits are benefits provided to former or inactive employees, their beneficiaries, and covered dependents after employment but before retirement, except for: a) benefits provided through a pension or postretirement benefit plan, b) individual deferred compensation arrangements, c) special or contractual termination benefits, and d) stock compensation plans.",
        "label": "Postemployment Benefit Plans, Policy [Policy Text Block]",
        "terseLabel": "Employees benefit plans"
       }
      }
     },
     "localname": "PostemploymentBenefitPlansPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PreferredStockAmountOfPreferredDividendsInArrears": {
     "auth_ref": [
      "r101"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate amount of cumulative preferred dividends in arrears.",
        "label": "Preferred Stock, Amount of Preferred Dividends in Arrears",
        "terseLabel": "Aggregate liquidation preference of shares"
       }
      }
     },
     "localname": "PreferredStockAmountOfPreferredDividendsInArrears",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ShareholdersEquityDeficitDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PreferredStockConvertibleConversionPrice": {
     "auth_ref": [
      "r331"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share conversion price of preferred stock.",
        "label": "Preferred Stock, Convertible, Conversion Price",
        "terseLabel": "Original issue price per share (in Dollars per share)"
       }
      }
     },
     "localname": "PreferredStockConvertibleConversionPrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ShareholdersEquityDeficitDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockConvertibleSharesIssuable": {
     "auth_ref": [
      "r331"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of common shares issuable upon conversion of preferred stock.",
        "label": "Preferred Stock, Convertible, Shares Issuable",
        "terseLabel": "Convertible preferred shares"
       }
      }
     },
     "localname": "PreferredStockConvertibleSharesIssuable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r10",
      "r329"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Convertible preferred shares, par value (in New Shekels per share)"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ConsolidatedBalanceSheet_Parentheticals"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Convertible preferred shares, authorized"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ConsolidatedBalanceSheet_Parentheticals"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r10",
      "r329"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Convertible preferred shares, issued",
        "verboseLabel": "Preferred Stock, Shares Issued (in Shares)"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ConsolidatedBalanceSheet_Parentheticals",
      "http://www.beil.com/role/LoansNetDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding",
        "terseLabel": "Convertible preferred shares, outstanding"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ConsolidatedBalanceSheet_Parentheticals"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r10",
      "r523"
     ],
     "calculation": {
      "http://www.beil.com/role/ConsolidatedBalanceSheet": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "terseLabel": "Convertible Preferred Shares of NIS 0.05 par value each: Authorized: 6,196,004 and 6,186,240 shares at December 31, 2022 and 2021, respectively; Issued and outstanding: 5,714,400 shares at December 31, 2022 and 2021"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseCurrentAndNoncurrent": {
     "auth_ref": [
      "r149",
      "r167",
      "r199"
     ],
     "calculation": {
      "http://www.beil.com/role/ScheduleofothercurrentassetsTable": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of expenditures made in advance of when the economic benefit of the cost will be realized, and which will be expensed in future periods with the passage of time or when a triggering event occurs.",
        "label": "Prepaid Expense",
        "terseLabel": "Prepaid expenses"
       }
      }
     },
     "localname": "PrepaidExpenseCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ScheduleofothercurrentassetsTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PresentValueOfFutureInsuranceProfitsAmortizationExpenseAccruedInterest": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense for present value of future profits of insurance contract acquired in business combination from accrued interest on unamortized balance.",
        "label": "Present Value of Future Insurance Profits, Amortization Expense, Accrued Interest",
        "terseLabel": "Amortization of discount and accrued interest relating to straight loan received from commercial Bank (see Note 6 and Note 7)"
       }
      }
     },
     "localname": "PresentValueOfFutureInsuranceProfitsAmortizationExpenseAccruedInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ScheduleoffinancingexpensesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrimeRateMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate charged by financial institutions to their most creditworthy borrowers.",
        "label": "Prime Rate [Member]",
        "terseLabel": "Prime Rate [Member]"
       }
      }
     },
     "localname": "PrimeRateMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/LoansNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProceedsFromDebtNetOfIssuanceCosts": {
     "auth_ref": [
      "r215"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from additional borrowings, net of cash paid to third parties in connection with debt origination.",
        "label": "Proceeds from Debt, Net of Issuance Costs",
        "terseLabel": "Net proceeds"
       }
      }
     },
     "localname": "ProceedsFromDebtNetOfIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ShareholdersEquityDeficitDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceInitialPublicOffering": {
     "auth_ref": [
      "r42"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from entity's first offering of stock to the public.",
        "label": "Proceeds from Issuance Initial Public Offering",
        "terseLabel": "Public offering price",
        "verboseLabel": "Initial public offering total amount (in Dollars)"
       }
      }
     },
     "localname": "ProceedsFromIssuanceInitialPublicOffering",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/GeneralDetails",
      "http://www.beil.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "auth_ref": [
      "r42"
     ],
     "calculation": {
      "http://www.beil.com/role/ConsolidatedCashFlow": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the additional capital contribution to the entity.",
        "label": "Proceeds from Issuance of Common Stock",
        "terseLabel": "Proceeds received from issuance of convertible advanced investments (Note 9)",
        "verboseLabel": "Issuance of convertible debt"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ConsolidatedCashFlow",
      "http://www.beil.com/role/GeneralDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfPrivatePlacement": {
     "auth_ref": [
      "r42"
     ],
     "calculation": {
      "http://www.beil.com/role/ConsolidatedCashFlow": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement.",
        "label": "Proceeds from Issuance of Private Placement",
        "terseLabel": "Proceeds from issuance of unit consist of straight loan and warrant granted to commercial bank, net (Note 6C)"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfPrivatePlacement",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromNotesPayable": {
     "auth_ref": [
      "r43"
     ],
     "calculation": {
      "http://www.beil.com/role/ConsolidatedCashFlow": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a borrowing supported by a written promise to pay an obligation.",
        "label": "Proceeds from Notes Payable",
        "terseLabel": "Proceeds received from paycheck protection program note (Note 6B)",
        "verboseLabel": "Net amounts raised"
       }
      }
     },
     "localname": "ProceedsFromNotesPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ConsolidatedCashFlow",
      "http://www.beil.com/role/GeneralDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromRelatedPartyDebt": {
     "auth_ref": [
      "r43"
     ],
     "calculation": {
      "http://www.beil.com/role/ConsolidatedCashFlow": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates.",
        "label": "Proceeds from Related Party Debt",
        "terseLabel": "Proceeds from loan received from related party"
       }
      }
     },
     "localname": "ProceedsFromRelatedPartyDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromRoyaltiesReceived": {
     "auth_ref": [
      "r47"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash received for royalties during the current period.",
        "label": "Proceeds from Royalties Received",
        "terseLabel": "Royalty amount received"
       }
      }
     },
     "localname": "ProceedsFromRoyaltiesReceived",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/LoansNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment": {
     "auth_ref": [
      "r40"
     ],
     "calculation": {
      "http://www.beil.com/role/ConsolidatedCashFlow": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.",
        "label": "Proceeds from Sale of Property, Plant, and Equipment",
        "terseLabel": "Selling of property and equipment"
       }
      }
     },
     "localname": "ProceedsFromSaleOfPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "auth_ref": [
      "r42",
      "r117"
     ],
     "calculation": {
      "http://www.beil.com/role/ConsolidatedCashFlow": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.",
        "label": "Proceeds from Stock Options Exercised",
        "terseLabel": "Proceeds received from exercise of share options into Ordinary Shares (Note 12)",
        "verboseLabel": "Exercise of share option value through paycheck protection"
       }
      }
     },
     "localname": "ProceedsFromStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ConsolidatedCashFlow",
      "http://www.beil.com/role/GeneralDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property and Equipment, Net [Abstract]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAndIntangibleAssetsTextBlock": {
     "auth_ref": [
      "r84",
      "r90"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for intangible assets and long-lived, physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, accounting policies and methodology, roll forwards, depreciation, depletion and amortization expense, including composite depreciation, accumulated depreciation, depletion and amortization expense, useful lives and method used, income statement disclosures, assets held for sale and public utility disclosures.",
        "label": "Property, Plant, and Equipment and Intangible Assets [Text Block]",
        "terseLabel": "Schedule of computing straight-line depreciation"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAndIntangibleAssetsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/SignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r89"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Long-Lived Tangible Asset [Axis]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ScheduleofcomputingstraightlineamortizationTable",
      "http://www.beil.com/role/ScheduleofcomputingstraightlinedepreciationTable",
      "http://www.beil.com/role/ScheduleofpropertyandequipmentnetTable",
      "http://www.beil.com/role/ScheduleofrevenuedisaggregatedbyprimarymajorproductlinesandservicesTable"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "auth_ref": [
      "r90",
      "r484",
      "r485",
      "r486"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment Disclosure [Text Block]",
        "terseLabel": "PROPERTY AND EQUIPMENT, NET"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/PropertyandEquipmentNet"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r87",
      "r189"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "terseLabel": "Property and equipment, gross"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ScheduleofpropertyandequipmentnetTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ScheduleofpropertyandequipmentnetTable"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r89",
      "r165",
      "r468",
      "r523"
     ],
     "calculation": {
      "http://www.beil.com/role/ConsolidatedBalanceSheet": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property and equipment, net",
        "verboseLabel": "Total property and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ConsolidatedBalanceSheet",
      "http://www.beil.com/role/ScheduleofpropertyandequipmentnetTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "auth_ref": [
      "r89",
      "r484",
      "r485"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "terseLabel": "Property and equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentSalvageValuePercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stated as a percentage, the estimated or actual value of the asset at the end of its useful life or when it is no longer serviceable (cannot be used for its original purpose) divided by its [historical] capitalized cost.",
        "label": "Property, Plant and Equipment, Salvage Value, Percentage",
        "terseLabel": "Property, plant and equipment, depreciation percentage"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentSalvageValuePercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ScheduleofcomputingstraightlinedepreciationTable"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r89"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "terseLabel": "Schedule of property and equipment net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/PropertyandEquipmentNetTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r87"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Long-Lived Tangible Asset [Domain]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ScheduleofpropertyandequipmentnetTable",
      "http://www.beil.com/role/ScheduleofrevenuedisaggregatedbyprimarymajorproductlinesandservicesTable"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ReceivablesNetCurrent": {
     "auth_ref": [
      "r164",
      "r177",
      "r523"
     ],
     "calculation": {
      "http://www.beil.com/role/ConsolidatedBalanceSheet": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount due to the entity within one year of the balance sheet date (or one operating cycle, if longer) from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such receivables to an amount that approximates their net realizable value.",
        "label": "Receivables, Net, Current",
        "terseLabel": "Trade receivables"
       }
      }
     },
     "localname": "ReceivablesNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RelatedPartyDomain": {
     "auth_ref": [
      "r349",
      "r440",
      "r441"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Domain]"
       }
      }
     },
     "localname": "RelatedPartyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ConvertibleAdvanceInvestmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionAxis": {
     "auth_ref": [
      "r183",
      "r440",
      "r441",
      "r587"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of related party transaction.",
        "label": "Related Party Transaction [Axis]"
       }
      }
     },
     "localname": "RelatedPartyTransactionAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/LoansNetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionDomain": {
     "auth_ref": [
      "r183"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Transaction between related party.",
        "label": "Related Party Transaction [Domain]"
       }
      }
     },
     "localname": "RelatedPartyTransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/LoansNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionDueFromToRelatedPartyCurrent": {
     "auth_ref": [
      "r552",
      "r585"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Receivables to be collected from (obligations owed to) related parties, net as of the balance sheet date within one year where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth.",
        "label": "Related Party Transaction, Due from (to) Related Party, Current",
        "terseLabel": "Gross amount (in New Shekels)"
       }
      }
     },
     "localname": "RelatedPartyTransactionDueFromToRelatedPartyCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/RelatedPartiesTransactionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RelatedPartyTransactionsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions [Abstract]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "auth_ref": [
      "r349",
      "r440",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r587"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Axis]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ConvertibleAdvanceInvestmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": {
     "auth_ref": [
      "r438",
      "r439",
      "r441",
      "r442",
      "r443"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
        "label": "Related Party Transactions Disclosure [Text Block]",
        "terseLabel": "RELATED PARTIES TRANSACTIONS"
       }
      }
     },
     "localname": "RelatedPartyTransactionsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/RelatedPartiesTransactions"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RepaymentsOfDebt": {
     "auth_ref": [
      "r546"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.",
        "label": "Repayments of Debt",
        "negatedLabel": "Repayment of accrued interest relating to straight loan"
       }
      }
     },
     "localname": "RepaymentsOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ScheduleofthereconciliationofthecarryingamountTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfFederalHomeLoanBankBorrowings": {
     "auth_ref": [
      "r546"
     ],
     "calculation": {
      "http://www.beil.com/role/ConsolidatedCashFlow": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for repayment of Federal Home Loan Bank (FHLBank) borrowing, classified as financing activity.",
        "label": "Payments of FHLBank Borrowings, Financing Activities",
        "negatedLabel": "Repayment of Facility Fee relating to straight loan received from commercial bank (Note 6)"
       }
      }
     },
     "localname": "RepaymentsOfFederalHomeLoanBankBorrowings",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfOtherLongTermDebt": {
     "auth_ref": [
      "r44"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for the payment of debt classified as other, maturing after one year or the operating cycle, if longer.",
        "label": "Repayments of Other Long-Term Debt",
        "negatedLabel": "Repayment of principal relating to straight loans"
       }
      }
     },
     "localname": "RepaymentsOfOtherLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ScheduleofthereconciliationofthecarryingamountTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfRelatedPartyDebt": {
     "auth_ref": [
      "r44"
     ],
     "calculation": {
      "http://www.beil.com/role/ConsolidatedCashFlow": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for the payment of a long-term borrowing made from a related party where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Payments for Advances from Affiliates.",
        "label": "Repayments of Related Party Debt",
        "negatedLabel": "Repayment of principal relating to straight loan received from commercial bank (Note 6)"
       }
      }
     },
     "localname": "RepaymentsOfRelatedPartyDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfSecuredDebt": {
     "auth_ref": [
      "r44"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to repay long-term debt that is wholly or partially secured by collateral. Excludes repayments of tax exempt secured debt.",
        "label": "Repayments of Secured Debt",
        "terseLabel": "Repayment amount"
       }
      }
     },
     "localname": "RepaymentsOfSecuredDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/LoansNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r118",
      "r182",
      "r596"
     ],
     "calculation": {
      "http://www.beil.com/role/ConsolidatedIncomeStatement": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and Development Expense",
        "negatedLabel": "Research and development expenses"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpensePolicy": {
     "auth_ref": [
      "r118"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.",
        "label": "Research and Development Expense, Policy [Policy Text Block]",
        "terseLabel": "Research and development expenses"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpensePolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ResearchAndDevelopmentInProcess": {
     "auth_ref": [],
     "calculation": {
      "http://www.beil.com/role/ScheduleofexpensesrelatedtoserviceagreementandtheofficeservicesagreementTable": {
       "order": 1.0,
       "parentTag": "us-gaap_IncreaseDecreaseInDueToOtherRelatedParties",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of purchased research and development assets that are acquired in a business combination have no alternative future use and are therefore written off in the period of acquisition.",
        "label": "Research and Development in Process",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentInProcess",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ScheduleofexpensesrelatedtoserviceagreementandtheofficeservicesagreementTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r13",
      "r103",
      "r162",
      "r476",
      "r477",
      "r523"
     ],
     "calculation": {
      "http://www.beil.com/role/ConsolidatedBalanceSheet": {
       "order": 6.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Accumulated deficit",
        "verboseLabel": "Accumulative deficit"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ConsolidatedBalanceSheet",
      "http://www.beil.com/role/GeneralDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r184",
      "r229",
      "r230",
      "r231",
      "r233",
      "r239",
      "r241",
      "r287",
      "r386",
      "r387",
      "r388",
      "r403",
      "r404",
      "r420",
      "r473",
      "r475"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Accumulated deficit"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueRecognitionPolicyTextBlock": {
     "auth_ref": [
      "r502",
      "r503"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.",
        "label": "Revenue [Policy Text Block]",
        "terseLabel": "Revenue recognition"
       }
      }
     },
     "localname": "RevenueRecognitionPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Revenues": {
     "auth_ref": [
      "r212",
      "r223",
      "r262",
      "r263",
      "r268",
      "r272",
      "r273",
      "r279",
      "r280",
      "r283",
      "r286",
      "r299",
      "r300",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r308",
      "r309",
      "r424",
      "r467",
      "r570"
     ],
     "calculation": {
      "http://www.beil.com/role/ConsolidatedIncomeStatement": {
       "order": 1.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).",
        "label": "Revenues",
        "terseLabel": "Revenues"
       }
      }
     },
     "localname": "Revenues",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ConsolidatedIncomeStatement",
      "http://www.beil.com/role/ScheduleofrevenuesbygeographicregionTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.",
        "label": "Sale of Stock [Domain]"
       }
      }
     },
     "localname": "SaleOfStockNameOfTransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ConvertibleAdvanceInvestmentDetails",
      "http://www.beil.com/role/GeneralDetails",
      "http://www.beil.com/role/LoansNetDetails",
      "http://www.beil.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.",
        "label": "Sale of Stock, Number of Shares Issued in Transaction",
        "terseLabel": "Shares issued (in Shares)"
       }
      }
     },
     "localname": "SaleOfStockNumberOfSharesIssuedInTransaction",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/LoansNetDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information pertaining to carrying amount and estimated fair value of short-term and long-term debt instruments or arrangements, including but not limited to, identification of terms, features, and collateral requirements.",
        "label": "Schedule of Carrying Values and Estimated Fair Values of Debt Instruments [Table Text Block]",
        "terseLabel": "Schedule of reconciliation of the fair value of derivative warrants liabilities"
       }
      }
     },
     "localname": "ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/DerivativeWarrantsLiabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock": {
     "auth_ref": [
      "r115"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit.",
        "label": "Share-Based Payment Arrangement, Cost by Plan [Table Text Block]",
        "terseLabel": "Schedule of company\u2019s equity-based awards recognized"
       }
      }
     },
     "localname": "ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ShareOptionsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "auth_ref": [
      "r121"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.",
        "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]",
        "terseLabel": "Schedule of loss (income) before taxes on income"
       }
      }
     },
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/TaxesonIncomeTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "auth_ref": [
      "r119"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.",
        "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]",
        "terseLabel": "Schedule of deferred income taxes reflect the net tax effects of net operating loss"
       }
      }
     },
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/TaxesonIncomeTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "auth_ref": [
      "r77",
      "r80",
      "r450"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ScheduleofcomputingstraightlineamortizationTable"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": {
     "auth_ref": [
      "r77",
      "r80"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]",
        "terseLabel": "Schedule of computing straight-line amortization"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/SignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfImpairedIntangibleAssetsTextBlock": {
     "auth_ref": [
      "r83"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of impaired intangible assets excluding goodwill. This may include a description of the facts and circumstances leading to the recording of impairment charges of intangible assets in the period, the amount of the impairment charges, the methods of determining fair value of the associated assets, the caption in the income statement in which the impairment losses are aggregated, and the segment in which the impaired intangible assets are reported.",
        "label": "Schedule of Impaired Intangible Assets [Table Text Block]",
        "terseLabel": "Schedule of intangible assets, net and goodwil"
       }
      }
     },
     "localname": "ScheduleOfImpairedIntangibleAssetsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/IntangibleAssetsNetandGoodwillTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amounts of other current assets.",
        "label": "Schedule of Other Current Assets [Table Text Block]",
        "terseLabel": "Schedule of other current assets"
       }
      }
     },
     "localname": "ScheduleOfOtherCurrentAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/OtherCurrentAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r89"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ScheduleofpropertyandequipmentnetTable"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRegulatoryLiabilitiesTextBlock": {
     "auth_ref": [
      "r181"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of regulatory liabilities. Detailed information about liabilities that result from rate actions of a regulator. Rate actions of a regulator can impose a liability on a regulated enterprise resulting in a regulatory liability.",
        "label": "Schedule of Regulatory Liabilities [Table Text Block]",
        "terseLabel": "Schedule of the reconciliation of the carrying amount of the Company"
       }
      }
     },
     "localname": "ScheduleOfRegulatoryLiabilitiesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/RelatedPartiesTransactionsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock": {
     "auth_ref": [
      "r33",
      "r70"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the names of foreign countries from which revenue is material and the amount of revenue from external customers attributed to those countries. An entity may also provide subtotals of geographic information about groups of countries.",
        "label": "Schedule of Revenue from External Customers Attributed to Foreign Countries by Geographic Area [Table Text Block]",
        "terseLabel": "Schedule of revenues by geographic region"
       }
      }
     },
     "localname": "ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/SegmentGeographicalInformationAndMajorCustomersTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "auth_ref": [
      "r67",
      "r68",
      "r69",
      "r74"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "terseLabel": "Schedule of expenses related to service agreement and the office services agreement"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/RelatedPartiesTransactionsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable": {
     "auth_ref": [
      "r116"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Details comprising a table providing supplementary information on outstanding and exercisable share awards as of the balance sheet date which stratifies outstanding options by ranges of exercise prices.",
        "label": "Share-Based Payment Arrangement, Option, Exercise Price Range [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ScheduleofoutstandingandexercisableshareoptionsseparatedrangesofexercisepricesTable"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock": {
     "auth_ref": [
      "r116"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms.",
        "label": "Share-Based Payment Arrangement, Option, Exercise Price Range [Table Text Block]",
        "terseLabel": "Schedule of outstanding and exercisable share options separated ranges of exercise prices"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ShareOptionsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r105",
      "r108",
      "r110"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "Share-Based Payment Arrangement, Option, Activity [Table Text Block]",
        "terseLabel": "Schedule of company\u2019s share option activity for employees and members of the board of directors"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ShareOptionsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfStockholdersEquityTableTextBlock": {
     "auth_ref": [
      "r99"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of changes in the separate accounts comprising stockholders' equity (in addition to retained earnings) and of the changes in the number of shares of equity securities during at least the most recent annual fiscal period and any subsequent interim period presented is required to make the financial statements sufficiently informative if both financial position and results of operations are presented.",
        "label": "Schedule of Stockholders Equity [Table Text Block]",
        "terseLabel": "Schedule of composition of shareholders' equity"
       }
      }
     },
     "localname": "ScheduleOfStockholdersEquityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ShareholdersEquityDeficitTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Geographical Information And Major Customers [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r259",
      "r260",
      "r261",
      "r266",
      "r267",
      "r271",
      "r275",
      "r276",
      "r277",
      "r278",
      "r279",
      "r282",
      "r283",
      "r284"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "terseLabel": "SEGMENT GEOGRAPHICAL INFORMATION AND MAJOR CUSTOMERS"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/SegmentGeographicalInformationAndMajorCustomers"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SellingAndMarketingExpense": {
     "auth_ref": [],
     "calculation": {
      "http://www.beil.com/role/ConsolidatedIncomeStatement": {
       "order": 4.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total amount of expenses directly related to the marketing or selling of products or services.",
        "label": "Selling and Marketing Expense",
        "negatedLabel": "Sales and marketing expenses"
       }
      }
     },
     "localname": "SellingAndMarketingExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SeriesCPreferredStockMember": {
     "auth_ref": [
      "r543",
      "r544",
      "r573"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Series C preferred stock.",
        "label": "Series C Preferred Stock [Member]",
        "terseLabel": "Series C Preferred Stock [Member]",
        "verboseLabel": "Series C Convertible Preferred Shares [Member]"
       }
      }
     },
     "localname": "SeriesCPreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/LoansNetDetails",
      "http://www.beil.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r51"
     ],
     "calculation": {
      "http://www.beil.com/role/ConsolidatedCashFlow": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "terseLabel": "Share-based compensation (Note 12)"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r365",
      "r366"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted average grant date fair value of share options granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ShareOptionsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agreed-upon price for the exchange of the underlying asset relating to the share-based payment award.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Exercise Price",
        "terseLabel": "Exercise price ($) (in Dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ScheduleofassumptionsusedtoestimatethefairvaluesoftheshareoptionsgrantedTable"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "auth_ref": [
      "r379"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "terseLabel": "Dividend yield (%)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ScheduleofassumptionsusedtoestimatethefairvaluesoftheshareoptionsgrantedTable"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "auth_ref": [
      "r378"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate",
        "terseLabel": "Volatility (%)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ScheduleofassumptionsusedtoestimatethefairvaluesoftheshareoptionsgrantedTable"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "auth_ref": [
      "r380"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "terseLabel": "Risk-free interest rate (%)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ScheduleofassumptionsusedtoestimatethefairvaluesoftheshareoptionsgrantedTable"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "auth_ref": [
      "r359"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number",
        "terseLabel": "Number of Share Options, Exercisable",
        "verboseLabel": "Options to purchase (in Shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/CommitmentsandContingentLiabilitiesDetails",
      "http://www.beil.com/role/ScheduleofcompanysshareoptionactivityforemployeesandmembersoftheboardofdirectorsTable"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": {
     "auth_ref": [
      "r372"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value",
        "terseLabel": "Total compensation"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ScheduleofcompanysequitybasedawardsrecognizedTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod": {
     "auth_ref": [
      "r575"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period",
        "negatedLabel": "Number of Share Options, Forfeited or expired"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ScheduleofcompanysshareoptionactivityforemployeesandmembersoftheboardofdirectorsTable"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r575"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price of options that were either forfeited or expired.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price",
        "terseLabel": "Weighted Average Exercise Price, Forfeited or expired"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ScheduleofcompanysshareoptionactivityforemployeesandmembersoftheboardofdirectorsTable"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "auth_ref": [
      "r361"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross number of share options (or share units) granted during the period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross",
        "terseLabel": "Number of Share Options, Granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ScheduleofcompanysshareoptionactivityforemployeesandmembersoftheboardofdirectorsTable"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock": {
     "auth_ref": [
      "r109"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the weighted-average grant-date fair value of equity options or other equity instruments granted during the year.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value [Table Text Block]",
        "terseLabel": "Schedule of assumptions used to estimate the fair values of the share options granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ShareOptionsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "auth_ref": [
      "r116"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value",
        "periodEndLabel": "Intrinsic value, Outstanding",
        "periodStartLabel": "Intrinsic value, Outstanding"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ScheduleofcompanysshareoptionactivityforemployeesandmembersoftheboardofdirectorsTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r357",
      "r358"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Number of Share Options, Outstanding",
        "periodStartLabel": "Number of Share Options, Outstanding"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ScheduleofcompanysshareoptionactivityforemployeesandmembersoftheboardofdirectorsTable"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r357",
      "r358"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Weighted Average Exercise Price, Outstanding",
        "periodStartLabel": "Weighted Average Exercise Price, Outstanding"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ScheduleofcompanysshareoptionactivityforemployeesandmembersoftheboardofdirectorsTable"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r374"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price",
        "terseLabel": "Weighted Average Exercise Price, Exercisable"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ScheduleofcompanysshareoptionactivityforemployeesandmembersoftheboardofdirectorsTable"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost": {
     "auth_ref": [
      "r384"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An excess of the fair value of the modified award over the fair value of the award immediately before the modification.",
        "label": "Share-Based Payment Arrangement, Plan Modification, Incremental Cost",
        "terseLabel": "Total incremental"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/LoansNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r353",
      "r354",
      "r355",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/LoansNetDetails",
      "http://www.beil.com/role/ScheduleofoutstandingandexercisableshareoptionsseparatedrangesofexercisepricesTable"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r362"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "terseLabel": "Weighted Average Exercise Price, Exercised"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ScheduleofcompanysshareoptionactivityforemployeesandmembersoftheboardofdirectorsTable"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r361"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "terseLabel": "Weighted Average Exercise Price, Granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ScheduleofcompanysshareoptionactivityforemployeesandmembersoftheboardofdirectorsTable"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "auth_ref": [
      "r356",
      "r375",
      "r376",
      "r377",
      "r378",
      "r381",
      "r389",
      "r390"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.",
        "label": "Share-Based Payment Arrangement [Policy Text Block]",
        "terseLabel": "Share-based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis": {
     "auth_ref": [
      "r113"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by range of option prices pertaining to options granted.",
        "label": "Exercise Price Range [Axis]"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ScheduleofoutstandingandexercisableshareoptionsseparatedrangesofexercisepricesTable"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain": {
     "auth_ref": [
      "r114"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Supplementary information on outstanding and exercisable share awards as of the balance sheet date which stratifies outstanding options by ranges of exercise prices.",
        "label": "Exercise Price Range [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ScheduleofoutstandingandexercisableshareoptionsseparatedrangesofexercisepricesTable"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ScheduleofoutstandingandexercisableshareoptionsseparatedrangesofexercisepricesTable"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit": {
     "auth_ref": [
      "r114"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The floor of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.",
        "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit",
        "terseLabel": "Exercise price (in Dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ScheduleofoutstandingandexercisableshareoptionsseparatedrangesofexercisepricesTable"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions": {
     "auth_ref": [
      "r107"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares reserved for issuance pertaining to the outstanding exercisable stock options as of the balance sheet date in the customized range of exercise prices for which the market and performance vesting condition has been satisfied.",
        "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable",
        "terseLabel": "Share options exercisable"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ScheduleofoutstandingandexercisableshareoptionsseparatedrangesofexercisepricesTable"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions": {
     "auth_ref": [
      "r106"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares reserved for issuance pertaining to the outstanding stock options as of the balance sheet date for all option plans in the customized range of exercise prices.",
        "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding",
        "terseLabel": "Share options outstanding"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ScheduleofoutstandingandexercisableshareoptionsseparatedrangesofexercisepricesTable"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SharePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Price of a single share of a number of saleable stocks of a company.",
        "label": "Share Price",
        "terseLabel": "Share price ($) (in Dollars per share)"
       }
      }
     },
     "localname": "SharePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ScheduleofassumptionsusedtoestimatethefairvaluesoftheshareoptionsgrantedTable"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r377"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term",
        "terseLabel": "Expected life (years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ScheduleofassumptionsusedtoestimatethefairvaluesoftheshareoptionsgrantedTable"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "auth_ref": [
      "r116"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value",
        "terseLabel": "Intrinsic value, Exercisable"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ScheduleofcompanysshareoptionactivityforemployeesandmembersoftheboardofdirectorsTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r374"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for fully vested and expected to vest exercisable or convertible options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term",
        "terseLabel": "Weighted average remaining contractual term (years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ScheduleofoutstandingandexercisableshareoptionsseparatedrangesofexercisepricesTable"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r112"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term of exercisable stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Remaining Contractual Term",
        "terseLabel": "Weighted average remaining contractual life, Exercisable"
       }
      }
     },
     "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ScheduleofcompanysshareoptionactivityforemployeesandmembersoftheboardofdirectorsTable"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r111"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term of outstanding stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Weighted average remaining contractual life, Outstanding"
       }
      }
     },
     "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ScheduleofcompanysshareoptionactivityforemployeesandmembersoftheboardofdirectorsTable"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.",
        "label": "Shares, Outstanding",
        "periodEndLabel": "Balance (in Shares)",
        "periodStartLabel": "Balance (in Shares)"
       }
      }
     },
     "localname": "SharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShortTermBorrowings": {
     "auth_ref": [
      "r4",
      "r146",
      "r160",
      "r523"
     ],
     "calculation": {
      "http://www.beil.com/role/ConsolidatedBalanceSheet": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.",
        "label": "Short-Term Debt",
        "terseLabel": "Current maturities of loans, net"
       }
      }
     },
     "localname": "ShortTermBorrowings",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShortTermDebtPercentageBearingVariableInterestRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of the carrying amount of short-term borrowings outstanding as of the balance sheet date, which accrues interest at a rate subject to change from time to time.",
        "label": "Short-Term Debt, Percentage Bearing Variable Interest Rate",
        "terseLabel": "Bearing interest rate"
       }
      }
     },
     "localname": "ShortTermDebtPercentageBearingVariableInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/LoansNetDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShortTermDebtTypeAxis": {
     "auth_ref": [
      "r20"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of short-term debt arrangement.",
        "label": "Short-Term Debt, Type [Axis]"
       }
      }
     },
     "localname": "ShortTermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/LoansNetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShortTermDebtTypeDomain": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of short-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing.",
        "label": "Short-Term Debt, Type [Domain]"
       }
      }
     },
     "localname": "ShortTermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/LoansNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r61",
      "r220"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "Significant Accounting Policies [Text Block]",
        "terseLabel": "SIGNIFICANT ACCOUNTING POLICIES"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/SignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [
      "r195",
      "r196",
      "r197",
      "r223",
      "r245",
      "r246",
      "r248",
      "r250",
      "r253",
      "r254",
      "r286",
      "r299",
      "r302",
      "r303",
      "r304",
      "r308",
      "r309",
      "r329",
      "r330",
      "r333",
      "r337",
      "r343",
      "r424",
      "r498",
      "r537",
      "r549",
      "r557"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by the different classes of stock of the entity.",
        "label": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ConvertibleAdvanceInvestmentDetails",
      "http://www.beil.com/role/LoansNetDetails",
      "http://www.beil.com/role/ScheduleofcompositionofshareholdersequityTable",
      "http://www.beil.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r28",
      "r99",
      "r184",
      "r209",
      "r210",
      "r211",
      "r229",
      "r230",
      "r231",
      "r233",
      "r239",
      "r241",
      "r252",
      "r287",
      "r345",
      "r386",
      "r387",
      "r388",
      "r403",
      "r404",
      "r420",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r437",
      "r473",
      "r474",
      "r475"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ConsolidatedBalanceSheet_Parentheticals",
      "http://www.beil.com/role/GeneralDetails",
      "http://www.beil.com/role/LoansNetDetails",
      "http://www.beil.com/role/ShareholdersEquityType2or3",
      "http://www.beil.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ConsolidatedBalanceSheet_Parentheticals",
      "http://www.beil.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r229",
      "r230",
      "r231",
      "r252",
      "r449"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ConsolidatedBalanceSheet_Parentheticals",
      "http://www.beil.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssued1": {
     "auth_ref": [
      "r57",
      "r58",
      "r59"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fair value of stock issued in noncash financing activities.",
        "label": "Stock Issued",
        "terseLabel": "Contribution to equity due to free interest loan from controlling shareholder (Note 14)"
       }
      }
     },
     "localname": "StockIssued1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": {
     "auth_ref": [
      "r27",
      "r99",
      "r100",
      "r103",
      "r321"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period as a result of the conversion of convertible securities.",
        "label": "Stock Issued During Period, Shares, Conversion of Convertible Securities",
        "terseLabel": "Exercise of share options into Ordinary Shares (Note 12) (in Shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": {
     "auth_ref": [
      "r10",
      "r11",
      "r99",
      "r103"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture",
        "terseLabel": "Share-based compensation (Note 12) (in Shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r10",
      "r11",
      "r99",
      "r103",
      "r362"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period",
        "negatedLabel": "Number of Share Options, Exercised",
        "terseLabel": "Exercised share options"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ScheduleofcompanysshareoptionactivityforemployeesandmembersoftheboardofdirectorsTable",
      "http://www.beil.com/role/ShareOptionsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueOther": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of shares of stock issued attributable to transactions classified as other.",
        "label": "Stock Issued During Period, Value, Other",
        "terseLabel": "Contribution to equity due to free interest loan from controlling shareholder (Note 14)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": {
     "auth_ref": [
      "r10",
      "r11",
      "r103",
      "r109"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture",
        "terseLabel": "Share-based compensation (Note 12)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueStockDividend": {
     "auth_ref": [
      "r28",
      "r99",
      "r103"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued to shareholders as a dividend during the period.",
        "label": "Stock Issued During Period, Value, Stock Dividend",
        "terseLabel": "Value of divided"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockDividend",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/LoansNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "auth_ref": [
      "r28",
      "r99",
      "r103"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued as a result of the exercise of stock options.",
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "terseLabel": "Exercise of share options into Ordinary Shares (Note 12)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r11",
      "r14",
      "r15",
      "r72",
      "r523",
      "r551",
      "r562",
      "r582"
     ],
     "calculation": {
      "http://www.beil.com/role/ConsolidatedBalanceSheet": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "Balance",
        "periodStartLabel": "Balance",
        "totalLabel": "Total shareholders\u2019 equity (deficit)"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ConsolidatedBalanceSheet",
      "http://www.beil.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityNoteAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shareholders\u2019 Equity (Deficit) [Abstract]"
       }
      }
     },
     "localname": "StockholdersEquityNoteAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r104",
      "r222",
      "r330",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r345",
      "r419"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "terseLabel": "SHAREHOLDERS\u2019 EQUITY (DEFICIT)"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ShareholdersEquityDeficit"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StraightLineRent": {
     "auth_ref": [
      "r51"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Difference between actual rental income due and rental income recognized on a straight-line basis.",
        "label": "Straight Line Rent",
        "terseLabel": "Straight loan"
       }
      }
     },
     "localname": "StraightLineRent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ScheduleoftheEffectiveDatemanagementbyassistanceofthirdpartyTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r431",
      "r445"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent Event [Member]"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r431",
      "r445"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r431",
      "r445"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]"
       }
      }
     },
     "localname": "SubsequentEventsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "auth_ref": [
      "r444",
      "r446"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.",
        "label": "Subsequent Events [Text Block]",
        "terseLabel": "SUBSEQUENT EVENTS"
       }
      }
     },
     "localname": "SubsequentEventsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/SubsequentEvents"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of sale of the entity's stock.",
        "label": "Sale of Stock [Axis]"
       }
      }
     },
     "localname": "SubsidiarySaleOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ConvertibleAdvanceInvestmentDetails",
      "http://www.beil.com/role/GeneralDetails",
      "http://www.beil.com/role/LoansNetDetails",
      "http://www.beil.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TechnologyEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equipment used in the creation, maintenance and utilization of information systems which include computers and peripherals.",
        "label": "Technology Equipment [Member]",
        "terseLabel": "Technology {Member]"
       }
      }
     },
     "localname": "TechnologyEquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ScheduleofcomputingstraightlineamortizationTable"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TemporaryEquitySharesAuthorized": {
     "auth_ref": [
      "r9"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of securities classified as temporary equity that are permitted to be issued by an entity's charter and bylaws. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity, Shares Authorized",
        "terseLabel": "Authorized shares"
       }
      }
     },
     "localname": "TemporaryEquitySharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TradeNamesMember": {
     "auth_ref": [
      "r122"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights acquired through registration of a business name to gain or protect exclusive use thereof.",
        "label": "Trade Names [Member]",
        "terseLabel": "Trade Names [Member]",
        "verboseLabel": "Trade names [Member]"
       }
      }
     },
     "localname": "TradeNamesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ScheduleofcomputingstraightlineamortizationTable",
      "http://www.beil.com/role/ScheduleofintangibleassetsnetandgoodwilTable"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r64",
      "r65",
      "r66",
      "r255",
      "r256",
      "r257",
      "r258"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of estimates in the preparation of financial statements"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_VariableInterestDifferenceBetweenCarryingAmountAndMaximumExposure": {
     "auth_ref": [
      "r126"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Difference between the carrying amount of assets and liabilities in the reporting entity's statement of financial position that relate to the reporting entity's variable interest in the variable interest entity (VIE) and the reporting entity's maximum exposure to loss as a result of its involvement with the VIE, where the reporting entity is not the VIE's primary beneficiary.",
        "label": "Variable Interest Entity, Nonconsolidated, Comparison of Carrying Amount of Assets and Liabilities to Maximum Loss Exposure",
        "terseLabel": "Ordinary shares per value (in New Shekels)"
       }
      }
     },
     "localname": "VariableInterestDifferenceBetweenCarryingAmountAndMaximumExposure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/GeneralDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_VariableRateAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of variable rate.",
        "label": "Variable Rate [Axis]"
       }
      }
     },
     "localname": "VariableRateAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/LoansNetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableRateDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.",
        "label": "Variable Rate [Domain]"
       }
      }
     },
     "localname": "VariableRateDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/LoansNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WarrantExercisePriceIncrease": {
     "auth_ref": [
      "r344"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share increase in exercise price of warrant. Excludes change due to standard antidilution provision.",
        "label": "Warrant, Exercise Price, Increase",
        "terseLabel": "Exercise price (in Dollars per share)"
       }
      }
     },
     "localname": "WarrantExercisePriceIncrease",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/LoansNetDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_WarrantMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.",
        "label": "Warrant [Member]",
        "terseLabel": "Warrant [Member]"
       }
      }
     },
     "localname": "WarrantMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/LoansNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WarrantsAndRightsOutstanding": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price.",
        "label": "Warrants and Rights Outstanding",
        "terseLabel": "Warrant total amount"
       }
      }
     },
     "localname": "WarrantsAndRightsOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/LoansNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r244",
      "r250"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Weighted average number of Ordinary Shares used in computing diluted net loss per share"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ConsolidatedIncomeStatement_Parentheticals"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r243",
      "r250"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Weighted average number of Ordinary Shares used in computing basic and diluted net loss per share (in Shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.beil.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 7
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "https://asc.fasb.org/topic&trid=2122149",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 201.5-02(24))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21488-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.F)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "https://asc.fasb.org/topic&trid=2208762",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)-(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=SL79508275-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "https://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5333-128473",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5728-111685",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "https://asc.fasb.org/topic&trid=2197479",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579240-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41638-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41675-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "815",
   "URI": "https://asc.fasb.org/topic&trid=2229140",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14172-108612",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=29642582&loc=d3e27862-108397",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=29642582&loc=d3e27881-108397",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.10)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.15(5))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.1)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Subparagraph": "e",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124504833&loc=d3e7104-158389",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124504833&loc=d3e7104-158389",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(10))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(1))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(5))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.10)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.15(a))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.15)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.12)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04.4)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=d3e14931-158439",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(c)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124508989&loc=d3e19393-158473",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "210",
   "Subparagraph": "(c)",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=99383244&loc=d3e12121-115841",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04.16(b)(4))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=120401414&loc=d3e603758-122996",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-06(3))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=120401414&loc=d3e604059-122996",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12)",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611133-123010",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13)",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611282-123010",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-14)",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611322-123010",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "405",
   "Topic": "980",
   "URI": "https://asc.fasb.org/extlink&oid=6500807&loc=d3e48068-110394",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "https://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(15))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(18))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 201.5-02(25))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226013-175313",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(1))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18726-107790",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(c))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(n))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1278-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.23)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8657-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8844-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-30)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8981-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "https://asc.fasb.org/topic&trid=2134510",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e557-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 201.5-02(26))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(8))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6036836-161870",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "712",
   "URI": "https://asc.fasb.org/topic&trid=2197446",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(f)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7,9)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.8)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(v)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(l)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.D.2.Q6)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "https://asc.fasb.org/topic&trid=2228938",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19)(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "https://asc.fasb.org/topic&trid=2144680",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "830",
   "URI": "https://asc.fasb.org/topic&trid=2175825",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918666-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "850",
   "URI": "https://asc.fasb.org/topic&trid=2122745",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "855",
   "URI": "https://asc.fasb.org/topic&trid=2122774",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "https://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(1)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(2)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a),(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B)",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D)",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "https://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "450",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=6491354&loc=d3e6049-115624",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Subparagraph": "(d)",
   "Topic": "958",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99779-112916",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99893-112916",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=SL120174063-112916",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r498": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=122137925&loc=d3e14258-109268",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r526": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r527": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r528": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r529": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r530": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r531": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r532": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r533": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r534": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r535": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r536": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(c))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4273-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(k)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "55",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2626-109256",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8672-108599",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27232-111563",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "https://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2443-110228",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "410",
   "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "https://asc.fasb.org/topic&trid=2127136",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4304-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4313-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4332-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "730",
   "Topic": "912",
   "URI": "https://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "https://asc.fasb.org/topic&trid=2122369",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "b",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(23))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "https://asc.fasb.org/topic&trid=2144416",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "44",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=29634951&loc=d3e1756-110224",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2459-110228",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "360",
   "URI": "https://asc.fasb.org/topic&trid=2155823",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "https://asc.fasb.org/topic&trid=2144648",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=126907703&loc=d3e12565-110249",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=d3e1835-112601",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126972273&loc=d3e12317-112629",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126972273&loc=d3e12355-112629",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "60",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=6402221&loc=d3e15743-112638",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "https://asc.fasb.org/topic&trid=2208564",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=109262497&loc=d3e20148-110875",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>112
<FILENAME>0001213900-23-032036-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001213900-23-032036-xbrl.zip
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M$#NAAT<>HH9SA$/50K[-#K3;Q</J.ZCBJ*B8VA1DHA)(/+=!C!:D< '%"S+
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MF2NAMHU[IW8-_!;N(-J=&O@M-+;;W1KX+;2UV_LU\%NX"K</:N"W<!%N'];
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M"VC+*QL_+6D$,I7/BQ8EDJ6ZGCJ<ZO\'4$L#!!0    ( %2"F%:>QXM%Q X
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MQJD+*']BV^Q/@FSV)QIR%X!Y"%S:#)W,#Q=,1--P3,\1,_>&=7>!"#"AP+6
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M1VE2KF7=BT$&!N<&X7=[!WPIU*$X"4C![DD^9<F(DQY/S'A^(:3[ELU/$E]
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MV7%FC9L 6.+05H3''BY,J[AWZR!OZZ8H9@PLU?I-3[+"W'[;F(IJ#@^H9C(
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M89K8VX#:UD'>)06NQ:@*1U^ZF\BZB2HZY)."[)@^%UG3_<TB!*XXP?XTIH@
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M4JZWLS@FB1)S#5^]AMFJKVFT(339.J''-77#E]4'M9VZ[5,@SBY#=E0N_?N
M9#-F0S-*[Z+(>_0#)2V3C "C]5<1LV,4$=O]+1!$9;6X\IU[/_ 3175O^Q2(
MLS-"_0=FUCR07QS*++TDUN2O>P#(\Y09LHG0$>^!G]^7[ =QHG&@MG\/A"6S
MF->^&#%FZLLH\IU)7^(JP\ LB?KQ=T;8SNHK(=K^,2!S\PVWN-7.A?+?PYU7
M%W[(M(5)X/QI0\*8J&XAC=_!('-# FX5,)N*ZX*XGSFN,DX=7T/9/'?.$[L1
MAID1J,)3]0.@Y7A+EGP1O2/1DCJ;%;<\+T-^D16WN%GHO7?^B-C6&B>,*%73
M,<TA <VF]#XF?Z:,^/D#WQF4N#W\!DJ^=;OK9"O^M55AJ^-K* 8[;<0[AQT"
M_4W-?!B8)5VW&]6Y;/T6[/!M,2#56>P> (S/;CM2G5VE<:!TM; UU=D[^ +E
MRE,R-LPTL3X &)^=)J<ZMRK#P*SN+N-3G5^%40#-;:D-JL.XZF!@^W^;;:JQ
M]TN& &4U-ULUN:M^!60U-=FMZGQU? T%6+O]JLZF= PXPZUBVJISV/09V.K6
M-&,UU-)H8"A[WUT1+PU(M.#/4BG?9.*$.OYRE;"/B;..F+0_"TX$8:4)Z8XY
MS%P\LJ'$]4'G4A\3?"X1MP_<S#YP]I:J'O-M@X!SN]D;K:0P6L-\.]-CN7,D
M<+[]G?6:P1,*ZW696:\&W"N,![<S[:@R*3/;QE_S?7J1)BFM+#:2'2]UY@SF
MUXL2D*^KS,SY8D%<;I:>\=<S)W26X@WM?LOH^MFS-/\[GWH;=GYMS69L1 1A
MLFS+B9C!$&3[COB1RZSQ+=N<F!32T&2YJ0\+9L3M:#,M2BDS%OF[7<PVJS3A
M8/*(BX#?V@QFHS0B_$3*VVP@#/6=G6Z^7Q\.!.@?V]%K$/W"\>F#$Z3LM][N
MTO>87_J"@UN(WNQZ4T/8.J7*G_UH?YUTLNND7[U.]@;"B"B\)F=[^MH/_76Z
M=G=WT90=QO3>SU82V].)LZ2$B%W01!&,J<!/F)MW4>QG<HA+]UB2A3B8&8S2
M$7$FXH3;6%",Q&V77],>&$EVJ2!LQ&C+SFZV&Z[)^IZQ(W3L/G*HQ]:>SU0R
MB:B),"$)0Q^:I0. VY-/;'/U8W&1VC/+#!1V;'.#AFTZ2WYLY'_';'S?-=O&
MP<B"&[S,9$G7&0-I3+PD*LRY\F:<B:C,[))OR,0SP *"(,;15ZAMMBIYA*'G
ML(/'B_GFO S]ST:S51X56M,7A3,IM\&-MN7F,3#05S$[Q8].,T"1+-LZ"? %
M5S%)^YJT2#P6\J:9JR^)8D(?V"8DSE]^_+)=C '%-83M3-GOXMTO#28%01!#
M+8.(W>B$&_&>\,,KR3R+_MZSJ#=/A?$0;%J/+ B[0G@9&4&3?1BP@Y9A&I*$
M_T1<:=FVR_Z3^UN<1-R18A,-[4\.>C.DY(&$[%2YWRYWWE5*EF8.0-E@\*;<
M5<3 8?<@;^=#*M-F9Z1C(B;E49&DX3$3:,F6\)*O^/LMLW+6#MVNN9-[0R,O
M=85GE=N)Q8(W%Y8I+;@])0\&/F/KP5<+"3_X FY?Z K,T.!/:1RHQ= 2!*'!
MKF0$&"7O#G[0X%9M(#CU+,(B-%@\_ 0^F*?TQJW!EV0$_*@$#5Y5AH%B6!I'
MH,6W\FB8Z2IY5('.IB4; YC=/,Q E\.#S\#V_O:W>PT.Y8, 74@J[_@:##9^
M!V3%Z#W2Z\C=;&0XL^ @X%6']99/>ZO!6>2F'!0V^W.VQ23;$B)*46I=W^<*
MX5!7E;^6Q-0BKY1GI'XC^/9\1I4G#K]B=R$G#9*7+W(R97YW8_AA\II]\CK_
MF]?USX?A-5H[?FC,:O;U7A\QF%VQ(:B;WI-7.\)Z_#8-4-KR40 6P+S*G-V:
MZ%8^W=G2&%PZ/-M,AS<G"/8<,3WU0_'$<<5H5[@B3PD)/>(5?/&/33*C"[UB
MU(+(K9 (>')Y1 L*@7-/@I]>IO&KI>-L?M\ETLX7>82=$USG#S*S>Q[%XR9U
MT.)B[@LGOA< Y..]YCO4:Q(D<?$3L6<)$+5(9FM:>SK9?: (6<?AOYG&CN&]
MM&>TRCI3CH*57$]TE3S_>D&CM9D(DTB*5429^??3RZ_8)V(5_.@&44R\GUXF
M-"W?^;5EPW.-V5G#_X<;EP].P(_#67*:.YE_YF\;P+)2HUFL5!O2Z]38LK@4
MX9.*ST1T-\0EC")_DV-WVIQ98%$UT["WK)0%TP).+H@WX.M(7.$KW %+HH%
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M(=%#WR7**9^]K._20(4UB:/6,FJFQ1>KY0W8?S*Q>"4Z;)\Z)+V7<\X$UJ(
M9L[N6E)4ETK11F#AC.9><T9$Z*'_0'YQ*&5F9GRX( VWZF+8RY#77Q+>/H;1
M/XBWK#P/#G (F7-B&O-E0!/O-.O!BM5W?0 5JAZ+?60RFO5:ZK\U\QYX]'"6
M-BBBAG7/3^[BWW_^CRC@(4HZL2$='_=X\ST<$VMM=%&R%4@A%T?U9;$#JQ'I
M['KM9V5%G-!C&LQ]W0VFGYF^E$:?E49WASA<]&B;>P24Z& M$TWB]CP"1II0
M">#3A'E$'@'1^:'2;/B,C>WZ2:].7(<-C'GZ'UHOKDYB/5L2U@;&7S;J=&U&
MN*I(N+NI=2N:8UL=><:';J1+_8%+)"KONJODF4 B[US0N>?]5XK,=/3G3"-F
MS%UPJG1/RG31+C<]N;'LT@-1J,H=IZ]TQN,BW$42GS_Q:9"=MUO_AE,;2N."
MT_ZM0>F5VF F#%C,OY,"6800-TQT-)>1:HW).^JP->(6!X-9[OL^$[0\'-+.
M+R77H^Q"\\CXII(.9;M[MJJPJXG\&KB.9P<6\<I1F 4O&S_-[&*?T>_B793Z
M5(H]'!3/&]5!RJ[6*PBQ,=Y]Y!I^2Y;< 'I'HB5U-BO?=8)R1'_HO7?^B.AI
M&B=L.M3XXI"3N2$;WO@K7&)=H-O(F+YB' XXP)59@:+=7$.)*"LW917X1F,6
MW:;W,?DS90R?/XAT5,/P\(-AL'2]C8RQKA\,B*;AK73LZK5$;!6];H=J--I<
M#ZD_V8I_;0WU>L(9&Q]C,E^<QXG/CC7P(B,'@UL,L-5+OS@$!:E<Y$5$B;\,
ML_@/MWIC"#WQGX$P-N),.[&V'7,^;*84Z(FT!];2?$RS-[M2,ARN>#M)32DK
MJALSG+*[>6&.PSHNN )3HCF=M:>((4JEFQL2$S8Q3O^,/) @$AD2N><Q/_2A
MW55RBE;-.3WA*0&H4F+2+%0NZ_5TNG+HDB O.PFQ"<E,!IM*&VG@U!1<T6D0
MGLZVJ8,F2GOHU@0S7&$JDYW0BE2'4EYGTFQM7A&F.>2*UYM#7HQ=E*:S^CKQ
M0BD9N7.,XXJGE<QDKN?M0"ET;C;:"*,X(>M-$(F0B!,2,GP2OI1C% M22FXZ
MJTB.G$('9N"86.S;MC+AZ8A1!TV%'LNZH3&,H,MHT[Q4T"DS;?WDQH\_=8JR
MN2N1ZE#VPB[51*.'B[P9LMGE6K3@Y3U EQE$N&M+3F]*[BP%]!1:&YMYGAV?
M_NP$*7G/[)N4DKTEBNQI5J8[]N5G@*2\7['!OEBD>\VIYX<.W;YA^_-;$<49
M9R76,D] ]A.C[;(7A=';E" P*O4BUA7N+!"_$SM[T9] E(@6\6)%=Q 1M:LO
MUQZ#3T*D?< KI-E5KE9;FD7^M+ZHVKZ<A!Q:IUV #.[GV&?RHKN+6PE-Y?#J
MPJH0$(R/@^O"^\@3-0W%*^N<%LT.Y@M1KT9_8>B--W:9&"!4B*C=W6&R@,X=
M&O)<X6M"Q7&'NXIDU,8N-F74BN=IF![;!V9++=F_GZDG'VX"KG=]B H122MO
MZXG)V?B)$W"G"?7O4XX3;V@T$S^( O;GRU)ZKH'<>HT_?A\4 (:%8(%C0_;)
M<N5TNBR15#S:<><,.USQ/,4F'$QE1S5"MY!T9Q")]=K@=[Q*5)^J%A,..+UU
M5\1+V4V;5WSW$W+%1%A[WQ8 H459&W PF45C@BY:(Y#VLK;UD(;!HPDZ>9B2
M']D09:4.ZG9JQY?WQWYU")Y-"?G]PFZ!"W^WE!*>9(%Y'6!'D\'24F^^[[KY
M,LK.#W[2C,)G"UMB?I*%Y7?+ SBV]=F4EM_OA9?KC>/3!M,1_9214[9KF_4N
M+*\%LG1QF8>"SMG*=KB-*6(<BVJ+V_=.DE+VOZA&A0D'$^XE8 2X2AO @;;5
MHJ% ;[M\2GT%1(O'W5J]6Y'W0D6ROMSL6GWF).2]$SI+86*>;)E"^''"?<S\
MKWWJ;41)EXYEU-P\%IJDO74C[TJ @S'HIEEEL=RS\(8L L9FS-CF,5RARY9S
M'G+ ?G3J4+KE12#6_"K?0PV 2$Y'#: P!LW;K;)8[-E</V-V<TP3KI6\Q#+?
M*GL(6VM@RP78]:2J!YD\F7>XTZ^E'TG?P_!9M"7IP@;+>%2C:=,99=!"1!%(
ME:/->F.0WL];7W9_D/V>69QO(L"8DRUJDGB[L&.VE?*=N,3=0-Y@"-ZL.HQA
M&X@ "VU$U;&[8FA,S\")M!8IN6KV84.HZ\N,!WM%?_LV)%%">#PU(15ZE?1R
M,C_G;B5<7>)]>$+*K@/D/9/+.EWO27]DPJ G?G8OX&ZRV9(20J0+KW&3@*0V
MP;XEX("/Z%!J;6C2:_D]DY8F.YG720QD'$H)V[3\#-J::" ZIN?0<F.3DJG6
M+Z3F"^YO4M*#QN!4H1TYWOD%8K 59\J01;\P>(<3"/F@O+A*&<LR3=-D%5'_
M,_'$J5SB5L0XGVS/GPAU_9A<4]\E-SPUR)IB]6?XN;77&4+&"F_"<(D,,^[8
M*U[>:HV!9H\.]?*U]$YX "_#:T+]R/N%^,L5PW#V0*BS).*7W.N_<W_@;HE6
MYV+W209>I^TJANHK4!\7:VE>'*"+B-9GM)]O7$XL;T9'P'PB0N:&<L4..(=Q
MQ/C"[]F#ZH&TTNU0%X2F/FI&-^C1=%+;>TUV7FON:D==B=VT+,3\*K=C4T1K
M/ [8]OYL^_NM626K9]*F;;^CW9!E&O"_W):]T^B'D82L50/)I#^;.J!H:72E
MIY'3P(EC?^$3[V0KDI\9UZD3E(-K!GJ?,F!E<K+O![Q* &]?;\)!%ZE2@S)F
MF6>_',!%H,7%Y+3 &.XQ!;%5^C7V#5V;>-O&JM4?A7Q]\P?HG%1N,.7%:@>\
MP^EQ8C&73+/C8R^\%1\=>RA!T2V!L9(E=<Q";ZA81E,NK&ZBQN+71%KU !UA
M-]">KVV3;0I:,I9%<5M>I>><(4U#)]B!,TNR*CY,$:*B+Q</X*>B$]\>XADE
MSA 7%FA.[3VI:74@Q9054L>\JRA<BI(FV?9QR #N7JU)?!I:H(LHT@L4.TF<
MY9*29>Y2S54259YJ-*U&JF@(4A%!E3O)4$=JO@%%"_:C3<HGR*?'WXC8Y\19
M\TE_%M,1LS ^33M*(;$YD,N$K*$[GRJ11*^@A79F2@FCK1HG")K7BHZ0S2IF
M-9UJ49@PK3_/RLS\]#+.%BSPYMA:A>-D>\<^GSWYT.JK0A'O"K)B7U(WO2>O
MV$_9U9 -V[(_:J\$I>(F95A1PH':RZJPC\_$N3"40$L4$>^4A1A?>97)*5:H
MJ:NY6HV:$IBVQ/C[5W8$B2Q%LG#2(!E:C!Q,Q:H8VK*\(^XJC()HN=T1?E^Q
MS(#DUT['JDM'8T<J"ZT#-:0;8'$Q%8Y\[KE?^9L815)=E&Q>"@Q%U0D<VE/5
M'74\\L%9$QP9U8:W=^DV74$U@!1O:%JA.:W,G9$-)6Y64N.:&5V\[L;RX-[0
M&+"C.Z+=:%_=RX$19J,IJ"JY6'LE_LTNUJ*R1U>!ZS.2.'X0:S#2<A%O+I>"
M1=JD-R$P,PWW]B$P*-W:A[FV#Z%"NR(T*"("< 8<O0$0W@#L50CO,X"6_-%M
M<'0;'-T&0[H-8IK\+I*S5+=;]D%)3NR_]C*JCH4DA5'LH@>HH0E%_:ZI(I:*
M?\;"1M>H:Q4XD7PN!^.K;4J:B%K8<53Q5-HW=/',"W" :6AU/"L^Q)9E5R!Z
M,&-HXTB0<)Y@0:V,-TI0JS.&WDFSWGGKC4,);W],J+]9$>H$G;[QEJZ"\E$F
MX[13A@5:R3GA^8*=S.0BI0RA5#"@+PWY&&/L4-$N# 5,E+QR<#;\K1,\.$LB
MTIG;'*IXUGP+=1O/%4,Y>(PE,J+Z^GL,(EX&ULW*P#JE\(5^Q>OKG8TT4G.5
MAND1VT(VCN_E.0#%X*'W(0IS&,#7CI2@I8Q='7E5-5\.(<:!]"YZ(#04B?%9
M41,>PY^QJZ!675_;JV>I*P,I#DCQLH*[1L$#+Y<.0L.;;7U621=BTB=78Q%E
M?"&*IDI@.@NG"R5Y>8SA#^;-ON,>*2R+,"^681R8W&JSU"P=;,/QRO@-M!Z+
MV6['H\8D2\@.^+:I+][F@&09D,<7R)&\0)JN@>/+XO%E\?BR>'Q9;)+EJ?"&
M$(H;CMQ&Q6ZXGFF(:QMD*(LM\SWBBJ>9QF3\Y1*HL)9.*Y?O:!0/9IIDQ,89
MU6_F2<WAP_&HSUPW7:>B.D\YP);].R!YB859*2.TE4E@\8*Q-<J4@4X]@),(
M=$B[=%X?R&"MZCFID9Z69JM<8*?@@K'@A/%WL?O9VT@HVKLOL_;,>U>,MB>[
MNVU\[:&JDXT6UTU+%RL,N@:=32$948U@AZ<Y7-(YNM(4;PL(@K&4Q-Z1@G.R
MS8HG\1*+",XC'<J(.[E2!";:0BQO_5JBP'(Y=3"Q9X$GQJ&XGW2IXUEO2IXH
M@\6C*/!FK%$NS)I<@'NJC&1N)4+5CM@QO%E\3]LGB2O'J=4^L7E[,MRIBB.\
M/GWYEGK,C!]84$!9\L<4>63Y&*3+:\<]Y_V;9VL>L*@1*-?RH<WFO /<4-K@
M0O(2"LY$ZZSW3NADS5BJ+$ [ !4H6G'RRG6UXLQ3 0[4[./\E5R(95>AQJ*2
MC6 KM'F0M26%#R5PK85J4;PY:RQ#1'LC/&>[E+*];551J5M<Z7)(D2HGB4B[
M!K6%?K)L(V,IJAI]H<KQ'6,\(V.6Q(F_YBJY$*W!R_56218@6X>CY&3OD8]P
MMR+G!?&L+WEY5>31N;Q#0!5,HZ2%OK1,+94.8[>!@0],D#=1P 9:WCV2X(&\
MC\)D-: G5(,GZ^D10.JCZ"K1D=;0?K,&WG*^?B4.O7N,K"K0 2O6K.01:<ZA
M='!N21T\P1_X$F)?G-3+1WY'Q(.-$_]\L2"\[3GA[<K6NVO@_9;W-HL3;H/R
MO_.IMQ$-LL .^S+=_?7S9#O;T>5_Q^B*QES&Y[PA&9.R;V>$^@\.)_:+P]O"
M)D4?FVU,R(<H(=\K<*\PR$B63S\!%O=9%=!PG..W>4HQM^!OX*/$:L/;SHV#
MD5D[>L!IC>*=)$J<0(08GD9A[+/QQ?:L\EK4\N4H#%68E=,*CHH':/!SAA(W
M"EVVL 63XD=N[FITA*NQ.%EZG2HW%2KB1\:^>\.!S1Y$I>,K,"P?8PS:KRVB
M0M\5(((]*++2+J6EQ3@@W+SC7;&NKZ_YZ:3R!B0;8@P9NGT$(\<(M&06)\D,
MZE:JER>75Y&C<DBHC#*"4]M8,$HH805B[PV[G45WX?A4U%SA73\#[OJF3E"5
M4_\.7JIDQV%%&\E6'V(U=[.!C.^3RY QF&9%T%W>'HY<,% 83R$!3ZR1TYOR
M7JJ!:B[/OT$_\M$LBZ/D"IDO>$=7SC+OS'I-R=I/UW&I"SK\>Y\)$Y.U;/J"
MGVO"-\ Q%5EIKOC:V7*SG*?U,/Y24F[-N]MJ]BU_X77!B(MGL+4;"R#7AV^!
M=_H;LG&V0N5XR^9[:&=);?BIFEWM>.6"^0[:SN)6W#6-7'8N,,XN"/0BK(]O
MK70@F'0:,,O%\WV7>'JO'!$/P-OKWA&Z1EY&=5J3/R,E4.8B_ 'V*#Q_XO4G
M4S]><<K9:D:)*NP@-/7=L O#PC?0F4UDY$];9DC=IO<Q^3/E%0DB_N_$"1/?
M"=Y'GJA#FD^':9%*>J;9N)-=>3V@+.0*7>;P,G2C-;ESGJH3RAO1[W_+KKYG
M_F)!>/TX']S-8,K%,S!-C050: 28JZG)*]S;:UYWF4]26BK8% (964K_VDE2
MZB=;CVE0'"VB-.$;C<<8#YC=%O=_*'J?$^#O;]R4V!/@AJ%93*'JF'T,_;VQ
MDU-CE\"R371-?2;NC1-<ACP<#3%JL!\OMM>4IORK-X=>0L#*G-9B"R<.T(@%
M^U?)H71!([QO,!U@DH?W%A@Q8=U 'E0-,MR5X@%[:0&B;)_/RAUK8:-RVX=
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M.UZ&![@,ZRY8B%NQD6R/-^/CS?AX,SY>YRK7.=B;\1?M9(#5RIN/8%"RH:8
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MW^=851!<9[N1@.AFK"N73!%GGL<63<S63?8/A5PSN70D0UM[H%=1QT)8,GC
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M" 3RMEJPE[4(A+#YFT><Q-[3 D:!>U>1'7/D][>+"_83F*>;PS&G<.BVXE'
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M4Y8#!.2&RP>;!.AU" JH8=]YB^!3-Z(\<G9WMIQ&:9C0[6GD0<2'=(\_@7-
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M?(LOWL)X-8O]9 .OT+B&14ZC8%I'%\J>P@0# W5+$*%&;E' $4X3#:S)]5#
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MW,-EDL+V7QH92,BS#'SI4+QF]*(H^3*&YT)\0;<?:C,727/W[HS8T&R'R,[
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MO%5?Y#5'G<3QSHN*<\<(6%H#FM8LI #2Y$"$BZ(M*!J[<5*)I'&(@\[T](Z
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MMH=7PNWA51^?B(G( KE8 FMBU@T=:/:K0@4@Z0^^#HH1OG%RE:LDIPHF"K$
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MMH+H-&S?A5&Y8(" _(V$C@5AM,.>99S&+DJR1B0/N6J]2*+(2UGQ/2Y,)*Y
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M.,1D9,\&(V6]M),.SF(_A>C,O(#%?V?QQ"?KFMUX3]Y]9#HCO)B>"SP*N6*
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M_,<^[*HQE+7C8D^3(?M/,<F3<)=[N?O+@.YB8\$>S$'1C5_UGET9$R :RKH
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M- P?H]R-C\8 TW6%VA[AQ@"W?@%P>[=PDY)5.TLC:[[Z0/G12T/L^<(IH ?
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M!QZL Q88F*A:@;1HQM+Q7:""(2):4<OF)/5KI=[GLSC+TQV^_JF<5#B$B5P
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M8/!;67MMGWPK,<K>I#R#'HY[.WP6,<!!I<& @Y-)G4O&-E#V &'9U/E1I \
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M307< F$%-W&[85$DT$EAV)B*7J'YND)1\:D4@;A0)HT*JZ?5 E(,)ICJ0E5
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M^F8R.S!3P\Z7!W&KN"4R,DPK_KW9&6MR:";'4IMB^W %VVB7@1\G"]<A?":
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M;VH=-<,U;B'.-XUTAC1_:M06N]A![$=;),V_G^_2U'Q(APX'MC=R#1X9X/Y
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MAYFKXJ'=V=.^S8U'BE!.OGAI0/X'QX;APBX(,(.YJP9AT6JD\@ 38#T Q1T
M[D'S:(TF$ZD9?(E3E1I8XSZ7752>RFI(NWR=I.&O,/@4HX^:**A%8E623'7Z
M"%,_S.!-&OJ0!)Y8_+3Z<6@[ MS\%%A/2\KF@+0'I /E*QO-1V8$:.)OK/]2
MZQ]>]15A#];.GKK,#7L'/0BS5@^T0:?"S;5-:(%R_P:-_?T%*,9^ >C?J4M+
MSBY>Z9?H@TEJ+ ?D4#?V S%I,:)[F!D,\YG2?=[/_U3E!AP,*""]= :$=$&E
M&RWF9=EN4_QMAUC.$YCEX<;+8;Z&2R],'W YVRQ9HG\2LS4IVJYPKA\8*#D_
MAV3!VM7OT#/A?8CEU\8.GFS0!Y@!D">@8@$@H@ S 0HN<'O\*\((*#D!)2LN
M']C:A&S+D3.T5'6>& S'E[)O=6@V+-TIVYC+6#[B$9R_ME%LX8ON>R:3C%=P
MA16H#S!!@V[7^/&4O$](E+&,.;:54Y++ N/+:#9TZX61$DZ=MXP[34UMK3OF
M+%XFZ<8K"S45<7^[+$\V,.UB.X4/,$;HO7]:U4.D<*7RP&Q@#FQM],-.@YE=
MF5 %+40WZ )$N I8K4@SCX**!7#_!/9,@(*+4;Q LP/6>E.W(-*Q?;5*>IH%
M+BR^%!U^-B/XB!DZVF_F0V9K:);$J_70M"=O.*U,A(/VZY#&)I=(H_1HR5$&
M^::E67D^'[;LE&Q\W22!$&&F#/TED;_M3YUPY-RE8AG2ICYS)6&/]%NW>88K
ML6,MBM3BI$;VU8_%!^, Y1:W )I/1NL6\R+,O-4*Z1%%=>3E;:%E#!%#P"5E
M.?"&QPOC@VIWP5]%V6D,V3EEQ-B\M!/.7SNLA3'R4!?<0G)6W_^*N%&'U@BV
M4U7)2N"LLWUI!6!X)#0$WRGCL,?Y<I%Z<>;YF-(P 8=B@E8#F83LL%0#KSC5
MQ_,>2EZ4K<@#N070?-7Q <8P]:KW>[+F*ZV7/4N30IUY T%:-C2^$;A7.4M>
MZ5:L&>I80NVQ5(P65D];]@6#OKRLQ^&%$PB +O/>JB^^R2I>KWR$^3H)B@)-
M$*J] 1%<2@H(6+N9Y//!?!M>E:QZP4@P8OF&4DY<U36EQ)PU;STD$I.93&MI
M.]9+EJ7>.?!<^P95Y:B2F:Y? )0$ 27OFM)XMFZJ59CJC[41F%#:HE4!'NU@
MU ML3])\ =/-!;P?KJH"BXKU%UA4-I@1;:CU$6X.</L7XWJLR!5;.V2;/6EM
MQ\\MC+P<OTY,\Z>A+7$^+9M&.)<3!HK*/H!T HU>(T&2E"2;>!(O0@\/]8]>
M&N(C]1:1& 1,% *6-Z$N!PSD5 T!;DE-^^<"+VP)-4'"F*16-AM<L1#G65+4
MN:G=+"D]--K,(CVH:9&.B^N>L:S \!:]TE.8L]0SN Z&4]%\F5WM>>-8+"B)
MG:Z]NA4]4TWESE@WS7'S=!E<FW!S '0YD%(=QG( L"7$TA+Z'@#G2?P TYPD
MW3LLLZYX*$@/9>F@D.6'E>UNWQV4_<%^@%$=**I"K'89I172.W@D2*@<1DK#
MV3N@5-CJ#;=1'&0Z<E6 7;\##_NN%V&.+S5G<1 ^A,'.BWX*\S79.?&+K'6X
M7233. ]53D+!384J11O6M09?#'R24?!E]WX<Y[<9FC*NKC=T%D;YD"7/O7P8
M(Z,M^11G6^B'RQ &YA[M,<>V]VB/Q0*S8F71WK&71DHR]8L][AQUS\;-)B2[
M7N;% =H5L2^:%)CP[L,HS-7OPE1'M)BH4I$UYBE9CT*R9._' 8V!1J:<:4EY
M?UBJKYNF)2!+2$UA4Q_5VCVM!G/&<#D2+4Y;YNKX[.ATIM,#F\JH;7UOE&+(
M3%Y>E_7 E&4HFRZWY\XG&EYEOY,?RV[F(1F6#"&,MK.-#&7,W4QMK73CK7?W
M.'TSVB2G#[A^W6"1 4PZE@L<LOA@ :YN#T@'9G" F_  D?1: 0+<J>O$VN*;
M@<DJA44Z8QINF+<XG6X6;^P.:7.N;O9-7==C$ZUW\[:&.D'-Z,@V:)0#(GG=
MK3W<Y# A^=F/RXR3$4I]BH@FKUL?@SZNDGXB&L*FVBO@10<GHS"K9.4DP$O7
M"6Y4+$'B[_"&1=R=%/%, N*ESY ]-\DG-TD8Y_/E(MS 3]LD/H]"_S-A[)@B
MHD97X.7  UO<FR2=0_W!#@T ?#+"M^ZD)#&_0T%)+\D 7Y%07.7S0/@A3;+L
M)DU\" .VA#8X]I6D#:SZ@17N"+9ESV^=V8CTF71DP9FO>?U6O/KE\5\L["WT
M(7YXSEK^Q1H"KR&"LG/UN[3L[O+KH$^H*P7.O WKER(9G*]QYN-9C!;WT@O3
M'W$RQOF2=]M(X')"\^>1H4 8'R3.+(H9[6]JO?*F-MP/^:TKHU=C^AUGGNX*
MFE8KA:).-ILD)B]6"9,GK ^M:%B^T"5-W<GGD&>:*Y4R*?N;V3F>2)RGY5OS
M\Q0&87X;9I_)0XFG!7S,SY"6^OG_+^_;>B/'D73_"I\654#V3ML]W3V#?4K?
M:HQ356G8KFGL-@X6<B;3UHPLY4I*NSR__C""I$1)O$F9)M5[%CMHERV&&$&*
MC.L7)J%?I-4Z*ZI]*;^7EAK^ NF1DA'LW/\1<AB\V-3D+XP03P15@$VP2C>4
M3U >R5>,[YN;FZ]%3?UNI;5*I;F2",B/,$($*$6\H%Q,:E;-0RA1/C;SZ3KI
M@TO:,JX=CI_UK36"_3&)1'K1!3>BAE/<]"Y/_:TU6*R-?K5FD/BUL2D4'NS'
M.2#EM%;E)LV3\NUDF6].1;.-?'-3TBTMV<'.?_,^GV$A7DU.,&9\RM'8>0!Y
M)R<@?OGO,2LN#Q2795-,EWY@V^*"END+^^,+_2V!/C9-?/NMHA2NC[^8-L55
M8SPL2+*M:8DF!=UNZ;I&'/[GI(+?YK3&O9(HW0H7N(_(ELDH7Z=)1C+Y5K9Y
M8"\Q)61=D]>T?B)%#CN*/!=L]^VA24SVQLA!1_D">&*#Y=5>DIUHR<-L_9>T
M0K6L) ]%_;3 S0<3;(BODYP\4,2IJ]@4,[8E'][(,TUR-OM]#7=J=P CM:$
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M@3-R./.^N$V\!8SDG2?5$[,2X3^@P;PD&:BBRUHB"&&VG$GB, K-;/Q!&;\
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MJ8Z(W0WS$-GH5OX(PIY;[Z;*U/='[1U07>>\BJ9W*!VMF5/EZ.:TDNV;^'3
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M)?LH:(\G/Y[^>0P0$#P_-R"@EH>^=FME-9 'IX/$T4"F3,<I:4C,%Z?$PN7
M_A@EG1D6;WY)<\B(?)--4/BCCLPX_^)-"#R!1EED&2QYTUI&C./MG/](%9Q6
M>>G.UR,MPH$Y7_=/O5?BK\Z3LGR#_8H7 /\54R>2?%H2V.271$AGGSI7CRPQ
M*(+JTI:_E>2E1B)_S5\QKXSW0W>,MLIINL@#W7:7W]>TJM0&H4P/4JQG_A=C
M:SD<W>V7BMU\% KBK_$<;WXL#E41?\$$6BLE^E5LE1:$CB A@A%&[,%HFKHE
MN-=C+[ :84/-@^1QV6'U !Q!GEPO"<7V"OHRK+ONQPDK=-MA?/5-\@;1#T<!
MBGR:B,=G4H"B9T*[$A9VHW:CO\Z9B0VGJ;X"PUD1I+:F3W,BB!D+56)_36/Y
MUZWE-!F&B72W:&-W3S3+A/+B %+#1Z7B%VN%]#/O^ZE-O(4$(IZ*Y[Z2$.[H
M1X%C@">T&K$,#H?F7[58_,U+F1V\[[J<9N.B/D"(_G[I@U<J8&[:>;)+ZR3#
M.%CZL(=9@6]G>=ZZ,90Z& TJG=X)AD2)2I6[PU2Z:D&1!=8ON&OL ($,_64'
M2S>4GUE;-MR6X?D72$?M*^G@I+\^3J;#9H\=>IS\G58U6JJRB<=] ;]23IE>
M:*/C<7_'!B[-+<%GB#I;T[RE+O#7O2MD$)SJ1C;^D$U>CK),[W$/'6/C!+RT
MNATC3D_'-<=@S\\M)M;R8(V)]5D-YB54Y_"7GWX:)6[V_.S$W?!@%W>/U8 F
M #/W=K2LWR"% 6+34'^,IMZGLJB,KB<Y:H%X<SS>WXQ<$!P;52FWLZ4[V7P$
M$2Z>4FQK=FK2SVQSY!5U]D 0CQ/Q_#RJY?4\#.(8-E8#?@C@/;W.V<LQ>4Q&
M#"&FB#5;&Q%*95>2V9$$_M>&Q**-R@*5!2]@VY"64-0OQ)]?O>-HG+2"-B!L
M(F/#KL%^Z?MJ@R651M-7V=9=*6IS)1?'6IUNI+Q"KN5R\X]]5?,>T+\EH&;6
MU2=,GMI<%>4=+5_8L6&.D#2C827E>"((D&U1$DDBZK?HQZ76&3]"/N$P8GB#
MNZ:V'5O<5;)*Y$V8!=7%GGYE.^O^E68O]$N1UT]&!P GJ-3\<Y)-9<V;M ,K
MPJ@2($LX7<()1PS]3Q9&_Z8\4*IA/0S+]7K_#+W:F"6GA.YDP$$T/[3W26M)
M$)7&8HX=T_S9-<34QDDK[&)"=#4KJGTID(NDW7]+<<HXKX'9[P%9:T]5UP/8
MQE&6#A. 5H,ZADS#;@-FJSY3T/'L9CD^QM,6-7"WD<S!SLSU]I^&N6 &W]<B
MQY37\7G ;"3AN<!^"<#![S\W:_V+SE<80;,\,"Y.-YB0_+6HJ<Q_,*DL\GD"
MDB X0J9\Q/:,:/DP^$0L//^! M6H$D-R U986%U;QPQ"\-=B,@F^>. 9^R,&
M%32R?(](@7') K:2;8N@5^6&G4;EV\DRWYSRG$S[):B6CS>#(6?U5*:Q#ES5
M\0K%C=P-PLS>$@D535:P!]A$)G>152$:(+%XSEUE1[(\,".G2"QP>%II^(WY
MN7 !77ZO:9DGV?F^JHMG-MUES7,=((@HNG.=0V9BR3@[>_M$B\<RV3VEZV5)
MDY$]U?&E_.:6KR7->TG[8@@IR[YIS;OA=FC?3N#UCG[L<7V&1Y>QW<GX3DL:
M%&:KX@45OQ5EMK'? _"LK$?!Q_OG?O ,^>'<^R>$F;_0&?*M6T1MZ,!^SBAJ
M$WG'76(,X?EXF-07@(=)O )#FUWO4R_XN>A&/^,ZDH\D,(>/Z@B+$30@=)SD
M2=IHH_=%G637<"SE5;I&&)P0YD0S#]6B:*;!88C^V+:%CZ3?P]CP7^$9X(?X
MLZ74D87+S^Y@%OTOR,\>"/$]-J!AI4+?MQG6/ NHKP$[HG#Z*P7M(/D^&8%&
MT&$7YY;I?U!W$[GV:13;VKMQ@N "K2V4FBSWF[0NRL\%!RPUJD/\,2*?B[,J
MF@FK(C?R$_A;@>[0/"8#)@VJ13?0.Q)BDV9C0([A9B;7/'$8QC1CYAK;^-%M
M>3?_X1QUJ^TV7=.K?9FG];ZDJK9IM\[X0-*,1-]/,W;@H@MLJSG9ZAMNGG((
MZ;BG6'O"9O(E*?])(6_!@8$B1J!1U8P9- 6+H4<86=$J! [& Y]6GXLDK_Y&
M,\P*2B"EJWPV^D+A60(/_[ MRA^J!*HD.JB2$:2O8T G=S.C035W=M5#"),9
MP2_IAF[.WKXQE> Z;Y)WVI"F#6 -X[J2!NC?'X ,L_X^*JE0+:G8#5"\>=8M
MW%B)!>]U./XHXRC0?@=:-/#G<<>:ER0"GVV&G:-)'YCXK>DR*^;YK6EX'O&M
M&26F?&L3,+*$P[_CP+^EC^G$;LX>Y&)T0W1/RP/B2A(A9YT0$J<SCZJ."<LZ
MA*SR%%:H(#(D'(F>3EB2ZY5S)<#]^8@9 +^;F-!E5YF9#>O?;"L/IN/NGKT-
MD7</33VUHR0[HKEQ"T#>29#VF.[[+E_@9.<^)H[ 5@!(30358T81>&Z-VH06
M4$@B50 5TB$3>>MXLZO; 2-E%=#ER=%UX$Z!TRVOOR;/9MA5CAW4/DS@Z4CK
M8II\WP=J9C!X,[\7*DJ07G.F3"89U"JPCYFIDKLDX_B3)M&W@PF.7A Q'L+L
M@H) ]8SI??#B4?>!C!!.2(-6E(K9G:/BH=DD\7<FK1.VAJO0!1*T8DN-X>+5
M]FH/3MCKO-J7?-&+;<K4+25'0EC-HL.HK*(UUU4@==%NJ-@2_@+2O(&(5RPZ
M"2MMN$WV9Y4OBIR'?@Q9Z;;!,5<AK#K<]!J\?'&&+I26C/BTYC.-H8CJ6-#J
MCF9> ]]?DT/W5TG*6V QU6?_+!-).*S-WXN,D8&Z3"@I>L?D()B$.!&4:2Q:
MT*-V)EB2%?L0#R#MH^9GC%WDH(@59?J2  1^4P3<S!9J"C,(RI9)9K93Y/BV
MCKJSH=@5TU*)#%;AQZK>1ADCIK U92*"?E64MY8TU::V'0 +;FELJ.#>K+57
ML(ZQ8,64QM13-6^UBU!BJ.!#,@+CJ)L:H)+20;H$=OZ-9+GO$YPDL0@-;T7D
MZ1/-X8N%C./-<YJC!0P?^)AXW(((*CS#NT-G&)V+'9YS<.P*U7D)+.QZ7C[O
MLN*-4I$[I%0E.0#4Y< ?2I$_I0P=@JG':'?CXDRW6I[B" >]?<[N22BS.2\V
MQ@\*GN'U3?!4O'1!=:Y]/]F0CW R7+(C= /'Z%66/)K;.(B'"#P5T>O8F6U?
MC!I6@JJZW,]\SG3T1UIYHD,WCG@Q;"'!GW\?@$!'=V[9.;3YWFTR":K-XH5S
MT-4\YD:.=2%/O8E'7,%!E&1FO.Z9,E>^\9KN"DNYJG69[F1*M4XG;D:1=AA1
MQD7$&;$SU-=X?=@/[(AJ4MUXF[K/%I"*-ONOT_ OLKXZG+_V:S"Q&> ^:0-G
MYQ3Z<6?7^89^_S_4U59$/$WP<<*>C]8%6SM[?6Q0RV+(*).LX$8%EMU-T) [
M6:,+C1V#^,\,+4O?"[TIM1<4B4H2;PV5J,]M'^$SF2P5W<=TH(A#[(9V0RXW
M&T:TXA7]KD]./+P0N HS:.;3G;[^F].Q&+H[+:)X?*'U4['IAI_+ZBG=N7&,
M!=P)IT!:$@O2$-&"&$>QM7V9U=K<XR054#F[?RWNGXI]Q8ZT^U<VAS?V"ZAL
M6#Z6E+K+FMC31(XGG "!WP$)TM"(C$3AR6-?<1LEFF N9XF]JSEE=6IT T4\
MFVY$!@;ZTK?R&<,A8 .0;>U_>(HWS1[T6HQK[9L 837\A77/#AV0(R"T&C<L
M^5V.B@S@:F9')WT7\]V;8$))Q#6[5O)'@%'C:9-?*41=/A7%YC7-)E5%^%$,
M>(6-G)I'<41+1R;=0]T.A.4$+4T2?K3JB%$K/"R0\)=9N)XDD!\Q;"?HR%*"
M01(;1.V[%1W^T,K.8&'<O =UM?H ,)EO13^@J\@)'VX&]?>FKV BPD7<4::&
M (J6+U*$&-#%B(BDNA@8T2V&E><(V0.B1*&-I^I4<QZ):,HVYJ$O#J=OC#-H
MF R>!+U+THV(:TC]*=^TVK<EP1E&:K(O8F4H.QC1+8(O^X%:ZIVS&RO=H,<=
M>@NL:?I"-X"]>7-S Y#>IL^@,X[(@;RWKA@:,=;CXJI_?_M)(72=F=I":YGG
M^R1K"D-$ IUWJS$^7*F9$00BM\WP8%%_B_N*YF!+C&T&Q@<S]G!K(.JIDAW:
MYHY*QX>*GCRM>OWP]T6QXHXP<:\">/4M$CA7R4EFOU'REAL_6@>_.S(^][ML
M+ET-_7$6)+#AHG[9MW1#>4X]UOZV#O?5ME<B!T_29[HQ75># [$ES2NW%TK(
M E3J?G4AD6^(7HY[F(#<Q^E4H0?T[M[2BC*9/3&UZ8*^T*S8\2Z3V(_$G!4A
MAZ$IJPQ$N%P^-*I1ZV!+;T)Y2"*P*=O=3A=T74(GNBM&@)TVN65]!A^I'+L@
MRN@9=475\.;^OHP""8=*H[D:L!H?H'V:BF/=,:J_?N78?B%V>.QZ!UO]R])3
M#H%,L9OS.]F0$Q,S>(1G]<)L=@XZ;;2+VX%$&4E@*!%CHQ6>N)CJKXFG%-HU
M\5+JFSH_Z#[,VZ%B"[&L>#7HZ<!XQ3A'KK=)]8"L"SI_ @W^3S2K*_D;U.E1
MG_=Z5>@:5LM<3%JW'()E?MA #D9I(W8QZD0]%K)3X.F20+1F<;)/Z77.=&]F
MONX?LG2]VK)]SXXAO^YQ3:M308-P(D12B5P/Z,NLWETV2E+!L4T@1?4^^=YV
MZW0F*8J,7 #_:4?-J)>IC2?="KEE$+@YU-12;I[NU2IJ%?K+[Y^27$3VOA:8
M!$8WO]'T\0EZ\;);B1E&V(KN@ITOC7W]C@7](OM.F2;A(8F:3;3MLM#,=4'D
M;(F8+F\[2&#"BN?D#]H8Y(B+IKTV9C"O\(G9GXO\$8"1P7#YDM3[$KU":KBN
M\01<Y[INXGK8Z/SQ!Z"*8<H%$83?%N0_F0E+5GE4].Z#6-;F"!TNPQA )^CS
ML6=KX"/Q6[;@-(S?K,)'6(P>@"\$185N+O:@EW"CA4,=*MB&34LAH\ORG3M#
M187*'RTDO4H_3=0SV@_:V\7Z]56$$UN(-K$+_?JK4*6\B\Y546XIMGV(C44Z
M7B+C5]\BV-#>T+1*'A]+^BA\3 +:&!%BW17*G<%J[U$;Q&P,OZ@/EUK?J+]X
M8FE [L24OFIS^7V=[:%75Y/GW&H 49=)SY9+?=&DIL0^/U$Q-I[QVM,3'A:'
M)^&DFAZ)2(V=I/A(+QFU$_&;SW%I%L"(P](EQ8 AO>5Z#0[WBMU@\.E#2B;'
M6_0'?I$DB*#!,U8%IJ45!"96+U9?CG5+.EI@8;TP3></!#3 IO"5NR-*V_^$
M0SPTXW0Y?Q'6S,Z5;IE\Y! L19]C&=18-K!YX:Y46=98V1/UE:%$C%5*/ZMA
MNGZ,G#\7<_U8D[<\0F94H0*[VGY-JQ]__/DF$>B2CN(J81NLMH2/@Z:!$O8S
M>M&+E:-! I,'_Z';GJHITZZ5Z&6&SZ;"3<N$]F(Q<QOP,QA\CTW]KN.@&AY.
M;47SX)@*_"4XF>I_#)Y2")IZA?899$X\0ABNR#VQ.1K#=5YH&TY^]%E77D((
MJW&IKF4,-J@FG%\=$0\D=:W9R!J7E2O]VCC%$/!S^9SF ")<TDU:7R7K/KHP
MSS)2FGN;BZ=SCK>,E(@DU8=C%KFJ"L&H,961S&O]$),$.+.(<^7H[MZXYZ]S
M;ICW8H*=#DB'Q):K P(&FD!RM_E5['JLL,LP*5K\#ALA:#3C,BES]I%5;'(\
MRN9W]\MAL)/X]O.$VHR!&&1G4;?L7E();;-XN(>:<[3-W#G<MZ9<2"W9R$K$
M1&%,=;L9Y1KD6P6PL>OUMESNV959E,NZ9K8#'D0VE.'K\ZM;(H8094P/=#@P
ML)J9#W5M?#@.BFN8,J. ?H8:TCY.AZ:O$.1^W!8(P^Z31L.)_X#4AY GIM9.
M\!(BWD).3@E_1U28PV,(2?>%'E'Z49NUL(/$'7G4]VC1 UG-HB]+ARMM0-A'
M$*$SHYJB2M#KBIQ;ETWBJ]A*9S2GV[3VB^PW1:W81$<2A7\I^<&",/D@2'^T
M=Y:-H7-/EXQ6@3Y4T &_6#8KK..2]5S7.;H;A.-4V;R61' <2#Y($A_!VN).
M&.D^5NC$MJ^\&=:M[$AIA4[2V=/[0K36N$E*CV S&T'J@H@Q1 R:26C9S([V
MQ'4P'QKF'/:%%B7%WAR@APZC68I8P#Q:9G0KX6(]QDKHTPG,R$B.1(MXJ^"7
M5F'E.:Q;\3Q+*G;["7R&57D+KB /7S&. TU"-NB%KG P=C$7Q["+,]W"^$DC
M%&#Y.;,2DG5]0\NJR'.:73XG:2; O2TI%#"&-(,(CI)(YC$6Q,5*W\IVLSVR
M+K</68)Q-24GE&[.WF[*]#DIW[XD_RC8X5AL]NL:H@( 8"\KA2="[1SZMD"%
MX4><LA?$#@_4=EY"SMZ(> W!]Q#Q(H)O0I35I@8]?L;)\7>4#E_G&&L1]DKY
M5!95Q5M<FTXI?$1T"H_L/5!FJ[L1!LP$4H_:;@Z7WQ&B(!7=+RT0#?QYIIN2
M=D2_$"=2VXHA$_U3W\YLM,+Y4=54W8)Y5Z9WY"IY[[QN3W&$/638-MG0K\DS
M57*4=$N"SQ%\<![-Z?L3UTE<SUQ@PTQIGWQ%S0ZF3E]H;IW!XY%/]=[DM=M:
MQU_0<T9<[A8H,?[WR'AA?!+Z-"B5@6B](4#M@7/IJ<@VS&C@5?$>'2(POLR?
MCNT\<'&CSUKRD4 (8U6DN0.$7RE*['@RU6U:_=.S&TUG/)@((@L-2%@ZU,2H
M /#BLZ_3CY-/P"3HJZS 3HBWS+:P9SW+)PD\.H-BC.',^T(W\1;*IF8:+*V4
M I#SFU+TU.$5"(Z^%3B<J%4Q+0%1FJU9AM!VL!^3 QMWC&S4:WF"RX=IL#OV
MEC=V3,+1B/"5T,QDBD/'12M<*Q3?*7FX8R0%=+$T-'AKFX&?):*GQ7,AAWX4
M'Q$%.A2^[F%?K[9\E[LJ??C3L$;B>Y_!>N@YZ O?QF=@A]2T=N C&H''\%N-
M;P$^H?OWA,,6DBJ2_.U.:5>T7+/70$Y]45X^[[+BC:+*RD_X"B%1SPI(4-Y>
MI"5=LS=,<[8?^=6A5.?W8L#CX!<O)'=JCRPBWPEX+J1Y*UX.XKT2E1=?C7CX
M\N5S<LR_SU8<WB[OL&P'?X9*U!(NO;9?F-I&[([NDA)B"K=0/,"FU<G]G_81
M'O7%$;2I8\[?XPM47L>U+Z4]7;=Q7?-.PE\*H[O%,7KM(-[W]QY[</CU'7W!
M@E:Z0AL@F"QT5W2D("D/0[)U/8_L(RT+>F^AD=>07:V+.LDPJM?IQV22.3Y.
M>+RR,R#F%V;@H?^)6%D-FG:NMB:X2M;4W@!@T*(!A@QP_^-W9F@YT6UW.]<!
MQ7^>[%*V$;[E*6_AVLQ"FS_$'R;X]()[ .(U7+"RH!.ZA=? X3-_2"E7,F/<
M<(3E0)\'"-0=N[@A3>]SFM-;BYCE<YA,1&YGD#':G[E.QGKN0N_E(G_$6B=>
MX73V]HD6CV6R>TK72TBT]ZM&0<@'7E(F6F<_O)&6$D%2LRL^&<>[]C.9(+TH
MW?5N&%GHPL7[4VXS9I96S$YU-K 968R$_N;V342^"AT*7LU_2'^/S,0Y?0SQ
MV7S8QUN>>+5M8FI8N@P>D<NJ3I_!,&L*FBMH'*CJ3I[G2Z?:36X83I%'^N6;
ME/)Q3&'OZ9N.,RAV"=SA M3>,\=?H9#5T(.&TQZH:;'Q ER=M#4\!6ZBW6 <
M?2Z2_+RH:G<6&/N<X&&"3T>U&32SUTG9R&1 "TW-L$0L9%JOMK(1D5WNG8Q3
M#@P--AN4^,I^3=VEB)QUJF=/NS">0@EJ25=/\#\((;\D&6R;6\K.P'3-3D?X
M SLMN[]0GN3IS,,258'B??E]_02N24A5N=QNJ3DD#'07O%N:0AZZS<HW$_X(
M7'J]7W9'\"D138WP@C03(W)F/.V'SRVN3AYV'?1^AO [(1BPRT6QYCZKM%HG
M&33.N6*_,7=4%8\3_CSOM(,C8E6;&1A0%]+)9\!C10%./_%!EH^NC"KSU?LL
M^OP$[:I F=Y$5SOT=C/+&[ZM!K9$]H/R]%@@*4"L$\3(9]XI6(%!D11G:#1,
MD(36?S%5H,%;0DM0%VT+>J8_F ,.\B$56@PUJ<B-H%T<Z0,/?G((<,(IA5W/
MM'QDN^=36;S63R)APE7()L80/D@FJT2RVQR\]"\7)]N!;3E-BU/L#L<V!;W)
MDC5"1_J9&8UE48 G#RF0AD1<F\^+2Y>UX9)/X$*7(G^\V//0+93&0YI"M613
M?.:9#5 .C"7 3.7\M$\ N( B*"#X_D"'M/KC)672D%X0A3BXZ&41-I@3S0L6
M1+X"S8+H#8<.DI#):W\$L0<M*&/GRW.1H_K%LVZY$F;&BH#'>9UJV^JMKV/&
ML._T?&@-,1O+,X!2Z:09-7^LQ%^K$V,YE!E?I9OSI3Q3-0_%];Q-$H1V<:=+
M-,S2MQ>]<-/>TAV@/^:/T K>;#(+!4?BKS6C"!\6RVZVL:+7;VQL![2@+[_#
MR_=I]02W-(].V/-<NB-D%&@QAV07,S.Z;\3%>F CK(<E+HM +M)L7\O*+@]X
MJ0$*O*B#*9HZ&(4(Z")(/NJRC>1<MY:3A!<4=+@Q*%$).D<_976=-[__E*3Y
MYZ*JC'XLU;SF1!9$D %<2O7/0(M\ &H?HRZL/].Z-1TKLI#+N2H?DUQ %4.*
M:)&E&]Y-(-^HV0:K[56:,XLH33(XX'F7@19WW.E'4]^S()TWH57120=AGWCS
M-M*^3@%Z)[_/)COHV!+4[:#W6:5P_0!QQU_G]T^J/\K:%0]F>*I3BGD<ZCK'
MI""E"0!6,EE[!T:K1IK ?C\%:+($0YXE<(Q5<(ZQ*RK'T!>SC;$-+-=)C%66
M,(X?\[3Z2# ?3!DL-;.H-X"+-]U7ZR>/H%V.78UC''UC/J&=96@:@W^\8*=.
MLT,]D[8\&@KY]A/B$[0V$\)'",Q3/3YFUN<\ZD)I WKQ=TY0/UJ_I<-76C?=
MUC\5Q>8US3(SX/J@6P8DY'QHV[5+"A]CQP=]V-1M!W_Q1&VA(/<IY I=%>5P
MARHMLY89UM2B%J7?[9AQ=/9VPQ9[_,G6G%CM*Q>8EX7^=39L=D=0#$EJCYYX
M2QKR;H:I-&BO9G]]A9XJ\5CD_-7.E/6N^0%/8;RRJ#,GU=-55KQB0*_)71!5
M^:D;=P63Y9   0I*"DA+(S[4@2^7 XMBE'2B=,)VMR5JKE=M(Z)X*=WVUD-Z
M[@*+F*<5IB^TZ7H#$<MN)<FROJ)0,HS.A'U=E&^=AXV.=4E:[3&$F:-=\@N2
MU$2\@32OZ _"'-7U#);V"!+3>N^/M1!!W8;85*=X?D[1V7"Q9[._@REO((?2
MWD"E';: UC8/E.E&*;/4,&GT_K6(?*G96=-ZYSR$$<S7MMS\8R\\0+?T?_9I
M23?0=8?O)LC\ H?$?0'P"^P&^%9!][H)EZ/R&B+?0^Z+Y@NG:/+ N^"W\#->
MI_ ^<-YYWJ6A+],C"Z]_Y[[+VH1MS.MQ6$E?Y87 <F0/\1L/+'M^G#&]_!7<
ME8??(,(?G.9$O@Z?%=7%S1M)\\H_U'4R0I13KY;1JQ4PIK_<;+ -0)+!#7&=
M"V@'\YDD'\<;!3:%&!%[K0V,:)5#&\_AC*>J,;JO]O6^I%_2/'W>/[>WW+><
M*21G*4:A,1]\^5A22D<4ZU9*-3A_"1%O450$@N\AXD4\^9XHK[+5@0>^/(XH
MLO[%<?35"&QL\/,';C>P-B&7,LWW$ ?9"4"BZHQNB[(]IRA@\M/TT0C*).X%
MGAO <Y);LJ2ER]1+(*S<(]@\G!./&SB>+A2]1_8P$8?.19= SY"VR9.5$-Z
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MSXR&T(78;]@_'MC&@&_I_P%02P,$%     @ 5(*85MMBT2?"50  .%\% !0
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MH"J$RP(#L_]MOJF"[>\! 4IJ[K8J4E?]%I#7U.2WRM/5\6THAK7[K_)D]L*
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M$,.#;J)E\L!6<L5L2QACZ>RI#!0GUP--YDMQQ<635]XZZ\Y$4CT IB2D/E[
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M-&/[=G>G/"=HL2%P*QY'MS7IV$4[@_3K/0,3D94)L6*T&A X#UKTJ6GE-M;
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M!-'A/4!CRQRS S#\IRNAS!+OVQ^)MJ 008L6P-/81=V\T:^/ ]E4^[G*%R3
M%$)6QQ GM:EJ[-"O1X+:5(*24^;/K"(*8?2J\*;E)ASQ(A?.>U?^W<\X"/X9
M1@_A#49Q%&)?Y-?,(E3=D*<EKE;^%#=8%Z&$8AG90#:(&U0SQ(G8O19V%!(R
M#C+HBN=PG;M@G\"DG8YA3L-_:.5((:.!WTG4:<IT!UI.9:B3B)IV,*40%43-
ME.9A=;[!=,4G@=#H(5GS\G040O@3S7"G$-3KY$LAL6'+G@YDW:S9X0DGI0JX
M:=B])CX44AFX<*FD+8^B 8085I;M<(@M5 <Z+4>OB2N%J(#*D91D=>DMZ2SU
M"?OM+$EPG+'..(;7 78BWEX78PJ!&8<B=)V)(M_(2=J_I@)Q*)HA3V6/]?"G
MD!M$C$)7=+,P3%&0!;= )%8!."GOK\J*0C@ ,0J#?.W>. -*J 9T:MNISI4B
MK^LR+%'V=P"EU0!V(D=6%V,*@0T>I3B$([-7BD!QV1S81"139T(AC\$K(\[S
MTETOHKQ&?G]"GD9IF-#=:>1#E')UPY_$*27%J$*,#J,5>2%D_A^^G*['/HK%
MSQ6H$Q);(U,*84'-O@,1UCLKPGHW;6&].P@+HKV>F; 6$;O\!?\F6R#;V AV
M4@=9,V,*B1F',8RD=<I^G-/;Z,'L=4$;S"D%!!LX4LC(O(C"4$K9(0HHHAS@
M],S>GA6%;)Q44%SQ6=:+=11"N.DU8!.Q;G4F%#(Q#DHH%S!S!:$8&9\Y%4!3
MR#555UX4)IL'&I0ED+T<6C H41CBP/B12R/ 2=BK9E84HAF\3VP32><;1(+<
MHH)*J0)X&J=_-V\*L3FHA<C[4^W>OKN[)8GA4^X:L(D<,G4F%!*!F%ZJ)8_S
M1T^,D#<V<8T )V'BFEE12,9AQ$!T%4)B*O492E!>' T2HFL$/ T3U\V;0FP.
M:A_VN2W/XWY]5KX>^HB:53]T@)V(V>MB3"&OP2,'>8+_@M#-I9F JI"FL8F.
M5E](P4%L(*?$^/PIPYG(OJ@LO1"!<0A 4P#\ BP:"@$(80]K$N=_C0&%**#*
M$9J;1/WM#:?B#L68_^O_ U!+ P04    " !4@IA657)LE2W1 P"H-1X &0
M &8R,&8R,#(R7V)E86UR:6UA9VEN9RYH=&WLO6MSVTBR-O@=OP+KF?>$'4O)
MDBS?N_V^M$39G+$E#2G;T[NQ,5$$BB3&(,#&11+[UV]>J@H%$!1UL2B:QHD3
MTS() H6JK*R\//GD;__[<A*ZYS))@SCZ_='N]LXC5T9>[ ?1Z/='[?Y!M_OH
M?[]S?ON_MK;<#S*2B<BD[PYF[D$\F?:]P#U+1)0.XV3B/LXF3]PM=YQETS=/
MGUY<7&Q[<$WJ!8E,XSSQ9(H?N%M;ZG8'B<2;O7$_QY';GB;NWKZ[^_K-\U?P
M_^Z7LP-W;V?O&5\^SF"0,- H?>/%>90EL]\?J>=<#I)P.Y7>]B@^?ZJ^? J_
MW'ND?N!GB;D8!T4_B)/14_CB:3:;2KQZ9VMG=VMO5_\FN,SJ?Q-$81#)?[_O
M?7J:Z1<7&4R=NLG>UNZ>=9,M&%CI1GJ@5]UG]_G6SJNM9V8P@TGY!08R"'$F
MZ2UW]XH+X9;?ZX>]M[/S["E^/1"I-!,C@_I9A"]*,QBD\?[>[LLK;JVNT#_
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M=&)Y #?ZQ^057S5YQ?F\8M.P<TUD_ =C-?0QL+OS4A\#^E!UP9"--?VT/LY
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M^^PUT*JH/%T,TX$,,AA D9'%Y%=)W'!IR]%]-^B?[$\1OW$D)A9 -">(/D;
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M>AM__.)YZ_F+O4)]\\D/LH*>9J41+4R1=/% W-MYV\WDQ'V^_9[.Q[VW)P5
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MC53:,F\4H$VH_*56D2*LY+8=+J>O*:$/AH98M<B%J.>RW8J9:P^)LY D2[$
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M@C@TFF SY(%[X+2,B]PRX#6V$UD*4%.$2&.'\!5DUX)I,# WE I#KZ53O)2
ML6+:C;ALA+@HG4&);S08["5N:<+B0.D2;$WOB;19_,U:_+F(FH:J2B]F0IQF
MO3=BO8GO<,:9.1,"Q=7'G8]42_"V.,FAN- ,<:-<!5?+(?TX+0ALL+  LX]3
M[ 7M*5B!\E,;P=D(P5%]0DL>IN'!#V<J6Z/Y*&V^3D*P4W=B!&<VXK 1XF!1
MCR(E)+4GL=:\0,054#2-\'D FJ%&%.Y1%$K(,UV!+D8"P:D%+:CJZ\8$U?K
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M.LP@1<NO ^*Z7:()=!/-4"%JULF#MH473.F8MXYO#36R0[]H5A9!TO(> JG
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M^@73,4?P^'Y(?P.S03TW$ 8:$;8(05!H8*O^!(4IS4ZMNE4XJWDBA3S-;JN
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M49( :'9%RC"9CQTY#?0%>4;@1:H%CJB.!&NUP61C?B:=G5+\CV,IPFSL>DF
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MR%@"73=$XA("(71\LELAXJ#O@J10+UF*;N&;LMJ%[\NM?*:%FK'C-DKU2<(
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MI<S)HBG!3 #YI9,KH*OXU<,V'LD)197H.C-9IBN7?>&Q2#RC\4$XR+JN^_A
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M"KID[A;!NZ<Z.U*'S;E3\TUY#'+<67#X6 8N<8E_&(6#NF\I*S>.!XG!-#A
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MCZ?P3Q1%M08(MO^VH5:&> P^^]._\@>?_NN$I+Q4XAG1QF/P?&+C97*H,..
M85X=KW2F@U).Z'F4Z-=W S&C6>JXH 1P#<QIUHS"@TH8)0QL2$$,#O^9G!F)
M%KE.J?CBUVU_51E7F#5H9C$5N='Z.@Q\/;FQ6'%8=%^ED\L[97+.(P[D3TYB
M>^45DLC^/WZ5A_P>OLXJ^LP[JD1TU__G=T]^AY_CH;#2G]_Z,>,\[F_HHT_^
M]7=DS?]S/^A%HKL&C)D^=CPV?B<&?[_6#\GW)P^_7Y_^X#-V)&:'K#\X_^U?
M/GS_@P\_L@-OX7K+)NW>JQXZ7J@DHR[U;CAXE(N%^,,^+HK-9H1"(&5&__?0
M[ZM1V3>+]4'488=J36'SN#OL^6O?<N\6)]8)#U!/&P5$L]Q2-Y"KUV.!+QBC
MM1Z+-NOCX+]1P],@&S ;EOA_ ^;MW[% 9-'\2,OVO!I_PM68S"OWZL4H^M!J
M[)OWD2I_%[=T\L=YP0VUZR!FS?$U%4^B^]6S;^'L_LC@CX'CV05JP93<7%-W
M(HG$'6CQWD$'@L)7S +8@>UAY0%'.4?H5__V+W_^\(_G9?I.+%,XJDH&2\"A
MFLY0R;[%_RC3@-7164J$6IK&/:_N.TL3V9KQ$ B@E4A385WM*]>/J5W-J50^
MUM$9 -)JJ0GKXZ_.Z^[=67?NA*X270PG'E-W+MO-N#;L-[N^E48*0I+,*R7G
M-?);6B/PS:=4YLQY'HW2=2W=,+3]7WSV]<N_7CS]L"#P4!TGO12VY" I4_MU
MO6OP+ZZ9[9$IH:M$4P/+<P"E,N4W_9%XZ"3AOC^*<#S:@RB3N(V?/4CC9/'5
MY:M+-/3%TSB^3'%-AR9C>KB<#XR&2_+JBCPOQ5_U4KS_JHL+U=DPJ^+4WTKQ
M%+(X9VOT[BR!.*]M6\N$W[!K/Z%J!;*+P4BN8)M2+HZ-\)8D9( BC*[\]5#M
M;H@MK1G1 3AA#D^ \H;PA<S^M&-V V"<CM$5(P3!#IP)]'4#HS)B/WZM00U,
MT0;GA?GN+$Q#<C9LBWQ[ZW(O!(KV%5(<5+-;H\L&I=#SDG@GEH0>5RD* RA)
MK8=!E>RT$K[TS/#XI!0@2X>6U7X6^<G_6E/0MA40*_W]RP%^4_+FF0*/_OR)
M.$_/Q[&.1NJ%8VO_[)/G+TJ'!U#E2$Z4.3H?'V^BI*M>6K/$MHZJMEPRRW>?
M+>$[M.R%:,2A>P7(2TUK5,.P#OT[D8L"VW[>:I%A;A+-&O%-'8;1P$+"M0(B
MJ_,B>G<6T<B L:F28U'=5M$0R<IBJ&YJQ%^U_0')K*&*1I. 7&2)KHZ3LI86
MPQ)+YYUR1R5(4=]=[(88P(Z@QI8&G[.=>H>6&*R&5H)F;-CQ:.QN:^JIJ(8.
M>$K&7J62* MBK^7WG0+VCHPM526Z:A=OTJ:"^J1^:\>A&;OS$GO'EAB3<3F1
M,I%I23Z>$G%:#"&$Y10,Q+_;YQ<H$)TOQ@N'C.)Y\;P+B\<7A9S.K7"9TJ%X
M0<C2P\[Z#O"[;31%QZ*M\#'P4U9WLU0&\J?J_[_@JQ2?:Y&^>+Y"_/#TPP\^
MX+Z%+4 X(I$DL0"$-5>8Y\7RT[*G?_FS+4[^?YKI-T&&7.A4_PH H$MBM(+.
M"EP%SK(-R"ZEO)C#+_?QRUM"4.%T$5+=&:5A_\:(.H:"$S%F8,:H^'S..?.K
M-#Z%?M8Q:[(:$?/02CN?09.LQGX& +\5 /C/9P#PVP. _WP& /_6]HJ":5\L
M5GGRSAUNB]FTTCKK1:47.FAQQ@TUP='80N;MGI#_9IWP,WX8,JO&IS/KB27N
M##@7:R(H(@I$ZC&1O(]O1MD-37R$AI$E_ALX<?[G9?S%\X+NX_HY5\()X1&\
MR_('@1JLM"$]];*A744:/#EYL&VZAFFV;QTCHL1IRO->F4ADEQV-@Q GRKD:
M'UHRG/+A\,4!FL3QEU]\]1>T;B6B"3GA&:/.S4_9>N;L,9IH6#J J=GO$RF:
M=R@3OTD<N2"/%I_"D00GM0!S"7D.\,3"5IQ1);O+K.M5'.#Z]"70]@<<V]T-
M2V\&O!=C &1G-ETVL4L#?MV3ZGO&OAD'JF;>\4(OJ8\C%^2D^^W"XY-EB,\/
M1OAN^M07<:GW+'N_MH>:1^S\F.XIIPFDQ(-R6ICQJ@X/S.FCX@0^11KN5HH,
M.W@Z8G0#7WBFJ+H!>3Y->^5-!Z9^>:E2@G#2"ZQA$B>JI^9 S<2E_L8=-::,
M\?NLF_@/A(&YJXEL"LV^/?<[&Y44"Z79UG0/[A_45K64DN)+D>2IR!;T8<+:
M <*2>-\X,'%N6%@@NP-:'%?U>NFOS)&FKSS?N>MFC?9-44#7I:SS$7*2K"56
M9:$CH18.>A3JZ;@L_M80HRW85\1.P_M$)XH<^S?UFLO[PT#6DMN_F96#,B%4
M34!*SCL$068C!X9,S!K]DTP;8$/RFHKA=;/P^SC:_XY^ZGB3-"!@!XJ#2#(1
M^+@\< R&_J MM.$J,_C309/EH!3K=+5M?RNNAVO6C+-$X336C/1B[ ?HAJGY
M6S*TLGWZ(=@)I6^=K&C:.+]OL"C_L+00_4[*!^]LL7+E;&E)P.E74X!TOVXU
M. <2FV.F3J7K?^[M9O+6?IKH@"+'8[9T@ELZNB<N%MWHMU]@[EC4<]#EU6GW
MJD(0Y[>(Y'D9N94_C%3\)*=Z7FB>+8U$Z,?:&OO"C*R<V0Y/$YJKVCV7T(P;
MR8DW@-IRO'$=:](#3NKOJ<U"VQ-$-BKHGU;:"&2/9!_%Y?7\/@R),T7&1LA'
MV)4CCL_!\?HELO6?+2;[F2?_*AZ UVBWO(B!5#_\!TW*OO;]L(DP2MS,[CJH
M[^ET*/C0.ZE90(Z0-@+VIE'I"A<)ZIW"*H?Z]DZLC\9&<"%HNR7*8^8.T#'2
M[ _N^^/8BX1)V_SOH5F3W?@E>G?O&?A??/??\VQQ.01+J4[D1&WZ;NJJI<0O
MG^S2*BI_K2UJ]%,K=G_ZT3BI6[#X*VZ[8!E;])@&IAZ^[>F(D#C8M IJ<GUZ
MINE)M0E'Q6@D3N;8;^D0(1DI4H]JXRF6BXS=D2LO)Z$[?_1L#?&&0Q]7TC9E
MR*_K/K4R0/-SI@=B&ZKP&VK)GU5$B@OJY@%=^%CGX*ZN7BN5KR6JNA1$CBQ^
MR#ILO'5+DVS+8!#D'-.QOB_=EAEO^H$ZU$PQ=@1)'\6U7)(.(ZT->C%VX9D+
MT&::J*1,AS%)*611C>4RF-P8!0A-LT!,M1:9Y6)U7$&#0V =#K01B+/&"+.T
MG)$3+64"D<I_33&TX]YQ:1#G;5!>=D5OD@1WFWX]YDS+_!8!BC-%)DG--(+'
M*855=H16IGVME%0DY/23G$:_28/TL@M>]RM;W+KNX\H4V V?_6#L[+?;?MUP
MFR_:,4O;6PMJ+(JB&,']*RJ,2JJ*#S IV(1&&].:2*'1_*;ZD8 W$B4=U^#J
M82O*E[:MG=.R8!&F)%/^Y5/*(#Y#VT,#ATE=70],@\!\P*C2OM+NFS(W7/ZH
MY>.>K31Q3[+F+5RT44K%8\D['GK=ZS(L;VW\M9P8_%76H$-?S'Z^(KXCDVI3
ML^49=Q?$4"=$N&6@.63FL'6<%^0[DD"J3)!C.Y:!!Z>7GTIE$F6Z9F)?DD!L
MU-SJRE%QSA,8.K<G$QBGA+]H[5;14=Y$6_?3>*6_@!TX[82^5:WRPW.M\NUK
ME1^>:Y6_JKWPP\]$(L>4?)!JF,? FX'ST9B\^OHO,*ZOXBU VU?\I>I>%\+7
MWD0')"YS[D""'*K(-0[$#I[.D4_^^O(%*V=0:!<O<&$=OG0E"%K50UB,Q2:Q
ME_J0T=:#@K E:CO)99]N.> 7^Z1>(X_[14WG=:UOP8_WS[ZA(0C$1PUWKTK5
M5E6-0[*<N"GC3R=&QI,J,[VWR;82$G,4M6GF521HW;<K49@#D=\^7K(:U@&/
M%$=!J I9V+=4P)5T>,7APY#0-79\#LB1N13Z%M/0U^;@1 S<L_J)S(ZO0JNW
M8RKQ=(B**J;XGA?$&+04!)1P51I.T_JXP53T6$"91J6KJ^&"O)U #4E@X?4@
M5O&_L:[\.2S>+_!""]["@YR0ZG<@DLF#K"#7IH'*L-\NC)0<I H+KWB>YZWI
MB7B2!)D'IC_26H,%SLKY/DN6!)\LH20JRY?K?=;]74?*=(N16&FA<+J1\XU\
MZ$R.E:1JX7RRJS7R#SP:28'4!>R2O1%!5IFH-40'H,::Q]T<CR\N6RE-Q\_2
M6.)MEQ=L&432  XCORQ6SY()064,?A\-G<G\Q5M?X?7EN<VEF_J&_#,[B/)#
M'V>N/]R78DK./S-*1TM0J:<LUV<W\[+X9!8)Y,^9'@R,"=+6$D^,#HC,-1&X
MIVP91PSW>ID3+9F9XD!ZB_@"X.B@E8W@9]^O7DMTG )BB7R4:[/=2](WO7\\
M.K!@?/:8JPX00L!4L4I5!Q92'F0N@(H)4E9A8CP[L2AH3 [$OQ_','X,@CIM
MHS1RRA4@]&CW)B3WK&5?LWB*T(CYZ'T=WW>U/YD!J/;*61K2(%SW%$,2V<GJ
MIEX?9(/U)'^YOJ[WWFG_A;.[OQ#RYX&G>IG*Y.-JB'-.!! ;E205ZAKF 9.@
M:$/A^Q@O7Z4$"S,*FOVKVO@)ROVV?"'F=* %#TOU\:N_E1GEW&K>M(/P/V1:
M[HO!^B\E3O<;=5<_AZI92,X"G0Z;2@SA;"EP]1SI%WZK.'7\#Z.!XQ1A,YK7
MRU0.DD/FSIM^8'YJN![)Y 3DUV[Z%D[9^K9?5:LC6<[#CM*U,"WB+W AMMF9
MN9=F5B('D0OP]RZ+;]AK;D:7>MST*Z(I%TTW1KUQ(EB(24Z]72 1/^)DM",,
M[EQ[+)0;[[)X17Y#NI>-72X9ESX@5-%"S)W1"2!3HD-9]/%IKP77:%MA I,9
MY^)E2QGM_@2""?Y&_/J]LYO&:]T':%;6<.%X:E,.WL^&-QG)RB>E@5JH)1-9
MO).5\)>6/@1R*< HOF718)FWP-"*>#1 I#D["RD=/;%3PZ%-).S6WH 3G347
M*9LMZE?PA'+I1:-G!TB0.#&)_ 9ASNCXRO,N"6K.B,-14;,XQU&O/GX!8(#4
M89$:[QE*P@_(?-O>#<C=>]4"<* "7I'$V;,.JQ:<J1>Z>?WNY-0@!9[(G_O=
MX#-Z>MN#*C:0S^ @#"Y:X$2M,*\+_BVNS9X2;[;FZ0 8N8,@+6I=NBS@M%5J
MM*L^SBTSJI(_T ]"U.HR@G(KYEU@N)4VL/ (Y@2!0?13)<+:1;<Q]5LL'BM)
MK:=T<:B:,!QWPCU"P@7$Y$9)8K($DYTD2Q.0(29533>)1FI87Y!I.YH$7.YN
M.5.'#[,=K#%RII$QU**8)7-7':XM"($G[R9+C,9<GF@Q*WK2:CP>Q(;Z2<_?
MC$0KO(&.[K*%KNX1A7KL2/5HUHTT^MD3JII47?!49%71]1!AZZ,'6D4_U'.2
MQ56<RBUWI*#1#&,\O^@6K.8&JQ./E([3.I"2KU800]!2.>(*E$<_!4S]V9-G
M3R L4WQ#_,[%W[D._]D0K])\)\#*>M6"/I2R(+9$*'W2,'US=>W9T^Z[LVS<
MVF5DZ(0F'=V05[$U/>!HI[T(D_(PF,@.\%N)#)SBSUR:D=FN,PF2&1T(GD%
M8\SPH,I%EA[Q/L?S.39@@8XN,<%%D[:_Z0>1-IGPE1>H&\1C;R0E$RDH)F(
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M.(R!];@+Z0>R-.S8;_9W%<.X-LVWTL:I6T,V@)CD^<H/>;>W!ZG%W0"HPK0
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M-$;%WYY].&@X3]!JD9A#U1;M>1"%LZ$B(@2)+B>$0LKL><=\DCTK3,41VM(
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MCH-JH"E1FA&;9;..E*+V&%'M\<!I2(E=:NBT)D'4,J>P\G39T=V.$<L0MV<
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M98I+5L+V(N9BWQZ#N0O$(I-[:5.J&TB D)Q ?R=T-\!3)WXS1[,GER UUXH
MW:+TG"7_?.*/!$8'US>:32@(^OULLV/*N'9+)1J!B=%9)QIJ*7&[W:?IQ+G7
MBB/8:P$P1PC3MDRRD EV-N^L91,W8ZCVSRZN%[U<VT![@;90<]WL07;#?C<#
M]S,G0\YK_R3&VZ?W0MD0:0QY]*2JU<?;*18[346CBNHYO9$B@444F1J :=[(
M:1VC@U.ML_@Y4^R><?F<=AJL+FF(+:CUC-[L*C^=Q?C*^M(BL<)A0)-&AN_2
M#^.9%N0=;1=.0O.',1X[EE)J:/C./ COQ!P3XSC<6)E6K268^IMF$,_S_4[,
M=V+3<7W/V4&F"V% 7$]A].HF6H'S G@W%@"7*)3PBQTCY4$F[5G"XFE]!TDW
MQV'R:U@"/_S*;X?,^>",S,F1.1^<D3EGB_5S6BQ2X27N+[-0[(<BT35JYR6E
M7^.Z_358J/.4_XB1!Z7_\4#45>6@KXA(*#,60_*5**^<::K>C=E//NJ>I1NV
M?1?#D>\$(P&ULIP$+:6.QM\(D=0O31K.13)-[AJ]Q;[/!;LUZZ?ES\KGX3AS
MAWP7.$BH!('B.7CL-E(1DUP?9<>GV3K)Q7D*#4IJ,;@'Z!GNI^UZFW:JU^&R
M\;6$JUN((7Q?QJH95H?MB-2_-.RO5H?!Z) GV;V)Z)PDZL+04*GG!X#@I;XI
M4J-7]4+>_1'ESQ6>^8F4I2;0,.ITN+B*<U"S4&3\:=4/E-9&+R9^08;@B-XB
M+3-7=X*(TUH,_T;2J=+D(HW1=2?T$*G,HGVGGA?L#%NE=DX1&-0FH;T %\(G
M A!]P7-3?&XX2,%X//WP@P^@FQ(#AWC5M0/=?/Z\M N12GQ-J(="YASE>FHN
MEH88QE@\_3,^_>*RH.&)P=BS)T]QD8"+?#E4A MY3B5T7/G5\^+SYU]^\?*S
M+_F7+VZJ'>7$/RQ^']_F8B4__ND/6A9CI<BF>#$0W#GNZW]4=V7QIP_>^^""
MW\1_Z/.AOVFN1 &N*SZEY1C^D9:C?/?])Q?/GCQYXM>96]Q</#ZYG-$I;BK/
M_6%/F I]VDRKN3 )Z3L2=Q7<Q&$HO(JR O]8!I/:@;*-E1Y&GP[/  N,XJA
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M=0]4C,&PS[4$7.D]+ZZD6B;%->+U(N=WNC_ZC-=*'/ZYN\/($;'N !0 T'H
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MOAP^B)S$T%6:E8(K%8LPR@7"22PYWO:U,YVM?YSA#+CS4GN]*K02 4%2)1<
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MPKP=+^,,AS*4@/)"N S9WTH.R*I>6R$0BYPP\YW_C#AI^@']T<Q+!LU9?+*
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MU)1&]LF?F#;(@T2%B'R </8WJ_+V)KMRO[D^D<V5&*189%*(GIE7L %6:$%
MH)YQERNT"3%]THIJJZ"CI(8&;\<\L%K<M+*9'9!/MDD?-OJ,&[/%W@*KT;5
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M;D6QPUAT*0O#EQD<;^]]B! );="-_S 7([&AW=\M-D:%9M"\L>+2J9S Y,$
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M7#1]0-S!(#,8W\22$C$W6X#A@[J#WI$C,'L1G$/CKQ?9Z=O9J4GB@@"^W[I
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MA" @=V#2(=BX\4,OE0).[]H&-S<N[;.ZADPC95H66M>./0+$M47[JM5,"C=
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M1PAKD9@N^ 'D42Q!+980@1K0A;:E8!PK>!K^AQHJQO96<//Q8'W7Q$T(VF[
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MD3A$]S<G/>;=M-9@,]18T*Y1$,7H=1*&( E+G;_KF!G:@9YC3S!0D^E"B0;
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MWX#A:W44#)$=&)T+$ZR/3O_P7Y_V=C8W\98P"D.JH[:Z7(5S]^-)EF.)@QZ
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MLU[Q$33;2ZR ]]QYB%2T/9ET' RY0,O9.$JR*O(G[. B)DM_$%[2<Z?IR]7
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M5^3[PU_>Q?^IX@A#AKCC!^$<G5/ > 6$?<V#?OCEBY"AY*I%%._*YH@#CWT
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M;:MW 3J3W,BWC,FQ[Q![:"5B!RL7S#A._;=JF%<HJ_LO,;[6WQ/Q&GG4AB_
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M[?S4'%1?-2EPUF@-G=;M[DZPLSMHB9"P]+JM)2,[6&008>EQIY3[1?4..IC
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M:VSDE<1&YG^M 9+7 ,EK@.0U0'(-F_6#*EG>F.C:<.$_JQ@=\+DN9*Y!':Q
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M@P@;G"392 -84OX!PT*.DA L"U.Z>OSQ?<__@Y #\*CAGX$3&R(_<3.[ =$
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M9=LG!7I,>MJ!*I'R=NM-OX@Q"XT";4BRD10!<?I!G/K'\!CFG@\V-U_V?"J
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MTK^;4-%)##:+W<X ;%E<%%/4ZYD^G'>2]WW3]DQK.>A=F,JWRR<!4HR'D9/
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M*R^=TEN+CL(G/.MP!W@,)75.S"H*GL/7P*\-[9?2Y_*5(7OXE=.>D]U[0_<
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M22 =3L!58S*_1Y\.&,&=@)JHIBUTZT#H> PF,-&63Y=+3Q8+A^H7# GX"N
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M[.9(KL8,_7^!Z@UM\0N:7_V+4GX6).YF$X"=,7:(*V:9&[$IP(P8,?:<^KF
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MC-V7!/<1.&-5HPUO<;V><J;_C\(FO%R<T^3<=@.'0HOJ;37NF=5&OPRK%9B
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M*Z*BYAT2,TWS5MLQIW DG-875']<68),CCIR%\932SV.[,-89CN%[AYE (4
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M7'%G\H3_W8/#\VJY>K(1K#41+%1-G#;?0OX2+3CH-TCV;LI_;K>33Y4^ 2F
MRM&IV $)=T/]'!#?-I9;U^TG&7 */22=M[[4^\\W2"@?"?5\@X1ZX#O@X[C]
MK6+V=^&%5T>HSXA'B]72R9M7>(Z>Z;<T7#(%]7%8H&">BR$2AKJ(MI0(9*LP
MFUMSZF.:7-0=QQ,+C$OCJ;R XBK#NV3P2$)S@_F925W5\V(BU"YXX)N^[\E/
M$"X/Z,?HG,0F1:FZ)!ZER*2T/5[G4DAXO7K\1LDNPJMNO!\9Q?-TEV2#NJU
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M\3)AX;/Q GC5M=?J"T8;7TW7 :$%12\D_(#H:*-3<DVI7)L)L&[9M_GF+Y?
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M[SP;I.JN/*&]BILUPF"M=S48%'3=:#M^@ZJMMZ:MRUAULM,\Q72<Z>H.+@O
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M!H2^ J*(C-DNCY@JA#M2>+844@YEY\=@]4RIELL;F$//\(LV1K4]%U/KXD1
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MYTFVP[7BW<9>7UEU%BR- 1]*AEV85/"_?B+ZJN!$$?_<B'@9AU5%][N83OB
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MA *5#J,0+C')S?<Y+7^(($1%M\Y?H5MBH#,6.ID!I+E&6H>Q[C 3/KCS/3J
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MLYM14@(9F7J.)UE2OI?V.G&!E&0F40H+WX*XS?:])Q_!SF]YNB9->>I L7M
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M(**+[E>ZPEIW4=P;1*J$O3 _7IZCVE8G?GP/.E!*WV(;R'QC%SHG8RN=\>:
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MJ+HJF[,*B&!)47,)=!O"I1C0?H79"$Z08%Z 38GN@FN\]F,?0^=6I/[)W,G
MRSRN;^^@S@.QJP"MW"U,((]??5;6X9H 7=G!R-.B4_OOVO<K+LL_:UQ^I\+\
M\WJ36@)CH][3:N,4OL)6PNETS74)4*YW>N8;0FH[7!,H+9N!:T7=L)J )$8
M1-TO?W([ZF;S!W;E1K"4L[/Z>;W:JIWJ9QL;9GYOS+PFO99M9CXKNL"-%U^Q
M>;K;J'T%*=RH7K1T!_636J-5/_L3);-)'-DP[JMBW)GY<_V@IPZ^%IV3R\;5
M90-DI_OU\I^U!M9KU-:$ ]>"T7[H>H43W8+TW'LHF'I')Y6':^H;0N_!I)ZB
M/XY@^R4;2;J8$E@D]THA;1OL)&R!A>5E)M=HI/>I>2H,5&HSMO*4NH<3KQ^
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M,,($5<0C2DGM@9UR^\G="K:M5B5$ JM4A^N"J+;'M"Y7E!B+]41,XXR08[L
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M.0._#WTO&;B5?4UM(:1@10<]*>?'@:ZQ6VWTBRB86A8JL*@0* M/MP&E":G
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MB8'NZV8=H@E%L091((6.,:9PV,D!!K#JL_'!_[K\TJ0NHZI!$;FI5/@<%OE
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M<._HL.+_.C[>*?_/M>]UXZ#KW1;O!MT/OU<M#)"&P@"I6A@@50L#1-S)#6H
M$Z.^M,6-W[S$%19SCX^+916@R0C_@YV_XR^SO>),$2IENPBH)V<C4KLQ'."[
M!ZMVCZC=WJZ"L; PM;$0%ZZ>:RRZOH%_@WV[S8)V$=R2Z9<Y9?,JQ?+_60R/
M*"ZXJ91NL,^@_ZMB;R&&Y6D7)\_'.D"XA1;!&Z:5#SO,F^)<+U?T KR5';6]
MUW+48'5'E0,Z:@>[1X<E_]?>Z$EK8D093AO''5/-\&8Y5WOVL>+?T4XUE<ZF
MCQGH44\^9M7A+680E_>YK^6:'[1RZ?5P2.GHX'@?.61__ZBTY_\JET99A+8/
M.P"DB[W=*M9+<#']"%\@#9; &&?^=3S$>FQDBI6PQM-O[%*Q\G]?,9M4LFQ2
M*95+[B7+\ZL09I3+%95WP15S"XS=U\P*NSFLL,]9D2 TT"N,$&'C>6+W7?#$
M<R3%WFOACMVCX_(1:1R5 ^&.O7'W20H?\,IT(CU-9=M?*F2Y7-;96P+K_-<P
M? 35L_ Z),G^:V&5'$&RGV65\\AC)!G9J4=+Z6 WH4?FH#[=Y6,\W>5#]]H?
M//B@UC8#X"O8Q']Z8>@_NE^\WL^"^P7?XM;95G'/!YTBO80^+J#(*N9SV_Y&
M4$WAOH-7S'T'6>[[@Y"X*/QR-82!L3ZHR?A5@ODTRG?PVQR6RV>G@S5FI^(*
M1=CA*V:BPW&W7;5S3SF+=4H&I/W-RC(Q<P^(E8[S>>;P??#,<V30T2MFGZ,L
M^YPB=1&D?(19^G$0*I=(:=)]9^XV^\J;[<8[>A_L-K>(.G[%/'8\)X]5Z&ZK
ME%]&ISI^'QSV'(%6+KUB;BN79E*KJ)Q*M*H,V\VC4I5+[X.=YO=(OVJ7]%B?
M].Q:5>5 V"F?;];96[TN8JCRG__Q:]^?N<"3TT$749&Z##=5><2+>39DT*%\
MEP-YA20@I6_&^I>ZV^P'/[$H.G4#IB]&ID@^(R[#&:H\6J_$.5[>?:,L-^(:
MG>!Q );+X:2Q'"E7*6:.9G@RG^V6Z4A=.[<6$>#EF.LE0OGE\7%:ZN"+P)II
MX96S[_DQ6F=]@O<+E3.XR_NO:Y?W1L.L:I<;OH"'$3"WKNQ6$B0O54/%7IWU
M2-5P%KK;DXXWISZ]],:;=*AR?C[4B4ZNL=+63J@M4TUW4I)X5[HW/:+"E'<]
MN#&VO&W5N-O:$+T96.P-7Y>/=_=>X@15BI5E$[(R'R'/=('%.A%R$G/N+ILY
M=Q?+G.4C@C$X*3KEW?W22W#=[K*Y;G=>KELRA9YLQ55>39[PJ!^@DJ/R('P"
M)8\.KY.@$WAQX"<SY2U6QN@^;\_BG]?:*A?K6&K^XCQ2[X78$?&_OS3.J<$@
MN7%.H_80B3^Z=&>IOHYRL7GR;<E$:'F_HE[4?701,;M''-1LW_E=;P)5EL,0
M)]7SU=/BQ NQ#1H=TO.@]_,:;>/%4N99#'-:.UL]D4X-FOH+T6A^[CFO?ED]
M8<Z]:S]<2[ZY0KB959/G2IN2LW'.4EAG&4F/)P@F1:@4< F!_HAX4J#%G8)6
M J8$& M;"$G>Z?@:HA(O?YN:'2'2]OHUX'ZU!8O/@:Y%]-EINYY;!_4,+CHC
MW1 5.622Y8'H\7]YJZ?SQ,X"T$1>:.]G*!_.,,@T\9.[B\XHNY2*E1'RA?[-
MU&KE5+[^<V5SAPJN$NJ(H$&VN0UD>^!(DT2-7AZ!/8&]-POZ)P2L9[J&IAC0
M(0Y\$?;;L-)"6&DTJOK,.TW (%4;"M4AARS?Q"%HDFN,5D8$,M\9P1EQ#TIE
M[#BTO\V.YENE=S=W_EZDKCTG I?H872!4"5OAG$O2.[<9-COA\2%#'<)/-I_
MY-[!C_J%:F8.=7-EBUQ0&[$!20KU=$F\_$11NG!@B$7-8R(6V<$&BRR#17:P
MP2);$"O.AKAX5'IQ'#)":6C6OUY46S\:M9=%3YP# $W19UV1ST"\.[%QG:)2
M>_VHZL)5$P*0UPC G]APOBF\7:SCN@E"0=-!/RJOFY!V&,6'A\'F[1W,"VA[
MPT00'[SAX"Z*X4;K.#@P80!@IS;.9\!_307S86\M?(2-$:[].R^\65,4G[?3
M.V3F=@3P%KS3__:A,@/.RI=:]7O#K7^O?D7$U//6Z0A,S&R.F[$&XP%2XHFM
M3O:>_NCNP0S//G5I3] :3\$"^:12;Y7KA8%-%F4F?WG\-,GPG@;*\YF/S [R
M/XS9BQYB;YQZ/GDB'Y./E%9%;N6XZX>OH8O(HA;_ZA;^%!,H/RK['MO$'VYT
M_8RN?_B6=?T\.BX8QF\J:T_=RR>/O& WT*3\D5<PAVOLM_6B$\E3OE8^J;6A
MSLGE1?/RO'Y:;=5.W7QTV%5RT5*-3>NEU:9[>>:>UDYJW[_4&NYNF5-?%CR+
MMWVT7R5C+' J,ZDV1Y\%;RKYA%,3E, WHN^,NR//=IZD];QEG6>1WIN7NEXF
M"LV7OV8GOGXYS82L(S_#Q?D&;ZQILUC)95V_.*W]M]NZ=-=M3R918R[?:,KC
M.?LL)_A&;0_)+-E@MC-#)KR#@6%T#I>MF+$52I&/)Z%P'^UG'(@2:U:YU_]Q
M$_3^IU0J?_A=.<@9PE-U$;=0=J^X)V:U33WVT&E_%L1==^OJI'KYQ:V??G+_
M&OSZU(MZ%\,N4*=-B0?PY@:^IPVD[L%U\[</'3_X5,7&F5&,S]?A:BSO'N[_
M]6/JX=]-M8]-F"FPW>7L:A6KG.WL&G_.Y)V1!+0%;\?T+:A@GIG5VN"+%U*V
M<_..8RB4LG[JMWUJ\ZJD#X5"L&)]+G+EDVAO5A*]./-.I]9NAEI-T_X!R'39
M]SE3G[,:,!$A]N\PC?'>=\^CA$-/&#8:P*C<[3IQ&4U\A,0+H.S^NC/?WD1R
MGE#5 K4;MKN82SFA6_OW$$'WMC"ON!T,MI=,W(-7Q+;[D^GL)7?N61@]+)L_
M#]>=/P^H_1\G$:4(:"KY#"D70) C%^R*G=V41'S-#8Z?8G0'W5O7"P=_^P!*
M4MS^VP<LJ/+_IU0N%?_5O_WP<;G=17-H,I/U?[PQ]',,_<K&T'_9:%Q6HLW:
M^VC<F2NOR9D;3=/2]H.5J/7ZLE)DZ,.#W]1W"VGOVZA=739:Z#9 "_JJ!O^Y
M:&%KWWJS56N "7WUX\MY_<2MGIQ<_KAH4;??>N.[LF<7-9,OD1=W:# T(5+
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M*P/XNA5:>F$263.X]\*A9P;/50)UN1\6]!&N'M 1IAIT2??K>AT?0=',_5Y
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M\LR]O*HUJJTZ_(#:5)Y<?K]JU+[5+IKU?]:<\\MF<_4+V/I1;!;A-@]#+TY
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MF^>^FN=N%F"WW Z6T>1N9_^PL"'V)\=S,#?F1)@:_0_'GU)4KV5W#I!F.ZW
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MJ7A&^_CMU4JL<?:.5D7$U,%&R)!M+&<ZI ,?:M.[(L>1T/0V*NGZ?DWFL$Q
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MZ*?V;U80JC_0??+7'^PG!P_201!.@I"<*%B&ZT$<].'X;+?LSL'!*3B]"-[
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M?,#QFH/ %]+56.0R\[#!'GFO:UH)J))]5=$;$JA\,GN*I  ,&2=Z^& K.VC
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MB [)K&SP) \0W^SZ"3>R*:X#&D.2J[<446F$NLZ-'C1]I^Z/A_0I(QB3RV@
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M\!T*/AD<?&8^DD@"_ !>3_7 A(>8,C< ?T04X0S%YOHE,SA/OGPK(XTH8C"
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M]HQ97]]299=/ G4!ZA389(BUS_/:J,UH5OL8:H%?NF]_EE9.1MW?4P6B9 Y
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M.'GV"^9F4GFBE]M7%6OQ<$/..;C7M(%>JA6&M(QCW4'3HJ./,R*20#;IKID
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MS% QDNL_IKZ0;SQ@2I-R;_SCN1_"\2O?0F(_[B=$// Z)MKS[<N;:SL"O>?
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M(]8%SCKJ[I^4R=WQ=3H';7?M/?OZ[H^+[];YG]^_7V#B\?;VXNY63]5+C:X
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MD9W&6=@R_>1;V_TOKKZ[K<Y1'GW:*/ MQ7W6M(2]#2YAH\%W9&POKL$I=IM
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M!>&Z*;J>.6X^Z)=I]]4-AQ8_\ADGX-9\^CQ,WN]@/,P6,TZ7B*6$O9PS.$=
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M'R/$W_*+N$4X<OFG?JL:]AZZD<I2$;CMML&.E/5EEH$(;5C>+Z'QP\6AI(Q
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M0-$7S%E@1I=9+A%[A(>BM+J#2R1" M@6DSM3M[[3H'..%WP=O$?X3NGP[0G
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M $N!.2;&X6/T@968)FS2$H.%2+X (3:!&N,73D7=C1!:D82&%S*!V>#WP%'
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MG1I!H-X^ '5>HNTTM/(14OICO7=K;Z"TA2+L=RN8N/P1H;0O N,!\X,^&%Z
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M#O$OUH3O@"BS.(5@#"O&OQ"(8+<M 02Y< G$P*:*G7R$9>:9[Y3?<<.$<5@
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M*Q]7R)C?2=!(+UMM*.G%4HVU^?@D24]*^_ /N.WPS$C]"[6NNXHX[=-4BK0
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MJ9/"B5Z)QIMG> N/NW)/Z E1T9ACN']2/:GM3)GA/Q)+6K$4RU2H;AQV!YF
M>)?ZCBR&$4\0B,_"Y0T8@I)!NH'I(>=/Y@DG7#"L*_%>HL2E.^.M7D_A9W_B
M&E1F,M^N]FRBB?<^YVUP4I=HK;9ZRP\1#LMQ[3HZ,PW5TW^HIOX&MWP]#;%F
M^":1?< +D4_YL]_5&=-1$[L^6 O_AE.SH5!9*O#G)" $DER? %/XW9[D7DZ
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MV;ECS+"][M'&CT+;7]I0Z!T-A=H,A5KJ*D*;G[NNHML<=(X6R'8LD-C^Q]7
MTWIU'[5 M-4F2+L7'Q)8M0E2%?Q+MK:&",^N:'-(['.H:7DYX=5[1WCU)'CU
MX1%>O8 \'"'4CQ#J'P5"/2__;QR$9^]1T:MJS1M4W.J7:[)HV>:^=ARSM'R_
MX+&?;Z?ZAH[]?%7T\P7_/+;T'5OZCBU]=;3TK8BB[VS?R@'GR ^NQ^BCY;@/
MKZ5ON'\M?9F3WP<N;@>4O#ZV]*W<\^$^M?2UM6ZC/QP>0DO?\%!:^MK-UAXU
MK90ZJHJU]/6S-8AOG5WWIJ7O0_>^;%5?E^M]T5I:H]<^]KX4['VI\\38>N]+
MUK;P?>C;V'KOR_#8^[+[O2^9W87U$3CM(]0U=?8I;-?I#QI:/Z.C<BQA2]OJ
M/8[Z'48A\Q8*5BMUQ2*=+;WFX-C94EXH=S\VV&T,LV(_;;BUI02*S;J&EJ,A
ML%O]+.?M0>,\:[SRJ'%VQPS80#M+?=KI:!WL8#M+.QNPVX[O]AZ:'1ON9NDT
MNNWS/>UGR3=,,]LXURW.\QA67.0[R# PN7QM[[$0=Z>J_8Z%N,="W&,A[DZ*
M9DHA;GY&.XQ:W.0 P,X6G!UN3/_@:@,_6$S^\"IQ6_M7B9LY6'_8TG90P?9C
M*>[*36_M52GNL-\89M6F6Z]MS$[W?2[%U9K#SMZ4XI;=[6,I[$<OA=VJOBQ7
M"COL-%I%88^.E;!U*NRM5\)VCRCP:[GC;&\I<JQKS1'-:G^$!&=[GV)@O4&K
M<7ZN'43EPI:W>H]C:(=1T+2%RI7U,;BB=:W=YOG@6&!26BAW/]36;G0[NPG9
M7F-=Z]$0V*VZ5JW1ZL(F!RIGKP^"#V4(;*"R]3C1I3[[8.<J6SO-8S_-=NR.
M#1>V:HW^H#9]7W-AZRJ@]ITO83VON(1U6 QJ/0MI'U_ A'M^=M@SK$@U)%OQ
MLBSXM^K!!;RT57^R7YGJL#DH*UPG_\KV=#/VNQ/\:F),I\PAM/4GYKTQQF\V
M8<#K$W6J&XZXVIXJ^ 522+?>__,_AFUM\-E5;QU@1]UYYY6;8&;RWYNZ"^*K
MOZ/9R?3Q"_X?/]?G<Q-,7EPIK-%V,+TRI^ NX4KC)4SH4'6.2K2ASA:F9\"O
MX,JG=[K"(BM*@5LBT/4+.YO9%GL7@-0V%\-3N%+WU#=[84[4%_T57P_>S0$3
MV'@-;A7^C?IBFZ"'7+@<5F.:T1OZW\KUT6H-1XE>!;=9-K.7:;#TXDWU\<5P
M!9"V"G\S@,)H/<@UCE]0];ARGVE/@&O^9)Z_-?B%DKXU')U]&[(?D>TM"+K6
MJEC2S^N5=#L<O 6A8"%'+L)L2II;%V)ZE\UU!]\058"M.IR=D"LCH@8KA1M.
M;=.TW]R?/RZ[:!6S"_#?.LN4@64P1R_>P?C$DD&RK@,BBV'ZY3UNFOHKW=>^
MB'SYG&!DRY.,C0C&W^M*[8>P1N#5VB$%$M1LDZ[@W\<4!O^8!X/VN !^0TT%
MZQH*X!:S8T/!>C8-G6M'-MU.[TOMK)HYZIVQZRW>>5*B04N&$E;>H-A7V?K"
M\K_.X;_I5CN 4B-*FM:K.JY<,*#XS7YC#O^;,3.\#%'C5C,WR/VNU>QK6@V3
M!0IN ,_AW$[CW1?I>9U>N]'O?EBP>DT;E S 9P_!YL[#K(K!:PC!W/V@?3*:
M5@,>;DF9BV=3$H/J1YD3.UAV.O%V9$YKMK(-*-ZMAJ=T:6I77EF],0-":VK=
M=!G:6G^1UM9V3DGE- S:[6&CFQ6C>0>:BU(U3KN]IQJG<YY)XVR]?6J---30
M];_9(_NPI*'[@:5AXP6/:T1C?QUXK=E?4QVR18VS]XYYM]-H9PV0[+S"V5<G
MNZT=Q/&[]Q[S00G#?GJ_U0C#+KB\G7UV>=?!/6Q/RW3VWN4]'[8;PZRE[+NN
M9CK[Z?+V0WA=^WSF=O;>Y>T.S\'/R0ALO//2L)\N;S?467,P+F\GXO)J^W3^
MAEI?=N[XW7N/M]-KM%H9@09V7M_LI\?;#V'1[/7IN_<>K]9JG'>V,?:Z#F'8
M3X^W&F'8!8^WN[\>;Z<Y6&.";D_+=/?>X^VWX,@]$(>WNY\.K];L'42.M[OW
M#N]!"<-^^KO5",..^;O=_4WQ=IO:SJ9XNWOO\+:'C>'!*)S]='@[66LZ=_WT
MW7N']Z"$83\=WFJ$81,.[^J6QU0IZ>VO']QK:F7 PW<>SWC-QNV]I]W-X5QL
M!]4ZPU,SJ,H,=\FB07O[Z<SWF[UN)@WZ<8'+UPCZWD<1*(MU%/3,@KZ?@8I:
M!7W#\8NX,;4.9_' <!FU7F_GM$[>-NY=Q^E?^\0"*B=VC_RS,3X\)JG6V[TP
M6MY4^:Y#4^\M[__7=C!:(V?J[B&T:NVJD?BT>I$;WX19(X&8U&<<0:A.$+4U
M J6Z!"WZS$=EJF"/(>@CHGP2)I/*0)XG*P >^5!J0HB$O[34-]U5_[9ST.B7
M?RT,[_W:<CUG0;MR"V_G/+[HEM X-[;U2O;BDDU(TQN_ N6N@'#1P0UI4#>]
M^,'<4-+)LHWQRYLF2S?>P$^<LX9A^A^ -.VX#XG(O!$1;:AP,?HRQBLSWS\P
ME&ZG:HW<KD\C?TW7IOXD-*E"M<82EC,AZ%JVQU%T ]QG0M%= KYNJDN/6_&T
M5@.,$,<#=U=EL[EIOS,6AI1.%<?SL#2V\DDCVH37K@L,P=?))RKRM8<,1M]8
M3)^Q>9Z80EHB'Y&)0+9A*0*T&\^^9<AP> V!4 YOZQI@P7(6ADOSJ*>,./\X
M!>H1GW81?E@*-G_\0-E%^:]I-;2.R(/^G[,S]<I@YN1G]0Z4[F>XVU\+Q(^'
MA_;ZGU52O/!W]>Q,_)*L8W_)<IW\Z6>>/8>+VV@ABT^DU=S'SS)@BQ9X\[A+
MX#^=UM-*6$X+?8^KL_#[RS?_K#Z^S^&=1X[^9(P_JS? :)PZ-S:2H7T>_M7?
MY<^(0K3/P78FT^K)8?J?9T\,V!MN/">RA]?;3U@OTC1,G=!N1YDL\>'A]>*+
M!+M9FN%22;P2Z#2,%+G,DDM+02S2>M?SY7+T_5Z]_C[Z]?KF5_7;X]?F#BPJ
MM*?;W*B;V\?+!_7Q5KVXO7FX_7;]=?1X^56]NKX9W5Q<C[ZI#X_PP??+F\<'
M]03#O<W33)M:Z[)/?F\^--4)HI@[>&XIWHN]<,$LP*-YS%#9T,F&AD)@&O*)
M#0B<6]G:,Q\--3Z.1ZKI$P-,&+QCR[#\O07%HM*("0U4_V^C^TOU]N[Q&O9:
MJ6<[<ZUQ%84V9!UWJ[:.._7&*_BL![):"?\_,C1&!VMQ)DRY!2Q3 6L.W"ZP
MI3P6#"*AB(8K1YLDAS7$X)*EN2>N?!R;?.!A$[VJ6:9;;MA$4:]=N _D@Z\:
MV!YWT!^1[?R7V-<Y%'6ED7UT;2UXYR33-1, __\D^J3Y0-^+)4]+$BP[#'\J
M#6L8:Y!Y>NIJQ/Q]?6_M@[YWJ[KWKEM^LI(G6V[KT)Y0<^F'.'_ZW41HXC]L
M.-0-T_#>U9.?3A-9:F=AP2.5O=W-I 1\>V$4V*2RMBB@Y3U8%GX<[ZP="N3-
MP:SZ]$M?:W8SHJRDTO6G_=JPX?YN6#>$4;1O&X;U]6=HM()=:MEOCC[WK=)5
MNXA:+7)HN<:_&3=<UQ:7#/9WE[7F,"Z6/YVM>>$]9FNMF5@^AMM?F+LW@WYP
M;[A_GDT=1D-H&;COGHJ#)6.G6&7]68EB5+7LG.\(*R%UKX"XUX*VZQBIT^S'
MT_IK!&>P*^=W_I<=)IT%JX5FW3FPM1["7=%<>7>@U6P5!JFKB?0;40^[<K06
MV*\XANG>G*L%WC9I2$E^_;!Q4(.OQJLQ8=9$?<>$:WUGZ3JYP):0,^/'V8LQ
M@>7\K/+_GTV!EF>#\T^_G.6CYJ;;MK.^RK"UZZ]RMIN]P)]^D;:N:AI3%LP-
MW>RANBJM47=S4YKQ[S<KM?<+U2^1EL,C+2NCY0;P"39&RXT?C-$I[>K)WS:N
M:W:GCCYYET.-/96 VN^.3)4PV/N5@T]L;G_B1;5K[/6^MJ<OVTDJO-]ILVSW
M6B5J8[I=-4")#(=V'&27F,XV8)LJIU?9?JN2&F;OZ%5:M6Q+%1R;6<.%>?VJ
M*_UZ]16'CJBB,]8IU< Z3E# ZUM-6P4Z<R3/CDQX3R1%\KF(OHWELAOFW4X?
M]1\IG3N-5CL>L,876U@.&]O/%K;,*^/0O57&;ZXZ?#-4SX:+>;=AM+BUJ6(!
M+:Y+M]Y5_W:NFG@[^*L..^7H*.YGIF$Q. 5= Z@,AR0257'87PO#A6-0=9GS
MBN>;J))MJ&\OQO@%&Q 7IH?5Z7"K6*,QOQC?39_/'?L'5>F:[VHU,1.@]8B*
MW4<>AF6_O-\Y]F0Q]D;6Y->%3E6^RY NO #4!W8AR-E!>UE016,>48&_)A8*
MA[<G0D]%TM-PB;1CL45/+-B!R2YV9VU(Q0RJ5C']>NO/9==?2&+&-N:4 ^G3
M31.X6O$"8:/F@\%GX !J%#ZC@(BJHSWLAMB@?#,]KLNAKDS=%:7R[CY4JE?+
M H-R]>3C%S99F$N+P*=?V4[<J0E<'E>< G#U[33Y(*!W %UDZM:QCOQ81WZL
M(]_#]S[6D1_KR/?Z"5NM([]G+FACL)K1;IFP5V;:<SP\ZZIW_5NMQ>0YW42"
MA9$4 $_D:_#^PD5,<0T3\'#JJ-?>*6(/MT3L\P](Z_,MT;J?,8"7E=8;"NO#
MR[BDQ,!-^I.!*_.\&Z'7TOKI 3P.>!O8Q>_RS=;N8=8FE=V.6I?6-H5(E[%=
M9+=)5UIY%")=%3,P-UXB\BNSF*.;I#OTR<RP#(RR(DQ;6:<Y&AO8723WTBI*
MD!"8910AX%J.20BNY_%JZHIV[,O&E5:0A3=.RRCJQXVK1ST7W[@RDVEVPM++
MAYI<-=YWLIE?.=1W&95<%H!%EO_X&"R$=7AM>8YAN<8X"HL:5^GM@ARVD_#N
M&]KN,HI\N]NM]786RGUWM[N,^M_R=F>MAZH P#YO1<Z&(?/2,YJ1]/S3S/G7
ME6'IUCAPH]P@/YJ<_T24V=B/*DBFTY_]3G.8M"-+B'AG_+H0<E]'/9-(C#>_
M*I?_Y^[RYN'RH:'>7#[ZJ'W;6J'<*;&,9?[)E_Y>MV=E4MH7"#\.AA&P^5?V
MY!U&ZEE*/&X2;&13:_<,:WFWHA_O4:)Z^YGJ&NF[TWG.8U[[8[WW;N2U:Y"V
M?<Y1[WT6/-]^IN?,+U[0UL8RVNA$GG%PK*OZY%5'@':#2G_1"%=/7,;4&]MC
MZGEM@&T[D5Y'RY73Z-IZ? F@6K&"SZ?0B!/HVJ=/\N P\CH&%:<D]X'P14("
ME1.^/<P8YSTDRA?QSBNG?+?3W_TT?-E#<C2S807_]F>U3 QWC#T"/!<W'H/K
M- G!A&'=,=5CVWXCA&K:NH4EV\QXA6NGCCW#HNL9QCAT4_VB6W^&]&Z?;DQ_
M'>Q(YU^90.\=!S\7C':U\!8.,)>[<)#+[AQ[:GANF,3"BQUQPDI4G)1@3RMC
M*'>W<^%E@JMUD[AW$(4:9>*9M3-Q)1V<.V6=QE?ZW9X84V/L*U(@RLQ-49@A
ME3C2-J@)0P.)4O&5-$(PHMC<_DE#4<LMO(FW4\1=<>_%#C[:#V+_OL'VI=1)
M[DVW<E9.:)?@A+TR><+":AKZ$\?VAG_(3K:Y[B#8MR^Y6O< 3)@P.4#[RW@[
M]65AW:J@3IJA?' LW]EUY9?U1;K;DMWZ#]S+'V,>!"+L8M#;4S!#P&#A)<@V
MENBX!U3,=%)+C$@2$7$YOP8D!+FG&J>(T+NP'+AY3/H+5A^L+&=*CLSMYZ[5
M8J7DV;3H7G6.-8.;KADLMV%:-PEC?H>+!3>8@M[?XJ/2U=XWMF7/:>AQAIX
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M!_07O./3>_B.Z@G^ U^@W?K\(-[TSK%Q,HY#'VN?3]%,EYB!L#ZXIS*#&[[
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M#N*E"]@/2R4_!2J%5A8*A6E[E:-4*&#U-&R3-OVI209J-<3D$! +1^*'P6W
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MHB5TQ82+C DLOAQ6G["1KRN\QI?<:$]$O3: #8\T2$EOY3I;?L+[;<_Q_O+
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MQU)JH&XN:X0OZ?) <>VT+Q+H&EG8UB V5<;658-H280PU08$<H4C^JGP%@I
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M/5Q144=577!@^MHDUT1)78HUZQU>U.-2QUH6\_5-\=',\,*D;3SAXO)CE1C
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MA?(:@$?DM8S+V:4R!LL_1WWB:[MMPT5;FF:[)PILHT].PX0!U0)<%-+A+BB
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MC1.EG0T%;TCJTOWVT?.LY/MNK>,)N!@)>G!.N"MY8W_9CZ*;X%=CNII<]L9
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M=C.8>Y)3A? B2SQO/,')-Q3T"XI)$\AL)>S7R GYV3BTT0_Y"*3M#&\WC"U
M_;<^O=CL/8% K;?=7Y+S85U+_ -)8_VEWC,&;?V^)P2I=[/1::S_-DVCME/,
M#,K8^#TORQR=U!/1=E;V895N=HM+R$W9V-:$,,\0:>.*>N*_>*K=:'II3]4H
MK*U1AZ6Y4"\6=.7^<ZAJ\+<]N<G8N7[7ZU/=/U)T'B3KCPB,O-1(OC181EU5
MG>Z%G6Z_;"+*]0 =0OBLCH(F9;_7X?EF,QDE#!<?6SW,R#M!MRO<%_LDY[C
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MPB)K"04\"^EY4&^$O'0R0*8>[M"IJ!_D,H?^)NWP\E @)2]P0PZYWA8A<85
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MP5,(IC:%X3:8SQW <3Z"'QFX@G&<A$GJP3&."E1?.BP0R?*CY#5$IF/8TCR
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M0H;<QC&84.2*6K30-^GQ&L;374O%0>SXF;=4JEOL%/*YH1(^2SHSY=KAW.O
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M^JPU>_8YZ08LF0]KD;DG6WN_^Y[K):;8&.X:">X'.].M;'[CP:4.R[F>JB;
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M_!*]!=7K[O?QTHRZQI<]<LF1JC-IV^LL;TS<1+W?,4?H92'<,<#T[/#+%Z>
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MXH(1F#./*OOD#+Y%I,EW&KQ.^>"L4&ZJI/9D4,7IA.-3.MQXW.AGE-(+VE9
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M0##'WJ>HO(RWA&>0<:GO_%/H4VXA@;&<SMR&"CEVT6CA^B& B'DQ<@AXA9[
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M;_OA;5ZHYMWI5C7? (/,[/D-P@?&7$CG^$LA'K:3A0;]UZ#S#=5Y#67ARRQ
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MN2/5THAU>^\7C75#"[6!U: KLP*E#LC]\*_R$/WVFEUVZ=9WY9(<HPQ*P/J
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M(V>6NJ%7R?9Z!6L6V/J./SL<B:9S=F #,X&&XAI]F;+\)]+$Z'GD0F$]NJ^
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MA0MP+NO(3_474S&^$@&$2Y+#.\7(G'1)^^NPA #-Z)TK(GUC:?G=:-N!?!;
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M**]NRM]_+02RBCC+"7/><B ,0^UM*&[:T?];8>E#:]2][__\W^U<^:W702Q
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M M,/2?<Z^BSBG\%[#<$&E"7_+1_$XZA6BX*(X@'CR3T'Z+1O'[2'$00A*[,
M;W"<Z^-,A7&X2/;'9!72&+IHYNYAG,WC5SQQJ)JY/LWBI;0W+$#RK5N(RZ]=
M:.K$7R1]_UPK*_H#JC,263KUIK^'D_N;LSTLB_I%G\(!,@5Z' #NL0#.XRM
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M(FUC?JRJHZ.@ZNYIL!\!00-VG[5$;2/=/%R+X,)4--F#Z*,M1UKYZ'$P<#9
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M52O!F)%4U<MN$2SM,B?^Y99>S3^W;WRBTTQN>NK&B4W*(@FO/&KDH@=2(<K
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MTIET.I4R?[8KG_J/66W%N'O\O6-=AS_.ZU=NTQ\"QYHO,])E#F2OV4S9S[K
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MV ]T25HT_-V>["20C_[U_*^@?E$H>#%>PPV3C'04]-G@EPF7^S:A[]S]NZN
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M:]E:%!?>""#CB-XXC[\P%!=8U /KUOD32P:^NPG+IM GN.,D3)Z=:CUZB9/
MGE_#B>[A:-)C#'Y9![+U!Z0,[8#Z#WE_^7V9(NAL4+6=4LOLYEMF?#XMMHO
M\;.HYJG$8'6\>-O1K%Z3NK[C%1CRVJ#(8X*<RM.ZEF-Q]7*6)@O]:1*#U8J8
M@W1[<79!*TPVK?FGU%V6?Z((:L>Q!^S!3)D$QWJ9$ L3_E"=^"F;N27.]#[>
M-LX<>4>S?YTF38/(45&<UOR:."Y5J](24VC#8O8<,5_4-,[E<DV,E4^*E>'#
M"^.>G)@-V+-7NU\/TPJ->0V.O)F;(72\,QX%FZ7=S.G_2$CL2)Q8-\JR(X?B
MJ/@/6+XWN[ 0D! =%5[^ K"&%8?LG4_R#E P,OR.6:Z:=]W S\$_9 :,I+?D
M/50<[:N<,3_]8RW3$$AD#5W7Z U[A/HK<"A?#F0P][L/_+@+?.":06$93T^%
MUMX/J+>?6UC=_?5O=7TBZY-=HW9(<! F"N>1.!Y*'-L$<1V'D*:Z)Q*$>"%-
M#=)\() C5A>)@(8.NR,5!F_/QXA^8@/6[N89?IGB8P,4Q&![,_P4#L$WN:(G
MLG6#LOD-M:LZG/1UE0USJK/T]6LD;[4<-F0NH;(H*F>,T_1?!ELT2'$'#\:?
MZ=V@>NG(8D)Z=0LJ:QK9@&Q4%VHBI1M]H;P\0.R60U!>FP*KG#HMM!X"@AY>
M='_\X6"6NN!)IX_%K%JI=^5=C>DGA$Z@):]6A+.63">Y*R;N,CEH*!,V (0]
M19LE!D9O'?_!$S(VC[C-:PO4*BVH,6Q1L1CR8P.NF0#78R_[!$4]P3.PW3+^
MW1,4J"#MQL\CA=9C-T0)ZM*2S!M8!+^L^V9_WXB_/(<->*!U3^U='^\Q2FO7
MPXIV&0CKE:D'J=UB:<_]$G@QVC4!^A:VB)N9S5\7^<_M&CM*AD$?]A*]I3+[
M7]DZA47$7Y18\W6N$NGI^AKGX"R0/W4C5$UE*V]74)>9 ]:"N9^:8"A0PG7\
M6,5A#PURV^Z@)G<UV_< "6Q 8IC*1@!ED-"W!4<HN% S_GMR'<)#\Q#%T&$^
M\A@)R,$?V- HKGK[38CUFV;GN9;[MH//_FH:?5F[&YP>DE/Z#7:'#=A=]4R4
MJ#1!X1G!GZYEC%L_I$"()NW1BJ%%$N3<A ;B"T-5WL=LP'K6NRD([P@C!>V3
M\:%:RAYX&[<VWLA=:F&9)T^0,MIV&=A"N9*[0#\_/G_UJN/EI_<>]8DN@NK^
MBS)7!A?-XQ9R&N"R<N8U^Y!XT%ED9P@F=H]N#XT+O.-F%U;0.S5.@[4U#C7]
MECQF$WCI^C\.MD;P8PJ12R=T]>MJEL8ZXJ)Q+R&@H-"V2T''7XA]2P2=GEBS
M:YG.>,]0<?535#F2W)CQ1CN73M?\R:S]4@RK0'T-BK0-."'6B=G:N#J$/D@[
MVJ<<Z--\YKC4=TWK:JH&X?]U[*E0]"G-P05S:X9#IJ+5YOR@26AQ-L ]2TQ6
M)T=1?VZXQEV/8?AOW:L'J:B2W =>$D^&_D&-7'[Q@&%:=Q:7<[?9BR2N 0YR
MT 6.FQ (!7HOUJ44:D)>'_!OOL"JA.X=!\2.PCG$!?3)TB'A3(,$JQV&CMM0
M[[_+L0%:B8KVX256UDM5=MXS.2T95!3S/>HE]#(MUF2( 8.1()<\K*,O)ZT:
MDH ;7KR$)8D)^G=%F-:]197LYBR,;:;)1_XKUBOX1(@K, IR8<\(PKJ$ 4ZL
MQ,,X)IXWI.!'E09@; !XV7YXL7D$4?ZI<]P;3,'\@DYHF-,.BM<X2]=&TY7K
M>/N6[7IOUGF+WV1M/>I]1UU?"\80UJ$3\]1P&GXNLF6 $?IM?*V"#2AZ6YZ'
MXYI=SE4X=MH_7X]M![^&W+?U%E M]DF0?$ ?=I&\N2@TBT[7A\*<M/ [A8F5
M&P)\T7>K=SS@/.V#W<_S4DD^/#Y=OR][$.!\HIW=:0895<T"N[1&Y!.&*07(
MD#C2BP$+N?%F,9V[;K(![0+KMXO$N@K+/?+4A552SC;]J$4=AIY]M=V=(2$5
M,TF#L@&GBYGYFJ[W4&U^)0A%&M0#32$KR3V'7H'EX$;<Q$]5CWP19@-@]J@G
M8QB$SK%\\F.@:&$!132\I1?(JC&=.FN:8E';$NJO4EM/UYR+/"L52[LH)RZ[
MG]Y+ZGZOR3-G#Q=C/*0(9!'#Q-L?5PTKM3PT:[ICKW/?UK;F:&(5[?9H)"^&
MB?D:[_54O?/RXZT=V1XI)^NH@.)YV7F/W\G&L<9^R<M-)7W-V+[T:7Q<!UF>
MXT.%:G"]!>9C78]NO*J!1YU&>(VW=;6<N*$OPVQDCU;8.DO60X?;^;].8>C2
MHB@W2+?[3F0<3^-X$%!/+B%]-'G"0R2Y'+)<7B"]/8J-^XOZ%S7>1-1Z2Q$H
M(%<1O\47N$M32V9Y&,9CF'U.3IB)8<DVOT?M4:C17U>#@7W+8RK#"M)VV8 S
M*94Q6N;MZ*K *,WU"%":.^54YQ'"W-/8^#\RZZ=,?3E(7_*9Y#^T)P&C45>.
MA;*)^*HZ/*99;QX8ZZ0\J@2L"(*W>4N-9HYJLTS&JTW.GS6Z8=+0S3 R^FCC
MB:H"0S?9@/L'^]-Q_;Z>-T'CSW+O\V2.E.GF7DB_P%V<DS]BZ>@[JN]D<>AO
M[7"T6KBEJ;;WO)/X0U;]S]J+3]YG;0Q&?'@Z^A77AN*D=W4'BIQ6JZ='ZAZS
M4JI-"(%S*C$,/7+*3]2%/2T.<YKDY_]6=4Z!%V8E?CFQ/??2&/:JT[I58T*N
MYGF1\F.*CP2>E\_BVMRDEL""X6)=!>[7/PSYJNQY!>:G-=8G/&B92^EK0-Z_
MX?SMGU8G,+8PAJ6->HZ)=SK-S-K;%*6ZT<J(\9SS>N'-UO.<*#Z&3D,U+#2#
M#/T WUBL;!Q@<,E_5I"K$3-^5$]NQA$:O8]'ITP^7J^QN8YZ!A8=4<1=7A%1
MB?;7:"URRST6&9O.NL/Z)@K60S4HV@XN?%68J/P;,L;(:B1FU%E??G$XU/MC
M_[[(_?:A,AW+@LCL8!>!/ YI8\T*'WBFG"<F#-CC<$?82;WVU W,%:/;W#+5
M,J-?>C?RIS;%]77EE+9,2A@FIVDMGSM]ODQKV'^S4Y"2OGAG$[H-NJFXBYZ9
MQXM/C>T<VY$SL@/.?_?/*URZ%WR$1FMF?<K/9@/P*CFQ3X[3O.IB4IWF737,
MQBS)&'VYD:OKU)4PC=<@A>7#76A/(H/?^F&XV#UWB81;'2KH^T_.7P4Z\&^$
M08[8@*27-DX(@6O&,L;ZNEZ%V[=V;Q46T[PW8?"FU:WGE+2[0FZ[4L(/0OLW
MU933Z9YCWH4+8S^YO#7PXD$A?1,+G^!^6./"]?B&@U7H!,=&4L$DJDTK3_V1
M\/OZC.R=F:C_^J(>J&+F.><NI\=2;K0;74Z*#.VW<1[[K@8RAM$=F8EY7,0^
M$+R/%36+1GYD ZYC8=?:S0NC+:8$;Z X6ZKAS<WT'&&GZ][^-\Q\4RW5^Z5[
M\C.?!CJ4JV\V(:,J&;:4$?P[_U7'?[,K_>_\$)ZO!X0<_Y0!8VL4XN[E.V^9
M?B9Y32SGM&_CP?8GX!5ZF.P>;'XT/(/@V'7U41\N:R>2/D.//:E.&;M1AI0,
MHOY:8=VL#RN^/A]NO#7UX@XHD@NA$LMXF$FF<J=Y5J7=HH?6DEK26A(5)$DL
MV:89-N#".*OY2(5LK-,M7'XOP>N,E)Y,]VC\\/*F3#M-28K>N?VTBNIE&[K3
M[%J >X %,IZ/,LS#*M5JSCQ#I[OOCE/7^S7\>S M<JZY=.UZ]V=)^ G&K-=,
M]L(F=7TH%[8C17TV/)_1(6[_QGIM8AVO"^D]&MLXB+S*MZ+0]7!BX7\<8O5"
M\V-?EBK)31_\'.AG]/@^[A3I#U5_)4W;[_KYU5QNF92U58C>'H+GFYQX,27Z
MOLVR9R[O0SIWFOZ(J4^.VF_#3%/?U+0U)B[@V^?2O!(47H7!SVD$I3W2?"AA
M1?2#A\KO/[D#0]6?Z+[@M^M:KBH+[;) 2E.NB*N:5,XT2H1,U/ DU4(4($$?
M_J @)A\OM7#/FFQ%L"XX$E?*$6=(_WZQ=\FF7;V(KF8RL@,XMO[UF0VT8PEN
M;;B +KVLBY,)!DOTOO!;C<@&_@WE'F$*&MRE*O&GI3YS<1G+ZMV'Q-ZEI=W6
M%>N9062D9HW4];[>=$%E_&*-0N8RS1W6Q,^2>_$W?F_"760%)'M@V7 VP :Z
M**1Q0DVLUWH3V"EV38KL_";J(!UUU^$D^).3.AFXGLDX'A4.G3#D:&<#.*N*
MI#9>^6NB\MB DHV08X6I>6S*9F '#[N5W7WF!B^DL")#G N-Y]#+>QBQH6\E
M1K=T^TI*X*Z%2_V_:[)7S*N0:QE.JZ@D6@O]O-O+(1:G!OD"7.J%+P),HPCH
MZG:R >\#J<W?.'[/P(4UHM)]XA@CS$+K'4&ZJ/LZ!X-_EHIJ/*'-!K3Q4RKE
M:,M>W>U<3]5^;8$[>9[,G\G_]=P:OK_J.,@24]V+<9>/!EM_0R^],O/Z_=6K
MR7=R:9'U^-;7F#]3_W\MH&7(W!(J'LM-1FTR*3=:[=+:N>Q9_&-MAMEGGE]P
MH"EF2(T)'YHX#_\X!5GIABXFL0$<SB= #/Z([K(WFY#6[8AG$S\E7%O#K-V>
M AO.-E4>]N<$W-+O+"^>+48EK2^DWOC099!**C3Z6[Q\7K:SOHL"=]UJJGF9
MV*DP[FR>:,K,$UF\$X^23C[Y/>(BMW;MW)1OT)6#7TLX'&[B-A\Q1ZN.'^+,
ML?AS#?@=DF%P+'.@XW>;,8F-9L7_@I%A[0O+Q=G_BD?(->+^6E-U<T!M1U8G
M'*G.&BTMD%/;>&/:W:KL"H_\_*G]@VKL>J4A_,9R6,P1T\9(^H&F=ISC1H.(
M :&LT<.<1I\7G3V/_>+C M>L#"0()1J?Y-=B^B7L'_81<9,0TB/UW))OW9^G
MSN@S"H[!8JTENOUM4RXW@+J<. @G7!CO$?C2J*S*!ARSJA*8"0'#=MB 1X-[
M2R,U4;'&=;-4?#-U&<P(UV!%9!XFW.YX_N/0=?3.8+9'ITEF/E@R7PXC:[?^
MEXEONU)RN]OR'65XI7K-%T^XR2PV1A0[,?PC:^L4.@[ .!J(HM>=JS J[JC]
M&V:5\CW&+$)X<UES(3<T909GI:G&OX 5JG?/7MX(JTJ(&$Y9ST65(4V0>'*Q
M!WKM$V[PHD,5*#5PKEQTRF<36BY^Y2:42SUBIP6MNCY4=YI;(WNO']8]MS%:
M>]U?YKFDE*ERH9K6RYFQ 3FY ;F),9(UUQQ9J-1*0?[]K;;5-L64ZNN97K*_
M4;PS!Y-^._>I3<W*147=_1)KUI@Y$]!'R'LD>'IU:(W/V[+Q[CZAUM=K?\5F
MEQ;#C&&6;Z8YD:<5MDR.1N=]V8!&$T"">D0N4P?Q@#@P9U(A+#$J9YG*6)<Z
M'7;/]WZW*;XE^$I8J\T4M9JBZE']?5U:TK+3;U<5%YB%='+T8O3^8FZWPJ^0
M'03;:8B;4IQ6!0:*J6ZF>8+;/5T>I9DQ354+'MLE?^FN5-D8TKC[>DWK<O3]
M_;W3J)11G"/#_T5*:W+DJ86JN83"-5_4MWNA%QCMS QX-:C&?<?&04?""97V
M,4=TD2I3/SU4>Y^ ,V7\>P/=BJEBV=GN#A4ZJ8KG[([M'@3)7N]R4?64O&WW
M==E@*B5_9+JLK^_W)F',$;^T+5B_S-DY99GXITB=?#1MD% K4#-8L"W%;2D9
MT!?LA/\*B<71;G=VLC[!Y$;>[BPD[+Z_5ONZ7[ORF*2QV(BQ'5&JRX@"0X^4
MR'5^^H8;YO;/1]$\]IL<!UGOPK5]&*HWQ ZL-T$, 6N#W.4GS8_S5'AC\=.W
M[U:=8I$/HQD7YH<*D/=9?QKE:P3C]CAJ!^&_#+]+IM\JRW'0\3HX)_$_3A1/
ME]J\5UBM1]'SZX=$X=^9-801/\D)S")$MMW9)TC?C^C#[X92J'*W;\$(E[=\
M8HXCVS,UTW,OD7?31;'=K@.XY>7MN% 44!,EL$97F7^?G4(+()T(;T%+!CU#
M/_RUOPD59W4 ?7.!Y+U GCX^H4V2M#0OOSVJ'OJO4\B6INO7]YA&K'SO<ZQ8
MIF'3+[E144A62%+BDT5<.V75]&U<T6!,GDG8E:_H)J^F<HR_W_/BX0[+-(_=
M-+L:L'I*56I9#<'4#OI5;Y>'LDS5321!.[+BK>P_>94=+>A?=-5"+=8TXSZR
M:HY5\&FD,+(_&2CH1/O;'>C%_3),V] W$HE\E"#D]6(2;W*GK@7&F@"!X RU
M^=@6SC85WNG_:KR)4QL1;Q?Q3*6[=SC(G$Q@CQ,O[0R%<[Z_R*L8H3.V;UHP
MY7A8L?(4+\,1B\M.+FN%D'G1Q!K//"['XO',"F\51')ET^O70QDPI)2NJ"8F
M7=LT)LW)/PV,Q2<?+ [V9GUR.J!9-K.J_CO+5.?!$J<H@@7(EM@ZTC@Q\7<6
M'6B<]GER3-I7F,@Q5<(=XF.YCZ/)U'4K /I(\>:DPHUZ36=RM\48I%K1Y(-=
M5)02_'*.PK$+RG6Z6EN--AU6'#URRPH3C#DZF+/>D'3_/&XW&>373G#)ENW)
MV/BAU9&-WD_1E!P'/=>"<; N@"AHXC:#3X6H$J7Y@#0-!@D@H+1"\1I7,IK8
MOUZFWFX=V[YL N4-BNC*[(Q?S.E"$S'G9Z#EB<@Z%?'7544ZUX:.T_O)PSR@
MJDSJ=^+WSJ&" %,=#7T-WUEK@M6(=[!-G/>-^T4R:<_4O46UGB_B6S;R0GTQ
MS3@Z;R<=A&JUTC0A@<ZN@BK&VA.%L)\*;-:12K2(KPAS6A/9HY>(32E>DW7/
M<]0/)&?9YXKITFUCS#RK+8:N9NL7SJ8W!;RP^7'L!/$T*14&#X0*IWAG%-/L
MJ;7,?+ (PI4L&).05RSU3M.9A$X4/TUV'(E+MSHJ_S0O:[]]<=8C)"Q5Q0MU
MY95[XU:1;[C0J'Z^S*;4#IJ<Q[JP2G=BX2'5N%@VP/UXD1JCWC2?(*$^O+:3
M3YK?/NON!"0SN]O10FZY8@VP,D']D69)9[&X.Y/N@WVOY+;\2UKN6U@T9BM_
M[4S%X FXS2P*ARTE(U[3M(@P84.@C76)WZ)DK62&;@SM3<[R>XQE=FYE>8O8
MPC\/E"XW!RE.OFZ!U7L]C]2(G2SB64*Y*OPAJVKZ=CR7L6ZS;C?.)J>N2/;8
M??7J&?&-(SSUB9*Q,LFU=LV):[7J&/1WEE8=?D=4GD1NC&0[;N<9%<+<)POW
M('1;!H0":4\$Z%!FB;A83YQ'XD0Q8Z9/J@L53A"(GV<#3@4])W5Q:AF0)CL)
MR^\1/M]I&<26W^Y&87>K*+CV6.$T4GROIYX>8P(*"G+NI$H7K8A,"<9>_O;T
M1J;J=IE]@I*-O9_[\70YGCZ\$M$75+B!.[8CYYF%V)-!$.I;F@[YH<[0OL([
M7+7\IQ("PXQ<6_390UPJX_$(PYEHCS^URKH[4(/G)DP%-;6+R\2(]LCG!8DL
MZWN9R;X6T= &_V8#LDO =41'@ZT7HTIR\M1!^R;[R"0%.?'!HRN5-FL^TQ,3
M)GXJ#V1,\BIF7EV^-(ER;PO:[;"QX_D"Y7B'>>=3:!Q4I-JL5U40()!9DQD[
MH*/73QV:8P-(?"YI):46CNH&J<46KQRFJM+L5? @MZ$TTO3T$4$:5$E0B9';
MM_ED^T[PKTI&P(N;-B_>H?"479Y=US7PP8.EA$FC5W'B#]]L2Q&XNX(2"8UA
MU3U\^66AZ,/@8'$HE3ZV6/>&#7 K>]Y/.D-Y- N[HY!*V%/>?7R@_-_>7$G'
M#UW7VO6WGK7).V#D_M$I(DIXU4EN8'Y8L4<OA0U0X-67>#&Y+#3K):HXL7VP
MFVV])LP1*\P='''T_K:E^W-8U]T.TPZ--EX/ YD,3?LJ;\1HV T_4A7V3(=+
M?7=,NZF13IVQ_WSOKZ\C&T27<C1OBI'_*!M0B ;@YKY"A+$\=JLL/@HZAQ+X
M4V#6[Q&%?SN-Q+S!^@F^EFG)%\ &? J?="3A7,%G6*,@#JSZ9">P'2/\,U=B
MIRJ,O-S9I FA"!JC*[D$EAX-U1P/=]49P>@O+ZU"?W/.-,<W:I?WLLIR#!6A
M6_=YVUFG^ZPVE<Z7+5;7US4UU3949/17-]0TUM<V5CT/<E0GS=@L#5I//@X]
M"6E6M[X)^]^B4(_?[]*5L8,";<7K#;)J$[V3[@KOO^\P()?K5C=<@I<T;K^7
M"<@S^UKD(B47;*FE-(11F4,9SM:AV^&$A_.8]A6& CF/=(99V$93[#->)Q6V
MSIYI1G+1T)1AVQ>V"$UR1J?8RRTX!\V^;2P_<OAF@Z&805C^@^)'W 2&!A.M
M":?TLLXS5;HDR,9-;,!%"A^ML.UH;%-EWNAA*UB*4M>*F9A_Z/@*AN2CG2!K
M_,Q5CS*IH\U3>KM"LTQ& [SNFR?\7AHRHIQ6?UU3&&2O74]+4< B.(_!Y'\,
M)QI23E.-HCP#BL,"J\(U'J78&@J!K]K8'J.XO$]0Y8X:VC+&Y-"-)5$S)B]*
M\Q; CM*VBPAL0*L.5L!MYC2-D^(\]VIP$[ZQ#_R YH"XX:(.0I9J_/US_3G7
M'SS#V*VEWUFYZ"+BR 9$!8@]?) @6[+NOG^X"=^^AMZ-6X_R^R,A9AF5OR+O
MJNO/OWRKQ"_4R\755=SQ!BID+!3Y-@+_RN9CJX'IN^HEZ]JR@+&"IH"5L![R
M,5FXSR7&@D1GJ:\H=6V@^-DJ8*<:$J1/,=<=Q*KHY;L3K#^PA!]^UB=EX05,
M2FDPAY';U;&QVT"=FS7,#))?\)><ZZ*3M/W3RHUAWQH.H!L:=!N$ K,"87F<
MB *,<Q0V()ZOU>DB;0,A"XF7T[REV"?:?> $Y [8!M+ RQVZEA3X6X2Q^*GO
M:TCN]S63\1D0E_ _7M*,GJ \UOD,BI\V+0RC7X!X=NRIADBS'XX"^@OH5@ZK
M;?2?:'[6/9K4HW11]$56_^S99O.@ S G&=4FYK0V(]QL6-!39K-F_;])]R.M
MM/(LXK24X8 GLXYU[BUQFV!(#6$V:/+0U6D*Q,W]R(AY:+0(O'.6D-Y.<IG]
MD$]S(7.VF[L3%I??@WD00BW8^C!(%X1_OVXL!V$__WW,-.'0GZFDV&MTMZQ\
M ;W+V*F]KO9BQ.'^N[3A8M6F]<)ON>YA!+3.P_'^ FGSY+2MZ9RC$M @&[#9
M0'] \Z,ZU="V*0_MR*XQF@$<$?M-Z_%21%P;&\ E7S,/OT*;[S1Q^;;2J/4M
MJ^#AZ5I"8EQ L&+#OIR;5_T0D?Y/NENX71;T+9(+V>ITEC9)/B"9=)C0I/7"
MF\4HA=0$YO?K@PQ]RDN\;;)[\UTZA*;1+E"G@KK NH"0&MO<OFIRP99QG^Q5
M-K+(!G2(<:^IN8X,]X4I4C]5:J#%<'.?<WD'('/Y+$UF$N-8D)"ZVQ)%@JJZ
M<J]"SF.OT=!/AHBT4,I;A(J[UO('-H!X:?AO3=_W\*[1G:5=4VRF9)1E[=#B
M4.>[6]0#\092"1L 1#C17"F<Q&:L='WM(%8J"-2-X@HP@K=FUB8%?%^1GI>[
MT3%S,<.Z(KG7=-B_*?A+,FMCW-[1R:VB73S3EIAZJK$R0+O<_GV12 EAR,PL
M9A%;+.*%JO+B-2G_/?'\BZ"==<S,P1B^+]"U%W0"YPXD',\R42<AF@TXW<C,
M H,0CLS_@4^N8:_24&0VH)L-J$%USPI.(DR9Q>6:@@H3#/M2!F\D3:@&R"DW
MN[4'$J%%[G"!S!Q*!7B3NF?8@,I$QN4HHMXFWWQHXANP(IFC$S612*TD4W.4
M\TBXB8SYC'<U1@H=/7FK>B(SA7/ RS:= <3$*[1_3F1I>?0^K:U_PMI?N!K#
MR#Q.[PSJ[#%2N# DR%*MD 3<2>"F%_T:XB9Y/RJ"<9[^&/G;BM#!!O A1.=D
MP_Z%B=QCF-)$PU1RPIY]<^#C(ZP\[0[V<[O@H1*8 E)D'02)=HN+4OH3YQ(_
MU(HX;!&VWZ98D5O&HIN5O#[3MG7(A3'^Z,W.0:4;W_4"RFAV]PL956YP).60
M#=CY<VO242BS1DK[J[]%@YK9 ;1Y8;K&JJ5LH(S%J%E,Y?/@-:IKU(>&%C9Z
M;B#O(?AICO1'M'NHTPCKO];6@Y&2@P$P/?MC\>A]4#A9S669A]Z XQE!1F=&
MXW^R =$O90_=F94HE\3+R-]8R1^# 27U#///06U>S^>)W=&#4VV:#[P^^V$<
M:+'ZKO9E?(X#31./2=U6;$#&K>=+N&\FL;/5UNW;$W0B)AHL0]LYM-;Y>S5<
M5$Y^9-3K8:>39#T;\#_4>TT-81GO[7W,82#6(GW2X/CEE?*[28Q41A@SOSF8
M;H1X,H:50CQH;LPP39JO)(_&GQE.7D4*D#V%Z,H1WR:#-R^T<ZABFU4RI_$,
M[%J&H^P^_D+EUK7"^(1_R:.][D^+U']T^!7?0_:;1<FDIKZ81[K;]LCF;TH5
MDI!7297!@PFB7.J&H LI<05&!:8&OM_RD+;R1825HU#6>2*<$M&>V=TA.WM2
M<O9#L[!RP5R9N,+):4/^W+<E"&-*5U5AJ1V&,,T9%&I&QKU?& G \7">3>C4
MS=Y(?SWP\OY1 R74;L 9*D3S&',:@"N!SD++4TBQ]O8K2\.:*M\=W'D\0OSM
M1I)!ZN,>HQD$9,6+\DNQIG[Y%:$[&7=)K#Z[P';XA"Q5!DK0<*B,L,D@'H0K
M8816!2\DZTDE@M48GED/*LC4^&\33YZ(I$5&@1N(VU&UC3E3UB9N2FC!-6.G
MF7.0*ARH#'&>$JI?.\RZR@:T.?KX4$3GQ3$!%+[YQ&CN0V!L@&%6;Q.*P^W2
MPVMN<J75'ZKI./[)/S=2/*W%0='+H4+E<@H0B7G&)/ #*4[';O\'S5)]O+XQ
MU86_=V/*S"PP-83>"+4.>\V*)!_KN"2B@[C7Q^9'/U;-WLL89+\LZ:]KEU;1
MZ=\KS7;P4(B>.;(GPFFW3A.VX^#EC+M$IN77I"W-KV0#PS/[I^\^G;6X\?<E
MUHMVC7Y]):0[0R&F(,:BHO*^%O-/Q*MZ%DGQ>\\QU%7]J*-;KH.ODK=C%.&B
M'AS=F=E\K5K#9FZ-OW@[G</$#A@1<4O!-V%FD,6%YC<@XLYAN11)I7-U3\,P
M[%3;/=')(FXGSGL.G9O^SUUN:Z7T4JDL'9+#$+C+QWJDT@'+OVI6(KE_(/:R
M\-9$E_ZM)M_?1QKN%:P<FCGT;9!SN%;=I>41;-,5KI"T.S:?= VRI0R\L[72
M'@W:5:=$]@8Z1]*JR(7M*,Z%X:@H31=PW&U\SQ61M)]=D/K3;R*Z$<L[Q;A3
M;,!<$>@RB\L=17X7%&CA/A<K;C0]/^W4-3^HGQST"3=W\1,FFQ% 1LVC.O2O
MCWDW:P\0#+">T3[7>'H$2\+UI5BGSSB1C=XYG<T% M<;I:+V;8\9&NH[FCYD
M/,%:B.$)8@/*7^+<?G]);'79<_FH#N.SXO%]E:&(.8W!EQA,$>SNKN-,=O$=
MFDC#3!_Y9_&_UGY_$^2+[[1;E8&E%S9MD)+#<?=QMRTW,)407:0D<F*VIGL3
M2+1A2.4Q'I&A4:4*J#'H>7$"T:][:S[+/!5C0M(EX911;FY8-5H8XQ01&#<#
MP5+*,YX1XU_NMJZ*#2?FC]OT! >'+O:*-?^N"TQJ64C251 )L+G^_HGGVJ#^
MGF_0PU9":W7CC[_'0.UBG#+1<UL^:*MT4&<]6Q=B[@@ZQFH"\ /T9$V8JT[S
M! D8)9+^J52TY?F1S>87<E<ABA_WX46.HQ-Q;YM[]8" K/%/<G@T,!Z;O%,A
MT].>]3*MZ*^9Y;*T08VFDKJ@58GFH]3K&U^S7KG;.ZI]VJ"90KE2?72N&#L;
M9).]X]8LBJQD3/-7NLPBFJN-=L'%5/MQQBHY/:T\J,JA:D!3ZZ)U8 8/7L+D
MNT-!6GF2*[PKC\1E0'WQNI:\%?U?QYS%5/T2'RI_.)9)[DXP)XY%\K6B+HI/
M/JIJM@^-#^RFFAK!YZ&B#A.%29@U977:)WBUPKGN_WN$7>&B^]<^LZ'%3/TE
MYCYB\;*==:1B-7GVG9-YOF,^9SGL@*I-H'>KCZ 9$=O>N49][I]7CTF@W2!<
M R9<3_>W#AA8&1/DAB GQP\WF]_D&_JQL(\L.WRJ6X1OZ!S;'/SML7W@.R<1
M8F7CX6N73VWQ"&]U583EX^=7BTV 8JZZO[V^[X;JP0.@&4XP$' >'[]_WR"X
MW"BEJ]K=-"CS3L>SM9'PHO-VFKBFS%C3IQ-Z1?L<[T5_"X1/E1J*_K/*Z^/%
M2ESPW-WH4;;N8&9R[7@H'_B!Y'QD2+AR.$VJ<#.''&A/$R0O$Y$%S$]D^K%8
M^#'2S.]%?(CR"W653(MBO"T87!Y1*-\2?.*4;Q2@&963_ U&VR:_7W5\F[V=
MN)40XM^ZK';$ _5!"-"<RQ&VK)G8=ACJ9AU1[H*6A[#BIX6:YLJJZN%_JYMT
M0Q'WM:\WU;Z$R&ZGW#3*ET3BYJW/$"L<[L;VWVKTK[A\P_ANV>D\E?,2#?SH
MZ_H/Y*0QYH=2[6"MKK]XMX7] JLRF9TR]>J7AU^_97F8^49D!:;,%!HE;AIV
M9&0>V]RBY:'MN:;XN5WG.PZZAW!M2V[KPE.["R(L!\A<Z=%E7QK4-CTH9Z)@
M-_!DQ=7G(?+[SP77?%$M,9WD@\TZN@$2K\P7% B--:6X%.0C+;P"3O<BUS1Z
M%= 7+X:-3B/3R'6;$<?N'/"?S$&=71<7'=/4*EH566<#2MPCSB4."[P\>M:-
MPY&M(.?Y1:H=S!??!4^CL;/*&,< )Z>HO;'1'(.[1=).2JYF?U]76P1[UMK9
M.>+QVV]V)PB,A^0&05-A2(UFZ?T77MV>_&H'4N)MN'J%\<8=%?+2.]NTI(W#
M29;FV_5?D&,NAJ C,N-7:6CB6TY^SE(NEG/*6S;@Q"3-M1 3PJ+B_AT+)"=&
M#>J>Z<O)F.WI)OC@-!.R-_:VN!#I'$ 1FQYZM&TY=&NZ:=*I,7"\."AZ4]>8
MST[;M-(GKJP_/=Y.7W9:J]J-#I\/J#+*?]R;-NNZZ_E3S*\KD&?O)NX\^%X7
M):AB>%N&D>IY"?P&\&"O9QOZ-[&CC]?+7'_RW'SOG3V.Q>W);9\5/;KFV *Z
M$_5&G5I%@M8^(L?"+87@?1'<XXLH,&QG5J0^E"_GU7[PO^[JXZ60ZL4O_#?7
MZ4Y&PXZS"E6#H[3$C=FOR^(NFC<ZJI]ECD4* J,++@C%/5D4VAE 5U/_IF0T
MYME_\MN8E:E*A,HS,SY9=]!M4X$.O&$:M6#LS#X]8^Z-Z"-"WHW?.PVM&F%!
M\X%P$V\?:#KT#/C"#,T:2C=JC^8;X3N%,U9;[Z8]QUDW<Q3VGDU9[#FH^IN+
M$I?M(<,D_I"%P;RJ&YKDM."\D'MF#LWECI*OZ\#MJWJ=#)4.E%V"Z4>S,NW,
M][<55_NY5)WD[R3*(C<<-\IGFM#)L^2G:*#<V-OFIU\L.<9I]RZB_UYDHM19
MIYL],04(2XK0^XAS",.=?\5GM>_O"V'V$IGE8-%Q6GO;45_IV'.AK=+NCX-G
MN/.8R0.5B9UVN,A90AU5=5A3=#XGU'90Z3N<-\QZTT3D'T'>D%MS[Y:_W$81
MYM&K(7YQUU1[9'<Z-?8K0]'++!G()B+YH$%ZJ#IG'S<]SDI S:6%5!_, IL5
MEI[8,X$5S.">?=7E&=P7,8].!4VIB\90SW1GC0OA:IL--LA_V0 9E@]J+B4W
M#!>N*!KZGG.A<_':U"E^O-4O-?CG4^-^T,'H#BR?[I74JCGQJ 0_EC49(]/\
M=:VS]59+<-F8#8%^R)*R2UF(::J#)X.%F6E8OL[_2J*)T+3F SZA2*9$> RY
MV[OKGJVWYIE -Y;OAY%HGIG?OTSS3HPJ7TN]I[)7!GT'J0KX6KB91V81S7GU
MB;AHELVO'GP$8.[BE>RWT*:11J\NE4 V(%+'7%]-L>8U+I>H<_FIQV53'<#_
MN_B/\Y\<@(P-*&4#6BT9+K<?=^#:T!&O.SYKG *>H?YRSN;>A*YI09?JV ".
MFRO021#9 L)GI[\H?)/LVOHK]RGX%9H<>>7,RZFS>D^*3GV3S1!-2'=\GWY3
MNK9X(#9Y6M<LT!$I^6U:16_LU6M+J,H?CV>O1EQT*_-DBI_2<E2EU2NLS1S*
MU0V-"7D4'/4JC<_%F2*K/7)18%,"'?(P60\1?B>L 1*/\@)5O8Q4;#GUY-WM
M#Q439)OR[8[BMT-_N:=+#LG,:#!'?F9N-.)_^5GJ@H0'1\036DV)!JQLL%!0
MV%[+O4$ILQ(QM%#7=L?FJ9U3B4-Z'V];HMQ_?>$PB(U9#9;J9]KK8[/L)L7E
M?=X51/Z1[4]44*@NT9M>-<LRJ)I>5QY3^5JIUX^J#ENH?7T4H>OROV,;%Q'.
M[;?S?G^?]17'OXF]%10YU-'8F3&1;TF'S^YDBQ<6S1[/EQ@;L,XZ8+PD3\)>
M.79?EKVA/_8*O[BONHZF,'[7,W.4[)GFYO55=?^KZEVJCN3_Y:UZ^I&JZNKP
MT; K3X*4?)&^!(ETF#<P[8[$^6F)B^)+%L:+7Q6:^11*2PGI$.ZX8U^VC%'\
M9*=;JBL(R#\LJ<;A?=!,B2X)JOBA_=;T&$A#[>?&_5SU76AU+J?O#(CP3_<X
M<S=7K3]DEQ6,7T#]Q$3,*)"[FAJ/(#(@B_ 'C!Y0(:8!,X8Z-X'W^KSYR0"7
MMN@L=*BKMHP3"[FR)\Q/.>06*3];NBR#V!O^2A0%V]C^IM:4]06$.4T#*TCB
MTI'NVJK^4S(CB*H<YJK*KY3 QB&GV#"3WL1)$_WZIL']M"KM_M"WOU;C>.)"
M7=4.^!ED&(@##/80;'S7>+;&7TZ"#;"*5 NCM5T67IW$:JT?Q3"_[DDKG0NX
M>T7W*:-V3G1G/H'I>W<4>YV\7_,MY19=I_3J1<0W?IGVVCG=L-#RL.\D[YN]
M);\C@6)FM7P9!!F;3+G.@:9"?/& GYWRDMD$@3"[#[Y(/M!(-XWLJ_QH_D>6
MKJ8_4,*OG)H7\+NL:?1(*ZF/]5/\ N4X94HW;U#TZ]/F4_K,;_VOPC.W(*MP
M(8P.FNG3OB85CH7?P8WC >&0Z^>9)G5VM+RY1Z]5;D[/U=3&:^5=18)4X#LF
M2D<GY#!9Q-EK>4\1.-D+YS1\QC@@RF$5D\*8+\0I[_/$U78.)ZRDN3Z>W[9V
MW4^JU_4%6JX@5)("^\L03?0M[>;((7DLT0R$/"UM>V0LYGMOA:K)>[_(K#D<
M*6]"]T,W>^<2+ZSY_IJY.D0((C7/:97/S6S7@T.7"Y<S&7M5@]AS-$64NWMZ
M;:UU^D"P:9^WP5W0C&<B;E+V_7\U'#ZS 03(W%(BJ;K>L%=:2AR>]3^01E6<
M2QK6:<X9O']H3PFDJE4W#&Q+#ERKK4I%%=OF:=AK_=*)0W]_MMKGI'*GZ*)=
M>/.\*39HJV725DMSUB+(WVTPG=_ @K20UV1,#\'\.LSXB2*;E<'G<OHV:S-0
MJ)(V-H"RE%3%(S@G\8_:C6_J3%BH+1L0GH^PHDT4KN6*#LHI/2[?NK&3O-I,
M\:H3L\A*]ALKX=F$HE&\J)<@P2!7RU=L@*O;UC*/RA_##NR/RS+\N%E>[CS^
M?6 K&_#."BM2^:.:1T=N899"N?K4,8399>D0NC4]R;^GZ(/X"!L*_]Q@CI:I
M V<Z,29A-76:5RRR8=H\7GYJ$AEIS6B_9IH&>>L .G:V@02K&=YO:J<SM0\E
MTCZO)E:EPU/4V(#T2"A2=C]B+O?M5WN8<OIK:P%?!T-@LN2DJ*8S?8#QY10]
M[1D+[\!H)WJ=;#>JJ/M1AY*Q18TYJ*1*)8)V^T:5+)>K\G+#8*L*[ZQ"+-$Q
M<II%U,OTTF3YK>"%S1M[8NO+/@W-4E8Y2E*A?1I:6_.P]<7)72T1M3!]LS1;
MCV0C1Z>QILT%9"_BYM"&9S4](.$RW/>$)O-DQ%$8C-;!!D3D:]ZG&$,F@425
MV'T<$&K'N#D*<=WF6H%R:NK!OQN&SK48+[=GXF)K9D7<K Y$_A<^.@F-LO0"
M+UM6#5MI.3N%AC[T*OAR38_J0\ZTL.<,J\R/VF#!M^^-.P]S%2!-#^F4KL(N
MW'OH.2R$!NJ <H$U$! RM!,'@!V\@D*#K+OM_$/Z<_B9A8S@M1"+/Q0/._$:
M6/HD9J6.*K)'G]QLS/FE&4*[Z/GC;W;JE*,+MU49-1C3B/KCJT,?BJ!S^3O"
M%YI "]>==YVG%_-NG71-EO_Q$-UT5<?RWN[8:>XY2BSZ9;+*M6>I70ML0,&'
M"<1/?<C:%NE=MGC!ZX/U/E0>_@-J;G:;)BE>5_2@: *)GY$?D(PA.QFZ$/'Q
M; #/E[_;:N94V'<EL5"+)N6&4XOA1^<KTG;)'2!5BBOC$I!U_O"2()*+!I=Z
M+U6C9MU X8C>'TD1NUA!BS =F7\.F;#<[%-/J^!+R5SZOMSD(3\+=JJ;MG>N
M.F^@&J>CJ;CP?:@$Z;'5.W&+0&@15)HMJYMBG65=03P> U^AO?,@Z%:1,.=^
MQSL+4K<C]OOLV^VVLN31Q5QVDR\(+B/-!Y)2XOKJWX>%O<@5'Q<M/_GO<^).
MK.5>;1EK-J1P=(NK#RO=VE*2T[-V/&EOA#RPJI?ZTU0_'+!I;AN8RK=3*?/V
M[3'E>Z%:CS/JQ2^4\_;D_4X<<*]D58%QC83GI-F3K","\BO/2?RMF1:>??JN
M^^+KT26844C[TVI3_F9M66?OY*B/FCLLRT_Z(-\[$_V,N_ GB#^]B33NL'7%
M;T.65TDYU=Y6*'F8^^J8F8^%-'%]I-T\N<0XRZH\"TDXF"[\/1PBD8;!/-P"
M1B"!S%RDI =A"QU*Q/.MCA[)IU'KT8ZT)#AW3?GT,M/!2L!)I#(Z;W6G(V;N
M2G!X(TAHI9)Q?6 #>PUQ;VAOD^^Q^BC&Y;[#6F-V2:G[:#[J9=_9I!*YLM9,
M3U2^JK-H\L6GG7\9?.)%81?;2#,D6+"E@8Z$H.!=PPO9/E?6[Z!/53:7-^?>
MC0M!5F(5AS<5UZ=15B,UWPP=P:0N.2?6@3G,,B4RZ"HV-_1?:/PB\7\O4MY"
M==K_=AL*GI]S,>._9<!]O\#EEI]*U6+HSJ:D[.2WNEW*G<^KOE:%Y\W<BZ0]
MF[3& H?IV\3MKD1NVLYO516]/%J\KNO@]C>=F.5LX$9P('#SQ@9&>/MOW-%B
MV1#?I5<_U0ZSW'5 VG]0]U &C(2$_J-1MS_>U]RPZUV#$A$<:GK QME5SW^%
MYH6$,2@RJ!O'ZU:>GBL3OMPA\IPO2E] SE"8#<C]TW6JFZF^'+>PK,142/4Y
M*Y-V0?$N8E]6M=.RQ%37[+7!F/>%T:8)738@8WFBCKNK4 DAYU^$=16YZU/]
MFN8/MUX.4X'\\V_]/U_.7T1WE)_*V)OIRX#\TWYDM11;XN@6>/2ZY.M:X)%R
M4;YC6)7AB&)H3W7\0^.&9>;UKEVC4/V-K::P1L)C#!NPNF(=1POM.@)&>SYO
M^;M_2^%42J/ ,_Y?^(*FNH_ ,:DU#BV)D/R'9URB(YB_"%#YAQN&\L"YEK 0
MZXG!+J*DMFF LZ>V ]E[=:?0Q5W-GH0"*N0,6M$RPKN>P0SV\E.=DJO3^V:7
M=R!.K-/'NM0(X4JLJ_W/6GK=VR:]C$QQ,,A5&KKD/LM;>OKP*G1UQGD%>;?^
M#>K[2-79>EQWL7X*]._!Q@D*GHCI@A).S:57D'N[C^"Q_H<(.XQ\AE=PC@>A
MGTO0@BXATAV%*<@P'7*IH%^&OLC:-#/^%+9]<Y&3H2I?]>&/[C\#;,#%%TFG
M4?M=$Q+V;I#-N+LLRR-3-N!TT$@AE"9=N.$TFI&A?,^)\;RJ:MC:)-?^S(A7
MN:(C"F&72="$>C\8.;WXAG6U#0>91V1QV-_H)$D;YRCI\DO>ZNHEJ.D:0:VF
M&\1*QSI7PJP>YI"^.TN;%AE82O_NF5;.<UTI"SU80=:C6JTA<[E(?AJ.LD[M
MH"2V@7C7L.>/$39P7FCN+TN2-MN%E1KV5SCOWEC:>#OW-CGC?;J<+EV?%@ O
M[_3S<R^:=1<P_46MX\V_-_FK3PZIL"* JU9A\/F1X)W &#: BR6T CG) C*,
M*('MT(G8]B.5CD3!(%P7](0_B!=*"_F-XD$.SVA5"X;T'049C%D-;;M6Q^R:
MIUU7'XM))VZ]&!A660_<+#EV+GQLP'O]X_M%9@E6D&%&SIRFB;:#A /B0?H4
M5$2>;.E*B$7CZ[>O;R-TOMCCJ6'>E_]'4KM>75M_OC4G\4]8[$\VX#)2]%@O
MMXP<<QG"B(CZP!)L_ $3,S=*G?#@L?_'0?.U>MW;&I"R2]T["7U!]-?I_J3\
MSW^ZZ*8JZ,Q%X3,AP4:WC61,THO-XA\7A=;J-X%?UBSO3L!?A 4\&>+ZT&UP
MP8!;>:D@H 1N)(K-KAUKVL)GLP'/V(!)0>HW9B$;X!8[RZL2CQ7OI2LP.,AG
MR\B[)$@<4IPF;Z]PEC4$$=VG?G(918H:DB9#XT- IV@N>8VSY3:SA(="0Z7"
M:5%QBGF%R%$82HPA15YOG;E*BZ7(=K@3\:>"3,U0/# 5\RJ\3ZD.* F>[PZ\
M_XN CY;;1 T\^WO-]ID-6-<*GHGE^S&,N$_\K[Y68_QF8CA+/(CC,6Z8\<AS
MTS\'^(#\+5,35],JD(OA?]_H@;0 P6-$_>-9?3!J0!U=41PZI[<92G>'L0'5
MR_'/AO8.7Y /6O%G3!802C34Z8Q.!4%69$X(@2(WHH1$4^XUI;O[,)2HS?>3
MS+M)/_8JZO$^QMP6W^9[)9'% Z^MMH=W[D_A^2/:GA=$Y4D&*9WO]*@.U3 ,
MI8+#F240+YP <A1U::PCI'<-#*(%$]]J8=H5HO ^BT#@ZAAJY])8.1A_-7*]
MHS%2+R=,\24!=/CJ1Q5''&H"TV:.<*?USIE$UHZ6%.F5KIG%6PW(&YS('V<#
M?OW3*W$A+I\-Z&WB?8KB[8%FDV%/,1DUU'<FM\L/A1ZCIWRW^BVXO]B:%/+3
MC]W5Z5$*)I)U-BB4I+)YC119A1N9LVD6)D_JIZMFF(XB_HDZ2#SM*6!=U0"A
M[(9Q=G*R 2<2<%^"T#&JUA&J]ZI=H5R"AF>@P'-=IE%R=L/#SI+NG;-9CO9C
M]A[;##8@A9P0W)%M^[[H0YXMT<?FB+O&?5>UBZ<XTXA>)'US;\AYOX1:2ADI
MC,,J,929J8JR;A#B$U;OC-! L^M\>N755;NH;K10D.C3J%8"3Y"-G4/KYY7&
M@H/HA4&GJ?8OL/N2+0=987"/9Z2 6$-8F+*6\JA29T(*O' R[_0MQ77[<_Y-
MH1QM17?T"NW;W3!)?HO=; !(M%>-5M(&$?1?#U:2TZ;NO\12P'486DE'9AS2
M3[F09,*W#IEL'-GO2#&ZG7!@W<Y3E"+P&KWR6GMF=@'<Y$JY+F8U[6JD>](U
M\;?7GX$?3LBM0V-@P]3=R3)4:K81VH3OHW-#R7"1R'BVCO^B\F'12%::9.@F
M?TT9M@XRC(CBNY@G]Y/<)<IIG"NJT/Y,$G].WB[-XX$=_)-1PX,AK]#1YMHP
ML 5ME[S6[E0SDM<PU#F:$W;QQUIM$.<]CF-W-^H9P]4TR<.*L[CSA-':+[L
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ML _)\=+P/U,.(+FE_17\#(1PWZ!IM-J0"/NN<\'H[-5[CK9M=L!M7HG_"1P
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M%LB,\+QI+U!BO1Q!5>ZV"MHR&B"!>1^\\J; VC72#>28TGCKMZ[-M>X]93[
M$?9E^!A;EK+_:729*EM"\QT05+-^/N/)K5U/.$%[W-Q<^]WFN8\R8Z7TW8XZ
M^Z0ALY(2BE/:\@IHTWR<8]V43>M3&= T:M@-!&M<'I6BG5,<,9O?G'_2/E9U
M)JUCUERA*PCAGNT!IO'17%E9JN?DNN5)QQ+O>(4*^L&'QPPNZU+=-C:+Z;A.
MO%459:B'%N;XF54P>9KMM8J\.7&RE"%G/>S2.A:X[J";)_<4EW4'1YMURW!N
M!776W3 +"?O^6]#"\9*>PCCMRTV#HL-L^^:CK90%$5_9""0U6EVM:[S[=9D)
M?Y2<E8F!>?Y@^6._C@N&V4%)&8PF8 ."\G3[/-.=2NSABT$ ZR.,.I\Q[TUX
M,T-+DA057$-;+2MG$2\Y@%>'ZF%G&TJTA7P1NZP8J_$Z8_!/#N#32V@VML1X
M>1B.)8.'N#9DYL_!+.D'!7;ACG1(=?AI>NW\)[;,*O+Z"%.[NE>I YM<NS(K
M(3 ;_F!4925\)")DY*\(8&Q/AF3SP:.6-3^[;_]R +H93*EY%9)YW#?+JWJ7
M7>[UF/*=^:Z7X]UVC1 < 96#.8[\8<>3GAJ'.YKJM875EBW>[]':5+\D)B^O
MI^'=1IO^]EC0NAUE^'__;? D4@(.HE4A2H3&+LP5(X_S><=4:-V1IE3BID;;
M?1%R^W#]S:O&U[_:X-9ZV\@)=H8JO9/Q.B28!J:"NK<%5XBB&$EWI.(XRHBR
M6)>^=B134K[\6"F:W<? (?%6LO<P[O%WW\.?N&@:)9(-#2O3/+.#L48HHXZI
M&?&$NYF*K8*K_;RQ11\;+-VX1,UF8'UMJ@U'RG30<8AR/Y:!\7KCB_C.P39^
M%JV15Q8DU/P@]R_"SCKX#ZA]W8B0)#2#5)>G(=3_$K\#-<T!7=_K"06J&ZZT
M:E(X -IEBDJ"4J3.I1"GSIKKAV #"B;'E?C/R[&QO5[TV&@^/8^"??HHY7%#
M]JQ*PB]+H5X/L-DEB^7I-Z#SX6N8P?K0UX).Z!]'O6WU#<W!.F$AN7K72JY5
M7^V;*(_OLJ2ET8L-B[8--:Y7OY O8U1$3/6'I#S-5 E22U3?"2X4CU";VY<X
M#X-+<H66ZY=,:SR9OM?W\T[J6,D6G09RK*>IY5#]2;GKC=87?VOL>OD?QTEY
MOC%\LXTJWU2*8_KO<:$?C>*&EOIHL9=F]P^6J97RH[2&T0.L.@IR!/G3;'D_
MM*F^K0KQF0I\W_K87WOKRGN?#\'OG;FT@A7U5\=VT5_JU+'8KX$O1"2-=!Y8
MV</.-DI^6FJA!X*F&@T<CLP]GMT9,M%?X \^*"/.6W<2U*9< IV%^W>:O/(P
MA9[H@>VQ9,'G,:4;V<DC*\U0M\-,ZFC^]2^^S3FM5;-JB]C9#;@Y?+(9%<?4
M+%C'T43M4DL)GNKI]@8!5^I%@U ']9^K/U_4=-#Q<E7]F 7:':L&?<0F 2G/
M0(G(&RF6E.!_ Y.,.G7$L&"EY]3SR$VABGE-'\2(%UHV&Y8D2L2//Y %I5QB
M\7  [=Y8K^TSLI$DXI0^*:^[SG8H;B^5#$Q"2C5DWG-MI$2"4N>(?_^@GEFH
MT3A.TEV$+LHO.>3ZTT,OZ=$%UC[BKELGG$]6;T?A9#H"_4&@&7KP,5T401!,
M;JC*>GG3;[P\*O]^RZQ9@O<J<!O]\\A+7<3-XO80K[B/XCT/Z;9$3ULAZS'#
M<().NCZ2_IJ]M2@=BE^<1=#I:1XR:1Y'K/7/(M6O5R?Q[GRJ:\,W0C@ >-S-
MQ 7[:S,M3I.P=NUV#@!+G,R[5)+BU>*=>5MY6HG]2QBU.UMZZWT0A:N,"Y07
M^*S4)-?>H^-V?/U',P/H^B'25?ENQ2<8R'.)E:5IXMT8EMLX4<'*:$%<Z]0M
M^2WAFO 7-4-W\5^NDF&0<GK/;4@J+ER9%)>NY.TCQO[\EA]TL*%X6_NP.JY8
M;^W.WD]V]/=-OQ>3BG_I+"!9R7<(',"$G4V0_J7TQLQ>@:+5R<GLJ/+7Q4XI
M^=)"S#?_ 4T VFWRHV<L$@Z207-2#7>F4;O)\F^'2][[^)S8TED66<;X]AY*
M3JQE8J=&JZ?B+Q#_V]Y&'E./C<D%8Y6TL'5TUJ>M3<CJGYT(YRLH!.#("4CN
M&\+^]\7*G>UQF%6M 7R 9#-9OHZ]OOGN6;_M!O^)4+\"=+3@ '2>;&9'@\ZZ
M?U-;;.KC #P*I?8>//R85N.M2!QUGG*DX9I2BF(?P;)EN(;+TDM9@1>#V>!_
MIW>RM%ST#T(".8"?;X?6K:P&!V4(@H42_=Y#2X+PRQP #UIV?X6+S %,2NWN
MSXV],SG O6KSCO!N3$T(SR%=';$';G\6Z75,K\U)1! <]4+V=V=>&U5 <L3Z
MC<HWM@.(=$I;3<;&]BT.8'UP:;Q; <5JUA+?B9 ?J9?_5#6?-3#4-R8Q"-L?
M(B4Z$55W48E,VTGH(IXP\&8V6ET.1[=!]!1>B#R:N6&VO'C,DW%B<B)$R(QV
M?7WVS"Q+^W?"G5 ?C<P[W8,6,B*=UB%UVX&N&7MVY=X'+# )BN>SH[8^"Q&;
M#YR?+1XH]!#2D6Y[F""7<VJFJB>KZDE-I7*?+S2$8AQQTJJA2OS-6QXO)SF2
M>K+65=@<5IB>TWY4Z=>-(+6!S4:+7_<WZ(UM33UM^G-"NN%%AN&<\HZ.^5=X
MI(TGM/R1]U9B_EGX@SB+ E9Z6S6<GL+.YA(&[<UBP*QBE8H_K:X8F;;@;*5+
M-G_LVZ8KFJU;QS8P'8Y6SRJ:]P'9=/+=01OR'?U8W-G:O\X*-T;9^J;'W#(S
MT)L^J$^;70^BK5;1R(HR%5W??^M<JY?C^>AD=KX2/6!UU^*C>9AL?E]Q 48!
M.K;T9,%]T.($KAK&.H.NY@!<P/S5*'+,Z.>):U29CPTWJTU$EZ8172WT?V?N
MF+E,E\(1P8NXGRV"?M/5B/<]OAQ .'#1,6:.C[^;A!5<L>TAB8>YUKL$2VT?
MOK/Y\-SB/;#E@Z]Z<._/$21DZ[N^B'@CZ,?\PJ$4]_=?=K9W?4UA*Q-;<-\\
MDJ/RK2[2YF#Q)47]H.+K-PPUY#5+ZB8\6:;C ^8&+XI_5<#O+7];*:2R,WXZ
MV#1_?759;CB%TL[&.K)SFR=CYB&A2DSM+ZO-W8TY;V7S K(*\'S;#K%=;L'-
M'R6_R",Q_Y;.XOE8_E#PP;>473RV0E*,*S[?5"RJZI+XT]"B@K&Z-.,V^_KP
M(0?5%?BKF/+8R*,V6[^B%4;Y6A,9)E/-C/-@*Y9FSMH"M]B@H=R =8)D3+&S
M06E/GK3CX:!FX$KAH75$Z%DP,8'-1G, %Y*GJ:G;\<M+[\XQ_,^#ULLX@'G?
ME/ PWX'0T4Z]BP?+FXA,VH$F_I?F:AM-V_V7(<\H)"<BN,:QC>C]&R;F>VK#
M7_PM\*%OY,8;KM7DR'IXP[$4B_$C.H>QKY;Z^NA3Q9%CP)U3N-[2??2O6R6W
MQ?G>)*&64T:QUHBYI(N/Y9B"!S3)EPNIU%HC+2DG]C]X-@@TQK7J*'Q173S]
M7O%I\E ZN<XAU$%R]6#+(RI*)JG0K,CBHY0Y8MOOL+JW$M%N;F/.YHED^%Q;
M?!@>/'%;MTF: WB](C+XXBC@&1?8D%E-[PO^XFY]PFXL_YV!HE?K:C$DX)-J
MKXOF]QT.8*H/2JO86V;S-(5E$BD62H1_MR1?T:E?@#FES+<!YSL]R&ORQ[>1
MV86^WG,A<K4[TT6X$CWK6X^$.( WB];TY&"!#X@8'TCCI7MD+?5?;T8,QCL7
M[AEA*O!ZI=EL4^4Y;SNNGM'NQP8C%<\?/_8J*!K/:#'* 1OS#9@*,ZVI2G&E
MF?BY*0+AL5(Z3W?)5+L,%HS$!\3:V_:]S248\/?>JT)SA^3,#R6//:6<3Z^B
M1W8=!=A^Q 6)ZI0B8(B2U6!KM>,VR'2.7[(6ZOS%2.U8/?,*I5 ;3V64%2'G
MEVZG&]28U@V(>]:V/G<^JT+=2,3"I9CWKF%-.("Y7.)9I@$9)# #/!?BN=UM
M6SPPG/YSQ$MV8OMDA++*FX20RL-!1%WUWG;^.OCG5+?]+?>)?$=B<[G9FO%4
MOYV#OX)ECC5^>Y$%2IW_]L+FE>?B'VMN2UN3^.#2P$MJ*"QP5GW;01._UCM-
M/,T!.*'B49=:E;UU"@*(O"'OO3>7CF%F^?EP&@0"KM&_J7? !Q?OWE4+O%C,
M?ID/MSV>\T30":R[Z52#7C,5%X4NH$R![P(OKRC.RE+LO_G_SNZ.NCUC"PRM
M*US_LWS$1:DN+@T7I3!M71M+.F'SUO4[<Y3>F.-2?CTYNEQ2"_-\G?#T2&T7
MR48ZD!.(22!AE3;]SD;;>E14N'R5+2L-S+?2[%*U.; 62/0O\[RS=BO--V\2
MZPJF:;A1I\> 42^0KB0K@^^E-QRZ]?ID0H/@,!_X8J>(]BUP8\5G7-=PET7!
MVBN/=EB&I]_ >&!$OYSPQJ'WK[95]R/X7W0Y,C$*JJH9H60QL;%79?06XQ%$
M6#A6(^#9RKP(1H3\IH* 0TO+U<*O#@_[^W;"5P5;[1!MRW:_I?B0C""&KR/)
MGW&**19I8L1+/.^1_B2/M_,\D_'K@_1_D>P_E<2S\/X&X'FHPA(%&J>:I_S0
MQY6RN2MAT@,^VK<I4#?B $XTI^?/MX:[.IG4>>S@QP_3K1.L\QIJK!RW!K=_
M;[:_],_VX>_1RS.\5&&=+%HDZA^P>F\79N?M<MUO1JF^:5%2B@Z%57GT''0*
MU5875"P92-]8N.4K,)&X0F=2-\$J1/@XBI\I 8T@07D\S6S6[$"U^Z:"=@6J
M/Z-0^]G*M:I%ROX'U0H^8ZQX!HI60V^#4@BDMM+(/2F)Q@2F/RUNH;GAL7"8
M4E1 *@<@P/O1/3Y4 _-MB'9VM*CA&P?0#]-L9OX[?I'[1]HI7JZ<I?<RC3Z2
MC!K]:I.(W?@C16#?HH.1L"-/I<S&C&1@(*___1U"UOR!$FP#@U#N"CD*L=WF
M-:FPE!K\HJ?D>A@*Q1TF+4X63;IAQY44Y9JQ$R$32DJRF3OK9AS U_<#A"'5
M[4:\HRT:H:66(/9CUORA5Q?<9N>=OLO!5;!\_[4;H$6L)I'N()_5V,I?/?Q6
MO\%/+\*?L,K\<BD[PN<(][3!871(3>)?+WVN@Z&!?Z>V_$!3>RQYWLL=%Q*=
M!%>+T@T\(C8V%Y>_'4Y>JRJ^,6AB?U"_*%M'U-O$?4%($9PQM=G"3V;>82T-
M)+AT<D0B8&G'2J@[[V[Q]\7;$=RS)B"N$QP >J@J3%I2+'DFJ+I,'#%F8KHB
M5%.?=VJ12_@V$OL4+MOLLT6T\6$0(!S $\KBQN+]>STW6OQ5<3"P7?"4(E;I
M6LSS#Z7G.YXN SO7Q\JVV1*>[FB7[WB,D4:BB_.IJ%Q$_],+*/KY4P'K<S3]
M646GH0-#-6)_Y!$'8!LQ&P=[-:JDC.?G(@]N#],J2LT"BA9-[--@=05$MK$(
M7$ATE#;*.,R#1K<*D[Q=+Q=-J-PK]M"A&/@HX"@[LK&)86FFCO4XAW!!BN5O
M/X=5R)>5K#NZ"EVO)VEJCU#'JO3\NO D+E&" U@L/[>+./VK? [7S']ML(0_
MCWL.5>U/0)L6A_'%AYM"2*9G/>$R30W?QS>KO.8'VAJNI;-E-6*FY.3"&F=2
MEA+>QHBAPA8A(:_E&V77#'?JB<UH#.W=EIN&2JE/R U;V@P4VWF=MNX_U]?J
M  GTON9 A^-E,TWK#%3KYY+=VC@ %,UM5Q_/$"(L!MWAZ<*.9[[\E_?'M_ZE
MJ(MVFW+3E_GZ-S]$T%4="7KCT-:EL;H(HV>UT8@;6[?V<&V'$09)\P#V<:YT
M3=EH,QK807P+U)55Y@ DT[U9EX&3.7EN<,,T\  $@F>O$TIZS/+U-&YZR&%J
M<-LYVL*=.N>R7U35:\9M+=1-W-+!G6IK=7Y2X[_#7/I'8$T=4?]G;XAT69<W
MHV7\RA"USK<(E>NKAZ5O-[;YA 3;UXX$2%P;,C]&VMA-Q:JK[/X,:X/)HKPM
M4)NG'M+2&N-XGZ_M<7D(9G1F08^"_%K#1Z<9FYJ]ZY''8-<B_[%;SU0=,15(
MM&^E9P]-(7B)D#3:TN+B\]D18HX+)'!0Y7JWP<UGAD%+!^9M:,BN?S#L!4.3
M]@_].4,Q9&B^-";\/L.6^80^,P=ZCY%5*.XCFT8?.$HV(DY#?,F!!W%7<*U7
MY^M;*05\ASQKM&<V0#Y_&KH!1[.FC+'/S?[OD^V5(V]D2P7=C?:6CBV=7FT(
M*X X:M%9U<"S,U/VB,JVL7K34[HEJXUJG?2_/7]W<MWRS^8 0.KT\OFN9)B#
M9*?>\!AWL_O6UKY15LCNHF;%;(+K(PX@<S*:L*$1#9IW@T00T" 1S.UPHQ$5
M5 Q1 .L!3F'+4H!1>^L14ITHOEOAOE0^.\H6JH00T:^MV8%_S,YK%F"^WEK;
MK!W);/.\W^,ML\$!U/L&S%5^C&A( KU0+V[)G;C]Q];@^\N5OB$;56.P,7H]
M"%&PG[(!XP!./F+E53(9?&^Q-3,-^<4&,.^+8"%ZWSQL/<>!,=K_#W:2+>V9
MI6M"Y*+%ICPY9#;]EN7+<D.4A+O3E4AY:K/]-#=6<NNK:H\#9=87 1+?NUD>
MNA'ISC''@/@J[3WP044N!^S!,YHWT$O][',CK *MJR0E,:8S*Z,>RP-N?%]
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MRY&YJ 0\B@M5I6>^P05^%N^66KPZ6B-T&]CVV24D$7VYV^+,.Y#1L#; ).T
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M90880Z'1087V!=^S7W;WZW]G84H^"$'P*J^E";V+RMB."VP K@W/(7:"1,"
M<Z[*D^*N?I#+6VQ RLT2C@"M42,-2=69F<4O7!Q?Y:*VAH30M7PL+-^KKWO@
M6C$AEUM)4[N:)$"F)/\AO"85N+]J)V2+.]*YXMX$@,&OZU)$)7"U'TD@'LBA
M 2:KLN,1-^%<S_=R#D;*$N[ZG<(= @?0X0*MDDI5Q3:I_<?EH5OJUI^_] SO
M75X)&(THB=4!PLO@/,)!9W#QLG'R0C0RQ*MY8=5_\RH#9P#N<'O._)JYZ5!X
MB:H6S:ERF/\'X:">;J5B'_CSL@^-(/PN@40S%.>@H#ZL7F"I6(_D2;7>$.Q\
M#U>)K,"X#97!'P4N9CGD*FO P3-!*:>,OAM_@<,M]#CMQ^NSG$?:/?/./3N
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M[2LR%'V$:P-)#%X@5SLR:!3E!*H#BGQ/4:90A[?BV'4W6)-M*7L-/,5+:Y!
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MQ][-1+S9;3S_16Z9+YG6TA2!^'KG^:K]3QN>,KNO;H0XM+BY2J_ N3U4ZVT
M$U'@XPM4!%CI58PM"LRFT_MBHY$W%]6<+TQG[9)J?'-B_3DC-].%]F].)F9-
MY"<2B&^=8Q>]:Z?.@[U=%(W--X!U*/6%9%4LW[G,V%%+5F;TUV*IXE,'VP,9
MHRNTCG8R:6PS: O\X6>";!Z3?3&-?@ HD.KP)/>CTK%(" 2(+683_!R/P#OP
MBH!WN)9&A'YMO_\2619WWU;;I==(WH7;ZJ9YH>N71Y75R^[@'_U$S\4$Y#9T
MTYC>@(7;. SBC-<4%5G-YW$8>]QQS,8A"X("V.:3/YNEASCZL3>(O F-Z:?_
MTQ-$V<BJ(\55U+C:7E!+A6K%'WD6N5P]=2%U:(@('F9$[RVC#1#'WQ@(9:3.
MZ@]3-="YXSW> JSCDM2GAYR$.V&7N@U-]RJZ>M/5,]@3S1DY=:45Y:2SHGR_
M_5=JJYZZ-7%@5$ILL 2B((2+JFI-V(M07U4))&ZY ]270)XLP>5P@2=[*%@+
MZV)<@0,8 MBK0\_VW(RT)EU.N]+WZY=]?_,RQ;-W@Y/3^2!:^MEDW92)5N1M
M6!QRSP)=5W@J@?]=E((PQJ#EZ-MQ-1P)I+$]L!&VAX[$D9S0L6-;NMG=XI9@
M3L<3Y+JE#OF2JL#08 \V8Z.W O@9C4MQ[*L@R<V4MH>&!9^X2_BVAEY8%)R?
MAJD882-9Z@C#1#@_&#R%3,*?Q183NLF[# ^DV74%V=I<J^!!'^K> >XFXT@<
MOY88(923T+$)5#[SI,>>T8.'<1KC2V!G?0ZF\#,^D?@!H*\$\G& 6:7=:X25
MGULS:80-9W &HEUF+64YRBT4&;4$[";AGJYE\%97115!0?PM>6PV[%*_[?)H
M;)S4;E# '$?R5=Y4U!)F#EF,5V>/FO,O@RJ"'3,S E=QNP123FG1,^<@_KXX
MLQ,LX$UQ]0J:J<"=?/B^'CT)Q%-=[3KI,T/6(L";OJ>7Z-6.;B0<CCQ7!>7H
M! #5:VV.E36AU$V_UEUW&$53)9!Q0]AZO $PP*\NZ\);\9C\=AXI4GQ<>)JW
M$F^(WM0.Z/"?@A-L:,*W]#LO0SBC[MVP7>"9!CJ"2NOB]E2XN<P/:I.ZSKU9
MV3:1@[BP2F,R8EB*%$8E_A2/RW\"!G.1BD(+T)+3\11A +[EA7"FFFSU__8N
M6&_;<+.9AQ2:M1]9_,.96U29L^$4FT5X,6ML8XH>=+N[@X\Q[Q8F8F<6'[(V
M!Q$?,7A7=9#K\7!&9"-CH] 1[R,X+?Y&U^WB5-7V"&UY<"[I,_+)F#88;A(S
MV:<W7Y+?H_3G:K^%3F# Y&<_N(5.\+8J/W:59B!:@5AO9G&Y9&8-NY#(%MUR
MZJE(0(-:K(7#'Z;_C!ZC574'S023H\-OUWTJ_]2K559:]<>OTIN&]/M/])ID
M<N*KCV5?<W;JUX%ED:OE>K'*5+.[)B\F&BB2)F,S-EH"V80W!QRG''N%<AST
MD%HS'5$%D)J&;0VNT7N,.M2F$;MYC$BZ#O[?OEH5SV(7PS 2"6_-KD,RG<3[
M*VH[\:8EF$"+D&0>7+ 5CP-("XJ\&O[]"O1Z2IS8>'C8E[BI%F>!O8FL1\9E
M[>Z]&UQXMS:$#7L2,"3*<.#]ZQ(;LUQW9,Z>P>/'%_V8Z[=EMX><XDUT"8(C
M-@HPT]6+3XVP#V%[\";YOB[D>G@<N4P"F0?8R%CZONX/1JZ,;=YCA\$SO#\V
MH =@,,Y_6SB3FN+M DW"RP+$,X!5'/73\ER=ZM0"0IO4Y+[C4Z\VMF)@&%G6
M$;.(@&$8O(MH:5+N,&S+-.=$@BP^&RS/!]=?Z\8S%'!RXXPF9&1Z+V$S#5"/
M'$84YPSBK?OQEH!!$\\G?9F>R;%QE4L@J\U6NRTT%]SY.'6BV'"1U?:M>[/Y
M*!K;*S3FI<UC %030[V"_*/*L)+':E9'M820Y19K3;F8=[4FL!@\]O9:$<J'
M<MU*YGVA_\>9CTWW;WCLRIYU3'\_-OKCCM)$!0M:F>;=[6:XKEM_?_6GC-;'
MT+7IFF?DB ]408U@/>8984 "49% ;DL@VW6+D N7!8:^!%52\[%6_GDJ>DB'
M[\S+SS"JI1]Z4>1B^T[H(\I:4FLWMP;\ZA:6TAF-V)C?Q(93$Y5Y;/D[@FM"
M=>#!2R_NIKL>&?99S0,V=;^Q\TX)MHXLP<2EU:?BN2,4@7I1>K[RW/&?-J^.
M&$VT%MD_?Q+PP-:8Z^47EI7EEI3D%I]SV<'.@7+J2&K_9INQ"RONO\-&S8??
MKI >,7SA6[U9ZX6'_[Y:)98!.II0>W NPP[4OB"1[#DS[<@E'6:Q(GD7^/NW
M>:+65YA@X^!L8\"KXR<IARJZD3Y(DHL,A3?5@E:0_D,(VRK!Z,LOBZOCBS$(
MC?)>H1/']<0QOANR4<.P]Q&@0<T=?FC%=RPH'/6A[6/T^/G;R8?#(FN=-J;-
M ^-U4+L>?[WB;N85M":*5J4T(>[C=R!<=<R][SC7LEY48%7GN7<6_^/U,W;5
M_L.;_F'-)>WP6?.;G_I:WEURP"PV#GYP4<H5NW.JZ!7:XHP19(\,G1C+&WQR
M%6/VG\GFJ\6'FLLG[_N^+NBK.5#U\GE26A^=[-?B3+7PW&ITY%K^6Q0TM(NT
M/R%XGTW0VW"Z$S_MK2!!H"^$#5ALY TWD*%T9=]6M@2R&?2R2;#I\DL<+1_+
MSEG][7[=-E#O95_31-^B\**^#>V'QI])U_-LK1VKRH) \7=W75&V%!I+6;)2
MY=>QT??P!UPA?@<O?9$S^68N6%NXWY&N@6'%(_;U"5TCC/Z'IV^/9[+]XU_/
MDR2D4A2QRJD2.I!"V]-12$N*'%=)C-@CI\ELE1PB]I3P1*R24P[+89;3%G-X
M2HBQ9=A)R&'<$W-G![_U_;U^OS_N?_9Z[75?]^=S?=Z'Z[ZOZ],^/BZ;>,";
MH6E4##0,C@K4;TZS' _%O5K?VT?<0$,AAPLZGJ*B:#50.EX-8T%_WSG>+E(5
M/$15&<V.K$**\(&8IQ9-PQN'[2SX:!V%+W4.7DR2J] E6I39J@KI17!4I-&>
M0^I$LS/$#SY\0.A+W6B,B8>]9[Z2(IU\@EV!Z'@A22J1W>1>'9BUG$F=U_29
MMO%]^:G8T_-D\<E;S[RZY@;IO<J7R8Z#_N[#)0OG$.?OAOLR7<B_!I?O>7BY
M_M2YEN3Y<N_"7<:C^ASR\_$OY1**+NH=2(C+%O^A$)RQD0H.+<P-M\AY2]>U
M"\G_8X<![D1N3&^81_0J!+B(3*I^Y&"7A%G!31OULNXXVHH[R;AGACH=KT-+
MRLVRKEL_V69 Z7H6QBTY(6'& 'JR+U04\Y;KU,1Y;<)-Q=-V-L8O F&7'U4*
MGJ&.U5%J*R(;^X9];//;C_<.7<$N7"RNG@QR/AZ[MVMHM"CG^T143?J<=-2.
M)5=Y+=$%-?G:PC@>4C>0%FJ3F9V(C;NQY=S?U(M5_*K@B)Z*3>&&8>%_'GCW
M3OI?-:D+.;"$.X#KY.AF.(%"OFWJ"QV4IKWHKRV6C[I6(;LNA(\_5P:N]M+0
M['O+AXG1*CIA_2_C?K08/@MG.J.:RDE1XA\Q_WXF[Q^X7'8YTC#;PO+[]]F\
M9XWH,P]3]I(N?-^P]\W]_W_)C12SY_TJI(J5!CN(;SDC5\!]/]DIT-+'O06N
M7&YV _.YQYEV7WA@?D=JZ-KR*)?S28%K\D]-MV2Z2@))DQGBA9P6>)"%CF[J
ML%,4@2Y7;[@V4?]PAU^:W?;H1(>-IX0?ZWAW58Q:(&=X1943O+%82V'L*B2S
M]JM6=<J]8GF@'$DF@";N[:_U(\SPSKVRHVG#PW*/IFLK^B\'>]?*Z:L0LO4C
MJV2+D*5FPY,:(P?//R#\.>\7#ZY!?@"\42F-ZXJ+U\R(AW'-"'Q7^E)52/3-
M>-52U/U[NHTW3ZQ"4A=VK(A)-C$X4SU,7[MK6/';052[*2+49YM<.RY6+R7-
M^+7)^I^F0T.C@8U6OZ![L3MRQ?& VD%/3-%GO8NV^ ;Q3^(A&O? K :"?[8#
M1EZ.BA>MB_UP>OJ>&9-H\>:]_XJ?VKW8[[C(_X:=-@J[\'[YQ4>&*3\-QPAW
MX4<\@?+KXY&J2M__-KI\ I_B!D<@0\DM[HF%SL6>S3JAT36O#4<J:/ F<</X
M<%34Y?:>%%1[MZT'WHP4BV+*8_5?:*1$R'*[RW]-_K )6XZ1KK!:H8 K6M/3
M5TXG[A0^VX=E50,?X*.KD*>,OZ:>$GOC>ZV6FGP]U9\%11U;A=R^]G/E/WO^
MDWN+I!0X[^V>'ORW^+'R]],ZV'YUB]:%MMT?DB_T*O#&^$%T?&C/0N;/NQ_6
M;GD9$/UE?Z+]Q2>R-QT.#AZ=5Z.6V,O[BV[.9E?UC<B=_*CNAW:ESWQ9H/:I
M_?W&>^0.?,;LB>TKKQO64K+']Z>$F^09G)*LE'I,NJ]OWFXS0!N;;]=(:E!:
M_#D=#B);D9NQI_FC>VPE0T6YKLP[EDXG'(_7I@6X!C_.F73OM[15/Z4RPIVB
M:-GD5/SX*OL7MD_>F0^1%5(UN7(V=0=3ODO>\S3XIX/(]A20UR9>-M4O]6_\
M:Y"LZ[7-IJ.9/WKDDHR57#NJT/V1*C=_A5B4O_W5NS0HV2YGT=Y'"[DBI].R
M+#L%3JYU%)&2X+=).^B"U[QY@OR@+,=._0; 1JH%ZL2.HJA[17H?@*7*@H)O
M8'K@LQ-FLY'=?M'BK/Q7_YW)E27?^,Z88#*7&[J83,]KW_/W'T%)C)0KZSAR
M4O$T7H."WS9O=\3\ Y-CR+PS;^=<..V6O^<@AY-G[]UGY=08XMI6)]^58\ML
M$EGEEY:S.\NF4:6<T6Y\A);ND+GE#[,[UT7-T6.G4>-GCM"#][\(U?(P#W5S
M>A$R)KG %$[*LE3LNA"<OR@N%]KKC;+_H"H2^+ 3UX.OZ9PM4XCL';)75!5Y
MC_Z>]$F^29*YU(!T#?2DNSG[PI,X1J+>Q)M,J0] <F(:Q"8-W)&:':A[N =M
MDL-TOJRW9VYZYA)C;C)[.4FNC@<U)8>PYV4O5R%H-!0;*7N)TY"&#%"W@)VM
M-O+X&V-$" ;9GO/%)B2)KN[N$6=!GW3MFS\3)3>HJDZH"&4?C_8]DD4)_/>,
M59J1ZBB:(X/SOXQ>1"<YH=%'?D$'<8? F78WSZ-/X8_)SG[VP*)U%'5[/\FJ
MZ]]%@L;1QL@ LXF\-YZZS^,OI,?=()%MN4;NX?8[7_A4^L:2DJ%;YU8AM7X#
ML-W!'X-@:GTP7=\*5@IZ?L\ 51<,FKG0",S3*\Y8SJ*;5%]WO47-%&,N\CZ]
M[LCZ85B=^?&&+$,:)ZO!!S1;BUU%JQ""W=55R#HVU@_<QT/OD)HS0Z2V(I(/
MJ =0+@*]\9$:VS$W)QT +F%)-9>D\FUZ)2KAEE69Q>;>RJ <K5RM9_^\0(=\
MWW\6OWG%C1@=%3$*O4AN8D8V#N>JJL,O,A3BW%;F?G7 RE;=N-.>X7=_KGG
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M#P;3<4>^1I@%F39;MU(.[:(L8-ME*J %D$I'UKE_),7C=6&&6%M9/M9]+"^
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ME88_F 75DN)2OW-\AL%W#-*W)>'1+K?[49^L :?C<#%K%4)Z9><*L'R^V;D
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ML75/Y?<*'<H520QQY2L1Z5H,-X1R5YPVW32V$QBI\S6H!D=#QOZ%Z3O'\OH
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M#J9SF%PGD5XS\8G4-E@[ _UFYA]954C2\NSXX<[HX@_;)R]^($-G5S!U/W_
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MP635>^]BJ4?,_$U=09HDY/A?S3)>/GA\E^9F?74UQ,69#=#U^QZX,RG[YLK
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M8O1/VQ3'.KOCIEI/+6FHEO6K_+6#@TBNR3IAEE&",M]SF]=FPH7+CD%*^]D
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MB[3XCIL\OU">&<SC7:S6M OMX20)7E*=)UUA#5B[=Y(-Z $+K.)4P1?A&]0
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M.&BJ;>BU0VW:TA7AYMW6=B<FXWQ5%@5L0'N3[9+-+:-IW4+4(* [/7#3+J#
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M+HXI(7S#XWF%UW>/VH0\Q@.SUO\ET37CH0QPF4H;M<9UB;3KXH P^5$S@#C
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MJ93$H+9FG1K1<:2#Q&'64E(#'$&8LRK^'^\:\2VJ1=?+N2#"+K>!J/%^J&E
M+C7P+04^U0JT.I!6-.EBJ.+]6,+E5J&G>P>G<NC1D!?->YU@XN=NTM[]13S6
MX1FYWB+ 7*.)K"BY!U#QU6?,HI&Z'$/&Q)ML"(P'8J<RY:#?:RJ&7I:3+$@-
MC\LG'!P]+AL-YT>;AAXO@ TJ>6&7<X<0BMEM^#U U$3WN-1((X[>3GK3Q&??
MRP#16,4%;$+[Z3_I@<LBS/!6%?$8^!WBIL(F^!WHQ,HY2[IRY 1PY,! @\F4
MI):S+S.\+8:;'UPL%_%S0'  )5:C? 39S#O,U%@B,5+;[4'[M04#GID/S!+F
M?FO29INS)LSX:1%100$P4)5@"^8T^5A.F@ZCA.E%;TJ0(65I$YPGBY1>+A_H
M^Q=%],JD!>?B/NM_&!%3$1.'7N]FR5"Z#L5H."><]8P[]$:MI-D[#2U@-W5#
MZ,M(2)R)P2.SPM[SU 23;L7=XFXB+# T]7S'V:G[-RP*A<>>GOWT;!I6G1JJ
MU*ANM.6RZXW@VP.\O1\4S@K@1G]E]S"G>&=Q/[%O]0XV,+U^4B-!)_S#SNRC
MR1Y 1$^,H]_/4:.7!9KB&0(-^YM[4FOKPR96P&[1?@\0H^ 79BF..3WA(9;(
M_C8QXR: VW_F9M/]/DY@RZT4[WNIV$&46]^H$(W:BH[@ 1G7V79,?1H)K;IH
M,X2\P%YLP?RG](SQ[G^98U!ZH\?B8Z;Z#RS5;B'5/@+G_LUC"V?_HFRR?K0<
M_'>@%+TNNBN*[):ZSJUHNN@A]=]031EH'[];O0!LIU4Z7P<VINF":3A-,!QS
M0E7[?>C^W<,,3=M-L!<S]"3ZERZZC-1<99YK^'-<>DNC-0 OLEPFT@I\-W%J
MJ(9Z'-6L0'@NOHLY@1!G2-5Z+F]2R<J=1-\%$7)G&TA"!BU]R6-G ENR$/+.
MR:   \_VP-D+I\(+%A^DQ^&2TV;8#I'\W.SH+T_O?IHR]/LW&&>?G!ZG75CR
MR07Y*'V\-F#RNO(YR.A@?#FIDAJ0087I41,Z4,U\J,DO3B?8):P^2OB4CKU>
MXV1?I)YR$Z.PI2^2=$1-5[F-<$8'Y.H5ZCT%.MON>SB'/F06OS8!Y)\;#$OS
MI_[WX_/AVH-$0B'P@Y0*$0$N<6!KM&Q5A66?< J:LD^$WIH3DUQ!-OM+E#^X
M"=/JX_PP.NR$?+,'4!Q97)ME\3'C9L-YBL@):)7-&[^_?B4HMB-&H$DKR "N
MX 04#-*_RQYE<!Q@K<^5A=,.L_#4]Z7*".U\"N0V*3#DIQ:4%5(7KSPB"6S%
M.T45=C[UT.D0$:(Z+(A<Q#P<]N?OVSX&71 RO!1-#[OMK8.\:Z^_!U!2)_HW
MJ*A%Y9L5%17?5?M$R#J7^$G/PA3L.#HS];W&Z6:!:"U1$NLNJ;C:J%RX)5FS
M$'R-<YI]__>@*6/Q=@K=R=-+.5T[IO['#1Y^)OAL0R6PR)P@ZXB>Q+34$4;8
M(BTF&]7[A31G/+(T_SP152K.YLFB*0-\X!Z=$WJ_PI[N 0C';?]X^!8D6L/W
MB1 &'7+J?)![?BC?3.;3V=+D9:PR)H&#134W(V48G6_W +0LO>-!(*-!/SLU
M >EVT!G.8Z]"^\Z3OJW!@7 :_(1XA/5-<>-5A9KY[+B>^]F*DJ[BP%Z>JVO"
MLZ%G#]O4I@?27>;*A(]+:G:$F2Q^(2T9<41,.TWI>P#*'H!N%$G/>A%.0[_>
M9\P39&%$GHH^35*[0^R?IZ94"#4H03/V;HSF9QWS,70'A9X6(2.3IQ[N"9;Y
MLN;])FOT0%@G]H>)LLL1E^>9*>EP7-F'FFCP^B87!'38&0FI>+QPX_B5@N0L
MPD>Q%/Q+W'JKUY/$<;"O6F9C&?ZDF;?N!N;%V_.I[E1I1][2M?"$G[,SV(U[
MW(][@.>@8[S>/4 5J 7Z3D3O/&-SZ\,&D-]=8T*G"7)>-G&UTTFNPM&WC80,
M^^U3+X/_9(VWERDPD1Y\N5Q&ML';*<ORKJ,F4Z%'X4UZO/VR KU6RY#!W*YB
M#@51V[[C\]YL*$<&V$?&8:7QES4BES1$Q((KTQ[<[SU<?-+'2/YX"?>$[-!4
MNHE+8EBO3K%J[BM^Z0Y*4L"8Q)5MP.&GM_X$8R^5V6=M:%)EFJ[,N[Y8#@,]
MTJZIJJ #&1%LO8D'!I-F)\WF_'8#T//K5W4[0ZIUE"?M"$2V?"OK-2K0J (U
M?7QJL3=4R)UE?OWA[.[/3&K6,:Z\5MBI/[Z\F,!_>P"2FB1H.:<I: ^@X_T[
M,3Y*IE%DX3.FL:F6A[>E)=$*WT.!+QA]$1FCJAE GMI?I/.\I48K]-3-9:B@
M6P7:=H-R#E16A;KVMV[0WPST05F4L!@3ZERGRX=M\E@2ZXY86]6G=&TK\W23
M^G<VBXJ_F8P6ABDT-'PLK4<J<_I ^S[)L$?_BR(ULCHUVC7:%)*=;W<KWIB
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M#%(A*&,*O(0J]0@IQT[!E>FN/]6(?F4&#6IT\;YC03&V(PVZV6/S5->13>V
M]#LP.I7/PR=(VS&6 NF574GV+W5;FVN2!I)[-E(C5??%V*H9)W4*#6:L1(%:
M(,"#05A::A1"R)DN('(')>@1@*;K'MS]61%4_Y#H+UW&ABLJYS %JA9.5KJ#
M<X*BM2&0,!]Q<>3.*[1T9JI637X9,745SHFJG+'$-8J/+OJ'[6SB'O55@";C
M]P#?E7"[E]A"=)MHE)OR>RNV"BMVQ/\6!\07M8D^'01V&%AI$H*R(:U;8G#"
M6VRU[IV"?DNSN[M6 XB72G*-(^7829R8X\I'Z>3+W,]9H0$G3HPC2JJ?NG9Y
M;<_97K\,9555H_S2UZCO4&=J]@ ?]JNA@7^*8@:ON<?4B*Q6-(103%7R6^4^
M*%VHJB<J[ &JIJY]<"7V3K>EGLAI?_[VB.TY9_^D1EAC\,Y$;,@QODTKA\JM
M;_?!=G8EFU5XCX6^1ZF8-+,?IIF+,E^"2[$]BC*UHZ/0=2WY8,6D''-D=J/N
MZ^7.!]QKKC\ZQ^*M-FU O_8 &+#YL^.;LWL &XFFNN?G5Y?T<A=MLG\PY8)\
M-_7_@"3\.(WL;['YQPR_0![&),4&FG2/]3J:++J$=BWGQWM\LE&X>*3GV(\N
M0PT334K::GTMGI, 8B4%9^BU7[Z!V;1T%=V9*E3#%CID..J;?804V_J+!XN_
M>G8(L@<HX3M)N,J[$*PS&0_C[V5:+U,4UN<;IK:10/-K07".Q<7+QJK3E\&J
M9S,CQ O%,[\W<+TGRC2N=(-M)+-2;<Q9E9#1P+\MCQK3+5%G8,GUXQY86!/>
MSY4ALFO.#MV5;P/BD F^LZW*$018X]T9^OC]MQ\]I*XQ7?+0ESYW;5NOZ8LZ
M?KV9_61!%+).,DN(JD,?DG)+U9E])>-<?F,Y=I>T!.2<E6O!98EQL:#)0N2)
MQJAG!&(#.!=ABZN-A;]7W!2G@$1-9?$2"6[I-M$YIUVR#!(OXEV/T?8 XM6C
MU.4#U^O2!37K- 7>_G4*<F!=P(38JN9:8Y6^_#EEO6NF*3/!59T+84<NO_KL
M:KGNH5*5LFC,FE[ KFG5V>&$N_I YE3T/X^M5*E>2@;( CW]91;G$$JTUS1_
MC=1D;4@/EB=-=^ZV4MF^&/-"$+0L])6)5@!D'=IGP'O)+&W,+RN$-;%64(;[
M4N9YN>HY1@SE@3W5=RDC$S))>%OSX9G?M>=A?)U+./J1NVGQ\@(N+D\"KW_J
M:&\Y:L2KH$>:0!NK2"L$Z.X<Z@%SOH\IM,]-:NQPWTDTA=I"YB-/QB*LV?Y3
MU B7@KH[A]/;65$%01F&_&_.GTE#*.O<[G:Q7*_,D=>JW .X^^P!7N9X?28?
MZCO=S:?7$#'+Y"RV=!@8G;;(2_*"ZOKMQK/O_K_AI[#%YV7U8:-_C[\4_XK:
MG2Z>F?G)_9L#7!4%/0"NLTD'R;,?]M5\Q)ZL!R)<!X'K<:2_KKASC]CA'21,
M@/AYPMAU9:"A]69?R(Q966:TKNER0!GG5?L>P%'R&%?:8;_4[Q?[HIZ/Z?T_
M3/UY/-3?__^/3ZM*DNR4J9#*EFQ9I_)$""'K8"ID"\F^S51"U@FAB"G;9!F3
M98Q]REI)=F,?9NQC,F,9PVQ?[]?G<OE=?G^>?\XYC_OCW._WV_7^>)QS*)ST
M9OA K12LX(3Z\C5^N P7X,C^P(9N]2!^"N 1R\-)C<+P9-N6[>IA)4BIQ-83
MJ/D5&&T#=?_]LJ_)ZE3_PO%AGUWP?W:AC] &.K5JL,\V^XC5A_\4JP)$0U%5
MD!;0%N6)ZP070!OHP'];UNJZ-,KR<,?A,,,7ZW>\'YW=W_X> &L=>>7,),\J
MC)8PSV2YN6<$<?(5.SVB=B6--RN0Q_->-$<ZL76F BXJK[G*4!->*L2-V-5@
M%LZ!>_P"O(%3(7E<P(%MO]:G+<W[N\Z*U6[R8@KN< %Z6N@^T%0.78@1PKSM
M,RO)_H*W'X&*1D<Z1JO/70!9#7[)=E'RDW.BG6^J"YN<S2KM\E?&0,[<"0Q5
M=['I3W(3GOZ\KN*$P:Y \Y#3EE]_"9UTDU_=C*EU&O%L2 +WV:UP ;U7\S/7
M5WE H5?/W><"@.H'PH/2:M.Y[_HA[[X3*%[7C"@9=[?9=0D,^C;5,I=1"F[H
MR=/__J8_)_:G90;6=LW:NUW)$@Q:W-[96^?IA-5 UFU%UQMI-D1D%__9Z#LX
M1B_-UW6 I3Y/!I/Y!"VIB[@$Z&E72%^ESP%:\M7M\8(9F8[--/-R$+PNW^_)
M&(8/U$ZO\"[SSA$M_&<Y0#8WLWH%'7:[DDI$W:1$CS0-/-$7H9WG08]7L31<
M_70<6DFHM*)2)%OUKR^<ID.F3:Y(J7]CGL;.GE4Q"3DO<B,BM_X54?Y$I3J3
M]Z5@R/Z7^MJV^NSU_I!C.\76+4-=BB.:.E@5G_I2\Z@.,X%OK1 LQ)M6R8]<
M.\D%@.SHAKIYX%F<>NY4Q]1/<LK:6/[3DEN;F!C7?W16)8_'8V(JC[7DHY&J
M)PAT.NJ.8BJM&[9T(6+9K)\=MC_V!R4N^7'!H=G4R<3F L/X+D@?Y#2O2]X0
M^"YE]K#1>*WR'<Q[B@O 1Q66/H'-N/]@^7P2<548QO\=]FC*'C]X,UD3)N#-
MAV_WZ9S"FB/-&DYN;,8SR%KUF7'.B;'/&KG>W9=25=@3*BR2^B]D<LA5>$Y,
M\?0/Y3J!<ACI9P\"%6!8Y?,"^0LI+K-M64-A/Y';V=CYS)O,5Q/\D.4.9-TK
M8=[8Y0)P1A7J'#1+(F20U%#/!9".L#CI!UY.!FW-!W(![[@ 1E*#S$9(S,L)
M[.N0F^ IYVXE]"4NX [DQC/O)LH[O]/V _(';5]A3C@!*SM$!F+Z*> RF=X0
M[PCF[>C[\2>/B-S]QJBPJ4OY_B+PE+';D3,FLV+94]7V[&/J<$G7<!WCL9;'
M9>-UV@&QNCIH1C>=. =^.S_,4BWNK5JKD#YZI\Z;KKDJ(G[OTY2_PA$9Q!*9
MU K=Z&SJ;B52S/I$797QZAM"TW7%'&IX\L.64?33O5HYA'#7>IE/O_3>\TK?
M&P6WAT!?8E,B%@N9($197"A>,1_+YC_7E!!PGTZ&+Z>UC/(39PC;Y-Q)W+OE
M:X+ *G[8,ZC<>2Y -R:U3;:''Z\'X[?L#'+]4_?&>M!TUV6]R)>]OFS>V+V!
M6XK_ XH*W! _2/S->-!&U#8=O2W !<1JR""ZH!?9+2UN1RX.;8/X.;U2@-HL
M S]1.RD@(Z%\&KSXL?:<\[C/B;O"AX&U95*/O-VY /V\CR>R-Q[Q".X%>LI)
M(_M2W$DI*:?I)&$.'$CU".M8W;:<X*<W,#[08)W8;BZ@3BEA/LK:>,.9I<<(
M*EJ#^FH<7WY(8W?:*^@;?<A*O73YCEPFO.-!%NC9RH\1Y)]Y#80:&$/9D$5E
MCNK!K5.*O[A/6N"WACF\($S\@^-&D5Q JM#RBCYN8-!5V]1$HXK2?*UX9K(9
M"&FW9%TX0J5;2JP2ZJJ*D%,M6"[@3##\-5! \>.GF[)MB<43XVN9E8_#_KFH
M=E+_S(*_"'Z747B26@C[-XE+)S#D>V+7H=*<(9!4FY3/-<E5+N L1\#+E2]C
M@O,P;;F3P*_8_6[W4&QA760JJN'7W?*+;Z_'2\)##S4^D34,L(OST]GL@MK?
MK+!ZD"5!K_OB].EA4Y>%V4>E@IVL[:A@T-\P>JP .1+2@1:96G(( 9[^X2%3
M?J>3/NOHTB/^"TR^\!TK1SD6N/F68X.NT36;]UU@&!*5>=?>DCHAIZ+-OZYJ
M9S6LNBDE$,75%)V=NW\/K1ME7)M_Z)64[,";<V*>HXG65'Q?9H,RU!2U:/UO
M:.L]JI75'Z")9.[;^C&;1KS_GIJ$9 5A#F3GSJGKBO\[YMAH:P4$H:&M!?/,
MM33JV-%P69EZ.T&W2&@1RVM\%O&5"Y"H_?^ONN?K>X:O[$^A?3G2UZVLUZ60
MVUS J:0XLQRB/05:\!+TOY,*AK%P@WU8JJ&AEOD=&?H8X>69/= D6WY&_QSK
MZ1CG7"_*Q0LVF;V[WZ+M+%O']M@.+S97K#V)X%5X\\=$4](YX*? VXIV'ZMK
MSN_2%[85OM"9RA]QP++=JL@LH<8(5SPLJ^ED\6AN$\A8E+Y)&T-^N5-(WO*9
M5'BP=O8($7+"U;O(R@OUPF\QI=?C15/TX(Y!<<>C3Z^PNOQ/& %<P+%7[#J<
MI^4I+P@OR)-_4JYG]A3C<4EX0A=48V3;S[YC]IBYO2,C@>3X.:=3>ZD1Y1QN
MXSRJ[JCL5CN,.BH:INR?W>27&V%T1RT3>B>"TOS\WFAUZL]34!VK+%4NX% /
MQOO[\*^;=2K\6CG/KITH$%<:%V1VBM1T?-0N..0< C&7TA34#BRQ#D)9B"[$
M0M>56QL? EL]FJ."Q_9T]7A:KW) K'2V^"J0^CR!8D]$GYKP@M6I$6HU*?:>
M;C?R. +H21VZU[<\QY%$,=X2QN[W2$*\W,! ALI"A)SND2&</,X'E :I!?68
M]=#ZVW$3W0$3S3U.;4W^+(.Y QW%NC?&\J/ZVF("WI,ECN>1PC$@B7!EQ^]S
MEJ@U)]<A&-%!/W(/\9 11 3Q,;S"X9TG@@^5I>K[@4Q:>.Z/8/(4[:_\W5,@
M9GID-1WZN'M7_T&$5>Y6JX%C4W.&ENR]L*)_CB#H[BVM/:E][T5<+L@P=^U^
M\%$;AW7KA-I4T_=EE)_YPUS ]_>S!>8!NP^OV2!E;]U5R9@TW85$(Q:>B#L4
MW"9A;W&"U2K[6N)XQ.;.A_2C4<:&+V;J"8[^3"X (FTWE9$'W9QTL=]9,?5X
M$A3W4VPEALU>&UJS/S1F=/;W@XP*W6NZO @S1X-)VM2N\-TD\RVG_<W967L,
M95=I_L^_F9W0YF&PW_"VVG%DV#OG+AUEX\;7\L@=YNY)^8.$,KKJ>H2!I]G,
M^U=(8:G#/=!KU.-EPKVSLH38ECNH\!#.F*M]4IB$ZY=GF9AFW;M'\SW>&/L&
MG$[_=>+CE4U4[ @',6\:!CO!L\<%:)><?%B/GIFR+V'K'9.WF/YE.N6B"#HV
M 40#3X#FZ@G8GO:IK_[*T1'_MQ& VD6WDF1P >W9HI&CB F9NX7]G:X7<CI<
MI>.>8I,DM?!,VZ+L&?=HQ9D9=A]AYH"LC^6SWT.UG0R0T$G$-]"K%O?-OJ5^
M(OKTJKXH'CTX0GV2W"DB)4I[\O7B>81 8_^EM^+ /EXCBO2_VV:?<O9BKY$W
MY^)^2)5#\\N]-@(4IW^>DWFWG2'C:R**-%'(G>CQYST+S1JU*%5Z[R$1LM9^
MLR;#W'&2WDI2K&(*_A*NL]XVWC8G\L<BJ ;*D_I__\'B<**ZWDRE\*%PW !+
MBZ@S8]1A^#J0I6D'%*1@7!0S+R)FHN^_3?\)]9W1A5"9\Y8_-B:<EN?KL\K(
M1?-]]83U"\8=]3FYG"_Z114^^_Z%;3+806138PO"9*2*I1_B C8MX$0L#%9B
M/O@AZ[+O*2GBLG9:TZ'K5S_W+JL\L#/2DOG2\$"II<;"M')N^=,2KI1_@NC'
MTT.HAL<JUO4=)]T95KOJOX0=YLB$I\V-M_:5S-8&1!%;#5R'W8=W[*F+]8GH
MM=#<I^G"BYB1!_?;/$;^-']X71:AG?$^K[YFCU!X^7_WT/^&>>TV'BS@1\IB
M:[F>":(=J22$V&IN576I4\_SX*]J!,'PU6&;U@&_D*\VG=E0\5&>>#6V68>3
MX306WV0'+__O'4$W0[Q_YD! GR\$3EC.7<D2N12A?X%AX?OU_8G.3&,DN[;O
M>9Y)6.9B9JWQ]T,U.YN>7<K'UA BH">X9"Z GZ5FF;33#X" ^^8O>';L0F7Q
M"KIA/*]V_.2[1((8OLXTP\XFRM8$0\>^;5A1C:QX0&"JJTX/@M]WA"M#:QG*
M)3X%QQE@*OC>Z+,JO\,L-49,R&DCZ64U35>QF3+OK<^!] NFDES S&U/&PG#
MS=ZC?Z-__ZYQQ?-KR<SS:,K0\=DS]D^ WPFVG/L,$OUM8S4-U$5.CK&>=\,D
MS^]1E\?;QI+*!\,)SO6XD2_\@D2-AN%G"R_"8$4N07_2FZ )7, /H+]:%AL'
M<^N[XF?NKS3/P'KRY=V2BD[V+O3E M1*=.L\&T&T;5L!=U"@F_#>#!,2?9EF
M'UN7P"CR"(^V#YG/'@G9$+E3Z)2=#I4DXZCP%<%IAZ^.3DO+!F//U CG7)WB
M0UU UGCG<O6N.KH^\B#DN=$L:LL.1K8"/9HBRQ3LWAWAJ#J=P("C?'M;KR_-
MDMJ;V--)^&_=R9[:O>WL0CG)XV/6G7J1(5^N/;#UQHK)-%I/*-438)"&Y:+(
MK!'/#>/"J(#% $4NX _[@ A?PQFE+.C!&\407HZOPN=Q9UF6(\_\4<Z3_2]6
MRQB@V]0#][[8H&G5)SJNKLS/!71F_YOY/$&W)!A)CQA/^=)4.2<G4#,,6"<!
MV'(JLWFER:7_38M)B4%I9D" S^76=F-!H]M6=/[9:H#IYN-):T0SNA$T5P4\
M5X=[Q05@D10"3;4G-Q?LZH,09MV9A\6UG7E%;!X)H=S=-1HXLC9&5P'6S4QU
MAB<69G260D,C&;WTDP?1'0SB8<!=)?PHV$2.*IDN8?\F.%%0NV/5*01)=S[G
MS/IXJ) 'G%4OX^>9\39U:RS$QRK[W!FKE/+N57.623,$C%K'6KJ9)F=4CL2,
MEB;1R;/+(Q"^8"[@I3=-AP3%46&W:7;I5>&]G4X*..%*ELFC^GUU.O),RE+[
M;H<('#GE31C?SWJ_&]G6*!Z_Z0L_2W"Q] OQ>#*X2GL.X]$'1M^GAG27<K0+
MS/+E'E)G/\.]B3#AF?!L'9#06F1I;'F?FF^43.%OL05]A9IZ;+7(H&%QGT=Q
MEB\O[ZW+3!R1OX-M/ _-GX.<]"VXW$KC3WH\4-)$"Q9-7_F]KX&Y4M*D)VC:
M/%27K])R)\"OA+,TN6:4Z2[-)[V#OM[67#_\;$-Y*6F(M"Z2@]W@:T=._)/#
M;M;'E$"6W?7! 0X+B?!\C0MA2G^\NP-+3IHT6] M?\^Z?-0=^L<%H-/W[9GG
M?39=H']!_!_]OZ1O%^-;]$Z8!07HBM@Y44@&I<Y*_RF^*-P9Z#^O8E)S]?9U
MJUZVS?FMQA\9H.]1,>;16*8B&+R"J-WHD'2YZ_7/?R-:OTTF0JU.4(T67KCB
M\@,6"7"9K'L177JO\\$)AD8G:W3C>-15+F"T/T:3"0=:,C<C"W"(P1?=NS7-
MG.;D7!?"SJ;.PQQKK4U6UOZM V9>)MN4C64BLQ@-VSV[<8$"+@Z=#$?T;[>*
M\PB+GSQ[VR7:;WAW%YJ )J "NS0'.@3_Q^<%V(0#7/A+%%?7Y (<9<NWF84J
MK*T-5M. >P-H<_;0MA5'_;OD2C^KM@UX[Q-L?7M5W<26*K0'14)A>M^A[^<R
MRB31,Y/.M%7%QH#5JC[_^QM73:W#K+S)_FV)H: <!$,!U+%,[6<)V?QPO=2<
M)#)TP'3H":0%]?V6V\FOC!R3'&MJ=%O4\]0;&1T=UY0_R#P^TK 7_?,^I$_>
ML;?$U2S@!?S"3,INKM\?"Y5Z<$"6T8T3;C^?968.*,(@.*HK_##9"?\=_@I1
M=R;Q28\]@X<6_[O#JF!J-TRCX"PCCN_;L%Q#XW.21IL"E9Z%;'D[,%6RU-+U
MY8I#"WI1DR0TJ;@!5\>=]4Z\.<XH< %U3;I;U<$\#<HR)DOJ!Z7F3_,\KX?#
M/HIQ 2X*;-\D>'W1AUX3TSBH[8D L1<F6^K(25O!45S"R(ZMJ>VWX)''DL/6
M;0?/)Q_"(=]JF&Y[P0/]2-^1&ZN[G/4QM,Z_0V\_C8. ;.&OS(S6/'R=@,,3
MD ]X1DCJR&S+'?\>]GH8.>70/I-I/WSKJMJHA6^)UTQ4;C %IK,>;CU43!FL
MB/"/VEA?I8&L&5JTO'G/KI@K-GP';AD=-0\1^NK034Z^JG2Y8$_HOR?OX^.U
M%&0.VW(!MQL;WB)4AKRX@$%+(]IYJ/Q <&N4<:[X=I]/A\7H=EYVHJL.&V@?
MKVC::_5JV,M+U*QMN+-'CJW@_&TR[C*<-?)L_(N10?5XHY&KA' .Q[%KY"B<
MXYAPQKY9'>9#H-[;F'0BDR#K.?.XXZYK?B$DR"MISEF7P!,1 ? W(3R-S=32
M$OU5=^]']:ERU)WUK]7=_L%J#AG3KM\KEHFKPR]2/HFJ-5;M-$_%1#,E[P9Y
M(^4\?".@4L;DNY/?#HRN&PT+O=2SW !3'JN4E/P>]]GK(8F1'DCN5N'$D!%I
M)&LX0PZVVXY82+8QT2\F8TK, F,SPH[L;?Q8IE6=;#\UE@3F L Y?4H;^WL2
MM"F?ZIY&[&_8ZKO;H,LH1M!>6%E81*"OB-+=>ZSG-XOP#,= .)K<%81M:BLY
MP1X=Z>5W$Y?RM+06A]$(D6F2X+*I_N:&1B_:\ M/H)$!&0\</I-K2C=#DM?.
M_R\^O!NK&<4T!H7(=[D=0'N^V)G6I@(N8+FUSTAN&%584WVWD@L(KR+<B#H.
M@);#KD]D<XA764L?/N":?C?NK!>QEEN#QD2O1(TT-S2$"FQ;)SSN^;K8%+B;
MX#-8O&NVSXS]G\.K;\]<CN*U3455!<FT!0\E/_>PXQ"Q,Q-I?RN-W9S'7GJ,
MA*!%U[Q]54]FZVE/C%<?'E+><S^AU<$%]-X^(_F5U\664R:;E;I.I-:*);XU
MDWDCWD]E52$#OEUJY0LJ.-O4A!F\D.W0B1=U?:304N>*/%W,@<6I_Z.4< %5
MV#/>83#\SY4Z<:>8BTZ*A1?/]?IQWI7D_<HI?_Z[Y."ALQ^531%"7K0)X4:"
M]0[T27O0E&$R<'OF4FD$_Z1"!+O3N.\4X78;:W=R<*-J="GICL"UB^\/S[#/
MB'G$)&AM/&39>H:*X!WC9_&4;%&=]"&W1D7<<CI[B02L!J5>DY4/DJ%@6&R%
M_V?N](J( )B';F3:>Q'>'."JE7$;. )$2+T V4R/B?'U-:,)SU!G:R+LQ9=$
MCGFP$GN0_GKD*QT.!;ZVS;6OKV:L([(UY'K_W4I?D$8XY_:/M ULLFO:KSY"
MU$J?Q=WWU__X-[R,_IQC>Z#</P29-7/:C)_NIVX7"1H^5H5!C8]Q >H>P)+'
MNM<E^VK>@Z5@@=*XCUQ 6@T<6M 24MD,.FL)ZM4V\&>LUFNR>?3T<40NH/[7
MI>G'J0A.9%;,09_O3B\/1HY8G+6KLR;L3VN5',@,R.4MWYQW6@2%K_E_/LIM
M'>5W'44>;Q8L=6].=>>L3!^'B8 2=+D !9&6,/.,*? ?/?>TNX0/Z<;X-)_*
M^LK4I62A@TYT!5P=01?2>(#_-HU'[ 13/GW^/&W7,D;&H(/I(T.*#7W8<DQ+
M7<X>\/2!;K)OTX2_@57S=#4\'DEQX@*Z&A2@_(PGM]P]VMZS#&%UC*0-RY.7
M:X#\X986HY=:L\:\W!J:_E2KF2_@J7U$9IPC,?'ORA>(TJV7DO]%0]?/-.N0
M8B$M$*H3!)X1OD'J3J3FW&].#(:_VO<8K4+Z\>WW/5:&MY@_OD!O:K >_!7T
M927Q2D+P;^'"L:JJ4^E'4)6PE]HMB2$:CKV(%RI3XPA_#/E164.9E@]!,6^/
ML,TZHV5JG6E>GXU?#66UI/?<=X!)!KV:(DQ^N2-^4CKC= S@NTU!Q%'!U0'X
MXZ3Z%6 9*%Z/?6>G,F]"Y!;PZ$;_OQZQBU)S+\*W>_#X ;^ZS# S#W:DQ&"*
M^\*D>8436QD&DGEJ>"G7X>/MJ:6]FNS^V8UA+%8.>4N=@X%1??N_3Q%B(51C
M^ 3>MKE.)!+='>-+U.QN-8!E]X;PI^KZQI1X#37)6/V^J'^,VI_@@3GW2Z'0
M+5#Y$WWSCE\ QQK&WP;T(0BTV,Q#  SKWUR +0T";_&85S["\.G^>_' _)U2
M2J/20\%1)YY<'Q+'Z!EM=IC7'4J;0NL5G[MF:[E[C/VA[;0WL#9AG4F5G]-X
MFSW@C3O1)L0",;S/V_$N@G_.GJ9:>S=E(R6JW>6CHIV(C@+2QDU/'R5)]DJY
MNEV3-;V&$0_:4DJ;+G.))K@B0_0K"C'PDI]''PV:&4: )8[!KN.H-F]38/5A
M\.F[+ES O!3CL=R'(2729<:CV>YEP.,OL!DC(] +C7<.&^BU<MQ[-.,ZWQ\K
MSB3P[(/* [28%V:X*?']X'E.]?[>LVMT_,PA:3Y$GO!PK+]8N:W@XJ)-,L*A
MK#AWK7)H;)4RL-3599$<:X*]^EMS9>Y?[I83+)UE#IV&G5;D\'.F"C3KFFIM
M&1',^^%VS)XF#2O#CZ/*0Z1[-+]/SPN-,7BGH1U>YHFI/[ER(\&>C1GK"NW+
MM)PN*!_L!"/9E?JWY,*0CX1(282GZL<O F:'L5ENN@;KBWE]0)IJ*(^;-Y)W
ML4'5?N?+ 6M;,Z1C: 'T0,M$J'CU'9H</6:DO]/E)G%(59%3-"^<]G^?\1^?
MU>ESKY'1OUQ;C]V4 <=<W_Z[>VD3\<>X:\;3F-9:FD "J_.6]99T?2&'#M3Z
M9Q./;0;GNT:8!.2"+[$17VLU9.H??"MIZ>C39:0(4<53 H7*M1G/;-Z7#[7.
MG[3QGBFN^L0NSMS-V+5%H=AQ+FXW5ZYCP.C7<,6%T6D?F?>A3L83JTA79-_=
M6\TYK!XNX!RLO\2^PO#=HQ<FYT\';XP'[HBOVOHZCBV7S]R*NJHI:>@Z&T78
MTMVY0LQ,_12P$9+%W(\,43#>6M9G@_B=]T?1E_3 6\#YAVXOD$?.+Z.'R12G
M;\4Y)S_4;W#([OPT('Q;G6!4["92G/D^HS9JI2F&I%J6QU/&!K57FO!V[28
MV; MCK#P?9+:QI7)K+T 7R5ZC0O^N?R@H? OR#H7,$7X?$S(RGE.>#OA!Q?
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M?O[H+T*<U#![VY)CODEYP$.X__,>+*@AZI']C;&Q@37HL\B6&NSGAU/#M[@
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M:ZG.UL@>HK>O.O$FRW_-G_I3G_W;MU7KW8V &E?GKS"MHEQE4A!]BYVG#IH
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M[YRI&/RMX4\5YK3RM_U%GYK2-;O4__:$M,KU?:^.+"V:A>\!_]0Q*E)43[N
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M6$RF&".X9?H)Q1_/O]DP*7;1^2@Z8%V[24[9R);%_:-:4_N,AE\(E^5A=@L
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M0PL+=ZHVC2E=QH3R('"PGX>GZU:E(VFD<9"T<D:O?L**1N:BP''MN9PB,0$
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M#&OQDX5XAGDSYXX T-HTRXYA7.%+B3%!7%4D^UI,ZWX04 "8TM*/$<YORDD
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M5KXTN\S-CY>V-FY1E.O,]FC'W:UT&&5S()4Q*VE7C=4&U3<$@'D8ZXL $!G
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M.>NO//5? L2_0]\#W%-3Z"B2T:GJ-V03F54681"2U4M&818H7%L%%[/?/VJ
M=X#E!O-XUXC&Y?2T)5T$1V(#3$3/VBHVW8Q_YG<.]5<V^/I&*QCZC/_9%B(F
M"7/P^XM^I+&RT#:MOFVCL]FCN^,F & <TC,2#IY] O\+5@.HM0XER!NM >?;
M/=K]BKRK3CY3J*OU_;W[TSNWD7\K"O'7Z8YI.]:ICQU=K+T*ZZ/GN_3=OR8_
MB_KO?$%2RKFZH(IY;%O#VK7VI\P+W5[!5?VAJ3*^4O6^ D".W<0 _:&;:%8U
M1N:4T< NR<J7?\&P;+-+BW_O)<]K_9P'O%JWSV7;MSC6Y$S+2;2Z[AG81)Z
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MW@^Q&77[P<Q@_KX#&!WU819V,PSF@_-X<$DLN#%['#6S'>@4,K-&T_R2?4<
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MJ0^E(!K5;BX-V@VHSO(0RM1*MNO3,=]-'Q&K-<(?G$QC&5EB*=)ZG?-BWC#
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M3;\>7FG="X.B<)TE80WL.W[/QO/X/5/ _WMV_X]7("0W7K/^GT7?!.X2KTD
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M!WOOHWTP.0@K,_?,7/=U7]?BF6<&"Y>W2-X20Y-:,@*T,V&++8XR%>.WN.3
M+I(AR%'VX5%#*#Y$$&_IU?\IB6C.@OU$X*4@(QA*_^/""XN+[L$]VOK]Y%A8
M,XTZ1"R!6V)H[BM%D%.X2'>1T!V-,=L;KIOXY\<VV.=#<]Q%ZUOTMG,XG<-V
M?^1A!3()";U'O?"R\AD%O'!%9EFV;L^?A*6N_2G^>,%/KS/\ :[7J^_!5\^N
MCWW$\MDKX+(O4A"A,JH/" 5#HC!A7XRV/B4LAQ3"O@:/ +&ZXC/JA;M/^79)
M8I1I8_C_.J6=1,)?B_ZIF?%R&5)P0**!$N?#\),]096EGRW[8P[HSY9(0;^K
M5]Q#&]>^[/>'>6R79"HO#+WN>C8WO>Z#?I\3G2@B%0^W+;MS)/\*[\(MTBJ_
MBTU-LMQ"UWP^OG+UX(&5S>$(#*X% D4 .^ SV7-A9BG079'^-\I%)R+Y\U?0
M2Q]#WQ$?(IOL=RVC[V]^TGFM5^[%_L8M7:PY1#2N9=^?"9*XF7*-GKNQ11VA
MCNG8]^E&1H^6P(22>/Q0E)Q1QHD#'[=><]-^TFD5\#F#@G*>NGC@Y5!Y2%!L
MTS+NXU>9[LDL?<T@24'<H G'SF'HKN [SXY>!/.-^_:0EJXD.7;O@?XBGZO)
M4\[<%SI,M8]>82I*<B4(F?QL<38/M5:F,P2OWC:\?7#\&O#RU>HKNS\9@0+)
M8"$OQ]WT03O."UBA'[K&W* \- @6OU\CFH]NV=U__T7;7P*C.OU*\*SW*BUH
M$)_)<6EZ$BNDOW,L>O<8]_L4([D+=X,6@WPU^8MQK7_J'_RY!GL*[(T$$_6K
M:8I^*@^V>/5XE]!">?&A6+G\R%!CC-'@AOF?>1MHDKP3*HY2T/M=^('&"WZZ
M\R7$9@KKR_*_KJTS[+L1:GA :+6T%T?K&GXBAKJ@I2#S"7IEQ- ,OQ!E"1^8
M@J,$% +3*7J\-.NG*-<PC?J)W.!KMWBY:]#]M#\J"BEY&[HRZBU9\X([/7E*
M%Q45_DXK18?K3<^-':<R3?D[-V*?"O]8*V:,;P^DG;TJQK:%:SS3[CK-(\.V
M+O62+YR.D(*FUBKU\D<-_LC9!UR*6D,I/1+N]^KXB^>B#_&@#ZLS]D]A!W!P
MWC.UD  _;$A=SJP/NDJ?,%V?N5NF[7P45F2P602*S7E&OA>J?1*V_O*\DD79
MSSJT@EM<X%8NVI[JMH*;H%7+LP](0;?G'&6,N_ARX="K8_ENND8/.4O5\5:.
M<#],SY_EGE7_NFUR"^W-B,988R4;/PO7>2S*-KHA!7UXQ\W[E'.Z/E,"#;TW
M-O\0+K%[.>T5$O8R>WZN79'\:H@IJ3K$'=1_^BTH(1Y7=4&??*GO?L3B+=&^
M7L>8OJU\A,XY+K9 $/BK;*#NPH+#^X]Y6^RRH[^D#5XY3AU4[H!S//=.WEY-
MIM<B(8A\M?6B@8M;Q3!%-_%G^3+&FM'>+1*5%_ZX$S>Q[R8(E7Z?UM8T3%2O
M78D6 !+<4.9]WTE8AMH_.6WJE<U$R?6(D6-/M#3IOV",A=)1PJF<KDE\J)(K
M0BDHF-_X4#%6+G.#FRS-M#?A5IN5'S<9?NM%;XV)=E>!('SF255HZY?K$F8H
MT1=B%-(072^M=G3<R%@V\+PE0BP_72Q/J/SU]=-5F4L(%PD7)6\KC_*NS+\-
M2!-/AT$D<:3EA65W9,!SS'O_E,K2+EY]6ADTWK5W>GE(0"C5UD*6O-F_&/.L
MG B;MI0W?$0O'-S?,9NYO*V&"U 6'.:5Y8^]89%LF[\U?WO>B_5BB7'$X-_(
M)OTXDG:6LCCJ_<, R9BER01?%$<\G#ATU.=5]OPF.H3YF(?^%7U]JQ3D<+U.
MC7MNJT7Z:\KB9\D/G(T?<#-$IY(Z_A-#:I[);J@GP4/>_-=8%(E*C,F-GO7/
M=TS\3)Q=5GNP?[5?%Z?P6X5FT@U.2%G1=.\GB]$_GV_K8X:?2B@G_XS7JYF<
MX[-Q1V/.*E=%F8%II;M'NN6\>\9:N)0GLI$7._RYP3A[$6Q9S>L"!QK2FS$T
M]6T.YT,YGQ[O1&4CZE0B:]\>Z*7IRN%ZWTRZG?*Z5JU=FCDS/=68GPA+24GZ
M"=LU7>C1J]JK:":FA@=KE9=1:7$ME6EF,=YX,[^.J%__C"$;"I],;+VF[+O,
M]:(2C;%1L941=6-B%>*;))$4A /4'&[[Z#IGSEXR1RQ2+S;EZ,NR_9K(T3[<
MRZ5\^&%MFW4W5T@U_GDW&C;]_*WG0X[X"8VXA3N#N+;'9#HF9O]7V+V@HSA.
M7R%,C7NQJOW-V^O4C$!OL;=CW8LDZJ[&8'W'9)$]O7)#:!'W)\5%;=?9]&8I
M* C+?8\UP_7-;XGP/K'^L%&E>)EK\.C]@XO/93YU?@MGL9?@-+!JV#C/";R4
MD&NQ_*$:3^5;<W<[^<=L:SBT[3UN\9:@W><SCDL[6?LM$ORY;2J&-DI8A6,6
M@O7)UJ?+@[T*\[":Z/5\,M4T!>-3_J0^I-GJ[A%T5!N"O_SZA\I#?8'/!MAD
MX9E=OKL*=C2KHD*B,:(OXX?WU6>/YD\OP"P=-O!0WD I!ZG%DH+:\ J?V,2M
M(;7(-SQ!5F"-<BVN[Z04Y(HNK1^H.X7[$LSUDFD4J'AZA2F.AUU!R6$_ZJ]_
M3VIZF]0.UG*XU! U!N-CKGBG*0,+_779FXM' AN -B^X\2#IDKB&/7$W-DT0
M*<Z0;))\65&8!&^J,XNN;SYLH)SJ$/#2.0264O\Q"7IQJ!09Y*^H^>%/+17Y
M^G7G/L'E@UW?$ &7R'I=3VXRY3MG]]P]&E/]P&YBZ_6FI\?V7ARY?YVK.VHZ
M-C3Y,^(*CY>6^?@\EDN,0LXA8S<X5/]]?7EYOU/8CA+ZR9Y9H00:</6$F?$U
MF=O9DZ#N>G#=?S9WH=WXF_EUT8H/" ;NIN"=/^[3T5_7;(KYEKJC1MB@D%ON
MTF#NTMPF>@\2'DT^A>[*,7JD/?[NE%K'8.:BPP+"4719_( BJV[X_DNFG?"[
M8&7LMMX(T-O!18:R1T/SCJV@L>UUJ33?#R#0^B(0:-5]]X%!MT<5Y[1^/BV.
MU2L@(ANC4UW/D?:>H2,DZ_!=%+6_+R>1@I@%$J/F=TU)K+D'HKTDQQM-^_@N
MG9H-,O5,DU_4Y;K)!HP[L_A)MGEW*,Q"QA\YH$,*2O)SEX)^[A*_*:I;&3*4
MX.!S"%'*TQ>N6>]>=M!#&,221T"A%,0[" %,BQ?[H;NQ8$UK_/3U( )?>4FD
MUB6Y@]"2_7DF!"Q*031$N"Z^=A9)"&.4955L99),!LD&_T19WL>'2;:N^WL0
M00IZ9MJI+++7Z9*"#*@4U@<<#PY; 8ED6KBMNE(&=&LLS=5YJ!J\L(*[+0OL
MR-1WW/*BLBA?"LJ$J2>)-FM)-ORB1!T"&BFS(H^A1-C\A4$&C]D+F-+$JR1[
MI2 6BV\J!:D@ZO[\.Q:5UX[:W).[))37N4 5C!F'X,'#:$Y )V,.<X5O(#F^
M$\9JD7U'6%DM0LCBJ*R0Q:&''>S_CS@.L7YWWW:]M2@VPG?, ?^4BV1K+HE#
M;,'QY@#9/-,O4'@LPO<UDCL,+1AO*E@*DBU'[>-_A[#9X_:>D<<7Q3C/?7R\
M9*NU<!6NSXQC*M&3@C9+0?Q7-V5;* >[?&&R'!,(0]PO-)&DVLDT?H4@.!5:
MGRQ;2*J0)@5M5U8^YCV01B).&F'WD$2;48)UH8T!G? V]AA)C,0O3Y[#M<FB
MN8R32?#+_Y[)E_]<4:?%&S#12I+DM&QG".EILDTQ$L=EECWBX_A +1''?R2)
M?64@^Q8LOBOG8\M1PS7S$>ZPSU]PA$[*]1W%TQ[X93&L&3=O\)_]W)>A:JV^
M..Y\61;_CA34S/?V@)*SXX=*8+S#D.]@V4II=5'9#34PP1#%/_"_Z>3_#Z;_
M5KHI>U+&N1KU3R79K84X9@+XS8G)$LPE^!)VU_219?I6K(;0P GLU8[KG11/
M2T&/E"MD3GMB$#:/DIP2R0Q?DIJD!?%'$9#9LJ00'RF(H_[W#/E.<?SYTJ1.
M>!=[Z)W,2<E^48_]^-^B;2M-(N\CE".N@0-M@,AM"%?Z@N@$')'U@Q4_@,IC
M3O!0';C5'B)7$C\I+A+!35\_X0KD5C*\2OOKFVIWAJUZ8)JQ1F.FO63?0>$W
MY=RZO90I1XV][>YY85F>GQRIP8R5D[NL=K0L''YZ55C!X&?"+"6[9"C8)@7Y
M,>Y35#$^?._.(8J&*1^77K\L<JJZ-"D%J5FGZ08TOZVOK4,CF1[7T%Q-LQVI
MSN;44WHE)K?.O6J2L4"+S,9?*9U$\A^+L>;3L8T1#1K"=4XJ[>YW7=,].RPR
M9..ZZ):>.?VIU:*9WLQ@8X\012I: MTSV6 M/(U=U8 3) 77:HE4G 5&"22+
M\HZ!6%WV@U?.DX%FB^148N55V,0?R:)L^=*^#\AP&28D+!,>_X-KD7G_JT+<
MNR#^I;_[#SD/^]P?!EPMA#'38=51,>!4[B+PO!)WW G[^C_SZLB_.\F2%8P6
M7=C5[Y)?!/Y9W"B<!H,L8K_9X5KT<'Z!4M W.L;SU&W,.1KNE8[X;!'^WY$D
M59?*:@UG";8 VQ4@,QNVV$YW")E-8W\I[R?O#'D%XW\<E-2O1?".(;XWRHVN
M(W5\/R]!$SM\T!W+#J$,8!%;]=_$E'D.UR+C-[\MWN'*]Z.EH)K25WZ+-=:R
ME+UKCNTX\AJL11?/I=J]E+A=I7B]^#>NMZ-O[QU[[-.,.V$X[P-CIB&JKP55
M&P#D8II$,_&%]X+-->QC"F^<^+U8$@NUD+%6WS<I:%F'XOG[WWUL>_/'KWY'
MQ8JD)N!G,:Y% W?UND\9C?U;GZ%>CR%\'1R4F>L6+<K5MV0NL:-MAJ$>>1?F
M<@7Q^C]81T6H@UB8A85+0?OF7\*8#\#53T_4F$%2CSOS\<FT<2G(MN;*LH4=
M C#$SX38,DA K12T"GC^NAR^=%ECI?Q_RC _%TELURSN%_9<N4BE7 #!BWW*
M.V3&-(I=^%[L!YO@5=KC "/EF3BDY!4LS6P1R*\ BQN(@[=W^6YOJNQQ"Z7[
M$"5''=,ARTM@6?;E+D>9BE2U!$<>=7/8(VK#4-,I%LXPE-%;Z@P6J<H)CIRI
MY,L6?+J\72SS_V87B8.I.V."*0OS"-D6;8O8T3S9)9O_ST?+-V',A[@:&78\
M*)K7I: JBFJ]H:S*#)<>I?"<>[_S;V'GV)P;DX34O"E)C"&<JK&2XV3J5C%V
M4V9<F 8Q&V&R!5JVE8*,L)?+1:H0P1&GD>U C3.E0R^"T"\W"0R-R1AU+4%\
M/R+D.\2$ATB+'"<)L[TFVB$:\&N,N2X_7/D7''-?)?91OW/]2]&\\/.%(.=
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M5I0[AVC<L[L:E';=ZN>;^#-I0JC9M?J-#1G'[]5J1 ;5U[[Y>WR>OX\-;RG
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M[9VD439@U'A)G37H&O;*3@L'9Q3_$IKVF3H3L=9IT'RVSI 9,T?*G?,'!=N
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MP&_!":,'R6=/+;B8!QO.%P8U5=;:/?FZ;"$J$]JP/RD3]ES\!;-8M?P7Z*<
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M?FX F[$>,66CDUTR8IEID?B\S$IK9]@O0EUO)S@-UC#1*@6I8[]0UL"N*S_
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MS9JK<EW:$&ZRRO?VH]]3[D2GQRU]M[N_>#"Q97')]-26$YN7$700 B3CV#A
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M^5.=2>I5B?G^6HMG'WMJRTY-3V8&+?VL_(88>%Q5G>!\RX#481(OV\X]=L7
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MF,8,M3 4\SA=8OUB^NNAT2A9&C_JP+',D8BL0$M.9?A$TO*Q&?:/*/A9MYX
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M0&)VFC5G!$5'T>'#'UA*\[)LZ3/>?=].YHWB \^5+V[!FWIE]SJ1G;A?\RA
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MU-4NLB"4?1!3W*&91<6N%>0"<*ON<IN*_406X]*1>[OZ?,,$8WPU@0O7.+>
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MI$"')=2R';HLJ4L!?/*_70,2]EORKNRR#O1_5NU,G[F[60UH;X4IX\UX8<#
MQ*P(\K@V-9T+.R4N&U4"?HBH@5]NJNKVSI9'R@DN 9XF#PE&G*71U@>.!21>
M<4C+KA$@S85[-2TJLO#>Q+D5Z:.++6FHT'Y>4D<I?S_8:>/),>-=!QZ)(%)5
MO)2,G^U,9#-C%^5Q!3INY.=+IFU!B6 _DP^8ZP4PH\H>TYFN*O_4WB;":K,F
MR';HLKK(NVZ');X1+8 N$F>-9=VXN'T6M46+3MI+L&:1-L-VYW4[F\/9Y\SA
M(:S%+9C:AY@==K"8>8(%JW/35BL;C:%RONSN1(VYP*XNPB7ARY+?Z6&NT;-@
M]'OX5'XK<0]0QI5H,3DT613UF"#!^4#_T_Q!\9S^DOE[/+5=N3W*'/'J_":Z
M>M!0XCK2Z/&:9!;?F6 V!*H3=G%#<Q[;D-O!W79P5GMS9E9I:B^H+M"N+^52
MPXJ_:0<G2=4'V9//#3!CSFG5<82=\_$5G?&3_6GLG\CA7VTC3O-:2O-0OCOF
MZ5CK2_QB(\JIF11N,%/K >:\=1$@@&#FXJX92^U!O?*LP+;/K,\63BRPANUC
MBL6DGJT.;S(V66@X67D'LJ)GQBL"V%RYY8FV9(X?$]<\9NT 1/'-I]"JA(LT
M6:(Z/IF^"R#"Y1K2<7E T#G5W1RMA$SGS'FG]Z^'HK62*RY"(JY5=G;-)U.]
M:#LMS6>SX8 CX0B7-&%-QW9%FU;1I<AR^;DO@61ZV3?LD*4<URG2\L#)?%?Z
M6T"J=2,J:C5+D=%R#WA@-J\I@M"S#RG5[G[5JY[\@SP\RZ(UBY%<U5"86H&.
M9NPBR')F]MN"DE3.FFV?KWDHJQ[>5#K>20$Z3M2&(I#@6+^_<(@W^*+U=N2X
M\*S).?H6:^X:NH=HCD?S^H%?$]@:?4LH'LX[#,1S7"\ Y,WNW_ DEDET12QR
M%[ZOI0]OVZ*4-N(]DP&EG_9Y-8(!S=XK@ON36Y37GF1TN"AN6#\I#O@'VDW:
MA*?PZAJX=])\Q+5 ::1)X_<R^]N*J7@T"QE'L&$=7G#LMGHMA93Q=M_*$=:V
M;)1N6NL<^*7Y,<(Z#,V '>I%8+I&H*R6C*%8DB?C,4S&W(Z3<ZJ_8LS,:J N
ME+L9S:'%$H^B ">7S#-<: QQ+P8%>TQ YF/ 7<E7^E;W'VM6[HK&\?!]QB,-
MV:FI6UKA1S@1",\[W,X7EEN%-74NW-B6H0W?^OSIABW]".].*9:A4VS(/\_C
M!R@1_GQ^/?I*71G!?;@#=\-'V2TUR19SR5'K)^(.C9RSM4&>L(WSJQD13T0
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M NRN9<Q-\ZWQ*':[<M03XK[I<=T/G,[V%EIL!G)XGF"6!RSS'+A9=8-$T_=
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M89.%U,E^P7$/#IJ]/S6V$)]L RAQWP^UNQMU^V=J5@_=Y-A3F&@E@2[7)(:
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MX8@_! A.$!O1 HL2XU<(1ZK9,6=G7<CO;R*9CB<R,R.041L:V;$8M@7<=C!
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M,<E"5XC9Q9P,;F:0EC1(*@A.M>6?I)YK0*XX&A$DAK2.$?]>*I9M(E2$Q^0
M[D"R")*Z6ZQ!M$G=%QH $231G2&.'#$$;B'/:3/.5I27@IV5E:Y8HY22@V&#
MPT6YE37882/Y>[ZI#SSJ[GWB#2E)_#B\9+TW<5]PV(4/R"T JMVICJN0$^F/
M1<K.B$4-BO*DJ/S)BA#K6%%>K71I="9H@YB&U9O_<.T.1H_"N+M ZG\(@7W$
M"?31<>@5QP8M$C.$1051/>(XT]A*0@5J-$,<9Z$XSG+2G2LBR#_IH5P1Y  /
M(*V#-(XZZ>;1D?+7R;\TF96GE482QZ06_>5BY0TEX6-/49^V.41H_XU-J^#
M(XM\*\Q&$=!IXZ':[Q=/EKB??H7*&_^@D"$5:FP1..UO<*^X/0_#YL/MR5=3
ME_[2C=YZNT8$L:'^< 65X&WP#1VT/(U3SW420?0P.9SJ!G%678$<<5;7?B?5
MFN>!W)!,8\"6Y%NZ$_H<&C8H6,(&&+6Z?(_I)K-\J6P0;FAANNS<]T_2*'*
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M"!%!?G3]4@/W&_#/D[J'.&(ZWF:I(X+\O$,&_-OGCX@@I]'-),&>WV-$TC/
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M)V_Q-([I^)N'0&1]Q)U2J4G_! <X#!X3=[SZ/^T0^7Z/_QM02P,$%     @
M5(*85C((^4(J_P( FP4#  T   !I;6%G95\P,#(N:G!GI+MW/)MO_#X:I8*V
MU"IJ1$NK*(HB1J0ZS)+:-4I;5%7M/6.U6K45K2)5*D9);:I$JL1HJ1E[!4&,
MQ(R(Y/A\S^_\SC_GC_,ZY\DK?^1UWZ_GN:_KOM[/];Z2)XPQQAS@O*&N@2Z
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MITJ4Q)_Z-.G]@:JA/1D BG3\^LC1:8K,K#7E+ZJ_E+)E6_^> IH'Q2%?$Q>
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M:G[Y'R3$.JNHN/2CCR3!%!&_K>?'K[G.F5Q<M956JTQ6"[N"+*6_28-C(AF
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MIF8_?@QXC <Q .SU'%]BTT-G#(BKGD75/<W1D&1X-B5@,Y0#Z1?\2=A'V-)
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M0')&LT]-##;7E!KCAT!N+<G=#:<48]O/"$(U6I\61"GCLE0[CSKZ-P?AB#O
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MW%)<RAX04&#YRUEJ*TTN$ 4MDKD%\.2(328?]K?(!6\Q@I:L)MTH3G;- !$
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M(QI1ZKL%R$37^,Y?+;R6$OG%5\&BTWB'2&1.&Y!<R"EN6IR6(S5%/866AC7
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MGK!==FF?V$K3L(6K,=PCDL.'\)S2O5.E17DE?9.-^)G3^DA-UB,_&4S$1DC
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MM/#;E,])5]>E:7_[Q%8-]N/;1XHFA\4-0[*BC,^":Z6+4JQMIE)3TW(H<SH
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MK2&,\N;6DTN\!=B]4K N<8Q/2_L;-O@I<B CE?#/0&-2:#<6_L-93K;HS45
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M\2-MP)$4$\*1* VY3L5V&X@L<@L2<5RLGC>"51)*P5XV"F,R,"[ _?X/'8X
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MQ%C\&/V;2&1L*?A/;G<=I&"#XM.<],'/IZUY7K/QPC+DGX(?LTY&2"WPCML
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MGIVSP2.E/L==M+B6YC$S"1?#OB'<QN)@'_T"YR"OV0)@]#@8Q^OI9+P_F_\
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M0"RO8KA(;N._TN2*ZMKFTGAG26-H[NTOKNWNCL$ES'*%G>3RH?+_ );38_M
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M %)!^8_BCHWA3]H:9K73O'VN?LF_&FTMI['1_$O@7PWI$_PE\81:?=S+:O\
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M3HMKH.K73ZUX^\&Z)9SVLB26YNM2\0:?96\\[<R)"LLZ-+L*D(&Q[?/.M_\
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MZVT-K9+?_9;01%N'MXHY%ZJX*KC_ %ZI25"@8P6"D$ @@D#!![?K[U_CN_\
M!8>\D@_X*M?\%#Q;17+2#]K7XH!C"H"$?VG+D/(,.BD\-)&R2)DLC*V"/H>&
MXQECUS)-*+W2>OS/+S24(T%SQC)IWBY)-Q:>ZNG9^:U/CB#QMXW>TN+BY\=^
M*(+@S$?8V\5^*1-*,](R=5^1CT5A@*2#D5--XW\7W5F1_P )MXTE:*-F"GQ;
MXAS"54D.C?VGEF0C*JQ89 R#FO(K75#;W+RW4SS&=&AEM7._;%(-DBK(0958
MJ2!*CB53AE<, :MW&O6_EF.WB,$6"I4,68J>"I=BTG/3[Q(^N<_:M)5:Z227
M/'1*WV3Q.:,U&:24I+WY)*\FM$Y/>32T3>RT/IC]GGQKXTN[G]HY9O%GC0P6
M?[(7Q_DMH;KQ+K<Z+/;Z;X3C@G3SK^3:T8.0R]" ^=P#5\^I\1_&T#PK+XW\
M:2+&_F+&?%OB()O2T!7:G]I!4^8#&T#'4=./8?V>+UGG_:.FG;S@/V.?VAEB
MC!\L _V?X2VAO*V%@>,EMQ/0U\EB22[+W7FE8(V<K(54,DBV>X0A-H# D!=S
M M@]?7JP:3Q$4U==4]5^.ASXU7PKO:S=MNMNV[W/7#\4/'=Q<I++XS\9-'))
M%OCC\6:_"@1'&"R0Z@@)4=R"3W-6;[Q[XTDCBCA\;^-#/,ZA0GBW7]X5V  7
M=J)4-SPS @-@DX!KQRVNGCW/&#,Q!R6;;DX[ G8.G<8'?V^_?^">W["_Q1_;
M_P#CGI_PY\%02Z3X0LV?4OB%X\GV_8_ _@FT9)+G4+ABOV=_$NJ0)<0:1IY4
MQ/<^3^YY)KV:5.=2NZ<*:<;2DI65Z<EMRNWNNVMUZGSV+I488%XJ59TIT)Q4
M:49.,:B?O.4HIKF::LDU>WNK>Q]V?\$<?V4OB[^VO?\ QDM=4USX@6_PJ\,^
M(?@;XDU_Q=-K^N+87=WHWB_Q3J9\,:??"\CNXI)=7U*TFNQIMS 9E(M;GS+0
MB _W/WO[.$JZ!IZ+K.I0WFG6$6EP2++,LE[!;:4ML#-<+()2#&H&2Y*D^9D2
M8:NR_8^_97^$W[)/P/TSX/?"WPY#HOAKPK9Z.EY=7$4:W?B'59C!)J.L>(I)
M6FN)[VXN%-QI*O*4AE*"VCA!(KZJU"6*6RBBMS!,CNSD,6W1F5/+=@V=P&TD
M;<A1U"@U_.?BIX2X/CJK_M^*=:I1K.$*-=^UC*4Y>T4^2IS+FBTHQ=FTK)'Z
MSX9^,..X0=*KA\$J</K-"4L1"*A4Y804+2J046[QU>J3['X(_%'P'\0/ 6L7
MEK?W>L7$32-<0Q_;;U[:2S0EV61C*<AHP002<@GD]O-M=MI_BA\//'7PX@\4
MZSI6M^)/#.J:=8K;ZE?6,=GJ[6TSZ'>B6WN()8SI^KFUO R. WE;)!)$60_M
M%\1_"]GK=O-#?V=M=HC.4QDW .TX$;ELL3T6.0M$QPKHRDBOS^\<_ G^S]</
MB31K:2VNHCYR1R3"%)/)/FK%+%"4C*.5".-FXJ3@U_GGQSX.\3>&/%W^LV34
M,QQL<%CL/6A]5E64:$:<XM*/L[*#Y5S*UK):'^FO!OB_PIXI\)XK(L;+*LLQ
M^(PGU>5>I2P\,3B74PTF^>JTIU(\S49*3:N]3^2OQJOB33O@+!\+_BGK?Q"T
M[5]#_:>^*7A2:\_X2?Q0NLZ/XBT'X>_#V?58M0NVU-9QI=LNJW%OI$?FFQOV
MOQ<W$4\T$$L7RJ/@)X[U>.T2P^)VK76C)]IF_M>[\?>)4O8D(9HXKNSMM8AW
M1*/]:846=ER$;?@C^IK]L;]D.S_:.^&-@FCM8> OBU:^-]:U"'4+J*"WT7Q[
M/)X4\+Z5--XFGG5[.QUN:STZQM+6[MXH)+N6&*YOGGF,LK?@)XO_ &9/B[X#
MUFXL]7\$:Y87%G.\;NUEJ4%@\5DV9-2M[^T(L[BP=4,K2K&[^2"R#.*_UC\(
MN.> _$[@W),+Q-C\+D>?X;"T,/BY8]TXXW%2]E"I*K*K5:K5%2<?8\TI.S?+
M=;'^6OC'P#QQP1Q#FM3),NQ&8Y-6Q%>M0GET9K#1BZTHI2C17)SS4N=:7<;G
MSY9?!2'1]5TH^(OBCXIFT&W>%K[0;/QMXHN=8UR\$BLEK-<QZSY=EHEX<6]T
M8F@U*.VE=H+B.=4=?TC_ &'[+Q;\6/VJOA+H_B#5-8@TAM6TOQKK&@KKVLK%
M;>"OAW<GQ>\>FK!>QK_9]V-/T[3-4EF)G<R-NE:260R?%_ASP-XUU6^>VT/P
M?J^NZGJTQTHV&F:-J-RTM_<-]EM)+:X:Q$270FD3R9V9%60J\C[02/VW_9A^
M"6H?L;?#/Q9X]^)ZV1^/7Q0TN'1;+PU:7,>L7_PG\$7=Y8ZA-H%Q>6Q>'[3X
MJFL;1)I]/5)].C9[>XG6T>XAEZ/';Q'\-_"_PSS_ "GAG.,!G.?9O@ZF"I5:
M$J,\30YX2P_L(U8R=6,:CG[1P4DI-<UKV9X_@[X6\>>(O'/#SS3+,=EV48+%
MT\PQ-6M&K&-J-2,[^\DK<L6GYDO_  5G^*.N+\$=)U?2Y9[Z]U_6K."RT#4M
M5U&&SURYU;XIZ/I%GH=\EM?VC/:W,ODQ7(6XMY/L\CXGC)\P?RWZ/X@^.G@M
MOC#+!IGCD'_A#/$/A#58]7\3>)+"73;+4=5MK^Y?1E\2:W.;[3-.6W@>*73M
M/EOA8P-8V>JQ6T[H_P"MG_!5+XX:SJOAG]EK1HK"V;1=8\7ZAKUR^I64=[I^
MJW?AKQU+JMKIE];3!?,L9+O2[1+BWBFMUGB5XY'"2REOS?\ V^/C'+\4CX"U
M6\U[P;K/Q8T@:SX7N+SPOHE]I.JZ9I]MI*2SV#F>XN]*ET^WU 6NA):PQ)#<
M03N[!G D'\Q^ ]''8?@>I4Q5)_6L93Q6+;FFY4U5IU9)1D[R2?/S.V[2>I_3
M'C7@L#'C3+<'@IQJ4<%&AAZE6-K\U&O1BUS>:@^MNY_19^QL_BGPO^R=\!=,
MU#Q3XBU74D^&FE7][>W^MZI=W)CUZ:WO]-@:6YNY9)4L[#4XXX2[,8HP"I!"
MD?2$&O:ZUO-*=:U9I%WJI?4;R0 8;^!YF0]!_#7S#^RMXV\->-/V;_@9K>DZ
MM:06J?#'PSH]G:W+!9KZ3PYI6F>&]2L"%(Q<V%WI4DR.W[V1T_>NX9@WT#:7
M4;"=,*L*J[YW'YMH).#DG)YQ@^V*_P R?%:>8OQ#X@]MB,0O^%KW$ZM2RC>=
MU%-Z+FZ)6N?ZK>$"R*?ASD]&G3PTZE/*8PK2=*FY<[IQ:NVKM\JZL]B\0W^I
MPZM:K%J.H(G]@^&U/^FW).%T+2'X8REE(?G(8$=#V%9Z:QJZX5=6U11O#<:C
M> [@<@AA/N!SZ&H]>OXFU>TBE(,LFB>%"I^[\DWA+3IV.%P#ND56R1D 8!"D
M@Y<EQ&A!5@<'(7UQV]>3^6><5^99K5Q,,QQ2=>L[NFU>K/\ Y]I=S]'R;*LK
MEEU"4J&&;?M&KT:;M[[T7NZ'0G6=:<%3K6L$-\I!U74""#P01]HY!S@BH_[8
MU: C&K:HK \?\3*]/(Z=9S_C[<5DVUP)'+M@*GSE,\D*<[1SG+8P/4TMP55"
M[L[N6\Q5(50J=3G: <8ZGD@9YSS7/0JXJ=7#<N(KI?6J::56>NB?<O-LGRYY
M9C?9X3"R7L)W_P!GI:.S_N]CJ?%?B75X_$FM[M7U1B^O:F&!U&\Y!NM4!ZS<
M9Z9&"!T[&N"F\0ZRLTI.J:FJ.&7/]I7G&<C()F[9SZUH^-&C?Q/XBP%"QZ]?
M$$.V5!NM3W'.[)XYP2?8#MQ%PVGLI6:Z X/ D(8Y'89Y..F>.QKZV2Q#QV*_
M?5?BH_\ +R?_ #Y]=2^$,CRZ>4X+GPN%CK-)>PI:KGN[^[KV$\2>+-3BLTMO
M[8U1II3M+#4;PX1^#E?.QC!Y[^XQ7-_"[4M8;QIX?FGU/5%1=4MX99OM]ZN6
MDO(EB92LPVLIP1MP<@$USUXTVHWKH8Y5,+;5C0H=]J#\TBL5?$@3)48<;L94
M_=/HWA.VL--USPY;,1)(^KZ5)M>Y 68-?0?OBZ6J;6MR=S()$1L8<%<U[N K
MUL/4455J1G-<RDIR4M/=W3OOYGO\68#*L#PUGD*>#P;G6RJ+YUAZ*FHK&4XN
M/-RWY6W=K9O<A3Q'J,*0D:YK4C?*P_XFNH'+1V]X8SQ<8P"!VP<8.>^+KGBG
M6YKR'3%UG5F26'S3)_:-VR*Q'(8&8A@,\JV5/0@CBLP7]G%I]G<BYC9Y+2 ^
M6MO+.#/+!:J<S1G9'N-W,-S?NT\S<1B-0N);S3'47>5%9'0^5N(&&_A^;@XS
MUZ@]",=;4,9/%U*KQ-=I7O>K-WOK_,=V0Y-EE6EA)U,)A%&&798HQ]A2Y;2P
M<9.RY;;[]SIK#5-7CE11K6J1.KJ3(MY<H#\P.1B4!?7(P1C(QBO7-!\1ZTMF
MI;6]74I.[B9=2O4RTR^7(S[9P'5D/*2!DXX6O+;6WCU&5+9'4$J!(F @ (PQ
M$B@/P#D8;Z5Z%%!#:V$=G$R$I@E59I')'H"Q8DGHN>3QS7AXS$5Y5YP]K4YK
MM7]I*^[V=]KDYUD^1UXSI?4L"US6<7AJ#3?1M<EF[=7K8Z@^/Y(A+)<:[JB)
M&K1S3?;[G=@##["TI4-C)! &#SVKE[WQ/=7LK31:QJ[#!=86UB?#P $M+O\
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M445Q'HD;\8(ZC./TK_&G_P""R0:7_@KE_P %$U0&XD/[7/Q00VS2F*)U.K3
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ME\/>,G&0_P!I\.@,TKG _M;6!S\QP,D$D<C&>M<S=>([V,^2LB&)H6#G>TF
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M )E9)YBZ?\6D\.$E=TA)8=5SGD#'-?/]U=%&ANB$>:,JP\U0RML(8!@!QD@
MLN' Y# X-?9W[1?P?\/R>._"LDW[1_[.FE1)\&/@E9C[=K7Q+42O:_#S3+-&
MCE/PUCE8I#!&H#6,"OM#. Q=F\2D^#OA.:,1-^TU^S9(%!R8]>^)V]QW5 GP
MT4[VZ#:0=Q&",#'KULPR['X58>G5C6]L^5TY-3C).#7*XNZ:=]4U;N;X7*\;
M2Q:ES5*,J5)R3A.4'95$[^ZT^A]]?\$V/CWKNF>+KWP%J?VS4?#^L0^>EW/J
M1\C1VCP"B07+,YC/)$:,'(^5,$C'[97VJV\\(GBN89@I\U6)P5C7+' & Q !
MQD'^E?B)^Q%\//!&E>.HK6;X\_LWZSJ5VD;B:T\1>/89U\J1?)CDBO/AM#&A
M4A=Q26V=CG=.G^L'[;WO@?1#IR+%\7?A3#(UI(B&/4O$CV\S-&P"6TG_  BC
M.SN<+&6)RQ7/%?YM>,'#&)P7'V,Q.&R^A1PSY^9T:$*<;NK?FM&$4FUVLM/-
MG^I/T=N/:5'@N&48O%U9UU3@J;J5IRDH1HN$DG*3:3GJTM+E?XN:HD'Q&\>>
M5(FT>,_&$42,5"E8-9E2!"[ D!0Q4L3D@DN6(R/$KC4$M-2U'6CJ.JW*ZD('
MEM+RZC.GQO:88&T12 I4KPD84.<*ZL#SW?Q3M?"^N>//%.M:/\:OA(NC:WXJ
M\17VD#4+_P 5K*ROJFJWEZ&C'A/,@$26GEA]P<1C Q))O\GN/">C2JL*?&WX
M-E-S&.-K[Q@55I.NW?X58(<GY3@!#R,8KXO#Y$YRYIQ5JK4I-Q7NV]VU[:;W
M/[6X7XIP-+*\OYZ[?+&=[RO?W[ZZ_F1S^/[*&X;(V[SM=L]B0#[<#)Z#BNR^
M'GCK2S\1? T)WN)_%OAI%^9P-\FLV2@G#>I&1T_#KY)J?PXTP-YC?&?X-_-T
M+:KXL50?]K'A487UYZ9]JW/AKX7T>+XE> VE^+OPIO((/&/A<&PT^_\ %$VL
MEUUNQ_>I ?"15K,8R7 \S;R&!P1]/EO"N!=:#O3JMK7GC&3B_P"575U?>Q]I
MF_&628O(L3A71E6E6E3A)T8IITU'F=*I9>]%S2FHNZNKVOJ49/B/ ^GV,T;@
MN=.LA+M"(9));*U:0?*HVEW4?=QC&%VCKYGXA\0PWTBZWI\2VTAD2WN(D=MT
MH+;26!)SD$@D4ZV\#Z%]CLR_QW^"D8EL=-FCABU#QE((2+*V807C/X69DO,X
M7RE(C+\%<$BD'@+P\"6/QQ^#8&X.P;4/&83(.[+ >%\ 9Y.!7O4^'L+0J5'#
MDA)R33A&,7HK;I7_ !-<KXLRRAA,&_98].%*,&^>I=QIVC3BWVA%<L%M&/NJ
MR,VVUU[I64J%8*V<MG P<]0>G^%9VKW$<T0V\E!N;G).!D\#H.,>W\MR#P'H
MRW+.GQV^"J(Y&-NH>,B<$X.,^%B._ (]_6KDG@SP[&VR3XY?!E]YVD_;O&(&
M&P#P/"P Q].E;_V9[/\ ASE*^K=^JT7X'TU3Q!RFK@ITE3QWM%*/+/GJ<\4H
MZI.]TFU>U[7\SD=,U;;:E9AE58J01CY"<,,@ \C@'.>^:8]^DZ$Q*1F0)G)/
MRDD'DDY]Q_(].H?P5X:B1D3XX_!=$().[4?&*KWY9V\*.4'<L =N"VTXP5M/
M!?AJ*(Q-\=O@:7+AP!KOB]V*YS@(/!BECCL&5B2 &4D&M88";3NV]>_D8_\
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M,WXA>"-;\!^)TD>RU'3+2;6)K6*UN[:0V:VTX!CA%]<"60H-V!)<S2(B\O\
M(#66?$&HV]K;/<Z&0+\RG3Q93&Z>X2WSO!2$^7M?&"2FT GMFOUOU_P!X:U^
M-HM8^._P%U83$^?'=:WXMO2X=/*=8H9? MPH=H\HJQP.22 (W; /D%]^RS\.
MKQ;/4-+^/OP.TF_TEIQ8:Q8ZU\1'.EQ3Y,T4^BR_#5-%N47)9C=6C':I'FQC
M+#^@^'O'"OAJ,:.=QH22G3A"K&S:AR6DY2?7GUW/\_\ Q5^@I#&XW'XKA+&J
MG2HTYS^HR2A44G>K&.$A%)PIN%U*--).I9[V/F3]F[Q/'>>._$<+V[0+)\ /
MVBY%$Q=)8VB^ 7Q3+(FU@=_RD*"?O8 %<7I%\J-Y),<4$I1X3*\@D:,$&?:2
MQ,C,N[ <L 3T'?[%^!W[-UOX<^(OB*36OC+\!M7L)OA7^T%917V@^)O&2ZG'
MIEY\(/B-9W5]>VMQX)N(X!'9SRNX@MBT8!,<9<+7"_\ "M?A7?ZGXATS0OVC
M/V>-7M- O]3@L9(M9^)4=]:6DABM;6UN;27X8_:[AK:>1MVH1LR$Y9W95 K]
MTR7CGAW,H8>KA\Q:G7BFZ<:S2YG;3E4DNO8_SQXX\'>(N$:^)PV9\/9W!X.5
M2G'%>SKK#SBIN\YOEY9:I6;O:-]CP]@VHF": EHYW,$[; $;:=BEB!A HZE-
MIP#D\9JN#)'!)8LD.5FW?: 6.Z,$DQ*/N;V'RCC=D]0<$>RZ5X \.66ZPL_V
MCOV=! D_[V"]U;XCJT<;N!*1+_PJ_P W[A;GS,KU!!P1T<?P@\-S6M_:3?M&
M?LZVCQRQW=E=2ZO\1E@=P?,2**7_ (5?ER[851*77G!'4']*H8VG5I1G3FYQ
M:33;ONKK77H?AV,RBK1J1YY1?.I24(V4J:4N7EFM^:_?HCYSL[\)=7,KSD*(
M654*H"TB*?+7(7<?F R,X/<,.N8+I85-Q#$W[GSO.57<-))(#Y8!# H23QL*
MD$DCG!KWVY^"'A\79@D_:#^ #B-HGFGM]<^(K1EY&!21@/A?G:IY*K@,!@#!
M--A^"_A=K$-%^T=\ @T\[!\ZK\1VW7$3?N&PWPP(4*X!*@!'_C5@36DJKG=I
MM633LVKIW=G:QSQPLZ+B[OEYXMJ^C:MNO30R?V;_ (_ZW^S9\=?A;\:O"&K7
M-A=> O&OA?Q+#<6[*# VCZW;ZA<VD\$B20W5M=6_VBRNTNHIUGL)GLI0]J%A
M'^NQ\&_B=X<^,GPJ^&WQ4\)7]K>^'/B'X-\.^+-'FM)FNXQ!KVDVFJ);&X!<
M,]GY[VDP<[TEA=9#O5A7^/SK_P $?#UK=K,_[2W[/5H[NJRQMJ_Q()9"1ND2
M$_"R:$.%)92('&X<HXXK_1'_ .#<?XU)XW_X)W>$_A7>_$7P9X_\2?L[^-=8
M\ :C?^"[_5=1TZU\,:Q?7VI>#8);G6]&\-7TLI^UWEG')-:W4I^Q&$[U0(/P
M+CW!Q4Y8Z$(Q]GSPJ.,4G*4YN2E)I7;26[N[/L?T7X>9@WA)8><Y-<]-14FV
ME:BUHGHE?>Q_0EAO[WZ"BF^9[?K_ /6HK\N^LKN_N7^1^H#+D Q-DL,="OWA
MQU4'(+#J,@C/45_CD_\ !9*]A/\ P5B_X*&1R6UHQC_:S^*#*8'D:YG9=3F(
MCG5F98E<C:[Q"-T!)4J0#7^QK<'"#KC(SCDX]O?\J_QN?^"SPAA_X*P_\%$)
MO.4/_P -8?%,E%2-7)&H3':751(<GCEL]3GH:^VX1E".9Q<HQ?NZ72=G=;76
MAY.;MK#M7=FG=7T>O5>A^:<E[-=7(TRSMMUX=P1F9@D<<G#0Y)PV0VW<V7 /
M# C-?HC^PK^RYXV_:R^-GA#X0?#K2O[0N/%.LV=EK_B&6V+Z?X)^']]JEE#>
M>('1T-G-?MIKW\0CNXY714$\92<+*OYYV\D$-S#<BW\YAMD $DBMN0AAO>-E
M<C(Y!;']/[S/^#>GX#Z%X0_9 TWX]7%O8VWB#XB>*/B-'<:A'!&MVU_X>U:T
M\):%I$4[Y,.EZ;IMEK6LQ1VGE07SWV^]6Z\BV,/[%E<(U\;6M%-1LK<J>KCI
MI_5DF]$C\KXQS*65Y?3J4X+]Y"2<E9/F4K=-;6U]=-6S]O+71]'\&65QX-T6
M,)X8\ ?#A/"NB11RS?9XK;PUX?M-%F,*M*Q=9$M-BO(TCQEBZ,KEF/C6I>*[
M>%-T$3L\JJA/F2'=U"#ER%[#*A3W)XKT#Q/>/:Q^+K59TNK@^#?&=RDR%54"
M.WTVY562/",?-N)B692QW[22BH!\PC5<I)'-+Y;B.,Q (AQ(P&.2O/)'!R!C
M@=BU"5/$8N-W;VL;)/1+D>RZ?(_':]6=6@L2X\DJS<TTK.2O:[>[WMJ=U]LB
ME!EO)WV,P=;-Y&<2-G(B;<Q+(Y^4HQ*-D@J5)%9M[?6SHZ,'MX]C".-(TCBS
M@[0YA",4_O?-DC.":X:]F,BHR73EE(9@H7<P7!.W ^4GH"H!!((YJ!=395"2
M/<,!T#A<'!Z,V-P'0$YR!SD5EB*JA&TM;IO77K8VPT9SC3<926FMFU=Z;]S5
MNK[:P83V_'F<!;C/[U/+DP'<IED)52P*H2" &&:I_P!N6ENK!D5CM/+M(8P<
M'E@K A<_>"C( ..<5S^I7H4.[3E 5;;&,,'./N[B"0&)P2"",YR#BN1NM0N8
MLLB*V[[BG!W,?N@DCN<#.>_:O"KXV%.^R;N_NT_K^F>U2HU&XWE)KS;.SO-=
M5I) 71(Q [H(;8LBN%)4LTJMP#R=Q*X'((R*QO[<M91N#0O:P9EG1HXQO,?S
M-D(H9@0"#'DJP)!!!Q7G&K>(+]9#;M)(L_ELRO%MV@;?]5Y8'E/DC:5=&!)P
MP.:XV;5+B >9*RVJ*_G2%R=\X0[F4QH< N 1A O7C'&/+>91DVF[J_5^O<]!
M8*<Y0<;K2SMI?7^OZT/I>\\313_#6PMK1E$$GCW6U,45NRLWE^&O!T\:I(5R
MA$MU,P*L%RX#954"^9KJ5Q!=^3)Y#(?WAGG2)I8HP<L$!4J9 /NY'+8Y-)=Z
MG<K\+=)M(;HV]_>?$GQ)%$L$>6>S;P=X&*HDET)88IOFRDCCY7P9"5!%>9W%
M\L,Q@?S+196C1'N[@7<T\H($BAXB4C:0G VA44G@ <5+Q])1DTHI][+MY'HP
MPDX.";;NKV;?DOZ_IG='6X@9KD+9VP,ODK)*9))6+':)1"CYR"=P2)5)(PN"
M17%:KK7]GS^6PCN+FZ;Y1*L$DRQR';YR7<:""WB4'<8B%OP!^ZD67:PY[4]0
M33B@4&>ZFD4!@Q+1AF !3G$;KU61 KH0&5@P&.(O=8:-8YI)H9!,9C-=*B"T
M5TR4?1K8*+>^EMR-UU->Q7$L;*2KJ1FO#QF91[[)]?,]G"8.<IQY&XJZNEHF
M^[MN[76MSJ]8U*SBGT])U"C38KFY:[A/F""26!T+R>9N\S9&20LH=01N #?-
M7SGXQU?4=1DA"SR6UOI/VEX;7=OBNUD#L)IU?>)E?@F&7?"RDILVDBNIU?5_
MM'R(?W#G-])*[1O>/G$2>6A5(]W"^7&L:.3AE8$UY+J&HR2_;WE ;S',(.0"
M$&555P> H/\ " 3WSTKY3,LX4*%2DIM*HFVE)I.UXZI/7>US]!R3)O:SC5G"
M,_9RBKRBI6NE+JG;57_X8\CU:S6XE2"<;H4)2'<3N0-(6 $@(D95<[D5V(7&
MU0%P*CETZ2RAGN;*YDM[G[+-&'@)AWCRV4*ZIM1L]"64GOFMRX033.< ^5ET
M_P!EEY4X&-Q!&2&SGH0>E6)(VDL9B1EO(E(X YV,>P!Z_P"/0XK\OQ-2FZE6
M2C'VDI-QG9<Z[VENM>Q^PX"5>,:6%BFZ;@I2WM%1]VR71-:Z'E7[4O[.?P2^
M*OBW19_B)\.])U&YN/A/\,;-O$^BV\>@^)U:7PC86BF"^TH6:W%XD<S_ &:7
M58KV#S]CW,4R;E/YA_&;_@FIX9\)>%9_&W@7XNZ5X>LVFD%IX8^*D TJ2Z*J
M7@M_"NNZ7YDVJS,P6*66[@^21MRLF 1^X7QWU#1M UU/$VMW"V.@^&_A?\.Y
M->N1(T;Z>+3P;I]W#;V95D9[BX\OY)@3<12%6CE1@"/Q*^)WQ'\1?%/QEJ.O
MZ@&MK2W:6#1=+010V^DZ1#GRKB$01Q>9/J$0#2RRF28LVXR;@#3R_'9]A9RG
M@\3>"G&5Z]6<I0DHM)4W*7NQY=6E9<UGN?+\:<495D&#J)*B\;RRL^6"FTGR
MN-U[UG+5K;ROM\$'X1_%;P'.FNZ%9MJDUM)Y8U'PG-%K:^6&RTJ&R-K?H !O
M#7"S;3R8VQ@_0/@S]L#XW?#>WBT7Q'IB^*;?8JK!J,VHZ=J5I'P&1%$L"1SJ
M"=CN04?#%AC([/,EK*EQ92/9W1D4K<VKM;SJX8%9/-B*.75L,&))! .<BFW4
M[SPRQZG'8ZMY@;S&U*PL+Z24$$,DUQ<V\D[H^2KJTA!&<@@FJS98/.I*7$&#
MH5\1*#2K4:,)2G"Z<G6FHN4YJ6D92;:AMIH?)\+>/N;Y-!5*,:V'ITJD8P=&
MI4I)T^6[7N2BK-[K9GL>A?MY_#;Q!"L?BO1-6\'ZE' +=Y)[%+ZR>0Q>1FVE
M6X<Q.P.'EB42N<NS.YS7O'A7XI?#SQK$DWAOQ=IFI2/'E;".X$5YYA'R1R6T
M[^:Y=B%\J$B1R=J$,0:_/?4?"W@.< 7W@C0Y5*&5A;O<6!5@-Q>%[.:'[/(.
M2CQ &-L,O(%8/_"$?#;3YXM2M?#FN6-PKI)!)H?C*>PGCD1@\;I-(_VE9$8*
MT<GF>8C ,K!AFODL7P!P_BZ%2K@,35PTX:*BY.*DY>\G&-U=17N^NA_3O"WT
MS:^$^HT,10=7#I1]K*K)SC%II->\VE=:ON]3]1M6FDN$^SE<$QLQ:5# @CP=
MQ!D)9L+DX!R>@Y(J]\)M"NXOC3\-);>Z)6?Q[X>AE:WN94N3;IJ]@XB6X5Q,
MH'. ) O0,"O%? .F?'G6_"MNEC::5-XCM(8C$D'BKQ%%=311;2&$E[;6JWKC
M;D-(;@R]65@P!KZC_9I_:PGO/V@O@KI#_!/X<1KJGQ9\%:>-2N?&GC6X9$NO
M$6DV\\OV&+5HEN-JR%S GEM*1Y:.C,"/C,+P5G^"Q%2MA/92P\)I2^L+FN[/
ME<>:^G+OYG]&8;Z:' LL!3A7M0K2Y)36$:IJ5HI-U%3MS23T3EKRW1@P7HBM
M[199%262.!90[(&D\NTA"EE01JTHP,2$B0M@F0$[@C7A<N%N#M ;C:IR,'CF
M[).?KSQUYKS)_P!L77)8H4L_@+\$H=\<L4)OO^%A76]+18XI[B2.Z\8*C>?&
MIS$TT,9!PKQ9WCCM1_:V\>R2D:?\*_@3I1Y&^T\':I>^5Z.!?^/;M&*?> D5
MD.,,I7(KU*G#.=5:D)UX4DYIN/L(J,;<UGSJ"UES;77PZ'U5#Z<WAG0PE.G)
M5)U:4>5J4DW)VZWNV^A[VMZ_"K([=@J1PH[9X"K(\[A&/1797"D@E6 P<@W6
MO27,@F-E;6D>6C*W$ES=/CD+/Y6^*)2  9%CP@RP4@5\ZZA^U5\6905M[+X6
M:9( <R6GPNT-S$<??66XUC4#$4^\)!;W!0C<()<>6T6G_M'_ !GOF ;Q+X>M
M\G&[2O!'@BT//4EI/#0G;'?#[B>A! KNAPEFG*N2="EM=54KM]&N:*TMII?4
M\7&_3UX#C&52EA)Q]FFE&*24^J;2T=MM?0^D_.O2P8AG52&9XII&"KD$MA[>
M(' &<&6('IYD?WAI)=74Q# S2_+LP7RS*005\J/4)&=B,@*L,K,<!4<D*? +
M;XQ?%:\ DG\:7 8$'=;Z3H-F001@JUKI4#(PZAE(*G!!!Z:*_$GXCW#*)?'.
MO,6;&$NO)SD@8S$L9&<XX((ZCG%5_JSCZ.E>I3FY:Q='1)+1J7*M[ZKR/B\;
M^T0X1A&I[/*Y*4+I)02Y^SE9:OI=WT\CV6XBU=_]1971'.TBWU%'!YP4;R$*
ML#T;>F#@[AU'I/@FP\17'PV_: NWT^^:YCT[X.AY1:W(9IW^*1@AW*LD:.NV
MVMU>%\13!")%;S)"_P JR>*/&]VKB;Q=XDFW*P*'7-35'R.4=4N55E8':58%
M6!P1VKUGP'?:]-\%_P!IEY-6UEG73/@3(Y.LZGC,GQ@F24E/M>TAXR5*[2O7
M !Z:T^'*DDW.K*#35ES-75M^G4^ S/\ :)8'$RYL%DE)QHW]VO1C*]3FYHRB
MI1>JCI=:ILDET;Q=&K2R6,[JZMO$GV.S"K@[B5EN6*@#)R$;@9"G&*RYH]6C
M 6:XL+/;C N-3L$VG_:PH)&>N>V:\1N//9B\D]S*W7=-<W$S#'=6ED=E(ZAE
M((/<'FN+U)!-(XE+2\,!YCN_TSN))_'.:Z(<.4XI\]5R;>G->5E;\-3YK$?M
M&LW?-&ED=*#>G-"FHN5E9-N*3=EHGK9:'TD\<\>^>76-!5$4O*[:S:%5106=
MBJ[OE"@DA48XSA23@X4NHP/(RKXI\.;2""IU==F"".!]D^4#U4 C'!!KYYAL
M8 5<0H&4AE8+@J5.01CN.OMCDUMV]DS_ #A2PX)!+<CN#SW]@.>QXJ_]7J'\
MZ^YGD3_:$<65Z57V& I03=OWU^:[B[.',[J*6]OM'J%YO=66#Q9X7B0Y;<NL
M%MIP3N^6U\P[<Y(5MQ_AYYJ&&V543S/&OA4_.K$_;KZ1L@@Y"O 58C&0K JQ
MX8$$BN9L=,#[6*B, J2<#( .20>2".3E3D>HK9;3XRI G<G!V@.XYYQR"".>
MA[?@*UI\/44G:=M>S['QV,^GIQY*H[8>ARN[MSM1>N]N:VW4CETWS)G*^._"
M$:,Q*AKB\C?=_"56"Q=F;/1!%+D\")\[3[OXPTRV'PA_9X^U^-?"[[=+^+YX
MGUF,N5^)%\0%+^'H8@6Q@%Y$0=7=%RP\"ETYC%('.]?+?(9V8D;3D9.6R1QG
M.?>O1?BA:M'\'/V< BA NG_%TC"@'CXE7N/F W9'KG/IR,UTT^'Z5FO::-[6
M?;U."?TYN/,1*%5X7#M44XJ[<N52DIV6KMMLNNIS+V]A<JMK:^+_  C  P+K
M)JLL4DW;8':WVAG'R@L=H)^88XK&D\/BUG66V\3^%4Q(DK;O$=L5RK!_F,\"
M1*H(Y+R1H!RSHO(\YD5RPR=P) ;<-Q(/7).3C&<'/'3BFPVJS2?<4J"."HZ9
M&0>,D?XD=ZF7#]*+5JEKZNR:OZV9U4OIX\9)7Q&!]HZ>B]E*?*E:[4K.UVU=
M>1ZZ/#U_+,DMIK/A>Z:1072T\5:%(TW3Y$07SL7?[JB-"Q) 12QQ730:'XPS
M"EO9V4VYDC 36]->1E9@NU$)4.Y!PBEERV!D9S7D%O#C:H)5#A&"EE78>&#(
MI"L"I.58$8X/6IY;>'(Y( (.%!0GGH"FT@^X.1SCM7/5X<C4::K/1-;M=;GI
MX3]H9Q%A*D>?*F]5>_,]%I;4]B_L+Q1;%TN='U)4.2_EVR7,>,$L6EMKLE5"
MYRR@[1D@'H:ES+J]E#*'LM32!09Y2;*ZD1!"-Y=F82,JH%);8.@(VMTKS*RN
M;VR<?9K_ %"W1V  BNKE-NX\$%905('.<Y'J.M=;9^*/$5I)&8-?U+Y9$8"2
MX:<$JP(!\]I<CL0<@C@@BN:IPW.+2A-S33N[MV=]MGT/OLH_:.45)5,VR7V;
M3C%.E3Y5*+C>3G9+FDI:)N[2NB])XJB6UBC%]<PK-=0BXB:=X()%WJ#OMKBS
MV,,9W*NTL.-P)W5[-^T1XKCC^-?Q@MXKTR0Q^+KMHT:\F5$)L=(.5574X[[5
MX[ #MXS/X\\4R0NLM]:W0\TC9>:3I%RK#GY7,UA(Y5LX;:V[!.#FO4_VE_'=
M[9?'_P",L,OASP=>*OC>ZC43V36K;?[+T=PO^AK _+\[E._.0I'%83R;$T;1
MC!S4E=WZ6TMJC[_+_I[<%8[$4L;B\'4A%6BG+[*DU-V;VU_$\EM?&MQO2!9)
M)%D9(R%ED>(J[!<.)68,A!PP(P1D$8S6G::Y())E-I!$IW-YH1 1U.]<KP1U
M&.X^E<#+\2-#EF1;OX:Z5<*N$E;2O$&KZ?A^ 74S:@40CJI9&13@LC+D&_)X
MV\ 3QHESX9\7:3D@;=+U[2]55<D<^5/:M//CKY*3QO+]Q71F##CJY;C(-<E)
MQNFWRNUW>UW9:NVA^LY+],KPXS&S6-^K0JRAS*K52=W'>*<EHEIIU/2K#5HA
MYDPE4R(K.I^4G<H++Q@CJ!@8P:;:WX^V_:_-D,Y#I&!+(H3S./\ 5JP0C)[K
MQ[8-<A;:K\.I60V'B;7=,<Q[I(M;\.S%8R!G>\MO<;55>K-M8!<L5;&*V]-M
M=&NI'?2_%V@7LC<(LTLMBTCGA4"SOA2[$*#CC.>N:Y*V Q25YT>:23Y7)<S2
MZI-K17Z(_6,F^D)X8YKR3I<0X*FXSA=5JU/FYW'F4H<T[JRNKJUF==)?3/#,
MS-)GR9.1-*"/D;H5<8/?(Y'L:GTZ[D:P9 /++-M,D3&&7+<;O,B*2%AG(8N6
MSR"",BBWA[6#;.\,<=X#&Y<V&H6MPJH5.6,8S+)@<[(V$C_=3G&*4=IJUC&B
MM8ZA'&'#LQLKCRE ()=W<L%1>68G@*"<8&*\_P"JU)*4:\-.:ZC)76BWLVEO
MU/U7)?$/@?-\;2QF$Q>6YO.G3=&=5YG1PLJ<I^_&FTZJ=3FBN?F:?+;E\CW_
M .$\H/BK6E=I9#/\)_C[;2X(DGFAF^$GQ$CDA+2[_-\Q6*[)MR/NPX920?E3
M7/AAX=N =1L81H6JPI,;37K)8EOTG>87:1:I'& MW9?;$B>YBGCF5H5>+;Y3
M%#]!?"75#-XN\0*PP;7X5?':4 ;E+8^#_BR5@K+@@NUS/@@@J9/E(V)MX7^U
M4N[97,4'FF,Q;%CB5L,I7#!5'F,<\,^6SSDG)KV<NQN;9<E++L2J7LZD)*,Z
MDDURK107/I&RU2LK]+GD9_PUP;QSB,9@<XPF54J6,IU(TJ,ZF$S.G5C-23J2
MYU5C"49M12;NU[VMCY!\617_ (9UNZ^W:!/J>FQQ13PZI:20Q13R1 /+)-'(
MN\Q/@F1$QA"P3:<5U"W>E7.GIJNFRW.HZ#J%C8/97C&*Y@346F6.[CNX &:&
M&U.0RPB)BBG;A^1[[J=A9ZC;&&Z@@D#1O&B7=K#)!F12H$KJGG+'SB1HG654
M+&-E;;CRB+X:W>@6M]+\/+JTLWNW#7OP\\08?3-2*.9?.\.:J=^H:9?3MQ:&
MYO1IRSO&UY!) LB'^D.!/&NK0EALJXBCAXX9N$98U)<\'%*'+*H];R?O;Z[G
M^8OTB/H31RC"YAQ'P3B'5JRQ<JD,#A$J=)0;<N54J*45%Q^RHI&U#):7AO8H
M&M;6:]TY;ZWFN8H;."(:?"9'B@$B"2:2X*;45V=BS *<\CD98G&GRVD:-GS)
M"CVZY3S),C>78%U&XY^4_*.5QC(I:9XOL;O54AUV6Y@U&*4:9J_AG5]*@74M
M#N698;>)T@MXKKRKIV5;/4;61(!N264E0:Z#5=2T*#2+?^RKZ9]4A\2ZR-0M
M6M9!]GT47$,&G':>'6S=R_F,#)/MVW#S+Q7]5Y+G>2YQ1]K@JM.I0:BHU%RO
MGYX<U[]7;1/L?YI\5\+<2\.XBMA,UPU3"XBG-)4TI0TA[DG9)?:W\SR[QE;0
M-!87<B074[6\UO/'<*)(Y%V%?+E0Y4*PRK.%#8).[(S7]=?_  :&_%,6WC3]
MI+X%G2]%LXK_ .'WASXEVNMZ9<S&777T+QOJ^G-:7FF/*UA;W&DIXKE!N;:U
MBNI$DC$TLA@MO)_D(UX-<)?O"\;36@,\-E)'.(I4VEW+REMR"0##88! 25VX
MK^E#_@U#O9D_X*#>.[55M[>#5/V=?B!J4L5@!]G,+>*_AVT$;,H)15NYIGPK
M(&9RK@IA1^4^*,Z&$PE.E3Y6L1B(R=DM4I*%G;=.^Q^E^&5"O6Y)U%**IN"D
MM;2_=N5WW:2M=]#_ $4QR!]!146XCH>.W Z=NU%?D'U>G_)#_P  B?N'L_/\
M/^"69!G;QG!R/J,8Z>]?XV?_  65TJ^O/^"KO_!1F^2+S;2+]K/XJQB5LJ!.
MNJ3[( B;2X; 4D N000<\G_9,F.%)'4*Q';H/;FO\=K_ (+%WDR?\%5_^"AD
M4D@\B+]K3XH7,$0"1J)X]3G>-W:,*[X=5)\PL&Q\P()%?4<(Q4\TE%[_ %>;
MCY23T?D^S6I\]GM7DP]."LI3JQUZ\J>J7D^I\9_ OX"^-_BWX^\#> _!=G;7
MOB3QOKL-AHEQJES;VNBV]I+<06\VIZR)5\Z+3=(>7[5>F+$CVL,OWV(%?Z%W
MP)^%6C?LM?L]_"7]G#P)K5]J6@?#;PCH5G)XAFB$*>)?$5Q%)=>)?$DH8,T9
MN-8O)-/M(XV2&XB"--$^XY_C?_X(]^&K[Q[^WA\)+B?PWJ?BK1]$FUW6)K/3
MX'%MHVGZ-I;2QZGXE:W$:6GAQ]9C@DU NR>=:B6)@\3-&W]T/CKP_P#9;>V9
MKMKJ]1IKC5;B&&*.P,FHNDL%M9PPQI!%%;2+&T$4$4<4;H"BJ2Q/[]P]@?J^
M$^NSBG?G4Y25W)ZV<F]VEHKMZ:+JC^;>/\]K5L;6RNFW.-/E:C>\8MK9+6VE
MW:RUN[/1G%Z??3W,?B5)999Y9_AGXVGE8,6=IVM=(3>HZ XZ1@"//5>M>,1?
M:7C$\G^C(R*FUU#S.5&$D"L#@@@$ 85B.01G/K/A"*]-SXM:6W*21_#3QA%:
MV;9 =9(='7[0TO\ K!U#8#[1V QQQC7D.C6LTT,<=W>,L<3W+J9Y+)90 XAM
MI_,MI'0$E&>%V+ ?-BO.J2C4K8NHDK2JJVB_D>Q\=2KUZE*A2JN25.'*HMNU
MG*^S=NA@,+B*W^T[2\3'RUP LCN> H4 %2S<#&,$@]JQY?F#>?<7$9=2JP_*
M "00 6 W@9/)!! SSFNC6SN[J%KF]9;.T+&>.1VVRSNOS@)"A"1LQ "A$4 D
M8  YY&[MU6:0*;IY"2R,V[:RYSM/.T \ LN& Y!SC'AXUN^[V?7S/?P3=DNB
M:_(S[N4C;;X,H8A%#$GECM W [@??.1P<\5CZJT%M#$Q9YG!4LBLP-N <^8I
M5E+F/[P5RRG;@@@XJ^;6^E=@L2PX^X\C;5+=MSOG8N0-S9&!SD8JE>6<EX0L
M"-]GB7;<WUQ+ D(E[I!Y:JTO.0-Q);@9ZU\WBDG>ZOON?28:I&-N9)M[72>F
MBZG#W,P6"1U2*,22<2O-*US+DG"QJSL$<]$"@?,5Q6"+3S+>>65)XI'#K&9,
MS><2I"I^]+F'>2%,D91TSE65AQVW]E&".1Y'BN$#Y50BL_!R!$2I(DXPA&"&
MP01@5DW]H+:!F@DWF56/D32.9$8@X*@L?F!/R^^!CK7CR22F[*]^WDSUXS4I
M0Y?=2CK;2[OIMY?@6KZ>5_A5H<=E)(C?\+6\2-)<2DSJD</@_P "F:,-<>:K
M*5!&PY4C((QG/G-[<QVENO[M(;G+I#; !T=I<K]JWN&9,$A]H(10/E '3U;6
M6@C^$&BV$4(BL[?XI>*9O*&_>9W\&>!V<FX8M<L'/\#3,G. H'%>':GYT$1>
M5O-9N85< LB$<+NQNVY]6]:XI8B%&G54TFVTTWJTDFFE?;6S]3U**4IT^9<V
MCWUZKN9UY=78NEE8P;O*.6W;F  YPK97.!D<=>0>M<)K.H2/<&21D(BBDCCB
M2**.&%'4B46\$:+#;M("1(\$<<CY+,Q/-7KW4Y"[AY!'($*HJQQD9QA5R4/&
M>,\D^M<K?.SNK,<E]H8X R&QGH !G)Z8]J^4Q^-4U)Q=K76CMYGUN P\9SI\
ML(I:7M%*_KIKH<QJ=U)&)W:0NEQA]AP=KH,QLK$97:P!^4@''.>_GE\[L2%=
ME0OYC#J=P(;=SG(Z'&<'H1@UV6HY<1YY+B;=[E00O Z8]@*Y$(2LC29PKG)Q
MRH!Y(  S@9P#DGTKX;'UYU)-\\W:Z^)][]S]3R; PFXT^;V3E:5H^[S)*S;M
M:]MM>A2AB3+'S!N?(+.,*<C^(C!53GDKR!R.>:MWTD&FZ-)?WC1103EK2V+2
M;/\ 2908XFDWL"L =E,C] H)SP*-8U'1?".AZSXF\57D.F>'-#19=7OW,?G0
M1E#+Y=E$_P ES))&I^5TD(;"X[5^47QV_:GUCXF7.J1>'$ETC1KN&\T^QB!2
M Z=IEO%)"[HB(OFW&KQ9"7$_F7-L\@>UE@=58>$O>JZZV[Z]7W,^)^+,#PW1
M=+VW+B'1FXN,N6;Y9<CU34OB?0^A?V_?C/'XB\7Z#\-/#EP9-"TSX;_"2_\
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M_5FMXQ]GCC281F+Y=OS*05VD$$$GA0V"W<'(KM-8UOP);Q) ?#'C!D0C*?\
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M00P"'Y.G<*#QG/&:Y*^N% RDNUV! ;C()& <8(R#G''IWKT>]\1?!QOM#O\
M#_XCI,P>-0OQ8T0AMP*A<?\ "C\#.0,XW#UKF3K7P>GD4'P!\2D5&4NR?%C0
MBZ*#EF42? YD+*,E?,4ID?.&7(KY;&0G*G)QDU9I:-K>[Z'Z5@:4'&$8PBI.
M/,FHI/2W56?XG%W/B+2O!N@>(/B%XB98?#G@_P /ZEXKU!Y)9$\U--L[B\M;
M%"KJYENY;;RHE1A)([A022!7\W/C/QAKGQ$\:>)O'/B2X^U:QXLU>_UFZ\R-
MXQ9V;SO!H\5NL0C@@MOL_E".SACCM(9<7"PK/F6OWN_X*'^/O@9\._@/\'?"
M4WP_^*VJW7QV-YK_ (BTJP^,?AK1Y]'T'P/K>IV]E!)>WOP)EB:&YO;6U:<P
MH1.H:*X6X@DEAD_%X^)?V94A6-?A!\;=D,)AC!_:5\",1&"7",S?LZEI K<K
MYC,5Z+@ "NO 4(QHWE&,I-IW:3>W=JY^><?YC/%*EET:D_=I5%*/,[-JJMU>
MS=M.IXKYDRKP4PO( ([<XSU/3H3BHGNY_L]WD #[//D@C@&-LD$CJ![]NM>R
M#Q/^S+D?\6>^-74?\W)> ?7_ +-SI[>)_P!F)(Y"WP<^-)0H_F*?VD/ ;ADV
MG<"B?L[([9&00CHYZ*ZG##O22V27H?F"PD8TZ4>6-X1:;LD]7?R-_P#:'96\
M>^'E!SCX)_ ]E!9P-[_#OPXY)R<$%KJ<X.1A\#A4"^%;6((^3!!&,XX/7O7V
MU\>?$/[.2^-/#T5]\)?C++.WP7^"LIF'Q]\$0D6H^'/A4QP@K^S[Y2D*,"4Q
MLPSN;=@BO"W\2_LQ!@%^$/QKY(&&_:0\ X))'!/_  SGP/?@XSSD4-)[I,RJ
M4_9U(?X7;R]ZVFK/&%3:,$(%/WOF/W>_?/0GI5RW\EB59P5'3G&.>Y&#Q]?P
M[5Z[)XD_9E!C"_!_XRC<R@@?M)^!"3D@8&?V=2,\\#FIE\0_LS(<K\'OC4I]
M3^T?X"8?B/\ AG,D_0<GMS7/7T<4M$T[I:)ZGL87WJ;YM;-6OK;1;7/(I&3(
M577J H..I/ /?DX/7OWJ!WE5@ 549Y.0<#VSW[BO:7\1?LR[58?!_P"-&[.<
MC]HGP2Q)SD80?L[*6/HH9=W0,/O!5UK]FV4@CX._&T8.<GX_^#%';)+-^S^P
M4#N2C <DJ<8//RKLON1TV79?<CQL,3&Q,FXA6.,CG@^F/I_3N?H?]E1))/VE
M?@5M.5/QB\#97 .5_P"$HT<8Z9!(X_+TJA:ZC^S>2K-\'_C2T8(9U7]H?P,[
M,@(+*%'[.J%F9>%4.A8_*&4\U]8?LRP_ /\ X7U\&1HWPJ^+5AJ3?%3PC<6.
MI:G\=_!\]O8S+K^EM;S7-I%\ <W,-O)LDFB1#+*B-&AWL,*27(]%OV79&=72
M-UH]=5H^G5'Q%I]M+]FMF$9WO;(Y//+R7,<;'T&5.,# '4 -6I!ITTD@WQ A
M2"/G88P>" ",X_(_3-?2UKJ/[/46FV+-\)OBQ-(+2"UEGB^._A)+*ZG5XFE>
MRC;X!_;(7>7+1BX=HE8J'7RP5J6RU;]GTSL#\'?C(H!^\WQ]\&$+[D#X C(&
M<D#L,"O,GI)VT]-.YXE:BJDV[)]_/5[ZJYXK9Z:8T0JN#E>Y/.1ZY_3U(]Z]
M TJRDD".XR4Q@XP,#U &#TSC!_6O:[&Z_9[EA5O^%5_%E<<@'X[>$><<X_Y(
M!WZ'_P#575:=?_ -2BK\+?BT 6"G_B^O@[&">1_R;_D#U(Z=<]<\>(;<HW=]
M'^9RSPD4U:$5?>R2OKZGCUG8"38K("-R@8 SR0"0!C/XY!.,\5T/]D(J*461
M6.,$HF,]LG' '<CZ^U>UVVK? ($(GPH^+*,A!W_\+U\).&P>FU?@&K-G' 1U
M8]%9201K2:K\#,(P^%WQ75%(+$_&GP\!M'+$LWP/< !>I(8 <[3T.!RUL.XN
M/+>-T[V=NOE(\8T_3MA4N02&7 ]2"#@@=0>.H]N]>]^!+5#\*?VAQL SH?P>
MZ 9_Y*5IG3U/Z9Z>]"V\0_ 0/N/PS^*+!/FV_P#"\_"JY*\XW?\ "@#C/]XJ
MP'7!QBO:_!FJ?"&3X<_&^:U\ ?$>+3+31_A=;ZY9M\5-%U"74GD^(6FM9-'?
M6_P2LQ9-;,05DBC6'< UQ%,FY"$*DE"7.E)WT<O>:5MDW>ROKZGR99Z4)I!Q
M-@,.=B#&".<@=NN*["RTQ(<965@" 25 QR#R1SCU]AQBO2K#6O@9N98OAC\5
M%!.,?\+CT4\'W/P3)_+\,=:Z>UUGX)C"+\,_BH Q"\_&#0FZG'\7P0/3\B.U
M!RV5Y:+?MZGG.G6K1-O(PN1@>G..O<<<?D>E=G9,3L!/'RGH./FZYQ7?VNK_
M  4>-(Q\-/BAE<9S\7?#X';KCX'#\<8/?@XQLP:G\& N!\-_B4N01D_%_02!
MSU('P0)('L<]AD]'=K9M#LELK''(J!%)8=LCU]NIQQ]/J*NQ%-I  R00,\\G
MIP?J 1SV(S7>VU_\&V4;OA]\1R%^;'_"V=& X'3CX(?F#BK0UGX/HZ*GPX^)
M!!=06_X6QHQP-PYY^"'8'/Z=JRJ-MJ[OH_S(G"$FN>HX-+1)M75]]'\CSH0D
MD!D4J2 1L'3O_#Z5Z=XPBC;X:_!C**<6'C]1P.G_  F^J<<?SZU-_;?P=7YF
M^'GQ)95Y*K\5]%+,!R0H_P"%'_>(X'O6MJOC[X4:CHGACP]<?#3QZMMX334H
M;66#XN:.UPZZW?2ZC<><A^")4#[;/).YP3&"4C*0JJ @DT[I/7]"53I)-*O-
M)[I2E9_B>#BS@D+1^4/F.1C.0Y!((YY.[! /'8C%6(]#1@<QR$D$?<7'/X#L
M?KUZU[#::I\%20Y^'/Q()!!S_P +:T@<CTQ\$1SC]>_2M^WO?@]*08_ 'Q(0
M CY6^+>CD'GU/P1)P>.1SCH15.ESZK2VFFGGW1R5XQA*/)-R33;=WO>W?L?/
MY\,Q/P;=LG &(U!Z\=!ZU*GA6W4C,$FX$;200-V>,X8=^OXU]&"Y^$0(/_"
M?$,8(/\ R5W2.W/_ $1*@W?PC9U;_A OB$5#*3_Q=S2.@(R#_P 61SR!R,=.
MG6M*="23LY+7N^W^(Q4J2_BSY7TN]UU_$^=9_"JLCD1# 1LA5))P"<#W/;UX
M'UXN_P#!JRLP2TE&]2I.P'&X%3C.>WIR2./4?9/]H?"$*5'@'X@*"",_\+:T
M?C.><GX'>_J*KM=?!Y<O)X#^(#*HW.H^+FB@LJ\D M\%8D!(& 6DC4'DR(,L
M-H0<)I-MW5]7?J_-F4Y4W4A[*?,K:Z[/FT_ ^"]0\#H(E$L$FU9U/* 8PPZE
M0.G?_P"L<=]\=_ T$_QB^*$K6X9Y/%FH74C!3EII(-)A=P.F6C^0*H"*3D*&
MY'TS>I\&)07/@/X@[7),7F?%SPS+'#)_!)+'#\+XY98T;#O$KAG4%5(8Y'H/
MQ6C^%!^)GQ :^\!>/KZ[?Q9JZS2VOQ*\-6J.BKI?D!@WPRF>-5R,O#!)*>H2
M5L*?0^S'T?Z'H0U@KZ^OHC\K;WP%"0RK;2@E2H'E#K@X[<<\<>O6N.U/X8PM
M"ZFSE&Y6).UCR0>>6(/J1TXP>*_3&YM_@HP82?#KXD1L00 OQ;TCDG. &/P2
M.TY. 3TSSP#6'<:?\$GX;X=?$XCMCXPZ'GTX'_"D<$D\ $$'GCGD-:<(6?NQ
MW71=O0_*.[^%4.^3_1I,[6_Y98Z ^@X/]??IP^J?"\)"[I#,) Q"_*5&>P."
M,9X!(Y'.#GBOUXNM$^!I60_\*U^*6XHXS_PM[0O0]O\ A2!'/7&/S'%<AJ/A
MWX&&/GX9_%-@/FQ_PM_0ADCD<GX($#D8YXYYXR!T4$K2=E>ZU^1JZ5&49.4E
M!K16TNK7OIYZ'XZZQX(U-$,4"N&13P 3R <?>W=\?EC':L6S\'ZG$<SPL>?F
M)4@X[\ #''?I^.:_66\\+? MYWD_X55\521\Q_XO'X=^;')X_P"%(8P?IWQ[
M5A7?A_X#*'$GPH^*B@JP+-\9?#L:KQC+/_PH]@JCJ6*L% W%3C%>KA=8SOK:
M2M?6WN]#S:BC"5H5'-/?5NSZ+?MJ?"?P2T^:W\;^)XGMV*?\*)_:1&[#?*#\
M$/%@W9]NO)/ ]:^<A 1+@;L!NF/YG&<5^KFA'X)>%-9U+4M*^$GQ1N+J]\'^
M,_!-]#>?'#PK&@L/'OAS4/"NJ7]B_P#PH']Y/'I6I3K$K[D1PLB!)%#KY/=>
M!_@ CR$_"7XM8"MN ^.WA/. I)P1\ L@X[CGZ=3O/2R6B>Z6S-</.+O2DDYS
M:<6TFTK-:-ZK773J?#%E:HQ3(VG<HW<_+R/FQR,CJ01@XYS7>:0"+M(X4:X.
MT JJ'YN>5R,%=W3(]SUKZHL? 'P+NI MO\)_B\BDA0?^%Z>%& R< D'X!%CC
MJ><D# KZ&\!?"7X"V\]O<2?##XIQ./+9I)_C;X8DC&U@29$;X#Q90 9<"6$E
M<CS8S\XYJJ2@VE9W6Q[F$X7Q./3A&4_WDXVU?PM:Q_PM[K;R/V"_X-B=!U#3
M?VG_ (^:E<1O#'<? +1XHT9>BM\1=(0J-V2?W=M",GGY-V<LY;^W"+YAD\D?
MXGT^E?RQ?\$*=&\"Z5\?/BO)X*\'^*_#CR_!FR@O+KQ)XUT?Q-;WEK%\0;':
MEE'H_@G0C"ZL0X>>5-P#([ D.G]3L/W?\^IKZ/!MO#T[MNRZN_1']!<)Y3+*
M,JAA)JUG%QBUI%<EFHKHF]7;KJ34445U'U%DME8**** ()^$"X!4D*RE0P*G
M (P0<Y!(]:_R"/\ @JOX0/BO_@K7_P %#[+[796:M^UE\3+9(K^5DL9U?5Y"
MCW!<20VUK [;KF58MJPAS*KJI!_U]+MF6(LK*K+EE9QN16'(9U\R+<H."P\V
M/(!'F)]X?Y:G[3OAP^*/^"W_ .WM%I.D236WA+]H3XRZ[?WE[XI\(>$+.+4X
MM<TUXM6NO$OC6WN$T_3=--Q<374OA[0/&NO6UMNN=+\+^(+V*TTVY^WX!I*K
MGM%-)I<NC5U\2[IK_A^V_P 9QUB9X/(<37C.4.6+3E&3C9VNM4UJ^GWJUKK^
MC7]A?2O^$0_99^%VFWK>'=/>U\'0:?8CP]XKMO%UI=WDFR[OKK18;B]-W!(Z
M(HO#-%*+*+?%;11P@PM],VSVMRLUX\V;4%HWDN+>(WLDA&/+@B:/:'<\(RJ"
M&*X(/->;_ S7M4F\$^&]):".[M;31A<17UEJL%PXN+JR$%S;V<<OA_P?+?Z9
M=QDPW&MV^G6M@(G:Y?2Y%S&W8OJ3->RRQ-'=&.3RMX@6V-BX; W>8@L;LQG!
MW10F=\'8X8@U_3./PS<(IZI479-72VV5M/0_CF-:,L17K-)NO5<VW9MVO&[?
M7?K_ , ZW2P9?^$K\F*:%!X&\:"&24F-V/V#1MNZ)2J')Q\K*5)X((//GC:G
M#I\<J>4'F>&)'89RVX;3CG"Y)X*X(X((-=SX=U*.5/%4D[F65?A[XME:4L<*
MY@T96?8N(QA0> FWO@5X[J]XTTS)!B*[9( D2@2(ZG $S,V[:03D@%17YK"A
M'ZSBU4A&:53W5.*ERKEE=1NG97UTZZGN4*G-!\CY;-7Y=+NW6WD+JEQ<7<Z1
MO,%1U^=AMPL) #Q;<8+%"1N(W\Y#9&:J7.H0V]OBWMEDAA5@UZ!B61U4_P"C
MB/[H#D;-ZH'&<A@0",FQC^V1SWEPTD5E:R'<Y+"1[J,Y5(P>&5G7 '*DD C!
MQ5K4"+>*<;)!=,(_L]N57RA _!F=<%-P!W9921C(Q7S6*;5>K%-J*D[16B6^
MRV/4P;<G*[;LU:^O1]SC=1>>[E>/<%C=&=W,:-B/:=\9W*1DKD>O.0:P]4EM
MK>V33[-((X=OFR7C(JB.0 MO:3&Y0GWSM88QGM75S J8[55:2YN&0E(E#,=[
M 8'! SD#!PH)Y&*\Y\2J?[0M/#UE)&RW3B[NIH6\V2WAB8&Y2X60NBHJ!_,"
M@87(&,5Y>*IN:]UM*SO;1-WZV/H\+I:WD9WGB.QN;GYH()Y1;Q:A<JH68'Y)
M8K8,"',@.U&(+ D%64\US]U=HL6]@(I8OWGVSAI)8D&XI\^=H8#!VA2.Q'6M
M77KBUU"_2TR?L.FK!;Z=!EE@25BHEE"(0KL6Y#2;BA^YMP*\VU[4WMI9BJ;W
M5'ADT_.Y4M2I$ET'/S[DCW.%W <=,5\YC**A1J7BFV[IM)OMN?0X/6K3OKZ_
M(L>,9X7^#FF);N'O+WXL>)>44+N,'A+P-);^8% #*DH5F5@5D *RAT)6OFG6
MPT4,D&U)&$$DLLJ 9#JC,5!&-I)&!MQ@^_3Z$U$K;_!:PU:YD5VMOBCXQM I
M509;F[\%>"4LYU"@ ?99&1B%PK;<2*P)!^:[ME+81B%GE5I269LEF&3ERVT8
M)^5<+C^&OSC,82G4E9M)<RT;MNS]$P$8I4FHQ3LM4DGT//KF$P11/(=YO79X
M@3DJB'Y^>I[\GD?E6?;HJSG:N[<55E8E@X(Y4JQ((;H1W!QTK=U3:KQ2LG[F
MU\R&"$D\>=E7<'.YL@G!8MMX(Q4'ART^W:KIEN6'F7-S&,GCRP95578<#$><
MG.00.=U?/2HU'/E<I.+=W%MV;OU6S/O,N;M>[NH-)WU2L]$^A^9?_!5342_C
MW]G;16N?MD'A3X,>);91+LFCBU/4?B-J,MS+") PCE2-AL*8-N5#0")AFORL
MDNY<[1*X!XQN/?CN?PSW)XK[9_;I\:KXY\5_#K7X,26;P_&33K.0,"&M-#^,
M'B#1+=%(QN6"*W5 S%F;;OD9Y"7/PQ,Z#8P'.02<GK]"<?U'>O6P]/DA9J^U
MK]%;I\S\?XCA*KFE:3E)N,II-MW2<[V3NBVLDF1^\?J/XF]?K3IW9H)@SL5,
M4@8%F(*E&!!&>01D&L_[1CD-R.GW:;]H9XIP6W?NI .%'.QO0?I^E;V79?<C
MYZ=*::M*2NM;2?\ \D?3O[0SQ_\ ";>$I  'D^"'P&=V&,DGX5>&IR>#\N94
M1_E  QM^Z2#X@NZ7D%CWZGU]![_A7L7[0,J'QOX/63G_ (L?\!1Z<_\ "I/#
MH[$?KQQ7C"3+'PAQQC^$\?B36<TDU96T_4XZU&;J4[RD_=>[;^UYM_<6"DA*
MDDY4@J?FR"#D$<#I^O>I)))TV'S' W*3AFR1D9 .>..X(QU!XJ-)7?!W948)
MX'3//;Z\]/>KJ)YY08R,KCC'? Z>_P"%<=?>/H_S/2P\'"#3ZM/\+$\'G705
M,S,'(0 RS%?F(7D;\$<X(/!Y!!KM-*T!F524;<""&#NI!X(8$,.1G(([C/N(
M]!TJ1V5RORHRL01S@$$]\_YSGFO4].LR(R N 0<GVYX'OV^I-9QIN=VKZ:;V
M\^Z.^E2]HI/LTOO5^Z*6E:)D*CO(V\A2#-,5.2."#)@@C@C&".N:^H_V7K3R
M/VB?@<"F9!\6O /ER ;71WU73YRZLN"")D1Q_=*X  RM>(65JB+EE.]>5.YA
MA@00<;L=>>1@\9'%?2G[,ELH_:)^"'RCCXM^"!WX$>O:7"G)_NQ.R^ISN.7P
M17L'M=V]?_M@JX9\KT_K[V>'1V \F,;!D1X!.6<F0Q[RS$[FW9YR3[5+8Z2H
MN%/E@9=<G)Z;AR1D_CTQBNBM(-T%L2.6B?/7DILVD]N"/3GH>:V[2Q7[[+]3
MEAD<9Q@C Z_3/:L:M"$(N\(MO6[2;T\]3Q:L'2E;5<UW]SL2V.CEE##[J8;
M)&0O.."/\\5JQ6[H[+C"#J!P0.AY&&&1T((([5LV8@AMS@89E;JS$]"/XFQ]
M/UI 8<].O!YZ@\'^+O[5YLX0:FW&+:>ETM-.G8RDWR-W=[[_ "16!P%'9>Q.
M01Z'.=P/<-D>U6#?)%&VX)\J,1^[CSE03P0N00<8Y'//K4<QA0,<84 D\D\
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M-*_G^)]/A*;FDU?1I?@F>7:E&(;0WUR%BMX%<00HL7G2L%)5@?M>]F8X RQ
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M8XY8&EN;FWMG"N8F12I_U0[\1^0YDV[ K;RZ&1-@!+;XUY=<9W(.6&5'6O\
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MVO1DPHJ=VDEK9V25_P 4<-97DZ;6,K87:QZ<X(/IZ"M^/4%D*EPQY7G)QU]
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M=$U;LM.A^39Q_OU3^NK)Z***[3RPHHHH H7Y?RF$9(8JVW !.X@A<9>/)SC
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MI.QF"LJ:A;.Y4G!"JS#+$'"C<O.!N .1(^LV"L,W]NJYP2TUD%4 \EF^U,0
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MOAVR?\*6_:LXZZ-\!#GGM\8)CP/RZU-?>*Z-/3YG3*,>27NK[EY'CMCJ$MN
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M.\I.VUVW;?8_?,IX=H8'#Q]E3IV7*VU3@K-1MT78\T\&_#N"UC3<FT@ 9^?
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M^*1$6=L:[=4F^?:NT%P/FW'+9YSG)K_9IE^[CM@G\1TK_&&_X+3S^7_P5O\
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M'U^PCW&/,BZ[.FP%;:+W&W"GF]PW5"_L0R!E*'A,]"</X8(;6D[.;*Q$I3;
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M]W>KE2*5_W0C2$ <Q9/ZX;&Y+Q.R$ZCM8MW[S!%G>TK/@<9_>C5H0Q2/;/V
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MJ4 BJXF+^O5HP2_'.>C%W*'@HRUCDS?A3JZ?9API.,@7[99>/4SI!HWYW@*
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MU3SPQSC-SB.-?$.+=#Z-G )V& G;VLU"V'@X41%>"SN@0(./69#Q9 R8(/5
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M3<FSX.%&,3,Z5-OG@K*ZECRS]46U.""52U)X2A,FZHHS). :*O\BH'A- <.
MO3+"^Z .[Z]8?&R:UD@0^_6$.E-Y(N3M.K.W(')2]MTWEVV.8#EK19-U<L[:
MMNJZEACD>X6EW( WV+%'KT3[<1[VZH;^93QV=!'(% ^PX=\TR$)WR=,NA2Z/
M6P#^V>Q^P2W@+@/>Z!9P_Q;@HA,[TRE4U]C<G-+#(CL1M6--<\/D(I%8_UBB
MDQJ7EIF@HY'L:#/[)'1T%>]O0%U4_.F%EK6FF/.QW[K(9&\3L(JA@5>SW*W%
M+2]S9DB+N^5&+KS67MY@M?X0*$00.1_\] ?L5>:PW@)!<-X<.;EEYWHG?R/"
MC:HH0NT2(N"S)7N$+HV;J4Z%\)XJZX;5?>_ *Y6 R3/P3,%UQ0U-0/&9&WYX
MW9I\^X9YDE$5C[(KQ\<,*DO+)TA$N,_J1PW2W*M]U(ON%MUM>EQ[+_KD6AJ)
M%.+&G^(3L 5(XUYK.NL ,615A*P#=O)7I@'B7>AZ%S/>U1B[TG072<L0<=)A
MUJ?3 4<SJ@?,9Y2P\I*L]"*%%4R+G_N.\30)5H5Y2H3= H0XI,I>%C7)KODR
M[*Q F)(-1!1ZZ6CF3YC .J!=]36R>L$TX]^!=O;&I$C>I^2Q'%SI2B"BJ6M*
MXOBS/$C>/<)K7!52/&X-0S.S/S?L[1Z(9#;B,45.O)#T>.JN<8B "Q<FSG]U
MA/]^F&%%'YEHY03K^VO(7SKA<G\P26N^J32D9'=F%E-L"2XQ@SU)^T_9F?\M
MM.+1=%[K\OZY\[S;2IO?9<;9P^ML>]PM((X5:1WOAB"PK9 UQYL0IE+[D()@
MWG1D[ZJ.K:WK9[7G3Q-\+<14$K\267T+:PS8>#!$CKIK%R>(@@(Z+1[M-8(@
M^L))T0#B*0J?^)T/E)1XGVXK>NR_6)7E=F+)^8:WG7E@4F#Z1E-NO[0D.*B_
MVSZI&(Q@2UJ64N !QF_)OBH].Q8.,*'IAM??&V(CY(=$,^$@#/?E0$X<1^VC
M#-"!&; &N+ EE=9]8-SXKTP![O?DBUS/+P:^M!]XU2>+M'4RF2HM%I2OVBH_
MAR?A$ EZ:4Z2O3%@U<;[NV'%B3X[>U;*9^DT=.1W4B+)OJWA9H'PRG"FV1;\
MP7R\A43Z'6)V-^'U5S*P_V)!#!O_8.)B85<Y;L,>+#X,D>@.0/SW2(K0>IEY
MQ$UNB+JJ2&G\K!7DG+_[Y\>F!IG@@+"1GE9ARLSPLV2: ["98FY$S;Z7-V86
M*R<=?YQC%AB"'LU+,X6 F""A@,I:)";,22  F&P%$);SZ@.<RZE6N:!\']\M
M2JTW]ZMA[8!?%>*.C_<BY1LFH\]FPZ8EVRH-KES#^W=, B75&Q>U3)N"G7?W
MO8W])Z,$WF4+_0[D7*\.E+I1C50$VC8OSCKZ@?L;S;.O@CY<\]>T=X\^@L81
M$9\G5OHD12Y6B^5J!^Q9I.US)G?WU=.H/?;#)*T"I#B3N@'HB<[(V)[C:VJT
M09&A8;SNV6?K.!]SR[2;*X9*X?P8GU.Y3\QB\(G"V*T>V4358_D\C3@3&3?W
M_""GWU [[DK_LSW$G],*4O98"!=)T@#^0NIT>9*;U>K+CEGSKX.44_4<[30'
MK47*N[[^[[DFAQ^S7W6AIR:+;@&&0M<^X=? R8F7^L(C*BJOTMG4$&R/)!G0
M*=V[SK.4Y$;'(T.&=C'&@F=ECMUO'+G?AV0395/H*(XYO4@Q4G?^:U[2![)]
MF_:SJ$JMJ**#\MLMX/W<%X(BMEEJD, ;#F$[8R((-2+DPBN%5?A3L$N@!"^9
MJJZPG- KISMMX0O,W"E(H9BWHR)?.A^$W W^'!S']MB;%^^]WM^4.:\7J>FF
M?^3#W^ST)K'&9B@:'"+G1!4C/KQ;F,*I"MW()AEF'F+*566RBZ75?JO^8SIE
MOK/R?RX8<L1[*+1>\;HUF9](NYJ J3\-*X%\UTK&O63@KP<WS:MI5"C9L ',
M]Z58&O)H?CJ\2;N'+$LHR$X45D_,&ZQP7UPX*O@-3[>VM@K?+.ZRN/*MXIB?
M_9S!:3$9U%21YQYV5%)NICVU,.U>K/-::6)I:*@;+%YEM11\PR!Y.;.M]-.P
M!14!#;I1N"G5DN=!ZK6@$(WJ"#=B=H8=6(O\M(=?M+O]UTT>W1I1Z6B#5Z*F
MU;_O\# XSO4#M"<G,@T?XSA&+IU=*[OB.EY^!FL8+)X:2\F93K!#1 <;=3AA
M45469]TL#5N/]9<LEVX!3N:J6\MCHD^5?AYR,#"Z?(\>6NJ/M@;S+[P(OX,O
M0SXO?Y%';JKE#=*=V -LC8R+L[WL[]K^]J5BZJO]@^-4)3HTP_7+ZSP%VZN'
M+*XR&(T9]V#3=%"E4WORV%BV&[0R)(XS[JD1T,%T_E4WUY0#!*W_1(E,??=$
M&^'1J3KEP*!E$7)]Z4(%+6!X41'F,.9?U'CX!V^\AMY/0+*"+,U=<@7B71^0
MJ!V\FYAFO7[&R8?)L*P]\+VK%)BE+KD(H]PS[A6:K].98*NMG_C09FYN\D89
MFMYI4+G;'>E(/&ZK=E7!S@RFU+CJ6V_:OP4X Q]%:DGUQ-F]G]*ZSU;":&@D
M\]5A5U(-E=BT;+*46+R7]S!$L*XZDG15.Q6P<_ZM>4@F1G102_! ._ALS<BP
MS-A@8YHKV".Y]6+N^C/[NFSC1ZEB_8<C7JDI>GXNC^;S! ER^)?,4:\F%\W6
M^*KY*LN%%8%48#4Y41TY'VM'O$[/3",_D8&A@Z$#J[AH(?548B!Q).F@]>N9
MA0#PS-BK*SK(4^R-1?=3.)*KW/858%QS% 1P*%1,9\0*>+/SJ(Y\!#RL8B,^
MBGSN,[3&\NU$:JO3JKYF+JXQ%<,X,.LWO73]FK0:)*V1)EWC7+B@Q9EI5*NI
MG%]TM[<'%/?J6'Q_J?0>T= -U3U56=2JG,M$X-':8RZPC!]ZSI=9^NRL?)MC
M[LV7AULV[L>"-TK:8K< 5@M?Q-&>>2.<R=Z3C,ZFYEBPKHF#\Q90=,8$U^G]
MGOOXT>:AON>T!=1(YJXZOX%Z<U.!IM.[OZ:>W=YIDN1@59*2-1CI=G!8PY^=
MLQW*Z';'W5<7(<\PP^A1'$7UZ%0V"P#%(#6F*Y$>86KGZ\BG5)*^=(^3B??I
M'IO(6J(B6FI,_=W3L75KQHLPM\2&IF@N];\5I'$IIH%<T"BP/[OK9V@->;=Z
M#Z.N4#'3RR#G,*2$R_F&\:3VX%<=D3Z#K(9 4YF7XY@J1,UP9_ZFAX,;.4T?
M<1I@ TQ!(9;MLP-+RUP8U;"D6S<UU1F1%N:H%/N#KO*85EIG.*(Q8J\EO3>7
M3 D$)(]<<$!H>*UK.5C3R^J5ED5K-#3)'_/[0T2F;@'];1"BX4'/'SS9WLYE
M;UVU5\)BW?;>\?%TO<])J]P_]W\N>S45V;_F/72"RJ_\$6""?[:DVBL$?^E%
M4A_&\/>=MH[LF_VOY\.C-K 'OWUZ]Y<"&&_F'G/_0+XX>"SW_\A[KZ\FN^A=
M- H*2 ?I)2A-I2E5BD1$"(B H-(A(M(%1%J0D"A(;P(""D*4*M*D2TN$T 05
MZ1($DJ#2(4$)KZ1P\NW]^P/.Q3G[9E_,BXR,,=\UYYIS/L_SCI4L6\]<]^Y9
MDD92?KN9@D561JMB]+;H[91M[_&6,ZD#G7V*^(];QRWMQ/357WV0Y[F>^[NT
M(JCAY"%(.^QVW=/*9=I4D?7JULR0?'2;^)BXH8T-W"@&/93ZQSKH9<IMB)PB
MY7&LK;T6,\;1M3K@[HWOA6JO=1]07R_+I'0,0F_80*]3"@DZ*M]WYUZ&ML09
MCU<]=N20RPY%5X/1C_#B!JTW'\8E%.=8JBQX'&ADI_^15E4MCMQNZ0H),EP-
M:QY,R#37Y%00NBAWCQP[=I'45>PA[D6N>GP]_4011.R85!8,L-'A\>7]J_Q/
M=M$WZIUKC>5+>?R[_B>AOI,<<H)A)?%3Z,'.$*$ NU'"4E+5ET2Y^T9.-RJ^
MM-3#F,+BKY!KP0J1BMN5I^PD7@RS4&ZP9MR*ZYQ_5:Q+#-5A.S, &!$I@Y,4
M<JRURTG%>XZ.4V\B(J1/#.J#3E1DF3X[(G?T(?0WY-00;VV@)^<I8.S+MWM\
M%A -CEEV<)7+YRF=:&Y+R=H?*M[,T7"V.T+1YY]U2*Q(LQ62]E2JO8^T73,W
M1T5HV%25LQV"9DOVIJWX?A3 AO9\G]40_3N4'4E1C[9GBK_4%#^PZLM-)X1?
MW"HQ.3CPVGTG'$ IA_NR/>@UXN.4HR[+OHY5R<O?>B;\"W/\(4\8R%PK[JK<
MD_^N7*S><$MLK#72C1(:OD7TQI^\+FETMA?\ 91W2>^HIJ;9(Y2C/S2BJFH]
M4]7=3;MV[:W->%20TB1F=NU'$8QR96[T?.IU>M8D1^,EBXMTOM@_Z?"D9#HL
M5#NA:2CDLW'PTX>:!N!^@0L[M_86(BUYT-H_-2_>9_<Y=RN1N^CF)_8GF6$[
M'M#:@-?-&B_?"YAH=:D^EO[YEG;1'0=$J7.QR:6GSA1S*6S^;-VFH9)W;\.K
M5!1:-[&?"@^J4I4>K,)Y/^3N_A1>RI[7__OQ;S7$SSW@#%(#87/[OB#)=?=U
MR7:A3?2*86;8K&Q<MY?S3+[HJ8IS7W9[VTS.?3D[?/6>55"_X1:[DG1<Y+/0
MU$-02ST&.IB56LW;9_,>R"&>4.&,TJXN5^D.U/F0C>=9N9-MFMV2G>LN\$:I
M>/[1?BRV'Q+<I=&!VE46K -2BA[E]CJ .(;LQJYHS98\^DGQ\*_>&'"XGH 7
MW'_(-=^RPIZ>>41:('JY\%=$D#\S4DUO)!W*]?A*;HX>\Y*!8U' H[^U3M']
MWA:?;LG=\U+^/<B!"IY^%Y^85=^U--JE+J(_&6AEZ%^UFK8H1^$LM#Q]<S?/
MFXU[D !5EEA61D_.?F[8.[[48O' AO.(B1QE5D+BZT/.(8_NR8:&Z9<OJY)?
MR3[0)U!P3X!TV9+64?<?_YY^N&?X\)%LZ)@_U"V&'_G<4MU\LR&6:;'=-U*,
MK[8;Z%!1V:YK\#@04U<?G#E2M-VF.?0M_>&#T!_@R8JP N'@3\JOA/@XW$(!
MWS_*3RRUOQ*3<W1 PND@RUZ"Z$/-1WROHTA%/P>'F\;.9)C(!M14RJ>'*?RQ
M2A'B++O>-3+R2;+:Q_X(Q]AS17W#:R[^7:X+^] J>R<G<ZW;]W.BFMO7'6]%
M1RNS=7PD/*+*<,B@7#*U$Q7\?4Z?SSGJ\WPS^72)5>,]L\L=JG-N9Y0?;,!L
M$%R,?.0EYKC!7GL2YAA" LBCQ-PH= U7[BT1G@EI\9N)ME=TQ8J8>D/B504*
MCEJ-[HC,MY;Z1+?,6."U&$;(/C#Y?E:*3M$7MB%8>T.&)YGZ,E"QOA1]Q/CD
MNOVGVA_91GH"KL ?4D09WOC9"1\9Z'6R6V=P]VGA^H*Z[["TF.%W)4(5EBKZ
MVBV/VC$]<W_F\A_TX)TBUY4ESAJVCZH'*O[:7D<*'()Z]5"$ JPLA%".%D$1
MQ<F*"8>@I\9<@.O-QC8 2_EZ@-<W,B0.%_KY3",4"6OU09A1TEARU"/]#H/@
M!/:'V,20DDD[2D)MY[FO8(;Z(<@',M=%A&R6D1U[44>8/(#+4A_F"-FLV<5I
MOBFVS)["2V^L^-I(P@H$"'\*>[LA*S?;&J944;WATKJP6!%UT;SD5[;<K4VD
M$$(4\"4K?UR4!-S):;T>$D ,>:<7'YN?1VS@ &Z:3;:XB_;AIY+\A69MVY]:
MA:I6;/M^^/ G6%U#UNK3SYB7DE[KH^P61TNW3KPQEV@ZJ4ON^!K:]?:K.*(N
MC]3S65U46S@W/7JASE#]7MT[^P65]8D8]/D5@YSG[\R_]!BL[OU9U[]\KD-&
M7Z93UB#V[%\0Q]'4#?:<.<75DW9F;"?.E#[^SP32X_@>F'"PQX])"YAP?(OC
M7.?4_G0J\]Z%X3?9+[34+1SQ)K@$.0-IT"HM>_97A+?"K><WCIT-WSB[O%OU
MV%;TUK^P[MRS?OO1]QT<'[B<'BCURA4^YC?2= IF +PD0PA#@\7G+G$LB_6%
M)(%%M2^:)H>'I'B<(*]DMKQ%#)S[+0,9D(RL]A=NRN$>$L(:Z09.O7VC*/9%
M!AQ11OM66[*FM5O6?P@BFZ(!!<>T")4>7S>6@$4@OVBNBP7O_K"J OB6KJ0L
M-%E:69]8MFY.*HD3E^>FR]T^!!U']8JA"'E+_'RO$8(T/KH0>7+]C>B!NY[Y
M=%F^MTF"K?Y>BF*JZH/QR^.#A&>K'Y^A[,^>O\3Q\ZSUN91W:<677-#=Z'=1
M5V^57:MU.S=19<\/_RKX"E9[KQ 5^F]FB6RY!"B[-C4SAY>X7KR5"YYLM3__
MZ*?,37;:,XO-@%HLV9(?4*)O-*&^TXCLV;GYT(E6S5JM86_F).[LZNTG]IJ<
M<MFPLK\1;V]5*^1462LV_<PH*&U+DAQY6+[=].-H[(Q0' K5##FO 2&D8\E6
M@71& U4!4+[HE<];MN[I>LGT7,!(N6R"Q3DHNX"U)Y;.:@$FEY92%+(/<M32
M9^$0).=^"['8'<BVN[8%JS$4F]R#+)M/RV!O,K4-M$O^5F-I#R$_@Z1%^4Z,
M]WF6=IDG:&-^">]&8PF)K-"BV"&;,F3I:O;S06*.H/A9A4"V.(-7?W?L('0!
M+)-+XG0"ZKL*@>W,9GBL[]I7'0Q*>J4'V1*Q8?T=O0"C_40E:'B:='5JUW?2
M+L)V5=9?N&/JKBSTY$&85^FYN4Q.VT,0>V+>E4\T-N18;4TZ_V;0/3X#MG97
MJ:3&X4N< Y=1A/@E,O3W3^9'</.<<4WIAA26H!"( %\QG-THZ6>N'X*6Y.EG
M_GO6\.USX3-3A!YY\.ZQIWU#1-P-C^>OL0I9PRC@P1!=<$/_$)2$HK.-8;+K
MT,$'V^?,6+7#A^H%.VZS?(.2*L.#?-DV#D'"F!+&Y899Z[2U S2E[.X!R@#Q
MC&EQ""*HT%,/VF165^T"VYN3_H&S<4Q.4];BGX#_W$$U4R\=SZX##\N$<:R:
M\S]ZP'(MB.J5,V%'LEQS<<C)<-SVS)X\A__D(+'.(@/L@@/(]DW;[8:?9_!E
M[>NHP8+F*OJS0]!'QW_">]<U&&PW6$.,9?*[60XL5[*L3\HZ\S4J"UY484 "
M%5&U)ND1'QBFFU4;3?$[4"\**O?/5[HU(_@K=<RFN;TMH])?T3OK<PXTK\1<
MC;7R)#39,O V=PB-$\&9 ;V^BN]@HP1Y)[--26=.'_3,%#7&0HIE1XK&)Y.8
M;.!=X5ZB+.!FV);ZU[]+?80R/TRO966.I0YZST!6!Y@L@O0Q/ ,&2:+;/#J(
MF:IAI8"UAW'VE;I,'(0MD0]*M]R[.:R_4RO)L/E?VV+'<L^JM#S)<]0*:UC,
ME7.'(!9'/=[61RQ@?*PZ! VC"^29G,TL/[4>T$U#LI'7I-D4+?P0]*(=9O,7
M#)Q>H0NU%G@RDHRYCBE#=CFF$_GKS1N?0=U^8^W:&JK^5. O<?RZJ7J)"W'+
M_]J\QRL9S%^=IWUU[Z?$*B0##T%!$(,6?D!AC"X<CQ-,#N>?8R,>+Q U=YBU
MG!)[,/S/#5.YN?I(4]_;\YD)>^I?A@J3BT(3784S/S&*C66^!PWB0KP>56H:
MKR47[=[U-BJ#-CY[?"ON"/CNEMT\JXULWGB2-P).%E1<U/BV6'CKYJV<\J*N
M6XS1EMJB7VW5_JN(:8[-&)HF_@@5%8\YF19 ?%"8=N?(T"(V.$^?D<L2Z0Y2
M*.)-.*SRN! ];$_L]<I27:S,3%$K-(0E0S+X^4UJ#$X6;J[U-G2455[LOJ6=
MJ=3MZ#?S%GM6?N4(30DYQCU)A"1"B6_1*X\";C.>8WT'AN@N#;P@ WIGDNT@
M%9->5A<V=B0QZ*+G6RA6[8SY-JU+,2JX%MNPG/_]L_TAZ,,>ZI_\2C@C#^M;
M?K^A;XR/9V_%SBB&#7&9?NP:RKMA;H>#J1:59*,_J,,7^Z%'8JPBENU_%F=0
MG\_/S[YS)2VH1L^&=VOQ<XK7A3" XI0R;_;%I;QN?_@?@3F*;O[-3W=!\X4S
MMU]#J,P<C3DO@M" 42C]PK=3<21#>+"<I8Y.IE^=HO#'+'$L/M)"T_4(>KO+
M -'ZUYCC-3V!G6WV7S;];<W3"CTI^\K:P@E!]Y YH4;Q9+K.!K0^3PFKA%A=
M:BK8W/[80#^7Q?/L8[K@6X&'%^*,%X:-\\!TS9#-;4<OA +YS?4[\<=6;$PD
M: Z/A!<QF?^[[8IGFN"2MH]N+3$ZA,TR!^L:X7EK'N\.0?-CA5F;&33=]_),
M$8ZG7TW$=T-B*(<@R/,=X%[6W'3=Q!>F$.!9)[KN.M#N/>4BOEV9R!VMG*G;
M,R^=*.5W^]JQW<^>RW/R6NCRR+=;K#%29;<G:15P:Y;1(6@ED58PD-I_;3[,
MX>W6_B>T5OMF&$VKG9><U+?)]Y!K^KS).C_]^B-9TCOLIB--U:(736A_^B*.
M<XQ:K\EG#J7F<^ZQ"SP2,(LU,[/O&T_,S-.+C7@**_ Q[7?,WWN'=<E%T4)W
MNY#]L*:TMM_ *0()]6.*\@_EMRS[?4!WA2K'>*ZA=G^S'LD)OQ)HQ1D2M"47
MLA6B?B9"J@73<YW70H)]WZ))^&SD9:,/J5>O@=^]K?-,>CW9(VD+^[?/M_BX
M463"W^%=[L*YW-E#D)*Q2<AW*:K^F5O,L<6CYXX0ZUI%.3(SBB]ORR3?C]/D
M[-5QQM[1^#X^.,,H,9;)9DXG$, I8J^7IU8N'<Q^9_AWB4W^FZZ]=*Q5THI)
MQ-%3(@)ZUJT/OMKN&6N& ,ICFVY+,=1(X/[BDM<47TPX\UOO<KJ R;;*?U]R
M;.J%=GUE%&*DAZ5S1F8Z2R9+.NRJ$WJW+\1='%39YDUA3-,3I/X7T#ENKAV"
MQCZ@6/,['C]];:3B:LE&">PW0II%)*YG?9=UD/7=[")_:H*Z7KH1]5?RM8A+
M"*"(I@OCPUYBO<$).6CJ9H3YV!0+S6,$3'9@L4'_N^^K/AUK.8W=FF9>_3/V
MK^(0] 3R!W()QN3Z#Q)6<@T/0?>RGOY\]H"$N^UXQ5P/>GK]'>7B>L[5X=6/
MFIKOV:'U_XUT%.%5B<)4*Z^O.R,;*;1>6%(=%A&-BHI@J<!]/;U \0_9WP)J
M!/A.I;-;S%RD,K>$U=#?U@TF?Z7BSR*>A;$>N]_\1Y$UWS-8H5C]>Q&-;73L
M]?W4RV$Q#9++?G9Y^K'</OOM: @A#46^]L_"'W(7''?=9/AK[KN] ]X[1R^9
MB+, %EGR/P&5$SFZ[S+NHE?M:QP@O):#-/Q#6"Y$'<WD9$7'7A66STAD<@@?
M@N[$W@JG2GXXN00\3*(+%3'3 PE13*Y6&--U=OW2R9[B2SVOU)@BS,L;MX.W
MZ\QGQDH<82G__);(5QL 1>YG7VC<=%X% ?/P6$<)&4U(VWG<E( )BVHVV)(Y
MZ$)=3*X!<I>=9'L<Y"YZ;M)JZOD1F>D=G"T_D$#R/I5C4="?W]G]8"2=36'\
M]+5T-OE$4!;V3'FUO6.K00 -+^BX]RVXQZ=VXW9@<[429N,5M8 (X_<KO-T6
M7^K7Z9/T!G]5;2L\0VA"1MZZK8TM9.YUTV0.?E$E%GTJ[N*,$/J4=;=#G_.\
M^?O2?MV/NGVU7TD7GB'=-W^D\^C9?4]M-K-/]VJYVR,$R\Z9H$[0YAO>]DKR
MW)&.?V9U ?)2>7<-CS83<0R)"FU;W"::G;PA5YIZ!O3_CYW5+ED[SV+KQ3ES
M3D=3S[S^O\5..+;S!X*R(W-D3-2O*.DKQQ#CSK(5X"/37X7"BAQAY!L061A\
MG[04QY1$#L!:? <8>H25_@Q;HF,R(H@H R-T2_*](67PVTQ&&*[^W4 )T,W(
MBV^OCV^(/C@5>$74/+T.8\GJI6OU-[15XQ\PUZZ8UH0EFN.>$7:K @5"=]M-
M68*-C9I+0??!4K#MMHE_^>=LJ<^!N8H?S'F8R%Y@E@3]]*31T0/%^!_PF\17
M@>6?Q#*,4$37E>D@%]U7UT^=USKVPZM=2.5Q[#^:$?([!@PP2#O2=.T.LD8_
M.!XK;BPF<P(EBU  :BI7.U$I?QEB_>1U7US)A8D]?KYUYNEO=&M"CW_+&J%U
M.CQMN+O81] K0OO"\ TX1SR$4 830BK!D2A)Q 7&$VP 6 80BO7J/[!)6)81
MNP4H\A746Q)A NLE)Z?4:VM;#T$IBS(SQU]%Q)Y>+=_R5?V:=B93^9Z@A@CM
M+$#ZL[RTU4Y97FY(-SI;AQ"@%."P\2A^%EF)U:(B*--/-RA>EN3;L_U8(> 7
M4QG X+]$V')#B6-B&U&\I72]D!- ?']^SOPJ\[1S>;-9A@KN$.2I@:\:.@3Q
MH7SXN>'GQJ@JC'=,9?]"Y51C+:CG<D/2 02G@N;>4 FE74:89$OA=NJ!V;Z"
ML: @U13%U<[VTV#%[B5=G5OI;'MC!-^!0Y 4W9F\^*866"+ ^L&/70:JDN^-
MJW7+4T[O]^$36]^ZF$I'L;FU?R![-)*LSSA9"[]W^MD-_<>I=?5S>31?(RT$
MH?_M$!2(9D<.Z[E$I00CG)=AG ,-AZ ^;W;=LP0L[P8^OYC4( RW)2YB4:<Y
M6H&D98WC@%X_\MS$7]'ONZLN 6ZF0I]")7+'D<+T.QC*T..]0U!RB0[@3M&@
M(B9;8HIMU )9<4L0R-2"=_-^A<?2._/?D/([R+/)K0SC1=SF S?#1;>E<L'R
MZU$)5Z _!Y+ZT)*(NXPDS 7DG(%L$0+E!TG!2BLPL!@!)S>3T,!JE[4E-HU-
M$J!,B+'2.D;'IQLK :>(-0U\RG-OHH.U=Y+UQE5T^K-'+X/KEUJ2AD;YY[H(
MC@/\F8NGO[4N"?H=@GBZ-1%6T40LKUF@1G*KWP\G%VBE?_7#C!!&E>+>G)5W
MT;Z:(4ZZW^R# _JC;6:)%*/4F!]A!,P1]"+)[?T[O'- E4GKU#.7=8/85J*
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M:V=9_ 6ACZE'J(Z;7RBN[L DF8/@.] @Y.*T]FAE )P(YJ='5*\]LOE3Z1R
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M*JHO7RAZ/NZ4;UN^0LX,U%2Q.41W"URD3N:/P_J/S6T,LM!"BXP>8AZ9O0-
M:-8(_ME)DD9?B&"@9#A&G4Q-(LF$X+*=@&7B4*;VPLF*_62D-( ?NCG%FO^C
M/5S9F[)]H[?&Z[RF-K-_[QZ" (__&& =]+HL[P3$<RG)A:,_I>[WY"&(Z!^(
M;?%-W MYXG)[BH.5!,Y-;35>YBEXXO1/_K=C!.Q[>,C-EE8[+Z76%52%WMJ'
M\=H'[VX[WU[)-B6.? H7=]=LSO<.K(PL),3Q[%\/_K441L-_4"WCV<&XC7AI
M"LK'+3H884R/5H3VVG/NO3;J!.=A6Y1[;?'%&$GD$#_1U5V>6@A\HAG38\C0
M@:44,8.E9&U(O LD<WF2?HRB;#Z]$UYL'LB]<'I\LI]Y=G+VFE7LZ:^[KH;P
M8^,QT4K0OS(JR[Y;?XP;*N8#T._!<>%!ZLMV+?'V,X[4;K)#F6ZV9VB8=!3^
ME8,=8&"8]DE5;=&UO#7.XG<Q2:"?TE63-:[Q'L_%7G-4X<G+?>B+?2W4R3C-
MFK/V;%4OP*//5+.WLDVY7-@?F&BFQVDJO;08>^!PV40FN5>FT<2HT=5,9:?4
M6)H\A..77(.U1_7#,K6^KVV05P8@S1Q]Z 2D3(^UPZ*:QW(_4X2E7/3Z%Q78
M<,?GOS*_MDSJ[/#J3ZO6!X53]<*NA^_K/XOM^7EU4/1[U:C*11]9+PD'X:,C
MGRVC%07!&C%:^C>,[R><UIVL*V[7O+?C^,]*2<("HC3H_H3Z;D38[^5M^QOK
M[XXMI(J%R 6I],H]V?R8^#\_O>+[[Z]&*5E;8>2R(;#0'G9.SX[L4Q3RU@5Q
MEE&+!"-N4K(+MPU]WI-A2=T:RY<,;V.?W)/[X>:*:0A1%1VYGONYL4^DO\OV
M&T0(<>0-_0X0L8Q-DCUE64[&]ML>!](^,N6<YD<P!AHI+5T]&C=TK5O+4BEJ
M.][Y$P[F7 ^R17FJVWJ$2%^Y\W -"D&+$M.4WPJX%0>>RSG:0>5;=TX(>/DZ
MA.M^X@D25QW!^>O?^2[/P5/UP&B/7;"77;"0XUZ; T2>*0DT4.G ,8*[!L&A
ME78>"*,6Y7XT<&]_R@0C@LEB@SL@^L7Q;C.B%+=5#/]1-\1-LECF(E@$;NIA
MR^_JXA1H[]<$3YUUZFC*"3I])D+J_>[$(2CQ+J,FW'9.B_JVLWFF6[Z&.7<(
M:C/&:"!":@'836ON/C!WR]A)_T)(WYPV[*A'H,-^-I!MS$;7L+[9[R+S&1];
M6;=L>W(-=:^K!^-/?('$,#)Y-+-/F2^>D%@YVW:EHHS3^\SI?T=KY3C+KJPF
MO]VNG6ULCY:]FSG1F-"N/2D@N5 )UZW.O9N\&.UT[JV]DQ!?/_X(.>0IA% $
M>U\?3\3R^0D@/QV"CFQG)6G+:.#L86YT7?*77\S7!\<SJORR?RRNB\V(B17F
M]>='3HIV3-6K5Y2L,1>,<CQ\?D;#GD"\-400$D 9[2X<0EB*[Y8O17Y!M3CV
M9LCWRPJ/:_O7T0W+X6+4I#1<B0)9+S5\'L*W?5,LR2B&V$N "/T(;#0?;TBI
M:_W+P*LD,BPSY^23KY0%O#T5F<\N5)O0[ANF.R,?)A06_^JQF<-$[4_TEM"@
M4I&RQID_XF^<Q3XI[J/*$@J#\I?6Y?TKX,N.V7./(:>,CP!=S!,:9 @!VGL(
MBL]%]GJP473+R,W$D'@,V&,C$MNZ\^3O:&PPC!,>.0JUM@Q/0Q__$E:1\7"+
M=S1I*MC^8W"_E5B!%+(2T/S3+SGTM"7(=*!0!)W8;5:]^NCV8 =Q>,]B;T'+
M?&KG#N3^!''VM877S&WOB.0%UWD<VQGS%).'4ATQ?AX7N-_X/39I+![)EE!]
MG+%TGJ/YGO29.U?JY>,&9[X+LKMJ20L*8\R]1-[W"Q;X^IP55PA2YN'B$1?B
MY/B],Y3U!"6#D*#,[%#K&<_ER>@4A"MIC&<5R<%XC>0$-MP[R?E)E"K<XLG4
MW<E>E__>%$=7F#Y$\S.UX)+;3&O9P7VGR;U#$.\Z7N0S=XB_?_7<Y0URP58$
M68NZP&B0W!B$\!^"?)Q0][#)DF(XK#1<:A!Y@<*_=8S(&S4 DT3R  W7.F"B
MR*]X]2SR_'6*35)H);S918TCL=MR><'49,I(XAULX-WJMU5KZ1?,>(7).D7?
MR(SVSLT?2L619K_*?3@_/E-U^"IOGC]SOFW2HM3_;O3#OPV>/ G.N[\0?6_Z
M.ME4&[]N_3I_(?]/:::9SQ6[@I_G))ZP3\24C\4A+R _AR'\&3E&@N2TWK:9
M0Q ;PI\P#TM$Z@*&QQAI\%$;0(\"(^Q1,TA@T-"[7N^H8)T=/K_.F7A?8IV/
MR<JZ2TG:VP!'E8M3RK1KT=9# SO 6605T8_.7<$<8+*1QP:>5 R5?:*@8< _
M8D\@P2%-WZ1JK40[Z?+$WU:@F-3U%RU)Q_#;\OM%ZOK55*Y[J&5>VF\]R&.@
M[]LMO[RZH13%]?%Y<;_HD?(?&_DG^FO8ND,X4%]N7BINSO=)%MJ-;OC0K#(L
M8N=A\?W%SPL)-\4CO#.>&QP+]I/)F7.B/Z7X;BJ3+#!'D</@QH2"[T;19,>K
M0,<;^#+U P65ZM/4)*L[8:0354V_TCDNA9LTC5#"AE!0I('MM(H-?-"K]RYS
M\/#1%071W:]9>_\I$B.(9Y>.:Q%JCH,:D[_IUC.$Y\?Q<Y4/1F_+E43_?.8_
MLJ/XN6U<9RISK@.F:YB?H[_BC!R-MVQN%^2\,2AW]A>[STUQ$]"Y='%-U9H@
MH1_GGJG?=G+C8L_AZ-(6M)5(-5N0BK"WF=P<?650LOJQC"?1GNOD$<#Y'7,$
MUE+P&'7O$\H7?!2NTK>HFT2 ;362:23TYMCK=8A "X2]/17BB^)".(X;:SG#
M'QUL[UMV-9(C&X@26<G=IX(JUG6_.EX9#U)JRCP[(8?L^H;11R[H8<Z2%Y)2
M#D&>K&T'K/IFD<KCX6,"  :"'^K%G"K"'8A,;Q5NE)RRY</#KRSN.,>>'AN;
MFC5K+ES<N:%;.LCEF1/QB,'!['\OZW,*-&+U^?+O:*O:.!+J'] )O>S54?3Y
M0[J8Q<];.6;^D.8[7Z.LBK\NYYR?4,[?+ ?=3I4^;E_!_SG!Z?AK_@SF480Z
M\(00@C>E3@+9)%X]ZR8R>G!'DBXZ@Y%UJV\,B4"A^..8W/# 7OQ/E];G#^37
MGJX;!$+O.5N&MNL_L#(<PG(9Q=8BYU'-LX,+NH.#J"04'Y*'^>W_X>L]HYKH
MOC#>6 $!0Q,$!$2:2A.E*(1$09J(451:@*A(C2$J D%"HK3047@%A1>BTE2:
M=&D)$(J\B'204$(212F1&0N,$L+EOV[Y<->Z]\/Y-FO6S)E]GOU[YLS>HRH*
M!I>;<#V"Y'.^=DH2.#,K\<OE]YXEY/^8M0$^_[?V-OYTPDT_UN_5&Y\Z4QL=
MX[7Z3+D>3M\UK^O*-EV=/E:J[GOV0X#\\2L%@:O?+Q5B30H^3FKJ_7AP=;#R
MWP^^NO4.QXK^B^YZ(+$#)N9\-<!Z]R>CK&#DI33,(UO7:>G?"UA9X@Z.86HM
M9:J Q^ANO3!P/IDSD$[>1AY@PULTPII^F:W]()9PUI+)QD%DG6&/KNL*85DN
M.:[)M5XW3GZAU$PO>N1UC29,7!)/(,_8^Z3NL=VS791#T]!0W%EU,*U3RG8W
M?-_VR=-I7F=L \]_N/BT[YRG1?,MW:Q'#ZHSA=5:;C=G9-[ Q(EMZK?W[CTQ
M8EG#5ER:I:N#=AV5RM/D&=I>(7)J\I,#T,>D5/^O6WQ<4W<QZP$5,R+PX5*2
M&)(M=B_CWK*53&FO IJT2\+OW#WDSG=Z6:9M>D=YHZ7M^%O-!V=V1I^!I<B(
M?E:S.J6"0^*/#W-MLLXZ[#>Z]3Y1_8:;V4>O"T A/@7)D9$]<$9#RUYDWJZ=
M\6G@"A2^'D(*WGAIZ%>7S2$W%_26"Z2 >TXJ[P&SSLID'6;O.GJ1VW'(8^(B
MJ-_SD*2"D,'4?Z5Y@*%I3U9U,:7O=>9_8R<K>;M+ 5WAGI@Y>V,5"6+Z:B78
MTXV6)^UK: 2=4N0]&%02#E!H0\(&OX?V7VF/@,=_>0=>37N>J5T4&+I!V]FQ
MH*^5)#I(+I,\-.0C_>KQZ12=I]4.JS&UI6(>7\-9JKS[B9)][R<DU2.4G'_8
M]^\?NB67>4!7.O#LYW:)L*XBKRG/NI8[IM9&CTAM>I_^O>'K#A.91SU$&FSI
MA+5 ;:Y2#+(UA'168DP2$$<X*$GB#8MFU)1&VS%,4 R3Y5N1;3Q>/T+<%U?"
MNE;GE7B,^/B3\5"M[Q@-W%K;77#61 ^MVAA5:]:A)@KYS)4\4 <;N@AIFS")
M%<3U8N@[\RHTRMK7\  I1[0*'.Y0,>O.D4PM223AN)&]WV_%>$1E,PD2;]FB
M'JC1Z]OY[7K[M[\8F\&*-)^\]C$D.CRK5_&4YIA/,:LV]<AYBZ\?;FZ,.&0J
M6K#TXY)%"U*J+%+LWW[];]OA'5OV3([2;K:E$/IVIR=JA]8/DV3>.F$OM(ST
MSU(!-C,KI^O5Z*WYFJRO=HT-U?&13A=,_NGS-:E]U*?"92*":XZ^^S/0IKIG
M$Q:=2-+<R"/#B(3VKQRS).%!X8"KMP%TG<NF(BU!,2J3L<4Q*WN#Q#F,&+HA
ML GKRE.V&JU#Q3&D!V)NW7.ON*4SLL)Y-V%05_7:;7$HL/XM:JF\O];LMF7+
M OV(7*G!O&>*SYLGJ$K+Q:?#M\;F'TMU3^Q\)J@/R+IQ24I1(Z4LV$<Z1LQ7
M6R3P)O5FYOF/V_[L ,.9J'H=?CN'+SYGF$+Q6R),4N8J2KF$;4L,14$@#YZ4
MOP?<A*685,(%*+ G7A"B$(U4@,+;CH1>:YIG5!*]ARTV8=)0L9=JG_VPRN>1
M6HO(A4IY+'&C2"@EN%,#]0 -JV\W<NYMPD2A9FY)M$"#FQY'DR$K0!-N2/FM
MS$B+01YI>0O:=!6G<__@_55E0/]X!.YE8(/JOM%@3@;K1T>4S>_]*V5/^!6;
M,"M4-1\V]46[#>:V^BK)Y.H>F?UMD]MO'RC45?K#H/?D_ARFYQ'4[WYS>"3Y
MV?%8G]YKA#/LP#:3VJH"C_.PK)$ C'_B\=IM?PQ!C8Y-6-T OY.N")T"4:O$
MVHTLE'\!#RL&,7E1F[!$LAYTF:O624C\:_<@-!(M.RDP!$S3@?F>J\ :M79
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M\ZT'DULI33)4,J3>.T*[.DA;O^PQ/@<J3V_!>[>$_MW7>G=/?YPP7=N68K?
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MX]FD^[.;U__LHY0OEH-5F[#@NHQ5[+8%K&(YP]<B\DK3N/H0?'E OIXFWN+
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M 'IU;30*8*0=AFWL-#5IP=4[O,ITFA196?+R&0@+*G FF"M[!+K 6J+Q@%A
M-D6VQ4+^":]2 <KV "^\*%U2U674)CN.W&NUL 8^#=;V.<@X)B\YICKZ#J^O
M4>G[^SBTR8\]<UW=-3?66"+M8Q &E4S_,,1J::+$8#J&%JM94_LKYVH=+GI]
M?-PGNY_O*WZHYH3:"_GN,;$C\AUW/0LSU)_TBO0_+8TQ;G]P'=$\+_E31,*A
M2/Y10<N0[:[V5-D/!G.,?PP0E49I&Y^5GR6&.R@F?[^V_/H!_"-_Q^I]:!,&
MC'1N82#" <CMIHGX-0'9RW7 R&HD:)L+GF#234:QSJ-"13;[8_ZA80.$;D7
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M=?-?Y5/!6B->?*T^M/36E&F C#EL#"D<?-G'P\8(S9=F#P-.LT]"@)\=LSO
ME?A0A@0DLPGK 8D-5IEM\^/B;!&,Z;,W@:I&PZ%1IMQ-V+GF"6/E*;2445-^
M-_;81EX=.WT3MH^L"L&YE$0&7D67:3:K/6JP8C( "V2(TT7TRY]5@9;\?^BB
MU"N,*Q.H6NV1%^G_-<L/L9^YJQ03CIZT%_FD)H'<WS^G;\AS23>M40&@_XEK
M>"?. 8^GC]TI<B-R+9$=(Q>R/J(.SU@V?.(].GPO_UJ<Q.1=9@]=5&"R4;FE
MN8Z<;*;R@+RPGU4239+T+8+\%EX E9W?2#ZOB:XV[K<J-*A7LKMJOM7G_%J]
M;#7NW!=PRZ?1QC^>B/B6FP444NK4NK:(F3*!4%NW72!OJX7N@"7=:A("K3E,
M>C12#%2+G64SD0< &V%&OL:8Y!"X\6-1X7[=KYSD3SA@6I3P%:/=D*$LO9-^
M8*.0?A!J. _)!H86NQ/MNINH?&PY>0"KBCB!"U1M+@@,1^X&1#KY&&P=P._G
MB<53N4YH:^!C*P<M=[XZZ#@4M D[G_9WVQW+WPNPH1&Z&'F,+#J*- AD2Y*/
M"J2 E>BM1'P57.E<)\AL'2HI\.4:)JI*-H*_Q_)?'!F^T03N(*K^7;)+&_M<
MFXD9#+5$?#PD'*S)GT; ?\/;*;%*"NWIL&_"[<"7\9K077G?:RIP]^OK0G:M
M)9 <N6RY(#-63R+B,C?*VT$+?_G*>*B75>34C<[6=SC=B+4S@=O/?&7+D0]!
MF1T4>90?9<_"WR=/ZM-!Y1Z4C#%</M6JBR#9B92#]'DT%?&G%=%_6,$SEYFK
M9@$LS[]D=DUR: C>LE.&"'\02F-E;JW;6-K^%@TPD>&_LI.8AG<5RF5'X^G[
M($RW!S6!I%X\@W-X3F1SE\GJ(R;*A:W@IQ&VAY<N9V,U/BM?N7'08QB#=_[Q
M@]-FB66B:OK'$]>]B#]7LU4/-;0."K  VP&830;^#D\.\^S IL6F^\21KF$O
M+Z,TQP$IR)])WCE8(:V9MO\YT/-7PK22\KH_JDUP<B.MDK0+*%E]"U'P/+=0
M739+XRKT1/4AUZ)U;X">0&R.)AW HE(%DG-_]'A-[M^76PZ:1%GA(L?=W=KU
MF9Z]B&N[F- 3<(3'>%A)U@BX_WLB1N\W383<O@F319[T;(BOU9WQ[Z!R!V+K
M6JU&SH_6ZO(]'"I\@5\NC\O? ZNO,NI^+_>73,\B+IVM<W78**(?\A+V,%1:
MO,IZBB'L:OX&32@!17_M:2(./@V(Z5Y%B>=VY\N #7&_,'VYY>A+4 @O-Z+L
M]PJ<U7O7^_ A$!ZW,A,ZHQ18WH:D0E2 Z@Q2.C9A,5CXH8E[GPSH2M#2*A'L
M[WZ^^A-AOBB0!GMB$5=?+<@?2\-_-WDOT D/Q&L-!G"SOBBVG3T8BM2%"%%<
MM=1-F CR2)[+\/@ QR4;Q-C3G)KCW0T,TSM-AFK[Q&Z\<Y;7:L!*7&C+T#C;
MZ'PI^E#Z3E"A$Y6R)11(W3X .[<)2ZE=B0]3W0F$/R"Y@]G<J2U1!M,3^74K
M"4WDTC=;X.(-!XI?X\,YM>/??ZU+HK&@2_F;R44/T[SGBSD285+M47?4,Z>$
M"H%J*H@3=RH74++T@X%JLO<:<_[[V28\B-U5$D.*^FR\5N )?$W]I;]7G+;3
M:S+0=OUL_1#)[F5/4>_1@="04JT/MYO?[F+O%Y@V3M!-! >@ZIPG17$-'3,*
MW(]Q42^F/?JT2\H,TWA#9<93[PT.M26Q/A'](L:F7QO-ZI7=9'69T,TA\R4N
MN[TRB2U6ML*_5[J2R)!L(<PE1WG/]6E5/#%,)AF]"9#R'CA ?,RMR;SD_L5M
M*K)'=E??(]Q'Q#;P1%?_NI4@$#+C14XI?[O58C)'2T;M]A\I<U%>WX3%JQY\
MBY4DII_+N/T8LS@,V7'WYMZO:64.O.HM)C*9\US>K4?=-!16.$B1#T4K#51\
M8^4GX@":QT:=X,@6S[BTMU@<:&ABQ F,GB\UN781I*9P&B=$?Z/5F*6!'N3G
M#<UZ+P&]$#?+,H\XJ GV%\M5Z&@>4%I P6K?A_:I&&#C4'+_*UV_U'S(IF$<
M+U I(L9<H __ L7%<[5';^9O?Y&$T7E*OV?CN/*-?()TN!'*#@'N+_:YU@VR
M.;3NK2 18-[5YW1AU_TFF&%TK:'Y(4Z^IMB^\4*$8X!ZONTVI3%'(QE[=*_:
MWJ*-<J'>-YH470MR78T&YE-#"DDWH5Z._@Y.90)=DFAV"9"N @Q36ZPY,^*V
MXPB; B<"[]NA45?TR'*H?K"ER]_%\>G^^P??-<+Z,[EPEAT7VQ5I.!G6TX&5
M\MG(#TU/I)^".',KR;@[G$V8*.ET-E/5%-)ZL<5R$V15MVGHA5Z+B7\0W6"8
MH%D[5O+31/+"L"XFX+O,8D _[+Y9''D?>8PF02 ?9 E,0<KREZBM$)8C708'
MNO3W(?!S*TFRN-4PE%2+8RC7L=DB=T.Y:]7<OFE8H_61#=&XK]@N-,+']TIB
MZR:,5\DLQW#7VK )6+%K3</W]#%<U$,3@MBL]QFY\L)/V*4<S_I,!_P>FNGJ
M?_.K7_X]]7/[V<Z@XH"=56KY)&M0A MOJXQO6DFJH!^?(H_E&XTC+L^AMPN.
M# _$"56(-V;A:B3;<>,5<:*%W7@E4O4,SB>0,W/Y4BYZPL3K3+GKU>H1O2]1
M2.[LJ9PC=X7JGL(Q-1A",@2L](#Z2@0A:%B[0J+04*!)B,]7!/SB=*)YJ002
M7J=]12H@S(5\9.AW^M[ VS-+JHIU()G!S47)+"CYCL4WI;_V9H9+:6?.:$<Y
MK#L(#C=!7P$++JH#HW)C@KFF>FK(U;9FO((3<6LYD79A3.;;V=*C]D.])?OB
M\D^=5Q17O A#6G"W[(:B,3H)J0TUK%M"E9R9HDU8)T,<LG:$$CF&2?3](+*&
MX^6\U.&R)@6Y=L_*M +S=2^6Q,C&3G?1DMX+^I3=&<(KKMFF_:_L5#YXYX)?
MN=W-P"9L-0Q*!ZEM'C>]3<<0AL 69?:0E89E]*TP7E;;Q!>;7 JB",6VK">S
MCXL#C_=4XL)8,A656FE/+.G_G)\PLIU5![2QR;.&,:?!C[GK6!)JXZ50%<<R
M*#%,"-8GJY!.NM5&!7]O\PK,$)A,"*0K E<*6%"DLV.D2DB'*FI0</E-$"YH
MJ/<U\>ZJ0TGL_SZMI=IN/!.@"7.2<"=0I%-9DL(-KEP_3S+8*!8>AIJ\#B]X
MJX#R-1ST%M0X-PZVZ'#BW^$='8!NVG/(HN-_.T5'+#=^?V^4+R*H-G-/57Y^
M1X\<#T)5U:>$HJ=.> PA?"CX.^M7!$A0)-I8UYV?]VL3%CN!U *$Y<5$%G[O
M28F0:N)(MT=>2;))@,SIB?!ZHP@G)1L90_&20$:=_@I?N9RD0IA2N$)C_E7H
M0.TFN26[),]1VR-"^\]AY:#U3N\#2MLG4R68A.LXA9@S$?PYQX+5?YY]P3W2
MKOAI/X$*4&,I=ZI:3)!$0()0#M51N1.:ZJ+M%:@*#T"1'$-58B;7NWG.TO$*
M0$E&^%0.\/)T/=\.MQPI@28<QQ$FG$K) )<<_\0Z%2PS//M^6K,VK73!]CA_
M6P%\V16HY(ITLA.PTD@D$=VAMN]W*@4-H&);9"8\]@G"R)* (7-F[W"WTY[Q
MJZ,:CP;*B&Q/T#7Q2X9+UL_^5J/<1+UE/?WRV_<8GYK1@&I=>)' 9+P6OH.D
ME[P:"_FNVP:0M\58-=;&6(V1M#C)43I<@SB?US8AEAV,Y KC#9$N!;/,_C#?
M<4.2W3RFM;I7!L@_NO%<:.XAT-]R"^O]E ZAQ%9TJ&SI<<W7=O@^B-GA+5,]
M?J\<Q\0JM>#GK@PA=:#(-J1VE"VK"V$]5RF[*,U\L>1J=N(,+T_<J\$QU^NX
MN/W(2(L)US"-)DFW),+G5CH-D\W]NUN5>2(/Z.I0Y9FQSX .%:'(,]P9Q);\
MWG+R_"3@F67NFH!0KNSA/MQYOZS).[/,??:Y]G?0A(C_%3\5V?RP%$2O7J%R
M77M6)M=XWQ]RF7,S& XUE1^JEG!?JS4SB(7NADLL-(DD3+3??E>7(5K+O]QN
MOI)D$H'0X:KO"7+D2*(]AU>^^P\61AD)6\&)V)8MZ[8+*FA''AFAU O,>)8B
MEX&2!./Z/W'"Q HW=-&BO&/C/T=R/LZ[#3$U]%*JO^]]06V;W;_Q$JD11*L+
M>\%9*N6K4_P-92%:%WLG4G[Q]C<#NLZ[+=5H8"IA4Q"^D=I5)S:2HF0O/6O!
MS;6>0(<9*0I$RMP"'[$4/[LL? 6S>VCI-!FDQC<U<;JV3@<\EB8J<(\$QK]V
M*>E$(W1X RH">^A9@7[>1+J+(T7YTPR$[J#L;1'3?GV=LQ[1$L-UBG1Y"\I)
MSSH8NUR74A%9[ETW@V+FLCM0,L3+W4)30B(2">:_>.5);.8>,-?,B0!W/:FD
M_AJ@TD6&#]7D7[J?242WD>6V%N7MC!:78N%:5[AIE7+S4E]F9B%)=:,(J0BI
MS3'BA' !&KK^J@M8X8C$TA6AT@XU&02\5&TW5.(.%*<7+"CY=V(E%^DJ+55@
M:E:-07:Q5X!Y<7)4.3+QM8?G>]^:I,]3]M/4;K0<>9@F(=PO,!Y&V(#A'>;A
MJ23,NAU1F1/7TVVIP_E*)4\1@)^=KA-#=A3NP!YBVLI5P#(]>>3\\&?AQ+BQ
M@_&6MVXO\YZ:"F"=5PT==O@ETMZOW'/?K[PT75XXZ@BN6N02KSDI#;2S][08
ML ZT%QQ?NMSP\&#.//@YVB1)&?<^=KN-I)R#1LTQD00*4P/JNP1%\)1GL-RH
M(BI_!W<EE07G2[\4V %KL2L3[?D*4.H<'V4]1%*_?GVNE.^)(Q\"DHC*'?6J
MXF!K6GFY7054:=TZGJ_O,=+)JF5-!9JU$UC6/72M!B@;/,&UZ^B#[R.= BB=
M%H2'JO+0=<Z*+ 9"G86H/)3$(GD/$@7%<-7D%L/_TFLHSQ?^IKUXCB%BK)3(
M>;B-UW<HY*:L4M\2+.:NFH)07W!FC!*(HSSX&]ZSLE?8;^XO.,J7[?+>SQAM
MT0=^8L#*'JP2L08S/M<$?(W]#4^J8<0&_Z)MGPQ@6<Z^YO!%SHS5\3U0TNAK
M='U@I*AUC%:(YA'2R.+@P'(#P.[)/PJ@$D/9"2Q:-Q[.54BL5=OM%= 47%="
M-&Q3HB8(9%^[NP>MA=\-8.4L&BTH-.7]8YYR/[@\/-*R/B]B5]G%_0\0Z^<W
M8=&!PEX:4*(G5/82Z $?_H+  =4]+5!.T]F_A.2Z2NEVSN0]*I1Y8/QO 3*S
M8M%C62%?]^WHQ<S=KP9G2IL8_>5% L6--RT*O!!P1QM-FKX31]8%==H-8]EP
M04@4J-.&E69-N(-V'9\$=OO8B<;&0':RL6[4\1XWQ@1]B%(TXYZ;:YDQW?'H
MD]YMUQR20\SJ*X"63M^[=3%4OG\XKS())1?:;'EAW6J,#A,<JGN[E5BW'(WX
M+"L()4T_!.5@))$64X[*J7(SQ!-,>4S'#+&AZ[Y-ZI-FQ\+%"_?M3>!I:M)(
M+?+@VRGAQ%_#]O[_58)UZ])@D$]'!DD?LBBWN8XC $N<@82/5:5!LQ9U2(WF
MT=^B+;[A@4'5_4<11GJ&$5IOKYR&-U;^HJ@1LSFM'ZFEQ(P^)DVJ3E_VXDA/
M"D*Y0,\CC%KI[>Z$]R_[EJ.0G)Y@\[O^682QZ^#4DO1,^UW]8=UW7^*^V/ZQ
M(8L+ARE2H0/QIBAEH29)<XPD!C1S76.11[WZ@.8V^M&MV^N$)PC5@>,;!>T*
MWKI>(=Z,(<2^(.'!M*DNI![5IN&9R:?E[\:1ZM<+O=$X[Q7>BAQ$:Z=M$T3Q
M]$^XUXW][^U,#.MK@C%#WL&_6.7$I8E?%)'%IC*EKK&TQ[N*JMT]%TTO3D\'
MCCOJTS(DY'\>JO\+I9^%2L")]OL*RWQ0GK?Z:"N\2K&)LP:0!8<M15)[!Q&
MKQU_9[J?@3<#7%C%19Q4NW89[;KGQ)@V^9RB^;K(@B7YGP%_*VAX3;.)O^>,
M?W1O6YU($"HXE0GN0G9@H$G"P1@.-5JH1?1>8F;+9[*GO;T$#JJ2.*\+PY>:
M\5_R2F(K\?:VETX$36A?C3 HB3BYHDB\O)HW@@B,J!3(0X^!ZK4.A?M^F<4H
MYDJ2ZMZ).@N*:)"YYU,Z VA(:8%3.#/.?TR4U96P$,%]/4#!Z!#+"V-AW],M
MN_H&+.D@B M< '2W"I(B3Q[<A$G6823%.14QG!G3B;/9J\^JH+S7)M3V_I#V
MK*H6T[!P\_P&J:THC:L5\^5(6G?0M28(<^FG1^_]1E<)9=P%UG4 )>X661]*
MM@=IG2?O*1]NP7 )D@'\(LAYO7,\!,YO1%A><YZ-0MD^7CE8-_0![(H(5TG]
MPF<-!">Y[>@P1D\V7QE"^;(3V37C13QE/+J;O1]A!!9/=6&E:+:9%X8-2.%@
M%DIF4>E[C4\!9OIY/;":^P9ZN4J\9^&PW-7Z)BKWG.FIQ&MC4 \0TH.5HJL(
M5( UYI8O(/I;@0T=6%6!(918,D,<L 9WO^#P72@[ H^S<O7]'0'AZX+%^F.+
M9K<\#C85."@=*/#ON_GW<V .,:Z\*Z]IJJFZ=WMGZ<Y2G;_M>@=%O_S<=@AK
MY/:^Z,F:KI1?)"9"XX=OHF_L]P_'LS)D%&/P ?_6WGIUVJC@B-O;G6=@,!C)
MC$N+9]=2N]+C:(K(_0(/$-[6IV+!%7E@0I.$_-VV((RF%FCV5[ZHM*PC'#1I
M2&JQJS"JCHS(XS6,I)RXL"^%^'@LUVD3YH<_9,A"G]UXR> <_'?ZVR9L#P\X
M/RM:EX0A[,5"@+M#L0?IBH]X9WI4"<FD::)%9]^[RT;#%1\NX5MCT#F&-;8T
MOSW''IY)LR]R%M]^,WH'7IS1O\Z4T[E%]N.GR-MTODJK, WK\K&6.B*%U3=#
MCATV+8B;23>QV^XL49!.>WA:57G=A&1$A\P %*>!*6EW)<:3 ?BE;^117K.L
M\"]S?F"2U_],O5>_>DG^K\7=-TEF\23"GU+V4>-$#=CA@]OY?<V^A?CEGA"5
M#Y@7MY[L?/.H,"GC_W-S]O\9N*CQ@1V!GZM.G[1TN\M8V>OZZO/E5\_AT:C@
MRCUN4,P6@,-H7I![F> Z8$=%!:R(+LV: [8/Y^2@]#MW."-SE(3[H=WE9G&8
MCPJK37Y598'9P_IIS^Y$:AA^*K]Q)T*_=>#C)DP*803T=*-JTOGJ<^S)DM6+
M(*T#K;A$WP>D3'BX;= *H"-OB-/P_0OX7<54@QJ?(NMR_1;Y^X^;'),=B\1.
MG.@Y>G3*;"FO/[7N/_OJLW&?T_N.[_OS7]I5+_JOQ,<_;;\\'JT-+DM;G&1\
M:HQ:"=$5_+?4.!-KX1S0,WDU;<KI->+-RU$K.3F-W8>38&2,<(:]@WYHQB.(
M+4?>#H6V7"\E.5+;V)+"4T29+@\+FA+D>!Y*?K&8+P(]D4Q=R_\[D$3>,[U!
M[[G\D(,K1W/\$TV6=,/"1VKM;]WG*W/2^6*\]'2&,E*/&,(U?080[")7]@KD
M %0<*1 XQ^PQI]=LJ2LG4LS$<%_ VE]JNK%RI+Y"UZP16)+PO:0^OBO8H.P>
M&CXC]>/<DN'"3I:GL_S3OJ;;-[-.*5Z=U Z]>MS6K;[G</+>BSL^PVLV8:^T
M3TB87W3&#H3>?8YW=E;+$L,_6#?'/XB1Z[IY6?&G^\&,TS]84[5G_J_?<Y&/
MJ,5YZP#^#RC^C#BVBE""2.6M,=F3M-5X*+UP&@-=GBM?Z52&*Y-TMO(G/(')
M">_41W%FHJ$*=<*+I5G36D"3?RAH+4N7D_TNR734X&L&?U8/ND,I)3JN=E F
MUU;#P:_ME;%"XXTLDP%)2D=K)N<#=@\!J2^(J&MN&C6."N]@[#$HBKGJA#X/
M14GD*T\@;$)PG*D5N;*FT*)?-7DZYQ@CFS"<@LW9]N,&^ZK=;Z38:_R\^;0S
M(R)R6.K'?RZ[#NW<^U]5K 5N'IV,4C5)CQ,B ;NML-Q#4@?#NQ@'B%/MLYI@
MK$?80^X*E2Q;\W:8M.\.ISG*3\C%'B 6,.5#O%KG&V_UW^V38WY)#7Z>4-%V
M^__L\?ZA!0\^HQ\3'-A2M&8F6XR.^H;4WU(/=&(.,H5N"5GRT"(+Y@T)M#;7
MU9RPS!=+.46U3=X%K[UF/1&F4@NRL^C_H[8WCX?J?>.']:FL2?8MID*2K;*5
M9:9226)*(09320PQ%3(Q9LJ^JX0B)MFS3/9],#/XE&0G(\;,E%W.R78^C/'H
M^_S^?Y[GC^>/^Y]SYC7GW/=]7??[_;[/=5_7HT?Z5CYKJ7\J.<S*M8A-0\\;
M7*6!%=+WG Z8$$_%,T@YHJ -%+BY];(:QH?"Z:(J>N^5@S+9"'H='H'%YC+F
M&'&?'STENAN^Q0;O-OM6I)ES)H[Q&_%@7A"OSHXKV &QH^@8GCQ$WK&@R>%*
M &F;UKIA%#\)(NA;@<@^T[V/#3@<Q6V^J)$)I6']9BN>A+9%NX)%C*__VZHN
M2W9%>5: /R'.'MKD;/,)X4S8:718-*D234?N\H3M@RO])?MLI,+.0-[/8WL
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MQK]_\B<2XXC2\".$7J)( .DY<S]!@.L/Z"82-''$OWN=8@?PUR"/8IQZ&TQ
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ML.L#OK>K1U;27AWX]G_C(EP>C&K=40$(*8H2WF8')>BZD0WM-<W@TEK65FK
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MUWZO(_*\8)O W.DRQ9M V<M@MA5:QMG3&,\[,J"?<,-\P."S#R?D?)?EL/J
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MEWP^ELQ]48H3L!,9_"4<+V$7>6[VWW]51F(C;[F]_*?!U^[PLQ^TO3;GOKS
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M7KJ&:N2#\1N38G28@).3!5 S;;.)C$1XM$AR3_2OFI2>1_G<@IAT5S4@OS*
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ML.X9\*INZX#*UTN:Z@9R.$<Q[178_X%I1,'H?>#/P/)FB7VCQ?%G@'J7H&^
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M)26".?:FN1Q-VIO85M%6?J,=72,W48Z?['9N3K]7NSUY:>+5@,5L(FAL?$3
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M&DR_?55L&2R^12K&Z*>"H<]G@\Y[<1FLZ\MVE:M-:L+N-I.*O@*V;;K<':W
MG\/%J[N:.,5.XT*[3E+!:7;&(>K\G+(8[\H!V&C*,KL;!2F#,2T]*V?$V [#
M2Y0!7H.VIX%1F[5?G@%X9^7EO$_^<#F^LGD*T01M15MW=\K4KS62],X\I&S=
MS 8C=PSJ"<)5"\^ %S=WPE7JU>K/JCO72;%FG6[0/BU9H>\5(RJ :^H*S'F=
MU5<T>A0\.QH;FJN#=1]96A$>1_/*W5F#RBQ9OR[\9/X9D)J9/*!>$:EMX^5E
M .I5S63RF*WS5%4(I+L40!!,&/,EC9F[6K0&(V_L>(VKR)-M\:J"&@7(J$Y-
M7\R$T-!B3FV*]1;PN^O1#P&/.P$2?@9XY)\6WQ*JIG2T=BE25$"/W[BW'Z&V
MJU%GP$MGA[C!.2^&OK%5G--G<;@=?]<=].5"5;8^QD=[>PFQGZ3^:,%,AF[:
M_@T5+ZW=_9'%2VU[,2I94X^.NIZ";0,8K=;@I6O6DN! I$#E, -ZRR;?.BC%
M3KRLHXUC-3]FTZDAJ9XT/;$^JJHK!*J@=-2<D7_"B.JQ5+<D57*#2!Z7.VS3
M1(KDE]<O/ (+ FO/8]@ZQ;P<9NP=>QMKK3N!78UZOQI6O;B J0F5LP ZP)^2
M&)+1014E,F+J'Z=U$$6FODTT=VJ\;HHY8;8FK8VOL>0C,?7DX3-&#$[3$9H8
MY&3GF8L]FP _TU(X(W2_+G=Y8[15O%AAO(F[[H@BK!I=RH-J /->+J9&<B^,
MS471.R>ZRTJ!VE&[W4I>7U=O+8-OVC%[1G'F^S0[]L ^ 1E/I+Y(4!C_Z9"0
M.#W,>X<GRAVBE%_<&N>79-_+E5+Y)[5>19?U)-[;4E"4!*R:F2?YM2-=+2L]
MI91Y1=4C:7[T=+7D7N#BS]1@)^N%?]:WCK):'>M6M\7;)N& ?PMG((D9>N;[
M\20L>K<?E%&CE?G(F#2>6UZ_P21#/BM]><N'52A\CW*DXY;TX/=TF(=9WRL:
MEHEUD%2Q'AYOHRY^A%OH*<KVI8MGN[=9V'Z0V2Y\7;2"G<1X^1:?]!O_9;[R
M+I>1@#<]411L2+,C_<J./UTQ+:=@S4 /NU 3S]MKE,[:KT62[8(W][::@8 _
MES:7^"&J;S3\E7+(7LS[7H+8^J@859"U+WUY%\\E17/I4NE- 8-LFKL-B&_"
MHX!__NFN(NM6?/-B*%)4 WJUO1@JJNM@K[MQ=K^QLK_!V*RW[2C:_?1[[%(W
MMF9;/I6]V1@[B17"00F7NC :=*30\4H[6YF<T1.D6 0WU?+P^/\B-DUB&W]S
M?P>F7,LO1W4N[^5S*F8]XP >7WI=W>I"#2(B[.I7 T]68_4> V;NM[Q/*ZX?
MVQX%]\/J0BD540G&2W'O=<&)>G02S'ZXTQ60"\-?WJZVO*V:T8ZWIXJ[(;)J
M-EJ31,)_>.Y9RNG8\<N]EM]J:4IF48D<N):\2<E(G3$P>'1O^7O!_L8_Q48X
M^T@U9M4YNB$]2E&7U=SW<#X3/=)T!TCI]8=29'Y.37%Z/[:@*<,$7]:1@J<\
MC.O*L[4NX-S[/A*%>-KOXP4W+%D3B\UBD)I$L'RK44Z'UKRQ*0[-7?D7^N<8
M^?X@A3HJBXZK@1?-!H:SX998;H-?62NO&BFRH:C'4=>%B$NMIO-Y$'):J/X.
MRD<70M4:U'TY<ISQV;9\#V/*8FW*?E7L@HOY50Z[/C8O8.;C%KZK]H[-WX)7
MF<EEIRGY>4#/9)D'9B9'UA/[L-SO_9.9[V?S2RX'Y%556V?UQ,TZ>#F+VJ2=
M]\&HGH3? FL[*0LA(_IF:**ON\W89<DF0+L=/S$/E*%I.#7]. ':ZZ%]]FR>
MEF]=0*+N%5F$DSO^\HS\M0KD@E^U"*KL(NR+MR#.S'+TV5Z5^V <<CY!M;.\
ML$0 4ICJ>PR3U01IB"?5ZR5Z%]90M(BJN KRW@HO==WF#1:L&Y"@ ?VMUFK)
M,<3YVJ44-ZGD_>50&LAEA#$U/3:OUK-AU=JQY%P"U>X,3EDX!2G[95Y?,VO<
M6IN&A?+I#CO0NI4U(0EMXZ(^A/=5.>RSG?TN?*)\;<V6XAGPG4\AK(4S/$TF
MZ3 -!-'2X"*_)>&*I%NYP$"Y4R3G>]#;\MW\UBD ,P_<ROF^V,O8F#;WV=&4
M4I+[7B6DK; I<L__L&'R+.,[D!W-.Z??US$$0025J2CR8E4*V;%70J]O23\^
M)3( B=*-1M]=]6:]^T09;?\1>9=XP'=I7)SN:.:@0D,IQ1O(&J4XH'-..F\4
M" ,*I>U[><9V-538S%/+9$2T3;';<KB:^]JZ7OF-O*L:+HC&E7,?G+T+C$8E
M[H$[#]G(D'[=3@E:N^S.3.#&0KT[AQ\':*L/+ZD#J(-DU$M/D/A#URK7RV4D
MC>7H797O04G-NZ9T*%U*2U5IZ56\*:4*GVT//8\/-J6O=34(53)9-?:25*,<
M*/G<&_C^'M ,:L]Q@VKTA%1& (18$-&+;"'RXK1!"<Z1_1],Y)3ZN.AX&K<'
M#S>527)OS&*2G\:I\&8=16DPCWSW?^&H\E!)SA:/0JX^;%9)/-GT;&=V"LG;
MUK?H\FE\S5IL8RI+<4O)F&^<:5B=7Z8CKQ]3R&/3\FB<S9\NQWX/9M'^@T-_
MZ0!2"&^KYSY+D7VE8T27LVZC\JXT?D,"QK ))Q6XC7L*Y1,#;C<-*)SZWGY[
M2DW?6C:  ?MUYS>*(/'?-/EA<PXW@=_$&3KCCHY>,RF1<A^A;#<6KPP4YAN"
MW-JR&!&>+<"(G>6QM/<Q$-B/O[A#5V*^&CE,NRS!IB[->B'R(]:,)QWS2?WD
M9NUI5+K[QW92?*_&\5$,99S[?@6X!I?A& !-A>55"MBXPQCXWLR9,ZD2.[YG
M\!:\+&N:E:["_K78JY">I0/:N"W>77C4%6WUF[K9>\KJLC(*>]G+F[U&&'!'
MV >( AZEG\!%8RIZ3<%Q&D$]^O(9%N+OS$T9B;4#K[_CYS;N%=M6AUPZP\-9
MVFR$];OFJ%O(OZ7\%Y-U]W.I+),*?00BV$.7NR*'$?5R"#V'T>7 B?$&C*"*
MYW%.U@%T<PVQTK<JL(:R)>M-LG:@P^OQ#>QYG=.*^LV83L+9O_HK2T</'],W
M^@RG(>JS?AKVMX=5&:?*.D+/@"]=.%[Q"A<DR2;E_SP7=#LCR@[3#1O^V#R8
M71AHVZ2S5UFQUU<HC7I1:#37S'WXF#ZSK9/F1EM&3DD,W^LGQV5ZUS_)9\(0
MGG(D3)347O!9\=*@@.R*N;F%X4WY?5+#S!,3PT1>NK+FGD;)(%>ZUMZ!BCQ8
M<[VE:N$)MQK?^XWJ>U1D=.&+:WH?/$27BH*1>'J2JAYO^K5/5??MS7&7GGU
M[N<W:H#\X1&:+"]!^$- ??W0GC8-NOB=RCVNUX,R!NO.4^!GZ%!$PS/@C>U#
M06?L;Y@M:([OU%:K9>W#=2R'PNR9H_MK78@5^]\EG=4QMQT^3_,&LUC#+V^?
M 73G,&;9T^ =H]6ZVR98VZ/L,8<K2?A.K-NAQ"O>#SJ?^PTQ89+;K(L-,,]M
M5A'S3W*\8Z?<Q!?F<%9'M$4X??KZ<GM34-X0\.%U8$_O)I C /49T,/>*:YM
MY7FEX_4#XK9!",/+-]!K6S4HR.E_^JH([$<>W9,O%\#WLEGLYR8O3'KSN1E5
MCM+*\4H@KE^NM%<L,0''&?+T*?!R$E?X*8L+?6^4,]Z%L #TI-#W)8DL-69P
M4<TA"]2JN;>WM^]P!K7?5$R?!OYRWK=EX_/C)XS)LZF)KV_S5#RW!3$X\DY)
MM,1@)'ZU_L1R1GOE<8^0JM%^W1-3R]<3]C9K^GN2*1VR:VMNK)Y-'$AHJ&3W
M&<!R7ND61E_]I600#R439Y<H&Z^):3%4)T_QH]8>&>H=,)[\'+9X'!5=6PO2
M^URY+CX-W5AAE2W3-3((1&%<>?^&48M\2E6BX\51W7A6R.W<WR9>>5+[;,7)
MR-+&9&8+0OA<Y!)08YA?<:+X@YB"L\,2!$]A"ZE9Y4)?&D'G]9F73L(^QCA;
M'N=ZJ@7OV_C^S()A HBVG_,59*Q%98M&$FU?![,LVQE)F7(^"IJ>Q^\M5KCC
MZYCNL8[>3 H#G9S\7:?$.W**= ?+H^,#"Y6\7LJ;O-(ZYDO -EVNT)R$$O01
MLI3$,R3J>UWU-15#\7-^=K1;FT_>7DWJGM#<;IW?Y:SA>1VB4X:X,HM^EJ6(
MEB!(B^PP&PRLFM/R+["68>R/L+(SW66J1IR=N!W)588,?2+HC4MX+TB?^?O,
M-3,!7/0,*-><J$_L+J_M+U5V4IKQ'J'"N1B^W?)=U*I-7NSL$(9/6A4W5UJ#
MY,=^L>J(V-H.M!FU!93W^!+8Q>TAT3IP=&/0T95@7!Z(H;F<4FD1*;#*E9+%
M_Q <G-<X7"VZWVELEZYHB81$H@L3OHK!Z[^^@1]/DNS6"8E$VET[% 4?+XH"
MG?58K.DS/&M/++%ZU5+T/%1M"ZX]%@L01O0&<R28NUQE9\HRF!A406 ')Q 0
M4=J?0[D<L=Z[]6*!T;V.CV]*V''"<) YE5RZ[YBRO2'-0B>^\QXBR<!^WP#3
M0X0_"TULY42&3.;7U6B'TP[[A:<?OX IP/U!U\VX-4_R4ZUWM<&0C2UT<D$Q
M+Z9"P7\8X .-Z9!/V&;&B3&$RTQTKY!,,^.";BI$[!DO+T(=O7+)S._!=%0A
M(J[9>2'>9:G"#>]^L-F;6R2W:4YWV#ME'JDZ.%6T[>^Y3+O7@HK,E_9O,#Y]
MQ&&H!D\D< L-D6/$87S![6!I**\9;E8') 2H]4S-74S-!5 _ZFWB#>U%4M]Q
M CE[NKN[C^-^6\9L+5!!E_K(*97.9+8HL\%?.!Q20WN;;07KLR<,:%+9/MFH
M%5F_5^QE]]G<V--?N+'D<J'7L2 #.#F1:_L/B!+34SWX/-"P9J6:>4APC.6H
M',8=T%U79IGB\1;_3ASD%B&F:3X\C\/3M:Z]__7QL7EJ_8R;$T0.YXE+W5O(
M/WC/49L_T] (5G1<IILNT.14Z$@]]S^M HL?T-U^5>*_N@$?S!228,KH.*W?
M R.DXWY6;)X\7=:][F/P-?T-N#U$B%)T40<#:%$3CYM:F$J&*KY6-VJVS?X]
MU2[+/VE0:!E]S<\GTGOS0)/I<] $@6D45ZBSRVTWJW)-T1L'S]+3=.9$'J;W
MGZYH9;MPMWN>.$\%7D55.5:S),;F'Y"=N2YE7AR.P)D?RLZ> <@=[=DE,AOQ
M\'%P[9<HS+=JF;C-Y+>.ACZX]3VX9^!Q?R=TYR&9D5N$ON:5MQW_08P/#21Q
M=O%JT(;(@2N!NTA0-$"4*KL%Y7  7)<^K:<H?O[+IK:V\W;1'P'!JHBD#W_2
MFBF(6@L:<J2ZHVXY\3I>:&C/OW["@*F%63=$!*P%!KVPQ]U.'.C>?_.IQG"Z
M0U7S/O,^B-!KBFFVB?J^ %]<0V/>T](F>XF>*J%'*S/;>4CTID(2?T2UB/;J
M\F**#@/5[9J)6CCJ&$Z\Y4CPP@+]PD9A<"X3!D19A<$]OB2J7J7HSQ2QN;R
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M.0I?NW)Q3$V<V+EPY\0_$Y"XC,I @#O<'C9K4GS4^,.0?%Z4Q]G62JYM-F"
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M!UOZ*L95#P-[>U]$!!=Z#IGJKG$UW(4;8WM-/0*,BV2,S^[D)=*:Z9>?O71
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M'3W'4^PQ_DYA-LS$DKR?=?I6B8%)SNQ[8Z?D*7[,#CYQ@C.3P!R1\S'A22.
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M?PIU,%1A%-.>J3UDNJ7EYCCC95GRRDN5.R:O>RT6[:_#Y(R;:U,LJIEL\#:
M3CICH,'CWZ\5T\B&RBB))VCIU(ZDG@#IDXQ@<YQZUTFC:= D2S"(.90>6 XP
MQ3H<8^[]:MZK86PMB#C=SM 4D\DG' XQG')'3(S62A)))*-DDE>][=/M%QJ1
M@VTV]>K_ ,E^IQ-UJ)EA,48P-N&(RO\ ,#MV%<DZHL@<MN6,D.0&+ O\P^4
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M&47RWBXNS3T2NGH_-'V64Y1BZTU*%6$J4GS4YIOWH/6,M_M1L_F?GM>0F23
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MG#?$'%%64<%"OR\SO.2EKKO>UM;WN?D(]J\ACO)/E$J;C)]V$F*)2Y\WB/D
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MQ!X715<-&"S="-F" HYZ\8Y':O!/%7AY5)\H#"AE<$ ;>,>V[VQGTK[Q\3:
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M;3[NW>YL+:2%7A9KF1)91O\ ,X]3UOPIX;_:-UGXA_#7X>7_ (JNM"^%,O\
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MDG#;O*$OE^> $9<QJJ+M S@[5SQP3DUZYX5T;2M*ND:*%I)?E!=R#C  4^G
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MGF7OQ \9W)Y.;GQ%=2JV,CG-H6., <@=,=!FL,>)/&<]QO?Q7KL@R,G^T9I
M< */G=8BW09_=KC[O(&3^EX.'U7#.A*,9RJ17M9S<G+G:]]Q:DDES7M=,_GS
M/N <9CLRIXI9E3HI3<J=.+@K1<KQC4YHMN25E*S6M]%T^V=1LW\N3=!.#C./
M(ES]WTV'/'^<FO-=1LIGC94@G/)_Y8R CGT*C YZ]??FO#FU[Q$\&V37-6D)
M4@L]Y(6)!(&>>H' ]AQFN6O+SQ$^YAK6JC.?^7Y^P _O<9]\XX[ULI2C&,8-
MQ44HIQWLE97;O=]S;#<&XVA-N<XSLW[Z:2GK\:T6DMUTU/5]2T^Y!(-O+E3D
MCRWXR 1T'/'?^HKCM0LI_F;R)<$#GRGQPH'3;D], 'K^->8W%_KZDA]5OV Q
M\S7<C,> >2">!G ]L5G2ZAJ;J%.H7C'N?M4HS^>.V!^&?K3PT*DH59TH2FDG
MS.]Y.VLI>_JWN[65]DCZK+LNJ8-.$7%MZ2<G?7K:S77UV.WGM,Y+(P/<,I##
MIU7 (SQU&2#P"*P;NV)+(J,3QQM(Z@'\?IGZUR+W>I1.Q^VW)] 9"YSCNS'G
M/7'N!V-4WO;V60L;N<,<9&[T 4=R.0 >O>LY44Y2?LX*[>BYK+79>^>_&G!1
MBI4X.223=MVEJ]^YIW=G*K.3$PZ$\#^Z/3U_,'\:Q9H@JDMA?4,0#GW'!Y^F
M1P>AJ6::[:, W,Y;D'Y@>Y]^>.GOZ5A3))(S>9.Y8XSN))Z#'3(Z=.>/K1+
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M7%25U4JSFF[N5VT^Y_9N#HQP^&PU+VU9^QH4:;YI1O+DIPC>5J:NW;5Z>A]
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M:E6W7[N<L.OR^O3DCW_SBMU"-EIT75]CJ>*H)VE*?,M':UKK>WNO2_F<P;<
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M0.05!09P>B%1[XJJ]L67Y0#U_B49_49_F#T[U]1^)_!,-P&4P!)&P2RA>0%
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M];;FZVNF[7O;7YL_0\LQK;B[QU2[]O4^VM%\6K;1HQ=&50!NW<YR<C;][@Y
M. #C(X(KT"Q\722IDG (X'/3)QT![=NW<5\4Z7K;29D#,5++\NX@<  \'U(/
M;O7L.BZ\"RH9 GRJ &)X^4=P"O/7K7Q^*P25U:5TVNG2_E_7F?:87&/W=5LN
M_9>?]>1[_P#VNMR%$B$')P^<9Y]/TY_D:Z*PO6DM6B W;#D[F&0"2PY)&>#T
M!.!]17@5QXE%N1"K@NF. &8?, X^8 KGYAW//4Y''4^'=?FN#,-W+E<*<\@
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M;0\_J.^/RXK^>ZVAVQ+$J@-@ACD#@DGKWXXP.G:O[)\#J4JG!F(T=OKD]O\
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M9Z=>.N:?.L<T;#.2 <<'KV'./P_&H?FV[F_$]>F?<GH*KR3!=XW8!]B<\ ]
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MY'3O4N;N[6M?3T-*685%:-:"]VT6TI7;6C>K>KL8S69))QU_W/\ &J\UI@8
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M=;*,-"M*I0JU<+6=17@ZE&<J4W!Q45RN46U>^G5G--;;?X>/^ __ %S_ (U
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M/#7PG\(^$B5M-+MX;F-I6^T_:+BZN7,DKRY>XFRS$>9@;B0JJ%7A0*WM1C@
M9=Q)7  ;).,#;DC(. 1C!Z<=17MXET744Z,FW3=HQ;7*TM%S))-W25[->5CS
M5.HTFYR3:3:6R?5*Z;LNEV>>W#2OE-Y(QCZ'KW _EZ^U8VH1,MNN&.X!MW3I
MN.#U]*Z2ZC =_+&2,>@QE01UQGGCO7&ZQ<M$C(YP>,=^2,\XSR/?TZ]JTPS;
MDYNUY-MK[*;;=DNRZ:O0PEN[ZN[U[ZG/32.)&RV>G))YP!SUZ50DGC#$NN3W
M.1SP/4$\#OFJ=W>!4/S8?G((/4].>G0COD<BL&2^.S<S8SG/7L< _P!/<>AS
M7J<DWJK6Z:=/O.65:2DTE'1M;/H_4U[N\4 A"5!Z#G/;/8#DY_PK%DN"V5)Q
M],D>O;OSZ\5AWFH,S$(V<8[$8R!Z@>_&*C6\!4%G /<'=D<\=/:MU"=EMLNG
ME_B.=UYW>D=WT??U-OSHU #*3GOD#/)]03QTYJ02QX_N^V"<?B!CGK7-RW9)
M&UL@'WP/<9]/\FI8;K?)@GTZ]3P/IQD8(Y_K4NC)N_?T_P RE65E?>VN^_W'
M11W)#J%8[1SW]>>V>_I[^U=/92/.P9/FR/4#IP0-V,8/],9[\7 ZO)M4Y88X
MY[X(Y/'2MZVFDM2<@+QD'(/7G^$G YZ\?I6%2"DW&5]--/+3S['12JN>EE;I
M:][*]NOD>E:4C?-)+,D2Q<JI(.>_.TL<9_3/M4)\5L/$6BVT1&TZUHJLR@X*
MOJFGQ*>@Y+ @CJ,9('!KSF;69$+H&;?(#P&(!   ]NP'4D^O>LO2-023Q-X?
M1G(9M:T-0"&)RNNV<C#."/N,#UP>@Y&*\W'THT\'5LV].MNM^R1U0JRCB:44
MHV5DKI[+3N?U(1$+&@8_,!\W?YN_(XZYZ5)O7U_0_P"%5U(90RG*L-P.",AO
MF'!YZ'OS3J_.Y?$_5_FSZN#O&+?6,7]Z18HHHI%!4<OW#^/\C4E,D!*D#G&?
MY'_$4 ?AG_P6>LDO= ^ J,W*>)_&) P>AT*PYST[8Z_TK\,="T47E^MOY;R1
MHN"P4L,$9.3C Y/?J<5^]'_!8"#[5I7P)C7:S+XF\8+MW*&!.A6'4$@_CC'\
MZ_*GX3^%3=P:]-]G\V:)XHX %5@I,2%AO!V+R2268#K7]@^">/C@N$Y*4Z2E
M+%-Q4[W^*^JYEW9_(/C#A*^+SW'0ITYN#HU>:<5[R^+X7:R^:9X5J7@2VD5@
ML6U23AO+.<@\YXSP<]OSXSY9K_@,P;FMV8GJ%"$= ,_>Q_\ 7_2OT O_  J\
M<1'D@@ Y("G#GEU&"0=KEEXX].,$^:ZSX9)<[X0%*M@[ >WH.?S'KT%?T7E?
M&$*>)IT)SC-+EC*+YG%-634?>^%6M&]]+;G\6<5^&JQ^'GBZ>#4:NLU4A&*G
M4<FY<]5N#O.;UFURIR;=EL?GAJ%I<65P8I%8@D#S",;@ ,G Y&TY7D>XR.:6
MUAM6FC(=%5S%$Y<A$DEN7FCAB+OM1)':"4!&9655$C!8W1V^C_%O@^)M[&WP
MV'*L .<>@ZCTYQG&<GO\[W5C<Z7?>5"]O:7$L\,-G-<>6\,=W<7UG9R:A=13
MLL9%A:7V^&3/EEAL5C*DB+]OCLYP]?)L57J67(I>S5+2\4GR\UW+6V]K:^1_
M/E?)LRX=SJE"5+]W.H[^UC)V7-JH\O(DNV^A]'6/Q=\2Z!\/_AGX6^'WC[QK
MX0L-(T;Q0/%VE>&_$6OZ#I<]]K/C#Q+?VLNJRZ//I4\NH)IMSIEW:10W6H6T
MMK/"KE)Q-;P]-\,M8T75O!'BKX;>+/$MMX4NM;\5^#?B3I?BC6K&_P!5T:X\
M5Z-9ZW;7VD^-;#3X]5U*.RUU-9U;68-;@CDOX-7>:^NWA@N('DYOQ=I/PI\"
M:_XE^'&H:#\3;'Q%X=TL1V'CEM4TDW7B&Z:V@N8;>X\%:EH4L!\$ZN;C-AJU
MO>W6H:@%E_LH2>3)!!U7P*^'>B>.=$\3RZSK-QX=O;N6?P%\*$T6\M(=)U'X
MO:EX/UWQ9;C5XY+6&V?1;'3M MM.#R>5;27'B.T0S?:YS&?YNQU3AZ5',ZU6
M@GB\1B<16C6:A[:$JE6<WR/ETLWU3=KG]%\,8C.I5L!6HUK8:%"A?#^]["<5
M3CI4CS7>FCM)'O7@;Q/X$^'=[\*O!]KXKT[Q3HOAKXI_\+ \:>-="TW4)?#0
MNFT^W\-:+9:-+J:6>L:H+;3;"?4]6U<64D4VI:I-):3S1+  -$#+O\C=MI-W
MX7\)Z7\0;W4OC%IGQ-D\6^"O%?A[3_#6C6?C'4X;_P 1:]?:9>66L:S/XZ@L
M-+L8M/GMK^\MI=,SJ=@)1:64+HD)D^>/AIHW@R?P/XY\>>+=/\27MAX.O/ &
MD6>B:%JNE^'KM[/QSJ&H>'IVFN;CP_>(L?AM-$BMP&D>6$#8ZI+'-''U.A^(
M/A1=7-M=KX5\:'2Y[2YLS;6OC[0M5NQ>)J%G:QZK_:%OX3\BZ%E";BW*0EG7
M[.8@'(5F_)LVP.0U)4\31CBIRBE+$U'*FVZKUJ.ZHK>=WK?U/Z$R'-LP:I2J
MRH474Q3HPA24XPC2Y^6*BI5)-65DM6O(^EM9L?!OBN/PIKMI\4?"6GW.G_#7
MP#HMYHFI:/XYGU:/5M \,66EW^GI<+X=&FJ5N)+?[#*TX6:TEBD+M)%=F+T7
MPIXWT%Y]/TRXEOIO#^M?"KPK\/\ Q)=644K:KI.LZ%+?:I9W>FV)CQJ,.D:F
M+"]NEV2SNLK6]HLS0.D?F5OX8^%.I_&G3OAEI^E>-=)T\^.KGPWK_B'5O%&A
MZY%-I&E6^MW$\5G;3>&;;^Q-8>>5H;>\MS=1)#I\$DS1RL(A4LO%GPLGEMHH
M='\5V3F[M3<W8^(.A^(9[?1FU.6+4+>*%_"]K'_;<,8)PCE'C 2TDN(_+=_D
M,92PBJQ5.-65*I[T>=Q;49.\=5%+9]C]<P&)J4<2HPJ.44[592=WS)VE9JRW
MONF?2D>A^&]#L96;X@Z9XEU.=4^P:=H%CJ=@-1$<2B?4]<NM=LK#^PYKV4/=
MRVMN\9669HY$68/&NYHUP$$:NJJ&12 "S*-XW;0S#<X4L5$A&),"12RL">.T
M;P):6WBC7;?5KL1?#[3+ ^)IM;M+"*!M4\*7B^=X9LHFM8(HYM:N]18Z3JEI
M9P&^AO;>XO;^VAM95N7T=&NEDE78)HXY"98X+EXY)K6.5O,2SDD@9X7:R5Q:
M[D=E(A&"W6LIT^:A-4XW=*\8IKI'2-TK:V6MK;;'W%'%VJ4DI)QJ*,FWJ_>2
M>FJ1Z_IT:3;6 ^4_@!R>Q&>N?;I7<Z)&EO-*!@!ROE]3NPJ@Y Z?,"/FQG''
M&*XC1L+&A/ ;.WW 9OQX]Z[K385DF0;R'4Y9<,0,\CG&WE2&^4GT.",5\[C:
M,E3YI04I25VI)VBWJU&VR3VW]6?:8&K&GRRA)IVBW9K71:O]?T/0[.$W<BK(
M"55, ]>2.,=N^,C].:+;0Y+74(+D1O%()3+'+#+@HR_(!.AR'RH!0Q[L(0&P
MP8#7T/;&5& P ^\>_7L1G@G'3M[UV*FWVK(X4=2O!Z@D<@9/;@FO K7@KT_W
M4K*[IMQ;>EWN^[/I\-*DVIP4:<Y6E*<$G*4GJY/GYXW;;;LK:[(ZCPUI7G6T
MEO*$FEN2\LC'DL6D9CEGQR.F#T[<5Y)^T9\&HOB]\,/&?@'S(+:V\3^'+K0;
MMY(-^Y-4<6LTD65_=SZ5':1WD,IQO-TR0,\BR*OL7A[5XH"Q)"E#M&0WW3@G
M)QQUZ^U=3K4BO;Q36K)*'19 B8)9GE\B.,KR?.N+C=%:0$>==R)(EM',T<BK
MEA,RQV79EA,7AZM2OC(*G*DZDI3Y$K-)<LH-)6[Z+KU-,9@:><9?F6!KU(4,
M)'#SJ5)<M*$JL^5N4JCG!P?.[MVBKMG\1/[6'[)7BO\ 9;\0^'=*\13_ -JZ
M5KMM?PZ#J\0E@6W%H[_9[;4+S_CU\[[,L8B1I1)(FU%!D!0?&LD<D8"2Q1@@
M*3Y9)'SJ'S\_S[B&RX8 ARPXK^BO_@KC\=_AUJVE:C\&]%L[#Q'\0XIH?[:U
MC='<Z'X#MM-CAFN-)+QADN/$=]*S;IM/>ZBTYY'LM1EMKNVN+>+^>66-' 9-
MQ\Q$E*N070RHLAB9NC&)F,6]248INC9D()_TA\(L[QN<\)X3&YE3]GC73P]%
MVC.$*EJ4$ZDE4G.;E)W;?,KN[Y4K7_S \6*>49+Q/B\OP57VN'E4Q%:K+FIR
ME&;JU'*-)TXQ@J:=U!.,FHV7,['$W\:&=B 0/EZ ]-BYZ=?7CGGVKV;X876D
MZCIFK>%KJR@:^U,8L-2$+-<VBG_6+PA8Y<L0P. ,9(P:\^F@09W("W?H2<C/
M;C/3^1K3\+7-WI>OZ;=::C"Z>0*LBJ66./>0ZM@8&[!Z\<_6OTG,)U8X6LJ<
M8RDG).Z;5UZ-'YCDM2A7S"G*22I2DI4Y;2<&[Q;;NFVK7:25[Z'U1\.O#J?#
MRTNM.LTD5KZ5I[J:66.4S2AFVL/+=P,IMX/*X"M\P('8R:V\%Y'+%)CS) '0
MDC#'&0-P7?D_W=W.02.:RHM2AO'A; A_=H)%W;B)2JF0_+S\\NZ0 = V#R*Z
M;3]%M#+;W-W$9W@+-%&"H!WN6#$YQQN!P2#VXK\1S?#15>I7K)QFZDY-*RC=
MR;>C3=K^=[']&9'B$Z>$PN&E:C2=.HY)^^I)1;5U[MK].5/S/8-&F=]->=AM
M+(&(R,CCY?<Y7G@'KR.#B9KHN ">,#U].#T'/^<5AVET56.%#F)P?,(^7;R=
MJX(!.!\OR@YQGWJ=VD5CV!/'/J>.AX_I7YUCXQE6K25[2J3:M:UG)/L?KV$Q
MK:C?E;Y5=N]V[:MZ[]S7@(<,B\L2,#IG\3@?K7=:;"+@QHYV*@'/!W="1QD\
M'(YQR,<BO.[5V7#'[W7UXR>YSV([_E756-^8(]S,%(XS\QYS[ ]>.G?K7R^*
MA/6RTN[;[=/R/HL+7C*S=M4GIYZOKYGLNCW5M91A%1,@\<#D9YY QC.?0\^^
M*]4TW6H+RWCAS&/E(ZC.=Q&".._3VSVKY=&H7#+N5SG!.,G@=1S[@COQGV-=
M9X7OYS.CN6;DY&\# W$=R/3_ #GCY7'T)14I)RNVWKY_+[OD?5X3%*T-(OW8
M]'V7G_5SU_6K2U8D8#.F"/ESRP##YL8Q@COQCGG..:2U5Y%;;@$@  ],<=/P
MSZ?AS73)+!=! 6 =U^YR3\G&=WW><9Z]Z2"T5KLQJN54KTQ_=#')/7G/?M]*
M^<E7JTV^?E44VD[/9:+5MZGL4J<:OO-M<VONV2UN]+IFCI5BKO'\N3W'3')Q
MU(^O!/%>R^&[!O-C41ML& #CKG)/UY)_'TKFO#^E+)+&J(2W<8QW.,DD#]3^
M?!^@/"GAZ1I(@$P>?EPI/WB1WP<]>.,$ CBO"S+$IJ3NM6V>_A<+912YK)*V
MU[6TZ=;FA:60ALV##:.W ]?3\>^/:NDTNWBC"YPKLRD  GCME@"/0]>.,C/%
M=C<>%[]M+$D%O$^<GY@H;Y6(Y+$="I'T QFL^PTRY4'SH<.%XV[0I*Y4A>>,
M$8.3UY'!S7S%>HYQ]QWE;7U_K^M#UYTE",;-WY5>]M[*_1=SMM*="Z;3D;4
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M*2&R&&>&!!Y&*ZL-E\^:]ZDKZZM/_P!M//E*;E)KV=FVUOLWIU-N\OTB#DN
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M;0K@S@*KS-\]:<R6Z)&D<"M$(XK=XD)B\H+Y4!*2D,38NCWD8=1B2\=8P6#
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MD&8V##YB@V] VY<%"#NQG&1QR?BW]N?]I?4?V8/@-XC\1:%-!'XY\47*^"/
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ML?OO ^*A.B^95%5<8\_/\*FU>2CHFHIW23;=NKW-B&Y,<F < 8_'(YS[9/\
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M2YM;*\GH>@3:]<,-QE:0D?>;.XX]>G3&!QV!/45FRZY*Z[#SC/)SWY[]>O?
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M@291]LM!@@X^UVW0X8<>;Z$' SU[=OZ>T\ >";B0--X&\&3Y(RLOA;2)(EZ
M$;QO/3+<=<@<8KJK'X;?#U=@_P"%?^ 3CNO@O1",DGH70,2.^0!QP"H%?=U/
MI$Y7"BX2R=-R7OODK?$TN:UJVUT_^"?B2^B!C)9A7Q2XORRE*>(JU/8U,NQ-
M25)SJ2E[.<X.,9SA?EE.%HR:;2LS^8RUUBT/E@7UIQU'VJ'U/^WSQZ9ZYSVK
MOM'UBP+)F[M">Y^V6X!Y/&#(.G8_D<<C^EVU^''P]4J3\/\ P%_X16A<<XXP
MO;W]N.*Z6V\!_#U%"CX>>!" "-X\%Z",Y)/0C.!TZ=N*^0S#QXPU>:G'+)1A
M%^Y&,*EG#[*E>HV]+=C]"R+Z,688:<5/-:57ELO:T^6G3JV27M*=.<'.G"=N
M:,)R<HQ:4FVF?SG:5K=H/+1+RUP.F+F$@9)/WQ(5."23@G\""*]'TK5H795-
MU;$>HN(2,9/</@__ *\FOW_C\!?#[.?^$"\$IGJP\(Z.H_!44X_#J>3UJ_%X
M)\$*V(O!OA!$'*E/"FD@<\D ;0?O9ZCGKTKX_'^+E'$2G4>7U$JDI3M&,M%-
MM]9/N?I.5>!F+P51Q>8T[0?+[TH=-.D5O;_(_#G1=4C6=8Q<0[!C#"6,J<\M
M@AB.I/3IT/( KVK0=6ME0*;N %B"!YJ <'_>QD<GK_\ 7_7.T\&^#1)M'@[P
MN2,#S!X<TQ >,\*!@8X''=2>IKHH?"?A5&\M/"7AE0 ,,- TP'GGZ\9.0 /R
MKY/$^(]&NY*675K<SLXIW:OINV?>8#PTQ.&DE',:+<;)J35KJR>UNSL?FGH>
MMVC>4%FC?@#<L@VD@X(!SCCD<=P,],5['X?GN+V2*/3H+J]G?@0VEM<76WYB
M!ODACDC0'KN9UP#R1BONNU\,^&41%'AGP\K#.631;)>K$CA1M'!QQG/7UQM6
MNFVUJ2MA86UBAXQIUG:V@.3D^8\9#D$Y/R@G'TKPL7Q11Q*;A3C'FN^62ES1
MOKRR]Y>\KV=K*]SZW+^&*]&?)4J2?(^5SBXJ,N73FC>+T=KKRZG@WA#P%KM^
M1-K,)TJ!BK"-FB:XF525(=(I':(G;QYJH<8/0U]!Z9H%EIJQFT0V\<$,;R&1
M?M$[I+.\(E*0B20Q&<.AD"E(P/WC(!6I9V07;N51R3P[,,DDDYDPY/=L@ $D
M*=NTUQWQ=^(NE?"#X<>*?B+J?S1>&--O+FRA <S7^K-%!#IE@XC#-)ITMY>6
M_F1#Y_.:><CR89G7YQU<1FU?#X;"<SK8C%.@XZZ)U.7W%?1Z[NZ6[3L[^YC,
M3A>'\#C<9B')PP>%=6+;5G*,&_>LE=76R<7;J?)7[9W[;/P^_95\.7.A"T7Q
MM\5-6AGN-"\"0.'M+!D3$>N>*KI5/V728@T4Z:9;S->7\3"X@M94G62OYM_B
M#\1_BW^UI\5-$O\ QAJ]EJGC'Q%<Z!X7\/-%;VVF^'=&L9[K4=2CLK=I&A%K
MIEN$E>YO;PP06,,;W.J2VI#D=?\ $.Q\1_$SQ?XB\?>,+R6_\6^)]3GU34-2
ME=Y+B".10D>BH6+1"TTNVCATNU,#-&;6SA8.P.2_X7?#6^LM)^*OC&UU;0?#
M]_;>$[GX>^$9O$&O6OA6U&L_$&.[M]=U&SUF[E$ O=*\&Z=KX60%&L7U*T9R
MC7-IY_\ 8W"/ ^5>&W!SXAJX6&-S_&<M2G+%)5?9RJP52U.%%4JD6I2M;VG1
M7\O\Q/%[C_BGQ*XI>!CBIX;)J&,KT*4<+[2FOJU.O.%*\JU2M!_NTM>2W8\#
MLOAQXFD\?:E\/I+;2X/$6G3^(+>X:WN_]%\_PQ8S:GK/V>Y=_LTZ/9037]G-
M!-+!JT3++H\M]'- TEOP7H>J>)M1FTC23;1?9O#^M^)3+>ZI<6EA-HV@VEYJ
MFJP1JEL\JLUC9W.ILA/G.7,$2&YVP5]4-X=GM_B9\ _&%YJWAW7M5\5>#=:^
M'_B%O#WBK3_$EA)\2O!'@C5/!_A72VUN.6-;G6M;\%GPK>SV\BH\]Q-*J-,(
M)7'A'[/44ECXE\3O-N@M_"7PL^+<VOZG=0L;?1[;2_!VJ>%S#JR7"JEA=:CK
M-[96EGI]UY5[>WMU);VMM-/:W:0?18+C_-LSP+]IBZ6&Q$*<5&E&G6C&#44N
M22G4E)N.S]Y/34_+*O#>'RG'J5;%SG&-1J\JE)N24MY6@DV]W9)7V2/6O"/P
M0U#5])/BJ'XI_ G3]*LQX?AU.35?&^KP+H$'BI[B/18==ANO!MW%;WUW<6T\
M-FOVN9H[>."XN!;131BN>L_AC=>-H-8NY-;\%:/X4TG5VT.7Q_K_ (J2W\+W
MVN1HTEMI]A-!9V^L>)[J:RCBNXH=!\/W<NG6$]FMZJ QS35O!RK+\&_C([00
MH1JOP7WF:WM8_(N;;Q)XB22"[L?)D@DEBPJD7;K+;<0NJ/$8UO\ C=)]0^"?
MP*FL9#%X8TNX^)?AW6U,P;3--\?:QJCW^H17%JMH%@U#6/ [>&TT;4P&>%Q-
M:V$KM \<?R>*XDXGIUW.>-K^QE.4I3@I*-G)N].[=H_RWOI:[/U/*(Y/B*=&
M%.TIJE34M8/WN2-_L]Q-/^#_ (HLO$_@/PCI<N@ZE'\2KN&P\%>(]"UE-;\-
M:O>S7EOI[RKK%REG)I5]::K=+I-SH7B2'1]8L[F-T-@;2)+EJ!^'GC"?XFK\
M))--AM?&I\5?\(?!823BW,FL2M<M D5PTJZ>\6MQVLVKV-U'=-9SV%S#>1W!
MMYH97^F?V=]%NK.U^"4>M1NUOKO[9'@2_P# EG?"2W4Z=I.DZR_C.YMXUCC>
M73_[>'ARUCNA&D>I:CISM";BZN'!W?@<\GQ?^)OPOUJ)"?B?\(/B%H46LSLP
MNK_QC\*I?$>HZ/I6H"*/=)=^+_AEJE];Z3J13S+R;P8]H((9X])U1K+YG&\:
MX^7UE3A*K[*I4BJDH5'.?+.2YY-32;DE=M)1O>UME^MY+E&!=*E1H3C2JU:<
M'\4$^:44]/=75GR?X/\ AWJWC.'4=476O!_@WPUI6K+H5UXR\::O<:=H%UK+
M6\=W!I-A;6B7FN:YJ<MC-9W)@T32;][.&\LFN5B6YMS+M7/PK\8V&O>!=*5O
M#^IV_P 1+ZRMO WBC3-=?6?#>M7&L7]KX8AGM]6N$M'L[NPU6X@M+W0-;@TO
M6=(E;9>6$-LBW#];XMT^>^^#/P@O;!2/#UGXB^,-CJMF'\VVT3QMXE\7)JLU
MO<VB6TIM)[WP;9>&!X>U"4_:[6UT:6PAV7#"W/I7P5LHX?!/PFEU*SOXT\2?
MM=_#:[^'UC*S3W?]G:/I"6_Q!O[:"=8[6+04U$>"]/74("MOJ>L>&]3>)[C5
M#?QQ?/8CBO,)4'.,*?M913A!QJV=]5S+VBE?776W8^\RS*/9UH4IU&Z=.T*D
MU)<UXV4FG9K5JZT9X7J?@'Q-X6\=7OPVU:S@3Q?I'B./P?<VEJY:&36#,;2W
ME%W;/+%>0ZJ4%_#<6TTUL\5RKI,8RI/K0^#?C72_B!XA^&%U'H]KXB\'6XO/
M%M\-8@TKPSH&E-8V^HSZEJ7B-99X_P"SX1>+;->%FMKG4$EL]/DN9!&C>EPA
MYK8?M/:M+!=7/PQT+X@>'?$*[9&M]3^*?@F[F\-?"B2=Y%S)=:[HOC/P_K/G
MJ)+5&\+7XN;B)[>94Z;XAFXN-+_:8BTR1]1UZUU+]GGQ5XFM[-&O+R^^'=AX
M :TOKK58"#<3Z4GC.?0M8OK&-7LY["W%U=@1R2NOSU;B;%XN4*:@U-**Q#Y9
MJ,:JLJBA>6D5*ZBI<SM:[9]OALJHX>7/)QE2;YH.\7)P>L7)I6<FK-M)*_1'
MD6K_  \U7PII:^+=/\0>#O'WA6SO18:SKG@'6KS75T+59(II["#7H=?MM*U.
MTTZ\L8DEL]:.EQ:)>^9;QV&H79NK-KGJM3\+:GX3O(DU5;6:\FT?0?$";)9G
MMTTKQ+HECXBT^Y"QA^3IFHV[M$ 95?<GEJ^%JQ\$+<V_ASXTZC&+1O#ME\);
MKPQJ5V]E#:Z!>^(5OS?>#K6W:WWV>HZA=:D$UBS>=O*M])LXK&"86SV/G^A_
M%R:1?%OAP#R[G_A)/AA\*X]-$>U6U&XF\!^']#,&FVS8FN6M]7AFT^XBMHY/
ML,D$GV@10QF0>1B\UQ2<DKM)M)VELF[=3ZK"8.,HP<96BXIQ5U=)JZ6W9GH'
MA[X0>)#J6KV.HZCI.DV'A6PTC4_$&NZIJD]GHVD)X@CCN=,M4,5O-)?7ET)U
MQ8Z<;V]7=YKV\<3*1W4>A7OAW6]*M$O=%U:*\MVNK+4O#NJ)J>DWEM&[+)(M
MPY6>VFBD5X+JUU&*TNHKN*>(0%45CZ9-XCLM'\7>/[:_T.R\5^#+U_!MEXIM
MI;BZL(-)UG1O#VGQPRC7K6&ZTS2]7MG6..$ZY+8P94!79!NJ >!](BE\->*/
M#,NLG0?$T$MU<:5K5U'J6HV-Y9W$NG7-I_:-K%'9WD,]U:37,-U8^9:O;S1D
MS.09&^:Q.8^T<EB$XJ[NXIIO75ZWW/LL'2H4H4^23E44(\Z;37-RKFM9)VOM
MKMW.YT*P?5+1)HY3FUSY@4\@ER5&,Y.00?E! Z$YS5[6;&^EB^R/'<1%HBQ;
MD*X RIW E1QCJ<]<X(..V\):;;Z?,\4< C$@5Y,.DJH657"$QLZG8&VD G#
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M4*5&&JI0=^LN9M_=)'1063D@1KN7L=RC)S@\$@]<@\9X_&M:&TG0A3A<9^7
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M TG4-+N(=3L+\/*C07MK)MBN&51AO+4L%1-SGRU8+\PS]Y# Y%B,%B,;2RK
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M-77E&,Y1>D4Y*Z;T6KU:N^NAUU@28R3U.?3^\?3^5:-NYWN%[<]^AY]OT_\
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M8Z*$%*<)N]X[);:7WTOT[G[;P[MI+=23Z=F8#I[8J:F1YV<_WG_+>V/TI]?
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M;C[KG*7*E*<K7D[:O7J?K^09UF4\1"O4Q>(A>THJ,:BBD[-*SOHMMSVCPO\
M%_Q#:Z_X]U2_T;PEXE\/_%+Q#>^)O&/@7Q/;ZA<^#]8UJ]U2ZU33]1BDTFYT
MCQ)H%[X4U2[NVM;K2KQYM5T6]O-'N6%L8(1[QX<^,+Z7K'@^Z\+>!/ ?A;P]
MX2UNZUVP\,Z+IVHP6VH7^I:=<VNK7WC/7]5UOQ/XLU![^UF^P"RTV\NK:T?]
MU9F'2X;8)\>Z'I_G7$*-%*5!!)"D<%L@XQGC/0#Z\\5])>%=%TA%6:9XXF5<
MGS9%4L02,&)B)%( X+(-PPP!!!/YKQ!P9E%",IPC1IPFY2E0ISBHRYFVU5BG
M9R_FLEK>UC^@^%\YQ]25-QQS7-&#_>PE:[2]&>A_\+DT#3_$/@GQ1X/^#WPZ
M\":UX,UNPU^TAT8>+WCU&YAA!N-*U03:W% -(\U0DXM09KJ0O<B,M(QJK<_$
M/0M5TMM/TGX/_#7P7J+76GW,'B#PJWC:]U#3KZTNSJ,]U;:;XA\4OX?N;"YF
MDDMI;>;3XIE7<%AF3;/)RVLQZ7=W2&%[95A"@LKH-Q"KV!!/?H/RX-,L([=6
M!3RS@G!W(#P< \D8_(<=J^)J\/8*-.*A[.,$E[.',K0BD^6,?[L5HD[Z6WL?
MJF7XZNZC<L1AG)N\GR5+N3?O/X^_]=_HW3?BSNFNM7T_X<?#CP[XQUBVO-*U
M3QGHVEZ_;:F+"X6&TGN-,TQ?$W_"+:+J&H6,ETEUJ6D^&K6]$RRM(MW+*;V[
MX6RL9Y8(K9PJ*B;S$'69TDE)EE$EP(+<3R^9(YFG,8::3?(S2,QD;#TXKN1M
MT8!SP)(R1RW8-G]*](T6V$H#X!W9P20,X8CC)&>0!]>/I\KB<%0P#K*BJ:<J
MDW*3M>[DVVK<O4^^P->M7C!2@FN6-I0C)*2LO>5V]'NC/MM/6':I&'&<@D$\
MG(R<X'!XR?PKM=!2>&5RHRK  @,"!P,\ GW[#WK8TOPK<:I(HMK:61W/[T&,
MQH@!*@B279&WR@']V[$'Y3A@0/2;+P.FCVSYW23,K;E)!VDY;KG:>#V)'/7M
M7R^88FDX<J:E.*M+K[RT?7:]^I]?EV%K1DI24E%V:Z.S5UTWMY'%;'(#1IPQ
M;< 5&.2#GD9SCG&?IV&UIMH7=<@;2>N1UR>V>#G/Y]^M31:/*&(==J[C_$IZ
MDYX#9[UT5EI\4:IA\-SD8;^\>?3//;M7A^TET>AZ[HN[]U;O=:_/4Z'1#':2
MHA4?+WQG))W8R![\_E@5[EX<N#(JMM7:H.22HX!]"0?H,=L]Z\/M8=C1E>><
M9_$\\\^QX]S7H.D37*O"L18[CAU&>/F([XSQSP3U^E>3B]92?=O\T>IA5:,5
MV27W)GMUM:I>Q-+'M>/D%=IP"I*D?,/4'.,]A7 >)O#KI>PSQ* 7>/=& O&%
M4#('9@-WL&_"O0O#OGI"T(8A2 5!4YY^9L\?WBW)P,<\@\[.K0*ML)YQ',@,
M .Q"9T:>8VT.6QSOF0KD$B, &0HN&KSL*ISQ$:4$FI/5V=[MZV^_L>I*$%0J
MXB3?+3;YG=65KWOH?/\ \1?B!H7PC\':KXO\6W;V^A:7%&8[/3T$NL:YJDL0
M^S:#:+(I\@3LRS3S0 Q0POYMS+$"Q'X,_'G]I'XE?'K5Y7\0:A=:/X5LFN(-
M"^'VGW4EMH6FQ"0B&^O+RQ9YM5U@X,YFD:2T225HH96A1"?O;]KK7KGX@^.?
M^$4@D9/#O@8R6=I"Q8B?Q'/!%-J>KW*@ 2QPK-)H$2?,P:Q%RBM;/',WPMK7
MP\MPCF&U\I%6-!M7Y(QY:[8MYP&:,8C9@2K,I8-@YK^VO!;A#(LMP\,]QT7/
M%U,-1K0IUW1=!2J4XSYE#V2J*5VW?VM]?)G^;7TE^+>.,XSVMP_D^/K8;*L-
M.O[F$=6,ZL*=2<8PK/VDX2@XI)I4XW[K2WS7($VH,.&"(A$F&D9E159W9-RD
MR,"Y.[.6!;!) EL\13 -E?J/7)[#WKK?$'A6YTIO-),4;D>1YN$\T !6,.\@
MS!7# M&&"L"I(8$5RLBRQHDSQ7/+*H(MKC,C-(842%1$6FD9E 6.(.Y'S[=A
M#5_3BHX;%X%SIXK#152"FH*<4HJ2YE&SDVE%.UKZ6/X;JU,PP687Q]"NJBJR
M]K-0FN::D^>2NGO*[.LMV#%<'/Z=6]ZV;6$[V9F*A@,?AQVSQW_.N:M/-601
M,I\U9(8'A!#31RSRI%%'+$"9(6:21 WF*A3<"^P D;L-T@2&0R*(YL".7)\H
ML?)(B,G*),1<1,('*RLK,WE[8W*_#8[ 2J5JU&E2G4IT</[1U(S@U*:BVVG:
MW(VKI;VZO<_7.$\YIM)UHU(NR]E9-7C9<KE>]VU:]K7=[([#34<,H/* G#$C
M!Y.>,YX/3CMT]?1=$TV*[D8LW&!@8/4<>GKGK^N.?*=.O5D6-HG5U;R\%3G(
MF!92PZJJ_<E8X%O('BG\N561?1- U.6-HHHU+O/((K=5RS7#O)&F80 3(BO/
M&LDJ!HHB3YC(%?'YQF-&4\/4J1H5'4C>Z<X<O-=W5K7W7<_=.',V<9QE*%11
M:BT[/5-*S^X[8VUO8N!)$3S@.2/FSR,8R1CISCD>P%;%A*CW* ( A4XY!QGG
MG\<YZX_ @<:NI/J80 <2 M'G*N<1+*<HVUXV6-@65U5@?E(# @:6D7)\V-D=
M6C QYA=50EY(450[$*7\RXB4J&+ GY@-CE?SS&8>=1-SG3@W>\;ZQ>MT[O=/
M0_:\IQU.<:<O?]Z$)?\ @44^WF;M[Y1E95PK!L' /?!R<>N1_GI6:SFE8;26
M08.=P';G@D'/8@<_7C#O*%S*KJQ=I%27,8,BE)"ZQD.@:,L3$X9 V]&!#A37
MH'A[1ENUC2;Y0UNERG(\V6"5)I%>.$9FE.R"4LD2,Z%-K*&P#\SC</\ 5(^T
MG6I-/WDE)7L]===]3] RG%SG-+D]U6LTG=K2U];?@<A96+APR%CC@X(XQ]?\
M\<"O2]!L9I8HP=Q#%@,<Y.]QSZ<C_#CFNYTSP)9PMYC$X:9X/F4C$D8W2;@P
M&Q$P0\S 1*X9#)O!4=UI&C:?9QB6+RI<LZ%0R?(57?GEONLA#AQ\C@C!)KX[
M%U7*4YQE3M*4FO1NZ^UY'W^$I2DHR]Y<R3MVND^W_#''Z587,$J1-A5S\F=I
MSN.X]&.#D]3Z^XKT2/PKJ6HJB0PE\#.5:,=>>"7&<>@X]A@UN:3H-M?RB5?O
MA3(0 2%6-!)]XC:#Y95]N[<0<8).*]A\,Z.EQ';K TJ2(ADW@JJ.K.SI@L5
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M'0?*#G)(7D$'@\=#TKC1:1>7(\TRQ,N_S))G$4"$991)=2%+>,E,, TJDY&
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MX)T:RA\+>$/&5QX;TV2Y@UJQ-U'/J4<,6H70N93+'<WLR2) R-#%UGA7PO\
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M6820KE6+;@K[L<[F&0#C&#QG Z9!P<UV]EXCLM.NE26[MXI$(+>;<1AAO&\
MH6W?=88X'&,9!Y_.<UPV3-U)8;ZM*<I2;BW!Q4F[M)*S23T2;;2ZO<_?.%L3
MF.$=)XB&8:0A=R4OY5=_ >U^(-:MXK"%W>99TE'E;5*O!.PW[VD?:SVHSA8
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MJN$#>8 Z,0V&!1'5#N .5Z5T^K^,-.U"!_LTL+J$P[%UW+N&5!SC<0I ^7/
MP<$5\B>&K6_U]I94M0UM%]Q K#RT7*J,G:> O;(P1VKM(M+%O'.TS21.",0>
M;@D* ,!=V06QD@@=>G(KX^6 I^UJ5(2:C.<YQ3E'12DVELMDSZZ&,7L:5.JG
MSPIPA-JZO*,4I/6_5&OJ-Q"I+Q)DR.QWC(4Y8XP>!@#@\]1@U!:W#1+OY\M3
MR1\_WB3R%W$CGMG&>G7!8VTVLQ>58V=SOM>)VF'EP)DEE*F4IO!4@L8R^"2#
M@\#>?2W@TYU)C6Z .YE 1#R=NW=CHI4'ID@GTK;V:6EWIITZ?(XI.HY2<7[K
M;<;I7LWI?5:V([?Q39Z4?.N8E  W+, ZS. ,DLI7>I!^5<A<@ C@@U#J'QS@
M(TRSTV::9[S5M-L2GF;75'U2R#!@^W:"22,XR,8)'-<#K]O<SQ".2X@!*,-Q
M1LGJ,< @8Z#V'O7SS<>&9T\5>'[JWU!HIO\ A)]&DG4%C%(BZCIZC:O;Y5 (
MXRP)QWKU899@:F4XK$S4_:Q4G9.'*W9MW3@WOO[QQ2Q>(HXVE0C/W:CCS7O=
M7:NHV:22Z73/Z<;613;Q-EAOW-ALELM(Y(.,]\@=L8Y/6K76LVU!^S6R?Q!%
M)'3JQ.?3D$''7GD Y%:(X ^@K\ED[U*JTM&I-+T4Y)?@C[VE_"IZM_NX:O=^
MZM7YC3(@+ GE<9X/&1D<XP>/3-1M.H;;D9.,?*W.0#Z>XJ*Y5G#!" 1C.#@Y
MVYY]>,?R]*S9[E(8\+(K2H!\@R9>2!N6,9D*#(WR*I1!NW, K8EMQY8M>TG4
M;]G3II\UNG->_P VK+J2JUJE;VE*<*%&BZDJS:4;I-Z-Z<KMIU\SY[_:S^+*
M? SX$?%SXK; ]]X/\$ZAJNEQR@F";5T\BVT1"%#',>L7=H6W  K,<ML1C'_"
MI8ZIJ5UJ%[J>M7\^HZUJ][<:MK.H7#RR2:GK6ISO?ZQJ.Y_F5+_4KBZNXHY-
MKPQ3)$R(RE%_J7_X*W_M!_#6+]GCQ?\ !$>,M'NOB%XJU+PJJ>&-/N'OM473
MX=;TW4M3COQ8QW$.G*-.@AO4CU*:T>ZBD3[,DQ=%/\M<5JZ.LCKM8L=P. 5P
MQ 7&2<J!MST)&1D$&O[1^B]PY7PV"S;&8W RIXG%5)U<+B*M*2JTX3;G3]E*
M<5:*YKJRWUN[)G^;7TO.-:68YUE639;CX3R_"0ABL92I5;REB4[U:-9QJ.#I
MJ4>5QY>:U_?V2[?4;S[3;6A7D 8( ;C#'/4>Q.!UJQ9J)'&UFR I("N.PZ$@
M ^_X5DQSYC@B"[@N?;JQ)ZD=,]NM=58M'&H8H 2...X..P_G^7K_ $;FN"KS
MDI593G.&DG*WOR6CE/2[<GJWIJ?S9PWG%&4Y2IJG3C7;J*,%)1IJ?O*--.3M
M"*=HI\S26K9T%A& L>9,=<=<_>(_GQSCL*ZF S(45-Q4<Y[<G)QW[X''^%<=
M;SAW7;@8.2,8P,\=<=1Z=L]QFNAAO'R%24!1VVL<'C/.W![D]B/PKXS,L(G%
MMQLW=M)*R?5+3:^Q^V9#FEO9I332C!)MN[2BM7:5K]]CTG39SY<98X//'.?O
MMP../J.W3I75VLJ.5 ;+>F#ZY')&.@]:\QTZZE4!Y#F,'EP/<Y^4?-WQT]>:
M[S3;B([)2_R=R0P.<D?=QGK[5\%CL).;FN712DE9:VOIW/UK*LS34-8_#'OV
M7F=WIZ;F56]_YMZ&O0]$B&X1A0 . WKDYZ>QR/3([\5Y[IS NCC)4C(8*Q&#
MGN!^'L>#7?Z5<1HRX8;N?7.,G'&,D'/\J^(S/"\O,N2;LVKV[.W8_1LKQK:@
M^>GK&+7S2_O'I^EQ"WVY?<5R=O;!8GMGL>WN*[S3+R(9?<J\<@9XQQ^/3/'?
MOWKRN+4HHXUW2A78'@ALG!(QG&/3O^=,AU6<RYCD;:3SU''3H0#GKTSZ^E?*
M8G 14>:<*J4E>^BO?7K'^OO/L\+CXRM&$HN2235[JZT:6NU_6Q]%:9JT;1EF
M92D><,<]=QX((SUR,[>G(XK7.N?[);T()Y';],9_7FO&].U...TVNS,S$[2-
MWS'<<^XP>.<9QD<5OPZ@CJH4G..AW9_,#'Y'ZU\WBL'&\K*5KNU[7M=VOHM?
MD?2X7&0]V\M;*ZOL[:]?Z_+U*SU,2L&!VD]5.>Q(Y)&.WJ>O2NCAN'8C;STQ
MSU[=\?4?GQ7D=E=RHZ9X#9*?,,X#$$]<C!SU'/4<5W^DWR3(F) 77<".01AV
M '( Z8.1_.O&E1JIM*$;)M*ZE>R>FS2^Y'LTJZJ/66G2UKV^:9VMO=&!P7<@
MG'R?,?IR..>_.16F]U]H)*_>(&5Z$8 ]< ^H^O/(-<XN92C*,@X [=&([\\8
MKH[.T1QN=PK,!E<C(QP,D9QT[_\ ZO.G"?/.\)7YI;1E;=[:;'8J::NJBL]5
M=QZ_(C6.1P#MSG/<'H2/7GI0T5PH)"-M'?/Y]&^O:M%Y(;) 2RDC.,D$'))]
M^WOQGUS4UOJT$B$,%R<]NO)'I@].HS_A/)/^27_@,O\ (W2II).:NDD_>CO]
MYC+*[H$V9R2,D\GD_P )P?4<XZ9'&,WDM)!$)&B8+@G@*<#)],GM]:?/+80I
M]LEF2)<Y8$-A-O"]%/4 -QV/KQ3HO%&D3#[/%J-J3C 3Y^I&2,E,=2203QGG
MG('1#!8NI#VD*,G32NWRR_R_X8YIXBE"?LY5(*;;45=:J^G4R+R/$1D0<'.
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MF(KT\2ZTDX6<8Q<E!K=<R;;?G9H]9O\ QC<W,N(9)9$.T$G"' 55/&0,9R.
M<]<9-5Y=8)B5XU19.=\S$EB<\9&<\#@<=!WSSPZW%M%%S,"5W;N&YY)Z[>O/
M3DU$-:M@&4G>O.&&X9/?@C<,$8Y';/(-<RR3"02A["3Y?=^%=-/^?9J\_P 1
M4;G]8@N=N5N:2MS:VLY]#K[CQK=62H))//B!(;8'4$9)QA@#QT/'7IP>)W^(
M\"64TMG:-Y[*0CMD< ;6(W@ 8((YQD].!7EU_>V\XVJZ@?W#GCW.1CGKQZ^M
M8T]V%MW@1@ H.&!'.[YCWSU)'(XP!FN[#</8634O8;Z[1ZZ_R?UY'E8OB+$I
MR7MHNS:O>71_XSHKWQ],C3RN?,EFA96.XY#DD  '_9QR./0FNM\%ZU_:5BL]
MR^S[T:+)D.SAV4*J'YWP0/F564'@MG-?-]Q!^^6:2<@"7&P9;<?O !0#G*XX
M&1@UY!\7_CI<^"K:'0/"TR?V]=+YLD@WM_9ULJ[7DC*KY<<ISYFQG\S<Q.S%
M>['@MYJZ5'!T%91C&HW&-U))*5K125GM=,^=Q/'<\EHULPQ&)I2P]&4W4IUW
M-R]UNZII58::62:?J?H#K'Q(\,^$56;Q1K-AIEG#*25N)LSNA&3BUC$ET_48
M"PMD8/3%?)_C_P"/GPJNIIT\/WEV]]<SD/<Q:')+:R1MC:T<ES]GD8",J'#Q
MJ5D#*H(56/YRS:KJFN7DNHZW?W&KZA,YG74-5N;BY>(OA@$MU+0J A5(P!PB
MIOVON 57FE=7\]@5/1T16RK8R!'N0*2,H,YVD;P&W ?5Y-X94LGYJ]=UU5D^
M:,8RI<K;UV]BW:_F?F.:>.L<[E4HX7 6IJ<XTZE.-5<]-2:A*[JM/FC9W2MJ
M?<T.K>&_[&U+Q/IOBZ&XU"S@*P:']@NK"4M*NYSY;1"W4L[%QLG;<&#$AF*C
MYC&JWQU*XO9A<&YNV<,\C$X29BXX))PH(4#T48XP:R],UC4((8PLL3J@8;%B
MC\QB68[I&D*[PO102<+@<8 J]/=7-](LDDH:0D;W,8C( PJ@HO'R($48R"%!
M&<YKVZ.4SHNK"4(<DYS:E)+G2<G;6R5[>6YXU7B>>/5*HW*$E"#Y$Y[V5U.\
MG>2V=K:GJ6G^+=7FTZ/2KN036L2,D1;[P5W9^YR,;N,]A[U5ALHW\LJ_5F;'
M<9<^OJ<XZ5S6GLRYPV\ ?>Z9[_=;!XS@<<XSR#FNAL[E79$5LLI.0588^8GJ
M0 <@]B0!QUI5*,:'NPT<?=NK:VLKZ)?@>EA,U^L6C5C=));2TTMU;.RL8!'"
M4Y/S#H">3\W;KU_F#TKK(+(O($",TD<:2.B R.J%002J L,@A@/O$$''.:K^
M#M(_MV^BM!<_9]WWF*.<-D@?PG<>!T!_.OO7X.>%-.\.V;G68+/4GN':(SR6
M:/,(#(X#%G7=\HPB@C.U1@8 )^'XIS[#Y=A)R3_VA)^[*[BY+?1-2>O]X_4>
M&LC_ +8=.-'F5XPMK%;I=XLH?"WX7>%O$?PUAUB31\>);"ZFDNKBX:8+=VGV
MVY:(B- 0OEVWDP[/OG83MYYKOX B\2>(4TZUT:VTBSBEA-U>1PR $)''C:9%
M1G+J QVABK$J<$8'VAX0TS3["TN!;0(+*Z+,H*(@90Q&"BX"@$8Y&2,$]36;
MXVOK2SBL8K"UMX'D+9,80.X#$,2Z\=1W;^0%?A*XOS6L\7&<J252M6E22572
M$IR<4KU7:R:1^X8;A7!4:6$C4IOVV'H4:<VN2TITZ<8R<O=NVY)M['?_  FT
MO3_#6E0Z+:J!#$3(7&Q3+()';<3P3G=P3P!QQTKZ/T^[TQ(U58U,C[OE8%G+
M,Y+;B%(Y8\=L8.:^)-)\22PO;"&4*H)'WB"QW$.".H&_<.<9 !'%>R:=XO=2
M&;"2*H_>;@P/ (/RDGH0#7YAG<,5C\15J5YSYO:U)>XVDVYMOXN;N?HV4U*>
M#HTZ5.$$E3A%W6JM%*RLTM+'T'<QQ. <1V[ 9 QEB"<J#MSVP>>U<9K=W=V5
MS%+(B26Q0C  / 7!S@D\G/&,5R]CXQOKV7'GVS"/[YD^0@ =?GVAN,8QGC'?
M@4/$WBM'BD3S8'_=[=T9PJMY8&%!P>"3GCKGJ.:\2&&K4_A<G;O?]+'JU\6N
M1>[#9='V]3QGXB2:9=71N(X?+N8V+.%!*DE5V] 5Y7;D@\$D'G('SWK$MS+<
M/<2(\:S%5(52R@1HL(/R!C\P0'H#R<\YKV.ZWW\[JY,C-(2<'=QG@<$_PX X
M/3GVIZWH1M=-BD2')E#X#*%V_.R]6]2,Y^G2OJ\#52ITHRMS*$%+U44G^-SY
MK&4W4<I)64FY+E\VWY_UUV/)M/B)DC,8+(IR6QCJ<GAL'@DCI7IEI<B*UC5D
MVQ;7\V5OE (=\<$ \8 R,^U8&EVL5BIGNMH4,=[95L?,Q VH6/ QG ^OI5^_
MDL[FTENH+K;&W[L*^Y80X4* J, WS%<G@#<37I3JN:LU&W1I.[73J9*'L80:
MNWRQ;YM=6E?:W=E&;QJ=/G,:,)TB;@*2!@@, '("G@\X;@\$ C K2^.3KUXB
M7 :VM[10HCRSA]ZAF)V;A]YFQ^=>7:G?*D\UJ$CD:-C^]B("-N ;@G'*EMI]
MP>U9<%Q-"Q,:D%B-PR,C\FP<CTS^&*WAA*4HQD^:\HINS5KM7[&53%U:BLU&
M.EKQ33_&3/2M5U&S2-H[5II%.X^;#&BR+N)<@&?RW.TL0..BC'&"<K2G%UNM
MO.N95FD#>=.0)4(."&"G&,C"[2?E"YYS5+3!YP$DQ^_G*G/&"5Y'7!QGFNIM
M;>&(B2/ <YX'KDC@G R?K]>G&%>G*FK0BK+1-IZI=[6WZ^>Q=)QA:5Y-M)M2
M=U=ZNUH[?-G90QA+9H50$[4"Y(RV%4$Y)'4@]3^([[&E1 , VU&1"'7&XKDD
MC)7(.00<@D8(Z=!S>GRRRN%/;K\RX]!ST/  X/7-='ODA23[/$3,XVO)N4 9
M&%(R1G V]"<'CK7#4<813<GS-7DM+)O=+2]D_,]*C/VEKI6?:_GY^0D=O'#<
MR3"3YY)5\V-5)V@8 R #U0 \>O2O:_#L%O,(GC(:(*O.&!!X#'80''S9SE>>
MHXQGQC2['4+3[5/+#)=22D,H4*XQM &""02  .N<Y%=YH7B2YT^../\ LR?[
M3(Q#,Z%0/G8*?F QA,=>N,CJ37G8IU:D%[T$FE;O:VE];7MN=<82A)N*BU=V
MNK_JCZ)TWP]:N3<O,(S*N8U)QG: G QQRIZ@=1CC!J65K/3U*R[GERP!R2&Y
M.!QG&!CJ1Z^]<%%KM[.]LSNT01 2.>IYP0.>^.!^-)J&H-.2\DI7D;0<DG'&
M>AQG'?GFO!]FZLY0G"-HR:ND[NSM=MMJ[]#TJ4E%1ESSYFDVDURIM7:2Y=%?
M;5Z=6=3-J<!78T9BQ_M9X;D'*EAR#GV)P><XC34;!;67[0Q=<-Y/WMRD[LEO
MER?F)_PKS.ZU5HV(,G3 SDG/ QTYZ8QZ'T[\Y=^(9DF6W$;.I*@$'KN ;IV/
M.#D?XUU*A"*4;/1);]E8'6C=]=7KKW]#OXII+N>4QREXU;.TG8%7 P!OV@\=
M=N<G.<U>LK@K<$H2NPCD!OF(&>PSUSC(QZ9&*YS2H)[I3.%:*-,>;C'&X9&0
M"2V1S\N>#CCDUVUG;QPL7P&;:K8/H5!!S[CKDY&<'!SB6K.RV6GW$7OKWU^\
MS-<O;_4)H]I=8X@!LVL0?E')R,'/7\\^E<)>^&Y-5NB\L!3(PQ&WC"A1QN!Y
M55/ []J]>WHP#%$7=G@X/0D=E([9Z\9YQ495O/7RPG)&X =!@#K@>@Z?C71#
M$3@DHJ*LDKV=].^IS5(J;:=]^G]/L?.>I_#^:*<"WAF?;G>50@ L-P&3@'@C
MH3CO@\5SME\.Y1K>DSG<LD6K:?(8V RHBU"QD<DYP<)A\ YP< 9X'V@EG-*G
MEP&!\X60%4+1[@.>>3D<_*21D9Y%7(?"$$4T,DZ))<)<6\I<!0&\V>S,6!GC
MB-EYZ%.< KG2MF]:&&GA[4^6:?,VI<R;WM[]E\TS.CE\)U8S]^\=K-6:6U[Q
MZ_J?H/ %,2$88?-@[<<;C@8(!&!QT[5+@>@_(5'!CREP,*=Q4?[+,2I_X$I#
M8/(S@@'(J6OC9?%*VW,_S/HX+EA%=HI?<K'A?[0<]U#\%?BBMDK?:G\!^*_L
M[)PPG;2GME4-G"EUN2 6*CJ?6OYT[KP> PBAAWVY#"-V0*6A0[8'(?:1OB"-
MA@&7(#*#D#^G7QAH</B/PSX@\/RC;#JNE7EB\@ ;)NK>1&4J.1M41$G&&# #
M<P('X;ZIX,N;2YETZXB,<]@9+2?<@0I-;$P2*V<#AHR%8'9(H$D3.C(Y_:_!
MW-J.7XO%QE-0JUE[+5VM"4;<T7HU*Z?5JZV/POQDR%YKA<-.5'VL:$O:QFTG
M.$D[\J;32BNBM>W4^$==\-.J2+Y0!7C[J]   >#W'O\ E3O G@W5+G1/B==^
M'? >A^-_%-CIW@FWTFTU_0(M?M;*VU;7=7M]2N8+2XO;*'S%BMXR8A*)I2?W
M<;U]%Z]X7"),#@@,_)7!ZG/!P?H>AZC(()X[2=)\-_V/\0O#WB#Q0GA.77D\
M%7&CZQ/HNLZM!YFBZGJ-QJ%H8] $EZB"">*X+3+'&[3%(7D='5?WS.LWQ-;(
M6L'B:D,1"N\+%TY2O.$'R1G*SNZDE9R:LF[VBEH?RI7X8P-:O6EC\.I*56I)
MW4-;S;?Q0>_],^35\!B'XEQ:A\=/@]X=LO#ND?!WXL>()O#>D^%(O L6LZ;I
M7A*XDU&ZT]1J<EE_PF%RUQ);Z9<7%Z4BA@MY9FMW.Q/(/"OPRTG1/'OQ*T'4
MWL_&?ARW^!'Q2^(/P^\2MILED=3T.+P^NK>$_%MK)'<K:R:Q:I=G2]9BO6AN
MK/5[>>UU*"UO)XX7^DKZR\)?#S7=7N].\9)XICUSX7_$3PU%?Z/X<US2([#7
M/$>AOI5I;WP\2R75[>P73!5+V]G';P @2S1QJ)#\[^!/B/H_@7P?\1O OBBT
M+75O\+_B/HOP9UR.&1[?1M?\;:=!:^(O#6J00"XNI/#?BR<66L::DJBWTKQ#
MI^IW-\UA;7MJTO+E&$XIQ,<-".)QDZ:I48S:E-R348Q;5VDK7;;:5DFW>R3_
M !+C".09#7Q*J8:E1C[>M[*5-0C*4%.7*V^6S;23;22;V2/0O!_Q-O)OAEXT
MUZ?X?_!^[USPWK'PRL-#O+_X?V!F$>O6_B^/46UD+J,?GZE>W&GVEW+,(RGG
M7!,C!DE*^H^#H_&]S\+/!^N_#CX,^%/&U]XC\2_%*[U^^E^&-OJXFN[#Q"\6
MG6D+#4S;V%K;V=Y;P6[W+P00P(B2R(Z.J_%WA?Q1H]C\//&_A20S?;]<\3_#
M>^T^642O+<Z?X;G\5B_N)941HDFMH+_3C*DLD<ES).WV9)MDNSV;PX/A_P"*
M_AMX T37?BY9_#K6/".K^/GO]*U/P=XY\0PW]IKVKZ=?Z7>6M]X2/V>%Y((9
M59)C)+$\1\V%0T>_CSWA/-J%>4^2O5=:<JDY5/:2;E.3E*7N);MOHSV^$N(L
MDKX6C-^R2C1I<J?*FTH*W-=_%;>UM;GO?AF3Q!!X)^+_ (BT_P"&?A/4?'UA
M\4?!NB+I-[\.7\06OA71;OPEXEFO(XO"FEW5R=&L;A]+L9'U&%S97%W/),]P
MMR;B.+3MO"VA3^+/#.MI\-M)L/%FN_L]?%;Q[JWPJ?P^TUCI_BC1['Q._@G5
M8O DEY/J&G-K]CING:\^F2R-?!M2>]N;:T2X6-/%-(^)$G@?P#XV\*^!?'>I
M2^([GXF^#?$NA^(=&/BK1M/UK2]*\->*--EGU-;R\L=1>WT?4=5MI'T:\MHH
M[U2LD27++-(O?)\4?#I^(.N_%&RUWQ5INL^.?AGXZ?7+7^T-?N=7\-?$KQ#X
M7US0Y+72M:;5VSHVJZM-'K5C;V\C:=HMIJL&F&:"/3W2+Y">4<1X>I42J8B$
M%.:A&\U&,5*R2\DM%;LO,_9LNSS)\1A8M5ZBE"G!*,'2Y5:*5DG3D[*VFI3\
M(>%8_&=S\.?$OQ(^&/A?X?\ B-?VB/@_X5T Z;X/O/ -G\3/#7BJ^N;7QSH.
MH^';YY9=:.AG3;&47-O;QVEP]X+."XEU"*[@BYF^M=8\6:/\;8?&7P@\.>"-
M.\$>%]>UGPSXR\.>!+WX::KX?\2Z)XI%AX%\-#59YKC3O%UMXDBN6T[^RY1%
MJ-ZNGSWEI;2Z0(+Z3S_P/XVU'3?BO\*_%OCWQ/XCU?2_!?COP?KM_=7NI:EK
M]];V>CZO8:A>WMA;:G+=+83[=.#R_8I)[F9KV1H8RY>-+VI>/9/&OP^\7>!?
M'OB;6=8M]$UG6?'/PIO=<EU+6[4ZM?K<:7J_@G7["-(/^))XGT74+:\LM9E:
MYO?"GB3P]]KL%AAU$EMZV2<0^SA4I0=24X1J.4_;/F<U=WY:D==;O39W\CTL
M!F61S52=>G&\927-:*<K-^]*Z:<GN[65[Z(]2\/^&=#A\:^/1X6T3P5XB^)$
M'@CX177PJ\(^*VL-.\):GJ=YX;T;5?B-?6-OJM[I>EZCXXBCU&/4=/\ #USJ
M*KJEO>0PVD$U\EU:6]SP!!J?B/\ :'\$>%/''P<T+P[XPMM!^(MQJG@^]\*7
M_AJS\7:AIW@7Q1J>A7UQX"NWM[&...^TZTM+B[TV[NM-DNT-Y+<PF\C6O$_$
M%]\+OB-XGUG^WO'6I>%&E\'?"_3/#OB;6_"UWXJT=]0T+PCH/AWQ78>*H-,B
MC\46?VR[T:34GO/#]EJ.E(]U]G@T;53$U_<>M>%OBOX%\-^,/@UHFK_$:\\:
M:+X*T/XN:5K_ ,0KSPSKL6EV5A\1/#NJZ?HOAK0--N86\;7N@>']5ALKUEO+
M:Q+MK$Z65M8V<+6=ESQRW.Z=:E-Y;C:KC&'M9)573YUI-T]_<<K\L7)M+=O<
MZ(X[)JLG:7)!M\JBX*T;Z+5/IY'*?$7_ (7+%X=M7\<_!G1O .FW%];7<.KZ
M7\,5\,3DF",PV<^H1W]RQM_)*"*ZV&!H1&X<@YKQBTOW#F6)T8,\F#%,9D5A
M(RN%E8+NV.&5L#:&#*I90&.MXF\)^"-!T6&?0OC%H_Q$U&)+*TDT:Q^'OCOP
MHTHCMXDFU&&YUW4+G3H@LJOY:EQ.Z;7:"-V:).5@EE94:0LQ*JH9GWMM3]VH
M+&.$DJJA?]6!@8R^ [?NO!^"IRRZ:QF%C"I4IJ3A+F4DW&[C+F=[INSZ-GPF
M?UJ;S&G+"R<J<)M7<DW9.RVLMD>@VVJ7,UN8+B1Y(Y,EB6X.&( QD'C@9(_3
MFK$%JURR[00!QMW#Y0"0.2>^-W'K@\Y%<O:W 551B0PSQAB "21R 1T.>#CL
M<&NTT:16P,_-GI@]B?7V]Z]YX>CA5:C3C3:TNDKK;9_YW(C4J5JL9U*M2<8.
MT82DW#E5[)K?96W-6TTY?-1<$D$<X./SQCT_EG-=S:6BVS!\$;0"5(SC^?7K
MP>/:L2T23<C(V#G[I!XY[\<\<@]B:ZI)F$>'7>V/O8/.>G;@ ?\ ULUXV-E*
MJFI2:[M:-MVNW>_?L?28)*$N=)>\[\K^%7N[)=$MDK[&M:7*.0Z(">G(Q]WC
MOCTSZ?7BM8W*-&PD51P<]^G3E0?Z]>N>!S%M)Y:%C\K<G'/')P./7M]1]*K7
M&H,H?+<8X/X>F<]1_3WKRJ6&E-V<JENEFKV^[J>[4Q=#DC&JHP2BE>.CT5NK
M?Y$^H3VRKE2%.3SM(YR?]G\NGT]((-:^QP'9(=[!MN X)Y..=N.V,DC\JY2X
MOG<D$Y /)YX'7MUX(/'N*I37#2(&C^9.>?N]"0>N",$'MR?:O6CEM!QBVZEW
M%7UCO;7[/<\7$9DJ<I>SJ7BI-1N[^ZGILTMO^ =5_P )/?*C"9BH.['S;LY)
M(^Z3VQ[_ (54B\02NY8SL%)X&'/3OC&<'Z=>U<C+<EB5).1C/7J1GL.O/J<<
M5<LX0 LQ.0V?EQZ$KW^F<5M/!8.G"/N7?*KN7*[NVNT?O/.>:UIM^SJ5&[O1
M-VO?9>7;78[V#68G0?,[,,Y.R0=SC[P7MBFW&LP0QLYR6?[N[< Q Q@,1MSZ
M -USFN::X4QR!1M"(6=@"0@ZY<@$+_P(KGC'%>K?#W]GGQ]\3]*_X2'37M+#
M1'NQ:1-JN]#J4FYHVDL8R1((HI$:)KDHMN)$8-*#D5XN.Q^7Y,O:8UM1J>_3
MC3<;\KUC=-/9.SL>K@JN/S*#]E@<4Z='W*M:2:C*4=)2B^6UI-75[Z/<\-U_
MQ#=6%K?Z[Y+I#HUM-J0C96^=H8,;"F-Q#*@D!"[3N 7)(!_/"]U"XUC5;_6K
MEY);G5Y);AY9&WK%;W3&:&.-225VPM&FW 8$$, 00/V1_:,_9J3X3? #QCXR
M\2>+H9M3C&F:5X=T5919WFISW7B+2DU-+:*Z,4NIPVUE_:I\^S6>W"6QMUE,
MQ2)_Q^CL6@"1W#1-+''$KF$812(U'E<?Q1#$<A_YZHY&17Z5X;8[+,ZPN,KX
M6->,H3FHR?+R-WNM735[)J_+)J[:O=-1_GKQGQ>*PF/P=%8R,,(U%5J%*I:3
MMI)54IM.>ZE[J5[Z)#+9E08(*C 51@MPH"YRH/7&>>0#SBM&($8<_=+$ CGD
MMQP,G]*VM+M+=XPK -YFX9(Z?,0#^@_R376Z/X=LHY'=Y%=/-1$#Y56E<;Q
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M]I<_S9)"YZ#</IZG'Z>O.*ZNUE!9MQ4 XR<YXP/3@_@*R++X8?%=)5$GPO\
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M;:Z-O!<31HDA\FYNIQ'&H>Y@^S2::+"22/,QE?[4]XF%R$MHU')C#?2$NG>
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M&+4:TIN#]U;I5(O[FCT"R3P GA_Q%XPT6?Q5J?A[P]XX\$Z-!IVIW%EHNO\
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MP1CVXJT_@L'<XBD9/[X P<#!QDY."".G..*T?[4MM/Q*)45"0"TF8U)/7:7
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M+8R<#(QQG.,5T!TJQLY"L$*-@C)P!P>0><9X(./PJ&&[BM\JK_=  P&ZX![
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M>LT<3;U#9*LP.2"22?48)XSC@9Z5U6G:.L%[:RF422_:K#<,D<C4[( <X X
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M6FK0EHDK7UTTMM;N<#A%MM-VN_ZV/'5^&$$$=K:020!K>,YF8,&E=B9)!OD
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M.?A]6/(V1C<!C-.CU/$NT7%S]ZFXV,P$)?3I&&FBIW:7)3VH7/EZZJQB](A
MP2.$D=[X,2BP*'JC82='4\6G;[KD0EOSI!-R8>4X-$9I5%BK07==%N);8@5S
M6OZIU03,BDK=C,?('#_/3]K'3!Z.Z:$=O21C NR+54XUC.N]Q#019&V:&_J7
M=X.Z17&OZQG"NVW">0US?C_2;-%JX:O\+L3B[U<_7Q*XL@^S_;?>TLU8'F0R
MM!K^]@+J("3RM\JN%F$!XAPQ' _@JB6+?^IA?MTG-R3](63(A?8'USU&4.&+
MU_5IL^IH'\C7??>'39'5\A(0[)7Q5J[O"#J,5>KQTB\<!EBF)*;DX($Y[66_
M3RR](:G7ZWU;O!-,@[2H;.AD(,;T)OUI/<*0%:5'^AS/'M.BP@179^1]UQ1D
MGT/%D5D7H.$X7T 6HUM5TL8-"><-B>,89KA?UB/L\BT^QHJP$GD40D4LZ<G,
MS0D*R!^&AI2Y)FYY@EQ?%C8EKU0VGA> Z[<;_:[Y:XVJK*VL>?-*/S<T4<IS
MX$XCKY^!TRTEKC^&X(2<L68)\J^X\;;QPG )B;0FA!HV![K>U/#)J".>(<9V
M$KFGC=L^1P=PGO$"870_XB $0;XPZ=T.1I0D.*9PJL+T97M[44JF&52ZQ=^5
MW]8A>"&28$067Y(^VXW=D?W2C5TR"UEJN9"6$:\>&=H(M-%9J%!J";J[UA.L
MB%_JC)/GP@DI]<GR5GC#8ZK 4K7;]#J!T'+%]-(%/7G7/,?,'I,5QP"H/UL#
MFH8_?ELZU+WT41JA=<\LC^G-,_8 N/8$G3(]@3M&H$Y>JU5S7M/'BC5$8J7V
M=(^*T';B2*3P)XA@T678D%B..U )1$A_L-042MEYC>J>9FMN?068/K,Q#VN6
MK@GL?)SS;G\>J6-O/.[F*\2B.GOW.[1B>6YQ4^P\!M]S_6#X0@J6@#V]Y+%E
M=),WP.?UG70(R=*M?#H:IAB+%-U.ML(L4H10N^3^0W<?)ZGD5M_R;XO3V#7#
M0"=U'+W<0J5S;8?J@^^,U3#N:IRX.6:\3>,L#Y.7=Q2H#2WC(>\P&1YA+,S:
M,.@8Y"A\TWS ]<L39A+M-;PM+W'/L(K7X,0PJX0]0,/XS*IJ\IW[0E/+^8LO
M5MH6SU88>)BT15,=Y%C9?KS]5$9J_W2=.K$?F9,]_LH>?.MBCMM7L'>M6/W^
M3^FM993(:O6>]X5X\/B7/R58J;ZE.[8S$C&O6B+^FWG3BL_MV&7Z_A58 @N?
MU58"!Q2D+C^/&4XGFW"PBSF&32[1H2[ ;Q-O.<=-?-J]=]?!IF[AAN0][BF>
M?P!\BY3JX^B+EJK;%>:5=SE3N/@%R@OY]IYQ8[)!=583[Q6D0%Q[AT,9P:*Q
MCI_ZL16Z^K&ES:/".9K-)?>YBT:&N:<LE\?\O&JV$KR><#7V^PW(?1A8U+#_
M^+-*[AA7S<8KQ]FV*!NF_TC5>8,T7O1]MC.FB7<*_4H]*KXG6^LQF.OIDR3N
MA'=2\FR5GNJ/7OR7IO!<//!7N)6SNYXAE:YF/_E!/&S/QK#_L'"1^]ND5RM\
ML5WD-_3(\D2!V4=XT54I6*@?GK:QJ5,R'+CE6URM>MO\CK!)JO&1=4D\^59"
MV:6GFM.(N^3ZXY%MZ>/=P+4SWZI,H)])SW-2!^HO[Y_$*RM\..C:VC+F_O#%
MLS"O)^_GQROE2U<T7P8__R!O5>JY@MF\>!K])%C*8:D:@CEG':@#6VL.<!^*
M2O_4+6%=0[=[8#7"BV;D/0H:HD<>?5G!N'\H,]4\'[@AD1PW#KW]9)/U=NF0
MLKP5?1=IPM.%.MYT/E(W2N.CM>#]Q!N22O<'9:3..QX?.^C37X_O'^\,.P$1
MKB;TFZJ,/E-KBEJ>WYO4N5^FDW<Y<-US8G1F->4)O*\\7R9DBX%>LYTS1'1;
MUI4=>*O]:6C,.;K2\XL5J\)+^_G;S)OZ.4CS<0DH=W6QD=^+#OZ_3\NF\ED,
MS!@I6LRNQGM%-K]QV-JX:N,KTV(<\SM._@0JMH7][TGS7SUTI'P!^:DH>*GH
MP?3GSSGD3'8_:<^[Y&/]%7\B99Q#7\9_-+%OVDA9/@C>TW,L=0CC=K1CE)5.
MM'X0OGAWD?68+-B0_&G\(P&LH?'2FH=&;?:6>DGORF"U"-_<I3G!M%:FN0.9
M.R&^$ ,8A!X@BN^RQ$ &U@70.W?LP,[-@)/(IQ^YDV"\\2XTF@X:8/&*E:9N
M6X.ZYMKP%U&4>)6TO\ ?#W]G%=#&JCI:*A2M=<7-6)-S?,MCO2%Q7A+!I6,D
MXI[ECZ,<W[KB1J_-:;?.J];-+G@1;.6HV*I@Y=)RY%X'O?3'<'&)LY>$X9^R
M>3\2ZF#./R49T+G<S8UIUA0ZOAF[OIION;6\\K?)ZRQ=OW!G=9A7%;5'5B@'
M4DHEZE&&O$V594K59G0U7"_'DL_\3MHX2=.&MU;[7?#YI<4=*T)>;OZ81%B4
M:;],611,1AGY=60M!)J?/S&;1KU<A;Z 9(XL2F:Z.8\$#K+1F,2\<8J7\UE1
MF$)EU9^8%PMH4=)]_+G1]',,(V)"C A1"C^B OR'CQF6^!:.P:E6[IB.+L3G
M_V5KK%/A 7/=9HH!J5= W]4L]LEK;09+$T<JB7^-0JUU-G,77C4E&T:S6+@+
M&\ZD;] WH5]&/$ZZN_LZ^L5"_/WJ6P2IF$N6_"W+A"@)8$7;B,T^$_0H[IY*
MTHP$&"E7-Z4&OR%QA>T>[=%,.&@*[\9.K%B/L#9Y+@S45S3MLHIU2SR+#-.K
M"#1CL=35]TQ#)TV>I.U8)PS7QS\SC&TO0.A*^:VCW*J.9L3FY9FP63OIS76-
MGS/LFJ2D'KI L2Y"7%C>Z0-+M1HMWBA#G\C%H'SS=77JI/Y6/5K8)^SOKA5R
M5\67!*KHACA@O]34W%;N0[Q$T=0RA(9B*WBP')9LK&D(>0CX;_*ID9?X>T1?
M2E/=W<PAN;!4IAN2E\*=X(1(YCO(JO0R*_#+$;Z,P&*,*I>RN-?SL%DC2(K%
M.DV*F$HY$PT3->VN2?5] E^?$,1@NGAZ8]H7,&)O;#>Q;7KX_?;L;;&"07?T
M(77QEX\.FJ<RGKT?<Q7_7KW^Y?4UW1 I^(J_K$F7MD17?%IDOX]?Q68[+BT!
MFD% PBX$?DSE,!OSR)8USY09"AMYFQFEK@VCDOVG+S[A&/;XJFT'2^='<$+^
M)N-[UN(P0PQCR625T+>W_M"RN:+"FJ]O6A_5%'H(+ J^"1AD&C /?GP]T1H1
MB:2X(;DSCP%W!VGQ)D$E]@_$8]HBS=0)/%=KMJY"9<BTC&)+RRVT/Y1VEE!T
MF4:C01Z85=@4\JGZ4J-,IW#N5_HLO9G4J:!O83N UI1S62-T@HY;4S,4J+E*
MWV??LV%'5OP(>9!W&\[U;\AWY5$?0]^O+[CF<M(;@F<K32?BJB."5TI<J^D&
M%L3?F]=-<W[2;P@1V >U6'.&_K?5ULG68TZI^,AXV^#[7DN 9=G QJ\TU!Y/
M@'7@B.7^.OZ&A&&M7M [CA<;X<N64\['^#>P3$K1Q-$]8C+O28@K!T?P\/(3
M?'P[?M@R2X>8B,OC .+TF'<ZA"-T9AIL(YFM$848Q%':.:T9)C7%\E_6D<($
M?YVE1Y].S'6YS'IJ>#\W.^^?7?L=WR%.9#_X:?M0_CX8OZ!'B$_/AR7@G"\Y
MV>6 %@=(&<2W9JB>V?BBY1A[J)&;9&8VM(08S/38!;</N0#;*87;-J3VP-IP
MBG%8:]D]W:S5S@A3.>B^<RI"4.2X8GC$Y&D\)#3F5AHYZ8LHC!@I X0UU^:G
MR7DU-B'VDJ4(O$*ZHM[:$:[CWT7?P3$MSA*D>SAE0K -@TMYO(54;?GA'Z>]
M T$8Q&X!MNM %@L+BT'EW6!?\OW\F"Y$=[.@Y%W&2F$0G_7DYXWGS1<R.GTR
MV@(O#0T\S"_&U)&*6<(XS-SN 5OB;.4R^R<$G0SWMDUV$0N_-GYC8F&Q/??W
M9 A+PQCCI<DX5)BA.PDV;#[)P\#5:TF?YWR%@@KAWJ6=AXU&,3;/!(]![LVO
MF49;<(4O \"Y6FO.(0G(SKW.!Y DF+WYI(207"]]X^9R()LUS23N/HV%A Q7
MTOR\I1A=;)QGT8>_>]#?+;$H3ROQH*:][P2-7G;JR0Z.)?@_+^GUN'_).?UF
MYE%GP=*.I=<GE9FCBXN[>=V2DW/ JWPWQ*Y3.[/O]"&31)N#%F(YL.(3V;M@
M /XTYM(;X2)E2\=-T/CH0V'-H4JP#;\,<(;XXY3(S2U<]QQ+?U;3-\2?&C<H
M+4B%C]E$GU7]:WK]EY4>QV^VKF*@]_/B+Z=?F/4.Q<FZ9P<\;6G9^IF^] F%
M09DD3_G ]_W#N^T!T^<-M8\1NH5K_.KZ!MD%DMEY^\>;KA<%S0G]+ T'9$1G
M;3Q?A/NEVC=(9D0\59S;_A!Q6+^N,^SHHO/>?1:1?+!DS:V0 (A$ZH_,K>)%
M_))\&N'J#L$#&S;Z<?6&Y/ZE 3X#G:65K@I<V!.%R#S#[W\S!5<>RPU3[(#=
MO\4#5=W08DRXII;6F2%+-7>/ RB"!S]RKX_^^M&XO!'^ L<1)K["M,/L'UF-
M3'@ -\";1=LW$= )ODR.:E/(-L:-6D+UI_VH9:CO6Z=K($6@'G)>C6S]A@0(
MER36XT288![J1%NL@G>/(A=S^US;=# 3K,],V99:RXO52^K$/4<PBCV]&OP^
MM>$T"K=$L[D_(HB,B<B<.!X19?&22:G]XN.*?3$CH)%$XYV\:8@RVK1JK LL
M/%%SE)85+9*5_N7._@3-K\!7G)8%+1'9! MYY,]AKV]!6A6S<-**7?C-V3[>
M_5573")^]'-K2?Q1<]4K4\EK(<5GHC\5"[[-;<4YTIY+UYH;2O>^Z^/J/Y2:
MX&"_(7&P);^T;&NL(>2F3=D&Y;I<RE1F!'?A6 "JCYN30GB5[PA_V!\1FFG]
M62=CJ8GHZ:VM#]3-P9><.!"YUC@HB6@]I@8.NDL.[$4;FQFPB> 0!ZZRW6GU
M+6U/-L)OIK/T!94MX' @%Z'U0 KBI(+*L=LQ14LEEAAS$H<W"[LT\R[=L;VG
M* 3_#T_*')O>>AHE(GR,,.IMM>XKZA78!'%08F!A$@IW]-KT5I9=3DZ\!D_.
MW!T"?35XZW^8CD(V8>#)HJA8,ZZ<#9>2HFF;A%2?MO?FZZ,O+"09[D1^WEG]
M[:_H[-)B"VIGJPX1&AL3B;*M6XFY9G3%S$:,=GZS^6.Z^5"CY^0\OJ+$%K18
M!^(>+ _Z/%0_5]1:V9AHOIVT )Z%W%X<?!KX@2H#EH6CC_JGL8?FL IE(K0
MIGA^S#F9WH<1E/)+SQ5!]Y5S;8^#%IDXQQ'?2!:T6U\G.+_#2_QZQR%W9VX/
MY8T/,26F8\=NP4IP>7T<D<'D4T<YDH</[665>N;#VPLU%);;[?W@&H$G<AZD
M*CR^Z7U["!N(WUZG1OVD$ZH!(GW-0*P2;_?NQW0T%?PQ[: ??V*:R4&Q%>M1
MU;"@(U$I]+UVQF=G*7CSI_%,>&5I:\UTX01T\OC \A CYBR$JCX_ 5%"M1,6
MNI%9;:Y>9K-FY<ZX (0@.[-P$?-7EVXS3Y_5LQ;K10_G]LR.*)OSQW#94.O
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M*$C:W"J.HJ!/M#],N@]O[U.MNUQV6F1W%%BHF$,]J>@KA3DKIQUNVY?-CSI
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MIM2Y*D^L<<J;(:R%.=5/O4\<>!.N*JK:2W7\W;RUSH=-22+R_GC)O[I)U^@
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M_:CRQ_Z^?!QQ_<!2D=/%<K97Z0%<H 6_'_:]KW"+"DS(TVN^[JM!IC\L!I\
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MX@;<_&KK4,C8B+ZKWE,=QR^AHK.J*[J<]X!YCX(&M0:"GF+HI%0<!WW;$5*
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M=,EU2J3*W.FGX&EK_A<QII(G99.?U%V(-M,1C3]TYK'>_=-'4K^>&F=:M>]
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M<A+?\/17&0Z6N$Y$]3B?8ME'_;?H"=K8*:;]?O>%S+SQWOB@D.[6M_A+!I=
M<O8.1& "1#%L588O<UYBCW,'*0K<$TLGNA$4X/8\$]?ME;"5CTM2C[[=@DO
M0L! @/\<2XY*U.U<R9KI.S<4TB_CYC\6ECG1_VKZL\;[Q_SK?W66?_COU8I[
M1@_*DZ(^N]6$@Y<+ARK=*)S\=/"@ALMD@1!?9HYM["&QK/.0QUV5NZ]I/+5Y
MN]^L(3;WP*V5KZM:O]<8A&BL+GLW)YX2. WK@2FQ;8'@/QT4(:Q>(%*8?#CP
MWPW6;)>7&'B9*_.S\EA\*3JOZ]^5+'=T23=9<&R.G'<!N!AQ+..UUZ\\M[,S
MUP(4/AO&+Y/R.OM!#5@'3(ZM#CY@V'KW$AH+%A%'P/"Y6<G K$GL&%*%H1N0
M/QNWGF:YN1AXFATNTW#?Y,?GBN6PQZ_.^?RFGQ<+,H557UBDWJ_U.2#Y*7S7
M_CT"4H_-!"0MS9071G]Z"6/D2MAG6);X.2_H+#KQ\J"QP>VF4W)<+<"IGNDE
M^4W+1O]+QPC)EJ%LXS06JNFX^+ X8X46M^(3_'B!E11$/!BC8PN[^/_-53M\
MO:<X3[';@4RO+X C(V,.U#V/D,=X]>!/$.%)]M<[D+T-_;+-DP<XKY ^A$2%
MBLYI2T#-=YQDOFT"9O?< [?;"_>GZ^7R^JI3TX#QC1*P[L_YIM09#]J)]V]C
MUI;S<+X<M7?CQ/56UV =&JUS:&PL<'*U)IBX C]8%SUA&Z[^^7?O+O>S)9_S
MPQY;2.\.5LX5=(4F\"JQ7H.J0W/O="J4!M/*O%X--/;!]J.->K#[QG2,M0"Y
M=H3^\!7S,G1%NZ?V\--I-,Z]UG8V@)0KNFUK8_][_86YS4C5X$W\]S0OKO V
M$Y8T!H#FS*V5LNWS[# 0OKO[;2MXIG(2<P*,*@$_]=KYN?5:@06,V3CN'I8.
MGHVC__237;LT$*JXO5]_Q>HSWNG]-G_U@$0]8[-(HF('LEN&$ZM#/!S#X+']
M7.)*ALGSS>'N>ZCP('A>^U_B*M$WP2K]YU>&_*'<F5792/]!JH56>N'D]@.0
MWP5LW89QAV%B&-T_.DDD%,N<@8A]J7: \^:/"XGU?7 A(BIZ]]7J1O?YYN$@
M55]S_=%VB[D32H(]:Q._^QCC25P1L+F=(,L]C/V*/0(JTI%[0<6._,2./J1
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MYA]./ #UVC^Y=&(V4.%)^1?5MCC^C1IWP#>>9% :@#@ '&LM14>:#MTI']F
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M,X<_('[<@#3J]"DH5SIPCB!V[:0-6)3ZI%WRML?EA2D<\CTG,YPF="7L3>)
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M/6HA.[%@1@^"I;14WQVQJ/99:"DOA$?<GCQ^8\7("%OIEE#$W)3,@RPO);&
M\ZP)^U[__4,$M9@_R\AEX2<Y(?9"HXXQ.DPL*[H J@1Q8BX80]=SV+P@#BE6
M9/@L>+) ?T1.)2&CPG+D95?IF:&/RHL@9<N7PXH?RO=YJ\D?L*]4;+_ZVRSF
MP^G::;T#^^&97&1[9A)+BR##02<@=[0=">+0I?!]9Z/EW%Q&=3.<ZRT$:P7>
M7ZY/YGP\WX>IQJAIAD&A+.]IS'C4YO*L8 6_#U6Y)=]1H,2_94AX4TW@#MQ
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MP 16L&N]0;R3H 18)RUO0*;&NV#RM:*3Y5\(3OR\N,OKCR5=GV(!2T8KFZU
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MPQO][W_66Z[DZOT:WOMA=SA$I,2G\C8@0CEP R+X%_3@#BB*W(%==*C)!B0
M-VG[5FP%8K@A&O\1,&7S-JPTL5(!*U%;%SP6&8!,H<20O)(Z/30. E-XHGBI
MRT/#]37PK?M;1<&V]3_KT7X U%0Q3/R6*3,$#R@!X]IUN&?!9@Y,&F_8D_</
MBI,)$9GR'3/;(CGDA"*UL5S.V(?O8[^/@F$UH/,9&UWOE.6]G*03X855&I&(
MG%%ZD!D$'\>U3A3;S"%@KUKYM0EP&*=VJY>+(J.,L>(#VS$7I5UL]ZGA1HM<
MFW?Y&S:6OG76A2T7S/ENXG;&!==ME6[>;6S^GC?TV3=.S^B(\5 =INC;URL/
M^_[ZEW)_ Q)RR]MH;U?"]]M&TQ_8>[[PC__UGXQP/Y%!4UI_A+RT]#GB MCP
M#)PZ#09PR)!I/*E[ Z(6NJ[A9]].WEIC'*;YW_($3;<;%Q)9^=,&E6H85J^]
MIYGA=F*(VYCMYW&N+GVHM%9X0CR$WOPG\2)Y _(JJ),T$=?#W E.\..<UBL0
M*H13, 7:]F#5(E-@O .5Z"\]<FV<:( M.L2OB<,B4@+*\>3V!A88WO?6NR+Y
MOMCP-?]O]/L D[+"@LS/6T)E/8WSSM0/ASX/?1224$@KO)DU\5F_]/2@K/J5
MQI.I'*:>R:[\@/["[G_+G"(9!OH?)5+V+L&6'=#RL%-;%1A(#'R3LVA&KUO6
M,CSMY^!PQ1=]\O*N?U#?'=/PHO73G,,EI\8.SR2<W_(6N6_%;-)M!K:P) $J
M[?62,LG_SWL+DUF 7Q5:B/O<F3M:^.34O!-U8S6A:"6"_^N1D&574J1*\_4J
MLZHA3LKEYM=.NCE#A=_<<KB9F4C)<-R 3AD)]I,F4%U-,#7+VK@B!)C$7;J/
M5&N3*9Z>)\H":NU:06Q<.D'W.2C;1;1^'7<66)XD=Z$5@L4P1C5A_UI-14R)
M23HK]:%+$YTRE+,!0=]LTR\)5K+K><&>EO5\;79SJ/!LQ]CL3(J!]@7%:=_N
MT"'[\E[]/A^?8R';=^;UH9GO;\,S&7#DYBS!Z\9TP[/#,Z^;G<NI#4V,Y3XG
M3U^UK,\8JSI?DW?Z7U,6SS[--LP=;CS49W$0$J:@>CWKT0O3UO?N06YMN=)>
M.9J830IE#D._[M^5<W8Y.;GEK7K0S<TR'Q<F>E"&1PR1!_LNWVFTN;MM[[/_
MUX7 @63^[[-@!+]@QK!]%1@K?C&/U%Y!I=A8)7&,L*V'+>C;G69@4L>XMO/I
MP9\XUUKH:H*A-!_7@.WE!BD1=?(?"%3V$H\JP6,T!=4+_0Q@HJ@)" .1<F:G
M3<Z],8T^H1K'(V&%)0^B?6DTX-Z]K]F1< DH; U\6#(?Y<EZ.87:@"@;-+H8
M>-XLY](Q:7@ZFTJ?*2CCOG_83:<H-[\3=LX8SS7_R**HK0AJ4PDN *R;O!-A
M36H_)KH,1"TRCJV7$O\6,Y R1 .1%%^N0T>/MI=!"H0F]D?.0'?X)V7@0 ^T
M<N/U,)S4?'[HV:%"9W3C6.G)UT,\/0CL)1V&L)ME_252GQE0Q_JKT_B6]/LT
M4X(.Z")7DTX*VLFHI1T QQV "]Y=O_U\'54^9973J"$1<"O6]==%1WNVI$KG
M()(2OF9,GTE6)9D:X*GW-%SV&7WM^1J_]]7WO6^OA,>K'SE/TB0BB8,(]?7G
MR*O0B7%.;^(-7*AF-4KP:3UKF;X3K^EY@<HW[*1KXX,$&8!!&I<$P<=V&NG7
M5+)-PL>^MW,^NW//:(37!S-FO=/3O_4N%"S<V:T_<NAE[F?B\>S<E%]S5[=K
M_5*Y=^/&@TSC1 BLJ,AJO8FH@R:<Y),[<1-3@E,@1>C@+SKTYN%I,(GSDT+?
M(M(&0R2Z3-GQ<D7P$(ARXJ.[9:=-VJYR8 O]I\=6:@EF089)-[R_F=2&?2Y+
MO.I/%QX1C]*TUXN782IO*N((&(#%07::[3@V0TYE;27N\9[\C!^0W##%=/GG
MRK35@+N/G?WYX3 _HR[M7<WU?,-XD0=[W<T=6$UI-''HV8"XC)P9'KB*76H1
MK9U-+YU;Z^Y>?%P^,3NVNI986^4[H%VP.0L7LCVBA5EBN9(?Z6X^X=EM5?KK
M2]G(ZIF,[$->^\)$S>LY<.=:_&<Q$TD5IQ3/A8NW@;P0=K(8@F&4-FF,IQ-W
MB3^AH?"3Q==ARM\;$M52,6)]?,&YL14SN?_FLIW91C#HIGO&JHR/D!4[DF"9
MGY32YLJ7=?F3@G"-G(INW(#<HZGBDUR!S$RB/MZC!R9'4&=C69KX@,L%731E
M\*1,IF7?/IH)F-3QJ[JG\&5_<4W!TRDP[<Q(Z'5*=-^4\?MEM;M(+#J>:+=>
M%+1>8=&/\FP ?8(DHZ0Z+S;0*'I88W:_32MB9G9%EJ0&(GV *YY,K!7-&F#6
M7R8]0^/=]9M'OHX83\KI?/H^['P2=U"B%4) >R> M: I-/3QCHSX'8R6%FEQ
M>"2OILR 'CIG(%G#A9XF0G/BHR-W7U_1BN[*7RRK#E:[[6#FTN?OJ).6>-D?
M)]R%26&3)\GB;:[ 7(=.OCZ=)PWT<8CDJR&!)L:A_1%<ZW:SS7-H!664AYK[
M^_*Y_ U(_ I2,?C0 )9Z80Q^['G#A_R<+W5[-U]DB7;H<N7)[ F:Z1P=0 U,
MNJ'6"V^8E(WC$#K49(0Z/=.D37J7,YREJ ?*AG >PW'1[!$&6GCEAV,3Y6&/
M590-K1J9^"SCB'A@.;.7/#G?@=R,#"S(G$1WBF%TL)Y=T(?^"XUWLP?**668
MJ*0T98Y#<PE(ZBQQ&FESBBG'6#G#UQ8?/4RK?&>R//7XYNZ6HCT8B[04(4YT
M1S)*&Q! LRM/L':1GD;4$QWWN\JFMF<F"+9:,JE\(\Y2^L+-T$PY$'V&\33?
M.>O2^*K50[#CU^V@9S^+5#1JBJNG9W,O)_]GSXU88'$W($DPP!F:M %IR(NU
M</'A+&72%$"4(&"P1F0WTVIK-=J&-NM :8H.CQ$<2:6>?55X8L<^M/ 0]G--
MF%\P]ZR&GGM^V0<GDP_%$($S<DI6T$8^%]O!%6]-XW,Z1FL;6WW2SW*YF0N=
M8=C+Y>BYP(ZE"]GC+F!S]//@<YC</6:F'BZ4ED?UMY4:DS#KB@Q+\_!-#JHI
M_YZ"-RE5]M1]&+3 _=C?X*2\)\-I\]6<T;)[I?>X6703L0YQ#-WTXVVU.1H<
MXI<(4* $;K=//0T9;8O  9W<\GKN0 8+2E"C?AQMPW&0V]$$RT&X'"<=UJEQ
M!U'/D=-L+[(;M]0R=]FS_).B96 4<IS$(&T/CKK9>K4,FW]QO?Q%^;R-25%M
M6;"[G%ZNQYI#:658F;_/NR73;\T,YM:Z5W5^&Y#6+@/XW5LD;:(9B)N1Z4 G
MHW<2W#!VS'1@M:-E/$U[^-T>VAAN>=[S,H-PI%P&@DR&NT:$;4YXUIOD95JC
MZQ%P? Z^) A?+VMD32(%$8-B.-[Y+4)O.$S.YQ3?A58"5/JT#?6FP^VX*.G@
MR=HD"BXQOY_#+/Q[JLM*K#N\N/QBD77.[Y"B2?5H_]?P585/!"G!T 8D[3U_
M7'!V_:&Q:*+Q#;;GO=!%%/SKT[P/+)[54%Y9 F9V1(57RQ[Z#MLINDE^ZWY"
M^H'O]1:9E!L5F=>X1UA2I>A[,"J29PYL7NZ^/),Y*=]GOUY'W-'CQZL>[[9Y
MTN0OM?[4PN]0A*N4WS2^]@30VQ6=MM-4R4-;OZU(-II\B',*<MA,C=1^BHZ!
M0H)A4 N2!JG=@@C_N4;M1JI.@-"W A;0O $)M$T8)Z"CG\YK&\0Y.#:"#?_D
M7VU*>QJ\&OC;*\:FW26+&EW:\IH2BVLB!2'OLW8B#DSBFWYS>A>ZN9D3E&7L
MM#;K6!V_-P.AAO^.4_-D>O?=?AZL.@#T=HM-*,,>9[.>-6%CO)U]"I[U&3OI
MG6I'A*VW$'K!>HGRGDGY^J_J>DNH^J.4EC;D)J*Y1=/"C@=7F>HY=^H,E!.E
ML<N)._2]'C])V4D[5!9^4'_'M9L[,X.?<!\XGCDGTT>FH'@N,[43:FQ$ ]^Y
M=RVPN<:NB"Q-3X"KSX#R+[CH9-K^;.;<DEBA=O//6UN_C5!"&<NMZU<6URYD
MGAUNC,96VY]K;7C5V-R:49%,PJ(@>%O!/Q*YR3O&U8QQ<P0R6F?H6\%7XYWA
M[OT<DH9+!%_&A:'93MP\:%$K5WA6+KI;O&?<TM9$V<7'2;^!/J*'OW'3L D1
M&D:_@4J@;>(;=J!2-B!**_0MUR=KTVD:!%E0).E]/WN>7 3;D9_4*>=VDB^W
M^.^#OE>3@@W(J?K$CE7WU,VC/ N'-W5#7Z=?^-N;?4-U+6E]!K%L#Y$BVG&D
MS;(*7$+%G1@DZH-H=E-<$/9V-<CED#IA$[GM""7\>=LC#-?A:M/J%92*\PL_
MK'4DL)I(B3$_S<\M?CXKX7H1)(;%1DT%<7[A"]YJX'H&/D=PR>UH*8(;7S6-
MG2F'WX"XC;7)\'4Z[<<H8-JL*GD'W'PFAG1Q7*R5TM9D/=E3@5F_5_I%62W9
MTL3\_.^%XF42C#A6M)]!,Y 0=.9;B5I'[ 57*T6'ABRJ29R:%^5X;@=19I!@
M8-GGG&Y_'$A,B>8\+D_K1BN&U4*]>CEIL&VS];-K-VRT*YXQYVF[A\O';B0,
M#+2,\RX*SXND1N!V'/HD51 $!LR@[Q(M^7D)<-T7!$?0B9]W#BS@#/PYF/X1
MUA5#VSDBML3XZX)79];W"X\WCN-"!Z#XAUVT;2-M;E>Q+^9NS1^:+D2(QSBD
M$Q(Q1)Y$LF5Z6/=)*@@('LUV[ XQ$R2AMV E9)1(U!$Y\V&=(<[LU>[,K?C3
MX^RQ@IIC-=XB!/^'2)\$)3BR*TT0K M C87<U<Y)<@*MGQWWTJDJ6&'VDG9M
M%7%<6V8#DK!U!IJ!4!H2V7.-4&EY3'5@H),.Z4@I 5E=V@A^8&/+.<"XQ+TY
M@W6"+Q.+JVH["P^1?Q$3<I7]J,V2HYDVU>J'=&C-9\VMV[IF\YC[BA5?!7C9
M&_V;L]6KY([Z-;,=$@!^\.CQ:+[5]0_U(O5U<AL.\)FA)L-E:T1!X/N*8*("
M*%,LL@?0;_>5 #^25YPEZ@FFL()3G=>@\C!"UUD$!'#/XT1/F[6/T0SY#A5
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MR!K2O98H+W=A"FBSWP^164_GE_!XG7I+Z+)5UV_R-^$KWIQT&8;PM RW1[\
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M5A;F$1/H=(VX?^4ZBQ9LVJ0GBANZP[\LQ>+"4KR'E^CBZ:/,@*5^)8UU#5N
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MUS5OTB1@ZQO%'D5_2E2V<RDB\8E-%<_&I;DY>CFA 916DAZ$#ULDF:B%-[D
MJKW0U>H#O!:6,(6<GN;+M9Z9G))N>AZ>60)NJ +DF(#>N)&QZOSM8!%W,V]3
M73[0D$)%JQF^E4(N'&"W]?L=RC!=H'UH5C%M)F:[&UTN18'2N,Y"$FF>-C?
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MT^#M.6#]58Q/;[L-/RGL9E/_RQUY$48&PE;?[]0H<UX@&';DY64\,BSXM&G
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MH " BP:<%J8'Y%':_9>9+@,ZKAS[)^W:!>8-_Z7E4V#SIT V+;.68(6'@%7
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MX9W19UC0OB%T_%G98>5D9Q&%[J03VC) O<BW;U!;<)NFL(OS7FN=.<SD5B1
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M"K]0J1"I:XT7#@,L?K)?WDDH9?L1_V23WDFH;68BO_S[Q =7);")O@U_3.R
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M(%XO_Z]]UO_?">5VZO\!4$L#!!0    ( %2"F%8TD/M4/R@  -,N   -
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M"-U QED9> #PX: 9],@<TQ? 7D^+@*YS<J1C\9'H[\(M:-E'"3HZ6VBOIL'
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MEJGYOW;&^3DBN+'2\'H#40\V_E$$3T_]#M:2-%3"5Z8E"^"E3#M!/;!9/Q[
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M_HAMX++'9B=M@%QTH $%0.Z/Z*/U(1K=B YN&#T+(?K_+((.;K23 93UX-S
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MJY:4'SR$$D#HAE#^+)XAL^[H>B)!VS&4.(4,')I"O^2F.\X)BK1?FO43S3V
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M%!0<_ W]1+OGTRY5,(@W1(OUGD+*T&],[@XO*^ R>5"H'[TKO58 ASNO6<4
M0#_PEG (+UQVEL$;4ILC8.0EU6'=48<5FYN^YJD,\18H5GS :3Q>4Q@ML@FI
M1JA0]"7%;,8N,ZP=4:85%NC*@9&5_X^5PPQ'Y:9@4C!+!L15+VYN:[Y^\TP;
M8?;4NZ;^+&@8^8YRXK?NP<.LCPW>8>M:L:R1'D^+I2FM'S+EV"@%QX"!_<4A
MQ.$+<O 6<7_?P#X<K((81#,7=_G+8.**DW-6WZ1A*RT33KT!?4+PD\ 4Y*23
M>4-ZB6<P225A.^+)5F<8#Y2P^.[N06VQR$Y@]!79.,5S#76<Q]IAN\M^T\N2
M]5N!=?-ZO=-M56;Q3+5W*1(LG^7==L_8<9MYLFQXK3H*H.18S\3H# YI,:W'
M)9W5W-2XK3$IM.'87UF87R;O\&4PQP9]-3%JX:;*=,;N(_Y2EZ2_\JP8I)))
M_?MK429I' RJ$)R!W+.N,,V>?>&4\:WT"AVW%"?9!D"0J<=; X5L2K*?4*]W
M5\HL4S@X;E'SM5Y2J@A!.'P9Q0G[GN!B)^KI=#ADNP54[V1+@B"F[I!75R%U
MQ "O0.2#[#[SL.F4JFZ+@IY,9Z),UV[9$ SQY*@QZ_240!ZZ<DT7:FDLT!O?
M(W !%"&;+@ A=;FI0]Z/02ZXOZT_33P_PGQ9VU(8]BB _@F2IP45EIXNS:WU
M&+7U?@I_JY*CU#D*1@@PAF:'#O>AQB-;AL=FU+=J>UM.J#DD8DY))U?VSNU3
M(*C;H^64YK[!O0DGDV&+=55/SH]-^E?R<]]4C6ZYLL9*&](YF7B\(BF1U)KK
MK'.$W'WWT9N:EU)*[>8KMZT)&E<DI2YTRMQ@W57B4S]*>M/ZZ4D^ )6H10-H
MD7>*U_HK83*=*5&$%#*=T:=733DPHOQ7G,8.(> U<HO@W_<)?LL#W?\VQ<6,
M*O4.(H'=9@LN,OH2-HP<GVH+<*N6'U.Z ,1RB2"Z;HP(\!^\JOZH/"F7D^XU
M7'UK0H77$ICGY_V;N^'T-)4 Y4>-S$UWC99Y73G+IW-.)@NIIQM>@:@<.9,]
MD8UX\Q+NRHBEK=6HU@A*U!YI#NIX\T V6=T=SGJ[>Z$YYB@M,_% =O;1II&!
M 6  <*S@B-$/P&9TQ'TI 5R@"YFE&J\TNVZ*CP[;PWUM?G>'-]M&'Q*:NGW%
M]39)6/?EZ(3D]"?YQ$[=B3GF\_P^D$CA=#6)POR@MJ1T:M*\LU'@$8LE2\J2
M:UZGQ%<LP[=]I5IA(GGT6(T3[_K/]\=0^EY?DKDWG!=L1[AC##L'*X475&:F
M^$1#+)PQ\LUD0H:$1P;!O3(D(KL='W[.-?4FN3"WG7I'$36' \\-ZBT6CN?#
MJ4E>[ PDH^XXFW'%M'#VW#4SG2 UL0/W\BVF<F<[Q^Z#_%F'X8^H3V\R4#(^
M)I7G$P^,NPYDR\4AO%*7D1/G())\X[&D=P'$49A:A7-:*7XYUJ'4856O@NCK
M#'"TECCE1<SW27H<%$@2*;+-KH/.N-61G^AQ /,X^/W#%!9Q3CG(1V>&O[?B
M_ M;X5) X:2T(PA%P-]_J: S+AJ;?^B+@<X =O/_/KG^_1(V5?1Z>2/.7R_^
M$T=M303R)A<V65=F^-W0LL%;.%1$'TJBLS7Y@9XB:U65_JV!0Q1?3B$@O:@O
MME!G4=I3M!F/.O[R]MGG'6%FYMSK2D(]1\(W@-M/*V>U,72'H,^^P>T?7M8Q
M&5H7X1=-.>)"7@#]8N_\+H"W1FRYHN,QGV1ZX%4E3"&+[3:H8UKW166.AIBH
M5YY^[DZT09&PR&!;R_SJ\ B8=T[-&M]+Z&)6%7[7^;[7S(<RN0+CB;JTE _H
M 54%M\$;3$1#DI6[KA+O$*GF:>?B[:NE='L\YVC(,L2D<*+,/.[%9MG H;8=
MM/=K2$2-9\09YUC^>6C?EFW,I6F]C :'9FE/J1?W3A>LH&H#H?BYT<KDS-=6
M7M93B5(B*CJ30\%#9OU_^GCVNP0Z-T/?^S\32A#-@SG:S\]VX+$NN-?T4^#?
MB6HQFP, 4Q9UG![IGE;*D23S3D9:Y92V[4N(CQ^)@@X4ZS7>T4M<]I"CK#74
M-I9;N$6CG-!*D?W&$=,VYG("+'%RU]D\SI1?FJ-U/Q>+933ZSSJQ6?U!W0A,
M7967>:A7.:B1^KE,$/&CJ(#!!/?OJ,:&IGZ# !'X^6X]4[:+&?W K4.XIU<^
M/J\E(LZN6: ].[Y81V\IE=(R4)?(6% :/!HP+&0TJ1HNF](6K)!/N9P-%Y55
MXB'- 8 <<%)2-?Y_K6,("@84=A\4M$[Z%_Z;8K_6L;'=( V,B(<D75'FI&K
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M8I-1 S%!.1EBIV>5PFA :"@<?'JO!0UHW]8WH6U?4S.Y04:A 5:567;Q%(?
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MO-[?'TI*I.6G\23]OJ#K;TLRI1GVW7#(WKS*-S^'A5,:NNDS6]E&4-/6K4J
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M!O0^^0/U4D&QP302YIW*&6OYZM*8$.>$[$XG/1K&67E7+M]B!.8'LSM(AZY
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MI"_M"F>[J7'+= I%X'T=OAL^+O=!-(#?K=^.14MH_G3_?;]#HYG.$";::;+
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M#RO;"PM.6CF* 9(#VN^+/MC R1,:90R%;X5+M06CL#D[/CZWH4WB[\YU<_3
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MVCR[&ZO&X<\7#2EH *&_O+VI8((/7_F7ON\54]R/J6.EG;QY.V@YCBY@_&A
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M_7PXF'*+![? WQ)2="5@#K&67-HL7<&19+QM_"]7_$,,8*4YX_13(5N.NAO
M-[-_-U&] 4 (6;%,(B;8(\@5QAHW^/W?';;',QX/%4@6\'@$80AV6I:H1FX
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M271)IVZM$+H'#PW"18DN)+& (DO:%^SP"#5[@(0@J2"I9$P<00QA?H%@R\T
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M9"<\YN)AMMIG#>W;63(_-3Q0-ZW8K[SCMI0KT]RRP^'] F']?P!02P,$%
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M8=)!YAC73-*(T=C(0J;Y9^D24H9[0]);/\_++ B"<V2GI#XJ$JAH5C+ @:!
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M-4\:!6//*6"*-*__0/]^?I[E=3.6GX%^9*BC)+;MK.90YM>*&3,W+*+%-OW
MD>QB4.=E%"XFO1?5.-*S?_37OR6-OV"N4KT,/%YVN^K/W \K^1Z;V?S6ET7
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M"LI6J7</GEW.M&>@"[CC!RUT EH_S]<,MG\TME/@/1"Z3V&XVR[9B;MTX6?
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M5.^;I*ZPB"$3SU.[Z,,UJEAIC]Q74A]M]W%L;R^J*ZC S*]2SE@2E=7E.%\
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M7$^&HE(%_GQ";%N]T'QZ_ M:Q_/^0&LIQ@I)H"L$TRHI=$^<*^W0S"R4G_<
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M0*L#<68!R-Q(%ZKEB8Q^'7JBN(!"$3T?6O8\;((>S38[BD>Y_&7 $]L(;#B
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MX-%;:=7DD$]%9(IX+.* ^;"9^+WDHHZ\^:U%KQFC6$L;CD%,[LZQMY:NP O
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M%L>5P3<7FE59A;? NV@?,?CS::\^)$W09&WM,IO/$[6.2+&OC%O'_<R*4XW
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M@$'?(%]&IQ?>ZY+6\PDG?PCVH_I*MH,TR#7_(PB7P=-Q!?E8T%@.Y*+/F:7
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M&_?@B_&14()*;K*EK(6RI:!=>TJLGZ:>WL301 J_ME:IK@?V.\;^N&T3(!G
MIO\YALCG+[H6J^O?!RE6HR5MPYN]=V0OVG^B1>T3HG3 #I-%JM 5WNO1Z1AG
M,I'+O1(>E4T1ZVWGI#S7L(Q*LO 7%+47>FC>D $>G=:G)G9.FNY^X2<>+T15
M5\>(HNFO@O62_);H/F'L3*X+>0^FL!(-"CW#Q1!1GI;\V8T',\]XKC(16/R_
MIKL,N2V]!POUDX5_<!5;&79Z3D$[D^,QJSXKAQ;5DQLV1<DS $J*BY:R]-B
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M":RP-D%\6>15DI=N[6XKK\J/DU\F"6]R#9 @89 FUY,5?::@.[)!H^2*WX7
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M &[)GX"L'[#\Y]/_T>.?2?Y/YU@A^P9L6KVR>>5JA16[@96;5BAL6B%K!*
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M&;!D>A[!NJ%Y5\,*X9YOKOB7#$@2X&VTI=$-T]( 5#P3HHVG=XNV9P=X_Y(
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M$[>EQ*/*6GDO]G;[#,G=4H@#\DJ7AZ9$1>.\NF$5%HFR4X(R>MZ3"/#X?_4
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MY)PUL>!S>5J_<3T1<CJ4]HZ0V/(W;3\6S3GTI?"@,9AR>) ,X*;M?G +3N3
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M3=3U)HX!8K6QQ7'>[+2CPS;^Y@B^PY"M#-#0(B8[L3L&,C%#J5,-F^)2CWT
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MC!V7 0@&*:";J]%3W(._%#U;-<F9I= ^0%L3/=9;Z"_PV32V*30T1!KT:^T
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M [*X@F2W\9-91#'67"[)^O-$].B$F)OG\GZ$G!\ZOVME*E?=K9P[=T*LMSG
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MW_%EE9:F<#;^A=;-?_5F3X5>*>_[]@=6T<);O@*!M,Q225U3&',HX^;JV#;
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M\!Y>)P-4! $CGQW6!?D116Z6;-TH9L2)]#O-VLF=9[F]WML=\?O>G7OBLY?
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MS-*RYL,<]%D()S2YZ[A2YP.WORZ(>%RXQ _[6HDL8-1F$6_$Q,N+6XOK @1
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M30%+W@DU/N.A[ W?2V9:[QT:=7**U0F$3J5%$+!*$_.H*9CHN)ZU"!:Q/H&
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M<N)$"O3,#9OC#\B,MH\Z<MD\UD]Q44\M9!<?ZIG#,0!XNBV@ZKK'5 CZ<YC
MQ??4N[^UIHXK=:V%0EM^?IHBKFCTK?UM\-_1AF+&4]WEQ97P0KO_C!;T4Z)G
M#/]]-B5J;6"'K5BH[$;J-#;FOUX1A4L'#,NV\*[T6T50I1F=E3 T)'5!WV;/
M<2YQ8)5&R%/"UALU;&T6SZ/@9TR-,8W0,4C7((JY^L2??PR=-[0U2'D+])"]
M-]F 6I[+V#FE__UAR.8.QXZ3L_7\)8.?]S^SU]1%&P/\.UK-,@<-_[+L6*6^
M>HM'XP,8ZITNJ!)7"#(,P^5]F:W[1LSC2H%?3W<=/3XYY9RY 1"QMVP.@95F
MUHDCHN1T7]U'*_:;*/*]D>&HZ,*/F],A*<6YC4+C;4,N';CD\[U'CWW2T"2/
M[O+22"U)%0/N/LI[<.WX,9HNU&67'AX!5#ED'\O*\$"<P@13\/7HZL5^-V9A
ME9WZUUA%V/DE,<4<?_]?O(2&0B.O5S+N*'*'AF)0G/PD0Q<( =E^^K_6@P<7
M[:M/AO_Y?N.[Y+,[<;CPA*?JHW^5K7BKQ$QHK9=%@DZ][[SM*,/J-)K#WT0E
M78[@56&">:U#\@&+<<%GRAY4_S-Z4&(WF99$FMX&5/S/C 'IVH5QUA@$!O2[
M'OD>]$DN.F@3"GS%;"Y(/]QQT9$A=HO=J8B;BDZ\=NR4O"2>PUZOZ82$Q05
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M,6FW3H'.5YU=VR 7AY"]-_AZBB-9_48U/QHD0L.-YG5,TN=./Q4K.>6>]Z6
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M>RT7T78;<RA7]U\;5/G4&)2?5N9=T.!]!@J.RVG<ZR5M#=3?]DM&\)-SF!/
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M=R;-GRO<R=IG+ +-1:L>Q77<\2Q9_'T.&6B;ZT84BWHS*#B>Y1LC=?Y^B?C
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M=6"P"*1^F_43NQ%GN7!Z2XQYC*_E"IK>;V1!2U9PF3,6=[OB>>O+H[*./)>
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M07ZNK%L,Q:1<M'DH_WQ'M7=ZKP$J6$::DU=MP*]:=T=)R#S,=M-YGW/ X]9
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M/.G+HJ9HK2V(O]'Z?OSIO*HZ[_:E%/50KCE^XH-M!FUA%VJ<G:0+_"7=(>D
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MH?[DYF&UC;V_=Y44?MR&BZ&GK*F<1B?*<$SQ8[,I JY&?^XTJD)SJYL8Y";
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M*)60@RWD5L1/##>*]>V+8V\FI4NH21R"^'WX20HDC[X<J-&,Z\GOP="3+[C
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M3N"56]!P<@BBPEQU@N/T/]8\RB5JJN+8BAGRJACEAS.$F_GA0>[2^N;T)N\
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MS3:)6Z,1>XNT,:FS0I_M1@]WG;U'9<_Q[^(?P4*(VP.]M(!M;Y')[3:&16I
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ML,-P^Q8!H(R6H*'%N:!@3\^/N1#X&J3'D+Y!K\S[DFW_H)[]?0S+RKC./SW
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MDKU(VJ0:%R".7W(1HA%D"M)M%;3(#4<5\BOJ-"%+=.;\+L)PY@J!F'^"8AN
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M,][#";9"VXJ0F?7=YQ1AS<;F+8>UEY:D3QN,:_5]'0I*R#1*TC3)UKD_.#<
MO+]QQ%%_Q<BB_E"% EN&5PD^N6(G7T>&R7;OQ.:Y%BVEU6HW%#CV#M[5:CB#
M=4X>U; VF!Y1L^N5.F-R=22E:=?^6P@"LGF? #"==Q'17(4P9,O]B #1]^4[
M<Z[#-5J!1WWJW68^H!XP=.*#"(#EQM,5Y73-*AV[]IAB4HQWX*"?GV_NK5VU
ML?Q6R^JCNO4W49DQC<D@U;<N@0Q;L"=HS __V._O#Y/YN:REH?=,XZEE[\X-
MCZ$/[[U[U-@)[6HK>EBU1MNP%K)'<Y]ED.E=XW-%HZ.= >=&GPUL@+^P<V8%
M@+$UC<2J#.48!##B ;N,;F1-U(+&0PYI9B/)D;W864]"C).,^Z*\[$A$Y!>1
MH@A5QE0=.>G?,9(=RD8 >!/>_NU0I*7$F%9F,^P6OT?HIRPH2-=@>DA4O5N>
M.UB%EQ8$K;1AJS:C3]+7XJ8)R0) V1?3[R3'%6WYTW0%MWN,2M2798NI!FI)
M#C^KZ$('=AK*1D^M!+5SA1X_N@'IX>F;R (>;/P7T84L:YN23YTYR#;?>$AO
M_,4 -M?.IV$\2QSL30L3PHM-K ;R3(9<AD[V_IN6O"4VHV9ZNH3&/UC,T&@5
M "JPS2BV+4*'[3GM*1%_$O?*_D%?O249)=Y#%@ DGU4JW,'A^A4P;=)[NHJ^
MJJWCQC_RV;^= ?NO L/?="-GY-T^*5Z$T/0V[SZT+"Y6J;[]K7!YX ')WKT4
M[%3NZ5=I^LF%79UW0Z5E^(V'&7\PS>%-KVKQ)G3^>Q7S 9TT VV%)J$/]C<J
M<L\S<+'\T_!3CC&N@]QKY$PV]D(B^<%"V="%V>Y:[5]>I6V^3$\2^Z/M)X7P
M58(!,=)/TN32F27%O]FACM]O&PUANM[P9836)!0D%; V4U%6' ]33I6VPJ''
M9TNPKG3L#"&6/^ VP/5^FN':\<X9.T4!KF\6LBV]%6HSS85:_Z>IYRX! .7!
MIU3HWA^CF450$/UUP58/_ N?IQI)WS&'SQO?!+8X8&9F.<K1&SM9MUZV<9"S
M+B7))YTJ: <BL.(2,SZ:Y._UAHFM@RA.?4-%@_T6T@)L<E.[ ,]S%D/=DX\;
MSQ( 8';MU56!]R .+B&S67ZDK%D,Q7[KT'F[ZT>_[0)_VN**SC9O?B^C<52$
M'R5N=@SR F"/)9(A,T;M=V59J*TO_(4 [95?'\-^07*  \7M\DL3 D 5BALD
ML;D3K"55,.$"VWF&WP[@EEGE)OP1:_QAOP&(- C&7L<QW 6 * & <FZF^]RZ
M92*NFCB5?NUM0>(5MT*%#9&J[17B[I]!AVS-[V&-3A&&/Z(< F$;S<5UJ"L1
M]OH^BRM\PTNTC"*03XMPK,)#@9^7#/VALVCV]UP&UAAQARX S--X=9!.&?=#
MVS"( S_+><,0HK!BF53"4H/4H?*5N;-<W2I?"9H$6P" \*O6"_,<,^/Z^)^1
MT!7'/G;C/3*6$2$ ="_TKAC;_%<0?,Y% &CTET#H'LC(OZS6]H&3KXY;XT%X
M0;\"1#,R&\ /V &\VX?/1\4]5>#3)[=3N;_8G)%\S9S>+ 32#W,4KST/W_J@
M=&4<X(.7BW)>NT+4>A?B.]<I&Y_SK[N>?'$'U.]W4X_WQ+5YD'(EF4:20Q(&
M:XJ>%VI\_,N;?I)+!VS2.A?'5^S,,8I#]1F<U=!>E)*3KXI&(_Y2L?N]>=]B
MH]Z<!]4GILN.;NM4;WVWVKK86R2+6^E[Q!,%\SHI0AHHGB;(/,/HI2HB:^'
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MFIR]WS>NNISG@3)D\))WN-;XWC+1^-<WK_&'=NPM-)BX&$!,UYK: 3XO3/%
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M_R+Y'H>=8\XH9S$-3%(>XK1/I-**XCD5E$Z&Z50T<^/^WG1$B>G"/FCEOGW
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M!)RZH('_K*<UZZ%FVF2"^7AJ@44[V-\76 V]/OD\Y!5F[;W$0WW$9X>'Z75
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M@[HT$+2'-)."0QWG!\CX*Y>648-YO6VZMF10=+AQ 62$"NP6;5NJ*_2H"_Y
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M5HG]#>TBEA -*'_3#L/SXOI8"8NX68;)AJ;NN \V9?!/=:BWF'[XJA7FSWB
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MC1PT_ZV5[O.6#.EH^9TR8ZQ25,+HT;D*46W4?TQAY;,!"J)M^WW1S:P?E6Q
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MKYGN/#CZX_0^H56'S!^92T9&U7(&'D3K.?G6LP ^XO$IJ))KN*>"8)OB A9
M8^'VP6K,C['U!;)G&@O@]ST/E'%EB?'LTZL7/X;=4,&)OZO6V3.":2;A:GN/
MWA-M,7=D,PLFJ8$=#)]I,7MFXP^3K>V*K2DTL:U.ILC6&I;H!?"+ MK$?W_
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M]#:9E;:N;UV8U^R/5V,I?:Z%!:  JU!=*)%62?]VW[3+I.;V*:[0*\X]?2S
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M6BT#8L;QX:CL(N*0VMBZ%W@ADB_Z^_3J1.KL[6=6ZVV:3I6K,.RE1W\]3@Z
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MZ N^IS3P-Y)]>Y-A^WZE1I=E$N;?O[(&; 7-[F^/W*(+1:[CB(X&KU#L(UP
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MQ9AM2U]0(O'#!G2Q^D-N::?*'"GRO74H'\9Q8]4YG0P\S?ZF/;#Y;&OP\./
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MKZIG)J*7NGEZ^%!?X)T^$\'\8@V;\G8^GCUI S&N"L4#V[)UROXW(%=3/F[
M="BG3V-T"AS+4:-&_+:29FP3[+^$D$ MD*B1*7'C]PO0&[/MSFK/:[Q#&ON&
M%U:,T#/^$T$M=H+20>HG<0014_7XM- J-R%F1,>TS)\<")^R61L70,P(DMEK
M5V-7LG]1'Z8<N=->*EM555$35#OH%\2?P._-?S7%*J([:9)#O<:_?6[_\'="
M3SWO<7H*D;@ ^@NJ7XS*C@,7D.C,GTT:]KZY:=4J8L](VLWWS(LW<\60$!OT
MF5!#+97M;^7W$7;)P$XU%!ZZ&6N@,*BG6<!(IEB/=*B)>E9O(?T$!"%EGA\=
M31:*O+3$H_-5:MYJ2!3*\&OEX<3^:F0ICU55=8NS>WB?)DPWXCH[IU'-=SB5
M%%U"43'B>*?_6<8='=F9U.I0:DCUZ$&Q9"M@+KOH,UTWK>,IPZT6PX%JZE<$
M+,T*<#55K(J;M+2;W33U]X8MTW8YQP;5!3M]N(#U7;]:<HD#7WQ;A!\G8MN0
M"SC,B_Q04 $1R 4TW^&(0U9$[%BZ5&"BGG<.S.A6;QD2&8!A/)W2#:FNAI7.
M#JCN).QKC/+?='O]_+%54YM+>CH'3L.RSH;85=-$TX)FN( W].Q+->\[)!HZ
MU?3\-?>C;_9-6T85[Q29"T\V-ES&E D%)R?+=S?K_># -:<3IXY3>].^R<?Z
M&B@TA^V5R")/.K1/B4:V6MB39=_/M@=K24GT+&5;J8T%KF[NT*1/N!D\_FO[
M:04DK"=&:4BT;1\6FL6?]*#7?P)_=S0/(+N>?/#Q'[&8RG6MC8X6X_K(ET[&
M&&4YX2GZE,ME]1N8'@,-FNXYZYO/T99?-SBYK"8TNZYH/^M<1;'^1>V*?-KV
M@%G_QN*.%IYJ"R8I*G75K35*4*=_::?U34CJ>1L<IFGA8HRV2TIDT8^&C!-W
MG4!F5:V>XG Q=;,CWX;WG-RK[E[O5.N:%OK**/(O\;8O2$$6>0^+(:1'X+=I
M_!3G0K+*B<H2J8APBPPZ#_RD?8@PTF^56.@5X&1/NC.]=&6#=!<RE1#/^DI5
M&6G6-[LO)4\+241<^Y/V8@5/TN+PT3#-S,E@TB$MFVD'*C)6:%RC6RDT]1&!
M\^[*ITK7'G7; 9#@(ON-)NK\LKU@&4V)GDX=BHG=<9 $W89<](:<@%^_DD^1
MW,[L4A-AQ-PUR_2 EJY+_9%4>C",+_-Q_:0W/:[LFWW>@/]=?MM8SRV+GB*D
M=^MD*=7T1C+]TRW,PWI3TM]/^2#5YU.$YW:?K:V71KXU[<E)(E.A"@C1_0-T
M/;*";ZT!2L-30#&:4#"$7<H1F&*$MV7<VXPQD&,@6SD"U.@$BM]IAM?*=+N4
M $T5Y9\'>[/G0"T^LV+XJ"Q^BVG^V2MXA#K6F#AW%@SG@2F)TPLZU6B=ZVQ"
MP]]FE-$,1BBE45];9Y&H"I86PX2B$MY*"HG2NU[*@+38T\M@)61B;!BBD/Q]
M]_O:\V$])<^@[^"3AJHE2!5,LI_?_M%OHW!^-GJ*0( <AP<PS6'A%.#;1JMO
MGER H!_+I)1U'=_' A8ZKHB*U?<F0H_BJHY&\7PLRP4S[M!<Y%4/'2YR4RFV
M>52 D1W>'K=?8L@0(!68-GST]%EE5@AE<SR3<C=;B#:5_IW1 CZW"CRQ"8[2
MS!(UU[7%#<"%Z@^X@$>55*=WY2<TF/<+[N>6UX8*:X8Z3=/&R %KTIR^G(Q&
MR5-:2D+'9Z!RGH.%5XV"%X(#YX_LAG768KJ\V4.F,!\;ESO6U"X19Y@IC1YL
M6_%6PG-KJG-E:#U<%V+U@?T%)PE+IBO1%NIFL9%TM$BC0H"[IS\9:FQ&([QE
M72Z%:5-0KX.^E[!09QE)$$'&*AAM$=UW?'#'27I%;/#;H)JO;'U*7NUQ] NO
M::KE-"I8/+&$\ YQ >:UM6C8\+._<E+I,960 .?_;N]YKW*4/*AGG-]<LMHW
M:1+NM1J2-U8R]]]XEV_+F/I"SSZ$>8?!1W>A MO4X@Q4:388IMDR EC/!;SU
M;ILZ"8E>I@8O.2TYRU>9NUL.PN]SM-J_E[N$TV'"X_/BB57CER9Z( *,! IA
MC2E+%Y@!743TU[]7D^(G,*+<J91;@6Q5.Z&QU/Z(TUR NQSE+CE7=-^"O\WX
MCPW>Z_<V1[LDJI5RU5UIS*H@Y\^G4NSYO(T=[TG<WB#C2^?,C6Z?[T-=N)(3
MA68D>OCWO3VLWT>VIB./ :TT[E8T4#D8:L&L6\I4"?+<.BH^2-?S2WO8B%AU
MFKU-41YDPM[12%W:(:]+:$RN*BC1:<[](+D%0K4"CL501)MXY&HYI(D_?&+G
M@DQ%36TY9_RZ(\G^3HU/%UU)2/7P<8AZI\_9@(7D*/#L,"0V^V2?&KR0=8]V
M94[!IG]NT(]U2U:[/N!5GVH%_?8\YL"DGBD,_&*>A+"L(CG GU0\$7G4OXL\
MLT(=^[#U9 6;Z[2B97+U<6WT/"U+(T\1=8YNX"$ERP6D!NWN-/X[NU9ZO>@4
MF)Z<\ CF3$OY] ,Y(8OE ORD!'R"S6T>"I60=AT0RIRU$L0-^%5&)(;Q<O87
M!T2MB87N_G;-_CNVP@4L9]K=-3]%_X>COW'D8T4EL$46;'] ^J65-<.\1JOW
M*<\RFAMK>A JB)\RDGU%N'"Y(9X+,( <@\-I4@E!1PEO&^V4@[D [VHMDL!L
M1('QP,)D], $LNT-9W,=XF48/$V[[I9X&3EAZ(W^BWS%!5 M-TG$V_W&;W9
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M?OF3$!$2?^"ZA) KIPE\.U+3H*6:$[M-U[O_:V(1M'Q*T(&=E)48!DE 7/3
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MFL9WNJV1J#^CGUBW? KD=1QYEC6IQ\5DMO5GF#MYR&Z_(],R)E[5*,4G'W3
MMK2&@H$3$@O3L!B1XN<.TI:ENSZO15%G=L-+05AK;V43?AW6$!/&+R&=9 5/
M0;Y!8I1!@!@;3R%+K4H;MY&WDLRF<#+CIPM8>=]RM4GDNH%*6NS$ONH U:6$
MPNKDH=DOE9Y=7TEHS^B1P7GR,^4#_!*H=A$Z S5BRNAL1L0I8#BA1]%W167E
M3#]6L1$?M'>\C!A2-N:K#&7?SDJJZE/W5<KY=+/M>5!*]?/7:2OU].-1W#LT
M;!^-=4-$*KP@L9"*)9&0%(*D+>G:#$M#1B>E4QFH:-D[1V9U"D$[#A(U@K0D
M 3)E$Z-PJ=K:H<G/0S\_,\75V<=^S[A^0P?IAB >(]5-]BG5KMK >:,.\239
MSN4]JJQ0WF&6?2+O@$9//U%E '(;MP]-MO5=,NC9[->\<\7B_AA*.]H1V@5^
M(03YPT?-&)W?P'%(,-2$57*IBV1&[XQQ5<SFQ/(__:[Q*+H]-Z',SRX554U\
MS$UXY-^J+U\B+-C00:.E.)[+H\&!S.WP[8!XBTUFSO73Y'#>-79EXW[ <$K$
M(P"?N1[!% 6^&X-D=&P)*_;H6YT?["8=*0'PEQK[XRW]@L(+:1>\?!].V*ZZ
M/@AVO;;O/H^R<9E[&A/ 3Q6<&<,.PP_!]##!@.(["A>!7FF![UC%[0+J&>N4
M'+!+#]P3%5%M1&Q>VC[KU/^A@'&Y7R\$ZEB":VYG,RX>XQJI);Q]M?]-O?(\
MQQRHD4@F3[[!*<(478&:\VQR+-R#)H%YPL_FW62X['7ZS-Z=PK  1V.E^XZR
MX/&K?KZ6)')U7R4SD#Y=0%?\4Z]30EIZ).5ST?@I$K (%I&<2P"!%4C'MX7K
M3I$7(@+56N QV%U A-=D VY2OE53\EKJ:&LCI&(0]]F?9/,.8UO;_VEEV]]*
M&NN%=ZAK(0X%A?PS.A_EY8O_"/<$CR!L@,$@MCP=WT( C6$.\=\W2OHX666S
M(^CH0=7!52%(J\7#'ZK&5OL&._DYX5HU&T*!*X\X^F1%)Z%?S&Y&?2CT(][/
M6B3LKOC@(QW0+:"L[!""W+2&M8_[_89[P9_3CV%EW_",62LG.P/^?IE</F^B
MVR%:+L(T2X2@)J?*O?2_FD?XSZ#G";*NOV)+_UQ@KR!0T9_'KBO #6V<T]@G
M5[\&;ZGV*SNGIB<+CYG&GP0.3N&!$S,B+MNIR#-CF5%1PVG?L'(5P"B[G<Z)
MH>?@)B7B,6:?'+V1TC!U-+%)P;&OREDK,>-%9Y#!Z_?#/T[>5TG)7H_<E@+B
M:"7D0OFE.$_<T"@G'2"SX0RP*+?(<HW*@%I+HQ9KOXA>815])G:RJM)S7Q<,
M_4#MKG]+ \@M1LE5^E&K3AGO'@_4\=\8V@7+#22Y2;U0S":\(-_#@;'C63'-
M!.4QS'8@G:N!#J8/\XMQOD'=JYVQ0I D-*P,:#Y(94JS]\V9VO1AU!G\+<WW
M!6.]2<<Z[JW'7'+1SJ_/D*N)!C_AE^N11R2NBZSP$@QK8[MR50$;QI*283/M
M8.>[<1Z$A8\E'7D+2U)^75"=EH\< :CV[-LUH55ME5G-G:%%FAJ?_#_E.]N<
M:E??^M^1  6UW;C)CW6(&!S]>$^CKN [9$^5:@]37QT9,U+81!#9!C[,5NDX
M9%_\5@TOBGQ<:!.K59#GS1E7MQQ8U(M[\"FH6*_8_YWLF%7$/'PX9JH-SS7C
M;0%0;#(E]$HY?1ZN!+CHAQ%VS%.4C[%JXNZ\7AT/:S8:^'?X:\8*17"L?*"R
M>'$QO:!?^FN_XZ_@E"+>/)O&#.0^!'P0$<CM$@N9K,')P7B82:OATT99S'T@
MB6LV.Z$-^.6C:ZZR2N85GN0PU%&2/)WR!F7] ;UZ8[(,QH3U,G.8;5?ZSG56
M^V?2O2_V_W +!2PM2_YK 0BC!RBZ?1I'Y\XT&9E\'X0ZAWOM)H1-@>70:;9]
M4.<IB)R+PV4]IIMA+,^6Z*M07)$S$';S\6&/H93Z:&KV+/D0)KA0,)&KSL_!
MW-X\S)*(PWDAI7B>@$GP-E)&5L1\*+A%^K]#9_;JN2!LP7\G/FE^PL!)%3T7
M#ZID+8<LV\W:8N895.8S!A&$G4!6#"Y,?;B?$<A38Q.?$S,92PEES)UD%J$%
MI71[?IX%OIAKZQ$_3+HKT8R+J_ZA6*A]&?6H]=FS=$)U:0U/O1-/^XQ@'DBI
M?(A&3O6O?P,KN)H]SVM"5B[%>+)@Z?O9YX0@4SPC(X>U?(&ZQUBV4V6J,TY!
MF<B6H$-X^Q"<KZRUUWU0^TGX2!X%JP$X!OB;KT!-A*"M['Z2R8>)TG)Q:=^
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MN$/Y0QB"3^$2R?=QPQ/M#%1R6V3CX6Q&)K5SNQO%(,G[/<X=HP5,B9#WX>G
MU9;7AO<;]Y;[QGT)'C_8=*Q8_V]>$YEU*\J#QJ9R3@<E/7N#?XJ3[UG^$[+(
MYF<XPL[ZR-G52NL%Z'K_^K[5\RJG2!PLV"DM5P!>N$!WJ(HK/5WE#E"Y-\M*
M@@O-<*@/+CYNG$R R"^ 97L7WW:Y/>QHLCZRU>Y#L,/W)S^"'YV'6]Y_'P\Z
M\?^Q^5;WJ_7RN/945P/ A-$I@QV!;X7!G!#OP5MY9P$(NY ^4(,*>+1$A,A@
MS-B&%&F;"VF6O<T+]SO($?J7#(_$:2BK@7:LAR=>N0(.?59*=\O ARR8_S.!
ML9;2>AM F BN)D^.C6SV)GN[,6HKB]\"1*XCQA7HI4?DNY@'GP+4J4:HF%6^
M@?'?4Y<4F W3.6&JXZ2KL])O,@[77YO6VR!PHOE154*0'':(5I')U!>I;2?/
M&+_WF*NL9#+W)EIG<W76@"9[& BF0P[,PJ6Q1_]5LY]J8E7NIZ)3D3N0/L;]
M02@)']QP0>:"\?R:ATJRQDN7IVM*%?-]:Y/8?8,U24,5[FFBM6 7B%?&1E(Z
M1W7I!*8+>W *_@T>0P!A5=&Z4X2(1O'[SP<9B%;X'IYQ?3<*N\];<*R7.%W>
M6PD11T_./0GV:BT:"=7/J6AY;QQ5_Z3V<G@IA(/BOX?!,1=9$GBX'T*6I]/#
M [.R7:K92Q3:,&$R%4UL:=S=WWAD]N^2'D2>Y\PF)#YF'E^A&A5&Y+^B 6:4
M.BR^T%MN,\V@[N*$=^HB7_^^K(UD[[G#W,DGU+=KQ=U/BB"$09&3M;AV@DX!
M#'A=A($ 9)9B*U:1I<7<QC69'Q'4LP1"4)O<2'0!:[0M]Q [)Z<LDZU")[>@
M%AYG.M=T09$>WOM;%#CIOJ<+/!@NDE;]1Q &-Y)6M%H(,;2:)2:*KDY[*@3M
MAQW"R/%?87>AJ]T*,.[_@[/SBFNBB]I]$&E2I0M"E*K25)I2$A6EB(B*@H 0
M%:5%B 4D2$A$I M145!0(M)4>@E(2X!05%Y$:@2$D,1"B\RHA)$4OOC=G:OS
M.^=B<C>9-7NOO9[G/WO/;# D$;\'(K(MNJM39\1\[BWBY0&;1W@=K"/.+)X=
ML5DR]\UB@1YHM?:M*IM0-=E^]WU8T+7X-8'!'M?.@MU?Y3;$[SUNE_65U/N2
MMTM*+E4)MF_IN-O[KSS\:3&0Q!$'&%QB<A\S-PUY"2-R*K1<@OSQDI X ,/*
MS"J\ 62SZ$G5G#]3CO9'QW ^+YSB6*1-:(164UV 4\?:SUSY21="O'55(]U[
MQ\6FOXF]!/EU6 1A:A.=AI03VO%W0V=X-CCQ.C#F#M\3#*9W$32L"9D,9?S.
M>?P&,#B35:G8$:C]=NB/A5AHX ;@1[J#1Z%?N*XU:-CSL>3-0.F$>=[);A^T
M\6+VF]V3;'WQIGUK"2=*VC;?D=J_?V5)ZLK:"9$]PP+'VT&+67AO=8J=^/P#
M]#I,":_"/P@@$LTX'1G'A2,@YJZUIUQ8[U?IH@L7(S%:KO?JIO>DELLP?O;%
MS>8F1XM:7Q*A ,D&V#CY RXT# RR\+=#:XSDGP9^)KP(7>W]$$D*09YONZR)
M:J'Q2MH)'U)&_B"9+H\5R^8(7;<1^P0/$-)8TNPJ#9DZHPC^#FVBZ^X2O$"&
MHM)L;JX=RWSE%X"U9<5T8Y2Q^6YUK3<WDS@[&SS"M]_89"FVF2R5O2N+P'6%
M=$ X]S(FG2#^O>43>7EBT!DLH:>MPX)]M19.LBPD(/N>7R+*P6;/<JE%FFVO
M<-; :O>JUB@>-C[V',G</&KE@3CWOBQUZN?;,9_M=E<)NH2U4;KK1!J^39$F
M/K5X +Z%CX%VL@;3X W&2RC0GG9]7I;Y;Q(- 36SD-KRQ]=A-YMN%&('F1:I
M?.U29,JC2-M(BCYU2/_MS8NG!D[*7CA+GQB"J0K^RXWOW9-DNC79>*QN]]>5
M\V$9<@<37WV]1BI#%*PXPG#[>=%\(Z@9].]D2)DCI,-FI,81VW"&@D+A%ARZ
M;DBX#2HZ!1!2R &V':]9!F.FQ>-1E1H!K5F^>N-Z]NJ]1TY+3&&T:_GR[&IH
MQ\TBMJ+<!/^(@$0(ABMB]19/7P8CR4SBI'A?P790]^D+3YW_5D_-:2F4 $Y'
M&\>KB^Z'50#KL+!BN?\^)<M5$MLOI=I+_93<,]*,K(JG4#(GM*\+;N'AN>.W
MD3NL4"G4)I].SZQU&#DD3;@)9R$HP!M!XNS!7HPB_]@0V2(5KHGSGR4HAYT\
MBS,%+.YBEJSE%0]"EUG^.XI3S@*57U^;-@T%O(OTWAFAO.]B#IL*AHLXY !E
M)TX!$EF<^)@.. RA@G,",;1' +5+1*^R+'HZ/TBBJHR]T]\5-*HO;VP5A4M[
M_6(:&T?[A5HHT&U7;[JVH,6I>G[Y^WFXR9_':J>5GEN2^L37897'\O9]N;R6
M)<:/AY;7!#O$16R:@JJ56GH]2X)!)AVU.-%O]<'903EL3%=Y!90XNYQ@+1_4
M;=.B?M<JP\P3]? W;=!A[?D287YR8&(G]WED@+>;NG'>%<AQ<"FM"H*S/3DZ
MY7SU8>%6R'Z6Q#'CF;O/(C6PVL>3:33O0#C$8:K2'8R91(UY.X4'YQWV:R1%
M$R2P>0&*O?3,DG.+1/,DYOWO<2;^[J[4XPYO[USIF(Q=_K,(!:W#JD_^GX/V
M:TR7CH9P4PJPS)3J(B7F^72A/D\=S6;VT08E<8[U8%\Z8J^(P*WK)[#:M)N(
MK;E^% "3C-"8"&"@]V:H)L>;N(XU]+N7YS].YOGZGT]3'%V'U0TN#<0""$PJ
M?#/%$'=@E&*)_T356HF HZ!.\&B$N8[DS+<VNZ8<O#J@> =G=N$- R['MP'D
M,[\)2878RY=&2R*.8I30,?13,^%U?I."I]^<YM?@0%E%J%3_?<LUX6FQOV*
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M SU<,5/A!+O=0DW9LAGI% D(WC5.DK/2L>\A;458XPX#JYW(.X%:]. "I-P
MNUJCA%\'%?5<ZUJ\<8.)3"G0JJ'C8ED9.IJVJ19_S#9PISPG2WT"1=0ZPI(:
M$:KR72#9."9)'"+X"AY1K+#T68^?A<"B1[X+0,K:-BRJ"@K0E"N4()E[(^;5
M],2BT.A36W3) #NI=90L4^40HYB&D1AQNJ%Z[1>JZ7A)V"Q!E"R IT5&H%Y,
M8H>NBJ 8=U#D1WKRGCW<%>:G4 T6,9/;9Y=3UAH;SO)KSF%'>!8T;_.KKV-9
M>]VVO)#C83YK]*S-I/R;SN^QF KB]M/QE@'^[N:OV8IBN""D'%^C%'J1CV6^
M!3P[E^7]C&GY\D;CPFUK-BFO_0(\7CLY+G.GSH6O:MP+%0[140WT3CADM,JQ
MC64O9^3HFD-]L_ 4QF8J4PP:F)7?*\J1U31KE"+F#""5:HWV5[?S24+H]Y3,
M6!-3JQJVSM\(\/<+]/]]S0;Q'&("O[DOP*KV0G< R7T*+'?JP(\.?:NE1P6@
M9IV3P)/DZ<BXM\_0)[")WF!D0C23=[@Q9Z%+6[HB."OVBJPA[;V)B]1W9 \I
MC:#5=H$'(W1ZM<F"_2RI%+PA1)M-;F)3DRBZ8,X#46-Y #I9)2^=9JM31(T=
MK4T5#\-O'^4,HV4'U9P,*B:_M37=+SXPY=];,X#]WX?.KRP(YQG:4]@S*XPD
M1I,/A\RDIKY^:5[)]%3"MK(1)-"B\SZ4(E!>/-8*$A+:_)D!/H?!E+M%.5@?
MK]K1Z!TS9GME:44]$;&&H[_CM_ V\Z_2":&D"0Q3H]=",RSO9II(CI3#;',*
M;$>B5I\V['.XS,0H+^JJ@I>_)^=Z#=Z03'N],*G#K66^,]YQ$1"6EQ0?C>@^
MM@Y[!F\PHW(80 M]MBH11''[/D4I3HRP \D10"[+IX>:A*S_GLTDII*DR=2M
MH??G"Z1^K0R$=!>8CE@%V/;<&OM8.,NCIK56+CLX5B_H;MX3-F3Y'QUU1#BQ
M5IU"O?!OK4C[<A<U8>UF==&"!EX-H"X- K:N0PU_VSQ9P2"RVS<EJ6&*YVCI
M?F;4X0A+1Y\VC*UGZ;YHO'QQ%--F'Q>ME1:2+Z8$48X!J(EU&#<=ZJ_$CU$4
MH=]L)!S*/B'(04904TG:%''<9L"1WZ^1A(<S^%L>&T-(ML?>;=W/;[ #RA(H
M.P?T&FT/8LILOO?ZS'M".\?)8-,Q2!\H4)Q89CE7BGAW,(L:MGQ;* ,,IE_<
M(.SZ^*-'U^!M"D^D-P[YZ[ -BS$;^MW FSEB6IGWQF].2,'X)T$>NZQSD?BY
M[S $!]QG&9S80HC.O34BU,+F<O&CT8H3VFR/S((44&K6J*08F]MI?()"_119
M\<?#OG<GT\SIT-B*A?5%71W0O)0MH; .>X,,(V;HZD"+/$=\!VD+SFPO-05A
M*/Q,JO7)C+@03,EQO6+-4/_LYEC9X,-MS!9070L@/T;9Q*,C\1*C'BV7'^VX
M$A_#VX4?NA7#T0&J1GKHMU2%"M!C)FHS&BXOM,+M:7ZT8%=-0]T+5%&,8!&E
M%Y1?2/[V:#H4C9);+'X%:MQ=B1#O%D=.'B7_]NS *&#KN4\ *4[T+$$+%PS1
MF4]P2-Y5_G6@*8D?!/2SCBS?;8MA(F4@]56:=PL\&;>S<C*LB44[*+=JZ5Y6
M8UZWH&%>M'K[6?5DX/AOKBVT4BK\,J/1U)K+U"!2F1I0".\ZA#[::(&62IFE
MIAR&8GFGY76WX9ZC9OG5&BD(?<:3K[R0+H:2>WPMJ7-N;(X$',\H1W-4N&_;
M&YH;VQHH @HRS(1GWV_R==2*-X \T0RL"'.C2Z?[4G]&]6?N_?XQP.[7;I53
M]5CKT]J8)!@N_J5P@+)#A R1R^FH^OA!3AP/2^AJ U!+K4 96_UA#K6AH%F]
M 1?&%HU_#=S.-T<GF[C1^>%Y%T-G-@V95T:E)"4_+W]/N!4<3#V-"A&4(72A
MHJZ\E"5QWMXY0H,M9^<+**Z7NH5_C2F";N<:B%QQ%G<1#$SYMX4[_=[2"Q!.
MI-95D\ZU>JI\GAOJN=ZK<]_TYL+3I-IYW<WKL$>-^$\$[GE2/4E8K3BIWNP)
M[2#=J19NYU]>A]W!89''P>5[E"WGT,@&9#?6)9.R=4$K\BF;HVJ\Q -W-D'A
MRUY#UHO8;\T&1[!^'P[42!AJWS_@B#P@N!/19L]"R4$/D9,,[L]Q V"FN62Q
MOU"4HT_IUB)F(4VLWB?W9K,RMX6-/UAL,4TM+*Z_OR/(X<GC_CY-@*#&MP*1
M' U>G' (J;#B.0GG/H$NS)*226*$D %"5X$F9 @F^D&8POXJ[(\34">Z K5@
M%U&0'V-3;35.T1YI[/V5[Q[2$';JLYN]*_XN,+CDQ1J4@W(/@&I]G#X>&OL&
MKHBVL>L93,9Y@1K,K#)F^W7&\:<E-EIC):2N@ W@TD^WZ6B-J33SLT^+M0_C
MECM?-Q$ZW0E7N'-U^(_PVC^O]L!EC4K !:?D=)?,?GM+J_1:DST1M8\W^,(<
MLOM^X:(%M\W;;$&+<] \J,'-$-Q?QITIPOJPC3+ RC^.(:S5#HYEK]\7._-$
MT(N&4HXP;>@GZ$ H-]"\L'0^T!$H2[^HT0)/LI;AAY2AW(R3?R00?/7O%F-N
M+YV/I]VP[]?WC_ /]?/M/S?8[!R(S@D+?L!_QUA:5B<XK,-F7T^.D^!+7F!^
MYRD7[J R/[CN$T(2M^]32G\\"Y6Z#E-S""K!WNAJ\;[K'+.@7M^V-O;EDA@W
MP&:GK7*"YYQ&2M1BI3XMSSP[+@I3]:<=[CE2A?'?WY;WX>/DQ,]FX<[_\%>>
ML =">F#XHXM(V38WGK-PFD2.H0EBN&F"4J$V%LY$TBPF\*N=,]J0)7B3QZ0D
MRO=E66'25:#D=9A?8\-P57'[*%E[ .[1E,[M9=DOGJEK\CVA=^A7-$KQ(D3F
MF>+I)%D1/0:Q;;M)60P)0NBRZ$0UD7TC0N?6ON5F4';R]: 4X*:9E!]]21\<
MJTQ^&@>J= AMA]M\+77LNZ^=6UQ3KV3.:?GWU;60[\6.K<,2J*'56]9AG<[(
M"#% G]V4A)>MS.U2G##WB(\6Y?JMF!XT2<6"Z]*#-!H?YYT$R^Z\'#+CN+L8
M_H>,>*NQZT>4O;O=6E490#TIR+9:SB UN7"<P)%3@B+\+IPQ9,+BV'>L!G6L
M673]6R=EV_6F9C%7Y.[B@46:76,+('*/2K@SEYF.LG[TJI4 IU-C57I ^Z-A
MU1'6)1B@F(EL\.S5,>:V@L9] D665"H'>8DXX<76Z!R<\&(MWZTT5\5*]=!)
MFA%5P5 K:.(?]-8]&K!$@<L=\5H_S\$-PAB;.=!NG[G!/N)$EP51*R7%/!)O
M(QPB;=*F><>\,T-(X (I4-R%JOXWJ,^![S72V.1ABXMMS34[(RG*3ZNV13L_
MM#VC])KPGI%(T*#(=_)D%PCU/CV#B:A&A=<L5"9%%LHLY\?2346XEM'RF8XP
MXE\G^H NW42EJ? \W8QXP>L0$0:J84M=K>!*[RTFO@&,Y ;_FSL:?[+_9 AE
M>L ?IP0O")=(23/&X&'Z *C1M1O%WPF5A56<G9X/W%X+)0#TTRE=DWU\ S^/
ME9+'/Q]7A'-OYH6DA=2TWC[G)-E\Y5+PS.[_-34BUKPT.)&!@OK+^%'C;3Z\
M"\+IO52:Q225[=)%DC]2C!_V&WO>(++#-ZJ=,$S_B$BZ<'-[2\G 0-+G!E"N
M._AKX5WX%QM'_5Y1]GJ!/[BK4"= .BMX20@C)B,V0$$\:QP,#$YY@=.":!4X
MQ\9F$)F..PGZT%H*:LO/];R@<LF]A658]/&LWZ=\?4OS% U'\VVRVIN$,E^F
M^+:\ +CGU#*W$OXWRA>^B$)@V;.4)C!7N"D$7* [0XM@ZVP"T+?4SK,-S_7B
M:]'YMD4#K">1;=%@E>+2H%)9AH,.RU'/W=]+.F\@:=3K:4FNS5RM:?;=?Q/A
M2\@[U+KHE$Z4=EFF&3545%Q9:1E.E&$FP.A5S,RE*O$5!O:-Z'QO%"F^J<=X
M3<9%FMMH6UUC:O1U ^_[N_!QPBY2PVK/@"R+E(;?(APJL*6 ,33JI#&[CV,8
MQ+/ .8^2LZ-F-.E"-;X'Z)*,"^'98$G^@9<N 1\3I;HM$IN81?%.GLV@\[VJ
M@9)=/G-EG183^2C(@]7<YOX*/X8D6_1JFO]):Q!9L,/XO=!@!\( Z&G)>&6.
MGY+/20 6CV)73O[X:V)65:(E>&QV_]"++080@1LO*&A0G,1P=:%JH-YG?,5B
M$WHO?HQ!%@6IBSLP].T"RS.)JM*VG^>!.S+:)@'JT^C9[KMK0<6[UH]XT9D5
M9E=(Y^.]=DC0(N6);PAAA*W0" W50%R28DY+=;?,I!5C?[-=>N3U^VXA2/&O
M?$.%.X;^$&X'(L>61!"SN5-]-$['LAN<RVO,#-F^O6 @\K^/D3I][T2T<@(^
MP>YF2.+%<&$B)-\J'&,T%B2PT4AER.O<L(,#J<&\$2=>V,]&I5/4ALAFQL>
MB6&+$=?A/P)X]UH2)3O<2%:.9#/4UO",\H!W")O!)O9B(..9#!#E3 9R.5L
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M!.2W;MC=?#7SP<BRK0/][;\Y%NIE E&X:X1_&>SCQD-.H$_/K9N/@U[.4XS
MP3M1U4H+C5IJ!84V19*9$:\9XE8V9:='+2RB>$<$_]G6SWQ1C7FKU^;%O?R
MR&D6Y>FN'(=CE2SBA-OP,2'X'TELJ3BT1+S([ZG\&\*(M)[4./50Q$_?;]AI
M&YU?MQ5/.?P]L)\OO9;U](5BMP5DY+FTAZ>-)7(O_/N2B+?@"45Z@;IY"1<&
MPGU&VJ)C@%6:<4_C+>I=A!5V89 68_+:"A790!E:BN#\:<46/G%N7(NO9_H=
M@H\)X9TZU;T6D&E2-^)4#16*QY5K]\MWES*X)X:-GDUK:&+E5I6[:ZOT=\AL
M?7=M<1T&'*W^NV<==G=&: P-KL/*BUBNPL?? B4P%FPIOOK>$Y)SRWBMH^[.
M33*-#*[+)W-\G'\VU_?0D[?2<C^NF=T].P"["J^E\U5BN"K@\M(-GK4(1:AU
MMAWM0=U"$T@&*#LUQC].4K!:]%0.")_L2VS0CRUO;/ZV#@NKY)N854Y7E6MG
MAUS;V*3^R^25^(_#XRL#(IT882MN",3F>D'$648""3C%2*%NH"AB?W3[9<Y0
MR['U3$4::DJ1&?ATEM=/50VHAZLTW@T>Q>FH5T<.A&\'_KMUY<I F:LG1?B.
M5 .G45,)=;9+\Q50"GN5\W 2=4\HAC,=BQZ4#J.2-7H\I#I0$\+M@ WQ-0JZ
M1:?9^)4\NR65;+VO+,Y_6G? R[VY*23!W?57R!0A$I5<L G:SU/#FC )7>LP
MZ3#\)H@P.S@IRSTRC-O)S%3>+/FX)"R16P %10WYEI^;]MR1]^O[]X6X_&;\
M1'3,-<>>=V&&>]^)K:5LNB+]]LS4M\S4W2I*09&.M0^6CN MP]9A]2Y+[>"_
MO6W%>;<"\)](DA0E_LEV8":3M]T/BV>S8I(='"O[R\+6FD37WVST6OUI='G1
MH-*9U'>U1GIN969;?H=DPVOK/*TNPQJ-!3K$IP5B/6_U@?V#;U%'^0G#U,O5
M$\O<^Z*1?%LX$T/:2MD,>;$NT^_^(4V8#])6_?BVRS;$L#=\:]!OX8&+8=7K
MRYK)ES(U%;<7>__^\F[N<+C8JE0G:L*+>P128\5[]<!A"!F<!A3"FG8YW/Z)
M_/P&LRD99U*(;M*%^T_M'R@M>Q4&9LR;*K,]1]ZY,%2]+AY2O2_U<!W6>;+2
M]"=RED0@!V0.D.LG9T0=8H8Y7S Y^>MC:'3\#6?A<./#F=^2"SH'RW)LSV_T
MO1*ALDU\"B$M[".)FFB^>A&_"]H)H#L9\M;K,*6S+D6+MC,Z32WI"SR7NI8"
M=UE?^9YO$Y\#[KW1#Z7?N*\2&Q1H*1JCKFE&@MO4\,N/&BXN,G&3<:G\3E.9
MV,HY,+8F/M>24A1JP#MR-RTQQ%XFNSP2-LMW$=6T?SOOX<))BE6E)&XXY E\
M6&!W+<<CNY<EYFSP8N!JPG*^9Q.5U*MED15%,%J'T;1*4PPL*CRJ';MW^THS
ME5L-FG;A-V/LN6V")^NPV4PJ,-*BD %&X UQ,0\MMH;A]]>.K*#A<-]0U$;$
MOKD97?#T8FQ^YB%/%8AP;+@M<.WNM^*QXPV3V1O=W[%1E'RA3#E Z-6%UXP@
MMHN*6#5B!];)=Z0R)56HPS\@*!7JHV<V@@$E?8]O3?[[F&2N4MC:3+;]7W5T
MR8*HX4-<T"&8R/0D> Q<U!XB8&(NJX;_6[OL>=<NLIPUF(+0;1-4F#H@B\()
M,@Y'WF#AW4)Y,K .6_H!5LG#('WOD2T?,]0S+VSUMAR\6!Y9^W67:8;!M=M8
M!F>(IR/L7X?5H99 UO*D#S<,0L\.3K2R4SK1Z[!-V'QFV3V\4NA-H=28PP46
MFJ@95J!5"R%9FE<"]$!*(GA4)_)'Q_"<[>:CX[\6>G_MU/O-=9O&$2 + ,5>
MYJNBF%(IZ[!08A)! :\'W1KAZD*Y+), *99Y=AE:2_T!RQ^9B5+T>/[]61YE
M3K]]SSO<'$GHR!;KWR*^Y]<48Z*U0X0UA$CD72U"7[42+@A:!$)87O[P"50
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M_F;>?9SZ8]RAR07OZV:M1=LF+WKE[%>SN(?0QK\C-,&3,"_ W$2$ GZH8"M
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M2%D0&-&T[%UR47)J@U<W(9>:OOZHN6%$^+R3(PX!+)A$5>+4,ZC\,C'A^,U
MMAI=01(Y/Z/W_7V(<>WK<G B<;?$;$^V6AW(0GH[9+@.AN5<[N;9 979%6>]
M_9.89JZ8W17=#C:2R2F81R4PA%?0WW;T<(83@VO9T8C=5CN#5F%/5SP?]O$0
M[<&R'N">3DF:*.D/_<?4'_C\F >3_>->3 [AE">;:=V9\;$F:EQ(5W]]5R7X
M.=S^ 8SONW:0V H-)@8&[YYAR/T$&X!ZCDH1H-H^:3*XW&OO (1]8FRS,K3'
ME+$];OZ,J%SQ0-=@ENQ.G?BTFF1_F+WE+F&86&T;1]_JB=<!TP ++I5_'A@3
M69&8HLF=Z^5T5;S'>B'A"*ZF7<,XEG>T%FGQ@:A&ZS'28GGT[1"; 9XYE))D
MDQ:OZ\+US%C3&RLS7R66A7Q4LN9]8\0-)&_L^AJ8[_9M-$"$J"N)YM=F6^H-
M6$CKC5TA34UW_+,,UI:?.ALWC%K38+)$_7?M/7O_5ONC]^0 @']]O@LJM-^$
MC#@,?*2AHAFRH<01%&]'1BIQ"I',KOFNBI;%6W.2_?H^/M)#RW^;U82;\XA[
M<JP-G9D$>>!%;PDNU<9^3=,GD7L<CD;@[=;SK4SQMR2+X0;^,K#QRIN;(\5#
MQ0AHP4_8M3?9NR@P5"+>(EQ(YL9F1B,"40IB1/7@MZ",=_4QM2@-D-PJG-TB
M/O]F9&[U/OB(^?PB>L6?=[B#O 6O #[BHA*)RG";0A#QP6IG3=,PW)J*<2W'
M!F]O>?V*GU>3\*LQ@Q81B>6'2LL<BFK!N&8,[#D4]?9 "BJ&>.?1PYXIVX5W
M;"5B@*>K Z@;MF8K?@3& +$F??&9(6 D6M:3T$\X,^0#>DXE.V$R/"X ,;.N
M5AI)G@,^6-:9EMX?Z<EU/<^_=8*/UC0DLF0LB>;H)Z-7T#733PD[@KPTJP8I
MP7 M@#BUHSS/&@AO;:RE:'TF\1X9<$M(H\$:,YL0.=Z]T6>_(R5I8.Q$T+!Y
M).%=]<0HVP8Q._TTM"8_(,LX/@SI?!.K>7FP-HY%^_BSB45[., _\ [K[-;<
ML.=!1#F;UM#T=;'D+X]D!TR#A\5C1!::YK^@OF8\9P4%$];.X4Y>'-R$^ J>
MY2H(^Q*L#DKPH9;:ZNF&UP>T$RK !Y=:@.VD>+@C+.Z9E2JP"2$%']^$*&-+
M4HT6#:DFX?7UM("[B9\8=PA=#'FX-Q N\ETGT_7QYP;?##2' -"IDO9@3;"N
M>Y0Y6S?+12B"Z"LLTP;^0M]QC\F@\/#PC.^0%QY]2L]3=7F'MLYF'55]LRK[
MP_[L=B7'_W5%P#H8L=J[P)82G/]E@)6N1_&?$FB"MEPTJ<!^;0*V,&DNM&H(
MI.#.+7BY/R_YR,)R_&(3_KX5;2X]2;.!X.H3-U3!PUU6)T&TQ)\5<'[#$BUN
MD_9FGNEJM[S#ZS/WTF UW^!HLG=A7(_;A\+'7K[_8HH,&N-O_>WS5T*=]2<-
M<AMZZR3>]POA=&_!^$?@9#M:MME66&[#0M!6RJ,\8! PG:FM"D#C*8<&^)IK
M9IRQF\)*TL.:_SSY4>"7Z"K7OCTJ5FD+@.J"?JN?0G21]P6R%9I112"C#:U4
MZWG"4D8V$2%%WX]C<*12[HH/U:LV/NXW#9;#Z;@/E@S7(L\@O7ZN?F[W2G&K
M"!8([M8V9/SBWCK3-\(3H4#--=,Q7#XZSDIMB /8IE8N+,(C ,7.R<, C$E,
MR(7G]A\F7=(V A-XZ^>=@<QXHP5L\7LSD7D]W8:<<P_K?>E'H.YJ62($5.66
MB!7'1*%@!V#>P5#%WU#M1!ITH>4.]"\+E,?Q%N 24,*I2^-JHO<&BAJ-XTVU
MI%ISCWVIQ2$KR;<#*/=8J:%S"9H3R&TJ_245^)WK_Q*@&[T9DT=H(+%,;#_T
M!L#VQI64(P$=[C"3^$S!)JS0W=[[MDIL.&\BBGDF(S4(\/RX>];=\ LQ:+SB
MP]BN-R<_KB@K;>$A=FPH@H>G2-&UJ7$(Z>7R9-G6+&41X^WL*G[T56<]7*I#
M^\ PWI62  MS>73_8K87().G!S/_Z)-2=WQ;?=V6=]B-[7BS@3!&2N2/8E*D
MJ>SH?@]H$HY%RRX:)E:)Y66C0U=B;U;/!!Z.4SBR-^/'G4^0-RZ=[+PC;V1/
M@;>G$#)B0R$J9D,#U.]$FK?F;A5^3N*@]KK9/W@0R<K23BKQN.%F+9JO'IA<
MJ$\\=G?+-X?O5XMVI]B+8D$MX9HH$7Q0BM<'BXKFW/N>A#7QI9P:JOK#**[M
MD6WS=!5 )8U+E)Z<;=Q(,,TH*IBX,:^!K.B)DLG[^RIL&_3?J"*E+7\:)(#;
M:B+A+(0L9D,;T,J,)P:IKT!E@E;U&$&CP_S':Y<QD3;,5;.&P,K9P(H <Z@B
M36O/S9I$C'*\.\9,8?:B6G/1N4GOE!HN6:RX"1$] @>!DTP)\MXBJX?*:H%U
M/>WNL,3%#0U\.-@C9+5[O/M"H?<6>P2YPQ[C73F],@&4$X/(MT45OQ5)OXH8
M+RP"#L0((H]LY5$?;T*J2MK0(^R.3/H),(J"]QT*2_8^3Q?V,A'R! 0^$*S/
MLR*'A&/*TFYSR%#<)L1-R,HA2GJP*);FMOR>FECQL/<A:Z;4ZR,0PR''T,WP
M5D!J&SE!PW[>:@M 3]-+X[; /2=G*0_R=_EBBLQ%B6F+]5F31Z^H^^E?RPP[
MZM5N _'[UB["','F3[J/ZM:O\QRFY9+_6:I$1%F-;U=4".>KP>7@J5WD7<U0
M ,ID[)6$*2-CGA.+( -R-@[A+=+"--<LL"<[[3AH1= .YE-#.VATO8_4?)VK
M9):<T59ZZWJTU80-!+\&)$V51#,"9+<BA6/<N.00"AC$NR84-?B([F.R]$I\
MN8Q=0:S(Q<=<2T670;W4Z\*,@H)YUK$>HR^RVYFZ!V7N8'HBQ 6\OH7K0I@H
M#2#&BB. @] $%?H1(2G.%+%SQEW0CDAB*VRH8NZ!J!M#PU>'#&E&MAP)4-1J
MH6_4YP8LT-1?K![U-S>OMC-B MTZM#4_2=N>YV0NR O/2X1#C  T6U<W(5WS
M?8K@'<&U]X/\YMMK#OC[ #76KW%XX>YR3_&0^"27&J]1F1V^#UL^T=)L?@9?
MJ6N\\WFCQF<P>Q.R;6T]9T-7?(YEI3_JAK\".@*PCOZVW!, :>$/@.;"/DR<
M[^)CO:5+&X )1K2II<XEP/1+HGR@3"DW"5->6T^K2?G,_UZ7H+,.R8^V"OGO
M]6C4&&*-:VP8:J]87YC7[SV\4@A()<'/EV+.]#T3^_-R"%%1FKOP-CRH)IBX
MY 28)X5EQX>.&5DAO=T;,77O!A<67JFP.GOG2X8)2J!Y!UI1+ 5$>0SH-8(Q
MPAY[H#AF"HN\&_R&=&%03#!90\D;LAXNWLK E&OMZ/<*W.*?)"_W5P&UIO^L
M]GG G^/ZQ.HD+A@I)*>:)(2U0)$ -08>4?*MJ+.H2%[B)KEZU0 []J[7W$'*
M =IP[1X+TC/(7[E_/8GE@D7" L[O3O9V#$):0G(Z9\&D*82\=5 6@]1L7Y3L
M<:7E6[%]5)W'K)&_1\\VN9:4JGRVQ[R9:YFQ4N=,8926I(]+)6Z[K7D]X]GJ
M%6W]>K ?<&ZE0YMJA_ G)5E'P-\%,+CDMF3M)=2!!7P?B7X,3"X%O9E79YT*
MSU^L8=6N91L=/-7OHBM?)ELA]A1&?2 @OM*5YB8/?GF:2=R&]X6F6JFN9\WQ
MD/7"X80%O#H7MGT,J?*ZR%;F-7&GL"_1E&]I,J84=>IV?8K)\_<O8<V.9Z'F
M^)#U7((<84!;H59HVTG<>@/7=:&&/K@2+'O3P3C4Z$%;K@$M<#LY07R4NWW(
M,*QO#V;7"?,TJVB;7SNY_]H;KSS#N48CIG(8->0G^# .(W[UA?@ZV,Y-W3;>
M$S5EZ2R* 7N P[PKA"U??5[EOQ_"&Q2!FY#K0W^']MH>SPY8.3KN5=:9H'XI
M+WIXQE1I2R\F%]HOMBN<&Y6--^FQ]+89KKAK0@FW'^*_:1Q<L3PC&AJ;& D2
MU6^G+%*F8T?UY&'=%?)2F4V(?R59I54?X6-;393VG&6H%8%NP\/.AS\X ]/<
MB:X/ ?GO<RU&#'5!+],QM'1Q2F8(I7MFF-6;W_GK9'Z-O7[JX.B1K9UP1V$V
M9SJ9 /42ZP/!T6(C+BPN:SC.-LX4"F'/:IAV/:T46Y1XC(W.NE]SW_;[A#6V
M*##CW;G0M[6]%T=,>GI_I^DV#^RR[5@EBA6Z1-=3URPN#=T!)[A4DHNYF<:K
MU-;4?1M?-B$:S6BA^P#6DO5(?U+ ^5G$PYYOSUHD%][4_U@T,]P@%+U,C!O]
MZ(<A92]/)D)^3-76O*NN>O*YT\BJ;<  <Z2"4Y^,76XYT?G9XY31WYS!13U[
MG[C3.BGR?O/;Y*KUAL)>UK\&%:?(T?1]((]+[8#)!M3+X:9Y#C0.%LUUJ8FJ
M",KZL5%O_@1^.I@3O&LV0[;B)*IXUAW[TB $4S3VY^&]FVCTE43W7\C<61M(
MA"N3$4>0 VE3*#7\<3"VR -,:D7+X0^7@;".+*7J"4-W>EKYB'4Q>ZPW).C:
MC?$*A8EV[/WJ0W1L]RVNH7DZ;EIT$S0'$&?! QQ!O)5*$V!&7CL#-K62Y0FJ
M6O8W62DE^3CRA\8KHRZ/WP9%#ER^6!/JW=#C=LGYR/Z<EX8]RH\\)0$.T2EX
M,KEUO<!*"1R>HG;TR4*5Q7"0Q/D3"E6=23*C%)NNO_KQX]5R4G!H)378**?S
M9:99O_%91JJ#_Z_8=M/;8/:45+NL>H?01<NUW8^'7">+;;VYU*=904$:G]Q=
M8JDS7@I#8G4.Q4^ O.&-4K'-"QB-[1/!G2R,LIK#-=TN75IU2H1T?*OVZ!96
M?NP:E7Z?WMN<)LWLX.2Z%1G.^7W31:Y9]2E6J%U[NON//Q-1#?O 5IS=A&C7
MYOBWF1-'T+741+@1#_'LC!.8?MTLZW>\6*'1(+"Q@SKBZX:W>,O<4!-RQ\<[
M 7J>-GE[><6Y22AL8?>1K9^:T1SDGBXKM6&X(I>O!Y/#.7>X[Z!R!(H!6:]>
M_NJHQ!&=!TL&:=)2KCGC05C=<?.W=<-G+IF_LX?0][IPKN'YO%1)X"0RT4\1
M>S:V@F1[H >4G4IFQX6A2*6%XFM@C&3VK8>:CQ=[!A(TCH&\\\VU0,N/NIS;
MQ+>!=8.]I84A-KY:U.>4':K\H"-;EZ8_,(1(](A.:ZY!?S,V8HJA@K<'I.(6
M*3 QC AT<>N9[.0O,QJQS8X[3:'2DI K]N5Z:!UV=BMXO'UUI)!WYY]^R"3;
M56P#AG!@202EX0TML9W0E22.F$*IC)@E<!E[P7)4TK7^L GCY:?_S&7A5PWE
M^BS+SN5W8SR869W>6I^<F/V%R7/+5Z5^^KV6"&K#^BOQA(7],)9NCNO[<,;H
MQZO)U\+P+G2MOP3>5<6**4AM[_68O0P94_(^>\[$ _LO+A;VR;*V0R:OFT\7
MTB_<>VTU4+*<C7HRP!K0Q.R\75]3GW+$Z$U=G)K1F_JX([SZ^KJ4T5-\UN3H
MQ)WZV%O2^T*853OT3FP?/0+)3_S_]7^O F_)R 1L&7+Z:^=_"HW+[EV2HII
MYH[FWA&=7G7\>?A!*@5BE>C_3TL*X66P-FE9HJ.01TJ]O"\;9)[#-OFTLWML
M3-Y)29GDW@D_M?IEZTSA7C6??2DO8[\Z[(*L_(S6LCGYR:L+<=D\]?PJ,5GR
MI+/6ZDJU_T]_[78]XKZF?H/%V3[N-ZW3@OE4AX:JZX?O';J^C;2+H3;7%']*
MD"NK=6I^7EDK#S99=L:4K]W?\FH3HGFX?V/W1YHZ*LWALNJ&O\$H5+1"^07/
MYJIV0N/8>WP';9D(#9QW*WNTHG^FBQGY(R53N_QA'KT_>%_X%:W8VLOI$66[
MCS\OMKY8 =N##P,M>5&6_M>$1&:?%"ZCIUU(#)AW=4<DF#RZ-,NZM^M*?3VK
MRCY)RU0SU-OY7M7)#L,+]2-CT'2&T-7>;&CC .&C^VWA&V#-"YSN3%*-AO?!
M-A15S.@J4K9KMD@+HA2_$-_T9-D=+."@2/LE;4=, H+(THL(/X0<FO")8*:M
M"5[(E)^OVSA2A]Y[K*49&Z)D"V^\:COT[,@.]@+3\C^(TA]6FIP'E=">$*#7
M=R\2Y3-GW7C7L;VB9\O%)D=4SM*Y0O_>CT=L+"Z'8&TV(8="Z@<.G^$8FWR^
MKRX<*,\0;FAJS_[$]KSB9J"32Y\63S00HYP4[/!./V[6?Z7.N/>(RM;_I1E0
M]/? GC&D%Q=IF**Z=RDPU8#,@XM DK4HZDXZ^71]6:6W8;C*^2=/9;HZT2H;
M2N .@=U@<P2O3QKGLL24Q03F6U/FSR"SYUY<^G0KU;;.F'IOX-+GJNXR^U='
M'M2Z+IU>.XB'DSV_T#7F1.1W;+$1Q2Q8R[V;H=X53_-0^K4?,!*7.)N9K;[*
MR!5P*'8Z=2<NQ[EX8&M.VBC90WW7@N8)<O_=Q0S8A*2:3>X'/B=S6DY.9;8U
M-.L*%[6\;];'K'EP;X8/!&7%TI)KP^O1 2UQ/[%HY%)XPECW8V1CA_S+5>7F
MXSV!TP/=0O7V58JA2@1:WCCH9&9]^T_AU1<EUI^+C,.=;O93U"X/_^N]\.+%
M4M"ZSDG\X2W.W"L]^Y/_=@F#YY^ZLMLIL6N0FM[FW%KJT'^_XD705<ER#,=,
M(J'])<\VCDKL/^(VMEQL#3!(<.7"H*76P)(YPN&ORQ2]X>N-^G%'#C:]&C!/
MBSEP[?R+"M*_:4ZX&.YT.W3'3)V7 6">BC_)(4MC5,V$@8VBFHH9D8997E18
MH.77MS5??7P2@\W:NE<XGM.]GI^>==V#]JGR;8%MA %$M?D"*N+1?9+7</.#
M\"FT<G>%QB), ;IW'&?K1GIXVB]W=/3O%0-]']=>LC+>EX=(W(3L7 Y^,MHT
M>99<#7U"./K?RW2D!>SF%F%=BV2,\;0@:>.?;)V[US8AN/<%^L(ZM7&3>?AP
M^HBW_@!%_;.XMM2!<NI:8J3=]9='[W=0=!S-RVIZ+%<=73Z>));#\ZZEZ.AT
M&PQVZOHFE,<_]74VG _T&1]P#JE)CUQ!O)W B-) 64YZOCU7-I$NU>\-R"3[
M<HT4D+9,=\OG7\46A)11O]([A]*0GU_?>]>CW#(P=9GU*[\IPD?VK# \M5D9
MV&I'E ,-F&=4$T)OZ,EI;D)DYLRRRNS-%T<M_'/[$W7VO]8+.'1KKKK\UJ%H
M\H\^[O*D2DP7N>KEAAF(+<6["/F9"\2I["3!]EE'I%5>F)(<&AFB^S0+8UQ>
MDGS@-2U[K<[ 3\3:&9V@DPD-EV1F'3BL8@)7SYON@.V=U6DE_M6,H<R.!C^&
MRS4VJU;-C'Y.?P!?+9170[T.$5E8E&M9>235B-H?8"V;MNYSY,D<% X;?A"*
M#EN4I.3<O+[=X55AZ1$[UXX[]P:+7Y!IHK38W6$,TG\X)@7FQ@%4UVBKYW\8
MR@!!*NYP>NOM)7U<:>"G'U#?<[%NG_GW?TU6I-\<[W9M_CL=$4!C0''0=M'D
M_O?#<$?.NAYLM\=LO=613,=&-_YR@*G==Y(]UCY*_VU3CK;!N4M&)\Z\_;@[
MU!2A"!(O#90 *@5EHR,!#]W_;N0O5D5$&AD9F90'."W^%&W\UG49'T/N_;AG
M2_R3JOUUJDL>HO@O4ZP5ZAC4FO'$H^4D<_7P0E,A>FS_A_>UC*^5)G\6JF4\
MJ0<:<Q4F()IVFA<?P$.X40)5O&+=>C;-HO/,>C&#1R7EPE_86-T"0X39[6=(
MR0>'N[8M .9Q>4)I4A.N>;'S"V9I5/T,Y7$;"]N3F:7RT*7_HJ"RCK5F1IA.
MXOWM!3W>Y6L/"_5RYT Q5'%S^LW*3<CG5XO4&M8:(0.-6VH5::MG=FF0XT,Q
MJ)UZKU3>XQUUAUPB3_7_3-&,7]GSZ-)QQ?-AP985 <I#__G"N7]#26!;%OC@
MFUDQ[ WV*']'@2YPJ^[H+5&:5RN^'DOSN5B;H0[G_[@LS:P<%0\"J&=XZ4?"
M8=%5T)JW"9''H=J]U %2#/PT3U9S=O+8<*B1[*4AL;Q0T*81^AQT"0QSL3ND
MP4Y80>_QF##$TFJ3I&]?)1EK2J$ >B:@.,5NA\:T,U>)B7CS8L* .VQAG3?A
M<;%A0,"'WQ#^;L]H[$H2ZY1,>'V[9#*/@:GBS.V$.]++/[D;)#O9]_2<.,</
M?_UC7]K/']4.["0OUR:4,$HUEJ=O:A!UVI0_O>L0-6KIR)+!<O6+IOYR.Z^9
MM?DVA/:&-&[P)E$&9\%U?8I'<MU>S(44!$9._-OX=/96VY[J.Z]95]S7\_8F
MDG:[O>K.5&;!F*B_=H6^=^Z@:R^9>MY'2\TL(2O<+YG"Y-S&QL>]9D15K0<+
MYC*^C!U*R3ZO]OV9[!]_33&#%ZR&,VB;/"8L?LR%C6Q"F-(% =JGA ^3IQCQ
M9I,JPD*K7<)-2#P>99J16C"7J_4+IK'1]FGN-XOEM/^I_/UDV,N\]$]_4I8^
MC/HSW?"R'*V+V,L=IJ@Q'5':4*U6.)*M3>6L$WILP2)B'J[FW-+]TM* WT7!
M_&X"WV57_/0]Q;VT:[]#1YI6]<2K>BO\ZO'K8,Z4OUK4]H0'+S*KOYI'Z$:9
MBB*H1<OA,X)5<AC74]6AL7]Y;:P7X4!G?9>;/8-=_KC]9Q6.587V=!LU,//Z
MU6^LX']+4_N>$^3B[39<#R^SM8^TVI(2RT,E:,L)/Y?B;YMEW6501JS?7M'&
M)-T3!#[06[LZ?*SO;F9AA .+KQX>< F5%BI(<*<^$T<(5:\ /G(W\)Y@,$\0
M3U #?J8I,^^-]5:ZB:& Y@C&3/ZM(5T5?,P9>X_WY+B$;L&NG"HX_>*H'4UH
MPX=;"G7:V/(Z((8B=@'".UH<IID,N>#FT\6@WQ+3?'6RY.U-N["0RG$PVW40
M:UQ1.W_)"']<A7R7>NC>Q>)CR?<^!_[8+?\S,&B!-K#(?SCPL58P.?R-A7=,
MZ+ISE"/\1[;\JZ-HDF57[EQ<<+1SN.7'I_SA"]1\]K(!LJ5ZJ.(-8_ N7U!Q
MM]^?UER;M2<;\X^VR8BAJLN/@H:$=Y<_J65\5WCXG=^9Y[JUH6\&X2XD1I]A
M/PT3Q%E!FX2PIW?QVSE)%E2% !=MF<;!A=!2_&D$"8ZL"#A3G+:>73PQ^>T&
M)8-2@O;X8U;SS_F+G^+SJKP$\MT;.IL0:^=U3&\IU-\<53\[-MT@PFD,=GQ)
M.4@%=!816:Y+[(U=NDJ.5Q_&_N_V1_Y/R^7YZ5>7G*Z^E=)F(.93EP82]7UW
M]NKJAA:I4P&;2=CWSAQJ:%9(2" _T #Q 42+:.O/Q"?7KK-!F6D/(#,9KAXB
M''-FF1H=G&ZM-S/+',YL7*&TO'8V':B-QV[/1_X2DX_I/&?BZMN)H%YFNP""
MBV'F'J.#)," *YL,/S_%E@,/RBKBEFX,F)ZNW6,9U&V@.4;1L"[\C!5D'9+3
M-ZDL.W@'V_>Z)=%@YI[8ESQU#'VUC>=K+ZU^\4LR_5,EK=ZLDK\V.CD&S?Y)
ME[NG%_[:WNS3B<BP$)K2>%D]H]8E(Q7I,NPP^M 6.K4) 77-27CI,,Z?YI-K
M%S;Z733"2<$5L 4335G5&R.!T*:&)XO.I;-'2T:^W6PU$=WWBZ!\ZM7^=N7%
M(?G\5=MHQM1K=@V55 SXY?'Z9)" /]/*$"#4\ Y4@C\M @6A0-E$#]XH-*]@
MITF!;W"(9<?7YLP+<](/PD-_O7M,Z=^MKP]T*7R->5:C_]'"HN,](VPBZF.I
M$9[?6%<)1 L]VAM/D23$KPR[7'LZR"I@]%XBMOP&;6#^%S+$3@*Y=6 $EI-C
MT>I"EJ<?= <?M&]"5 0$XYG5J/-OND/7^+;V2<C@78&+B14FIV_'[?FH<W^Q
MF'7G4_XY5Q;>?@V"UP74U@OU4AU9H=FIHS>63\.=W[IYS#J$XL3F6)., ?!1
M8GJ-XVL_EI_1^VS^94["]NS;-@_H)ERSAEQOEWFD(7W(MS_L1=*C45?ZV_EV
MT)S3N]?2;9#3K.]4JF[1C9WP8@UCS"@C&<N(;^8?LJ!,V!.& K13^QB= :H*
MZ6,<O;02+^/T]5=<2XUN]M7!S&O#CJ$]),Q'F^6JR][OHR/,ZKX??.&3V;">
MO0GQ(<L2>E:IS :\)I>H.$?0!$G<XUPB>%Z0T5]+W154K5D0%<$IHE57H6H\
M.R(PP:':"F"=^HNS='<E%V5<P9DN:TZ5V\>O!09V@YEM/QR<__6L:\RQZYY]
M5%S7'S8%-YL:+U'<>]<C_6K;G;R^G:S"'Y_S7)1X3D<9-4<ZCP>V*#F[3^1D
M/B/\->-ET R^+AN?'YVHP5]!Q_T*JK[1ID<;0'"N>=%IMU8M7EA%C<5K^:F/
M^R[M?G+#!O5 N+7527P.^-UQ/+#4 Z1R8=$+5ON"?NY24%1)5QJD+.9A LII
MS7:EWS8A_BWBV4RL>;N[H>_9)&/'F_/0> \32C[[0I1;I78WL(\^)E.FJQOP
M<38LM&BNH<B/TC1F[P]:B,*$I*<KYJP5R*3Y"R@$I\A)>2V;4)MSFA^:NA<G
MT[8Q9%V4G2_0'4ZH-"X:,MZ=+IMSXG9=YH14/,*/^A=(N@ZT\,?-,\R@\K6(
MG>XXDMT -^ER'%0!I[\X[RAD,"U/7AWH'@_0-A1.%*W4_;.:SDA[^VVFT;(P
MZ:#'PO/\5"K7%#_1M E!#SO;MD? [W4K">^55#R:$;O0RP2A HJ@^@06X;\)
M40Z*K">AF,')=#.)YJ-W8\Z8T0K!.YZ:;59:JJ.5,?#(.%(I2'7]<B>5J?%K
M=+Q]O1R#N?>ER[ .BFE@OE BI%\ I?(#ZB?5AJ:&PYJ:4J7%CL!T1P"?VG\0
MPT=U-?HU%*'RXSL/)4IKA;UE[5PT=]!IKU%.4U)R7)E;'UZ1!&=?U/Z>HTC4
MMP=-I]SOS@U4"Z+* Y?FQL*;D1*S\3H$MD\%/ZO^6#;K=4*HG5DY"S/.CBG&
MI?0X)4996" )\IL0:#4NTO.!4Z-P^4*Z%BNOU"PDD7>7Z/\HRO:K:0_YJ:0%
MFSV$->UT_:&?K##HCC%<5)N7OG ]KJG4H^IK6/".8EJ1Y]RD0M/0WJ[KC!I)
M]C8-^X<:?+LFN7(ZXUPB*^5,TXLFY*D^V[JDSS_NG'+5>86HL-V^.^PE!Q:X
M8XAZ.) XY7)S8H%:AHSJ:D.05F'ML+]F-G9_T1LR-IE0IT%@IA&<AJ\K%KWG
M-J:=AU9R'-R,*(Y4VL1ED<#CWS_V&4,GRO?]G68[Y_ALZ^((XN9>;J)!;L6_
M<Z<MQU[U.<M>S-5X%N#D4J)YXV&5Q&2<@OYW'P_^ST7<'/D?4$L#!!0    (
M %2"F%8#O6$R3 4  -\&   -    :6UA9V5?,#$P+FIP9YV3>U2,:1C GZ]O
M;MW4=!&9FJY*K,N4J:PQRE:;/7M2+MF.XY:$SF%52-0GDZ)=/BE9]IR=%!L=
MMS"(; D;N70AD4BQ)MK6I*FF9N9[]YW67BQ[?;[S_O%\S_7WO,^+[J,G8#D]
M.#08"(* A?@#]!"F 8_#X7+8/"Z7:VS,,S&S,3<S-34;;F5M8>-@+W1TL!<(
MG-S&>CBYC'$5"#Q]1XT9/\''QT?HX2_Q$TT>Z^TC,B0A>,;&9J9FP\S-AXF<
M!<ZB_RRH O@\L(7').$"1GR"Y!/H"@@!"#8Q*/!&"".2Q>9P><8FIMA!80E&
M!$D:L4@VF\7"UA1L!Q:?;>4\(8!C';Z(Z[+:1I26O9_G&EARR3:B3N7FO3A^
ML[')4+MAP^W=1WIXCO+RF2CV]?.?-.VCH."0CT.GSYPU>T[DW,^BHI?$+(U=
MMGQ%0N*:M>N2UB?+TK=D9&[=EK4K)W=WWIZO]NXK*#QP\-NB0X>+3YXZK3AS
M]ESI^<K+5ZY^7W7M>G7]G;L-]QKO/VAJ;7OZ[(?GRO87+[M>=ZM[>OLT_0,&
M+@)(XE=Y+Q<?<QFQ6"2+:^ BC-89'/@LMO,$CE5 .'?1:FL741K/)C![?\DE
M8U?O")7MXO@ZDZ%N/JWN70:T0;)_![;Y?Y']!O8[5Q.8D02^/)(/4N@;&$V4
MN:^X&=;[S1E10EIQ6!H".H*J=(U#$/!I @+.*01=LXC:\'D(="[B<K5-HU05
M)T5@&_*V.G6$;][:IBT'\L[N#)&4R2P$,J]F97;/D56:@+(/$$P=(=2J/1&D
M!S<RF_<I&?-8!&V'_JP#_C&BLD5-E" H#Z3?$WH>NXY\$QK)%#8I&0[5\TY<
MX&3QE.>[!=':D@M.NC0C6A-$O90<HY[@(E%O*9LLL.^'N :FV^XQ2.7LZ( @
MGV*"<Q!D%3+\!0-TG%PS',&]MY1\DK&DAR"HQ?"NH0BNAB/@A656/2I)E.P=
M&Q,Q)5T<)%1E(;B[ 8^NHH91"%5?\*LULGG<$NU</YW)TVY#BHO6VCTM&E$I
M@J>Y5*5= 16OQ4./E.KB:4WPRO+V98W25^>DF@:AZLM'5&W=,:KE<ZJK&*2M
MIG72TA0$LM%RQA\WG>S1-ZY<%8-OK,HPJJ4=3,;V!$8K0[#=T-BM1KVYO5+?
MQT5@;RA[RRWENF)K55_TO>.6J8$S#"&^GR"0'\4)N&?+=<G_4-V\'H&R X-=
MZGR%P+&0L7PTCDE5U.@<'^-]>2EMM2\3%&7U7%U9)>ZD*RI#7H3H7)N*]$.2
ME?K^DPB>)4/>P\KS:P[>7,=OCC/K.A%CU>$;/\JU(2KBB&2KRYD..6YHPRP$
M^VMPC7+Q AW]3H)VSV,4P^^<R61*$AC= ^JU1*BB5\C5_AWRON<W$&2WD_D%
M>*Z:$$78@*"G1ML=@^":6J-VF"Z^D70A:F=T85 L7=\\@]-I$SZ5C8_MQ-"5
M3G=B\^K:0AOBCWK9S;]8X22_&>FNO]@6UC]07Z[BA#&2(!N@5B7E,*FGC^L(
MO")T^-^;YZ0H=RANF,I8VXJJ*\C2A8D"[?K,_KH@B$2PA3Y"U2AHO0IOWVRA
MJJ2'[N_%&_R=$&]>018><W2'L+LS&L%&PPL+;]X8UG!TX?K'MZN# G;E3\K1
M_.2G.U2PR5O:FC2?JAUBH66H2EHSWTZN)F4,ODS58(Z_MMTNTQ<N.7%N?&CK
MFMV;N/$M/^+68OL;*,WRXP.YU.N#")IP>HL_J@@R]B$X'(+ :X&^.,N3G'F9
M.FVG<W-TOY-(:8*GU/0^3)?=TJ;JO][A38^)[;;MS/UEMH8C1 ]^!E!+ P04
M    " !4@IA6Y(-NKMP0  #-$0  #0   &EM86=E7S Q,2YJ<&>=EGDTU/^_
MQS_6L2:,?9DL92=;91U+9(E!(GM)B4)"IK&,)1(AXQLE6Y9$,6$&,0@QEHJ0
M?<F0?<:,==(P/_U^OWM_]YYS[SGW=Y_O\_SK]3RO<Q[O]_N\WR_Z&/T'<-S*
MW-(<8&!@ *X>+8 ^"9@";*RL(%86-A (Q,[.QL$%YN;BY.02X>/G 4N(0B0E
M1,7%3\BJRIV05I81%Y<_JZ!\6EU+2PLBIV-P3D-?55-+XT\3!C9V=BY.+F%N
M;F$-*7$IC7];](\ +]M1'UXF!FF D9>!B9>!_@F    #"\/?!?Q3#(Q,S"RL
M(#9V#LZC /8XP,C Q,3(S,3"PLQ\5(TZJ@/,O"Q\4NK&K/SVUT#2P6"-V(Q7
M;#(FU6T"#M_(LIK>]^+8.02%A$5$3YZ2DU=0U-(^<_:<CJ[I>3/S"Q:65I<<
M+SLY7W%QO>YSXZ;O+3__D-"P^^'P!XCXAPF)CY(>)Z,R_WJ6E?W\14Y1<4GI
MZ[(WY14UM1AL77W#A\;VCD^=7?CNGM[!H>'O(Z-CXQ-SA/F%GXM+RRNKE,VM
M[9W=/>JO_3]<#  3PW_H?^3B/>)B9&9F8@;]X6)@#/\3X&5FD5)GY3.V!UT+
MYI?6B&4#FV2\JFYCE]%T( MXW_O&(2BK-7>2\@?M[V3_-["X_Q?9?X+]BVL"
MX&)B.#H\)EX "NSMRQ?%<"B*!$K%AMLH!Z/?OA=PORWJ%U!T. G=^7ZKEG$'
M_"DTPU3FK0*I3+K B 5L;R2>G19XV.=7"FI!]<YXF)];RM'!%<DH_NJ[+\Z!
MZMJR'=P>;1[:4-OY*\>>0SGD)<HKGT&.DV3)6$JY7#(:<LO3D4<17W%^D^A.
MM$-G&4XEIW>:+\X,]JADD?18/W2N79'25(ZP/9.PQ%(7YYSKE.*8$:7LN]8B
MKU;"?LVZ3^^EC=6$TMM[4#B3;EZK@EZ\ G%4NV1&'1LW:I^SV[7Y_9VT96FB
MF0-1S/>VZHA,];R.<)75K'6#QFSSZXRH@*!3;Z\I6VK4ZIF7ANOTR WG;NJ-
M9"=C)M=2T'P8P<S>4T,J\TE%_,T/47R@<A&!R.JQ^VX2JGD$X1UNV+K:]7 _
M)=/=I):!BI8[#S@L )2.3&+;8K6^*2&4/)M\LP&7=XB7_,O'[>[LVLFMNZ>A
M.(3O(/9472YUL_VG]]./C:'=@P&_3(6>Q!9X\OR\7+7MTT)]+##]Y476C(I*
MAFQHKU+MC_2+1#FR-N<S@_.5]Z)T(_*4.C;*5U']$2'WVF\FCXDPDCY>(7B1
MGL3FTS(M9M0Q]37#<JVU39BL-@=+XL)EW[$ECCYLTK715O_VR4H_2<G&;][)
MOWO>-Z5I?X@S&-3.%%^$.MMOYMY3S^G],'0R'\);EU>R:LG2F?<^H<K!''7?
MQ2TD<CSHX]:L@+]ZD%U-1%XA):SF9778]8A; 431'2<?NQL)B)J8*<BN&R@#
M]IYRN7F'V-PT/N-:.JRBC:EGJZA5G \7Z24;_XHAU.@[7WL07#ZK+SADA2[T
M,"D]_M3GIKO:\+YC8]J+L+"(N>X1$9/*9Y\=>C $Z6^*J3.YBZ7R"1F(OB[!
M\&RG-\HD K8Y1*)T(:E(X3GC79TI#88NHR^ASQ8;C^4QODZ]'O9Z+1WI*^MM
ML9#E5=O^C0[T&5U95UH6&BU%>%P<A!E;7I$O2HXS298O9/Q?S*S=24WI[.<T
MJ'O>(9-8($('6I!=6/U+Y=JEJ,GS8UF1"VFO(D9SO:P%<*<L2RP&D/SB',O%
MMONU%EV+-XNC'BB_=E&]\8"'HLGO6$F[N%OSL 5V!K+QYE<VS3]OL;FL]CA*
M+^+AN3=A!I!+Z;8>)AYG2$KF"]:R9A?F5ZBC1<4"Q6=J5A&"!>48CFQ!H9/V
MB3_E9Y5X2N]/0![+#%M-N@>D+=47'Q@<O&V/E"O'!:BD5,N;4P_2@SVL9C"!
M56F7ATD.NO'N.[>4QAX;[:ZZ]I(/*[3S),5:]#LVNT$W)9!X2J7K5DYM[6D$
MB\!GZE#7/BP6DUZ_&OAYD^^]&WYO,<B8N!KAS!DTSY.BN\ 940*'PC UT=YN
MX^HR:H%5K?MLA3Q7BW %%ZCHM^/PN%%C2FOBZT$2*?<"2V=C;=>Z+4A\P;<Q
MT[/Z[X_"/WQ9+,#9MKFI 8MIK<LGC!'@1<]<BO0/?NB&&D3),^X(?*)V.%*(
M:67,T>"!.V%B9QYI] 3+.[F<A61OH(4[[P91H(2+T4HPKK.)H;%O<='>;8OY
MYH.S$9\G!R2W&4B.SMEJ*='2*XU.M>7P1QV(&WG89P\SVRE]K9$5YN"8A7FQ
M5L4U' ]Z"E[0EA.(#0<'P\+%-$N,B,R::B*RNX7'TO[;!4B=OFY^_VI%L6QF
M#(OST(X>MRMKPQ Z@#3G+.]3_\PC_%BQ3#/@7I0L#_S33%_U;T0_71/2N(CO
MK7]\8:5@S=.@PGUZ=>^FW]A#R#WU/3MD_LX*'> +F/*?1,;=1>]\Q&]7G;BR
M>0[MQG,#_/7YK;3^N:#8RB><!&YS*:4LJ$]JETEL%PVQ5%:*Z.A"F7>OOGMR
MVO%)G%)/M!!U1EB$IE/^64;:Z;=XVMUC,/4"?-FHP)K&%W%>_9I&O"CCY_6[
M8$2F^[DTY"W2#;TM?S@R-1("2<!9<Q_$K0\%QE\#69206DV'H[63@IK73 EJ
M:=X4P==9C1'\91/\=;!?JP>3*V/1VNESTZI13C]OOG"Y,["020=4H.,"RY=@
MXV4&7Y[]"C,(G\.\4RZ+I0-)R@W[2W2@TF,),4_C9^"),#QMZ @IIP,<ZWJC
MV<XNM?EN^?S!HO"A7=29\+7%L>6GI#3!GY:7+W73@:@M*L?>F:O)+L]9F%"W
MVY_T_* #$ZY^&Y.]F!'O2?"7=MIJP]+!]B1U%.L_<:,.6S*]DAV;BAVV ;]R
M _D)ZX_XI"CG1/:#4<WOTOF#GGQPL*]^DFX:=SN!LO%ICWSA<>@7K16;".ZI
M4Q<_+7V>1@E<#OYJ"]7=4GL"Y<;I_6AF@C5_>]5@^1K'JX/RG@_L@G[F6,6%
MOFHY"P<T%A[X/Z #\ '6[P6?4I%6Y-WJ2GA_1YEUW&2?H!T^;X_K=XLMS#ZV
M7X+Z;H^R]ZEU79,@0/9(7F%4PSP(N!NYH52U[FN@\[LU(;2 GQ:B%H>Y#:L>
MQX>5>WU9F,"K35V:3D?;J6]<T<W/I%A0HW>7["BV&<PF$Q?R9_1.FU0-NH0+
M;&\828A#CQ>V4J\%SRN).<S8-'6/#$*GP\XIND'0I?=&D&":%R%*4:F5G7IZ
MF@6V_6(I^XZW[0I$J4GR TV)J0VY>:=%B@[4%RQ@E^D V_4KAP++4F#YT[7B
MB.P[.4 WN:"3V_33H>0(KI(-G80I9/*;Z^;+S>AZX&G,++J%?&0H13'+3HN$
M&1;,W<<UX'"L^[RJLS7\,@L1.T&_%YL@B06;KC@D'?!PHP/FHK"'D$V'%FGD
MZ-[A]ZP8@WR<P]JA;47?(0YVF(38;:18M_[2?:FV3X'NGUQF&C \20=Z-"F0
M W@/[6T?C7,>)HB.">WC8:/:8&5K'J,()()11O:4FS]7ZAAS.$UIV/ 4\B@O
M]"=?\:B-.JB6X'K<C+-1[GK:0O?4 +,7=XMT?6JF':9EZ&O!6S^2(($K]YY%
M=[\,\W'C=RGH9-V9)K3'BB<3>=/_[<W)F\T-V3XZNPL(\9"ONLXZ<_$:-"MJ
M24#M4HK?9_A:DQRD,NBPWV3T4&"JQ7862AQ\0%W+5=6D>L>HP",(B87Z+D()
MN!M%W#*.!1!?U-EI<,FVQ/XV,W^_N .\GM YFD@+DDLD;@L-G[I](^(:9]ZF
MU6S8_?FRYJLT./M!ZX_:H'0B!/L^'1(A5HP_-'!2!9\E6OI;@$2#92;W;(Q$
MA6;Y(B_-;3#8H.'Q'?:NLRK[DQ?N>&2XGG'?Z/\RQ6OG2;.A8'_&KQE*DJVM
MBQ2SW5+*#A;>Z-84GIC?>@O!J-$R'>D FMJZ+80V&_*VH!GX\<GS5E;(VP]P
MQR<#6^.&TK/4EW.A.3,)K[2GAYHF9EQ_M:ZRMKNTD70N44>5R#+N%&;1@+IG
M07.[+\VS-IU>.FRI_ZQKZYIM0VY4U)//7Y\+3T:N$9 '?-B@'SW/(\'?4ULB
M*2JCV6E-."Q^S4CT+!(<5AGR20AQ(89FF%,_-GEGK[:OYGC4!\E'(/WYV$NW
M(. P 8J/IR E/U$KRFH>XIOU7S?Q,G3\AQNRO:5A\_XO.A"8^17O3G3W);_K
M3X^%8G&2 92#XMVZS;J#]<"+R/FQPF,IG5X"-\C]:?A'0N=1M)X[:* ^9-%:
MR=?_NO@QW9%3KRC7NSP%F[$%G?G'TOJL&C*OHA3"-0Y//+75:>L*AN'.!TTD
M?ZR)K[=1_K!^W^!6], )2&)DFMGV%5I.C '/(1^WTB&RB+:,%BF*,8!VY2@,
M8Q8:'H?;!&1]7.V;I=W^:O9F&QU8!7,A%Z+,/[P'!'^^6F:G [XTI:)GGAXB
M)3<&R$''_?JOO=4D'GQ>0DB.DQ3IP&[";ODUB53BP=1(^9ZWW\N@GS-- <Z6
MR01!S/")4-)9[E+8FRH7#.=+!6CHFKY'TH]#Z6:!<SW^ :%=8[<0]]Z'@)Y?
MH&W?2>]M[#LWWFO&YY.K6)$^6+L=)6/7\O1D<PEZHY[#\.CW"'I$T\IQ?4RR
MR%I.*R:5#=%NYV,=&S,4K@P.*K.^?(T'B1UN94RGNWXK2MYZ^2&VASK_T?5"
MNM8G[+!II[XLMOFS5[0TXL"8I/0$2P[J3.6#5*]$:[]OJ#6NTXS@];U,_"Y&
M!TS07D4Q^CE]<]R[U>4=Y?"M3R&W@]BG)7*OEG @;0UB7&<I0K&JVJU)GA"*
MK'.UZ;&_3@]H\'FAX :-HV%F0+ 7+XY%*#WTELK(^OC,A/7B)*S^+JA!9H R
M-. $D,^FATTRE<*+NXZ?>7[ISN/KK.-RPC_TGHDC]D<K[(TD@U[1M!L'HP56
M/7FBS$7DFK;N3[%U7YY-FTT(,^0:D"6W/@PE"OH-$JPM>D5X[XHMRI7-NVW;
M@3CG@AC=J4A\M R%J_Z;C>"[GZB3)ES(,R088HFG RF\'*TYHHUF7]L5W-U_
M]]JEN"FI5O5*G3HF/LZ61^+VZ*U"UC=2YB18B+OR#..'3 *Q-95EVX2M<-.F
MK@-W2,S669EIZI5G$NO4U:/&MT_DIX/[N+*SB!S='5(ALP*@>"UV?94Y";WS
M6:$-J&\<(KSW$_L$CV8_8S/@;HLP6:(K=GZ6%Y[L-O8ZQ4GVG>)#X<. J?R=
M6+7VC>/P"(^FX4@6@C!F3$TL=.2L/2D)$LA3CA>1Q*YIV8%>P"/FLE[1 79'
M3WE*%O:@MJ(MO?:":$ B_U@L<3*V7W^DF"KX\U"E<QY:?_Z$M9?,^N0Q&E$I
M=WO#XPN8 1]I0?8YU"$WK@CN94PT-%CB>L#OVQ.%Y]<\S)H_Q,.2Q]Z?E';\
M:L"J>!1NBS2@1IV-IVF6+^]E?YM.&9\QH4BY*YUP#YE-[B!#.^B */74+^4
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M,S$N>'-D4$L! A0#%     @ 5(*85I['BT7$#@   JD  !0
M ( !DAP  &)M<BTR,#(R,3(S,5]C86PN>&UL4$L! A0#%     @ 5(*85@7B
M%K+G5   \A\% !0              ( !B"L  &)M<BTR,#(R,3(S,5]D968N
M>&UL4$L! A0#%     @ 5(*85N$\ SSNS0  1]() !0              ( !
MH8   &)M<BTR,#(R,3(S,5]L86(N>&UL4$L! A0#%     @ 5(*85MMBT2?"
M50  .%\% !0              ( !P4X! &)M<BTR,#(R,3(S,5]P<F4N>&UL
M4$L! A0#%     @ 5(*85E5R;)4MT0, J#4> !D              ( !M:0!
M &8R,&8R,#(R7V)E86UR:6UA9VEN9RYH=&U02P$"% ,4    " !4@IA6%=E3
M7;4&  !/+   'P              @ $9=@4 9C(P9C(P,C)E>#$R+3%?8F5A
M;7)I;6%G:6YG+FAT;5!+ 0(4 Q0    ( %2"F%;I#>&!T@8  /LK   ?
M          "  0M]!0!F,C!F,C R,F5X,3(M,E]B96%M<FEM86=I;F<N:'1M
M4$L! A0#%     @ 5(*85I%5)%5T P  B0\  !\              ( !&H0%
M &8R,&8R,#(R97@Q,RTQ7V)E86UR:6UA9VEN9RYH=&U02P$"% ,4    " !4
M@IA6SB#SK&L#   P#P  'P              @ '+AP4 9C(P9C(P,C)E>#$S
M+3)?8F5A;7)I;6%G:6YG+FAT;5!+ 0(4 Q0    ( %2"F%8NB8 71!@  !6$
M   >              "  7.+!0!F,C!F,C R,F5X,BTQ7V)E86UR:6UA9VEN
M9RYH=&U02P$"% ,4    " !4@IA6)'.D$5E9 P"J:0, #0
M@ 'SHP4 :6UA9V5?,# Q+FIP9U!+ 0(4 Q0    ( %2"F%8R"/E"*O\" )L%
M P -              "  7?]" !I;6%G95\P,#(N:G!G4$L! A0#%     @
M5(*85OLD7*.6)0, 0"P#  T              ( !S/P+ &EM86=E7S P,RYJ
M<&=02P$"% ,4    " !4@IA6\:*E N1D  !?;0  #0              @ &-
M(@\ :6UA9V5?,# T+FIP9U!+ 0(4 Q0    ( %2"F%8N(T7:9BP  %@S   -
M              "  9R'#P!I;6%G95\P,#4N:G!G4$L! A0#%     @ 5(*8
M5C20^U0_*   TRX   T              ( !+;0/ &EM86=E7S P-BYJ<&=0
M2P$"% ,4    " !4@IA6!S[YAP:/  #)FP  #0              @ &7W \
M:6UA9V5?,# W+FIP9U!+ 0(4 Q0    ( %2"F%82_1>0:6\  "-\   -
M          "  <AK$ !I;6%G95\P,#@N:G!G4$L! A0#%     @ 5(*85BP)
M!I "K ( !;H"  T              ( !7-L0 &EM86=E7S P.2YJ<&=02P$"
M% ,4    " !4@IA6 [UA,DP%  #?!@  #0              @ &)AQ, :6UA
M9V5?,#$P+FIP9U!+ 0(4 Q0    ( %2"F%;D@VZNW!   ,T1   -
M      "  0"-$P!I;6%G95\P,3$N:G!G4$L%!@     6 !8 E@4   >>$P
!  $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
